<SEC-DOCUMENT>0001612630-26-000022.txt : 20260313
<SEC-HEADER>0001612630-26-000022.hdr.sgml : 20260313
<ACCEPTANCE-DATETIME>20260312193353
ACCESSION NUMBER:		0001612630-26-000022
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		95
CONFORMED PERIOD OF REPORT:	20251231
FILED AS OF DATE:		20260313
DATE AS OF CHANGE:		20260312

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			JOINT Corp
		CENTRAL INDEX KEY:			0001612630
		STANDARD INDUSTRIAL CLASSIFICATION:	PATENT OWNERS & LESSORS [6794]
		ORGANIZATION NAME:           	05 Real Estate & Construction
		EIN:				900544160
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36724
		FILM NUMBER:		26749577

	BUSINESS ADDRESS:	
		STREET 1:		16767 N PERIMETER DRIVE
		STREET 2:		SUITE 110
		CITY:			SCOTTSDALE
		STATE:			AZ
		ZIP:			85260
		BUSINESS PHONE:		480 245 5960

	MAIL ADDRESS:	
		STREET 1:		16767 N PERIMETER DRIVE
		STREET 2:		SUITE 110
		CITY:			SCOTTSDALE
		STATE:			AZ
		ZIP:			85260
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>jynt-20251231.htm
<DESCRIPTION>FORM 10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019b096a-603d-78f6-a834-c229229c770d,g:a2c624eb-8b4f-420f-a77d-d91a250e6a25,d:af8338e230dd46e38cf560e1698dc7ef-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:jynt="http://www.thejoint.com/20251231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>jynt-20251231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-33">0001612630</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-34">2025</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-35">FY</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-36">false</ix:nonNumeric><ix:nonNumeric contextRef="c-64" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="f-425">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="c-68" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="f-430">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="c-72" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="f-437">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="c-74" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="f-439">P2Y</ix:nonNumeric><ix:nonNumeric contextRef="c-18" name="us-gaap:ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="f-447">http://fasb.org/us-gaap/2025#GainLossOnSalesOfAssetsAndAssetImpairmentCharges</ix:nonNumeric><ix:nonNumeric contextRef="c-101" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="f-588">1</ix:nonNumeric><ix:nonNumeric contextRef="c-102" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="f-589">1</ix:nonNumeric><ix:nonNumeric contextRef="c-103" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="f-590">1</ix:nonNumeric><ix:nonNumeric contextRef="c-104" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="f-591">1</ix:nonNumeric><ix:nonNumeric contextRef="c-105" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="f-592">1</ix:nonNumeric><ix:nonNumeric contextRef="c-106" xsi:nil="true" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="f-593"></ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="jynt-20251231.xsd"/></ix:references><ix:resources><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="clinic"><xbrli:measure>jynt:clinic</xbrli:measure></xbrli:unit><xbrli:unit id="corporation"><xbrli:measure>jynt:corporation</xbrli:measure></xbrli:unit><xbrli:unit id="option"><xbrli:measure>jynt:option</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="installment"><xbrli:measure>jynt:installment</xbrli:measure></xbrli:unit><xbrli:unit id="lease"><xbrli:measure>jynt:lease</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>jynt:segment</xbrli:measure></xbrli:unit><xbrli:unit id="franchise"><xbrli:measure>jynt:franchise</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-03-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FranchiseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FranchiseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:AdvertisingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:AdvertisingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:TechnologyServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:TechnologyServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:FranchisedUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:FranchisedUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:FranchisedUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:FranchisedUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:FranchisedUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:EntityOperatedUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:EntityOperatedUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:EntityOperatedUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:EntityOperatedUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:EntityOperatedUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jynt:KansasAndMissouriMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:EntityOperatedUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">jynt:OperatingLeaseRightOfUseAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">jynt:OperatingLeaseRightOfUseAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:FranchiseRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:FranchiseRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">jynt:OperatingLeaseRightOfUseAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">us-gaap:FiniteLivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">jynt:DiscontinuedOperationsHeldForUseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">jynt:DiscontinuedOperationsHeldForUseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">jynt:OperatingLeaseRightOfUseAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">jynt:DiscontinuedOperationsHeldForUseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:FiniteLivedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">jynt:DiscontinuedOperationsHeldForUseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">jynt:AssetsHeldForSaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">jynt:AssetsHeldForSaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">jynt:DiscontinuedOperationsHeldForUseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">jynt:DiscontinuedOperationsHeldForUseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">jynt:OperatingLeaseRightOfUseAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">jynt:DiscontinuedOperationsHeldForUseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:FiniteLivedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2027-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2028-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2029-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2030-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2031-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">jynt:PropertyPlantAndEquipmentExcludingConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">jynt:PropertyPlantAndEquipmentExcludingConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">jynt:DiscontinuedOperationsHeldForUseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">jynt:DevelopmentLineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:A2022CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:A2022CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:A2022CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">jynt:DevelopmentLineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-28</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:A2022CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-28</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:A2022CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-28</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:A2022CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-28</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">jynt:FederalReserveBankOfNewYorkRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:A2022CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-28</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:A2022CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-06-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-11-04</xbrli:startDate><xbrli:endDate>2025-11-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">jynt:CaliforniaAlternativeMinimumTaxCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">stpr:AZ</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">stpr:AZ</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">stpr:TX</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">stpr:TX</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalTaxJurisdictionOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalTaxJurisdictionOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">jynt:EmploymentMattersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">jynt:MedicalInjuryClaimMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-25</xbrli:startDate><xbrli:endDate>2025-02-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">jynt:MedicalInjuryClaimMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:FranchiseOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:FranchiseOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FranchiseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:FranchiseOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FranchiseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:FranchiseOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:TechnologyServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:FranchiseOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:TechnologyServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:FranchiseOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jynt:BanderaPartnersLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">jynt:FranchiseLicensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">jynt:FranchiseLicensesOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">jynt:FranchiseLicensesTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">jynt:FranchiseLicensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">jynt:FranchiseLicensesOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">jynt:FranchiseLicensesTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">jynt:MrJeffersonGrammMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">jynt:FranchiseLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">jynt:UnaffiliatedFranchiseeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">jynt:MrJeffersonGrammMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">jynt:UnaffiliatedFranchiseeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">jynt:UnaffiliatedFranchiseeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">jynt:MrJeffersonGrammMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-10-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-K</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:1.979%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.821%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-4">December 31</ix:nonNumeric>, 2025</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">OR</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.972%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-5">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from _______ to ________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">001-36724</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%;text-decoration:underline">The <ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-7">Joint Corp</ix:nonNumeric>.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-8">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-9">90-0544160</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(State or Other Jurisdiction of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Incorporation)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Identification No.)</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-10">16767 North Perimeter Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-11">Suite 110</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-12">Scottsdale</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-13">Arizona</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-14">85260</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-15">480</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-16">245-5960</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.462%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Trading</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Title Of Each Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Name Of Each Exchange On Which Registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, $0.001 Par Value Per Share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">JYNT</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">The <ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" id="f-19">NASDAQ</ix:nonNumeric> Capital Market LLC</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Securities Registered Pursuant to Section 12(g) of the Act:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">None</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;Yes&#160;&#160;&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-20">No</ix:nonNumeric>&#160;&#160;&#160; &#9745;</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.&#160;&#160;Yes&#160;&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-21">No</ix:nonNumeric>&#160;&#160; &#9745;</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-22">Yes</ix:nonNumeric>&#160;&#160; &#9745;&#160;&#160;&#160;&#160;&#160;&#160;No&#160;&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-23">Yes</ix:nonNumeric>&#160;&#160; &#9745;&#160;&#160;&#160;&#160;&#160;&#160;No&#160;&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:53.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Large accelerated filer&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-24">Non-accelerated filer</ix:nonNumeric> &#9745;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="f-25">&#9745;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company <ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-26">&#9744;</ix:nonNumeric></span></div></td></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-false" id="f-27">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false" id="f-28">&#9744;</ix:nonNumeric></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#9744;</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160;&#160;Yes&#160;&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-29">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;&#160;&#160;No&#160;&#160; &#9745;</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-5" name="dei:EntityPublicFloat" scale="6" id="f-30">172.5</ix:nonFraction> million as of June 30, 2025 based on the closing sales price of the common stock on the NASDAQ Capital Market.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-31">14,114,334</ix:nonFraction> shares of the registrant&#8217;s common stock outstanding as of March&#160;9, 2026.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Documents Incorporated by Reference</span></div><ix:nonNumeric contextRef="c-1" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="f-32" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Portions of the registrant&#8217;s Proxy Statement relating to its 2026 Annual Meeting of Stockholders, filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) pursuant to Regulation&#160;14A within 120 days after the registrant&#8217;s fiscal year ended December&#160;31, 2025, are incorporated by reference in Part&#160;III of this Form&#160;10-K.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:80.305%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.711%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Numbers</span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_16">PART I</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_19">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_19">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_19">1</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_22">Item&#160;1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_22">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_22">14</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_49">Item&#160;1B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_49">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_49">26</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_52">Item&#160;1C.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_52">Cybersecurity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_52">26</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_55">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_55">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_55">27</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_58">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_58">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_58">26</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_61">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_61">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_61">27</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_64">PART II</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_67">Item&#160;5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_67">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_67">28</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_70">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_70">[Reserved]</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_73">28</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_73">Item&#160;7.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_73">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_73">28</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_109">Item 7A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_109">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_109">39</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_112">Item&#160;8.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_112">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_112">39</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_187">Item&#160;9.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_187">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_187">77</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_190">Item&#160;9A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_190">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_190">77</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_196">Item&#160;9B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_196">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_196">78</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_199">Item&#160;9C.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_199">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_199">78</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_202">PART&#160;III</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_205">Item&#160;10.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_205">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_205">78</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_208">Item&#160;11.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_208">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_208">78</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_211">Item&#160;12.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_211">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_211">78</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_214">Item&#160;13.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_214">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_214">79</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_217">Item&#160;14.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_217">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_217">79</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_220">PART IV</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_223">Item&#160;15.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_223">Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_223">79</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_229">Item&#160;16.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_229">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_229">83</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_232">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_232">84</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements and Terminology</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The information in this Annual Report on Form 10-K (this &#8220;Form 10-K&#8221;), including the discussions under the headings &#8220;Business&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; contains forward-looking statements and information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), which are subject to the &#8220;safe harbor&#8221; created by those sections. All statements, other than statements of historical facts, included or incorporated in this Form 10-K could be deemed forward-looking statements, particularly statements about our plans, strategies and prospects under the headings &#8220;Business&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; In some cases, you can identify forward-looking statements by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;intend,&#8221; &#8220;seek,&#8221; &#8220;strive,&#8221; or the negative of these terms, &#8220;mission,&#8221; &#8220;goal,&#8221; &#8220;objective,&#8221; or &#8220;strategy,&#8221; or other comparable terminology. All forward-looking statements in this Form 10-K are made based on our current expectations, forecasts, estimates and assumptions, and involve risks, uncertainties and other factors that could cause results or events to differ materially from those expressed in the forward-looking statements. In evaluating these statements, you should specifically consider various factors, uncertainties and risks that could affect our future results or operations as described from time to time in our SEC reports, including those risks outlined under &#8220;Risk Factors&#8221; in Item 1A of this Form 10-K. These factors, uncertainties and risks may cause our actual results to differ materially from any forward-looking statement set forth in this Form 10-K. You should carefully consider the trends, risks and uncertainties described below and other information in this Form 10-K and subsequent reports filed with or furnished to the SEC before making any investment decision with respect to our securities.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We undertake no obligation to update or revise publicly any forward-looking statements, other than in accordance with legal and regulatory obligations. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by this cautionary statement. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The specific forward-looking statements in this Form 10-K include the following:</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our mission to improve quality of life through routine and affordable chiropractic care and to offer quality, affordable and convenient care to our patients;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">that we seek to be the leading provider of chiropractic care in the markets we serve and to become the most recognized brand in our industry;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">that we will continue the franchise-focused expansion of chiropractic clinics in key markets throughout North America and potentially abroad; </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">that</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">we strive to accomplish our mission by making quality care readily available and affordable in a retail setting;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">that our future growth strategy will focus on accelerating the development of our franchise base through the sale of additional franchises and through the continued support of our regional developer network;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that our approach, especially our commitment to affordable pricing and our ready service delivery model, will attract existing consumers of chiropractic services and will also appeal to the growing market of consumers who seek alternative or non-invasive wellness care, but have not yet tried chiropractic;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that we are a key driver in expanding the overall market for chiropractic;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that the demand for our chiropractic services will continue to grow as a result of several additional drivers, such as the growing recognition of the benefits of regular maintenance therapy coupled with an increasing awareness of the convenience of our service and of our pricing at a significant discount to the cost of traditional chiropractic adjustments and, in most cases, at or below the level of insurance co-payment amounts;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that certain characteristics of the chiropractic industry are evidence of an underserved market with potential consumer demand that is favorable for an efficient, low-cost, consumer-oriented provider;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that most chiropractors who use a third-party reimbursement model would find it economically difficult to discount the prices they charge for their services to levels comparable with our pricing; </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that certain industry and cultural trends favor our business model;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that certain competitive strengths have contributed to our success and will continue to position us for future growth;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our intention to continue to drive awareness of our brand by continuing to locate clinics mainly at retail centers and convenience points, displaying prominent signage and employing consistent, proven and targeted marketing tools;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that the time our chiropractors save by not having to perform administrative duties related to insurance reimbursement allows more time to see more patients, establish and reinforce chiropractor/patient relationships, and educate patients on the benefits of chiropractic maintenance therapy;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that our model helps us to recruit chiropractors who want to focus their practice principally on patient care;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that our strongest competitive advantages are our convenience and affordability;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that our pricing and service offering structure helps us to generate higher usage;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that as the leader in the vertical, and as one of few players of scale, we occupy an advantageous position in an otherwise highly fragmented market;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that our geographic reach represents a competitive advantage and that we are able to remain competitive nationally when extraordinary events heavily impact specific markets;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that our management team&#8217;s experience and demonstrated success in building and operating a robust franchise system is a key driver of our growth and has positioned us well for achieving our long-term strategy;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our goal not only to capture a significant share of the existing market, but also to expand the market for chiropractic care;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our long-term growth tactics;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that the experience we have gained in developing and refining management systems, operating standards, training materials and marketing and customer acquisition activities has contributed to our system&#8217;s revenue growth;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that increasing awareness of our brand has contributed to revenue growth, particularly in markets where the number and density of our clinics has made cooperative and mass media advertising attractive;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that our ability to leverage aggregated and general media digital advertising and search tools will continue to grow as the number and density of our clinics increases;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our intention that to elevate our brand equity and drive awareness, we will strive to increase our active patient count by improving the intake process, by expanding the roll out of setting up appointments for the initial visits only, and by optimizing local clinic marketing;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our plan to lengthen the time patients stay engaged with The Joint Corp. and to reactivate lapsed patients by leveraging new content, automated messaging, and enticing promotions;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our intention to employ new media campaigns to increase our new patient leads;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our intention to transition to a pure-play franchisor business from our historical operations of both franchisor and operator of chiropractic clinics;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our focus on growing our franchise business through the strategic divestitures of all of our company-owned or managed clinics;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that to secure leadership in our industry and to maximize our opportunities in our markets, it is important to gain brand equity and consumer awareness as rapidly as possible, consistent with a disciplined approach to opening clinics; </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that continued sales of franchises in selected markets is the most effective way to drive brand awareness in the short term; </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that we were able to achieve our current scale faster by using a regional developer model, which is employed by many successful franchisors;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our plan to continue to support our franchisees and regional developers to open clinics and to achieve sustainable performance as rapidly as possible;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our expectation to drive greater efficiencies across our operations, development and marketing programs and further leverage our technology and existing support infrastructure; </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that we will be able to control corporate costs over time to enhance margins as general and administrative expenses grow at a slower rate than our clinic base and sales;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our expectation, at the clinic level, to drive margins and labor efficiencies through continued sales growth and consistently applied operating standards as our clinic base matures and the average number of patient visits increases; </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our continued consideration of introducing selected and complementary branded products such as nutraceuticals or dietary supplements and related additional services;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our expectation that the regulatory focus on privacy, security and data use issues will continue to increase and laws and regulations concerning the protection of personal information will expand and become more complex;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that our operations comply</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> with legally required standards for privacy and security of personal information to the extent applicable under federal or state law and that we strive to comply with additional standards that we identify as </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">best practices</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations of the various risks and uncertainties for our business related to potential state and federal regulations;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our expectation that other direct competitors will join our industry as our visibility, reputation and perceived advantages become more widely known;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that our first mover advantage, proprietary operations systems and potential for strong unit level economics will continue to accelerate our growth even with the spawning of additional competition;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that a strong culture of engagement and alignment is essential to the ongoing success of our business and therefore, it is important to attract, develop and retain a diverse and engaged workforce at all levels of our business;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our commitment to fostering a workplace where our employees feel aligned with our mission, proud of our culture and engaged in their work, with opportunities to grow and develop in their careers, supported by competitive compensation and benefits;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that our employees are among our most valuable resources and are critical to our continued success;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">that we strive to make The Joint the career path of choice for chiropractors, with opportunities for our chiropractors to grow and develop in their careers, supported by competitive compensation and benefits, and with our simple business model that allows our chiropractors to focus on patient care;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our plan to continue to expand and strengthen our relationship with chiropractic colleges to increase engagement with students and to increase the applicant flow of qualified candidates;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our plan to continue to utilize engagement surveys to understand the perception of our brand as an employer and the effectiveness of our employee and compensation programs and to learn where we can improve across our company;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our commitment to providing market competitive compensation and benefits;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our intention that our compensation practices are merit-based, focused on roles, responsibilities, experience and performance with no consideration given to gender, age, ethnicity or other similar factors;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our plan to re-engage the KnowBe4 system in 2026 with a heightened focus on phishing awareness;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our expectation that we will not pay cash dividends on our common stock in the foreseeable future;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our current strategy to grow through the continued sale and development of additional franchises;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our plan to refranchise or sell the full portfolio of our company-owned or managed clinics, which refined strategy will leverage our greatest strength &#8212; our capacity to build a franchise &#8212; to drive long-term growth for both our franchisees and The Joint as a public company;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our goal to generate significant proceeds that will provide us with value creating capital allocation opportunities, which opportunities could include reinvestment in the brand and related marketing, continued investment in our IT platforms, the repurchase</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> of regional developer terri</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">tories, certain merger or acquisition opportunities and/or a stock repurchase program;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our expectation that 2026 will continue to be a volatile macroeconomic environment;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that we have created a robust framework for the refranchising effort, organizing clinics into clusters, and generating comprehensive disclosure packets for marketing efficiency, and that we have received significant interest to date from our existing franchisees;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that our existing cash and cash equivalents, our anticipated cash flows from operations and amounts available under our line of credit will be sufficient to fund our anticipated operating and investment needs for at least the next 12 months;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief as of the date of this Form 10-K, that we have adequate capital resources and sufficient access to external financing sources to satisfy our current and reasonably anticipated requirements for funds to conduct our operations and meet other needs in the ordinary course of our business;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our expectation for 2026 that we will use or redeploy our cash resources to support our business within the context of prevailing market conditions, which, given the ongoing uncertainties described herein, could rapidly and materially deteriorate or otherwise change; and</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our belief that our long-term capital requirements, primarily for acquisitions and other corporate initiatives, could be dependent on our ability to access additional funds through the debt and/or equity markets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Factors that could contribute to these differences include, but are not limited to, our inability to identify and recruit enough qualified chiropractors and other personnel to staff our clinics, due in part to the nationwide labor shortage and an increase in operating expenses due to measures we may need to take to address such shortage; inflation, leading to increased labor costs and interest rates, as well as changes to import tariffs, may lead to reduced discretionary spending, all of which may negatively impact our business; our failure to profitably operate company-owned or managed clinics; our failure to refranchise as planned; short-selling strategies and negative opinions posted on the internet, which could drive down the market price of our common stock and result in class action lawsuits; our failure to remediate future material weaknesses in our internal control over financial reporting, which could negatively impact our ability to accurately report our financial results, prevent fraud, or maintain investor confidence; and other factors described in our filings with the SEC, including in the section entitled &#8220;Risk Factors&#8221; in this Form 10-K and subsequent filings with the SEC.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Additionally, there may be other risks that are otherwise described from time to time in the reports that we file with the SEC. Any forward-looking statements in this Form 10-K should be considered in light of various important factors, including the risks and uncertainties listed above, as well as others.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terminology</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As used in this Form 10-K:</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;we,&#8221;&#160;&#8220;us,&#8221; &#8220;our&#8221; and &#8220;our company&#8221; refer to The Joint Corp., its variable interest entities (&#8220;VIEs&#8221;) and its wholly owned subsidiary, The Joint Corporate Unit No. 1, LLC, collectively (&#8220;The Joint&#8221;); </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a &#8220;clinic&#8221; refers to a chiropractic clinic operating under our &#8220;Joint&#8221; brand, which may be (i) owned by a franchisee, (ii) owned by a professional corporation or limited liability company and managed by a franchisee; (iii) owned directly by us; or (iv) owned by a professional corporation or limited liability company and managed by us;</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">when we identify an &#8220;operator&#8221; of a clinic, a party that is &#8220;operating&#8221; a clinic or a party by whom a clinic is &#8220;operated,&#8221; we are referring to the party that operates all aspects of the clinic in certain jurisdictions, and to the party that manages all aspects of the clinic other than the practice of chiropractic in certain other jurisdictions; and</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;GAAP&#8221; refers to accounting principles generally accepted in the United States of America. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;I</span></div><div style="text-align:center"><span><br/></span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_19"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;&#160;&#160;BUSINESS</span></div><div style="padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#008ba2;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:100%">"</span><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Our</span><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </span><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">mission </span><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:100%">is to</span><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%"> improve</span></div><div style="text-align:center"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">quality of life </span><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:100%">through</span><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%"> routine </span><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:100%">and</span></div><div style="text-align:center"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">affordable chiropractic </span><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:100%">care."</span></div></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are a growing franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. We seek to be the leading provider of chiropractic care in the markets we serve and to become the most recognized brand in our industry. We delivered over 14.4 million patient visits in 2025, down from 14.7 million patient visits in 2024, generating over $532.4 million and $530.3 million of system-wide sales, respectively, across our highly franchised network. We will continue the franchise-focused expansion of chiropractic clinics in key markets throughout North America and potentially abroad. We strive to accomplish our mission by making quality care readily available and affordable in a retail setting. We have created a growing network of modern, consumer-friendly chiropractic clinics operated or managed by franchisees and by us that employ licensed chiropractors. Our model enables us to price our services below most competitors&#8217; pricing for similar services and below most insurance co-payment levels (i.e., below the patient co-payment required for an insurance-covered service).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Since acquiring the predecessor to our company in March 2010, we have grown our enterprise from eight to 960 clinics in operation as of December&#160;31, 2025, with an additional 82 franchise licenses sold but not yet developed across our network, and 57 letters of intent for 57 future clinic licenses. As of December&#160;31, 2025, our franchisees owned or managed 885 clinics, and we owned or managed 75 clinics. Our future growth strategy will focus on accelerating the development of our franchise base through the sale of additional franchises and through the continued support of our regional developer network. We collect a royalty of 7.0% of gross sales from franchised clinics. We remit a 3.0% royalty to our regional developers on the gross sales of franchises opened within certain regional developer protected territories. We also collect a national marketing fee of 2.0% of gross sales of all franchised clinics. We receive an initial franchise fee of $39,900 for each franchise we sell directly and offer a veterans discount, as well as a $10,000 per license discount for franchisees who purchase multiple location franchises. For each franchise sold through our network of regional developers, the regional developer typically receives up to 50% of the respective franchise fee. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November 14, 2014, we completed our initial public offering (the &#8220;IPO&#8221;) of 3,000,000 shares of common stock at an initial price to the public of $6.50 per share. Our underwriters exercised their option to purchase 450,000 additional shares of common stock to cover over-allotments on November 18, 2014. After giving effect to the over-allotment exercise, the total number of shares offered and sold in our IPO was 3,450,000 and we received aggregate net proceeds of $19.8 million. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November 25, 2015, we closed our follow-on public offering of 2,272,727 shares of common stock at a price to the public of $5.50 per share. Our underwriters exercised their option to purchase 340,909 additional shares of common stock to cover over-allotments on December 30, 2015. After giving effect to the over-allotment exercise, the total number of shares offered and sold in our follow-on public offering was 2,613,636 shares and we received aggregate net proceeds of $13.3 million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We deliver convenient, appointment-free chiropractic adjustments in an inviting, open bay environment at prices that are approximately 51% lower than the average industry cost for comparable procedures offered by traditional chiropractors, according to 2025 industry data from Chiropractic Economics. In support of our mission to offer quality, affordable and convenient care to our patients, our clinics offer a variety of customizable membership and wellness treatment plans and packages, which provide additional value pricing as compared with our single-visit pricing schedules. These flexible plans are designed to attract patients and encourage repeat visits and routine usage as part of an overall health and wellness program.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We intend to transition to a pure-play franchisor business from our historical operations of both franchisor and operator of chiropractic clinics. We are focused on growing our franchise business through the strategic divestitures of all of our company-owned or managed clinics. During the year ended December 31, 2024, we completed five clinic divestitures. During the year ended December 31, 2025, we completed 41 clinic divestitures and entered into an Asset Purchase Agreement for the sale of 22 additional clinics, which represents a major milestone of our strategic shift to a pure-play franchisor business and our financial statements now reflect our previous company-owned or managed clinic segment as discontinued operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2025, we had 960 franchised or company-owned or managed clinics in operation in 43 states. The map below shows the states in which we or our franchisees manage or operate clinics and the number of clinics open in each state as of December&#160;31, 2025.</span></div><div style="margin-top:12pt;text-align:justify"><img src="jynt-20251231_g1.jpg" alt="CLINIC-MAP-FOR-DECKS_Updated-5.13.56&#8239;PM.jpg" style="height:446px;margin-bottom:5pt;vertical-align:text-bottom;width:720px" id="i-1"/></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our retail locations have been selected to be visible, accessible and convenient. We offer a welcoming, consumer-friendly experience that attempts to redefine the chiropractic doctor/patient relationship. Our clinics are open longer hours than many of our competitors, including weekend days, and our patients do not need appointments. We accept cash or major credit cards in return for our services. We do not accept insurance and do not provide Medicare covered services. We believe that our approach, especially our commitment to affordable pricing and our ready service delivery model, will attract existing consumers of chiropractic services and will also appeal to the growing market of consumers who seek alternative or non-invasive wellness care, but have not yet tried chiropractic. According to our patient survey conducted in 2024 by WestGroup Research, 36% of our new patients had never tried chiropractic care before they came to The Joint. This is also an increase from 16% from the same survey in 2013, demonstrating our continued impact on the chiropractic market and offering validation to our thesis that we are a key driver in expanding the overall market for chiropractic.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our patients arrive at our clinics without appointments at times convenient to their schedules. Once a patient has joined our system and is returning for treatment, they simply swipe their membership card at a card reader at the reception desk or check in using the official mobile app to announce their arrival. The patient is then escorted to our open adjustment area, where they are required to remove only their outerwear to receive their adjustment. Each patient&#8217;s records are digitally updated for retrieval in our proprietary data storage system by our chiropractors in compliance with all applicable medical records security and privacy regulations. The adjustment process, administered by a licensed chiropractor, takes approximately 15 to 20 minutes on average for a new patient and five to seven minutes on average for a returning patient.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our consumer-focused service model targets the non-acute treatment market, which is part of the $21.9 billion chiropractic services market, according to an IBIS market research report in October 2025. As our model does not focus on the treatment of severe or acute injury, we do not provide expensive and invasive diagnostic tools such as MRIs and X-rays. Instead, we refer those with severe or acute symptoms to alternate healthcare providers, including traditional chiropractors.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Our Industry</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Chiropractic care is widely accepted among individuals with a variety of medical conditions, particularly back pain. A 2018 Gallup report commissioned by Palmer College of Chiropractic shows that among all U.S. adults, including those who did not have neck or back pain, 16% went to a chiropractor in the last 12 months. These numbers represent a marked increase over the 2012 National Health Interview Survey that measured chiropractic use at 8% of the population. According to the American Chiropractic Association, 80% of Americans experience back pain at least once in their lifetime. According to the same 2018 Gallup report commissioned by the Palmer College of Chiropractic, eight in 10 adults in the United States (80%) prefer to see a health care professional who is an expert in spine-related conditions for neck or back pain care instead of a general medicine professional who treats a variety of conditions (15%).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Chiropractic care is increasingly recognized as an effective treatment for pain and potentially for a variety of other conditions. The American College of Physicians (the &#8220;ACP&#8221;) now recommends non-drug therapy such as spinal manipulation as a first line of treatment for patients with chronic low-back pain. The ACP states that treatments such as spinal manipulation are shown to improve symptoms with little risk of harm. The National Center for Complementary and Integrative Health of the National Institutes of Health has stated that spinal manipulation appears to benefit some people with low-back pain and also may be helpful for headaches, neck pain, upper- and lower-extremity joint conditions and whiplash-associated disorders. The Mayo Clinic has recognized chiropractic as safe when performed by trained and licensed chiropractors, calling out research that shows spinal manipulation works to treat certain types of lower back and neck pain. The Cleveland Clinic has stated that chiropractors are established members of the mainstream medical team with chiropractic adjustments being an effective treatment option for all ages and the most common alternative treatment option in the United States.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The chiropractic industry in the United States is large and highly fragmented. An article appearing in the Journal of the American Medical Association entitled &#8220;US Healthcare Spending by Payer and Health Condition, 1996-2016&#8221; estimates that $134 billion was spent in 2016 on back pain in the United States. According to a report issued by IBIS World Chiropractors Market Research in October 2025, expenditures for chiropractic services in the U.S. are approximately $21.9 billion annually. The United States Bureau of Labor Statistics expects employment of chiropractors to grow 10% from 2023 to 2033, much faster than the average for all occupations. Some of the factors that the Bureau of Labor Statistics identified as driving this growth are rising interest in integrative or complementary healthcare, which has led to more acceptance of chiropractic treatment of the back, neck, limbs, and involved joints; an aging population (specifically the continued aging of the large baby boomer generation) requiring more health care and technological advances; and the need to replace workers who exit the labor force through retirement. We believe that the demand for our chiropractic services will continue to grow as a result of several additional drivers, such as the growing recognition of the benefits of regular maintenance therapy coupled with an increasing awareness of the convenience of our service and of our pricing at a significant discount to the cost of traditional chiropractic adjustments and, in most cases, at or below the level of insurance co-payment amounts.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Today, most chiropractic services are provided by sole practitioners, generally in medical office settings. The chiropractic industry differs from the broader healthcare services industry in that it is more heavily consumer-driven, market-responsive and price sensitive, in large measure a result of many treatment options falling outside the bounds of traditional insurance reimbursable services and fee schedules. According to the October 2025 IBIS market research report, no single company accounts for more than 5% of the total industry market share. We believe these characteristics are evidence of an underserved market with potential consumer demand that is favorable for an efficient, low-cost, consumer-oriented provider.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Most chiropractic practices are set up to accept and to process insurance-based reimbursement. While chiropractors typically accept cash payment in addition to insurance, Medicare and Medicaid, they continue to incur overhead expenses associated with maintaining the capability to process third-party reimbursement. We believe that most chiropractors who use this third-party reimbursement model would find it economically difficult to discount the prices they charge for their services to levels comparable to our pricing.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, we believe these and certain other trends favor our business model. Among these are:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">People, most notably Millennials &#8211; the largest portion of our patient base &#8211; have increasingly active lifestyles and are expected to live longer, requiring more medical, maintenance and preventative support;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As people age, there is increasing focus on longevity and health, with emphasis on mobility cognition, independence and quality of life;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">People are increasingly open to alternative, non-pharmacological types of care;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Utilization of more conveniently situated, local-sited urgent-care or &#8220;mini-care&#8221; alternatives to primary care is increasing; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Popularity of health clubs, massage and other non-drug, non-invasive wellness maintenance providers is growing.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Our Competitive Strengths</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We believe the following competitive strengths have contributed to our success and will continue to position us for future growth:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail, consumer-driven approach</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;To support our consumer-focused model, we use strong, recognizable retail approaches to stimulate brand-awareness and attract patients to our clinics. We intend to continue to drive awareness of our brand by continuing to locate clinics mainly at retail centers and convenience points, displaying prominent signage and employing consistent, proven and targeted marketing tools. We offer our patients the flexibility to visit our clinics without an appointment where they will receive prompt attention. Additionally, most of our clinics offer extended hours of operation, including weekends, which is not typical among our competitors.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We attracted an average of 827 new patients per clinic (for all clinics open for the full 12 months of 2025) during the year ended December&#160;31, 2025, as compared to the most recent chiropractic industry average of 364 new patients per year for traditional insurance-based non-multidisciplinary or integrated practices, according to a 2025 Chiropractic Economics survey (published in June 2025).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quality, empathetic service</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;Across our system we have a community of more than 2,500 fully licensed chiropractic doctors, who performed approximately 14.4 million adjustments in 2025 alone. Our doctors provide personal and intuitive patient care focused on pain relief and ongoing wellness to promote healthy, active lifestyles. We provide our doctors with one-on-one training, as well as ongoing coaching and mentoring. Our doctors continually refine their skills, as our clinics see an average of 291 patient visits per week (for clinics open for the full 12 months of 2025), as compared to the most recent chiropractic industry average of 138 patients per week for non-multidisciplinary or integrated practices, according to the same 2025 Chiropractic Economics survey referred to above. Our service offerings encourage consumer trial, repeat visits and sustainable patient relationships.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">By eliminating the administrative burdens of insurance processing, our model helps chiropractors focus on patient service. We believe the time our chiropractors save by not having to perform administrative duties related to insurance reimbursement allows more time to see more patients, establish and reinforce chiropractor/patient relationships, and educate patients on the benefits of chiropractic maintenance therapy.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our approach has made us an attractive alternative for chiropractic doctors who want to spend more time treating patients than they typically do in traditional practices, which are burdened with greater overhead, personnel and administrative expense. We believe that our model helps us to recruit chiropractors who want to focus their practice principally on patient care.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accessibility</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">.&#160;We believe that our strongest competitive advantages are our convenience and affordability. By focusing on non-acute care in an open-bay environment and by not participating in insurance or Medicare reimbursement, we are able to offer a much less expensive alternative to traditional chiropractic services. We can do this because our clinics do not have the expenses of performing certain diagnostic procedures and processing reimbursement claims. Our model allows us to pass these savings on to our patients. According to Chiropractic Economics, published in September 2024, the average fee for a chiropractic treatment involving spinal manipulation in a cash-based practice in the United States is approximately $76. By comparison, our average fee as of December&#160;31, 2025 was approximately $37, approximately 51% lower than the industry average price.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We believe our pricing and service offering structure helps us to generate higher usage. The following table sets forth our average price per adjustment as of December&#160;31, 2025 for patients who pay by single adjustment plans, multiple adjustment packages and multiple adjustment membership plans. Our price per adjustment as of December&#160;31, 2025 averaged approximately $37 across all three groups.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">The Joint Service Offering</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Single Visit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Package(s)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Membership(s)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Price per adjustment</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$55</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$21&#8212;$37</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$17&#8212;$25</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Proven track record of opening clinics and growing revenue at the clinic level. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We have grown our clinic revenue base consistently. From January 2012 through December&#160;31, 2025, we have increased the annual system-wide sales from $22.3 million to $532.4 million (which is a non-GAAP financial measure for the year ended December&#160;31, 2025). During this period, we increased the number of clinics in operation from 33 to 960. Please see Part II, Item 7 &#8211; Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations &#8211; Overview &#8211; Key Performance Measures for a description of system-wide sales as a non-GAAP financial measure.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We continue to be encouraged by the ability of individual clinics to generate growth. While there is significant variation in results in our system, and the results of our top-performing clinics are not representative of our system overall, we believe it is worth noting that in January 2012, the highest-performing clinic in our system was a franchised clinic that had monthly sales of approximately $45 thousand and in December 2025, the highest performing clinic in our system was a franchised clinic that had monthly sales of approximately $165 thousand.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Market leading position with significant nationwide scale</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. We are the largest chiropractic franchisor in the United States with over 960 clinics operating across the United States. Our chiropractic brand is approximately six times larger than the next largest chiropractic chain, as of December 2025. As the leader in this vertical, and as one of few players of scale, we believe that we occupy an advantageous position in an otherwise highly fragmented market. In conjunction with our scale, we have been able to achieve broad geographic diversification across the United States with clinics in 43 states as of December 2025. Our geographic reach represents a competitive advantage, as we have demonstrated success across various markets, and we are able to remain competitive nationally when extraordinary events heavily impact specific markets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Strong and proven management team</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. Our strategic vision is directed by our President and Chief Executive Officer, Sanjiv Razdan. Mr. Razdan has served as our President and Chief Executive Officer and as a director since October 2024. Prior to his employment with us, he served as the President, Americas &amp; India for International Coffee &amp; Tea, LLC d/b/a The Coffee Bean &amp; Tea Leaf from March 2021 until May 2024. The Coffee Bean &amp; Tea Leaf is a global specialty coffee and tea house operating approximately 1,200 cafes throughout 30 countries. From April 2018 to June 2020, Mr. Razdan served as the Chief Operating Officer of Sweetgreen, Inc., which is a public company in the food service industry operating more than 230 locations across multiple states. Mr. Razdan also served as the Senior Vice President and Chief Operations Officer of Applebee&#8217;s Neighborhood Grill &amp; Bar, a division of the public company Dine Brands Global, Inc., from November 2014 to September 2017. Applebee&#8217;s Neighborhood Grill &amp; Bar is the world&#8217;s largest casual dining restaurant chain, with $4.5 billion in system sales at the time of his employment. In addition, Mr. Razdan served in various positions at the public company, Yum! Brands, Inc., from June 1995 to October 2014, including most recently as the Country General Manager for India from October 2011 to October 2014. Mr. Razdan&#8217;s executive leadership team includes the following individuals:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Scott J. Bowman has served as our Chief Financial Officer since June 2025. Mr. Bowman is a seasoned executive and three-time public company Chief Financial Officer with more than 30 years of experience across retail, restaurant, consumer goods, and manufacturing industries. He served as Chief Financial Officer at Leslie&#8217;s Inc., a $1.5 billion publicly traded pool supply retailer from 2023 to 2025; at True Food Kitchen, a $270 million privately held restaurant company rooted in nutritional science, from 2021 to 2023; at Dave &amp; Buster&#8217;s, a $1.4 billion publicly traded dining and entertainment company, from 2019 to 2021; and at Hibbett Sports, a $1 billion publicly traded athletic specialty retailer that was subsequently acquired by JD Sports, from 2012 to 2019. Prior to that for over two decades, he worked in a series of roles with increasing responsibilities in the finance and accounting departments at The Home Depot, divisions of Newell Rubbermaid, and The Sherwin-Williams Company. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Charles Nelles joined us as our Chief Technology Officer in January 2022, bringing more than 20 years of technology experience in the healthcare and financial services industries. Prior to working at our company, Mr. Nelles held the role of the Vice President of Technology for American Express Global Business Travel. Prior to that, he served as the Vice President of Technical Operations Support and Cloud Enablement for Western Union.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Debbie Gonzalez has served as our Chief Marketing Officer since October 2025. Ms. Gonzalez is an experienced Chief Marketing Officer and board director known for building brands, modernizing go-to-market engines, and elevating customer experience with data, analytics, and artificial intelligence. Most recently, she was the Chief Marketing Officer/Senior Vice President of Global Marketing and Communications at Concentrix, a Fortune 500 company, where she led a global team across corporate and employer branding, performance marketing, digital, public relations/communications, and creative. Previously, she was the Chief Brand/Marketing Officer at Massage Envy Franchising, where she repositioned the business to a Total Body Care wellness platform, centralized performance marketing and digital, lifted brand awareness, and improved reputation ratings. Ms. Gonzalez also operated her own consultancy for multi-site consumer services, restaurant, and franchise brands. Early in her career, she held product leadership roles at PetSmart, Herman Miller and Gerber. She currently serves on the board of El Pollo Loco, chairing the Compensation and sitting on the Nominating and Governance Committees.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Beth Gross has served as our Senior Vice President, Human Resources since September 2024 and has over two decades of experience in human resources. Most recently, Ms. Gross held the role of Vice President of Human Resources at Spear Education, a private equity-owned dental education organization based in Scottsdale, Arizona. She owned all aspects of organizational development and evolution, including talent acquisition strategy and execution, and established and led the employer branding strategy. Under her guidance, Spear Education was a five-time "Top Companies to Work For in AZ" selection.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Craig Sherwood has served as our Senior Vice President, Development since March 2025. Mr. Sherwood brings over 25 years of executive leadership experience in global franchise development in both the fitness and QSR industries. Most recently, he served as the Chief Development Officer at Lumin Fitness, an AI-powered fitness start-up. Mr. Sherwood also served as the Chief Development Officer at Gold&#8217;s Gym International, where he revitalized global franchising and drove record breaking expansion. His career also includes leadership roles at Wingstop, Little Caesars, Sonic Corp., and Yum! Brands.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Andra Terrell has served as our Senior Vice President, Legal since May 2025. Ms. Terrell most recently served as Senior Assistant General Counsel at Franchise World Headquarters (Subway), where she closed the sale of Subway to Roark Capital, the largest whole business securitization on record and a significant refinancing. Prior to that, she served as the SVP, General Counsel and Corporate Secretary at Regis Corporation, and as the VP, Deputy General Counsel and Assistant Secretary at Cajun Operating Company. She also held legal roles at Luxottica Retail North America, GNC Franchising and Decorating Den Systems.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Ron Stilwell has served as our Senior Vice President, Operations and Patient Experience since January 2026. Mr. Stilwell most recently served as President and Chief Development Officer of FullSpeed Automotive, a prominent automotive aftermarket conglomerate that operates and franchises quick oil change and service centers where he was responsible for the operational excellence and strategic growth initiatives for flagship brands such as Grease Monkey, SpeeDee Oil Change, and Kwik Kar Automotive. From 2018 to 2021, Mr. Stilwell was Vice President and Chief Development Officer of Marco&#8217;s Pizza, which he helped position as a top franchise brand known for industry-leading growth and operational excellence. From 2007 through 2009, Mr. Stilwell served as SVP and Brand President for Kahala Brands, a diverse portfolio of nationally and internationally acclaimed quick-service restaurant franchise brands. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Steven Knauf, D.C. was promoted to our Vice President of Chiropractic and Compliance in 2022. Dr. Knauf began working at our company in 2011. After spending four years as a chiropractor in one of the clinics, he took the role of Senior Doctor of Chiropractic for 13 company-owned clinics and, subsequently, he was elevated to a director position at the corporate office. In August 2017, he was appointed by the governor to serve on the Arizona Board of Chiropractic Examiners, where he served for six years. He is an active member of both the International Chiropractors Association and the American Chiropractic Association.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our management team&#8217;s experience and demonstrated success in building and operating a robust franchise system is a key driver of our growth and has positioned us well for achieving our long-term strategy. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Our Growth Strategy</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our goal is not only to capture a significant share of the existing market but also to expand the market for chiropractic care. We are accomplishing this through the geographic expansion of our affordable franchising program and the continued support of our regional developer network. Accordingly, our long-term growth tactics include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the continued growth of system sales through the increased attraction and retention of patients;&#160;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the increase in royalty income through the acceleration of the opening of clinics already in development, the sale of additional franchises and the refranchising of our remaining company-owned or managed clinics; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">improving operational margins and expanding additional revenue streams within our clinics.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Continued Growth of System Sales</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">System-wide same-store sales (&#8220;Comp Sales&#8221;) for 2025 increased by $2.1 million but were flat on a percentage basis, reflecting the continued resilience of our business model. Comp Sales include the sales from both company-owned or managed clinics and franchised clinics that in each case have been open at least 13 full months and exclude any clinics that have closed. We believe that the experience we have gained in developing and refining management systems, operating standards, training materials and marketing and customer acquisition activities has contributed to our system&#8217;s revenue growth. In addition, we believe that increasing awareness of our brand has contributed to revenue growth, particularly in markets where the number and density of our clinics has made cooperative and mass media advertising attractive. We believe that our ability to leverage aggregated and general media digital advertising and search tools will continue to grow as the number and density of our clinics increases.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">To elevate our brand equity and drive awareness, we will strive to increase our active patient count by improving the intake process, by expanding the roll out of setting up appointments for the initial visits only, and by optimizing local clinic marketing. We plan to lengthen the time patients stay engaged with The Joint and to reactivate lapsed patients by leveraging new content, automated messaging, and enticing promotions. Additionally, we intend to employ new media campaigns and tactics to increase our new patient leads.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executing Strategic Divestitures</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In 2024, we made the strategic decision to transition to a pure-play franchisor business from our historical operations of both franchisor and operator of chiropractic clinics. During the year ended December 31, 2024, we completed five clinic divestitures. During the year ended December 31, 2025, we completed 41 clinic divestitures and entered into an Asset Purchase Agreement for the sale of 22 additional clinics, which represents a major milestone of our strategic shift to a pure-play franchisor business. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling Additional Franchises</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We will continue to sell franchises. We believe that to secure leadership in our industry and to maximize our opportunities in our markets, it is important to gain brand equity and consumer awareness as rapidly as possible, consistent with a disciplined approach to opening clinics. We believe that continued sales of franchises in selected markets is the most effective way to drive brand awareness in the short term. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we were able to achieve our current scale faster by using a regional developer model, which is employed by many successful franchisors. We sell a regional developer the rights to open a minimum number of clinics in a defined territory. They in turn help us to identify and qualify potential new franchisees in that territory and assist us in providing field training, clinic openings and ongoing support. In return, we share part of the initial franchise fee and pay the regional developer 3% of the 7% ongoing royalties we collect from the franchisees in their protected territory. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opening Clinics in Development</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our 960 operating clinics as of December&#160;31, 2025, we have granted franchises, either directly or with our regional developers&#8217; support, for an additional 82 clinics that we believe will be developed in the future and executed letters of intent for 57 future clinic licenses. We will continue to support our franchisees and regional developers to open these clinics and to achieve sustainable performance as rapidly as possible.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Continuing to Improve Margins</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As we continue to grow, we expect to drive greater efficiencies across our operations, development and marketing programs and further leverage our technology and existing support infrastructure. We believe we will be able to control corporate costs over time to enhance margins as general and administrative expenses grow at a slower rate than our clinic base and sales. At the clinic level, we expect to drive margins and labor efficiencies through continued sales growth and consistently applied operating standards as our clinic base matures and the average number of patient visits increases. In addition, we continue to consider introducing selected and complementary branded products such as nutraceuticals or dietary supplements and related additional services.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Environment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">HIPAA and State Privacy and Breach Notification Rules</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Numerous federal and state laws, regulations, standards and other legal obligations govern the collection, dissemination, use, access to, confidentiality, security and processing of personal information, including cybersecurity breach notification and targeted advertising. For example, the Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;) imposes extensive privacy and security requirements governing the transmission, use and disclosure of health information by covered entities in the healthcare industry. While we have determined that we are not a &#8220;covered entity&#8221; and thus do not currently fall under the purview of HIPAA, we may have access to sensitive data regarding our patients, and we recognize that some of the standards established by HIPAA represent &#8220;best practices&#8221; for our business.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Even when entities are not covered by HIPAA, the Federal Trade Commission (the &#8220;FTC&#8221;) has taken the position that a failure to take appropriate steps to keep consumers&#8217; personal information secure may constitute unfair acts or practices in or affecting commerce in violation of the Federal Trade Commission Act. The FTC expects a company&#8217;s data security measures to be reasonable and appropriate in light of the sensitivity and volume of consumer information it holds, the size and complexity of its business, and the cost of available tools to improve security and reduce vulnerabilities. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The California Consumer Privacy Act of 2018 (the &#8220;CCPA&#8221;) creates individual privacy rights for California consumers and increases the privacy and security obligations of entities handling certain personal information. The CCPA regime</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">became more complex as of January 1, 2023, pursuant to amendments adopted pursuant to the California Privacy Rights Act (the &#8220;CPRA&#8221;). The CPRA imposes additional data protection obligations on covered businesses, including additional consumer rights processes, limitations on data uses, new audit requirements for higher risk data, and opt outs for certain uses of sensitive data. The CPRA also creates a new California data protection agency to implement and enforce the CCPA and the CPRA, which could result in increased privacy and information </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">security enforcement. The CCPA has prompted a number of proposals for new privacy legislation. A new Virginia privacy law, the Virginia Consumer Data Protection Act (&#8220;VCDPA&#8221;), and a new Colorado law, the Colorado Privacy Act (&#8220;CPA&#8221;), impose many similar obligations regarding the processing and storing of personal information as the CCPA and the CPRA. Other states have enacted or are considering enacting privacy laws. All 50 states and the District of Columbia have adopted some form of breach notification laws, requiring businesses to notify individuals of security breaches of personal information.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We expect that the regulatory focus on privacy, security and data use issues will continue to increase and laws and regulations concerning the protection of personal information will expand and become more complex. Such new privacy laws add additional requirements, restrictions and potential legal risk and require additional investment in resources for compliance programs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our operations comply with legally required standards for privacy and security of personal information to the extent applicable under federal or state law, and we strive to comply with additional standards that we identify as &#8220;best practices.&#8221; Such ongoing compliance involves significant time, effort and expense.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Despite the security measures we have in place to ensure compliance with applicable laws and rules, our facilities and systems, and those of our third-party service providers, may be vulnerable to security breaches, acts of cyber terrorism, vandalism or theft, computer viruses, misplaced or lost data, programming and/or human errors or other similar events. For example, in November 2022, one of our marketing vendors notified us that it had suffered a data breach that resulted in the release of certain information (names, email addresses, physical addresses consisting of city state, and zip codes, phone numbers and birthdates) of many of our patients and employees. The vendor further notified us that the information that had been released did not include credit card or bank account numbers, social security numbers or similar sensitive personal information. In addition, our vendor reported that they had quickly identified the source of the breach and rectified the situation, preventing the disclosure of additional information. We believe that a very limited number of affected individuals (all of whom had thejoint.com domain email address, with the exception of one) received ransom demands. Upon learning the details of the breach, we immediately embarked on an investigation and retained outside legal counsel to provide guidance with respect to any applicable legal obligations. Based on our investigation and the legal guidance we received, it was determined that the breach did not result in the release of &#8220;personal information,&#8221; as defined in the relevant data breach notification laws of all but two states. With respect to those two states, on or about May 1, 2023, counsel for The Joint Corp. delivered notices to the respective state Offices of the Attorneys General in compliance with state disclosure regulations. As of the current date, neither state has issued a response. Upon receipt of the root cause analysis from the vendors, we followed up with its leadership team to ensure that the specific breach had been remediated and to confirm that related processes and practices for future data protection had been updated. Based upon our investigation, we believe that the data breach did not have a material adverse effect on our business or result in any material damage to us. Furthermore, we are entitled to indemnification under the contract with the vendor for costs we incurred in addressing the data breach, including any costs with respect to breach notification.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State Regulations on Corporate Practice of Chiropractic </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In states that regulate the &#8220;corporate practice of chiropractic,&#8221; chiropractic services are provided solely by legal entities organized under state laws as professional corporations (&#8220;PCs&#8221;) or their equivalents. Each of the PCs in our system is wholly owned by one or more licensed chiropractors and employs or contracts with chiropractors in one or more offices. We do not own any capital stock of (or have any other ownership interest in) any such PC. We and our franchisees that are not owned by chiropractors enter into management services agreements with PCs to provide the PCs on an exclusive basis with all non-clinical administrative services needed by the chiropractic practice.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the State of Washington Chiropractic Quality Assurance Commission delivered notices that it was investigating complaints made against three chiropractors who own clinics, or are (or were) employed by clinics, in Washington. These clinics receive management services from our franchisees that are not owned by chiropractors. The notices contained allegations of fee-splitting, specifically targeting a provision in our Franchise Disclosure Document (&#8220;FDD&#8221;) providing for the payment of royalty fees based on revenue derived from the furnishing of chiropractic care. The notices appeared to question our business model. The Commission posed a number of questions to the chiropractors and requested documentation describing the fee structure and related matters. All three chiropractors responded to the Commission, and the Commission has since closed the investigations with respect to two of the chiropractors, finding that the evidence did not support any claim of violation. It appears that the investigation with respect to the third chiropractor has either been closed or gone dormant. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In February 2019, a bill was introduced in the Arkansas state legislature prohibiting the ownership and management of a chiropractic corporation by a non-chiropractor. The bill was drafted by the Arkansas State Board of Chiropractic Examiners. This bill has since been withdrawn. While it is questionable whether the prohibition would have been applicable to our business model in Arkansas, the bill could have been interpreted to challenge that model if it had passed in its proposed form. We have no assurance that another bill posing a similar or greater challenge to our business model will not be introduced in the future. Previously, in 2015, the Arkansas </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Board had questioned whether our business model might violate Arkansas law in its response to an inquiry we made on behalf of one of our franchisees. While the Arkansas Board did not thereafter pursue the matter of a possible violation, it might choose to do so at any time in the future.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In February 2019, the North Carolina Board of Chiropractic Examiners delivered notices alleging certain violations to sixteen chiropractors working for clinics in North Carolina for which our franchisees that are not owned by chiropractors provide management services. We retained legal counsel in this matter, and a preliminary hearing was conducted on February 21, 2019. The North Carolina Board issued its findings to each of the individual chiropractors, which generally included an overall finding that probable cause existed to show that the chiropractors violated one or more of the North Carolina Board&#8217;s rules. The findings each also proposed an Informal Settlement Agreement in lieu of proceeding to a full hearing before the North Carolina Board. On April 22, 2019, each of the chiropractors, through their attorneys, delivered to the North Carolina Board notices refuting the North Carolina Board&#8217;s findings and seeking revisions to the Settlement Agreement. The North Carolina Board replied with certain counterproposals, and all chiropractors have since accepted the terms. While the allegations consisted primarily of quality of care and advertising issues, it is possible that the actions of the North Carolina Board arose out of concerns related to our business model, and if so, we have no assurance that the North Carolina Board will not pursue other claims against the chiropractors in the future.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, the Oregon Board of Chiropractic Examiners adopted changes to its rules to prohibit a chiropractor from owning or operating a chiropractic practice as a surrogate for a non-chiropractor. As in the case of the proposed Arkansas bill, it is questionable whether this prohibition is applicable to our business model in Oregon; however, depending upon how the amended rules are interpreted, they could similarly pose a threat. Since our franchisees began operating in Oregon, the Oregon Board has made several inquiries with respect to our business model. We have typically satisfied these inquiries by providing a brief response or documentation. In February 2018, the Oregon Board asked us for clarification regarding ownership of our franchise locations operating in Oregon, and we responded with the requested clarification. The Oregon Board has not taken any further action, but we have no assurance that it will not do so in the future or that we have satisfied the Oregon Board&#8217;s concerns. One of our franchisees received a letter from the Oregon Board alleging a violation of the rules against the corporate practice of chiropractic, but after a further exchange of correspondence with the franchisee, the Oregon Board notified the franchisee in August 2018 that the case was closed.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2015, the California Board of Chiropractic Examiners commenced an administrative proceeding to which we were not a party, in which it claimed that the doctor who owns the PC that we manage in southern California violated California&#8217;s prohibition on the corporate practice of chiropractic, among other claims, because our management of the clinics operated by his PC involved the exercise of control over certain clinical aspects of his practice. The claims were subsequently dismissed congruent with the decision of the administrative law judge who conducted the proceeding; however, we cannot assure you that similar claims will not be made in the future, either against us or our affiliated PCs.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In a June 2015 Assurance of Discontinuance with the New York Attorney General, Aspen Dental Management, a provider of business support services to independently owned dental practices, agreed to settle claims that it improperly made business decisions impacting clinical matters, illegally engaged in fee-splitting with dental practices and required the dental practices to use the &#8220;Aspen Dental&#8221; trade name in a manner that had the potential to mislead consumers into believing that the &#8220;Aspen Dental&#8221;- branded offices were under common ownership with the provider. Pursuant to the settlement, Aspen Dental paid a substantial fine and agreed to change its business and branding practices, including changes to its website and marketing materials in order to make clear that the Aspen-branded dental offices were independently owned and operated. While it has not done so to date, we cannot assure you that the New York Attorney General will not similarly choose to challenge our contractual relationships with our affiliated PCs in New York and, in particular, to question whether use of The Joint trademark by our affiliated PCs misleads consumers, causing them to incorrectly conclude that we are the provider of chiropractic treatment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Kansas Healing Arts Board, in response to a third-party complaint about one of our franchisees, sent a letter to the franchisee in February 2015 questioning whether the franchise business model might violate Kansas law regarding the unauthorized practice of chiropractic care. At the time, we and the franchisee had several communications with the Kansas Healing Arts Board with respect to modifying the management agreement to address its concerns. While we have had no further communications with the Kansas Healing Arts Board since that time, we have also received no assurance that changes to the agreement satisfied all of its concerns, and thus we cannot assure you that similar claims will not be made in the future, either against us or our affiliated PCs.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">While the effect of the Arkansas bill if passed, the Oregon rules changes, and the proceedings in Washington, North Carolina, California, New York and Kansas may be that our business practices in those states are under stricter scrutiny than elsewhere, we believe we are in substantial compliance with all applicable laws relating to the corporate practice of chiropractic.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Please see the risk factor in Item 1A for additional discussion of the &#8220;Risks Related to State Regulation of the Corporate Practice of Chiropractic&#8221; as they relate to our business model.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulation Relating to Franchising</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the rules and regulations of the FTC and various state laws regulating the offer and sale of franchises. The FTC and various state laws require that we furnish an FDD containing certain information to prospective franchisees, and a number of states require registration of the FDD at least annually with state authorities. Included in the information required to be disclosed in our FDD is our business experience, material litigation, all fees due to us from franchisees, a franchisee&#8217;s estimated initial investment, restrictions on sources of products and services we impose on franchisees, development and operating obligations of franchisees, whether we provide financing to franchisees, our training and support obligations and other terms and conditions of our franchise agreement. We are operating under exemptions from registration in several states based on our qualifications for exemption as set forth in those states&#8217; laws. As of December&#160;31, 2025, we were registered to sell franchises in every state (where registrations are required) except for Wyoming, North and South Dakota and could sell franchises in 47 of all 50 states.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Substantive state laws regulating the franchisor-franchisee relationship presently exist in many states. State laws often limit, among other things, the duration and scope of non-competition provisions and the ability of a franchisor to terminate or refuse to renew a franchise. A policy from the North American Securities Administrators Association, Inc. (&#8220;NASAA&#8221;) rejects the use of required representations or waivers of claims by franchisees in franchise agreements for the purpose of insulating a franchisor from liability in disputes related to alleged fraud or misrepresentations during the offer and sale of a franchise. Although NASAA has no legal authority to prohibit such provisions, it is likely that state regulators will follow NASAA&#8217;s guidance and limit their use, as California has already done.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Franchisors risk exposure to unfair trade practice claims by state regulators if they try to use a franchisee&#8217;s representations in a manner that offends NASAA&#8217;s policy. The use of such offending representations also could increase the likelihood of successful lawsuits against franchisors by franchisees over claims of fraud or misrepresentation. Bills also have been introduced in Congress from time to time providing for protection of franchisee rights, including certain currently pending bills seeking to establish what are described as fair franchise practices. Compliance with new, complex and changing laws may cause our expenses to increase, and non-compliance with such laws could result in penalties or enforcement actions against us. However, we believe that our FDD and franchising procedures currently comply in all material respects with both the FTC guidelines and all applicable state laws regulating franchising in those states in which we have offered franchises. As those guidelines and laws change, we will revise our FDD and franchising procedures accordingly.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Other Federal, State and Local Regulation</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to varied federal regulations affecting the operation of our business. We are subject to the U.S. Fair Labor Standards Act (the &#8220;FLSA&#8221;), the U.S. Immigration Reform and Control Act of 1986, the Occupational Safety and Health Act, Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act of 1990 and various other federal and state laws governing such matters as minimum wage requirements, overtime, fringe benefits, workplace safety and other working conditions and citizenship requirements. A significant number of our clinic service personnel are paid at rates related to the applicable minimum wage, and increases in the minimum wage are likely to increase our labor costs. As of January 1, 2026, the minimum wage increased in a number of states, the District of Columbia and local municipalities, with many of these wage increases triggered automatically by increases in the cost of living due to high inflation. Many of our smaller franchisees qualify for exemption from the requirement to either provide health insurance benefits or pay a penalty to the IRS if not provided because of their small number of employees. The imposition of any requirement that we or our franchisees provide health insurance benefits to our or their employees that are more extensive than the health insurance benefits that we currently provide to our employees or that franchisees may or may not provide, or the imposition of additional employer paid employment taxes on income earned by our employees, could have an adverse effect on our results of operations and financial position. Our distributors and suppliers also may be affected by higher minimum wage and benefit standards, which could result in higher costs for goods and services supplied to us.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Joint Employer Rules</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Significance of Joint Employer Rules for our Business Model. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The replacement or withdrawal of the National Labor Relations Act (the &#8220;NLRA&#8221;) and FLSA rules or new standards under federal and state discrimination statue (such as Title VII), which include or reinstate expansive definitions of &#8220;joint employer,&#8221; have implications for our business model. If we are considered a joint employer, we could have responsibility for damages, reinstatement, back pay and penalties in connection with labor law and employment discrimination violations by our franchisees. Furthermore, it may be easier for our franchisees&#8217; employees to organize into unions, require us to participate in collective bargaining with those employees, provide those employees and their union representatives with bargaining power to request that we have our franchisees raise wages, and make it more expensive and less profitable to operate a franchised clinic.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Americans with Disabilities Act</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are required to comply with the accessibility standards mandated by the Americans with Disabilities Act of 1990 and related federal and state statutes, which generally prohibit discrimination on the basis of disability in places of public accommodation. We may, in the future, have to modify our clinics to provide service to or make reasonable accommodations for disabled persons. While these expenses could be material, our current expectation is that any such actions will not require us to expend substantial funds.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The chiropractic industry is highly fragmented. According to the October 2025 IBIS market research report, no single company accounts for more than 5% of the total industry market share. Our competitors include approximately 38,500 independent chiropractic offices currently open throughout the United States, according to a 2025 Kentley Insights market research report, as well as certain multi-unit operators. We may also face competition from traditional medical practices, outpatient clinics, physical therapists, med-spas, massage therapists and sellers of devices intended for home use to address back and joint discomfort. Our four largest multi-unit competitors are Airrosti, HealthSource Chiropractic, 100% Chiropractic and ChiroOne all of which are insurance-based models.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have identified six competitors who are attempting to duplicate our cash-only, low-cost, appointment-free model. Based on publicly available information, five of these competitors each operate fewer than 16 clinics as franchises, and the largest competitor operated 24 clinics as franchises as of December&#160;31, 2025. We anticipate that other direct competitors will join our industry as our visibility, reputation and perceived advantages become more widely known. We believe our first mover advantage, proprietary operations systems and strong unit level economics will continue to accelerate our growth even with the spawning of additional competition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:107%">Human Capital Resources </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We believe that a strong culture of engagement and alignment to be essential to the ongoing success of our business. Therefore, it is important to attract, develop and retain a diverse and engaged workforce at all levels of our business. To facilitate talent attraction and retention, we are committed to fostering a workplace where our employees feel aligned with our mission, proud of our culture and engaged in their work, with opportunities to grow and develop in their careers, supported by competitive compensation and benefits. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Workforce</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2025, we and our consolidated VIEs employed approximately 202 persons on a full-time basis and approximately 128 persons on a part-time basis. None of our employees are members of unions or participate in other collective bargaining arrangements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recruitment</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We believe our employees are among our most valuable resources and are critical to our continued success. We focus significant attention on attracting and retaining talented and experienced individuals to operate our clinics and support our operations, and our management believes in a continuous improvement culture and routinely reviews employee turnover rates at various levels of the organization. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In order to continue our growth through clinic development and, in light of the recent shortage of qualified chiropractors, it is crucial that we continue to attract and retain qualified chiropractors. We strive to make The Joint the career path of choice for chiropractors, with opportunities for our chiropractors to grow and develop in their careers, supported by competitive compensation and benefits, and with our simple business model that allows our chiropractors to focus on patient care. Our competitive employment program for chiropractors includes (i) full time and flexible hours, with full benefits and paid time off, (ii) part time and flexible hours with some benefits, (iii) company-paid malpractice insurance, (iv) tuition reimbursement, sign-on and referral bonuses in certain circumstances, and (v) a competitive starting base salary. We continue to fine-tune and re-strategize our search for chiropractors. In addition, we continue to expand and strengthen our relationship with chiropractic colleges to increase engagement with students and to increase the applicant flow of qualified candidates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In order to ensure that we are meeting our human capital objectives, we will continue to utilize engagement surveys to understand the perception of our brand as an employer and the effectiveness of our employee and compensation programs and to learn where we can improve across our company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Talent Management and Development</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our employees&#8217; personal and professional growth is critical for the success of our business. Our approach to performance and development is designed to motivate our employees to develop, leverage their strengths, and support a coaching and feedback culture. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We offer numerous online courses and encourage our employees to attend conferences, training courses, and continuing education classes. Additionally, we conduct periodic assessments to identify talent needs and growth paths for our employees.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation, Benefits, and Equity</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are committed to providing market competitive compensation and benefits. To ensure we remain competitive, we conduct periodic benchmarking to analyze our compensation data and take steps to ensure gender and other demographic equality is addressed. Our compensation practices are intended to be merit-based, focused on roles, responsibilities, experience and performance, with no consideration given to gender, age, ethnicity or other similar factors. We use a combination of fixed and incentive pay, including base salary, bonuses, and stock-based compensation. The principal purposes of our equity incentive plans are to attract, retain and motivate selected leaders through the granting of stock-based compensation awards. Our benefit offerings include comprehensive medical coverage, paid time off, a retirement savings plan and free family wellness membership at our clinics. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Code of Conduct &amp; Ethics</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In 2024, we updated our Code of Conduct to reinforce our commitment to adhering to moral and ethical principles. We hold ourselves to the highest standards of acting with integrity as outlined in our core values statements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Facilities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We lease the property for our corporate headquarters and all of the properties for our company-owned or managed clinics. As of December&#160;31, 2025, we leased 80 facilities in which we currently operate or manage, with our corporate headquarters being the only leased property that will remain after the completion of our refranchising strategy. We are obligated under three additional leases for facilities in which we have ceased clinic operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate headquarters are located at 16767 N. Perimeter Center Drive, Suite 110, Scottsdale, Arizona 85260. The term of our lease for this location expires on May&#160;31, 2031. The primary functions performed at our corporate headquarters are finance and accounting, treasury, marketing, operations, human resources, information systems support and legal.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are also obligated under non-cancellable leases for the clinics which we own or manage. Our clinics are on average 1,200 square feet. Our clinic leases generally have an initial term of five years, include one to two options to renew the term for five years each, and require us to pay a proportionate share of real estate taxes, insurance, common area maintenance charges and other operating costs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2025, we had 960 franchised or company-owned or managed clinics in operation in 43 states. All of our locations are leased.&#160;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trademarks, Trade Names and Service Marks</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our registered trademarks include the following in the United States:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.163%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.559%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.880%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Trademark</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Registration Date</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Registration Number</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">DON'T DO PAIN. DO YOU.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">August 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">6810062</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">THE JOINT CHIROPRACTIC</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">December 2016</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">5095943</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">THE JOINT CHIROPRACTIC (STYLIZED-BLACK BOX)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">April 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">6331815</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">THE JOINT CHIROPRACTIC (STYLIZED-HORIZ LOGO)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">April 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">6331917</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">THE JOINT CHIROPRACTIC (STYLIZED-STCKD LOGO)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">April 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">6331918</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">YOU'RE BACK, BABY.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">August 2020</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">6131833</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">YOU'RE BACK, BABY</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">December 2019</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">5940161</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">BACK-TOBER</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">September 2018</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">5571732</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">RELIEF RECOVERY WELLNESS</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">February 2018</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">5398367</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">PAIN RELIEF IS AT HAND</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">February 2018</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">5395995</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">WHAT LIFE DOES TO YOUR BODY, WE UNDO</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">February 2018</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">5396012</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">RELIEF. ON SO MANY LEVELS.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">December 2015</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">4871809</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">THE JOINT</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">April 2015</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">4723892</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.163%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.559%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.880%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">THE JOINT&#8230; THE CHIROPRACTIC PLACE (STYLIZED)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">April 2013</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">4323810</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">THE JOINT&#8230; THE CHIROPRACTIC PLACE</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">February 2011</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">3922558</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our registered trademarks include the following in Canada:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">THE JOINT</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">July 2019</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">TMA1044029</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">THE JOINT CHIROPRACTIC</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">July 2019</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">TMA1044040</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">THE JOINT CHIROPRACTIC and Design</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">July 2019</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">TMA1044026</span></div></td></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Information </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are a Delaware corporation. Our common stock is traded on the NASDAQ Capital Market under the symbol &#8220;JYNT.&#8221; Our corporate offices headquarters are located at 16767 N. Perimeter Center Drive, Suite 110, Scottsdale, Arizona 85260, and our telephone number is (480) 245-5960. Our website is www.thejoint.com. Except as specifically indicated otherwise, the information on, or that can be accessed through, our website or any other website identified herein is not incorporated by reference into this Form 10-K. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We make available free of charge, through our website, our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to these reports as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC. The SEC&#8217;s website, www.sec.gov, contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;&#160;&#160;RISK FACTORS</span></div><div><span><br/></span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_25"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">RISKS RELATED TO OPERATING OUR BUSINESS</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">The nationwide labor shortage has negatively impacted our ability to recruit chiropractors and other qualified personnel, and the measures we have taken in response have reduced our net revenues.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The current nationwide labor shortage and, in particular the shortage of qualified chiropractors, has negatively impacted our ability and the ability of our franchisees to recruit and retain qualified chiropractors, wellness coordinators and other qualified personnel. This shortage has limited our ability to open new clinics and has required us to enhance wages and benefits and shorten clinic operating hours. All of these measures have reduced our net revenues and increased our operating expenses and may continue to do so if labor shortages continue.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Inflation has led to increased labor costs and interest rates and may lead to reduced discretionary spending, all of which may negatively impact our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The primary inflationary factor affecting our operations is labor costs. Beginning in the fourth quarter of 2021 and through 2025, company-owned or managed clinics were negatively impacted by wage increases, which increased our general and administrative expenses and decreased profitability. A significant number of our clinic service personnel are paid at rates related to the applicable minimum wage, and increases in the minimum wage could increase our labor costs. As of January 1, 2024, the minimum wage increased in a number of states, the District of Columbia and local municipalities, with many of these wage increases triggered automatically by increases in the cost of living due to high inflation. Such wage increases likely will further increase our general and administrative expenses in the affected jurisdictions. A continued increase in labor costs is likely to continue to have an adverse impact on profitability and may result in additional price increases to offset their impact. Further, should we fail to continue to increase our wages competitively in response to any continued increase in wage rates, the quality of our workforce could decline, causing our patient services to suffer. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition to relief and recovery, our services emphasize preventive and maintenance care, which is generally not a medical necessity, and may be viewed as a discretionary medical expenditure. Discretionary spending is negatively impacted by, among other things, those factors disclosed in this Form 10-K under the caption &#8220;Significant Events and/or Recent Developments&#8221; in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations -- unfavorable global economic or political conditions, such as labor shortages, inflation and other cost increases, and elevated interest rates. As further disclosed under the aforementioned caption, we anticipate that fiscal 2026 will continue to be a volatile macroeconomic environment and expect elevated levels of cost inflation to persist for 2026. Reductions in discretionary spending may adversely impact our business, financial condition, or results of operations. Elevated interest rates will also continue to make it more expensive for potential franchisees to finance new clinic acquisitions and thus may reduce the pool of available franchisees, which also could adversely impact our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the event that a continued deterioration of economic conditions causes a significant decrease in demand for our services, this could negatively impact our ability to meet the financial covenants in our credit facility, although we were in compliance as of December&#160;31, 2025. Furthermore, a deterioration of equity and credit markets may make other debt or equity financing difficult to obtain in a timely manner and on favorable terms, if at all, and if obtained, may be more costly or more dilutive. If we are unable to access our credit facility as a result of noncompliance with its covenants or are unable to obtain other debt or equity financing, this could limit our opportunity to acquire more clinics and regional developer rights and to pursue other corporate initiatives.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">New clinics, once opened, may not be profitable, and the increases in average clinic sales and comparable clinic sales that our franchisees have experienced in the past may not be indicative of future results.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our clinics continue to demonstrate increases in comparable clinic sales even as they mature. Our annual Comp Sales for the full year 2025 were flat. As such, we cannot assure you that increases in previous years in comparable clinic sales will continue for our existing clinics or that clinics that are opened in the future will see similar results. In new markets, the length of time before average sales for new clinics stabilize is less predictable and can be longer than we expect because of our limited knowledge of these markets and consumers&#8217; limited awareness of our brand. New clinics may not be profitable, and their sales performance may not follow historical patterns. In addition, our average clinic sales and comparable clinic sales for existing clinics may deteriorate from the rates achieved over the past several years. Our franchisee's ability to operate new clinics profitably and increase average clinic sales and comparable clinic sales depends on many factors, some of which are beyond our control, including: (i) consumer awareness and understanding of our brand and changes in consumer preferences and discretionary spending; (ii) general economic conditions, which can affect clinic traffic, local rent and labor costs and prices we </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">pay for the supplies we use; (iii) competition, either from our competitors in the chiropractic industry or our own and our franchisees&#8217; clinics; (iv) the identification and availability of attractive sites for new facilities and the anticipated commercial, residential and infrastructure development near our new facilities; (v) changes in government regulation; (vi) in certain regions, decreases in demand for our services due to inclement weather; and (vii) other unanticipated increases in costs, any of which could give rise to delays or cost overruns.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If our new clinics do not perform as planned, our business and future prospects could be harmed. In addition, if we are unable to achieve our expected average clinics sales, our business, financial condition and results of operations could be adversely affected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Our failure to manage our growth effectively could harm our business and operating results.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our growth plan includes a significant number of new franchised clinics. Our existing clinic management systems, administrative staff, financial and management controls and information systems may be inadequate to support our continued expansion. Those demands on our infrastructure and resources may also adversely affect our ability to manage our existing clinics. Managing our growth effectively will require us to continue to enhance these systems, procedures and controls and to hire, train and retain managers and team members. We may not respond quickly enough to the changing demands that our expansion will impose on our management, clinic teams and existing infrastructure which could harm our business, financial condition and results of operations. We replaced and upgraded our IT platform in 2021, but we cannot provide assurances that our on-going improvements and enhancements efforts will be executed without delays, difficulties or service interruptions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Our expansion into new markets may be more costly and difficult than we currently anticipate, which would result in slower growth than we expect.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Clinics our franchisees open in new markets may take longer to reach expected sales and profit levels on a consistent basis and may have higher construction, occupancy, marketing or operating costs than clinics opened in existing markets, thereby affecting our overall profitability. New markets may have competitive conditions, consumer preferences and discretionary spending patterns that are more difficult to predict or satisfy than our existing markets. We may need to make greater investments than we originally planned in advertising and promotional activity in new markets to build brand awareness. If we do not successfully execute our plans to enter new markets, our business, financial condition and results of operations could be materially adversely affected</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Opening new clinics in existing markets may negatively affect revenue at existing clinics.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The target area of our franchised clinics varies by location and depends on a number of factors, including population density, other available retail services, area demographics and geography. As a result, the opening of a new clinic in or near markets in which our franchisees already have clinics could adversely affect the revenues of those existing clinics. Existing clinics could also make it more difficult to build the patient base for a new clinic in the same market. Our business strategy does not entail opening new franchised clinics that we believe will materially affect revenue at existing clinics, but we may selectively open new franchised clinics in and around areas of existing clinics that are operating at or near capacity to effectively serve the patients. Revenue &#8220;cannibalization&#8221; between clinics may become significant in the future as we continue to expand our operations and could affect our revenue growth, which could, in turn, adversely affect our business, financial condition and results of operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Damage to our reputation or our brand in existing or new markets could negatively impact our business, financial condition and results of operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We believe we have built our reputation on high quality, empathetic patient care, and we must protect and grow the value of our brand to continue to be successful in the future. Our brand may be diminished if we do not continue to make investments in areas such as marketing and advertising, as well as the day-to-day investments required for facility operations, equipment upgrades and staff training. Any incident, real or perceived, regardless of merit or outcome, that erodes our brand, such as failure to comply with federal, state or local regulations including allegations or perceptions of non-compliance or failure to comply with ethical and operating standards, could significantly reduce the value of our brand, expose us to adverse publicity and damage our overall business and reputation. Further, our brand value could suffer and our business could be adversely affected if patients perceive a reduction in the quality of service or staff.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Our marketing programs may not be successful.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We incur costs and expend other resources in our marketing efforts to attract and retain patients. Our marketing activities are principally focused on increasing brand awareness and driving patient volumes. As we open new clinics, we undertake aggressive marketing campaigns to increase community awareness about our growing presence. We plan to continue to utilize targeted marketing efforts within local neighborhoods through channels such as radio, digital media, community sponsorships and events, and a robust online/social media presence. These initiatives may not be successful, resulting in expenses incurred without the benefit of higher revenue. Our ability to market our services may be restricted or limited by federal or state law.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">We will be subject to risks associated with leasing space subject to long-term non-cancelable leases for clinics that we intend to operate.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We do not own, and we do not intend to own, any of the real property where our company-owned or managed clinics operate. We anticipate that our leases generally will have an initial term of five or ten years and generally can be extended only in five-year increments (at increased rates). We expect that all of our leases will require a fixed annual rent, although some may require the payment of additional rent if clinic sales exceed a negotiated amount. We expect that our leases will typically be net leases, which require us to pay all of the costs of insurance, taxes, maintenance and utilities, and that these leases will not be cancellable by us. If a future company-owned or managed clinic is not profitable, resulting in its closure, we may nonetheless be committed to perform our obligations under the applicable lease including, among other things, paying the base rent for the balance of the lease term. These risks are heightened as we continue to increase our refranchising efforts which may adversely affect our financial condition or results of operations. In addition, we are secondarily liable on certain franchisees&#8217; clinic lease agreements, including lease agreements that we have guaranteed or assigned to franchisees, and our operating results and/or growth prospects could be impacted by any rent obligations to the extent such franchisees default on these lease agreements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Changes in economic conditions and adverse weather and other unforeseen conditions could materially affect our ability to maintain or increase sales at our clinics.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our services emphasize maintenance therapy, which is generally not a medical necessity, and should be viewed as a discretionary medical expenditure. The United States in general or the specific markets in which we operate may suffer from depressed economic activity, recessionary economic cycles, higher fuel or energy costs, low consumer confidence, high levels of unemployment, reduced home values, increases in home foreclosures, investment losses, personal bankruptcies, reduced access to credit or other economic factors that may affect consumer discretionary spending. As noted in a previous risk factor, the current period of high inflation, which is expected to persist through at least 2026, is likely to reduce consumer discretionary spending. Traffic in our clinics could decline if consumers choose to reduce the amount they spend on non-critical medical procedures. Negative economic conditions might cause consumers to make long-term changes to their discretionary spending behavior, including reducing medical discretionary spending on a permanent basis. In addition, given our geographic concentrations in the West, Southwest, Southeast, and mid-Atlantic regions of the United States, economic conditions in those particular areas of the country could have a disproportionate impact on our overall results of operations, and regional occurrences such as local strikes, terrorist attacks, increases in energy prices, adverse weather conditions, tornadoes, earthquakes, hurricanes, floods, droughts, fires or other natural or man-made disasters could materially adversely affect our business, financial condition and results of operations. All of our clinics depend on visibility and walk-in traffic, and the effects of adverse weather may decrease visits to malls in which our clinics are located and negatively impact our revenues. If clinic sales decrease, our profitability could decline as we spread fixed costs across a lower level of revenues. Reductions in staff levels and potential clinic closures could result from prolonged negative clinic sales, which could materially adversely affect our business, financial condition and results of operations.</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_28"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">RISKS RELATED TO USE OF THE FRANCHISE BUSINESS MODEL</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Our dependence on the success of our franchisees exposes us to risks, including the loss of royalty revenue and harm to our brand.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A substantial portion of our revenues comes from royalties generated by our franchised clinics, which royalties are based on the revenues generated by those clinics. We anticipate that franchise royalties will represent a substantial part of our revenues in the future. As of December&#160;31, 2025, we had franchisees operating or managing 885 clinics. We rely on the performance of our franchisees in successfully opening and operating their clinics and paying royalties and other fees to us on a timely basis. Our franchise system subjects us to a number of risks as described here and in the next four risk factors. These risks include a significant further decline in our franchisees&#8217; revenue, which occurred in 2020 as a result of the COVID-19 pandemic. Furthermore, in 2020, we took additional actions to support our franchisees that experienced challenges during the COVID-19 pandemic, further reducing our royalty revenues and other fees from franchisees. In 2020, for a period of time, we waived minimum royalty requirements, monthly software fees for clinics forced to close temporarily due to the pandemic, and minimum required marketing expenditures. We may need to re-implement, expand or extend these accommodations to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">franchisees, further reducing our revenues from franchised clinics and reducing the visibility of &#8220;The Joint&#8221; brand in the marketplace. Any new or re-implemented accommodations and the occurrence of any of the other events described here and in the next four risk factors could impact our ability to collect royalty payments from our franchisees, harm the goodwill associated with our brand, and materially adversely affect our business and results of operations. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:107%">Our franchisees are independent operators over whom we have limited control.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Franchisees are independent operators, and their employees are not our employees. Accordingly, their actions are outside of our control. Although we have developed criteria to evaluate and screen prospective franchisees, we cannot be certain that our franchisees will have the business acumen or financial resources necessary to operate successful franchises in their approved locations, and state franchise laws may limit our ability to terminate or modify these franchise agreements. Moreover, despite our training, support and monitoring, franchisees may not successfully operate clinics in a manner consistent with our standards and requirements, or may not hire and adequately train qualified personnel. The failure of our franchisees to operate their franchises successfully and the actions taken by their employees could have a material adverse effect on our reputation, our brand and our ability to attract prospective franchisees, and on our business, financial condition and results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:107%">We are subject to the risk that our franchise agreements may be terminated or not renewed.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Each franchise agreement is subject to termination by us as the franchisor in the event of a default, generally after expiration of applicable cure periods, although under certain circumstances a franchise agreement may be terminated by us upon notice without an opportunity to cure. The default provisions under the franchise agreements are drafted broadly and include, among other things, any failure to meet operating standards and actions that may threaten our intellectual property. In addition, each franchise agreement has an expiration date. Upon the expiration of the franchise agreement, we or the franchisee may, or may not, elect to renew the franchise agreement. If the franchise agreement is renewed, the franchisee will receive a new franchise agreement for an additional term. Such option, however, is contingent on the franchisee&#8217;s execution of the then- current form of franchise agreement (which may include increased royalty payments, advertising fees and other costs) and the payment of a renewal fee. If a franchisee is unable or unwilling to satisfy any of the foregoing conditions, we may elect not to renew the expiring franchise agreement, in which event the franchise agreement will terminate upon expiration of its term. The termination or non-renewal of a franchise agreement could result in the reduction of royalty payments we receive.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Our franchisees may not meet timetables for opening their clinics, which could reduce the royalties we receive.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our franchise agreements specify a timetable for opening the clinic. Failure by our franchisees to open their clinics within the specified time limit would result in the reduction of royalty payments we would have otherwise received and could result in the termination of the franchise agreement. As of December&#160;31, 2025, we had active licenses and letters of intent for 139 clinics which we believe to be developable within the specified time periods, but we cannot be certain of this.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Our regional developers are independent operators over whom we have limited control.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our regional developers are independent operators. Accordingly, their actions are outside of our control. We depend upon our regional developers to sell a minimum number of franchises within their territories and to assist the purchasers of those franchises to develop and operate their clinics. The failure by regional developers to sell the specified minimum number of franchises within the time limits set forth in their regional developer license agreements would reduce the franchise fees we would otherwise receive, delay the payment of royalties to us and result in a potential event of default under the regional developer license agreement. Of our total of 15 regional developers as of December&#160;31, 2025, five had not met their minimum franchise sales requirements within the time periods specified in their regional developer agreements.</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_31"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">FINANCIAL RISK FACTORS</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Our level of debt could impair our financial condition and ability to operate.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">As of December&#160;31, 2025, we had access to draw $20.0 million under the Credit Agreement (defined at Note 6, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Debt</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">). Our level of debt could have important consequences to investors, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">requiring a portion of our cash flows from operations be used for the payment of interest on our debt, thereby reducing the funds available to us for our operations or other capital needs;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">limiting our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate because our available cash flow, after paying principal and interest on our debt, may not be sufficient to make the capital and other expenditures necessary to address these changes;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">increasing our vulnerability to general adverse economic and industry conditions, since we will be required to devote a proportion of our cash flow to paying principal and interest on our debt during periods in which we experience lower earnings and cash flow;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">limiting our ability to obtain additional financing in the future to fund working capital, capital expenditures, acquisitions, and general corporate requirements; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">placing us at a competitive disadvantage to other relatively less leveraged competitors that have more cash flow available to fund working capital, capital expenditures, acquisitions, and general corporate requirements.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">We have identified a material weakness in our internal control over financial reporting. If we fail to maintain an effective system of internal controls over financial reporting, we may not be able to accurately report our financial results, prevent fraud, or maintain investor confidence.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the internal control requirements of Section 404 of the Sarbanes-Oxley Act of 2002, which require management to assess the effectiveness of our internal control over financial reporting. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Internal controls related to the operation of financial reporting and accounting systems are critical to maintaining adequate internal control over financial reporting. As discussed in Part II, Item 9A of this Form 10-K, our management concluded that our internal controls over financial reporting were not effective as of December 31, 2024 due to a material weakness in internal controls related to the accounting treatment in significant and complex areas. We did not design, implement and maintain effective controls to analyze and account for non-routine, unusual or complex transactions. Specifically, we did not design, implement and maintain controls to timely analyze and account for the impairment associated with certain assets held for sale within discontinued operations and for the application of valuation methodologies impacting impairment charges related to assets held for sale. We have undertaken and implemented remediation measures to address the material weakness, which measures will result in additional resources and other compliance expenses. During the fourth quarter of 2025, we completed our testing of the operating effectiveness of the implemented controls and found them to be effective. As a result, we have concluded the material weakness has been remediated as of December 31, 2025.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to maintain effective internal control over financial reporting or disclosure controls and procedures, our ability to record, process and report financial information accurately, and to prepare financial statements within required time periods could be adversely affected, which could subject us to litigation or investigations requiring management resources and payment of legal and other expenses, negatively affect investor confidence in our financial statements and adversely impact our stock price.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Internal controls related to the operation of financial reporting and accounting systems are critical to maintaining adequate internal control over financial reporting. We cannot provide any assurance that additional material weaknesses will not occur in the future. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Our balance sheet includes intangible assets and goodwill. A decline in the estimated fair value of an intangible asset or a reporting unit could result in an impairment charge recorded in our operating results, which could be material.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is tested for impairment annually and between annual tests if an event occurs or circumstances change that would indicate the carrying amount may be impaired. Also, we review our amortizable intangible assets for impairment if an event occurs or circumstances change that would indicate the carrying amount may not be recoverable. If the carrying amount of our goodwill or another intangible asset were to exceed its fair value, the asset would be written down to its fair value, with the impairment charge recognized as a noncash expense in our operating results. Adverse changes in future market conditions or weaker operating results compared to our expectations may impact our projected cash flows and estimates of weighted average cost of capital, which could result in a potentially material impairment charge if we are unable to recover the carrying value of our goodwill and other intangible assets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Our balance sheet includes a significant number of long-lived assets in our corporate clinics, including operating lease right-of-use assets and property, plant and equipment. A decline in the current and projected cash flows in our corporate clinics could result in impairment charges, which could be material.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets, such as operating lease right-of-use (&#8220;ROU&#8221;) assets and property, plant and equipment in our corporate clinics, are tested for impairment if an event occurs or circumstances change that would indicate the carrying amount may not be recoverable. If the carrying amount of a long-lived asset were to exceed its fair value, the asset would be written down to its fair value and an impairment charge recognized as a noncash expense in our operating results. Adverse changes in future market conditions or weaker operating results compared to our expectations may impact our projected cash flows and estimates of weighted average cost of capital, which could result in a potentially material impairment charge if we are unable to recover the carrying value of our long-lived assets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Our increased reliance on sources of revenue other than from company-owned or managed clinics exposes us to risks including the loss of revenue and reduction of working capital.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As our portfolio of company-owned or managed clinics has matured, we have placed more reliance on revenues from company-owned or managed clinics. As we execute on our refranchising strategy, we will place a greater reliance on revenue from franchise fees and royalties. As company-owned or managed clinics are sold to franchisees, the total amount of revenue will decrease. In addition, the length of time to complete the refranchising efforts could be in excess of our current expectations, and result in increased levels of general and administrative expenses for longer than anticipated. We may experience insufficient working capital to fully implement our growth plans, and our business, financial condition and results of operations could be adversely affected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">We have experienced net losses and may not achieve or sustain profitability in the future.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced periods of net losses in the past, and while we have achieved profitability from 2018 through 2022, and again in 2025, we have experienced net losses in both 2023 and 2024. As we execute on our refranchising strategy, the total amount of revenue will decrease and our ability to decrease our general and administrative expenses accordingly will drive our ability to achieve profitability in the future. Our ability to achieve profitability will be affected by the other risks and uncertainties described in this section and in Management&#8217;s Discussion and Analysis. If we are not able to achieve or sustain profitability, our business may be materially adversely affected and the price of our common stock may decline.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Any audit by the IRS with respect to our receipt of an employee retention credit (&#8220;ERC&#8221;) under The Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;) could result in additional taxes or costs to our company.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We received an ERC pursuant to the CARES Act in March 2023. Our eligibility to receive the ERC remains subject to audit by the IRS for a period of five years. If the IRS audits us during that time, it may find that we were not eligible to receive some or all of the ERC, in which case we would be required to return some or all of the ERC to the IRS. Additionally, 20% of the ERC was paid to an outside third party as a consulting fee. In the event we are required to return some or all of the ERC, we may not be able to recoup the consulting fee.</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_34"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">RISKS RELATED TO INDUSTRY DYNAMICS AND COMPETITION</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Our clinics and chiropractors compete for patients in a highly competitive environment that may make it more difficult to increase patient volumes and revenues.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The business of providing chiropractic services is highly competitive in each of the markets in which our clinics operate. The primary basis of such competition are quality of care, reputation, price of services, marketing and advertising strategy implementation, convenience, traffic flow, visibility of office locations, and hours of operation. Our clinics compete with all other chiropractors in their local market. Many of those chiropractors have established practices and reputations in their markets. Some of these competitors and potential competitors may have financial resources, affiliation models, reputations or management expertise that provide them with competitive advantages over us, which may make it difficult to compete against them. Our four largest multi-unit competitors are Airrosti, which currently operates 154 clinics; HealthSource Chiropractic, which currently operates 143 clinics; ChiroOne, which currently operates 109 clinics; and 100% Chiropractic, which currently operates 61 clinics. All of these competitors are currently operating under an insurance-based model, including two of which also accept private pay. In addition, a number of other chiropractic franchises and chiropractic practices that are attempting to duplicate or follow our business model are currently operating in our markets and in other parts of the country and may enter our existing markets in the future.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Our success is dependent on the chiropractors who control the PCs, or PC owners, with whom we enter into management services agreements, and we may have difficulty locating qualified chiropractors to replace PC owners.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In states that regulate the corporate practice of chiropractic, our chiropractic services are provided by legal entities organized under state laws as PCs and their equivalents. Each PC employs or contracts with chiropractors in one or more offices. Each of the PCs is wholly owned by one or more licensed chiropractors, or medical professionals as state law may require, and we do not own any capital stock of any PC. We and our franchisees that are not owned by chiropractors enter into management services agreements with PCs, to provide to the PCs on an exclusive basis, all non-clinical services of the chiropractic practice. The PC owner is critical to the success of a clinic because he or she has control of all clinical aspects of the practice of chiropractic and the provision of chiropractic services. Upon the departure of a PC owner, we may not be able to locate one or more suitably qualified licensed chiropractors to hold the ownership interest in the PC and maintain the success of the departing PC owner.</span></div><div><span><br/></span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_37"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">RISKS RELATED TO STATE REGULATION OF THE CORPORATE PRACTICE OF CHIROPRACTIC </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Our management services agreements, under which we provide non-clinical services to affiliated PCs, could be challenged by a state or chiropractor under laws regulating the practice of chiropractic. Some state chiropractic boards have made inquiries concerning our business model or have proposed or adopted changes to their rules that could be interpreted to pose a threat to our business model</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The laws of every state in which we operate contain restrictions on the practice of chiropractic and control over the provision of chiropractic services. The laws of many states where we operate permit a chiropractor to conduct a chiropractic practice only as an individual, a member of a partnership or an employee of a PC, limited liability company or limited liability partnership. These laws typically prohibit chiropractors from splitting fees with non-chiropractors and prohibit non-chiropractic entities, such as chiropractic management services organizations, from owning or operating chiropractic clinics or engaging in the practice of chiropractic and from employing chiropractors. The specific restrictions against the corporate practice of chiropractic, as well as the interpretation of those restrictions by state regulatory authorities, vary from state to state. However, the restrictions are generally designed to prohibit a non-chiropractic entity from controlling or directing clinical care decision-making, engaging chiropractors to practice chiropractic or sharing professional fees. The form of management agreement that we utilize, and that we recommend to our franchisees that are management service organizations, explicitly prohibits the management service organization from controlling or directing clinical care decisions. However, there can be no assurance that all of our franchisees that are management service organizations will strictly follow the provisions in our recommended form of management agreement. The laws of many states also prohibit chiropractic practitioners from paying any portion of fees received for chiropractic services in consideration for the referral of a patient. Any challenge to our contractual relationships with our affiliated PCs by chiropractors or regulatory authorities could result in a finding that could have a material adverse effect on our operations, such as voiding one or more management services agreements. Moreover, the laws and regulatory environment may change to restrict or limit the enforceability of our management services agreements. We could be prevented from affiliating with chiropractor-owned PCs or providing comprehensive business services to them in one or more states. Please see Part I, Item 1 &#8211; Business &#8211; Regulatory Environment &#8211; State Regulations on Corporate Practice of Chiropractic for a description of certain of these actions by states, including state legislatures, state chiropractic regulatory bodies and a state attorney general, to regulate and restrict the corporate practice of chiropractic.</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_40"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">RISKS RELATED TO OTHER LEGAL AND REGULATORY MATTERS</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Uncertainties with federal regulations under the new presidential administration expanding the meaning of &#8220;joint employer&#8221; and evolving state laws increase our potential liability for employment law violations by our franchisees and the likelihood that we may be required to participate in collective bargaining with our franchisees&#8217; employees. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Please see Part I, Item 1 &#8211; Business &#8211; Regulatory Environment &#8211; Joint Employer Rules for a detailed description of the background and current status of federal and state &#8220;joint employer&#8221; laws and regulations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in the above-cited section, the proposed rules issued under the NLRA and the withdrawal of the Trump-era rules issued under the FLSA include or reinstate expansive definitions of &#8220;joint employer,&#8221; which could be used to deem a franchisor to be a joint employer of a franchisee&#8217;s employees. In the event of a finding of joint employer status under the NLRA, a franchisor would be required to collectively bargain or otherwise deal with a union that does not represent the franchisor&#8217;s own employees, lose the protections against union picketing of neutral employers in the event of a labor disagreement between a franchisee and a franchisee&#8217;s employees, and share in liability for labor and employment violations committed by a franchisee.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the reversion to a more expansive definition of &#8220;joint employer&#8221; under the FLSA, a franchisor could be held jointly liable with its franchisee for minimum wages and overtime pay violations by the franchisee, depending on the extent of control and supervision the franchisor is able to exercise over the franchisee&#8217;s employees. Furthermore, there is an expectation that new rules will be issued by the Equal Employment Opportunity Commission, similarly expanding &#8220;joint liability&#8221; with respect to the enforcement of anti-discrimination laws. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Such expansions of joint employer liability have implications for our business model. We could have responsibility for damages, reinstatement, back pay and penalties in connection with labor law and employment discrimination violations by our franchisees over whom we have limited control. Furthermore, it may be easier for our franchisees&#8217; employees to organize into unions, require us to participate in collective bargaining with those employees, provide those employees and their union representatives with bargaining power to request that we have our franchisees raise wages, and make it more expensive and less profitable to operate a franchised clinic. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Similarly, state laws, such as California&#8217;s AB-5 and similar laws adopted or being considered for adoption in other states, raise concerns with respect to the expansion of joint liability to the franchise industry. While AB-5 is not a franchise-specific law and does not address joint employer liability, a significant concern exists in the franchise industry that an expansive interpretation of AB-5 or similar law could be used to hold franchisors jointly liable for the labor law violations of its franchisees. Courts addressing this issue have come to differing conclusions, and it remains uncertain as to how the joint employer issue will finally be resolved in California, although potential new federal laws or regulations may ultimately be controlling on this issue. Furthermore, there have been private lawsuits in which parties have alleged that a franchisor and its franchisee &#8220;jointly employ&#8221; the franchisee&#8217;s staff, that the franchisor is responsible for the franchisees&#8217; staff (under theories of apparent agency, ostensible agency, or actual agency), or otherwise.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Evolving labor and employment laws, rules and regulations, and theories of liability could result in expensive litigation and potential claims against us as a franchisor for labor and employment-related and other liabilities that have historically been borne by franchisees. This could negatively impact the franchise business model, which could materially and adversely affect our business, financial condition and results of operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">An increased regulatory focus on the establishment of fair franchise practices could increase our risk of liability in disputes with franchisees and the risk of enforcement actions and penalties.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Recently, there has been an increased focus on unfair franchise practices. A policy from NASAA rejects the use of required representations or waivers of claims by franchisees in franchise agreements for the purpose of insulating a franchisor from liability in disputes related to alleged fraud or misrepresentations during the offer and sale of a franchise. It is expected that state regulators will follow NASAA&#8217;s guidance and limit their use, as California has already done. We risk exposure to unfair trade practice claims by state regulators if we try to use a franchisee&#8217;s representations in a manner that offends NASAA&#8217;s policy. The use of such offending representations also could increase the likelihood of successful lawsuits against us by our franchisees over claims of fraud or misrepresentation. Bills also have been introduced in Congress from time to time providing for protections of franchisee rights, including certain currently pending bills seeking to establish what are described as fair franchise practices. Compliance with new, complex and changing laws may cause our expenses to increase, and non-compliance with such laws could result in penalties or enforcement actions against us. Please see Part I, Item 1 Business Regulatory Environment &#8211; Regulation Relating to Franchising for a description of other federal and state regulation related to franchising. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">We conduct business in a heavily regulated industry, and if we fail to comply with these laws and government regulations, we could incur penalties or be required to make significant changes to our operations. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We, our franchisees and the chiropractor-owned PCs to which we and our franchisees provide management services are subject to extensive federal, state and local laws, rules and regulations, including: (i) federal and state laws governing the franchisor-franchisee relationship; (ii) state regulations on the corporate practice of chiropractic; (iii) federal and state laws governing the collection, dissemination, use, security and confidentiality of sensitive personal information; (iv) federal and state laws which contain anti-kickback and fee-splitting provisions and restrictions on referrals; (v) the federal Fair Debt Collection Practices Act and similar state laws that restrict the methods that we and third-party collection companies may use to contact and seek payment from patients regarding past due accounts; and (vi) federal and state labor laws, including wage and hour laws.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Many of the above laws, rules and regulations applicable to us, our franchisees and our affiliated PCs are ambiguous, have not been definitively interpreted by courts or regulatory authorities and vary from jurisdiction to jurisdiction. Accordingly, we may not be able to predict how these laws and regulations will be interpreted or applied by courts and regulatory authorities, and some of our activities could be challenged. In addition, we must consistently monitor changes in the laws and regulations that govern our operations. Furthermore, a review of our business by judicial, law enforcement or regulatory authorities could result in a determination that could adversely affect our operations. Although we have tried to structure our business and contractual relationships in compliance with these laws, rules and regulations in all material respects, if any aspect of our operations were found to violate applicable laws, rules or regulations, we could be subject to significant fines or other penalties, required to cease operations in a particular jurisdiction, prevented from commencing operations in a particular state or otherwise be required to revise the structure of our business or legal arrangements. Our efforts to comply with these laws, rules and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">regulations may impose significant costs and burdens, and failure to comply with these laws, rules and regulations may result in fines or other charges being imposed on us.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Our chiropractors are subject to ethical guidelines and operating standards which, if not complied with, could adversely affect our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The chiropractors who work in our system are subject to ethical guidelines and operating standards of professional and trade associations and private accreditation agencies. Compliance with these guidelines and standards is often required by our contracts with our chiropractors, patients and franchise owners (and their contractual relationships) and serve to maintain our reputation. The guidelines and standards governing the provision of healthcare services may change significantly in the future. New or changed guidelines or standards may materially and adversely affect our business. In addition, a review of our business by accreditation authorities could result in a determination that could adversely affect our operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">We, along with our affiliated PCs and their chiropractors, are subject to malpractice and other similar claims and may be unable to obtain or maintain adequate insurance against these claims. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The provision of chiropractic services by chiropractors entails an inherent risk of potential malpractice and other similar claims. While we do not have responsibility for compliance by affiliated PCs and their chiropractors with regulatory and other requirements directly applicable to chiropractors, claims, suits or complaints relating to services provided at the offices of our franchisees or affiliated PCs may be asserted against us. We have experienced a number of malpractice claims since our founding in March 2010, which we have defended or are vigorously defending and do not expect their outcome to have a material adverse effect on our business, financial condition or results of operations. The assertion or outcome of these claims could result in higher administrative and legal expenses, including settlement costs or litigation damages. Although we maintain insurance in amounts that we believe are reasonable, we may not be able to maintain such insurance on acceptable terms, and claims may exceed the amount of insurance coverage available to us. Our current minimum professional liability insurance coverage required for our franchisees, affiliated PCs and company-owned clinics is $1.0 million per occurrence and $3.0 million in annual aggregate. In addition, we have a corporate business owner&#8217;s policy with coverage of $2.0 million per occurrence and $4.0 million in annual aggregate. If we are unable to obtain adequate insurance, our franchisees or franchisee doctors fail to name our company as an additional insured party, or if there is an increase in the future cost of insurance to us and the chiropractors who provide chiropractic services or an increase in the amount we have to self-insure, there may be a material adverse effect on our business and financial results.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Events or rumors relating to our brand names or our ability to defend successfully against intellectual property infringement claims by third parties could significantly impact our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Recognition of our brand names, including &#8220;THE JOINT CHIROPRACTIC,&#8221; and the association of those brands with quality, convenient and inexpensive chiropractic maintenance care, are an integral part of our business. The occurrence of any events or rumors that cause patients to no longer associate the brands with quality, convenient and inexpensive chiropractic maintenance care may materially adversely affect the value of the brand names and demand for chiropractic services at our franchisees or their affiliated PCs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to compete effectively depends in part upon our intellectual property rights, including but not limited to our trademarks. Our use of contractual provisions, confidentiality procedures and agreements, and trademark, copyright, unfair competition, trade secret and other laws to protect our intellectual property rights may not be adequate. Litigation may be necessary to enforce our intellectual property rights, or to defend against claims by third parties that the conduct of our businesses or our use of intellectual property infringes upon such third party&#8217;s intellectual property rights. Any intellectual property litigation or claims brought against us, whether or not meritorious, could result in substantial costs and diversion of our resources, and there can be no assurances that favorable final outcomes will be obtained in all cases. Our business, financial condition or results of operations could be adversely affected as a result.</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_43"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">RISKS RELATED TO INFORMATION TECHNOLOGY, CYBERSECURITY AND DATA PRIVACY </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Our failure to comply with applicable federal and state data privacy and security laws could result in civil or criminal sanctions or damage awards, and the proliferation of such laws increases our costs of compliance.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The data protection landscape is rapidly evolving, and we are or may become subject to numerous state and federal laws and regulations governing the collection, use, disclosure, retention, and security of personal information, including health-related information. While we have determined that we are not currently regulated as a covered entity under HIPAA and thus are not subject to its requirements or penalties, any entity may be prosecuted under HIPAA&#8217;s criminal provisions either directly or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">under aiding-and-abetting or conspiracy principles. Consequently, depending on the facts and circumstances, we could face substantial criminal penalties if we knowingly receive individually identifiable health information from a HIPAA-covered healthcare provider that has not satisfied HIPAA&#8217;s requirements for disclosure of individually identifiable health information. Even when entities are not covered by HIPAA, the FTC has taken the position that a failure to take appropriate steps to keep consumers&#8217; personal information secure may constitute unfair acts or practices in or affecting commerce in violation of the Federal Trade Commission Act. The FTC expects a company&#8217;s data security measures to be reasonable and appropriate in light of the sensitivity and volume of consumer information it holds, the size and complexity of its business, and the cost of available tools to improve security and reduce vulnerabilities. The FTC has broad authority to seek monetary redress for affected consumers and injunctive relief.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, many states impose restrictions related to the confidentiality of personal information that apply more broadly than HIPAA. Please see Part I, Item 1 &#8211; Business &#8211; Regulatory Environment &#8211; HIPAA and State Privacy and Breach Notification Rules for a description of some of these state privacy rules.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Such information may include certain identifying information and financial information of our patients. These state laws may impose notification requirements in the event of a breach of such personal information. Violations of these laws may result in criminal, civil and administrative sanctions and also may provide individuals with a private right of action with respect to disclosures of personal information. Failure to comply with such data confidentiality, security and breach notification laws may result in substantial monetary penalties or awards of damages.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We expect that the regulatory focus on privacy, security and data use issues will continue to increase and laws and regulations concerning the protection of personal information will expand and become more complex.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Such new privacy laws add additional requirements, restrictions and potential legal risk and require additional investment in resources for compliance programs. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Our business model depends on proprietary and third-party management information systems that we use to, among other things, track financial and operating performance of our clinics, and any failure to successfully design and maintain these systems or implement new systems could materially harm our operations.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We depend on integrated management information systems, some of which are provided by third parties, and standardized procedures for operational and financial information, patient records and billing operations. In 2021, we replaced, upgraded and rolled out our new IT platform, and any problems with system performance could cause disruptions in our business operations, given the pervasive impact of the new system on our processes. In general, we may experience unanticipated delays, complications, data breaches or expenses in replacing, upgrading, implementing, integrating, and operating our systems. Our management information systems regularly require modifications, improvements or replacements that may require both substantial expenditures as well as interruptions in operations. Our ability to implement these systems is subject to the availability of skilled information technology specialists to assist us in creating, implementing and supporting these systems. Our failure to successfully design, implement and maintain all of our systems could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">If we fail to properly maintain the integrity of our data or to strategically implement, upgrade or consolidate existing information systems, our reputation and business could be materially adversely affected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We increasingly use electronic means to interact with our customers and collect, maintain and store individually identifiable information, including, but not limited to, personal financial information and health-related information. Despite the security measures we have in place to ensure compliance with applicable laws and rules, our facilities and systems, and those of our third-party service providers, may be vulnerable to security breaches, acts of cyber terrorism, vandalism or theft, computer viruses, misplaced or lost data, programming and/or human errors or other similar events. Please see Part I, Item 1 &#8211; Business &#8211; Regulatory Environment &#8211; HIPAA and State Privacy and Breach Notification Rules for a description of the November 2022 data breach suffered by one of our vendors, which resulted in the release of certain information with respect to our patients and employees. Additionally, the collection, maintenance, use, disclosure and disposal of individually identifiable data by our businesses are regulated at the federal and state levels as well as by certain financial industry groups, such as the Payment Card Industry organization. Federal, state and financial industry groups may also consider from time-to-time new privacy and security requirements that may apply to our businesses. Compliance with evolving privacy and security laws, requirements, and regulations may result in cost increases due to necessary systems changes, new limitations or constraints on our business models and the development of new administrative processes. They also may impose further restrictions on our collection, disclosure and use of individually identifiable information that is housed in one or more of our databases. Noncompliance with privacy laws, financial industry group requirements or a security breach involving the misappropriation, loss or other unauthorized disclosure of personal, sensitive and/or confidential information, whether by us or by one of our vendors, could have material adverse effects on our business, operations, reputation and financial condition, including decreased revenue; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">material fines and penalties; increased financial processing fees; compensatory, statutory, punitive or other damages; adverse actions against our licenses to do business; and injunctive relief whether by court or consent order.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">If our security systems are breached, we may face civil liability and public perception of our security measures could be diminished, either of which would negatively affect our ability to attract and retain patients.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Techniques used to gain unauthorized access to corporate data systems are constantly evolving, and there is a potential for increased cyber-attacks and security challenges as our employees and employees of our vendors and franchisees work remotely from non-corporate managed networks. We may be unable to anticipate or prevent unauthorized access to data pertaining to our patients, including credit card and debit card information and other personally identifiable information. Our systems, which are supported by our own systems and those of third-party vendors, are vulnerable to computer malware, trojans, viruses, worms, break-ins, phishing attacks, denial-of-service attacks, attempts to access our servers in an unauthorized manner, or other attacks on and disruptions of our and third-party vendor computer systems (as in the case of the November 2022 data breach of a vendor&#8217;s computer system referenced in the preceding risk factor), any of which could lead to system interruptions, delays, or shutdowns, causing loss of critical data or the unauthorized access to personally identifiable information. If an actual or perceived breach of security occurs on our systems or a vendor&#8217;s systems, we could face civil liability and reputational damage, either of which would negatively affect our ability to attract and retain patients. We also could be required to expend resources, time and/or effort to mitigate the breach of security and to address related matters, as we did in the case of the aforementioned November 2022 data breach, although we are entitled to indemnification under the contract with the vendor for costs incurred in the case of the November 2022 breach.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to effectively control the unauthorized actions of third parties who may have access to the patient data we collect. Any failure, or perceived failure, by us to maintain the security of data relating to our patients and employees, and to comply with our posted privacy policy, laws and regulations, rules of self-regulatory organizations, industry standards and contractual provisions to which we may be bound, could result in the loss of confidence in us, or result in actions against us by governmental entities or others, all of which could result in litigation and financial losses, and could potentially cause us to lose patients, revenue and employees.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">We are subject to a number of risks related to credit card and debit card payments we accept.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We accept payments through credit and debit card transactions. For credit and debit card payments, we pay interchange and other fees, which may increase over time. An increase in those fees would require us to either increase the prices we charge for our services, which could cause us to lose patients and revenue, or absorb an increase in our operating expenses, either of which could harm our operating results.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we or any of our processing vendors have problems with our billing software, or the billing software malfunctions, it could have an adverse effect on patient satisfaction and could cause one or more of the major credit card companies to disallow our continued use of their payment products. In addition, if our billing software fails to work properly, and as a result, we do not automatically process monthly membership fees to our patients&#8217; credit cards on a timely basis or at all, or there are issues with financial insolvency of our third-party vendors or other unanticipated problems or events, we could lose revenue, which would harm our operating results.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to payment card association operating rules, certification requirements and rules governing electronic funds transfers, which could change or be reinterpreted to make it more difficult for us to comply. Based on the self-assessment completed as of February 3, 2026, we are currently in compliance with the Payment Card Industry Data Security Standard, or PCI DSS, the payment card industry&#8217;s security standard for companies that collect, store or transmit certain data regarding credit and debit cards, credit and debit card holders and credit and debit card transactions. There is no guarantee that we will maintain PCI DSS compliance. Our failure to comply fully with PCI DSS in the future could violate payment card association operating rules, federal and state laws and regulations and the terms of our contracts with payment processors and merchant banks. Such failure to comply fully also could subject us to fines, penalties, damages and civil liability and could result in the suspension or loss of our ability to accept credit and debit card payments. Although we do not store credit card information and we do not have access to our patients&#8217; credit card information, there is no guarantee that PCI DSS compliance will prevent illegal or improper use of our payment systems or the theft, loss, or misuse of data pertaining to credit and debit cards, credit and debit card holders and credit and debit card transactions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to adequately control fraudulent credit card transactions, we may face civil liability, diminished public perception of our security measures and significantly higher credit card-related costs, each of which could adversely affect our business, financial condition and results of operations. If we are unable to maintain our chargeback or refund rates at acceptable levels, credit and debit card companies may increase our transaction fees, impose monthly fines until resolved or terminate their </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">relationships with us. Any increases in our credit and debit card fees could adversely affect our results of operations, particularly if we elect not to raise our rates for our service to offset the increase. The termination of our ability to process payments on any major credit or debit card would significantly impair our ability to operate our business.</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_46"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">GENERAL RISK FACTORS </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">We have restated our Previously Issued Financial Statements, which may lead to additional risks and uncertainties, including loss of investor confidence and negative impacts on our stock price. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On August 12, 2025, we restated our consolidated financial statements as of and for the years ended December 31, 2024 and 2023 and for the quarterly period ended March 31, 2025 (the &#8220;2024/2025 Restated Periods&#8221;). The determination to restate the financial statements for the 2024/2025 Restated Periods was made by our Audit Committee and our Board of Directors upon management&#8217;s recommendation following the identification of an error over the application of asset valuation accounting related to assets held for sale reported in discontinued operations that impacted impairment charges. Our management, after consultation with our independent registered accountants, concluded that our Previously Issued Financial Statements for the 2024/2025 Restated Periods should no longer be relied upon. Our Annual Report on Form 10-K for the years ended December 31, 2024 and 2023 has been amended by Form 10-K/A filed on August 12, 2025 and our Quarterly Report on Form 10-Q for the quarters ended March 2025 and 2024 has been amended by Form 10-Q/A filed on August 12, 2025 to, among other things, reflect the restatement of our financial statements for the 2024/2025 Restated Periods</span><span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On September 26, 2023, we restated our consolidated financial statements as of and for the years ended December 31, 2022 and 2021 and for the quarterly periods within the fiscal years ended December 31, 2022 and 2021 (the &#8220;2022 Restated Periods&#8221;). The determination to restate the financial statements for the 2022 Restated Periods was made by our Audit Committee and our Board of Directors upon management&#8217;s recommendation following the identification of an error related to our method of accounting for the reacquisition of regional developer rights and transfer pricing adjustments for our VIEs. Our management, after consultation with our independent registered accountants, concluded that our Previously Issued Financial Statements for the 2022 Restated Periods should no longer be relied upon. Our Annual Report on Form 10-K for the years ended December 31, 2022 and 2021 has been amended by Form 10-K/A filed on September 26, 2023 to, among other things, reflect the restatement of our financial statements for the 2022 Restated Periods.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The restatement of our Previously Issued Financial Statements has been time-consuming and expensive and could expose us to additional risks that could materially adversely affect our financial position, results of operations and cash flows, including unanticipated costs for accounting and legal fees in connection with or related to the restatement and the risk of potential stockholder litigation. If lawsuits are filed, we may incur additional substantial defense costs regardless of the outcome of such litigation. Likewise, such events might cause a diversion of our management&#8217;s time and attention. If we do not prevail in any such litigation, we could be required to pay substantial damages or settlement costs. In addition, the restatement may lead to a loss of investor confidence and have negative impacts on the trading price of our common stock.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Short-selling strategies and negative opinions posted on the internet may drive down the market price of our common stock and could result in class action lawsuits.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Short selling occurs when an investor borrows a security and sells it on the open market, with the intention of buying identical securities at a later date to return to the lender. A short seller hopes to profit from a decline in the value of the securities between the sale of the borrowed securities and the purchase of the replacement shares. Because it is in the short seller&#8217;s best interests for the price of the stock to decline, some short sellers publish, or arrange for the publication of, opinions or characterizations regarding an issuer, its business prospects, and similar matters which may create a negative depiction of our company. This information is often widely distributed, including through platforms that mainly serve as hosts seeking advertising revenue. Issuers who have limited trading volumes and are thus susceptible to higher volatility levels than large-cap stocks can be particularly vulnerable to such short seller attacks.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may be subject to short selling strategies that may drive down the market price of our common stock. In 2021, we were the target of negative allegations posted on an internet platform designed to advise short sellers, which precipitated a decline in the price of our stock. Shortly thereafter, several plaintiffs' law firms announced investigations into potential securities laws violations based on these allegations. While we believe these allegations are without merit, and no litigation has been commenced to date regarding such allegations, we still face the potential (albeit a diminishing one, given the passage of time) for litigation to be initiated against us. While we would vigorously defend against any such litigation, regardless of outcome, litigation can be costly and time-consuming, divert the attention of our management team, adversely impact our reputation and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">brand, and if a plaintiff claim were successful, could result in significant liability, all of which could harm our business and financial condition.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Future sales of our common stock may depress our stock price and our share price may decline due to the large number of shares eligible for future sale or exchange.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The market price of our common stock could decline as a result of sales of a large number of shares of common stock in the market or the perception that such sales could occur. These sales, or the possibility that these sales may occur, might also make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate. As of December&#160;31, 2025, we had 14,142,626 outstanding shares of common stock and are authorized to sell up to 20,000,000 shares of common stock. The trading volume of shares of our common stock averaged approximately 76,000 shares per day during the year ended December&#160;31, 2025. Accordingly, sales of even small amounts of shares of our common stock by existing stockholders may drive down the trading price of our common stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:103%">Claims for indemnification by our directors and officers may reduce our available funds to satisfy successful third-party claims against us and may reduce the amount of money available to us.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation and bylaws provide that we will indemnify our directors and officers, in each case to the fullest extent permitted by Delaware law. In addition, we have entered and expect to continue to enter into agreements to indemnify our directors, executive officers and other employees as determined by our Board of Directors. Under the terms of such indemnification agreements, we are required to indemnify each of our directors and officers, to the fullest extent permitted by the laws of the state of Delaware, if the basis of the indemnitee&#8217;s involvement was by reason of the fact that the indemnitee is or was a director or officer of our company or any of its subsidiaries or was serving at our request in an official capacity for another entity. Any claims for indemnification by our directors and officers may reduce our available funds to satisfy successful third-party claims and may reduce the amount of money available to us. </span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_49"></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1B.&#160;&#160;&#160;&#160;UNRESOLVED STAFF COMMENTS</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_52"></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1C.&#160;&#160;&#160;&#160;CYBERSECURITY</span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" id="f-38" continuedAt="f-38-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" id="f-37" continuedAt="f-37-1" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" id="f-39" escape="true">Our <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true" id="f-40">Chief Technology Officer (&#8220;CTO&#8221;)</ix:nonNumeric> is responsible for cybersecurity within our company, including information technology risks, controls, strategies and procedures.</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-42" continuedAt="f-42-1" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" id="f-41" continuedAt="f-41-1" escape="true">The <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-43" escape="true">Cybersecurity Subcommittee</ix:nonNumeric> of the Board of Directors oversees cybersecurity for our company and meets with the CTO at least quarterly to discuss the status of cybersecurity efforts as well as any security incidents. </ix:nonNumeric></ix:nonNumeric></ix:nonNumeric><ix:continuation id="f-41-1"><ix:continuation id="f-42-1"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" format="ixt:fixed-true" id="f-44">Cybersecurity Subcommittee materials are provided to the Audit Committee as well as the full Board of Directors.</ix:nonNumeric> The members of the Cybersecurity Subcommittee collectively bring at least 40 years of expertise and executive-level experience in information technology and cybersecurity to successfully support the CTO to maintain a strong cybersecurity strategy within our company.</ix:continuation> The Board of Directors believes that a strong cyber strategy based on industry accepted best practices is vital to protect our business, customers and assets.</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" id="f-45" escape="true">Our CTO leverages more than 20 years of technology experience in the healthcare and financial services industries involving managing information security, developing cybersecurity strategy, implementing effective information and cybersecurity programs and managing within highly regulated global environments. He has managed technology compliance under the regulatory governance of frameworks such as HIPAA, GDPR, FDA, CCPA and TJC Hospital Accreditation.</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" id="f-46" escape="true"><ix:continuation id="f-37-1">Management has the responsibility to manage risk and bring to the Board of Directors attention the most material near-term and long-term risks to our Company. The CTO leads management&#8217;s assessment and management of cybersecurity risk and regularly reviews cybersecurity matters with management. The CTO reports to our Chief Executive Officer.</ix:continuation></ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A dedicated team of technology professionals works throughout the year to monitor all matters of risk relating to cybersecurity. We completed our ISO 27001 Information Security Management certification project culminating in a primary and secondary audit against the standard. We received our ISO 27001 certification after the successful completion of an external audit and remediation steps and will complete a regular external audit in March 2026. Additionally, we operate and are compliant under the following provisions: HIPAA attestation for the HIPAA Security Rule and the Health Information Technology for Economic and Clinical Health Act (HITECH) Breach Notification requirements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" format="ixt:fixed-true" id="f-47" continuedAt="f-47-1">Vendors that have access to our information are required to manage such information in accordance with laws and appropriate privacy and security standards. Standards are applied on a per-contract basis and include requirements to have an information security program and report to us any incidents in which its confidential information or systems are compromised. Depending </ix:nonNumeric></span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-38-1"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-47-1">on the nature of the vendors&#8217; access to our information, we monitor and evaluate the controls and governance established with the vendors ranging from a continuous cadence to at least quarterly.</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have not directly encountered any incidents from cybersecurity threats to date, but in November 2022, a breach was suffered by one of our vendors, which resulted in the release of certain information with respect to our patients and employees. This breach is discussed in more detail in Item 1. Business, under Regulatory Environment entitled "HIPAA and State Privacy and Breach Notification Rules". <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-false" id="f-48">Based upon our investigation and the cooperation with our vendor, we believe the data breach did not have a material adverse effect on our business or result in any material damage to us and do not believe are reasonably likely to materially affect our business strategy, results of operations, or financial condition.</ix:nonNumeric> Although we have not yet been materially impacted by any cybersecurity incident, we are subject to cybersecurity threats, as discussed in Item 1A. Risk Factors, including in the risk factor entitled &#8220;If we fail to properly maintain the integrity of our data or to strategically implement, upgrade or consolidate existing information systems, our reputation and business could be materially adversely affected&#8221; and &#8220;If our security systems are breached, we may face civil liability and public perception of our security measures could be diminished, either of which would negatively affect our ability to attract and retain patients&#8221;.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We annually assess our cybersecurity programs against third-party requirements, including HIPAA and the Sarbanes-Oxley Act of 2002. We test multiple aspects of cybersecurity regularly, including annual pen testing over our proprietary information systems and our technical recovery and incident response procedures annually.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a robust privacy compliance program. Employees receive periodic email communications, which train them to detect and report malware, ransomware and other malicious software and social engineering attempts that may compromise our information technology systems. In the second quarter of 2024, we implemented the KnowBe4 security training system and completed our first annual training in August 2024. In 2025, we completed a semi-annual security and privacy training cycle utilizing the SIMBUS360 platform. In 2026, we will re-engage the KnowBe4 system with a heightened focus on phishing awareness.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" id="f-49" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" format="ixt:fixed-true" id="f-50">Currently, we rely on an established major incident management and communication process to address any potential cybersecurity incidents.</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" format="ixt:fixed-true" id="f-51">This established process includes the use of third party partnerships to make available the distinct skill sets needed to assist in properly responding to any cybersecurity threat.</ix:nonNumeric> We have established defined response procedures to effectively address any cyber threat that may occur regardless of the safeguards in place that minimize the chance of a successful cyberattack. The response procedures are designed to identify, analyze, contain and remediate such cyber incidents expeditiously. These procedures and approach to safeguard our information and assets will be continuously monitored by management and updated to evolve with the current cyber landscape in alignment with the ISO 27001 standard mentioned above.</span></div></ix:nonNumeric></ix:continuation><div id="iaf8338e230dd46e38cf560e1698dc7ef_55"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160; PROPERTIES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We lease the property for our corporate headquarters and all of the properties for our company-owned or managed clinics. As of December&#160;31, 2025, we leased 80 facilities in which we operate, with our corporate headquarters being the only leased property that will remain after the completion of our refranchising strategy. We are obligated under three additional leases for facilities in which we have ceased clinic operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate headquarters are located at 16767 N. Perimeter Center Drive, Suite 110, Scottsdale, Arizona 85260. The term of our lease for this location expires on May 31, 2031. The primary functions performed at our corporate headquarters are finance and accounting, treasury, marketing, operations, human resources, information systems support and legal.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are also obligated under non-cancellable leases for the clinics that we own or manage. Our clinics are on average 1,200 square feet. Our clinic leases generally have an initial term of five years, include one to two options to renew the term for five years each, and require us to pay a proportionate share of real estate taxes, insurance, common area maintenance charges and other operating costs.</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_58"></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. &#160;&#160;&#160;&#160;LEGAL PROCEEDINGS &#160;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding our legal proceedings is discussed in Note 10, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">in the Notes to the consolidated financial statements, which is incorporated herein by reference.</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_61"></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;MINE SAFETY DISCLOSURES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_67"></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.&#160;&#160;&#160;&#160;MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is traded on the Nasdaq Capital Market under the symbol &#8220;JYNT.&#8221;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Holders</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2025, there were approximately&#160;38 holders of record of our common stock and&#160;14,142,626 shares of our common stock outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchases of Equity Securities by the Issuer</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On June 3, 2025, our Board of Directors approved a stock repurchase program (the "2025 SRP") to repurchase up to $5.0 million of our common stock, par value $0.001 per share, from time to time until June 3, 2027 or such other date as we have exhausted, or the Board of Directors otherwise terminates, the repurchase authorization. On November 4, 2025, the Board of Directors authorized an additional $12.0&#160;million for a total of $17.0 million authorized for repurchase under the 2025 SRP and extended the repurchase date through November 4, 2027.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The timing, volume, price, and terms of the repurchases will depend on market and business conditions, applicable legal requirements, and other factors. The repurchases may be made on the open market, in privately negotiated transactions, or in such other manner (e.g., accelerated share repurchase transactions, block trades, derivatives, or otherwise) that complies with the terms of applicable federal and state securities laws and regulations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes our monthly common stock repurchase activity under the 2025 SRP during the three months ended December&#160;31, 2025.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.549%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%">Total Number of Shares Purchased</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%">Average Price Paid per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Total Number of Shares Repurchased Under the 2025 SRP</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Approximate Dollar Value of Shares that May Yet be Purchased Under the 2025 SRP</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Repurchases from October 1 - 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">312,571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8.64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">312,571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Repurchases from November 1 - 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">628,234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">628,234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,734,509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Repurchases from December 1 - 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">126,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">126,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,675,604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,067,485&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8.45&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,067,485&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,675,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Since our initial public offering, we have not declared nor paid dividends on our common stock, and we do not expect to pay cash dividends on our common stock in the foreseeable future.</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_70"></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6. &#160;&#160;&#160;&#160;[Reserved]</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_73"></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7.&#160;&#160;&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion and analysis of our results of operations and financial condition for the years ended December&#160;31, 2025 and 2024 should be read in conjunction with the consolidated financial statements and the notes thereto, and other financial information contained elsewhere in this Form 10-K.</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_76"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are a growing franchisor that uses a private pay, non-insurance, cash-based model. We seek to be the leading provider of chiropractic care in the markets we serve and to become the most recognized brand in our industry. We delivered over 14.4 million patient visits in 2025, down from 14.7 million patient visits in 2024, generating over $532.4 million and $530.3 million </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">of system-wide sales, respectively, across our highly franchised network. We will continue the franchise-focused expansion of chiropractic clinics in key markets throughout North America and potentially abroad. We saw 797,100 new patients in 2025, and according to our patient survey conducted in 2024, approximately</span><span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">36%</span><span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">of new patients were visiting a chiropractor for the first time. We are not only increasing our percentage of market share, but are also expanding the chiropractic market.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Key Performance Measures.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We receive monthly performance reports from our system and our clinics, which include key performance indicators per clinic, including gross sales, Comp Sales, number of new patients, conversion percentage and member attrition. In addition, we review monthly reporting related to system-wide sales, clinic openings, clinic license sales and various earnings metrics in the aggregate and per clinic. We believe these indicators provide us with useful data with which to measure our performance and to measure our franchisees&#8217; and clinics&#8217; performance. Comp Sales include the sales from both company-owned or managed clinics and franchised clinics that in each case have been open at least 13 full months and exclude any clinics that have closed. System-wide sales are neither required by, nor presented in accordance with, GAAP. System-wide sales are the sum of company-owned or managed clinics and clinics operated by our franchisees. Our GAAP total revenue in our consolidated statements of income is limited to company-owned or managed clinic revenue and franchise revenue from our franchisees. Accordingly, system-wide sales should not be considered in isolation or as a substitute for our results reported under GAAP. Management believes the information is important in understanding the overall brand&#8217;s financial performance, because these sales are the basis on which we calculate and record royalty fees and are indicative of the financial health of the franchisee base.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2025:</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Comp Sales of clinics that have been open for at least 13 full months were flat.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">System-wide sales for all clinics open for any amount of time slightly increased to $532.4 million but remained flat on a percentage basis.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We saw 797,100 new patients in 2025, compared with 957,000 new patients in 2024.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Key Clinic Development Trends</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;As of December&#160;31, 2025, we and our franchisees operated or managed 960 clinics, of which 885 were operated or managed by franchisees and 75 were operated as company-owned or managed clinics. Our franchisees opened 29 clinics during 2025. This compares to 57 clinics opened in 2024, all of which were franchised clinics. Of the 75 company-owned or managed clinics at December&#160;31, 2025, 30 were constructed and developed by us, and 45 were acquired from franchisees.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our current strategy is to grow through the sale and development of additional franchises. After evaluating options for improvement, during 2023 the Board of Directors authorized management to initiate a plan to refranchise or sell the majority of our company-owned or managed clinics. During the third quarter of 2024, we, with the authorization of the Board of Directors, expanded the refranchising plan to include the full portfolio of our company-owned or managed clinics, marketing the clinics in large clusters grouped by geographic territory. This refined strategy will leverage our greatest strength &#8212; our capacity to build a franchise &#8212; to drive long-term growth for both our franchisees and The Joint as a public company. We have created a robust framework for the refranchising effort, organizing clinics into clusters, and generating comprehensive disclosure packets for marketing efficiency. We had given initial preference to existing franchisees and in the third quarter of 2024 expanded the marketing efforts to larger multi-unit, multi-brand operators and certain private equity firms interested in purchasing and operating large market-based clinic clusters and have received significant interest to date in most markets. In early 2025, we received draft letters of intent for our full portfolio of company-owned or managed clinics.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2025, we closed on the sale of 31 company-owned or managed clinics and associated franchise licenses located in Arizona and New Mexico to an existing franchisee, Joint Ventures, LLC, in exchange for $8.3 million in cash and the regional developer territory rights of the Northwest region. We carried an upfront regional developer fee liability balance associated with the transaction of $42 thousand, representing the unrecognized fee collected upon the execution of the regional developer agreement. We accounted for the acquisition of the regional developer rights as a release of liability and were included as part of the total consideration received to calculate the gain or loss on the sale. Losses on the sale were included with the loss on the sale of assets included in Net loss on disposition or impairment from discontinued operations. As part of the sale, Joint Ventures, LLC agreed to open an additional 10 clinics in the same region. On June 23, 2025, we also closed the sale of five clinics along with future development rights located in Kansas and Missouri to an existing franchisee, 93 Chiro, LLC. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On December 5, 2025, we entered into an Asset Purchase Agreement with Addisco Value, LLC, a North Carolina limited liability company, Triangle Chiropractic Associates P.C., a North Carolina professional corporation, and Bluffton TJ, LLC, a South Carolina limited liability company, collectively as &#8220;buyers&#8221;, and Alex Klaus, an individual, Todd Wegerski, DC, an individual, Lisa Ezell, an individual, Andrew Michael Evec, an individual, and Susan Ruth Train, an individual, collectively as </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">guarantors, pursuant to which we will sell the assets of, and grant franchise rights to, 22 company-owned or managed clinics located in Virginia, North Carolina and South Carolina for an aggregate purchase price of approximately $1.5 million, subject to certain adjustments. In mid-December 2025, the buyers assumed business operations under Management Service Agreements that will remain in effect until lease reassignments are completed to permit ownership transfer. As of December 31, 2025, the transaction had not officially closed and therefore, the net assets and liabilities of the 22 clinics remain in our consolidated balance sheets. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In March 2026, we signed a letter of intent with a new potential buyer for five corporate-owned or managed clinics located in northern California. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our goal will be to generate significant proceeds that will provide us with value creating capital allocation opportunities. These opportunities could include, but are not limited to, reinvestment in the brand and related marketing, continued investment in our IT platforms, the repurchase of regional developer territories, certain merger or acquisition opportunities and/or further repurchases of our outstanding common stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The number of franchise licenses sold for the year ended December&#160;31, 2025 was 31, compared with 46 and 55 licenses for the years ended December&#160;31, 2024 and 2023, respectively. We ended 2025 with 15 regional developers who were responsible for 26% of the 31 licenses sold during the year. We will continue to leverage the power of the regional developer program to accelerate the number of clinics sold, and eventually opened, across the country.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On June 24, 2024, we entered into an agreement pursuant to which we repurchased the right to develop franchises in various counties in Maryland. The total consideration for the transaction was $0.6 million. We carried an upfront regional developer fee liability balance associated with this transaction of $0.1 million, representing the unrecognized fee collected upon the execution of the regional developer agreement. We accounted for the termination of development rights associated with unsold or undeveloped franchises as a cancellation, and the associated upfront regional developer fee liability was netted against the aggregate purchase price. We recognized the net amount of $0.5&#160;million as a general and administrative expense for the year ended December 31, 2024.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we continue to have a sound business concept and will benefit from the fundamental changes taking place in the manner in which Americans access chiropractic care and their growing interest in seeking effective, affordable natural solutions for general wellness. These trends join with the preference we have seen among chiropractic doctors to reject the insurance-based model produce a combination that benefits the consumer and the service provider alike. We believe that these forces create an important opportunity to accelerate the growth of our network.</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_79"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Significant Events and/or Recent Developments</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Recent developments that may impact our business include unfavorable global economic or political conditions, such as uncertainties that come with changes to the presidential administration, labor shortages, and inflation and other cost increases. We anticipate that 2026 will continue to be a volatile macroeconomic environment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The primary inflationary factor affecting our operations is labor costs. In 2024 and 2025, clinics owned or managed by us or our franchisees were negatively impacted by labor shortages and wage increases, which increased our general and administrative expenses. Further, should we fail to continue to increase our wages competitively in response to increasing wage rates, the quality of our workforce could decline, causing our patient service to suffer. While we anticipate that these continued headwinds can be partially mitigated by pricing actions, there can be no assurance that we will be able to continue to take such pricing actions. A continued increase in labor costs could have an adverse effect on our operating costs, financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the expectation that interest rates will continue to remain elevated may adversely affect patients&#8217; financial conditions, resulting in reduced spending on our services. While the impact of these factors continues to remain uncertain, we will continue to evaluate the extent to which these factors will impact our business, financial condition, or results of operations. These and other uncertainties with respect to these recent developments could result in changes to our current expectations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchase Program</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On June 3, 2025, our Board of Directors approved the 2025 SRP to repurchase up to $5.0 million of our common stock, par value $0.001 per share, from time to time until June 3, 2027 or such other date as we have exhausted, or the Board of Directors otherwise terminates, the repurchase authorization. On November 4, 2025, the Board of Directors authorized an additional $12.0&#160;million under the 2025 SRP and extended the repurchase date through November 4, 2027.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The timing, volume, price, and terms of the repurchases will depend on market and business conditions, applicable legal requirements, and other factors. The repurchases may be made on the open market, in privately negotiated transactions, or in such other manner (e.g., accelerated share repurchase transactions, block trades, derivatives, or otherwise) that complies with the terms of applicable federal and state securities laws and regulations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2025, we repurchased $11.3 million of our common stock at an average price of $8.73 per share, excluding related costs and fees. As of December&#160;31, 2025, we had a remaining $5.7 million authorized for repurchasing shares of our common stock. All shares of common stock that were repurchased are held as treasury stock. </span><span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_82"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Officer Changes</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Effective June 9, 2025, Jake Singleton resigned as our Chief Financial Officer. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Effective June 10, 2025, the Board of Directors appointed Scott J. Bowman as our Chief Financial Officer. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Effective October 10, 2024, Peter D. Holt resigned as our President and Chief Executive Officer and as a member of the Board of Directors. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Effective October 14, 2024, the Board of Directors appointed Sanjiv Razdan as our President and Chief Executive Officer and as a member of the Board of Directors.</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_85"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Factors Affecting Our Performance</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our operating results may fluctuate significantly as a result of a variety of factors, including the timing of new clinic sales, openings, closures, markets in which they are contained and related expenses, general economic conditions, cost inflation, labor shortages, consumer confidence in the economy, consumer preferences, competitive factors, and disease epidemics and other health-related concerns, such as the COVID-19 pandemic.</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_88"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Polices and Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements requires us to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. We base our accounting estimates on historical experience and other factors that we believe to be reasonable under the circumstances. Actual results could differ from those estimates. We have discussed the development and selection of critical accounting policies and estimates with our Audit Committee. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We allocate the purchase price of acquired companies to the assets acquired and liabilities assumed based on estimated fair values at the acquisition date, with the excess of purchase price over the estimated fair value of the identifiable net assets acquired recorded as goodwill. When an acquisition is accounted for in accordance with the acquisition of assets rather than a business, goodwill is not recognized and instead, any excess of the cost of the acquisition over the fair value of net assets acquired is allocated to certain assets on the basis of relative fair values. The allocation of the purchase price requires us to make significant estimates and assumptions to determine the fair value of assets acquired and liabilities assumed and the related useful lives of the acquired assets, when applicable, as of the acquisition date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">Examples of critical estimates used in valuing certain intangible assets we have acquired or may acquire in the future include, but are not limited to, future expected cash flows and member relationships, revenue growth rates, the period of time the acquired member relationships will continue to be used, anticipated member attrition rates, and discount rates used to determine the present value of estimated future cash flows. We engage third-party valuation experts to assist in determining the fair value associated with our acquisitions and related identifiable intangible assets. These estimates are inherently uncertain and unpredictable, and if different estimates were used, the purchase price for the acquisition could be allocated to the acquired assets and assumed liabilities differently from the allocation that we have made.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist primarily of reacquired franchise rights and customer relationships.&#160;We amortize the fair value of reacquired franchise rights over the remaining contractual terms of the reacquired franchise rights at the time of the acquisition, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">which range from one to ten years. The fair value of customer relationships is amortized over their estimated useful life which ranges from two to four years.&#160;Intangible assets are attributable entirely to discontinued operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill consists of the excess of the purchase price over the fair value of tangible and identifiable intangible assets acquired in the acquisitions of franchises treated as a business combination under GAAP. Goodwill and intangible assets deemed to have indefinite lives are not amortized but are subject to annual impairment tests. As required, we perform an annual impairment test of goodwill as of the first day of the fourth quarter or more frequently if events or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. No impairments of goodwill were recorded for the years ended December&#160;31, 2025 and 2024. Goodwill is attributable entirely to discontinued operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Assets</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recovered. We look primarily to estimated undiscounted future cash flows in the assessment of whether or not long-lived assets are recoverable. We record an impairment loss when the carrying amount of the asset is not recoverable and exceeds its fair value.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We account for share-based payments by recognizing compensation expense based on the estimated fair value of the awards on the date of grant. We determine the estimated grant-date fair value of restricted shares using the closing price on the date of the grant and the grant-date fair value of stock options using the Black-Scholes-Merton model. In order to calculate the fair value of the options, certain assumptions are made regarding the components of the model, including risk-free interest rate, volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. We recognize compensation costs ratably over the period of service using the straight-line method. Forfeitures are estimated based on historical and forecasted turnover, which is approximately 5%.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue through royalties, franchise fees, advertising fund contributions, IT-related income and computer software fees from our franchisees. Additionally, as we execute on our strategy to refranchise and divest from all of our company-owned or managed clinics, revenue generated through our company-owned or managed clinics is included in Income (loss) from discontinued operations before income tax expense.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues from Company-Owned or Managed Clinics.&#160;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We earn revenue from clinics that we own and operate or manage throughout the United States. In those states where we own and operate the clinic, revenues are recognized when services are performed. We offer a variety of membership and wellness packages which feature discounted pricing as compared with our single-visit pricing. Amounts collected in advance for membership and wellness packages are recorded as deferred revenue and recognized when the service is performed. Any unused visits associated with monthly memberships are recognized on a month-to-month basis. We recognize a contract liability (or a deferred revenue liability) related to the prepaid treatment plans for which we have an ongoing performance obligation. We recognize this contract liability, and recognize revenue, as the patient consumes his or her visits related to the package and we perform the services. If we determine that it is not subject to unclaimed property laws for the portion of the package that we do not expect to be redeemed (referred to as &#8220;breakage&#8221;), then we recognize breakage revenue in proportion to the pattern of exercised rights by the patient. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Franchise Fees.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We require the entire non-refundable initial franchise fee to be paid upon execution of a franchise agreement, which typically has an initial term of 10 years. Initial franchise fees are recognized ratably on a straight-line basis over the term of the franchise agreement.&#160;Our services under the franchise agreement include training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. We provide no financing to franchisees and offer no guarantees on their behalf.&#160;The services we provide are highly interrelated with the franchise license and as such are considered to represent a single performance obligation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Software Fees.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We collect a monthly fee from our franchisees for use of our proprietary chiropractic software, computer support, and internet services support. These fees are recognized ratably on a straight-line basis over the term of the respective franchise agreement.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regional Developer Fees </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have a regional developer program where regional developers are granted an exclusive geographical territory and commit to a minimum development obligation within that defined territory. Regional developer fees are non-refundable and amortized on a straight-line basis over the term of the regional developer agreement and recognized as a decrease to franchise and regional developer cost of revenues.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we pay regional developers fees, which are funded by the initial franchise fees collected from franchisees upon the sale of franchises within their exclusive geographical territory, and a royalty of 3% of sales generated by franchised clinics in their exclusive geographical territory. Fees related to the sale of franchises within their exclusive geographical territory are initially deferred as deferred franchise costs and are recognized as an expense in franchise cost of revenues when the respective revenue is recognized, which is generally over the term of the related franchise agreement. Royalties of 3% of gross sales generated by franchised clinics in their regions are also recognized as franchise cost of revenues as franchisee clinic level sales occur, which is funded by the 7% royalties we collect from the franchisees in their regions. Certain regional developer agreements result in the regional developer acquiring the rights to existing royalty streams from clinics already open in the respective territory. In those instances, the revenue associated from the sale of the royalty stream is recognized over the remaining life of the respective franchise agreements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accounting guidance for leases requires lessees to recognize an ROU asset and a lease liability in the balance sheet for most leases. The lease liability is measured at the present value of the fixed lease payments over the lease term and the ROU asset is measured at the lease liability amount, adjusted for lease prepayments, lease incentives received and the lessee&#8217;s initial direct costs. Certain leases include one or more renewal options, generally for the same period as the initial term of the lease. The exercise of lease renewal options is generally at our sole discretion and, as such, we typically determine that exercise of these renewal options is not reasonably certain. As a result, we do not include the renewal option period in the expected lease term and the associated lease payments are not included in the measurement of the ROU asset and lease liability. When available, we use the rate implicit in the lease to discount lease payments; however, the rate implicit in the lease is not readily determinable for substantially all of our leases. In such cases, we estimate our incremental borrowing rate as the interest rate we would pay to borrow an amount equal to the lease payments over a similar term, with similar collateral as in the lease, and in a similar economic environment. We estimate these rates using available evidence such as rates imposed by third-party lenders in recent financings or observable risk-free interest rate and credit spreads for commercial debt of a similar duration, with credit spreads correlating to our estimated creditworthiness.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For operating leases that include rent holidays and rent escalation clauses, we recognize lease expense on a straight-line basis over the lease term from the date it takes possession of the leased property. Pre-opening costs are recorded as incurred in general and administrative expenses. Variable lease payments, such as percentage rentals based on location sales, periodic adjustments for inflation, reimbursement of real estate taxes, any variable common area maintenance and any other variable costs associated with the leased property are expensed as incurred and are also included in general and administrative expenses on the consolidated income statements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We recognize deferred tax assets and liabilities for both the expected impact of differences between the financial statement amount and the tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax losses and tax credit carryforwards. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We record a valuation allowance against deferred tax assets when it is considered more likely than not that all or a portion of our deferred tax assets will not be realized. In making this determination, we are required to give significant weight to evidence that can be objectively verified. It is generally difficult to conclude that a valuation allowance is not needed when there is significant negative evidence, such as cumulative losses in recent years. Forecasts of future taxable income are considered to be less objective than past results. Therefore, cumulative losses weigh heavily in the overall assessment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition to considering forecasts of future taxable income, we are also required to evaluate and quantify other possible sources of taxable income in order to assess the realization of our deferred tax assets, namely the reversal of existing temporary differences, the carry back of losses and credits as allowed under current tax law, and the implementation of tax planning strategies. Evaluating and quantifying these amounts involves significant judgments. Each source of income must be evaluated based on all positive and negative evidence; this evaluation involves assumptions about future activity. The actual realization of deferred tax assets may differ from the amounts we have recorded.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgment is also required in evaluating our uncertain tax positions. We establish accruals for uncertain tax positions when we believe that the full amount of the associated tax benefit may not be realized. If we prevail in matters for which accruals have been established previously or pay amounts in excess of reserves, there could be an effect on our income tax provisions in the period in which such determination is made. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We regularly assess the tax risk of our tax return filing positions, and we have identified $0.6 million and $0.9 million in uncertain tax positions as of December&#160;31, 2025 and 2024, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss Contingencie</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">s</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accounting Standards Codification 450, Contingencies (&#8220;ASC 450&#8221;), governs the disclosure of loss contingencies and accrual of loss contingencies in respect of litigation and other claims. We record an accrual for a potential loss when it is probable that a loss will occur and the amount of the loss can be reasonably estimated. When the reasonable estimate of the potential loss is within a range of amounts, the minimum of the range of potential loss is accrued, unless a higher amount within the range is a better estimate than any other amount within the range. Moreover, if an accrual is not required, we provide additional disclosure related to litigation and other claims when it is reasonably possible (i.e., more than remote) that the outcomes of such litigation and other claims include potential material adverse impacts on us. Legal costs to be incurred in connection with a loss contingency are expensed as such costs are incurred.</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_91"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Results of Operations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion and analysis of our financial results encompasses our consolidated results and results of our business segment: Franchise Operations. All financial results and metrics discussed below are on a continuing operations basis.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As discussed further in Note 3, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">in the Notes to consolidated financial statements, since the fourth quarter of 2024, we have classified our corporate clinic business segment as held for sale. The results of operations of the corporate clinic business segment are reported in Income (loss) from discontinued operations before income tax expense in the consolidated income statements for all periods presented and the related assets and liabilities associated with discontinued operations are classified as discontinued operation assets and liabilities in the consolidated balance sheets for all periods presented. The consolidated statement of cash flows includes cash flows related to the discontinued operations and accordingly, cash flow amounts for discontinued operations are disclosed in Note 3, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">in the Notes to consolidated financial statements</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Revenues</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Components of revenues for the year ended December&#160;31, 2025, as compared to the year ended December&#160;31, 2024, were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr style="height:30pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Change from</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Prior Year</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Percent Change</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">from Prior Year</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Royalty fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">33,203,885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">32,144,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,059,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Franchise fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,371,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,997,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">373,654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Advertising fund revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,451,281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,180,281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,271,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Software fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,037,385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,687,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">350,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,831,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,153,177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(321,640)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(14.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">54,895,592&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">52,163,430&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,732,162&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues increased by $2.7 million, primarily due to the continued expansion and revenue growth of our franchise base, and included:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Royalty fees and advertising fund revenue increased due to an increase in the number of franchised clinics in operation during 2025, along with continued sales growth in existing franchised clinics. As of December&#160;31, 2025 and 2024, there were 885 and 842 franchised clinics in operation, respectively.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Franchise fees increased due to the continued increase in active franchise licenses and the impact of accelerated revenue recognition resulting from terminated franchise license agreements, with 34 and 24 franchise license agreements terminated during the years ended December&#160;31, 2025 and 2024, respectively.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Software fees increased due to an increase in our franchised clinic base and the related revenue recognition over the term of the franchise agreement as described above.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenues</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:47.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.257%"/><td style="width:0.1%"/></tr><tr style="height:30pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Change from<br/>Prior Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Percent Change<br/>from Prior Year</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,225,474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,516,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(291,374)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2025, as compared with the year ended December&#160;31, 2024, the total cost of revenues decreased due to a reduction in regional developer royalties and sales commissions. We ended 2025 with 15 regional developers, as compared to 16 regional developers in 2024. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling and Marketing Expenses</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr style="height:30pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Change from</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Prior Year</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Percent Change</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">from Prior Year</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling and Marketing Expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,299,399&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,973,610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,325,789&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Selling and marketing expenses increased $2.3 million for the year ended December&#160;31, 2025, as compared to the year ended December&#160;31, 2024, driven by an increase in expenses associated with our digital marketing transformation efforts and the impact of a larger franchise base.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Depreciation and Amortization Expenses</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr style="height:30pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Change from</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Prior Year</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Percent Change</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">from Prior Year</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and Amortization Expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,644,161&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,371,389&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">272,772&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expenses increased $0.3 million for the year ended December&#160;31, 2025, as compared to the year ended December&#160;31, 2024, primarily due to depreciation expenses related to internal use software enhancements and developments, including the launch of our official mobile app.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expenses</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr style="height:30pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Change from</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Prior Year</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Percent Change</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">from Prior Year</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and Administrative Expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">29,632,036&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">30,124,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(492,553)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses decreased during the year ended December&#160;31, 2025 compared to the year ended December&#160;31, 2024, primarily due to a decrease in professional fees, partially offset by an increase in payroll and related expenses. As a percentage of revenue, general and administrative expenses were 54% and 58% during the year ended December 31, 2025 and 2024, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Included in general and administrative expenses from continuing operations above are expenses of $1.2 million and $1.0 million related to workers&#8217; compensation insurance for the years ended December 31, 2025 and 2024, respectively, of which we believe that approximately $1.1 million and $0.9 million, respectively, relate to expenses that will not be incurred upon the completion of our refranchising strategy.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss on Disposition or Impairment</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr style="height:30pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Change from</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Prior Year</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Percent Change</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">from Prior Year</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net Loss on Disposition or Impairment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,898&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">66,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(58,121)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(88.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net loss on disposition or impairment decreased for the year ended December&#160;31, 2025, as compared to the year ended December&#160;31, 2024, primarily due to lower disposals of property and equipment.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss from Continuing Operations</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr style="height:30pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Change from</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Prior Year</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Percent Change</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">from Prior Year</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss from Continuing Operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(913,376)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,889,025)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">975,649&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">51.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Loss from continuing operations decreased by $1.0 million for the year ended December&#160;31, 2025 compared to the year ended December&#160;31, 2024, primarily due to the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase of $2.7 million in total revenues; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a decrease of $0.3 million in total cost of revenues;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a decrease of $0.5 million in general and administration expenses; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a decrease of $0.1 million in loss on disposition or impairment; partially offset by</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase of $2.3 million in selling and marketing expenses, and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase of $0.3 million in depreciation expenses. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income, Net </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr style="height:30pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Change from</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Prior Year</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Percent Change</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">from Prior Year</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other Income, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">683,872&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">280,287&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">403,585&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">144.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net increased during the year ended December&#160;31, 2025 compared to the year ended December&#160;31, 2024, primarily due to the deployment of additional cash and cash equivalents during the middle of 2025 into higher interest rate money market funds resulting in increased interest income.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Expense</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr style="height:30pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Change from</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Prior Year</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Percent Change</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">from Prior Year</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income Tax Expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">38,653&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">33,047&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">589.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2025 and 2024, the effective tax rates were (16.8)% and (0.3)%, respectively. The fluctuation in the effective rate was primarily attributable to state income taxes (net of federal tax and permanent differences), changes in tax rates, stock-based compensation, shortfall/windfall on stock compensation expense, change in valuation allowance and uncertain tax positions during the year ended December&#160;31, 2025, as compared to the year ended December&#160;31, 2024. </span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_94"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles net income (loss) to Adjusted EBITDA for continuing operations, discontinuing operations and net operations for the years ended December&#160;31, 2025 and 2024:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.239%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.018%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">from Continuing Operations</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">from Discontinued Operations</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">from Continuing Operations</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">from Discontinued Operations</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net Operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Non-GAAP Financial Data:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(268,157)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,175,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,907,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,614,344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,182,549)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5,796,893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net interest (income) expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(799,273)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(799,034)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(280,287)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(278,173)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,644,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">69,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,713,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,371,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,350,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,722,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">38,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">63,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">210,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">215,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">615,384&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,270,426&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,885,810&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(517,636)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(619,424)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,137,060)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,297,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,297,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,679,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,679,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition related expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">478,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">478,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss on disposition or impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,441,010&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,448,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">66,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,714,555&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,780,574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Costs related to restatement filings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">115,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">115,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring Costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,077,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">745,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,823,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">607,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">495,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,102,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Litigation expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">386,439&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">401,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,481,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,481,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,128,795</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,843,417</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,972,212</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,313,329</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,071,228</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,384,557</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA from continuing, discontinuing and net operations and consists of net income (loss) before interest, income taxes, depreciation and amortization, acquisition related expenses (which includes contract termination costs associated with reacquired regional developer rights), stock-based compensation expense, bargain purchase gain, (gain) loss on disposition or impairment, costs related to restatement filings, restructuring costs (consisting of non-recurring refranchising costs of all company-owned or managed clinics and non-recurring expenses related to changes to our executive leadership team), and litigation expenses (consisting of legal and related fees for specific proceedings that arise outside of the ordinary course of our business). We have provided Adjusted EBITDA, a non-GAAP measure of financial performance because it is commonly used for comparing companies in our industry. You should not consider Adjusted EBITDA as a substitute for operating profit as an indicator of our operating performance or as an alternative to cash flows from operating activities as a measure of liquidity. We may calculate Adjusted EBITDA differently from other companies.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the use of Adjusted EBITDA provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing our financial measures with other outpatient medical clinics, which may present similar non-GAAP financial measures to investors. In addition, you should be aware when evaluating Adjusted EBITDA, in the future we may incur expenses similar to those excluded when calculating these measures. Our presentation of these measures should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. Our computation of Adjusted EBITDA may not be comparable to other similarly titled measures computed by other companies, because all companies do not calculate Adjusted EBITDA in the same manner.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our management does not consider Adjusted EBITDA in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of Adjusted EBITDA is that it excludes significant expenses and income that are required by GAAP to be recorded in our financial statements. Some of these limitations include the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA does not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA does not reflect the interest expense, or the cash requirements necessary to service interest or principal payments, on our debts;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA does not reflect the (gain) loss on disposition or impairment, which represents the impairment of assets as of the reporting date. We do not consider this to be indicative of our ongoing operations; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">While not included in the presented periods, Adjusted EBITDA would not reflect any bargain purchase gain, which would represent the excess of the fair value of net assets acquired over the purchase consideration.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Because of these limitations, Adjusted EBITDA should not be considered in isolation or as a substitute for performance measures calculated in accordance with GAAP. We compensate for these limitations by relying primarily on our GAAP results and using Adjusted EBITDA only supplementally. You should review the reconciliation of Net Income (Loss) to Adjusted EBITDA above and not rely on any single financial measure to evaluate our business. </span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_97"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of Liquidity</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2025, we had cash and short-term bank deposits of $23.6 million. We generated $1.8 million of cash flows from operating activities from both continuing and discontinued operations in the year ended December&#160;31, 2025. While unfavorable global economic or political conditions create potential liquidity risks, as discussed further below, we believe that our existing cash and cash equivalents, our anticipated cash flows from operations and amounts available under our line of credit will be sufficient to fund our anticipated operating and investment needs for at least the next 12 months.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">While the interruptions, delays and/or cost increases resulting from political instability and geopolitical tensions, adverse weather conditions, economic weakness, inflationary pressures, elevated interest rates and other factors have created uncertainty as to general economic conditions for 2026, as of the date of this Form 10-K, we believe we have adequate capital resources and sufficient access to external financing sources, upon the completion of our anticipated amendment to the fixed charge coverage ratio debt covenant under our 2022 Credit Facility in the first half of 2026, to satisfy our current and reasonably anticipated requirements for funds to conduct our operations and meet other needs in the ordinary course of our business. For 2026, we expect to use or redeploy our cash resources to support our business within the context of prevailing market conditions, which, given the ongoing uncertainties described above, could rapidly and materially deteriorate or otherwise change. Our long-term capital requirements, primarily for corporate initiatives, could be dependent on our ability to access additional funds through the debt and/or equity markets. If the equity and credit markets deteriorate, including as a result of economic weakness, political unrest or war, or any other reason, it may make any necessary equity or debt financing more difficult to obtain in a timely manner and on favorable terms, if at all, and if obtained, it may be more costly or more dilutive. From time to time, we consider and evaluate transactions related to our portfolio and capital structure, including debt financings, equity issuances, purchases and sales of assets, and other transactions. Given the ongoing uncertainties described above, the levels of our cash flows from operations for 2026 may be impacted. There can be no assurance that we will be able to generate sufficient cash flows or obtain the capital necessary to meet our short and long-term capital requirements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Analysis of Cash Flows</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Net cash provided by operating activities for both continuing and discontinued operations was $1.8 million for the year ended December&#160;31, 2025, compared to net cash provided by operating activities for both continuing and discontinued operations of $9.4 million for the year ended December&#160;31, 2024. The decrease in net cash provided by operating activities was primarily attributable to a change in accrued expenses of $3.4 million related to the settlement of a medical injury claim during the first quarter of 2025, which was partially offset by a related change in accounts receivable of $1.9 million for insurance recoveries, a decrease in payroll liabilities of $3.2 million primarily due to paid time off and payroll accruals related to employees no longer employed by us due to the divestiture and closures of company-owned or managed clinics during 2025, and $0.8 million related to a decrease in our deferred revenue liabilities due to the decrease in company-owned or managed clinics. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by operating activities is subject to variability period over period as a result of the timing of collections and payments related to accounts receivable, accrued expenses, and other operating assets and liabilities. Royalties and other fees are collected from our franchisees semi-monthly, two working days after each sales period has ended.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by investing activities was $6.3 million and net cash used in investing activities was $0.6 million during the years ended December&#160;31, 2025 and 2024, respectively.&#160;For the year ended December&#160;31, 2025, net cash provided by investing activities was driven by $7.8 million of proceeds from the sale of company-owned or managed clinics, partially offset by $1.5 million of purchases of property and equipment. For the year ended December&#160;31, 2024, net cash used in investing activities was driven by $1.2 million of purchases of property and equipment, partially offset by $0.6 million of proceeds from the sale of company-owned or managed clinics.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities was $9.8 million and $2.0 million during the years ended December&#160;31, 2025 and 2024, respectively.&#160;For the year ended December&#160;31, 2025, net cash used in financing activities was driven by $11.3 million of common stock purchases under the 2025 SRP, partially offset by cash receipts from stock option exercises of $1.5 million. For the year ended December&#160;31, 2024, net cash used in financing activities was driven by the payoff of the outstanding balance on our Debt under the Credit Agreement of $2.0 million. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Capital Composition</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In 2025, our Board of Directors approved the 2025 SRP to repurchase a total of $17.0 million of our common stock. During the year ended December&#160;31, 2025, we repurchased 1,295,295 shares under the 2025 SRP. Refer to the &#8220;Significant Events and/or Recent Developments&#8221; section above for more information and Part III, Item 12 &#8211; Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters of this Form 10-K for our monthly repurchase activity during the quarter ended December&#160;31, 2025.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our material contractual obligations from continuing operations at December&#160;31, 2025 and the effect that such obligations are expected to have on our liquidity and cash flows in future periods:</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_100"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Material Contractual Cash Requirements from Continuing Operations</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Payments Due by Fiscal Year</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2029</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2030</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Thereafter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,421,699&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">268,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">467,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">479,129&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">491,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">503,374&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">211,904&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_103"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Please see Note 1, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nature of Operations and Summary of Significant Accounting Policies </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">in the Notes to consolidated financial statements included in Item 8 of this Form 10-K for information regarding recently issued accounting pronouncements that may impact our financial statements.</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_106"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2025, we did not have any relationships with unconsolidated organizations or financial partnerships, such as structured finance or special purpose entities that were established for the purpose of facilitating off-balance sheet arrangements.</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_109"></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7A.&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments held by us as of December&#160;31, 2025 include cash and cash equivalents. A portion of our cash is affected by short-term interest rates, which are currently low. Given the higher interest income generated from our cash after investing a portion into higher yielding money market funds, any reduction in interest rates would not have a material impact on our interest income.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the Credit Agreement bear interest at a rate equal to an applicable margin plus a variable rate. As such, the Revolver exposes us to market risk for changes in interest rates. As we do not maintain a debt position under the Credit Agreement as of December&#160;31, 2025, the effect of a change in interest rates would not have an impact to our interest expense.</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_112"></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 8.&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">The Joint Corp.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_115">Report of Independent Registered Public Accounting Firm</a></span><span style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-52">BDO USA, P.C.</ix:nonNumeric>; Phoenix, Arizona; PCAOB ID #<ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-53">243</ix:nonNumeric>)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_115">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_118">Consolidated Balance Sheets as of </a>December&#160;31, 2025<a style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_118"> and </a>2024</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_118">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_121">Consolidated Income Statements for the Years Ended </a>December&#160;31, 2025<a style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_121"> and </a>2024</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_121">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_124">Consolidated Statements of Changes in Stockholders&#8217; Equity for the </a>Years Ended December 31, 2025 and 2024</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_124">45</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_127">Consolidated Statements of Cash Flows for the </a>Years Ended December 31, 2025 and 2024</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_127">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_133">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#3051f2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_133">48</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Shareholders and Board of Directors</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Joint Corp.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Scottsdale, Arizona</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Consolidated Financial Statements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We have audited the accompanying consolidated balance sheets of The Joint Corp. (the &#8220;Company&#8221;) as of December 31, 2025 and 2024, the related consolidated statements of income, changes in stockholders&#8217; equity, and cash flows for each of the years then ended, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2025 and 2024, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Basis for Opinion</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Critical Audit Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of the critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Impairment of Long-Lived Assets Held for Sale</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As described in Notes 1, 3, and 5 to the consolidated financial statements, the Company recorded an estimated net loss on disposal on assets and liabilities held for sale of $2.7 million for the year ended December 31, 2025. Long-lived assets that meet the criteria for the held for sale designation are reported at the lower of their carrying value or fair value less estimated cost to sell. The estimated fair values of the certain long-lived assets, including company-owned or managed clinics, is determined by management using fair values derived from an income approach based on a discounted cash flow model.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We identified the impairment of long-lived assets held for sale as a critical audit matter. Significant judgments are required to be made by management to determine the fair value for company-owned or managed clinics including the discount rate assumption used in the income approach. Auditing management&#8217;s assumption used in the impairment of long-lived assets held for sale involved especially challenging and subjective auditor judgment due to the nature and extent of audit effort required to address this matter and the extent of specialized skill or knowledge needed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The primary procedure we performed to address this critical audit matter included:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:13.8pt">Utilizing professionals with specialized skill and knowledge to assist in assessing the reasonableness of the discount rate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Impairment of Goodwill - Corporate Clinic Reporting Unit</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As described in Notes 1 and 3 to the consolidated financial statements, the Company&#8217;s consolidated goodwill balance was $3.5 million as of December 31, 2025. The Company performs an annual impairment test of goodwill as of the first day of the fourth quarter or more frequently if a triggering event occurs. During each quarter of 2025, the Company determined it was necessary to re-evaluate goodwill of the corporate clinics reporting unit due to the reporting unit meeting the criteria to be classified as a discontinued operation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We identified the impairment of goodwill specific to the corporate clinic reporting unit as a critical audit matter. Significant judgments are required to be made by management to determine the fair value for the corporate clinic reporting unit including the discount rate assumption used in the income approach. Auditing management&#8217;s assumption used in the impairment assessment of goodwill involved especially challenging and subjective auditor judgment due to the nature and extent of audit effort required to address this matter and the extent of specialized skill or knowledge needed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The primary procedure we performed to address this critical audit matter included:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Utilizing professionals with specialized skill and knowledge to assist in assessing the reasonableness of the discount rate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">/s/ BDO USA, P.C.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2021.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-54">Phoenix, Arizona</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">March 12, 2026</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_118"></div><hr style="page-break-after:always"/><div style="min-height:22.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">THE JOINT CORP.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-55">23,601,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-56">25,051,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-57">700,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-58">945,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="0" id="f-59">2,849,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="0" id="f-60">2,586,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred franchise and regional development costs, current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="0" id="f-61">945,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="0" id="f-62">1,055,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="0" id="f-63">1,744,556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="0" id="f-64">1,787,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations current assets ($<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="f-65">1.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="f-66">1.1</ix:nonFraction> million attributable to VIEs, respectively)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="0" id="f-67">22,246,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="0" id="f-68">43,151,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="0" id="f-69">52,088,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="0" id="f-70">74,577,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="0" id="f-71">3,159,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="0" id="f-72">3,206,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="0" id="f-73">1,572,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="0" id="f-74">555,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred franchise and regional development costs, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:ContractWithCustomerAssetNetNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-75">3,827,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:ContractWithCustomerAssetNetNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-76">4,513,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deposits and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:DepositsAssetsNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-77">319,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:DepositsAssetsNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-78">300,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="0" id="f-79">60,966,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="0" id="f-80">83,154,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="0" id="f-81">1,588,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="0" id="f-82">1,750,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-83">1,501,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-84">1,505,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Co-op funds liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="jynt:CoOpFundsLiabilityCurrent" format="ixt:num-dot-decimal" scale="0" id="f-85">700,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="jynt:CoOpFundsLiabilityCurrent" format="ixt:num-dot-decimal" scale="0" id="f-86">945,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Payroll liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-87">4,055,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-88">3,551,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability, current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="0" id="f-89">194,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="0" id="f-90">483,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred franchise fee revenue, current portion</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="0" id="f-91">2,519,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="0" id="f-92">2,546,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Upfront regional developer fees, current portion</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="jynt:UpfrontRegionalDeveloperFeesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-93">277,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="jynt:UpfrontRegionalDeveloperFeesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-94">288,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-95">611,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-96">603,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations current liabilities ($<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="f-97">6.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="f-98">7.1</ix:nonFraction> million attributable to VIEs, respectively)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="0" id="f-99">21,368,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="0" id="f-100">37,367,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-101">32,816,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-102">49,042,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-103">1,815,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-104">311,689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred franchise fee revenue, net of current portion</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-105">10,899,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-106">12,450,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Upfront regional developer fees, net of current portion</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="jynt:UpfrontRegionalDeveloperFeesNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-107">355,556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="jynt:UpfrontRegionalDeveloperFeesNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-108">672,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="0" id="f-109">45,886,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="0" id="f-110">62,476,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-111"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-5" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-112"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Series A preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-113"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-114">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-115"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-116">50,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-117"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-118"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-119"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-120">zero</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="0" id="f-121">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="0" id="f-122">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-123"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-124">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-125"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-126">20,000,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-127">15,471,715</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-128">14,142,626</ix:nonFraction> shares outstanding and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-129">15,192,893</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-130">15,159,878</ix:nonFraction> shares outstanding, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="0" id="f-131">15,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="0" id="f-132">15,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="0" id="f-133">52,026,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="0" id="f-134">49,210,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-135">1,329,089</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-136">33,015</ix:nonFraction> shares, at cost, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="0" id="f-137">12,192,081</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="0" id="f-138">870,058</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="0" id="f-139">24,795,205</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="0" id="f-140">27,702,470</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total The Joint Corp. stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-141">15,054,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-142">20,653,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlling Interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="0" id="f-143">25,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="0" id="f-144">25,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-145">15,079,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-146">20,678,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-147">60,966,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-148">83,154,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">See notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">THE JOINT CORP. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED INCOME STATEMENTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Royalty fees</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-149">33,203,885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-150">32,144,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Franchise fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-151">3,371,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-152">2,997,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Advertising fund revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-153">10,451,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-154">9,180,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Software fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-155">6,037,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-156">5,687,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-157">1,831,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-158">2,153,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-159">54,895,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-160">52,163,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Franchise and regional development cost of revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="0" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="0" id="f-161">9,500,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="0" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="0" id="f-162">10,063,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">IT cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="0" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="0" id="f-163">1,724,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="0" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="0" id="f-164">1,453,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="0" id="f-165">11,225,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="0" id="f-166">11,516,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="0" id="f-167">13,299,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="0" id="f-168">10,973,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="0" id="f-169">1,644,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="0" id="f-170">1,371,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="0" id="f-171">29,632,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="0" id="f-172">30,124,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="0" id="f-173">44,575,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="0" id="f-174">42,469,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss on disposition or impairment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="0" id="f-175">7,898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="0" id="f-176">66,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-177">913,376</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-178">1,889,025</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="0" id="f-179">683,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="0" id="f-180">280,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss from continuing operations before income tax expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-181">229,504</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-182">1,608,738</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-183">38,653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-184">5,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-185">268,157</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-186">1,614,344</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations before income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="0" id="f-187">3,200,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="0" id="f-188">3,972,286</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" format="ixt:num-dot-decimal" scale="0" id="f-189">25,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" format="ixt:num-dot-decimal" scale="0" id="f-190">210,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-191">3,175,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-192">4,182,549</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" id="f-193">2,907,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" id="f-194">5,796,893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income from continuing operations per common share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="f-195">0.02</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-18" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="f-196">0.11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="f-197">0.02</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-18" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="f-198">0.11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from discontinued operations per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="f-199">0.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-18" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="f-200">0.28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="f-201">0.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-18" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="f-202">0.28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per common share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-203">0.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-18" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-204">0.39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-205">0.19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-18" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-206">0.38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-207">15,134,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-208">14,919,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-209">15,134,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-210">15,147,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">See notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">THE JOINT CORP. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.102%"><tr><td style="width:1.0%"/><td style="width:24.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.207%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.899%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.749%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.136%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.646%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Additional<br/>Paid In Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total The Joint Corp. stockholder's equity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlling Interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-19" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-211">14,783,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-212">14,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-213">47,498,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-214">32,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="0" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-215">860,475</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="0" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-216">21,905,577</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-217">24,746,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-218">25,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-219">24,771,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="0" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="0" id="f-220">1,679,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="0" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="0" id="f-221">1,679,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="0" id="f-222">1,679,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-28" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-223">181,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="0" id="f-224">181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="0" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="0" id="f-225">181</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="0" id="f-226">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-28" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-227">227,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" id="f-228">228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-229">33,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-230">33,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-231">33,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of treasury stock under employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="INF" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="0" id="f-232">891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="0" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-233">9,583</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="0" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-234">9,583</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-235">9,583</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="0" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="0" id="f-236">5,796,893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="0" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="0" id="f-237">5,796,893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="0" id="f-238">5,796,893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-31" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-239">15,192,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-240">15,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-241">49,210,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-33" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-242">33,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="0" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-243">870,058</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="0" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-244">27,702,470</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-245">20,653,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-246">25,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-247">20,678,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="0" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="0" id="f-248">1,297,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="0" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="0" id="f-249">1,297,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="0" id="f-250">1,297,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-39" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-251">155,362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="0" id="f-252">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="0" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="0" id="f-253">155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="0" id="f-254">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-39" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-255">123,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" id="f-256">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-257">1,518,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-258">1,518,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-259">1,518,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of treasury stock under employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-40" decimals="INF" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="0" id="f-260">779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="0" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-261">8,440</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="0" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-262">8,440</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-263">8,440</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common stock repurchased under authorized stock repurchase programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-40" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-264">1,295,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="0" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="0" id="f-265">11,313,583</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="0" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="0" id="f-266">11,313,583</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="0" id="f-267">11,313,583</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="0" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="0" id="f-268">2,907,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="0" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="0" id="f-269">2,907,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="0" id="f-270">2,907,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2025</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-42" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-271">15,471,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-272">15,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-273">52,026,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-44" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-274">1,329,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-44" decimals="0" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-275">12,192,081</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="0" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-276">24,795,205</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-277">15,054,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-278">25,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-279">15,079,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">See notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">THE JOINT CORP. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="0" id="f-280">2,907,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="0" id="f-281">5,796,893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="0" id="f-282">1,713,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="0" id="f-283">4,722,137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss on disposition or impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="jynt:NetGainLossOnDispositionOfAssetsOrAssetImpairment" format="ixt:num-dot-decimal" scale="0" id="f-284">5,448,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="jynt:NetGainLossOnDispositionOfAssetsOrAssetImpairment" format="ixt:num-dot-decimal" scale="0" id="f-285">7,780,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net franchise fees recognized upon termination of franchise agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="jynt:GainLossOnTerminationOfFranchisingAgreements" format="ixt:num-dot-decimal" scale="0" id="f-286">347,097</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="jynt:GainLossOnTerminationOfFranchisingAgreements" format="ixt:num-dot-decimal" scale="0" id="f-287">239,335</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="0" id="f-288">93,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="0" id="f-289">55,556</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="0" id="f-290">286,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="0" id="f-291">220,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-292">1,297,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-293">1,679,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="0" id="f-294">1,534,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="0" id="f-295">1,645,078</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="0" id="f-296">35,389</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="0" id="f-297">101,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred franchise costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:num-dot-decimal" scale="0" id="f-298">547,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:num-dot-decimal" scale="0" id="f-299">499,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deposits and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:IncreaseDecreaseInDepositOtherAssets" format="ixt:num-dot-decimal" scale="0" id="f-300">5,276</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInDepositOtherAssets" format="ixt:num-dot-decimal" scale="0" id="f-301">8,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="0" id="f-302">391,127</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="0" id="f-303">68,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="0" id="f-304">2,994,297</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="0" id="f-305">4,609,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Payroll liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="0" id="f-306">839,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="0" id="f-307">2,398,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="0" id="f-308">5,103,266</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="0" id="f-309">3,796,648</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="0" id="f-310">1,444,410</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="0" id="f-311">597,489</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Upfront regional developer fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="jynt:IncreaseDecreaseInRegionalDeveloperFees" format="ixt:num-dot-decimal" scale="0" id="f-312">285,443</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="jynt:IncreaseDecreaseInRegionalDeveloperFees" format="ixt:num-dot-decimal" scale="0" id="f-313">421,213</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="0" id="f-314">543,663</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="0" id="f-315">121,408</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="0" id="f-316">1,838,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="0" id="f-317">9,415,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of clinics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="0" id="f-318">7,778,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="0" id="f-319">554,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="0" id="f-320">1,503,785</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="0" id="f-321">1,185,647</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="0" id="f-322">6,274,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="0" id="f-323">631,547</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Payments of finance lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:num-dot-decimal" scale="0" id="f-324">4,354</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:num-dot-decimal" scale="0" id="f-325">25,484</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of treasury stock under employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-326">8,440</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-327">9,583</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of common stock under stock repurchase programs<br/></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="0" id="f-328">11,313,583</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="0" id="f-329">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-330">1,518,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-331">33,708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of Debt under the Credit Agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:fixed-zero" scale="0" id="f-332">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="0" id="f-333">2,000,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="0" id="f-334">9,807,579</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="0" id="f-335">2,001,359</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="0" id="f-336">1,694,568</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="0" id="f-337">6,782,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="0" id="f-338">25,996,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="0" id="f-339">19,214,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash, end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="0" id="f-340">24,301,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="0" id="f-341">25,996,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation of cash, cash equivalents and restricted cash:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-342">23,601,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-343">25,051,355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:RestrictedCash" format="ixt:num-dot-decimal" scale="0" id="f-344">700,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:RestrictedCash" format="ixt:num-dot-decimal" scale="0" id="f-345">945,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="0" id="f-346">24,301,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="0" id="f-347">25,996,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Supplemental cash flow disclosures:</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents supplemental cash flow disclosures and non-cash investing and financing activities:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash paid for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" id="f-348">50,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" id="f-349">69,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="0" id="f-350">626,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="0" id="f-351">610,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing activity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="0" id="f-352">245,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="0" id="f-353">124,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock option exercise receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="jynt:StockOptionExerciseReceivable" format="ixt:fixed-zero" scale="0" id="f-354">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="jynt:StockOptionExerciseReceivable" format="ixt:num-dot-decimal" scale="0" id="f-355">896,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">See notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">THE JOINT CORP. </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_136"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 1: &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="f-356" continuedAt="f-356-1" escape="true">Nature of Operations and Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="f-356-1" continuedAt="f-356-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-357" continuedAt="f-357-1" escape="true"><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="f-357-1">These financial statements represent the consolidated financial statements of The Joint Corp., which includes its variable interest entities (&#8220;VIEs&#8221;), and its wholly owned subsidiary, The Joint Corporate Unit No. 1, LLC (collectively, the &#8220;Company&#8221;). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amount of assets, liabilities, revenue, costs, expenses, other (expenses) income, and income taxes that are reported in the consolidated financial statements and accompanying disclosures. These estimates are based on management&#8217;s best knowledge of current events, historical experience, actions that we may undertake in the future and on various other assumptions that are believed to be reasonable under the circumstances. As a result, actual results may be different from these estimates.</ix:continuation> For a discussion of significant estimates and judgments made in recognizing revenue, accounting for leases, and accounting for income taxes, see Note 2, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Revenue Disclosures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, Note 9, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, and Note 10, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The results of operations of the corporate clinic segment are reported in Income (loss) from discontinued operations before income tax expense in its consolidated income statements for all periods presented and the related assets and liabilities associated with discontinued operations are classified as discontinued operation assets and liabilities in the consolidated balance sheets at December&#160;31, 2025 and 2024. The consolidated statement of cash flows includes cash flows related to the discontinued operations and accordingly, cash flow amounts for discontinued operations are disclosed in Note 3, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Divestitures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">. All results and information in the consolidated financial statements are presented as continuing operations and exclude the corporate clinic segment unless otherwise noted specifically as discontinued operations. For additional information, refer to Note 3, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Divestitures.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-358" continuedAt="f-358-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-358-1">The accompanying consolidated financial statements include the accounts of The Joint and its wholly owned subsidiary, The Joint Corporate Unit No. 1, LLC, which was dormant for all periods presented. We consolidate VIEs in which we are the primary beneficiary in accordance with Accounting Standards Codification 810, Consolidations (&#8220;ASC 810&#8221;). Non-controlling interests represent third-party equity ownership interests in VIEs. All significant inter-affiliate accounts and transactions between The Joint and its VIEs have been eliminated in consolidation.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="f-359" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income (Loss)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) and comprehensive income (loss) are the same for the years ended December&#160;31, 2025 and 2024.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="jynt:NatureofOperationsPolicyPolicyTextBlock" id="f-360" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Operations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Joint Corp., a Delaware corporation, was formed on March 10, 2010 for the principal purpose of franchising, developing, selling regional developer rights, supporting the operations of franchised chiropractic clinics at locations throughout the United States of America. The franchising of chiropractic clinics is regulated by the Federal Trade Commission and various state authorities.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFranchisorDisclosureTableTextBlock" id="f-361" continuedAt="f-361-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the number of clinics in operation under franchise agreements and as company-owned or managed for the years ended December&#160;31, 2025 and 2024. All company-owned or managed clinics operations are recorded as discontinued operations:</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-356-2" continuedAt="f-356-3"><ix:continuation id="f-361-1"><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Franchised clinics:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinics open at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic" contextRef="c-48" decimals="INF" name="us-gaap:NumberOfStores" scale="0" id="f-362">842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic" contextRef="c-49" decimals="INF" name="us-gaap:NumberOfStores" scale="0" id="f-363">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Opened during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic" contextRef="c-50" decimals="INF" name="jynt:ClinicsOpenedDuringThePeriod" scale="0" id="f-364">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic" contextRef="c-51" decimals="INF" name="jynt:ClinicsOpenedDuringThePeriod" scale="0" id="f-365">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Acquired during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic" contextRef="c-50" decimals="INF" name="jynt:ClinicsAcquiredDuringPeriod" scale="0" id="f-366">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic" contextRef="c-51" decimals="INF" name="jynt:ClinicsAcquiredDuringPeriod" scale="0" id="f-367">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Sold during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic" contextRef="c-50" decimals="INF" name="jynt:ClinicsSoldDuringPeriod" format="ixt:fixed-zero" scale="0" id="f-368">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic" contextRef="c-51" decimals="INF" name="jynt:ClinicsSoldDuringPeriod" format="ixt:fixed-zero" scale="0" id="f-369">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Closed during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="clinic" contextRef="c-50" decimals="INF" name="jynt:ClinicsClosedDuringThePeriod" scale="0" id="f-370">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="clinic" contextRef="c-51" decimals="INF" name="jynt:ClinicsClosedDuringThePeriod" scale="0" id="f-371">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinics in operation at the end of the year</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic" contextRef="c-52" decimals="INF" name="us-gaap:NumberOfStores" scale="0" id="f-372">885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic" contextRef="c-48" decimals="INF" name="us-gaap:NumberOfStores" scale="0" id="f-373">842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Company-owned or managed clinics:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinics open at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic" contextRef="c-53" decimals="INF" name="us-gaap:NumberOfStores" scale="0" id="f-374">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic" contextRef="c-54" decimals="INF" name="us-gaap:NumberOfStores" scale="0" id="f-375">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Opened during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic" contextRef="c-55" decimals="INF" name="jynt:ClinicsOpenedDuringThePeriod" format="ixt:fixed-zero" scale="0" id="f-376">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic" contextRef="c-56" decimals="INF" name="jynt:ClinicsOpenedDuringThePeriod" format="ixt:fixed-zero" scale="0" id="f-377">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Acquired during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic" contextRef="c-55" decimals="INF" name="jynt:ClinicsAcquiredDuringPeriod" format="ixt:fixed-zero" scale="0" id="f-378">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic" contextRef="c-56" decimals="INF" name="jynt:ClinicsAcquiredDuringPeriod" format="ixt:fixed-zero" scale="0" id="f-379">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Sold during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="clinic" contextRef="c-55" decimals="INF" name="jynt:ClinicsSoldDuringPeriod" scale="0" id="f-380">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="clinic" contextRef="c-56" decimals="INF" name="jynt:ClinicsSoldDuringPeriod" scale="0" id="f-381">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Closed during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="clinic" contextRef="c-55" decimals="INF" name="jynt:ClinicsClosedDuringThePeriod" scale="0" id="f-382">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="clinic" contextRef="c-56" decimals="INF" name="jynt:ClinicsClosedDuringThePeriod" scale="0" id="f-383">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinics in operation at the end of the year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic" contextRef="c-57" decimals="INF" name="us-gaap:NumberOfStores" scale="0" id="f-384">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic" contextRef="c-53" decimals="INF" name="us-gaap:NumberOfStores" scale="0" id="f-385">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total clinics in operation at the end of the year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic" contextRef="c-4" decimals="INF" name="us-gaap:NumberOfStores" scale="0" id="f-386">960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic" contextRef="c-5" decimals="INF" name="us-gaap:NumberOfStores" scale="0" id="f-387">967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinic licenses sold but not yet developed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic" contextRef="c-4" decimals="INF" name="jynt:ClinicLicensesSoldButNotYetDeveloped" scale="0" id="f-388">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic" contextRef="c-5" decimals="INF" name="jynt:ClinicLicensesSoldButNotYetDeveloped" scale="0" id="f-389">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Executed letters of intent for future clinic licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic" contextRef="c-4" decimals="INF" name="jynt:ExecutedLettersOfIntentForFutureClinicLicenses" scale="0" id="f-390">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic" contextRef="c-5" decimals="INF" name="jynt:ExecutedLettersOfIntentForFutureClinicLicenses" scale="0" id="f-391">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationVariableInterestEntityPolicy" id="f-392" continuedAt="f-392-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Interest Entities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Certain states prohibit the &#8220;corporate practice of chiropractic,&#8221; which restricts business corporations from practicing chiropractic care by exercising control over clinical decisions by chiropractic doctors. In states that prohibit the corporate practice of chiropractic, we typically enter into long-term management agreements with professional corporations (&#8220;PCs&#8221;) that are owned by licensed chiropractic doctors, which, in turn, employ or contract with doctors who provide professional chiropractic care in our clinics. Under these management agreements with PCs, we provide, on an exclusive basis, all non-clinical services of the chiropractic practice. We have entered into such management agreements with <ix:nonFraction unitRef="corporation" contextRef="c-4" decimals="INF" name="jynt:ManagementAgreementNumberOfProfessionalCorporations" format="ixt-sec:numwordsen" scale="0" id="f-393">four</ix:nonFraction> PCs. In connection with the sale of <ix:nonFraction unitRef="clinic" contextRef="c-58" decimals="INF" name="jynt:ClinicsSoldDuringPeriod" format="ixt-sec:numwordsen" scale="0" id="f-394">five</ix:nonFraction> company-owned or managed clinics located in Kansas and Missouri, we terminated our management agreement with <ix:nonFraction unitRef="corporation" contextRef="c-59" decimals="INF" name="jynt:ManagementAgreementTerminationNumberOfProfessionalCorporations" format="ixt-sec:numwordsen" scale="0" id="f-395">one</ix:nonFraction> PC as of June 30, 2025. For additional information on clinic sales, refer to Note 3, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> If an entity is deemed to be the primary beneficiary of a VIE, the entity is required to consolidate the VIE in its financial statements. An entity is deemed to be the primary beneficiary of a VIE if it has both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE&#8217;s economic performance, and (b) the obligation to absorb the majority of losses of the VIE or the right to receive the majority of benefits from the VIE. In accordance with relevant accounting guidance, these PCs were determined to be VIEs, as fees paid by the PCs to us as our management service provider are considered variable interests because the fees do not meet all the following criteria: (1) the fees are compensation for services provided and are commensurate with the level of effort required to provide those services; (2) the decision maker or service provider does not hold other interests in the VIE that individually, or in the aggregate, would absorb more than an insignificant amount of the VIE&#8217;s expected losses or receive more than an insignificant amount of the VIE&#8217;s expected residual returns; and (3) the service arrangement includes only terms, conditions, or amounts that are customarily present in arrangements for similar services negotiated at arm&#8217;s length. Additionally, we have determined that we have the ability to direct the activities that most significantly impact the performance of these PCs and has an obligation to absorb losses or receive benefits which could potentially be significant to the PCs. Accordingly, the PCs are VIEs for which we are the primary beneficiary and are consolidated by us. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The revenues of VIEs represent the revenues of company-managed clinics in states that prohibit the corporate practice of chiropractic. Our involvement with VIEs affects our financial performance and cash flows primarily through amounts recorded as revenues from company-owned or managed clinics and general and administrative expenses, which are principally comprised of payroll and related expenses, merchant card fees and insurance expense, all of which are reported in Income (loss) from discontinued operations before income tax expense in our consolidated income statements. The management fees/income </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-356-3" continuedAt="f-356-4"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-392-1">provided by the management agreements are considered intercompany transactions and therefore eliminated upon consolidation of VIEs.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfVariableInterestEntitiesTextBlock" id="f-396" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">VIE net income (including the management fee) for the years ended December&#160;31, 2025 and 2024 is included in Income (loss) from discontinued operations before income tax expense and income tax expense from discontinued operations in the consolidated income statements as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.984%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations before income tax expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="0" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="0" id="f-397">1,011,689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="0" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="0" id="f-398">1,641,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="0" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" format="ixt:num-dot-decimal" scale="0" id="f-399">25,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="0" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" format="ixt:num-dot-decimal" scale="0" id="f-400">210,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="0" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-401">986,482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="0" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-402">1,431,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of the VIEs&#8217; assets and liabilities is included in discontinued operations as of December&#160;31, 2025 and 2024 in the consolidated balance sheets as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.276%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="0" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="0" id="f-403">994,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="0" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="0" id="f-404">1,087,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="0" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="0" id="f-405">6,079,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="0" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="0" id="f-406">7,125,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-407" continuedAt="f-407-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-407-1">We consider all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. We continually monitor our positions with, and the credit quality of, the financial institutions with which we invest. As of the balance sheet date and periodically throughout the period, we have maintained balances in various operating accounts in excess of federally insured limits. We invest our cash primarily in short-term bank deposits and money market funds. We</ix:continuation> had $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-408">19.2</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="usd" contextRef="c-5" decimals="INF" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="0" id="f-409">zero</ix:nonFraction> cash equivalents invested in money market funds as of December&#160;31, 2025 and 2024, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="f-410" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash relates to cash that franchisees and company-owned or managed clinics contribute to our National Marketing Fund and cash that franchisees provide to various voluntary regional Co-Op Marketing Funds. Cash contributed by franchisees to the National Marketing Fund is to be used in accordance with our Franchise Disclosure Document with a focus on regional and national marketing and advertising. While such cash balance is not legally segregated and restricted as to withdrawal or usage, our accounting policy is to classify these funds as restricted cash.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Credit Losses </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="f-411" escape="true">Accounts receivable primarily represent amounts due from franchisees for royalty and software fees. Receivables are unsecured; however, the franchise agreements provide us the right to withdraw funds from the franchisee&#8217;s bank account or to terminate the franchise for nonpayment.</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="us-gaap:CreditLossFinancialInstrumentPolicyTextBlock" id="f-412" escape="true">We record an allowance for credit losses as a reduction to our accounts receivables for amounts that we do not expect to recover. An allowance for credit losses is determined through assessments of collectability based on historical trends, the financial condition of our franchisees, including any known or anticipated bankruptcies, and an evaluation of current economic conditions, as well as our expectations of conditions in the future. Actual losses ultimately could differ materially in the near term from the amounts estimated in determining the allowance.</ix:nonNumeric> As of December&#160;31, 2025, we had a $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="f-413">0.4</ix:nonFraction> million allowance for credit losses. As of December&#160;31, 2024, we had a $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="f-414">0.2</ix:nonFraction> million allowance for credit losses on accounts receivable.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="f-415" continuedAt="f-415-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a rollforward of the activity related to our allowance for credit losses:</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-356-4" continuedAt="f-356-5"><ix:continuation id="f-415-1"><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.351%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Allowance for credit losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="0" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:fixed-zero" scale="0" id="f-416">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt expense recognized during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="0" id="f-417">220,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Write-off of uncollectible amounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" format="ixt:fixed-zero" scale="0" id="f-418">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2024</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="0" id="f-419">220,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt expense recognized during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="0" id="f-420">286,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Write-off of uncollectible amounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" format="ixt:num-dot-decimal" scale="0" id="f-421">77,638</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2025</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="0" id="f-422">429,487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:DeferredChargesPolicyTextBlock" id="f-423" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Franchise Costs and Regional Development Costs</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Deferred franchise and regional development costs represent commissions that are direct and incremental to us and are paid in conjunction with the sale of a franchise license or regional development rights. These costs are recognized as an expense, in franchise and regional development cost of revenues when the respective revenue is recognized, which is generally over the term of the related franchise or regional developer agreement.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-424" continuedAt="f-424-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-424-1">Property and equipment are stated at cost and relate mostly to the corporate headquarters leasehold improvements, its furniture and fixtures and other office and computer equipment. Depreciation is computed using the straight-line method over estimated useful lives, which is generally <span style="-sec-ix-hidden:f-425">three</span> to <ix:nonNumeric contextRef="c-65" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="f-426">ten years</ix:nonNumeric>. Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the assets. Maintenance and repairs are charged to expense as incurred; major renewals and improvements are capitalized. When items of property or equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is included in income.</ix:continuation> We recorded Net loss on disposition or impairment of $<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="3" id="f-427">8</ix:nonFraction> thousand and $<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="3" id="f-428">17</ix:nonFraction> thousand in our consolidated income statements related to continuing operations for the years ended December&#160;31, 2025 and 2024, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:InternalUseSoftwarePolicy" id="f-429" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitalized Software</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize certain software development costs, including costs to implement cloud computing arrangements that is a service contract. These capitalized costs are primarily related to software used by clinics for operations and by us for the management of operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct, are capitalized as assets in progress until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. We also capitalize costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Internally developed software is recorded as part of property and equipment. Maintenance and training costs are expensed as incurred. Internally developed software is amortized on a straight-line basis over its estimated useful life, which is generally <span style="-sec-ix-hidden:f-430">three</span> to <ix:nonNumeric contextRef="c-69" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="f-431">five years</ix:nonNumeric>. Implementation costs incurred in&#160;connection with a cloud computing arrangement that is a service contract are included in prepaid expenses in our consolidated balance sheets.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-432" continuedAt="f-432-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We lease property and equipment under operating and finance leases. We lease our corporate office space and the space for each of the company-owned or managed clinics in the portfolio. We recognize a right-of-use (&#8220;ROU&#8221;) asset and lease liability for all leases. The lease for our corporate office space is recognized as a ROU and lease liability in our consolidated balance sheets as continuing operations while all other leases for each of the company-owned or managed clinics are reported in discontinued operations. Certain leases include <ix:nonFraction unitRef="option" contextRef="c-4" decimals="INF" name="jynt:LesseeOperatingLeaseNumberOfRenewalOptions" format="ixt-sec:numwordsen" scale="0" id="f-433">one</ix:nonFraction> or more renewal options, generally for the same period as the initial term of the lease. The exercise of lease renewal options is generally at our sole discretion and, as such, we typically determine that exercise of these renewal options is not reasonably certain. As a result, we do not include the renewal option period in the expected lease term and the associated lease payments are not included in the measurement of the ROU asset and lease liability. When available, we use the rate implicit in the lease to discount lease payments; however, the rate implicit in the lease is not readily determinable for substantially all of our leases. In such cases, we estimate our incremental borrowing rate as the interest rate we would pay to borrow an amount equal to the lease payments over a similar term, with similar collateral as in the lease, and in a similar economic environment. We estimate these rates using available evidence such as rates imposed by third-party lenders to us in recent financings or observable risk-free interest rate and credit spreads for commercial debt of a similar duration, with credit spreads correlating to our estimated creditworthiness.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-356-5" continuedAt="f-356-6"><ix:continuation id="f-432-1"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For operating leases that include rent holidays and rent escalation clauses, we recognize lease expense on a straight-line basis over the lease term from the date we take possession of the leased property. Pre-opening costs are recorded as incurred in general and administrative expenses. Variable lease payments, such as percentage rentals based on location sales, periodic adjustments for inflation, reimbursement of real estate taxes, any variable common area maintenance and any other variable costs associated with the leased corporate office space are expensed as incurred in general and administrative expenses on the consolidated income statements. Any variable costs associated with the leased property for company-owned or managed clinics are expensed as incurred and are included in Income (loss) from discontinued operations before income tax expense in our consolidated income statements.</span></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2025 and 2024, certain leases related to discontinued operations were terminated early with the landlord as a result of corporate clinic closures. The net losses to terminate the leases were recorded in Income (loss) from discontinued operations before income tax expense in our consolidated income statements of $<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-5" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" scale="6" id="f-434">1.4</ix:nonFraction> million for the year ended December&#160;31, 2025 and $<ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-5" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" scale="6" id="f-435">0.4</ix:nonFraction> million for the year ended December&#160;31, 2024.</span><span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:IntangibleAssetsFiniteLivedPolicy" id="f-436" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist primarily of reacquired franchise rights and customer relationships. All of our intangible assets are reported in discontinued operations. We amortize the fair value of reacquired franchise rights over the remaining contractual terms of the reacquired franchise rights at the time of the acquisition, which generally range from <span style="-sec-ix-hidden:f-437">one</span> to <ix:nonNumeric contextRef="c-73" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="f-438">nine years</ix:nonNumeric>. The fair value of customer relationships is amortized over their estimated useful life of <span style="-sec-ix-hidden:f-439">two</span> to <ix:nonNumeric contextRef="c-75" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="f-440">four years</ix:nonNumeric>. Intangible assets are attributable entirely to discontinued operations.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="f-441" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill consists of the excess of the purchase price over the fair value of tangible and identifiable intangible assets acquired in the acquisitions of franchises. Goodwill and intangible assets deemed to have indefinite lives are not amortized but are tested for impairment annually and more frequently if a triggering event occurs that makes it more likely than not that the fair value of a reporting unit is below carrying value. As required, we perform an annual impairment test of goodwill as of the first day of the fourth quarter or more frequently if a triggering event occurs. Goodwill is attributable entirely to discontinued operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2025, we performed a quantitative assessment of the fair value of the reporting unit and concluded that the fair value of the corporate clinic reporting unit exceeded its carrying value. The fair value of the reporting unit was determined using Level 2 inputs, which includes a potential buyer agreed-upon selling price, or Level 3 inputs, which includes consideration of a market approach using a multiple of earnings assumption based on clinic-level historical financial performance as well as an income approach using discounted cash flow models that use significant unobservable inputs and assumptions.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-442"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-443">No</ix:nonFraction></ix:nonFraction> impairment of goodwill was recorded for the years ended December&#160;31, 2025 and 2024.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DiscontinuedOperationsPolicyTextBlock" id="f-444" continuedAt="f-444-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Discontinued Operations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In determining whether a group of assets which has been disposed of (or is to be disposed of) should be presented as discontinued operations, we first analyze whether the group of assets being disposed of represents a component of the entity or group of components of the entity. A component typically has historic operations and cash flows that are clearly distinguishable for both operations and financial reporting purposes. In addition, we consider whether the disposal represents a strategic shift that has or will have a major effect on our operations and financial results. This strategic shift could include a disposal of a major geographical area, a major line of business, a major equity method investment or other major parts of an entity.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-444-1">We report financial results for discontinued operations separately from continuing operations to distinguish the financial impact of disposal transactions from ongoing operations. The assets and liabilities of a discontinued operation held for sale, other than goodwill, are measured at the lower of its carrying amount or fair value less cost to sell. When a portion of a reporting unit that constitutes a business is to be disposed of, the goodwill associated with that business is included in the carrying amount of the business based on the relative fair values of the business to be disposed of and the portion of the reporting unit that will be retained.</ix:continuation> See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="f-445" continuedAt="f-445-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Assets - Continuing Operations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recovered. We look primarily to estimated undiscounted future cash flows in our assessment of whether </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-356-6" continuedAt="f-356-7"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-445-1" continuedAt="f-445-2">or not long-lived assets are recoverable. We record an impairment loss when the carrying amount of the asset is not recoverable and exceeds its fair value.</ix:continuation> <ix:nonNumeric contextRef="c-1" name="us-gaap:DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" id="f-446" continuedAt="f-446-1" escape="true">During the year ended December&#160;31, 2024, certain long-lived asset groups were determined to not be recoverable and were written down from their carrying values to their respective fair values resulting in the following non-cash impairment losses which are included in <span style="-sec-ix-hidden:f-447">Net loss on disposition or impairment</span> related to continuing operations. Net impairment losses on long-lived assets were not material for the year ended December&#160;31, 2025.</ix:nonNumeric></span></div><ix:continuation id="f-446-1"><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.271%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net loss on disposition or impairment related to continuing operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="0" name="jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment" format="ixt:num-dot-decimal" id="f-448">57,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="0" name="jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment" format="ixt:num-dot-decimal" id="f-449">40,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="0" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" id="f-450">17,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="0" name="jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment" format="ixt:num-dot-decimal" id="f-451">703,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="0" name="jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment" format="ixt:num-dot-decimal" id="f-452">667,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="0" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" id="f-453">36,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="0" name="jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment" format="ixt:num-dot-decimal" id="f-454">12,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="0" name="jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment" format="ixt:fixed-zero" id="f-455">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="0" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" id="f-456">12,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Total Net loss on disposition or impairment related to continuing operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" id="f-457">66,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Assets - Discontinued Operations</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="f-458" continuedAt="f-458-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2024, certain long-lived asset groups classified as held and used were determined to not be recoverable were written down from their carrying values to their respective fair values resulting in the following non-cash impairment losses which are included in Income (loss) from discontinued operations before income tax expense in the consolidated income statements. </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.338%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.149%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net loss on disposition or impairment related to discontinued operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="0" name="jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment" format="ixt:num-dot-decimal" id="f-459">3,929,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="0" name="jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment" format="ixt:num-dot-decimal" id="f-460">2,755,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" id="f-461">1,173,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="0" name="jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment" format="ixt:num-dot-decimal" id="f-462">5,779,712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="0" name="jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment" format="ixt:num-dot-decimal" id="f-463">4,347,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" id="f-464">1,432,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="0" name="jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment" format="ixt:num-dot-decimal" id="f-465">298,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="0" name="jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment" format="ixt:num-dot-decimal" id="f-466">252,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" id="f-467">45,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Total Net loss on disposition or impairment related to discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" id="f-468">2,651,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-445-2">Long-lived assets that meet the criteria for the held for sale designation are reported at the lower of their carrying value or fair value less estimated cost to sell.</ix:continuation> <ix:continuation id="f-458-1" continuedAt="f-458-2">As a result of its evaluation of the recoverability of the carrying value of the assets and liabilities held for sale relative to the clinics estimated fair values, we recorded an estimated net loss on disposal, which is included in Income (loss) from discontinued operations before income tax expense in the consolidated income statements:</ix:continuation></span><ix:continuation id="f-458-2" continuedAt="f-458-3"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Net loss on disposition or impairment related to discontinued operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" id="f-469">2,734,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" id="f-470">4,540,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></ix:continuation></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="jynt:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" scale="6" id="f-471">6.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="jynt:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" scale="6" id="f-472">5.1</ix:nonFraction> million as of December&#160;31, 2025 and 2024, respectively, are included in Discontinued operations current assets on the consolidated balance sheets.</span></div><ix:continuation id="f-458-3" continuedAt="f-458-4"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the composition of our impairment losses and disposal gains and losses recorded in Income (loss) from discontinued operations before income tax expense for the years ended December&#160;31, 2025 and 2024:</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-356-7" continuedAt="f-356-8"><ix:continuation id="f-458-4" continuedAt="f-458-5"><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Impairment on long-lived assets held for use</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:fixed-zero" id="f-473">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" id="f-474">1,173,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:fixed-zero" id="f-475">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" id="f-476">1,432,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:fixed-zero" id="f-477">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" id="f-478">45,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Impairment on assets held for sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" id="f-479">2,734,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" id="f-480">4,540,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Loss on disposal of assets other than by sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" id="f-481">383,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" id="f-482">161,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" id="f-483">1,396,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" id="f-484">406,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Loss (gain) on the sale of assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" id="f-485">926,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="0" sign="-" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" id="f-486">44,807</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Total net loss on disposition or impairment related to discontinued operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" id="f-487">5,441,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" id="f-488">7,714,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="jynt:AdvertisingFundPolicyTextBlock" id="f-489" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising Fund</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have established an advertising fund for national or regional marketing and advertising of services offered by our clinics. The monthly marketing fee is <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="jynt:FranchiseMonthlyMarketingFeeGrossSalesPercentage" scale="-2" id="f-490">2</ix:nonFraction>% of clinic sales. We segregate the advertising funds collected and any unspent amounts, if applicable, are included in restricted cash on our consolidated balance sheets. As amounts are expended from the fund, we recognize a related expense. Such costs are included in selling and marketing expenses on the consolidated income statements.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="jynt:CoOpMarketingFundsPolicyPolicyTextBlock" id="f-491" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Co-Op Marketing Funds&#160;&#160;&#160;&#160;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Some franchises have established regional Co-Ops for advertising within their local and regional markets. We maintain a custodial relationship under which the Co-Op Marketing Funds collected are segregated and used for the purposes specified by the Co-Ops&#8217; officers. The Co-Op Marketing Funds are included in restricted cash on our consolidated balance sheets.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-492" continuedAt="f-492-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue primarily through company-owned or managed clinics and through royalties, franchise fees, advertising fund contributions, IT related income and computer software fees from our franchisees.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues from Company-Owned or Managed Clinics.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> We earn revenues from clinics that we own and operate or manage throughout the United States. Revenues from clinics that we own and operate are recognized when services are performed and are related to discontinued operations. We offer a variety of membership and wellness packages which feature discounted pricing as compared with our single-visit pricing. Amounts collected in advance for membership and wellness packages are recorded as deferred revenue and recognized when the service is performed. Any unused visits associated with monthly memberships are recognized on a month-to-month basis. We recognize a contract liability (or a deferred revenue liability) related to the prepaid treatment plans for which we have an ongoing performance obligation. We derecognize this contract liability, and recognize revenue, as the patient consumes his or her visits related to the package and we transfer our services. If we determine that it is not subject to unclaimed property laws for the portion of the package that we do not expect to be redeemed (referred to as &#8220;breakage&#8221;), then we recognize breakage revenue in proportion to the pattern of exercised rights by the patient.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalties and Advertising Fund Revenue.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> We collect royalties, as stipulated in the franchise agreement, equal to <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="jynt:FranchiseRoyaltyGrossSalesPercentage" scale="-2" id="f-493">7</ix:nonFraction>% of gross sales, and a marketing and advertising fee currently equal to <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="jynt:FranchiseMonthlyMarketingFeeGrossSalesPercentage" scale="-2" id="f-494">2</ix:nonFraction>% of gross sales. Royalties, including franchisee contributions to advertising funds, are calculated as a percentage of clinic sales over the term of the franchise agreement. The revenue accounting standard provides an exception for the recognition of sales-based royalties promised in exchange for a license (which generally requires a reporting entity to estimate the amount of variable consideration to which it will be entitled in the transaction price). As the franchise agreement royalties, inclusive of advertising fund contributions, represent sales-based royalties that are related entirely to our performance obligation under the franchise agreement, such sales-based royalties are recognized as franchisee clinic level sales occur. Royalties are collected semi-monthly, two working days after each sales period has ended.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-356-8" continuedAt="f-356-9"><ix:continuation id="f-492-1"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Franchise Fees.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> We require the entire non-refundable initial franchise fee to be paid upon execution of a franchise agreement, which typically has an initial term of <ix:nonNumeric contextRef="c-1" name="jynt:RevenueRecognitionFranchiseAgreementTerm" format="ixt-sec:duryear" id="f-495">10</ix:nonNumeric> years. Initial franchise fees are recognized ratably on a straight-line basis over the term of the franchise agreement. Our services under the franchise agreement include the training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. We provide no financing to franchisees and offer no guarantees on their behalf. The services provided by us are highly interrelated with the franchise license and as such are considered to represent a single performance obligation. Renewal franchise fees, as well as transfer fees, are also recognized as revenue on a straight-line basis over the term of the respective franchise agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Software Fees.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We collect a monthly fee from our franchisees for the use of our proprietary chiropractic software, computer support and internet services support. These fees are recognized ratably on a straight-line basis over the term of the respective franchise agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Capitalized Sales Commissions. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Sales commissions earned by the regional developers and our sales force are considered incremental and recoverable costs of obtaining a franchise agreement with a franchisee. These costs are deferred and then amortized as the respective franchise fees are recognized ratably on a straight-line basis over the term of the franchise agreement. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Upfront Regional Developer Rights Fees </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have a regional developer program where regional developers are granted an exclusive geographical territory and commit to a minimum development obligation within that defined territory. Upon granting of the exclusive rights to develop a territory, a regional developer will pay an upfront fee to us. Upfront regional developer fees represent consideration received from a vendor to act as our agent within an exclusive territory. The upfront regional developer rights fee is accounted for as a reduction of cost of revenues, in franchise and regional development cost of revenues, to offset the respective future commissions paid to the regional developer. The fees are ratably recognized over the term of the related regional developer agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Regional developers receive fees which are funded by the initial franchise fees collected from franchisees upon the sale of franchises within their exclusive geographical territory and a royalty of <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="jynt:RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" scale="-2" id="f-496">3</ix:nonFraction>% of sales generated by franchised clinics in their exclusive geographical territory. Initial fees related to the sale of franchises within their exclusive geographical territory are initially deferred as deferred franchise costs and are recognized as an expense in franchise cost of revenues when the respective revenue is recognized, which is generally over the term of the related franchise agreement. Royalties of <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="jynt:RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" scale="-2" id="f-497">3</ix:nonFraction>% of sales generated by franchised clinics in their regions are also recognized as franchise cost of revenues as franchisee clinic level sales occur. This <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="jynt:RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" scale="-2" id="f-498">3</ix:nonFraction>% fee is funded by the <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="jynt:FranchiseRoyaltyGrossSalesPercentage" scale="-2" id="f-499">7</ix:nonFraction>% royalties we collect from the franchisees in their regions. Certain regional developer agreements result in the regional developer acquiring the rights to existing royalty streams from clinics already open in the respective territory. In those instances, fees collected from the sale of the royalty stream is recognized as a decrease to franchise and regional developer cost of revenues over the remaining life of the respective franchise agreements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:106%">Regional Developer Rights Contract Termination Costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, subject to our strategy, regional developer rights are reacquired by us, resulting in a termination of the contract. The termination costs to reacquire the regional developer rights are recognized at fair value, less any unrecognized upfront regional developer fee liability balance, as a general and administrative expense in the period in which the contract is terminated in accordance with the contract terms and are recorded within general and administrative expenses.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="f-500" continuedAt="f-500-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Advertising Costs</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-500-1">Advertising costs are advertising and marketing expenses incurred by us, primarily through advertising funds. We expense production costs of commercial advertising upon first airing and expenses the costs of communicating the advertising in the period in which the advertising occurs.</ix:continuation> Advertising expenses, excluding National Marketing Fund costs, were $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AdvertisingExpense" scale="6" id="f-501">0.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="us-gaap:AdvertisingExpense" scale="6" id="f-502">0.8</ix:nonFraction> million for the years ended December&#160;31, 2025 and 2024, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-503" continuedAt="f-503-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for using a balance sheet approach known as the asset and liability method. The asset and liability method accounts for deferred income taxes by applying the statutory tax rates in effect at the date of the consolidated balance sheets to differences between the book basis and the tax basis of assets and liabilities. Deferred tax assets and liabilities represent the future tax consequence for those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. The differences relate principally to depreciation of property and equipment and treatment of revenue for franchise fees and regional developer fees collected. Tax positions are reviewed at least quarterly and adjusted as </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-356-9" continuedAt="f-356-10"><ix:continuation id="f-503-1"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">new information becomes available. The recoverability of deferred tax assets is evaluated by assessing the adequacy of future expected taxable income from all sources, including reversal of taxable temporary differences, forecasted operating earnings and available tax planning strategies. These estimates of future taxable income inherently require significant judgment. To the extent it is considered more likely than not that a deferred tax asset will be not recovered, a valuation allowance is established. We applied the intra-period allocation rules under ASC 740-20-45-1 to allocate the tax provision between continuing operations and discontinued operations. The tax provision amount reported as Income tax expense and disclosed at Note 9, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> is all related to continuing operations and the remaining provision amount is allocated as discontinued operations and reported as Income tax expense from discontinued operations for the years ended December&#160;31, 2025 and 2024.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We account for uncertainty in income taxes by recognizing the tax benefit or expense from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the position. We measure the tax benefits and expenses recognized in the consolidated financial statements from such a position based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution. We have identified $<ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-504">0.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-505">0.9</ix:nonFraction>&#160;million in uncertain tax positions related to our VIEs in discontinued operations as of December&#160;31, 2025 and 2024, respectively. Interest and penalties associated with tax positions are recorded in the period assessed as general and administrative expenses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">With exceptions due to the generation and utilization of net operating losses or credits, as of December&#160;31, 2025, we are no longer subject to federal and state examinations by taxing authorities for tax years before 2022 and 2021, respectively.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-506" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings (Loss) per Common Share</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per common share is computed by giving effect to all potentially dilutive common shares including restricted stock and stock options. Diluted earnings (loss) per common share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-507" continuedAt="f-507-1" escape="true"><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-508">268,157</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-509">1,614,344</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-510">3,175,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-511">4,182,549</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="0" id="f-512">2,907,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="0" id="f-513">5,796,893</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8212; basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-514">15,134,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-515">14,919,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock and stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-516">52,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-517">228,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8212; diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-518">15,186,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-519">15,147,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings (loss) per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="f-520">0.02</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-18" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="f-521">0.11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="f-522">0.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-18" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="f-523">0.28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-524">0.19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-18" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-525">0.39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="f-526">0.02</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-18" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="f-527">0.11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="f-528">0.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-18" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="f-529">0.28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-530">0.19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-18" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-531">0.38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive securities excluded from the calculation of diluted net income (loss) per common share as the effect would be anti-dilutive were as follows:</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-356-10" continuedAt="f-356-11"><ix:continuation id="f-507-1"><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-532">71,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-533">87,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-534" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We account for share-based payments by recognizing compensation expense based upon the estimated fair value of the awards on the date of grant. We determine the estimated grant-date fair value of restricted shares using the closing price on the date of the grant and the grant-date fair value of stock options using the Black-Scholes-Merton model. In order to calculate the fair value of the options, certain assumptions are made regarding the components of the model, including risk-free interest rate, volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. We recognize compensation costs ratably over the period of service using the straight-line method. Forfeitures are estimated based on historical and forecasted turnover, which is approximately <ix:nonFraction unitRef="number" contextRef="c-4" decimals="2" name="jynt:ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage" scale="-2" id="f-535">5</ix:nonFraction>%.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:PostemploymentBenefitPlansPolicy" id="f-536" continuedAt="f-536-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Retirement Benefit Plan</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-536-1">Our employees are eligible to participate in a defined contribution retirement plan, the Joint Corp. 401(k) Retirement Plan (the &#8220;401(k) Plan&#8221;), under Section 401(k) of the Internal Revenue Code. Under the 401(k) Plan, employees may contribute their eligible compensation, not to exceed the annual limits set by the IRS. The 401(k) Plan allows us to match participants&#8217; contributions in an amount determined in our sole discretion. We matched participants&#8217; contributions for the years ended December&#160;31, 2025 and 2024, up to a maximum of <ix:nonFraction unitRef="number" contextRef="c-18" decimals="2" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="f-537"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="f-538">4</ix:nonFraction></ix:nonFraction>% of the employee&#8217;s eligible compensation.</ix:continuation> Employer contributions for both continuing and discontinued operations totaled $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="f-539"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="f-540">0.6</ix:nonFraction></ix:nonFraction> million for each of the years ended December&#160;31, 2025 and 2024.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="f-541" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Loss Contingencies</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ASC Topic 450 governs the disclosure of loss contingencies and accrual of loss contingencies in respect of litigation and other claims. We record an accrual for a potential loss when it is probable that a loss will occur and the amount of the loss can be reasonably estimated. When the reasonable estimate of the potential loss is within a range of amounts, the minimum of the range of potential loss is accrued, unless a higher amount within the range is a better estimate than any other amount within the range. Moreover, if an accrual is not required, we provide additional disclosure related to litigation and other claims when it is reasonably possible (i.e., more than remote) that the outcomes of such litigation and other claims include potential material adverse impacts on us. Legal costs to be incurred in connection with a loss contingency are expensed as such costs are incurred.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-542" continuedAt="f-542-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-542-1">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Items subject to significant estimates and assumptions include loss contingencies, share-based compensations, useful lives and realizability of long-lived assets, deferred revenue and revenue recognition related to breakage, deferred franchise costs, calculation of ROU assets and liabilities related to leases, realizability of deferred tax assets, impairment of goodwill, intangible assets, other long-lived assets, and purchase price allocations and related valuations. Deferred revenue related to breakage, goodwill and intangible assets are related to discontinued operations.</ix:continuation> Refer to Note 3,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Divestitures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for more information on discontinued operations.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-543" continuedAt="f-543-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Guidance and Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (&#8220;ASU 2023-09&#8221;), which requires public entities to provide greater disaggregation within their annual rate reconciliation, including new requirements to present reconciling items on a gross basis in specified categories, disclose both percentages and dollar amounts, and disaggregate individual reconciling items by jurisdiction and nature when the effect of the items meet a quantitative threshold. ASU 2023-09 also requires disaggregating the annual disclosure of income taxes paid, net of refunds received, by federal (national), state, and foreign taxes, with separate presentation of individual jurisdictions that meet a quantitative threshold. ASU 2023-09 is effective for annual periods beginning after December 15, 2024 on a prospective basis, with a retrospective option, and early adoption is permitted. We have adopted ASU 2023-09 for the 2025 annual period on a retrospective basis. Refer to Note 9, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for the revised disclosures. </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-543-1"><ix:continuation id="f-356-11"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (&#8220;ASU 2023-07&#8221;), which requires public entities with a single reportable segment to provide all the disclosures required by this standard and all existing segment disclosures in Topic 280 on an interim and annual basis, including new requirements to disclose significant segment expenses that are regularly provided to the Chief Operating Decision Maker (&#8220;CODM&#8221;) and included within the reported measure(s) of a segment&#8217;s profit or loss, the amount and composition of any other segment items, the title and position of the CODM, and how the CODM uses the reported measure(s) of a segment&#8217;s profit or loss to assess performance and decide how to allocate resources. ASU 2023-07 is effective for annual periods beginning after December 15, 2023 and interim periods beginning after December 15, 2024, applied retrospectively with early adoption permitted. We have adopted ASU 2023-07 for the 2024 annual period and have identified no material effect on our consolidated financial statements or disclosures.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (&#8220;ASU 2024-03&#8221;), and in January 2025, the FASB issued ASU No. 2025-01, Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date, which clarified the effective date of ASU 2024-03. ASU 2024-03 will require us to disclose the amounts of purchases of inventory, employee compensation, depreciation and intangible asset amortization, as applicable, included in certain expense captions in the consolidated statements of operations, as well as qualitatively describe remaining amounts included in those captions. ASU 2024-03 will also require us to disclose both the amount and our definition of selling expenses. The transition method is prospective with the retrospective method permitted and will be effective for our annual period ending December 31, 2027 and interim periods for the interim period beginning January 1, 2028. We are currently evaluating the impact of adoption of ASU 2024-03 on our consolidated financial statements and disclosures.</span></div></ix:continuation></ix:continuation><div id="iaf8338e230dd46e38cf560e1698dc7ef_142"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 2:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="f-544" continuedAt="f-544-1" escape="true">Revenue Disclosures</ix:nonNumeric></span></div><ix:continuation id="f-544-1" continuedAt="f-544-2"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Franchising Fees, Royalty Fees, Advertising Fund Revenue, and Software Fees</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2025, we had <ix:nonFraction unitRef="clinic" contextRef="c-52" decimals="INF" name="us-gaap:NumberOfStores" scale="0" id="f-545">885</ix:nonFraction> franchised clinics in operation, <ix:nonFraction unitRef="clinic" contextRef="c-4" decimals="INF" name="jynt:ClinicLicensesSoldButNotYetDeveloped" scale="0" id="f-546">82</ix:nonFraction> clinic licenses sold but not yet developed and <ix:nonFraction unitRef="clinic" contextRef="c-4" decimals="INF" name="jynt:ExecutedLettersOfIntentForFutureClinicLicenses" scale="0" id="f-547">57</ix:nonFraction> executed letters of intent for future clinic licenses. The franchise arrangement is documented in the form of a franchise agreement. The franchise arrangement requires us to perform various activities to support the brand that do not directly transfer goods and services to the franchisee, but instead represent a single performance obligation, which is the transfer of the franchise license. The intellectual property subject to the franchise license is symbolic intellectual property as it does not have significant standalone functionality, and substantially all of the utility is derived from its association with our past or ongoing activities. The nature of our promise in granting the franchise license is to provide the franchisee with access to the brand&#8217;s symbolic intellectual property over the term of the license. The services provided by us are highly interrelated with the franchise license and as such are considered to represent a single performance obligation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price in a standard franchise arrangement primarily consists of (a) initial franchise fees, (b) continuing franchise fees (royalties), (c) advertising fees, and (d) software fees. The revenue accounting standard provides an exception for the recognition of sales-based royalties promised in exchange for a license (which otherwise requires a reporting entity to estimate the amount of variable consideration to which it will be entitled in the transaction price). </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the primary components of the transaction price as follows:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Initial and renewal franchise fees, as well as transfer fees, are recognized as revenue ratably on a straight-line basis over the term of the respective franchise agreement commencing with the execution of the franchise, renewal, or transfer agreement. As these fees are typically received in cash at or near the beginning of the contract term, the cash received is initially recorded as a contract liability until recognized as revenue over time.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are entitled to royalties and advertising fees based on a percentage of the franchisee&#8217;s gross sales as defined in the franchise agreement. Royalty and advertising revenue are recognized when the franchisee&#8217;s sales occur. Depending on timing within a fiscal period, the recognition of revenue results in either what is considered a contract asset (unbilled receivable) or, once billed, accounts receivable, on the consolidated balance sheets.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are entitled to a software fee, which is charged monthly. We recognize revenue related to software fees ratably on a straight-line basis over the term of the franchise agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In determining the amount and timing of revenue from contracts with customers, we exercise significant judgment with respect to collectability of the amount; however, the timing of recognition does not require significant judgment as it is based on either the franchise term or the reported sales of the franchisee, neither of which requires estimation. We believe that our franchising arrangements do not contain a significant financing component.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-544-2" continuedAt="f-544-3"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We recognize advertising fees received under franchise agreements as advertising fund revenue.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capitalized Sales Commissions</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Sales commissions earned by the regional developers and our sales force are considered incremental and recoverable costs of obtaining a franchise agreement with a franchisee. These costs are deferred and then amortized as the respective franchise fees are recognized ratably on a straight-line basis over the term of the franchise agreement.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the captions contained on the consolidated income statements appropriately reflect the disaggregation of our revenue by major type for the years ended December&#160;31, 2025 and 2024. Other revenues primarily consist of merchant income associated with preferred vendor royalties associated with franchisees&#8217; credit card transactions.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-548" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows our revenues disaggregated according to the timing of transfer of services:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized at a point in time</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" id="f-549">45,486,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" id="f-550">43,478,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized over time</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" id="f-551">9,408,889</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" id="f-552">8,685,176</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" id="f-553">54,895,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" id="f-554">52,163,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rollforward of Accounts Receivable</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="f-555" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Changes in our accounts receivable, net during the years ended December&#160;31, 2025 and 2024 were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.351%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Accounts Receivable, Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="0" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="0" id="f-556">2,580,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash received against accounts receivable included at the beginning of the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="jynt:AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance" format="ixt:num-dot-decimal" scale="0" id="f-557">2,387,577</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net increase during the year ended December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="jynt:AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance" format="ixt:num-dot-decimal" scale="0" id="f-558">2,614,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="0" id="f-559">220,893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="0" id="f-560">2,586,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash received against accounts receivable included at the beginning of the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="jynt:AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance" format="ixt:num-dot-decimal" scale="0" id="f-561">2,067,962</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net increase during the year ended December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="jynt:AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance" format="ixt:num-dot-decimal" scale="0" id="f-562">2,760,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" id="f-563">429,487</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2025</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="0" id="f-564">2,849,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="f-565" continuedAt="f-565-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Changes in our contract liability for deferred franchise fees during the years ended December&#160;31, 2025 and 2024 were as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.684%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Revenue<br/>Short and Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="0" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" id="f-566">16,113,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized that was included in the contract liability at the beginning of the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" id="f-567">2,841,085</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net increase during the year ended December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" format="ixt:num-dot-decimal" id="f-568">1,724,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2024</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" id="f-569">14,997,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized that was included in the contract liability at the beginning of the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" id="f-570">3,006,059</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net increase during the year ended December 31, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" format="ixt:num-dot-decimal" id="f-571">1,427,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2025</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" id="f-572">13,418,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-544-3"><ix:continuation id="f-565-1"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our deferred franchise and development costs represent capitalized sales commissions. Changes during the years ended December&#160;31, 2025 and 2024 were as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Franchise and Development Costs<br/>Short and Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="0" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" id="f-573">6,251,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Recognized as cost of revenue during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="jynt:ContractWithCustomerAssetRecognizedAsCostsOfRevenue" format="ixt:num-dot-decimal" id="f-574">1,221,140</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net increase during the year ended December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="jynt:CostsIncurredAndDeferredDuringTheYear" format="ixt:num-dot-decimal" id="f-575">539,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2024</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" id="f-576">5,569,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Recognized as cost of revenue during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="jynt:ContractWithCustomerAssetRecognizedAsCostsOfRevenue" format="ixt:num-dot-decimal" id="f-577">1,190,555</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Net increase during the year ended December 31, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="jynt:CostsIncurredAndDeferredDuringTheYear" format="ixt:num-dot-decimal" id="f-578">394,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2025</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" id="f-579">4,773,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" id="f-580" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates revenues expected to be recognized in the future related to performance obligations that were unsatisfied (or partially unsatisfied) as of December&#160;31, 2025. We have elected to exclude short term contracts, sales and usage-based royalties and any other variable consideration recognized on an &#8220;as invoiced&#8221; basis.</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Contract liabilities expected to be recognized in:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="0" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" id="f-581">2,519,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="0" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" id="f-582">2,413,277</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="0" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" id="f-583">2,254,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="0" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" id="f-584">1,899,640</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="0" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" id="f-585">1,630,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="0" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" id="f-586">2,701,180</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" id="f-587">13,418,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="iaf8338e230dd46e38cf560e1698dc7ef_148"></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 3:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="f-594" continuedAt="f-594-1" escape="true">Divestitures</ix:nonNumeric></span></div><ix:continuation id="f-594-1" continuedAt="f-594-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Clinic Segment Divestiture</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In 2023, we initiated plans to refranchise the majority of our company-owned or managed clinics with plans to retain a small portion of high-performing clinics. During the third quarter of 2024, we expanded the refranchising plan to include additional clinic markets of company-owned or managed clinics, marketing the clinics in clusters grouped by proximity to larger private equity firms. Because we have formalized a plan to sell our entire corporate clinic reportable segment, we have concluded that the overall refranchising plan represents a strategic shift that will have a major effect on our operations and financial results. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Since December&#160;31, 2024, the corporate clinics classified as held for sale are reported separately as discontinued operations in the consolidated income statements and consolidated balance sheets. As permitted, we elected not to adjust the consolidated statements of cash flows for the years ended December&#160;31, 2025 and 2024 to exclude cash flows attributable to discontinued operations. Accordingly, we disclosed the depreciation and amortization, capital expenditures and significant operating and investing non-cash items related to the corporate clinic segment below.</span></div><ix:continuation id="f-458-5" continuedAt="f-458-6"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The key components of Net income (loss) from discontinued operations that were included in our consolidated income statements are as follows:</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-594-2" continuedAt="f-594-3"><ix:continuation id="f-458-6" continuedAt="f-458-7"><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from company-owned or managed clinics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:num-dot-decimal" scale="0" id="f-595">54,038,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:num-dot-decimal" scale="0" id="f-596">69,982,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:num-dot-decimal" scale="0" id="f-597">54,038,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:num-dot-decimal" scale="0" id="f-598">69,982,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">IT cost of revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" format="ixt:num-dot-decimal" scale="0" id="f-599">20,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" format="ixt:num-dot-decimal" scale="0" id="f-600">47,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" format="ixt:num-dot-decimal" scale="0" id="f-601">20,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" format="ixt:num-dot-decimal" scale="0" id="f-602">47,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="0" name="jynt:DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses" format="ixt:num-dot-decimal" scale="0" id="f-603">5,755,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="0" name="jynt:DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses" format="ixt:num-dot-decimal" scale="0" id="f-604">7,850,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="0" id="f-605">69,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="0" id="f-606">3,350,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="0" id="f-607">39,450,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="0" id="f-608">54,988,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="0" name="jynt:DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses" format="ixt:num-dot-decimal" scale="0" id="f-609">45,276,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="0" name="jynt:DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses" format="ixt:num-dot-decimal" scale="0" id="f-610">66,190,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss on disposition or impairment from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" scale="0" id="f-611">5,441,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" scale="0" id="f-612">7,714,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-613">3,300,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="0" sign="-" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-614">3,970,172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="0" sign="-" name="jynt:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" format="ixt:num-dot-decimal" scale="0" id="f-615">99,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="0" sign="-" name="jynt:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" format="ixt:num-dot-decimal" scale="0" id="f-616">2,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income tax expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="0" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="0" id="f-617">3,200,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="0" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="0" id="f-618">3,972,286</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="0" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" format="ixt:num-dot-decimal" scale="0" id="f-619">25,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="0" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" format="ixt:num-dot-decimal" scale="0" id="f-620">210,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from discontinued operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="0" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-621">3,175,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-110" decimals="0" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-622">4,182,549</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the major classes of assets and liabilities of discontinued operations that were included in our consolidated balance sheets:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" format="ixt:num-dot-decimal" scale="0" id="f-623">315,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" format="ixt:num-dot-decimal" scale="0" id="f-624">2,484,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="0" id="f-625">581,504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="0" id="f-626">549,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="0" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="0" id="f-627">20,051,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="0" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="0" id="f-628">38,395,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" format="ixt:num-dot-decimal" scale="0" id="f-629">67,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" format="ixt:num-dot-decimal" scale="0" id="f-630">208,074</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets (attributable to VIEs)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="0" name="jynt:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent" format="ixt:num-dot-decimal" scale="0" id="f-631">994,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="0" name="jynt:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent" format="ixt:num-dot-decimal" scale="0" id="f-632">1,087,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deposits and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" format="ixt:num-dot-decimal" scale="0" id="f-633">235,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" format="ixt:num-dot-decimal" scale="0" id="f-634">425,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets, discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="0" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="0" id="f-635">22,246,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="0" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="0" id="f-636">43,151,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" format="ixt:num-dot-decimal" scale="0" id="f-637">83,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" format="ixt:num-dot-decimal" scale="0" id="f-638">67,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-639">2,519,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-640">5,066,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Payroll liabilities ($<ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="jynt:DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent" scale="6" id="f-641">0.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="jynt:DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent" scale="6" id="f-642">0.9</ix:nonFraction> million attributable to VIEs, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="0" name="jynt:DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-643">988,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="0" name="jynt:DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-644">2,333,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="0" name="jynt:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="0" id="f-645">651,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="0" name="jynt:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="0" id="f-646">153,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="0" name="jynt:DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent" format="ixt:fixed-zero" scale="0" id="f-647">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="0" name="jynt:DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="0" id="f-648">38,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities (attributable to VIEs)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="0" id="f-649">756,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="0" id="f-650">1,079,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities to be disposed of ($<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="f-651">4.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="f-652">5.2</ix:nonFraction> million attributable to VIEs, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="0" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="0" id="f-653">16,368,318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="0" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="0" id="f-654">28,629,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, discontinued operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="0" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="0" id="f-655">21,368,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="0" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="0" id="f-656">37,367,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-594-3" continuedAt="f-594-4"><ix:continuation id="f-458-7" continuedAt="f-458-8"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The key components of cash flows from discontinued operations are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Significant operating and investing non-cash items</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:DepreciationAndAmortizationDiscontinuedOperations" format="ixt:num-dot-decimal" scale="0" id="f-657">69,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:DepreciationAndAmortizationDiscontinuedOperations" format="ixt:num-dot-decimal" scale="0" id="f-658">3,350,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss on disposition or impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" scale="0" id="f-659">5,441,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="0" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:num-dot-decimal" id="f-660">7,714,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Capital expenditures</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="0" name="us-gaap:CapitalExpenditureDiscontinuedOperations" format="ixt:num-dot-decimal" id="f-661">84,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="0" name="us-gaap:CapitalExpenditureDiscontinuedOperations" format="ixt:num-dot-decimal" id="f-662">664,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The clustered clinics are in varying stages of sales negotiations with approximately all of the company-owned or managed clinics expected to be recognized as a completed sale within <ix:nonNumeric contextRef="c-117" name="jynt:DisposalGroupHeldForSaleClinicsExpectedToSellPeriod" format="ixt-sec:durwordsen" id="f-663">one year</ix:nonNumeric> with an estimated fair value of $<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="jynt:DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue" scale="6" id="f-664">2.6</ix:nonFraction> million at December&#160;31, 2025. Effective with the designation as held for sale, we discontinued recording depreciation on property and equipment, net, amortization of intangible assets, net and amortization of ROU assets for the clinics as required by GAAP. We reported the related assets and liabilities of the clinics as held for sale as discontinued operations in our December&#160;31, 2025 and 2024 consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets that meet the criteria for the held for sale designation are reported at the lower of their carrying value or fair value less estimated cost to sell. As a result of our evaluation of the recoverability of the carrying value of the assets and liabilities held for sale relative to the clinics estimated fair values, we recorded an estimated loss on disposal of $<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-5" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" scale="6" id="f-665">2.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" scale="6" id="f-666">4.5</ix:nonFraction> million for the years ended December&#160;31, 2025 and 2024, respectively, in Income (loss) from discontinued operations before income tax expense in our consolidated income statements and a valuation allowance included in discontinued operations current assets in our consolidated balance sheets. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2025, in connection with the sale of company-owned or managed clinics classified as held for sale as of December&#160;31, 2024 for a combined sales price of $<ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="6" id="f-667">7.8</ix:nonFraction> million, we sold $<ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" name="jynt:DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold" scale="6" id="f-668">16.4</ix:nonFraction> million assets held for sale, net of a $<ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="jynt:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" scale="6" id="f-669">1.0</ix:nonFraction> million valuation allowance and $<ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" name="jynt:DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold" scale="6" id="f-670">7.4</ix:nonFraction> million of liabilities to be disposed of in the consolidated balance sheets as of December&#160;31, 2024. As a result of the sales, we recorded a loss of $<ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" scale="6" id="f-671">0.6</ix:nonFraction> million included in Income (loss) from discontinued operations before income tax expense on the consolidated income statements for the year ended December&#160;31, 2025.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2024, in connection with the sale of company-owned or managed clinics classified as held for sale as of December 31, 2023 for a combined sales price of $<ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="6" id="f-672">0.6</ix:nonFraction> million, we sold $<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="jynt:DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold" scale="6" id="f-673">1.3</ix:nonFraction> million assets held for sale, net of a $<ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="jynt:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" scale="6" id="f-674">0.1</ix:nonFraction> million valuation allowance and $<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="jynt:DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold" scale="6" id="f-675">0.8</ix:nonFraction> million of liabilities to be disposed of in the consolidated balance sheets as of December 31, 2023. As a result of the sales, we recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" scale="6" id="f-676">0.1</ix:nonFraction> million included in Income (loss) from discontinued operations before income tax expense on the consolidated income statements for the year ended December&#160;31, 2024.</span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-458-8"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The principal components of the held for sale assets and liabilities to be disposed of as of December&#160;31, 2025 and 2024 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" format="ixt:num-dot-decimal" id="f-677">4,497,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" format="ixt:num-dot-decimal" id="f-678">8,457,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="0" name="jynt:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent" format="ixt:num-dot-decimal" id="f-679">14,111,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="0" name="jynt:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent" format="ixt:num-dot-decimal" id="f-680">19,643,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" format="ixt:num-dot-decimal" id="f-681">4,288,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" format="ixt:num-dot-decimal" id="f-682">6,906,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent" format="ixt:num-dot-decimal" id="f-683">3,482,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent" format="ixt:num-dot-decimal" id="f-684">8,459,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="0" name="jynt:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" format="ixt:num-dot-decimal" id="f-685">6,327,644</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="0" name="jynt:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" format="ixt:num-dot-decimal" id="f-686">5,071,603</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="0" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" id="f-687">20,051,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="0" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" id="f-688">38,395,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="0" name="jynt:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" id="f-689">11,065,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="0" name="jynt:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" id="f-690">20,526,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue from company-owned or managed clinics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent" format="ixt:num-dot-decimal" id="f-691">5,302,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="0" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent" format="ixt:num-dot-decimal" id="f-692">8,102,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities to be disposed of</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="0" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" id="f-693">16,368,318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="0" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" id="f-694">28,629,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-594-4"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The pre-tax income of the clinics designated as held for sale as of December&#160;31, 2025 was $<ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" scale="6" id="f-695">4.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" scale="6" id="f-696">4.7</ix:nonFraction> million for the years ended December&#160;31, 2025 and 2024, respectively, the results of which exclude the allocation of corporate overhead.</span></div></ix:continuation><div id="iaf8338e230dd46e38cf560e1698dc7ef_151"></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 4:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="f-697" continuedAt="f-697-1" escape="true">Property and Equipment</ix:nonNumeric></span></div><ix:continuation id="f-697-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-698" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consist of the following:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Office and computer equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="0" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="0" id="f-699">982,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="0" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="0" id="f-700">937,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="0" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="0" id="f-701">1,594,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="0" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="0" id="f-702">1,585,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Internally developed software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="0" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="0" id="f-703">7,103,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="0" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="0" id="f-704">5,914,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="0" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="0" id="f-705">9,680,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="0" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="0" id="f-706">8,437,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="0" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="0" id="f-707">7,511,832</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="0" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="0" id="f-708">5,982,533</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="0" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="0" id="f-709">2,169,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="0" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="0" id="f-710">2,454,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="0" id="f-711">990,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="0" id="f-712">751,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property and Equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="0" id="f-713">3,159,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="0" id="f-714">3,206,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-715">1.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-716">1.4</ix:nonFraction> million for the years ended December&#160;31, 2025 and 2024, respectively.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Construction in progress at December&#160;31, 2025 and 2024 related primarily to internal use software in development.</span></div></ix:continuation><div id="iaf8338e230dd46e38cf560e1698dc7ef_154"></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 5:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-717" continuedAt="f-717-1" escape="true">Fair Value Consideration</ix:nonNumeric></span></div><ix:continuation id="f-717-1" continuedAt="f-717-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments include cash and cash equivalents, restricted cash, accounts receivable, accounts payable and accrued expenses. The carrying amounts of our financial instruments, excluding cash equivalents, approximate their fair value due to their short maturities. Cash equivalents consist of money market funds for which cost approximates fair values. Cash equivalents have an approximate fair value of $<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-718">19.2</ix:nonFraction>&#160;million as of December&#160;31, 2025, which was determined using Level 1 inputs.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="f-719" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Authoritative guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The guidance establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability, developed based on market data obtained from sources independent of our company. Unobservable inputs are inputs that reflect our assumptions of what market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on reliability of the inputs as follows:</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level 1:&#160;&#160;&#160;&#160;Observable inputs such as quoted prices in active markets;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level 2:&#160;&#160;&#160;&#160;Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly;&#160;and</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level 3:&#160;&#160;&#160;&#160;Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its   own assumptions.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2025 and 2024, we did not have any financial instruments that were measured on a recurring basis as Level 1, 2 or 3.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our non-financial assets, included in both continuing and discontinued operations, which primarily consist of goodwill, intangible assets, property, plant and equipment, and operating lease ROU assets, are not required to be measured at fair value on a recurring basis, and instead are reported at their carrying amount. However, on a periodic basis whenever events or changes in circumstances indicate that their carrying amount may not be fully recoverable (and at least annually for goodwill), non-financial assets are assessed for impairment. If the fair value is determined to be lower than the carrying amount, an impairment charge is recorded to write down the asset to its fair value, which is considered Level 3 within the fair value hierarchy. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-717-2"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The assets and liabilities resulting from acquisitions, included in discontinued operations, were recorded at fair values on a nonrecurring basis at the date of acquisition and are considered Level 3 within the fair value hierarchy.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets that meet the held for sale criteria are reported at the lower of their carrying value or fair value, less estimated costs to sell. The estimated fair values of the company-owned or managed clinics classified as Held for Sale (see Note 3, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">) were recorded in discontinued operations current assets at fair values on a nonrecurring basis and are based upon Level 2 inputs, which includes a potential buyer agreed-upon selling price or Level 3 inputs, which includes consideration of a market approach using a multiple of earnings assumption based on clinic-level historical financial performance as well as an income approach using discounted cash flow ("DCF") models that use significant unobservable inputs and assumptions. Key inputs in the DCF models included projected cash flows over a <ix:nonNumeric contextRef="c-130" name="jynt:AssetsHeldForSaleCashFlowForecastPeriod" format="ixt-sec:duryear" id="f-720">10</ix:nonNumeric>-year forecast period, based on clinic-level historical financial performance and management's expectations of future operating results. A terminal value was estimated using the Gordon Growth Model for locations with positive cash flows. For locations with projected negative cash flows, no terminal value was assigned, as these clinics were assumed to cease operations upon lease termination. The future cash flows and terminal value were discounted to present value using a discount rate of <ix:nonFraction unitRef="number" contextRef="c-131" decimals="3" name="jynt:AssetsHeldForSaleMeasurementInputPositiveCashFlow" scale="-2" id="f-721">13.5</ix:nonFraction>% for clinics with positive cash flows and <ix:nonFraction unitRef="number" contextRef="c-131" decimals="3" name="jynt:AssetsHeldForSaleMeasurementInputNegativeCashFlow" scale="-2" id="f-722">4.2</ix:nonFraction>% for clinics with negative cash flows, which reflect the risk profile of the underlying operations and market conditions as of the measurement date. The fair value measurement of the assets held for sale as of December&#160;31, 2025, which included all company-owned or managed clinics, was recorded as $<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-5" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="f-723">0.1</ix:nonFraction> million based upon Level 2 inputs and $<ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-5" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="f-724">2.5</ix:nonFraction> million based upon Level 3 inputs. As a result, we maintain a valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="jynt:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" scale="6" id="f-725">6.3</ix:nonFraction> million to adjust the carrying value of the disposal group to fair value less cost to sell as of December&#160;31, 2025. The fair value measurement of the assets held for sale as of December&#160;31, 2024, which included all company-owned or managed clinics, was recorded as $<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-5" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="f-726">0.4</ix:nonFraction>&#160;million based upon Level 2 inputs and $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="f-727">26.9</ix:nonFraction>&#160;million based upon Level 3 inputs as of December&#160;31, 2024. As a result, we recorded a valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="jynt:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" scale="6" id="f-728">5.1</ix:nonFraction>&#160;million to adjust the carrying value of the disposal group to fair value less cost to sell during the year ended December&#160;31, 2024.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets classified as held and used where the asset group was not determined to be recoverable are tested for impairment. During the years ended December&#160;31, 2025 and 2024, in connection with the planned sale or determined closure of certain company-owned or managed clinics, we recorded an impairment loss of <ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" format="ixt:fixed-zero" scale="0" id="f-729">zero</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-5" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" scale="6" id="f-730">2.7</ix:nonFraction>&#160;million, respectively, included in Income (loss) from discontinued operations before income tax expense in our consolidated income statements for impairment of long-lived assets classified as held and used where the asset group was not determined recoverable. The asset group was determined to be the clinic level, as this is the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. The long-lived assets fair values were determined by the following: Level 1 inputs, which included observable inputs from executed lease termination agreements; Level 2 inputs where available, which included using a valuation multiple (e.g., price per square foot) based on observable prices for comparable long-lived assets; and Level 3 inputs, which included a multiple of earnings assumption using our historical earnings trend data, comparable historical asset sales by us and franchisees that were not exact matc</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">hes, and (for calculating the fair value of intangible assets specifically) our historical experience, future projections and comparable market data include future cash flows, long-term growth rates, attrition rates and discount rates. Generally, a change in the assumption used for the multiple inputs would have resulted in a directionally similar change of the fair value measurement where a multiple of earnings assumption was used.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of these asset groups impaired to their fair value during the year ended December&#160;31, 2024 included ROU assets of $<ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment" scale="6" id="f-731">5.8</ix:nonFraction>&#160;million that were written down to $<ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment" scale="6" id="f-732">4.3</ix:nonFraction>&#160;million determined by Level 1 and Level 2 inputs. The carrying values of these asset groups impaired to their fair value also included property and equipment of $<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" name="jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment" scale="6" id="f-733">3.9</ix:nonFraction>&#160;million that were written down to $<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" name="jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment" scale="6" id="f-734">2.8</ix:nonFraction>&#160;million and reacquired rights of $<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment" scale="3" id="f-735">299</ix:nonFraction> thousand that were written down to $<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment" scale="3" id="f-736">253</ix:nonFraction> thousand both determined by Level 3 inputs discussed above. The carrying value for nearly all company-owned or managed asset groups were reclassified to assets held for sale as of December&#160;31, 2024.</span></div></ix:continuation><div id="iaf8338e230dd46e38cf560e1698dc7ef_160"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 6:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-737" continuedAt="f-737-1" escape="true">Debt</ix:nonNumeric></span></div><ix:continuation id="f-737-1" continuedAt="f-737-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Agreement</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2020, we entered into a Credit Agreement (the &#8220;Credit Agreement&#8221;), with JPMorgan Chase Bank, N.A., individually, and as Administrative Agent and Issuing Bank (&#8220;JPMorgan Chase&#8221; or the &#8220;Lender&#8221;). The Credit Agreement provided for senior secured credit facilities (the &#8220;Credit Facilities&#8221;) in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="f-738">7.5</ix:nonFraction> million, including a $<ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-739">2.0</ix:nonFraction> million revolver (the &#8220;Revolver&#8221;) and a $<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-740">5.5</ix:nonFraction> million development line of credit (the &#8220;Line of Credit&#8221;). The Revolver included amounts available for letters of credit of up to $<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="f-741">1.0</ix:nonFraction> million and an uncommitted additional amount of $<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" name="jynt:LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount" scale="6" id="f-742">2.5</ix:nonFraction> million. All outstanding principal and interest on the Revolver were due on February 28, 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2022, we entered into an amendment to the Credit Facilities (as amended, the &#8220;2022 Credit Facility&#8221;) with the Lender. Under the 2022 Credit Facility, the Revolver increased to $<ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="f-743">20.0</ix:nonFraction> million (from $<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="f-744">2.0</ix:nonFraction> million), the portion of the Revolver available for letters of credit increased to $<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="f-745">5.0</ix:nonFraction> million (from $<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="f-746">1.0</ix:nonFraction> million), the uncommitted additional amount increased to </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-737-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="jynt:LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount" scale="6" id="f-747">30.0</ix:nonFraction> million (from $<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-5" name="jynt:LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount" scale="6" id="f-748">2.5</ix:nonFraction> million) and the developmental line of credit of $<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-5" sign="-" name="us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet" scale="6" id="f-749">5.5</ix:nonFraction> million was terminated. The Revolver will be used for working capital needs, general corporate purposes and for acquisitions, development and capital improvement uses. At our option, borrowings under the 2022 Credit Facility bear interest at: (i) the adjusted Secured Overnight Financing Rate (&#8220;SOFR&#8221;), which is the daily simple SOFR, plus <ix:nonFraction unitRef="number" contextRef="c-148" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-750">0.10</ix:nonFraction>%, plus <ix:nonFraction unitRef="number" contextRef="c-149" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-751">1.75</ix:nonFraction>%, payable on the last day of the selected interest period of one, three or six months, and on the three-month anniversary of the beginning of any six-month interest period, if applicable; or (ii) an Alternative Base Rate (ABR), plus <ix:nonFraction unitRef="number" contextRef="c-150" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-752">1.00</ix:nonFraction>%, payable monthly. The ABR is the greatest of: (A) the prime rate (as published by the Wall Street Journal), (B) the Federal Reserve Bank of New York rate, plus <ix:nonFraction unitRef="number" contextRef="c-151" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-753">0.5</ix:nonFraction>%, and (C) the adjusted one-month term SOFR rate. Amounts outstanding under the Revolver on February 28, 2022 continued to bear interest at the rate selected under the Credit Facilities prior to the amendment until the last day of the interest period in effect, at which time, if not repaid, the amounts outstanding under the Revolver will bear interest at the 2022 Credit Facility rate. The 2022 Credit Facility will terminate and all principal and interest will become due and payable on the fifth anniversary of the amendment (February 28, 2027). On January 17, 2024, we paid down the outstanding balance on our Debt under the Credit Agreement of $<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-754">2.0</ix:nonFraction> million. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Facilities contain customary events of default, including but not limited to nonpayment; material inaccuracy of representations and warranties; violations of covenants; certain bankruptcies and liquidations; cross-default to material indebtedness; certain material judgments; and certain fundamental changes such as a merger or sale of substantially all assets (as further defined in the Credit Facilities). The Credit Facilities require us to comply with customary affirmative, negative and financial covenants, including minimum interest coverage and maximum net leverage. A breach of any of these operating or financial covenants would result in a default under the Credit Facilities. If an event of default occurs and is continuing, the lenders could elect to declare all amounts then outstanding, together with accrued interest, to be immediately due and payable. The Credit Facilities are collateralized by substantially all of our assets, including the assets in our company-owned or managed clinics. We intend to use the Revolver for general working capital needs. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2025, we entered into a consent and third amendment to the Credit Agreement (as amended, the &#8220;2025 Credit Facility&#8221;) with the Lender. Among other things, the 2025 Credit Facility contains the consent of the Lender to our refranchising of all company-owned or managed clinics which would have triggered certain default events included in the Credit Agreement. The 2025 Credit Facility also extended the maturity date of the Credit Facilities to August 31, 2027.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2025, there are <ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:LineOfCredit" format="ixt-sec:numwordsen" scale="0" id="f-755">no</ix:nonFraction> outstanding balances under our Credit Facilities or the 2025 Credit Facility. As of December&#160;31, 2025, we were in default of our Credit Facilities due to a violation of our fixed charge coverage ratio covenant primarily due to stock repurchases under the 2025 SRP, which constitute restricted payments. This prohibits our ability to draw upon our $<ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="f-756">20.0</ix:nonFraction>&#160;million Revolver under the 2022 Credit Facility until the covenant violation is resolved.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the issuance of the Credit Facilities and the 2022 Credit Facility, we incurred debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:DeferredFinanceCostsGross" scale="3" id="f-757">53</ix:nonFraction> thousand and $<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:DeferredFinanceCostsGross" scale="3" id="f-758">76</ix:nonFraction> thousand, respectively. Interest expense and amortization expense related to debt issuance costs are being amortized to &#8220;Other expense, net&#8221; and was $<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="f-759">22</ix:nonFraction> thousand and $<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="f-760">79</ix:nonFraction> thousand for the years ended December&#160;31, 2025 and 2024, respectively.</span></div></ix:continuation><div id="iaf8338e230dd46e38cf560e1698dc7ef_1806"></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 7: &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-761" continuedAt="f-761-1" escape="true">Stockholders</ix:nonNumeric></span><ix:continuation id="f-761-1" continuedAt="f-761-2"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">'</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> Equity</span></ix:continuation></div><ix:continuation id="f-761-2" continuedAt="f-761-3"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchase Program</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On June 3, 2025, our Board of Directors approved the 2025 SRP to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="srt:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="f-762">5.0</ix:nonFraction>&#160;million of our common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-158" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-763">0.001</ix:nonFraction> per share, from time to time until June 3, 2027 or such other date as we have exhausted, or the Board of Directors otherwise terminates, the repurchase authorization. On November 4, 2025, the Board of Directors authorized an additional $<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-5" name="jynt:ShareRepurchaseProgramAdditionalAuthorizedAmount" scale="6" id="f-764">12.0</ix:nonFraction>&#160;million under the 2025 SRP and extended the repurchase date through November 4, 2027.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The timing, volume, price, and terms of the repurchases will depend on market and business conditions, applicable legal requirements, and other factors. The repurchases may be made on the open market, in privately negotiated transactions, or in such other manner (e.g., accelerated share repurchase transactions, block trades, derivatives, or otherwise) that complies with the terms of applicable federal and state securities laws and regulations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">During the year ended December&#160;31, 2025, we repurchased $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-765">11.3</ix:nonFraction> million of common stock at an average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="f-766">8.73</ix:nonFraction> per share, excluding related costs and fees. As of December&#160;31, 2025, we had a remaining $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="6" id="f-767">5.7</ix:nonFraction> million authorized for repurchasing shares of our common stock. All shares of common stock that we repurchased are held as treasury stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Treasury Stock</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-761-3"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2025 and 2024, shares of common stock at a total cost of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="f-768">8</ix:nonFraction> thousand and $<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="f-769">10</ix:nonFraction> thousand, respectively, were netted and surrendered as payment for minimum statutory withholding obligations in connection with the vesting of outstanding stock awards. hares surrendered by the participants in accordance with the applicable award agreements and plan are deemed repurchased by us but are not part of publicly announced stock repurchase programs.</span></div></ix:continuation><div id="iaf8338e230dd46e38cf560e1698dc7ef_163"></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 8:&#160;&#160;&#160;&#160; <ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-770" continuedAt="f-770-1" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="f-770-1" continuedAt="f-770-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We grant stock-based awards under our 2024 Incentive Stock Plan (the &#8220;2024 Plan&#8221;). The shares issued as a result of stock-based compensation transactions generally have been funded with the issuance of new shares of our common stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may grant the following types of incentive awards under the 2024 Plan: (i) non-qualified stock options; (ii) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; and (v) restricted stock units. Each award granted under the 2024 Plan is subject to an award agreement that incorporates, as applicable, the exercise price, the term of the award, the periods of restriction, the number of shares to which the award pertains, and such other terms and conditions as the plan committee determines. Awards granted under the 2024 Plan are classified as equity awards, which are recorded in stockholders&#8217; equity in our consolidated balance sheets. Through December&#160;31, 2025, we have granted under the 2024 Plan (i) non-qualified stock options; (ii) incentive stock options; and (iii) restricted stock. There were no stock appreciation rights or restricted stock units granted under the 2024 Plan as of December&#160;31, 2025. As of December&#160;31, 2025, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-771">1,725,057</ix:nonFraction> shares of common stock remained available for issuance under the 2024 Plan.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our closing price on the date of grant is the basis of fair value of its common stock used in determining the value of share-based awards. To the extent that the value of our share-based awards involves a measure of volatility, we use available historical volatility of our common stock over a period of time corresponding to the expected stock option term. We use the simplified method to calculate the expected term of stock option grants to employees. Accordingly, the expected life of the options granted is based on the average of the vesting term, which is generally <ix:nonNumeric contextRef="c-160" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-772">four years</ix:nonNumeric> and the contractual term, which is generally <ix:nonNumeric contextRef="c-160" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="f-773">ten years</ix:nonNumeric>. The risk-free interest rate is based on United States Treasury yields in effect at the date of grant for periods corresponding to the expected stock option term. Forfeitures are estimated based on historical and forecasted turnover, which is approximately <ix:nonFraction unitRef="number" contextRef="c-161" decimals="2" name="jynt:ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage" scale="-2" id="f-774">5</ix:nonFraction>%.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-770-2" continuedAt="f-770-3"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We did <ix:nonFraction unitRef="shares" contextRef="c-160" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="f-775">not</ix:nonFraction> grant any options during the year ended December&#160;31, 2025. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-776" continuedAt="f-776-1" escape="true">We have computed the fair value of all options granted using the Black-Scholes-Merton model during the year ended December&#160;31, 2024, using the following assumptions:</ix:nonNumeric></span></div><ix:continuation id="f-776-1"><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.578%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-162" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-777">64</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-162" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-778">6.25</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-162" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-779">3.86</ix:nonFraction>%</span></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-780" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The information below summarizes the stock options activity:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-163" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-781">486,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-163" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-782">8.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-164" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-783">3.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="0" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-784">1,903,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted at market price</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-162" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-785">38,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-162" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-786">10.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-162" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-787">227,952</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-162" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-788">4.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" id="f-789">1,435,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-162" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-790">9,201</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-162" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-791">26.52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-162" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-792">5,263</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-162" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-793">41.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December&#160;31, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-165" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-794">281,977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-165" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-795">11.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-162" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-796">3.3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="0" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-797">777,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-160" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-798">123,460</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-160" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-799">5.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" id="f-800">656,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-160" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-801">89,604</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-160" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-802">19.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-160" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" id="f-803">432</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-160" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-804">45.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December&#160;31, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-161" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-805">68,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-161" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-806">14.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-160" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-807">6.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="0" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-808">59,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December&#160;31, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-161" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-809">39,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-161" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-810">17.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-160" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-811">4.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="0" id="f-812">59,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at December&#160;31, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-161" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-813">66,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-161" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="f-814">14.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-160" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-815">5.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="0" id="f-816">59,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant-date fair value of our stock options granted during the year ended December&#160;31, 2024 was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-162" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-817">6.21</ix:nonFraction>.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate fair value of our stock options vested during 2025 and 2024 was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="3" id="f-818">157</ix:nonFraction> thousand and $<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="3" id="f-819">319</ix:nonFraction> thousand, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We recognize compensation costs ratably over the period of service using the straight-line method. Forfeitures are estimated based on historical and forecasted turnover, which is approximately <ix:nonFraction unitRef="number" contextRef="c-161" decimals="2" name="jynt:ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage" scale="-2" id="f-820">5</ix:nonFraction>%. For the years ended December&#160;31, 2025 and 2024, stock-based compensation expense for stock options was $<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-821">73</ix:nonFraction> thousand and $<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-822">141</ix:nonFraction> thousand, respectively. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Unrecognized stock-based compensation expense for stock options as of December&#160;31, 2025 was $<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="3" id="f-823">166</ix:nonFraction> thousand, which is expected to be recognized ratably over the next <ix:nonNumeric contextRef="c-160" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-824">2.8</ix:nonNumeric> years.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock awards granted to employees generally vest in <ix:nonFraction unitRef="installment" contextRef="c-166" decimals="INF" name="jynt:ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments" format="ixt-sec:numwordsen" scale="0" id="f-825">four</ix:nonFraction> equal annual installments.</span><span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock awards granted to non-employee directors vest on the earlier of (i) <ix:nonNumeric contextRef="c-167" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-826">one year</ix:nonNumeric> from the grant date and (ii) the date of the next annual meeting of the shareholders of our company occurring after the date of grant.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-770-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="f-827" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The information below summarizes the restricted stock activity:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.445%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant-Date Fair Value per Award</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at December&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-168" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-828">231,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-168" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-829">17.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-169" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-830">285,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-169" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-831">9.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-169" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-832">107,103</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-169" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-833">16.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-169" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-834">104,472</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-169" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-835">14.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at December&#160;31, 2024</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-170" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-836">305,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-170" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-837">11.97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-171" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-838">301,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-171" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-839">10.54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-171" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-840">107,854</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-171" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-841">12.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-171" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-842">146,534</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-171" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-843">11.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at December&#160;31, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-166" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-844">353,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-166" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-845">10.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2025 and 2024, stock-based compensation expense for restricted stock was $<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-846">1.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-847">1.5</ix:nonFraction> million, respectively. Unrecognized stock-based compensation expense for restricted stock awards as of December&#160;31, 2025 was $<ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="f-848">2.9</ix:nonFraction> million to be recognized ratably over <ix:nonNumeric contextRef="c-171" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-849">2.9</ix:nonNumeric> years.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax Benefits</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) for 2025 and 2024 included pre-tax expense related to stock-based compensation of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-850">1.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-851">1.7</ix:nonFraction> million, respectively. We recognized federal income tax benefits of <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt-sec:numwordsen" scale="6" id="f-852">zero</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="f-853">0.1</ix:nonFraction> million from the exercises of stock options and restricted stock awards for 2025 and 2024, respectively.</span></div></ix:continuation><div><span><br/></span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_166"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 9:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-854" continuedAt="f-854-1" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="f-854-1" continuedAt="f-854-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="f-855" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The components of loss from continuing operations before the provision for income taxes, by taxing jurisdiction are as follows: </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Domestic </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="0" id="f-856">229,504</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="0" id="f-857">1,608,738</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-858">229,504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-859">1,608,738</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="f-860" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense reported in the consolidated income statements is comprised of the following:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Current expense:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">State, net of state tax credits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-861">38,653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-862">62,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total current expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-863">38,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-864">62,759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Deferred expense (benefit):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-865">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-866">57,153</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-867">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-868">57,153</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-869">38,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-870">5,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-871" continuedAt="f-871-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The tax effects of temporary differences that give rise to significant components of the deferred tax assets and liabilities are provided below:</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-854-2" continuedAt="f-854-3"><ix:continuation id="f-871-1"><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" format="ixt:num-dot-decimal" scale="0" id="f-872">757,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" format="ixt:num-dot-decimal" scale="0" id="f-873">1,607,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:DeferredTaxAssetsDeferredIncome" format="ixt:num-dot-decimal" scale="0" id="f-874">3,535,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:DeferredTaxAssetsDeferredIncome" format="ixt:num-dot-decimal" scale="0" id="f-875">3,909,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="jynt:DeferredTaxAssetsOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="0" id="f-876">3,795,895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="jynt:DeferredTaxAssetsOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="0" id="f-877">5,710,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill - component 1</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="jynt:DeferredTaxAssetsGoodwillComponent1" format="ixt:num-dot-decimal" scale="0" id="f-878">383,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="jynt:DeferredTaxAssetsGoodwillComponent1" format="ixt:fixed-zero" scale="0" id="f-879">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill - component 2</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="jynt:DeferredTaxAssetsGoodwillComponent2" format="ixt:num-dot-decimal" scale="0" id="f-880">49,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="jynt:DeferredTaxAssetsGoodwillComponent2" format="ixt:num-dot-decimal" scale="0" id="f-881">55,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="0" id="f-882">471,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="0" id="f-883">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonqualified stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="jynt:DeferredTaxAssetsNonqualifiedStockOptions" format="ixt:num-dot-decimal" scale="0" id="f-884">117,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="jynt:DeferredTaxAssetsNonqualifiedStockOptions" format="ixt:num-dot-decimal" scale="0" id="f-885">322,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="0" id="f-886">3,261,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="0" id="f-887">3,029,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="0" id="f-888">35,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="0" id="f-889">35,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="jynt:DeferredTaxAssetsIntangibleAssets" format="ixt:num-dot-decimal" scale="0" id="f-890">3,416,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="jynt:DeferredTaxAssetsIntangibleAssets" format="ixt:num-dot-decimal" scale="0" id="f-891">3,921,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="0" id="f-892">141,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="0" id="f-893">139,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="0" id="f-894">15,968,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="0" id="f-895">18,730,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="0" id="f-896">11,327,659</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="0" id="f-897">12,307,555</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="0" id="f-898">4,640,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="0" id="f-899">6,423,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Lease ROU asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="jynt:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="0" id="f-900">4,320,092</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="jynt:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="0" id="f-901">5,392,996</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred franchise costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="jynt:DeferredTaxLiabilitiesDeferredFranchiseCosts" format="ixt:num-dot-decimal" scale="0" id="f-902">320,837</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="jynt:DeferredTaxLiabilitiesDeferredFranchiseCosts" format="ixt:num-dot-decimal" scale="0" id="f-903">75,284</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill - component 1</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" format="ixt:fixed-zero" scale="0" id="f-904">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" format="ixt:num-dot-decimal" scale="0" id="f-905">807,824</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="0" id="f-906">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="0" id="f-907">147,143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" id="f-908">4,640,929</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" id="f-909">6,423,247</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income taxes</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:DeferredTaxLiabilities" format="ixt:fixed-zero" scale="0" id="f-910">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:DeferredTaxLiabilities" format="ixt:fixed-zero" scale="0" id="f-911">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="f-912">11.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="f-913">12.3</ix:nonFraction> million was recorded against the deferred tax asset balance of The Joint Corp., without its VIEs, as of December&#160;31, 2025 and 2024, respectively. During the year ended December&#160;31, 2025, the valuation allowance decreased by $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="f-914">1.0</ix:nonFraction> million. As of each reporting date, we consider new evidence, both positive and negative, that could impact our view with regard to future realization of deferred tax assets in each reporting jurisdiction. A significant piece of objective evidence evaluated was the cumulative loss incurred in each jurisdiction over the three-year period ended December&#160;31, 2025. Such objective evidence limits the ability to consider other subjective evidence, such as projections for future growth, in evaluating the need for a valuation allowance. As a result, we determined that it is more likely than not that The Joint Corp. will not realize its deferred tax assets as of December&#160;31, 2025, and has recorded a valuation allowance after consideration of any recorded deferred tax liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, deferred tax assets attributable to its VIEs of $<ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-5" name="jynt:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent" scale="6" id="f-915">1.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="jynt:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent" scale="6" id="f-916">1.1</ix:nonFraction> million were classified as discontinued operations as of December&#160;31, 2025 and 2024, respectively, and are related to deferred revenue. See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for more information on discontinued operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Joint Corp., without the VIEs, has federal gross net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-917">10.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-918">12.3</ix:nonFraction> million as of December&#160;31, 2025 and 2024, respectively. The federal tax effected impacts of these net operating losses were $<ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-919">2.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-920">2.6</ix:nonFraction> million as of December&#160;31, 2025 and 2024, respectively. $<ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="6" id="f-921">7.8</ix:nonFraction> million of the federal net operating loss as of December&#160;31, 2025 is subject to a 20-year carryforward, with a portion beginning to expire in 2036. $<ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" scale="6" id="f-922">2.3</ix:nonFraction> million of the federal net operating loss as of December&#160;31, 2025 has an indefinite carryforward period.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Joint Corp., without the VIEs, has state net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-923">10.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-924">3.6</ix:nonFraction>&#160;million as of December&#160;31, 2025 and 2024, respectively. The determination of the state net operating loss carryforwards is dependent upon apportionment percentages and state laws that can change from year to year and impact the amount of such carryforwards. If such net operating loss carryforwards are not utilized, a portion will begin to expire in 2026.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have research and development credits of $<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="us-gaap:TaxCreditCarryforwardAmount" scale="3" id="f-925">14</ix:nonFraction> thousand that will begin to expire in 2031 and California Alternative Minimum Tax credits of $<ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="us-gaap:TaxCreditCarryforwardAmount" scale="3" id="f-926">22</ix:nonFraction> thousand that do not expire.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-854-3" continuedAt="f-854-4"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-927" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes differs from the amount calculated using the statutory federal corporate income tax rate of 21% due to the following items:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.162%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Percent</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss from continuing operations before provision for income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-928">229,504</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-929">1,608,738</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected federal tax expense at U.S. federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="0" id="f-930">48,388</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-931">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="0" id="f-932">337,835</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-18" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-933">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes (net of federal income tax effect) (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:num-dot-decimal" id="f-934">128,782</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-935">56.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:num-dot-decimal" scale="0" id="f-936">79,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-18" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-937">5.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Changes in valuation allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="0" id="f-938">507,419</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="f-939">221.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="0" id="f-940">66,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-18" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="f-941">4.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nontaxable or nondeductible items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Section 162(m) officer compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="jynt:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount" format="ixt:fixed-zero" scale="0" id="f-942">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="jynt:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent" format="ixt:fixed-zero" scale="-2" id="f-943">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="jynt:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount" format="ixt:num-dot-decimal" scale="0" id="f-944">85,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-18" decimals="3" sign="-" name="jynt:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent" scale="-2" id="f-945">5.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Share based compensation (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="0" id="f-946">28,302</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="f-947">12.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="0" id="f-948">119,263</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-18" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="f-949">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Payroll tax penalty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="jynt:EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount" format="ixt:num-dot-decimal" scale="0" id="f-950">45,749</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="jynt:EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent" scale="-2" id="f-951">19.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="jynt:EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount" format="ixt:fixed-zero" scale="0" id="f-952">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-18" decimals="3" name="jynt:EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent" format="ixt:fixed-zero" scale="-2" id="f-953">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Meals and entertainment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" format="ixt:num-dot-decimal" scale="0" id="f-954">23,549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" scale="-2" id="f-955">10.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" format="ixt:num-dot-decimal" scale="0" id="f-956">30,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-18" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" scale="-2" id="f-957">1.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" format="ixt:num-dot-decimal" scale="0" id="f-958">17,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="f-959">7.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" format="ixt:num-dot-decimal" scale="0" id="f-960">26,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-18" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="f-961">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Changes in unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:IncomeTaxReconciliationTaxContingencies" format="ixt:num-dot-decimal" scale="0" id="f-962">300,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" scale="-2" id="f-963">130.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:IncomeTaxReconciliationTaxContingencies" format="ixt:num-dot-decimal" scale="0" id="f-964">212,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-18" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" scale="-2" id="f-965">13.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Other adjustments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Deferred true-up to deferred franchise costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="jynt:EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount" format="ixt:num-dot-decimal" scale="0" id="f-966">285,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="jynt:EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent" scale="-2" id="f-967">124.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="jynt:EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount" format="ixt:fixed-zero" scale="0" id="f-968">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-18" decimals="3" name="jynt:EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent" format="ixt:fixed-zero" scale="-2" id="f-969">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Current year expirations of non-qualified stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="0" id="f-970">217,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="f-971">94.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:fixed-zero" scale="0" id="f-972">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-18" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" format="ixt:fixed-zero" scale="-2" id="f-973">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" format="ixt:num-dot-decimal" scale="0" id="f-974">47,819</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="f-975">20.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" format="ixt:num-dot-decimal" scale="0" id="f-976">39,286</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-18" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="f-977">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax expense and effective rate</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-978">38,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-979">16.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-980">5,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-18" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-981">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">___________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(1) State taxes in Arizona, California and Texas made up the majority (greater than 50%) of the tax effect in this category.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(2) Share based compensation includes incentive stock options, non-qualified stock options and restricted stock awards.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Changes in our income tax expense relate primarily to state income taxes (net of federal tax and permanent differences), changes in tax rates, stock compensation, shortfall/windfall on stock compensation expense, change in valuation allowance and uncertain tax positions during the year ended December&#160;31, 2025, as compared to the year ended December&#160;31, 2024. For the years ended December&#160;31, 2025 and 2024, effective tax rates were (<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-982">16.8</ix:nonFraction>)% and (<ix:nonFraction unitRef="number" contextRef="c-18" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-983">0.3</ix:nonFraction>)%, respectively. The difference between the statutory federal income tax rate and our effective tax rate was primarily due to the uncertain tax position net impact and state taxes (net of federal taxes) for the year ended December&#160;31, 2025. The difference between the statutory federal income tax rate and our effective tax rate was primarily due to the valuation allowance, change in tax rate and uncertain tax position for the year ended December&#160;31, 2024. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We apply a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit or obligation as the largest amount that is more than 50% likely of being realized upon ultimate settlement. We consider many factors when evaluating and estimating our tax positions and tax benefits, which may require periodic adjustments.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2025 and 2024, we had gross uncertain tax positions attributable to the VIEs, recorded as discontinued operations, of $<ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-984">0.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-985">0.9</ix:nonFraction>&#160;million, respectively. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="f-986" escape="true"><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="0" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="0" id="f-987">948,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="0" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="0" id="f-988">1,175,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for expiration of the statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="0" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="0" id="f-989">314,468</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="0" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="0" id="f-990">227,584</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="0" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="0" id="f-991">633,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="0" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="0" id="f-992">948,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-854-4"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2025 and December&#160;31, 2024, there were $<ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="3" id="f-993">20</ix:nonFraction> thousand and $<ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="3" id="f-994">22</ix:nonFraction> thousand, respectively, of unrecognized tax benefits that if recognized would affect the annual effective tax rate.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Interest and penalties associated with tax positions are recorded in the period assessed as general and administrative expenses. Accrued interest and penalties were $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" scale="3" id="f-995">178</ix:nonFraction> thousand and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" scale="3" id="f-996">202</ix:nonFraction> thousand for the years ended December&#160;31, 2025 and 2024, respectively, and recorded as other liabilities.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="f-997" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The amount of cash paid for income taxes (net of refunds received) was as follows: </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:IncomeTaxPaidFederalAfterRefundReceived" format="ixt:num-dot-decimal" scale="0" id="f-998">321,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:IncomeTaxPaidFederalAfterRefundReceived" format="ixt:num-dot-decimal" scale="0" id="f-999">285,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">State:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Arizona</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="0" name="us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived" format="ixt:num-dot-decimal" scale="0" id="f-1000">62,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="0" name="us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived" format="ixt:fixed-zero" scale="0" id="f-1001">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;California</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="0" name="us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived" format="ixt:num-dot-decimal" scale="0" id="f-1002">168,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="0" name="us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived" format="ixt:num-dot-decimal" scale="0" id="f-1003">182,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Texas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="0" name="us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived" format="ixt:num-dot-decimal" scale="0" id="f-1004">62,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="0" name="us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived" format="ixt:num-dot-decimal" scale="0" id="f-1005">51,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other state jurisdictions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="0" name="us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived" format="ixt:num-dot-decimal" scale="0" id="f-1006">13,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="0" name="us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived" format="ixt:num-dot-decimal" scale="0" id="f-1007">91,956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid (net of refunds received)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="0" id="f-1008">626,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="0" id="f-1009">610,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">With exceptions due to the generation and utilization of net operating losses or credits, as of December&#160;31, 2025, we are no longer subject to federal and state examinations by taxing authorities for tax years before 2022 and 2021, respectively.</span></div></ix:continuation><div id="iaf8338e230dd46e38cf560e1698dc7ef_169"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 10:&#160;&#160;&#160;&#160;  <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-1010" continuedAt="f-1010-1" escape="true">Commitments and Contingencies </ix:nonNumeric></span></div><ix:continuation id="f-1010-1" continuedAt="f-1010-2"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-1011" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the components of lease expense and income statement location for the years ended December&#160;31, 2025 and 2024:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.239%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.423%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Line Item in our Consolidated Income Statements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Operating lease costs:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="0" id="f-1012">355,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="0" id="f-1013">325,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="0" id="f-1014">355,912</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="0" id="f-1015">325,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="jynt:AssetsAndLiabilitiesLesseeTableTextBlock" id="f-1016" continuedAt="f-1016-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information and balance sheet location related to leases for the years ended December&#160;31, 2025 and 2024 was as follows:</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-1010-2" continuedAt="f-1010-3"><ix:continuation id="f-1016-1"><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of -use asset</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="0" id="f-1017">1,572,173</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="0" id="f-1018">555,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability, current portion</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="0" id="f-1019">194,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="0" id="f-1020">483,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-1021">1,815,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-1022">311,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liability</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="0" id="f-1023">2,009,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="0" id="f-1024">795,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining lease term (in years):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1025">5.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-5" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1026">3.6</ix:nonNumeric></span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1027">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1028">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases for the years ended December&#160;31, 2025 and 2024 were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in measurement of liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="0" id="f-1029">460,056</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="0" id="f-1030">505,577</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash transactions: ROU assets obtained in exchange for lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="0" id="f-1031">1,554,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="0" id="f-1032">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-1033" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of December&#160;31, 2025 were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.789%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="0" id="f-1034">268,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="0" id="f-1035">467,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="0" id="f-1036">479,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="0" id="f-1037">491,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="0" id="f-1038">503,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="0" id="f-1039">211,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="0" id="f-1040">2,421,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="0" id="f-1041">411,993</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total lease obligations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="0" id="f-1042">2,009,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="0" id="f-1043">194,179</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Long-term lease obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-1044">1,815,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guaranties in Connection with the Sale of the Divested Business</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale of company-owned or managed clinics, we guaranteed <ix:nonFraction unitRef="lease" contextRef="c-4" decimals="INF" name="jynt:NumberOfFutureOperatingLeasesCommitted" scale="0" id="f-1045">39</ix:nonFraction> future operating lease commitments assumed by the buyers. We are obligated to perform under the guaranties if the buyers fail to perform under the lease agreements at any time during the remainder of the term of the lease agreements, the latest of which expires on December&#160;31, 2033. As of December&#160;31, 2025, the undiscounted maximum remaining lease payments totaled $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="jynt:GuarantorObligationsRemainingExposureUndiscounted" scale="6" id="f-1046">5.0</ix:nonFraction> million. We have not recorded a liability with respect to our obligations under the guaranties as of December&#160;31, 2025, as we concluded that payment under the guaranties was not probable.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-1010-3"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we are party to litigation and claims from time to time. We maintain insurance to cover certain litigation and claims, subject to policy limits. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2024, we entered into settlement agreements from litigation related to employment matters of $<ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-5" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="6" id="f-1047">1.5</ix:nonFraction>&#160;million that was outside the normal course of business which we have accrued for in discontinued operations current liabilities as of December&#160;31, 2025. The settlement is expected to be paid out during the first quarter of 2026.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, ongoing litigation related to a medical injury claim between a patient (&#8220;the Claimant&#8221;) and us filed on September 5, 2023 reached a settlement agreement on February 25, 2025. Per the terms of the settlement agreement, we and our insurance will pay the claimant $<ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-5" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="6" id="f-1048">3.4</ix:nonFraction> million. We accrued the settlement recorded in discontinued operations current liabilities for $<ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-5" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="f-1049">3.4</ix:nonFraction> million as of December&#160;31, 2024. The expense from the accrual was offset by a receivable recorded as discontinued operations current assets from our insurance providers for $<ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-5" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="f-1050">1.9</ix:nonFraction> million as of December&#160;31, 2024. The settlement was paid in full during the first quarter of 2025.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In 2025, we determined that the likelihood of a loss related to multiple lawsuits, including three cases consolidated into one class action lawsuit (but not yet certified), six individual cases related to each other by the court and two unrelated individual cases, all filed against us and a chiropractor employed by the professional corporation providing clinical services in 2024, 2025 and 2026 in the State of California became probable. The initial lawsuit was filed against us on June 6, 2024 with the Superior Court of California in Los Angeles County. The lawsuits allege, among other claims, an invasion of privacy, negligence, emotional distress, sexual harassment, unlawful recording, failure to provide a safe environment and trespass on person at one of our company-owned or managed clinics. The lawsuits are currently in discovery and trial is scheduled to begin in early 2027. We intend to continue to defend these cases vigorously, but it is not possible at this time to reasonably estimate the outcome of or any potential liability from these cases and therefore, no accrual exists as of December&#160;31, 2025. We also note that our exposure to these cases may be limited by our insurance coverage, but the potential exposure is undetermined as of December&#160;31, 2025.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2025, we incurred litigation expenses, including settlement costs related to employment matters that were outside the normal course of business, of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:LitigationSettlementExpense" scale="6" id="f-1051">0.4</ix:nonFraction>&#160;million, included as Income (loss) from discontinued operations before income tax expense in our consolidated income statements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2024, we incurred litigation expenses, including settlement costs related to employment matters that were outside the normal course of business and a medical injury claim, of $<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="us-gaap:LitigationSettlementExpense" scale="6" id="f-1052">3.0</ix:nonFraction>&#160;million, included as Income (loss) from discontinued operations before income tax expense in our consolidated income statements.</span></div></ix:continuation><div id="iaf8338e230dd46e38cf560e1698dc7ef_172"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 11:  <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-1053" continuedAt="f-1053-1" escape="true">Segment Reporting</ix:nonNumeric></span></div><ix:continuation id="f-1053-1" continuedAt="f-1053-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">An operating segment is defined as a component of an enterprise for which discrete financial information is available and is reviewed regularly by the Chief Operating Decision Maker (&#8220;CODM&#8221;) to evaluate performance and make operating decisions. We have identified the Chief Executive Officer as our CODM.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we had <ix:nonFraction unitRef="segment" contextRef="c-190" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-1054">two</ix:nonFraction> operating business segments: (1) Corporate Clinics, and (2) Franchise Operations. The Corporate Clinics segment is comprised of the activities of the company-owned or managed clinics. In the fourth quarter of 2024, as part of our refranchising strategy, all but one of the company-owned or managed clinics in the Corporate Clinic segment met the criteria to be reported as discontinued operations as of December 31, 2024 (Refer to Note 3, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for financial information on the discontinued operating Corporate Clinics segment). Therefore, since December 31, 2024, we have had <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-1055">one</ix:nonFraction> reportable segment: Franchise Operations. As of December 31, 2025, all company-owned or managed clinics in the Corporate Clinic segment met the criteria to be reported as discontinued operations. In accordance with Accounting Standards Codification 205-20, Discontinued Operations, expenses that in prior periods were partially allocated to the Corporate Clinic segment that are not wholly related to the activity of the segment have been recast to be presented in continuing operations, which is now Franchise Operations. Additionally, any expenses previously identified as Corporate Unallocated have been allocated entirely to the Franchise Operations segment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue primarily from customers by providing access to our franchise license, which represents symbolic intellectual property (See Note 2, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Disclosures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for additional details). The Franchise Operations segment is managed on a consolidated basis because all operations are located within a similar economic and regulatory environment, provide the same services and share the same business model and pricing strategies. As of December&#160;31, 2025, the franchise system consisted of <ix:nonFraction unitRef="clinic" contextRef="c-52" decimals="INF" name="us-gaap:NumberOfStores" scale="0" id="f-1056">885</ix:nonFraction> clinics in operation. The accounting policies for the franchise segment are the same as those described in Note 1, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nature of Operations and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. The CODM uses the following metrics to </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-1053-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">assess performance and determine how to allocated resources; Net Income, Gross Profit, Operating Income, and Adjusted EBITDA. Net Income, Gross Profit, and Operating Income are reported on the consolidated income statements. Adjusted EBITDA is presented in </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations, Non-GAAP Financial Measures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and is reconciled back to consolidated Net loss from continuing operations on the consolidated income statements. The measure of segment assets is reported on the balance sheet as total consolidated assets. The CODM uses these financial measures to evaluate income generated from segment assets (return on assets) in deciding whether to reinvest profits in the Franchise Segment or into other parts of the entity, such as new products or services, expanding into new geographic territories, acquisitions or reacquisitions, or stock buybacks. Net Income and Adjusted EBITDA are used to monitor budget verses actual results. The CODM also uses Net Income and Adjusted EBITDA in conjunction with certain non-financial metrics in competitive analysis by benchmarking to our competitors. The competitive analysis along with the monitoring of budgeted verses actual results are used in assessing performance of the segment and in establishing management&#8217;s compensation. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-1057" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes total revenue and significant expense categories and amounts for our reportable segment that aligns with the segment level information that is regularly provided to the CODM:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" id="f-1058">54,895,592</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" id="f-1059">52,163,430</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Franchise and regional developer cost of revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="0" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" id="f-1060">9,500,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="0" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" id="f-1061">10,063,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">IT cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="0" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" id="f-1062">1,724,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-196" decimals="0" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" id="f-1063">1,453,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="0" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" id="f-1064">13,299,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="0" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" id="f-1065">10,973,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="0" name="jynt:GeneralAndAdministrativeExpenseAdjusted" format="ixt:num-dot-decimal" id="f-1066">27,256,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="0" name="jynt:GeneralAndAdministrativeExpenseAdjusted" format="ixt:num-dot-decimal" id="f-1067">27,359,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="0" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" id="f-1068">1,297,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="0" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" id="f-1069">1,679,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items, net</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="0" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" id="f-1070">401,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="0" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" id="f-1071">871,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="0" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" id="f-1072">1,644,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="0" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" id="f-1073">1,371,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" id="f-1074">38,653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" id="f-1075">5,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Segment loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-191" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-1076">268,157</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-192" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-1077">1,614,344</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-191" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" id="f-1078">268,157</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-192" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" id="f-1079">1,614,344</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="0" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" id="f-1080">3,175,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-192" decimals="0" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" id="f-1081">4,182,549</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="0" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" id="f-1082">2,907,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-192" decimals="0" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" id="f-1083">5,796,893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">(a) </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other segment items, net includes interest income, acquisition related expenses, net loss on disposition or impairment, costs related to restatement filings, and restructuring costs.</span></div></ix:nonNumeric></ix:continuation><div id="iaf8338e230dd46e38cf560e1698dc7ef_178"></div><div style="margin-top:12pt;padding-left:40.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 12:   <ix:nonNumeric contextRef="c-1" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="f-1084" continuedAt="f-1084-1" escape="true">Related Party Transactions</ix:nonNumeric></span></div><div style="padding-left:40.5pt;text-align:justify;text-indent:-40.5pt"><span><br/></span></div><ix:continuation id="f-1084-1" continuedAt="f-1084-2"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Jefferson Gramm, Managing Partner of Bandera Partners LLC, who is a beneficial holder of more than 5% of our outstanding common stock (approximately <ix:nonFraction unitRef="number" contextRef="c-197" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-1085">28</ix:nonFraction>% as of December&#160;31, 2025), was appointed to the Board of Directors effective as of January 2, 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, we sold <ix:nonFraction unitRef="franchise" contextRef="c-198" decimals="INF" name="us-gaap:SignificantChangesFranchisesSold" format="ixt-sec:numwordsen" scale="0" id="f-1086">two</ix:nonFraction> franchise licenses at $<ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="3" id="f-1087">40</ix:nonFraction> thousand and $<ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="3" id="f-1088">30</ix:nonFraction> thousand each (which reflects the $<ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="jynt:RelatedPartyTransactionAmountsOfTransactionDiscount" scale="3" id="f-1089">10</ix:nonFraction> thousand multi-unit discount for the second license per the Franchise Disclosure Document) to Marshall Gramm, who is a family member of Mr. Jefferson Gramm. In April 2020 and 2021, we sold <ix:nonFraction unitRef="franchise" contextRef="c-201" decimals="INF" name="us-gaap:SignificantChangesFranchisesSold" format="ixt-sec:numwordsen" id="f-1090">two</ix:nonFraction> franchise licenses at $<ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="3" id="f-1091">40</ix:nonFraction> thousand and $<ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="3" id="f-1092">30</ix:nonFraction> thousand, respectively (which reflects the $<ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="jynt:RelatedPartyTransactionAmountsOfTransactionDiscount" scale="3" id="f-1093">10</ix:nonFraction> thousand multi-unit discount for the second license per the Franchise Disclosure Document), to a franchisee of which Mr. Jefferson Gramm is a <ix:nonFraction unitRef="number" contextRef="c-201" decimals="2" name="jynt:RelatedPartyTransactionCoPartnerPercentage" scale="-2" id="f-1094">50</ix:nonFraction>% co-partner in the business. In the fourth quarter of 2024, Mr. Jefferson Gramm divested his interest in the clinics to which he is a <ix:nonFraction unitRef="number" contextRef="c-204" decimals="2" name="jynt:RelatedPartyTransactionCoPartnerPercentageDivested" scale="-2" id="f-1095">50</ix:nonFraction>% co-partner in the business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">These transactions involved terms no less favorable to us than those that would have been obtained in the absence of such affiliation. Although we have no way of estimating the aggregate amount of franchise fees, royalties, advertising fund fees, IT </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><ix:continuation id="f-1084-2"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">related income and computer software fees that these franchisees will pay over the life of the franchise licenses, the franchisees affiliated with Mr. Gramm are subject to such fees under the same terms and conditions as all other franchisees.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, Mr. Gramm loaned approximately $<ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-3" name="us-gaap:NotesReceivableNet" scale="3" id="f-1096">370</ix:nonFraction> thousand to an unaffiliated franchisee that owns and operates <ix:nonFraction unitRef="clinic" contextRef="c-206" decimals="INF" name="jynt:NumberOfClinics" format="ixt-sec:numwordsen" scale="0" id="f-1097">one</ix:nonFraction> franchise clinic. The loan is not secured by the assets of the business and there are no foreclosure rights. As of December&#160;31, 2025, the remaining balance on the unsecured loan was approximately $<ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-3" name="us-gaap:NotesReceivableNet" scale="3" id="f-1098">196</ix:nonFraction> thousand.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_181"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 13:   <ix:nonNumeric contextRef="c-1" name="us-gaap:QuarterlyFinancialInformationTextBlock" id="f-1099" continuedAt="f-1099-1" escape="true">Quarterly Financial Data (Unaudited)</ix:nonNumeric></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock" id="f-1100" escape="true"><ix:continuation id="f-1099-1"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Selected quarterly financial data for the years ended December&#160;31, 2025 and 2024 is summarized below:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.068%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.232%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.232%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.232%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.232%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.232%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.232%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.232%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.232%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.232%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.407%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Q1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Q2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Q3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Q4</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Q1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Q2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Q3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Q4</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-1101">13,077,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" id="f-1102">13,270,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-1103">13,380,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-1104">15,167,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-1105">54,895,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-1106">12,184,716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-1107">12,610,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-1108">12,654,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-1109">14,714,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-1110">52,163,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Total costs of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="0" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="0" id="f-1111">2,972,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="0" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" id="f-1112">2,772,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="0" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" id="f-1113">2,661,234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="0" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" id="f-1114">2,819,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" id="f-1115">11,225,474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="0" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="0" id="f-1116">2,704,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="0" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="0" id="f-1117">2,812,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="0" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="0" id="f-1118">2,814,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="0" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="0" id="f-1119">3,184,984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" id="f-1120">11,516,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Selling and marketing expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="0" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" id="f-1121">3,505,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="0" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" id="f-1122">3,483,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="0" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="0" id="f-1123">2,816,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="0" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" id="f-1124">3,494,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" id="f-1125">13,299,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="0" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" id="f-1126">2,237,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="0" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" id="f-1127">3,440,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="0" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" id="f-1128">2,504,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="0" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" id="f-1129">2,791,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" id="f-1130">10,973,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="0" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" id="f-1131">361,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="0" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" id="f-1132">402,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="0" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="0" id="f-1133">446,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="0" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" id="f-1134">433,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" id="f-1135">1,644,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="0" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" id="f-1136">329,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="0" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" id="f-1137">342,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="0" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" id="f-1138">345,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="0" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" id="f-1139">353,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" id="f-1140">1,371,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="0" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" id="f-1141">6,914,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="0" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" id="f-1142">7,745,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="0" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="0" id="f-1143">7,295,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="0" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" id="f-1144">7,676,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" id="f-1145">29,632,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="0" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" id="f-1146">7,339,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="0" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" id="f-1147">7,793,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="0" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" id="f-1148">7,478,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="0" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" id="f-1149">7,513,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" id="f-1150">30,124,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Total selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="0" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" id="f-1151">10,782,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="0" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" id="f-1152">11,631,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="0" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="0" id="f-1153">10,558,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="0" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" id="f-1154">11,603,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" id="f-1155">44,575,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="0" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" id="f-1156">9,906,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="0" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" id="f-1157">11,576,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="0" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" id="f-1158">10,328,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="0" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" id="f-1159">10,658,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" id="f-1160">42,469,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Net loss on disposition or impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="0" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="0" id="f-1161">1,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="0" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" format="ixt:num-dot-decimal" id="f-1162">4,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="0" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" format="ixt:fixed-zero" scale="0" id="f-1163">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="0" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="0" id="f-1164">1,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" format="ixt:num-dot-decimal" id="f-1165">7,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="0" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="0" id="f-1166">275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="0" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="0" id="f-1167">662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="0" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="0" id="f-1168">3,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="0" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="0" id="f-1169">61,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" format="ixt:num-dot-decimal" id="f-1170">66,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(Loss) income from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-208" decimals="0" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-1171">678,534</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-209" decimals="0" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" id="f-1172">1,138,167</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="0" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-1173">160,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="0" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-1174">742,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" id="f-1175">913,376</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-212" decimals="0" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-1176">426,596</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-213" decimals="0" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-1177">1,779,325</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-214" decimals="0" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-1178">492,820</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="0" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" id="f-1179">809,716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" id="f-1180">1,889,025</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="0" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="0" id="f-1181">185,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="0" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" id="f-1182">159,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="0" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="0" id="f-1183">139,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="0" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="0" id="f-1184">198,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" id="f-1185">683,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="0" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="0" id="f-1186">36,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="0" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="0" id="f-1187">80,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="0" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="0" id="f-1188">83,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="0" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="0" id="f-1189">79,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" id="f-1190">280,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(Loss) income from continuing operations before income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-208" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-1191">492,617</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-209" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" id="f-1192">978,245</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="0" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-1193">300,716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="0" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-1194">940,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" id="f-1195">229,504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-212" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-1196">390,337</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-213" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-1197">1,698,854</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-214" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-1198">408,992</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="0" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-1199">889,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" id="f-1200">1,608,738</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-1201">13,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" id="f-1202">11,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-1203">10,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-1204">3,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" id="f-1205">38,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-1206">8,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-1207">11,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-1208">5,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-215" decimals="0" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-1209">19,536</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" id="f-1210">5,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Net (loss) income from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-208" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-1211">506,021</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-209" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" id="f-1212">989,635</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="0" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-1213">290,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="0" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-1214">937,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" id="f-1215">268,157</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-212" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-1216">398,919</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-213" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-1217">1,710,023</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-214" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-1218">414,383</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="0" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-1219">908,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" id="f-1220">1,614,344</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations before income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="0" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="0" id="f-1221">1,577,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="0" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" id="f-1222">1,183,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="0" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="0" id="f-1223">664,269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-211" decimals="0" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="0" id="f-1224">224,068</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" id="f-1225">3,200,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="0" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="0" id="f-1226">1,516,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-213" decimals="0" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="0" id="f-1227">1,719,222</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-214" decimals="0" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="0" id="f-1228">2,693,562</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-215" decimals="0" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="0" id="f-1229">1,075,745</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" id="f-1230">3,972,286</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Income tax expense(benefit) from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="0" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" format="ixt:num-dot-decimal" scale="0" id="f-1231">103,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="0" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" format="ixt:num-dot-decimal" scale="0" id="f-1232">100,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="0" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" format="ixt:num-dot-decimal" scale="0" id="f-1233">99,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-211" decimals="0" sign="-" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" format="ixt:num-dot-decimal" scale="0" id="f-1234">278,036</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" format="ixt:num-dot-decimal" id="f-1235">25,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="0" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" format="ixt:num-dot-decimal" scale="0" id="f-1236">170,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="0" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" format="ixt:num-dot-decimal" scale="0" id="f-1237">167,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="0" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" format="ixt:num-dot-decimal" scale="0" id="f-1238">57,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-215" decimals="0" sign="-" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" format="ixt:num-dot-decimal" scale="0" id="f-1239">184,429</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" format="ixt:num-dot-decimal" id="f-1240">210,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="0" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-1241">1,473,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="0" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-1242">1,082,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="0" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-1243">564,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="0" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-1244">53,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" id="f-1245">3,175,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="0" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-1246">1,345,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-213" decimals="0" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-1247">1,886,375</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-214" decimals="0" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-1248">2,750,756</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-215" decimals="0" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-1249">891,316</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" id="f-1250">4,182,549</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="0" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" id="f-1251">967,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="0" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="0" id="f-1252">93,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="0" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="0" id="f-1253">855,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="0" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="0" id="f-1254">991,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" id="f-1255">2,907,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="0" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="0" id="f-1256">946,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-213" decimals="0" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="0" id="f-1257">3,596,398</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-214" decimals="0" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="0" id="f-1258">3,165,139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="0" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="0" id="f-1259">17,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" id="f-1260">5,796,893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Net (loss) income from continuing operations per common share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-208" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="f-1261">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-209" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="f-1262">0.06</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-210" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="f-1263">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-211" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="f-1264">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="f-1265">0.02</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-212" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="f-1266">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-213" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="f-1267">0.11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-214" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="f-1268">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-215" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="f-1269">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-18" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="f-1270">0.11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-208" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="f-1271">0.03</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-209" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="f-1272">0.06</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-210" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="f-1273">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-211" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="f-1274">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="f-1275">0.02</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-212" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="f-1276">0.03</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-213" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="f-1277">0.11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-214" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="f-1278">0.03</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-215" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="f-1279">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-18" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="f-1280">0.11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss) from discontinued operations per common share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-208" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="f-1281">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-209" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="f-1282">0.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-210" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="f-1283">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-211" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="f-1284">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="f-1285">0.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-212" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="f-1286">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-213" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="f-1287">0.13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-214" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="f-1288">0.18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-215" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="f-1289">0.06</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-18" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="f-1290">0.28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-208" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="f-1291">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-209" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="f-1292">0.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-210" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="f-1293">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-211" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="f-1294">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="f-1295">0.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-212" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="f-1296">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-213" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="f-1297">0.12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-214" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="f-1298">0.18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-215" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="f-1299">0.06</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-18" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="f-1300">0.28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss) per common share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-208" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1301">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-209" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1302">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-210" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1303">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-211" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1304">0.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1305">0.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-212" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1306">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-213" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1307">0.24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-214" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1308">0.21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-215" decimals="2" name="us-gaap:EarningsPerShareBasic" format="ixt:fixed-zero" scale="0" id="f-1309">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-18" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1310">0.39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-208" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1311">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-209" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1312">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-210" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1313">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-211" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1314">0.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1315">0.19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-212" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1316">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-213" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1317">0.24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-214" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1318">0.21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-215" decimals="2" name="us-gaap:EarningsPerShareDiluted" format="ixt:fixed-zero" scale="0" id="f-1319">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-18" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1320">0.38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_187"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9.&#160;&#160;&#160;&#160;CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_190"></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9A.&#160;&#160;&#160;&#160;CONTROLS AND PROCEDURES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Evaluation of disclosure controls and procedures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are designed to provide reasonable assurance that information required to be disclosed in our reports filed under the Exchange Act, such as this Form 10-K, is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures also include, without limitation, controls and procedures that are designed to provide reasonable assurance that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. The Chief Executive Officer and the Chief Financial Officer, with assistance from other members of management, have reviewed the effectiveness of our disclosure controls and procedures as of December 31, 2025 and, based on their evaluation, have concluded that the disclosure controls and procedures were effective as of such date due to the material weakness remediation in internal control over financial reporting, described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Management&#8217;s Report on Internal Control Over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act). Internal control over financial reporting is the process designed under the Chief Executive Officer&#8217;s and the Chief Financial Officer&#8217;s supervision, and effected by our Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Internal control over financial reporting has inherent limitations. Internal control over financial reporting is a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures. Internal control over financial reporting also can be circumvented by collusion or improper management override. Because of such limitations, there is a risk that material misstatements will not be prevented or detected on a timely basis by internal control over financial reporting. Therefore, it is possible to design safeguards into the process to reduce, though not eliminate, this risk.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of December&#160;31, 2025, as required by Exchange Act Rule 13a-15(c). In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in the 2013 Internal Control Integrated Framework (2013).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As disclosed in Part II, Item 9A &#8211; Controls and Procedures in our Form 10-K/A for the year ended December 31, 2024, we previously identified a material weakness as discussed below. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We identified a material weakness in internal controls related to the accounting treatment for non-routine, unusual or complex transactions. Specifically, we did not adequately design, implement and maintain controls to timely analyze and account for the impairment associated with certain assets held for sale within discontinued operations and for the application of valuation methodologies impacting impairment charges related to assets held for sale.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During 2025, management implemented our previously disclosed remediation plan that included modifying internal controls to address the accounting treatment for non-routine, unusual or complex transactions and the application of valuation methodologies impacting impairment charges, specifically through the utilization of subject matter experts to review conclusions over our impairment methodologies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2025, we completed our testing of the operating effectiveness of the implemented controls and found them to be effective. As a result, we have concluded the material weakness has been remediated as of December 31, 2025. Our Chief Executive Officer and Chief Financial Officer have certified that, based on their knowledge, the financial </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">statements and other financial information included in this Form 10-K fairly present in all material respects the financial condition, results of operations and cash flows of our company as of, and for, the periods presented in this Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This on Form 10-K does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Our report was not subject to attestation by our registered public accounting firm pursuant to an exemption for non-accelerated filers from the internal control audit requirements of Section 404(b) of the Sarbanes-Oxley Act of 2002.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Limitations on effectiveness of controls and procedures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures (as that term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)) that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including our</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:120%"> Chief Executive Officer and Chief Financial Officer</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, as appropriate, to allow timely decisions regarding required disclosures. In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of our controls and procedures relative to their costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Controls over Financial Reporting </span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other than the changes in connection with our implementation of the remediation plan discussed above, no other changes in our internal control over financial reporting (as defined in Rules 13a-15(f) or 15d-15(f) of the Exchange Act) that occurred during the fourth quarter of 2025 have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_196"></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9B.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended December&#160;31, 2025, no director or officer of our company <ix:nonNumeric contextRef="c-211" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1321"><ix:nonNumeric contextRef="c-211" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1322">adopted</ix:nonNumeric></ix:nonNumeric> or <ix:nonNumeric contextRef="c-211" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1323"><ix:nonNumeric contextRef="c-211" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1324">terminated</ix:nonNumeric></ix:nonNumeric> a &#8220;Rule 10b5-1 trading arrangement&#8221; or a &#8220;non-Rule 10b5-1 trading arrangement&#8221; (in each case, defined in Item 408 of Regulation S-K).</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_199"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">ITEM 9C.&#160;&#160;&#160;&#160;DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_202"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_205"></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 10.&#160;&#160;&#160;&#160;DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will be included in our Proxy Statement to be filed pursuant to Regulation 14A within 120 days after our year ended December&#160;31, 2025 in connection with our 2026 Annual Meeting of Stockholders (the &#8220;2026 Proxy Statement&#8221;) and is incorporated herein by reference.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Code of Ethics and Business Conduct</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will be included in the 2026 Proxy Statement and is incorporated herein by reference.</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_208"></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 11.&#160;&#160;&#160;&#160;EXECUTIVE COMPENSATION</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will be included in the 2026 Proxy Statement and is incorporated herein by reference, except for the information required by Item 402(v) of Regulation S-K, which is specifically not incorporated herein by reference.</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_211"></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 12.&#160;&#160;&#160;&#160;SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND &#160;&#160;&#160;&#160;RELATED STOCKHOLDER MATTERS</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item will be included in the 2026 Proxy Statement and is incorporated herein by reference.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_214"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 13.&#160;&#160;&#160;&#160;CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">The information required by this item will be included in the 2026 Proxy Statement and is incorporated herein by reference. </span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_217"></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 14.&#160;&#160;&#160;&#160;PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will be included in the 2026 Proxy Statement and is incorporated herein by reference.</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_220"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_223"></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 15.&#160;&#160;&#160;&#160;EXHIBITS, FINANCIAL STATEMENT SCHEDULES</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Documents filed as part of this report.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt">Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. The consolidated financial statements listed on the index to Item 8 of this Form 10-K are filed as a part of this Annual Report.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt">Financial Statement Schedules.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> All financial statement schedules have been omitted since the information is either not applicable or required or is included in the consolidated financial statements or notes thereof.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt">Exhibits.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_226"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">EXHIBIT INDEX  </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.747%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.681%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by Reference</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Form</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">File No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Filing Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Provided<br/>Herewith</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex3-2.htm">Amended and Restated Certificate of Incorporation of the Registrant.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">333-198860</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9/19/2014</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000162828023033040/ex32amendedandrestatedbyla.htm">Fourth Amended and Restated Bylaws</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9/26/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000162828020003113/exhibit41descriptionof.htm">Description of the Registrant&#8217;s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/6/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex10-1.htm">Form of Indemnification Agreement between the Registrant and each of its directors and officers and related schedule.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">333-198860</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9/19/2014</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-3.htm">Amended and Restated 2014 Incentive Stock Plan.&#160;</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-136724</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5/25/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.3#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000162828020003113/exhibit106amendmenttos.htm">Amendment to Amended and Restated 2014 Incentive Stock Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/6/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.4#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000162828022005982/a105amendmenttoamendedandr.htm">Amendment to Amended and Restated 2014 Incentive Stock Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/14/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.5#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-4.htm">Form of Incentive Stock Option Agreement under 2014 Stock Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">333-207632</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10/27/2015</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.6#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000117184319002226/exh_101.htm">Form of Incentive Stock Option Agreement under Amended and Restated 2014 Stock Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">333-207632</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4/3/2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.7#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000162828020003113/exhibit109formisoagree.htm">2020 Amended Form of Incentive Stock Option Agreement under Amended and Restated 2014 Stock Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/6/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.8#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-5.htm">Form of Nonstatutory Stock Option Agreement under 2014 Stock Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">333-207632</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10/27/2015</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.9#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000117184319002226/exh_102.htm">Form of Nonstatutory Stock Option Agreement under Amended and Restated 2014 Stock Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">333-207632</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4/3/2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.10#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000162828020003113/exhibit1012formnsoagre.htm">Amended Form of Nonstatutory Stock Option Agreement under Amended and Restated 2014 Stock Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/6/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.11#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000114420415061069/v422731_ex10-6.htm">Form of Nonstatutory Stock Option Agreement under 2014 Stock Plan for Article 7, Annual Option Grants.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">333-207632</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10/27/2015</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.12#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000117184318001818/exh_1054.htm">Form of Restricted Stock Award under Amended and Restated 2014 Stock Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.54</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/9/2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.13#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000117184319002226/exh_103.htm">2019 Amended Form of Restricted Stock Award Agreement under Amended and Restated 2014 Stock Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">333-207632</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4/3/2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.14#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000162828020003113/exhibit1016formrestric.htm">2020 Amended Form of Restricted Stock Award Agreement under Amended and Restated 2014 Stock Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/6/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.15#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001612630/000117184321000548/exh_101.htm">Executive Short-Term Incentive Plan (amended January 25, 2021)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1/27/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.16#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001612630/000162828021016032/ex101executivestiprevised0.htm">Executive Short-Term Incentive Plan (amended May 2, 2021)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8/6/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.17#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000117184318007798/exh_101.htm">Employment Letter Agreement between The Joint Corp. and Jake Singleton dated November 6, 2018</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11/8/2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.18#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000117184318007798/exh_102.htm">Confidentiality, Noncompetition and Nonsolicitation Agreement between the Registrant and Jake Singleton dated November 6, 2018</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11/8/2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.19#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000162828020003113/exhibit1032amendmentto.htm">Amendment to Employment Letter Agreement between the Registrant. and Jake Singleton dated March 3, 2020</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.32</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/6/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.20#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000117184318008352/exh_101.htm">Employment Letter Agreement between the Registrant and Peter Holt dated December 11, 2018</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12/6/2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.747%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.681%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.21#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000117184319001609/exh_1047.htm">Confidentiality, Noncompetition and Nonsolicitation Agreement between the Registrant and Peter Holt dated December 11, 2018</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.47</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/11/2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.22</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000162828020003113/exhibit1020thejointlea.htm">Lease Agreement dated May 17, 2019 between the Registrant and Terra Verde Owner LLC for the Registrant&#8217;s office located at 16767 North Perimeter Drive, Suite 110, Scottsdale, Arizona 85260</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.20</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/6/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000162828023033039/exhibit1024formofregionald.htm">Form of the Registrant&#8217;s Regional Developer License Agreement.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-K/A</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.24</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9/26/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.24</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000162828023033039/exhibit1025-formoffranchis.htm">Form of the Registrant&#8217;s Franchise Agreement.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-K/A</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.25</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9/26/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.25</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001612630/000117184320001432/exh_101.htm">Credit Agreement, dated as of February 28, 2020, among the Registrant JPMorgan Chase Bank, N.A., as the Lender, and JPMorgan Chase Bank, N.A., as Administrative Agent and Sole Bookrunner and Sole Lead Arranger</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/3/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.26</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001612630/000117184320001432/exh_102.htm">Pledge and Security Agreement, dated as of February 28, 2020, among the Registrant and JPMorgan Chase Bank, N.A., as Administrative Agent</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/3/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.27</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001612630/000117184320001432/exh_103.htm">Term A Loan Note dated February 28, 2020</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/3/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.28</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001612630/000117184320001432/exh_104.htm">Revolving Loan Note dated February 28, 2020</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/3/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.29</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001612630/000117184320002630/exh_101.htm">Loan Note dated as of April 9, 2020</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4/15/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000162828022012960/exhibit101.htm">Corrected Second Amendment to Credit Agreement, dated as of February 28, 2022 (the &#8220;2022 Amendment&#8221;) with Annex 1 Credit </a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5/6/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.31</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000117184322001641/exh_102.htm">Amended and Restated Revolving Loan Note dated February 28, 2022</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/4/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.32</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000117184319004724/exh_101.htm">Asset Purchase Agreement dated July 17, 2019, by and among the Registrant, TJ of Savannah &#8211; Twelve Oaks, LLC, a Georgia limited liability company, TJ of Pooler, LLC, a Georgia limited liability company, and TJ of Bluffton, LLC, a Georgia limited liability company , Robyn Meglin and Allen Meglin, as amended</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7/23/2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.33</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000117184319005139/exh_101.htm">Asset and Franchise Purchase Agreement, dated August 1, 2019, among the Registrant, RJJ, LLC a South Carolina limited liability company, Robin Willey and Judy Willey</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8/5/2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.34</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001612630/000162828021004004/jynt-20201231xex1040thejoi.htm">North Carolina Regional Developer License Purchase Agreement dated as of December 31, 2020 by and among the Registrant as purchaser, Wellness Incorporated, a North Carolina corporation as seller, and Paul Trindel as guarantor</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.40</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/5/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.35</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001612630/000162828021004004/jynt-20201231xex1041thejoi.htm">Georgia Regional Developer License Purchase Agreement dated as of January 1, 2021 by and among the Registrant as purchaser, Midtown Health Solutions, Inc., a Georgia corporation as seller, and Dr. Patrick Greco as guarantor</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.41</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/5/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.747%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.681%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.36</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000162828022021260/ex101shakarianassetpurchas.htm">Asset and Franchise Purchase Agreement dated May 19, 2022 among the Registrant, SJV Tempe Marketplace, LLC, an Arizona limited liability company (&#8220; TM &#8221;), Shakarian Joint Ventures, LLC, an Arizona limited liability company (&#8220; SJV &#8221;), SJV East Mesa, LLC, an Arizona limited liability company (&#8220; EM &#8221;), SJV Apache Junction, LLC, an Arizona limited liability company (&#8220; AJ &#8221;), Dr. Aaron Shakarian, an individual and Stacie Shakarian, an individual (TM, SJV, EM, AJ, Dr. Aaron Shakarian and Stacie Shakarian, collectively, the &#8220;Seller &#8221;), and Shakarian Holdings, LLC, an Arizona limited liability company, Dr. Aaron Shakarian, an individual and Stacie Shakarian, an individual (collectively, the &#8220; Shareholder &#8221;)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8/5/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.37#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000161263023000005/jynt-20230331xex10161.htm">Executive Short-Term Incentive Plan (STIP) (Amended March 7, 2023)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-Q/A</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10/30/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.38#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000162828023037571/confidentialityagreementba.htm">Confidentiality Agreement</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11/8/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.39#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000117184324003088/exh_101.htm">The Joint Corp. 2024 Incentive Stock Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5/24/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.40#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000162828025012702/a1041stockoptionagreement-.htm">Form of Stock Option Agreement (Incentive Stock Option Granted Under The Joint Corp. 2024 Incentive Stock Plan)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.41</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/14/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.41#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000162828025012702/a1042stockoptionagreement-.htm">Form of Stock Option Agreement (Nonstatutory Stock Option Granted Under The Joint Corp. 2024 Incentive Stock Plan)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.42</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/14/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.42#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000162828025012702/a1043restrictedstockawarda.htm">Form of Restricted Stock Award (The Joint Corp. 2024 Incentive Stock Plan)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.43</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/14/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.43#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000162828025012702/a1044confidentialityandnon.htm">Form of Confidentiality and Nonsolicitation Agreement</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.44</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/14/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.44#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000117184324005643/exh_101.htm">Separation Agreement and Release, dated October 13, 2024, by and between the Registrant and Peter D. Holt</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10/15/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.45#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000117184324005643/exh_102.htm">Employment Agreement, dated October 14, 2024, by and between the Registrant and Sanjiv Razdan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10/15/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.46#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000117184324005643/exh_103.htm">Restricted Stock Award Grant Agreement, dated as of October 14, 2024, by and between the Registrant and Sanjiv Razdan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10/15/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.47#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000117184324005643/exh_104.htm">Stock Option Agreement, dated as of October 14, 2024, by and between the Registrant and Sanjiv Razdan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10/15/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.48#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000117184324005643/exh_105.htm">Confidentiality and Nonsolicitation Agreement, dated as of October 14, 2024, by and between the Registrant and Sanjiv Razdan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10/15/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.49</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000117184324007066/exh_101.htm">Amended and Restated Nomination and Standstill Agreement, dated as of December 19, 2024, by and among The Joint Corp., Bandera Master Fund L.P., Bandera Partners LLC, Gregory Bylinsky, and Jefferson Gramm</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12/23/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.50#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000162828025012702/a1051executivestip.htm">Executive Short-Term Incentive Plan (STIP) (Amended March 10, 2025)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.51</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/14/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.51#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000162828025030452/employmentagreement-bowm.htm">Employment Agreement, dated June 10, 2025, by and between the Registrant and Scott J. Bowman</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6/10/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.52***</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000161263025000037/ex102-apaxjyntxjointventur.htm">Asset Purchase Agreement, dated June 23, 2025, by and between the Registrant and Joint Ventures, LLC, a Nevada limited liability company</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8/12/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.53#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000161263025000044/separationagreement-jakesi.htm">Separation Agreement and Release, dated August 22, 2025, by and between the Registrant and Jake Singleton</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8/27/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.747%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.681%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.54</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000161263025000060/thirdamendmenttocreditagre.htm">Consent and Third Amendment to Credit Agreement, dated as of September 30, 2025, by and between the Registrant and JPMorgan Chase Bank, N.A.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10/6/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.55</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="socalapa.htm">Asset Purchase Agreement, dated November 2, 2025, by and among the Registrant, Elite Chiro Group, and Gadi Emein</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.56</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="southeastapa.htm">Asset Purchase Agreement, dated December 5, 2025, by and among the Registrant, Addisco Value, LLC, Triangle Chiropractic Associates P.C., Bluffton TJ, LLC, Alex Klaus, Todd Wegerski, DC, Lisa Ezell, Andrew Michael Evec, and Susan Ruth Train</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.57</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000161263026000004/banderagramm2025agreement.htm">Letter Agreement, dated as of January 5, 2026, by and among the Registrant, Bandera Partners LLC, and Jefferson Gramm</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1/9/2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000162828025012702/a191insidertradingpolicy.htm"><ix:nonNumeric contextRef="c-1" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true" id="f-1325">Insider trading policies and procedures</ix:nonNumeric></a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/14/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000114420414056976/v389460_ex21-1.htm">List of subsidiaries of the Registrant</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">333-198860</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9/19/2014</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="consentofbdousapc2025xex231.htm">Consent of BDO USA, P.C.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="jynt-20251231x10xkxex311.htm">Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="jynt-20251231x10kxex312.htm">Certification of Principal Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">32**</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="jynt-20251231x10kxex321.htm">Certification by Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002&#160;</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">97</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1612630/000161263025000033/executiveofficerclawbackpo.htm">The Joint Corp. Executive Officer Clawback Policy</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10-K/A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">001-36724</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">97</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8/12/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:79.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.673%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document (the instance document does not appear in the Interactive Data File<br/>because its XBRL tags are embedded within the inline XBRL document)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"># Management contract or compensatory plan or arrangement </span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">** Furnished, not filed</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">*** Certain schedules and exhibits have been omitted from this filing pursuant to Item 601(a)(5) of Regulation S-K. We agree to furnish supplementally a copy of any omitted schedule or exhibit to the Securities and Exchange Commission upon request.</span></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">___________________</span></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_229"></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16.&#160;&#160;&#160;&#160;FORM 10-K SUMMARY</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><div id="iaf8338e230dd46e38cf560e1698dc7ef_232"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaf8338e230dd46e38cf560e1698dc7ef_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on March&#160;12, 2026.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:45pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"/><td style="width:56.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">The Joint Corp.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Scott J. Bowman</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Scott J. Bowman, Chief Financial Officer<br/>(Principal Financial Officer and <br/>Principal Accounting Officer)</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons in the capacities and on the dates indicated.</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.078%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.166%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.990%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Signature</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Date</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ Sanjiv Razdan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">President, Chief Executive Officer and Director&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">March 12, 2026</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Sanjiv Razdan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer) and Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ Scott J. Bowman</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">March 12, 2026</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Scott J. Bowman</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ Matthew E. Rubel</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Lead Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">March 12, 2026</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Matthew E. Rubel</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ Ronald V. DaVella</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">March 12, 2026</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Ronald V. DaVella</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ Suzanne M. Decker</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">March 12, 2026</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Suzanne M. Decker</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ Jefferson Gramm</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">March 12, 2026</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Jefferson Gramm</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ Christopher Grandpre</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">March 12, 2026</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Christopher Grandpre</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ Abe Hong</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">March 12, 2026</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Abe Hong</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ Sandi Karrmann</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">March 12, 2026</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Sandi Karrmann</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>socalapa.htm
<DESCRIPTION>EXHIBIT-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i8ba13c149bc24dcc83656e3a640f212f_85"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%">ASSET PURCHASE AGREEMENT</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%">BY AND BETWEEN</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%">THE JOINT CORP., as Seller</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%">ELITE CHIRO GROUP</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">,</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%">, as Buyer</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%">GADI EMEIN, as Guarantor</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%">Effective Date&#58;  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%;text-decoration:underline">  November 2, 2025   </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">Contents</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">1.     Purchase and Sale............................................................................................................................. - 1 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">2.     Assumed Liabilities&#59; Excluded Assets............................................................................................. - 3 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">3.     Purchase Price.................................................................................................................................. - 4 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">4.     Payment of Purchase Price&#59; PostClosing Reconciliation................................................................. - 5 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">5.     Closing.............................................................................................................................................. - 7 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">6.     Representations, Warranties and Covenants of Seller...................................................................... - 8 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">7.     Representations and Warranties of Buyer&#8230;.................................................................................. - 10 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">8.     PreClosing Events.......................................................................................................................... - 10 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">9.     Buyer Closing Conditions.............................................................................................................. - 12 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">10.   Seller Closing Conditions............................................................................................................... - 12 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">11.   Confidential Information&#59; NonDisparagement&#59; Personal Guaranty............................................... - 13 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">12.   Termination.................................................................................................................................... - 14 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">13.   Indemnification of Buyer............................................................................................................... - 15 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">14.   Indemnification of Seller................................................................................................................ - 16 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">15.   Indemnification Threshold and Cap............................................................................................... - 16 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">16.   Survival.......................................................................................................................................... - 17 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">17.   Notice of Indemnification Claim.................................................................................................... - 17 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">18.   Resolution of Claims...................................................................................................................... - 18 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">19.   Third Party Suits............................................................................................................................. - 18 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">20.   Damages......................................................................................................................................... - 19 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">21.   Expenses......................................................................................................................................... - 19 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">22.   Schedules........................................................................................................................................ - 19 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">23.   Parties&#8217; Review............................................................................................................................... - 19 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">24.   Publicity.......................................................................................................................................... - 20 -</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">ii</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">25.   Notices............................................................................................................................................ - 20 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">26.   Further Assurances and Cooperation.............................................................................................. - 20 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">27.   Waiver............................................................................................................................................ - 21 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">28.   Entire Agreement...............&#8230;........................................................................................................ - 21 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">29.   Assignment.................................................................................................................................... - 21 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">30.   No ThirdParty Beneficiaries.......................................................................................................... - 21 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">31.   Construction................................................................................................................................... - 22 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">32.   Severability.................................................................................................................................... - 22 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">33.   Counterparts................................................................................................................................... - 22 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">34.   Governing Law............................................................................................................................... - 22 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">35.   No MultiParty Actions................................................................................................................... - 22 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">36.   Counsel........................................................................................................................................... - 23 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">37.   Binding Effect................................................................................................................................ - 23 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">38.   Fully Informed Parties and Capacity.............................................................................................. - 23 -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">39.   Specific Performance...................................................................................................................... - 23 - </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:107%">                  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">iii</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.197%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:112%">EXHIBITS</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">SCHEDULES</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit A</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Franchise Agreements</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Schedule A</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">List of Clinics</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit B</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Development Agreement</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Schedule 1(b)(i)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Personal Property</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit C</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Letter of Intent</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Schedule 1(b)(iv)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Telephone Numbers</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit D</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Leases</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Schedule 1(b)(viii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Assumed Contracts</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit E</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Lease Assignments</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 2(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Excluded Assets</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit F</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Records Transfer Agreement</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Schedule 4(b)(iii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Security Deposits</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit G</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Refresh Schedule</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Schedule 6(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Consents</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit H</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Bill of Sale</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Schedule 6(e)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Condition of Assets&#47;Conduct of Operations</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit I</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Seller&#8217;s Certificate</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 6(d)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Compliance with Laws</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit J</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Buyer&#8217;s Certificate</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Schedule 6(f)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Claims</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit K-1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Management Agreement</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Schedule 6(g)(i)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Employees</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit K-2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">PC Management Agreement</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Schedule 6(g)(ii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Organizational Chart and Business Plan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit K-3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Submanagement Agreement</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Schedule 6(h)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Contracts</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit L</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Promissory Note and Security Agreement</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">iv</font></div></div></div><div id="i8ba13c149bc24dcc83656e3a640f212f_37"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%">ASSET PURCHASE AGREEMENT</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">THIS ASSET PURCHASE AGREEMENT (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221;) is made and entered into as of </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">  November 2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">, 2025 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221;), by and between </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%">THE JOINT CORP</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">, a Delaware corporation doing business as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:118%">The Joint Chiropractic</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%"> with its principal place of business at 16767 N. Perimeter Dr., Suite 110, Scottsdale, Arizona 85260 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Seller</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221;), on the one hand, and on the other hand, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%">ELITE CHIRO GROUP</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">, a California corporation with a principal place of business at 10660 Wilshire Blvd, Unit 409, Los Angeles, CA 90024 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Buyer</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221;), and GADI EMEIN</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%">, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">an individual residing at 1237 S Holt St, Apr 203, Los Angeles, CA 90035(&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Guarantor</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221;). Seller and Buyer shall at times be collectively referred to as the &#8220;Parties.&#8221;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Background&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">A.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:7.31pt">The Seller is the franchisor of </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:118%">The Joint Chiropractic</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%"> franchise system, and owns the assets of, and contractually engages a professional chiropractic company to operate forty-five (45) </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:118%">The Joint Chiropractic</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%"> &#8220;Clinics&#8221; listed in Schedule A attached hereto  (the physical locations of the Clinics are collectively referred to herein as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Premises</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221;, and the Clinics are also referred to herein collectively as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Businesses</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221;)&#59; </font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">B.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:7.92pt">Except for the Excluded Assets (as defined herein), Seller will sell to Buyer, and Buyer will purchase from Seller, all of Seller&#8217;s interest in the Businesses, on the terms and conditions set forth in this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Transaction</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221;)&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">C.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:7.92pt">The Parties acknowledge that Seller will franchise the Businesses to the Buyer pursuant to forty-five (45) </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:118%">The Joint Chiropractic</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%"> franchise agreements entered into by the Parties through separate transactions at Closing, and copies of which will be attached hereto in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%"> (&#34;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Franchise Agreements</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#34;)&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">D.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:7.31pt">Seller will acquire the non-exclusive development rights for ten (10) </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:118%">The Joint Chiropractic</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#174; clinic pursuant to a development agreement entered into by the Parties through a separate transaction at Closing as further described herein, and a copy of which will be attached hereto in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%"> (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Development Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#34;).</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">NOW, THEREFORE, in consideration of the mutual agreements, covenants and undertakings herein contained and other valuable consideration, the adequacy of which is acknowledged by all Parties, the Parties hereby agree as follows&#58;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:125%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:125%;padding-left:9.75pt">Purchase and Sale</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:5.8pt">Except as provided herein, at the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Closing</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221; (as hereinafter defined in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Section 5</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">) of the transactions contemplated hereby, Seller shall sell, assign, transfer and deliver, or cause its affiliates to assign, transfer and deliver, to Buyer, and Buyer shall purchase and accept from Seller the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Assets</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221; (as defined below at Section 1(b))&#59; free and clear of any and all liens, claims (including, without limitation, title claims and claims of taxing authorities), encumbrances, pledges, security interests or charges of any kind whatsoever, and shall assume the obligations only as specifically stated herein, for the purchase price set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%"> hereof.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:5.18pt">For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Acquired Assets</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221; shall mean&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-1-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:7.63pt">all of Seller&#8217;s interest in equipment, machinery, tools, maintenance supplies, fixed assets, office equipment, leasehold improvements, furniture, fixtures, inventories and supplies and other similar items of tangible personal property (together the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Personal Property</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221;) used or held for use by Seller in the Businesses, which is more particularly listed and described in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%;text-decoration:underline">Schedule 1(b)(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">attached hereto and made a part hereof&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:4.58pt">all of Seller&#8217;s interest in any membership agreements, prepaid services packages and other agreements or arrangements Seller has made with patients of the Businesses&#59; provided however for the avoidance of doubt, that all gross Business sales received by the Seller prior to the Closing, shall remain wholly the Seller&#8217;s gross sales&#59;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(iii) all of Seller&#8217;s goodwill attributable to the Businesses (the Buyer specifically acknowledges that any intellectual property used for the benefit of the Businesses shall remain the sole property of Seller, and the applicable intellectual property rights necessary to operate the Businesses have been licensed to the Buyer through the Franchise Agreements)&#59; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(iv) the telephone numbers utilized by the Businesses listed in Schedule 1(b)(iv) attached hereto and made a part hereof&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(v) copies of all medical records with respect to patients of the Businesses and all documents and records in the possession of Seller pertaining to patients and employees of the Businesses, to the extent held by the Seller&#59; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(vi) to the extent transferable, all licenses, government approvals and permits and all other approvals and permits relating to the Businesses&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(vii) all of Seller&#8217;s interests as tenant (including leasehold improvements) under its six (6) leases for the Premises, a copy of which are attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%;text-decoration:underline">Exhibit D</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">and made a part hereof (hereinafter, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Leases</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221;)&#59; such transfer completed through forty-five (45) &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Lease Assignment Agreements</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221; entered into contemporaneously with the execution of this Agreement and attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%;text-decoration:underline">Exhibit E</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#59; and</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(viii)     the agreements and contracts which Buyer has expressly agreed to assume and which are listed on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%;text-decoration:underline">Schedule 1(b)(viii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%"> (together, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Assumed Contracts</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221;).</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">               (c)        The Buyer agree and acknowledge a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Due Diligence Request List</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; was submitted through the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Letter of Intent</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; on or about September 11, 2025 that is attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">, the Seller has responded to the Due Diligence Request List and provided the materials requested therein to the Buyer&#8217;s satisfaction. The Buyer further agrees and acknowledges that as of the Effective Date of this Agreement, the Buyer has no additional Due Diligence requests and waives any claims against the Seller that the Seller failed to timely or fully furnish any Due Diligence materials to the Buyer&#8217;s satisfaction.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">               (d)        </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Required Approval of the Professional Corporation</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">. The Buyer acknowledges that in accordance with California laws and regulations, the forty-five (45) California Clinics are currently operated from a clinical standpoint by </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">FENTON CHIROPRACTIC CORPORATION OF CALIFORNIA</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">, a California professional service corporation having its principal place of business at 11033 La Maida Street, North Hollywood, California 91601, and its owner </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">MARK FENTON, DC</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%"> (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">PC</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;). The Buyer agrees and acknowledges that the execution of this Agreement is conditioned upon the PC&#8217;s acceptance and acknowledgement of this Agreement. The PC, through the acknowledgement below, agrees to be bound by certain terms of this Agreement (i.e., Confidentiality and Use of Information, Public Announcements, and acting in good faith). The Buyer further agrees and acknowledges that the Buyer shall be required to provide (and disclose to Seller) its own California </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-2-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">professional chiropractic corporation (or proof of California chiropractic licensing) prior to the Closing to ensure regulatory compliance regarding the transfer of patient records and the post-Closing clinical operation of the Clinics. The Buyer agrees and acknowledges that it shall be required to enter into the transfer of patient records agreement attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit F </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Records Transfer Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), which shall be furnished by the Seller prior to the Closing.   </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(e)        For purposes herein, the following definitions shall apply&#58;</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(i)         &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Seller Parties</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall include The Joint Corp., and any and all of its past, present and future affiliates, parents, subsidiaries or related companies, divisions and partnerships, past, present and future officers, directors, shareholders, members, owners, members, predecessors, successors, assigns, heirs, beneficiaries, trustees, franchise owners, attorneys, accountants, auditors, representatives, chiropractors, related chiropractic corporations, contractors, vendors, insurance carriers, insurance brokers)&#59;  </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(ii)  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Buyer Parties</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall include Elite Chiro Group and Gadi Emein, and any and all of his past, present and future affiliates, spouses, parents, subsidiaries or related companies, divisions and partner-ships, past, present and future officers, directors, shareholders, members, owners, members, predecessors, successors, assigns, heirs, beneficiaries, trustees, attorneys, accountants, auditors, representatives, chiropractors, related chiropractic corporations, contractors, vendors, insurance carriers, and insurance brokers&#59;   </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(iii) &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Financing Commitment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; means proof of funds or a binding financing commitment&#59;   </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(iv) &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Purchase Agreement Response Deadline</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; means October 27, 2025&#59;   </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(v) &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Financing Commitment Extension</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; means November 8, 2025&#59;    </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(vi) &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">LOI</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; means the letter of intent signed by the parties on the LOI Execution Date defined below&#59; and  </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(vii) &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">LOI Execution Date</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; means September 11, 2025.   </font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:125%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:125%;padding-left:9.75pt">Assumed Liabilities&#59; Excluded Assets</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:5.8pt">Buyer shall assume and agree to pay, discharge and perform according to their terms the following liabilities and obligations of Seller (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Assumed Liabilities</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221;)&#58; </font></div><div><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-28.37pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:18pt">All liabilities and obligations arising out of operation of the Businesses or the use or ownership of the Acquired Assets from and after the Closing&#59;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-31.42pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:18pt">All liabilities and obligations under or arising out of the Assumed Contracts and the Leases from and after the Closing&#59; in addition, Buyer shall not assume any liabilities or obligations arising out of or in connection with Seller&#8217;s breach or alleged breach of such Assumed Contracts or Leases which occurred prior to the Closing&#59;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-34.47pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:18pt">All liabilities and obligations arising under any business licenses, registrations, expenses and similar obligations from and after the Closing, to the extent such liabilities and obligations relate solely to Buyer&#8217;s use or ownership of the Businesses or the Assets, except to the extent that such liabilities and obligations otherwise constitute Excluded Liabilities or Excluded Assets&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-3-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-33.87pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:18pt">Safeguarding of all medical records (including compliance with all related privacy and HIPAA laws and regulations) and other materials delivered by the Buyer to the Seller in accordance with this Agreement&#59; and</font></div><div><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-30.82pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(v)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:18pt">All liabilities and obligations relating to the employment of any employees or contractors that continue from and after the Closing.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:5.18pt">Notwithstanding anything to the contrary contained in this Agreement, it is expressly acknowledged by Buyer that Seller will not convey to Buyer the following (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Excluded Assets</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221;)&#58; (i) any cash, cash equivalents, working capital,  accounts receivable, or any Tenant Improvement Allowances (defined below) (ii) any of the proceeds of the Transaction described in this Agreement, (iii) the books and records of Seller, except that Seller shall provide copies of any separate patient listings and employee records, (iv) the items listed on the attached </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%;text-decoration:underline">Schedule 2(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%">,</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%"> (v) any other assets, properties or rights of Seller owned or used by Seller but not used in or directly related to the Businesses&#59; (vi) six (6) clinics located at Midtown Crossing, Inglewood, West Hollywood, Santa Monica, Mission Viejo, and San Marcos in California (the aforementioned clinics are collectively referred to herein as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Excluded Clinics</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221;)&#59; (vii) the gross sales received by the Seller for all patient adjustment packages sold prior to the Closing Date&#59; and (viii) any asset not specifically identified herein as an Acquired Asset. </font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:5.8pt">Further to the above regarding Excluded Assets, the Buyer agrees and acknowledges that as of the Closing, the Seller may hold at certain Clinics, tenant improvement allowances (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Tenant Improvement Allowances</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221;) that the Seller shall endeavor to collect from the applicable landlords following the Closing, and that the Buyer is not entitled to collection of any of the Tenant Improvement Allowances (or allocation or credit of the Tenant Improvement Allowances for any purpose, including without limitation, the Post Closing Adjustments (as defined below)). The Buyer further agrees and acknowledges that the Seller shall, following the Closing, have the continued right to communicate with the applicable landlords regarding the administration and collection of the Tenant Improvement Allowances, and that such communications shall not constitute a breach of this Agreement, the applicable Lease Assignment Agreements, or any laws in equity or common laws. Last, the Buyer agrees and acknowledges that it shall reasonably cooperate with the Seller and the applicable landlords in the Seller&#8217;s collection of the Tenant Improvement Allowances.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:125%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:125%;padding-left:9.75pt">Purchase Price</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">The aggregate purchase price for this acquisition to purchase the Acquired Assets to be paid by the Buyer to the Seller will be a wire transfer payment in immediately available funds of </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%">Four Million, Five Hundred Thousand and NO&#47;100 Dollars ($4,500,000.00) </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Purchase Price</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221;), consisting of the following&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:5.8pt">the cash consideration for the Acquired Assets in the amount of Three Million, One Hundred and Fifty-four Thousand, Five Hundred and NO&#47;100 Dollars ($3,154,500.00) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Cash Consideration</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221;)&#59; plus</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:5.18pt">the pro-rated franchise fees in the amount of One Million, Three Hundred Forty-Five Thousand Five hundred and NO&#47;100 ($1,345,500.00) which shall be remitted by the Buyer to the Seller pursuant to the Franchise Agreements and as required of the Seller to acquire franchise rights to the Clinics pursuant to the terms therein (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Franchise Fees</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221;)&#59; plus</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-4-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:5.8pt">the development fee in the amount of Ninety Thousand and NO&#47;Dollars ($90,000.00) which shall be remitted by the Buyer to the Seller pursuant to the Development Agreement and as required of the Seller to acquire development rights pursuant to the terms therein (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Development Fee</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221;).</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:81%">4.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:81%;padding-left:9.75pt">Payment of Purchase Price&#59; Post-Closing Reconciliation </font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:5.8pt">Payment of Purchase Price.  </font></div><div><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:118%">(i)&#160;&#160;&#160;&#160;Downpayment and Exclusivity Conditions</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">.  Seller has the option to offer the Clinics for sale or accept another offer to purchase the Clinics after execution of this Agreement and until the Closing Date until Seller receives the Downpayment (as hereinafter defined).  After Seller receives the Downpayment, Seller will not have the right to offer the Clinics for sale or accept another offer to purchase the Clinics unless Buyer does not satisfy the Financing Commitment or meet the Purchase Agreement Response Deadline. </font></div><div><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:118%">(ii) Downpayment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">. Subject to Section 4(a)(i) herein, Buyer shall pay to Seller a downpayment of the Purchase Price in the amount of One Hundred Thousand and NO&#47;100 Dollars ($100,000.00) (the &#8220;Downpayment&#8221;), and remit the balance of the Purchase Price to the Seller at Closing (the &#8220;Purchase Price Balance&#8221;). The Downpayment shall be deemed fully-earned when paid, and is not refundable.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:118%">(iii) Method of Payment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">. The Purchase Price shall be paid by Buyer to the Seller for the Acquired Assets subject to adjustments as set forth herein. Buyer will pay to Seller the Purchase Price by wire transfer on the day of the Closing in accordance with certain wire instructions and details, which the Seller shall send to the Buyer by separate electronic delivery prior to the Closing.  </font></div><div><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:118%">(iv) Funding Contingency. </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">If Buyer cannot pay the Purchase Price Balance at Closing, sign the promissory Note attached hereto as Exhibit K (the &#8220;Promissory Note&#8221;) in the amount of the Purchase Price Balance.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">Following Seller&#8217;s full receipt of the Purchase Price, the Seller shall execute its obligations herein and initiate the transfer of the Acquired Assets to the Buyer. Buyer&#8217;s failure to timely or fully remit the Purchase Price shall constitute a material breach of the terms of this Agreement&#59; for which the Seller may immediately and unilaterally terminate this Agreement upon delivery of Notice of termination to the Buyer.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(d)   Reconciliation. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(i)         Within ninety (90) days after Closing, the Parties shall conduct a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Reconciliation</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221; to tally the various costs borne between the Parties by the following items, as determined and applicable by the Parties&#58; (A) any amounts required to be paid to the landlords in connection with the assignment of the Leases&#59; (B) decreases for any cash (or cash equivalents) collected by the Seller for patient membership plans or package plan services transacted after the Closing&#59; and (C) any outstanding or accrued royalties, advertising contributions and other fees under the Franchise Agreements, appropriate pro-rations for rent, state and local real estate taxes and transfer taxes, sales tax, service and utility contracts, any merchant card collections on account of the Businesses, balance of any security deposits held by the landlords under the Leases that transfer to the Buyer, or other expenses charged to the Buyer that are the obligations of the Seller as of and subsequent to the Closing </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-5-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Post Closing Adjustments</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221;). Notwithstanding the foregoing, the gross sales received by the Seller for all patient adjustment packages or treatments sold prior to the Closing of the Transaction shall remain wholly the Seller&#8217;s gross sales. For the avoidance of doubt, there shall be no payment or compensation remitted at any time by the Seller to the Buyer for any sales proceeds collected by the Seller prior to the Closing.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(ii)        The Buyer agrees that as part of the Reconciliation, it shall fully compensate the Seller for any fees incurred by the Seller related to the Lease assignments, or the transfers of the Security Deposits. The Parties shall endeavor to complete the Reconciliation within such ninety (90) day period, and if the Parties are unable to do so, the Parties shall agree to extend such period for a reasonable amount of time.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(iii)       Regarding the Leases, the Buyer shall be responsible for reconciliation payment to the Seller of the current &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Security Deposits</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221; in the amounts for the Clinics listed in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%;text-decoration:underline">Schedule 4(b)(iii</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%"> attached hereto. The foregoing Security Deposits shall transfer from the Seller to the Buyer by separate lease assignment agreements, and the Buyer shall also compensate the Seller for any lease assignment fees paid by the Seller to the applicable landlords to transfer the Leases, and other related applicable lease expenditures. The Buyer acknowledges that the above recitation of Security Deposits reflects the current information in the applicable Leases, and may not reflect other fees and costs added by the applicable landlord. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(iv)       Also regarding the Leases, in recognition of the fact that the applicable forty-five (45) landlords may not timely provide formal assignment approvals, the Parties agree that as a Closing condition, the Seller must obtain, with the Buyer&#47;Guarantor&#8217;s cooperation, and at least two (2) weeks prior to the Closing, lease assignments or landlord consents for no less than thirty-eight (38) of the forty-five (45) leases (&#8220;Lease Assignment Threshold&#8221;).  The term of the Lease Assignments shall be at least ten (10) years, including options. In the event the Lease Assignment Threshold is met, the Parties agree that the Closing may proceed as scheduled, and the Parties shall continue to complete the remaining lease assignments as soon as practicable (and that those applicable Clinics may transfer subsequent to the Closing). The Buyer&#47;Guarantor agrees that it shall reasonably and timely cooperate with the Seller in securing any approvals or furnishing any information requested or required by the landlords for the Premises. In the event the Lease Assignment Threshold is not met, the following shall occur&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(A)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:2.74pt">The Parties will complete a Closing for the Clinics that have secured a Lease Assignment, and the Parties shall continue to obtain the remaining lease assignments as soon as practicable&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(B)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:3.35pt">For the Clinics that are located in a state </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:118%">without</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%"> professional corporation requirements for the provision of chiropractic care, Seller and Buyer shall execute the management Agreement attached hereto as Exhibit K-1 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Management Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221;) which shall terminate for any Clinic once a Lease Assignment is obtained and Closing occurs, and </font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(C)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:3.35pt">For the Clinics that are located in a state </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:118%">with</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%"> professional corporation requirements for the provision of chiropractic care, Seller and Buyer&#8217;s P.C. shall execute the P.C. management agreement attached hereto as Exhibit K-2 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">P.C. Management Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221;), and Seller and Buyer shall execute the sub management agreement attached hereto as Exhibit K-3 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Submanager Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">&#8221;), both of which shall terminate for any Clinic once a Lease Assignment is obtained and Closing occurs.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(v) The Parties shall cooperate to determine the amounts of the Post Closing Adjustments and shall use commercially reasonable efforts to determine amounts within sixty (60) days after the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-6-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">Closing and shall reimburse the other party as necessary and as detailed below. The agreed amount of the Post Closing Adjustments shall be documented by a written calculation signed by the Parties hereto (the &#8220;Post Closing Adjustment Agreement&#8221;) no later than ninety (90) days after the Closing. Following the documentation of the written calculation, the Party owing the net of the Post Closing Adjustments shall remit such amounts to the other Party within thirty (30) days following the date of the documentation of the written calculation. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(e) Refresh Schedule</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:118%">.  Buyer acknowledges and agrees that Buyer&#8217;s agreement to refresh the Clinics in accordance with the refresh schedule set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:118%">Exhibit G</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:118%"> attached hereto is a material inducement for Seller&#8217;s agreement to execute the Franchise Agreements and this Agreement. The Refresh Schedule shall be incorporated in an amendment to the Franchise Agreements. As of September 3, 2025, capex for the remodels are estimated to be approximately Two Hundred and Forty-Eight Thousand and NO&#47;100 Dollars ($248,000.00) not including any necessary IT upgrades.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(e)   Refresh Schedule.  Buyer acknowledges and agrees that Buyer&#8217;s agreement to refresh the Clinics in accordance with the refresh schedule set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:118%">Exhibit G</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%"> attached hereto is a material inducement for Seller&#8217;s agreement to execute the Franchise Agreements and this Agreement. The Refresh Schedule shall be incorporated in an amendment to the Franchise Agreements. As of September 3, 2025, capex for the remodels are estimated to be approximately Two Hundred and Forty-Eight Thousand and NO&#47;100 Dollars ($248,000.00) not including any necessary IT upgrades.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">(f) Development Agreement.  Buyer agrees and acknowledges that as a condition of the Seller&#8217;s agreement to the Transaction, Buyer shall execute the Development Agreement for the development of ten (10) clinics. This additional development agreement shall be non-exclusive and have commercially reasonable terms granting Buyer the right to develop a clinic in the metropolitan statistical areas (&#8220;MSAs&#8221;) of an area agreed upon by the Parties (the &#8220;Development Area&#8221;) in accordance with the schedule shown in the table below&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.769%"><tr><td style="width:1.0%"></td><td style="width:34.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.268%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Clinic</font></td><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Clinic Opening Deadline</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Clinic 1</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Month 24</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Clinic 2 and 3</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Month 30 - 36</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Clinic 4 and 5</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Month 36 - 42</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Clinic 6 and 7</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Month 42 - 48</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Clinic 8, 9 and 10</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Month 48 - 60</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">5.           Closing</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">Subject to the satisfaction or waiver of the conditions described in Sections 9 and 10, the &#8220;Closing&#8221; of the transactions described herein shall take place shall take place remotely via electronic exchange of documents which the parties agree shall be effective as of 11&#58;59 a.m. Arizona Time on a date agreed upon by the parties, but in any event no later than November 11, 2025 or November 25, 2025 if the Financing Commitment Deadline is extended, and on the &#8220;Bill of Sale Effective Date&#8221; (defined at Exhibit H). At the Closing, Seller and shall deliver, the &#8220;Bill of Sale and Assignment,&#8221; attached hereto at Exhibit H. Following the Closing, the Parties shall cooperate fully with each other and shall make available to the other, as reasonably requested and at the expense of the requesting party, and to any taxing or regulatory authority, all information, records or documents relating to tax obligations and regulatory compliance matters of Seller for all periods on or prior to the Closing, and shall preserve all </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-7-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">such information, records and documents until the expiration of any applicable statute of limitations and extensions thereof. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">6.           Representations, Warranties and Covenants of Seller</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">Seller hereby represents and warrants to Buyer as follows, and further memorialized hereto at Exhibit I &#8211; Seller&#8217;s Certificate&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(a)          Organization.  Seller is a corporation duly organized and validly subsisting under the laws of the State of Delaware, and has full power and authority to conduct its business as it is now being conducted, and to execute, deliver and perform this Agreement. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(b)          Authority. Seller is not a party to, subject to, or bound by any agreement, judgment, order, writ, injunction, or decree of any court or governmental body that prevents or impairs the carrying out of this Agreement. The execution, delivery and performance of this Agreement and all other documents, instruments and agreements contemplated hereby have been duly authorized by all required corporate, limited liability company or limited partnership action of Seller. All other actions (including all action required by state law and by the organizational documents of Seller) necessary to authorize the execution, delivery and performance by Seller of this Agreement, the bills of sale transferring the Acquired Assets, the assignments in connection herewith and the other documents, instruments and agreements necessary or appropriate to carry out the transactions herein contemplated, have been taken by Seller. Upon the execution of this Agreement and the other documents and instruments contemplated hereby by Seller (and assuming the due execution and delivery by the other parties), this Agreement and such other documents and instruments will be the valid and legally binding obligations of Seller, enforceable against it in accordance with their respective terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium and similar laws affecting creditors&#8217; rights generally, and subject, as to enforceability, to general principles of equity, including principles of commercial reasonableness, good faith and fair dealing (regardless of whether enforcement is sought in a proceeding at law or in equity). Except as set forth on Schedule 6(b), no authorization, consent, approval or other order of, declaration to or filing with any third party, including any governmental body or authority is required for the approval or consummation by Seller of the transactions contemplated by this Agreement. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(c)          Taxes.  Seller has filed when due in accordance with all applicable laws (or properly and timely filed an extension therefor) all tax returns required under applicable statutes, rules or regulations to be filed by it. As of the time of filing, such returns were accurate and complete in all material respects.  All taxes due with respect to Seller and the Acquired Assets, and all additional assessments received, have been paid. Seller is not delinquent in the payment of any such tax and none has requested any extension of time within which to file any tax return, which return has not since been filed.  There are no federal, state, local or other tax liens outstanding on any of the Acquired Assets being sold hereunder.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(d)          Title to and Condition of Acquired Assets. Seller has good and marketable title to (or, with respect to any Acquired Assets that are leased, a valid leasehold interest in) all of the Acquired Assets to be acquired by Buyer at the Closing, free from any liens, adverse claims, security interest, rights of other parties or like encumbrances of any nature.  The Acquired Assets consisting of physical property are in good condition and working order, normal wear and tear excepted, and function properly for their intended uses. To the best of Seller&#8217;s knowledge, except as described in Schedule 6(b), no party has sold, encumbered, assigned, or transferred any assets or properties which would have been included in the Assets, except for the sale, use, or consumption of inventory in the ordinary course of business consistent with past practice.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-8-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(e)          Compliance with Laws.  To the best of Seller&#8217;s knowledge, except as referenced on Schedule 6(e), neither Seller nor the Businesses are in violation of, nor are they or any of them subject to any liability in respect of, any federal, state, county, township, city or municipal laws, codes, regulations or ordinances (including without limitation those relating to environmental protection, health, hazardous or toxic substances, fire or safety hazards, occupational safety, labor laws, employment discrimination, subdivision, building or zoning) with respect to the conduct of the Businesses, nor has Seller received any notices of investigation or violation pertaining to any such matters. To the best of Seller&#8217;s knowledge, Seller has, and all professional employees or agents of Seller have, all licenses, franchises, permits, authorizations or approvals from all governmental or regulatory authorities required for the conduct of the Businesses and neither Seller nor the professional employees or agents of Seller have violated any such license, franchise, permit, authorization or approval or any terms or conditions thereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(f)           Claims Against Acquired Assets or the Businesses. To the best of Seller&#8217;s knowledge, except as referenced on Schedule 6(f), Seller represents and warrants that it has no knowledge of any action, claim, judgment, demand, lawsuit or proceeding pending, threatened against or affecting the Acquired Assets or the Businesses (or against the Seller that has or may affect the Acquired Assets or the Businesses), or relating to or arising out of, the ownership or operation of the Acquired Assets or the Businesses&#59; including without limitation claims by employees of the Businesses or the applicable professional chiropractic entity.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(g)          Employees. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">i.               Schedule 6(g)(i) referenced hereto contains a complete and correct list of the name, position, current rate of compensation and any vacation or holiday pay and any other compensation arrangements or fringe benefits, of each current employee of Seller or the professional chiropractic entity overseeing the clinical components at the Clinics, who is directly employed in the Businesses (collectively, the &#8220;Employees&#8221;). Buyer  hereby agrees to hire (or, as applicable, to negotiate with the applicable professional chiropractic entity do the same) all of the Employees as of the Closing and pay any and all compensation due the Employees after the Closing&#59; including, but not limited to, all base pay, hourly pay, bonuses and com-mission, vacation and sick time, and any severance obligations. Seller agrees to pay, by the Closing Date, any and all compensation due the Employees prior to the Closing&#59; including, but not limited to, all base pay and hourly pay. Such hiring or contracting shall constitute a closing condition. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">ii.              Buyer will also retain an upper-level management team for the Clinics and implement a portion of the existing infrastructure to help grow Buyer&#8217;s team shown in the Organizational Chart and Business Plan attached as Schedule 6(g)(ii). </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">iii.           For the avoidance of doubt, the Buyer agrees and acknowledges that only the incoming licensed California chiropractor operating the clinic and managing all clinical decisions may hire Doctors of Chiropractic, and that therefore, the Seller cannot exert any influence over such hiring practices or make any representations regarding such hiring decisions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(h)          Contracts.  Seller has delivered to Buyer copies of the Leases.  Except as set forth in Schedule 6(h), no consent or approval of any third party is required for the assignment to Buyer of any contracts that Buyer is assuming pursuant to Section 1(b).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(i)           Financial Statements.  Seller has delivered to Buyer the financial statements requested in the Due Diligence Request for the Businesses (collectively, the &#8220;Financial Statements&#8221;). </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-9-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">7.           Representations and Warranties of Buyer</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">Buyer represents and warrants to Seller as follows, and further memorialized hereto at Exhibit K &#8211; Buyer&#8217;s Certificate&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(a)          Organization of Buyer.  Buyer consists of one legal entity organized and operating in the State of California, and Buyer has full power and authority to conduct its business as it is now being conducted, and to execute, deliver and perform this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(b)          Authorization.  Buyer is not a party to, subject to or bound by any agreement, judgment, order, writ, injunction, or decree of any court or governmental body that prevents or impairs the carrying out of this Agreement. All actions (including all action required by state law) necessary to authorize the execution, delivery and performance by Buyer of this Agreement, the bill of sale transferring the Acquired Assets, the assignments in connection herewith and the other documents, instruments and agreements necessary or appropriate to carry out the transactions herein contemplated, have been taken by Buyer. Upon the execution of this Agreement and the other documents and instruments contemplated hereby by Buyer, this Agreement and such other documents and instruments will be the valid and legally binding obligations of Buyer, enforceable against each in accordance with their respective terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium and similar laws affecting creditors&#8217; rights generally, and subject, as to enforceability, to general principles of equity, including principles of commercial reasonableness, good faith and fair dealing (regardless of whether enforcement is sought in a proceeding at law or in equity).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(c)          No Consent or Approval Required.  No authorization, consent, approval or other order of, declaration to or filing with any governmental body or authority, including, without limitation, with respect to environmental matters, is required for the consummation by Buyer or of the transactions contemplated by this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(d)          No Violation of Other Agreements.  Neither the execution and delivery of this Agreement nor compliance with the terms and conditions of this Agreement by Buyer will breach or conflict with any of the terms, conditions or provisions of any agreement or instrument to which Buyer is or may be bound or constitute a default thereunder or result in a termination of any such agreement or instrument.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(e)          Financial Capability.  Buyer will have at Closing, sufficient internal funds available to pay the Purchase Price and any fees or expenses incurred by Buyer in connection with the transactions contemplated hereby.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">8.           Pre-Closing Events</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(a)          General.  Pending Closing, the Parties shall use commercially reasonable efforts to take all actions that may be necessary to close the transaction in accordance with the terms of this Agreement (but Buyer shall not be required to waive any of the Buyer Closing Conditions, and Seller shall not be required to waive any of the Seller Closing Conditions).  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(b)        Conduct of Businesses.  Pending Closing, Seller shall&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(i)           operate the Businesses in the ordinary course&#59; and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-10-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(ii)          not take any affirmative action that results in the occurrence of an event of default under any contract or agreement to which Seller is a party and take any reasonable action within Seller&#8217;s control that would avoid the occurrence of such default.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(c)        Access to Information.  Pending Closing, Seller shall&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(i)           afford Buyer and its representatives (including its lawyers, accountants, consultants and the like) reasonable access during normal business hours, but without unreasonable interference with operations, to the Seller&#8217;s books and records and other documents relating to the Businesses&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(ii)          promptly respond to reasonable inquiries by Buyer and its representatives regarding Seller&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(iii)         cause Seller to furnish Buyer and its representatives with all information and copies of all documents concerning Seller that Buyer and its representatives reasonably request&#59; and</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(iv)         otherwise cooperate with Buyer in its due diligence activities.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(d)        Notice of Developments.  Pending Closing, Seller shall promptly give Notice to Buyer of&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(i)           any fact or circumstance of which Seller becomes aware that causes or constitutes a material inaccuracy in or material breach of any of Seller&#8217;s representations and warranties in Section 6 as of the date of this Agreement&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(ii)          any fact or circumstance of which Seller becomes aware that would cause or constitute a material inaccuracy in or material breach of any of Seller&#8217;s representations and warranties in Section 6 if those representations and warranties were made on and as of the date of occurrence or discovery of the fact or circumstance&#59; or </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(iii)         the occurrence of any event of which Seller becomes aware that reasonably could be expected to make satisfaction of any Buyer Closing Condition impossible or unlikely.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(e)      Supplements to Schedules.  Pending Closing, Seller may supplement or correct the Schedules to this Agreement as necessary to ensure their completeness and accuracy. No supplement or correction to any Schedule or Schedules to this Agreement shall be effective, however, to cure any breach or inaccuracy in any of the representations and warranties&#59; but if Buyer does not exercise its right to terminate this Agreement under Section 12 and closes the transaction, the supplement or correction shall constitute an amendment of the Schedule or Schedules to which it relates for all purposes of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">9.           Buyer Closing Conditions </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">                Except as provided herein, Buyer&#8217;s obligation to close the transaction is subject to the satisfaction of each of the following conditions (the &#8220;Buyer Closing Conditions&#8221;) at or prior to Closing&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(a)          Seller&#8217;s representations, warranties and covenants in Section 6, as qualified or limited by any exceptions in the Schedules to Section 6, are true, correct and fulfilled on the Closing as if </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-11-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">made at and as of Closing (other than representations and warranties that address matters as of a certain date, which were true and correct as of that date)&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(b)          Seller has executed and delivered all the documents, including but not limited to, the information requested by Buyer during Due Diligence, and instruments that they are required to execute and deliver or enter into prior to or at Closing&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(c)          no material adverse change in the Seller&#8217;s assets, financial condition, operations, operating results or prospects relating to the Businesses has occurred since the date of this Agreement&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(d)          no suit has been initiated or, to the Seller&#8217;s knowledge, threatened by a third party that challenges or seeks damages or other relief in connection with the transaction or that could have the effect of preventing, or making illegal the transaction&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(e)          Seller has obtained and delivered to Buyer all consents listed on Schedule 6(b)&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(f)           Seller has confirmed the assignments of at least the amount of the Lease Assignment Threshold in forms reasonably acceptable to Buyer, such Lease Assignments are attached hereto as Exhibit D, and delivered such executed lease assignment documentation to Buyer (Buyer acknowledges that the Buyer shall be solely responsible for any post-Closing negotiations with the Landlord regarding any revisions or changes to the existing Lease terms) or, if the Lease Assignment Threshold is not met, Seller and Buyer have executed the Management Agreement and, if applicable, the PC Management Agreement and Submanager Agreement&#59; and  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(g)          If applicable, Seller has delivered payoff letters and releases of security interests or liens from any secured lenders or lessors.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">Buyer may waive any condition specified in this Section 9 by a written waiver delivered to Seller at any time prior to or at Closing.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">10.        Seller Closing Conditions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">Seller&#8217;s obligation to close the transaction is subject to the satisfaction of each of the following conditions (the &#8220;Seller Closing Conditions&#8221;) at or prior to Closing&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(a)          Buyer&#8217;s representations and warranties in Section 7 were true and correct as of the date of this Agreement and are true and correct on the Closing as if made at and as of Closing&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(b)          Buyer has executed and delivered all of the documents and instruments that it is required to execute and deliver or enter into prior to or at Closing (including signing the Promissory Note if Buyer does not pay the Purchase Price Balance at Closing), and has performed, complied with or satisfied in all material respects all of the other obligations, agreements and conditions under this Agreement that it is required to perform, comply with or satisfy prior to or at Closing&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(c)          no suit has been initiated or, to Buyer&#8217;s knowledge, threatened by a third party since the date of this Agreement that challenges or seeks damages or other relief in connection with the transaction or that could seek to prevent the transaction.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">Seller may waive any condition specified in this Section 10 by a written waiver delivered to Buyer at any time prior to or at Closing.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-12-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">11.        Confidential Information&#59; Non-Disparagement&#59; Personal Guaranty</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(a)          Definitions.  Wherever used in this Section 11, the term &#8220;Seller&#8221; shall refer to The Joint Corp. and any affiliate, subsidiary, or any successor or assign of Seller. Wherever used in this Section, the phrase &#8220;directly or indirectly&#8221; includes, but is not limited to, acting, either personally or as principal, owner, member, employee, independent contractor, agent, manager, partner, joint venturer, consultant, or in any other capacity or by means of any corporate or other device, or acting through the spouse, children, parents, brothers, sisters, or any other relatives, friends, invitees, agents, or associates of any of the undersigned parties.  Wherever used in this Section, the term &#8220;employees&#8221; shall refer to employees of The Joint Corp.&#59; any affiliate, subsidiary, or any successor or assign of The Joint Corp.&#59; and any franchisee of The Joint Corp. existing as of the date of this Agreement and, to the extent allowable by law, any other person that has been an employee (as defined above) in the twelve (12) months preceding the date of this Agreement.  Whenever used in this Section, the term &#8220;Confidential Information&#8221; shall be defined as provided in the Franchise Agreements, which provisions are hereby incorporated by reference and shall expressly further include any audio or video recordings possessed by Seller of conversations between Seller&#8217;s employees and both Seller. &#8220;Confidential Information&#8221; shall also include the terms of this Agreement, and any related communications or negotiations thereto&#59; unless the disclosure of such information shall be required of the Parties for the purposes of tax or legal disclosures.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(b)          Consideration.  The undersigned parties acknowledge that consideration for this Agreement has been provided and is adequate.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(c)          Need for this Agreement.  The undersigned parties recognize that in the highly competitive business in which Seller and its affiliates and franchisees are engaged, preservation of Confidential Information is crucial and personal contact is important in securing new franchisees and employees, and retaining the goodwill of present franchisees, employees, customers, and suppliers. Personal contact is a valuable asset and is an integral part of protecting the business of Seller. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(d)          Confidential Information.  Buyer agrees at all times following the date of this Agreement, to hold the Confidential Information in the strictest confidence and not to use such Confidential Information for Buyer&#8217;s personal benefit, or the benefit of any other person or entity other than Seller, Guarantor, and Buyer and its employees, affiliates, agents, and officers, or disclose it directly or indirectly to any person or entity without Seller&#8217;s express authorization or written consent.  Buyer fully understands the need to protect the Confidential Information and all other confidential materials and agree to use all reasonable care to prevent unauthorized persons from obtaining access to Confidential Information at any time.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(e)          Tolling.  To ensure that Seller will receive the full benefit of this Section 11, the provisions  of Subsections (e) and (f) of this Section 11 will shall be extended by a length of time equal to (i) the period during which Buyer is in violation of Buyer&#8217;s agreements under such Subsections, and (ii) without duplication, any period during which litigation that Seller institutes to enforce the Buyer&#8217;s agreements under such Subsections is pending (to the extent that Buyer is in violation of Buyer&#8217;s agreements under such Subsections during this period).</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(f)           Non-Disparagement. Each of the Parties expressly covenant and agree not to make any false representations, or to defame, disparage, discredit or deprecate any of the other Parties or otherwise communicate with any person or entity in a manner intending to damage any of the other Parties, the business conducted by any of the other Parties, or the reputation of any of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-13-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">other Parties. For purposes of clarity, the obligations in this Section apply to all methods of communications, including the making of statements or representations through direct verbal or written communication as well as the making of statements or representations on the Internet, through social media sites or through any other verbal, digital or electronic method of communication. The obligations in this Section also prohibit the Parties from indirectly violating this Section by influencing or encouraging third parties to engage in activities that would constitute a violation of this Section if conducted directly by one of the Parties.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(g)          Personal Guaranty. The Guarantor personally and unconditionally agrees to perform and keep of this Agreement, each and every covenant, obligation, payment, agreement, and undertaking on the part of Guarantor in this Agreement (&#8220;Guaranty&#8221;). The Guarantor consents and agrees that&#58; (1) the direct and immediate liability under this Guaranty shall be joint and several&#59; (2) Guarantor will make any payment or render any performance required under the Agreement on demand if Guarantor fails or refuses to do so when required&#59; (3) the Guarantor&#8217;s liability will not be contingent or conditioned on our pursuit of any remedies against Guarantor or any other person or legal entity&#59; (4) the Guarantor&#8217;s liability will not be diminished, relieved or otherwise affected by any extension of time, credit or other indulgence which the Seller may from time to time grant to Guarantor or to any other person or legal entity, including without limitation, the acceptance of any partial payment or performance, or the compromise or release of any claims&#59; and (5) this Guaranty will continue and be irrevocable and incorporated into this Agreement at all periods, and afterward for so long as the Guarantor has any obligations under this Agreement. If the Seller is required to enforce this Guaranty in a judicial proceeding or defense of a claim or action, the Seller will be entitled to reimbursement of its reasonable costs and expenses, including, but not limited to, reasonable accountants&#8217;, attorneys&#8217;, attorneys&#8217; assistants&#8217;, mediation, arbitrators&#8217; and expert witness fees, costs of investigation and proof of facts, court costs, other litigation expenses and travel and living expenses, whether incurred prior to, in preparation for or in contemplation of the filing of any such proceeding.  If the Seller is required to engage legal counsel in connection with any failure by the Guarantor to comply with this Guaranty, the Guarantor agrees upon receipt of written demand to reimburse the Seller for any of the above-listed costs and expenses incurred by the Seller or its affiliates, employees, insurance carriers, contractors, directors, attorneys, agents, or other representatives.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">12.        Termination</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(a)          This Agreement may be terminated by Buyer, upon Notice to Seller, if prior to or at Closing&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(i)           Seller defaults in the performance of any of their material obligations under this Agreement and the default is not cured within five (5) business days after Buyer gives Notice of the default to Seller&#59; </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(ii)          the Lease Assignments Threshold is not met&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(iii)         any Seller Closing Condition is not satisfied as of the Closing Date, or satisfaction of any Seller Closing Condition is or becomes impossible (other than as a result of Buyer&#8217;s breach of or failure to perform its obligations under this Agreement), and Buyer does not waive satisfaction of the condition&#59; or</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(iv)         Closing does not occur on or before November 11, 2025 or November 25, 2025 if the Financing Commitment Deadline is extended (other than as a result of Buyer&#8217;s breach of or failure to perform its obligations under this Agreement).</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(b)          This Agreement may be terminated by Seller, upon Notice to Buyer, if prior to or at Closing&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(i)           Buyer fails to obtain proof of funds or a binding financing commitment by the Financing Commitment Deadline&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-14-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(ii)          Buyer does not provide comments to this Agreement, if any, on or before October 27, 2025 or November 8, 2025 if the Financing Commitment Deadline is extended&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(iii)         Buyer defaults in the performance of any of its material obligations under this Agreement and the default is not cured within five (5) Business Days after Seller gives Notice of the default to Buyer&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(iv)         the Lease Assignment Threshold is not met&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(v)          any Buyer Closing Condition is not satisfied as of the Closing Date, or satisfaction of any Buyer Closing Condition is or becomes impossible (other than as a result of Seller&#8217;s breach of or failure to perform its obligations under this Agreement) and Seller does not waive satisfaction of the condition&#59; or</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(vi)         Closing has not occurred by November 11, 2025 (other than as a result of Seller&#8217;s breach of or failure to perform their obligations under this Agreement)&#59; or</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(c)       The Parties agree to terminate this Agreement.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(d)       The right of termination under this Section 12 is in addition to any other rights that a party may have under this Agreement or otherwise, and a party&#8217;s exercise of its right of termination shall not be considered an election of remedies. Notwithstanding the termination of this Agreement pursuant to this Section 12, the Parties&#8217; confidentiality obligations under Section 11(g) shall survive termination and continue indefinitely.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">13.        Indemnification of Buyer</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(a)          Subject to Sections 15 and 16, Seller agrees to indemnify the Buyer against, and hold Buyer harmless from&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(i)           and any loss, liability, damage, cost or expense, including reasonable attorneys&#8217; fees, expert witness fees, court expenses, travel costs, and cost of investigation (&#8220;Loss&#8221;) that Buyer may suffer or incur that is caused by, arises out of or relates to the Acquired Assets, or the Seller&#8217;s operation of the Businesses prior to the Closing, or arising from or related to the Seller&#8217;s inaccuracy in, or breach of any representation and warranty by Seller in Section 6 of this Agreement&#59; </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(ii)          any Loss that Buyer may suffer or incur that is caused by, arises out of or relates to Seller&#8217;s negligence, breach of or failure to perform any of their covenants and obligations in this Agreement in any material respect&#59; or </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(iii)         any Loss that Buyer may suffer or incur that is caused by, arises out of or relates to the assertion against Buyer of an Excluded Liability.    </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">      </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(b)          Claims asserted by the Buyer under subsections 13(a)(i), (ii) and (iii) above are hereinafter referred to as Buyer&#8217;s &#8220;Indemnification Claim(s).&#8221; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(c)          The benefit of Seller&#8217;s indemnification obligations under this Section 13 shall extend to the Buyer Parties.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">14.        Indemnification of Seller</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(a)          Subject to Sections 15 and 16, Buyer agrees to indemnify Seller against, and hold each of them harmless from&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-15-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(i)           any Loss that Seller may suffer or incur that is caused by, arises out of or relates to any inaccuracy in or breach of any representation and warranty by Buyer in Section 7 of this Agreement&#59; </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(ii)          any Loss that Seller may suffer incur that is caused by, arises out of or relates to Buyer&#8217;s negligence, breach of or failure to perform any of its obligations in this Agreement in any material respect&#59; or </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(iii)         any Loss that Seller may suffer or incur that is caused by, arises out of or relates to Buyer&#8217;s operation of the Businesses on or after Closing.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(b)          Claims asserted by Seller under subsections 14(a)(i), (ii) and (iii) above are hereinafter referred to as Seller&#8217;s &#8220;Indemnification Claim(s).&#8221; </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(c)          The benefit of Buyer&#8217;s indemnification obligation under this Section 14 shall extend to the Seller Parties.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">15.        Indemnification Threshold and Cap</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(a)          In respect of Buyer&#8217;s assertion of an Indemnification Claim under Section 13(a), Buyer shall not be entitled to indemnification until the aggregate amount for which indemnification is sought exceeds $5,000.00. If this threshold is reached, Buyer may assert an Indemnification Claim for the full amount of the claim (going back to the first dollar) and may assert any subsequent Indemnification Claim under Section 13(a) without regard to any threshold. The maximum aggregate amount for which Buyer may assert Indemnification Claims, including any Loss caused by, arising out of or relating to any fraud or intentional misrepresentation, shall be Two Million, Two Hundred and Fifty Thousand and 00&#47;100 US Dollars ($2,250,000) (&#8220;Indemnification Cap&#8221; with respect to this Section 15(a) and Section 15(b)). </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(b)          In respect of Seller&#8217;s assertion of an Indemnification Claim under Section 14(a), Seller shall not be entitled to indemnification until the aggregate amount for which indemnification is sought collectively exceeds $5,000.00. If this threshold is reached, Seller may assert an Indemnification Claim for the full amount of the claim (going back to the first dollar) and may assert any subsequent Indemnification Claim under Section 14(a) without regard to any threshold. The maximum aggregate amount for which Seller may assert Indemnification Claims shall not exceed the Indemnification Cap, except that any Loss caused by, arising out of or relating to any fraud or intentional misrepresentation, shall not be subject to the Indemnification Cap. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(c)          In no event shall any indemnifying party hereunder be liable to any indemnified party hereunder for any punitive, incidental, consequential, special or indirect damages, including loss of future revenue or income, loss of business reputation or opportunity relating to the breach or alleged breach of this Agreement, or diminution of value or any damages based on any type of multiple.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(d)          Payments by an indemnifying party hereunder in respect of any Loss shall be limited to the amount of any liability or damage that remains after deducting therefrom any insurance proceeds and any indemnity, contribution or other similar payment received or reasonably expected to be received by the indemnified party hereunder in respect of any such claim. The indemnified party hereunder shall use its commercially reasonable efforts to recover under insurance policies or indemnity, contribution or other similar agreements for any Losses prior to seeking indemnification under this Agreement.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(e)          Notwithstanding the foregoing, the Indemnification Cap shall not be implicated, waived or reduced if a party&#8217;s applicable insurance coverage provides coverage and&#47;or insurance proceeds in relation to, or in the defense or settlement of, an Indemnification Claim.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-16-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">16.        Survival</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(a)          An Indemnification Claim under Sections 13(a) and 14(a) may be asserted at any time prior to the fifth (5th) anniversary following the Closing, with the exception that&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(i)           an Indemnification Claim under Section 13(a)(i) in respect of any inaccuracy in or breach of any of the representations and warranties in Section 6(c) (&#8220;Taxes&#8221;) may be asserted at any time prior to the expiration of the applicable statute of limitation&#59; and</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(ii)          an Indemnification Claim under Section 13(a)(i) in respect of any inaccuracy in or breach of any of the representations and warranties in Sections 6(b) (&#8220;Authority&#8221;) and 6(d) (&#8220;Title to and Condition of Acquired Assets&#8221;), may be asserted at any time without limit, but only as to Indemnification Claims related to title to Acquired Assets, not the condition of Acquired Assets.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(b)          An Indemnification Claim under Sections 13(a)(ii) and (iii) and Sections 14(a)(ii) and (iii) may be asserted at any time prior to ninety (90) days after the expiration of the applicable statute of limitation.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">17.        Notice of Indemnification Claim</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(a)          The indemnified party may assert an Indemnification Claim by giving Notice of the Indemnification Claim to the indemnifying party. The indemnified party&#8217;s Notice shall provide reasonable detail of the facts giving rise to the Indemnification Claim and a statement of the indemnified party&#8217;s Loss or an estimate of the Loss that the indemnified party reasonably anticipates that it will suffer. The indemnified party may amend or supplement its Indemnification Claim at any time, and more than once, by Notice to the indemnifying party.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(b)          If or to the extent that the Indemnification Claim is not in respect of a Third-Party Suit, Section 18 shall apply.  If or to the extent that the Indemnification Claim is in respect of a Third-Party Suit, Section 19 shall apply.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">18.        Resolution of Claims</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(a)          If the indemnifying party does not object to an Indemnification Claim during the thirty (30)-day period following receipt of the indemnified party&#8217;s Notice of its Indemnification Claim, the indemnified party&#8217;s Indemnification Claim shall be considered undisputed, and the indemnified party shall be entitled to recover the actual amount of its indemnifiable loss from the indemnifying party, subject to the Indemnification Cap.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(b)          If the indemnifying party gives Notice to the indemnified party within the thirty (30)-day objection period that the indemnifying party objects to the indemnified party&#8217;s Indemnification Claim, the indemnifying party and the indemnified party shall attempt in good faith to resolve their differences during the thirty (30)-day period following the indemnified party&#8217;s receipt of the indemnifying party&#8217;s Notice of its objection. If they fail to resolve their disagreement during this 30-day period, either party may seek remedy in a state or federal court in Maricopa County, Arizona in accordance with Section 34 below.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">19.        Third Party Suits </font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(a)          Indemnified party shall promptly give Notice to indemnifying party of any suit, demand, or claim by a third person against indemnified party, for which indemnified party is entitled to indemnification under Section 13(a) or Section 14(a) (a &#8220;Third Party Suit&#8221;), which may be given </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-17-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">by Notice of an Indemnification Claim in respect of the Third-Party Suit. Indemnified party&#8217;s failure or delay in giving this Notice shall not relieve indemnifying party from its indemnification obligation under this Section 19(a) in respect of the Third-Party Suit, except to the extent that indemnifying party suffers or incurs a loss or is prejudiced by reason of indemnified party&#8217;s failure or delay.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(b)          The indemnifying party shall have the right to participate in, or by giving Notice to the indemnified party, to assume the defense of any Third-Party Suit at the indemnifying party&#8217;s expense and by the indemnifying party&#8217;s own counsel, and the indemnified party shall cooperate in good faith in such defense. If the indemnifying party assumes the defense of any Third-Party Suit, subject to Section 19(c), it shall have the right to take such action as it deems necessary to avoid, dispute, defend, appeal or make counterclaims pertaining to any such Third-Party Suit in the name and on behalf of the indemnified party. The indemnified party shall have the right, at its own cost and expense, to participate in the defense of any Third-Party Suit with counsel selected by it subject to the indemnifying party&#8217;s right to control the defense thereof. If the indemnifying party elects not to compromise or defend such Third-Party Suit or fails to promptly notify the indemnified party in writing of its election to defend as provided in this Agreement, the indemnified party may, subject to Section 19(c), pay, compromise, defend such Third-Party Suit and seek indemnification for any and all Losses based upon, arising from or relating to such Third-Party Suit. Seller and Buyer shall cooperate with each other in all reasonable respects in connection with the defense of any Third-Party Suit, including making available records relating to such Third-Party Suit and furnishing to the defending party, management employees of the non-defending party as may be reasonably necessary for the preparation of the defense of such Third-Party Suit.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(c)          Notwithstanding any other provision of this Agreement, the indemnifying party shall not enter into settlement of any Third-Party Suit without the prior written consent of the indemnified party (which consent shall not be unreasonably withheld or delayed), except as provided in this Section 19(c). If a firm offer is made to settle a Third-Party Suit without leading to liability or the creation of a financial or other obligation on the part of the indemnified party and provides, in customary form, for the unconditional release of each indemnified party from all liabilities and obligations in connection with such Third-Party Suit and the indemnifying party desires to accept and agree to such offer, the indemnifying party shall give Notice to that effect to the indemnified party. If the indemnified party fails to consent to such firm offer within ten (10) business days after its receipt of such Notice, the indemnified party may continue to contest or defend such Third-Party Suit and in such event, the maximum liability of the indemnifying party as to such Third-Party Suit shall not exceed the amount of such settlement offer. If the indemnified party fails to consent to such firm offer and also fails to assume defense of such Third-Party Suit, the indemnifying party may settle the Third-Party Suit upon the terms set forth in such firm offer to settle such Third-Party Suit. If the indemnified party has assumed the defense pursuant to Section 19(b), it shall not agree to any settlement without the written consent of the indemnifying party (which consent shall not be unreasonably withheld or delayed).</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(d)          Indemnified party&#8217;s failure to defend a Third-Party Suit shall not relieve indemnifying party of its indemnification obligation under Section 13 or Section 14 of this Agreement if indemnified party gives indemnifying party at least thirty (30) days&#8217; prior Notice of indemnified party&#8217;s intention not to defend the Third-Party Suit and affords indemnifying party the opportunity to assume the defense without having to satisfy the conditions in Section 19(c) for assuming the defense.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">20.        Damages</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-18-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">                EXCEPT AS OTHERWISE PROVIDED IN THIS AGREEMENT, EACH OF THE PARTIES WILL BE LIABLE TO THE OTHER ONLY FOR ANY DIRECT DAMAGES ARISING OUT OF OR RELATING TO ITS PERFORMANCE OR FAILURE TO PERFORM ITS OBLIGATIONS UNDER THIS AGREEMENT. UNDER NO CIRCUMSTANCES WILL A PARTY BE LIABLE TO THE OTHER PARTY OR ANY THIRD PARTY FOR ANY CONSEQUENTIAL, INDIRECT, SPECIAL, PUNITIVE, LIQUIDATED, OR INCIDENTAL DAMAGES, OR CLAIMS FOR LOST PROFITS, LOST REVENUES OR LOSS OF USE, ARISING FROM OR RELATED TO THE BUSINESSES, THE PREMISES, THE ASSETS, ,  OR OTHER SUBJECT MATTERS RELATING TO, OR ARISING FROM, THIS AGREEMENT. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">21.        Expenses</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">Each party shall pay its own expenses in connection with the negotiation and preparation of this Agreement and the Closing of this transaction, including the process of determining and paying the amount of the Post Closing Adjustments under Section 4(d) above. In the event of termination of this Agreement prior to Closing pursuant to Section 12, each Party&#8217;s obligation to pay its own expenses shall be subject to any right of recovery as a result of a default under this Agreement by the other party.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">22.        Schedules</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">Nothing in any Schedule to Section 6 shall be considered adequate to constitute an exception to the related representation and warranty in Section 6 unless the Schedule describes the relevant facts in reasonable detail. Any exception in a Schedule to Section 6 shall be considered an exception to any other representation and warranty in Section 6 to which the exception relates if it is reasonably apparent on its face that the exception in question relates to such other representation and warranty.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">23.        Parties&#8217; Review</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">Any knowledge acquired by a party (or that should have been or could have been acquired) as a result of any due diligence or other review or investigation in connection with the negotiation and execution of this Agreement and the Closing of the transaction shall not limit that party&#8217;s right to rely on the other party&#8217;s representations and warranties in this Agreement or circumscribe that party&#8217;s entitlement to indemnification under this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">24.        Publicity</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">Any public announcement or similar publicity regarding this Agreement or the transaction shall be issued only as, when and in the manner and form that Seller determines.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">25.        Notices</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(a)          All notices under this Agreement shall be in writing and sent by certified or registered mail, overnight messenger service, or personal delivery (&#8220;Notice&#8221;), as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(i)          if to Buyer, or in the care of&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">                &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Gadi Emein</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">                                                     Email&#58; Gadiemein&#64;gmail.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">              with a required copy to&#58; Michael Aminpour</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-19-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">              &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Email Shall Suffice To&#58; Michael&#64;elitefamilymedicine.com</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(ii)           if to Seller, to&#58;</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">                The Joint Corp.</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">                16767 N. Perimeter Dr. Suite 110</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">                Scottsdale, AZ  85260              </font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">                Attention&#58; Craig Sherwood</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">                craig.sherwood&#64;thejoint.com </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">                with a required copy to&#58;</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">                The Joint Corp.</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">                16767 N. Perimeter Dr. Suite 110</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">                Scottsdale, AZ  85260              </font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">                Attention&#58; Andra Terrell, SVP-Legal</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">                andra.terrell&#64;thejoint.com and notices&#64;thejoint.com</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(b)          A Notice sent by certified or registered mail shall be considered to have been given five business days after being deposited in the mail. A Notice sent by overnight courier service or personal delivery shall be considered to have been given when actually received by the intended recipient. A party may change its address for purposes of this Agreement by Notice in accordance with this Section 25.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">26.        Further Assurances and Cooperation</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(a)          The Parties agree to (i) furnish to one another other such further information, (ii) execute and deliver to one another such further documents and (iii) do such other acts and things that any party reasonably requests for the purpose of carrying out the intent of this Agreement and the documents and instruments referred to in this Agreement. The Parties acknowledge that Seller may be required to conduct audits of the financial statements of the businesses operated using the Acquired Assets, and the Buyer agrees to cooperate with Seller and to provide it with any information reasonably available to the Buyer to assist Seller and its representatives in conducting such audits. For ninety (90) days following the Closing, Buyer shall provide to Seller such assistance as Seller reasonably requests to help ensure a smooth and orderly transition of ownership of the Business.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(b)          The Parties acknowledge that Seller is a publicly traded company and may be required by applicable laws and regulations to include financial statements and information relating to the Business and this Agreement in its financial statements, and Seller may be required to perform audits of the Business&#8217; financial statements.  Accordingly, during the period prior to Closing, the Buyer agrees to cooperate with Seller and to provide it with any information reasonably available to the Buyer to assist Seller and its representatives in obtaining such financial statements, conforming such financial statements to applicable accounting standards and conducting such audits (&#8220;Section 26(b) Duties&#8221;). Such information includes, but is not limited to, the financial books, records and work papers of Buyer. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">27.        Waiver</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">The failure or any delay by any party in exercising any right under this Agreement or any document referred to in this Agreement shall not operate as a waiver of that right, and no single or partial exercise of any right shall preclude any other or further exercise of that right or the exercise of any other right. All waivers shall be in writing and signed by the party to be charged with the waiver, and no waiver that may be given by a party shall be applicable except in the specific instance for which it is given.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-20-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">28.        Entire Agreement</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">This Agreement supersedes all prior agreements between the parties with respect to its subject matter and constitutes (together with (a) the Exhibits, (b) the Schedules and (c) the Parties&#8217; Closing Documents) a complete and exclusive statement of the terms of the agreement between the parties with respect to its subject matter. This Agreement may not be amended except by a written agreement signed by the party to be charged with the amendment.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">29.        Assignment</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">No party may assign any of its rights under this Agreement without the prior written consent of the other party. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">30.        No Third-Party Beneficiaries</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">Nothing in this Agreement shall be considered to give any person other than the parties any legal or equitable right, claim or remedy under or in respect of this Agreement or any provision of this Agreement. This Agreement and all of its provisions are for the sole and exclusive benefit of the parties and their respective successors, permitted assigns, heirs and legal representatives.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">31.        Construction</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(a)          All references in this Agreement to &#8220;Section&#8221; or &#8220;Sections&#8221; refer to the corresponding section or sections of this Agreement.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(b)          All words used in this Agreement shall be construed to be of the appropriate gender or number as the context requires.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(c)          Unless otherwise expressly provided, the word &#8220;including&#8221; does not limit the preceding words or terms.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">(d)          The captions of articles and sections of this Agreement are for convenience only and shall not affect the construction or interpretation of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">32.        Severability</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">The invalidity or unenforceability of any term or provision, or part of any term or provision, of this Agreement shall not affect the validity and enforceability of the other terms and provisions of this Agreement, and this Agreement shall be construed in all respects as if the invalid or unenforceable term or provision, or part, had been omitted.  In the event that any provision of this Agreement is determined by a court of competent jurisdiction to be unenforceable because it is too broad, such provision shall be interpreted to be only as broad as is enforceable.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">33.        Counterparts</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">This Agreement may be signed in any number of counterparts (including by facsimile or portable document format (pdf)), all of which together shall constitute one and the same instrument.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">34.        Governing Law</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-21-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">This Agreement shall be governed by the Laws of the State of Arizona, without giving effect to any choice of law provision or rule (whether of the State of Arizona or any other state) that would cause the laws of any state other than the State of Arizona to govern this Agreement. The Parties agree that any appropriate state or federal court located in Maricopa County, Arizona has exclusive jurisdiction over any dispute arising under or in connection with this Agreement and is the proper forum in which to adjudicate the case or controversy&#59; provided, however, that notwithstanding the foregoing any action initiated by TJC may, at TJC&#8217;s election, be brought in any jurisdiction where Buyer is domiciled or that has jurisdiction over Buyer. The Parties hereto irrevocably submit to the jurisdiction of, and venue in, any such court, and hereby waive any objection or defense thereto. THE PREVAILING PARTY, UPON DELIVERY OF WRITTEN DEMAND TO THE NON-PREVAILING PARTY, SHALL BE ENTITLED TO FULL COMPENSATION OF ITS FEES AND EXPENSES (INCLUDING WITHOUT LIMITATION, ATTORNEYS&#8217; FEES, COURT AND EXPERT WITNESS FEES, TRAVEL EXPENSES, AND RELATED REASONABLE EXPENSES INCURRED IN SUCH ACTION).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">35.            No Multi-Party Actions </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">             The Buyer Parties hereby waives the right to initiate or participate in a class, consolidated or multi-party action in any forum against The Seller Parties, including without limitation, any suits, actions, arbitrations or other type of disputes, and waive the right to seek or collect any damages, including but not limited to, punitive, consequential and special damages in any forum, including in arbitration or by any forum. The Buyer Parties hereby further waive the right, if any, of any association or membership group to assert claims on its behalf in any action. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAWS, THE BUYER PARTIES HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVE ANY RIGHT TO ASSERT ANY CLAIMS AGAINST THE SELLER PARTIES AS A REPRESENTATIVE OR MEMBER OF ANY CLASS ACTION, REPRESENTATIVE ACTION, JOINT ACTION, SINGLE ACTION, OR ARBITRATION. THE BUYER PARTIES HEREBY ACKNOWLEDGE AND CERTIFY TO THE SELLER PARTIES (A) THAT THE BUYER PARTIES HAVE CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (B) THAT THE BUYER PARTIES MAKE THIS WAIVER VOLUNTARILY, AND (C) THAT THE BUYER PARTIES HAVE BEEN INDUCED IN GOOD FAITH TO ENTER INTO THIS AGREEMENT.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">36.        Counsel</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">The Parties hereto have been represented by separate counsel of their choice in connection with the preparation and execution of this Agreement, or such persons have elected to not be represented by counsel.  Accordingly, this Agreement shall be construed only in accordance with its fair meaning.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">37.        Binding Effect</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">         This Agreement shall apply to, be binding in all respects upon and inure to the benefit of parties and their respective heirs, legal representatives, successors and permitted assigns.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">38.        Fully Informed Parties and Capacity</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">          The Parties have been represented in the negotiations for and in the preparation of this Agreement by counsel of their own choosing&#59; they have reviewed and understand the provisions of this Agreement&#59; they have had it fully explained to them by their counsel&#59; and they are fully aware of and understand its contents and its legal effect. Each Party acknowledges that it enters into this Agreement freely and voluntarily and is not acting under coercion, duress, economic compulsion, nor is entering into this Agreement because of any supposed disparity in bargaining power&#59; rather, each party is freely and voluntarily signing this Agreement for its own benefit.  Furthermore, each of the individuals signing this Agreement represents and warrants that he or she has full power and authority to bind the Party identified above his or her name. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-22-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:115%">39.         Specific Performance</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">          The Parties agree that irreparable damage would occur if any provision of this Agreement were not performed in accordance with the terms hereof (including if the Parties fail to take such actions as are required to consummate the transactions contemplated hereby) or were otherwise breached. Each Party hereto shall be entitled to an injunction or injunctions to prevent breaches or threatened breaches of this Agreement or to enforce specifically the performance of the terms and provisions hereof in the courts described in Section 34 without proof of actual damages, in addition to any other remedy to which it is entitled at law or in equity. No Party will oppose the granting of an injunction, specific performance, or other equitable relief provided herein on the basis that the other Party has an adequate remedy at law or that an award of specific performance is not an appropriate remedy for any reason at law or equity. No other party or any other person or legal entity shall be required to obtain, furnish, or post any bond or similar instrument in connection with or as a condition to obtaining any remedy referred to in this Section, and each party hereto irrevocably waives any right it may have to require the obtaining, furnishing, or posting of any such bond or similar instrument. The right of specific enforcement is an integral part of the transactions contemplated hereby and without that right, neither party would have entered into this Agreement.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:115%">&#91;SIGNATURES FOLLOW BELOW&#93; </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-23-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:118%">IN WITNESS WHEREOF, the Parties hereto affix their signatures and execute this Asset Purchase Agreement as of the Effective Date.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.684%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8220;BUYER&#8221; </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:112%">&#8220;SELLER&#8221;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ELITE CHIRO GROUP, a California corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">THE JOINT CORP., a Delaware corporation liability company</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sign&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Gadi Emein</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sign&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Sanjiv Razdan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Print&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gadi Emein</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Print&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanjiv Razdan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buyer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2025</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2025</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8220;GUARANTOR&#8221;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sign&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Scott Bowman</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gadi Emein, an individual</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Print&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scott Bowman</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sign&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Gadi Emein</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2025</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Print&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gadi Emein</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2025</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:112%">ACKNOWLEDGED AND ACCEPTED BY THE &#8220;PC&#8221;&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">FENTON CHIROPRACTIC CORPORATION OF CALIFORNIA, a California professional service corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sign&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Print&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>southeastapa.htm
<DESCRIPTION>EXHIBIT-10.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i18ca8508352a4371bf0e3564a4a2ddf2_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div id="i18ca8508352a4371bf0e3564a4a2ddf2_4"></div><div style="text-align:center;text-indent:4.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">ASSET PURCHASE AGREEMENT </font></div><div style="text-align:center;text-indent:4.5pt"><font><br></font></div><div style="text-align:center;text-indent:4.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">between and among</font></div><div style="text-align:center;text-indent:4.5pt"><font><br></font></div><div style="text-align:center;text-indent:4.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Addisco Value, LLC, a North Carolina limited liability company</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Triangle Chiropractic Associates P.C., a North Carolina professional corporation </font></div><div style="text-align:center;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Bluffton TJ, LLC a South Carolina limited liability company</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">  And</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">The Joint Corp., a Delaware corporation</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Dated as of </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">December 5, 2025</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">ASSET PURCHASE AGREEMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">This Asset Purchase Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) is entered into as of December 5, 2025, between and among&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">          </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Addisco Value, LLC</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, a North Carolina limited liability company as owned by Alexander Klaus (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Addisco</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Triangle Chiropractic Associates P.C.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, a North Carolina professional corporation as owned by Todd Wegerski, DC (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Triangle Chiropractic</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), and </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Bluffton TJ, LLC</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, a South Carolina limited liability company as owned by Andrew Michael Evec and Susan Ruth Train (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Bluffton</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) (Addisco, Triangle Chiropractic and Bluffton collectively referred to herein as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Buyer(s)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;)(Alex Klaus, Lisa Ezell, Andrew Michael Evec, and Susan Ruth Train (collectively the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Guarantor(s)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;)&#59; and </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">The Joint Corp.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, a Delaware corporation doing business as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">The Joint Chiropractic</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> (hereafter, as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">The Joint</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Seller</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Buyer(s) and Seller are referred to collectively herein as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Parties</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; and individually as a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Party</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">RECITALS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">WHEREAS, is the franchisor of </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">The Joint Chiropractic</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#174; franchise system, and owns the assets of, and contractually engages a professional chiropractic company to operate twenty-two (22) </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">The Joint Chiropractic</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#174; clinics listed in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule A</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> attached hereto  (collectively referred to herein as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Clinics</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; or the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Businesses</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;, each as a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Clinic</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; or a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Business</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;, the physical locations of the Clinics are collectively referred to herein as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Premises</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">WHEREAS, Addisco, Triangle Chiropractic, and Bluffton each desire to purchase and assume from Seller the assets and liabilities of their respective clinics specifically allocated to said Buyer(s) on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule A-1</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> for Addisco, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule A-2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> for Triangle Chiropractic and </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule A-3</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> for Bluffton (collectively the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Allocated Clinics</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), and to close contemporaneously under this single Agreement&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">WHEREAS, the Seller desires to sell, transfer and assign to Buyer(s), and Buyer(s) desires to purchase and assume from Seller, substantially all the assets of the Clinics, which transfer includes and assignment of all the leasehold interests for the Premises, subject to the terms and conditions set forth herein (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Transaction</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;)&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">WHEREAS, Seller will franchise the Businesses to the Buyer(s) pursuant to The Joint Chiropractic franchise agreements for each Clinic and entered into by the Parties through separate transactions at Closing as further described herein, copies of which will be attached hereto in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> (collectively, the &#34;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Franchise Agreements</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#34;, and each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Franchise Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;)&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">WHEREAS, the Franchise Agreements shall each be amended pursuant to the amendments as further described herein, copies of which will be attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Franchise Agreement Amendments</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;, and each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Franchise Agreement Amendment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;)&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">WHEREAS, Addisco will acquire the non-exclusive development rights for one (1) </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">The Joint Chiropractic</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#174; clinic pursuant to a development agreement entered into by the Parties through a separate transaction at Closing as further described herein, and a copy of which will be attached hereto in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Exhibit C</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Development Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#34;)&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">WHEREAS, Seller will sell, transfer and assign the leases, as further described herein and copies of which will be attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Exhibit D </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Leases</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), to Buyer(s) pursuant to twenty-two (22) lease assignments, as further described herein and copies of which will be attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Exhibit E</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Lease Assignments</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">NOW, THEREFORE, in consideration of the mutual representations, warranties, covenants and agreements hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE 1 </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">PURCHASE AND SALE OF ASSETS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Basic Transaction</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  At the Closing, Seller shall sell, assign, transfer, convey and deliver to each Buyer(s), and each Buyer(s) shall purchase from Seller, free and clear of all Liens, all right, title and interest in and to the Acquired Assets associated with such Buyer(s)&#8217;s Allocated Clinics. To be clear, this Agreement is to purchase the Acquired Assets from all the Clinics, as such, this Agreement is expressly conditioned upon the acquisition of the Acquired Assets of all the Clinics and is in no way to be interpreted as allocating value to, or offering to acquire any specific clinic, singularly. Notwithstanding the terms herein, this shall not conflict with Buyer(s)&#8217;s ability to assign and manage the acquisition in accordance with the terms and conditions set forth herein, as well as the terms and conditions of the Franchise Agreements and the Development Agreement. For avoidance of doubt, each Buyer(s)&#8217;s obligations,     representations, and liabilities under this Agreement apply only to its Allocated Clinics, and no Buyer(s) shall have any responsibility for the obligations or liabilities of another Buyer(s) hereunder.   </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-1-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Assumption of Liabilities</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  In accordance with the terms and upon the conditions of this Agreement, at the Closing, Buyer(s) shall assume all the Assumed Liabilities referenced in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 1.2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, if any, which the Parties shall continue to negotiate, and shall amend in accordance with such negotiations, through the Closing. Unless Buyer(s) explicitly agrees that an item is an Assumed Liability on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 1.2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, such item shall constitute an Excluded Liability notwithstanding anything to the contrary herein.  Buyer(s) shall not assume and shall not have any responsibility with respect to the Excluded Liabilities.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">1.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Purchase Price</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  The aggregate purchase price for the Acquired Assets is </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">One Million, Four Hundred and Eighty-two Thousand, Eight Hundred and NO&#47;Dollars ($1,482,800.00)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Aggregate Purchase Price</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). The Aggregate Purchase Price shall be allocated among the Buyer(s) according to the Allocated Clinics. Each Buyer(s) shall pay the portion of the Purchase Price applicable to its Allocated Clinics as set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 1.3</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> attached hereto (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Allocated Purchase Price</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), and all references herein to &#8216;Buyer(s)&#8217; in respect of payments, prorations, or liabilities shall mean the Buyer(s) responsible for such Allocated Clinics.  The Aggregate Purchase Price is comprised of the following&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(a) the Cash Consideration of One Million and NO&#47;100 Dollars ($1,000,000.00) (as hereinafter defined), including any Cash Consideration Downpayment (as hereinafter defined) plus </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(b) the Pro-Rated Franchise Fees (as hereinafter defined), estimated to be in the amount of Six Hundred Sixty-Seven Thousand, Eight Hundred and NO&#47;Dollars ($667,800.00) which shall be remitted by the Buyer(s) to the Seller pursuant to the Franchise Agreements and as required of the Seller to acquire franchise rights to the Clinics pursuant to the terms therein (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Franchise Fees</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;)&#59; less</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(c ) a credit of One Hundred and Eighty-five Thousand and NO&#47;100 Dollars ($185,000.00) &#160;&#160;&#160;&#160;for Clinic refreshes as set forth in the Revised Refresh Schedule (as defined below).</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">1.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Aggregate Purchase Price Contingency</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. Notwithstanding anything to the contrary herein, the Parties acknowledge and agree that the Aggregate Purchase Price is based upon the Seller&#8217;s trailing twelve-month (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">TTM</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) unadjusted EBITDA as of October 31, 2025. As a condition precedent to the consummation of the Transaction, the Seller&#8217;s unadjusted TTM EBITDA shall not (i) fall below Five Hundred Fifty-Seven Thousand and No&#47;100 Dollars ($557,000), nor (ii) rise above Six Hundred Fifty-Three Thousand and No&#47;100 Dollars ($653,000) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">EBITDA Collar</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), prior to Closing. In the event that the Seller&#8217;s unadjusted TTM EBITDA falls outside the EBITDA Collar, the Aggregate Purchase Price shall be adjusted in accordance with Exhibit J attached hereto and incorporated herein by reference (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Adjusted Aggregate Purchase Price</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). If the unadjusted TTM EBITDA remains within the EBITDA Collar, the Aggregate Purchase Price shall remain $1,750,000, and Exhibit J shall be deemed null and of no effect in the final version of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">1.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Payment and Delivery of Aggregate Purchase Price or Allocated Purchase Price</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Downpayment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. Seller shall have the right to require Buyer(s) to pay, via wire transfer to Seller, a total of One Hundred Thousand and NO&#47;Dollars ($100,000.00) upon execution of this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Cash Consideration Downpayment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), which shall be credited against the Cash Consideration set forth in Section 1.3(a). The Cash Consideration Downpayment shall be non-refundable and fully-earned upon receipt. The </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-2-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Cash Consideration Downpayment shall be refundable to Buyer(s) in the event Seller fails to satisfy any condition precedent in Article 7 or breaches any pre-Closing covenant. </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Signing Commitment.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">  Upon execution of this Agreement, Buyer(s) shall each&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(i)&#160;&#160;&#160;&#160;sign a promissory note for the adjusted allocated Purchase Price for their respective Clinics attached hereto in Exhibit K-1 for Addisco and Exhibit K-2 for Bluffton (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Promissory Note(s)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; and each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Promissory Note</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) in the amount of the Adjusted Aggregate Purchase Price less the Cash Consideration Downpayment, if applicable (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Adjusted Allocated Purchase Price</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), and </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(ii)&#160;&#160;&#160;&#160;sign the Management Agreements as described in Section 7.1(d)(ii).</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(c ) At Closing, the Buyer(s) shall&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(i)&#160;&#160;&#160;&#160;For each Clinic with an executed Lease Assignment, at a Closing for that Clinic, pay to Seller the pro-rated amount for each Clinic in accordance with the formula or allocation described in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 1.5(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Clinic Pro-Rated Purchase Price</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), which shall be applied to the principal of the Promissory Note for those Allocated Clinics&#59; </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(ii)&#160;&#160;&#160;&#160;pay Three Hundred and Four Hundred Thirty-Six Thousand Five Hundred Forty and NO&#47;100 ($436,540.00) of the Franchise and Transfer Fees (subject to Section 4.7(f)) (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Franchise Fee Downpayment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;)&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(iii)&#160;&#160;&#160;&#160;pay the development fee in the amount of Ten Thousand and NO&#47;Dollars ($10,000.00) which shall be remitted by the Buyer(s) to the Seller pursuant to the Development Agreement and as required of the Seller to acquire development rights pursuant to the terms therein (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Development Fee</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;)&#59; and</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(iv)&#160;&#160;&#160;&#160;pay the Debt Amount, if any, pursuant to the payoff letters delivered by Seller to Buyer(s) pursuant to </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 5.1(e)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#59; or</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">&#169; Post Closing Reconciliation</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(i)&#160;&#160;&#160;&#160;Within ninety (90) days following the Closing, Seller shall prepare and deliver to Buyer(s) a statement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Post-Closing Statement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) setting forth its calculation and reconciliation of the various costs or expenses borne between the Parties by the following items, as determined and applicable by the Parties (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Reconciliation</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), including without limitation&#58; (A) the total Pro-Rated Franchise Fees (as defined below) </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">less</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> the Franchise Fee Downpayment (as defined below)&#59; (B) any appropriate pro-rations for rent, state and local real estate taxes and transfer taxes, sales taxes, service and utility or vendor contracts, or other expenses charged to the Seller that are the obligations of the Buyer(s) as of, or subsequent to the Closing, (C)  as credits to the Seller, cash deposit collections received after the Closing, resulting from pre-Closing gross sales (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Post-Closing Adjustments</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), and (D) any outstanding Deficit Advances as defined in the Management Agreement for that Clinic. For the various Lease Assignments, Seller agrees that it shall be responsible for the payment of any the Lease Assignment or transfer fees (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Lease Assignment Fees</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) imposed by any of the landlords for the Clinics, and that the various security deposits that are listed in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 1.5(d)(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Security Deposits</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) for the Leases are an Acquired Asset which Seller represents and warrants constitutes all security deposits for the Leases. The Lease Assignments shall stipulate the Security Deposits are assigned from Seller to Buyer(s).  Buyer(s) agree and acknowledge that the gross sales </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-3-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">received by the Seller for all patient adjustment packages or treatments sold prior to the Closing of the Transaction shall remain wholly the Seller&#8217;s property. </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(ii)&#160;&#160;&#160;&#160;The items set forth at </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 1.5(d)(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> are not exhaustive and the Seller may include any applicable items in the Post-Closing Statement for obligations of the Buyer(s) as of, or after the Closing. Notwithstanding the foregoing, the gross sales received by the Seller for all patient adjustment packages or treatments sold prior to the Closing of the Transaction shall remain wholly the Seller&#8217;s gross sales. </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(iii)&#160;&#160;&#160;&#160;After receiving the Post-Closing Statement, Buyer(s) shall have thirty (30) days (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Review Period</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#34;) to review the Post-Closing Statement. During the Review Period, Buyer(s) shall have full access to the records reviewed and prepared by Seller and&#47;or Seller&#8217;s accounting professionals to the extent that they relate to the Post-Closing Statement and to such historical financial information (to the extent in Seller's possession and used as a basis for the Post-Closing Statement) relating to the Post- Closing Statement as Buyer(s) may reasonably request for the purpose of reviewing the Closing Statement and to prepare a Statement of Objections as defined below.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(iv)&#160;&#160;&#160;&#160;On or prior to the last day of the Review Period, Buyer(s) may object to the Post-Closing Statement by delivering to Seller a written statement setting forth Buyer(s)'s objections in reasonable detail (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Statement of Objections</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#34;). If Buyer(s) fails to deliver the Statement of Objections before the expiration of the Review Period, the Post-Closing Statement, and the Post-Closing Adjustments, as the case may be, reflected in the Post-Closing Statement shall be deemed to have been accepted by Buyer(s). If Buyer(s) delivers the Statement of Objections before the expiration of the Review Period, Buyer(s) and Seller shall negotiate in good faith to resolve such objections within thirty (30) days after the delivery of the Statement of Objections (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Resolution Period</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#34;), and, if the same are so resolved within the Resolution Period, the Post-Closing Adjustments and the Post-Closing Statement with such changes as may have been previously agreed in writing by Buyer(s) and Seller, shall be final and binding.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(v)&#160;&#160;&#160;&#160;If Seller and Buyer(s) fail to reach an agreement with respect to all of the matters set forth in the Statement of Objections before expiration of the Resolution Period, then any amounts remaining in dispute (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Disputed Amounts</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#34; and, any amounts not so disputed, the &#34;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Undisputed Amounts</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#34;) shall be submitted for resolution to Independent Accountants as defined below. Buyer(s) and Seller shall appoint by prior mutual agreement an independent accounting individual or firm (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Independent Accountants</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#34;) who, acting as experts and </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">not arbitrators</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, shall resolve the Disputed Amounts only, and adjust the Post-Closing Adjustments and the Post-Closing Statement, as applicable (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Independent Accountants Assessment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). The Parties hereto agree that all Post-Closing Adjustments shall be made without regard to materiality. The Independent Accountants shall only assess and determine the Disputed Amounts by the Parties and their decision for each Disputed Amount must be within the range of values assigned to each such item in the Post-Closing Statement and the Statement of Objections, respectively. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-4-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(vi)&#160;&#160;&#160;&#160;The fees and expenses of the Independent Accountants shall be paid one-half by Seller and one-half by Buyer(s).</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(vii)&#160;&#160;&#160;&#160;The Independent Accountants shall make a determination within sixty (60) days following the formal engagement of the Independent Accountants (and instruction by one or both Parties to commence assessment of the Post-Closing Adjustments) (or such other time as the Parties hereto shall agree in writing), and their resolution of the Disputed Amounts and their adjustments to the Post-Closing Statement and&#47;or the Post-Closing Adjustments shall be conclusive and binding upon the Parties hereto.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(e)&#160;&#160;&#160;&#160;The Parties agree that any Undisputed Amounts shall be reconciled separately and independent of the Independent Accountants Assessment, and that the Party owing the net of the Undisputed Amounts pursuant to </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 1.4(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> shall deliver to the other Party by wire transfer such amount in immediately available funds within thirty (30) days following the Resolution Period. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(f)&#160;&#160;&#160;&#160;The Parties agree that following the Independent Accountants Assessment, the Party owing the net of the Disputed Amounts shall deliver to the other Party by wire transfer such amount in immediately available funds within thirty (30) days following the receipt of the findings of the Independent Accountant Assessment.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">(g)&#160;&#160;&#160;&#160;Withholding</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  The Parties and any other applicable withholding agent will be entitled to deduct and withhold from any amounts payable pursuant to or as contemplated by this Agreement any Taxes or other amounts required under the Code or any applicable Law to be deducted and withheld, and, to the extent that any amounts are so deducted or withheld, such amounts will be treated for all purposes of this Agreement as having been paid to the Person in respect of which such deduction and withholding was made.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">(h)&#160;&#160;&#160;&#160;Reconciliation Communications</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. Any communication contemplated by this </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 1.4</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> may be delivered by and between the Parties by email or by written notice. Any emails shall be deemed delivered and received within twenty-four (24) hours of the time the email was sent to the applicable Party. The Parties may utilize other email addresses for compliance with this </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 1.4</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. However, the Parties agree that the following primary sender&#47;recipient names and email addresses for </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 1.4</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> communications shall be designated as set forth in Section 12.7 herein.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">1.6&#160;&#160;&#160;&#160;Allocation</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.   The Parties agree that the Purchase Price shall be allocated among the Assets as follows, and each Party shall utilize appropriate tax forms to report the sale and purchase for tax purposes in a manner consistent with this allocation. Specifically, an amount of $591,500 shall be allocated to Class V assets, consisting of tangible personal property, furniture, fixtures, and equipment, and an amount of $223,500 shall be allocated to Class VI assets, consisting of certain identifiable intangible assets other than goodwill (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Total Allocation</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). The Total Allocation equals the Aggregate Purchase Price, and the Parties shall file all tax returns and related filings consistent with this allocation and shall not take any position inconsistent therewith unless required by law. The Parties agree to modify the Total Allocation if the Aggregate Purchase Price must be adjusted in accordance with Section 1.4 herein.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-5-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">1.7&#160;&#160;&#160;&#160;Closing</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Subject to the terms and conditions of this Agreement, the consummation of the transactions contemplated by this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Closing</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) for each of the Clinics shall take place&#58; </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(a) effective as of 11&#58;59 p.m. Eastern Time on the date Closing occurs (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Closing Date</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), which shall be the 10</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> or the 25</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> of the month following the date a Lease Assignment is signed or effective (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Closing Date Deadline</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;)&#59; and</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(b) remotely via electronic exchange of documents once all the conditions to the Closing set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Article 7</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> have been either satisfied or waived for any Clinic (other than conditions which, by their nature, are to be satisfied on the Closing Date).</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">If Closing is done separately for any Clinic, Seller and Buyer(s) agree to enter into an amendment to this Agreement to memorialize the Closing Date.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">1.8&#160;&#160;&#160;&#160;Excluded Assets and Tenant Improvement Allowances</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:108%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:108%;padding-left:4.7pt">Notwithstanding anything to the contrary contained in this Agreement, it is expressly acknowledged by Buyer(s) that Seller will not be conveying to Buyer(s) (i) any cash, cash equivalents, working capital, accounts receivable, or any Tenant Improvement Allowances (as hereinafter defined) (ii) any of the proceeds of the Transaction described in this Agreement, (iii) the books and records of Seller, except that Seller shall provide copies of any separate patient listings and employee records, and (iv) any other assets, properties or rights of Seller owned or used by Seller but not used in or directly related to the Clinics (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:108%;text-decoration:underline">Excluded Assets</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:108%">&#8221;).</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:108%">(b)&#160;&#160;&#160;&#160; Further to the above regarding the Excluded Assets, the Buyer(s) agrees and acknowledges that as of the Closing, the Seller holds at certain Clinics, tenant improvement allowances (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:108%;text-decoration:underline">Tenant Improvement Allowances</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:108%">&#8221;) that the Seller shall endeavor to collect from the applicable landlords following the Closing, and that the Buyer(s) is not entitled to collection of any of the Tenant Improvement Allowances (or allocation or credit of the Tenant Improvement Allowances for any purpose, including without limitation, the adjustments related to the Reconciliation). The Buyer(s) further agrees and acknowledges that the Seller shall, following the Closing, have the continued right to communicate with the applicable landlords regarding the administration and collection of the Tenant Improvement Allowances, and that such communications shall not constitute a breach of this Agreement, the applicable Lease Assignment Agreements, or any laws in equity or common laws. Last, the Buyer(s) agrees and acknowledges that it shall reasonably cooperate with the Seller and the applicable landlords in the Seller&#8217;s collection of the Tenant Improvement Allowances.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:108%">1.8       </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:108%;text-decoration:underline">Non-Assignable Assets</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:108%">. Notwithstanding anything to the contrary in this Agreement, and subject to the provisions herein, to the extent that the sale, assignment, transfer, conveyance or delivery, or attempted sale, assignment, transfer, conveyance or delivery, to Buyer(s) of any Acquired Asset would result in a violation of applicable law, or would require the consent, authorization, approval or waiver of a party who is not a party to this Agreement (including any governmental authority), and such consent, authorization, approval or waiver shall not have been obtained prior to the Closing, this Agreement shall not constitute a sale, assignment, transfer, conveyance or delivery, or an attempted sale, assignment, transfer, conveyance or delivery, thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:108%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:108%">, that the Closing shall occur notwithstanding the foregoing without any adjustment to the Purchase Price on account thereof. Following the Closing, Seller and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-6-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:108%">Buyer(s) shall use commercially reasonable efforts, and shall cooperate with each other, to obtain any such required consent, authorization, approval or waiver, or any release, substitution or amendment required to assign or novate all Contracts and liabilities that constitute Assumed Liabilities or to obtain in writing the unconditional release of all parties to such arrangements, so that, in any case, Buyer(s) shall obtain all Acquired Assets and shall all be solely responsible for such Assumed Liabilities from and after the Closing&#59; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:108%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:108%">, that neither Seller nor Buyer(s) shall be required to pay any consideration therefor, except that Seller shall be solely responsible for and shall pay all Lease assignment transfer fees imposed by any of the landlords for the Clinics. Once such consent, authorization, approval, waiver, release, substitution or amendment is obtained, Seller shall sell, assign, transfer, convey and deliver to Buyer(s) the relevant Acquired Asset to which such consent, authorization, approval, waiver, release, substitution or amendment relates for no additional consideration. The Parties shall pay their own income taxes in connections with the transactions contemplated in this Agreement. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:108%">ARTICLE 2</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">REPRESENTATIONS AND WARRANTIES OF BUYER</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Buyer(s) represents and warrants to Seller that the statements contained in this </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Article 2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> with respect to Buyer(s) are correct and complete as of the date hereof and as of the Closing Date. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">2.1 &#160;&#160;&#160;&#160;Organization of Buyer(s)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Buyer(s) are limited liability companies duly formed, validly existing and in good standing under the Laws of their state of organization.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">2.2&#160;&#160;&#160;&#160;Authorization of Transaction</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Buyer(s) has full company power and authority to execute and deliver this Agreement and to perform Buyer(s)&#8217;s obligations hereunder.  Buyer(s) has full company power and authority to execute and deliver the Ancillary Agreements to which Buyer(s) is a party and to perform Buyer(s)&#8217;s obligations thereunder.  The execution and delivery by Buyer(s) of this Agreement and the Ancillary Agreements to which Buyer(s) is a party and the performance by Buyer(s) of the transactions contemplated hereby and thereby have been duly approved by all requisite company action of Buyer(s).  Assuming the due authorization, execution and delivery of this Agreement and the Ancillary Agreements by the other parties thereto, this Agreement and each Ancillary Agreement to which Buyer(s) is a party constitute the valid and legally binding obligation of Buyer(s), enforceable against Buyer(s) in accordance with their terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium and similar laws affecting creditors generally and by the availability of equitable remedies.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">2.3&#160;&#160;&#160;&#160;Non-contravention</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Neither the execution and the delivery of this Agreement nor the Ancillary Agreements to which Buyer(s) is a party, nor the consummation of the transactions contemplated hereby and thereby, will (i) violate or conflict with any Law or Order to which Buyer(s) is subject, (ii) violate any provision of the Organizational Documents of Buyer(s), or (iii) conflict with, result in a breach of, constitute a default under, result in the acceleration of, create in any party the right to accelerate, terminate, modify, or cancel, or require any notice or Consent under any Contract to which Buyer(s) is a party or by which it is bound or to which any of its assets is subject.  </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-7-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">2.4&#160;&#160;&#160;&#160;Brokers&#8217; Fees</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Buyer(s) does not have any obligation to pay any fees or commissions to any broker, finder or agent with respect to the transactions contemplated by this Agreement.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">2.5&#160;&#160;&#160;&#160;Information to Obtain Consents</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Buyer(s) covenants and agrees to provide any and all information reasonably requested by any third-party from whom a Consent is requested pursuant to the terms of this Agreement to facilitate obtaining such Consent.  Buyer(s) further agrees to provide such requested information within three (3) business days of any such request for information, and further represents and warrants that such information provided shall be true and correct in all material respects. The Buyer acknowledges that in accordance with North Carolina laws and regulations, the Clinics located in North Carolina are currently operated from a clinical standpoint by TRIANGLE CHIROPRACTIC ASSOCIATES PC, a North Carolina professional corporation having its principal place of business at 1012 Market Center Drive,Morrisville, NC 27560, and its owner TODD WEGERSKI, DC (collectively, the &#8220;PC&#8221;). Addisco agrees and acknowledges that the execution of this Agreement for Clinic 12033 - PARK TOWNE VILLAGE is conditioned upon the PC&#8217;s acceptance and acknowledgement of this Agreement. The PC, through the acknowledgement below, agrees to be bound by certain terms of this Agreement (i.e., Confidentiality and Use of Information, Public Announcements, and acting in good faith). Addisco further agrees and acknowledges that Addisco shall be required to provide (and disclose to Seller) its own North Carolina professional chiropractic corporation (or proof of North Carolina chiropractic licensing) prior to the Closing to ensure regulatory compliance regarding the transfer of patient records and the post-Closing clinical operation of 12033 - PARK TOWNE VILLAGE. The Buyer agrees and acknowledges that to acquire the patient records of Clinic 12033 - PARK TOWNE VILLAGE, Buyer (or its authorized North Carolina chiropractic company) shall be required to enter into the transfer of patient records agreement attached hereto as Exhibit M (the &#8220;Records Transfer Agreement&#8221;), which shall be furnished by the Seller prior to the Closing.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">2.6&#160;&#160;&#160;&#160;Solvency</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(a)        As of the Closing, the Buyer(s) or the Guarantors (including without limitation the Buyer(s)&#8217;s affiliates, subsidiaries, owners, members, directors, or parent companies) (a) have not filed, nor otherwise sought any protections, or are not parties to such actions, in accordance with any United States state or federal bankruptcy statutes (as further provided below and in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 10.3</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> herein)&#59; or (b) are not parties (or subject to any related obligations) to any threatened or pending criminal or civil actions which may result in financial penalties, judgments, reputational impacts, or similar adverse results that could disrupt or interfere with the Buyer(s)&#8217;s ability to perform its obligations hereunder.</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(b)       Immediately after giving effect to the transactions contemplated hereby, Buyer(s) shall be solvent and shall&#58; (i) be able to pay its debts as they become due&#59; (ii) own property that has a fair saleable value greater than the amounts required to pay its debts (including a reasonable estimate of the amount of all contingent liabilities)&#59; and (iii) have adequate capital to carry on its business. No transfer of property is being made and no obligation is being incurred in connection with the transactions contemplated hereby with the intent to hinder, delay or defraud either present or future creditors of Buyer(s) or Seller. In connection with the transactions contemplated hereby, Buyer(s) has not incurred, nor plans to incur, debts beyond its ability to pay as they become absolute and matured.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-8-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">2.7&#160;&#160;&#160;&#160;Sufficiency</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. Buyer(s) has sufficient cash on hand or other sources of immediately available funds to enable it to make payment of the Purchase Price, and consummate the transactions contemplated by this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">2.8&#160;&#160;&#160;&#160;Legal Proceedings</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. There are no actions, suits, claims, investigations or other legal proceedings pending or, to Buyer(s)'s Knowledge, threatened against or by Buyer(s) or any Affiliate of Buyer(s) that challenge or seek to prevent, enjoin or otherwise delay the transactions contemplated by this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">2.9&#160;&#160;&#160;&#160;Independent Investigation</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">Buyer(s) has conducted its own independent investigation, review and analysis of the Clinics, the Acquired Assets, the Premises and other related documentation, and acknowledges that it has been provided adequate access to the Clinics, Employees, personnel, Premises, Acquired Assets, books and records, and other documents and data of Seller for such purposes.</font><font style="background-color:#ffffff;color:#000000;font-family:'Open Sans',sans-serif;font-size:13.5pt;font-weight:400;line-height:112%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Buyer(s) has inspected the Acquired Assets that Buyer(s) is purchasing, the Clinics and the Premises, and has carefully reviewed Seller&#8217;s representations regarding them. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">Buyer(s) agrees and acknowledges that, as of the Closing, the Buyer(s) has no outstanding due diligence requests provided to Seller during the Due Diligence Period (as hereinafter defined), and waives any claims against the Seller that the Seller failed to timely or fully furnish any due diligence materials to the Buyer(s)&#8217;s satisfaction.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">Buyer(s) acknowledges that&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-24.33pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">i.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:18pt">neither Seller nor any other Person on behalf of Seller has made any representation or warranty, express or implied, as to Seller, the Businesses, the Assets, or the accuracy or completeness of any information regarding Seller, or the Assets furnished or made available to Buyer(s) and its representatives, or any other matter related to the transactions contemplated herein, other than those representations and warranties expressly set forth herein (including the related portions of the Exhibits and Schedules)&#59; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-27.66pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">ii.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:18pt">in determining to enter into this Agreement, Buyer(s) has not relied on any representation or warranty from Seller or any other party on behalf of Seller, or upon the accuracy or completeness of any information regarding the regarding Seller, the Clinics, or the Acquired Assets furnished or made available to Buyer(s) and its representatives, other than those representations and warranties expressly set forth herein (including the related portions of the Exhibits and Schedules)&#59; and </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-30.99pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">iii.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:18pt">neither Seller nor any other party acting on behalf of Seller shall have any liability to Buyer(s) or any other party with respect to any projections, forecasts, estimates, plans, or budgets of future revenue, expenses, or expenditures, future results of operations, future cash flows, or the future financial condition of the Acquired Assets, the Clinics, the Premises or the future business, operations, or affairs of the Clinics. </font></div><div style="text-align:justify;text-indent:108pt"><font><br></font></div><div style="text-align:center;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE 3</font></div><div style="text-align:justify;text-indent:108pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">REPRESENTATIONS AND WARRANTIES OF SELLER</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-9-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Seller represents and warrant to Buyer(s) that the statements contained in this </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Article 3</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> are correct as of the date hereof and as of the Closing Date, except as set forth in the corresponding section of the Schedules or any disclosure schedule. For the avoidance of doubt, for the purpose of this </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Article 3</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, each instance where the use of &#8220;each Clinic&#8221;, &#8220;any Clinic&#8221;, or similar phrase occurs, it shall be read as meaning each of the Clinics, such that each of the representations and warranties contained in this </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Article </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">3 shall pertain and relate to each of the Clinics, respectively. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">3.1&#160;&#160;&#160;&#160;Organization, Qualification, and Power</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Seller is a corporation duly incorporated, validly existing and in good standing under the Laws of the State of Delaware.  Seller, and its operation of each respective Clinic, is duly authorized to conduct its business and is in good standing under the Laws of each jurisdiction where such qualification is required.  Seller, and its ownership and operation of each Clinic, has full company power and authority and all Permits necessary to carry on the Business and to own, lease and use the properties owned, leased and used by the Clinics.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">3.2&#160;&#160;&#160;&#160;Authorization of Transaction</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Seller has full power, authority, and legal capacity (including, in the case of each Clinic, full company power and authority) to execute and deliver this Agreement and the Ancillary Agreements to which it is a party and to perform its obligations hereunder and thereunder.  The execution and delivery by Seller of this Agreement and the Ancillary Agreements to which the Seller is a party and the performance by Seller of the transactions contemplated hereby and thereby have been duly approved by all requisite action.  Assuming the due authorization, execution and delivery of this Agreement and the Ancillary Agreements by the other parties thereto, this Agreement and each Ancillary Agreement to which the Seller is a party constitute the valid and legally binding obligation of the Seller, as applicable, enforceable against the Seller in accordance with their terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium and similar laws affecting creditors generally and by the availability of equitable remedies.  Except as set forth on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, Seller is not required to give any notice to, make any filing with, or obtain any Consent of any Governmental Body or any other Person in order to consummate the transactions contemplated by this Agreement or the Ancillary Agreements to which Seller is a party.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">3.3&#160;&#160;&#160;&#160;Capitalization</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  All the Clinics are owned solely, beneficially and of record by Seller.  There are no other shares of stock, membership or other ownership interests in any one (1) of the Clinics or outstanding securities convertible or exchangeable into shares of stock, membership or other ownership interests of any Clinic, and there are no options, warrants, purchase rights, subscription rights, conversion rights, exchange rights, calls, puts, rights of first refusal or other Contracts that could require Seller to issue, sell or otherwise cause to become outstanding or to acquire, repurchase or redeem stock, membership or other ownership interests in any Clinic. There are no profit participation or similar rights with respect to any of the Clinics.   Upon the Closing, the Acquired Assets will be delivered to Buyer(s) free and clear of all Liens (other than any Liens which may result from any actions taken by Buyer(s) or Permitted Liens), Buyer(s) will have good and marketable title to the Acquired Assets, and Buyer(s) will be the sole owner, beneficially and of record, of one hundred percent (100%) of the Acquired Assets.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">3.4&#160;&#160;&#160;&#160;Non-contravention</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Neither the execution and the delivery of this Agreement nor the Ancillary Agreements, nor the consummation of the transactions contemplated hereby or thereby, will (a) violate or conflict with any Law or Order to which any Seller is subject, (b) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-10-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">violate or conflict with any provision of the Organizational Documents of Seller, or (c) except as set forth on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.4</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, conflict with, result in a breach of, constitute a default under, result in the acceleration of, create in any party the right to accelerate, terminate, modify, or cancel, or require any notice, Consent or payment under any Contract or Permit to which any of Seller or a Clinic, respectively, is a party or by which any Seller or Clinic is bound or to which any of the Seller or an individual Clinic&#8217;s assets is subject (or result in the imposition of any Lien upon any of the Acquired Assets).  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">3.5&#160;&#160;&#160;&#160;Brokers&#8217; Fees</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Except for advisory fees to Capstone Partners, which are the sole and exclusive responsibility of Seller, Seller has no liability or obligation to pay any fees or commissions to any broker, finder or agent with respect to the transactions contemplated by this Agreement or any Ancillary Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">3.6&#160;&#160;&#160;&#160;Assets</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">Seller has good and marketable title to, or a valid leasehold interest or license in, the properties and assets (tangible and intangible) used by the Clinics, located on the Clinics&#8217; premises, or listed in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.6(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, free and clear of all Liens, except for Permitted Liens and as set forth on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.6(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  The Acquired Assets are all the assets, properties and rights used or held for use by each Clinic in the operation of the Business, and the Acquired Assets are sufficient for the continued conduct of the Business, consistent with past practice.  The Acquired Assets include all the operating assets of the Clinics except for the Excluded Assets. </font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">The physical Acquired Assets are provided and delivered to the Buyer(s) in its </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">&#8220;AS-IS, WHERE-IS&#8221; &#8220;WITH ALL FAULTS&#8221;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> condition without representation or warranty whatsoever. </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.6(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> lists, by Clinic, each piece of equipment or other tangible personal property included in the Transaction and having a value exceeding Two Thousand, Five Hundred and 00&#47;100 Dollars ($2,500), including, but not limited to, all chiropractor chairs.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">3.7&#160;&#160;&#160;&#160;Financial Statements&#59; Interim Conduct</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:9pt">Exhibit F</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> of this Agreement includes correct and complete copies of the following consolidated financial statements of Seller relating to each Clinic and the Clinics, as follows&#58; (i) reviewed and compiled statements of profit and loss (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), each as of and for the fiscal years ended December 31, 2021, December 31, 2022, December 31, 2023, and December 31, 2024 (the &#8220;Most Recent Fiscal Year End&#8221;)&#59; (ii) reviewed and compiled statements of profit and loss (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Most Recent Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) as of and for the three (3) month period ended August 31, 2025 (the &#8220;Most Recent Fiscal Month End&#8221;)&#59; and (iii) reviewed and compiled trailing twelve month statements of profit and loss for the trailing twelve month periods ending June 30, 2024, October 31, 2024, November 30, 2024, and August 31, 2025.  Except as set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.7(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, the Financial Statements are correct and complete and consistent with the books and records of the Clinics (which are in turn correct and complete), have been prepared in accordance with GAAP consistently applied, and present fairly in all material respects the financial </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-11-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">condition, results of operation, collectively, as of and for their respective dates and for the periods then ending&#59; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, that the Most Recent Financial Statements are subject to normal, recurring year-end adjustments and lack notes required by GAAP (none of which will be material individually or in the aggregate).  Seller maintains a standard system of accounting that is uniform for all the Clinics and which is established and administered in accordance with GAAP.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">Since the Most Recent Fiscal Year End, the Businesses have been conducted in the Ordinary Course of Business, and there has not been any Material Adverse Change and no event has occurred which could reasonably be expected to result in a Material Adverse Change.  Without limiting the generality of the foregoing, except as set forth on Schedule 3.7(b), since the Most Recent Fiscal Year End the Seller, on behalf of any Clinic, has not&#58;</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9.68pt">sold, leased, transferred or assigned any assets or property (tangible or intangible) with a value greater than $1,000&#59;</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">engaged in any promotional, sales or discount or other activity that has or could reasonably be expected to have the effect of accelerating sales prior to the Closing that would otherwise be expected to occur subsequent to the Closing&#59; or </font></div><div style="padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">c.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9.68pt">taken or omitted to take any action which could be reasonably anticipated to have a Material Adverse Effect&#59;</font></div><div style="padding-left:108pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">3.8&#160;&#160;&#160;&#160;Undisclosed Liabilities</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  To the Knowledge of Seller, neither the Seller nor any of the respective Clinics, have any, and there is no basis for any, liability (whether known or unknown, whether asserted or unasserted, whether absolute or contingent, whether accrued or unaccrued, whether liquidated or unliquidated, and whether due or to become due), except for liabilities that (a) are accrued or reserved against in the Most Recent Financial Statements, (b) were incurred subsequent to the Most Recent Fiscal Month End in the Ordinary Course of Business, or (c) are liabilities and obligations pursuant to any Contract listed in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 5.1(a)(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> or not required by the terms of </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 5.1(a)(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> to be listed in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 5.1(a)(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, in either case which arose in the Ordinary Course of Business and did not result from any default, tort, breach of contract or breach of warranty.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">3.9&#160;&#160;&#160;&#160;Legal Compliance</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">To the Knowledge of Seller, the Seller has complied with and is compliant with all applicable Laws and Orders, and no Proceeding has been filed or commenced or, to the Knowledge of Seller, threatened against any of Seller or the Clinics alleging any failure so to comply.  Since January 1, 2023, Seller and the Clinics have not received any notice or communication alleging any non-compliance of the foregoing, except as set forth on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.9(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">To the Knowledge of Seller,</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline"> Schedule 3.9(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> sets forth a correct and complete list and description of all Permits held by Seller for each Clinic.  Such Permits (i) constitute all material Permits necessary for the operation of the Business and (ii) are in full force and effect.  No Proceeding is pending or, to the Knowledge of Seller, threatened to revoke or limit any Permit and no violations have been alleged in respect of any Permit. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-12-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">To the Knowledge of Seller, neither the Seller, nor any of its officers, directors, , agents, employees, contractors, or any other Persons acting on its behalf has (i) made any illegal payment or provided any unlawful compensation or gifts to any officer or employee of any Governmental Body, or any employee, customer or supplier of any one (1) Clinic, or (ii) accepted or received any unlawful contributions, payments, expenditures or gifts&#59; and no Proceeding has been filed or commenced alleging any such payments, contributions, expenditures or gifts.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">4.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">To the Knowledge of Seller,  in the past one (1) year, and as of the date hereof there are not, nor have there been, any internal investigations or inquiries being conducted by Seller or, to the Knowledge of Seller, any third party or Governmental Body concerning any conflict of interest, self-dealing, fraudulent or deceptive conduct or other misfeasance or malfeasance issues relating to the operation or the business of the Clinics. Except as provided in Schedule 3.9(d) attached hereto, Seller represents that, as of the Closing Date, no arrearages exist under any Lease and no landlord has delivered any default or termination notice.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">3.10&#160;&#160;&#160;&#160;Tax Matters</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">To the Knowledge of Seller, the Seller and each Clinic have filed with the appropriate taxing authorities all Tax Returns each has been required to file.  All such Tax Returns are true, correct and complete and prepared in accordance with applicable Laws.  All Taxes required to be paid by Seller and each Clinic (whether or not shown on any Tax Return) have been paid.  Each Tax election made by or on behalf of Seller and any specific Clinic has been timely and properly made. Seller is not currently the beneficiary of any extension of time within which to file any Tax Return or pay any Tax.  There are no Liens for Taxes (other than Permitted Liens) upon the ownership interests or any of the assets of Seller.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">To the Knowledge of Seller, the unpaid Taxes of Seller and each Clinic (i) did not, as of the Most Recent Fiscal Month End, exceed the reserve for Tax liabilities (rather than any reserve for deferred Taxes established to reflect timing differences between book and Tax income) set forth on the face of the Most Recent Financial Statements (rather than in any notes thereto) and (ii) do not exceed that reserve as adjusted for the passage of time through the Closing Date in accordance with the past custom and practice of Seller in filing its Tax Returns.  </font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">To the Knowledge of Seller, no deficiency or proposed adjustment for any amount of Tax has been proposed, asserted or assessed by any taxing authority against Seller or with respect to each Clinic that has not been paid, settled or otherwise resolved.  There is no Proceeding or audit now pending, proposed or, to the Knowledge of Seller, threatened against Seller which concerns any Clinic with respect to any Taxes.  Seller has not been notified by any taxing authority that any issues have been raised with respect to any North Carolina, South Carolina or Georgia Tax Return.  There has not been, within the past five (5) calendar years, an examination or written notice of potential examination in respect of Taxes of Seller by any North Carolina, South Carolina or Georgia taxing authority.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-13-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">4.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">To the Knowledge of Seller, all Taxes that are required to be withheld or collected by Seller and each Clinic, including, but not limited to, Taxes arising as a result of payments (or amounts allocable) to foreign persons or to employees, agents, contractors or shareholders of Seller, have been duly withheld and collected and, to the extent required, have been properly paid or deposited (or, in circumstances where such Taxes have not yet become due and payable, have been set aside in segregated accounts to be paid to the proper Governmental Body) as required by applicable Laws, and all required information returns with respect to any such amounts have been correctly prepared and timely filed to the extent such return were required to have been filed on or before the Closing Date.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">5.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">To the Knowledge of Seller, no claim has ever been made by any taxing authority in a jurisdiction where Seller and each Clinic does not file Tax Returns that they are or may be subject to taxation by that jurisdiction.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">6.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">To the Knowledge of Seller, the Seller and each Clinic is not party to any Tax allocation, sharing, indemnity, or reimbursement agreement or arrangement.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">7.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">Except as described in Schedule 3.10(g), Seller has filed all Tax Returns for the Tax periods ended on or after December 31, 2021, which Tax Returns are true, correct, and complete in all material respects and are listed on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.10(g)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">3.11&#160;&#160;&#160;&#160;Real Property</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt;text-decoration:underline">Schedule 3.11(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> sets forth the address of each parcel of Leased Real Property, and a true and complete list of all Leases for each parcel of Leased Real Property. Seller has made available to Buyer(s) a true and complete copy of each Lease, and in the case of any oral Lease, a written summary of the material terms of such Lease.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">Subject to the respective terms and conditions in the Leases, Seller and each Clinic, as applicable, is the sole legal and equitable owner of the leasehold interest in the Leased Real Property and possesses good and marketable, indefeasible title thereto, free and clear of all Liens (other than Permitted Liens and except as set forth on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.6(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">To the Knowledge of Seller, with respect to each parcel of Leased Real Property&#58; (i) there are no pending or threatened condemnation Proceedings, suits or administrative actions relating to any such parcel or other matters affecting adversely the current use, occupancy or value thereof&#59; (ii) the ownership and operation of the Leased Real Property in the manner in which it is now owned and operated comply with all zoning, building, use, safety or other similar Laws&#59; (iii) all Improvements on any such parcel are in good operating condition, ordinary wear and tear excepted, are supplied with utilities and other services necessary for the operation of the Businesses as currently conducted at such facilities and safe for their current occupancy and use&#59; (iv) Seller has not received any notice of any special Tax, levy or assessment for benefits or betterments that affect any parcel of Leased Real Property and no such special Taxes, levies or assessments are pending or contemplated&#59; (v) there are no Contracts granting to any third party or parties the right of use or occupancy of any such parcel, and there are no third parties (other than </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-14-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Seller) in possession of any such parcel&#59; and (vi) each such parcel abuts on and has adequate direct vehicular access to a public road and there is no pending or threatened termination of such access.  The Leased Real Property comprises all the real property used or intended to be used in the Businesses, and the Seller is not a party to any Contract or option to purchase any real property or any portion thereof or interest therein.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">3.12&#160;&#160;&#160;&#160;Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">As disclosed to Buyer(s) in Seller&#8217;s franchise disclosure document, the Seller owns and possesses or has the right to use pursuant to a valid and enforceable written Contract, all Intellectual Property necessary to franchise and operate the Businesses pursuant to the Franchise Agreements. For avoidance of doubt, Seller&#8217;s Intellectual Property is an Excluded Asset, except however, Seller shall include all of Seller&#8217;s social media accounts for the Clinics (and related password and login information) as Acquired Assets and listed in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.12(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> attached hereto, provided Seller is able to obtain and transfer title of the foregoing to Buyer(s) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Transferable Social Media Accounts</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). </font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">Seller owns and possesses or has the right to use, pursuant to a valid and enforceable written Intellectual Property Agreement, all Software used by the Clinics in the operation of the Businesses.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">To the Knowledge of Seller, the Systems are adequate in all material respects for the operations of Clinics by Seller.  Seller has taken commercially reasonable measures to (i) protect the integrity of the Systems, including any data stored or contained therein or transmitted thereby, and (ii) maintain commercially reasonable and industry standard data security, disaster recovery, and business continuity plans, procedures, systems and facilities.  For the past year there has not been (1) any material failure, outage or other adverse event with respect to the Systems that has not been remedied in all material respects or (2) any material security breaches relating to, or violations of any security policy regarding, or any unauthorized access of, any Systems, including any data or information stored or contained therein or used in the Business.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">3.13&#160;&#160;&#160;&#160;Contracts</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">Schedule 3.13(a) lists the following Contracts, if any, that are an Assumed Liability of Buyer(s) and to which Seller and each Clinic is a party&#58;</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9.68pt">each Contract with any customer or client or supplier of the Seller and each Clinic&#59;</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">any individual or employer group subscription Contract or membership Contract providing for the participation in a network&#59;</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">c.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9.68pt">each lease, rental or occupancy agreement, license, installment and conditional sale agreement, and other Contract affecting the ownership of, leasing of, title to, use of, or any leasehold or other interest in, any real or personal property&#59;</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">d.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">each Contract containing any covenant that purports to restrict the business activity of Seller or limit the freedom of Seller to engage in any line of business or to compete with any Person&#59;</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">e.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9.68pt">each Contract in which a Governmental Body is a counterparty&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-15-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">f.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:11.01pt">each Contract related to professional services, management services or administrative services&#59;</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">g.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">each Contract related to Debt&#59;</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">h.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">each Contract providing for the payment of any cash or other compensation or benefits in connection with the transactions contemplated by this Agreement&#59;</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">i.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:11.67pt">each Contract with any labor union or any bonus, pension, profit sharing, retirement or any other form of deferred compensation plan or practice, whether formal or informal, or any severance agreement or arrangement&#59;</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">j.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:11.67pt">each vendor or service center agreements&#59;</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">k.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">each employment or consulting Contract or other Contract with any of its officers, directors, independent contractors, consultants, or employees&#59;</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">l.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:11.67pt">each Contract that provide for the indemnification of any Person or the assumption of any Tax, environmental or other liability of any Person&#59;</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">m.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:5.67pt">each Contract which purports to be binding on Affiliates of Seller&#59; and</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">n.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">any other agreement material to Seller relating to any Clinic, whether or not entered into in the Ordinary Course of Businesses.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">To the Knowledge of the Seller, the Seller has delivered to Buyer(s) a correct and complete copy of each written Material Contract, together with all amendments, exhibits, attachments, waivers or other changes thereto.  Schedule 3.13(b) contains an accurate and complete description of all material terms of all oral Material Contracts (if any).</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">To the Knowledge of the Seller, each Material Contract is legal, valid, binding, enforceable, in full force and effect and will continue to be legal, valid, binding and enforceable on identical terms following the Closing Date.  Except as specifically disclosed and described in Schedule 3.13(c), (i) no Material Contract has been breached or cancelled by Seller or, to the Knowledge of Seller, any other party thereto, (ii) Seller has performed all obligations under such Material Contracts required to be performed by Seller, (iii) there is no event which, upon giving of notice or lapse of time or both, would constitute a breach or default under any such Material Contract or would permit the termination, modification or acceleration of such Material Contract, and (iv) Seller has not assigned, delegated or otherwise transferred to any Person any of its rights, title or interest under any such Material Contract.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">4.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">Seller has not entered into any promissory note, payment plan, or Contract  with any patient of the Clinics whereby any patient will pay cash after the Closing for services purchased prior to the Closing to Seller&#8217;s Knowledge&#59; provided, however, that the parties acknowledge and agree that certain cash transactions made up to forty-eight (48) hours before the Closing might not officially be deposited into Seller&#8217;s bank accounts until after the Closing and that such delay is not a breach of this </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 3.13(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-16-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">3.14&#160;&#160;&#160;&#160;Insurance</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. There is no claim by Seller relating to any Clinic or any other Person relating to any Clinic pending under any such policies and bonds as to which coverage has been questioned, denied or disputed.  All premiums payable under all such policies and bonds have been paid.  There are no threatened terminations of, or material premium increases with respect to, any of such policies or bonds.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.14</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> sets forth a list of all open claims made under the Company Insurance Agreements for the benefit of any Clinics, or under any other insurance policy, bond or agreement covering Seller or its operations relating to the Clinics for the period December 31, 2023 through the Closing Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Open Insurance Claims</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-24.33pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">i.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:18pt;text-decoration:underline">General Litigation&#59; Professional Liability&#59; Product Liability</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  </font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">Except as set forth in Schedule 3.15(a), there are no (and during the last two (2) years, there have not been any) unresolved complaints, charges, Proceedings, Orders, or investigations pending or, to the Knowledge of Seller, threatened or anticipated relating to or affecting Seller in relation to any Clinic (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Unresolved Complaints</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).  There is no outstanding Order relating to any Clinic to which Seller is subject.  The Seller and each Clinic (or the applicable insured individual or legal entity) is fully insured with respect to each of the matters set forth on Schedule 3.15(a).</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">Except as set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.15(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">,  the Seller nor any Clinic is engaged in or a party to or, to the Knowledge of Seller, threatened with any complaint, charge, Proceeding, Order or other process or procedure for settling disputes or disagreements with respect to Seller and each Clinic or the transactions contemplated by this Agreement, and none of the Seller or any Clinic has received written or, to the Knowledge of Seller, oral notice of a claim or dispute that is reasonably likely to result in any such complaint, charge, Proceeding, Order or other process or procedure for settling disputes or disagreements with respect to the Seller or the transactions contemplated by this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">3.16&#160;&#160;&#160;&#160;Employees</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.16(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> sets forth a complete and correct list of all employees, including employees on temporary leave of absence (including family medical leave, military leave, temporary disability and sick leave) of the Seller with respect to each Clinic, showing for each&#58; (i) name, (ii) hire date, (iii) current job title, (iv) current job assignment, start date of such assignment, and anticipated end date of such assignment, (v) accrued but unused vacation, paid time off, and sick leave, (vi) full-time or part-time status, (vii) hourly or salary status, (viii) exempt or non-exempt status, and (ix) leave status (i.e., military, medical, disability, workers&#8217; compensation or otherwise) and the date such employee became inactive as well as the expected return to work date, (x) actual base salary, bonus, commission or other remuneration paid during 2024, (xi) 2025 base salary level and 2025 target bonus, and (xii) indication of whether there has been any increase in compensation, bonus, incentive, or service award or any grant of any severance or termination pay or any other increase in benefits or any commitment to do any of the foregoing since January 1, 2025.  The employees set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.16(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> are, in Seller&#8217;s opinion, all the employees reasonably necessary to operate the Clinics, consistent with past practice. The Buyer(s) acknowledges that as referenced in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4.4</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, Buyer(s) hereby agrees to hire (or, as applicable, to negotiate with the applicable professional chiropractic entity do the same) all of the Employees as of the earlier of the date of a Management Services Agreement or the Closing (the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-17-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Employee Transfer Date</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) and pay any and all compensation due the Employees after the Employee Transfer Date&#59; including, but not limited to, all base pay, hourly pay, bonuses and commission, vacation and sick time, and any severance obligations. Seller agrees to pay, by the Employee Transfer Date, any and all compensation due the Employees prior to the Employee Transfer Date&#59; including, but not limited to, all base pay and hourly pay. Such hiring or contracting shall constitute a closing condition. For the avoidance of doubt, the Buyer(s) agrees and acknowledges that only the incoming licensed North Carolina, South Carolina or Georgia chiropractor, as the case may be, operating the clinic and managing all clinical decisions may hire Doctors of Chiropractic, and that therefore, the Seller cannot exert any influence over such hiring practices or make any representations regarding such hiring decisions.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.16(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, to the Knowledge of Seller, sets forth a complete and correct list of all independent contractors or consultants of the each Clinic, including for each&#58; (i) his or her start date, (ii) whether he or she is contracted in his or her individual status or with a corporation or other entity, (iii) type of services to be provided, including any exclusivity of such services, (iv) anticipated completion date, and (v) hourly or per diem rate or other form of pay of such contractor.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">To the Knowledge of Seller, the Seller has provided Buyer(s) with complete and correct copies of (i) all existing severance, accrued vacation or other leave agreement, policies or retiree benefits of any such officer, employee, independent contractor, or consultant, (ii) all employee trade secret, non-compete, non-disclosure and invention assignment agreements and (iii) all manuals and handbooks applicable to any current or former manager, officer, employee, independent contractor or consultant of each Clinic.  Except as set forth on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.16(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, the employment or consulting arrangement of each manager, officer, employee, independent contractor, or consultant of the Clinics are, subject to applicable Laws involving the wrongful termination of employees, terminable at will (without the imposition of penalties or damages) by Seller, and the Seller does not have any severance obligations if any such manager, officer, employee, independent contractor, or consultant is terminated.  Except as set forth on Schedule 3.16(c), to the Knowledge of Seller, no executive or key employee of the Clinics or any group of employees of the Clinics have any plans to terminate employment with the Clinics.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">To the Knowledge of Seller, the Clinics have not experienced (nor, to the Knowledge of Seller, have they been threatened with) any strike, slowdown, work stoppage or material grievance, claim of unfair labor practices, or other collective bargaining dispute within the past one (1) year.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">To the Knowledge of Seller, the Clinics have not committed any material unfair labor practice.  The Seller has no Knowledge of any organizational effort presently being made or threatened by or on behalf of any labor union with respect to employees of the Clinics.  Seller has paid in full to all its employees and independent contractors all wages, salaries, commissions, bonuses, benefits and other compensation due and payable to such employees and independent contractors, excluding any severance obligations, which will remain sole and exclusive obligation of Seller.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">To the Knowledge of Seller, the Seller, with respect to the Clinics is, and has at all times been, in compliance in all material respects with all Laws relating to the employment of labor, including all such Laws relating to wages and hours (including compliance with Laws relating to overtime pay, meal and rest periods, travel time, off-the-clock work, on-call pay, and piece rate pay), the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-18-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">WARN Act and similar state laws, collective bargaining, equal opportunity, discrimination and harassment, retaliation, whistleblowing, safety and health and workers&#8217; compensation, engagement of independent contractors (including the classification of individuals as employees or independent contractors), government contracting (including compliance with all Orders, background and exclusion screening requirements, government submissions and affirmative action plans), immigration control and naturalization, drug testing, data privacy, background checks, termination pay, vacation pay, paid sick leave, fringe benefits, unemployment insurance and the withholding and payment of income and employment taxes any similar Tax.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">To the Knowledge of Seller, the Seller and the Clinics have no unsatisfied payment of any salary, wage, benefit, bonus, vacation pay, sick leave, insurance, employment tax or similar liability of Seller with respect to any Clinic for any employee, independent contractor, director or other person or entity allocable to services performed on or prior to the Closing Date.  To the Knowledge of Seller, there has been no &#8220;mass layoff&#8221; or &#8220;plant closing&#8221; as defined by the WARN Act or any similar layoff or closing as defined by any Law with respect to Seller and the Clinics.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">To the Knowledge of Seller, the Seller is in compliance and has complied with all applicable Laws pertaining to employment and employment practices to the extent they relate to employees, volunteers, interns, consultants and independent contractors, including but not limited to all Laws relating to the classification of individuals as an employee, non-employee, or an independent contractor.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">To the Knowledge of Seller, all individuals who have performed services for the Clinics have been properly classified as&#58; (i) exempt or non-exempt under the Fair Labor Standards Act and all similar Laws.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">To the Knowledge of Seller, all individuals characterized and treated by Seller as independent contractors or consultants are properly treated as independent contractors under all applicable Laws.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">To the Knowledge of Seller, there are no filed or threatened inquiries, audits or actions by any Governmental Body or arbitrator concerning such classifications, without limitation, any charge, investigation, or claim relating to wages, hours, overtime compensation, working conditions, workers&#8217; compensation, unemployment insurance, employee classification, or any other employment related matter arising under any applicable law.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">To the Knowledge of Seller, the Seller is compliant with and has complied with all immigration laws.  Seller has completed and maintained in its files Form I-9 with respect to each of its employees.  Seller has been, and is, in compliance with all requirements applicable to government contractors and subcontractors.  In the past one (1) year, to the Knowledge of Seller, the Seller has not received any written notice from any governmental authority that any of their employees has a name or Social Security Number that does not match the name or Social Security Number maintained by such governmental authority.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">To the Knowledge of Seller, all employees of the Seller and the Clinics working in the United States are legally authorized to work in the United States.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-19-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">To the Knowledge of Seller, all individuals who have performed services for Seller or who otherwise have claims for compensation from Seller have been properly classified as an employee or an independent contractor pursuant to all applicable Laws, including, but not limited to, the Code and ERISA.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">To the Knowledge of Seller, neither Seller nor any Clinic is, nor has been for the past three (3) years, the subject of any audit, investigation or enforcement action by any Governmental Authority in connection with any Government Contract or related compliance with Section 503, VEVRAA or E.O. 13706. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">To the Knowledge of Seller, neither Seller nor any Clinic has been debarred, suspended or otherwise made ineligible from doing business with the United States government or any government contractor. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">3.17&#160;&#160;&#160;&#160;Employee Benefits</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt;text-decoration:underline">Schedule 3.17(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> lists each Employee Benefit Plan that the Seller maintains or to which it contributes or has any obligation to contribute, with respect to which any employee of a respective Clinic is a participant.</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9.68pt">Each Employee Benefit Plan (and each related trust, insurance Contract, or fund) has been maintained, funded and administered in accordance with the terms of such Employee Benefit Plan and complies in form and in operation in all respects with the applicable requirements of ERISA, the Code, and other applicable Laws.</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">As further described in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.17(a)(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, all required reports and descriptions (including Form 5500 annual reports, summary annual reports, and summary plan descriptions) have been timely filed and&#47;or distributed in accordance with the applicable requirements of ERISA and the Code with respect to each such Employee Benefit Plan.  The requirements of COBRA have been met in all material respects with respect to each Employee Benefit Plan and each Employee Benefit Plan maintained by an ERISA Affiliate that is an Employee Welfare Benefit Plan subject to COBRA.</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">c.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9.68pt">All contributions (including all employer contributions and employee salary reduction contributions) that are due have been made within the time periods prescribed by ERISA and the Code to each such Employee Benefit Plan that is an Employee Pension Benefit Plan and all contributions for any period ending on or before the Closing Date which are not yet due have been made to each such Employee Pension Benefit Plan or accrued in accordance with the past custom and practice of Seller.  All premiums or other payments for all periods ending on or before the Closing Date have been paid with respect to each such Employee Benefit Plan that is an Employee Welfare Benefit Plan.</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">d.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">Each such Employee Benefit Plan which is intended to meet the requirements of a &#8220;qualified plan&#8221; under Code &#167;401(a) is so </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-20-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">qualified and has received a determination from the Internal Revenue Service that such Employee Benefit Plan is so qualified, and nothing has occurred since the date of such determination that could adversely affect the qualified status of any such Employee Benefit Plan.</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">e.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9.68pt">Each Employee Benefit Plan which is intended to be qualified under Section 401(a) of the Code and each trust forming a part thereof has been timely amended within the applicable Remedial Amendment Period (as that term is defined in Code Section 401(b)) and in accordance with applicable procedures set forth in Revenue Procedure 2005-66.  All master, prototype and volume submitter plans which are part of any Employee Benefit Plan were submitted to the IRS for an opinion or advisory letter within the applicable Remedial Amendment Period, set forth in Revenue Procedure 2005-66.</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">f.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:11.01pt">There have been no Prohibited Transactions with respect to any such Employee Benefit Plan or any Employee Benefit Plan maintained by an ERISA Affiliate.  No Fiduciary has any liability for material breach of fiduciary duty or any other failure to act or comply in connection with the administration or investment of the assets of any such Employee Benefit Plan.  No Proceeding with respect to the administration or the investment of the assets of any such Employee Benefit Plan (other than routine claims for benefits) is pending or, to the Knowledge of Seller, threatened.</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">g.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">Seller has made available to Buyer(s) correct and complete copies of the plan documents and summary plan descriptions, the three (3) most recent determination letter received from the Internal Revenue Service, the most recent annual report (Form 5500, with all applicable attachments), and all related trust agreements, insurance Contracts, and other funding arrangements which implement each such Employee Benefit Plan.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">Neither Seller nor any ERISA Affiliate contributes to, has any obligation to contribute to, or has any liability under or with respect to any Employee Pension Benefit Plan that is a &#8220;defined benefit plan&#8221; (as defined in ERISA &#167;3(35)) or a Multiemployer Plan.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt;text-decoration:underline">Schedule 3.17(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> lists each written agreement, contract, or other arrangement, whether or not an Employee Benefit Plan (collectively, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), to which Seller is a party that is a &#8220;nonqualified deferred compensation plan&#8221; subject to Code Section 409A.  Each such Plan complies in all material respects with the requirements of Code Section 409A(a)(2), (3), and (4) and any Internal Revenue Service guidance issued thereunder.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">3.18&#160;&#160;&#160;&#160;Debt</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Except as set forth on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule  3.6(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, the Seller does not have any Debt that encumbers the Acquired Assets, and is not liable for any Debt of any other Person, that encumber the Acquired Assets.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-21-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">3.19&#160;&#160;&#160;&#160;Environmental, Health, and Safety Matters</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  To the Knowledge of Seller, the Seller, and each Clinic, are and for the prior two (2) years has been in material compliance with all Environmental, Health, and Safety Requirements.  To the Knowledge of Seller, the Seller has obtained and is and for the prior two (2) years has been in compliance with all Permits and other authorizations that are required pursuant to Environmental, Health, and Safety Requirements for the occupation of the Leased Real Property and the operation of the business of the Clinics and each such Permit is in full force and effect and there is no action pending or threatened to revoke, terminate, cancel or modify any Permits required pursuant to Environmental, Health, and Safety Requirements.  A list of all such Permits is set forth on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.19</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  To the Knowledge of Seller, the Seller has not received any notice, suit, complaint, citation, demand, order, report or other communication regarding any actual or alleged violation of Environmental, Health, and Safety Requirements, or any liabilities or potential liabilities arising under Environmental, Health, and Safety Requirements.  To the Knowledge of Seller, the Seller has not entered into any consent order, consent decree, settlement agreement or other similar agreement with any Government Body that imposes ongoing or outstanding obligations under any Environmental, Health, and Safety Requirement on Seller, the Leased Real Property, or the Acquired Assets.  To the Knowledge of Seller no Leased Real Property contains any (i) underground storage tanks currently, nor, to the Knowledge of Seller, has contained any underground storage tanks in the past or (ii) friable or damaged asbestos containing materials that must be removed or abated to comply with Environmental, Health, and Safety Requirements.  Seller has not treated, stored, disposed of, arranged for or permitted the disposal of, transported, handled, released or exposed any Person to any substance, including without limitation any Hazardous Substance, or owned or operated any property or facility (and no such property or facility is contaminated by any such substance) either in violation of any Environmental, Health, and Safety Requirement or in a manner that could result in any liability under any Environmental, Health, and Safety Requirement.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">3.20&#160;&#160;&#160;&#160;Privacy Laws</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  To the Knowledge of Seller, the Seller is conducting and has conducted at all times its business in compliance in all material respects with all applicable Laws governing the privacy, security, confidentiality or breach of &#8220;personal information&#8221; (or similar terms such as &#8220;personally identifiable information&#8221; or &#8220;sensitive personal information&#8221;) as defined by applicable Laws, medical records, or other records generated in the course of providing or paying for health care services (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Privacy Laws</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).  To the Knowledge of Seller, there have been no complaints to or investigations by the U.S. Department of Health and Human Services Office for Civil Rights or other state or federal regulators with respect to Privacy Law compliance by Seller, its business associates or its subcontractors.  To the Knowledge of Seller, no Clinic nor any of its business associates or subcontractors has experienced any &#8220;breach of security&#8221; (or similar terms such as &#8220;breach of security of the system&#8221;) as defined by the Privacy Laws with respect to personal information.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Reserved.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">3.22&#160;&#160;&#160;&#160;Healthcare Compliance.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Except as set forth on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.22(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, to the Knowledge of Seller, the Seller, and each Clinic, are currently operating, and have at all times during the last year operated, in compliance in all material respects with all applicable Health Care Laws.  Except as set forth on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.22(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, to the Knowledge of the Seller, none of the Clinics nor any of their officers, or professional personnel (whether employees or independent contractors) is, or has been within the last one (1) year, under investigation for, violation of any Health Care Law by which such Person is bound or to which any business activity or professional services performed by such Person for the Clinics is subject.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">To the Knowledge of Seller, the Seller has </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-22-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">timely filed all material regulatory reports, schedules, statements, documents, filings, submissions, forms, registrations and other documents, together with any amendments required to be made with respect thereto, that each was required to file with any Governmental Body, including state health and insurance regulatory authorities and any applicable federal regulatory authorities.  To the Knowledge of Seller, all such regulatory filings complied in all material respects with applicable Health Care Laws.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">3.23&#160;&#160;&#160;&#160;Disclosure</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Neither this Agreement nor any agreement, attachment, schedule, exhibit, certificate, document delivered to Buyer(s) as part of Buyer(s)&#8217;s due diligence or other statement delivered  pursuant to this Agreement or in connection with the transactions contemplated hereby includes any untrue statement of a material fact or omits to state a material fact necessary in order to make the statements and information contained herein or therein, not misleading.  To the Knowledge of Seller, the Seller is not aware of any information necessary to enable a prospective purchaser of the Acquired Assets or the Businesses to make an informed decision with respect to the purchase of such Acquired Assets or Businesses that has not been expressly disclosed herein.  To the Knowledge of Seller, the Buyer(s) has been provided full and complete copies of all documents referred to in the Schedules. All documents provided to Buyer(s) in due diligence are true, correct, and complete in all material respects. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">3.24&#160;&#160;&#160;&#160;No Other Representations or Warranties</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. Except for the representations and warranties contained in this Agreement (including the related portions of the Schedules or Exhibits), neither Seller nor any other Person has made or makes any other express or implied representation or warranty, either written or oral, on behalf of Seller, including any representation or warranty as to the accuracy or completeness of any information regarding the Clinics, the Premises, the Businesses, or the Acquired Assets furnished or made available to Buyer(s) (including the Buyer(s)&#8217;s representatives) of any information, documents or materials delivered to Buyer(s) (including the Buyer(s)&#8217;s representatives), or management presentations or in any other form in expectation of the transactions contemplated hereby, or as to the future revenue, profitability or success of the Businesses or the Clinics, or any representation or warranty arising from statute or otherwise in law.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE 4</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">POST-CLOSING COVENANTS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">The Parties agree as follows with respect to the period following the Closing.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">4.1&#160;&#160;&#160;&#160;Further Assurances</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">In case at any time after the Closing any further action is necessary to carry out the purposes of this Agreement, each of the Parties will take such further action (including the execution and delivery of such further instruments and documents) as any other Party reasonably may request, all at the sole cost and expense of the requesting Party (unless the requesting Party is entitled to indemnification therefor under</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline"> Article 8</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> below).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Notwithstanding anything to the contrary in this Agreement, in the event that&#58; (i) an assignment or purported assignment to Buyer(s) of any Acquired Asset, or any claim, right or benefit arising thereunder or resulting therefrom, without the consent of other parties thereto, would constitute a breach thereof or would not result in Buyer(s) receiving all of the rights thereunder of the respective Clinic&#59; and (ii) such consent shall not have been obtained prior to the Closing, then the Seller </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-23-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">will use their Commercially Reasonable Efforts to obtain any such consent after the Closing and Buyer(s) shall use Commercially Reasonable Efforts to cooperate to give effect to the foregoing.  If such consent is not obtained, the Seller shall reasonably cooperate with Buyer(s) in any reasonable arrangement to provide Buyer(s) with the full claims, rights and benefits under any such Acquired Asset, including enforcement at the cost and for the benefit of Buyer(s) of any and all rights of the respective Clinic against a third party thereto arising out of the breach or cancellation by such third party or otherwise, and any amount received by the Clinic in respect thereof shall be held for and paid over to Buyer(s).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">4.2&#160;&#160;&#160;&#160;Litigation Support</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  In the event and for so long as Buyer(s) actively is contesting or defending against any Proceeding in connection with any fact, situation, circumstance, action, failure to act or transaction that occurred on or prior to the Closing Date involving the Acquired Assets or Assumed Liabilities, Seller will cooperate with Buyer(s) (as the case may be) and its or their counsel in the contest or defense and provide such testimony and access to Seller&#8217;s books and records as shall be necessary in connection with the contest or defense, all at the sole cost and expense of Buyer(s) (unless Buyer(s) is entitled to indemnification therefor under </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Article 8</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> below).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">4.3&#160;&#160;&#160;&#160;Transition</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Seller shall not take any action that is designed or intended to have the effect of discouraging any lessor, licensor, customer, supplier, or other business associate of the Seller from maintaining the same business relationships with Buyer(s) after the Closing as it maintained with the Clinics prior to the Closing.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">4.4&#160;&#160;&#160;&#160;Hired Employees</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  As of the Closing, Buyer(s) will extend an offer of employment to Seller&#8217;s Employees listed on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.16(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Buyer(s)&#8217;s offers may be conditioned upon the execution of Buyer(s)&#8217;s standard written employment terms, but will include Seller&#8217;s existing paid time off structure and assumption of the paid time off balances (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Buyer(s)&#8217;s Offers</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).  Seller&#8217;s Employees who accept Buyer(s)&#8217;s Offers upon the Closing Date are hereinafter defined as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Hired Employees</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;.  All Hired Employees terms of employment will be &#8220;at will,&#8221; with Buyer(s) retaining the right to terminate any Hired Employee&#8217;s continued employment, in Buyer(s)&#8217;s sole and absolute discretion. Buyer(s) shall timely pay all amounts due to employees of Buyer(s) whose employment with Buyer(s) terminates as of the Closing because of the transactions contemplated by this Agreement, including all accrued but used vacation, sick pay, and paid time off accrued, but unused as of the Closing.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">4.5       </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">4.5&#160;&#160;&#160;&#160;Chiropractic Physicians&#8217; Board of Relevant States</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.   The Parties shall work together in good faith to comply with all requirements necessary or appropriate to effectuate the sale of the Acquired Assets, and take all reasonable actions, and negotiate, execute, deliver and perform under any documents or agreements, necessary or appropriate to comply with any applicable state or local laws.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">4.6       </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Guarantor(s)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.   Guarantors are the primary beneficial owners of Buyer(s) and join in the execution of this Agreement to guaranty the obligations of each Guarantors corresponding Buyer(s) only (&#8220;Guaranty&#8221;), up to and for which such Guaranty, shall not exceed a maximum aggregate liability of Two Hundred Fifty Thousand dollars ($250,000.00) or the amount of any Promissory Note or Seller&#8217;s liability under any Lease Assignment (the &#8220;Guaranty Cap&#8221;).</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">The Guarantors consent and agree that Guarantors will make any payment or render any performance required under the Agreement on demand if Buyer(s) fails or refuses to do so when required as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-24-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">finally determined by agreement, arbiter, or non-appealable court order. Each Guarantor shall guarantee only the obligations of its respective Buyer(s). No Guarantor shall be liable for any obligations of another Buyer(s).  Seller shall have the right to require Triangle Chiropractic and&#47;or Todd Wegerski, DC and Lisa Ezell to obtain an additional guarantor meeting Seller&#8217;s then-current financial requirements for a franchisee.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">4.7&#160;&#160;&#160;&#160;Franchise Agreements</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Pro-Rated Franchise Fees</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Seller agrees to amend the Franchise Agreements pursuant to the amendment attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Exhibit B-1</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, to include a pro-ration the Franchise Fees based on the total Lease Term, including options, set forth in the Lease Assignments (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Pro-Ration Amendment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).  Such pro-ration is based upon a ten-year Term of the Franchise Agreement equal to a Franchise Fee of Two Thousand, Nine Hundred and Ninety and NO&#47;100 Dollars ($2,990.00) per year (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Yearly Pro-Ration</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).  The parties agree the Yearly Pro-Ration shall not be further adjusted, thus if the Lease Term is less than a full year, the full amount of the Yearly Pro-Ration shall be due.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Franchise Agreement Term</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. Seller agrees to amend twelve (12) Franchise Agreements pursuant to the amendment attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Exhibit B-2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, to include a Term (as defined therein), that is equal to the initial term plus extensions of the Leases transferred to Buyer(s) and set forth in the Lease Assignments (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">FA Term Alignment Amendment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).  For avoidance of doubt, the Franchise Agreement Term will not be further extended if Buyer(s) negotiates additional term on the Leases after the Closing Date.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Revised Refresh Schedule</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. The Parties have agreed to a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Revised Refresh Schedule</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; regarding certain Clinics that will be incorporated into an addendum to the Franchise Agreements attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Exhibit B-3</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Refresh Addendum</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">National Marketing Fund Cap and Local Marketing Commitment Reduction</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Seller agrees to amend the Franchise Agreements to include the following pursuant to the addendum attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Exhibit B-4</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">National Marketing Fund and Local Marketing Commitment Addendum</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;)&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">during the period from the Closing through January 1, 2029, if Seller elects to increase its franchisee&#8217;s contribution to the National Marketing Fund (as defined in the Franchise Agreements) to three percent (3%) per month, Buyer(s)&#8217;s National Marketing Fund Fee in the Franchise Agreements shall increase to two and one-half percent (2.5%) per month through the end of the initial Term of the Franchise Agreements or the duration of the increase (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">National Marketing Fund Cap</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;)&#59; and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> during the period from the Closing through January 1, 2029, if Seller increases the National Marketing Fund Fee as previously described, Buyer(s) may reduce their Local Marketing Commitment (as defined in the Franchise Agreements), to the greater of four and one-half percent (4.5%) per month or Two Thousand, Seven Hundred and NO&#47;100 Dollars ($2,700.00) per month through the end of the initial Term of the Franchise Agreements or the duration of the increase (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Local Marketing Commitment Reduction</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Personal Guaranty</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Seller agrees to amend the Franchise Owner Agreement pursuant to the amendment attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Exhibit B-5</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, for each Franchise Owner Agreement to limit the liability of each Guarantor </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">to </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">a maximum aggregate liability </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">of Two Hundred Fifty Thousand </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">dollars</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> ($250,000.00) or </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">the amount of any Promissory Note or </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Seller&#8217;s liability </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">under any</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> Lease Assignment </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Franchise Owner Agreement Amendment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). Subject to any assignments described herein.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Franchise Agreement Transfers</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Seller agrees to amend the Transfer Addendum of the Franchise Agreements pursuant to the amendment attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Exhibit B-6</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, to permit Buyer(s) to assign any or all the Franchise Agreements to Buyer(s)&#8217;s subsidiaries in accordance with the transfer provisions of the Franchise Agreements (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Transfer Addendum Amendment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).  Additionally, the Transfer Addendum Amendment shall state if such assignment occurs within six (6) months from the Closing Date and in accordance the applicable Franchise Agreement, Seller agrees to waive the transfer fee for </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-25-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">that assignment only.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">No cross default</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. The Parties acknowledge and agree that the Clinics and related Acquired Assets purchased under this Agreement being acquired in a stand-alone transaction. Accordingly, Buyer(s)&#8217;s obligations, liabilities, or performance defaults (if any) relating to these specific Clinics or Franchise Agreements shall not constitute or be deemed to cause a default, breach, or cross-default under any other franchise agreement, development agreement, lease, loan, guaranty, or other obligation of Buyer(s), its affiliates, or their respective principals. The Seller acknowledges that this separation is intentional and necessary due to the distressed condition of the assets being acquired, and that each Clinic and Franchise Agreement is isolated for purposes of Buyer(s)&#8217; ongoing operations, liabilities, and franchise compliance. Nothing in Seller&#8217;s loan or guaranty agreements shall encumber, restrict, or otherwise affect Buyer(s)&#8217;s ownership, operation, or rights in and to non-related Franchise Agreements or assets. Furthermore, Seller agrees to  incorporate the foregoing understanding regarding cross-default pursuant to the addendum attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Exhibit B-8</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Cross-Default Addendum</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">4.8&#160;&#160;&#160;&#160;Development Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Buyer(s) agrees and acknowledges that as a condition of the Seller&#8217;s agreement to the Transaction, Buyer(s) shall execute the Development Agreement for the development of one (1) clinic. This additional development agreement shall be non-exclusive and have commercially reasonable terms granting Buyer(s) the right to develop one (1) clinic in the metropolitan statistical areas (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">MSAs</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) of Myrtle Beach, South Carolina (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Development Area</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), by the deadlines shown below&#58; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">ClinicClinic Opening Deadline</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Clinic 1Month 24</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">   In accordance with the terms of the Development Agreement, in addition to the Purchase Price and the Franchise Fees, the Buyer(s) shall remit to Seller the Development Fee. Moreover, the Buyer(s) agrees and acknowledges that all individual owners and signatories (whether as individuals or as members, officers, or owners of a legal entity) to the Development Agreement shall also enter into personal guarantees to fully and severally personally guarantee the performance of all obligations of the Buyer(s), as franchisee, that</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%"> are set forth in the Franchise Agreements.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Exclusivity</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. Seller agrees to amend the Franchise Agreements pursuant to the amendment attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Exhibit B-7 </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">to provide that for a period of eighteen (18) months following Closing, neither Seller nor any affiliate shall establish, develop, or franchise any new </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">The Joint Chiropractic</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#174; clinic within fifteen (15) miles of the geographic areas containing the Clinics acquired by Buyer(s) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Exclusivity Period</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), excepting Charlotte store 12033. This restriction is intended to preserve the value of the Acquired Assets and shall survive Closing.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Seller&#8217;s Chiropractors</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Seller is assisting certain employees and&#47;or independent contractors of the Clinics with student loan payments. Seller shall retain all liability for such student loan payments from and after the Closing regardless of whether Buyer(s) makes an offer of employment to, or assumes the employment agreement of any such person (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Seller&#8217;s Student Loan Repayments</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). The Parties acknowledge and agree that Seller&#8217;s Student Loan Repayments constitute Excluded Liabilities. Seller represents and warrants that Seller&#8217;s Loan Repayments listed on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 4.10</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> is a complete and correct summary of Seller&#8217;s Student Loan Repayments as of the Closing.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE 5</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">CLOSING DELIVERIES</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">5.1&#160;&#160;&#160;&#160;Closing Deliveries of Seller</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  At or prior to the Closing, Seller shall deliver to Buyer(s)&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">possession of Acquired Assets (</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, that notwithstanding anything to the contrary herein, (i) only those Contracts that are listed on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.13(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> shall be part of the Acquired </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-26-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Assets acquired by Buyer(s), and (ii) any and all equipment listed on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 5.1(a)(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> shall be part of the Excluded Assets)&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">a certificate of the Secretary of Seller, dated as of the Closing Date, attaching and certifying the (i) Organizational Documents of Seller, (ii) resolutions of the board of directors of Seller authorizing the execution and delivery by Seller of this Agreement and the Ancillary Agreements to which Seller is a party and the consummation of the transactions contemplated hereby and thereby, (iii) the incumbency and signatures of the Persons signing this Agreement and the Ancillary Agreements to which Seller is a party, and (iv) good standing certificates for Seller from its jurisdiction of organization and each jurisdiction in which Seller is qualified to do business&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">a counterpart signature page to the Bill of Sale signed by Seller&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">if applicable, all documentation necessary to obtain releases of all Liens (other than the Permitted Liens), including appropriate UCC termination statements&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">if applicable, payoff and release letters from the holders of the Debt set forth on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 5.1(e)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> that (i) reflect the amounts required in order to pay in full such Debt and (ii) provide that, upon payment in full of the amounts indicated, all Liens with respect to the assets of the Seller shall be terminated and of no further force and effect, together with UCC-3 termination statements with respect to the financing statements filed against the assets of the Seller by the holders of such Liens&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">if applicable, any Consent or Order required to be obtained or made in connection with the execution and delivery of this Agreement or the performance of the transactions contemplated herein and any Consent required under any Contract or Permit set forth on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 5.1(f)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">a counterpart signature page to the Franchise Agreements&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">a counterpart signature page to the Pro-Ration Amendment, the FA Term Alignment Amendment, the Refresh Amendment, the National Marketing Fund and Local Marketing Commitment Amendment, the Guaranty Amendment, and the Franchise Agreement Transfer Amendment&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">a counterpart signature page to the Development Agreement&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">a counterpart signature page to each Assignment and Assumption of Lease&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Seller Closing Certificate, stating that, as of the Closing, all of Seller&#8217;s representations and warranties are true and correct, all Seller&#8217;s conditions precedent have been satisfied and all Seller&#8217;s covenants have been duly performed. Certification of TTM EBITDA to the best of Seller&#8217;s knowledge, signed by Seller and accompanied by supporting financial workpapers&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">all other instruments and documents required by this Agreement to be delivered by the Seller to Buyer(s), and such other instruments and documents which Buyer(s) or its counsel may reasonably request to effectuate the transactions contemplated hereby.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">All such agreements, documents and other items shall be in form and substance satisfactory to Buyer(s).  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">5.2&#160;&#160;&#160;&#160;Closing Deliveries of Buyer(s)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  At or prior to the Closing, Buyer(s) shall deliver to Seller&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">a certificate from a duly authorized officer of Buyer(s), dated as of the Closing Date, attaching and certifying (i) the Organizational Documents of Buyer(s), (ii) the authorizing resolutions of Buyer(s), and (iii) the incumbency and signatures of the Persons signing this Agreement and the other Ancillary Agreements to which Buyer(s) is a party&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">counterpart signature pages, signed by Buyer(s), to&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">the Bill of Sale&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">the Franchise Agreements&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">the Pro-Ration Amendment, the FA Term Alignment Amendment, the Refresh Amendment, the National Marketing Fund and Local Marketing Commitment Amendment, the Guaranty Amendment, and the Franchise Agreement Transfer Amendment&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">the Development Agreement&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">each Assignment and Assumption of Lease&#59; and</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Buyer(s) Closing Certificate, stating that, as of the Closing, all of Buyer(s)&#8217;s representations and warranties are true and correct, all Buyer(s)&#8217;s conditions precedent have been satisfied and all Buyer(s)&#8217;s covenants have been duly performed.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">all other instruments and documents required by this Agreement to be delivered by Buyer(s) to Seller, and such other instruments and documents which Seller or their counsel may reasonably request to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-27-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">effectuate the transactions contemplated hereby.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">All such agreements, documents and other items shall be in form and substance satisfactory to the Seller.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE 6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">COVENANTS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">6.1&#160;&#160;&#160;&#160;Conduct of Business Prior to the Closing</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  From the date hereof until the Closing, except as otherwise provided in this Agreement or consented to in writing by Buyer(s) (which consent shall not be unreasonably withheld or delayed), Seller shall&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(a) conduct the Businesses in the ordinary course of business consistent with past practice&#59; and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(b) use commercially reasonable efforts to maintain and preserve intact its current business organization, operations, and franchise, and to preserve the rights, franchises, goodwill, and relationships of its employees, customers, lenders, suppliers, regulators, and others having relationships with the Businesses.  Without limiting the foregoing, from the date hereof until the Closing Date, Seller shall&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Preserve and maintain all Permits required for the conduct of the Businesses as currently conducted or the ownership and use of the Acquired Assets&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Pay the debts, Taxes, and other obligations of the Businesses when due, unless contested by lawful proceedings and with adequate reserves set aside&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Continue to collect Accounts Receivable in a manner consistent with past practice, without discounting such Accounts Receivable except in a manner consistent with past practice&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Maintain the properties and assets included in the Acquired Assets in the same condition as they were on the date of this Agreement, subject to reasonable wear and tear&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Continue in full force and effect without modification all Insurance Policies, except as required by applicable Law&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Take commercially reasonable actions to defend and protect the Acquired Assets from infringement or usurpation&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Perform all of its obligations under all Assigned Contracts in the ordinary course consistent with past practice&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Maintain the books and records in accordance with past practice&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Comply in all material respects with all Laws applicable to the conduct of the Business or the ownership and use of the Acquired Assets&#59; and</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Not take or permit any action that would cause any of the changes, events, or conditions described in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 3.7(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> to occur.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">6.2&#160;&#160;&#160;&#160;Due Diligence &#38; Access to Information</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(a)        Buyer(s)&#8217;s due diligence period will terminate fifteen (15) days prior to the Closing Date Deadline, subject to the terms and conditions, including any conditions precedent, set forth in this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Due Diligence Period</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(b)       During the Due Diligence Period, Seller shall&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(i)        afford Buyer(s) and its Representatives reasonable access to tour the clinics and the right to inspect all of the properties, assets, premises, books and records, Contracts, and other documents and data related to the Businesses at reasonable times and with reasonable prior notice&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(ii)       furnish Buyer(s) and its Representatives with such financial, operating, and other data and information related to the Businesses as Buyer(s) or any of its Representatives may reasonably request (which shall include, but not be limited to, immediately upon the Parties executing this Agreement, providing Buyer(s) and its representatives with a complete and accurate census of all employees of the Clinics and their emails and phone numbers)&#59; and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(iii)      instruct the Representatives of Seller to cooperate with Buyer(s) in its investigation of the Businesses.  Any investigation shall be conducted in such manner as not to interfere unreasonably with the conduct of the Businesses.  No investigation by Buyer(s) or other information received by Buyer(s) shall operate as a waiver or otherwise affect any representation, warranty or agreement given or made by Seller in this Agreement. Notwithstanding any other provision of this Agreement, upon the Parties execution of this Agreement, Buyer(s) and&#47;or its Representatives may reasonably communicate with any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-28-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">employee of the Clinics to offer employment to any such employee as of the Closing and to begin the employment onboarding process with respect to such employee, all without further notice to Seller. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">6.3&#160;&#160;&#160;&#160;No Solicitation of Other Bids</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(a)        For a period of sixty (60) days after the Effective Date of this Agreement or the Closing, whichever occurs first (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Exclusivity Period</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), pursuant to </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Article 10</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, Seller shall not authorize or permit any of its Affiliates or any of its or their Representatives to, directly or indirectly, do any or all of the following&#58; (i) encourage, solicit, initiate, facilitate, or continue inquiries regarding an Acquisition Proposal&#59; (ii) enter into discussions or negotiations with, or provide any information to, any Person concerning a possible Acquisition Proposal&#59; or (iii) enter into any agreements or other instruments (whether or not binding) regarding an Acquisition Proposal.  For purposes hereof, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Acquisition Proposal</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any inquiry, proposal or offer from any Person (other than Buyer(s) or any of its Affiliates) relating to the direct or indirect disposition, whether by sale, merger or otherwise, of all or any portion of Seller, the Business, or the Acquired Assets.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(b)        In addition to the other obligations under this </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 6.3</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, after the Exclusivity Period, Seller shall promptly (and in any event within five (5) Business Days after receipt thereof by Seller or its Representatives) advise Buyer(s) orally and in writing of any Acquisition Proposal, any request for information with respect to any Acquisition Proposal, or any inquiry with respect to or which could reasonably be expected to result in an Acquisition Proposal, and the material terms and conditions of such request, Acquisition Proposal or inquiry.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">6.4&#160;&#160;&#160;&#160;Notice of Certain Events</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(a)        From the date hereof until the Closing, Seller shall promptly notify Buyer(s) in writing of&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(i)         Any fact, circumstance, event, or action the existence, occurrence, or taking of which (A) has had, or could reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (B) has resulted in, or could reasonably be expected to result in, any representation or warranty made by Seller hereunder not being true and correct in any material respect, or (C) has resulted in, or could reasonably be expected to result in, the failure of any of the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 7.2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> to be satisfied&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(ii)        Any notice or other communication from any Person alleging that the consent of such Person is or may be required in connection with the transactions contemplated by this Agreement&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(iii)       Any notice or other communication from any Governmental Authority in connection with the transactions contemplated by this Agreement&#59; and</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(iv)       Any Actions commenced or, to Seller&#8217;s Knowledge, threatened against, relating to, or involving or otherwise affecting the Business, the Acquired Assets or the Assumed Liabilities that, if pending on the date of this Agreement, would have been required to have been disclosed pursuant to </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4.1(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> or that relates to the consummation of the transactions contemplated by this Agreement.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">6.5&#160;&#160;&#160;&#160;No Waiver</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. Buyer(s)&#8217;s receipt of information from Seller shall not operate as a waiver or otherwise affect any representation, warranty or agreement given or made by Seller in this Agreement and shall not be deemed to amend or supplement any of the Schedules.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  All information provided by Seller to Buyer(s) shall be subject to the following confidentiality obligations (which shall terminate upon the Closing of the Transaction)&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(a)        The information Seller furnishes or has furnished to Buyer(s) or its agents may include information that is nonpublic, confidential, or proprietary in nature (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Information</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). Buyer(s) agrees to use the Information solely in connection with performing his due diligence and consummating the Transaction contemplated by this Agreement. Buyer(s) will transmit the Information only to its representatives who need to know it as determined by Buyer(s) in its </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-29-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">discretion.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(b)        Buyer(s) will maintain the confidentiality of all Information. If the Transaction is not consummated, Buyer(s) shall redeliver to Seller all documents or papers (including other media for electronic storage of information) relating to any Information pertaining to Seller that are in the possession or under the control of Buyer(s) without making copies or summaries of any such Information. If the Transaction is completed, Buyer(s) may retain the Information. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(c)        Buyer(s) agrees that if it should violate the provisions of this Section, Seller may suffer irreparable harm if Buyer(s) fails to comply with any of the obligations under this Agreement and that monetary damages will be inadequate to compensate Seller for such breach. Accordingly, Buyer(s) agrees that Seller shall be entitled, in addition to any other remedies available to Seller either at law or in equity, to injunctive relief to enforce the terms of this Agreement.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Seller agrees to maintain as confidential any non-public information disclosed to it by Buyer(s) and his authorized agents and, if the Transaction is not consummated, Seller will return all confidential information to Buyer(s). Seller agrees not to use any confidential information disclosed to it by Buyer(s) for any purpose other than determining the feasibility of this Transaction. With respect to Buyer(s), Seller agrees to abide by rules identical to those described herein.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">6.7&#160;&#160;&#160;&#160;Waiver of Transfer Fees</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. Seller covenants and agrees to waive any and all applicable transfer fees associated with a traditional franchise license sale. The Buyer(s) shall remain obligated to remit the standard Franchise Fees for the twenty-two (22) Clinics.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">6.8&#160;&#160;&#160;&#160;Lease Assignment Costs</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Seller shall pay, and shall be solely responsible for, all costs and expenses relating to any assignment of any Lease regardless of whether such assignment became effective before, on, or after the Closing. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE 7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">CONDITIONS TO CLOSING</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">7.1&#160;&#160;&#160;&#160;Conditions to Obligations of All Parties</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  The obligations of each party to consummate the transactions contemplated by this Agreement shall be subject to the fulfillment, at or prior to the Closing, of each of the following conditions&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(a)        No Governmental Authority shall have enacted, issued, promulgated, enforced or entered any Law (whether temporary, preliminary, or permanent), that is then in effect and that enjoins, restrains, makes illegal, or otherwise prohibits the consummation of the transactions contemplated by this Agreement.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(b)        All material consents of, or registrations, declarations, or filings with, any Governmental Authority legally required for the consummation of the transactions contemplated by this Agreement shall have been obtained or filed in form and substance reasonable satisfactory to Buyer(s) and Seller.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(c)        No temporary or permanent restraining order or preliminary or permanent injunction or other order shall have been issued by, any Governmental Authority, that would prohibit the consummation of the transactions contemplated by this Agreement.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(d)       Seller shall seek assignment approval from the twenty-two (22) landlords, for the Leased Real Property set forth on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.11(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, with the intent to have all leases assigned by the Closing. In recognition of the fact that the applicable twenty-two (22) landlords may not timely provide formal assignment approvals, the Parties agree that as a Closing condition, Seller must obtain, with the Buyer(s)&#8217;s cooperation, and at least one (1) week prior to the Closing, lease assignments or landlord consents.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">If Buyer(s) has executed a Promissory Note, if Seller obtains at least seventeen (17) of the twenty-two (22)  leases (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Lease Assignment Threshold</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), Buyer(s) agrees to pay the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-30-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">amount remaining due on the Promissory Note.  Such payment shall be due within five (5) days from Seller achieving the Lease Assignment Threshold. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">In the event the Lease Assignment Threshold is not met, the following shall occur&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">The Parties will complete a Closing for the Clinics that have secured a Lease Assignment, and the Parties shall continue to obtain the remaining lease assignments as soon as practicable, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">For the Clinics that are located in a state </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">without</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> professional corporation requirements for the provision of chiropractic care, Seller and Buyer(s) shall execute the management Agreement attached hereto as Exhibit L-1 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Management Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) which shall terminate for any Clinic once a Lease Assignment is obtained and Closing occurs, and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">For the Clinics that are located in a state </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">with</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> professional corporation requirements for the provision of chiropractic care and Buyer(s) is not a professional corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">P.C.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), Seller and Buyer(s)&#8217;s P.C. shall execute the P.C. management agreement attached hereto as Exhibit L-2 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">P.C. Management Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), and Seller and Buyer(s) shall execute the sub management agreement attached hereto as Exhibit L-3 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Submanager Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), both of which shall terminate for any Clinic once a Lease Assignment is obtained and Closing occurs.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Prior to the Closing, Seller shall have worked in good faith with Buyer(s), and with Buyer(s)&#8217;s meaningful input and consent, to obtain from the landlord for the Pooler Clinic Number 4018 renewal options or extensions of the existing lease term, on terms substantially consistent with the current lease or otherwise reasonably acceptable to Buyer(s). </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">7.2.      </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Conditions to Obligations of Buyer(s)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. The obligations of Buyer(s) to consummate the transactions contemplated by this Agreement shall be subject to the fulfillment or Buyer(s)&#8217;s waiver, at or prior to the Closing, of each of the following conditions&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(a)        The representations and warranties of Seller contained in this Agreement, the Ancillary Documents, and any certificate or other writing delivered pursuant hereto shall be true and correct in all respects (in the case of any representation or warranty qualified by materiality or Material Adverse Effect) or in all material respects (in the case of any representation or warranty not qualified by materiality or Material Adverse Effect) on and as of the date hereof and on and as of the Closing Date with the same effect as though made at and as of such date (except those representations and warranties that address matters only as of a specified date, the accuracy of which shall be determined as of that specified date in all respects).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(b)        Seller shall have duly performed and complied in all material respects with all agreements, covenants, and conditions required by this Agreement and each of the Ancillary Documents to be performed or complied with by Seller prior to or on the Closing Date.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(c)        No Action shall have been commenced against Buyer(s) or Seller which could be reasonably foreseen to prevent the Closing.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(d)       The Required Consents and such other consents from the parties to the Assigned Contracts which require consent to the transfer of the rights of Seller thereunder to Buyer(s) shall have been received and executed counterparts thereof shall have been delivered to Buyer(s) at or prior to the Closing&#59; provided, however, that with regard to the Premises, Closing can occur once the Lease Assignment Threshold is met.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(e)        From the date of this Agreement there shall not have occurred any Material Adverse Effect, nor shall any event or events have occurred that, individually or in the aggregate, with or without the lapse of time, is reasonably likely to result in a Material Adverse Effect.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(f)        Seller shall have delivered to Buyer(s) duly executed counterparts to the Ancillary Documents and such other documents and deliveries set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 5.1</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(g)        Buyer(s) shall have received all Permits that are necessary for it to conduct the Business as conducted by Seller as of the Closing Date.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(h)        As applicable, all Encumbrances (other than Permitted Encumbrances) relating to the Acquired Assets shall have been released in full, and Seller shall have delivered to Buyer(s) written evidence, in form satisfactory to Buyer(s) in its reasonable discretion, of the release of such Encumbrances.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(i)         </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-31-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Buyer(s) shall have received a certificate, dated the Closing Date and signed by a duly authorized officer of Seller, that each of the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 7.2(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 7.2(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> have been satisfied, and such certificate shall be attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Exhibit G</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Seller Closing Certificate</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(j)         Buyer(s) shall have received a certificate of a duly authorized officer of Seller certifying that attached thereto are true and complete copies of resolutions adopted by the appropriate officers&#47;directors of Seller authorizing the execution, delivery, and performance of this Agreement and the Ancillary Documents and the consummation of the transactions contemplated hereby and thereby, by Seller, and that all such resolutions are in full force and effect and are all the resolutions adopted in connection with the transactions contemplated hereby and thereby.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(k)        Buyer(s) shall have received a certificate of an officer of Seller certifying the names and signatures of the officers of Seller authorized to sign this Agreement, the Ancillary Documents and the other documents to be delivered hereunder and thereunder. Seller shall have received a certificate pursuant to Treasury Regulations Section 1.1445-2(b) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">FIRPTA Certificate</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) that Buyer(s) are not foreign persons within the meaning of Section 1445 of the Code duly executed by Buyer(s).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(m)       Seller shall have delivered to Buyer(s) such other documents or instruments as Buyer(s) reasonably requests and are reasonably necessary to consummate the transactions contemplated by this Agreement.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(n)       Buyer(s) shall purchase the Acquired Assets of all twenty-two (22) Clinics, as such, this Agreement is expressly conditioned upon the acquisition of the Acquired Assets of all Clinics and is in no way to be interpreted as allocating value to, or offering to acquire any specific clinic, singularly.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(o)        The Parties shall have mutually agreed on the final form of all Exhibits and shall have mutually agreed on the final drafts of the Schedules to be incorporated into this Agreement at the Closing.    </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">7.3.      </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Conditions to Obligations of Seller</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. The obligations of Seller to consummate the transactions contemplated by this Agreement shall be subject to the fulfillment or Seller&#8217;s waiver, at or prior to the Closing, of each of the following conditions&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(a)        The representations and warranties of Buyer(s) contained in this Agreement, the Ancillary Documents, and any certificate or other writing delivered pursuant hereto shall be true and correct in all respects (in the case of any representation or warranty qualified by materiality or Material Adverse Effect) or in all material respects (in the case of any representation or warranty not qualified by materiality or Material Adverse Effect) on and as of the date hereof and on and as of the Closing Date with the same effect as though made at and as of such date (except those representations and warranties that address matters only as of a specified date, the accuracy of which shall be determined as of that specified date in all respects).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(b)        Buyer(s) shall have duly performed and complied in all material respects with all agreements, covenants, and conditions required by this Agreement and each of the Ancillary Documents to be performed or complied with by Buyer(s) prior to or on the Closing Date.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(c)        No Action shall have been commenced against Buyer(s) or Seller which could be reasonably foreseen to prevent the Closing.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(d)       The Required Consents and such other consents from the parties to the Assigned Contracts which require consent to the transfer of the rights of Seller thereunder to Buyer(s) shall have been received and executed counterparts thereof shall have been delivered to Buyer(s) at or prior to the Closing.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(e)        Buyer(s) shall have delivered to Seller duly executed counterparts to the Ancillary Documents and such other documents and deliveries set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 5.2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(f)        Seller shall have received a certificate, dated the Closing Date and signed by a duly authorized officer of Buyer(s), that each of the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 7.3(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> and </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 7.3(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> have been satisfied, and such certificate shall be attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Exhibit H</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Buyer(s) Closing Certificate</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(g)        Seller shall have received a certificate of a duly authorized officer of Buyer(s) certifying that attached thereto are true and complete copies of resolutions adopted by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-32-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">the board of directors of Buyer(s) authorizing the execution, delivery, and performance of this Agreement and the Ancillary Documents and the consummation of the transactions contemplated hereby and thereby, and that all such resolutions are in full force and effect and are all the resolutions adopted in connection with the transactions contemplated hereby and thereby.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(h)        Seller shall have received a certificate of an officer of Buyer(s) certifying the names and signatures of the officers of Buyer(s) authorized to sign this Agreement, the Ancillary Documents and the other documents to be delivered hereunder and thereunder.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Seller shall have received from Buyer(s) shall the executed Franchise Agreements, which Franchise Agreements shall include executed guaranty(s) from the beneficial owners of Buyer(s) severally guarantying the obligations of Buyer(s) under the Franchise Agreements. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(j) Buyer(s) have provided all documents requested by Seller to complete an assessment of the Buyer(s) and the Guarantors and such financial assessment meets Seller&#8217;s then-current financial qualifications for Seller&#8217;s franchisees.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE 8</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">REMEDIES FOR BREACHES OF THIS AGREEMENT</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">8.1&#160;&#160;&#160;&#160;Indemnification by Seller</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Subject to the terms and conditions of this </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Article 8</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, Seller will indemnify and hold harmless Buyer(s) and each of its Affiliates, and its successors and assigns (the &#8220;Buyer(s) Indemnitees&#8221;) from and against the entirety of any Adverse Consequences that any Buyer(s) Indemnitee may suffer or incur (including any Adverse Consequences they may suffer or incur after the end of the survival period set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8.3</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> below, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> that an indemnification claim with respect to such Adverse Consequence is made pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Article 8</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> prior to the end of any applicable survival period set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8.3</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> below) resulting from, arising out of, relating to, in the nature of, or caused by (i) any breach or inaccuracy of any representation or warranty made in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Article 3</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> or made by Seller in any Ancillary Agreement&#59; (ii) any breach of any covenant or agreement of the Seller in this Agreement or in any Ancillary Agreement&#59; (iii) Indemnified Taxes&#59; or (iv) any Excluded Liability. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Seller agrees that it shall pay and otherwise fully satisfy and discharge all Excluded Liabilities, and shall indemnify and hold all Buyer(s) Indemnitees harmless from, and shall reimburse all Buyer(s) Indemnitees for, all Adverse Consequences that any Buyer(s) Indemnitee may suffer or incur in connection with any Excluded Liabilities.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">8.2&#160;&#160;&#160;&#160;Indemnification by Buyer(s).  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Subject to the terms and conditions of this </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Article 8</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, Buyer(s) will indemnify and hold harmless Seller, their respective Affiliates, and their respective successors and assigns (the &#8220;Seller Indemnitees&#8221;) from and against the entirety of any Adverse Consequences they may suffer or incur (including any Adverse Consequences they may suffer or incur after the end of any applicable survival period, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> that an indemnification claim with respect to such Adverse Consequence is made pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Article 8</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> prior to the end of the survival period set forth in Section 8.3 herein) resulting from, arising out of, relating to, in the nature of, or caused by (a) any breach or inaccuracy of any representation or warranty made by Buyer(s) in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Article 2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> or in any Ancillary Agreement, (b) any breach of any covenant or agreement of Buyer(s) in this Agreement or in any Ancillary Agreement, or (c) any of the Acquired Assets including, without limitation, the Assumed Accounts Payable, Assumed </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-33-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Accounts Receivable,  Assumed Liabilities, Clinics, Leases, and the Premises, from and after the Closing Date.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">8.3&#160;&#160;&#160;&#160;Survival and Time Limitations.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> All representations, warranties, covenants and agreements of the Parties in this Agreement or any other certificate or document delivered pursuant to this Agreement will survive the Closing.  Seller will not have liability with respect to any claim under </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8.1(a) or Section 8.1(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> unless Buyer(s) notifies Seller of such a claim on or before the twenty-four (24) month anniversary of the Closing Date&#59;  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, that, notwithstanding the foregoing, any claim related Excluded Liabilities or to intentional or fraudulent breaches of the representations and warranties may be made by the Buyer(s) at any time without limitation.  Buyer(s) will have no liability with respect to any claim under </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8.2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">  unless the Seller notifies Buyer(s) of such a claim on or before the twenty-four (24) month anniversary of the Closing Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, that Buyer(s) shall have ongoing liability beyond the twenty-four (24) month anniversary of the Closing Date for any claim related to intentional or fraudulent breaches of the representations and warranties, and such claim may be made by the Seller at any time without limitation.  If Buyer(s) or Seller, as applicable, provides proper notice of a claim within the applicable time period set forth above, then liability for such claim will continue until such claim is resolved.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">8.4&#160;&#160;&#160;&#160;Limitation on Indemnification by Seller&#59; Payment by Seller</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">With respect to the matters described in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8.1(a)(i) &#8211; (ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, Seller will not have liability with respect to such matters until Buyer(s) Indemnitees have suffered aggregate Adverse Consequences by reason of all such breaches in excess of Two Hundred Fifty Thousand and NO&#47;100 US Dollars ($250,000.00) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Indemnification Threshold</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), after which point the Seller will be obligated to indemnify Buyer(s) Indemnitees from and against all Adverse Consequences from and including the first dollar&#59; provided, that the foregoing limitations shall not apply in respect of any Adverse Consequences relating to (i) Indemnified Taxes, (ii) breaches of the Excluded Liabilities, or (iii) any intentional misrepresentation or fraud.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">With respect to the matters described in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8.1(a)(i)-(iii),</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> the aggregate maximum liability of Seller shall be Eight Hundred and Seventy-Five Thousand NO&#47;100 US Dollars ($875,000.00) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Indemnification Cap</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, that, notwithstanding the foregoing, from and after the Closing, there is no limit on Seller&#8217;s liability resulting from any Adverse Consequences related to Excluded Liabilities or any intentional misrepresentation or fraud. To the extent Indemnified Taxes also constitute Excluded Liabilities, they shall be deemed Excluded Liabilities under this Article 8. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">From and after the Closing, subject to the Indemnification Cap set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> above, Seller shall promptly Buyer(s), in immediately available funds, all amounts due related to Adverse Consequences of Buyer(s) arising out of and subject to the limitations above. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">8.5&#160;&#160;&#160;&#160;Limitations on Indemnification by Buyer(s)&#59; Payment by Buyer(s)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">With respect to the matters described in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8.2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, Buyer(s) will have no liability with respect to such matters until Seller Indemnitees have suffered Adverse Consequences by reason of all such breaches in excess of the Indemnification Threshold, after which point Buyer(s) will be obligated to indemnify Seller Indemnitees from and against all Adverse Consequences from and including the first dollar&#59; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, that the foregoing limitations shall not apply in respect of any Adverse Consequences relating to  any intentional misrepresentation or fraud.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">With respect to the matters described in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8.2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, the aggregate maximum liability of Buyer(s) shall be the Indemnification Cap for </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">ALL</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> Seller indemnification claims, regardless of the number of Clinics implicated by an indemnification claim, or the number of total indemnification claims. The </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-34-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Indemnification Cap on aggregate maximum liability of Buyer(s) shall not apply in respect of any Adverse Consequences relating to (a) any intentional misrepresentation or fraud, or (b) the Purchase Price due hereunder. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">8.6&#160;&#160;&#160;&#160;Third-Party Claims</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">If a third party initiates a claim, demand, dispute, lawsuit or arbitration (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Third-Party Claim</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) against any Person (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Indemnified Party</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) with respect to any matter that the Indemnified Party might make a claim for indemnification against any Party (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Indemnifying Party</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) under this </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Article 8</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, then the Indemnified Party must promptly notify the Indemnifying Party in writing of the existence of such Third-Party Claim and must deliver copies of any documents served on the Indemnified Party with respect to the Third-Party Claim&#59; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, that any failure on the part of an Indemnified Party to so notify an Indemnifying Party shall not limit any of the obligations of the Indemnifying Party under this </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Article 8</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> (except to the extent such failure materially prejudices the defense of such proceeding).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Upon receipt of the notice described in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8.6(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, the Indemnifying Party will have the right to defend the Indemnified Party against the Third-Party Claim with counsel reasonably satisfactory to the Indemnified Party, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">provided</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, that (i) the Indemnifying Party notifies the Indemnified Party in writing within fifteen (15) days after the Indemnified Party has given notice of the Third-Party Claim that the Indemnifying Party will indemnify the Indemnified Party from and against the entirety of any Adverse Consequences the Indemnified Party may suffer resulting from, arising out of, relating to, in the nature of, or caused by the Third-Party Claim, (ii) the Indemnifying Party provides the Indemnified Party with evidence reasonably acceptable to the Indemnified Party that the Indemnifying Party will have the financial resources to defend against the Third-Party Claim and fulfill its indemnification obligations hereunder, (iii) the Third-Party Claim involves only money damages and does not seek an injunction or other equitable relief, (iv) settlement of, or an adverse judgment with respect to, the Third-Party Claim is not, in the good faith judgment of the Indemnified Party, likely to establish a precedential custom or practice adverse to the continuing business interests or the reputation of the Indemnified Party, and (v) the Indemnifying Party conducts the defense of the Third-Party Claim actively and diligently.  The Indemnifying Party will keep the Indemnified Party apprised of all material developments, including settlement offers, with respect to the Third-Party Claim and permit the Indemnified Party to participate in the defense of the Third-Party Claim.  So long as the Indemnifying Party is conducting the defense of the Third-Party Claim in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8.6(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, the Indemnifying Party will not be responsible for any attorneys&#8217; fees or other expenses incurred by the Indemnified Party regarding the defense of the Third-Party Claim.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">In the event that any of the conditions under </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8.6(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> is or becomes unsatisfied, however, (i) the Indemnified Party may defend against, and consent to the entry of any judgment on or enter into any settlement with respect to, the Third-Party Claim in any manner it may reasonably deem appropriate subject to the commercially reasonable approval of the Indemnifying Party, which shall not be unreasonably withheld, conditioned or delayed, (ii) the Indemnifying Parties will reimburse the Indemnified Party promptly and periodically for the costs of defending against the Third-Party Claim (including reasonable attorneys&#8217; fees and expenses), and (iii) the Indemnifying Parties will remain responsible for any Adverse Consequences the Indemnified Party may suffer resulting from, arising out of, relating to, in the nature of, or caused by the Third-Party Claim to the fullest extent provided in this</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline"> Article 8</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Except in circumstances described in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8.6(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, neither the Indemnified Party nor the Indemnifying Party will consent to the entry of any judgment or enter into any settlement with respect to the Third-Party Claim without the prior written consent of the other party, which consent will not be unreasonably withheld or delayed.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-35-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">8.7&#160;&#160;&#160;&#160;Other Indemnification Matters</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  All indemnification payments under this </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Article 8 </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">will be deemed adjustments to the Cash Payment for Tax purposes, unless otherwise required by Law.  For purposes of determining whether there has been any misrepresentation or breach of a representation or warranty, and for purposes of determining the amount of Adverse Consequences resulting therefrom, all qualifications or exceptions in any representation or warranty relating to or referring to the terms &#8220;material&#8221;, &#8220;materiality&#8221;, &#8220;in all material respects&#8221;, &#8220;Material Adverse Effect&#8221; or any similar term or phrase shall be disregarded, it being the understanding of the Parties that for purposes of determining liability under this</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline"> Article 8</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, the representations and warranties of the Parties contained in this Agreement shall be read as if such terms and phrases were not included in them.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE 9</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">TAX MATTERS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">The following provisions will govern the allocation of responsibility as between Buyer(s) and Seller for certain tax matters following the Closing Date&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">9.1&#160;&#160;&#160;&#160;Tax Indemnification</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  In addition to the indemnification provisions of</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline"> Article 8</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, Seller shall be liable for, and indemnify and hold Buyer(s) Indemnitees harmless from all Taxes of Seller.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">9.2&#160;&#160;&#160;&#160;Straddle Period</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  In the case of any Straddle Period, the amount of any Taxes based on or measured by income, receipts, or payroll for the Pre-Closing Tax Period shall be determined based on an interim closing of the books as of the close of business on the Closing Date, and the amount of other Taxes for a Straddle Period which relate to the Pre-Closing Tax Period shall be deemed to be the amount of such Tax for the entire taxable period multiplied by a fraction the numerator of which is the number of days in the taxable period ending on the Closing Date and the denominator of which is the number of days in the Straddle Period.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">9.3&#160;&#160;&#160;&#160;Cooperation on Tax Matters</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Buyer(s) and Seller will cooperate, as and to the extent reasonably requested by the other Party, in connection with the filing and preparation of Tax Returns and any Proceeding related thereto.  Such cooperation will include the retention and (upon the other Party&#8217;s request) the provision of records and information that are reasonably relevant to any such Proceeding and making employees available on a mutually convenient basis to provide additional information and explanation of any material provided hereunder.  Buyer(s) and Seller will retain all books and records with respect to Tax matters pertinent to the Clinics relating to any Tax period beginning before the Closing Date until thirty (30) days after the expiration of the statute or period of limitations of the respective Tax periods.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE 10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">TERMINATION</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">10.1&#160;&#160;&#160;&#160;Termination</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">This Agreement may be terminated at any time prior to the Closing&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">By the mutual written consent of Seller and Buyer(s)&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">By Buyer(s) by written notice to Seller if&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Buyer(s) is not then in material breach of any provision of this Agreement and there has been a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-36-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">breach, inaccuracy in, or failure to perform any representation, warranty, covenant, or agreement made by Seller pursuant to this Agreement that would give rise to the failure of any of the conditions specified in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:112%;text-decoration:underline">Article 7</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> and such breach, inaccuracy, or failure has not been cured by Seller within ten (10) days of Seller&#8217;s receipt of written notice of such breach from Buyer(s)&#59; or</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">any of the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:112%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> or </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:112%;text-decoration:underline">Section 7.2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> shall not have been, or if it becomes apparent that any of such conditions will not be, fulfilled by July 15</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, 2025, unless such failure shall be due to the failure of Buyer(s) to perform or comply with any of the covenants, agreements or conditions hereof to be performed or complied with by it prior to the Closing&#59;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">by Seller by written notice to Buyer(s) if&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Seller is not then in material breach of any provision of this Agreement and there has been a breach, inaccuracy in or failure to perform any representation, warranty, covenant, or agreement made by Buyer(s) pursuant to this Agreement that would give rise to the failure of any of the conditions specified in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:112%;text-decoration:underline">Article 7</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> and such breach, inaccuracy or failure has not been cured by Buyer(s) within ten (10) days of Buyer(s)&#8217;s receipt of written notice of such breach from Seller&#59; or</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">any of the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:112%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> or </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:112%;text-decoration:underline">Section 7.3</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> shall not have been, or if Seller reasonably determines in good faith and in consultation with Buyer(s) that any of such conditions will not be, fulfilled by September 30, 2025, unless such failure shall be due to the failure of Seller to perform or comply with any of the covenants, agreements or conditions hereof to be performed or complied with by it prior to the Closing&#59; or</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">by Buyer(s) or Seller in the event that (i) there shall be any Law that makes consummation of the transactions contemplated by this Agreement illegal or otherwise prohibited or (ii) any Governmental Authority shall have issued a Governmental Order restraining or enjoining the transactions contemplated by this Agreement, and such Governmental Order shall have become final and non-appealable.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">10.2     </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">10.2&#160;&#160;&#160;&#160;Effect of Termination</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> In the event of termination of this Agreement as provided in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 10.1</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, this Agreement shall forthwith become void and there shall be no liability on the part of any Party except as to the provisions relating to confidentiality, public announcements, this </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:112%;text-decoration:underline">Section 10.2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, and </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:112%;text-decoration:underline">Article 12</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, and (b) that nothing herein shall relieve any party from liability for any breach of the foregoing surviving provisions of this Agreement or any agreement made as of the date hereof or subsequent thereto pursuant to this Agreement.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">10.3     </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Bankruptcy Proceedings</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. If within ninety-one (91) days after the payment of the Purchase Price clears the Seller&#8217;s bank account, the Buyer(s) becomes the subject of a voluntary or involuntary bankruptcy petition (as set forth in any state proceeding or the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">United States Bankruptcy Code</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; (e.g., </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Title 11</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> of the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">United States Code</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), and the applicable &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Federal Rules of Bankruptcy Procedure</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), or makes an assignment for the benefit of creditors, and the Seller is required to disgorge any portion or all of the Purchase Price, then this Agreement shall be of no force or effect whatsoever, and the Seller shall immediately have the right to avail itself of all remedies under this Agreement, or any remedies available at law or in equity. In the event an attempt is made by a trustee, debtor, or any other party which alleges standing to recover all or any portion of the Purchase Price as a preferential transfer under section of the United States Bankruptcy Code or similar state or federal statute, the Seller shall immediately be released from all of its obligations herein, and recover from the Buyer(s) and the Guarantors all monies owed to the Seller under this Agreement, less any portion that is </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">not</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> recovered as a preferential transfer.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE 11  </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">DEFINITIONS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-37-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Acquired Assets</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means all right, title, and interest in and to all of the assets of Seller that relate to any Clinic, including but not limited to&#58; (a) all Assumed Accounts Receivable to the extent not collected prior to the Closing&#59; (b) all prepayments, prepaid expenses or other deferred items, including those arising under any Contract listed in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.13(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, (c) all machinery, equipment, vehicles, supplies and inventory, including, but not limited to all tangible personal property listed on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.6(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#59; (d) all Contracts listed on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.13(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, including all rights and benefits under any such Contract, all franchise rights (including all rights under the Franchise Agreement(s), personal property lease, real property lease, purchase option, customer order, purchase order, plan, instrument, document, commitment, arrangement, undertaking or authorization of each Clinic&#59; (e) all Permits relating to operation of the Businesses by each Clinic&#59; (f) all rights and benefits under all insurance policies (except as related to Employee Benefit Plans)&#59; (g) all computer programs (including any licenses to such items licensed by each Clinic), subject to the terms of applicable software agreements&#59; (h) all logs, client lists, books of insurance business, expiration lists, customer and supplier lists, customer relationships, drawings, and specifications, creative materials, business and financial records and files (other than original company records and minute books), employee files, data and books of account, payroll, personnel and medical records, whether printed or computerized&#59; (i) all intangible rights and goodwill of Seller relating to each Clinic&#59; (j) all Intellectual Property and other general intangibles of Seller relating to each Clinic&#59; telephone numbers, facsimile numbers of each Clinic, and the internet addresses and e-mail addresses of employees of Seller who work for any Clinic&#59; (k) all advertising and marketing materials and supplier information&#59; (l) all rights, causes of action, rights of recovery, set off and claims, counterclaims, credits, rights and interests, rights to indemnification or similar rights, known or unknown, matured or unmatured, assumed or contingent, against third parties&#59; (k) all security or other deposits relating to any of the foregoing&#59; and (l) all other tangible and intangible assets, wherever located&#59; provided, however, in each case, that the Acquired Assets shall not include the Excluded Assets.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">&#8220;Adverse Consequences&#8221;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> means all actions, suits, proceedings, hearings, investigations, charges, complaints, claims, demands, Orders, dues, penalties, fines, costs, amounts paid in settlement, liabilities, obligations, Taxes, Liens, losses, damages, deficiencies, costs of investigation, court costs, and other expenses (including interest, penalties and reasonable attorneys&#8217; fees and expenses, whether in connection with Third Party Claims or claims among the Parties related to the enforcement of the provisions of this Agreement).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">&#8220;Affiliate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> means, with respect to the Person to which it refers, (a) a Person that directly or indirectly, through one or more intermediaries, controls, is controlled by or is under common control with, such Person, (b) any officer, director, manager or member of such Person, (c) any parent, sibling, descendant or spouse of such Person or of any of the Persons referred to in clauses (a) and (b), and (d) any corporation, limited liability company, general or limited partnership, trust, association or other business or investment entity that directly or indirectly, through one or more intermediaries controls, is controlled by or is under common control with any of the foregoing individuals.  For purposes of this definition, the term &#8220;control&#8221; of a Person shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies, whether through the ownership of voting securities, by contract or otherwise.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Agreement&#8221; has the meaning set forth in the preface above.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-38-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Allocation Schedule</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 1.5 </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">above.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Ancillary Agreements</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means all of the agreements and instruments being executed and delivered pursuant to this Agreement.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Assignment and Assumption of Lease</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means certain Assignment and Assumption of Lease dated as of the date hereof for the Premises, between the landlords under the Leases outlined on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.11(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> and Seller and Buyer(s) and attached hereto in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Exhibit E</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Assumed Accounts Payable</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means amounts related to the provision of services that are included as account payables on the books of each Clinic, that are payable to Persons other than Affiliates of Seller, which arose in the ordinary course of business, and only to the extent accrued for and included as a current liability and assumed, in writing, by Buyer(s).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Assumed Accounts Receivable</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means all amounts owed to each Clinic any of its customers or clients arising from the provision of services to such customers or clients by each Clinic whether said amounts are billed or unbilled or recorded on the books of Seller.  For purposes hereof, all Assumed Accounts Receivable are deemed to arise immediately upon the provision of such services by each Clinic to a customer or client.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Assumed Liabilities</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Assumed Liability</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means&#58; (a) Assumed Accounts Payable&#59; (b) all obligations of each Clinic under the Contracts listed on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 3.13(a)(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, either (i) to furnish goods, services, and other non-Cash benefits to another party after the Closing or (ii) to pay for goods, services, and other non-Cash benefits that another party will furnish to it after the Closing but, for the avoidance of doubt, not obligations for any breach or violation of such Contracts that occurred prior to the Closing&#59; (c) all deferred revenue of the Clinics relating to customer prepayments for services that should be accrued as of the Closing Date&#59;  (d) all liabilities and obligations arising out of operation of the Businesses or the use or ownership of the Acquired Assets arising from and after the Closing&#59; (e) Hired Employees as set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4.4</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#59; and (f) all deferred maintenance obligations relating to any equipment or under the Leases&#59; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, that the Assumed Liabilities shall not include the Excluded Liabilities, and </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, that no item shall constitute an Assumed Liability unless it is included on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 1.2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> as of the Closing. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Bill of Sale</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means that certain Assignment, Bill of Sale and Assumption of Liabilities Agreement dated as of the date hereof between Seller and Buyer(s) and attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Exhibit I</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Business</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; and &#8220;Businesses&#8221; means, with respect to each Clinic and all of the Clinics, collectively, the business of providing chiropractic, pain relief and preventative care.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Business Day</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any day that is not a Saturday, Sunday or any other day on which banks are required or authorized by Law to be closed where the Clinic is located</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Buyer(s)&#8221; has the meaning set forth in the preface above.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Buyer(s) Closing Certificate</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means that certain Buyer(s)&#8217;s certificate dated as of the date hereof, executed by Buyer(s) and attached hereto as Exhibit H.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-39-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Buyer(s) Indemnitees&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8.1(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> above.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Cap</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8.4(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> above.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">CARES Act</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means the Coronavirus Aid, Relief, and Economic Security Act (Pub. L. 116-136) and any administrative or other guidance published with respect thereto by any Governmental Entity (including IRS Notices 2020-22 and 2020-65), or any other Law or executive order or executive memorandum (including the Memorandum on Deferring Payroll Tax Obligations in Light of the Ongoing COVID-19 Disaster, dated August 8, 2020) intended to address the consequences of COVID-19 (in each case, including any comparable provisions of state, local or non-U.S. Law and including any related or similar orders or declarations from any Governmental Entity).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Cash&#8221; means the aggregate amount of cash and cash equivalents of Seller on a consolidated basis as determined in accordance with GAAP, consistently applied&#59; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, that if such aggregate amount of cash and cash equivalents is a negative number, then it shall include the amount of all fees, penalties or interest related to such negative amount of Cash.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Cash Consideration</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means as described herein. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Cash Payment&#8221; means the amount equal to (a) the Cash Consideration, plus (b) the Franchise Fees, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> the Debt Amount, if any.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Clinics&#8221; and&#47;or &#8220;Clinic&#8221; has the meaning set forth in the preface above.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Closing&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 1.7</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> above.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Closing Date&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 1.7</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> above.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;COBRA&#8221; means the requirements of Part 6 of Subtitle B of Title I of ERISA and Code &#167;4980B and of any similar state Law.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Code&#8221; means the Internal Revenue Code of 1986, as amended, and any applicable rules and regulations thereunder, and any successor to such statute, rules or regulations.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Company Insurance Agreements</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; has the meaning set forth herein.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any information concerning the business and affairs of Seller or the Business not already generally available to the public.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Consent</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means, with respect to any Person, any consent, approval, authorization, permission or waiver of, or registration, declaration or other action or filing with or exemption by such Person. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Contract</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any oral or written contract, obligation, understanding, commitment, lease, license, purchase order, bid or other agreement.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Copyrights</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; has the meaning set forth in the definition of </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> below.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-40-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Customer</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any Person who (a) purchased products or services from Seller (or its predecessors) during the three (3) years prior to the Closing Date, (b) was called upon or solicited by Seller (or its predecessors) during such three (3) year period, or (c) was a distributor, sales representative, agent or broker for Seller during such three (3) year period.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Data Security Requirements</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means, collectively, all of the following to the extent related to the collection, use, processing, storage, protection, transfer or disposition of data, or otherwise relating to privacy, data protection and security, anti-spam, security breach notification requirements applicable to the Seller&#58; (a) all applicable Laws, including any legislation currently in force in any jurisdiction worldwide concerning the protection or processing of personal data, such as the Children&#8217;s Online Privacy Protection Act (COPPA), the Computer Fraud and Abuse Act (CFAA), the California Consumer Privacy Act (CCPA), the Telephone Consumer Protection Act (TCPA), and the Data Protection Act 2018, the General Data Protection Regulation ((EU) 2016&#47;679), the Privacy and Electronic Communications (EC Directive) Regulations 2003 (SI 2426&#47;2003) and any legislation which implements the European Union&#8217;s Directive 95&#47;46&#47;EC and the Privacy and Electronic Communications Directive (2002&#47;58&#47;EC), each as amended, or which implements any other current legal act of the European Union or the United Kingdom concerning the protection and processing of personal data, as applicable&#59; (b) Seller&#8217;s own rules, policies and procedures&#59; (c) industry standards applicable to the industry in which Seller operates, such as the Payment Card Industry (PCI) Data Security Standards&#59; and (d) all contractual commitments of Seller.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Debt&#8221; means any (a) obligations relating to indebtedness for borrowed money, (b) obligations evidenced by bonds, notes, debentures or similar instruments, (c) obligations in respect of capitalized leases (calculated in accordance with GAAP), (d) the principal or face amount of banker&#8217;s acceptances, surety bonds, performance bonds or letters of credit (in each case whether or not drawn), (e) obligations for the deferred purchase price of property or services, including, without limitation, the maximum potential amount payable with respect to earnouts, purchase price adjustments or other payments related to acquisitions (other than current accounts payable to suppliers and similar accrued liabilities incurred in the Ordinary Course of Business, paid in a manner consistent with industry practice), (f) obligations under any existing interest rate, commodity or other swap, hedge or financial derivative agreement entered into by Seller prior to Closing, (g) Off-Balance Sheet Financing of Seller in existence immediately prior to the Closing, (h) other long term or non-ordinary course liabilities (i) any liabilities or obligations resulting from Seller&#8217;s deferral of any employment and payroll taxes pursuant to the CARES Act, (j) indebtedness or obligations of the types referred to in the preceding clauses (a) through (i) of any other Person secured by any Lien on any assets of Seller, even though Seller has not assumed or otherwise become liable for the payment thereof, and (k) obligations in the nature of guarantees of obligations of the type described in clauses (a) through (g) above of any other Person, in each case together with all accrued interest thereon and any applicable prepayment, redemption, breakage, make-whole or other premiums, fees or penalties.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Debt Amount</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means all Debt of Seller applicable to assets of any specific Clinic (on a consolidated basis) as of the Closing Date plus, without duplication, any amounts required to fully pay or otherwise satisfy all such Debt (including, but not limited to, any prepayment premium or penalty, breakage costs, accrued interest and costs and expenses), including any Deferred Payroll Taxes.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-41-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Deferred Payroll Taxes</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any &#8220;applicable employment taxes&#8221; (as defined in Section 2302(d)(1) of the CARES Act) that the Practice has elected to defer pursuant to Section 2302 of the CARES Act.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Designated Courts</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 12.10</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> below.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Disclosure Schedules&#8221; means the disclosure schedule, if any, delivered by Seller to Buyer(s) on the date hereof.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Employee Benefit Plan&#8221; means the plans listed in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.17(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> that include any (a) qualified or nonqualified Employee Pension Benefit Plan or deferred compensation or retirement plan, fund, program, or arrangement, (b) Employee Welfare Benefit Plan, (c) &#8220;employee benefit plan&#8221; (as such term is defined in ERISA &#167;3(3)), (d) equity-based plan, program, or arrangement (including any equity option, equity purchase, equity ownership, equity appreciation, phantom equity, or restricted equity plan) or (e) other retirement, severance, bonus, profit-sharing, incentive, health, medical, surgical, hospital, indemnity, welfare, sickness, accident, disability, death, apprenticeship, training, day care, scholarship, tuition reimbursement, education, adoption assistance, prepaid legal services, termination, unemployment, vacation or other paid time off, change in control, or other similar plan, fund, program, or arrangement, whether written or unwritten, that is sponsored, maintained, or contributed to, or required to be maintained or contributed to, by Seller or any ERISA Affiliate for the benefit of any present or former officers, employees, agents, managers, directors, consultants, or independent contractors of Seller or an ERISA Affiliate.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Employee Pension Benefit Plan&#8221; has the meaning set forth in ERISA &#167;3(2).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Employee Welfare Benefit Plan&#8221; has the meaning set forth in ERISA &#167;3(1).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Environmental, Health, and Safety Requirements&#8221; means all Laws and Orders concerning public health and safety, worker and occupational health and safety, natural resources and pollution or protection of the environment, including all those relating to the presence, use, production, generation, handling, transportation, treatment, storage, disposal, distribution, labeling, testing, processing, recycling, discharge, release, threatened release, control, or cleanup of any Hazardous Substances.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means the Employee Retirement Income Security Act of 1974, as amended.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">ERISA Affiliate</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any Person that, together with Seller, would be treated as a single employer under Section 414 of the Code or Section 4001 of ERISA and the regulations thereunder. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Excluded Assets</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; shall mean (a) Cash, (b) the articles of organization, operating agreements, buy sell agreements, qualifications to conduct business as a foreign company, arrangements with registered agents relating to foreign qualifications, taxpayer, and other identification numbers, seals, minute books, transfer books, blank interest certificates, and other documents relating to the formation, maintenance, and existence of each Clinic as a limited liability company, (c) all rights of Seller under this Agreement, (d) any assets of, or specifically relating to, any Employee </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-42-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Benefit Plans of Seller including Student Loans, (e) certain personal assets not related to the operations of the Clinics, (f) all Contracts not referenced on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.13(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, and (g) all equipment referenced on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.6(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Excluded Liabilities</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Excluded Liability</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any liability or obligation of Seller  for which Buyer(s) is alleged to be liable, that is not an Assumed Liability, including but not limited to, (a) any Debt of Seller, (b) all Transaction Expenses, (c) any obligation of Seller to indemnify or hold harmless any current or former director or officer of Seller for claims that relate to periods prior to the Closing, (d) any refunds, overpayments or other similar amounts payable to a Governmental Body or any other Person, (e) any liability or obligation related to any Excluded Asset, (f) all accounts payable that do not constitute Assumed Accounts Payable, (g) all accrued payroll or other ordinary course expenses that are not Assumed Employee Obligations including </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Seller&#8217;s Student Loan Repayments, (h) any liability or obligation of Seller for Taxes, including income, transfer, sales, use, and other Taxes arising in connection with the consummation of the transactions contemplated hereby, (i) any liability or obligation of Seller under their Employee Benefit Plans, and (j) any liability or obligation set forth on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 8(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, in each case (A) including, without limitation, any of the foregoing arising from matters disclosed to Buyer(s) or its Affiliates or otherwise referenced in this Agreement, and whether any related claim arises before or after the Closing and (B) whether such matters are known or unknown, contingent or otherwise, whether accrued, liquidated, matured or unmatured.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Excluded Representations</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8.3</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> above.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Federal Health Care Program</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any &#8220;federal health care program&#8221; as defined in 42. U.S.C. &#167;1320a-7b(f) (including Medicare, state Medicaid programs, state CHIP programs, TRICARE and similar or successor programs with or for the benefit of any Governmental Body).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Fiduciary&#8221; has the meaning set forth in ERISA &#167;3(21).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Financial Statements&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 3.7(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> above.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Franchise Agreement(s)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means the thirty (30) separate Franchise Agreements to be entered into between Buyer(s) and Seller in the form of the standard &#8220;The Joint Chiropractic Franchise Agreements&#8221; customarily entered into by franchisees of The Joint Corp.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Franchisor</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means Seller.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;GAAP&#8221; means generally accepted accounting principles in effect from time to time in the United States as set forth in pronouncements of the Financial Accounting Standards Board (and its predecessors) and the American Institute of Certified Public Accountants.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Governmental Authority</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any federal, state, local, or foreign government or political subdivision thereof, or any agency or instrumentality of such government or political subdivision, or any self-regulated organization or other non-governmental regulatory authority or quasi-governmental authority (to the extent that the rules, regulations or orders of such organization or authority have the force of Law), or any arbitrator, court or tribunal of competent jurisdiction.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-43-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Governmental Body</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any foreign or domestic federal, state or local government or quasi-governmental authority or any department, agency, subdivision, court or other tribunal of any of the foregoing.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Governmental Order</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any order, writ, judgment, injunction, decree, stipulation, determination or award entered by or with any Governmental Authority.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Hazardous Substances&#8221; means (a) petroleum or petroleum products, byproducts, flammable materials, explosives, radioactive materials, radon gas, lead-based paint, asbestos in any form, urea formaldehyde foam insulation, polychlorinated biphenyls (PCBs), transformers or other equipment that contain dielectric fluid containing PCBs, toxic mold or fungus of any kind or species, materials, or wastes, chemical substances, or mixtures, pesticides, noise, or radiation, (b) any chemicals or other materials or substances which are defined as or included in the definition of &#8220;hazardous substances,&#8221; &#8220;hazardous wastes,&#8221; &#8220;hazardous materials,&#8221; &#8220;toxic substances,&#8221; &#8220;toxic pollutants,&#8221; &#8220;contaminants,&#8221; &#8220;solid waste,&#8221; &#8220;pollutants,&#8221; or words of similar import under any applicable Environmental, Health, and Safety Requirements, and (c) any other chemical, material or substance exposure to which is prohibited, limited or regulated under any applicable Environmental, Health, and Safety Requirements.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Health Care Laws</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means all Laws and Orders relating to health care providers and facilities, participation in Federal Health Care Programs, the practice of medicine, institutional, equipment and professional licensure, pharmacology and the securing, administering and dispensing of drugs, devices, medicines and controlled substances, medical documentation, physician orders, medical record retention, laboratory services, surgery, radiation therapy, research, unprofessional conduct, fee-splitting, referrals, billing and submission of false or fraudulent claims, claims processing, quality, safety, medical necessity, appropriate use, medical privacy and security, patient confidentiality, informed consent, the hiring of employees or acquisition of services or supplies from Persons excluded from participation in Federal Health Care Programs, standards of care, quality assurance, risk management, utilization review, peer review, mandated reporting of incidents, occurrences, diseases and events and advertising or marketing of health care services, including Medicare, Medicaid, CHIP, the TRICARE laws (10 U.S.C. &#167; 1071, et seq.), the False Claims Act (31 U.S.C. &#167; 3729, et seq.), the Civil Monetary Penalties Law (42 U.S.C. &#167; 1320a -7a), federal and state anti-kickback statutes (including 42 U.S.C. &#167; 1320a 7b), federal and state referral laws (including 42 U.S.C. &#167; 1395nn), criminal false claims statutes (e.g. 18 U.S.C. &#167;&#167; 287 and 1001), the Program Fraud Civil Remedies Act of 1986 (31 U.S.C. &#167; 3801, et seq.), the Beneficiary Inducement Statute (42 U.S.C. &#167; 1320a-7 a(a)(5)), the Clinical Laboratory Improvement Act (42 U.S.C. &#167; 263a, et seq.), the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (P.L. 108-173, 117 Stat. 2066), the Food, Drug and Cosmetic Act of 1938 (21 U.S.C. &#167; 301, et seq.), the Prescription Drug Marketing Act of 1987 (P.L. 100-293, 102 Stat. 95), the Deficit Reduction Act of 2005 (P.L. 109-171, 120 Stat. 4), the Controlled Substances Act (21 U.S.C. &#167; 801, et seq.) and HIPAA, the rules and regulations promulgated under the foregoing statutes, and any other similar state and local Law.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">HIPAA</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means the Health Insurance Portability and Accountability Act of 1996, (42 U.S.C. &#167;1320d et seq.), as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, and any implementing regulations promulgated thereunder (including the Standards for Privacy of Individually Identifiable Health Information, the Security Standards for the Protection of Electronic Protected Health Information and the Standards for Electronic </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-44-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Transactions and Code Sets promulgated thereunder) and applicable state Laws regarding patient privacy and the security, use or disclosure of health care records.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Hired Employees</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4.4</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> above.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Improvements&#8221; means all buildings, structures, fixtures, building systems and equipment, and all components thereof (including the roof, foundation and structural elements), included in the Leased Real Property.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Indemnified Party&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8.6(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> above.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Indemnified Taxes</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means (a) all Taxes (or the non-payment thereof) of Seller for any Pre-Closing Tax Period, (b) any and all Taxes of any member of an affiliated consolidated, combined or unitary group of which Seller (or any predecessor thereof) is or was a member on or prior to the Closing Date, including pursuant to Treasury Regulations section 1.1502-6 or any analogous or similar state, local or foreign Law, (c) any and all Taxes of any Person imposed on Seller as a transferee or successor, by Contract or pursuant to any Law, which Taxes are imposed on Seller as a result of an event or transaction occurring on or prior to the Closing Date, and (d) all Taxes imposed on or incurred by Seller.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Indemnifying Party&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8.6(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> above.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Independent Accountants</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; refers to the future mutual appointment by the Buyer(s) and the Seller of an independent accounting individual or firm who, acting as experts and not arbitrators, shall resolve (a) the Disputed Amounts and make adjustments to the Post-Closing Adjustments and the Closing Statement as set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 1.4(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, and (b) any disputes regarding the Purchase Price Allocation as set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 1.5</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Information</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 6.6(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> above. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Intellectual Property&#8221; means all intellectual property and other similar proprietary rights, whether registered or unregistered, including all of the following in any jurisdiction throughout the world&#58; (a) all inventions and discovery inventions (whether patentable or unpatentable and whether or not reduced to practice), all improvements thereto, and all patents, patent applications, and counterparts claiming priority therefrom, and related patent disclosures, together with all reissuances, continuations, continuations-in-part, divisions, extensions, and reexaminations thereof and all rights associated with any of the foregoing (together, the &#8220;Patents&#8221;), (b) all trademarks, service marks, trade dress, logos, slogans, trade names, corporate and business names, and other source or business identifiers, together with all translations, adaptations, derivations, and combinations thereof and including all goodwill associated therewith, and all applications, registrations, and renewals in connection therewith (together, the &#8220;Trademarks&#8221;), (c) all copyrights and works of authorship, and other copyrightable works, whether or not copyrightable, and whether published or unpublished, including software code, translations, documentation, marketing and training materials, user interface designs, compilations, and databases, and all applications, registrations, and renewals in connection therewith, and all derivative works, adaptions, compilations, and combinations of the foregoing (together, the &#8220;Copyrights&#8221;), (d) all trade secrets and other confidential and proprietary business information and other information that derives economic value from not being generally known (including ideas, research and development, know-how, formulas, compositions, processes and techniques, technical data and information, designs, drawings, specifications, customer and supplier lists, pricing and cost information, and business and marketing plans and proposals) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-45-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">(together, the &#8220;Proprietary Information&#8221;), (e) all Software, (f) all social media accounts (including, but not limited to, Facebook, Instagram, X, LinkedIn, and YouTube relating to each Clinic, along with passwords and access to all each social media accounts, and (g) all other proprietary rights.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Intellectual Property Agreements</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means (a) any Contract for the development of any Intellectual Property by any third party for, with or on behalf of Seller, and (b) all licenses, sublicenses and other agreements whereby (i) Seller is authorized to use or access any Intellectual Property (other than for off-the-shelf commercially available Software, freeware, or Open Source Software, in each case, that do not require payment of any recurring license fees, subscription fees, or any recurring support and maintenance and which have not been customized in any material way) or (ii) Seller licenses or otherwise authorizes a third party to use or access any Intellectual  Property.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Knowledge&#8221; means(a) in the case of an individual, the actual knowledge of such individual, upon reasonable inquiry, (b) in the case of Buyer(s), the actual knowledge of Chris O&#8217;Neal, upon reasonable inquiry, and (c) in the case of Seller, the actual knowledge of the applicable Seller&#8217;s employee, upon reasonable inquiry.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Law</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any foreign or domestic federal, state or local law, statute, code, ordinance, regulation, rule, consent agreement, constitution or treaty of any Governmental Body, including common law.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Leased Real Property&#8221; means all leasehold or subleasehold estates and other rights to use or occupy any land, buildings, structures, Improvements, fixtures or other interest in real property held by each Clinic, as described on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.11(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Leases&#8221; means all written or oral leases, subleases, licenses, concessions and other agreements, including all amendments, extensions, renewals, guaranties, and other agreements with respect thereto, pursuant to which Seller holds any Leased Real Property.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Lien&#8221; means any lien, mortgage, pledge, encumbrance, charge, security interest, adverse claim, liability, interest, charge, preference, priority, proxy, transfer restriction (other than restrictions under the Securities Act and state securities laws), encroachment, Tax, order, community property interest, equitable interest, option, warrant, right of first refusal, easement, profit, license, servitude, right of way, covenant or zoning restriction.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Material Adverse Effect&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Material Adverse Change</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any event, change, development, or effect that, individually or in the aggregate, will or could reasonably be expected to have a materially adverse effect on (a) the business, operations, condition (financial or otherwise), value of the Acquired Assets (including intangible assets), liabilities, prospects, operating results, value, employee, customer or supplier relations, or financial condition of Seller or (b) the ability of Seller to timely consummate the transactions contemplated by this Agreement.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Material Contracts</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means, collectively, the Contracts required to be listed in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 3.13(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, the Leases, and the Company Insurance Agreements (which Insurance Agreements shall not be transferred to Buyer(s)).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Medicaid</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means the medical assistance program established by Title XIX of the Social Security Act of 1965, 42 U.S.C. &#167; 1396, et seq.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-46-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Medical Waste</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means (a) pathological waste, (b) blood, (c) wastes from surgery or autopsy, (d) dialysis waste, including contaminated disposable equipment and supplies, (e) cultures and stocks of infectious agents and associated biological agents, (f) contaminated animals, (g) isolation wastes, (h) contaminated equipment, (i) laboratory waste, and (j) various other biological waste and discarded materials contaminated with or exposed to blood, excretion, or secretions from human beings or animals. &#8220;Medical Waste&#8221; also includes any substance, pollutant, material, or contaminant listed or regulated under the Medical Waste Tracking Act of 1988, 42 U.S.C. &#167;&#167;6992, et seq.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Medicare</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means the health insurance program established by Title XVIII of the Social Security Act of 1965, 42 U.S.C. &#167; 1395, et seq.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Most Recent Financial Statements&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 3.7(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> above.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Most Recent Fiscal Month End&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 3.7(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> above.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Most Recent Fiscal Year End&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 3.7(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> above.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Objection Statement&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 1.5</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> above. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Off-Balance Sheet Financing&#8221; means (a) any liability of Seller under any sale and leaseback transactions which does not create a liability on the consolidated balance sheet of Seller and (b) any liability of Seller under any synthetic lease, Tax retention operating lease, off-balance sheet loan or similar off-balance sheet financing product where the transaction is considered indebtedness for borrowed money for federal income Tax purposes but is classified as an operating lease in accordance with GAAP for financial reporting purposes.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Open Source</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any software or other material that is made generally available to the public, under &#8220;open source&#8221; licenses (including but not limited to the GNU General Public License (GPL), GNU Lesser General Public License (LGPL), Mozilla Public License (MPL), BSD, the Apache License or any similar license arrangement) and without requiring the payment of any fees or royalties.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Order</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any order, award, decision, injunction, judgment, ruling, decree, charge, writ, subpoena or verdict entered, issued, made or rendered by any Governmental Body or arbitrator.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Ordinary Course of Business&#8221; means the ordinary course of business consistent with past custom and practice (including with respect to quantity and frequency).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Organizational Documents</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means (a) any certificate or articles of organization, operating agreement or buy sell agreements, (b) any documents comparable to those described in clause (a) as may be applicable pursuant to any Law and (c) any amendment or modification to any of the foregoing.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Party&#8221; has the meaning set forth in the preface above.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Patents</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; has the meaning set forth in the definition of </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> above.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Permit&#8221; means any license, import license, export license, franchise, Consent, permit, certificate, certificate of occupancy or Order issued by any Person.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-47-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Permitted Lien</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any (a) liens for Taxes not yet due or payable or for Taxes that Seller is contesting in good faith through appropriate proceedings in a timely manner, in each case for which adequate reserves have been established, (b) liens of landlords, carriers, warehousemen, workmen, repairmen, mechanics, material men and similar liens arising in the Ordinary Course of Business and not incurred in connection with the borrowing of money, (c) restrictions, easements, covenants, reservations, rights of way or other similar matters of title to the Leased Real Property of record, and (d) zoning ordinances, restrictions, prohibitions and other requirements imposed by any Governmental Body, all of which do not materially interfere with the conduct of the business of Seller.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Person&#8221; means any individual, corporation, partnership, limited liability company, firm, joint venture, association, joint-stock company, trust, unincorporated organization, Governmental Body or other entity.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Privacy Laws</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 3.20</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> above. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Proceeding</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any action, audit, lawsuit, litigation, investigation or arbitration (in each case, whether civil, criminal or administrative) pending by or before any Governmental Body or arbitrator.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Prohibited Transaction&#8221; has the meaning set forth in ERISA &#167;406 and Code &#167;4975.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Proprietary Information</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; has the meaning set forth in the definition of </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> above.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Public Software Licenses</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any license for Software pursuant to which&#58; (a) such Software is made generally available to the public without requiring payment of fees or royalties&#59; or (b) any derivative of such Software is or may be required to be disclosed or licensed on the same terms as such license.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Purchase Price</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means the Base Purchase Price, as adjusted upwards or downwards as set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 1.3</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> above.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">RDA</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">The Joint Chiropractic</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> Regional Development Agreement (&#8220;RDA&#8221;) dated June 26, 2013, as amended on July 1, 2016, July 18, 2017 and June 23, 2023.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Referral Recipient</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any Person to whom a Referral Source refers, recommends or arranges for the referral of patients or other health care business to the Group Companies or any of their Affiliates.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Referral Source</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any past, present or potential patient, physician, supplier, contractor, customer, Third-Party Payor or other Person in a position to refer, recommend or arrange for the referral of patients or other health care business.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">Representative</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means, with respect to any Person, any and all directors, officers, employees, consultants, financial advisors, counsel, accountants and other agents of such Person.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Required Consents</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means the consent required of any third party, included any applicable consent of Landlords and the persons or entities referenced in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 6.7</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> above, to close the Transaction on the terms described in this Agreement.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-48-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means the Securities Act of 1933, as amended, and any applicable rules and regulations thereunder, and any successor to such statute, rules or regulations.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Securities Exchange Act&#8221; means the Securities Exchange Act of 1934, as amended, and any applicable rules and regulations thereunder, and any successor to such statute, rules or regulations.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Seller&#8221; has the meaning set forth in the preface above.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Seller Closing Certificate</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means that certain Seller&#8217;s certificate dated as of the date hereof, executed by Buyer(s) and attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">Exhibit G</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Seller Indemnitees&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8.2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> above.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Software&#8221; means computer software programs (and all enhancements, versions, releases, and updates thereto), including software compilations, software tool sets, compilers, higher level or &#8220;proprietary&#8221; languages and all related programming and user documentation, whether in source code, object code or human readable form, or any translation or modification thereof that substantially preserves its original identity.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Straddle Period</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any taxable period that includes (but does not end on) the Closing Date.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Systems&#8221; means all computers, software, databases, hardware, firmware, middleware, servers, workstations, routers, hubs, switches, circuits, networks, databases, data communications and telecommunication lines and all other information technology systems and equipment (including communications equipment, terminals, and hook-ups that interface with third-party software or systems), including any outsourced systems and processes reasonably within Seller&#8217;s control, that are owned, licensed, leased or otherwise used or relied on by Seller.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Tax&#8221; or &#8220;Taxes&#8221; means (a) any federal, state, local and foreign net income, alternative or add-on minimum, estimated, gross income, gross receipts, sales, use, ad valorem, value added, transfer, franchise, capital profits, lease, service, license, withholding, payroll, employment, excise, severance, stamp, occupation, premium, property, abandoned property or escheat, environmental or windfall profit tax, customs duty or other tax, governmental fee or other like assessment or charge, (b) any interest, fines, penalties, assessments, deficiencies or additions thereto, or incurred in connection with or in lieu of any items described herein or any related contest or dispute, (c). and any liability for Taxes of another Person incurred or borne by virtue of the application of Treasury Regulation Section 1.1502-6 (or any similar or corresponding provision of state, local or foreign Law), as a transferee or successor, by Contract or otherwise.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Tax Return</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any return, declaration, report, claim for refund, or information return or statement relating to Taxes, including any schedule or attachment thereto, and including any amendment thereof.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;Third-Party Claim&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8.6(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> above.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Trademarks</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; has the meaning set forth in the definition of Intellectual Property above.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Trademark Assignment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means that certain Trademark Assignment dated as of the date hereof between Seller and Buyer(s).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Transaction Expenses</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any and all legal, accounting, tax, financial advisory, investment bank, environmental consultants and other professional or transaction related costs, fees and expenses incurred by Seller in connection with this Agreement or in investigating, pursuing or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-49-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">completing the transactions contemplated hereby (including any amounts owed t</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">o </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">any consultants, auditors, accountants, attorneys, brokers or investment bankers)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">,</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> (b) payments, bonuses or severance which become due or are otherwise required to be made as a result of or in connection with the Closing, and (c) payroll, employment or other Taxes, if any, required to be paid by Buyer(s) with respect to the amounts payable pursuant to this Agreement or the amounts described in clause (a) and (b). </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Transaction Expenses Amount</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means an amount equal to all Transaction Expenses that have not been paid prior to the Closing Date, whether or not Seller has been billed for such expenses.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE 12</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">MISCELLANEOUS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">12.1&#160;&#160;&#160;&#160;Press Releases and Public Announcements</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Neither Party shall make any announcement of the Transaction contemplated by this Agreement without the prior written approval of the other Party, which approval will not be unreasonably withheld or delayed&#59; provided however that if any announcement or disclosure of the Transaction is required by applicable rule or regulations of the Securities and Exchange Commission (since the Seller is a publicly traded company), the Seller shall not be required to secure such prior written approval from Buyer(s). The foregoing shall not restrict in any respect either Party&#8217;s ability to communicate information concerning the transactions contemplated hereby to the Parties&#8217; respective affiliates&#8217;, officers, directors, employees, attorneys, accountants and professional advisers, and, to the extent relevant, to third parties whose consent is required in connection with the Transaction contemplated by this Agreement.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">12.2&#160;&#160;&#160;&#160;No Third-Party Beneficiaries</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  This Agreement shall not confer any rights or remedies upon any Person other than the Parties and their respective successors and permitted assigns.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">12.3&#160;&#160;&#160;&#160;Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  This Agreement (including the documents referred to herein) and the Ancillary Agreements constitute the entire agreement among the Parties and supersedes any prior understandings, agreements, or representations by or among the Parties, written or oral, to the extent they relate in any way to the subject matter hereof.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">12.4&#160;&#160;&#160;&#160;Succession and Assignment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  This Agreement shall be binding upon and inure to the benefit of the Parties named herein and their respective successors and permitted assigns.  No Party may assign either this Agreement or any of its rights, interests, or obligations hereunder without the prior written approval of Buyer(s) and the Seller&#59; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, that Buyer(s) may (a) assign any or all of its rights and interests hereunder to one or more of its Affiliates and designate one or more of its Affiliates to perform its obligations hereunder (in any or all of which cases Buyer(s) nonetheless shall remain responsible for the performance of all of its obligations hereunder), (b) assign its rights under this Agreement for collateral security purposes to any lenders providing financing to Buyer(s) or any of its Affiliates or (c) assign its rights under this Agreement to any Person that acquires Buyer(s) or any of its assets.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">12.5&#160;&#160;&#160;&#160;Counterparts</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  This Agreement may be executed in one or more counterparts (including by means of facsimile or portable document format (.PDF)), each of which shall be deemed an original but all of which together will constitute one and the same instrument.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-50-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">12.6&#160;&#160;&#160;&#160;Headings</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  The section headings contained in this Agreement are inserted for convenience only and shall not affect in any way the meaning or interpretation of this Agreement.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">12.7&#160;&#160;&#160;&#160;Notices</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  All notices, requests, demands, claims, and other communications hereunder will be in writing.  Any notice, request, demand, claim, or other communication hereunder shall be deemed duly given (a) when delivered personally to the recipient, (b) when sent by electronic mail or facsimile, on the date of transmission to such recipient, (c) one (1) Business Day after being sent to the recipient by reputable overnight courier service (charges prepaid), or (d) four (4) Business Days after being mailed to the recipient by certified or registered mail, return receipt requested and postage prepaid, and addressed to the intended recipient as set forth below&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">If to the Seller&#58;&#160;&#160;&#160;&#160;The Joint Corp.</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">ATTN&#58; Scott Bowman, Chief Financial Officer</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">16767 N. Perimeter Drive, Suite 110</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Scottsdale, Arizona 85260</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">E-mail&#58; scott.bowman&#64;thejoint.com  </font></div><div style="padding-left:108pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Copy to&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Joint Corp</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">ATTN&#58; Andra Terrell, Sr. VP of Legal and Secretary</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">16767 N. Perimeter Drive, Suite 110</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Scottsdale, Arizona 85260</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">E-mail&#58;  notices&#64;thejoint.com </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%"> </font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">If to Buyer(s)&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Addisco Value, LLC</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Address&#58;                                                                      </font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Phone Number&#58;                                                                       </font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Email Address&#58;                                                                       </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="padding-left:108pt;text-align:justify"><font><br></font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Triangle Chiropractic Associates P.C</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Address&#58;                                                                      </font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Phone Number&#58;                                                                       </font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Email Address&#58;                                                                       </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="padding-left:108pt;text-align:justify"><font><br></font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Bluffton TJ, LLC,  </font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Address</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">&#58;                                                                      </font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Phone Number&#58;                                                                       </font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Email Address&#58;                                                                       </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Copy to&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Grabowski Law Firm, PLLC</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Attn&#58; Austin Grabowski</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">4539 Hedgemore Dr, suite 103</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Charlotte, NC 28209</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">info&#64;grabowskilawfirm.com</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">704 644 5997</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-51-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Any Party may change the address to which notices, requests, demands, claims, and other communications hereunder are to be delivered by giving the other Parties notice in the manner herein set forth.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">12.8&#160;&#160;&#160;&#160;Governing Law</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  This Agreement and any claim, controversy or dispute arising out of or related to this Agreement, any of the transactions contemplated hereby, the relationship of the Parties, and&#47;or the interpretation and enforcement of the rights and duties of the Parties, whether arising in contract, tort, equity or otherwise, shall be governed by and construed in accordance with the domestic Laws of the State of Delaware (including in respect of the statute of limitations or other limitations period applicable to any such claim, controversy or dispute), without giving effect to any choice or conflict of Law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Delaware.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">12.9&#160;&#160;&#160;&#160;Waiver of Jury Trial</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  EACH OF THE PARTIES WAIVES THEIR RESPECTIVE RIGHTS TO A TRIAL BY JURY OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OR RELATED TO THIS AGREEMENT IN ANY ACTION, PROCEEDING OR OTHER LITIGATION OF ANY TYPE BROUGHT BY ANY OF THE PARTIES AGAINST ANY OTHER PARTY OR ANY AFFILIATE OF ANY OTHER SUCH PARTY, WHETHER WITH RESPECT TO CONTRACT CLAIMS, TORT CLAIMS OR OTHERWISE.  THE PARTIES AGREE THAT ANY SUCH CLAIM OR CAUSE OF ACTION SHALL BE TRIED BY A COURT TRIAL WITHOUT A JURY.  WITHOUT LIMITING THE FOREGOING, THE PARTIES FURTHER AGREE THAT THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY IS WAIVED BY OPERATION OF THIS SECTION AS TO ANY ACTION, COUNTERCLAIM OR OTHER PROCEEDING WHICH SEEKS, IN WHOLE OR IN PART, TO CHALLENGE THE VALIDITY OR ENFORCEABILITY OF THIS AGREEMENT OR ANY PROVISION HEREOF.  THIS WAIVER SHALL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS OR MODIFICATIONS TO THIS AGREEMENT.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">12.10&#160;&#160;&#160;&#160;Exclusive Venue</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">THE PARTIES AGREE THAT ALL DISPUTES, LEGAL ACTIONS, SUITS AND PROCEEDINGS ARISING OUT OF OR RELATING TO THIS AGREEMENT MUST BE BROUGHT EXCLUSIVELY IN A FEDERAL DISTRICT COURT FOR THE DISTRICT OF ARIZONA LOCATED IN MARICOPA COUNTY, ARIZONA OR AN ARIZONA STATE COURT LOCATED IN MARICOPA COUNTY, ARIZONA (COLLECTIVELY THE &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">DESIGNATED COURTS</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).  EACH PARTY HEREBY CONSENTS AND SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE DESIGNATED COURTS. NO LEGAL ACTION, SUIT OR PROCEEDING WITH RESPECT TO THIS AGREEMENT MAY BE BROUGHT IN ANY OTHER FORUM.  EACH PARTY HEREBY IRREVOCABLY WAIVES ALL CLAIMS OF IMMUNITY FROM JURISDICTION AND ANY OBJECTION WHICH SUCH PARTY MAY NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE OF ANY SUIT, ACTION OR PROCEEDING IN ANY DESIGNATED COURT, INCLUDING ANY RIGHT TO OBJECT ON THE BASIS THAT ANY DISPUTE, ACTION, SUIT OR PROCEEDING BROUGHT IN THE DESIGNATED COURTS HAS BEEN BROUGHT IN AN IMPROPER OR INCONVENIENT FORUM OR VENUE.  EACH OF THE PARTIES ALSO AGREES THAT DELIVERY OF ANY PROCESS, SUMMONS, NOTICE OR DOCUMENT TO A PARTY IN COMPLIANCE WITH </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">SECTION 12.7</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> OF THIS AGREEMENT SHALL BE EFFECTIVE SERVICE OF PROCESS FOR ANY ACTION, SUIT OR PROCEEDING IN A </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-52-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">DESIGNATED COURT WITH RESPECT TO ANY MATTERS TO WHICH THE PARTIES HAVE SUBMITTED TO JURISDICTION AS SET FORTH ABOVE.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT OR THE OTHER TRANSACTION DOCUMENTS IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES AND, THEREFORE, EACH SUCH PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LEGAL ACTION ARISING OUT OF OR RELATING TO THIS AGREEMENT, THE OTHER TRANSACTION DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH PARTY TO THIS AGREEMENT CERTIFIES AND ACKNOWLEDGES THAT (i) NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT SEEK TO ENFORCE THE FOREGOING WAIVER IN THE EVENT OF A LEGAL ACTION, (ii) SUCH PARTY HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (iii) SUCH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (iv) SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION. THE PARTIES FURTHER AGREE THAT ALL DISPUTES SUBMITTED TO THE COURT PURSUANT TO THIS SECTION SHALL BE TRIED TO THE COURT SITTING WITHOUT A JURY, NOTWITHSTANDING ANY STATE OR FEDERAL CONSTITUTIONAL OR STATUTORY RIGHTS OR PROVISIONS. THE PREVAILING PARTY, UPON DELIVERY OF WRITTEN DEMAND TO THE NON-PREVAILING PARTY, SHALL BE ENTITLED TO FULL COMPENSATION OF ITS FEES AND EXPENSES (INCLUDING WITHOUT LIMITATION, ATTORNEYS&#8217; FEES, COURT AND EXPERT WITNESS FEES, TRAVEL EXPENSES, AND RELATED REASONABLE EXPENSES INCURRED IN SUCH ACTION).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">12.11&#160;&#160;&#160;&#160;Amendments and Waivers</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  No amendment of any provision of this Agreement shall be valid unless the same shall be in writing and signed by each of the Parties hereto.  No waiver by any Party of any provision of this Agreement or any default, misrepresentation, or breach of warranty or covenant hereunder, whether intentional or not, shall be valid unless the same shall be in writing and signed by the Party making such waiver nor shall such waiver be deemed to extend to any prior or subsequent default, misrepresentation, or breach of warranty or covenant hereunder or affect in any way any rights arising by virtue of any prior or subsequent such occurrence.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">12.12&#160;&#160;&#160;&#160;Injunctive Relief&#59; Specific Performance</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  The Parties agree that irreparable damage would occur if any provision of this Agreement were not performed in accordance with the terms hereof (including if the Parties fail to take such actions as are required to consummate the transactions contemplated hereby) or were otherwise breached. Each Party hereto shall be entitled to an injunction or injunctions to prevent breaches or threatened breaches of this Agreement or to enforce specifically the performance of the terms and provisions hereof in the courts described in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 12.10</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> without proof of actual damages, in addition to any other remedy to which it is entitled at law or in equity. No Party will oppose the granting of an injunction, specific performance, or other equitable relief provided herein on the basis that the other Party has an adequate remedy at law or that an award of specific performance is not an appropriate remedy for any reason at law or equity. No other party or any other person or legal entity shall be required to obtain, furnish, or post any bond or similar instrument in connection with or as a condition to obtaining any remedy referred to in this Section, and each Party hereto </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-53-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">irrevocably waives any right it may have to require the obtaining, furnishing, or posting of any such bond or similar instrument. The right of specific enforcement is an integral part of the transactions contemplated hereby and without that right, neither party would have entered into this Agreement.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">12.13&#160;&#160;&#160;&#160;Severability</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions hereof or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">12.14&#160;&#160;&#160;&#160;Expenses</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Except as otherwise expressly provided in this Agreement, each Party will bear its own costs and expenses (including legal fees and expenses) incurred in connection with this Agreement and the transactions contemplated hereby&#59; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, that all Transaction Expenses incurred by the Seller in connection with this Agreement shall be paid by the Seller.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">12.15&#160;&#160;&#160;&#160;Construction</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  The Parties have participated jointly in the negotiation and drafting of this Agreement.  In the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any of the provisions of this Agreement.  Any reference to any Law shall be deemed also to refer to all rules and regulations promulgated thereunder, unless the context requires otherwise.  The word &#8220;including&#8221; shall mean including without limitation.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">12.16&#160;&#160;&#160;&#160;Incorporation of Exhibits, Schedules and Disclosure Schedules</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  At Closing, the Exhibits, Disclosure Schedules, and other Schedules identified in this Agreement will be agreed to by the Parties, will be incorporated herein by reference, and will be made a part hereof. After the Parties&#8217; execution of this Agreement, the Parties shall work in good faith to mutually agree on the final form of the Exhibits and on the final Schedules and Disclosure Schedules. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">12.17&#160;&#160;&#160;&#160;Schedules</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.  Nothing in the schedules hereto shall be deemed adequate to disclose an exception to a representation or warranty made herein unless the schedule identifies the exception with reasonable particularity and describes the relevant facts in reasonable detail.  Without limiting the generality of the foregoing, the mere listing (or inclusion of a copy) of a document or other item shall not be deemed adequate to disclose an exception to a representation or warranty made herein (unless the representation or warranty has to do with the existence of the document or other item itself).  The Parties intend that each representation, warranty, and covenant contained herein shall have independent significance. If any Party has breached any representation, warranty or covenant contained herein in any respect, the fact that there exists another representation, warranty or covenant relating to the same subject matter (regardless of the relative levels of specificity) which the Party has not breached shall not detract from or mitigate the fact that the Party is in breach of the first representation, warranty, or covenant.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">12.18&#160;&#160;&#160;&#160;Remedies Cumulative</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. No remedy set forth or referred to in this Agreement is intended to be exclusive, but shall be cumulative and in addition to any other remedy set forth or referred to in this Agreement, in any other agreement between the Parties, or otherwise available under applicable Law.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-54-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">12.19   Damages. </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">EACH OF THE PARTIES WILL BE LIABLE TO THE OTHER FOR ANY DIRECT DAMAGES ARISING OUT OF OR RELATING TO A BREACH OF ITS REPRESENTATIONS OR WARRANTIES, OR ITS PERFORMANCE OR FAILURE TO PERFORM ITS OBLIGATIONS UNDER THIS AGREEMENT. UNDER NO CIRCUMSTANCES WILL A PARTY BE LIABLE TO THE OTHER PARTY OR ANY THIRD PARTY FOR ANY CONSEQUENTIAL, INDIRECT, SPECIAL, PUNITIVE, LIQUIDATED, OR INCIDENTAL DAMAGES, OR CLAIMS FOR LOST PROFITS.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">            </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">12.20   Fully Informed Parties and Capacity</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. The Parties have been represented in the negotiations for and in the preparation of this Agreement by counsel of their own choosing&#59; they have reviewed and understand the provisions of this Agreement&#59; they have had it fully explained to them by their counsel&#59; and they are fully aware of and understand its contents and its legal effect. Each Party acknowledges that it enters into this Agreement freely and voluntarily and is not acting under coercion, duress, economic compulsion, nor is entering into this Agreement because of any supposed disparity in bargaining power&#59; rather, each party is freely and voluntarily signing this Agreement for its own benefit.  Furthermore, each of the individuals signing this Agreement represents and warrants that he or she has full power and authority to bind the Party identified above his or her name. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">12.21   Force Majeure</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.   Neither Party shall be responsible for any loss or damage resulting from any delay or failure in performing any provision of this Agreement due to any act of God, fire, explosion, flood, storm, pandemic, earthquake, war, riot, disease or from any delay or failure, or by any cause beyond either Party&#8217;s control or by the order, requisition, request or recommendation of any governmental agency or acting body, or compliance therewith or by governmental proration, regulation or priority or the inability of a Party to perform its obligations herein as a result from any other delay or failure due to any cause beyond the affected Party&#8217;s control, similar or dissimilar to any such causes (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Force Majeure Event</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). A Force Majeure Event shall not affect another Party&#8217;s obligations hereunder. Notwithstanding the foregoing, performance times under this Agreement shall be considered extended for a period of time equivalent to the time lost because of any delay which is excusable under this Section&#59; provided, however, that if any such delay continues for a period of more than thirty (30) calendar days, the Party not claiming excusable delay may terminate this Agreement, upon five (5) day written notice to the other Party.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">12.22   Buyer(s) Interpretation</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">. Each Buyer(s) executes this Agreement solely with respect to its Allocated Clinics. Any reference to &#8216;Buyer(s)&#8217; shall be construed to apply separately and severally to each Buyer(s) as to its Allocated Clinics. The term &#8220;Buyer(s),&#8221; as used throughout this Agreement, shall refer collectively to Addisco Value, LLC, Triangle Chiropractic Associates P.C., and Bluffton TJ, LLC. Unless expressly stated otherwise, any reference to &#8220;Buyer(s)&#8221; shall be construed as applying both to all Buyer(s) collectively and to each Buyer(s) severally, as applicable to that Buyer(s)&#8217;s Allocated Clinics, Acquired Assets, Assumed Liabilities, and related representations, warranties, covenants, and obligations. Each Buyer(s)&#8217;s obligations are several and not joint, and no Buyer(s) shall be liable for the performance or obligations of any other Buyer(s).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#91;Signatures appear on the following page&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-55-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, the Parties have executed this Agreement as of the date first above written.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:48.659%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.141%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">BUYERS</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:112%">&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">ADDISCO VALUE, LLC, a North Carolina limited liability company</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">By&#58; Name&#58;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline"> Alexander Klau</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">s Titl</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">e&#58; Mana</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Date&#58; _______________________________</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">SELLER</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:112%">&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">THE JOINT CORP., a Delaware corporation</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">By&#58; Name&#58; Sanjiv Razdan Title&#58; Chief Executive Offi</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Date&#58; _______________________________</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">ADDISCO VALUE, LLC, a North Carolina limited liability company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">THE JOINT CORP., a Delaware corporation</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">&#47;s&#47; Alexander Klaus</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">&#47;s&#47; Sanjiv Razdan</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Alexander Klaus</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Sanjiv Razdan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; Manager</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;  Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; 12&#47;5&#47;2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; 12&#47;6&#47;2025</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">TRIANGLE CHIROPRACTIC<br>ASSOCIATES P.C., a North Carolina limited<br>liability company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">&#47;s&#47; Scott Bowman</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Scott Bowman</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">&#47;s&#47; Todd Wegerski, DC</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;  Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Todd Wegerski, DC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; 12&#47;6&#47;2025</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; Manager</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; 12&#47;6&#47;2025</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">&#47;s&#47; Lisa Ezell</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Lisa Ezell</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; Manager</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; 12&#47;6&#47;2025</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">BLUFFTON TJ, LLC a South Carolina<br>limited liability company</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">&#47;s&#47; Andrew Michael Evec</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58; Andrew Michael Evec</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; Manager</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; 12&#47;5&#47;2025</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">&#47;s&#47; Susan Ruth Train</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Name&#58; Susan Ruth Train</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; Manager</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; 12&#47;5&#47;2025</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">-56-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:47.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.865%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">GUARANTORS&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%">(As to Section 4.6 Guaranty Obligations)</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%"> &#47;s&#47; Alex Klaus</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Name&#58; Alex Klaus</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Date&#58; 12&#47;5&#47;2025</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">&#47;s&#47; Todd Wegerski, DC</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Name&#58; Todd Wegerski, DC</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Date&#58; 12&#47;6&#47;2025</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">By&#58; &#47;s&#47; Lisa Ezell</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Name&#58; Lisa Ezell</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Date&#58; 12&#47;6&#47;2025</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">&#47;s&#47; Andrew Evec, DC</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Name&#58; Andrew Michael Evec</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Date&#58; 12&#47;5&#47;2025</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%"> &#47;s&#47; Susan Ruth Train</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Name&#58; Susan Ruth Train</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Date&#58; 12&#47;5&#47;2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:108%">ACKNOWLEDGED AND ACCEPTED BY THE &#8220;PC&#8221;&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:108%">TRIANGLE CHIROPRACTIC ASSOCIATES, PC, a North Carolina professional corporation</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:108%">Sign&#58;  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:108%">&#47;s&#47; Todd Wegerski, DC</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:108%">Print&#58; Todd Wegerski, DC</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:108%">Title&#58; President</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Date&#58; 12&#47;6&#47;2025</font></div></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>consentofbdousapc2025xex231.htm
<DESCRIPTION>EXHIBIT-23.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="iea62536f65124ea49ed49f46775c1cf3_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 23.1</font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Consent of Independent Registered Public Accounting Firm</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-208262, 333-225898, 333-272190, 333-279792 and 333-290541) of The Joint Corp. (the Company) of our reports dated March 12, 2026, relating to the consolidated financial statements which appear in this Annual Report on Form 10-K.</font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:0.04pt;padding-left:0.45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; BDO USA, P.C.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:0.04pt;padding-left:0.45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Phoenix, Arizona</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">March 12, 2026</font></div><div style="margin-bottom:0.04pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-0.18pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>jynt-20251231x10xkxex311.htm
<DESCRIPTION>EXHIBIT-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="if51b79207e00408f9319b9d0ca7fbe14_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">I, Sanjiv Razdan, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">I have reviewed this annual report on Form 10-K of The Joint Corp.&#59;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:81pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:81pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:81pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:81pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:81pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:81pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.237%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 12, 2026</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Sanjiv Razdan</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Sanjiv Razdan<br>President and Chief Executive Officer<br>(Principal Executive Officer)<br></font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>jynt-20251231x10kxex312.htm
<DESCRIPTION>EXHIBIT-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i3ae234745ed74903bb20f9b7b07aafdd_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">I, Scott Bowman, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">I have reviewed this annual report on Form 10-K of The Joint Corp.&#59;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:85.5pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.57pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:85.5pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:85.5pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.57pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:85.5pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:85.5pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.57pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:85.5pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:52.194%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.615%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 12, 2026</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Scott Bowman</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Scott Bowman<br>Chief Financial Officer<br>(Principal Financial Officer and Principal Accounting Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>jynt-20251231x10kxex321.htm
<DESCRIPTION>EXHIBIT-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i4a22aa7defa44fb097377edb0771a54a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION&#160;1350,</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION&#160;906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of Section&#160;1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of The Joint Corp., a Delaware corporation (&#8220;Company&#8221;), does hereby certify, to such officer&#8217;s knowledge, that&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (&#8220;Form 10-K&#8221;) of the Company fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.731%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.615%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; March 12, 2026</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Sanjiv Razdan</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Sanjiv Razdan<br>President and Chief Executive Officer<br>(Principal Executive Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.731%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.615%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; March 12, 2026</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Scott Bowman</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Scott Bowman<br>Chief Financial Officer<br>(Principal Financial Officer and Principal Accounting Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>jynt-20251231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019b096a-603d-78f6-a834-c229229c770d,g:a2c624eb-8b4f-420f-a77d-d91a250e6a25-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:jynt="http://www.thejoint.com/20251231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.thejoint.com/20251231">
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/cyd-af-sub/2025" schemaLocation="https://xbrl.sec.gov/cyd/2025/cyd-af-sub-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2025" schemaLocation="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="jynt-20251231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="jynt-20251231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="jynt-20251231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="jynt-20251231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.thejoint.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.thejoint.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.thejoint.com/role/ConsolidatedBalanceSheets">
        <link:definition>9952151 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.thejoint.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>9952152 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedIncomeStatements" roleURI="http://www.thejoint.com/role/ConsolidatedIncomeStatements">
        <link:definition>9952153 - Statement - Consolidated Income Statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofChangesinStockholdersEquity" roleURI="http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity">
        <link:definition>9952154 - Statement - Consolidated Statements of Changes in Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>9952155 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofOperationsandSummaryofSignificantAccountingPolicies" roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPolicies">
        <link:definition>9952156 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisclosures" roleURI="http://www.thejoint.com/role/RevenueDisclosures">
        <link:definition>9952157 - Disclosure - Revenue Disclosures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Divestitures" roleURI="http://www.thejoint.com/role/Divestitures">
        <link:definition>9952158 - Disclosure - Divestitures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipment" roleURI="http://www.thejoint.com/role/PropertyandEquipment">
        <link:definition>9952159 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueConsideration" roleURI="http://www.thejoint.com/role/FairValueConsideration">
        <link:definition>9952160 - Disclosure - Fair Value Consideration</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.thejoint.com/role/Debt">
        <link:definition>9952161 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.thejoint.com/role/StockholdersEquity">
        <link:definition>9952162 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.thejoint.com/role/StockBasedCompensation">
        <link:definition>9952163 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.thejoint.com/role/IncomeTaxes">
        <link:definition>9952164 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.thejoint.com/role/CommitmentsandContingencies">
        <link:definition>9952165 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.thejoint.com/role/SegmentReporting">
        <link:definition>9952166 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://www.thejoint.com/role/RelatedPartyTransactions">
        <link:definition>9952167 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyFinancialDataUnaudited" roleURI="http://www.thejoint.com/role/QuarterlyFinancialDataUnaudited">
        <link:definition>9952168 - Disclosure - Quarterly Financial Data (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9955511 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofOperationsandSummaryofSignificantAccountingPoliciesTables" roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>9955512 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisclosuresTables" roleURI="http://www.thejoint.com/role/RevenueDisclosuresTables">
        <link:definition>9955513 - Disclosure - Revenue Disclosures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DivestituresTables" roleURI="http://www.thejoint.com/role/DivestituresTables">
        <link:definition>9955514 - Disclosure - Divestitures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentTables" roleURI="http://www.thejoint.com/role/PropertyandEquipmentTables">
        <link:definition>9955515 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.thejoint.com/role/StockBasedCompensationTables">
        <link:definition>9955516 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.thejoint.com/role/IncomeTaxesTables">
        <link:definition>9955517 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTables" roleURI="http://www.thejoint.com/role/CommitmentsandContingenciesTables">
        <link:definition>9955518 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.thejoint.com/role/SegmentReportingTables">
        <link:definition>9955519 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyFinancialDataUnauditedTables" roleURI="http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedTables">
        <link:definition>9955520 - Disclosure - Quarterly Financial Data (Unaudited) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails" roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails">
        <link:definition>9955521 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - Clinics in Operation Under Franchise Agreements or Company-Owned or Managed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>9955522 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEIncomeStatementDetails" roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEIncomeStatementDetails">
        <link:definition>9955523 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - VIE Income Statement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEAssetsandLiabilitiesDetails" roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEAssetsandLiabilitiesDetails">
        <link:definition>9955524 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - VIE Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofOperationsandSummaryofSignificantAccountingPoliciesReconciliationofofAccountsReceivableAllowanceforCreditLossesDetails" roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesReconciliationofofAccountsReceivableAllowanceforCreditLossesDetails">
        <link:definition>9955525 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - Reconciliation of of Accounts Receivable Allowance for Credit Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofOperationsandSummaryofSignificantAccountingPoliciesNetLossGainonDispositionorImpairmentRelatedtoContinuingOperationsDetails" roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNetLossGainonDispositionorImpairmentRelatedtoContinuingOperationsDetails">
        <link:definition>9955526 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - Net Loss (Gain) on Disposition or Impairment Related to Continuing Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails" roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails">
        <link:definition>9955527 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - Impairment Losses and Disposal Gains and Losses Recorded in (Loss) Income from Discontinued Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails" roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails">
        <link:definition>9955528 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - Earnings (Loss) Per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisclosuresNarrativeDetails" roleURI="http://www.thejoint.com/role/RevenueDisclosuresNarrativeDetails">
        <link:definition>9955529 - Disclosure - Revenue Disclosures - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisclosuresDisaggregationofRevenueDetails" roleURI="http://www.thejoint.com/role/RevenueDisclosuresDisaggregationofRevenueDetails">
        <link:definition>9955530 - Disclosure - Revenue Disclosures - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisclosuresRollforwardofAccountsReceivableDetails" roleURI="http://www.thejoint.com/role/RevenueDisclosuresRollforwardofAccountsReceivableDetails">
        <link:definition>9955531 - Disclosure - Revenue Disclosures - Rollforward of Accounts Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisclosuresRollforwardofContractLiabilitiesDetails" roleURI="http://www.thejoint.com/role/RevenueDisclosuresRollforwardofContractLiabilitiesDetails">
        <link:definition>9955532 - Disclosure - Revenue Disclosures - Rollforward of Contract Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisclosuresRollforwardofDeferredFranchiseandDevelopmentCostsDetails" roleURI="http://www.thejoint.com/role/RevenueDisclosuresRollforwardofDeferredFranchiseandDevelopmentCostsDetails">
        <link:definition>9955533 - Disclosure - Revenue Disclosures - Rollforward of Deferred Franchise and Development Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisclosuresEstimatedRevenueRelatedtoPerformanceObligationsDetails" roleURI="http://www.thejoint.com/role/RevenueDisclosuresEstimatedRevenueRelatedtoPerformanceObligationsDetails">
        <link:definition>9955534 - Disclosure - Revenue Disclosures - Estimated Revenue Related to Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisclosuresEstimatedRevenueRelatedtoPerformanceObligationsDetails_1" roleURI="http://www.thejoint.com/role/RevenueDisclosuresEstimatedRevenueRelatedtoPerformanceObligationsDetails_1">
        <link:definition>9955534 - Disclosure - Revenue Disclosures - Estimated Revenue Related to Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails" roleURI="http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails">
        <link:definition>9955535 - Disclosure - Divestitures - Key Components of Net (Loss) Income from Discontinued Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails" roleURI="http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails">
        <link:definition>9955536 - Disclosure - Divestitures - Assets and Liabilities of Discontinued Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DivestituresKeyComponentsofCashFlowsfromDiscontinuedOperationsDetails" roleURI="http://www.thejoint.com/role/DivestituresKeyComponentsofCashFlowsfromDiscontinuedOperationsDetails">
        <link:definition>9955537 - Disclosure - Divestitures - Key Components of Cash Flows from Discontinued Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DivestituresNarrativeDetails" roleURI="http://www.thejoint.com/role/DivestituresNarrativeDetails">
        <link:definition>9955538 - Disclosure - Divestitures - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails" roleURI="http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails">
        <link:definition>9955539 - Disclosure - Divestitures - Held For Sale Assets and Liabilities To Be Disposed Of (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentSummaryofPropertyandEquipmentDetails" roleURI="http://www.thejoint.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails">
        <link:definition>9955540 - Disclosure - Property and Equipment - Summary of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNarrativeDetails" roleURI="http://www.thejoint.com/role/PropertyandEquipmentNarrativeDetails">
        <link:definition>9955541 - Disclosure - Property and Equipment - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueConsiderationDetails" roleURI="http://www.thejoint.com/role/FairValueConsiderationDetails">
        <link:definition>9955542 - Disclosure - Fair Value Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtDetails" roleURI="http://www.thejoint.com/role/DebtDetails">
        <link:definition>9955543 - Disclosure - Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDetails" roleURI="http://www.thejoint.com/role/StockholdersEquityDetails">
        <link:definition>9955544 - Disclosure - Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationNarrativeDetails" roleURI="http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails">
        <link:definition>9955545 - Disclosure - Stock-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationValuationAssumptionsusedforStockOptionsDetails" roleURI="http://www.thejoint.com/role/StockBasedCompensationValuationAssumptionsusedforStockOptionsDetails">
        <link:definition>9955546 - Disclosure - Stock-Based Compensation - Valuation Assumptions used for Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockOptionsActivityDetails" roleURI="http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails">
        <link:definition>9955547 - Disclosure - Stock-Based Compensation - Stock Options Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationRestrictedStockActivityDetails" roleURI="http://www.thejoint.com/role/StockBasedCompensationRestrictedStockActivityDetails">
        <link:definition>9955548 - Disclosure - Stock-Based Compensation - Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesLossFromContinuingOperationsBeforetheProvisionforIncomeTaxesDetails" roleURI="http://www.thejoint.com/role/IncomeTaxesLossFromContinuingOperationsBeforetheProvisionforIncomeTaxesDetails">
        <link:definition>9955549 - Disclosure - Income Taxes - Loss From Continuing Operations Before the Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxExpenseDetails" roleURI="http://www.thejoint.com/role/IncomeTaxesIncomeTaxExpenseDetails">
        <link:definition>9955550 - Disclosure - Income Taxes - Income Tax Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>9955551 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.thejoint.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>9955552 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesEffectiveIncomeTaxReconciliationDetails" roleURI="http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails">
        <link:definition>9955553 - Disclosure - Income Taxes - Effective Income Tax Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesUncertainTaxPositionRollforwardDetails" roleURI="http://www.thejoint.com/role/IncomeTaxesUncertainTaxPositionRollforwardDetails">
        <link:definition>9955554 - Disclosure - Income Taxes - Uncertain Tax Position Rollforward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails" roleURI="http://www.thejoint.com/role/IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails">
        <link:definition>9955555 - Disclosure - Income Taxes - Cash Paid For Income Taxes (Net of Refunds Received) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails" roleURI="http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails">
        <link:definition>9955556 - Disclosure - Commitments and Contingencies - Lease Expense and Supplemental Lease Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails" roleURI="http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails">
        <link:definition>9955557 - Disclosure - Commitments and Contingencies - Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails_1" roleURI="http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails_1">
        <link:definition>9955557 - Disclosure - Commitments and Contingencies - Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesNarrativeDetails" roleURI="http://www.thejoint.com/role/CommitmentsandContingenciesNarrativeDetails">
        <link:definition>9955558 - Disclosure - Commitments and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingNarrativeDetails" roleURI="http://www.thejoint.com/role/SegmentReportingNarrativeDetails">
        <link:definition>9955559 - Disclosure - Segment Reporting - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails" roleURI="http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails">
        <link:definition>9955560 - Disclosure - Segment Reporting - Total Revenue and Significant Expense Categories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsDetails" roleURI="http://www.thejoint.com/role/RelatedPartyTransactionsDetails">
        <link:definition>9955561 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyFinancialDataUnauditedDetails" roleURI="http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails">
        <link:definition>9955562 - Disclosure - Quarterly Financial Data (Unaudited) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="jynt_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jynt_CoOpFundsLiabilityCurrent" abstract="false" name="CoOpFundsLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_UpfrontRegionalDeveloperFeesCurrent" abstract="false" name="UpfrontRegionalDeveloperFeesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_UpfrontRegionalDeveloperFeesNoncurrent" abstract="false" name="UpfrontRegionalDeveloperFeesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract" abstract="true" name="IncomeLossFromContinuingOperationsPerBasicShareAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jynt_NetGainLossOnDispositionOfAssetsOrAssetImpairment" abstract="false" name="NetGainLossOnDispositionOfAssetsOrAssetImpairment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_GainLossOnTerminationOfFranchisingAgreements" abstract="false" name="GainLossOnTerminationOfFranchisingAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_IncreaseDecreaseInRegionalDeveloperFees" abstract="false" name="IncreaseDecreaseInRegionalDeveloperFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_SupplementalCashFlowNetCashPaidAbstract" abstract="true" name="SupplementalCashFlowNetCashPaidAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jynt_StockOptionExerciseReceivable" abstract="false" name="StockOptionExerciseReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_NatureofOperationsPolicyPolicyTextBlock" abstract="false" name="NatureofOperationsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="jynt_AdvertisingFundPolicyTextBlock" abstract="false" name="AdvertisingFundPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="jynt_CoOpMarketingFundsPolicyPolicyTextBlock" abstract="false" name="CoOpMarketingFundsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="jynt_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="jynt_CorporateClinicsMember" abstract="true" name="CorporateClinicsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward" abstract="true" name="ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jynt_ClinicsOpenedDuringThePeriod" abstract="false" name="ClinicsOpenedDuringThePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="jynt_ClinicsAcquiredDuringPeriod" abstract="false" name="ClinicsAcquiredDuringPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="jynt_ClinicsSoldDuringPeriod" abstract="false" name="ClinicsSoldDuringPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="jynt_ClinicsClosedDuringThePeriod" abstract="false" name="ClinicsClosedDuringThePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="jynt_ClinicLicensesSoldButNotYetDeveloped" abstract="false" name="ClinicLicensesSoldButNotYetDeveloped" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="jynt_ExecutedLettersOfIntentForFutureClinicLicenses" abstract="false" name="ExecutedLettersOfIntentForFutureClinicLicenses" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="jynt_OperatingLeaseRightOfUseAssetMember" abstract="true" name="OperatingLeaseRightOfUseAssetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="jynt_KansasAndMissouriMember" abstract="true" name="KansasAndMissouriMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="jynt_ManagementAgreementNumberOfProfessionalCorporations" abstract="false" name="ManagementAgreementNumberOfProfessionalCorporations" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="jynt_ManagementAgreementTerminationNumberOfProfessionalCorporations" abstract="false" name="ManagementAgreementTerminationNumberOfProfessionalCorporations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="jynt_LesseeOperatingLeaseNumberOfRenewalOptions" abstract="false" name="LesseeOperatingLeaseNumberOfRenewalOptions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage" abstract="false" name="FranchiseMonthlyMarketingFeeGrossSalesPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="jynt_FranchiseRoyaltyGrossSalesPercentage" abstract="false" name="FranchiseRoyaltyGrossSalesPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="jynt_RevenueRecognitionFranchiseAgreementTerm" abstract="false" name="RevenueRecognitionFranchiseAgreementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" abstract="false" name="RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment" abstract="false" name="ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment" abstract="false" name="ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_DiscontinuedOperationsHeldForUseMember" abstract="true" name="DiscontinuedOperationsHeldForUseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="jynt_AssetsHeldForSaleMember" abstract="true" name="AssetsHeldForSaleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="jynt_AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward" abstract="true" name="AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jynt_AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance" abstract="false" name="AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance" abstract="false" name="AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_ContractWithCustomerLiabilityRollForward" abstract="true" name="ContractWithCustomerLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jynt_ContractWithCustomerAssetRollForward" abstract="true" name="ContractWithCustomerAssetRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jynt_ContractWithCustomerAssetRecognizedAsCostsOfRevenue" abstract="false" name="ContractWithCustomerAssetRecognizedAsCostsOfRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_CostsIncurredAndDeferredDuringTheYear" abstract="false" name="CostsIncurredAndDeferredDuringTheYear" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_CapitalExpendituresDiscontinuedOperationsAbstract" abstract="true" name="CapitalExpendituresDiscontinuedOperationsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jynt_DisposalGroupHeldForSaleClinicsExpectedToSellPeriod" abstract="false" name="DisposalGroupHeldForSaleClinicsExpectedToSellPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="jynt_DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" abstract="true" name="PropertyPlantAndEquipmentExcludingConstructionInProgressMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="jynt_AssetsHeldForSaleCashFlowForecastPeriod" abstract="false" name="AssetsHeldForSaleCashFlowForecastPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="jynt_AssetsHeldForSaleMeasurementInputPositiveCashFlow" abstract="false" name="AssetsHeldForSaleMeasurementInputPositiveCashFlow" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="jynt_AssetsHeldForSaleMeasurementInputNegativeCashFlow" abstract="false" name="AssetsHeldForSaleMeasurementInputNegativeCashFlow" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="jynt_DevelopmentLineOfCreditMember" abstract="true" name="DevelopmentLineOfCreditMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="jynt_SeniorSecuredCreditFacilitiesMember" abstract="true" name="SeniorSecuredCreditFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="jynt_A2022CreditFacilityMember" abstract="true" name="A2022CreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="jynt_FederalReserveBankOfNewYorkRateMember" abstract="true" name="FederalReserveBankOfNewYorkRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="jynt_LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount" abstract="false" name="LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_ShareRepurchaseProgramAdditionalAuthorizedAmount" abstract="false" name="ShareRepurchaseProgramAdditionalAuthorizedAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments" abstract="false" name="ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="jynt_DeferredTaxAssetsOperatingLeaseLiability" abstract="false" name="DeferredTaxAssetsOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_DeferredTaxAssetsGoodwillComponent1" abstract="false" name="DeferredTaxAssetsGoodwillComponent1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_DeferredTaxAssetsGoodwillComponent2" abstract="false" name="DeferredTaxAssetsGoodwillComponent2" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_DeferredTaxAssetsNonqualifiedStockOptions" abstract="false" name="DeferredTaxAssetsNonqualifiedStockOptions" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_DeferredTaxAssetsIntangibleAssets" abstract="false" name="DeferredTaxAssetsIntangibleAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" abstract="false" name="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_DeferredTaxLiabilitiesDeferredFranchiseCosts" abstract="false" name="DeferredTaxLiabilitiesDeferredFranchiseCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_CaliforniaAlternativeMinimumTaxCreditMember" abstract="true" name="CaliforniaAlternativeMinimumTaxCreditMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="jynt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" abstract="true" name="OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jynt_WeightedAverageRemainingLeaseTermAbstract" abstract="true" name="WeightedAverageRemainingLeaseTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jynt_LeasesWeightedAverageDiscountRateAbstract" abstract="true" name="LeasesWeightedAverageDiscountRateAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jynt_CashFlowLesseeAbstract" abstract="true" name="CashFlowLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jynt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" abstract="true" name="RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jynt_EmploymentMattersMember" abstract="true" name="EmploymentMattersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="jynt_MedicalInjuryClaimMember" abstract="true" name="MedicalInjuryClaimMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="jynt_NumberOfFutureOperatingLeasesCommitted" abstract="false" name="NumberOfFutureOperatingLeasesCommitted" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="jynt_GuarantorObligationsRemainingExposureUndiscounted" abstract="false" name="GuarantorObligationsRemainingExposureUndiscounted" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_FranchiseOperationsMember" abstract="true" name="FranchiseOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="jynt_GeneralAndAdministrativeExpenseAdjusted" abstract="false" name="GeneralAndAdministrativeExpenseAdjusted" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_BanderaPartnersLLCMember" abstract="true" name="BanderaPartnersLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="jynt_FranchiseLicensesMember" abstract="true" name="FranchiseLicensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="jynt_FranchiseLicensesOneMember" abstract="true" name="FranchiseLicensesOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="jynt_FranchiseLicensesTwoMember" abstract="true" name="FranchiseLicensesTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="jynt_UnaffiliatedFranchiseeMember" abstract="true" name="UnaffiliatedFranchiseeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="jynt_MrJeffersonGrammMember" abstract="true" name="MrJeffersonGrammMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="jynt_RelatedPartyTransactionAmountsOfTransactionDiscount" abstract="false" name="RelatedPartyTransactionAmountsOfTransactionDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jynt_RelatedPartyTransactionCoPartnerPercentage" abstract="false" name="RelatedPartyTransactionCoPartnerPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="jynt_RelatedPartyTransactionCoPartnerPercentageDivested" abstract="false" name="RelatedPartyTransactionCoPartnerPercentageDivested" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="jynt_NumberOfClinics" abstract="false" name="NumberOfClinics" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>jynt-20251231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019b096a-603d-78f6-a834-c229229c770d,g:a2c624eb-8b4f-420f-a77d-d91a250e6a25-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.thejoint.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="jynt-20251231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019b096a-61dc-731f-baf5-375d80fa7ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019b096a-61dc-77d5-be4d-d3bb51e3c139" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019b096a-61dc-731f-baf5-375d80fa7ea5" xlink:to="loc_us-gaap_AccountsPayableCurrent_019b096a-61dc-77d5-be4d-d3bb51e3c139" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019b096a-61dc-79a6-b604-3c8354b5d47c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019b096a-61dc-731f-baf5-375d80fa7ea5" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019b096a-61dc-79a6-b604-3c8354b5d47c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CoOpFundsLiabilityCurrent_019b096a-61dc-72fc-be5a-8b5b0057d832" xlink:href="jynt-20251231.xsd#jynt_CoOpFundsLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019b096a-61dc-731f-baf5-375d80fa7ea5" xlink:to="loc_jynt_CoOpFundsLiabilityCurrent_019b096a-61dc-72fc-be5a-8b5b0057d832" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019b096a-61dc-798c-8c7d-fd633f389436" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019b096a-61dc-731f-baf5-375d80fa7ea5" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019b096a-61dc-798c-8c7d-fd633f389436" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019b096a-61dc-7cd5-aba1-54c1bf2375f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019b096a-61dc-731f-baf5-375d80fa7ea5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019b096a-61dc-7cd5-aba1-54c1bf2375f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019b096a-61dc-7b42-af1a-9e1feeac9fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019b096a-61dc-731f-baf5-375d80fa7ea5" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019b096a-61dc-7b42-af1a-9e1feeac9fd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_UpfrontRegionalDeveloperFeesCurrent_019b096a-61dc-7f7f-a9db-dcdd2df44307" xlink:href="jynt-20251231.xsd#jynt_UpfrontRegionalDeveloperFeesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019b096a-61dc-731f-baf5-375d80fa7ea5" xlink:to="loc_jynt_UpfrontRegionalDeveloperFeesCurrent_019b096a-61dc-7f7f-a9db-dcdd2df44307" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_019b096a-61dc-7fc3-a982-50bc8ea1f46c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019b096a-61dc-731f-baf5-375d80fa7ea5" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_019b096a-61dc-7fc3-a982-50bc8ea1f46c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-61dc-7510-83b0-19b33a242cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019b096a-61dc-731f-baf5-375d80fa7ea5" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-61dc-7510-83b0-19b33a242cfb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019b096a-61dc-7fe5-a2d6-f74cd7415ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_019b096a-61dc-7d8b-898b-1aa507e0d7be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerAssetNetNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019b096a-61dc-7fe5-a2d6-f74cd7415ed1" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_019b096a-61dc-7d8b-898b-1aa507e0d7be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019b096a-61dc-78b8-bc96-4df095ef2bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019b096a-61dc-7fe5-a2d6-f74cd7415ed1" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019b096a-61dc-78b8-bc96-4df095ef2bcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019b096a-61dc-71cf-a42d-39f33cd9188d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019b096a-61dc-7fe5-a2d6-f74cd7415ed1" xlink:to="loc_us-gaap_AssetsCurrent_019b096a-61dc-71cf-a42d-39f33cd9188d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_019b096a-61dc-7a4d-a837-36bc075eee3f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019b096a-61dc-7fe5-a2d6-f74cd7415ed1" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent_019b096a-61dc-7a4d-a837-36bc075eee3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019b096a-61dc-72c2-be16-d6d12cee4e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019b096a-61dc-7fe5-a2d6-f74cd7415ed1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019b096a-61dc-72c2-be16-d6d12cee4e5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019b096a-61dc-7f86-a90f-64ba542a6fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_019b096a-61dc-74b4-a981-aa6ed23ff2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019b096a-61dc-7f86-a90f-64ba542a6fc6" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_019b096a-61dc-74b4-a981-aa6ed23ff2a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019b096a-61dc-7c43-aa0e-3f839f144106" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019b096a-61dc-7f86-a90f-64ba542a6fc6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019b096a-61dc-7c43-aa0e-3f839f144106" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_019b096a-61dc-7c9a-b14b-f08c75bcb271" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019b096a-61dc-7f86-a90f-64ba542a6fc6" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_019b096a-61dc-7c9a-b14b-f08c75bcb271" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_019b096a-61dc-7ece-b6b1-74e489414127" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019b096a-61dc-7f86-a90f-64ba542a6fc6" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_019b096a-61dc-7ece-b6b1-74e489414127" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019b096a-61dc-7a82-8895-069e03d405cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019b096a-61dc-7f86-a90f-64ba542a6fc6" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019b096a-61dc-7a82-8895-069e03d405cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-61dc-7cd3-a8e7-cf9bbd66c3f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019b096a-61dc-7f86-a90f-64ba542a6fc6" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-61dc-7cd3-a8e7-cf9bbd66c3f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019b096a-61dc-74be-8d6c-ca4aad58c2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019b096a-61dc-77b2-809e-16eade9427c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019b096a-61dc-74be-8d6c-ca4aad58c2b3" xlink:to="loc_us-gaap_LiabilitiesCurrent_019b096a-61dc-77b2-809e-16eade9427c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019b096a-61dc-7046-9824-e7ee1a7cddb1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019b096a-61dc-74be-8d6c-ca4aad58c2b3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019b096a-61dc-7046-9824-e7ee1a7cddb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_019b096a-61dc-7509-bae7-617bd8c0f38e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019b096a-61dc-74be-8d6c-ca4aad58c2b3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_019b096a-61dc-7509-bae7-617bd8c0f38e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_UpfrontRegionalDeveloperFeesNoncurrent_019b096a-61dc-7151-a333-a02905262b8c" xlink:href="jynt-20251231.xsd#jynt_UpfrontRegionalDeveloperFeesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019b096a-61dc-74be-8d6c-ca4aad58c2b3" xlink:to="loc_jynt_UpfrontRegionalDeveloperFeesNoncurrent_019b096a-61dc-7151-a333-a02905262b8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_019b096a-61dc-7cad-b799-482366bad7ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019b096a-61dc-7b47-9584-80b8047575ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_019b096a-61dc-7cad-b799-482366bad7ff" xlink:to="loc_us-gaap_StockholdersEquity_019b096a-61dc-7b47-9584-80b8047575ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_019b096a-61dc-72ae-bce3-b45272c64133" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_019b096a-61dc-7cad-b799-482366bad7ff" xlink:to="loc_us-gaap_MinorityInterest_019b096a-61dc-72ae-bce3-b45272c64133" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019b096a-61dc-7f44-b647-6446e0ac8957" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019b096a-61dc-75bd-9995-e8bdc624832b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019b096a-61dc-7f44-b647-6446e0ac8957" xlink:to="loc_us-gaap_Liabilities_019b096a-61dc-75bd-9995-e8bdc624832b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019b096a-61dc-7ad5-a42b-6c64016e856a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019b096a-61dc-7f44-b647-6446e0ac8957" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019b096a-61dc-7ad5-a42b-6c64016e856a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_019b096a-61dc-7e9b-b759-a8e303f5fc9c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019b096a-61dc-7f44-b647-6446e0ac8957" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_019b096a-61dc-7e9b-b759-a8e303f5fc9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019b096a-61dc-7d6f-8447-3862bd298637" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_019b096a-61dc-7a6f-8024-806c792c5bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019b096a-61dc-7d6f-8447-3862bd298637" xlink:to="loc_us-gaap_PreferredStockValue_019b096a-61dc-7a6f-8024-806c792c5bb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019b096a-61dc-78a3-bf98-c0c456728adc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019b096a-61dc-7d6f-8447-3862bd298637" xlink:to="loc_us-gaap_CommonStockValue_019b096a-61dc-78a3-bf98-c0c456728adc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019b096a-61dc-7a95-b602-2cbf4089bc0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019b096a-61dc-7d6f-8447-3862bd298637" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019b096a-61dc-7a95-b602-2cbf4089bc0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_019b096a-61dc-7b4a-a0e5-036377893581" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019b096a-61dc-7d6f-8447-3862bd298637" xlink:to="loc_us-gaap_TreasuryStockCommonValue_019b096a-61dc-7b4a-a0e5-036377893581" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019b096a-61dc-742e-a2dd-509ad154dc78" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019b096a-61dc-7d6f-8447-3862bd298637" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019b096a-61dc-742e-a2dd-509ad154dc78" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/ConsolidatedIncomeStatements" xlink:type="simple" xlink:href="jynt-20251231.xsd#ConsolidatedIncomeStatements"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/role/ConsolidatedIncomeStatements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019b096a-61dc-74e1-9dd3-2297dc1d93a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_019b096a-61dc-7058-b1ad-f2d18cbed17e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019b096a-61dc-74e1-9dd3-2297dc1d93a0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_019b096a-61dc-7058-b1ad-f2d18cbed17e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_019b096a-61dc-7222-932f-7404f58aa1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019b096a-61dc-74e1-9dd3-2297dc1d93a0" xlink:to="loc_us-gaap_CostOfRevenue_019b096a-61dc-7222-932f-7404f58aa1fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019b096a-61dc-70fc-981d-0833b73af976" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019b096a-61dc-74e1-9dd3-2297dc1d93a0" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019b096a-61dc-70fc-981d-0833b73af976" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_019b096a-61dc-715a-8f4f-abb0c3c93bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019b096a-61dc-74e1-9dd3-2297dc1d93a0" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_019b096a-61dc-715a-8f4f-abb0c3c93bf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019b096a-61dc-7713-8d58-73535b7c89dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_019b096a-61dc-7d9d-b2a5-837f9697d748" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019b096a-61dc-7713-8d58-73535b7c89dc" xlink:to="loc_us-gaap_SellingAndMarketingExpense_019b096a-61dc-7d9d-b2a5-837f9697d748" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_019b096a-61dc-7497-8f5d-81dd320f75e4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019b096a-61dc-7713-8d58-73535b7c89dc" xlink:to="loc_us-gaap_DepreciationAndAmortization_019b096a-61dc-7497-8f5d-81dd320f75e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019b096a-61dc-78b3-96a4-194fa9d34395" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019b096a-61dc-7713-8d58-73535b7c89dc" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019b096a-61dc-78b3-96a4-194fa9d34395" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_019b096a-61dc-7855-86f1-a9f7134fdd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-61dc-7d5c-ac56-e0d60ab04695" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_019b096a-61dc-7855-86f1-a9f7134fdd7b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-61dc-7d5c-ac56-e0d60ab04695" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-61dc-7b67-863b-3b98bcd2aedd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_019b096a-61dc-7855-86f1-a9f7134fdd7b" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-61dc-7b67-863b-3b98bcd2aedd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019b096a-61dc-7065-a361-fda6c7b30b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019b096a-61dc-7688-a37a-d268d5cae54c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019b096a-61dc-7065-a361-fda6c7b30b5f" xlink:to="loc_us-gaap_OperatingIncomeLoss_019b096a-61dc-7688-a37a-d268d5cae54c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019b096a-61dc-7bb0-ae84-49f14ae0de33" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019b096a-61dc-7065-a361-fda6c7b30b5f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019b096a-61dc-7bb0-ae84-49f14ae0de33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_019b096a-61dc-7c58-b2ad-23e82e80ee8a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfRevenue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_019b096a-61dc-7c23-8975-58ad58f8a00d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostOfRevenue_019b096a-61dc-7c58-b2ad-23e82e80ee8a" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_019b096a-61dc-7c23-8975-58ad58f8a00d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_019b096a-61dc-71e9-b818-9b9ffa7a8fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_019b096a-61dc-7160-852e-6a0aa87f3b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_019b096a-61dc-71e9-b818-9b9ffa7a8fcb" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_019b096a-61dc-7160-852e-6a0aa87f3b1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_019b096a-61dc-77f8-9da7-46ab620df307" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_019b096a-61dc-71e9-b818-9b9ffa7a8fcb" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_019b096a-61dc-77f8-9da7-46ab620df307" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-61dc-77ec-8cb3-319f37ce9c43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b096a-61dc-708d-956e-e50a7197a1d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-61dc-77ec-8cb3-319f37ce9c43" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b096a-61dc-708d-956e-e50a7197a1d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_019b096a-61dc-7d38-84ea-6d07e8aeda00" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-61dc-77ec-8cb3-319f37ce9c43" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_019b096a-61dc-7d38-84ea-6d07e8aeda00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_019b096a-61dc-70ae-b24d-1fbc8887df98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_019b096a-61dc-7edc-9b7f-2a7f2ad02b95" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_019b096a-61dc-70ae-b24d-1fbc8887df98" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_019b096a-61dc-7edc-9b7f-2a7f2ad02b95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_019b096a-61dc-7ace-9694-db1d7c66df5f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_019b096a-61dc-70ae-b24d-1fbc8887df98" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_019b096a-61dc-7ace-9694-db1d7c66df5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-61dc-7c6f-a2ae-09b78d021b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019b096a-61dc-7ea3-9445-b6b706db956e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-61dc-7c6f-a2ae-09b78d021b3a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019b096a-61dc-7ea3-9445-b6b706db956e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-62aa-7976-aa9c-a6a09b38edd4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-61dc-7c6f-a2ae-09b78d021b3a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-62aa-7976-aa9c-a6a09b38edd4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="jynt-20251231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b096a-62ab-7cdd-bc7c-d79fda1727f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019b096a-62ab-7f41-a1b6-bf10a0e7caf6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b096a-62ab-7cdd-bc7c-d79fda1727f0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019b096a-62ab-7f41-a1b6-bf10a0e7caf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_019b096a-62ab-7f05-bfae-c4a8d985335a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b096a-62ab-7cdd-bc7c-d79fda1727f0" xlink:to="loc_us-gaap_ProfitLoss_019b096a-62ab-7f05-bfae-c4a8d985335a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDepositOtherAssets_019b096a-62ab-71e5-9a77-8d609928fb58" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b096a-62ab-7cdd-bc7c-d79fda1727f0" xlink:to="loc_us-gaap_IncreaseDecreaseInDepositOtherAssets_019b096a-62ab-71e5-9a77-8d609928fb58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_019b096a-62ab-72de-aba6-28c7ad08a7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b096a-62ab-7cdd-bc7c-d79fda1727f0" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_019b096a-62ab-72de-aba6-28c7ad08a7d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019b096a-62ab-7dbb-9878-011651119286" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b096a-62ab-7cdd-bc7c-d79fda1727f0" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019b096a-62ab-7dbb-9878-011651119286" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_019b096a-62ab-73a7-a0ef-2fb8f5b64281" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b096a-62ab-7cdd-bc7c-d79fda1727f0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_019b096a-62ab-73a7-a0ef-2fb8f5b64281" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019b096a-62ab-7e1f-a33e-8184d8404feb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b096a-62ab-7cdd-bc7c-d79fda1727f0" xlink:to="loc_us-gaap_ShareBasedCompensation_019b096a-62ab-7e1f-a33e-8184d8404feb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_019b096a-62ab-77ff-a8ee-afcc77fd2f44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b096a-62ab-7cdd-bc7c-d79fda1727f0" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_019b096a-62ab-77ff-a8ee-afcc77fd2f44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_019b096a-62ab-7743-b905-8e66c9ea6bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b096a-62ab-7cdd-bc7c-d79fda1727f0" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_019b096a-62ab-7743-b905-8e66c9ea6bdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019b096a-62ab-7d16-85d9-e9b60a5ef9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b096a-62ab-7cdd-bc7c-d79fda1727f0" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019b096a-62ab-7d16-85d9-e9b60a5ef9cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_019b096a-62ab-74a7-9bf2-47c031525774" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b096a-62ab-7cdd-bc7c-d79fda1727f0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_019b096a-62ab-74a7-9bf2-47c031525774" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_GainLossOnTerminationOfFranchisingAgreements_019b096a-62ab-7147-9593-59d6fa86ef8f" xlink:href="jynt-20251231.xsd#jynt_GainLossOnTerminationOfFranchisingAgreements"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b096a-62ab-7cdd-bc7c-d79fda1727f0" xlink:to="loc_jynt_GainLossOnTerminationOfFranchisingAgreements_019b096a-62ab-7147-9593-59d6fa86ef8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_019b096a-62ab-7641-87d5-8c44cfacac19" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b096a-62ab-7cdd-bc7c-d79fda1727f0" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_019b096a-62ab-7641-87d5-8c44cfacac19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_NetGainLossOnDispositionOfAssetsOrAssetImpairment_019b096a-62ab-7809-9146-246d60d8cdad" xlink:href="jynt-20251231.xsd#jynt_NetGainLossOnDispositionOfAssetsOrAssetImpairment"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b096a-62ab-7cdd-bc7c-d79fda1727f0" xlink:to="loc_jynt_NetGainLossOnDispositionOfAssetsOrAssetImpairment_019b096a-62ab-7809-9146-246d60d8cdad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_019b096a-62ab-78d3-9e42-664f5a9fbce5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b096a-62ab-7cdd-bc7c-d79fda1727f0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_019b096a-62ab-78d3-9e42-664f5a9fbce5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_019b096a-62ab-7a6b-85e5-8b16057b16ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b096a-62ab-7cdd-bc7c-d79fda1727f0" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_019b096a-62ab-7a6b-85e5-8b16057b16ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_IncreaseDecreaseInRegionalDeveloperFees_019b096a-62ab-7df6-958d-a349d988fcb9" xlink:href="jynt-20251231.xsd#jynt_IncreaseDecreaseInRegionalDeveloperFees"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b096a-62ab-7cdd-bc7c-d79fda1727f0" xlink:to="loc_jynt_IncreaseDecreaseInRegionalDeveloperFees_019b096a-62ab-7df6-958d-a349d988fcb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019b096a-62ab-7763-b64b-5582a59ce6a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b096a-62ab-7cdd-bc7c-d79fda1727f0" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019b096a-62ab-7763-b64b-5582a59ce6a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019b096a-62ab-76b5-a2fe-d6eebb7b8844" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_019b096a-62ab-7308-aa2d-407bff8a983c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019b096a-62ab-76b5-a2fe-d6eebb7b8844" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_019b096a-62ab-7308-aa2d-407bff8a983c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_019b096a-62ab-76ce-940e-53f2224c06d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019b096a-62ab-76b5-a2fe-d6eebb7b8844" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_019b096a-62ab-76ce-940e-53f2224c06d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_019b096a-62ab-7245-8ff3-63fcab9979f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019b096a-62ab-76b5-a2fe-d6eebb7b8844" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_019b096a-62ab-7245-8ff3-63fcab9979f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_019b096a-62ab-7109-bdf7-15efb9921ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019b096a-62ab-76b5-a2fe-d6eebb7b8844" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_019b096a-62ab-7109-bdf7-15efb9921ee8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_019b32bf-18ec-7987-87df-bf0f9b511c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019b096a-62ab-76b5-a2fe-d6eebb7b8844" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_019b32bf-18ec-7987-87df-bf0f9b511c2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019b096a-62ab-758d-b407-002d788881f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b096a-62ab-7c10-97fd-66e948dbc1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019b096a-62ab-758d-b407-002d788881f9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b096a-62ab-7c10-97fd-66e948dbc1a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019b096a-62ab-7988-9268-0030f5368e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019b096a-62ab-758d-b407-002d788881f9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019b096a-62ab-7988-9268-0030f5368e4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019b096a-62ab-7508-a55e-5505d15f4859" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019b096a-62ab-758d-b407-002d788881f9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019b096a-62ab-7508-a55e-5505d15f4859" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019b096a-62ab-7947-9448-6bcdf4247386" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_019b096a-62ab-7cba-b6aa-57108311fed6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019b096a-62ab-7947-9448-6bcdf4247386" xlink:to="loc_us-gaap_RestrictedCash_019b096a-62ab-7cba-b6aa-57108311fed6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019b096a-62ab-718b-9457-0ec92ee0c4af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019b096a-62ab-7947-9448-6bcdf4247386" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019b096a-62ab-718b-9457-0ec92ee0c4af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019b096a-62ab-7da0-b9df-0ff6d2fe559c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019b096a-62ab-701e-9034-3a4fc65d0496" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019b096a-62ab-7da0-b9df-0ff6d2fe559c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019b096a-62ab-701e-9034-3a4fc65d0496" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_019b096a-62ab-77d0-8d48-9e1a626de2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019b096a-62ab-7da0-b9df-0ff6d2fe559c" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_019b096a-62ab-77d0-8d48-9e1a626de2f6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019b096a-62ab-7025-a956-77478f7fc35d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019b096a-62ab-7ba5-8530-2cdb65ee4f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019b096a-62ab-7025-a956-77478f7fc35d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019b096a-62ab-7ba5-8530-2cdb65ee4f3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_019b096a-62ab-7322-89e3-abab8ac726da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019b096a-62ab-7025-a956-77478f7fc35d" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_019b096a-62ab-7322-89e3-abab8ac726da" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses_019b096a-62ab-790b-8445-dab1a91de70f" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses_019b096a-62ab-7d53-a908-59b08d50530d" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses_019b096a-62ab-790b-8445-dab1a91de70f" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses_019b096a-62ab-7d53-a908-59b08d50530d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_019b096a-62ab-7305-b6f3-f775cfd861f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses_019b096a-62ab-790b-8445-dab1a91de70f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_019b096a-62ab-7305-b6f3-f775cfd861f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_019b096a-62ab-7fa6-aa1b-415832961343" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses_019b096a-62ab-790b-8445-dab1a91de70f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_019b096a-62ab-7fa6-aa1b-415832961343" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b096a-62ab-7b80-b829-188f89412463" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_019b096a-62ab-78c4-9250-86d261a2209f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b096a-62ab-7b80-b829-188f89412463" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_019b096a-62ab-78c4-9250-86d261a2209f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_019b096a-62ab-7458-9ca4-63345858b9c1" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b096a-62ab-7b80-b829-188f89412463" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_019b096a-62ab-7458-9ca4-63345858b9c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_019b096a-62ab-7bc1-9ffc-ebf518c68981" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_019b096a-62ab-70a0-a723-416871feb6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_019b096a-62ab-7bc1-9ffc-ebf518c68981" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_019b096a-62ab-70a0-a723-416871feb6b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_019b096a-62ab-776c-8980-e25fef108e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_019b096a-62ab-7bc1-9ffc-ebf518c68981" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_019b096a-62ab-776c-8980-e25fef108e2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses_019b096a-62ab-7eab-8b91-ea516a9af5d3" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_019b096a-62ab-7bc1-9ffc-ebf518c68981" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses_019b096a-62ab-7eab-8b91-ea516a9af5d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019b096a-62ab-778f-bf95-502e11aa4fef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_019b096a-62ab-7bc1-9ffc-ebf518c68981" xlink:to="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019b096a-62ab-778f-bf95-502e11aa4fef" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_019b096a-62ab-734e-81bf-60b47e5dde63" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_019b096a-62ab-7d3e-a507-fe0fc14af6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_019b096a-62ab-734e-81bf-60b47e5dde63" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_019b096a-62ab-7d3e-a507-fe0fc14af6b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_019b096a-62ab-720f-9485-a594911b34cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_019b096a-62ab-734e-81bf-60b47e5dde63" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_019b096a-62ab-720f-9485-a594911b34cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b330e-a057-7050-945d-35e8cbc3bbe1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_019b096a-62ab-734e-81bf-60b47e5dde63" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b330e-a057-7050-945d-35e8cbc3bbe1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_019b330e-a057-7295-b097-0b214a74be90" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_019b096a-62ab-734e-81bf-60b47e5dde63" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_019b330e-a057-7295-b097-0b214a74be90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent_019b330e-a057-7260-befd-32cd3a0dcd68" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_019b096a-62ab-734e-81bf-60b47e5dde63" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent_019b330e-a057-7260-befd-32cd3a0dcd68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_019b330e-a057-7e3d-a726-2e6beef160cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_019b096a-62ab-734e-81bf-60b47e5dde63" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_019b330e-a057-7e3d-a726-2e6beef160cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_019b096a-62ab-7bb3-825f-5a2c2387df2b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_019b096a-62ab-75c0-9184-9f46d6a90000" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_019b096a-62ab-7bb3-825f-5a2c2387df2b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_019b096a-62ab-75c0-9184-9f46d6a90000" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_019b096a-62ab-7fe7-8743-02de65a8a1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_019b096a-62ab-7bb3-825f-5a2c2387df2b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_019b096a-62ab-7fe7-8743-02de65a8a1ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent_019b330e-fb36-79ab-b2f3-319ead3b1733" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_019b096a-62ab-7bb3-825f-5a2c2387df2b" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent_019b330e-fb36-79ab-b2f3-319ead3b1733" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_019b330e-fb36-7169-9b2f-57ad7e7333d6" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_019b096a-62ab-7bb3-825f-5a2c2387df2b" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_019b330e-fb36-7169-9b2f-57ad7e7333d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent_019b330e-fb36-7304-98aa-8dcb4d76869f" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_019b096a-62ab-7bb3-825f-5a2c2387df2b" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent_019b330e-fb36-7304-98aa-8dcb4d76869f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_019b330e-fb36-7a87-b40e-d9ed47e5a2c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_019b096a-62ab-7bb3-825f-5a2c2387df2b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_019b330e-fb36-7a87-b40e-d9ed47e5a2c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b330e-fb36-7463-8cd2-be7350c2b94e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_019b096a-62ab-7bb3-825f-5a2c2387df2b" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b330e-fb36-7463-8cd2-be7350c2b94e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b337b-21af-73f9-8cfd-71e5726bfaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_019b337b-21af-753c-ae26-13f850c3de86" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b337b-21af-73f9-8cfd-71e5726bfaa4" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_019b337b-21af-753c-ae26-13f850c3de86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent_019b337b-21af-765e-9b0f-e290a9278360" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b337b-21af-73f9-8cfd-71e5726bfaa4" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent_019b337b-21af-765e-9b0f-e290a9278360" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-72fa-9d59-9dc4f2ac8604" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_019b096a-62ab-79af-ac9b-440ccaab2cad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-72fa-9d59-9dc4f2ac8604" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_019b096a-62ab-79af-ac9b-440ccaab2cad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent_019b096a-62ab-712a-a43b-642f16109afe" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-72fa-9d59-9dc4f2ac8604" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent_019b096a-62ab-712a-a43b-642f16109afe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_019b096a-62ab-7bf5-95b5-d1347fe90393" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-72fa-9d59-9dc4f2ac8604" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_019b096a-62ab-7bf5-95b5-d1347fe90393" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent_019b096a-62ab-791e-8f90-4ba964145730" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-72fa-9d59-9dc4f2ac8604" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent_019b096a-62ab-791e-8f90-4ba964145730" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_019b096a-62ab-7bfb-ba19-c74277961751" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-72fa-9d59-9dc4f2ac8604" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_019b096a-62ab-7bfb-ba19-c74277961751" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#PropertyandEquipmentSummaryofPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019b096a-62ab-7269-b787-c78c1ab837f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_019b096a-62ab-70ec-b59f-011c4299823e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_019b096a-62ab-7269-b787-c78c1ab837f8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_019b096a-62ab-70ec-b59f-011c4299823e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019b096a-62ab-782f-b105-eeb40285c5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_019b096a-62ab-7269-b787-c78c1ab837f8" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019b096a-62ab-782f-b105-eeb40285c5eb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/IncomeTaxesLossFromContinuingOperationsBeforetheProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#IncomeTaxesLossFromContinuingOperationsBeforetheProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/role/IncomeTaxesLossFromContinuingOperationsBeforetheProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019c663d-861e-7c31-9571-19156c0eb913" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_019c663d-861e-7b68-a89c-707d862ff180" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019c663d-861e-7c31-9571-19156c0eb913" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_019c663d-861e-7b68-a89c-707d862ff180" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/IncomeTaxesIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#IncomeTaxesIncomeTaxExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/role/IncomeTaxesIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_019b096a-637d-7042-9ffd-aa77560fd400" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_019b096a-637d-74b5-af7f-81c4e553344e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_019b096a-637d-7042-9ffd-aa77560fd400" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_019b096a-637d-74b5-af7f-81c4e553344e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-7d68-b40c-f2e60a7a6c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_019b096a-637d-78c3-9f35-05b6e7f5e68a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-7d68-b40c-f2e60a7a6c1d" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_019b096a-637d-78c3-9f35-05b6e7f5e68a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_019b096a-637d-7bc2-b3bf-c72e4af493db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-7d68-b40c-f2e60a7a6c1d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_019b096a-637d-7bc2-b3bf-c72e4af493db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_019b096a-637d-7fb9-90b5-3a74da5f587f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_019b096a-637d-7f34-afb2-507577dc3dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_019b096a-637d-7fb9-90b5-3a74da5f587f" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_019b096a-637d-7f34-afb2-507577dc3dd6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_019c664c-711f-7e52-a2e0-d3255a210867" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_019c664c-711f-7152-803d-793e7c8659fc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_019c664c-711f-7e52-a2e0-d3255a210867" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_019c664c-711f-7152-803d-793e7c8659fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_019c664c-711f-710f-a652-0f1974fcca56" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_019c664c-711f-7e52-a2e0-d3255a210867" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_019c664c-711f-710f-a652-0f1974fcca56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_019b096a-637d-76de-83b8-e654721d763e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_019b096a-637d-768b-9263-832b0cfb2a90" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_019b096a-637d-76de-83b8-e654721d763e" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_019b096a-637d-768b-9263-832b0cfb2a90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_019b096a-637d-7704-8508-101431e79bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_019b096a-637d-76de-83b8-e654721d763e" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_019b096a-637d-7704-8508-101431e79bbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DeferredTaxAssetsOperatingLeaseLiability_019b096a-637d-737e-a0c1-6d739b61b9c6" xlink:href="jynt-20251231.xsd#jynt_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_019b096a-637d-76de-83b8-e654721d763e" xlink:to="loc_jynt_DeferredTaxAssetsOperatingLeaseLiability_019b096a-637d-737e-a0c1-6d739b61b9c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DeferredTaxAssetsGoodwillComponent1_019b096a-637d-735f-9e9c-760a599d00b1" xlink:href="jynt-20251231.xsd#jynt_DeferredTaxAssetsGoodwillComponent1"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_019b096a-637d-76de-83b8-e654721d763e" xlink:to="loc_jynt_DeferredTaxAssetsGoodwillComponent1_019b096a-637d-735f-9e9c-760a599d00b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DeferredTaxAssetsGoodwillComponent2_019b096a-637d-7931-9659-8d71edf7071b" xlink:href="jynt-20251231.xsd#jynt_DeferredTaxAssetsGoodwillComponent2"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_019b096a-637d-76de-83b8-e654721d763e" xlink:to="loc_jynt_DeferredTaxAssetsGoodwillComponent2_019b096a-637d-7931-9659-8d71edf7071b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_019b096a-637d-73b1-b917-4a70ccea489e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_019b096a-637d-76de-83b8-e654721d763e" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_019b096a-637d-73b1-b917-4a70ccea489e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DeferredTaxAssetsNonqualifiedStockOptions_019c90ad-6ccb-7807-83cc-d8de964dafaf" xlink:href="jynt-20251231.xsd#jynt_DeferredTaxAssetsNonqualifiedStockOptions"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_019b096a-637d-76de-83b8-e654721d763e" xlink:to="loc_jynt_DeferredTaxAssetsNonqualifiedStockOptions_019c90ad-6ccb-7807-83cc-d8de964dafaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_019b096a-637d-75fc-b4b9-2429cefb222c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_019b096a-637d-76de-83b8-e654721d763e" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_019b096a-637d-75fc-b4b9-2429cefb222c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_019c664e-441a-7d10-8233-eda71f85e9b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_019b096a-637d-76de-83b8-e654721d763e" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_019c664e-441a-7d10-8233-eda71f85e9b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DeferredTaxAssetsIntangibleAssets_019c664e-441a-7729-a4a9-cdf8ec57ed1b" xlink:href="jynt-20251231.xsd#jynt_DeferredTaxAssetsIntangibleAssets"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_019b096a-637d-76de-83b8-e654721d763e" xlink:to="loc_jynt_DeferredTaxAssetsIntangibleAssets_019c664e-441a-7729-a4a9-cdf8ec57ed1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_019b096a-637d-7d4d-9128-91da4a249443" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_019b096a-637d-76de-83b8-e654721d763e" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_019b096a-637d-7d4d-9128-91da4a249443" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_019b096a-637d-7862-9768-bf9253f7122a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_019b096a-637d-7952-ad5d-a31f1f082583" xlink:href="jynt-20251231.xsd#jynt_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_019b096a-637d-7862-9768-bf9253f7122a" xlink:to="loc_jynt_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_019b096a-637d-7952-ad5d-a31f1f082583" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DeferredTaxLiabilitiesDeferredFranchiseCosts_019b096a-637d-74be-91bc-630244171ab1" xlink:href="jynt-20251231.xsd#jynt_DeferredTaxLiabilitiesDeferredFranchiseCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_019b096a-637d-7862-9768-bf9253f7122a" xlink:to="loc_jynt_DeferredTaxLiabilitiesDeferredFranchiseCosts_019b096a-637d-74be-91bc-630244171ab1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_019b096a-637d-78c8-827c-630f844b5163" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_019b096a-637d-7862-9768-bf9253f7122a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_019b096a-637d-78c8-827c-630f844b5163" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_019b096a-637d-70dc-9adc-11c90e85766f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_019b096a-637d-7862-9768-bf9253f7122a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_019b096a-637d-70dc-9adc-11c90e85766f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_019b096a-637d-7060-887e-cc7cb24ec339" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_019b096a-637d-70cb-8424-e3579e9b8975" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_019b096a-637d-7060-887e-cc7cb24ec339" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_019b096a-637d-70cb-8424-e3579e9b8975" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_019b096a-637d-71c3-b47b-233d43dd93a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_019b096a-637d-7060-887e-cc7cb24ec339" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_019b096a-637d-71c3-b47b-233d43dd93a5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#IncomeTaxesEffectiveIncomeTaxReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-7f13-bc92-a93b9cd9ae62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_019b096a-637d-7578-a0e0-4b5235e7f8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-7f13-bc92-a93b9cd9ae62" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_019b096a-637d-7578-a0e0-4b5235e7f8ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_019b096a-637d-743f-9de9-40ca8d9f53b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-7f13-bc92-a93b9cd9ae62" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_019b096a-637d-743f-9de9-40ca8d9f53b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_019b096a-637d-709a-b8bd-49869e2f181e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-7f13-bc92-a93b9cd9ae62" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_019b096a-637d-709a-b8bd-49869e2f181e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount_019b096a-637d-754c-bbe0-c3f0681ddd1c" xlink:href="jynt-20251231.xsd#jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-7f13-bc92-a93b9cd9ae62" xlink:to="loc_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount_019b096a-637d-754c-bbe0-c3f0681ddd1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_019b096a-637d-773c-abbc-363683e952d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-7f13-bc92-a93b9cd9ae62" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_019b096a-637d-773c-abbc-363683e952d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount_019b096a-637d-73ac-80d5-734e3957961c" xlink:href="jynt-20251231.xsd#jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-7f13-bc92-a93b9cd9ae62" xlink:to="loc_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount_019b096a-637d-73ac-80d5-734e3957961c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_019b096a-637d-7069-b2d9-20a897c26679" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-7f13-bc92-a93b9cd9ae62" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_019b096a-637d-7069-b2d9-20a897c26679" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_019b096a-637d-716d-98bb-0d61ff17468e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-7f13-bc92-a93b9cd9ae62" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_019b096a-637d-716d-98bb-0d61ff17468e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_019b096a-637d-71b2-98a5-a8a1fb844f45" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-7f13-bc92-a93b9cd9ae62" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_019b096a-637d-71b2-98a5-a8a1fb844f45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount_019cb9c9-9703-77a9-8bab-5eb2cf02f77c" xlink:href="jynt-20251231.xsd#jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-7f13-bc92-a93b9cd9ae62" xlink:to="loc_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount_019cb9c9-9703-77a9-8bab-5eb2cf02f77c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_019cb9c9-c252-7364-b517-a2b96864d097" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-7f13-bc92-a93b9cd9ae62" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_019cb9c9-c252-7364-b517-a2b96864d097" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_019b096a-637d-77e1-b076-23f77e378d95" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-7f13-bc92-a93b9cd9ae62" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_019b096a-637d-77e1-b076-23f77e378d95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019b096a-637d-7f07-988d-aabdcc2167b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_019b096a-637d-7afe-8ecb-24a83eae4e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019b096a-637d-7f07-988d-aabdcc2167b9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_019b096a-637d-7afe-8ecb-24a83eae4e4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_019b096a-637d-7d3f-8596-5562e55d9ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019b096a-637d-7f07-988d-aabdcc2167b9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_019b096a-637d-7d3f-8596-5562e55d9ce5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_019b096a-637d-7f5e-92f1-5587568fce32" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019b096a-637d-7f07-988d-aabdcc2167b9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_019b096a-637d-7f5e-92f1-5587568fce32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent_019b096a-637d-7a87-b885-6f6b29e216e5" xlink:href="jynt-20251231.xsd#jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019b096a-637d-7f07-988d-aabdcc2167b9" xlink:to="loc_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent_019b096a-637d-7a87-b885-6f6b29e216e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_019b096a-637d-7faf-adec-901fc9539596" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019b096a-637d-7f07-988d-aabdcc2167b9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_019b096a-637d-7faf-adec-901fc9539596" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent_019b096a-637d-7971-a8c0-9faaf1d607a0" xlink:href="jynt-20251231.xsd#jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019b096a-637d-7f07-988d-aabdcc2167b9" xlink:to="loc_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent_019b096a-637d-7971-a8c0-9faaf1d607a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_019b096a-637d-781e-8192-994f2de4613d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019b096a-637d-7f07-988d-aabdcc2167b9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_019b096a-637d-781e-8192-994f2de4613d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_019b096a-637d-76d4-a5be-de31c2b634f7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019b096a-637d-7f07-988d-aabdcc2167b9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_019b096a-637d-76d4-a5be-de31c2b634f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_019b096a-637d-7b9c-8a23-d40411e49284" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019b096a-637d-7f07-988d-aabdcc2167b9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_019b096a-637d-7b9c-8a23-d40411e49284" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent_019cb9c9-f11d-75f8-b89a-ef78dba8a065" xlink:href="jynt-20251231.xsd#jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019b096a-637d-7f07-988d-aabdcc2167b9" xlink:to="loc_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent_019cb9c9-f11d-75f8-b89a-ef78dba8a065" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_019cb9ca-1aa6-77d6-aa9a-485361282e14" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019b096a-637d-7f07-988d-aabdcc2167b9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_019cb9ca-1aa6-77d6-aa9a-485361282e14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_019b096a-637d-7bb0-ac9c-6ce25248f3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019b096a-637d-7f07-988d-aabdcc2167b9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_019b096a-637d-7bb0-ac9c-6ce25248f3e1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/role/IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_019c669b-1739-7dcf-b486-f90fdf5f5ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPaidFederalAfterRefundReceived_019c669b-1739-7240-b7e4-960c255fbfcf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPaidFederalAfterRefundReceived"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxesPaidNet_019c669b-1739-7dcf-b486-f90fdf5f5ee0" xlink:to="loc_us-gaap_IncomeTaxPaidFederalAfterRefundReceived_019c669b-1739-7240-b7e4-960c255fbfcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPaidStateAndLocalAfterRefundReceived_019c669b-1739-7eb7-8d95-3894d7bc0bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPaidStateAndLocalAfterRefundReceived"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxesPaidNet_019c669b-1739-7dcf-b486-f90fdf5f5ee0" xlink:to="loc_us-gaap_IncomeTaxPaidStateAndLocalAfterRefundReceived_019c669b-1739-7eb7-8d95-3894d7bc0bfd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_019b096a-637d-7c39-be33-96b073899e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_019b096a-637d-79ea-a057-4a47d1e001e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_019b096a-637d-7c39-be33-96b073899e7e" xlink:to="loc_us-gaap_OperatingLeaseCost_019b096a-637d-79ea-a057-4a47d1e001e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_019b096a-637d-744b-b39c-556534d3e7db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019b096a-637d-7906-98e7-bb9dff702539" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_019b096a-637d-744b-b39c-556534d3e7db" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019b096a-637d-7906-98e7-bb9dff702539" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019b096a-637d-7b02-9fbb-c0d00938bf14" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_019b096a-637d-744b-b39c-556534d3e7db" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019b096a-637d-7b02-9fbb-c0d00938bf14" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019b096a-637d-71a0-8483-4cd8caa298d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_019b096a-637d-7af0-aec0-1f64bbaf6dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019b096a-637d-71a0-8483-4cd8caa298d0" xlink:to="loc_us-gaap_OperatingLeaseLiability_019b096a-637d-7af0-aec0-1f64bbaf6dfa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019b096a-637d-75d6-a710-d9df02053d78" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019b096a-637d-71a0-8483-4cd8caa298d0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019b096a-637d-75d6-a710-d9df02053d78" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="jynt-20251231.xsd#CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019b096a-637d-705d-b0d7-23808a3ef534" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_019b096a-637d-77d4-b2c2-4a2385cd91bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019b096a-637d-705d-b0d7-23808a3ef534" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_019b096a-637d-77d4-b2c2-4a2385cd91bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_019b096a-637d-7203-8fc4-737082e956ce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019b096a-637d-705d-b0d7-23808a3ef534" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_019b096a-637d-7203-8fc4-737082e956ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019b096a-637d-766a-a0a3-ce1b5a9bda10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019b096a-637d-705d-b0d7-23808a3ef534" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019b096a-637d-766a-a0a3-ce1b5a9bda10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_019b096a-637d-74ea-9fdd-25e5cdecce55" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019b096a-637d-705d-b0d7-23808a3ef534" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_019b096a-637d-74ea-9fdd-25e5cdecce55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019b096a-637d-76b5-afb1-524089329228" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019b096a-637d-705d-b0d7-23808a3ef534" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019b096a-637d-76b5-afb1-524089329228" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019b096a-637d-71de-91fe-3e2ed1861881" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019b096a-637d-705d-b0d7-23808a3ef534" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019b096a-637d-71de-91fe-3e2ed1861881" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-637d-76f8-ab81-3faf7fc36f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_019b096a-637d-7106-94fd-db0986f696f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-637d-76f8-ab81-3faf7fc36f2b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_019b096a-637d-7106-94fd-db0986f696f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_019b096a-637d-74c3-9a96-591d32c54e58" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-637d-76f8-ab81-3faf7fc36f2b" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_019b096a-637d-74c3-9a96-591d32c54e58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_019b096a-637d-70dc-855c-9bec5394edbb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-637d-76f8-ab81-3faf7fc36f2b" xlink:to="loc_us-gaap_SellingAndMarketingExpense_019b096a-637d-70dc-855c-9bec5394edbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_GeneralAndAdministrativeExpenseAdjusted_019b096a-637d-7651-82e0-ef2a1ac5bf5f" xlink:href="jynt-20251231.xsd#jynt_GeneralAndAdministrativeExpenseAdjusted"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-637d-76f8-ab81-3faf7fc36f2b" xlink:to="loc_jynt_GeneralAndAdministrativeExpenseAdjusted_019b096a-637d-7651-82e0-ef2a1ac5bf5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019b096a-637d-7d0e-b566-1407984fb6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-637d-76f8-ab81-3faf7fc36f2b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019b096a-637d-7d0e-b566-1407984fb6b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_019b096a-637d-7bb4-9478-d611db07560c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-637d-76f8-ab81-3faf7fc36f2b" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_019b096a-637d-7bb4-9478-d611db07560c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_019b096a-637d-74d3-b15f-b331463f3b68" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-637d-76f8-ab81-3faf7fc36f2b" xlink:to="loc_us-gaap_DepreciationAndAmortization_019b096a-637d-74d3-b15f-b331463f3b68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-7f7f-bdaa-1b7063e07313" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-637d-76f8-ab81-3faf7fc36f2b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-7f7f-bdaa-1b7063e07313" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>jynt-20251231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019b096a-603d-78f6-a834-c229229c770d,g:a2c624eb-8b4f-420f-a77d-d91a250e6a25-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.thejoint.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="jynt-20251231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019b096a-61dc-7bc8-8ee7-f1aa41d06a21" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:to="loc_us-gaap_StatementTable_019b096a-61dc-7bc8-8ee7-f1aa41d06a21" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_019b096a-61dc-7404-9123-c8cca82b6cd5" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019b096a-61dc-7bc8-8ee7-f1aa41d06a21" xlink:to="loc_srt_ConsolidatedEntitiesAxis_019b096a-61dc-7404-9123-c8cca82b6cd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_019b096a-61dc-7404-9123-c8cca82b6cd5_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_019b096a-61dc-7404-9123-c8cca82b6cd5" xlink:to="loc_srt_ConsolidatedEntitiesDomain_019b096a-61dc-7404-9123-c8cca82b6cd5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_019b096a-61dc-7b38-9df0-99f8b2121b51" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_019b096a-61dc-7404-9123-c8cca82b6cd5" xlink:to="loc_srt_ConsolidatedEntitiesDomain_019b096a-61dc-7b38-9df0-99f8b2121b51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_019b096a-61dc-730a-a3c0-e6f905cbd386" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_019b096a-61dc-7b38-9df0-99f8b2121b51" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_019b096a-61dc-730a-a3c0-e6f905cbd386" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-61dc-7222-8418-9f529cc400be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-61dc-7222-8418-9f529cc400be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-61dc-7647-a26c-792e6da4ccff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-61dc-7647-a26c-792e6da4ccff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_019b096a-61dc-7b19-a405-8c8bd60d6b43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_019b096a-61dc-7b19-a405-8c8bd60d6b43" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_019b096a-61dc-7cec-afcc-8a39bfb4637a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_019b096a-61dc-7cec-afcc-8a39bfb4637a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_019b096a-61dc-7041-8ccc-1d7b66672c44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:to="loc_us-gaap_PreferredStockSharesIssued_019b096a-61dc-7041-8ccc-1d7b66672c44" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_019b096a-61dc-756d-afe7-a74ac410e522" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_019b096a-61dc-756d-afe7-a74ac410e522" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_019b096a-61dc-7f3d-8ad7-eb0e4c91f8e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_019b096a-61dc-7f3d-8ad7-eb0e4c91f8e5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_019b096a-61dc-7f8e-ab48-fd6eae8b4f38" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_019b096a-61dc-7f8e-ab48-fd6eae8b4f38" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_019b096a-61dc-747d-b026-8a0e48573280" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:to="loc_us-gaap_CommonStockSharesIssued_019b096a-61dc-747d-b026-8a0e48573280" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019b096a-61dc-7856-a8a8-551822b2e31b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019b096a-61dc-7856-a8a8-551822b2e31b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_019b096a-61dc-75d5-853d-50810cc577af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:to="loc_us-gaap_TreasuryStockCommonShares_019b096a-61dc-75d5-853d-50810cc577af" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/ConsolidatedIncomeStatements" xlink:type="simple" xlink:href="jynt-20251231.xsd#ConsolidatedIncomeStatements"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/ConsolidatedIncomeStatements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019b096a-61dc-73d8-927c-1915c102547d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_StatementTable_019b096a-61dc-73d8-927c-1915c102547d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019b096a-61dc-7b7c-bbc9-af729868182c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019b096a-61dc-73d8-927c-1915c102547d" xlink:to="loc_srt_ProductOrServiceAxis_019b096a-61dc-7b7c-bbc9-af729868182c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019b096a-61dc-7b7c-bbc9-af729868182c_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_019b096a-61dc-7b7c-bbc9-af729868182c" xlink:to="loc_srt_ProductsAndServicesDomain_019b096a-61dc-7b7c-bbc9-af729868182c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019b096a-61dc-774a-b512-b8df3bfc3266" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_019b096a-61dc-7b7c-bbc9-af729868182c" xlink:to="loc_srt_ProductsAndServicesDomain_019b096a-61dc-774a-b512-b8df3bfc3266" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_019b096a-61dc-7896-a7ea-dcc84916df56" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019b096a-61dc-774a-b512-b8df3bfc3266" xlink:to="loc_us-gaap_RoyaltyMember_019b096a-61dc-7896-a7ea-dcc84916df56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchiseMember_019b096a-61dc-7170-8cc0-6c9fbda801f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchiseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019b096a-61dc-774a-b512-b8df3bfc3266" xlink:to="loc_us-gaap_FranchiseMember_019b096a-61dc-7170-8cc0-6c9fbda801f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingMember_019b096a-61dc-7ce0-ae5b-a44cf6a7c5de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdvertisingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019b096a-61dc-774a-b512-b8df3bfc3266" xlink:to="loc_us-gaap_AdvertisingMember_019b096a-61dc-7ce0-ae5b-a44cf6a7c5de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyServiceMember_019b096a-61dc-7b46-af5b-e4cdb67a6280" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TechnologyServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019b096a-61dc-774a-b512-b8df3bfc3266" xlink:to="loc_us-gaap_TechnologyServiceMember_019b096a-61dc-7b46-af5b-e4cdb67a6280" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_019b096a-61dc-7e7a-b6b5-13f4e0c4b9e4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019b096a-61dc-774a-b512-b8df3bfc3266" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_019b096a-61dc-7e7a-b6b5-13f4e0c4b9e4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_019b096a-61dc-7ada-9a95-b2891f19c49c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_RevenuesAbstract_019b096a-61dc-7ada-9a95-b2891f19c49c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_019b096a-61dc-7c39-9ce7-b51c1cd33073" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_019b096a-61dc-7ada-9a95-b2891f19c49c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_019b096a-61dc-7c39-9ce7-b51c1cd33073" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_019b096a-61dc-7aad-a2fa-35365f7f3a90" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_CostOfRevenueAbstract_019b096a-61dc-7aad-a2fa-35365f7f3a90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_019b096a-61dc-7468-b5d3-31dfeeb4946c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfRevenueAbstract_019b096a-61dc-7aad-a2fa-35365f7f3a90" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_019b096a-61dc-7468-b5d3-31dfeeb4946c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_019b096a-61dc-776f-b14f-c66739633904" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfRevenueAbstract_019b096a-61dc-7aad-a2fa-35365f7f3a90" xlink:to="loc_us-gaap_CostOfRevenue_019b096a-61dc-776f-b14f-c66739633904" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_019b096a-61dc-7c9c-a917-1eea7f3bd9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_SellingAndMarketingExpense_019b096a-61dc-7c9c-a917-1eea7f3bd9ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_019b096a-61dc-70c8-a2d3-2bcbc96199af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_DepreciationAndAmortization_019b096a-61dc-70c8-a2d3-2bcbc96199af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019b096a-61dc-7d1f-809f-26cc3954e08e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019b096a-61dc-7d1f-809f-26cc3954e08e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019b096a-61dc-781d-b6bc-6e177fb5b5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019b096a-61dc-781d-b6bc-6e177fb5b5a3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_019b096a-61dc-777e-a85c-a10341de9408" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_019b096a-61dc-777e-a85c-a10341de9408" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019b096a-61dc-7a61-979d-c46216704700" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_OperatingIncomeLoss_019b096a-61dc-7a61-979d-c46216704700" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019b096a-61dc-7c49-9b43-680e514d75e4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019b096a-61dc-7c49-9b43-680e514d75e4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019b096a-61dc-7acf-88d3-425e6d1b1070" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019b096a-61dc-7acf-88d3-425e6d1b1070" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-61dc-7ad2-883f-b75f299cc214" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-61dc-7ad2-883f-b75f299cc214" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-61dc-7247-9885-13be35815545" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-61dc-7247-9885-13be35815545" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract_019b096a-61dc-7f2f-94ac-8fef0ffd829e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract_019b096a-61dc-7f2f-94ac-8fef0ffd829e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b096a-61dc-7e8f-9d37-0cdde7a11cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract_019b096a-61dc-7f2f-94ac-8fef0ffd829e" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b096a-61dc-7e8f-9d37-0cdde7a11cc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_019b096a-61dc-76aa-8ba0-0e66528854df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract_019b096a-61dc-7f2f-94ac-8fef0ffd829e" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_019b096a-61dc-76aa-8ba0-0e66528854df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-61dc-7cb4-ab4d-5a5a8958bee0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract_019b096a-61dc-7f2f-94ac-8fef0ffd829e" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-61dc-7cb4-ab4d-5a5a8958bee0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_019b096a-61dc-70a9-bc83-80d62d08c94e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_ProfitLoss_019b096a-61dc-70a9-bc83-80d62d08c94e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract_019b096a-61dc-7577-bf74-1e8eaeaeaa64" xlink:href="jynt-20251231.xsd#jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract_019b096a-61dc-7577-bf74-1e8eaeaeaa64" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_019b096a-61dc-7749-89f8-bfd78fcecbf3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract_019b096a-61dc-7577-bf74-1e8eaeaeaa64" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_019b096a-61dc-7749-89f8-bfd78fcecbf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_019b096a-61dc-7107-9cee-be911c56911b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract_019b096a-61dc-7577-bf74-1e8eaeaeaa64" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_019b096a-61dc-7107-9cee-be911c56911b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract_019b096a-61dc-7685-91cc-35228aaa51b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract_019b096a-61dc-7685-91cc-35228aaa51b3" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_019b096a-61dc-74c6-9207-38657488ff66" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract_019b096a-61dc-7685-91cc-35228aaa51b3" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_019b096a-61dc-74c6-9207-38657488ff66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_019b096a-61dc-7f65-a00d-723f6ca2ba10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract_019b096a-61dc-7685-91cc-35228aaa51b3" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_019b096a-61dc-7f65-a00d-723f6ca2ba10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019b096a-61dc-7d9c-bb49-52e33cefb9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_EarningsPerShareAbstract_019b096a-61dc-7d9c-bb49-52e33cefb9b9" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_019b096a-61dc-705c-bcb3-b44d5e9de0fb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019b096a-61dc-7d9c-bb49-52e33cefb9b9" xlink:to="loc_us-gaap_EarningsPerShareBasic_019b096a-61dc-705c-bcb3-b44d5e9de0fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_019b096a-61dc-7275-80ae-d60b6ef37520" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019b096a-61dc-7d9c-bb49-52e33cefb9b9" xlink:to="loc_us-gaap_EarningsPerShareDiluted_019b096a-61dc-7275-80ae-d60b6ef37520" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019b096a-61dc-74df-aafb-07c04cc5be84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019b096a-61dc-74df-aafb-07c04cc5be84" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019b096a-61dc-7278-b29f-d09e8a81fabb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019b096a-61dc-7278-b29f-d09e8a81fabb" xlink:type="arc" order="18"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="simple" xlink:href="jynt-20251231.xsd#ConsolidatedStatementsofChangesinStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019b096a-62ab-756f-bfb5-69afdff76325" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019b096a-62ab-7854-a2e9-c3826ebacf44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_019b096a-62ab-756f-bfb5-69afdff76325" xlink:to="loc_us-gaap_StatementTable_019b096a-62ab-7854-a2e9-c3826ebacf44" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019b096a-62ab-7a7c-ace8-3596a46ccfdb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019b096a-62ab-7854-a2e9-c3826ebacf44" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019b096a-62ab-7a7c-ace8-3596a46ccfdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019b096a-62ab-7a7c-ace8-3596a46ccfdb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019b096a-62ab-7a7c-ace8-3596a46ccfdb" xlink:to="loc_us-gaap_EquityComponentDomain_019b096a-62ab-7a7c-ace8-3596a46ccfdb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019b096a-62ab-7768-88a3-33db9bd72422" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019b096a-62ab-7a7c-ace8-3596a46ccfdb" xlink:to="loc_us-gaap_EquityComponentDomain_019b096a-62ab-7768-88a3-33db9bd72422" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_019b096a-62ab-7300-bf62-e0375b429f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019b096a-62ab-7768-88a3-33db9bd72422" xlink:to="loc_us-gaap_ParentMember_019b096a-62ab-7300-bf62-e0375b429f9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019b096a-62ab-7ff6-b941-b2f72c0ac014" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_019b096a-62ab-7300-bf62-e0375b429f9c" xlink:to="loc_us-gaap_CommonStockMember_019b096a-62ab-7ff6-b941-b2f72c0ac014" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_019b096a-62ab-72b8-910a-d2681e48e148" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_019b096a-62ab-7300-bf62-e0375b429f9c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_019b096a-62ab-72b8-910a-d2681e48e148" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_019b096a-62ab-7d81-bbff-b355b6d67d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_019b096a-62ab-7300-bf62-e0375b429f9c" xlink:to="loc_us-gaap_TreasuryStockCommonMember_019b096a-62ab-7d81-bbff-b355b6d67d1d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_019b096a-62ab-7f60-81bb-96794e23a1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_019b096a-62ab-7300-bf62-e0375b429f9c" xlink:to="loc_us-gaap_RetainedEarningsMember_019b096a-62ab-7f60-81bb-96794e23a1ac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_019b096a-62ab-7add-9ac5-2e4f7ced1faa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019b096a-62ab-7768-88a3-33db9bd72422" xlink:to="loc_us-gaap_NoncontrollingInterestMember_019b096a-62ab-7add-9ac5-2e4f7ced1faa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019b096a-62ab-756f-bfb5-69afdff76325" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019b096a-62ab-779a-a228-eb90802750a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019b096a-62ab-779a-a228-eb90802750a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_019b096a-62ab-7886-8742-9dd2e9ff1081" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_019b096a-62ab-7886-8742-9dd2e9ff1081" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_019b096a-62ab-7d01-9680-8440cb38547f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_TreasuryStockCommonShares_019b096a-62ab-7d01-9680-8440cb38547f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019b096a-62ab-7ae5-bf90-164c5d53b87d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019b096a-62ab-7ae5-bf90-164c5d53b87d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_019b096a-62ab-7d26-9ce1-c92f9d90a7e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_019b096a-62ab-7d26-9ce1-c92f9d90a7e2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_019b096a-62ab-77c3-8362-f803f658ed39" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_019b096a-62ab-77c3-8362-f803f658ed39" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019b096a-62ab-7b2d-ade5-73d4e15a237a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019b096a-62ab-7b2d-ade5-73d4e15a237a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019b096a-62ab-7942-b808-68fef78f25bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019b096a-62ab-7942-b808-68fef78f25bf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_019b096a-62ab-7938-9e7b-2bf384ffa21a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_019b096a-62ab-7938-9e7b-2bf384ffa21a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_019b096a-62ab-748b-9400-ee150578f385" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_019b096a-62ab-748b-9400-ee150578f385" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_019be491-de24-7472-80ad-73eeb8d7d07c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_019be491-de24-7472-80ad-73eeb8d7d07c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_019be491-de24-7946-b831-73ec6131abba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_019be491-de24-7946-b831-73ec6131abba" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_019b096a-62ab-7e8c-ae7f-271620bd8346" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_ProfitLoss_019b096a-62ab-7e8c-ae7f-271620bd8346" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019b096a-62ab-7eb0-8320-14bfcd3b7d99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_019b096a-62ab-7bbc-a2d8-8e601e52eace" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_019b096a-62ab-7214-9d14-73b8fb3674b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_019b096a-62ab-7f4c-93e6-554a7395f818" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-7553-b4e9-1b31f9021a10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductInformationLineItems_019b096a-62ab-7f4c-93e6-554a7395f818" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-7553-b4e9-1b31f9021a10" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisorDisclosureAxis_019b096a-62ab-7a17-9ab3-cbde2aa6d0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisorDisclosureAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-7553-b4e9-1b31f9021a10" xlink:to="loc_us-gaap_FranchisorDisclosureAxis_019b096a-62ab-7a17-9ab3-cbde2aa6d0d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisorDisclosureDomain_019b096a-62ab-7a17-9ab3-cbde2aa6d0d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisorDisclosureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FranchisorDisclosureAxis_019b096a-62ab-7a17-9ab3-cbde2aa6d0d5" xlink:to="loc_us-gaap_FranchisorDisclosureDomain_019b096a-62ab-7a17-9ab3-cbde2aa6d0d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisorDisclosureDomain_019b096a-62ab-7799-9614-d544c6e054c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisorDisclosureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FranchisorDisclosureAxis_019b096a-62ab-7a17-9ab3-cbde2aa6d0d5" xlink:to="loc_us-gaap_FranchisorDisclosureDomain_019b096a-62ab-7799-9614-d544c6e054c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisedUnitsMember_019b096a-62ab-75c4-bde2-ea9d8aff6316" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisedUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FranchisorDisclosureDomain_019b096a-62ab-7799-9614-d544c6e054c6" xlink:to="loc_us-gaap_FranchisedUnitsMember_019b096a-62ab-75c4-bde2-ea9d8aff6316" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityOperatedUnitsMember_019b096a-62ab-73db-8c1d-c6d3f449407c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EntityOperatedUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FranchisorDisclosureDomain_019b096a-62ab-7799-9614-d544c6e054c6" xlink:to="loc_us-gaap_EntityOperatedUnitsMember_019b096a-62ab-73db-8c1d-c6d3f449407c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-705c-acb8-4b85791574ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-7553-b4e9-1b31f9021a10" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-705c-acb8-4b85791574ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-705c-acb8-4b85791574ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-705c-acb8-4b85791574ab" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-705c-acb8-4b85791574ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-77c4-9c58-bc2f348d2816" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-705c-acb8-4b85791574ab" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-77c4-9c58-bc2f348d2816" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019b096a-62ab-79c3-b59a-8b86b4c7b8be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-77c4-9c58-bc2f348d2816" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019b096a-62ab-79c3-b59a-8b86b4c7b8be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-76c2-9956-ccd50926ac84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-7553-b4e9-1b31f9021a10" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-76c2-9956-ccd50926ac84" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-76c2-9956-ccd50926ac84_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-76c2-9956-ccd50926ac84" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-76c2-9956-ccd50926ac84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-714c-ab3b-5b39263297d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-76c2-9956-ccd50926ac84" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-714c-ab3b-5b39263297d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019b096a-62ab-795b-998c-cf289781c2a1" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-714c-ab3b-5b39263297d7" xlink:to="loc_jynt_CorporateClinicsMember_019b096a-62ab-795b-998c-cf289781c2a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward_019b096a-62ab-7b33-ba4a-79aafa9b20ae" xlink:href="jynt-20251231.xsd#jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019b096a-62ab-7f4c-93e6-554a7395f818" xlink:to="loc_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward_019b096a-62ab-7b33-ba4a-79aafa9b20ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_019b096a-62ab-75cd-8ef0-9e8196484ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfStores"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward_019b096a-62ab-7b33-ba4a-79aafa9b20ae" xlink:to="loc_us-gaap_NumberOfStores_019b096a-62ab-75cd-8ef0-9e8196484ac4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ClinicsOpenedDuringThePeriod_019b096a-62ab-7829-a6d9-8b4fcf2e04a0" xlink:href="jynt-20251231.xsd#jynt_ClinicsOpenedDuringThePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward_019b096a-62ab-7b33-ba4a-79aafa9b20ae" xlink:to="loc_jynt_ClinicsOpenedDuringThePeriod_019b096a-62ab-7829-a6d9-8b4fcf2e04a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ClinicsAcquiredDuringPeriod_019b096a-62ab-7ec8-8c02-6194d4e91225" xlink:href="jynt-20251231.xsd#jynt_ClinicsAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward_019b096a-62ab-7b33-ba4a-79aafa9b20ae" xlink:to="loc_jynt_ClinicsAcquiredDuringPeriod_019b096a-62ab-7ec8-8c02-6194d4e91225" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ClinicsSoldDuringPeriod_019b096a-62ab-7eae-9fc5-9ff373dcc230" xlink:href="jynt-20251231.xsd#jynt_ClinicsSoldDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward_019b096a-62ab-7b33-ba4a-79aafa9b20ae" xlink:to="loc_jynt_ClinicsSoldDuringPeriod_019b096a-62ab-7eae-9fc5-9ff373dcc230" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ClinicsClosedDuringThePeriod_019b096a-62ab-71b2-8701-985769708eaa" xlink:href="jynt-20251231.xsd#jynt_ClinicsClosedDuringThePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward_019b096a-62ab-7b33-ba4a-79aafa9b20ae" xlink:to="loc_jynt_ClinicsClosedDuringThePeriod_019b096a-62ab-71b2-8701-985769708eaa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_019b096a-62ab-7b74-99cd-a9bfb020e925" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfStores"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ClinicLicensesSoldButNotYetDeveloped_019b096a-62ab-7a57-ad12-884126c648ed" xlink:href="jynt-20251231.xsd#jynt_ClinicLicensesSoldButNotYetDeveloped"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019b096a-62ab-7f4c-93e6-554a7395f818" xlink:to="loc_jynt_ClinicLicensesSoldButNotYetDeveloped_019b096a-62ab-7a57-ad12-884126c648ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ExecutedLettersOfIntentForFutureClinicLicenses_019b096a-62ab-7c67-85db-2651eea41da4" xlink:href="jynt-20251231.xsd#jynt_ExecutedLettersOfIntentForFutureClinicLicenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019b096a-62ab-7f4c-93e6-554a7395f818" xlink:to="loc_jynt_ExecutedLettersOfIntentForFutureClinicLicenses_019b096a-62ab-7c67-85db-2651eea41da4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-77a1-8051-051799d4fc01" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-77a1-8051-051799d4fc01" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019be4a5-e4b7-733c-8cf4-3d945e3676b2" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-77a1-8051-051799d4fc01" xlink:to="loc_srt_RangeAxis_019be4a5-e4b7-733c-8cf4-3d945e3676b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019be4a5-e4b7-733c-8cf4-3d945e3676b2_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019be4a5-e4b7-733c-8cf4-3d945e3676b2" xlink:to="loc_srt_RangeMember_019be4a5-e4b7-733c-8cf4-3d945e3676b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019be4a5-e4b7-734e-aec2-5bb59fd2d038" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019be4a5-e4b7-733c-8cf4-3d945e3676b2" xlink:to="loc_srt_RangeMember_019be4a5-e4b7-734e-aec2-5bb59fd2d038" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019be4a5-e4b7-76ff-aec9-6425ae69acab" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019be4a5-e4b7-734e-aec2-5bb59fd2d038" xlink:to="loc_srt_MinimumMember_019be4a5-e4b7-76ff-aec9-6425ae69acab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019be4a5-e4b7-7125-97c7-5bf2b8b2422f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019be4a5-e4b7-734e-aec2-5bb59fd2d038" xlink:to="loc_srt_MaximumMember_019be4a5-e4b7-7125-97c7-5bf2b8b2422f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_019be4a7-8dfc-7099-ab1a-92f94bc80214" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-77a1-8051-051799d4fc01" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_019be4a7-8dfc-7099-ab1a-92f94bc80214" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019be4a7-8dfc-7099-ab1a-92f94bc80214_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_019be4a7-8dfc-7099-ab1a-92f94bc80214" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019be4a7-8dfc-7099-ab1a-92f94bc80214_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019be4a7-8dfc-7f0b-a9e7-4ebe54f2bfc7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_019be4a7-8dfc-7099-ab1a-92f94bc80214" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019be4a7-8dfc-7f0b-a9e7-4ebe54f2bfc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_019be4a7-8dfc-7436-8e17-2b704ca955cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019be4a7-8dfc-7f0b-a9e7-4ebe54f2bfc7" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_019be4a7-8dfc-7436-8e17-2b704ca955cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchiseRightsMember_019be4a8-1ab8-7b5a-a190-67f94c06d5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchiseRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019be4a7-8dfc-7f0b-a9e7-4ebe54f2bfc7" xlink:to="loc_us-gaap_FranchiseRightsMember_019be4a8-1ab8-7b5a-a190-67f94c06d5e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_019be4a8-1ab8-769c-aeed-09468865037d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019be4a7-8dfc-7f0b-a9e7-4ebe54f2bfc7" xlink:to="loc_us-gaap_CustomerRelationshipsMember_019be4a8-1ab8-769c-aeed-09468865037d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019be4a7-f034-7c8f-83df-f3efb0a2da6b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-77a1-8051-051799d4fc01" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019be4a7-f034-7c8f-83df-f3efb0a2da6b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019be4a7-f034-7c8f-83df-f3efb0a2da6b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019be4a7-f034-7c8f-83df-f3efb0a2da6b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019be4a7-f034-7c8f-83df-f3efb0a2da6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019be4a7-f034-79c7-951a-aabc092f876e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019be4a7-f034-7c8f-83df-f3efb0a2da6b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019be4a7-f034-79c7-951a-aabc092f876e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019c65ca-fa2e-79e6-8168-2f417a472950" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019be4a7-f034-79c7-951a-aabc092f876e" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019c65ca-fa2e-79e6-8168-2f417a472950" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_019be4a7-f034-7afe-96df-2dadf3d808d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019be4a7-f034-79c7-951a-aabc092f876e" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_019be4a7-f034-7afe-96df-2dadf3d808d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_019be4a8-c413-76be-bb35-4df5e7ef4563" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019be4a7-f034-79c7-951a-aabc092f876e" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_019be4a8-c413-76be-bb35-4df5e7ef4563" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_019be4a7-f034-7bc1-b87d-d9dc58e58b60" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-77a1-8051-051799d4fc01" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_019be4a7-f034-7bc1-b87d-d9dc58e58b60" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019be4a7-f034-7bc1-b87d-d9dc58e58b60_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_019be4a7-f034-7bc1-b87d-d9dc58e58b60" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019be4a7-f034-7bc1-b87d-d9dc58e58b60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019be4a7-f034-74a4-8cb2-6a3e6e3a3fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_019be4a7-f034-7bc1-b87d-d9dc58e58b60" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019be4a7-f034-74a4-8cb2-6a3e6e3a3fd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_OperatingLeaseRightOfUseAssetMember_019be4a7-f034-7b4c-97b0-ac8d51bc63ee" xlink:href="jynt-20251231.xsd#jynt_OperatingLeaseRightOfUseAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019be4a7-f034-74a4-8cb2-6a3e6e3a3fd0" xlink:to="loc_jynt_OperatingLeaseRightOfUseAssetMember_019be4a7-f034-7b4c-97b0-ac8d51bc63ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019be4a7-f034-7036-a95e-929e8a13fcf3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-77a1-8051-051799d4fc01" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019be4a7-f034-7036-a95e-929e8a13fcf3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019be4a7-f034-7036-a95e-929e8a13fcf3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019be4a7-f034-7036-a95e-929e8a13fcf3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019be4a7-f034-7036-a95e-929e8a13fcf3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019be4a7-f034-7c91-8fad-9a68dd6c60c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019be4a7-f034-7036-a95e-929e8a13fcf3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019be4a7-f034-7c91-8fad-9a68dd6c60c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019be4a7-f034-766b-8dd0-15695c6809e6" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019be4a7-f034-7c91-8fad-9a68dd6c60c3" xlink:to="loc_jynt_CorporateClinicsMember_019be4a7-f034-766b-8dd0-15695c6809e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_019c65ca-fa2e-76a9-9023-45610a3f00b6" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-77a1-8051-051799d4fc01" xlink:to="loc_srt_StatementGeographicalAxis_019c65ca-fa2e-76a9-9023-45610a3f00b6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_019c65ca-fa2e-76a9-9023-45610a3f00b6_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_019c65ca-fa2e-76a9-9023-45610a3f00b6" xlink:to="loc_srt_SegmentGeographicalDomain_019c65ca-fa2e-76a9-9023-45610a3f00b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_019c65ca-fa2e-715d-882e-59a512003f9d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_019c65ca-fa2e-76a9-9023-45610a3f00b6" xlink:to="loc_srt_SegmentGeographicalDomain_019c65ca-fa2e-715d-882e-59a512003f9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_KansasAndMissouriMember_019c9094-1709-78a0-b719-b5fdf89cd8ec" xlink:href="jynt-20251231.xsd#jynt_KansasAndMissouriMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_019c65ca-fa2e-715d-882e-59a512003f9d" xlink:to="loc_jynt_KansasAndMissouriMember_019c9094-1709-78a0-b719-b5fdf89cd8ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisorDisclosureAxis_019c65ca-fa2e-7c3c-90a2-9c63e49c527e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisorDisclosureAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-77a1-8051-051799d4fc01" xlink:to="loc_us-gaap_FranchisorDisclosureAxis_019c65ca-fa2e-7c3c-90a2-9c63e49c527e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisorDisclosureDomain_019c65ca-fa2e-7c3c-90a2-9c63e49c527e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisorDisclosureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FranchisorDisclosureAxis_019c65ca-fa2e-7c3c-90a2-9c63e49c527e" xlink:to="loc_us-gaap_FranchisorDisclosureDomain_019c65ca-fa2e-7c3c-90a2-9c63e49c527e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisorDisclosureDomain_019c65ca-fa2e-7d4e-bcdb-6e91e31d98c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisorDisclosureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FranchisorDisclosureAxis_019c65ca-fa2e-7c3c-90a2-9c63e49c527e" xlink:to="loc_us-gaap_FranchisorDisclosureDomain_019c65ca-fa2e-7d4e-bcdb-6e91e31d98c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityOperatedUnitsMember_019c65ca-fa2e-73f8-9c70-3fb53d9a8887" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EntityOperatedUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FranchisorDisclosureDomain_019c65ca-fa2e-7d4e-bcdb-6e91e31d98c9" xlink:to="loc_us-gaap_EntityOperatedUnitsMember_019c65ca-fa2e-73f8-9c70-3fb53d9a8887" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_019c9083-23cc-766c-a7ee-d917bff32fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-77a1-8051-051799d4fc01" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_019c9083-23cc-766c-a7ee-d917bff32fbe" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_019c9083-23cc-766c-a7ee-d917bff32fbe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_019c9083-23cc-766c-a7ee-d917bff32fbe" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_019c9083-23cc-766c-a7ee-d917bff32fbe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_019c9083-23cc-7a92-a720-4c4f9c8f5509" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_019c9083-23cc-766c-a7ee-d917bff32fbe" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_019c9083-23cc-7a92-a720-4c4f9c8f5509" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_019c9083-8cbc-7840-afb2-a5d840d3a9d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_019c9083-23cc-7a92-a720-4c4f9c8f5509" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_019c9083-8cbc-7840-afb2-a5d840d3a9d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ManagementAgreementNumberOfProfessionalCorporations_019be4a5-36c8-7242-bed4-adcaa1328ade" xlink:href="jynt-20251231.xsd#jynt_ManagementAgreementNumberOfProfessionalCorporations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_jynt_ManagementAgreementNumberOfProfessionalCorporations_019be4a5-36c8-7242-bed4-adcaa1328ade" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ClinicsSoldDuringPeriod_019c65ca-fa2e-7778-af98-e54f4a77621f" xlink:href="jynt-20251231.xsd#jynt_ClinicsSoldDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_jynt_ClinicsSoldDuringPeriod_019c65ca-fa2e-7778-af98-e54f4a77621f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ManagementAgreementTerminationNumberOfProfessionalCorporations_019c65ca-fa2e-7fda-85d8-227e40bf9e30" xlink:href="jynt-20251231.xsd#jynt_ManagementAgreementTerminationNumberOfProfessionalCorporations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_jynt_ManagementAgreementTerminationNumberOfProfessionalCorporations_019c65ca-fa2e-7fda-85d8-227e40bf9e30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_019be4a5-6dd2-742b-b19a-5e9173c1e15c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_019be4a5-6dd2-742b-b19a-5e9173c1e15c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019be4a5-97db-71e1-b91a-ccd15a411127" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019be4a5-97db-71e1-b91a-ccd15a411127" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_019be4a5-e4b7-7d24-a360-a562b3a12aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_019be4a5-e4b7-7d24-a360-a562b3a12aa4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_019be4a5-e4b7-791f-aa0a-9fbe6fdd7787" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_019be4a5-e4b7-791f-aa0a-9fbe6fdd7787" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_019be4a7-8dfc-7f01-a717-baeb83919e11" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_019be4a7-8dfc-7f01-a717-baeb83919e11" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_LesseeOperatingLeaseNumberOfRenewalOptions_019be4a7-b2f9-7c9e-80cc-1dd9a0279bb4" xlink:href="jynt-20251231.xsd#jynt_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_jynt_LesseeOperatingLeaseNumberOfRenewalOptions_019be4a7-b2f9-7c9e-80cc-1dd9a0279bb4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019be4a7-f034-78a3-a98d-a20d0563dad3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019be4a7-f034-78a3-a98d-a20d0563dad3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_019be4a8-4d14-7452-91f2-f564f5c1c637" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_019be4a8-4d14-7452-91f2-f564f5c1c637" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_019be4a8-c413-715d-a62d-3ea9eecf5746" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_019be4a8-c413-715d-a62d-3ea9eecf5746" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage_019be4ac-75fa-767f-822f-e2be2cf2e0ed" xlink:href="jynt-20251231.xsd#jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage_019be4ac-75fa-767f-822f-e2be2cf2e0ed" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_FranchiseRoyaltyGrossSalesPercentage_019be4ac-9c07-7035-8f6a-5415e1a3c6f1" xlink:href="jynt-20251231.xsd#jynt_FranchiseRoyaltyGrossSalesPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_jynt_FranchiseRoyaltyGrossSalesPercentage_019be4ac-9c07-7035-8f6a-5415e1a3c6f1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_RevenueRecognitionFranchiseAgreementTerm_019be4ac-bff5-76d4-8479-7ab125b9e07a" xlink:href="jynt-20251231.xsd#jynt_RevenueRecognitionFranchiseAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_jynt_RevenueRecognitionFranchiseAgreementTerm_019be4ac-bff5-76d4-8479-7ab125b9e07a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage_019be4ac-e011-7b25-8d21-bb0184b6a556" xlink:href="jynt-20251231.xsd#jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage_019be4ac-e011-7b25-8d21-bb0184b6a556" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_019be4ad-00f3-76b6-bab6-6cf1adef847f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_us-gaap_AdvertisingExpense_019be4ad-00f3-76b6-bab6-6cf1adef847f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_019be4ad-2371-7872-9b96-115557c6e37a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_019be4ad-2371-7872-9b96-115557c6e37a" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage_019be4e0-d6f8-762c-9fa3-7f3a445d10c6" xlink:href="jynt-20251231.xsd#jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage_019be4e0-d6f8-762c-9fa3-7f3a445d10c6" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_019be4ad-4f44-79ad-b0ca-606bfbeaba8c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_019be4ad-4f44-79ad-b0ca-606bfbeaba8c" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_019be4ad-4f44-7030-bfca-b23a2045630c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_019be4ad-4f44-7030-bfca-b23a2045630c" xlink:type="arc" order="20"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEIncomeStatementDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEIncomeStatementDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEIncomeStatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_019b096a-62ab-7f4d-93db-578083d33fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_019b096a-62ab-710b-a798-f67b2a1beac1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_019b096a-62ab-7f4d-93db-578083d33fc2" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_019b096a-62ab-710b-a798-f67b2a1beac1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_019b096a-62ab-702f-bc9e-c22dfdfe75b5" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_019b096a-62ab-710b-a798-f67b2a1beac1" xlink:to="loc_srt_ConsolidatedEntitiesAxis_019b096a-62ab-702f-bc9e-c22dfdfe75b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_019b096a-62ab-702f-bc9e-c22dfdfe75b5_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_019b096a-62ab-702f-bc9e-c22dfdfe75b5" xlink:to="loc_srt_ConsolidatedEntitiesDomain_019b096a-62ab-702f-bc9e-c22dfdfe75b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_019b096a-62ab-7336-98e8-683affeda9b0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_019b096a-62ab-702f-bc9e-c22dfdfe75b5" xlink:to="loc_srt_ConsolidatedEntitiesDomain_019b096a-62ab-7336-98e8-683affeda9b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_019b096a-62ab-7bed-ad8f-7394c51045d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_019b096a-62ab-7336-98e8-683affeda9b0" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_019b096a-62ab-7bed-ad8f-7394c51045d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-77a6-905b-9e5a7d72c548" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_019b096a-62ab-710b-a798-f67b2a1beac1" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-77a6-905b-9e5a7d72c548" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-77a6-905b-9e5a7d72c548_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-77a6-905b-9e5a7d72c548" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-77a6-905b-9e5a7d72c548_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-75f7-88f3-790df5e423f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-77a6-905b-9e5a7d72c548" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-75f7-88f3-790df5e423f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019b096a-62ab-7530-a276-c339413f4415" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-75f7-88f3-790df5e423f0" xlink:to="loc_jynt_CorporateClinicsMember_019b096a-62ab-7530-a276-c339413f4415" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b096a-62ab-797a-a28b-f9780e161754" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_019b096a-62ab-7f4d-93db-578083d33fc2" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b096a-62ab-797a-a28b-f9780e161754" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_019b096a-62ab-7a6a-a278-4c0b64f2eea8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_019b096a-62ab-7f4d-93db-578083d33fc2" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_019b096a-62ab-7a6a-a278-4c0b64f2eea8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-62ab-77c5-8b8b-08d10b60b750" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_019b096a-62ab-7f4d-93db-578083d33fc2" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-62ab-77c5-8b8b-08d10b60b750" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_019b096a-62ab-77d6-85d0-1563a3b4f93f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_019b096a-62ab-7c8d-9801-92347c69f7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_019b096a-62ab-77d6-85d0-1563a3b4f93f" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_019b096a-62ab-7c8d-9801-92347c69f7a8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_019b096a-62ab-7cba-affb-c56aadc91aea" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_019b096a-62ab-7c8d-9801-92347c69f7a8" xlink:to="loc_srt_ConsolidatedEntitiesAxis_019b096a-62ab-7cba-affb-c56aadc91aea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_019b096a-62ab-7cba-affb-c56aadc91aea_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_019b096a-62ab-7cba-affb-c56aadc91aea" xlink:to="loc_srt_ConsolidatedEntitiesDomain_019b096a-62ab-7cba-affb-c56aadc91aea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_019b096a-62ab-7129-b7af-f1eb1b84afd4" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_019b096a-62ab-7cba-affb-c56aadc91aea" xlink:to="loc_srt_ConsolidatedEntitiesDomain_019b096a-62ab-7129-b7af-f1eb1b84afd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_019b096a-62ab-7d56-b68c-0c6271b98447" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_019b096a-62ab-7129-b7af-f1eb1b84afd4" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_019b096a-62ab-7d56-b68c-0c6271b98447" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7ed3-896d-775b2a5db644" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_019b096a-62ab-7c8d-9801-92347c69f7a8" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7ed3-896d-775b2a5db644" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-7ed3-896d-775b2a5db644_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7ed3-896d-775b2a5db644" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-7ed3-896d-775b2a5db644_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-73dd-b30d-905af9008c16" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7ed3-896d-775b2a5db644" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-73dd-b30d-905af9008c16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019b096a-62ab-74a4-995c-62be4b98b7a9" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-73dd-b30d-905af9008c16" xlink:to="loc_jynt_CorporateClinicsMember_019b096a-62ab-74a4-995c-62be4b98b7a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-7b3c-b0d0-367881a051a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_019b096a-62ab-77d6-85d0-1563a3b4f93f" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-7b3c-b0d0-367881a051a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-706b-9cb8-64c763eeea4f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_019b096a-62ab-77d6-85d0-1563a3b4f93f" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-706b-9cb8-64c763eeea4f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNetLossGainonDispositionorImpairmentRelatedtoContinuingOperationsDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#NatureofOperationsandSummaryofSignificantAccountingPoliciesNetLossGainonDispositionorImpairmentRelatedtoContinuingOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNetLossGainonDispositionorImpairmentRelatedtoContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_019b096a-62ab-75e1-b7e9-63404224d269" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_019b096a-62ab-7f03-8276-57a47c2393e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_019b096a-62ab-75e1-b7e9-63404224d269" xlink:to="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_019b096a-62ab-7f03-8276-57a47c2393e3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_019b096a-62ab-7c39-810a-fba93e65a221" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_019b096a-62ab-7f03-8276-57a47c2393e3" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_019b096a-62ab-7c39-810a-fba93e65a221" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_019b096a-62ab-7c39-810a-fba93e65a221_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_019b096a-62ab-7c39-810a-fba93e65a221" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_019b096a-62ab-7c39-810a-fba93e65a221_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_019b096a-62ab-7b75-840e-acc2ec70c2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_019b096a-62ab-7c39-810a-fba93e65a221" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_019b096a-62ab-7b75-840e-acc2ec70c2d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_019b096a-62ab-7601-be12-7388ab5fae50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_019b096a-62ab-7b75-840e-acc2ec70c2d0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_019b096a-62ab-7601-be12-7388ab5fae50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_OperatingLeaseRightOfUseAssetMember_019b096a-62ab-7001-bb90-4b9b101e16dd" xlink:href="jynt-20251231.xsd#jynt_OperatingLeaseRightOfUseAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_019b096a-62ab-7b75-840e-acc2ec70c2d0" xlink:to="loc_jynt_OperatingLeaseRightOfUseAssetMember_019b096a-62ab-7001-bb90-4b9b101e16dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMember_019b096a-62ab-7d3a-9c42-e34e7cf1dd28" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_019b096a-62ab-7b75-840e-acc2ec70c2d0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMember_019b096a-62ab-7d3a-9c42-e34e7cf1dd28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_019b096a-62ab-7676-bebc-860a4808d015" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_019b096a-62ab-75e1-b7e9-63404224d269" xlink:to="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_019b096a-62ab-7676-bebc-860a4808d015" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment_019b096a-62ab-71f8-b3f4-5f5da0c38a23" xlink:href="jynt-20251231.xsd#jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_019b096a-62ab-75e1-b7e9-63404224d269" xlink:to="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment_019b096a-62ab-71f8-b3f4-5f5da0c38a23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment_019b096a-62ab-7e2d-bbc5-93a2a6dabe54" xlink:href="jynt-20251231.xsd#jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_019b096a-62ab-75e1-b7e9-63404224d269" xlink:to="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment_019b096a-62ab-7e2d-bbc5-93a2a6dabe54" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_019b096a-62ab-7d40-a6ab-699a6ff18c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_019b096a-62ab-75e1-b7e9-63404224d269" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_019b096a-62ab-7d40-a6ab-699a6ff18c6c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_019b096a-62ab-7272-8bf5-3a9c431714b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_019b096a-62ab-77d6-b748-dcfca1eb3852" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_019b096a-62ab-7272-8bf5-3a9c431714b2" xlink:to="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_019b096a-62ab-77d6-b748-dcfca1eb3852" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-7662-a2e3-f4f0ea448698" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_019b096a-62ab-77d6-b748-dcfca1eb3852" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-7662-a2e3-f4f0ea448698" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7662-a2e3-f4f0ea448698_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-7662-a2e3-f4f0ea448698" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7662-a2e3-f4f0ea448698_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-756d-899f-ddd41de3cef1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-7662-a2e3-f4f0ea448698" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-756d-899f-ddd41de3cef1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_019b096a-62ab-76af-afb3-bb2af36f5fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-756d-899f-ddd41de3cef1" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_019b096a-62ab-76af-afb3-bb2af36f5fb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DiscontinuedOperationsHeldForUseMember_019b096a-62ab-7447-8edb-54c7326c3fcf" xlink:href="jynt-20251231.xsd#jynt_DiscontinuedOperationsHeldForUseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDiscontinuedOperationsMember_019b096a-62ab-76af-afb3-bb2af36f5fb0" xlink:to="loc_jynt_DiscontinuedOperationsHeldForUseMember_019b096a-62ab-7447-8edb-54c7326c3fcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_019b096a-62ab-7adb-856c-b96aaf7127e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDiscontinuedOperationsMember_019b096a-62ab-76af-afb3-bb2af36f5fb0" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_019b096a-62ab-7adb-856c-b96aaf7127e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_019b096a-62ab-723b-add8-ccdf99ca9fda" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDiscontinuedOperationsMember_019b096a-62ab-76af-afb3-bb2af36f5fb0" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_019b096a-62ab-723b-add8-ccdf99ca9fda" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_019b096a-62ab-73d7-b659-e60195bda422" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDiscontinuedOperationsMember_019b096a-62ab-76af-afb3-bb2af36f5fb0" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_019b096a-62ab-73d7-b659-e60195bda422" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_019b096a-62ab-7efa-913a-f8aac622e62f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_019b096a-62ab-77d6-b748-dcfca1eb3852" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_019b096a-62ab-7efa-913a-f8aac622e62f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019b096a-62ab-7efa-913a-f8aac622e62f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_019b096a-62ab-7efa-913a-f8aac622e62f" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019b096a-62ab-7efa-913a-f8aac622e62f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019b096a-62ab-7e60-bd73-6157dc41f7ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_019b096a-62ab-7efa-913a-f8aac622e62f" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019b096a-62ab-7e60-bd73-6157dc41f7ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_019b096a-62ab-7640-9270-c4ab09545a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019b096a-62ab-7e60-bd73-6157dc41f7ff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_019b096a-62ab-7640-9270-c4ab09545a1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_OperatingLeaseRightOfUseAssetMember_019b096a-62ab-79aa-bca2-a69be272e486" xlink:href="jynt-20251231.xsd#jynt_OperatingLeaseRightOfUseAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019b096a-62ab-7e60-bd73-6157dc41f7ff" xlink:to="loc_jynt_OperatingLeaseRightOfUseAssetMember_019b096a-62ab-79aa-bca2-a69be272e486" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMember_019b096a-62ab-7194-9dda-0cdfdcc1fea9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019b096a-62ab-7e60-bd73-6157dc41f7ff" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMember_019b096a-62ab-7194-9dda-0cdfdcc1fea9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AssetsHeldForSaleMember_019b096a-62ab-7601-9a8d-375a92906cca" xlink:href="jynt-20251231.xsd#jynt_AssetsHeldForSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019b096a-62ab-7e60-bd73-6157dc41f7ff" xlink:to="loc_jynt_AssetsHeldForSaleMember_019b096a-62ab-7601-9a8d-375a92906cca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b32ea-7e1b-7640-a1fa-9b0044041181" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_019b096a-62ab-77d6-b748-dcfca1eb3852" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b32ea-7e1b-7640-a1fa-9b0044041181" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b32ea-7e1b-7640-a1fa-9b0044041181_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b32ea-7e1b-7640-a1fa-9b0044041181" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b32ea-7e1b-7640-a1fa-9b0044041181_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b32ea-7e1b-786e-8144-dec28161e4fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b32ea-7e1b-7640-a1fa-9b0044041181" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b32ea-7e1b-786e-8144-dec28161e4fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019b32ea-7e1b-7431-a642-e083507e1d2e" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b32ea-7e1b-786e-8144-dec28161e4fd" xlink:to="loc_jynt_CorporateClinicsMember_019b32ea-7e1b-7431-a642-e083507e1d2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment_019b096a-62ab-7189-9486-474396109c95" xlink:href="jynt-20251231.xsd#jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_019b096a-62ab-7272-8bf5-3a9c431714b2" xlink:to="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment_019b096a-62ab-7189-9486-474396109c95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment_019b096a-62ab-7ce6-a714-e9ace7c78a35" xlink:href="jynt-20251231.xsd#jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_019b096a-62ab-7272-8bf5-3a9c431714b2" xlink:to="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment_019b096a-62ab-7ce6-a714-e9ace7c78a35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019b096a-62ab-73ec-a348-233731d6a5b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_019b096a-62ab-7272-8bf5-3a9c431714b2" xlink:to="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019b096a-62ab-73ec-a348-233731d6a5b9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/RevenueDisclosuresNarrativeDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#RevenueDisclosuresNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/RevenueDisclosuresNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-7e3f-afd1-85343617d84e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_019b096a-62ab-79b8-99eb-b85cf96b3881" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-7e3f-afd1-85343617d84e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_019b096a-62ab-79b8-99eb-b85cf96b3881" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisorDisclosureAxis_019b096a-62ab-7602-a76e-6567a28cd3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisorDisclosureAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019b096a-62ab-79b8-99eb-b85cf96b3881" xlink:to="loc_us-gaap_FranchisorDisclosureAxis_019b096a-62ab-7602-a76e-6567a28cd3c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisorDisclosureDomain_019b096a-62ab-7602-a76e-6567a28cd3c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisorDisclosureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FranchisorDisclosureAxis_019b096a-62ab-7602-a76e-6567a28cd3c3" xlink:to="loc_us-gaap_FranchisorDisclosureDomain_019b096a-62ab-7602-a76e-6567a28cd3c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisorDisclosureDomain_019b096a-62ab-750e-9600-92fd6b885951" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisorDisclosureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FranchisorDisclosureAxis_019b096a-62ab-7602-a76e-6567a28cd3c3" xlink:to="loc_us-gaap_FranchisorDisclosureDomain_019b096a-62ab-750e-9600-92fd6b885951" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisedUnitsMember_019b096a-62ab-7438-8902-e9e8795c4ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisedUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FranchisorDisclosureDomain_019b096a-62ab-750e-9600-92fd6b885951" xlink:to="loc_us-gaap_FranchisedUnitsMember_019b096a-62ab-7438-8902-e9e8795c4ff6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_019b096a-62ab-74ff-a652-0007db17220f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfStores"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-7e3f-afd1-85343617d84e" xlink:to="loc_us-gaap_NumberOfStores_019b096a-62ab-74ff-a652-0007db17220f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ClinicLicensesSoldButNotYetDeveloped_019b096a-62ab-79ac-9305-944e2d9520b2" xlink:href="jynt-20251231.xsd#jynt_ClinicLicensesSoldButNotYetDeveloped"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-7e3f-afd1-85343617d84e" xlink:to="loc_jynt_ClinicLicensesSoldButNotYetDeveloped_019b096a-62ab-79ac-9305-944e2d9520b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ExecutedLettersOfIntentForFutureClinicLicenses_019b096a-62ab-7f9e-a15e-16958a39697d" xlink:href="jynt-20251231.xsd#jynt_ExecutedLettersOfIntentForFutureClinicLicenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-7e3f-afd1-85343617d84e" xlink:to="loc_jynt_ExecutedLettersOfIntentForFutureClinicLicenses_019b096a-62ab-7f9e-a15e-16958a39697d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/RevenueDisclosuresDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#RevenueDisclosuresDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/RevenueDisclosuresDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-7596-936f-4c1130a5bd1c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_019b096a-62ab-7aee-bbdc-03fdb0d6a95f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-7596-936f-4c1130a5bd1c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_019b096a-62ab-7aee-bbdc-03fdb0d6a95f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_019b096a-62ab-7a59-bd29-77946fa6f2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019b096a-62ab-7aee-bbdc-03fdb0d6a95f" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_019b096a-62ab-7a59-bd29-77946fa6f2dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_019b096a-62ab-7a59-bd29-77946fa6f2dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_019b096a-62ab-7a59-bd29-77946fa6f2dc" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_019b096a-62ab-7a59-bd29-77946fa6f2dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_019b096a-62ab-75ca-99d9-fb38e7c061b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_019b096a-62ab-7a59-bd29-77946fa6f2dc" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_019b096a-62ab-75ca-99d9-fb38e7c061b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredAtPointInTimeMember_019b096a-62ab-7388-89dc-47273ea2a87b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransferredAtPointInTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_019b096a-62ab-75ca-99d9-fb38e7c061b0" xlink:to="loc_us-gaap_TransferredAtPointInTimeMember_019b096a-62ab-7388-89dc-47273ea2a87b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_019b096a-62ab-772c-b67a-5289b3b6648c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_019b096a-62ab-75ca-99d9-fb38e7c061b0" xlink:to="loc_us-gaap_TransferredOverTimeMember_019b096a-62ab-772c-b67a-5289b3b6648c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_019b096a-62ab-73a3-aa0a-a915a5647057" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-7596-936f-4c1130a5bd1c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_019b096a-62ab-73a3-aa0a-a915a5647057" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/RevenueDisclosuresEstimatedRevenueRelatedtoPerformanceObligationsDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#RevenueDisclosuresEstimatedRevenueRelatedtoPerformanceObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/RevenueDisclosuresEstimatedRevenueRelatedtoPerformanceObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-75bb-8c0d-6b21b4088740" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_019b096a-62ab-72bc-850d-a5b3eff7aa04" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-75bb-8c0d-6b21b4088740" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_019b096a-62ab-72bc-850d-a5b3eff7aa04" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_019b096a-62ab-7e3d-b7f3-ddae9ba58401" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019b096a-62ab-72bc-850d-a5b3eff7aa04" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_019b096a-62ab-7e3d-b7f3-ddae9ba58401" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_019b096a-62ab-781c-b8d5-75acd8a6687f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-75bb-8c0d-6b21b4088740" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_019b096a-62ab-781c-b8d5-75acd8a6687f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_019b096a-62ab-7165-b7f7-7e93ddef8de9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-75bb-8c0d-6b21b4088740" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_019b096a-62ab-7165-b7f7-7e93ddef8de9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/RevenueDisclosuresEstimatedRevenueRelatedtoPerformanceObligationsDetails_1" xlink:type="simple" xlink:href="jynt-20251231.xsd#RevenueDisclosuresEstimatedRevenueRelatedtoPerformanceObligationsDetails_1"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/RevenueDisclosuresEstimatedRevenueRelatedtoPerformanceObligationsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-75bb-8c0d-6b21b4088740" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_019b096a-62ab-72bc-850d-a5b3eff7aa04" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-75bb-8c0d-6b21b4088740" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_019b096a-62ab-72bc-850d-a5b3eff7aa04" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_019b096a-62ab-781c-b8d5-75acd8a6687f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-75bb-8c0d-6b21b4088740" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_019b096a-62ab-781c-b8d5-75acd8a6687f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_019b096a-62ab-7165-b7f7-7e93ddef8de9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-75bb-8c0d-6b21b4088740" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_019b096a-62ab-7165-b7f7-7e93ddef8de9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-70d9-a1e2-61e9508201f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-70d9-a1e2-61e9508201f9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-79a4-a251-eb03372ed062" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-70d9-a1e2-61e9508201f9" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-79a4-a251-eb03372ed062" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-79a4-a251-eb03372ed062_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-79a4-a251-eb03372ed062" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-79a4-a251-eb03372ed062_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7df4-9075-86ec71b7420e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-79a4-a251-eb03372ed062" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7df4-9075-86ec71b7420e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019b096a-62ab-7cf1-91d5-5f5b9de25236" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7df4-9075-86ec71b7420e" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019b096a-62ab-7cf1-91d5-5f5b9de25236" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7b5a-a529-f13154e7c34e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-70d9-a1e2-61e9508201f9" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7b5a-a529-f13154e7c34e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-7b5a-a529-f13154e7c34e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7b5a-a529-f13154e7c34e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-7b5a-a529-f13154e7c34e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-79ee-9951-4529d1f6f91f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7b5a-a529-f13154e7c34e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-79ee-9951-4529d1f6f91f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019b096a-62ab-7cb7-876b-777193823415" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-79ee-9951-4529d1f6f91f" xlink:to="loc_jynt_CorporateClinicsMember_019b096a-62ab-7cb7-876b-777193823415" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_019b096a-62ab-75b5-b944-9f98edcb2f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_us-gaap_RevenuesAbstract_019b096a-62ab-75b5-b944-9f98edcb2f2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_019b096a-62ab-7342-8b4c-acd88cdb8c25" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_019b096a-62ab-75b5-b944-9f98edcb2f2a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_019b096a-62ab-7342-8b4c-acd88cdb8c25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_019b096a-62ab-7023-b260-41855aa16c44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_us-gaap_CostOfRevenueAbstract_019b096a-62ab-7023-b260-41855aa16c44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_019b096a-62ab-7b75-9537-764a16bc6dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfRevenueAbstract_019b096a-62ab-7023-b260-41855aa16c44" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_019b096a-62ab-7b75-9537-764a16bc6dbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses_019b096a-62ab-7f34-bf5d-7a8f73cb11cc" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses_019b096a-62ab-7f34-bf5d-7a8f73cb11cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_019b096a-62ab-7d14-97b8-7a79cddd200a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_019b096a-62ab-7d14-97b8-7a79cddd200a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_019b096a-62ab-7bb2-989a-3338a8b70683" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_019b096a-62ab-7bb2-989a-3338a8b70683" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses_019b096a-62ab-7dad-9537-97e4d962c943" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses_019b096a-62ab-7dad-9537-97e4d962c943" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019b096a-62ab-704d-a530-971dec2c5c16" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019b096a-62ab-704d-a530-971dec2c5c16" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_019b096a-62ab-7f4f-9778-14bd7b608079" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_019b096a-62ab-7f4f-9778-14bd7b608079" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_019b096a-62ab-7425-9ca8-3738318f9be6" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_019b096a-62ab-7425-9ca8-3738318f9be6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b096a-62ab-7649-9d66-cdf141924078" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b096a-62ab-7649-9d66-cdf141924078" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_019b096a-62ab-7973-96af-2d291fa25361" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_019b096a-62ab-7973-96af-2d291fa25361" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-62ab-7c93-becf-4d75c9b00491" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-62ab-7c93-becf-4d75c9b00491" xlink:type="arc" order="11"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-75b5-9a4d-df88728b27b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-77f5-885a-eb44f526c8ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-75b5-9a4d-df88728b27b7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-77f5-885a-eb44f526c8ec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-717d-b266-0d9e36baf10c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-77f5-885a-eb44f526c8ec" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-717d-b266-0d9e36baf10c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-717d-b266-0d9e36baf10c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-717d-b266-0d9e36baf10c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-717d-b266-0d9e36baf10c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7a52-8a9f-02e63fd2b5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-717d-b266-0d9e36baf10c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7a52-8a9f-02e63fd2b5ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019b096a-62ab-7b5d-b205-d465656316ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7a52-8a9f-02e63fd2b5ae" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019b096a-62ab-7b5d-b205-d465656316ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_019b096a-62ab-725c-9cdd-b3d63a2e391a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7a52-8a9f-02e63fd2b5ae" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_019b096a-62ab-725c-9cdd-b3d63a2e391a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7dd6-8d93-802249ec5c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-77f5-885a-eb44f526c8ec" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7dd6-8d93-802249ec5c1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-7dd6-8d93-802249ec5c1d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7dd6-8d93-802249ec5c1d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-7dd6-8d93-802249ec5c1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-78f0-b769-88f84bcb6e01" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7dd6-8d93-802249ec5c1d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-78f0-b769-88f84bcb6e01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019b096a-62ab-7270-97f6-dd783b914d4f" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-78f0-b769-88f84bcb6e01" xlink:to="loc_jynt_CorporateClinicsMember_019b096a-62ab-7270-97f6-dd783b914d4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_019b096a-62ab-786c-b75f-bd519a3cc116" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-77f5-885a-eb44f526c8ec" xlink:to="loc_srt_ConsolidatedEntitiesAxis_019b096a-62ab-786c-b75f-bd519a3cc116" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_019b096a-62ab-786c-b75f-bd519a3cc116_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_019b096a-62ab-786c-b75f-bd519a3cc116" xlink:to="loc_srt_ConsolidatedEntitiesDomain_019b096a-62ab-786c-b75f-bd519a3cc116_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_019b096a-62ab-7dc9-b173-1cc731793e27" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_019b096a-62ab-786c-b75f-bd519a3cc116" xlink:to="loc_srt_ConsolidatedEntitiesDomain_019b096a-62ab-7dc9-b173-1cc731793e27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_019b096a-62ab-7b4d-9bd0-9e78094eb0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_019b096a-62ab-7dc9-b173-1cc731793e27" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_019b096a-62ab-7b4d-9bd0-9e78094eb0c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7c38-bb0d-bf4aff1d0b70" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-75b5-9a4d-df88728b27b7" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7c38-bb0d-bf4aff1d0b70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_019b096a-62ab-7c06-88b2-05e9038c326e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7c38-bb0d-bf4aff1d0b70" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_019b096a-62ab-7c06-88b2-05e9038c326e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_019b096a-62ab-794e-9dbe-a5c758ddcfde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7c38-bb0d-bf4aff1d0b70" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_019b096a-62ab-794e-9dbe-a5c758ddcfde" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-7433-ab53-5f60fe425c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7c38-bb0d-bf4aff1d0b70" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-7433-ab53-5f60fe425c4b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_019b096a-62ab-7da4-a36f-7b6045018a45" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7c38-bb0d-bf4aff1d0b70" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_019b096a-62ab-7da4-a36f-7b6045018a45" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent_019b096a-62ab-7728-999b-46e8bcc4dd47" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7c38-bb0d-bf4aff1d0b70" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent_019b096a-62ab-7728-999b-46e8bcc4dd47" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_019b096a-62ab-7e24-8b91-0cd345d9b94d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7c38-bb0d-bf4aff1d0b70" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_019b096a-62ab-7e24-8b91-0cd345d9b94d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_019b096a-62ab-767a-b588-f245221d913e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7c38-bb0d-bf4aff1d0b70" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_019b096a-62ab-767a-b588-f245221d913e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7962-9d3e-6a6f1423e975" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-75b5-9a4d-df88728b27b7" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7962-9d3e-6a6f1423e975" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_019b096a-62ab-79d1-995e-af70e60728b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7962-9d3e-6a6f1423e975" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_019b096a-62ab-79d1-995e-af70e60728b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_019b096a-62ab-720e-bdfb-a8fd0434cc26" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7962-9d3e-6a6f1423e975" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_019b096a-62ab-720e-bdfb-a8fd0434cc26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent_019b096a-62ab-7163-becf-e022778f39f8" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7962-9d3e-6a6f1423e975" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent_019b096a-62ab-7163-becf-e022778f39f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_019b096a-62ab-71aa-978d-4630490dc40f" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7962-9d3e-6a6f1423e975" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_019b096a-62ab-71aa-978d-4630490dc40f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent_019b096a-62ab-78a7-b971-f31792ef6f8d" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7962-9d3e-6a6f1423e975" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent_019b096a-62ab-78a7-b971-f31792ef6f8d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_019b096a-62ab-7fd1-a715-5e1655674f36" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7962-9d3e-6a6f1423e975" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_019b096a-62ab-7fd1-a715-5e1655674f36" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-7e8b-9996-d95c0a304784" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7962-9d3e-6a6f1423e975" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-7e8b-9996-d95c0a304784" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_019b096a-62ab-7550-a502-d8e7037667a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7962-9d3e-6a6f1423e975" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_019b096a-62ab-7550-a502-d8e7037667a3" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/DivestituresKeyComponentsofCashFlowsfromDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#DivestituresKeyComponentsofCashFlowsfromDiscontinuedOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/DivestituresKeyComponentsofCashFlowsfromDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-758e-b066-07761b31aafe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-73a3-b1e3-cc1dc4d5e312" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-758e-b066-07761b31aafe" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-73a3-b1e3-cc1dc4d5e312" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-792a-8237-e4f4230494be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-73a3-b1e3-cc1dc4d5e312" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-792a-8237-e4f4230494be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-792a-8237-e4f4230494be_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-792a-8237-e4f4230494be" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-792a-8237-e4f4230494be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7b05-b89e-b12d4b01fa63" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-792a-8237-e4f4230494be" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7b05-b89e-b12d4b01fa63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019b096a-62ab-7013-bc0e-cfbf760926bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7b05-b89e-b12d4b01fa63" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019b096a-62ab-7013-bc0e-cfbf760926bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7f13-a938-239dd8cc3d37" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-73a3-b1e3-cc1dc4d5e312" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7f13-a938-239dd8cc3d37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-7f13-a938-239dd8cc3d37_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7f13-a938-239dd8cc3d37" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-7f13-a938-239dd8cc3d37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-7368-8a8f-385dcda78412" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7f13-a938-239dd8cc3d37" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-7368-8a8f-385dcda78412" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019b096a-62ab-7e49-b3ac-c6cd070d90b2" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-7368-8a8f-385dcda78412" xlink:to="loc_jynt_CorporateClinicsMember_019b096a-62ab-7e49-b3ac-c6cd070d90b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAlternativeCashFlowInformationAbstract_019b096a-62ab-703e-9602-b55a868f4204" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationAlternativeCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-758e-b066-07761b31aafe" xlink:to="loc_us-gaap_DiscontinuedOperationAlternativeCashFlowInformationAbstract_019b096a-62ab-703e-9602-b55a868f4204" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortizationDiscontinuedOperations_019c92a7-3fba-7237-b868-82a70b802628" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortizationDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DiscontinuedOperationAlternativeCashFlowInformationAbstract_019b096a-62ab-703e-9602-b55a868f4204" xlink:to="loc_us-gaap_DepreciationAndAmortizationDiscontinuedOperations_019c92a7-3fba-7237-b868-82a70b802628" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019b096a-62ab-75df-a8bd-94fce59e6e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DiscontinuedOperationAlternativeCashFlowInformationAbstract_019b096a-62ab-703e-9602-b55a868f4204" xlink:to="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019b096a-62ab-75df-a8bd-94fce59e6e2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CapitalExpendituresDiscontinuedOperationsAbstract_019b096a-62ab-7cbf-b99e-f96df9198ef2" xlink:href="jynt-20251231.xsd#jynt_CapitalExpendituresDiscontinuedOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-758e-b066-07761b31aafe" xlink:to="loc_jynt_CapitalExpendituresDiscontinuedOperationsAbstract_019b096a-62ab-7cbf-b99e-f96df9198ef2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpenditureDiscontinuedOperations_019b096a-62ab-77f2-9e64-17b62fb88d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalExpenditureDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jynt_CapitalExpendituresDiscontinuedOperationsAbstract_019b096a-62ab-7cbf-b99e-f96df9198ef2" xlink:to="loc_us-gaap_CapitalExpenditureDiscontinuedOperations_019b096a-62ab-77f2-9e64-17b62fb88d7a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/DivestituresNarrativeDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#DivestituresNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/DivestituresNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b3317-fa4b-7555-bd1d-61df467eb2f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-71e0-9ba4-afd69ecd4586" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b3317-fa4b-7555-bd1d-61df467eb2f1" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-71e0-9ba4-afd69ecd4586" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019b3317-fa4b-7fc9-b4a8-bab3ae155e53" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-71e0-9ba4-afd69ecd4586" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019b3317-fa4b-7fc9-b4a8-bab3ae155e53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019b3317-fa4b-7fc9-b4a8-bab3ae155e53_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019b3317-fa4b-7fc9-b4a8-bab3ae155e53" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019b3317-fa4b-7fc9-b4a8-bab3ae155e53_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019b3317-fa4b-7092-958d-3c311f35a144" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019b3317-fa4b-7fc9-b4a8-bab3ae155e53" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019b3317-fa4b-7092-958d-3c311f35a144" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_019b3317-fa4b-744c-86e4-2a4c728dcb87" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019b3317-fa4b-7092-958d-3c311f35a144" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_019b3317-fa4b-744c-86e4-2a4c728dcb87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_019b3317-fa4b-7744-b568-b19680c7bd59" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019b3317-fa4b-7092-958d-3c311f35a144" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_019b3317-fa4b-7744-b568-b19680c7bd59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b3317-fa4b-703b-98bd-961111018b65" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-71e0-9ba4-afd69ecd4586" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b3317-fa4b-703b-98bd-961111018b65" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b3317-fa4b-703b-98bd-961111018b65_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b3317-fa4b-703b-98bd-961111018b65" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b3317-fa4b-703b-98bd-961111018b65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b3317-fa4b-7741-a582-b566b4a2741b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b3317-fa4b-703b-98bd-961111018b65" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b3317-fa4b-7741-a582-b566b4a2741b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019b3317-fa4b-7c67-a3e7-5ff4faf73ad9" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b3317-fa4b-7741-a582-b566b4a2741b" xlink:to="loc_jynt_CorporateClinicsMember_019b3317-fa4b-7c67-a3e7-5ff4faf73ad9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_019b3317-fa4b-7e97-8efb-d99ff17fc259" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-71e0-9ba4-afd69ecd4586" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_019b3317-fa4b-7e97-8efb-d99ff17fc259" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019b3317-fa4b-7e97-8efb-d99ff17fc259_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_019b3317-fa4b-7e97-8efb-d99ff17fc259" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019b3317-fa4b-7e97-8efb-d99ff17fc259_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019b3317-fa4b-786c-a270-725463d7de5b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_019b3317-fa4b-7e97-8efb-d99ff17fc259" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019b3317-fa4b-786c-a270-725463d7de5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AssetsHeldForSaleMember_019b3317-fa4b-7c7a-bb98-4817464467ad" xlink:href="jynt-20251231.xsd#jynt_AssetsHeldForSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019b3317-fa4b-786c-a270-725463d7de5b" xlink:to="loc_jynt_AssetsHeldForSaleMember_019b3317-fa4b-7c7a-bb98-4817464467ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupHeldForSaleClinicsExpectedToSellPeriod_019c5395-8c72-7a55-a4a1-425ba8af1f8d" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupHeldForSaleClinicsExpectedToSellPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b3317-fa4b-7555-bd1d-61df467eb2f1" xlink:to="loc_jynt_DisposalGroupHeldForSaleClinicsExpectedToSellPeriod_019c5395-8c72-7a55-a4a1-425ba8af1f8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue_019b3317-fa4b-73e4-8e70-72b94e3a6019" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b3317-fa4b-7555-bd1d-61df467eb2f1" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue_019b3317-fa4b-73e4-8e70-72b94e3a6019" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019b3317-fa4b-7e8b-aa9f-829ac20ad167" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b3317-fa4b-7555-bd1d-61df467eb2f1" xlink:to="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019b3317-fa4b-7e8b-aa9f-829ac20ad167" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_019b3317-fa4b-7067-a57a-e1cbbf882cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b3317-fa4b-7555-bd1d-61df467eb2f1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_019b3317-fa4b-7067-a57a-e1cbbf882cb5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold_019b3317-fa4b-7d50-aca1-18d0bd0d0272" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b3317-fa4b-7555-bd1d-61df467eb2f1" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold_019b3317-fa4b-7d50-aca1-18d0bd0d0272" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_019b3317-fa4b-78e9-8af1-a17a5ad00b2c" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b3317-fa4b-7555-bd1d-61df467eb2f1" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_019b3317-fa4b-78e9-8af1-a17a5ad00b2c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold_019b3317-fa4b-7f1d-bc80-4e94996f6fb9" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b3317-fa4b-7555-bd1d-61df467eb2f1" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold_019b3317-fa4b-7f1d-bc80-4e94996f6fb9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b3317-fa4b-7515-8fce-a9e8d8ebcec6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b3317-fa4b-7555-bd1d-61df467eb2f1" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b3317-fa4b-7515-8fce-a9e8d8ebcec6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_019b331a-2308-790d-834c-ca0d5f4e1cff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b3317-fa4b-7555-bd1d-61df467eb2f1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_019b331a-2308-790d-834c-ca0d5f4e1cff" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-74cd-9895-6c92f66d7e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-7d56-9bae-f0bbebef1fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-74cd-9895-6c92f66d7e8a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-7d56-9bae-f0bbebef1fc3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-76d7-aea3-74af76c2f010" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-7d56-9bae-f0bbebef1fc3" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-76d7-aea3-74af76c2f010" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-76d7-aea3-74af76c2f010_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-76d7-aea3-74af76c2f010" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-76d7-aea3-74af76c2f010_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7d4f-8f22-c080bcaadd50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-76d7-aea3-74af76c2f010" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7d4f-8f22-c080bcaadd50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_019b096a-62ab-7d8a-b384-845b540f61f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7d4f-8f22-c080bcaadd50" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_019b096a-62ab-7d8a-b384-845b540f61f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7f67-9ea8-206c7464e57f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-7d56-9bae-f0bbebef1fc3" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7f67-9ea8-206c7464e57f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-7f67-9ea8-206c7464e57f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7f67-9ea8-206c7464e57f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-7f67-9ea8-206c7464e57f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-7c7d-94e8-9b97044d7422" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7f67-9ea8-206c7464e57f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-7c7d-94e8-9b97044d7422" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019b096a-62ab-79ed-837f-1c367cc17cbd" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-7c7d-94e8-9b97044d7422" xlink:to="loc_jynt_CorporateClinicsMember_019b096a-62ab-79ed-837f-1c367cc17cbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-72bf-8b1b-35b421dfb7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-74cd-9895-6c92f66d7e8a" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-72bf-8b1b-35b421dfb7b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_019b096a-62ab-74e4-8b95-05f37f7bc427" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-72bf-8b1b-35b421dfb7b1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_019b096a-62ab-74e4-8b95-05f37f7bc427" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent_019b096a-62ab-70c7-bab4-a0ae2de1278d" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-72bf-8b1b-35b421dfb7b1" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent_019b096a-62ab-70c7-bab4-a0ae2de1278d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_019b096a-62ab-70a0-a64f-9599c0f4c53b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-72bf-8b1b-35b421dfb7b1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_019b096a-62ab-70a0-a64f-9599c0f4c53b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent_019b096a-62ab-753d-9673-b05abedb3abe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-72bf-8b1b-35b421dfb7b1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent_019b096a-62ab-753d-9673-b05abedb3abe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_019b096a-62ab-7074-b481-ea4693a686e7" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-72bf-8b1b-35b421dfb7b1" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_019b096a-62ab-7074-b481-ea4693a686e7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-730d-98fd-253ca4d55291" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-72bf-8b1b-35b421dfb7b1" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-730d-98fd-253ca4d55291" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7908-ba89-81f7d45ae7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-74cd-9895-6c92f66d7e8a" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7908-ba89-81f7d45ae7bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_019b096a-62ab-7f01-a8c7-413602355d18" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7908-ba89-81f7d45ae7bc" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_019b096a-62ab-7f01-a8c7-413602355d18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent_019b096a-62ab-7e55-981e-14dcd3988e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7908-ba89-81f7d45ae7bc" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent_019b096a-62ab-7e55-981e-14dcd3988e2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-7ffd-80a2-fc1e60159d51" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7908-ba89-81f7d45ae7bc" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-7ffd-80a2-fc1e60159d51" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#PropertyandEquipmentSummaryofPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019b096a-62ab-7202-b466-e030049a9b73" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019b096a-62ab-7e21-bbea-22b750e987b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019b096a-62ab-7202-b466-e030049a9b73" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019b096a-62ab-7e21-bbea-22b750e987b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019b096a-62ab-74ba-ae3b-9796439ad2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019b096a-62ab-7e21-bbea-22b750e987b0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019b096a-62ab-74ba-ae3b-9796439ad2cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019b096a-62ab-74ba-ae3b-9796439ad2cc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019b096a-62ab-74ba-ae3b-9796439ad2cc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019b096a-62ab-74ba-ae3b-9796439ad2cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019b096a-62ab-7cb4-b6a6-c9d43ab36660" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019b096a-62ab-74ba-ae3b-9796439ad2cc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019b096a-62ab-7cb4-b6a6-c9d43ab36660" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_019b096a-62ab-7e1c-93aa-00f6dfcee395" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019b096a-62ab-7cb4-b6a6-c9d43ab36660" xlink:to="loc_us-gaap_OfficeEquipmentMember_019b096a-62ab-7e1c-93aa-00f6dfcee395" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_019b096a-62ab-7cb6-a9dc-ec90de7b0398" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019b096a-62ab-7cb4-b6a6-c9d43ab36660" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_019b096a-62ab-7cb6-a9dc-ec90de7b0398" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_019b096a-62ab-77c1-8922-2503c1aae069" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019b096a-62ab-7cb4-b6a6-c9d43ab36660" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_019b096a-62ab-77c1-8922-2503c1aae069" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember_019b096a-62ab-709d-b552-d7e1953d7d79" xlink:href="jynt-20251231.xsd#jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019b096a-62ab-7cb4-b6a6-c9d43ab36660" xlink:to="loc_jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember_019b096a-62ab-709d-b552-d7e1953d7d79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_019b096a-62ab-7dc3-9a0e-b3c237d07ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019b096a-62ab-7202-b466-e030049a9b73" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_019b096a-62ab-7dc3-9a0e-b3c237d07ad7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019b096a-62ab-7d60-a18a-06bd09ef269a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019b096a-62ab-7202-b466-e030049a9b73" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019b096a-62ab-7d60-a18a-06bd09ef269a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019b096a-62ab-7d08-827d-ccf7b12161fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019b096a-62ab-7202-b466-e030049a9b73" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019b096a-62ab-7d08-827d-ccf7b12161fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_019b096a-62ab-7b56-94ec-45735d2bc2a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019b096a-62ab-7202-b466-e030049a9b73" xlink:to="loc_us-gaap_ConstructionInProgressGross_019b096a-62ab-7b56-94ec-45735d2bc2a1" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/FairValueConsiderationDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#FairValueConsiderationDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/FairValueConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c661d-986d-79c9-bb4b-39d4cb0e73f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019b096a-62ab-7968-b17e-b149817702c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c661d-986d-79c9-bb4b-39d4cb0e73f0" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019b096a-62ab-7968-b17e-b149817702c6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_019c661d-986d-7a16-ba3e-d4663d1476d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019b096a-62ab-7968-b17e-b149817702c6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_019c661d-986d-7a16-ba3e-d4663d1476d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019c661d-986d-7a16-ba3e-d4663d1476d0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_019c661d-986d-7a16-ba3e-d4663d1476d0" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019c661d-986d-7a16-ba3e-d4663d1476d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019c661d-986d-72e5-af27-70d780b7bbd8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_019c661d-986d-7a16-ba3e-d4663d1476d0" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019c661d-986d-72e5-af27-70d780b7bbd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_019c661d-986d-708a-b267-006a50b43e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019c661d-986d-72e5-af27-70d780b7bbd8" xlink:to="loc_us-gaap_MoneyMarketFundsMember_019c661d-986d-708a-b267-006a50b43e8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019c661d-986d-7e43-ac92-7252df9a02e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019b096a-62ab-7968-b17e-b149817702c6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019c661d-986d-7e43-ac92-7252df9a02e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c661d-986d-7e43-ac92-7252df9a02e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019c661d-986d-7e43-ac92-7252df9a02e2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c661d-986d-7e43-ac92-7252df9a02e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c661d-986d-7ec4-9e98-ea11f33ea9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019c661d-986d-7e43-ac92-7252df9a02e2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c661d-986d-7ec4-9e98-ea11f33ea9f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_019c661d-986d-7481-9452-079c3bccdbda" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c661d-986d-7ec4-9e98-ea11f33ea9f4" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_019c661d-986d-7481-9452-079c3bccdbda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_019c661d-df28-7011-9485-092e5b7b8a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c661d-986d-7ec4-9e98-ea11f33ea9f4" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_019c661d-df28-7011-9485-092e5b7b8a2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_019c661d-df28-7a66-aca7-3e8b6acef3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c661d-986d-7ec4-9e98-ea11f33ea9f4" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_019c661d-df28-7a66-aca7-3e8b6acef3b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_019c661d-df28-75b6-8d8a-7805d0459b76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019b096a-62ab-7968-b17e-b149817702c6" xlink:to="loc_us-gaap_ValuationTechniqueAxis_019c661d-df28-75b6-8d8a-7805d0459b76" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_019c661d-df28-75b6-8d8a-7805d0459b76_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_019c661d-df28-75b6-8d8a-7805d0459b76" xlink:to="loc_us-gaap_ValuationTechniqueDomain_019c661d-df28-75b6-8d8a-7805d0459b76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_019c661d-df28-7639-9e0e-f21a7f943efb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_019c661d-df28-75b6-8d8a-7805d0459b76" xlink:to="loc_us-gaap_ValuationTechniqueDomain_019c661d-df28-7639-9e0e-f21a7f943efb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_019c661d-df28-7316-954b-ef3b91f6eb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_019c661d-df28-7639-9e0e-f21a7f943efb" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_019c661d-df28-7316-954b-ef3b91f6eb1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_019c661d-df28-77de-92f1-aeae03da6640" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019b096a-62ab-7968-b17e-b149817702c6" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_019c661d-df28-77de-92f1-aeae03da6640" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_019c661d-df28-77de-92f1-aeae03da6640_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_019c661d-df28-77de-92f1-aeae03da6640" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_019c661d-df28-77de-92f1-aeae03da6640_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_019c661d-df28-7afd-b103-7fca4f4bdecf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_019c661d-df28-77de-92f1-aeae03da6640" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_019c661d-df28-7afd-b103-7fca4f4bdecf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_019c661d-df28-7eb5-a39d-51eaba81e583" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019c661d-df28-7afd-b103-7fca4f4bdecf" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_019c661d-df28-7eb5-a39d-51eaba81e583" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019c661d-df28-7428-81f4-cb1d02923e04" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019b096a-62ab-7968-b17e-b149817702c6" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019c661d-df28-7428-81f4-cb1d02923e04" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019c661d-df28-7428-81f4-cb1d02923e04_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019c661d-df28-7428-81f4-cb1d02923e04" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019c661d-df28-7428-81f4-cb1d02923e04_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019c661d-df28-7d99-8ad2-26cf312692fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019c661d-df28-7428-81f4-cb1d02923e04" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019c661d-df28-7d99-8ad2-26cf312692fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_019c661d-df28-7923-b4c3-9836a097cbab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019c661d-df28-7d99-8ad2-26cf312692fe" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_019c661d-df28-7923-b4c3-9836a097cbab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DiscontinuedOperationsHeldForUseMember_019c661d-df28-75f3-8e23-5f4afaec9586" xlink:href="jynt-20251231.xsd#jynt_DiscontinuedOperationsHeldForUseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019c661d-df28-7d99-8ad2-26cf312692fe" xlink:to="loc_jynt_DiscontinuedOperationsHeldForUseMember_019c661d-df28-75f3-8e23-5f4afaec9586" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019c661d-df28-7294-b3c5-c2e8817ec58d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019b096a-62ab-7968-b17e-b149817702c6" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019c661d-df28-7294-b3c5-c2e8817ec58d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019c661d-df28-7294-b3c5-c2e8817ec58d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019c661d-df28-7294-b3c5-c2e8817ec58d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019c661d-df28-7294-b3c5-c2e8817ec58d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019c661d-df28-7455-b079-0c4719402e15" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019c661d-df28-7294-b3c5-c2e8817ec58d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019c661d-df28-7455-b079-0c4719402e15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019c661d-df28-717c-a34f-2f1667541fda" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019c661d-df28-7455-b079-0c4719402e15" xlink:to="loc_jynt_CorporateClinicsMember_019c661d-df28-717c-a34f-2f1667541fda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_019c661e-024d-7522-a0ec-80df995ec952" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019b096a-62ab-7968-b17e-b149817702c6" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_019c661e-024d-7522-a0ec-80df995ec952" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019c661e-024d-7522-a0ec-80df995ec952_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_019c661e-024d-7522-a0ec-80df995ec952" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019c661e-024d-7522-a0ec-80df995ec952_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019c661e-024d-758e-8f6d-5de1fe51cba7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_019c661e-024d-7522-a0ec-80df995ec952" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019c661e-024d-758e-8f6d-5de1fe51cba7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_OperatingLeaseRightOfUseAssetMember_019c661e-024d-7cbd-8c6f-1367a22c8a88" xlink:href="jynt-20251231.xsd#jynt_OperatingLeaseRightOfUseAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019c661e-024d-758e-8f6d-5de1fe51cba7" xlink:to="loc_jynt_OperatingLeaseRightOfUseAssetMember_019c661e-024d-7cbd-8c6f-1367a22c8a88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_019c661e-024d-7c6d-8c6c-911270663384" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019c661e-024d-758e-8f6d-5de1fe51cba7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_019c661e-024d-7c6d-8c6c-911270663384" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMember_019c661e-024d-78e6-933f-47e3e3ea6eef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019c661e-024d-758e-8f6d-5de1fe51cba7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMember_019c661e-024d-78e6-933f-47e3e3ea6eef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019c661d-986d-7be9-8b53-a4b91ed1b207" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c661d-986d-79c9-bb4b-39d4cb0e73f0" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019c661d-986d-7be9-8b53-a4b91ed1b207" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AssetsHeldForSaleCashFlowForecastPeriod_019c661d-df28-74b4-8ae7-c6ef0532d330" xlink:href="jynt-20251231.xsd#jynt_AssetsHeldForSaleCashFlowForecastPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c661d-986d-79c9-bb4b-39d4cb0e73f0" xlink:to="loc_jynt_AssetsHeldForSaleCashFlowForecastPeriod_019c661d-df28-74b4-8ae7-c6ef0532d330" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AssetsHeldForSaleMeasurementInputPositiveCashFlow_019c661d-df28-7230-9c64-3b594a84670b" xlink:href="jynt-20251231.xsd#jynt_AssetsHeldForSaleMeasurementInputPositiveCashFlow"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c661d-986d-79c9-bb4b-39d4cb0e73f0" xlink:to="loc_jynt_AssetsHeldForSaleMeasurementInputPositiveCashFlow_019c661d-df28-7230-9c64-3b594a84670b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AssetsHeldForSaleMeasurementInputNegativeCashFlow_019c661d-df28-7c86-a655-dcb050a0e631" xlink:href="jynt-20251231.xsd#jynt_AssetsHeldForSaleMeasurementInputNegativeCashFlow"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c661d-986d-79c9-bb4b-39d4cb0e73f0" xlink:to="loc_jynt_AssetsHeldForSaleMeasurementInputNegativeCashFlow_019c661d-df28-7c86-a655-dcb050a0e631" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019c661d-df28-78fc-908c-4258023a0d07" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c661d-986d-79c9-bb4b-39d4cb0e73f0" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019c661d-df28-78fc-908c-4258023a0d07" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_019c661d-df28-7699-9879-c7e96824c2f5" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c661d-986d-79c9-bb4b-39d4cb0e73f0" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_019c661d-df28-7699-9879-c7e96824c2f5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019c661d-df28-7730-ac3e-36f588946830" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c661d-986d-79c9-bb4b-39d4cb0e73f0" xlink:to="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019c661d-df28-7730-ac3e-36f588946830" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment_019c661e-024d-78bd-a28b-a14c3835f481" xlink:href="jynt-20251231.xsd#jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c661d-986d-79c9-bb4b-39d4cb0e73f0" xlink:to="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment_019c661e-024d-78bd-a28b-a14c3835f481" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment_019c661e-024d-7e6c-ae60-24ed2414567a" xlink:href="jynt-20251231.xsd#jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c661d-986d-79c9-bb4b-39d4cb0e73f0" xlink:to="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment_019c661e-024d-7e6c-ae60-24ed2414567a" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/DebtDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#DebtDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/DebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_019c66ac-a438-7b6e-8774-65d1f3b11952" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_019b096a-62ab-79ca-8601-8b4e7b9c4096" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019c66ac-a438-7b6e-8774-65d1f3b11952" xlink:to="loc_us-gaap_DebtInstrumentTable_019b096a-62ab-79ca-8601-8b4e7b9c4096" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_019c66ac-a438-7c9b-960a-b4b44786ef81" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_019b096a-62ab-79ca-8601-8b4e7b9c4096" xlink:to="loc_us-gaap_CreditFacilityAxis_019c66ac-a438-7c9b-960a-b4b44786ef81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_019c66ac-a438-7c9b-960a-b4b44786ef81_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_019c66ac-a438-7c9b-960a-b4b44786ef81" xlink:to="loc_us-gaap_CreditFacilityDomain_019c66ac-a438-7c9b-960a-b4b44786ef81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_019c66ac-a438-742b-97bc-bbebe7349617" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_019c66ac-a438-7c9b-960a-b4b44786ef81" xlink:to="loc_us-gaap_CreditFacilityDomain_019c66ac-a438-742b-97bc-bbebe7349617" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_019c66ac-a438-7daf-8588-159cf7e9a86b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_019c66ac-a438-742b-97bc-bbebe7349617" xlink:to="loc_us-gaap_SecuredDebtMember_019c66ac-a438-7daf-8588-159cf7e9a86b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_019c66ac-a438-7b12-a70e-d29f1b4c0ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_019c66ac-a438-742b-97bc-bbebe7349617" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_019c66ac-a438-7b12-a70e-d29f1b4c0ee7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DevelopmentLineOfCreditMember_019c66ac-a438-7d53-9126-fb05f583e538" xlink:href="jynt-20251231.xsd#jynt_DevelopmentLineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_019c66ac-a438-742b-97bc-bbebe7349617" xlink:to="loc_jynt_DevelopmentLineOfCreditMember_019c66ac-a438-7d53-9126-fb05f583e538" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_019c66ac-a438-7e23-b78f-8d713743198c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_019c66ac-a438-742b-97bc-bbebe7349617" xlink:to="loc_us-gaap_LetterOfCreditMember_019c66ac-a438-7e23-b78f-8d713743198c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019c66ac-a438-76e0-972b-c0ba288685f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_019b096a-62ab-79ca-8601-8b4e7b9c4096" xlink:to="loc_us-gaap_DebtInstrumentAxis_019c66ac-a438-76e0-972b-c0ba288685f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019c66ac-a438-76e0-972b-c0ba288685f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_019c66ac-a438-76e0-972b-c0ba288685f6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019c66ac-a438-76e0-972b-c0ba288685f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019c66ac-a438-7ab0-ac2c-e38e0aee282d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_019c66ac-a438-76e0-972b-c0ba288685f6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019c66ac-a438-7ab0-ac2c-e38e0aee282d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_SeniorSecuredCreditFacilitiesMember_019c66ac-a438-70d6-b263-1cad781ebc4d" xlink:href="jynt-20251231.xsd#jynt_SeniorSecuredCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019c66ac-a438-7ab0-ac2c-e38e0aee282d" xlink:to="loc_jynt_SeniorSecuredCreditFacilitiesMember_019c66ac-a438-70d6-b263-1cad781ebc4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_A2022CreditFacilityMember_019c66ac-a438-7f87-8f7a-449c37371214" xlink:href="jynt-20251231.xsd#jynt_A2022CreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019c66ac-a438-7ab0-ac2c-e38e0aee282d" xlink:to="loc_jynt_A2022CreditFacilityMember_019c66ac-a438-7f87-8f7a-449c37371214" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019c66ac-a438-76c3-b47c-9a22c90366c0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_019b096a-62ab-79ca-8601-8b4e7b9c4096" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019c66ac-a438-76c3-b47c-9a22c90366c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019c66ac-a438-76c3-b47c-9a22c90366c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019c66ac-a438-76c3-b47c-9a22c90366c0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019c66ac-a438-76c3-b47c-9a22c90366c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019c66ac-a438-7a11-9545-da2fcabe28ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019c66ac-a438-76c3-b47c-9a22c90366c0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019c66ac-a438-7a11-9545-da2fcabe28ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_019c66ac-a438-76ad-a537-ab0fddaec703" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019c66ac-a438-7a11-9545-da2fcabe28ad" xlink:to="loc_us-gaap_LineOfCreditMember_019c66ac-a438-76ad-a537-ab0fddaec703" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019c66ac-f58b-7dd3-8d4c-cb50bec7adc4" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_019b096a-62ab-79ca-8601-8b4e7b9c4096" xlink:to="loc_srt_RangeAxis_019c66ac-f58b-7dd3-8d4c-cb50bec7adc4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019c66ac-f58b-7dd3-8d4c-cb50bec7adc4_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019c66ac-f58b-7dd3-8d4c-cb50bec7adc4" xlink:to="loc_srt_RangeMember_019c66ac-f58b-7dd3-8d4c-cb50bec7adc4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019c66ac-f58b-7461-ac5c-4b6fce5656f2" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019c66ac-f58b-7dd3-8d4c-cb50bec7adc4" xlink:to="loc_srt_RangeMember_019c66ac-f58b-7461-ac5c-4b6fce5656f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019c66ac-f58b-7d9c-b652-314e412306eb" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019c66ac-f58b-7461-ac5c-4b6fce5656f2" xlink:to="loc_srt_MinimumMember_019c66ac-f58b-7d9c-b652-314e412306eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019c66ac-f58b-7c1d-a544-ca7841cfebac" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019c66ac-f58b-7461-ac5c-4b6fce5656f2" xlink:to="loc_srt_MaximumMember_019c66ac-f58b-7c1d-a544-ca7841cfebac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_019c66ac-f58b-7cbb-9b1f-34decf490eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_019b096a-62ab-79ca-8601-8b4e7b9c4096" xlink:to="loc_us-gaap_VariableRateAxis_019c66ac-f58b-7cbb-9b1f-34decf490eb9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_019c66ac-f58b-7cbb-9b1f-34decf490eb9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_019c66ac-f58b-7cbb-9b1f-34decf490eb9" xlink:to="loc_us-gaap_VariableRateDomain_019c66ac-f58b-7cbb-9b1f-34decf490eb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_019c66ac-f58b-7d45-8f38-5e6a13cd9619" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_019c66ac-f58b-7cbb-9b1f-34decf490eb9" xlink:to="loc_us-gaap_VariableRateDomain_019c66ac-f58b-7d45-8f38-5e6a13cd9619" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrMember_019c66ac-f58b-7697-917d-e4d73a9078cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SecuredOvernightFinancingRateSofrMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_019c66ac-f58b-7d45-8f38-5e6a13cd9619" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrMember_019c66ac-f58b-7697-917d-e4d73a9078cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_019c66ac-f58b-71e2-b567-b85fb9d0a195" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_019c66ac-f58b-7d45-8f38-5e6a13cd9619" xlink:to="loc_us-gaap_BaseRateMember_019c66ac-f58b-71e2-b567-b85fb9d0a195" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_FederalReserveBankOfNewYorkRateMember_019c66ac-f58b-7ab4-ba77-a3451a4523e1" xlink:href="jynt-20251231.xsd#jynt_FederalReserveBankOfNewYorkRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_019c66ac-f58b-7d45-8f38-5e6a13cd9619" xlink:to="loc_jynt_FederalReserveBankOfNewYorkRateMember_019c66ac-f58b-7ab4-ba77-a3451a4523e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_019c66ac-a438-75c7-9ea8-0fc5795e7601" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019c66ac-a438-7b6e-8774-65d1f3b11952" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_019c66ac-a438-75c7-9ea8-0fc5795e7601" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_019c66ac-a438-76f3-923c-ec5c5bce6486" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019c66ac-a438-7b6e-8774-65d1f3b11952" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_019c66ac-a438-76f3-923c-ec5c5bce6486" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount_019c66ac-a438-777b-bfc2-93b92c8a33c5" xlink:href="jynt-20251231.xsd#jynt_LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019c66ac-a438-7b6e-8774-65d1f3b11952" xlink:to="loc_jynt_LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount_019c66ac-a438-777b-bfc2-93b92c8a33c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_019c66ac-f58b-70d6-aa6d-abf88e88893b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019c66ac-a438-7b6e-8774-65d1f3b11952" xlink:to="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_019c66ac-f58b-70d6-aa6d-abf88e88893b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_019c66ac-f58b-776c-a634-29bac83ebbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019c66ac-a438-7b6e-8774-65d1f3b11952" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_019c66ac-f58b-776c-a634-29bac83ebbe5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_019c66ac-f58b-7fb2-a9c5-13c839ff25e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019c66ac-a438-7b6e-8774-65d1f3b11952" xlink:to="loc_us-gaap_LongTermDebt_019c66ac-f58b-7fb2-a9c5-13c839ff25e5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_019c66ac-f58b-78c3-952f-f2319694e26a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019c66ac-a438-7b6e-8774-65d1f3b11952" xlink:to="loc_us-gaap_LineOfCredit_019c66ac-f58b-78c3-952f-f2319694e26a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_019c66ac-f58b-7010-b6f2-e50d2866195d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019c66ac-a438-7b6e-8774-65d1f3b11952" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_019c66ac-f58b-7010-b6f2-e50d2866195d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_019c66ac-f58b-758d-9137-c92bc71e0433" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019c66ac-a438-7b6e-8774-65d1f3b11952" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_019c66ac-f58b-758d-9137-c92bc71e0433" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ab-7950-88ef-6df5b2df7d32" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ab-7950-88ef-6df5b2df7d32" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019b3352-44d3-7fe0-ba13-7fff13044628" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ab-7950-88ef-6df5b2df7d32" xlink:to="loc_us-gaap_AwardTypeAxis_019b3352-44d3-7fe0-ba13-7fff13044628" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b3352-44d3-7fe0-ba13-7fff13044628_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019b3352-44d3-7fe0-ba13-7fff13044628" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b3352-44d3-7fe0-ba13-7fff13044628_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b3352-44d3-7e47-8a90-92dc3746bd40" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019b3352-44d3-7fe0-ba13-7fff13044628" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b3352-44d3-7e47-8a90-92dc3746bd40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019b3352-44d3-7ae3-a6c6-2668b16740e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b3352-44d3-7e47-8a90-92dc3746bd40" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019b3352-44d3-7ae3-a6c6-2668b16740e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_019b3352-8e51-734f-9b24-08fdf64c0e17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b3352-44d3-7e47-8a90-92dc3746bd40" xlink:to="loc_us-gaap_RestrictedStockMember_019b3352-8e51-734f-9b24-08fdf64c0e17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_019b3352-8e51-7b08-a352-1c7f278164b6" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ab-7950-88ef-6df5b2df7d32" xlink:to="loc_srt_TitleOfIndividualAxis_019b3352-8e51-7b08-a352-1c7f278164b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_019b3352-8e51-7b08-a352-1c7f278164b6_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_019b3352-8e51-7b08-a352-1c7f278164b6" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_019b3352-8e51-7b08-a352-1c7f278164b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_019b3352-8e51-7624-b890-d777c3f35f25" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_019b3352-8e51-7b08-a352-1c7f278164b6" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_019b3352-8e51-7624-b890-d777c3f35f25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_019b3352-8e51-7428-a37a-5cc606a5d518" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_019b3352-8e51-7624-b890-d777c3f35f25" xlink:to="loc_srt_DirectorMember_019b3352-8e51-7428-a37a-5cc606a5d518" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019c8ad7-2467-7f6e-8700-b3b56f101be1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019c8ad7-2467-7f6e-8700-b3b56f101be1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_019b3352-44d3-7691-a305-376fbc1c1af7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_019b3352-44d3-7691-a305-376fbc1c1af7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_019b3352-44d3-7275-a94e-c961e255fdb1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_019b3352-44d3-7275-a94e-c961e255fdb1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage_019b3352-44d3-7de4-a2d5-050050a431a3" xlink:href="jynt-20251231.xsd#jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage_019b3352-44d3-7de4-a2d5-050050a431a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019ca0bf-18e9-75af-b00e-198cdbd4ae68" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019ca0bf-18e9-75af-b00e-198cdbd4ae68" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019b3352-6924-7cde-9258-c65884b5a8fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019b3352-6924-7cde-9258-c65884b5a8fd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_019b3352-6924-7e0f-bc6b-3bd743e57602" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_019b3352-6924-7e0f-bc6b-3bd743e57602" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019b3352-6924-7c6b-bafa-8b534e1f9f62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019b3352-6924-7c6b-bafa-8b534e1f9f62" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_019b3352-6924-7ea9-b33d-95d9b19d8348" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_019b3352-6924-7ea9-b33d-95d9b19d8348" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019b3352-6924-7bd0-b5d6-e19a4ac929f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019b3352-6924-7bd0-b5d6-e19a4ac929f6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments_019b3352-8e51-793d-800a-adc2b8dae57f" xlink:href="jynt-20251231.xsd#jynt_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_jynt_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments_019b3352-8e51-793d-800a-adc2b8dae57f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019b3352-b010-7e38-958c-e9c841503ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_us-gaap_ShareBasedCompensation_019b3352-b010-7e38-958c-e9c841503ee3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_019b3352-b010-7f54-ac93-7805842425ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_019b3352-b010-7f54-ac93-7805842425ec" xlink:type="arc" order="12"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/StockBasedCompensationValuationAssumptionsusedforStockOptionsDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#StockBasedCompensationValuationAssumptionsusedforStockOptionsDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/StockBasedCompensationValuationAssumptionsusedforStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ab-73ae-a6c9-ad17f0685c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ab-7971-a978-c34fd1e11233" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ab-73ae-a6c9-ad17f0685c4c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ab-7971-a978-c34fd1e11233" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019b096a-62ab-756b-80b4-8a5229c0823e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ab-7971-a978-c34fd1e11233" xlink:to="loc_us-gaap_AwardTypeAxis_019b096a-62ab-756b-80b4-8a5229c0823e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-62ab-756b-80b4-8a5229c0823e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019b096a-62ab-756b-80b4-8a5229c0823e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-62ab-756b-80b4-8a5229c0823e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-62ab-700f-96a9-da1487406227" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019b096a-62ab-756b-80b4-8a5229c0823e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-62ab-700f-96a9-da1487406227" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019b096a-62ab-71e2-98c2-860337c25732" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-62ab-700f-96a9-da1487406227" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019b096a-62ab-71e2-98c2-860337c25732" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_019b096a-62ab-7e83-8c72-2e399e7ead55" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ab-73ae-a6c9-ad17f0685c4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_019b096a-62ab-7e83-8c72-2e399e7ead55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019b096a-62ab-74ce-a5f3-6ae8c6e47f19" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ab-73ae-a6c9-ad17f0685c4c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019b096a-62ab-74ce-a5f3-6ae8c6e47f19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_019b096a-62ab-7dee-866a-5995cd656a08" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ab-73ae-a6c9-ad17f0685c4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_019b096a-62ab-7dee-866a-5995cd656a08" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#StockBasedCompensationStockOptionsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-751a-a6ed-483eb2e27e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ab-740f-87aa-ffcd2eea5be0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-751a-a6ed-483eb2e27e2a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ab-740f-87aa-ffcd2eea5be0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019b096a-62ab-7034-8280-55f0fc88b20c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ab-740f-87aa-ffcd2eea5be0" xlink:to="loc_us-gaap_AwardTypeAxis_019b096a-62ab-7034-8280-55f0fc88b20c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-62ab-7034-8280-55f0fc88b20c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019b096a-62ab-7034-8280-55f0fc88b20c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-62ab-7034-8280-55f0fc88b20c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-62ab-7dd3-aedc-5fce32ad5a05" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019b096a-62ab-7034-8280-55f0fc88b20c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-62ab-7dd3-aedc-5fce32ad5a05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019b096a-62ac-759e-a2b3-74fe2a83af3d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-62ab-7dd3-aedc-5fce32ad5a05" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019b096a-62ac-759e-a2b3-74fe2a83af3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019b096a-62ac-727b-addf-67571c34b3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-751a-a6ed-483eb2e27e2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019b096a-62ac-727b-addf-67571c34b3a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019b096a-62ac-751c-b765-0a12758ece3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019b096a-62ac-727b-addf-67571c34b3a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019b096a-62ac-751c-b765-0a12758ece3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019b096a-62ac-79b2-bcc6-2302afedb11e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019b096a-62ac-727b-addf-67571c34b3a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019b096a-62ac-79b2-bcc6-2302afedb11e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019b096a-62ac-7c79-a57e-3e9fed0eece9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019b096a-62ac-727b-addf-67571c34b3a0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019b096a-62ac-7c79-a57e-3e9fed0eece9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_019b096a-62ac-7054-b325-44d6e7b06fed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019b096a-62ac-727b-addf-67571c34b3a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_019b096a-62ac-7054-b325-44d6e7b06fed" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_019b096a-62ac-7b80-848f-a5aa10ec7a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019b096a-62ac-727b-addf-67571c34b3a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_019b096a-62ac-7b80-848f-a5aa10ec7a1f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019b096a-62ac-77cf-99a7-919a182f4005" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_019b096a-62ac-77ff-838e-d187c5c21a14" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-751a-a6ed-483eb2e27e2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_019b096a-62ac-77ff-838e-d187c5c21a14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_019b096a-62ac-78d9-ad94-4d82705bc025" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-751a-a6ed-483eb2e27e2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_019b096a-62ac-78d9-ad94-4d82705bc025" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019b096a-62ac-71af-a0f7-3d4ed08459c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-751a-a6ed-483eb2e27e2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019b096a-62ac-71af-a0f7-3d4ed08459c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019b096a-62ac-7517-a7e4-6e568c75e907" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019b096a-62ac-71af-a0f7-3d4ed08459c9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019b096a-62ac-7517-a7e4-6e568c75e907" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019b096a-62ac-749e-803c-d76fa31dbaee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019b096a-62ac-71af-a0f7-3d4ed08459c9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019b096a-62ac-749e-803c-d76fa31dbaee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_019b096a-62ac-75f4-8a6c-fb8a7cafd318" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019b096a-62ac-71af-a0f7-3d4ed08459c9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_019b096a-62ac-75f4-8a6c-fb8a7cafd318" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_019b096a-62ac-7c63-bf14-c5ffc96fdc27" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019b096a-62ac-71af-a0f7-3d4ed08459c9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_019b096a-62ac-7c63-bf14-c5ffc96fdc27" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_019b096a-62ac-771e-8242-b488bddc51ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019b096a-62ac-71af-a0f7-3d4ed08459c9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_019b096a-62ac-771e-8242-b488bddc51ed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019b096a-62ac-7ed3-a6c3-540b118f36c8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_019b096a-62ac-7a01-a4a5-816dceee316c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-751a-a6ed-483eb2e27e2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_019b096a-62ac-7a01-a4a5-816dceee316c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_019b096a-62ac-7b06-92f0-b11bcd8818dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-751a-a6ed-483eb2e27e2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_019b096a-62ac-7b06-92f0-b11bcd8818dc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_019b096a-62ac-792b-9672-fe1c642b957a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-751a-a6ed-483eb2e27e2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_019b096a-62ac-792b-9672-fe1c642b957a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_019b096a-62ac-726c-8682-babfd0dd8919" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_019b096a-62ac-792b-9672-fe1c642b957a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_019b096a-62ac-726c-8682-babfd0dd8919" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_019b096a-62ac-79e0-aefc-5f15159d39eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-751a-a6ed-483eb2e27e2a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_019b096a-62ac-79e0-aefc-5f15159d39eb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_019b096a-62ac-747b-aab2-06ee7f041bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-751a-a6ed-483eb2e27e2a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_019b096a-62ac-747b-aab2-06ee7f041bdc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_019b096a-62ac-748b-9b1a-967a6c6f08a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-751a-a6ed-483eb2e27e2a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_019b096a-62ac-748b-9b1a-967a6c6f08a6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_019b096a-62ac-7b54-9de0-e0c76d8c0a30" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_019b096a-62ac-748b-9b1a-967a6c6f08a6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_019b096a-62ac-7b54-9de0-e0c76d8c0a30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_019b096a-62ac-78e0-9180-3dac6fc65b17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_019b096a-62ac-748b-9b1a-967a6c6f08a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_019b096a-62ac-78e0-9180-3dac6fc65b17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_019b096a-62ac-76e0-9de8-02352fc367aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_019b096a-62ac-748b-9b1a-967a6c6f08a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_019b096a-62ac-76e0-9de8-02352fc367aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_019b096a-62ac-79c3-89fa-09d03c36ba03" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_019b096a-62ac-748b-9b1a-967a6c6f08a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_019b096a-62ac-79c3-89fa-09d03c36ba03" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/StockBasedCompensationRestrictedStockActivityDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#StockBasedCompensationRestrictedStockActivityDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/StockBasedCompensationRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-7a6b-a02d-17e1caa816c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ac-7052-9d11-91563b7d1fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-7a6b-a02d-17e1caa816c7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ac-7052-9d11-91563b7d1fe1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019b096a-62ac-72ca-ba49-58805ee0a0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ac-7052-9d11-91563b7d1fe1" xlink:to="loc_us-gaap_AwardTypeAxis_019b096a-62ac-72ca-ba49-58805ee0a0e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-62ac-72ca-ba49-58805ee0a0e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019b096a-62ac-72ca-ba49-58805ee0a0e0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-62ac-72ca-ba49-58805ee0a0e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-62ac-7298-96fa-f5406fc8303b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019b096a-62ac-72ca-ba49-58805ee0a0e0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-62ac-7298-96fa-f5406fc8303b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_019b096a-62ac-7a88-a0b0-e0d88cc751c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-62ac-7298-96fa-f5406fc8303b" xlink:to="loc_us-gaap_RestrictedStockMember_019b096a-62ac-7a88-a0b0-e0d88cc751c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019b096a-62ac-7df8-b43c-63befb45a351" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-7a6b-a02d-17e1caa816c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019b096a-62ac-7df8-b43c-63befb45a351" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019b096a-62ac-7ee7-900a-02c8620ee866" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019b096a-62ac-7df8-b43c-63befb45a351" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019b096a-62ac-7ee7-900a-02c8620ee866" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019b096a-62ac-7f8d-9301-e8cc7793f52a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019b096a-62ac-7df8-b43c-63befb45a351" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019b096a-62ac-7f8d-9301-e8cc7793f52a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_019b096a-62ac-7a04-ab8d-b8e75e76bcd5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019b096a-62ac-7df8-b43c-63befb45a351" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_019b096a-62ac-7a04-ab8d-b8e75e76bcd5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019b096a-62ac-7e9c-9e84-fa7d41ecbd57" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019b096a-62ac-7df8-b43c-63befb45a351" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019b096a-62ac-7e9c-9e84-fa7d41ecbd57" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019b096a-62ac-7a57-b890-f192bd919377" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019b096a-62ac-7e7c-92e4-5d1e1c92628f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-7a6b-a02d-17e1caa816c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019b096a-62ac-7e7c-92e4-5d1e1c92628f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019b096a-62ac-7710-917b-f52175490082" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019b096a-62ac-7e7c-92e4-5d1e1c92628f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019b096a-62ac-7710-917b-f52175490082" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019b096a-62ac-711a-8c91-31372561edcb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019b096a-62ac-7e7c-92e4-5d1e1c92628f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019b096a-62ac-711a-8c91-31372561edcb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_019b096a-62ac-78d6-bbfd-fe6cffe0f70c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019b096a-62ac-7e7c-92e4-5d1e1c92628f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_019b096a-62ac-78d6-bbfd-fe6cffe0f70c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019b096a-62ac-7da8-8486-cd5d078e2634" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019b096a-62ac-7e7c-92e4-5d1e1c92628f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019b096a-62ac-7da8-8486-cd5d078e2634" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019b096a-62ac-72dc-898d-083fb269cb4e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_019b096a-637d-722e-8d0d-8c6793f59081" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_019b096a-637d-722e-8d0d-8c6793f59081" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019c669b-f797-793d-ba68-767980976ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_019b096a-637d-722e-8d0d-8c6793f59081" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019c669b-f797-793d-ba68-767980976ddd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019c669b-f797-793d-ba68-767980976ddd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019c669b-f797-793d-ba68-767980976ddd" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019c669b-f797-793d-ba68-767980976ddd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019c669b-f797-7954-a093-86c8e80f7c88" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019c669b-f797-793d-ba68-767980976ddd" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019c669b-f797-7954-a093-86c8e80f7c88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019c669b-f797-789a-8e86-8c5f9c74cda4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019c669b-f797-7954-a093-86c8e80f7c88" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019c669b-f797-789a-8e86-8c5f9c74cda4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019c669b-f797-7e6c-a89a-f8f992cd9823" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_019b096a-637d-722e-8d0d-8c6793f59081" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019c669b-f797-7e6c-a89a-f8f992cd9823" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019c669b-f797-7e6c-a89a-f8f992cd9823_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019c669b-f797-7e6c-a89a-f8f992cd9823" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019c669b-f797-7e6c-a89a-f8f992cd9823_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019c669b-f797-73f2-b392-931d06a31b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019c669b-f797-7e6c-a89a-f8f992cd9823" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019c669b-f797-73f2-b392-931d06a31b8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019c669b-f797-729d-aa3e-889c73c451f9" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019c669b-f797-73f2-b392-931d06a31b8b" xlink:to="loc_jynt_CorporateClinicsMember_019c669b-f797-729d-aa3e-889c73c451f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_019c669b-f797-70a1-989b-adc693b783d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_019b096a-637d-722e-8d0d-8c6793f59081" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_019c669b-f797-70a1-989b-adc693b783d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_019c669b-f797-70a1-989b-adc693b783d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_019c669b-f797-70a1-989b-adc693b783d7" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_019c669b-f797-70a1-989b-adc693b783d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_019c669b-f797-7e30-83b9-faa67d2c5066" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_019c669b-f797-70a1-989b-adc693b783d7" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_019c669b-f797-7e30-83b9-faa67d2c5066" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_019c669b-f797-7cea-91c4-242b1312644f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_019c669b-f797-7e30-83b9-faa67d2c5066" xlink:to="loc_us-gaap_DomesticCountryMember_019c669b-f797-7cea-91c4-242b1312644f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_019c90ae-93eb-7f74-80b5-36d0bb9fdd1f" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticCountryMember_019c669b-f797-7cea-91c4-242b1312644f" xlink:to="loc_country_US_019c90ae-93eb-7f74-80b5-36d0bb9fdd1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_019cc457-7737-7cbb-b12a-4cac2f732829" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_019c669b-f797-7e30-83b9-faa67d2c5066" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_019cc457-7737-7cbb-b12a-4cac2f732829" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_019c669b-f797-76f5-a8ed-3df5c5846ced" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_019b096a-637d-722e-8d0d-8c6793f59081" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_019c669b-f797-76f5-a8ed-3df5c5846ced" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_019c669b-f797-76f5-a8ed-3df5c5846ced_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_019c669b-f797-76f5-a8ed-3df5c5846ced" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_019c669b-f797-76f5-a8ed-3df5c5846ced_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_019c669b-f797-7674-8211-d351d68af05e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_019c669b-f797-76f5-a8ed-3df5c5846ced" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_019c669b-f797-7674-8211-d351d68af05e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_019c669b-f797-7fc7-9c38-2910dc7c4a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_019c669b-f797-7674-8211-d351d68af05e" xlink:to="loc_us-gaap_ResearchMember_019c669b-f797-7fc7-9c38-2910dc7c4a1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CaliforniaAlternativeMinimumTaxCreditMember_019c669b-f797-7ce2-a744-dc15fa7e6083" xlink:href="jynt-20251231.xsd#jynt_CaliforniaAlternativeMinimumTaxCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_019c669b-f797-7674-8211-d351d68af05e" xlink:to="loc_jynt_CaliforniaAlternativeMinimumTaxCreditMember_019c669b-f797-7ce2-a744-dc15fa7e6083" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_019c669b-f797-7718-b8e9-9b06756c330a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_019c669b-f797-7718-b8e9-9b06756c330a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_019cc53f-6adb-7a01-82a4-84ae07807ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_019cc53f-6adb-7a01-82a4-84ae07807ea0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent_019c669b-f797-7a42-9c4a-87ae7dca8497" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent_019c669b-f797-7a42-9c4a-87ae7dca8497" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_019c669b-f797-7d06-b923-f8d4902513c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:to="loc_us-gaap_OperatingLossCarryforwards_019c669b-f797-7d06-b923-f8d4902513c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_019c669b-f797-73c0-820f-0cd55a21f622" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_019c669b-f797-73c0-820f-0cd55a21f622" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_019c669b-f797-718b-9c5f-9175f19ad489" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_019c669b-f797-718b-9c5f-9175f19ad489" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_019c669b-f797-7c7b-9f18-917ba345b1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_019c669b-f797-7c7b-9f18-917ba345b1f8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019c669c-7f76-7e38-a2e8-c1484597a876" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019c669c-7f76-7e38-a2e8-c1484597a876" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_019c669c-7f76-73bb-a69f-7fc08e64b69e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_019c669c-7f76-73bb-a69f-7fc08e64b69e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_019cb99e-c6c2-7e54-bb4d-601397c64dca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_019cb99e-c6c2-7e54-bb4d-601397c64dca" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_019c669c-c052-74bd-a52f-3cc6b327294b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_019c669c-c052-74bd-a52f-3cc6b327294b" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/IncomeTaxesUncertainTaxPositionRollforwardDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#IncomeTaxesUncertainTaxPositionRollforwardDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/IncomeTaxesUncertainTaxPositionRollforwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_019b096a-637d-708e-89ac-01a27cd7d97b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_019b096a-637d-7e3e-9c6a-ce9106e97313" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019b096a-637d-708e-89ac-01a27cd7d97b" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_019b096a-637d-7e3e-9c6a-ce9106e97313" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-637d-78e8-a394-221cecf2b25a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_019b096a-637d-7e3e-9c6a-ce9106e97313" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-637d-78e8-a394-221cecf2b25a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-637d-78e8-a394-221cecf2b25a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-637d-78e8-a394-221cecf2b25a" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-637d-78e8-a394-221cecf2b25a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-637d-7dd7-bb85-1490be1826cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-637d-78e8-a394-221cecf2b25a" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-637d-7dd7-bb85-1490be1826cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019b096a-637d-7706-9e41-a5acda33c19a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-637d-7dd7-bb85-1490be1826cb" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019b096a-637d-7706-9e41-a5acda33c19a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-637d-7cc8-bf25-b66e8e2195c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_019b096a-637d-7e3e-9c6a-ce9106e97313" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-637d-7cc8-bf25-b66e8e2195c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-637d-7cc8-bf25-b66e8e2195c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-637d-7cc8-bf25-b66e8e2195c7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-637d-7cc8-bf25-b66e8e2195c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-637d-7cf1-813f-34b521a06fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-637d-7cc8-bf25-b66e8e2195c7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-637d-7cf1-813f-34b521a06fd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019b096a-637d-7536-9fd7-0396c4362d91" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-637d-7cf1-813f-34b521a06fd6" xlink:to="loc_jynt_CorporateClinicsMember_019b096a-637d-7536-9fd7-0396c4362d91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_019b096a-637d-7451-afa5-9ee6e450caeb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019b096a-637d-708e-89ac-01a27cd7d97b" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_019b096a-637d-7451-afa5-9ee6e450caeb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_019b096a-637d-7151-89d1-2f63a516b153" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_019b096a-637d-7451-afa5-9ee6e450caeb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_019b096a-637d-7151-89d1-2f63a516b153" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_019b096a-637d-7eca-8df8-5a5da16726a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_019b096a-637d-7451-afa5-9ee6e450caeb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_019b096a-637d-7eca-8df8-5a5da16726a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_019b096a-637d-7516-9c7e-8a4829b2331f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems_019c6696-ab89-7b73-8641-dabc37395426" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPaidByIndividualJurisdictionTable_019c6696-3a1e-700f-b311-f41a99d0b24b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPaidByIndividualJurisdictionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems_019c6696-ab89-7b73-8641-dabc37395426" xlink:to="loc_us-gaap_IncomeTaxPaidByIndividualJurisdictionTable_019c6696-3a1e-700f-b311-f41a99d0b24b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_019c6697-c97b-715b-8d6d-6b977828dbc8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxPaidByIndividualJurisdictionTable_019c6696-3a1e-700f-b311-f41a99d0b24b" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_019c6697-c97b-715b-8d6d-6b977828dbc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_019c6697-c97b-715b-8d6d-6b977828dbc8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_019c6697-c97b-715b-8d6d-6b977828dbc8" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_019c6697-c97b-715b-8d6d-6b977828dbc8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_019c6697-c97b-7eee-b7c0-dfab71e995e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_019c6697-c97b-715b-8d6d-6b977828dbc8" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_019c6697-c97b-7eee-b7c0-dfab71e995e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_019c6698-526c-72a1-b171-3e3e5f9801b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_019c6697-c97b-7eee-b7c0-dfab71e995e2" xlink:to="loc_us-gaap_DomesticCountryMember_019c6698-526c-72a1-b171-3e3e5f9801b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AZ_019c6698-9038-74f3-b940-399cf31b87c9" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_AZ"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticCountryMember_019c6698-526c-72a1-b171-3e3e5f9801b4" xlink:to="loc_stpr_AZ_019c6698-9038-74f3-b940-399cf31b87c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_019c6698-b839-7e9a-8312-ce31169c731a" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticCountryMember_019c6698-526c-72a1-b171-3e3e5f9801b4" xlink:to="loc_stpr_CA_019c6698-b839-7e9a-8312-ce31169c731a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_019c6698-df18-7266-a56e-fc612d4f5d4d" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_TX"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticCountryMember_019c6698-526c-72a1-b171-3e3e5f9801b4" xlink:to="loc_stpr_TX_019c6698-df18-7266-a56e-fc612d4f5d4d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalTaxJurisdictionOtherMember_019c6699-1dec-7588-b695-05c9d73776b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StateAndLocalTaxJurisdictionOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticCountryMember_019c6698-526c-72a1-b171-3e3e5f9801b4" xlink:to="loc_us-gaap_StateAndLocalTaxJurisdictionOtherMember_019c6699-1dec-7588-b695-05c9d73776b8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPaidFederalAfterRefundReceived_019c6696-ab89-7740-b510-5424a2af265a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPaidFederalAfterRefundReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems_019c6696-ab89-7b73-8641-dabc37395426" xlink:to="loc_us-gaap_IncomeTaxPaidFederalAfterRefundReceived_019c6696-ab89-7740-b510-5424a2af265a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPaidStateAndLocalAfterRefundReceived_019c6697-2ef4-7b54-b3d2-b5b669b8b7fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPaidStateAndLocalAfterRefundReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems_019c6696-ab89-7b73-8641-dabc37395426" xlink:to="loc_us-gaap_IncomeTaxPaidStateAndLocalAfterRefundReceived_019c6697-2ef4-7b54-b3d2-b5b669b8b7fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_019c6699-c29d-7a0e-aa0e-07ddbc37ab16" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems_019c6696-ab89-7b73-8641-dabc37395426" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_019c6699-c29d-7a0e-aa0e-07ddbc37ab16" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c66aa-756e-7651-a786-fe641de37607" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_019b096a-637d-7e4d-94d9-6b763b724a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c66aa-756e-7651-a786-fe641de37607" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_019b096a-637d-7e4d-94d9-6b763b724a5b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_019c66aa-9479-7d9b-996f-230226890a62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_019b096a-637d-7e4d-94d9-6b763b724a5b" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_019c66aa-9479-7d9b-996f-230226890a62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_019c66aa-9479-7d9b-996f-230226890a62_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_019c66aa-9479-7d9b-996f-230226890a62" xlink:to="loc_us-gaap_LossContingencyNatureDomain_019c66aa-9479-7d9b-996f-230226890a62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_019c66aa-9479-7895-9f52-37c69a84140f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_019c66aa-9479-7d9b-996f-230226890a62" xlink:to="loc_us-gaap_LossContingencyNatureDomain_019c66aa-9479-7895-9f52-37c69a84140f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_EmploymentMattersMember_019c66aa-9479-7e0f-80b5-dd102adfd1e1" xlink:href="jynt-20251231.xsd#jynt_EmploymentMattersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_019c66aa-9479-7895-9f52-37c69a84140f" xlink:to="loc_jynt_EmploymentMattersMember_019c66aa-9479-7e0f-80b5-dd102adfd1e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_MedicalInjuryClaimMember_019c66aa-9479-70c4-a64f-0181ee1109c2" xlink:href="jynt-20251231.xsd#jynt_MedicalInjuryClaimMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_019c66aa-9479-7895-9f52-37c69a84140f" xlink:to="loc_jynt_MedicalInjuryClaimMember_019c66aa-9479-70c4-a64f-0181ee1109c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_NumberOfFutureOperatingLeasesCommitted_019c66aa-756e-7f33-98f0-47704ff75f60" xlink:href="jynt-20251231.xsd#jynt_NumberOfFutureOperatingLeasesCommitted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c66aa-756e-7651-a786-fe641de37607" xlink:to="loc_jynt_NumberOfFutureOperatingLeasesCommitted_019c66aa-756e-7f33-98f0-47704ff75f60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_GuarantorObligationsRemainingExposureUndiscounted_019c66aa-756e-7223-8d7c-ac0fc7c16567" xlink:href="jynt-20251231.xsd#jynt_GuarantorObligationsRemainingExposureUndiscounted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c66aa-756e-7651-a786-fe641de37607" xlink:to="loc_jynt_GuarantorObligationsRemainingExposureUndiscounted_019c66aa-756e-7223-8d7c-ac0fc7c16567" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_019c66aa-9479-78b8-b58c-139a76bdacdc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c66aa-756e-7651-a786-fe641de37607" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_019c66aa-9479-78b8-b58c-139a76bdacdc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019c66aa-9479-7205-8218-65411eb796f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c66aa-756e-7651-a786-fe641de37607" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019c66aa-9479-7205-8218-65411eb796f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019c66aa-9479-7da5-9234-ae3a12246166" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c66aa-756e-7651-a786-fe641de37607" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019c66aa-9479-7da5-9234-ae3a12246166" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_019c66aa-9479-78a4-a149-c2f5a0619e76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c66aa-756e-7651-a786-fe641de37607" xlink:to="loc_us-gaap_LitigationSettlementExpense_019c66aa-9479-78a4-a149-c2f5a0619e76" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#SegmentReportingNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/SegmentReportingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-73c8-9d39-82b6e26eb250" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019b096a-637d-7e8e-be04-98a24a1f4e21" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-73c8-9d39-82b6e26eb250" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019b096a-637d-7e8e-be04-98a24a1f4e21" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisorDisclosureAxis_019b096a-637d-7857-9afa-445516ad00a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisorDisclosureAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019b096a-637d-7e8e-be04-98a24a1f4e21" xlink:to="loc_us-gaap_FranchisorDisclosureAxis_019b096a-637d-7857-9afa-445516ad00a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisorDisclosureDomain_019b096a-637d-7857-9afa-445516ad00a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisorDisclosureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FranchisorDisclosureAxis_019b096a-637d-7857-9afa-445516ad00a1" xlink:to="loc_us-gaap_FranchisorDisclosureDomain_019b096a-637d-7857-9afa-445516ad00a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisorDisclosureDomain_019b096a-637d-7000-8dac-dcacf0fa3776" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisorDisclosureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FranchisorDisclosureAxis_019b096a-637d-7857-9afa-445516ad00a1" xlink:to="loc_us-gaap_FranchisorDisclosureDomain_019b096a-637d-7000-8dac-dcacf0fa3776" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisedUnitsMember_019b096a-637d-794f-b1b6-6e8d96a246e9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisedUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FranchisorDisclosureDomain_019b096a-637d-7000-8dac-dcacf0fa3776" xlink:to="loc_us-gaap_FranchisedUnitsMember_019b096a-637d-794f-b1b6-6e8d96a246e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_019b096a-637d-794c-8154-9fc4ba4695ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-73c8-9d39-82b6e26eb250" xlink:to="loc_us-gaap_NumberOfOperatingSegments_019b096a-637d-794c-8154-9fc4ba4695ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_019b336b-c94c-7dff-b0ed-b0512ba204f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-73c8-9d39-82b6e26eb250" xlink:to="loc_us-gaap_NumberOfReportableSegments_019b336b-c94c-7dff-b0ed-b0512ba204f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_019b096a-637d-7aad-9ad2-3cfa313fff8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfStores"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-73c8-9d39-82b6e26eb250" xlink:to="loc_us-gaap_NumberOfStores_019b096a-637d-7aad-9ad2-3cfa313fff8b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-7b18-a1d7-39ad51018b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019b096a-637d-7c98-9c9e-9365d24b4643" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-7b18-a1d7-39ad51018b1d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019b096a-637d-7c98-9c9e-9365d24b4643" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_019b096a-637d-7439-a548-200cd6e040d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019b096a-637d-7c98-9c9e-9365d24b4643" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_019b096a-637d-7439-a548-200cd6e040d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_019b096a-637d-7439-a548-200cd6e040d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_019b096a-637d-7439-a548-200cd6e040d8" xlink:to="loc_us-gaap_SegmentDomain_019b096a-637d-7439-a548-200cd6e040d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_019b096a-637d-7a0b-a787-6290355c7eba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_019b096a-637d-7439-a548-200cd6e040d8" xlink:to="loc_us-gaap_SegmentDomain_019b096a-637d-7a0b-a787-6290355c7eba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_FranchiseOperationsMember_019b096a-637d-73f0-ba10-e11b6af8ad7e" xlink:href="jynt-20251231.xsd#jynt_FranchiseOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_019b096a-637d-7a0b-a787-6290355c7eba" xlink:to="loc_jynt_FranchiseOperationsMember_019b096a-637d-73f0-ba10-e11b6af8ad7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019b096a-637d-7ef8-9233-21d00c3b513a" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019b096a-637d-7c98-9c9e-9365d24b4643" xlink:to="loc_srt_ProductOrServiceAxis_019b096a-637d-7ef8-9233-21d00c3b513a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019b096a-637d-7ef8-9233-21d00c3b513a_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_019b096a-637d-7ef8-9233-21d00c3b513a" xlink:to="loc_srt_ProductsAndServicesDomain_019b096a-637d-7ef8-9233-21d00c3b513a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019b096a-637d-75f4-8d37-c36336022167" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_019b096a-637d-7ef8-9233-21d00c3b513a" xlink:to="loc_srt_ProductsAndServicesDomain_019b096a-637d-75f4-8d37-c36336022167" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchiseMember_019b096a-637d-7179-abf6-5d8b38502bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchiseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019b096a-637d-75f4-8d37-c36336022167" xlink:to="loc_us-gaap_FranchiseMember_019b096a-637d-7179-abf6-5d8b38502bf0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyServiceMember_019b096a-637d-7a99-9a61-df4fc5fc289c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TechnologyServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019b096a-637d-75f4-8d37-c36336022167" xlink:to="loc_us-gaap_TechnologyServiceMember_019b096a-637d-7a99-9a61-df4fc5fc289c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_019b096a-637d-750f-b0ae-ee9672c752ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-7b18-a1d7-39ad51018b1d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_019b096a-637d-750f-b0ae-ee9672c752ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_019b096a-637d-70c4-8753-44a820a64698" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-7b18-a1d7-39ad51018b1d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_019b096a-637d-70c4-8753-44a820a64698" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_019b096a-637d-7a39-8644-fbdf72e9d0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-7b18-a1d7-39ad51018b1d" xlink:to="loc_us-gaap_SellingAndMarketingExpense_019b096a-637d-7a39-8644-fbdf72e9d0b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_GeneralAndAdministrativeExpenseAdjusted_019b096a-637d-7c9e-b703-4c7cf4f79752" xlink:href="jynt-20251231.xsd#jynt_GeneralAndAdministrativeExpenseAdjusted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-7b18-a1d7-39ad51018b1d" xlink:to="loc_jynt_GeneralAndAdministrativeExpenseAdjusted_019b096a-637d-7c9e-b703-4c7cf4f79752" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019b096a-637d-7345-a070-abb98800af76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-7b18-a1d7-39ad51018b1d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019b096a-637d-7345-a070-abb98800af76" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_019b096a-637d-7377-bc1c-60300288ffaa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-7b18-a1d7-39ad51018b1d" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_019b096a-637d-7377-bc1c-60300288ffaa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_019b096a-637d-7457-a23a-632a6ae236f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-7b18-a1d7-39ad51018b1d" xlink:to="loc_us-gaap_DepreciationAndAmortization_019b096a-637d-7457-a23a-632a6ae236f2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-7bc0-80c8-b3deaffeb4a4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-7b18-a1d7-39ad51018b1d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-7bc0-80c8-b3deaffeb4a4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-637d-784e-ab75-73e951bacdf4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-7b18-a1d7-39ad51018b1d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-637d-784e-ab75-73e951bacdf4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_019b096a-637d-7e5f-b207-9986bffb891f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-7b18-a1d7-39ad51018b1d" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_019b096a-637d-7e5f-b207-9986bffb891f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-637d-7b06-bee6-9a228cda2552" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-637d-7136-8cb1-376158009d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_019b096a-637d-7e5f-b207-9986bffb891f" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-637d-7136-8cb1-376158009d3c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_019b096a-637d-7fea-88c8-a0a2ed9ffe9f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_019b096a-637d-7e5f-b207-9986bffb891f" xlink:to="loc_us-gaap_ProfitLoss_019b096a-637d-7fea-88c8-a0a2ed9ffe9f" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#RelatedPartyTransactionsDetails"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_019b096a-637d-7831-9250-6daa9cdd1dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019b096a-637d-78d4-88f7-551db85472c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b096a-637d-7831-9250-6daa9cdd1dd2" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019b096a-637d-78d4-88f7-551db85472c4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_019b096a-637d-7203-a0e2-dbfe9bd00d30" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019b096a-637d-78d4-88f7-551db85472c4" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_019b096a-637d-7203-a0e2-dbfe9bd00d30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_019b096a-637d-7203-a0e2-dbfe9bd00d30_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_019b096a-637d-7203-a0e2-dbfe9bd00d30" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_019b096a-637d-7203-a0e2-dbfe9bd00d30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_019b096a-637d-7605-b31a-1561cef6923d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_019b096a-637d-7203-a0e2-dbfe9bd00d30" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_019b096a-637d-7605-b31a-1561cef6923d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_BanderaPartnersLLCMember_019b096a-637d-739b-aba5-55d5dc161fa4" xlink:href="jynt-20251231.xsd#jynt_BanderaPartnersLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_019b096a-637d-7605-b31a-1561cef6923d" xlink:to="loc_jynt_BanderaPartnersLLCMember_019b096a-637d-739b-aba5-55d5dc161fa4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019b096a-637d-70e2-8468-36fd0ed8026e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019b096a-637d-78d4-88f7-551db85472c4" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019b096a-637d-70e2-8468-36fd0ed8026e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_019b096a-637d-70e2-8468-36fd0ed8026e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019b096a-637d-70e2-8468-36fd0ed8026e" xlink:to="loc_us-gaap_RelatedPartyDomain_019b096a-637d-70e2-8468-36fd0ed8026e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_019b096a-637d-7b0a-8a36-db8d2c7b630c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019b096a-637d-70e2-8468-36fd0ed8026e" xlink:to="loc_us-gaap_RelatedPartyDomain_019b096a-637d-7b0a-8a36-db8d2c7b630c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_019b096a-637d-7ecd-b6b4-87b5ea569be3" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_019b096a-637d-7b0a-8a36-db8d2c7b630c" xlink:to="loc_srt_DirectorMember_019b096a-637d-7ecd-b6b4-87b5ea569be3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_019b096a-637d-7ef0-82ac-a1c8567202d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019b096a-637d-78d4-88f7-551db85472c4" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_019b096a-637d-7ef0-82ac-a1c8567202d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_019b096a-637d-7ef0-82ac-a1c8567202d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_019b096a-637d-7ef0-82ac-a1c8567202d8" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_019b096a-637d-7ef0-82ac-a1c8567202d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_019b096a-637d-74b5-8618-d2d4f555274a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_019b096a-637d-7ef0-82ac-a1c8567202d8" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_019b096a-637d-74b5-8618-d2d4f555274a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_FranchiseLicensesMember_019b096a-637d-701e-bbd5-f76e1796fad3" xlink:href="jynt-20251231.xsd#jynt_FranchiseLicensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_019b096a-637d-74b5-8618-d2d4f555274a" xlink:to="loc_jynt_FranchiseLicensesMember_019b096a-637d-701e-bbd5-f76e1796fad3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_FranchiseLicensesOneMember_019b096a-637d-7326-869b-2c58aaaaa33c" xlink:href="jynt-20251231.xsd#jynt_FranchiseLicensesOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jynt_FranchiseLicensesMember_019b096a-637d-701e-bbd5-f76e1796fad3" xlink:to="loc_jynt_FranchiseLicensesOneMember_019b096a-637d-7326-869b-2c58aaaaa33c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_FranchiseLicensesTwoMember_019b096a-637d-7f9c-b1cf-b94d49323999" xlink:href="jynt-20251231.xsd#jynt_FranchiseLicensesTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jynt_FranchiseLicensesMember_019b096a-637d-701e-bbd5-f76e1796fad3" xlink:to="loc_jynt_FranchiseLicensesTwoMember_019b096a-637d-7f9c-b1cf-b94d49323999" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_019b096a-637d-7349-b069-414f852f18b4" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019b096a-637d-78d4-88f7-551db85472c4" xlink:to="loc_srt_CounterpartyNameAxis_019b096a-637d-7349-b069-414f852f18b4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019b096a-637d-7349-b069-414f852f18b4_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_019b096a-637d-7349-b069-414f852f18b4" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019b096a-637d-7349-b069-414f852f18b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019b096a-637d-77d0-a0c5-4f2c87e4504c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_019b096a-637d-7349-b069-414f852f18b4" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019b096a-637d-77d0-a0c5-4f2c87e4504c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_UnaffiliatedFranchiseeMember_019b096a-637d-788d-b23c-8c02cbe4912a" xlink:href="jynt-20251231.xsd#jynt_UnaffiliatedFranchiseeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019b096a-637d-77d0-a0c5-4f2c87e4504c" xlink:to="loc_jynt_UnaffiliatedFranchiseeMember_019b096a-637d-788d-b23c-8c02cbe4912a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019b096a-637d-729d-b41d-6fcdb038b5d0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019b096a-637d-78d4-88f7-551db85472c4" xlink:to="loc_dei_LegalEntityAxis_019b096a-637d-729d-b41d-6fcdb038b5d0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019b096a-637d-729d-b41d-6fcdb038b5d0_default" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_019b096a-637d-729d-b41d-6fcdb038b5d0" xlink:to="loc_dei_EntityDomain_019b096a-637d-729d-b41d-6fcdb038b5d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019b096a-637d-746d-a416-679c924b0d3d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_019b096a-637d-729d-b41d-6fcdb038b5d0" xlink:to="loc_dei_EntityDomain_019b096a-637d-746d-a416-679c924b0d3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_MrJeffersonGrammMember_019b096a-637d-7226-a65c-d1c72985f28e" xlink:href="jynt-20251231.xsd#jynt_MrJeffersonGrammMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_019b096a-637d-746d-a416-679c924b0d3d" xlink:to="loc_jynt_MrJeffersonGrammMember_019b096a-637d-7226-a65c-d1c72985f28e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_UnaffiliatedFranchiseeMember_019b096a-637d-776c-9c1b-4f4dfb6f5103" xlink:href="jynt-20251231.xsd#jynt_UnaffiliatedFranchiseeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_019b096a-637d-746d-a416-679c924b0d3d" xlink:to="loc_jynt_UnaffiliatedFranchiseeMember_019b096a-637d-776c-9c1b-4f4dfb6f5103" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_019b096a-637d-7e3c-a1d8-e9ed09b5ce8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b096a-637d-7831-9250-6daa9cdd1dd2" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_019b096a-637d-7e3c-a1d8-e9ed09b5ce8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangesFranchisesSold_019b096a-637d-7dda-af06-59c29c6d8954" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantChangesFranchisesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b096a-637d-7831-9250-6daa9cdd1dd2" xlink:to="loc_us-gaap_SignificantChangesFranchisesSold_019b096a-637d-7dda-af06-59c29c6d8954" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_019b096a-637d-73dd-99f9-65414670960b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b096a-637d-7831-9250-6daa9cdd1dd2" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_019b096a-637d-73dd-99f9-65414670960b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_RelatedPartyTransactionAmountsOfTransactionDiscount_019b096a-637d-71b9-bc8a-d1a0dd06052c" xlink:href="jynt-20251231.xsd#jynt_RelatedPartyTransactionAmountsOfTransactionDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b096a-637d-7831-9250-6daa9cdd1dd2" xlink:to="loc_jynt_RelatedPartyTransactionAmountsOfTransactionDiscount_019b096a-637d-71b9-bc8a-d1a0dd06052c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_RelatedPartyTransactionCoPartnerPercentage_019b096a-637d-76c8-91f0-0d2b2b4981ba" xlink:href="jynt-20251231.xsd#jynt_RelatedPartyTransactionCoPartnerPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b096a-637d-7831-9250-6daa9cdd1dd2" xlink:to="loc_jynt_RelatedPartyTransactionCoPartnerPercentage_019b096a-637d-76c8-91f0-0d2b2b4981ba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_RelatedPartyTransactionCoPartnerPercentageDivested_019b096a-637d-7ab4-97e3-9ca2f4c1c868" xlink:href="jynt-20251231.xsd#jynt_RelatedPartyTransactionCoPartnerPercentageDivested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b096a-637d-7831-9250-6daa9cdd1dd2" xlink:to="loc_jynt_RelatedPartyTransactionCoPartnerPercentageDivested_019b096a-637d-7ab4-97e3-9ca2f4c1c868" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_019b096a-637d-7aef-9a28-0206fe5d6070" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b096a-637d-7831-9250-6daa9cdd1dd2" xlink:to="loc_us-gaap_NotesReceivableNet_019b096a-637d-7aef-9a28-0206fe5d6070" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_NumberOfClinics_019b096a-637d-7b29-810b-47f08e40f8cf" xlink:href="jynt-20251231.xsd#jynt_NumberOfClinics"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b096a-637d-7831-9250-6daa9cdd1dd2" xlink:to="loc_jynt_NumberOfClinics_019b096a-637d-7b29-810b-47f08e40f8cf" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc" order="691"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>jynt-20251231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019b096a-603d-78f6-a834-c229229c770d,g:a2c624eb-8b4f-420f-a77d-d91a250e6a25-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_019b096a-6432-7e9a-ba6a-7f67f233d440_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of clinics</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_019b096a-637e-7978-b6d7-0fde14025f1c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_WeightedAverageRemainingLeaseTermAbstract_019b096a-64bb-7015-a8a1-dd65897657f0_terseLabel_en-US" xlink:label="lab_jynt_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining lease term (in years):</link:label>
    <link:label id="lab_jynt_WeightedAverageRemainingLeaseTermAbstract_label_en-US" xlink:label="lab_jynt_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Remaining Lease Term [Abstract]</link:label>
    <link:label id="lab_jynt_WeightedAverageRemainingLeaseTermAbstract_documentation_en-US" xlink:label="lab_jynt_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_WeightedAverageRemainingLeaseTermAbstract" xlink:href="jynt-20251231.xsd#jynt_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_WeightedAverageRemainingLeaseTermAbstract" xlink:to="lab_jynt_WeightedAverageRemainingLeaseTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PostemploymentBenefitPlansPolicy_019b096a-637d-7244-b2be-7eb1fd582c1f_terseLabel_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retirement Benefit Plan</link:label>
    <link:label id="lab_us-gaap_PostemploymentBenefitPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Postemployment Benefit Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PostemploymentBenefitPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PostemploymentBenefitPlansPolicy" xlink:to="lab_us-gaap_PostemploymentBenefitPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_CashFlowLesseeAbstract_019b096a-637e-7fcd-b981-4e38df05009c_terseLabel_en-US" xlink:label="lab_jynt_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for amounts included in measurement of liabilities:</link:label>
    <link:label id="lab_jynt_CashFlowLesseeAbstract_label_en-US" xlink:label="lab_jynt_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow, Lessee [Abstract]</link:label>
    <link:label id="lab_jynt_CashFlowLesseeAbstract_documentation_en-US" xlink:label="lab_jynt_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash Flow, Lessee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CashFlowLesseeAbstract" xlink:href="jynt-20251231.xsd#jynt_CashFlowLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_CashFlowLesseeAbstract" xlink:to="lab_jynt_CashFlowLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_019b096a-64bb-79c3-9885-4b3047b564e1_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current year expirations of non-qualified stock options</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_019b096a-64bb-70fe-8581-7cba7c3117a2_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_CaliforniaAlternativeMinimumTaxCreditMember_019b096a-6432-73a2-9eed-d5a9bd2c4851_terseLabel_en-US" xlink:label="lab_jynt_CaliforniaAlternativeMinimumTaxCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">California Alternative Minimum Tax Credit</link:label>
    <link:label id="lab_jynt_CaliforniaAlternativeMinimumTaxCreditMember_label_en-US" xlink:label="lab_jynt_CaliforniaAlternativeMinimumTaxCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">California Alternative Minimum Tax Credit [Member]</link:label>
    <link:label id="lab_jynt_CaliforniaAlternativeMinimumTaxCreditMember_documentation_en-US" xlink:label="lab_jynt_CaliforniaAlternativeMinimumTaxCreditMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">California Alternative Minimum Tax Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CaliforniaAlternativeMinimumTaxCreditMember" xlink:href="jynt-20251231.xsd#jynt_CaliforniaAlternativeMinimumTaxCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_CaliforniaAlternativeMinimumTaxCreditMember" xlink:to="lab_jynt_CaliforniaAlternativeMinimumTaxCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_019b096a-6432-77d3-a208-491c0cfde4ea_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_019b096a-6432-7040-b008-5419fd92996a_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recently Adopted Accounting Guidance and Accounting Pronouncements Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrMember_019b096a-6432-7ede-8c1f-86eb7cd8183c_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SOFR</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SecuredOvernightFinancingRateSofrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_019b096a-64bb-7c07-baaa-79e29cf00e27_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_019b096a-6433-759e-9a57-7910a7a3db4d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Disclosures</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_019b096a-6433-7a59-9eaf-db88ab4c704f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_019c8aba-bacf-7716-9dad-0d7df69fb759_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_019b096a-6432-77fa-b772-4d3dc672e73c_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current expense</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_019b096a-6432-71dd-827e-4f8e7bee5326_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets, discontinued operations</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_DeferredTaxAssetsOperatingLeaseLiability_019b096a-637d-7114-8476-7ce384ad9693_terseLabel_en-US" xlink:label="lab_jynt_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_jynt_DeferredTaxAssetsOperatingLeaseLiability_label_en-US" xlink:label="lab_jynt_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Lease, Liability</link:label>
    <link:label id="lab_jynt_DeferredTaxAssetsOperatingLeaseLiability_documentation_en-US" xlink:label="lab_jynt_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DeferredTaxAssetsOperatingLeaseLiability" xlink:href="jynt-20251231.xsd#jynt_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_DeferredTaxAssetsOperatingLeaseLiability" xlink:to="lab_jynt_DeferredTaxAssetsOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance_019b096a-64bb-79f3-95d6-56966f4e8e41_negatedTerseLabel_en-US" xlink:label="lab_jynt_AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cash received against accounts receivable included at the beginning of the year</link:label>
    <link:label id="lab_jynt_AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance_label_en-US" xlink:label="lab_jynt_AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Decrease From Cash Received Included In Opening Balance</link:label>
    <link:label id="lab_jynt_AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance_documentation_en-US" xlink:label="lab_jynt_AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Decrease From Cash Received Included In Opening Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance" xlink:href="jynt-20251231.xsd#jynt_AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance" xlink:to="lab_jynt_AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward_019b096a-64bb-7521-b1e2-8f8c2beb9dbb_terseLabel_en-US" xlink:label="lab_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product Information, Franchised Clinics, Company-Owned Or Managed Clinics, Activity [Roll Forward]</link:label>
    <link:label id="lab_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward_label_en-US" xlink:label="lab_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Information, Franchised Clinics, Company-Owned Or Managed Clinics, Activity [Roll Forward]</link:label>
    <link:label id="lab_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward_documentation_en-US" xlink:label="lab_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Product Information, Franchised Clinics, Company-Owned Or Managed Clinics, Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward" xlink:href="jynt-20251231.xsd#jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward" xlink:to="lab_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_019b096a-6432-7c58-995d-44fe5e0bf566_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_019b096a-6432-7887-8884-d266b5111cdb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_019b096a-6432-7909-892d-9f6a062761d8_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019b096a-64bb-7820-804b-82e60fbb2162_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableNet_019b096a-6433-73a3-abbb-10173bef0447_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unsecured loan</link:label>
    <link:label id="lab_us-gaap_NotesReceivableNet_label_en-US" xlink:label="lab_us-gaap_NotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableNet" xlink:to="lab_us-gaap_NotesReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_019b096a-6432-79d6-86a9-fb11b629c3a6_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_EmploymentMattersMember_019b096a-6432-784f-8cc4-f9af1a908318_terseLabel_en-US" xlink:label="lab_jynt_EmploymentMattersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employment Matters</link:label>
    <link:label id="lab_jynt_EmploymentMattersMember_label_en-US" xlink:label="lab_jynt_EmploymentMattersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employment Matters [Member]</link:label>
    <link:label id="lab_jynt_EmploymentMattersMember_documentation_en-US" xlink:label="lab_jynt_EmploymentMattersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employment Matters</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_EmploymentMattersMember" xlink:href="jynt-20251231.xsd#jynt_EmploymentMattersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_EmploymentMattersMember" xlink:to="lab_jynt_EmploymentMattersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019b096a-6432-721d-b563-f12b2aa13025_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_FranchiseOperationsMember_019b096a-637e-71a5-b1f4-2102e8fb574e_terseLabel_en-US" xlink:label="lab_jynt_FranchiseOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Franchise Operations</link:label>
    <link:label id="lab_jynt_FranchiseOperationsMember_label_en-US" xlink:label="lab_jynt_FranchiseOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchise Operations [Member]</link:label>
    <link:label id="lab_jynt_FranchiseOperationsMember_documentation_en-US" xlink:label="lab_jynt_FranchiseOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Franchise Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_FranchiseOperationsMember" xlink:href="jynt-20251231.xsd#jynt_FranchiseOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_FranchiseOperationsMember" xlink:to="lab_jynt_FranchiseOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount_019b096a-6432-78db-a4f7-c025b56934e4_terseLabel_en-US" xlink:label="lab_jynt_LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum borrowing capacity, additional amount</link:label>
    <link:label id="lab_jynt_LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount_label_en-US" xlink:label="lab_jynt_LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity, Additional Amount</link:label>
    <link:label id="lab_jynt_LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount_documentation_en-US" xlink:label="lab_jynt_LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity, Additional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount" xlink:href="jynt-20251231.xsd#jynt_LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount" xlink:to="lab_jynt_LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_019b096a-637e-7790-8b45-c31e840c78c2_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total The Joint Corp. stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_019b096a-6432-76c4-a617-2057704ba866_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_019b096a-6433-7876-9ec9-fedb75585b58_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_RelatedPartyTransactionAmountsOfTransactionDiscount_019b096a-637e-77e7-a223-244ecd12b83a_terseLabel_en-US" xlink:label="lab_jynt_RelatedPartyTransactionAmountsOfTransactionDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount per the franchise disclosure document</link:label>
    <link:label id="lab_jynt_RelatedPartyTransactionAmountsOfTransactionDiscount_label_en-US" xlink:label="lab_jynt_RelatedPartyTransactionAmountsOfTransactionDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Amounts Of Transaction, Discount</link:label>
    <link:label id="lab_jynt_RelatedPartyTransactionAmountsOfTransactionDiscount_documentation_en-US" xlink:label="lab_jynt_RelatedPartyTransactionAmountsOfTransactionDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Amounts Of Transaction, Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_RelatedPartyTransactionAmountsOfTransactionDiscount" xlink:href="jynt-20251231.xsd#jynt_RelatedPartyTransactionAmountsOfTransactionDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_RelatedPartyTransactionAmountsOfTransactionDiscount" xlink:to="lab_jynt_RelatedPartyTransactionAmountsOfTransactionDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_DeferredTaxAssetsIntangibleAssets_019b096a-64bb-70d1-af5c-6cc49c293d10_terseLabel_en-US" xlink:label="lab_jynt_DeferredTaxAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_jynt_DeferredTaxAssetsIntangibleAssets_label_en-US" xlink:label="lab_jynt_DeferredTaxAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Intangible Assets</link:label>
    <link:label id="lab_jynt_DeferredTaxAssetsIntangibleAssets_documentation_en-US" xlink:label="lab_jynt_DeferredTaxAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets excluding goodwill.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DeferredTaxAssetsIntangibleAssets" xlink:href="jynt-20251231.xsd#jynt_DeferredTaxAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_DeferredTaxAssetsIntangibleAssets" xlink:to="lab_jynt_DeferredTaxAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019b096a-64bb-7f7a-84d5-ae436a33e7fa_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_019cc457-7737-7786-852f-376fb8f17465_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019b332c-b9ff-7d95-b233-14b758c0d383_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents fair value</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_019b3303-d92e-75da-86d0-c87786bd0b30_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Divestitures</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_019b096a-637d-7d9c-8d1d-52771f6da7dc_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_019b096a-6433-77cc-a344-e23489cb7aba_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable, weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_019b096a-64bb-72fb-89fb-3f75c86d3276_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_019b096a-6432-789b-930e-0c8211c1ef04_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impaired Long-Lived Assets Held and Used by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impaired Long-Lived Assets Held and Used by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:to="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_NumberOfFutureOperatingLeasesCommitted_019b096a-637d-7fc0-8524-2a788d9bbbbe_terseLabel_en-US" xlink:label="lab_jynt_NumberOfFutureOperatingLeasesCommitted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of future operating leases committed</link:label>
    <link:label id="lab_jynt_NumberOfFutureOperatingLeasesCommitted_label_en-US" xlink:label="lab_jynt_NumberOfFutureOperatingLeasesCommitted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Future Operating Leases Committed</link:label>
    <link:label id="lab_jynt_NumberOfFutureOperatingLeasesCommitted_documentation_en-US" xlink:label="lab_jynt_NumberOfFutureOperatingLeasesCommitted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Future Operating Leases Committed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_NumberOfFutureOperatingLeasesCommitted" xlink:href="jynt-20251231.xsd#jynt_NumberOfFutureOperatingLeasesCommitted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_NumberOfFutureOperatingLeasesCommitted" xlink:to="lab_jynt_NumberOfFutureOperatingLeasesCommitted" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_CostsIncurredAndDeferredDuringTheYear_019b096a-64bb-7ea5-bf8b-384a024017f0_terseLabel_en-US" xlink:label="lab_jynt_CostsIncurredAndDeferredDuringTheYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net increase during the year</link:label>
    <link:label id="lab_jynt_CostsIncurredAndDeferredDuringTheYear_label_en-US" xlink:label="lab_jynt_CostsIncurredAndDeferredDuringTheYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs Incurred And Deferred During The Year</link:label>
    <link:label id="lab_jynt_CostsIncurredAndDeferredDuringTheYear_documentation_en-US" xlink:label="lab_jynt_CostsIncurredAndDeferredDuringTheYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the amount of costs incurred and deferred during the period related to contract with customer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CostsIncurredAndDeferredDuringTheYear" xlink:href="jynt-20251231.xsd#jynt_CostsIncurredAndDeferredDuringTheYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_CostsIncurredAndDeferredDuringTheYear" xlink:to="lab_jynt_CostsIncurredAndDeferredDuringTheYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_019b096a-6432-7d12-a1c7-37d33ca5d8b9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_019b096a-6432-792d-9f53-201892259aca_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unvested restricted stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalUseSoftwarePolicy_019b096a-64bb-7417-8554-399c13b24995_terseLabel_en-US" xlink:label="lab_us-gaap_InternalUseSoftwarePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized Software</link:label>
    <link:label id="lab_us-gaap_InternalUseSoftwarePolicy_label_en-US" xlink:label="lab_us-gaap_InternalUseSoftwarePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Internal Use Software, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalUseSoftwarePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalUseSoftwarePolicy" xlink:to="lab_us-gaap_InternalUseSoftwarePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_019b096a-637e-7e09-a193-17d09fb4f060_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-637e-795a-9b8d-879aee26e287_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_019b096a-64bb-710b-a25b-1ab1ece30703_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restricted Stock Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_RelatedPartyTransactionCoPartnerPercentage_019b096a-6433-76c9-a98d-68ff72c37f75_terseLabel_en-US" xlink:label="lab_jynt_RelatedPartyTransactionCoPartnerPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Co-partner percentage</link:label>
    <link:label id="lab_jynt_RelatedPartyTransactionCoPartnerPercentage_label_en-US" xlink:label="lab_jynt_RelatedPartyTransactionCoPartnerPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Co-Partner Percentage</link:label>
    <link:label id="lab_jynt_RelatedPartyTransactionCoPartnerPercentage_documentation_en-US" xlink:label="lab_jynt_RelatedPartyTransactionCoPartnerPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Co-Partner Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_RelatedPartyTransactionCoPartnerPercentage" xlink:href="jynt-20251231.xsd#jynt_RelatedPartyTransactionCoPartnerPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_RelatedPartyTransactionCoPartnerPercentage" xlink:to="lab_jynt_RelatedPartyTransactionCoPartnerPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_019b096a-64bb-78b4-b2fc-5f1f8de62049_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019b096a-637d-748c-8910-b404070108a4_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss from continuing operations before income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019b096a-637d-79f2-9e5a-580bee46a2e8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss from continuing operations before provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_019b096a-6432-7db5-a682-9edaf4995639_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeAndExpensesLesseeAbstract_019b096a-6432-7c1e-ab57-f2116538a700_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeAndExpensesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease costs:</link:label>
    <link:label id="lab_us-gaap_IncomeAndExpensesLesseeAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeAndExpensesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income and Expenses, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeAndExpensesLesseeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeAndExpensesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeAndExpensesLesseeAbstract" xlink:to="lab_us-gaap_IncomeAndExpensesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_019b096a-6433-7912-b6a8-6c25c96a2aa9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019b096a-6432-7546-b251-9cbeb7a4df32_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discontinued Operations, Held-for-Sale or Disposed of by Sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operations, Held-for-Sale or Disposed of by Sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_019b096a-6432-7e91-afe6-ef35f2ec80dc_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_019b096a-637d-72d0-908e-041276b76ff5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_019c6694-0101-75f4-b9b2-435356d645b9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Cash Paid For Income Taxes (Net of Refunds Received)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_ClinicsAcquiredDuringPeriod_019b096a-64bb-7fe4-b67a-93b6b0d546b9_terseLabel_en-US" xlink:label="lab_jynt_ClinicsAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired during the year</link:label>
    <link:label id="lab_jynt_ClinicsAcquiredDuringPeriod_label_en-US" xlink:label="lab_jynt_ClinicsAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Clinics Acquired During Period</link:label>
    <link:label id="lab_jynt_ClinicsAcquiredDuringPeriod_documentation_en-US" xlink:label="lab_jynt_ClinicsAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the number of clinics acquired during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ClinicsAcquiredDuringPeriod" xlink:href="jynt-20251231.xsd#jynt_ClinicsAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_ClinicsAcquiredDuringPeriod" xlink:to="lab_jynt_ClinicsAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_019b096a-637e-7874-a6d8-984221b800fb_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_TX_019c6698-df18-7424-af7a-2c86d042ab62_terseLabel_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Texas</link:label>
    <link:label id="lab_stpr_TX_label_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">TEXAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_TX"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_TX" xlink:to="lab_stpr_TX" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_019c663b-3d88-7176-9e36-282daae4d930_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_019b096a-6432-7c6d-980d-c63bb23926bd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liability, current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_019b096a-6432-773f-8113-b744017dadaa_negatedLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: Current obligations</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_019b096a-64bb-7e5e-86eb-3f86edc0419f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_019b096a-6432-7d85-93fe-1e84a5da2897_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_019b096a-6432-7c0a-9f9d-29a28a1c6efd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_019b096a-6432-7d44-91a9-91dd6bb44632_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_CoOpMarketingFundsPolicyPolicyTextBlock_019b096a-64bb-7a3f-a1db-f2a54b183532_terseLabel_en-US" xlink:label="lab_jynt_CoOpMarketingFundsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Co-Op Marketing Funds</link:label>
    <link:label id="lab_jynt_CoOpMarketingFundsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_jynt_CoOpMarketingFundsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Co-Op Marketing Funds, Policy [Policy Text Block]</link:label>
    <link:label id="lab_jynt_CoOpMarketingFundsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_jynt_CoOpMarketingFundsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for co-op marketing funds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CoOpMarketingFundsPolicyPolicyTextBlock" xlink:href="jynt-20251231.xsd#jynt_CoOpMarketingFundsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_CoOpMarketingFundsPolicyPolicyTextBlock" xlink:to="lab_jynt_CoOpMarketingFundsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_019b096a-64bb-76db-b3e9-d0b384936316_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_019b096a-64bb-755c-9b9b-958087345c5d_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred franchise fee revenue, net of current portion</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_019b096a-6432-7de1-9d25-3a754448d4a3_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_019b096a-6432-7e36-af64-5bd771ae6dd5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_AssetsHeldForSaleMeasurementInputNegativeCashFlow_019c661b-7551-75cd-aa39-e7dc3ce43fc2_terseLabel_en-US" xlink:label="lab_jynt_AssetsHeldForSaleMeasurementInputNegativeCashFlow" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets, held-for-sale, measurement input, negative cash flow</link:label>
    <link:label id="lab_jynt_AssetsHeldForSaleMeasurementInputNegativeCashFlow_label_en-US" xlink:label="lab_jynt_AssetsHeldForSaleMeasurementInputNegativeCashFlow" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Held-For-Sale, Measurement Input, Negative Cash Flow</link:label>
    <link:label id="lab_jynt_AssetsHeldForSaleMeasurementInputNegativeCashFlow_documentation_en-US" xlink:label="lab_jynt_AssetsHeldForSaleMeasurementInputNegativeCashFlow" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Assets, Held-For-Sale, Measurement Input, Negative Cash Flow</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AssetsHeldForSaleMeasurementInputNegativeCashFlow" xlink:href="jynt-20251231.xsd#jynt_AssetsHeldForSaleMeasurementInputNegativeCashFlow"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_AssetsHeldForSaleMeasurementInputNegativeCashFlow" xlink:to="lab_jynt_AssetsHeldForSaleMeasurementInputNegativeCashFlow" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_019b096a-64bb-77bb-baf7-93abea5d7ccc_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_019b096a-6432-798e-afd4-c37b5f969fbb_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_019b096a-6432-7aed-996a-c212b3b71177_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in valuation allowances</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_ClinicsClosedDuringThePeriod_019b096a-64bb-75eb-8157-139ff646bbc6_negatedTerseLabel_en-US" xlink:label="lab_jynt_ClinicsClosedDuringThePeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Closed during the year</link:label>
    <link:label id="lab_jynt_ClinicsClosedDuringThePeriod_label_en-US" xlink:label="lab_jynt_ClinicsClosedDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Clinics Closed During The Period</link:label>
    <link:label id="lab_jynt_ClinicsClosedDuringThePeriod_documentation_en-US" xlink:label="lab_jynt_ClinicsClosedDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the number of clinics closed during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ClinicsClosedDuringThePeriod" xlink:href="jynt-20251231.xsd#jynt_ClinicsClosedDuringThePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_ClinicsClosedDuringThePeriod" xlink:to="lab_jynt_ClinicsClosedDuringThePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_019b096a-637e-7afe-854e-07352a9630c7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_019b32c9-9b43-7d33-90a8-37fa49d8d972_terseLabel_en-US" xlink:label="lab_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Loss, Financial Instrument [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditLossFinancialInstrumentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:to="lab_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_019b096a-6433-7226-b49a-d29586a11dbd_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItemsAbstract_019cb999-9315-73be-bee1-7e12f01c408b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other adjustments:</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItemsAbstract" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019b096a-64bb-7622-8ae9-c0db11709027_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding, beginning (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019b096a-64bb-7920-bb6d-23c8ad5bce3c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding, ending (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_019b096a-64bb-7ae4-b436-c6186132bf76_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_ShareRepurchaseProgramAdditionalAuthorizedAmount_019c8ad0-847c-777f-ba7f-7c52dfc6199b_terseLabel_en-US" xlink:label="lab_jynt_ShareRepurchaseProgramAdditionalAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share repurchase additional authorized amount</link:label>
    <link:label id="lab_jynt_ShareRepurchaseProgramAdditionalAuthorizedAmount_label_en-US" xlink:label="lab_jynt_ShareRepurchaseProgramAdditionalAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Additional Authorized, Amount</link:label>
    <link:label id="lab_jynt_ShareRepurchaseProgramAdditionalAuthorizedAmount_documentation_en-US" xlink:label="lab_jynt_ShareRepurchaseProgramAdditionalAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Additional Authorized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ShareRepurchaseProgramAdditionalAuthorizedAmount" xlink:href="jynt-20251231.xsd#jynt_ShareRepurchaseProgramAdditionalAuthorizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_ShareRepurchaseProgramAdditionalAuthorizedAmount" xlink:to="lab_jynt_ShareRepurchaseProgramAdditionalAuthorizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_DeferredTaxLiabilitiesDeferredFranchiseCosts_019b096a-6432-737a-a17c-783dcacd45fa_negatedTerseLabel_en-US" xlink:label="lab_jynt_DeferredTaxLiabilitiesDeferredFranchiseCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred franchise costs</link:label>
    <link:label id="lab_jynt_DeferredTaxLiabilitiesDeferredFranchiseCosts_label_en-US" xlink:label="lab_jynt_DeferredTaxLiabilitiesDeferredFranchiseCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Deferred Franchise Costs</link:label>
    <link:label id="lab_jynt_DeferredTaxLiabilitiesDeferredFranchiseCosts_documentation_en-US" xlink:label="lab_jynt_DeferredTaxLiabilitiesDeferredFranchiseCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Deferred Franchise Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DeferredTaxLiabilitiesDeferredFranchiseCosts" xlink:href="jynt-20251231.xsd#jynt_DeferredTaxLiabilitiesDeferredFranchiseCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_DeferredTaxLiabilitiesDeferredFranchiseCosts" xlink:to="lab_jynt_DeferredTaxLiabilitiesDeferredFranchiseCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance_019b096a-6432-71bf-9d38-6473a7bb4903_terseLabel_en-US" xlink:label="lab_jynt_AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net increase during the year</link:label>
    <link:label id="lab_jynt_AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance_label_en-US" xlink:label="lab_jynt_AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Increase (Decrease) From Other Than Cash Received Included In Opening Balance</link:label>
    <link:label id="lab_jynt_AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance_documentation_en-US" xlink:label="lab_jynt_AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Increase (Decrease) From Other Than Cash Received Included In Opening Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance" xlink:href="jynt-20251231.xsd#jynt_AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance" xlink:to="lab_jynt_AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_019b096a-6432-75f4-9693-a358afb63d2f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_019b096a-6432-72ab-95a5-39e6f64316f1_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance, beginning common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_019b096a-6432-7f77-b638-769336722cdf_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance, ending common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_019b096a-6432-73d0-b0cd-a479569fe465_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for credit losses</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_019b096a-6432-7301-b6af-ea96fd0b3fe6_verboseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Bad debt expense recognized during the year</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent_019b096a-637d-750b-9530-aaa1faf0d2fc_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue from company-owned or managed clinics</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent_019cb998-f762-7f0a-b2ed-b38946c290fe_terseLabel_en-US" xlink:label="lab_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred true-up to deferred franchise costs</link:label>
    <link:label id="lab_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent_label_en-US" xlink:label="lab_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deferred Franchise Costs, Deferred True Up, Percent</link:label>
    <link:label id="lab_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent_documentation_en-US" xlink:label="lab_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deferred Franchise Costs, Deferred True Up, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent" xlink:href="jynt-20251231.xsd#jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent" xlink:to="lab_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_019b096a-6433-7f47-a262-3c767cf84496_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_019cc53f-89c0-7618-ad84-df1a3e638f39_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets, valuation allowance decrease</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019b096a-6432-78ea-b2b0-42b7416d3904_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_019b096a-6432-74ec-b29b-9b3c82315d75_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nature of Operation, Product Information, Concentration of Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nature of Operation, Product Information, Concentration of Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable" xlink:to="lab_us-gaap_ScheduleOfProductInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_019b096a-637e-7810-884a-a7e24cbef18f_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019b096a-6433-74f0-a9bf-e13191709c37_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_019b096a-6433-7cbb-a2e5-4e8c31861a9e_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_019b096a-6433-7a27-943a-062a1aaecec1_verboseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Discontinued operation (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019b096a-6433-7fbc-9599-4c0a32abfac6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_019b096a-64bb-784a-abd8-10904d5f533e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_019b096a-6432-7d80-9bbe-1a9e71f9b586_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_019b096a-6432-7603-9083-ca3c675d9496_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_019b096a-6432-77e6-9022-22105a0f71df_netLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_019b096a-6432-7556-b666-2b8bdeca7210_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_019b096a-637d-7b12-bb03-824ffd29601e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_019b096a-637e-7418-9af7-0c35655e2c62_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_019b096a-637e-75d9-8671-ddf878a5df65_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_019b096a-6433-79c8-aa37-d5f531ac53e3_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series A preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_019b096a-6433-7d82-ac23-102002ec7a43_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock_019b096a-6432-7717-81e0-28ab9151b6fd_terseLabel_en-US" xlink:label="lab_us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Net Loss (Gain) on Disposition or Impairment Related to Continuing Operations</link:label>
    <link:label id="lab_us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock_label_en-US" xlink:label="lab_us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Details of Impairment of Long-Lived Assets Held and Used by Asset [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" xlink:to="lab_us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_DeferredTaxAssetsNonqualifiedStockOptions_019c90ac-912b-75ae-9e6a-01728e2dc2b1_terseLabel_en-US" xlink:label="lab_jynt_DeferredTaxAssetsNonqualifiedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nonqualified stock options</link:label>
    <link:label id="lab_jynt_DeferredTaxAssetsNonqualifiedStockOptions_label_en-US" xlink:label="lab_jynt_DeferredTaxAssetsNonqualifiedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Nonqualified Stock Options</link:label>
    <link:label id="lab_jynt_DeferredTaxAssetsNonqualifiedStockOptions_documentation_en-US" xlink:label="lab_jynt_DeferredTaxAssetsNonqualifiedStockOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Nonqualified Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DeferredTaxAssetsNonqualifiedStockOptions" xlink:href="jynt-20251231.xsd#jynt_DeferredTaxAssetsNonqualifiedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_DeferredTaxAssetsNonqualifiedStockOptions" xlink:to="lab_jynt_DeferredTaxAssetsNonqualifiedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_019b096a-6432-704b-ae70-785014439c89_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_019b096a-637d-7e96-9183-c7dc01ace702_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_A2022CreditFacilityMember_019b096a-64bb-7eb8-afc3-0f6d4c9a007f_terseLabel_en-US" xlink:label="lab_jynt_A2022CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022 Credit Facility</link:label>
    <link:label id="lab_jynt_A2022CreditFacilityMember_label_en-US" xlink:label="lab_jynt_A2022CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2022 Credit Facility [Member]</link:label>
    <link:label id="lab_jynt_A2022CreditFacilityMember_documentation_en-US" xlink:label="lab_jynt_A2022CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2022 Credit Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_A2022CreditFacilityMember" xlink:href="jynt-20251231.xsd#jynt_A2022CreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_A2022CreditFacilityMember" xlink:to="lab_jynt_A2022CreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember_019b096a-6432-74f2-a1c7-2e4bffe1f1b4_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discontinued Operations, Assets Held For Sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operations, Held-for-Sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_019b096a-64bb-717e-81a7-f73407c3f3db_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_019b096a-6432-7573-838f-f6929d983cd2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPaidFederalAfterRefundReceived_019c6696-ab89-709a-916b-852146959ca0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPaidFederalAfterRefundReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPaidFederalAfterRefundReceived_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPaidFederalAfterRefundReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Paid, Federal, after Refund Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPaidFederalAfterRefundReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPaidFederalAfterRefundReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPaidFederalAfterRefundReceived" xlink:to="lab_us-gaap_IncomeTaxPaidFederalAfterRefundReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_019b096a-6432-78a2-af68-b52e1d6a6410_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested and expected to vest , weighted average remaining contractual life (in year)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_019b096a-6432-7944-9a8e-2c4e772fb182_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_019b096a-64bb-71e5-b218-553726336ad1_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_019b096a-637d-70ab-90d2-781519674239_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other items</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_ClinicsSoldDuringPeriod_019b096a-6432-7469-bce2-5017553b91b8_negatedLabel_en-US" xlink:label="lab_jynt_ClinicsSoldDuringPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Sold during the year</link:label>
    <link:label id="lab_jynt_ClinicsSoldDuringPeriod_019b096a-6432-7c9f-977d-87c1aaa4c6e0_terseLabel_en-US" xlink:label="lab_jynt_ClinicsSoldDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of clinics sold</link:label>
    <link:label id="lab_jynt_ClinicsSoldDuringPeriod_label_en-US" xlink:label="lab_jynt_ClinicsSoldDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Clinics Sold During Period</link:label>
    <link:label id="lab_jynt_ClinicsSoldDuringPeriod_documentation_en-US" xlink:label="lab_jynt_ClinicsSoldDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Clinics Sold During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ClinicsSoldDuringPeriod" xlink:href="jynt-20251231.xsd#jynt_ClinicsSoldDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_ClinicsSoldDuringPeriod" xlink:to="lab_jynt_ClinicsSoldDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_019b096a-637e-769e-ad3a-d2d250f148e3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019b096a-6432-7597-ac51-6b5c6072e3d4_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Non-vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019b096a-6432-7ad5-9379-db089733970c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Non-vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FranchisorDisclosureAxis_019b096a-637d-793f-967a-2621aad8dfb1_terseLabel_en-US" xlink:label="lab_us-gaap_FranchisorDisclosureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Franchisor Disclosure [Axis]</link:label>
    <link:label id="lab_us-gaap_FranchisorDisclosureAxis_label_en-US" xlink:label="lab_us-gaap_FranchisorDisclosureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchisor Disclosure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisorDisclosureAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisorDisclosureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FranchisorDisclosureAxis" xlink:to="lab_us-gaap_FranchisorDisclosureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_019b096a-6433-7132-85e8-ea770a675f64_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b096a-6432-759d-8116-ce1b81ee198b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FranchiseRightsMember_019b096a-64bb-748b-bbc4-2a82196b38e9_terseLabel_en-US" xlink:label="lab_us-gaap_FranchiseRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reacquired franchise rights</link:label>
    <link:label id="lab_us-gaap_FranchiseRightsMember_label_en-US" xlink:label="lab_us-gaap_FranchiseRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchise Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchiseRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchiseRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FranchiseRightsMember" xlink:to="lab_us-gaap_FranchiseRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_019b096a-64bb-7b86-8149-e862173a74d1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Useful life, property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_019b096a-6432-7dc8-975c-b47d8c9898ea_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series A preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_019b096a-6432-71ec-87aa-cf677df52f9b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Valuation Assumptions used for Stock Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_019b096a-64bb-75a0-ad63-2db973e0a73f_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_019b096a-6432-7232-b2f6-80cff81de706_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_019b096a-6433-7b61-802c-11134254d121_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested and expected to vest , weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_019b332c-b9ff-7558-8ea8-ea34a4c21db7_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money Market Funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_019b096a-637d-71b1-bf41-6b9686a2e8bb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_019b096a-6432-72fb-b48a-2bfb06bd70dc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_ClinicLicensesSoldButNotYetDeveloped_019b096a-6432-77ca-bf63-68250d544a3b_terseLabel_en-US" xlink:label="lab_jynt_ClinicLicensesSoldButNotYetDeveloped" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Clinic licenses sold but not yet developed</link:label>
    <link:label id="lab_jynt_ClinicLicensesSoldButNotYetDeveloped_label_en-US" xlink:label="lab_jynt_ClinicLicensesSoldButNotYetDeveloped" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Clinic Licenses Sold But Not Yet Developed</link:label>
    <link:label id="lab_jynt_ClinicLicensesSoldButNotYetDeveloped_documentation_en-US" xlink:label="lab_jynt_ClinicLicensesSoldButNotYetDeveloped" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of clinics that have been sold as franchises, but are not yet operational.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ClinicLicensesSoldButNotYetDeveloped" xlink:href="jynt-20251231.xsd#jynt_ClinicLicensesSoldButNotYetDeveloped"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_ClinicLicensesSoldButNotYetDeveloped" xlink:to="lab_jynt_ClinicLicensesSoldButNotYetDeveloped" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyServiceMember_019b096a-637e-7833-a5a0-4933b9c90e1d_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Software fees</link:label>
    <link:label id="lab_us-gaap_TechnologyServiceMember_label_en-US" xlink:label="lab_us-gaap_TechnologyServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Technology Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TechnologyServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyServiceMember" xlink:to="lab_us-gaap_TechnologyServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent_019b096a-6433-7903-a48a-3da1ceafb0c2_terseLabel_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease liability</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Finance Lease Liability, Current</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent_documentation_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Finance Lease Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent" xlink:to="lab_jynt_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_019b096a-6432-797c-9d1c-f3496760c6d2_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impaired Long-Lived Assets Held and Used [Line Items]</link:label>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_label_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impaired Long-Lived Assets Held and Used [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems" xlink:to="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_019b336b-c94c-7d13-9c5d-36215a452e24_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_019b096a-6433-7a3a-88c3-c561e9b4149e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_KansasAndMissouriMember_019c9094-1709-780b-b8a1-581d809b31a0_terseLabel_en-US" xlink:label="lab_jynt_KansasAndMissouriMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kansas and Missouri</link:label>
    <link:label id="lab_jynt_KansasAndMissouriMember_label_en-US" xlink:label="lab_jynt_KansasAndMissouriMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kansas and Missouri [Member]</link:label>
    <link:label id="lab_jynt_KansasAndMissouriMember_documentation_en-US" xlink:label="lab_jynt_KansasAndMissouriMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kansas and Missouri</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_KansasAndMissouriMember" xlink:href="jynt-20251231.xsd#jynt_KansasAndMissouriMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_KansasAndMissouriMember" xlink:to="lab_jynt_KansasAndMissouriMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_019b096a-637d-7f0b-97db-4fef3c66d3db_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advertising Costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_019b096a-6433-7dcf-aef7-b2a0e27cf29b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_019b096a-6432-7001-8bd1-b395e90f4902_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Payments of finance lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent_019b096a-6432-7c82-a3e6-daccb62c853b_terseLabel_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payroll liabilities ($0.6 million and $0.9 million attributable to VIEs, respectively)</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent_label_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Payroll Liabilities, Current</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent_documentation_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Payroll Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent" xlink:to="lab_jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_019b096a-6432-7c43-8fa4-5ea19eb4a959_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_019b096a-637d-7d6c-91fd-12d9c10ea25c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_019b096a-6432-72c4-8e0c-7ad90a7f968f_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_FranchiseLicensesTwoMember_019b096a-6433-7d7f-a57c-37058953094f_terseLabel_en-US" xlink:label="lab_jynt_FranchiseLicensesTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Franchise Licenses Two</link:label>
    <link:label id="lab_jynt_FranchiseLicensesTwoMember_label_en-US" xlink:label="lab_jynt_FranchiseLicensesTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchise Licenses Two [Member]</link:label>
    <link:label id="lab_jynt_FranchiseLicensesTwoMember_documentation_en-US" xlink:label="lab_jynt_FranchiseLicensesTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Franchise Licenses Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_FranchiseLicensesTwoMember" xlink:href="jynt-20251231.xsd#jynt_FranchiseLicensesTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_FranchiseLicensesTwoMember" xlink:to="lab_jynt_FranchiseLicensesTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_019b096a-6433-79a4-b6ff-ceda8be8ddad_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_019b096a-637d-780d-8ed7-9f071febaf14_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue_019b096a-6432-7ed3-8094-919814701767_terseLabel_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue_label_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Estimated Fair Value</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue_documentation_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Estimated Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue" xlink:to="lab_jynt_DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_019b096a-637d-77ee-aa27-ac1f69bf5efb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Deferred Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_019b096a-6432-73c6-ac79-0bf2cf386c46_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_019c666b-49c4-7411-9d08-b69b191ecf73_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share based compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_019b096a-64bb-7a87-9489-0303d48095a0_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_019b096a-637d-7227-8825-9d9a346fa70c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019b096a-637e-7c5c-81d7-6c9616f183e1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent_019b096a-6432-7263-87e3-b64d9b4c7ed5_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_019b096a-6432-7c2d-b93d-67f30aa2a618_terseLabel_en-US" xlink:label="lab_jynt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases:</link:label>
    <link:label id="lab_jynt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_jynt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Assets and Liabilities, Lessee [Abstract]</link:label>
    <link:label id="lab_jynt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_jynt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Lease, Assets and Liabilities, Lessee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:href="jynt-20251231.xsd#jynt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_jynt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_GainLossOnTerminationOfFranchisingAgreements_019b096a-64bb-77da-b7cf-7fae62eb343b_negatedLabel_en-US" xlink:label="lab_jynt_GainLossOnTerminationOfFranchisingAgreements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Net franchise fees recognized upon termination of franchise agreements</link:label>
    <link:label id="lab_jynt_GainLossOnTerminationOfFranchisingAgreements_label_en-US" xlink:label="lab_jynt_GainLossOnTerminationOfFranchisingAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) On Termination Of Franchising Agreements</link:label>
    <link:label id="lab_jynt_GainLossOnTerminationOfFranchisingAgreements_documentation_en-US" xlink:label="lab_jynt_GainLossOnTerminationOfFranchisingAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gain (loss) related to the termination of franchising agreements with third parties.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_GainLossOnTerminationOfFranchisingAgreements" xlink:href="jynt-20251231.xsd#jynt_GainLossOnTerminationOfFranchisingAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_GainLossOnTerminationOfFranchisingAgreements" xlink:to="lab_jynt_GainLossOnTerminationOfFranchisingAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_NatureofOperationsPolicyPolicyTextBlock_019b096a-637d-7437-bd72-41036403a938_terseLabel_en-US" xlink:label="lab_jynt_NatureofOperationsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nature of Operations</link:label>
    <link:label id="lab_jynt_NatureofOperationsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_jynt_NatureofOperationsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nature of Operations Policy [Policy Text Block]</link:label>
    <link:label id="lab_jynt_NatureofOperationsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_jynt_NatureofOperationsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for nature of operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_NatureofOperationsPolicyPolicyTextBlock" xlink:href="jynt-20251231.xsd#jynt_NatureofOperationsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_NatureofOperationsPolicyPolicyTextBlock" xlink:to="lab_jynt_NatureofOperationsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_019b096a-6432-756a-bf3c-ea71db7dc9a8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_AdvertisingFundPolicyTextBlock_019b096a-6432-7c0a-af5f-a074d9b2f809_terseLabel_en-US" xlink:label="lab_jynt_AdvertisingFundPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advertising Fund</link:label>
    <link:label id="lab_jynt_AdvertisingFundPolicyTextBlock_label_en-US" xlink:label="lab_jynt_AdvertisingFundPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising Fund, Policy [Policy Text Block]</link:label>
    <link:label id="lab_jynt_AdvertisingFundPolicyTextBlock_documentation_en-US" xlink:label="lab_jynt_AdvertisingFundPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for the advertising fund.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AdvertisingFundPolicyTextBlock" xlink:href="jynt-20251231.xsd#jynt_AdvertisingFundPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_AdvertisingFundPolicyTextBlock" xlink:to="lab_jynt_AdvertisingFundPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_AssetsHeldForSaleCashFlowForecastPeriod_019b096a-637d-732d-81a8-d05263af1c93_terseLabel_en-US" xlink:label="lab_jynt_AssetsHeldForSaleCashFlowForecastPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets held for sale cash flow forecast period</link:label>
    <link:label id="lab_jynt_AssetsHeldForSaleCashFlowForecastPeriod_label_en-US" xlink:label="lab_jynt_AssetsHeldForSaleCashFlowForecastPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Held-For-Sale, Cash Flow Forecast Period</link:label>
    <link:label id="lab_jynt_AssetsHeldForSaleCashFlowForecastPeriod_documentation_en-US" xlink:label="lab_jynt_AssetsHeldForSaleCashFlowForecastPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Assets, Held-For-Sale, Cash Flow Forecast Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AssetsHeldForSaleCashFlowForecastPeriod" xlink:href="jynt-20251231.xsd#jynt_AssetsHeldForSaleCashFlowForecastPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_AssetsHeldForSaleCashFlowForecastPeriod" xlink:to="lab_jynt_AssetsHeldForSaleCashFlowForecastPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_019b096a-64bb-7e76-b5c6-c7b8ee97aad7_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019b096a-6433-7d4e-b4b3-bc640cf3b53f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage_019b096a-64bb-71ea-b7ce-fb393986793a_terseLabel_en-US" xlink:label="lab_jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Monthly marketing fee</link:label>
    <link:label id="lab_jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage_label_en-US" xlink:label="lab_jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchise Monthly Marketing Fee, Gross Sales Percentage</link:label>
    <link:label id="lab_jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage_documentation_en-US" xlink:label="lab_jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the percentage of gross sales a franchise pays for monthly marketing fees as stipulated in the typical franchise agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage" xlink:href="jynt-20251231.xsd#jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage" xlink:to="lab_jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019b096a-6433-7e4f-8a6a-f3fd96006d15_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_019b096a-637d-7943-8e39-b9576b07ba20_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred franchise fee revenue, current portion</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019b096a-6432-79e6-baf6-0ae94bf1edcb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_019b096a-6433-71ea-b32c-addfe977bb1d_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_019b096a-64bb-7fae-b0fd-8aeec0318280_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected federal tax expense at U.S. federal statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_019b096a-637e-77f1-8d7b-a9f5ff970dab_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total consideration</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpenditureDiscontinuedOperations_019c909e-f42d-72ef-aeba-64d2a819cc6a_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpenditureDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_CapitalExpenditureDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CapitalExpenditureDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Expenditure, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpenditureDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalExpenditureDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpenditureDiscontinuedOperations" xlink:to="lab_us-gaap_CapitalExpenditureDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_019b096a-64bb-771a-b73c-a8661ff07f53_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_019b096a-64bb-72b1-8872-9fe000fbc499_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_019b096a-637d-7132-8294-4507729fc810_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Franchise Costs and Regional Development Costs</link:label>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Charges, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:to="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_019b096a-6433-7461-be47-36b338289f0b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Meals and entertainment</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_019b096a-64bb-7f52-8eb5-ea531fb9f0f3_totalLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income (loss) from discontinued operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_019b096a-64bb-7576-b568-9facfffb4a8e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income (loss) from discontinued operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_019b32b1-33fe-7623-8568-19e06e91f80c_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchases of treasury stock under employee stock plans (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_019b096a-6432-7ceb-844a-18a205a96d6f_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impaired Long-Lived Assets Held and Used, Asset Name [Domain]</link:label>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_label_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impaired Long-Lived Assets Held and Used, Asset Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:to="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-637d-7132-a9ef-1bdca201c444_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_CorporateClinicsMember_019b096a-6432-7ea2-9cb4-703ac854922a_terseLabel_en-US" xlink:label="lab_jynt_CorporateClinicsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate Clinics</link:label>
    <link:label id="lab_jynt_CorporateClinicsMember_label_en-US" xlink:label="lab_jynt_CorporateClinicsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Clinics [Member]</link:label>
    <link:label id="lab_jynt_CorporateClinicsMember_documentation_en-US" xlink:label="lab_jynt_CorporateClinicsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the corporate clinics segment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_CorporateClinicsMember" xlink:to="lab_jynt_CorporateClinicsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent_019b096a-64bb-711e-8650-768cac77be2a_terseLabel_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets (attributable to VIEs)</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent_label_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Tax Assets, Current</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent_documentation_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Tax Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent" xlink:to="lab_jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_019b096a-64bb-716b-a788-7d53cb854363_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_019b096a-64bb-7050-998c-6727fdcf130c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019b096a-637e-72cd-a4b1-6ee732f70ce8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_019b096a-6432-7c9a-97d0-f8d2fca12207_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title and Position [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title and Position [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019b096a-64bb-7d34-a711-38a705b82509_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_019b096a-6433-7600-b3a5-20b1a03a08e0_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage_019b096a-637d-7644-9b6d-0584cce047a9_terseLabel_en-US" xlink:label="lab_jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty sales generated by franchises percentage</link:label>
    <link:label id="lab_jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage_label_en-US" xlink:label="lab_jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Regional Developers, Royalty Sales Generated By Franchises, Percentage</link:label>
    <link:label id="lab_jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage_documentation_en-US" xlink:label="lab_jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the percentage of sales generated by franchised clinics in their region regional developers receive as royalties.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" xlink:href="jynt-20251231.xsd#jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" xlink:to="lab_jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_019b096a-637d-713f-aa19-63a6f2dafd30_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_019b096a-637e-7675-b82b-e63f4048a7e0_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019b096a-637e-7a0f-a946-e3f1490f370b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_019b096a-6432-7c60-b0a1-17a2984139f2_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding, weighted average remaining contractual life (in year)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_019b096a-6432-779e-aefb-88e7ded123ec_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Termination of line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Increase (Decrease), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:to="lab_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStores_019b096a-637e-7c67-a019-d806757574d1_periodStartLabel_en-US" xlink:label="lab_us-gaap_NumberOfStores" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Clinics open at beginning of year</link:label>
    <link:label id="lab_us-gaap_NumberOfStores_019b096a-637e-730c-8376-281c941f8cb2_periodEndLabel_en-US" xlink:label="lab_us-gaap_NumberOfStores" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Clinics in operation at the end of the year</link:label>
    <link:label id="lab_us-gaap_NumberOfStores_019b096a-637e-7c8d-9939-8e80b390d399_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStores" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of clinics</link:label>
    <link:label id="lab_us-gaap_NumberOfStores_label_en-US" xlink:label="lab_us-gaap_NumberOfStores" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Stores</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfStores"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStores" xlink:to="lab_us-gaap_NumberOfStores" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_019b096a-637e-76f8-9407-47cf607eecb9_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current liabilities (attributable to VIEs)</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationAlternativeCashFlowInformationAbstract_019c909c-ecc6-7dc3-b0f1-bb95e9bfb106_verboseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationAlternativeCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Significant operating and investing non-cash items</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationAlternativeCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationAlternativeCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Alternative Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAlternativeCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationAlternativeCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationAlternativeCashFlowInformationAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationAlternativeCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_019b096a-6432-7011-ace2-8c1d93d8c234_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net operating losses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_DevelopmentLineOfCreditMember_019b096a-64bb-7585-bf85-c46668d4bed1_terseLabel_en-US" xlink:label="lab_jynt_DevelopmentLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Development Line of Credit</link:label>
    <link:label id="lab_jynt_DevelopmentLineOfCreditMember_label_en-US" xlink:label="lab_jynt_DevelopmentLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Development Line of Credit [Member]</link:label>
    <link:label id="lab_jynt_DevelopmentLineOfCreditMember_documentation_en-US" xlink:label="lab_jynt_DevelopmentLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Development Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DevelopmentLineOfCreditMember" xlink:href="jynt-20251231.xsd#jynt_DevelopmentLineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_DevelopmentLineOfCreditMember" xlink:to="lab_jynt_DevelopmentLineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-6432-7284-91e9-8dd6eb73be49_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-6432-7dd2-a643-72d40d11e841_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-6432-7fa2-9de4-e159d2928b8e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019b096a-6432-718d-8754-f0fd902acce0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_019b096a-6432-70b9-a38c-61af365f9216_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-controlling Interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_019b096a-6433-760d-8f8a-5b9787716a05_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_019b096a-64bb-7deb-8b0a-bb60828df981_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advertising expense</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_019b096a-6432-716d-8fe7-43038f23ecc1_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_019b096a-6432-7ec4-8bfa-89d8ff1a8b29_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discontinued Operations, Sale of Assets</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operations, Disposed of by Sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_UpfrontRegionalDeveloperFeesCurrent_019b096a-637e-7674-93ec-451eb334ad64_terseLabel_en-US" xlink:label="lab_jynt_UpfrontRegionalDeveloperFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Upfront regional developer fees, current portion</link:label>
    <link:label id="lab_jynt_UpfrontRegionalDeveloperFeesCurrent_label_en-US" xlink:label="lab_jynt_UpfrontRegionalDeveloperFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Upfront Regional Developer Fees, Current</link:label>
    <link:label id="lab_jynt_UpfrontRegionalDeveloperFeesCurrent_documentation_en-US" xlink:label="lab_jynt_UpfrontRegionalDeveloperFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Upfront Regional Developer Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_UpfrontRegionalDeveloperFeesCurrent" xlink:href="jynt-20251231.xsd#jynt_UpfrontRegionalDeveloperFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_UpfrontRegionalDeveloperFeesCurrent" xlink:to="lab_jynt_UpfrontRegionalDeveloperFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_019b096a-637e-7233-ae4b-5b4c9220969d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_019b096a-6432-777f-9eb5-ba71ddcb1d29_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation expenses</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Settlement, Fee Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_019b096a-6433-7436-874d-ffbd30086ef6_negatedLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Revenue recognized that was included in the contract liability at the beginning of the year</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_019b096a-6433-79fe-bbb7-708d5232274d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payroll liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_019b096a-6432-7f57-887f-304b166fa234_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Reconciliation of Accounts Receivable Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_AssetsHeldForSaleMeasurementInputPositiveCashFlow_019c6619-ce73-7c5a-a8b6-b67f67599222_terseLabel_en-US" xlink:label="lab_jynt_AssetsHeldForSaleMeasurementInputPositiveCashFlow" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets, held-for-sale, measurement input, positive cash flow</link:label>
    <link:label id="lab_jynt_AssetsHeldForSaleMeasurementInputPositiveCashFlow_label_en-US" xlink:label="lab_jynt_AssetsHeldForSaleMeasurementInputPositiveCashFlow" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Held-For-Sale, Measurement Input, Positive Cash Flow</link:label>
    <link:label id="lab_jynt_AssetsHeldForSaleMeasurementInputPositiveCashFlow_documentation_en-US" xlink:label="lab_jynt_AssetsHeldForSaleMeasurementInputPositiveCashFlow" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Assets, Held-For-Sale, Measurement Input, Positive Cash Flow</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AssetsHeldForSaleMeasurementInputPositiveCashFlow" xlink:href="jynt-20251231.xsd#jynt_AssetsHeldForSaleMeasurementInputPositiveCashFlow"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_AssetsHeldForSaleMeasurementInputPositiveCashFlow" xlink:to="lab_jynt_AssetsHeldForSaleMeasurementInputPositiveCashFlow" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount_019c666d-481a-7fd1-87b2-3088b126b3a6_terseLabel_en-US" xlink:label="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payroll tax penalty</link:label>
    <link:label id="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount_label_en-US" xlink:label="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Payroll Tax Penalty, Amount</link:label>
    <link:label id="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount_documentation_en-US" xlink:label="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Payroll Tax Penalty, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount" xlink:href="jynt-20251231.xsd#jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount" xlink:to="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_019b096a-64bb-7cee-8e12-afc33b3443f3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_019b096a-64bb-77c5-82f6-9c81aaf86683_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_019b096a-6432-71a3-99b5-4e87a6cc78b8_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract_019b096a-64bb-7470-afc6-6df2fbc7ab58_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discontinued operations:</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_RevenueRecognitionFranchiseAgreementTerm_019b096a-6432-74e8-8ff7-496574f97ba8_terseLabel_en-US" xlink:label="lab_jynt_RevenueRecognitionFranchiseAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Franchise agreement term</link:label>
    <link:label id="lab_jynt_RevenueRecognitionFranchiseAgreementTerm_label_en-US" xlink:label="lab_jynt_RevenueRecognitionFranchiseAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Recognition, Franchise Agreement, Term</link:label>
    <link:label id="lab_jynt_RevenueRecognitionFranchiseAgreementTerm_documentation_en-US" xlink:label="lab_jynt_RevenueRecognitionFranchiseAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue Recognition, Franchise Agreement, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_RevenueRecognitionFranchiseAgreementTerm" xlink:href="jynt-20251231.xsd#jynt_RevenueRecognitionFranchiseAgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_RevenueRecognitionFranchiseAgreementTerm" xlink:to="lab_jynt_RevenueRecognitionFranchiseAgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_019b096a-6432-7d87-a610-88fdc0f4b605_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling and marketing expenses</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_019b096a-6432-71fe-b283-3b8ce36a181f_netLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Selling and marketing expenses</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_019b096a-6432-7893-b0b6-1e5d9e4469b3_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Selling and marketing expenses</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_019b096a-6432-7b16-9e20-5bc231488088_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_OperatingLeaseRightOfUseAssetMember_019b096a-6432-77b1-a248-24512ca7a358_terseLabel_en-US" xlink:label="lab_jynt_OperatingLeaseRightOfUseAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use asset</link:label>
    <link:label id="lab_jynt_OperatingLeaseRightOfUseAssetMember_label_en-US" xlink:label="lab_jynt_OperatingLeaseRightOfUseAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-Of-Use Asset [Member]</link:label>
    <link:label id="lab_jynt_OperatingLeaseRightOfUseAssetMember_documentation_en-US" xlink:label="lab_jynt_OperatingLeaseRightOfUseAssetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-Of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_OperatingLeaseRightOfUseAssetMember" xlink:href="jynt-20251231.xsd#jynt_OperatingLeaseRightOfUseAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_OperatingLeaseRightOfUseAssetMember" xlink:to="lab_jynt_OperatingLeaseRightOfUseAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyMember_019b096a-6432-7cf7-b3b2-c83b6fc7ba39_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty fees</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyMember" xlink:to="lab_us-gaap_RoyaltyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-6432-7c03-9903-1c763465bb56_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-6432-7e6b-8310-ed012c05b2f7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_019b096a-64bb-7cd6-bb82-327eafd33b58_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other nontaxable or nondeductible items</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercentAbstract_019cb99a-3842-751b-b19d-7987baf25de7_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other adjustments:</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercentAbstract_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercentAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_019b096a-6432-72d7-a73e-0c537761dbd4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_019b096a-637d-7331-b24e-c06a7480e6cb_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_ExecutedLettersOfIntentForFutureClinicLicenses_019b096a-6432-7739-86df-dc24cdd20ef2_terseLabel_en-US" xlink:label="lab_jynt_ExecutedLettersOfIntentForFutureClinicLicenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executed letters of intent for future clinic licenses</link:label>
    <link:label id="lab_jynt_ExecutedLettersOfIntentForFutureClinicLicenses_label_en-US" xlink:label="lab_jynt_ExecutedLettersOfIntentForFutureClinicLicenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executed Letters Of Intent For Future Clinic Licenses</link:label>
    <link:label id="lab_jynt_ExecutedLettersOfIntentForFutureClinicLicenses_documentation_en-US" xlink:label="lab_jynt_ExecutedLettersOfIntentForFutureClinicLicenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of future clinic's licenses that have an executed letter of intent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ExecutedLettersOfIntentForFutureClinicLicenses" xlink:href="jynt-20251231.xsd#jynt_ExecutedLettersOfIntentForFutureClinicLicenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_ExecutedLettersOfIntentForFutureClinicLicenses" xlink:to="lab_jynt_ExecutedLettersOfIntentForFutureClinicLicenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FranchisedUnitsMember_019b096a-6432-7b9e-8965-da7afa5f84cd_terseLabel_en-US" xlink:label="lab_us-gaap_FranchisedUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Franchised Clinics</link:label>
    <link:label id="lab_us-gaap_FranchisedUnitsMember_label_en-US" xlink:label="lab_us-gaap_FranchisedUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchised Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisedUnitsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisedUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FranchisedUnitsMember" xlink:to="lab_us-gaap_FranchisedUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_019b096a-64bb-7abb-b2f2-cdccf0584801_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repayment of Debt under the Credit Agreement</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_019b096a-6433-7b12-bfcb-0c45e955579a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_019b096a-6432-7880-a536-dc2573864c90_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_019b096a-64bb-7240-b05a-546d18f82f6a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDiscontinuedOperationsMember_019b096a-6433-706c-bc43-68257ee3e98c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_SegmentDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDiscontinuedOperationsMember" xlink:to="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_019b096a-64bb-702e-a720-abb0fb3edcb1_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Goodwill - component 1</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_019b096a-637d-72c3-a7d7-48d32343d571_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_019b096a-64bb-79e0-b20a-bfb4f2aec414_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FranchisorDisclosureDomain_019b096a-6433-78e8-a124-a7973d859df2_terseLabel_en-US" xlink:label="lab_us-gaap_FranchisorDisclosureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Franchisor Disclosure [Domain]</link:label>
    <link:label id="lab_us-gaap_FranchisorDisclosureDomain_label_en-US" xlink:label="lab_us-gaap_FranchisorDisclosureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchisor Disclosure [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisorDisclosureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisorDisclosureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FranchisorDisclosureDomain" xlink:to="lab_us-gaap_FranchisorDisclosureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019b096a-6432-718f-bd4a-8151738b9010_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019b096a-6432-7329-9cbb-f4d49acd0db8_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_019b096a-6432-7adf-9d21-7a7644137683_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of stock options vested</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment_019b096a-6433-7588-949c-f5073bfa1a63_terseLabel_en-US" xlink:label="lab_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment_019b096a-6433-71ed-a0db-aa5e09e4d3b1_verboseLabel_en-US" xlink:label="lab_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Carrying value of impaired asset before impairment</link:label>
    <link:label id="lab_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment_label_en-US" xlink:label="lab_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impaired Long-Lived Assets Held And Used, Carrying Value Before Impairment</link:label>
    <link:label id="lab_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment_documentation_en-US" xlink:label="lab_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Impaired Long-Lived Assets Held And Used, Carrying Value Before Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment" xlink:href="jynt-20251231.xsd#jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment" xlink:to="lab_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMember_019b096a-6432-73fb-ac98-55d91624026e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMember" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_019b096a-637d-7899-9865-47018c3b2013_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_019b096a-637d-7ba8-9ccb-d3d263a0bbbd_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series A preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_019b096a-637e-79a6-8443-e8622a759cff_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State, net of state tax credits</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract_019b096a-6433-7019-9157-3adf8b5f17e5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income (loss) from discontinued operations per common share:</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract_019b096a-6433-794a-ba7d-570dba0e0893_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income (loss) from discontinued operations per common share:</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_019b096a-6432-7064-81fa-82c200588673_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_019b096a-64bb-709a-bbb4-59f719ecb0bf_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_019b096a-6432-7bbd-9cd7-c3ea2a4ba7fd_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019b332c-b9ff-7e55-baf6-4e9dc12e382b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_019b096a-6432-724f-b557-a5d73bf59c9d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_019b096a-6433-790f-9bca-d3387a264be9_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for credit losses on accounts receivable</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_019b096a-6433-7968-a82a-0cabd5dcc6b4_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_019b096a-6433-74fa-ad3f-04cff6d12f7b_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_019b096a-6433-7655-9dda-1b433f0e291d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_019b096a-637d-7f0d-9809-91b4576043ed_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable, weighted average remaining contractual life (in year)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_ManagementAgreementNumberOfProfessionalCorporations_019b096a-637d-7e6e-95bf-bce1bd41d7ab_terseLabel_en-US" xlink:label="lab_jynt_ManagementAgreementNumberOfProfessionalCorporations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of agreements with PCs</link:label>
    <link:label id="lab_jynt_ManagementAgreementNumberOfProfessionalCorporations_label_en-US" xlink:label="lab_jynt_ManagementAgreementNumberOfProfessionalCorporations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Management Agreement, Number Of Professional Corporations</link:label>
    <link:label id="lab_jynt_ManagementAgreementNumberOfProfessionalCorporations_documentation_en-US" xlink:label="lab_jynt_ManagementAgreementNumberOfProfessionalCorporations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Management Agreement, Number Of Professional Corporations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ManagementAgreementNumberOfProfessionalCorporations" xlink:href="jynt-20251231.xsd#jynt_ManagementAgreementNumberOfProfessionalCorporations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_ManagementAgreementNumberOfProfessionalCorporations" xlink:to="lab_jynt_ManagementAgreementNumberOfProfessionalCorporations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019b096a-64bb-7fa4-afc8-ccdd360162f0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_019b096a-6432-7ff3-9281-533319f38b38_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_019b096a-6432-7b1e-bc96-08c840657b56_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance, beginning</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_019b096a-6432-780d-9958-24ca48a8bb84_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance, ending</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_019b3338-b6e2-7a33-9cc1-4bc9dd5be7ac_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Average cost of stock repurchased (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract_019b096a-6432-7634-8a33-58ca58895578_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income from continuing operations per common share</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_019b096a-6433-71b2-8f87-bc7cb94dd7e3_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_019b096a-637e-7c3a-a829-fb343abfc699_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_019b096a-637e-73a8-a84a-6e453f45ad3b_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_019b096a-6432-77a3-b46f-0beab2951301_verboseLabel_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Office and computer equipment</link:label>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_label_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Office Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OfficeEquipmentMember" xlink:to="lab_us-gaap_OfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_019b096a-6432-7d7b-a47e-1db1e78482fd_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_019b096a-64bb-79b7-b0db-55c358b191ad_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_019b096a-637e-754f-ae1a-38e2a73b3aba_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent_019b096a-637e-776b-b015-a77edf2ce03c_terseLabel_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use asset</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent_label_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease, Right-of-Use Asset, Current</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent_documentation_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease, Right-of-Use Asset, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent" xlink:to="lab_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StockRepurchaseProgramAuthorizedAmount1_019b3338-b6e2-766f-9c49-d8e3c72e2d94_terseLabel_en-US" xlink:label="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase amount authorized</link:label>
    <link:label id="lab_srt_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Authorized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_ClinicsOpenedDuringThePeriod_019b096a-6432-74de-9509-6bf7a28dfc6a_terseLabel_en-US" xlink:label="lab_jynt_ClinicsOpenedDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Opened during the year</link:label>
    <link:label id="lab_jynt_ClinicsOpenedDuringThePeriod_label_en-US" xlink:label="lab_jynt_ClinicsOpenedDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Clinics Opened during the period</link:label>
    <link:label id="lab_jynt_ClinicsOpenedDuringThePeriod_documentation_en-US" xlink:label="lab_jynt_ClinicsOpenedDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the number of number of clinics opened during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ClinicsOpenedDuringThePeriod" xlink:href="jynt-20251231.xsd#jynt_ClinicsOpenedDuringThePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_ClinicsOpenedDuringThePeriod" xlink:to="lab_jynt_ClinicsOpenedDuringThePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_019b096a-6432-74a4-af27-e539b885140e_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-637d-7532-931e-52028b05db02_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_019b096a-637e-728f-97e6-94266e5598bf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_019b32bd-fb42-7896-bfd9-a5b1fb0c578d_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of treasury stock under employee stock plans</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b096a-6432-7fa0-be13-c42518bcf541_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income (loss) from discontinued operations before income tax expense</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b096a-6432-73e2-a2a2-54d80646d2d8_netLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Income from discontinued operations before income tax expense</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b096a-6432-7c95-9f86-4b3711f98e6f_totalLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income (loss) before income tax expense</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b096a-6432-7c1f-94b2-111116b9223a_verboseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income (loss) from discontinued operations before income tax expense</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_019b096a-6432-7aa4-a087-5ed3dc577219_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_019b096a-637e-78a6-8f9a-16c1ad1dae6e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Remaining Contractual Life</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_MrJeffersonGrammMember_019b096a-6432-7dd0-bc0c-279c50bf81db_terseLabel_en-US" xlink:label="lab_jynt_MrJeffersonGrammMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Mr Jefferson Gramm</link:label>
    <link:label id="lab_jynt_MrJeffersonGrammMember_label_en-US" xlink:label="lab_jynt_MrJeffersonGrammMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mr Jefferson Gramm [Member]</link:label>
    <link:label id="lab_jynt_MrJeffersonGrammMember_documentation_en-US" xlink:label="lab_jynt_MrJeffersonGrammMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Mr Jefferson Gramm</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_MrJeffersonGrammMember" xlink:href="jynt-20251231.xsd#jynt_MrJeffersonGrammMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_MrJeffersonGrammMember" xlink:to="lab_jynt_MrJeffersonGrammMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_DisposalGroupHeldForSaleClinicsExpectedToSellPeriod_019b096a-6433-7afa-8e69-4f1ca703d1b0_terseLabel_en-US" xlink:label="lab_jynt_DisposalGroupHeldForSaleClinicsExpectedToSellPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Clinics expected to sell, period</link:label>
    <link:label id="lab_jynt_DisposalGroupHeldForSaleClinicsExpectedToSellPeriod_label_en-US" xlink:label="lab_jynt_DisposalGroupHeldForSaleClinicsExpectedToSellPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Held-for-Sale, Clinics Expected To Sell, Period</link:label>
    <link:label id="lab_jynt_DisposalGroupHeldForSaleClinicsExpectedToSellPeriod_documentation_en-US" xlink:label="lab_jynt_DisposalGroupHeldForSaleClinicsExpectedToSellPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Held-for-Sale, Clinics Expected To Sell, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupHeldForSaleClinicsExpectedToSellPeriod" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupHeldForSaleClinicsExpectedToSellPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_DisposalGroupHeldForSaleClinicsExpectedToSellPeriod" xlink:to="lab_jynt_DisposalGroupHeldForSaleClinicsExpectedToSellPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_019b096a-64bb-7ed3-968e-d21346569d98_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt under credit agreement</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_019b332c-b9ff-79ca-b885-a88838512a15_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward_019b096a-6432-7e02-9457-f26cda65a799_terseLabel_en-US" xlink:label="lab_jynt_AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Net</link:label>
    <link:label id="lab_jynt_AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward_label_en-US" xlink:label="lab_jynt_AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current [Roll Forward]</link:label>
    <link:label id="lab_jynt_AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward_documentation_en-US" xlink:label="lab_jynt_AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward" xlink:href="jynt-20251231.xsd#jynt_AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward" xlink:to="lab_jynt_AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_019b096a-6432-7d8f-a7f0-73a10e0d3a9e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019b096a-637d-7487-985d-ad09204eac55_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_019b096a-637e-7472-93ce-d3cc28a1c0d7_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income (loss) per common share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_019b096a-6432-7254-8b30-332ab0529951_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_019b096a-6432-732d-81a5-4cc491dbf716_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_019b096a-6432-75e5-987b-c7536c57b67e_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_LeasesWeightedAverageDiscountRateAbstract_019b096a-6433-7b43-83f9-95ddc9472682_terseLabel_en-US" xlink:label="lab_jynt_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average discount rate:</link:label>
    <link:label id="lab_jynt_LeasesWeightedAverageDiscountRateAbstract_label_en-US" xlink:label="lab_jynt_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases, Weighted Average Discount Rate [Abstract]</link:label>
    <link:label id="lab_jynt_LeasesWeightedAverageDiscountRateAbstract_documentation_en-US" xlink:label="lab_jynt_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Leases, Weighted Average Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_LeasesWeightedAverageDiscountRateAbstract" xlink:href="jynt-20251231.xsd#jynt_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_LeasesWeightedAverageDiscountRateAbstract" xlink:to="lab_jynt_LeasesWeightedAverageDiscountRateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_019b096a-64bb-7d12-9cb4-8857b3e1f527_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_019b096a-64bb-732e-b03a-0f715a0933b3_periodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance, beginning treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_019b096a-64bb-7a1d-9910-948bdf97de7c_periodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance, ending treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPaidStateAndLocalAfterRefundReceived_019c6697-2ef4-7998-a94f-aaec1482677d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPaidStateAndLocalAfterRefundReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State:</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPaidStateAndLocalAfterRefundReceived_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPaidStateAndLocalAfterRefundReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Paid, State and Local, after Refund Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPaidStateAndLocalAfterRefundReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPaidStateAndLocalAfterRefundReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPaidStateAndLocalAfterRefundReceived" xlink:to="lab_us-gaap_IncomeTaxPaidStateAndLocalAfterRefundReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-6432-7566-8d6c-b457323f20b9_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income (loss) from discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-6432-72e9-b9c0-319e4325e3c4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income (loss) from discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-6432-7f6f-8b79-c0fa2f4bed26_netLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Net income (loss) from discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_019b096a-637e-7a8f-8ccb-bd17916a87f0_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_019b096a-637e-7990-82d4-03fc8cd1bf7d_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_019b096a-6432-77c7-9b80-8be36a2a80e4_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Domestic Tax Jurisdiction</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Domestic Tax Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_019b096a-64bb-7cdd-a630-37a363c056d6_terseLabel_en-US" xlink:label="lab_jynt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash transactions: ROU assets obtained in exchange for lease liabilities</link:label>
    <link:label id="lab_jynt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_label_en-US" xlink:label="lab_jynt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Lease Liability [Abstract]</link:label>
    <link:label id="lab_jynt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_documentation_en-US" xlink:label="lab_jynt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:href="jynt-20251231.xsd#jynt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:to="lab_jynt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019b096a-64bb-7ebd-a779-cddf6b12f3c0_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: Imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses_019b096a-6432-7fa8-9163-72f4d33b16fb_totalLabel_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total selling, general and administrative expenses</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses_label_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Selling, General And Administrative Expenses</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses_documentation_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Selling, General And Administrative Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses" xlink:to="lab_jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_019b096a-64bb-781d-997c-e9c9d4cff753_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_019b096a-637d-769f-af0d-172db7622028_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other nontaxable or nondeductible items</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_019b096a-6432-796c-b9c0-4b30ef92893d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_019c6699-e6df-7042-b972-3b6640bf359d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income taxes paid (net of refunds received)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-6432-718f-b8be-712e7b6a9cc4_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discontinued operations current assets ($1.0 million and $1.1 million attributable to VIEs, respectively)</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-6432-7054-b0b3-c68a3e31a48f_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Discontinued operations current assets</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-6432-783f-a183-c5a2afd80ffd_netLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-6432-7815-995d-1b572b2cbd9d_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019b096a-637e-74ca-abd5-ce9a32e6b010_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted at market price, weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_019b096a-6432-72d8-aeae-e674b41e6cde_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_019b096a-64bb-7243-a3e5-16eb5e8e257a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payroll liabilities</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_019b096a-6432-7407-b8eb-4a49b825bccd_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019b096a-6433-7ecc-a2c8-9c0d31d0fc68_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_019b096a-6432-7d10-af1b-8d5c1494fc5b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_019b096a-6432-769a-8227-c76e19b73fbf_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of related party transaction</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Amounts of Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductInformationLineItems_019b096a-637d-7d52-ade6-eec923f240ea_terseLabel_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductInformationLineItems_label_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductInformationLineItems" xlink:to="lab_us-gaap_ProductInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_019b096a-637e-7e21-b307-4aa17c173259_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_019b096a-637e-76d2-94f4-c5fa3f64df50_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract_019b096a-6432-7436-9f4a-7fe1a9291f61_terseLabel_en-US" xlink:label="lab_jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income from continuing operations per common share:</link:label>
    <link:label id="lab_jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract_label_en-US" xlink:label="lab_jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share [Abstract]</link:label>
    <link:label id="lab_jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract_documentation_en-US" xlink:label="lab_jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract" xlink:href="jynt-20251231.xsd#jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract" xlink:to="lab_jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_019b096a-64bb-7253-94a3-0d26c486dafd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_019b096a-637e-7615-a5e0-9a2f3de21940_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_019b096a-637d-7f74-bd95-82a698536ede_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_019b096a-6433-7c96-b240-312e6d46b621_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected federal tax expense at U.S. federal statutory rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_019b096a-6432-7431-8315-b4620a13ad9c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_019b096a-64bb-7cd4-b4bd-0c2bc0e329b4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_019b096a-637e-7df8-acf0-1b18fa669536_negatedLabel_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_label_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Income (Expense)</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_documentation_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:to="lab_jynt_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_019c666a-b0bd-7bcd-9927-9182bf7b142d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share based compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_019b096a-6432-784a-a85d-3385880f1b3e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State and local income taxes (net of federal income tax effect)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_019b096a-6432-780d-ab67-ffc495ce59fd_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold_019c8ac9-7581-7bb2-9204-8caca19aa915_terseLabel_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities sold that were previously classified as held for sale</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold_label_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities Held For Sale, Sold</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold_documentation_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities Held For Sale, Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold" xlink:to="lab_jynt_DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019b096a-6433-7071-9ef8-25e75130c421_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected term (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019b096a-6432-711f-91ff-9a8213f8ad24_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019b096a-637e-77bf-a4d2-81ed429287e5_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss on disposition or impairment from discontinued operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019b096a-637e-726a-b112-67f5bc209fad_verboseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss on disposition or impairment related to discontinued operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019b096a-637e-7d96-a3f9-dad411ce2f10_netLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Net loss on disposition or impairment</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Provision for Loss (Gain) on Disposal, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_019b096a-64bb-783a-b840-210a2289a186_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Rollforward of Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019b096a-6433-77e6-b627-102cc31a8e26_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Grant-Date Fair Value per Award</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019c8ad7-2467-77c6-a392-b5e751a0db6e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock available for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019b096a-6432-7893-a512-0a28f4c692e6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average grant-date fair value for options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_019b096a-6432-7d28-9ce5-85d26310d58a_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_019b096a-637d-7fa1-b25d-b3395e4f65c4_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_019b096a-637d-75e2-b148-24456f69fb60_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_019b096a-637d-7c0d-883f-099c46a2a2d2_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019b096a-6433-794c-8604-b81c29e4c4e1_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_019b096a-637d-7d50-a3f0-ba01b27ca4d5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_019b096a-6432-798f-ae93-95852055df63_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_019b096a-64bb-7a98-bdcf-5b7a3d7e196a_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_GuarantorObligationsRemainingExposureUndiscounted_019b096a-64bb-745e-a268-86da8745b73b_terseLabel_en-US" xlink:label="lab_jynt_GuarantorObligationsRemainingExposureUndiscounted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Guarantor obligations, remaining exposure, undiscounted</link:label>
    <link:label id="lab_jynt_GuarantorObligationsRemainingExposureUndiscounted_label_en-US" xlink:label="lab_jynt_GuarantorObligationsRemainingExposureUndiscounted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Guarantor Obligations, Remaining Exposure, Undiscounted</link:label>
    <link:label id="lab_jynt_GuarantorObligationsRemainingExposureUndiscounted_documentation_en-US" xlink:label="lab_jynt_GuarantorObligationsRemainingExposureUndiscounted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Guarantor Obligations, Remaining Exposure, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_GuarantorObligationsRemainingExposureUndiscounted" xlink:href="jynt-20251231.xsd#jynt_GuarantorObligationsRemainingExposureUndiscounted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_GuarantorObligationsRemainingExposureUndiscounted" xlink:to="lab_jynt_GuarantorObligationsRemainingExposureUndiscounted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_019b096a-64bb-7d15-8204-89c0b7ea0b75_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_019c8abb-42be-7efe-a366-aa5524c16937_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of restricted stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_019b3338-b6e2-783d-ad88-3fbf960e4cb4_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Authorized amount remaining for repurchasing shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Remaining Authorized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_019b096a-6432-7907-8e90-a74d3a126b35_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenues</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Product and Service Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_019b096a-637e-790a-a0f9-d7e5704395ba_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_019b096a-64bb-7967-af29-bc9d270b4832_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discontinued Operations, Disposal Other than Sale By Sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operations, Disposed of by Means Other than Sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_019b096a-6433-745e-bd11-f3d11faa26b1_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_019b096a-64bb-744f-93c4-94eda2c89c4d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_019b096a-6432-7f9e-80d8-ac77eb329d48_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_019b096a-64bb-7972-a80d-bf109c553a6e_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_019b096a-6432-7753-8407-afdbd7e0443a_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation Technique, Discounted Cash Flow</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:to="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_019b096a-6432-76f5-98a4-28785df6e10d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Variable Interest Entities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019b096a-64bb-7cfa-8caf-bad1919a2aaa_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding, weighted average exercise price, beginning (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019b096a-64bb-7673-8cd1-6fff00f57d09_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding, weighted average exercise price, ending (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_NetGainLossOnDispositionOfAssetsOrAssetImpairment_019b096a-6432-73bd-b5e8-5b592979e321_negatedTerseLabel_en-US" xlink:label="lab_jynt_NetGainLossOnDispositionOfAssetsOrAssetImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net loss on disposition or impairment</link:label>
    <link:label id="lab_jynt_NetGainLossOnDispositionOfAssetsOrAssetImpairment_label_en-US" xlink:label="lab_jynt_NetGainLossOnDispositionOfAssetsOrAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Gain (Loss) On Disposition Of Assets Or Asset Impairment</link:label>
    <link:label id="lab_jynt_NetGainLossOnDispositionOfAssetsOrAssetImpairment_documentation_en-US" xlink:label="lab_jynt_NetGainLossOnDispositionOfAssetsOrAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net Gain (Loss) On Disposition Of Assets Or Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_NetGainLossOnDispositionOfAssetsOrAssetImpairment" xlink:href="jynt-20251231.xsd#jynt_NetGainLossOnDispositionOfAssetsOrAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_NetGainLossOnDispositionOfAssetsOrAssetImpairment" xlink:to="lab_jynt_NetGainLossOnDispositionOfAssetsOrAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_019b096a-6432-76ec-beb8-2735b84db5a2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_019b096a-637e-7750-8614-08f26c625f6a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_019b096a-6432-7f6e-9857-1d7a75e2d1b6_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current expense:</link:label>
    <link:label id="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Federal, State and Local, Tax Expense (Benefit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock_019b096a-6432-74b9-80fb-d7396946bf48_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Franchisor Disclosure</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Franchisor Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_019b096a-6433-798a-84d5-2c9be7077cdd_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_ManagementAgreementTerminationNumberOfProfessionalCorporations_019c65ca-fa2e-73df-a9f8-784cc90289d3_terseLabel_en-US" xlink:label="lab_jynt_ManagementAgreementTerminationNumberOfProfessionalCorporations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of professional corporations with management agreements terminated</link:label>
    <link:label id="lab_jynt_ManagementAgreementTerminationNumberOfProfessionalCorporations_label_en-US" xlink:label="lab_jynt_ManagementAgreementTerminationNumberOfProfessionalCorporations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Management Agreement, Termination, Number Of Professional Corporations</link:label>
    <link:label id="lab_jynt_ManagementAgreementTerminationNumberOfProfessionalCorporations_documentation_en-US" xlink:label="lab_jynt_ManagementAgreementTerminationNumberOfProfessionalCorporations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Management Agreement, Termination, Number Of Professional Corporations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ManagementAgreementTerminationNumberOfProfessionalCorporations" xlink:href="jynt-20251231.xsd#jynt_ManagementAgreementTerminationNumberOfProfessionalCorporations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_ManagementAgreementTerminationNumberOfProfessionalCorporations" xlink:to="lab_jynt_ManagementAgreementTerminationNumberOfProfessionalCorporations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_019b096a-6432-797c-b427-6969a83e553b_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_NumberOfClinics_019b096a-6433-74dc-9702-6914897c5b1c_terseLabel_en-US" xlink:label="lab_jynt_NumberOfClinics" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of clinics</link:label>
    <link:label id="lab_jynt_NumberOfClinics_label_en-US" xlink:label="lab_jynt_NumberOfClinics" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Clinics</link:label>
    <link:label id="lab_jynt_NumberOfClinics_documentation_en-US" xlink:label="lab_jynt_NumberOfClinics" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Clinics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_NumberOfClinics" xlink:href="jynt-20251231.xsd#jynt_NumberOfClinics"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_NumberOfClinics" xlink:to="lab_jynt_NumberOfClinics" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_019b096a-637e-7564-8652-f8326e25cb4c_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unpaid purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_019b096a-6433-7da7-a08f-e77dec00861d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_019b096a-64bb-7652-905b-006785aebec1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019b096a-6432-7aef-bfcc-1c7f5db80459_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_019b096a-6433-7bcd-839d-fbe658b00654_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_019b096a-6433-7c5f-9ea4-1d8dd1c6e350_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchMember_019b096a-6432-757c-bcc3-d8888009ccf6_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research Tax Credit Carryforward</link:label>
    <link:label id="lab_us-gaap_ResearchMember_label_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research Tax Credit Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchMember" xlink:to="lab_us-gaap_ResearchMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_019b096a-64bb-78d2-952e-716b6c102682_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_019b096a-6432-759e-a169-5e880f19e127_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019b096a-6432-7352-9267-1915789f7a21_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">(Decrease) increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_019b096a-6432-7ace-b1cb-1c2c200748ae_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unvested restricted stock and stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_019b096a-64bb-774a-afd0-5c93e5d2e480_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_019b096a-6433-7b93-b69e-177bbba063cd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_019b096a-6433-7d2c-8a17-93486d1a67a9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average dilutive securities:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted, Other Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_019b096a-6432-7e9f-8f0f-5d46d9ff8ca2_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_019b096a-6432-7ade-bb3b-19e5007576dd_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_019b096a-637e-7ce6-9c02-f9a954ebd4fd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_019b096a-64bb-78cc-8be1-b00cebf148df_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_019b096a-637d-7404-85fb-6e4652df57b2_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Assets - Continuing Operations</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_019b096a-6432-79fe-ae8d-c0ebf84a0503_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic earnings (loss) per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_019b096a-64bb-7c28-9a71-c9a45c86d0a2_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_019b096a-6432-7c98-bc8d-ceb4f8c678af_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Impairment Losses and Disposal Gains and Losses Recorded in (Loss) Income from Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_019b096a-6432-766b-8997-a9cff96b4673_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_019b096a-6432-71b8-b0b0-403230fe4f0e_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred franchise and regional development costs, current portion</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_019b32b1-beb3-7e99-afd0-7c8382fa0dc0_negatedNetLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xml:lang="en-US">Purchases of treasury stock under employee stock plans</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_019b3338-b6e2-7028-89c5-0fadec610ad2_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock surrendered and netted as payment for minimum statutory withholding requirements</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_019b096a-6433-7233-9e2a-1735cb84b024_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income (loss) per common share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_019b096a-6432-7c97-81bd-460579791885_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_019b096a-64bb-7b2f-a5d4-9ab750c4b499_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_019b096a-6432-7d6e-98c4-070f4a020c01_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax benefit from exercise of stock options and restricted stock awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_019b096a-6433-7b4d-8b0c-a1932dd7af7f_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input, Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_019b096a-6432-7496-a349-d0c1e5254e9b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Total Revenue and Significant Expense Categories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_019b096a-6433-7ff2-beeb-2934011db8ea_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred expense (benefit):</link:label>
    <link:label id="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount_019c6669-4b72-7867-9420-fe61b442d92b_terseLabel_en-US" xlink:label="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Section 162(m) officer compensation</link:label>
    <link:label id="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount_label_en-US" xlink:label="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Officer Compensation, Amount</link:label>
    <link:label id="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount_documentation_en-US" xlink:label="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Officer Compensation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount" xlink:href="jynt-20251231.xsd#jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount" xlink:to="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_019b096a-64bb-733c-8336-a9cd475550e0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue expected to be recognized, amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_019b096a-6432-7cfd-b6f5-e06ce63071a8_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_019b096a-637e-7365-a148-378ab77f6b5c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impaired Long-Lived Asset, Held and Used [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impaired Long-Lived Asset, Held and Used [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:to="lab_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_019b096a-6432-7d5c-a74c-97bc31567ab6_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_019b096a-6432-759d-93ec-697ee7f1862f_verboseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Variable Interest Entity</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_019b096a-6433-72af-9fe8-332b2881144a_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_019b096a-6433-7328-b912-8b83527863f5_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stock compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_019b096a-6432-794d-80b8-69c4b7611e08_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_019b096a-6432-7edc-9649-caefb77281d5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_019b096a-64bb-75a4-9a0e-333e414c937a_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent_019c666e-08ac-74cb-8591-b47f237cc378_terseLabel_en-US" xlink:label="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payroll tax penalty</link:label>
    <link:label id="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent_label_en-US" xlink:label="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Payroll Tax Penalty, Percent</link:label>
    <link:label id="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent_documentation_en-US" xlink:label="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Payroll Tax Penalty, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent" xlink:href="jynt-20251231.xsd#jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent" xlink:to="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019b096a-6432-7d2f-b125-dec1bc6672e9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_MedicalInjuryClaimMember_019b096a-6432-7112-9f3b-820b1e7420c8_terseLabel_en-US" xlink:label="lab_jynt_MedicalInjuryClaimMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medical Injury Claim</link:label>
    <link:label id="lab_jynt_MedicalInjuryClaimMember_label_en-US" xlink:label="lab_jynt_MedicalInjuryClaimMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medical Injury Claim [Member]</link:label>
    <link:label id="lab_jynt_MedicalInjuryClaimMember_documentation_en-US" xlink:label="lab_jynt_MedicalInjuryClaimMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Medical Injury Claim</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_MedicalInjuryClaimMember" xlink:href="jynt-20251231.xsd#jynt_MedicalInjuryClaimMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_MedicalInjuryClaimMember" xlink:to="lab_jynt_MedicalInjuryClaimMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_019b096a-637e-7939-bd82-82415d89f7a1_negatedLabel_en-US" xlink:label="lab_jynt_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Lease ROU asset</link:label>
    <link:label id="lab_jynt_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_jynt_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Operating Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_jynt_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_jynt_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:href="jynt-20251231.xsd#jynt_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:to="lab_jynt_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_019b096a-637e-7609-a38e-834ed46dccd4_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_019b096a-64bb-712e-a8b7-0123330db138_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Maturities of Operating Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_019b096a-6433-7be5-8c3f-7d2f8687c330_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-6432-7bea-924d-d817d05178a8_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-6432-7f9c-996b-60c731732393_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-6432-7623-88bc-166823e7e458_netLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Net loss from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_019b096a-6432-75b0-a937-9f24c598e5ae_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Meals and entertainment</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_019b096a-6432-788f-b922-1c59a5f4a451_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_019b096a-64bb-7978-b25b-8a7ef6474013_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_019b096a-64bb-74e3-9e9b-3e356bbb5a95_netLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_019b096a-64bb-7e33-a8f2-46641be63d97_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_019b096a-6432-7646-bbc5-8fe5cef60c9f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued interest and penalties</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Examination, Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_019b096a-6432-71b7-884d-526ca672d957_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_019b096a-6433-7dee-b5bf-6ca5053f55e9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_019b096a-637d-7a6d-ad1b-4694935200e3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019b096a-6432-7555-95d7-6253d87182de_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_019c53a5-294f-7ad2-acb7-34a4156ea557_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt issuance costs incurred</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_019b096a-64bb-77df-8db9-af18a98723a7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expired, weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_019b096a-6433-7a13-a2c5-3b9bff3f6e58_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-6433-7a93-add5-2f7a5a7b4613_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_019c6638-88fa-7bd1-8656-be5b2fd17011_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Loss From Continuing Operations Before the Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_019b096a-637d-78d5-8ab6-fa35fd181116_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_DiscontinuedOperationsHeldForUseMember_019b096a-6432-7b6d-a447-1b07e0aafbab_terseLabel_en-US" xlink:label="lab_jynt_DiscontinuedOperationsHeldForUseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discontinued Operations, Held For Use</link:label>
    <link:label id="lab_jynt_DiscontinuedOperationsHeldForUseMember_label_en-US" xlink:label="lab_jynt_DiscontinuedOperationsHeldForUseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operations, Held For Use [Member]</link:label>
    <link:label id="lab_jynt_DiscontinuedOperationsHeldForUseMember_documentation_en-US" xlink:label="lab_jynt_DiscontinuedOperationsHeldForUseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Discontinued Operations, Held For Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DiscontinuedOperationsHeldForUseMember" xlink:href="jynt-20251231.xsd#jynt_DiscontinuedOperationsHeldForUseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_DiscontinuedOperationsHeldForUseMember" xlink:to="lab_jynt_DiscontinuedOperationsHeldForUseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_019b096a-64bb-716d-a74b-66abafb96a1e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_019b096a-6432-7483-b876-fbcc154466fa_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_ContractWithCustomerAssetRecognizedAsCostsOfRevenue_019b096a-6432-7cb3-9585-442ca196f84a_negatedLabel_en-US" xlink:label="lab_jynt_ContractWithCustomerAssetRecognizedAsCostsOfRevenue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Recognized as cost of revenue during the year</link:label>
    <link:label id="lab_jynt_ContractWithCustomerAssetRecognizedAsCostsOfRevenue_label_en-US" xlink:label="lab_jynt_ContractWithCustomerAssetRecognizedAsCostsOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract With Customer, Asset Recognized As Costs Of Revenue</link:label>
    <link:label id="lab_jynt_ContractWithCustomerAssetRecognizedAsCostsOfRevenue_documentation_en-US" xlink:label="lab_jynt_ContractWithCustomerAssetRecognizedAsCostsOfRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the amount recognized as costs of revenue during the period related to contracts with customers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ContractWithCustomerAssetRecognizedAsCostsOfRevenue" xlink:href="jynt-20251231.xsd#jynt_ContractWithCustomerAssetRecognizedAsCostsOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_ContractWithCustomerAssetRecognizedAsCostsOfRevenue" xlink:to="lab_jynt_ContractWithCustomerAssetRecognizedAsCostsOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_019b096a-6432-737e-8703-328888db62dc_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_019b096a-6433-7cde-90ed-5efe02671033_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_019b096a-6433-79fc-b6c4-5b1bdcbde46f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_019b096a-6432-7f20-b3b9-0932b00fe05c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_019c65ca-fa2e-7cd5-a5fb-1b2bebdf96ab_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_019b096a-6433-7a48-b7c1-1d462f9e65eb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019b096a-6433-70e3-8d29-d0dc05fea567_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_019b096a-637e-7168-8298-9aa1af993332_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nature of Operations and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_019b096a-6432-7f8d-9a02-d260af5ea90c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other segment items, net</link:label>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_label_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Other Segment Item, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:to="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_019b096a-637d-7863-99a6-fc67fce43993_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_019b096a-6432-7a2c-aab6-7aa8ee294d52_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss on disposition or impairment related to continuing operations</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_019b096a-64bb-756c-9e48-e4b02f166a69_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_019b096a-6432-7e13-8b88-feea6a32bfdc_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_019b096a-637e-78f9-a4a9-2e5883cd7ed7_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_019b096a-6433-753b-892e-3387bc2e2857_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_019b096a-6432-7768-848c-71dcb30e98e1_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_019b096a-6433-7d0b-b817-78575dc49ea6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State and local income taxes (net of federal income tax effect)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_019b096a-64bb-702e-91a5-94cc0b78de2a_terseLabel_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance in discontinued operations current assets</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_019b3318-486b-75ec-bd97-9b273b5a6ac2_verboseLabel_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_019b096a-64bb-798d-a04e-032dd7bd44f3_negatedTerseLabel_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_label_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Valuation Allowance, Current</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_documentation_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Valuation Allowance, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" xlink:to="lab_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock_019b096a-637e-7a46-bd85-ca9d5098f8a6_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operations, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:to="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_019b096a-6433-7ef5-8df8-f91c2e8d0260_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_DeferredTaxAssetsGoodwillComponent1_019c6641-9572-7606-9c76-ccf5575cc26b_terseLabel_en-US" xlink:label="lab_jynt_DeferredTaxAssetsGoodwillComponent1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill - component 1</link:label>
    <link:label id="lab_jynt_DeferredTaxAssetsGoodwillComponent1_label_en-US" xlink:label="lab_jynt_DeferredTaxAssetsGoodwillComponent1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Goodwill - Component 1</link:label>
    <link:label id="lab_jynt_DeferredTaxAssetsGoodwillComponent1_documentation_en-US" xlink:label="lab_jynt_DeferredTaxAssetsGoodwillComponent1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Goodwill - Component 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DeferredTaxAssetsGoodwillComponent1" xlink:href="jynt-20251231.xsd#jynt_DeferredTaxAssetsGoodwillComponent1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_DeferredTaxAssetsGoodwillComponent1" xlink:to="lab_jynt_DeferredTaxAssetsGoodwillComponent1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_019b096a-6433-745e-99f2-3e3b996240a1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_019b096a-637e-704d-903b-a54d89e60987_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash investing and financing activity:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems_019c6696-ab89-704d-92dd-b6fc17020509_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Paid, by Individual Jurisdiction [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Paid, by Individual Jurisdiction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems" xlink:to="lab_us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_019c90ae-93eb-74c4-a1d2-c165b85ffbc7_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019b096a-6432-7e5a-b7f2-5e136b38b434_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_019b096a-6433-76e6-916b-0fca837703ae_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in valuation allowances</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_019b096a-637e-72fb-9311-16f301d69738_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Fixed assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_019b096a-637e-7e71-a19d-c4a8c649de6f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_019b096a-6432-7d2a-a31c-201f7516a80d_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_019b096a-637e-7c80-9c05-a62a8393bdb4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_DeferredTaxAssetsGoodwillComponent2_019b096a-637d-7a36-ad90-fa16efa2380b_terseLabel_en-US" xlink:label="lab_jynt_DeferredTaxAssetsGoodwillComponent2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill - component 2</link:label>
    <link:label id="lab_jynt_DeferredTaxAssetsGoodwillComponent2_label_en-US" xlink:label="lab_jynt_DeferredTaxAssetsGoodwillComponent2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Goodwill - Component 2</link:label>
    <link:label id="lab_jynt_DeferredTaxAssetsGoodwillComponent2_documentation_en-US" xlink:label="lab_jynt_DeferredTaxAssetsGoodwillComponent2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to the difference between the book value and the taxable value of goodwill.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DeferredTaxAssetsGoodwillComponent2" xlink:href="jynt-20251231.xsd#jynt_DeferredTaxAssetsGoodwillComponent2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_DeferredTaxAssetsGoodwillComponent2" xlink:to="lab_jynt_DeferredTaxAssetsGoodwillComponent2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_019b096a-6432-75bc-b9a3-6da2b717c74b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Quarterly Financial Data</link:label>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019b096a-64bb-7f12-b578-ec0893448892_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019b096a-64bb-7369-adf0-9ff6fe7fb4f8_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019b096a-64bb-7c3c-9b4f-e9fc93bafc95_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_019b096a-64bb-7dfd-8bad-5f2e408a65a3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_LesseeOperatingLeaseNumberOfRenewalOptions_019b096a-637d-7821-b441-bdb6890f4b81_terseLabel_en-US" xlink:label="lab_jynt_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of lease renewal options</link:label>
    <link:label id="lab_jynt_LesseeOperatingLeaseNumberOfRenewalOptions_label_en-US" xlink:label="lab_jynt_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Options</link:label>
    <link:label id="lab_jynt_LesseeOperatingLeaseNumberOfRenewalOptions_documentation_en-US" xlink:label="lab_jynt_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:href="jynt-20251231.xsd#jynt_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:to="lab_jynt_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_019b096a-637e-709d-967a-1b9b6ad6681a_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_019b096a-637e-74ab-adae-04a43072fe93_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_019b096a-637e-7b63-8190-10aa3021420f_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_019b096a-6432-72bf-bd2c-4e3e66e59b8e_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total The Joint Corp. stockholder's equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_019b096a-6432-78c9-8c2e-3ea2eab9c5f6_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_019b096a-6432-71a5-aeda-1a1b4c362b75_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_019b096a-6432-7f9a-b835-05a7f8f90ca1_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPaidByIndividualJurisdictionTable_019c6696-3a1e-744b-97bf-9f864509209a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPaidByIndividualJurisdictionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Paid, by Individual Jurisdiction [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPaidByIndividualJurisdictionTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPaidByIndividualJurisdictionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Paid, by Individual Jurisdiction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPaidByIndividualJurisdictionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPaidByIndividualJurisdictionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPaidByIndividualJurisdictionTable" xlink:to="lab_us-gaap_IncomeTaxPaidByIndividualJurisdictionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_FranchiseLicensesOneMember_019b096a-6432-79fe-9d1e-ee4769310505_terseLabel_en-US" xlink:label="lab_jynt_FranchiseLicensesOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Franchise Licenses One</link:label>
    <link:label id="lab_jynt_FranchiseLicensesOneMember_label_en-US" xlink:label="lab_jynt_FranchiseLicensesOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchise Licenses One [Member]</link:label>
    <link:label id="lab_jynt_FranchiseLicensesOneMember_documentation_en-US" xlink:label="lab_jynt_FranchiseLicensesOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Franchise Licenses One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_FranchiseLicensesOneMember" xlink:href="jynt-20251231.xsd#jynt_FranchiseLicensesOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_FranchiseLicensesOneMember" xlink:to="lab_jynt_FranchiseLicensesOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_019b096a-6432-78b4-864b-55e44cb2fa52_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_019b096a-6432-7f5a-9455-237988f15569_verboseLabel_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_019b096a-6432-7e33-9aa4-94b4648ac22d_terseLabel_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_documentation_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:to="lab_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_019b096a-64bb-78cb-8cfc-fe41cab03077_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Rollforward in Contract Liabilities and Contract Assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_019b096a-637d-71b0-a50b-87f46c68c455_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Net deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_IncreaseDecreaseInRegionalDeveloperFees_019b096a-64bb-70bc-91a6-07e086357b79_terseLabel_en-US" xlink:label="lab_jynt_IncreaseDecreaseInRegionalDeveloperFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Upfront regional developer fees</link:label>
    <link:label id="lab_jynt_IncreaseDecreaseInRegionalDeveloperFees_label_en-US" xlink:label="lab_jynt_IncreaseDecreaseInRegionalDeveloperFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Regional Developer Fees</link:label>
    <link:label id="lab_jynt_IncreaseDecreaseInRegionalDeveloperFees_documentation_en-US" xlink:label="lab_jynt_IncreaseDecreaseInRegionalDeveloperFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Regional Developer Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_IncreaseDecreaseInRegionalDeveloperFees" xlink:href="jynt-20251231.xsd#jynt_IncreaseDecreaseInRegionalDeveloperFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_IncreaseDecreaseInRegionalDeveloperFees" xlink:to="lab_jynt_IncreaseDecreaseInRegionalDeveloperFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019b096a-64bb-751e-990d-2e9d6c13c7bc_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_019b096a-637e-7f32-ac3d-7fcf587fa800_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_019b096a-637e-7aae-a5ae-9ed9c22baa87_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">General and administrative expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_019b096a-637d-73ba-9693-9dc32beb1e05_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total lease costs</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_019b096a-6433-7d99-b9e3-34e9cd5b2d12_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Lease Expense</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_019b096a-6432-763c-8e67-01bbc63a6b2a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_019b096a-64bb-7500-add9-588cdad0bf11_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_AssetsHeldForSaleMember_019b096a-64bb-78d7-99f7-737cae120675_terseLabel_en-US" xlink:label="lab_jynt_AssetsHeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_jynt_AssetsHeldForSaleMember_label_en-US" xlink:label="lab_jynt_AssetsHeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets Held For Sale [Member]</link:label>
    <link:label id="lab_jynt_AssetsHeldForSaleMember_documentation_en-US" xlink:label="lab_jynt_AssetsHeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AssetsHeldForSaleMember" xlink:href="jynt-20251231.xsd#jynt_AssetsHeldForSaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_AssetsHeldForSaleMember" xlink:to="lab_jynt_AssetsHeldForSaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_019b096a-6432-7ac3-9da0-964a01c0d133_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_019b096a-6432-7b47-9048-2809647d1648_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current year expirations of non-qualified stock options</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_019b096a-6432-7280-8f94-6cf010a15c62_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental cash flow disclosures:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019b096a-6432-78f9-b507-aff9fb9e6fd9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_019b096a-6433-76a5-b63d-22bc56644ae8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_019b096a-6432-77e1-86be-492fa12cac16_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019b096a-637d-75c4-86c6-414856fa17aa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_019b096a-64bb-7e14-88c3-8b83a961659f_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_019b096a-637d-7c25-b6e2-3b05c6456dc5_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment_019b096a-6432-776f-b1ba-8d09c45e6ec7_terseLabel_en-US" xlink:label="lab_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment_019b096a-6432-738f-8fdb-2ab1c12b56b4_verboseLabel_en-US" xlink:label="lab_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair value of impaired asset after impairment</link:label>
    <link:label id="lab_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment_label_en-US" xlink:label="lab_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impaired Long-Lived Assets Held And Used, Carrying Value After Impairment</link:label>
    <link:label id="lab_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment_documentation_en-US" xlink:label="lab_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Impaired Long-Lived Assets Held And Used, Carrying Value After Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment" xlink:href="jynt-20251231.xsd#jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment" xlink:to="lab_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_019b096a-64bb-7f2b-ab2d-7e37d9c2c9b2_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_019b096a-6432-727b-ae9a-ca4971d56945_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue expected to be recognized, period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_019b096a-637d-7266-ab3b-fc4acf4a8d49_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_019b096a-6433-75d3-ab7c-8fc8141bbe11_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_019b096a-64bb-7d89-bc47-a7f6fcd22711_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_019b096a-6432-71df-834a-1cf655d60ea4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019b096a-6433-7e6f-a3ed-08c9547195bb_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019b096a-6433-7117-b8d8-5d278184575a_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Effective rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_019b096a-64bb-72ed-bb16-6c60af330efd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease costs</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_019b096a-6432-7f52-b30f-29bcf616e33e_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Computer Software</link:label>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_label_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019b096a-6432-743d-bedb-2e57c56a2f42_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized stock-based compensation, period of recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019b096a-6432-75f0-81e2-274dce206e77_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019b096a-6432-7623-9d5e-dabeff866dd7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_019b096a-637e-7063-bb2c-a0749f0cf0ca_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_019b096a-637e-7fed-a9af-2a3ce5f9f206_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets, valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_019b096a-637d-748c-b00a-0bb06d8ee9a2_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-6432-7b7b-8fc2-38925a602ea5_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_019b096a-6432-7ea6-ad4f-872e8fecb274_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total cost of revenues</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Costs of Goods Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_019b096a-637d-7d24-9201-88698806d3dd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_019b096a-637d-7c95-b220-77bc2c079310_totalLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_019b096a-6432-7cef-b171-2b288d562b50_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash and Cash Equivalent, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_019b096a-637e-7562-bddb-6d53d4a94944_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_019b096a-6433-757e-a516-92cea085e88f_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_019b096a-6432-7da2-83ab-7046b0dffeab_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingMember_019b096a-6432-7c04-8dc9-3bfa58c2392d_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advertising fund revenue</link:label>
    <link:label id="lab_us-gaap_AdvertisingMember_label_en-US" xlink:label="lab_us-gaap_AdvertisingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdvertisingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingMember" xlink:to="lab_us-gaap_AdvertisingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_019b096a-6432-7d95-a807-617ef1b3cba7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_019b096a-6432-7719-bc0c-6bc38c784f61_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent_019b096a-6432-7674-a748-6b665346bbda_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred franchise and regional development costs, net of current portion</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerAssetNetNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_019b3344-7cfe-79cf-9e93-fae3511a1dc4_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_019b096a-64bb-7c95-b365-9fa492be2a2e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_019b096a-6432-77f4-827d-0078c56438cf_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_RelatedPartyTransactionCoPartnerPercentageDivested_019b096a-64bb-7873-9ce2-a0d8f7173934_terseLabel_en-US" xlink:label="lab_jynt_RelatedPartyTransactionCoPartnerPercentageDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Co-partner percentage divested</link:label>
    <link:label id="lab_jynt_RelatedPartyTransactionCoPartnerPercentageDivested_label_en-US" xlink:label="lab_jynt_RelatedPartyTransactionCoPartnerPercentageDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Co-Partner Percentage, Divested</link:label>
    <link:label id="lab_jynt_RelatedPartyTransactionCoPartnerPercentageDivested_documentation_en-US" xlink:label="lab_jynt_RelatedPartyTransactionCoPartnerPercentageDivested" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Co-Partner Percentage, Divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_RelatedPartyTransactionCoPartnerPercentageDivested" xlink:href="jynt-20251231.xsd#jynt_RelatedPartyTransactionCoPartnerPercentageDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_RelatedPartyTransactionCoPartnerPercentageDivested" xlink:to="lab_jynt_RelatedPartyTransactionCoPartnerPercentageDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_019b096a-6433-792a-92ce-d8e3fa85a1c8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_UpfrontRegionalDeveloperFeesNoncurrent_019b096a-6433-722c-b329-e713e22467f7_terseLabel_en-US" xlink:label="lab_jynt_UpfrontRegionalDeveloperFeesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Upfront regional developer fees, net of current portion</link:label>
    <link:label id="lab_jynt_UpfrontRegionalDeveloperFeesNoncurrent_label_en-US" xlink:label="lab_jynt_UpfrontRegionalDeveloperFeesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Upfront Regional Developer Fees, Noncurrent</link:label>
    <link:label id="lab_jynt_UpfrontRegionalDeveloperFeesNoncurrent_documentation_en-US" xlink:label="lab_jynt_UpfrontRegionalDeveloperFeesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Upfront Regional Developer Fees, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_UpfrontRegionalDeveloperFeesNoncurrent" xlink:href="jynt-20251231.xsd#jynt_UpfrontRegionalDeveloperFeesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_UpfrontRegionalDeveloperFeesNoncurrent" xlink:to="lab_jynt_UpfrontRegionalDeveloperFeesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019b096a-6432-717f-9e72-c10917acac8d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cancelled (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_019b096a-6432-7f28-9fce-3e90121a0b02_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Consideration</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_019b096a-637e-7f99-a5a4-5aa87776aa61_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_019b096a-6433-70b8-aac9-a3e573490155_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_019be491-de24-75d6-aa69-f00470f0640c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Common stock repurchased under authorized stock repurchase programs</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_019b096a-6432-7d97-9ca2-5c1661cca7fc_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock repurchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_019b096a-64bb-748f-a402-cc582775a50b_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_019b096a-6432-7ba3-a2ab-b1e96931240a_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Operating lease liability, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_019b096a-6432-7b1b-b1d6-a0ec4858b320_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liability, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_019b096a-6432-7831-98a0-6af047a484d0_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Long-term lease obligations</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_019b096a-6432-7d8c-885b-7666dc06111f_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_019b096a-6432-7b6b-a8a1-f4b8711edf1e_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_019b096a-637e-730a-9825-54dfd8b8b74b_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities, discontinued operations</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_019b096a-6433-7714-be1a-061b3e974959_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_019b096a-64bb-7456-9e40-258016ad92f2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested and expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalTaxJurisdictionOtherMember_019c6699-1dec-7294-8965-cb15b69dbfbf_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalTaxJurisdictionOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other state jurisdictions</link:label>
    <link:label id="lab_us-gaap_StateAndLocalTaxJurisdictionOtherMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalTaxJurisdictionOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State and Local Tax Jurisdiction, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalTaxJurisdictionOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StateAndLocalTaxJurisdictionOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalTaxJurisdictionOtherMember" xlink:to="lab_us-gaap_StateAndLocalTaxJurisdictionOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_019b096a-637e-7132-9158-6d3cfffa4502_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_019b096a-6432-72ef-94b6-368edd61bdb9_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019b096a-6433-77f1-8df3-9cf5bb94cb10_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019b096a-6432-7a2c-853f-e87db694cf31_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositsAssetsNoncurrent_019b096a-6433-7e95-adf1-e112055abac8_terseLabel_en-US" xlink:label="lab_us-gaap_DepositsAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deposits and other assets</link:label>
    <link:label id="lab_us-gaap_DepositsAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DepositsAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deposits Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssetsNoncurrent" xlink:to="lab_us-gaap_DepositsAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangesFranchisesSold_019b096a-6433-7b14-9c90-86f494e72be6_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangesFranchisesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of franchises</link:label>
    <link:label id="lab_us-gaap_SignificantChangesFranchisesSold_label_en-US" xlink:label="lab_us-gaap_SignificantChangesFranchisesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Changes, Franchises Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangesFranchisesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantChangesFranchisesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangesFranchisesSold" xlink:to="lab_us-gaap_SignificantChangesFranchisesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent_019c6669-bc15-739d-a7cf-401eeed220de_terseLabel_en-US" xlink:label="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Section 162(m) officer compensation</link:label>
    <link:label id="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent_label_en-US" xlink:label="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Officer Compensation, Percent"</link:label>
    <link:label id="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent_documentation_en-US" xlink:label="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Officer Compensation, Percent"</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent" xlink:href="jynt-20251231.xsd#jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent" xlink:to="lab_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_AZ_019c6698-9038-760c-b3d5-98058d4faa70_terseLabel_en-US" xlink:label="lab_stpr_AZ" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arizona</link:label>
    <link:label id="lab_stpr_AZ_label_en-US" xlink:label="lab_stpr_AZ" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ARIZONA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AZ" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_AZ"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_AZ" xlink:to="lab_stpr_AZ" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortizationDiscontinuedOperations_019c92a7-3fba-7aa2-b8c2-451a1ee0446e_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortizationDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortizationDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortizationDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation and Amortization, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortizationDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortizationDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortizationDiscontinuedOperations" xlink:to="lab_us-gaap_DepreciationAndAmortizationDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_019b096a-6432-7254-a9fa-d7cd7b229ce0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_019b096a-6432-7020-a22b-87a0ecc1617a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fixed assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_019b096a-64bb-7c27-b6c7-67cad63aaeb5_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense from discontinued operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_019b096a-64bb-7390-99a8-ec60b66f273f_netLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Income tax expense from discontinued operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_019b096a-64bb-76d1-b57c-80db139d3df7_verboseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense(benefit) from discontinued operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Tax Effect of Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:to="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019b096a-6433-716c-b37f-5126e76c4627_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Non-vested (in dollar per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019b096a-6433-7e39-a4e9-9f44dd10dc38_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Non-vested (in dollar per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FranchiseMember_019b096a-6432-7993-b546-eade0efb87c1_verboseLabel_en-US" xlink:label="lab_us-gaap_FranchiseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Franchise fees</link:label>
    <link:label id="lab_us-gaap_FranchiseMember_019b096a-6432-7d8c-ae15-dae9fd9b1ced_terseLabel_en-US" xlink:label="lab_us-gaap_FranchiseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Franchise</link:label>
    <link:label id="lab_us-gaap_FranchiseMember_label_en-US" xlink:label="lab_us-gaap_FranchiseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchise [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchiseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchiseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FranchiseMember" xlink:to="lab_us-gaap_FranchiseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_019b096a-637e-7213-b775-8943525ab3de_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_019b096a-6432-74bf-b03f-699943c4bc5b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company matching contribution (maximum)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_019b096a-637e-7a7c-8d9a-c9bc1ee75e46_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019b096a-637e-7c4e-9d64-0df5c5caa37b_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_019b096a-6432-7cd2-91d9-65528a6942f8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deposits and other assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_019b096a-637e-7db3-bf49-758d8e3abb21_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested and expected to vest, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_019b096a-6432-7626-b36f-8683d149cc6f_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_019b096a-637e-7f9c-bc8d-6b68943d5fcf_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_019b096a-6432-736e-9bf2-f7a009fc9fa3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Estimated Revenue Related to Performance Obligations</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019b096a-637e-7579-8955-bb8dfb8952b9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_UnaffiliatedFranchiseeMember_019b096a-6432-73ec-bc9a-ee65902508c9_terseLabel_en-US" xlink:label="lab_jynt_UnaffiliatedFranchiseeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unaffiliated Franchisee</link:label>
    <link:label id="lab_jynt_UnaffiliatedFranchiseeMember_label_en-US" xlink:label="lab_jynt_UnaffiliatedFranchiseeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unaffiliated Franchisee [Member]</link:label>
    <link:label id="lab_jynt_UnaffiliatedFranchiseeMember_documentation_en-US" xlink:label="lab_jynt_UnaffiliatedFranchiseeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unaffiliated Franchisee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_UnaffiliatedFranchiseeMember" xlink:href="jynt-20251231.xsd#jynt_UnaffiliatedFranchiseeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_UnaffiliatedFranchiseeMember" xlink:to="lab_jynt_UnaffiliatedFranchiseeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019b096a-6432-752d-af4f-489af88a43dc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_019b096a-64bb-7ed6-a4c2-b327405d34b9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings (Loss) per Common Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_019b096a-6432-72c7-8f62-ff62e2eed08d_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenues:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_019b096a-6432-79d0-b005-24e37ed32346_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenues:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_019b096a-6432-7b7e-9e19-4db41027e4fc_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net increase during the year ended</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_019b096a-6432-7e9d-aec2-13b82ac19a63_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series A preferred stock, $0.001 par value; 50,000 shares authorized, zero issued and outstanding, respectively</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_019b096a-6433-7001-908f-c80876c4bb26_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_019b096a-637e-749e-ba35-200f116e6a45_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.001 par value; 20,000,000 shares authorized, 15,471,715 shares issued and 14,142,626 shares outstanding and 15,192,893 shares issued and 15,159,878 shares outstanding, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_019b096a-637e-71f7-abbb-4978beed332d_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title and Position [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title and Position [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_019b096a-64bb-7380-90f9-c38ef2750e4d_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies (Note 10)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_019b096a-6433-7535-816d-e5ff4ebd9383_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-controlling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_ContractWithCustomerLiabilityRollForward_019b096a-6432-75ac-99d4-dbe9ad0e59e5_terseLabel_en-US" xlink:label="lab_jynt_ContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Revenue Short and Long-Term</link:label>
    <link:label id="lab_jynt_ContractWithCustomerLiabilityRollForward_label_en-US" xlink:label="lab_jynt_ContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_jynt_ContractWithCustomerLiabilityRollForward_documentation_en-US" xlink:label="lab_jynt_ContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ContractWithCustomerLiabilityRollForward" xlink:href="jynt-20251231.xsd#jynt_ContractWithCustomerLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_ContractWithCustomerLiabilityRollForward" xlink:to="lab_jynt_ContractWithCustomerLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_019b096a-6433-78af-9359-aa55bd20e6e9_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment, ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_019c664c-711f-789c-b64c-c6c9969d925c_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_019b096a-637e-76d0-8e1e-2bdf6146ac90_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted earnings (loss) per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_019b096a-6432-7356-9a45-72cf56711552_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Net loss on disposition or impairment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_019b096a-6432-7e07-9560-e3be75c09e11_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net loss on disposition or impairment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Sale of Assets and Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:to="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_FranchiseRoyaltyGrossSalesPercentage_019b096a-6433-7e17-a6df-539d46b13611_terseLabel_en-US" xlink:label="lab_jynt_FranchiseRoyaltyGrossSalesPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalties percentage</link:label>
    <link:label id="lab_jynt_FranchiseRoyaltyGrossSalesPercentage_label_en-US" xlink:label="lab_jynt_FranchiseRoyaltyGrossSalesPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchise Royalty Gross Sales Percentage</link:label>
    <link:label id="lab_jynt_FranchiseRoyaltyGrossSalesPercentage_documentation_en-US" xlink:label="lab_jynt_FranchiseRoyaltyGrossSalesPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the percentage of gross sales collected as royalties from franchises typically collected bi-monthly two working days after each sales period has ended as stipulated in the franchise agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_FranchiseRoyaltyGrossSalesPercentage" xlink:href="jynt-20251231.xsd#jynt_FranchiseRoyaltyGrossSalesPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_FranchiseRoyaltyGrossSalesPercentage" xlink:to="lab_jynt_FranchiseRoyaltyGrossSalesPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_019b096a-6432-77c0-b88c-0d771f62fd3f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Uncertain Tax Position Rollforward</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CA_019c6698-b839-749d-b1b4-4678ff65b763_terseLabel_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">California</link:label>
    <link:label id="lab_stpr_CA_label_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CALIFORNIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CA" xlink:to="lab_stpr_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_BanderaPartnersLLCMember_019b096a-6433-7406-b086-7454b0f7c0ed_terseLabel_en-US" xlink:label="lab_jynt_BanderaPartnersLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bandera Partners LLC</link:label>
    <link:label id="lab_jynt_BanderaPartnersLLCMember_label_en-US" xlink:label="lab_jynt_BanderaPartnersLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bandera Partners LLC [Member]</link:label>
    <link:label id="lab_jynt_BanderaPartnersLLCMember_documentation_en-US" xlink:label="lab_jynt_BanderaPartnersLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Bandera Partners LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_BanderaPartnersLLCMember" xlink:href="jynt-20251231.xsd#jynt_BanderaPartnersLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_BanderaPartnersLLCMember" xlink:to="lab_jynt_BanderaPartnersLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_019b096a-6433-7c4b-8547-10e49be6ab66_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember_019b096a-6432-7c72-aeba-d02b7ea695af_terseLabel_en-US" xlink:label="lab_jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, excluding Construction in progress</link:label>
    <link:label id="lab_jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember_label_en-US" xlink:label="lab_jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property Plant and Equipment, Excluding Construction in Progress [Member]</link:label>
    <link:label id="lab_jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember_documentation_en-US" xlink:label="lab_jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale, not including construction in progress.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" xlink:href="jynt-20251231.xsd#jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" xlink:to="lab_jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019b096a-6432-7fc8-b430-269ea5e1f26f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_019b096a-637d-75ae-8011-34747c6da353_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">General and administrative expenses</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredAtPointInTimeMember_019b096a-6433-7a58-94bc-1d024fd5361b_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredAtPointInTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue recognized at a point in time</link:label>
    <link:label id="lab_us-gaap_TransferredAtPointInTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredAtPointInTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transferred at Point in Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredAtPointInTimeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransferredAtPointInTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredAtPointInTimeMember" xlink:to="lab_us-gaap_TransferredAtPointInTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_019b096a-637e-715d-a2d3-a425459649eb_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_019b096a-6432-7556-a878-0abce30993a2_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_019b096a-6432-70b7-b6ba-4a31d33284a2_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_019b096a-64bb-7b34-9a8a-20a23e39d42a_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of cash, cash equivalents and restricted cash:</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_019b096a-637e-7f3b-b3ad-be222660083f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_019c65ca-fa2e-70f7-b729-7a1087c3d259_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_019b096a-64bb-72c2-a342-dfebdd40e1f8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_019b096a-6432-7384-9bac-41cc32d941be_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Quarterly Financial Data (Unaudited)</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_AuditInformationAbstract_label_en-US" xlink:label="lab_jynt_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_jynt_AuditInformationAbstract_documentation_en-US" xlink:label="lab_jynt_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AuditInformationAbstract" xlink:href="jynt-20251231.xsd#jynt_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_AuditInformationAbstract" xlink:to="lab_jynt_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_019b096a-6432-7e5a-8634-da58895e6c0d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_SeniorSecuredCreditFacilitiesMember_019b096a-6432-7a9f-add9-1c0c38c082e1_terseLabel_en-US" xlink:label="lab_jynt_SeniorSecuredCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facilities</link:label>
    <link:label id="lab_jynt_SeniorSecuredCreditFacilitiesMember_label_en-US" xlink:label="lab_jynt_SeniorSecuredCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Secured Credit Facilities [Member]</link:label>
    <link:label id="lab_jynt_SeniorSecuredCreditFacilitiesMember_documentation_en-US" xlink:label="lab_jynt_SeniorSecuredCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Secured Credit Facilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_SeniorSecuredCreditFacilitiesMember" xlink:href="jynt-20251231.xsd#jynt_SeniorSecuredCreditFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_SeniorSecuredCreditFacilitiesMember" xlink:to="lab_jynt_SeniorSecuredCreditFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_019b096a-6432-7f1b-8d72-183554429f43_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_019b096a-6432-73b2-b709-2af70e827e64_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_019b096a-6432-71a7-96fc-146ff529bfa9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-6432-7c50-8b43-207732c82653_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_CapitalExpendituresDiscontinuedOperationsAbstract_019b096a-6432-7aa9-aa46-bf1b90e56664_verboseLabel_en-US" xlink:label="lab_jynt_CapitalExpendituresDiscontinuedOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_jynt_CapitalExpendituresDiscontinuedOperationsAbstract_label_en-US" xlink:label="lab_jynt_CapitalExpendituresDiscontinuedOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Expenditures, Discontinued Operations [Abstract]</link:label>
    <link:label id="lab_jynt_CapitalExpendituresDiscontinuedOperationsAbstract_documentation_en-US" xlink:label="lab_jynt_CapitalExpendituresDiscontinuedOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Capital Expenditures, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CapitalExpendituresDiscontinuedOperationsAbstract" xlink:href="jynt-20251231.xsd#jynt_CapitalExpendituresDiscontinuedOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_CapitalExpendituresDiscontinuedOperationsAbstract" xlink:to="lab_jynt_CapitalExpendituresDiscontinuedOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_019b096a-6432-733b-9dae-317634dcf8c5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income (loss) per common share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_019b096a-6432-7f8e-bac2-dbc2733b2c51_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Earnings (loss) per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_019b096a-6432-755e-ab5e-f7bbc51992f3_netLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Net income (loss) per common share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_019b096a-64bb-73bd-ad02-acce6aa7f4ce_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2030</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_019b096a-637d-7a0c-b498-6e662d4085e7_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credits</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019b096a-6432-7a91-9b7f-5bfc0ec17d40_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses_019b096a-637e-7ff8-818e-31289c597b95_terseLabel_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling and marketing expenses</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses_label_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Selling And Marketing Expenses</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses_documentation_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Selling And Marketing Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses" xlink:to="lab_jynt_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_019b096a-64bb-76aa-86b4-6e1c3c716f9a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_019b096a-6432-7c97-9d38-2681b38f2b86_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock repurchased under authorized stock repurchase programs (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_019b096a-64bb-7c82-ab6c-3cffcc92d868_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised, weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_019b096a-637d-7306-848d-412cd5c07e28_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_019b096a-6432-7cf8-9cfb-bf82c8c8cea2_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_019b096a-6433-7bd7-aa4b-d257484bab41_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_019b096a-6432-7045-8be6-7a96783056ca_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_019b096a-64bb-76e6-8eba-b73574e698f3_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_019b096a-6432-7746-9f09-8e641e5422d4_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_019b096a-637d-74ed-908b-55a138ec1f3d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other items</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_019b096a-6432-7d9f-bf42-1ec2714e40f1_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_019b096a-637d-7965-831b-41b89861a573_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series A preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_019b32be-d502-7e1b-bba9-c99a7e9f903e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of common stock under stock repurchase programs</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_019b096a-6433-7b30-8b3f-40a163a25484_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_019b096a-6433-7a72-a7de-b01317374987_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_019b096a-6433-7294-85af-b17018513861_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_StockOptionExerciseReceivable_019b096a-64bb-7d9f-8523-a4b1e9754819_terseLabel_en-US" xlink:label="lab_jynt_StockOptionExerciseReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock option exercise receivable</link:label>
    <link:label id="lab_jynt_StockOptionExerciseReceivable_label_en-US" xlink:label="lab_jynt_StockOptionExerciseReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Option Exercise Receivable</link:label>
    <link:label id="lab_jynt_StockOptionExerciseReceivable_documentation_en-US" xlink:label="lab_jynt_StockOptionExerciseReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Option Exercise Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_StockOptionExerciseReceivable" xlink:href="jynt-20251231.xsd#jynt_StockOptionExerciseReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_StockOptionExerciseReceivable" xlink:to="lab_jynt_StockOptionExerciseReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_SupplementalCashFlowNetCashPaidAbstract_019b096a-64bb-70a8-94b8-5fff9efd86fe_terseLabel_en-US" xlink:label="lab_jynt_SupplementalCashFlowNetCashPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net cash paid for:</link:label>
    <link:label id="lab_jynt_SupplementalCashFlowNetCashPaidAbstract_label_en-US" xlink:label="lab_jynt_SupplementalCashFlowNetCashPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow, Net Cash Paid [Abstract]</link:label>
    <link:label id="lab_jynt_SupplementalCashFlowNetCashPaidAbstract_documentation_en-US" xlink:label="lab_jynt_SupplementalCashFlowNetCashPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Supplement Of Net Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_SupplementalCashFlowNetCashPaidAbstract" xlink:href="jynt-20251231.xsd#jynt_SupplementalCashFlowNetCashPaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_SupplementalCashFlowNetCashPaidAbstract" xlink:to="lab_jynt_SupplementalCashFlowNetCashPaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_FederalReserveBankOfNewYorkRateMember_019b096a-6432-7ac7-8ca6-d2f9cf255e60_terseLabel_en-US" xlink:label="lab_jynt_FederalReserveBankOfNewYorkRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal Reserve Bank Of New York Rate</link:label>
    <link:label id="lab_jynt_FederalReserveBankOfNewYorkRateMember_label_en-US" xlink:label="lab_jynt_FederalReserveBankOfNewYorkRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Federal Reserve Bank Of New York Rate [Member]</link:label>
    <link:label id="lab_jynt_FederalReserveBankOfNewYorkRateMember_documentation_en-US" xlink:label="lab_jynt_FederalReserveBankOfNewYorkRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Federal Reserve Bank Of New York Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_FederalReserveBankOfNewYorkRateMember" xlink:href="jynt-20251231.xsd#jynt_FederalReserveBankOfNewYorkRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_FederalReserveBankOfNewYorkRateMember" xlink:to="lab_jynt_FederalReserveBankOfNewYorkRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_CoOpFundsLiabilityCurrent_019b096a-6433-7f61-a5ac-194a886bed16_terseLabel_en-US" xlink:label="lab_jynt_CoOpFundsLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Co-op funds liability</link:label>
    <link:label id="lab_jynt_CoOpFundsLiabilityCurrent_label_en-US" xlink:label="lab_jynt_CoOpFundsLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CoOp Funds Liability, Current</link:label>
    <link:label id="lab_jynt_CoOpFundsLiabilityCurrent_documentation_en-US" xlink:label="lab_jynt_CoOpFundsLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Aggregate carrying amount of Co-op funds liability (due within one year or within the normal operating cycle if longer).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CoOpFundsLiabilityCurrent" xlink:href="jynt-20251231.xsd#jynt_CoOpFundsLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_CoOpFundsLiabilityCurrent" xlink:to="lab_jynt_CoOpFundsLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_019b096a-6432-7262-9346-71d791df6193_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_019b096a-6432-7efa-9cee-ea584941bb99_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss from continuing operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_019b096a-637d-72c4-a539-cc5d317e3ad1_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_019b096a-64bb-7a1a-a711-880460bdfdea_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_AssetsAndLiabilitiesLesseeTableTextBlock_019b096a-6432-705a-a086-1285d09c26cc_terseLabel_en-US" xlink:label="lab_jynt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Supplemental Lease Information</link:label>
    <link:label id="lab_jynt_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_jynt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_jynt_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_jynt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Assets And Liabilities, Lessee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="jynt-20251231.xsd#jynt_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_jynt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_019b096a-6432-7cd1-a6da-3b6c3cb1085a_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue recognized over time</link:label>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transferred over Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredOverTimeMember" xlink:to="lab_us-gaap_TransferredOverTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-6432-70a4-a778-597436d65c51_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discontinued operations current liabilities ($6.1 million and $7.1 million attributable to VIEs, respectively)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-6432-7d17-8fcb-fc7effd54238_netLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Discontinued operations current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-6432-7298-8a21-7f38b8421842_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Liabilities to be disposed of</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-6432-7558-835c-75a9e288a038_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities to be disposed of</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_019b096a-637e-7742-932b-c6f671630614_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_019b096a-637e-77f1-9efd-8b6b4f9087a8_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_019b096a-6432-7e94-bc0a-8c1dbd42cf95_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount_019cb998-a3d7-799f-b6f0-3082972d1e77_terseLabel_en-US" xlink:label="lab_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred true-up to deferred franchise costs</link:label>
    <link:label id="lab_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount_label_en-US" xlink:label="lab_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deferred Franchise Costs, Deferred True Up, Amount</link:label>
    <link:label id="lab_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount_documentation_en-US" xlink:label="lab_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deferred Franchise Costs, Deferred True Up, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount" xlink:href="jynt-20251231.xsd#jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount" xlink:to="lab_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_019b096a-64bb-7665-b765-f5b55e94fa71_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred expense (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019b096a-64bb-79e9-8b3d-eebf8ad91c0f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_019b096a-6432-7970-92d1-09e61bd8c2dd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Reductions for expiration of the statute of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019b096a-6432-7e8b-8ea4-ea2b82b89d76_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_019b096a-64bb-7645-9757-8038b73e1dd2_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of loss</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_019b096a-6433-7d3b-8943-56ac23a0abfc_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_019b096a-64bb-78f6-a209-17f48430f2cc_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_019b096a-64bb-73b2-867d-902284ebde5e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_019b096a-6433-7a3f-ac1d-722495757836_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_019b096a-637e-7c8e-b01b-6ba64329d10b_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Internally developed software</link:label>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Software Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareDevelopmentMember" xlink:to="lab_us-gaap_SoftwareDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_019b096a-6432-76f4-80f7-8eb3c0fb2bca_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Treasury stock 1,329,089 shares and 33,015 shares, at cost, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_019b096a-6432-741f-b6c6-515083cda869_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred franchise costs</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_019b096a-64bb-7d9c-a2d4-771a0a44d58a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_019b096a-637e-753d-965a-d1d2a8525023_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock Options Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019b096a-637d-79bb-90da-6b9d8ab64f9f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019b096a-637d-7967-914a-cd132c0e4aee_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments_019b096a-637d-753c-9d47-68b9a2619a1d_terseLabel_en-US" xlink:label="lab_jynt_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of equal annual installments</link:label>
    <link:label id="lab_jynt_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments_label_en-US" xlink:label="lab_jynt_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Equity Instruments Other than Options, Vesting, Number of Annual Installments</link:label>
    <link:label id="lab_jynt_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments_documentation_en-US" xlink:label="lab_jynt_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Equity Instruments Other than Options, Vesting, Number of Annual Installments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments" xlink:href="jynt-20251231.xsd#jynt_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments" xlink:to="lab_jynt_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_019b096a-6433-7e94-9860-98fa87ae7bb7_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits that if recognized would affect the annual effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_019b096a-64bb-7230-b096-4f9760c5168a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Earnings (Loss) per Common Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_019b096a-637d-7f46-89a1-eb0c009a0953_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Directors</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_019b096a-64bb-75db-a5a1-2e3aa8a06865_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_019b096a-6432-73ee-8c00-e67568967547_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable, number of shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_019b096a-6432-7419-ad08-4a674b142dda_totalLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cost of revenues</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_019b096a-6432-74cf-8d8d-cfd77a8a93e8_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total costs of revenues</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_019b096a-6433-7452-9df9-3939ddff61a9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Write-off of uncollectible amounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-637e-797c-9da4-c35a38e392af_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_019b096a-637d-7ec2-8a26-4c0d2a23d4ab_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_019b096a-6432-7721-bc27-cf60f8601272_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019ca0bf-530c-7519-aab8-e255b74fde06_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019b096a-637d-78cf-89ad-cd1506d3de7c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted at market price (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_019b096a-637d-7f1d-af92-9dae8ddfdabc_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_019b096a-64bb-7edd-a120-f5b8bef4a21e_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_019b096a-637e-726d-80f1-8d0f01b39d04_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_019b096a-6432-7638-a911-25843e43605e_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Settlement agreement amount</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage_019b096a-6432-7951-a89a-d405f64ead88_terseLabel_en-US" xlink:label="lab_jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forecasted turnover percentage</link:label>
    <link:label id="lab_jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage_label_en-US" xlink:label="lab_jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Forfeitures, Historical And Forecasted Turnover, Percentage</link:label>
    <link:label id="lab_jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage_documentation_en-US" xlink:label="lab_jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Forfeitures, Historical And Forecasted Turnover, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage" xlink:href="jynt-20251231.xsd#jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage" xlink:to="lab_jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDepositOtherAssets_019b096a-6432-7515-8df2-d96af2486c79_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deposits and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDepositOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Deposit Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_019b096a-637d-78f7-8894-078692c0d246_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cancelled, weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityOperatedUnitsMember_019b096a-637d-7ef0-a0be-80a03344667d_terseLabel_en-US" xlink:label="lab_us-gaap_EntityOperatedUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company-Owned or Managed Clinics</link:label>
    <link:label id="lab_us-gaap_EntityOperatedUnitsMember_label_en-US" xlink:label="lab_us-gaap_EntityOperatedUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Operated Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityOperatedUnitsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EntityOperatedUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityOperatedUnitsMember" xlink:to="lab_us-gaap_EntityOperatedUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_019b096a-6432-7dec-b753-b340d6f78461_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other revenues</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_019b096a-6433-777c-879d-e17f25bffa13_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_019b332c-b9ff-741d-8f3f-ce58ebe645db_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold_019b3317-fa4b-725c-977c-23b4ee2abc09_terseLabel_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets sold that were previously classified as held for sale</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold_label_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets Held For Sale, Sold</link:label>
    <link:label id="lab_jynt_DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold_documentation_en-US" xlink:label="lab_jynt_DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets Held For Sale, Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold" xlink:to="lab_jynt_DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_019b096a-6432-7e80-81bd-7d97fb25cadc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net operating losses with an indefinite carryforward</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_GeneralAndAdministrativeExpenseAdjusted_019b096a-637d-7b56-bb98-f345033135df_terseLabel_en-US" xlink:label="lab_jynt_GeneralAndAdministrativeExpenseAdjusted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjusted General and administrative expenses</link:label>
    <link:label id="lab_jynt_GeneralAndAdministrativeExpenseAdjusted_label_en-US" xlink:label="lab_jynt_GeneralAndAdministrativeExpenseAdjusted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General And Administrative Expense, Adjusted</link:label>
    <link:label id="lab_jynt_GeneralAndAdministrativeExpenseAdjusted_documentation_en-US" xlink:label="lab_jynt_GeneralAndAdministrativeExpenseAdjusted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">General And Administrative Expense, Adjusted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_GeneralAndAdministrativeExpenseAdjusted" xlink:href="jynt-20251231.xsd#jynt_GeneralAndAdministrativeExpenseAdjusted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_GeneralAndAdministrativeExpenseAdjusted" xlink:to="lab_jynt_GeneralAndAdministrativeExpenseAdjusted" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_ContractWithCustomerAssetRollForward_019b096a-637e-7a9d-b2f2-eaa9c5ba26da_terseLabel_en-US" xlink:label="lab_jynt_ContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Franchise and Development Costs Short and Long-Term</link:label>
    <link:label id="lab_jynt_ContractWithCustomerAssetRollForward_label_en-US" xlink:label="lab_jynt_ContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset [Roll Forward]</link:label>
    <link:label id="lab_jynt_ContractWithCustomerAssetRollForward_documentation_en-US" xlink:label="lab_jynt_ContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ContractWithCustomerAssetRollForward" xlink:href="jynt-20251231.xsd#jynt_ContractWithCustomerAssetRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_ContractWithCustomerAssetRollForward" xlink:to="lab_jynt_ContractWithCustomerAssetRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_019b096a-637d-7a9a-83da-21ea0d42bb7d_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_019b096a-6433-76ab-aac1-a33774bbb96f_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jynt_FranchiseLicensesMember_019b096a-6432-74f1-9fd2-a99109470cb7_terseLabel_en-US" xlink:label="lab_jynt_FranchiseLicensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Franchise Licenses</link:label>
    <link:label id="lab_jynt_FranchiseLicensesMember_label_en-US" xlink:label="lab_jynt_FranchiseLicensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchise Licenses [Member]</link:label>
    <link:label id="lab_jynt_FranchiseLicensesMember_documentation_en-US" xlink:label="lab_jynt_FranchiseLicensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Franchise Licenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_FranchiseLicensesMember" xlink:href="jynt-20251231.xsd#jynt_FranchiseLicensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jynt_FranchiseLicensesMember" xlink:to="lab_jynt_FranchiseLicensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_019b096a-6432-72a9-8f4d-1fd6ef184089_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_019b096a-6433-73d3-bac1-2d856c27e6ea_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>jynt-20251231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019b096a-603d-78f6-a834-c229229c770d,g:a2c624eb-8b4f-420f-a77d-d91a250e6a25-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.thejoint.com/role/CoverPage" xlink:type="simple" xlink:href="jynt-20251231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019b096a-61dc-7158-bdc6-24346a7dbbb0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_DocumentType_019b096a-61dc-7158-bdc6-24346a7dbbb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_019b096a-61dc-7179-9314-d2f3f74eedee" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_DocumentAnnualReport_019b096a-61dc-7179-9314-d2f3f74eedee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019b096a-61dc-7a05-add7-5d1211462305" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_DocumentPeriodEndDate_019b096a-61dc-7a05-add7-5d1211462305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_019b096a-61dc-7590-b2d4-9bec475f493b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_CurrentFiscalYearEndDate_019b096a-61dc-7590-b2d4-9bec475f493b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_019b096a-61dc-74f0-96e3-79dad4edf459" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_DocumentTransitionReport_019b096a-61dc-74f0-96e3-79dad4edf459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019b096a-61dc-772a-a3b5-e98e366cf9fd" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_EntityFileNumber_019b096a-61dc-772a-a3b5-e98e366cf9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019b096a-61dc-7181-8b43-88bfb850c079" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_EntityRegistrantName_019b096a-61dc-7181-8b43-88bfb850c079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_019b096a-61dc-7ea6-91cd-75eb852e7886" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_EntityIncorporationStateCountryCode_019b096a-61dc-7ea6-91cd-75eb852e7886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_019b096a-61dc-7af8-8d35-0f971999771d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_EntityTaxIdentificationNumber_019b096a-61dc-7af8-8d35-0f971999771d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019b096a-61dc-744b-8aca-ffaca73af473" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_EntityAddressAddressLine1_019b096a-61dc-744b-8aca-ffaca73af473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_019b096a-61dc-7d2c-a7e2-436ca68f5377" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_EntityAddressAddressLine2_019b096a-61dc-7d2c-a7e2-436ca68f5377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019b096a-61dc-776b-b840-a85981557954" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_EntityAddressCityOrTown_019b096a-61dc-776b-b840-a85981557954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019b096a-61dc-7c8d-9755-e27df8c41a74" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_EntityAddressStateOrProvince_019b096a-61dc-7c8d-9755-e27df8c41a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019b096a-61dc-7db9-b3fc-a7335d7c39b0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_EntityAddressPostalZipCode_019b096a-61dc-7db9-b3fc-a7335d7c39b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_019b096a-61dc-7d21-a2c9-9120fba82b22" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_CityAreaCode_019b096a-61dc-7d21-a2c9-9120fba82b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_019b096a-61dc-759c-a09e-0cf504813ef3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_LocalPhoneNumber_019b096a-61dc-759c-a09e-0cf504813ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_019b096a-61dc-7379-a257-fbee1f81d7a2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_Security12bTitle_019b096a-61dc-7379-a257-fbee1f81d7a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_019b096a-61dc-7c00-a262-0f5da4df729c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_TradingSymbol_019b096a-61dc-7c00-a262-0f5da4df729c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_019b096a-61dc-71de-80ff-e211b053d1a7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_SecurityExchangeName_019b096a-61dc-71de-80ff-e211b053d1a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_019b096a-61dc-787a-9491-8187b569d2b6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_019b096a-61dc-787a-9491-8187b569d2b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_019b096a-61dc-7cfe-9702-1b75af05f608" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_EntityVoluntaryFilers_019b096a-61dc-7cfe-9702-1b75af05f608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_019b096a-61dc-72d8-80b2-272da30f9895" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_EntityCurrentReportingStatus_019b096a-61dc-72d8-80b2-272da30f9895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_019b096a-61dc-79df-b0a5-16b08fc15d50" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_EntityInteractiveDataCurrent_019b096a-61dc-79df-b0a5-16b08fc15d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_019b096a-61dc-71ea-bda3-e5f7e0de9143" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_EntityFilerCategory_019b096a-61dc-71ea-bda3-e5f7e0de9143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_019b096a-61dc-7fa7-866e-1724abfb2efe" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_EntitySmallBusiness_019b096a-61dc-7fa7-866e-1724abfb2efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_019b096a-61dc-720a-96db-7934a3960b7a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_EntityEmergingGrowthCompany_019b096a-61dc-720a-96db-7934a3960b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_019b096a-61dc-7d3d-a0dc-30d0c279389a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_IcfrAuditorAttestationFlag_019b096a-61dc-7d3d-a0dc-30d0c279389a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_019b096a-61dc-7960-a719-29f282b8f05a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_019b096a-61dc-7960-a719-29f282b8f05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_019b096a-61dc-720b-8b6b-d9c5754ddc4c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_EntityShellCompany_019b096a-61dc-720b-8b6b-d9c5754ddc4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_019b096a-61dc-740a-bd8c-b32a4b96dcde" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_EntityPublicFloat_019b096a-61dc-740a-bd8c-b32a4b96dcde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_019b096a-61dc-7df5-9d56-189b32daa914" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_019b096a-61dc-7df5-9d56-189b32daa914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_019b096a-61dc-76b9-9639-d3ede50b97cb" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_019b096a-61dc-76b9-9639-d3ede50b97cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019b096a-61dc-7981-aaba-2a745807d7fb" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_EntityCentralIndexKey_019b096a-61dc-7981-aaba-2a745807d7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_019b096a-61dc-7d22-ad60-70601a159019" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_DocumentFiscalYearFocus_019b096a-61dc-7d22-ad60-70601a159019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_019b096a-61dc-72fd-855b-79cd31b1bb8e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_DocumentFiscalPeriodFocus_019b096a-61dc-72fd-855b-79cd31b1bb8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019b096a-61dc-7b62-b781-420c50d45dd8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b096a-61dc-74c8-8057-ec6a44e633a4" xlink:to="loc_dei_AmendmentFlag_019b096a-61dc-7b62-b781-420c50d45dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/AuditInformation" xlink:type="simple" xlink:href="jynt-20251231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AuditInformationAbstract_019b096a-61dc-709f-8ebe-8f9dabee6680" xlink:href="jynt-20251231.xsd#jynt_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_019b096a-61dc-7cf4-a833-e6266093b735" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_AuditInformationAbstract_019b096a-61dc-709f-8ebe-8f9dabee6680" xlink:to="loc_dei_AuditorName_019b096a-61dc-7cf4-a833-e6266093b735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_019b096a-61dc-788d-a018-35d652e9f054" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_AuditInformationAbstract_019b096a-61dc-709f-8ebe-8f9dabee6680" xlink:to="loc_dei_AuditorFirmId_019b096a-61dc-788d-a018-35d652e9f054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_019b096a-61dc-7838-b0f4-7e643fcd5e47" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_AuditInformationAbstract_019b096a-61dc-709f-8ebe-8f9dabee6680" xlink:to="loc_dei_AuditorLocation_019b096a-61dc-7838-b0f4-7e643fcd5e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="jynt-20251231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_019b096a-61dc-773f-9cf9-1e50ba333c88" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_019b096a-61dc-7ebb-891a-bee22ac42e61" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019b096a-61dc-773f-9cf9-1e50ba333c88" xlink:to="loc_us-gaap_AssetsAbstract_019b096a-61dc-7ebb-891a-bee22ac42e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_019b096a-61dc-7606-9c85-446a4bd06b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019b096a-61dc-7ebb-891a-bee22ac42e61" xlink:to="loc_us-gaap_AssetsCurrentAbstract_019b096a-61dc-7606-9c85-446a4bd06b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019b096a-61dc-7380-9fcd-4a44b98edd65" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019b096a-61dc-7606-9c85-446a4bd06b9d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019b096a-61dc-7380-9fcd-4a44b98edd65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_019b096a-61dc-7caf-94f0-8673e891a880" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019b096a-61dc-7606-9c85-446a4bd06b9d" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_019b096a-61dc-7caf-94f0-8673e891a880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_019b096a-61dc-7aee-8dbe-31176ee8a6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019b096a-61dc-7606-9c85-446a4bd06b9d" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_019b096a-61dc-7aee-8dbe-31176ee8a6bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_019b096a-61dc-7a01-b33c-a849c137fed7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019b096a-61dc-7606-9c85-446a4bd06b9d" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_019b096a-61dc-7a01-b33c-a849c137fed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019b096a-61dc-7b23-ade4-54f2a14593b5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019b096a-61dc-7606-9c85-446a4bd06b9d" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019b096a-61dc-7b23-ade4-54f2a14593b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-61dc-7d96-bf97-44947dccb272" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019b096a-61dc-7606-9c85-446a4bd06b9d" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-61dc-7d96-bf97-44947dccb272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019b096a-61dc-796d-9ff3-a7c4f69a8ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019b096a-61dc-7606-9c85-446a4bd06b9d" xlink:to="loc_us-gaap_AssetsCurrent_019b096a-61dc-796d-9ff3-a7c4f69a8ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019b096a-61dc-7cc9-a5ed-b31954b0cb69" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019b096a-61dc-7ebb-891a-bee22ac42e61" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019b096a-61dc-7cc9-a5ed-b31954b0cb69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019b096a-61dc-7da9-ab7e-8e7734259482" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019b096a-61dc-7ebb-891a-bee22ac42e61" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019b096a-61dc-7da9-ab7e-8e7734259482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_019b096a-61dc-737b-b1df-54be091f644f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerAssetNetNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019b096a-61dc-7ebb-891a-bee22ac42e61" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_019b096a-61dc-737b-b1df-54be091f644f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_019b096a-61dc-76b3-a330-740bf4764039" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019b096a-61dc-7ebb-891a-bee22ac42e61" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent_019b096a-61dc-76b3-a330-740bf4764039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019b096a-61dc-7f76-9e25-156ab8a2c3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019b096a-61dc-7ebb-891a-bee22ac42e61" xlink:to="loc_us-gaap_Assets_019b096a-61dc-7f76-9e25-156ab8a2c3aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019b096a-61dc-7746-9178-7e6d81ea9f34" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019b096a-61dc-773f-9cf9-1e50ba333c88" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019b096a-61dc-7746-9178-7e6d81ea9f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_019b096a-61dc-7a18-a62f-4711d2659825" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019b096a-61dc-7746-9178-7e6d81ea9f34" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_019b096a-61dc-7a18-a62f-4711d2659825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019b096a-61dc-7ba7-90a9-53698a741982" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019b096a-61dc-7a18-a62f-4711d2659825" xlink:to="loc_us-gaap_AccountsPayableCurrent_019b096a-61dc-7ba7-90a9-53698a741982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019b096a-61dc-7632-9926-a6d9f10e7f16" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019b096a-61dc-7a18-a62f-4711d2659825" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019b096a-61dc-7632-9926-a6d9f10e7f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CoOpFundsLiabilityCurrent_019b096a-61dc-76d7-9f1c-329b81b1f5d6" xlink:href="jynt-20251231.xsd#jynt_CoOpFundsLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019b096a-61dc-7a18-a62f-4711d2659825" xlink:to="loc_jynt_CoOpFundsLiabilityCurrent_019b096a-61dc-76d7-9f1c-329b81b1f5d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019b096a-61dc-7b0e-822e-db42914ef890" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019b096a-61dc-7a18-a62f-4711d2659825" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019b096a-61dc-7b0e-822e-db42914ef890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019b096a-61dc-7447-9e6d-eabb83f6f720" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019b096a-61dc-7a18-a62f-4711d2659825" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019b096a-61dc-7447-9e6d-eabb83f6f720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019b096a-61dc-78e8-9ff0-4d546eb25bda" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019b096a-61dc-7a18-a62f-4711d2659825" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019b096a-61dc-78e8-9ff0-4d546eb25bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_UpfrontRegionalDeveloperFeesCurrent_019b096a-61dc-7905-97ae-ca51916f14fc" xlink:href="jynt-20251231.xsd#jynt_UpfrontRegionalDeveloperFeesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019b096a-61dc-7a18-a62f-4711d2659825" xlink:to="loc_jynt_UpfrontRegionalDeveloperFeesCurrent_019b096a-61dc-7905-97ae-ca51916f14fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_019b096a-61dc-78e6-8fc1-4158c81f2798" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019b096a-61dc-7a18-a62f-4711d2659825" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_019b096a-61dc-78e6-8fc1-4158c81f2798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-61dc-7e5b-bcec-0a86583eb6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019b096a-61dc-7a18-a62f-4711d2659825" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-61dc-7e5b-bcec-0a86583eb6fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019b096a-61dc-7cb2-a112-fc381112ef46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019b096a-61dc-7a18-a62f-4711d2659825" xlink:to="loc_us-gaap_LiabilitiesCurrent_019b096a-61dc-7cb2-a112-fc381112ef46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019b096a-61dc-7071-9d88-b319619a2038" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019b096a-61dc-7746-9178-7e6d81ea9f34" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019b096a-61dc-7071-9d88-b319619a2038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_019b096a-61dc-7b43-8308-6ee123493a77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019b096a-61dc-7746-9178-7e6d81ea9f34" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_019b096a-61dc-7b43-8308-6ee123493a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_UpfrontRegionalDeveloperFeesNoncurrent_019b096a-61dc-7971-afaf-56c41ef68b09" xlink:href="jynt-20251231.xsd#jynt_UpfrontRegionalDeveloperFeesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019b096a-61dc-7746-9178-7e6d81ea9f34" xlink:to="loc_jynt_UpfrontRegionalDeveloperFeesNoncurrent_019b096a-61dc-7971-afaf-56c41ef68b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019b096a-61dc-7c7a-8889-fa1dcd21a84a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019b096a-61dc-7746-9178-7e6d81ea9f34" xlink:to="loc_us-gaap_Liabilities_019b096a-61dc-7c7a-8889-fa1dcd21a84a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019b096a-61dc-7635-b20c-3a2e147b06b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019b096a-61dc-7746-9178-7e6d81ea9f34" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019b096a-61dc-7635-b20c-3a2e147b06b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_019b096a-61dc-710f-a010-b14b226b2f00" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019b096a-61dc-7746-9178-7e6d81ea9f34" xlink:to="loc_us-gaap_StockholdersEquityAbstract_019b096a-61dc-710f-a010-b14b226b2f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_019b096a-61dc-7bbc-953f-b54212106e02" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019b096a-61dc-710f-a010-b14b226b2f00" xlink:to="loc_us-gaap_PreferredStockValue_019b096a-61dc-7bbc-953f-b54212106e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019b096a-61dc-7b49-b55e-899bfa686ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019b096a-61dc-710f-a010-b14b226b2f00" xlink:to="loc_us-gaap_CommonStockValue_019b096a-61dc-7b49-b55e-899bfa686ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019b096a-61dc-7997-96e9-1f6fecf079e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019b096a-61dc-710f-a010-b14b226b2f00" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019b096a-61dc-7997-96e9-1f6fecf079e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_019b096a-61dc-7e18-bd7c-1bdfbecefb7e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019b096a-61dc-710f-a010-b14b226b2f00" xlink:to="loc_us-gaap_TreasuryStockCommonValue_019b096a-61dc-7e18-bd7c-1bdfbecefb7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019b096a-61dc-76a6-8cf9-a521b86949c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019b096a-61dc-710f-a010-b14b226b2f00" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019b096a-61dc-76a6-8cf9-a521b86949c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019b096a-61dc-754b-82ae-01c001d10e16" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019b096a-61dc-710f-a010-b14b226b2f00" xlink:to="loc_us-gaap_StockholdersEquity_019b096a-61dc-754b-82ae-01c001d10e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_019b096a-61dc-7a4a-8b7c-b6da592bc525" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019b096a-61dc-710f-a010-b14b226b2f00" xlink:to="loc_us-gaap_MinorityInterest_019b096a-61dc-7a4a-8b7c-b6da592bc525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_019b096a-61dc-7167-92ee-2e7872469830" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019b096a-61dc-710f-a010-b14b226b2f00" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_019b096a-61dc-7167-92ee-2e7872469830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019b096a-61dc-736b-9534-2838de90789e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019b096a-61dc-7746-9178-7e6d81ea9f34" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_019b096a-61dc-736b-9534-2838de90789e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="jynt-20251231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_019b096a-61dc-7355-90e3-9e8e495d3a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019b096a-61dc-7bc8-8ee7-f1aa41d06a21" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019b096a-61dc-7355-90e3-9e8e495d3a3c" xlink:to="loc_us-gaap_StatementTable_019b096a-61dc-7bc8-8ee7-f1aa41d06a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_019b096a-61dc-7404-9123-c8cca82b6cd5" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019b096a-61dc-7bc8-8ee7-f1aa41d06a21" xlink:to="loc_srt_ConsolidatedEntitiesAxis_019b096a-61dc-7404-9123-c8cca82b6cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_019b096a-61dc-7b38-9df0-99f8b2121b51" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_019b096a-61dc-7404-9123-c8cca82b6cd5" xlink:to="loc_srt_ConsolidatedEntitiesDomain_019b096a-61dc-7b38-9df0-99f8b2121b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_019b096a-61dc-730a-a3c0-e6f905cbd386" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_019b096a-61dc-7b38-9df0-99f8b2121b51" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_019b096a-61dc-730a-a3c0-e6f905cbd386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019b096a-61dc-7bc8-8ee7-f1aa41d06a21" xlink:to="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-61dc-7222-8418-9f529cc400be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-61dc-7222-8418-9f529cc400be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-61dc-7647-a26c-792e6da4ccff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-61dc-7647-a26c-792e6da4ccff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_019b096a-61dc-7b19-a405-8c8bd60d6b43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_019b096a-61dc-7b19-a405-8c8bd60d6b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_019b096a-61dc-7cec-afcc-8a39bfb4637a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_019b096a-61dc-7cec-afcc-8a39bfb4637a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_019b096a-61dc-7041-8ccc-1d7b66672c44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:to="loc_us-gaap_PreferredStockSharesIssued_019b096a-61dc-7041-8ccc-1d7b66672c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_019b096a-61dc-756d-afe7-a74ac410e522" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_019b096a-61dc-756d-afe7-a74ac410e522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_019b096a-61dc-7f3d-8ad7-eb0e4c91f8e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_019b096a-61dc-7f3d-8ad7-eb0e4c91f8e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_019b096a-61dc-7f8e-ab48-fd6eae8b4f38" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_019b096a-61dc-7f8e-ab48-fd6eae8b4f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_019b096a-61dc-747d-b026-8a0e48573280" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:to="loc_us-gaap_CommonStockSharesIssued_019b096a-61dc-747d-b026-8a0e48573280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019b096a-61dc-7856-a8a8-551822b2e31b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019b096a-61dc-7856-a8a8-551822b2e31b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_019b096a-61dc-75d5-853d-50810cc577af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-77eb-a15b-063c446eedd3" xlink:to="loc_us-gaap_TreasuryStockCommonShares_019b096a-61dc-75d5-853d-50810cc577af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/ConsolidatedIncomeStatements" xlink:type="simple" xlink:href="jynt-20251231.xsd#ConsolidatedIncomeStatements"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/ConsolidatedIncomeStatements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_019b096a-61dc-78aa-ab38-41f6735a9a79" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019b096a-61dc-73d8-927c-1915c102547d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019b096a-61dc-78aa-ab38-41f6735a9a79" xlink:to="loc_us-gaap_StatementTable_019b096a-61dc-73d8-927c-1915c102547d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019b096a-61dc-7b7c-bbc9-af729868182c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019b096a-61dc-73d8-927c-1915c102547d" xlink:to="loc_srt_ProductOrServiceAxis_019b096a-61dc-7b7c-bbc9-af729868182c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019b096a-61dc-774a-b512-b8df3bfc3266" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_019b096a-61dc-7b7c-bbc9-af729868182c" xlink:to="loc_srt_ProductsAndServicesDomain_019b096a-61dc-774a-b512-b8df3bfc3266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_019b096a-61dc-7896-a7ea-dcc84916df56" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019b096a-61dc-774a-b512-b8df3bfc3266" xlink:to="loc_us-gaap_RoyaltyMember_019b096a-61dc-7896-a7ea-dcc84916df56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchiseMember_019b096a-61dc-7170-8cc0-6c9fbda801f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchiseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019b096a-61dc-774a-b512-b8df3bfc3266" xlink:to="loc_us-gaap_FranchiseMember_019b096a-61dc-7170-8cc0-6c9fbda801f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingMember_019b096a-61dc-7ce0-ae5b-a44cf6a7c5de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdvertisingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019b096a-61dc-774a-b512-b8df3bfc3266" xlink:to="loc_us-gaap_AdvertisingMember_019b096a-61dc-7ce0-ae5b-a44cf6a7c5de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyServiceMember_019b096a-61dc-7b46-af5b-e4cdb67a6280" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TechnologyServiceMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019b096a-61dc-774a-b512-b8df3bfc3266" xlink:to="loc_us-gaap_TechnologyServiceMember_019b096a-61dc-7b46-af5b-e4cdb67a6280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_019b096a-61dc-7e7a-b6b5-13f4e0c4b9e4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019b096a-61dc-774a-b512-b8df3bfc3266" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_019b096a-61dc-7e7a-b6b5-13f4e0c4b9e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019b096a-61dc-73d8-927c-1915c102547d" xlink:to="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_019b096a-61dc-7ada-9a95-b2891f19c49c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_RevenuesAbstract_019b096a-61dc-7ada-9a95-b2891f19c49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_019b096a-61dc-7c39-9ce7-b51c1cd33073" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_019b096a-61dc-7ada-9a95-b2891f19c49c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_019b096a-61dc-7c39-9ce7-b51c1cd33073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_019b096a-61dc-7aad-a2fa-35365f7f3a90" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_CostOfRevenueAbstract_019b096a-61dc-7aad-a2fa-35365f7f3a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_019b096a-61dc-7468-b5d3-31dfeeb4946c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_019b096a-61dc-7aad-a2fa-35365f7f3a90" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_019b096a-61dc-7468-b5d3-31dfeeb4946c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_019b096a-61dc-776f-b14f-c66739633904" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_019b096a-61dc-7aad-a2fa-35365f7f3a90" xlink:to="loc_us-gaap_CostOfRevenue_019b096a-61dc-776f-b14f-c66739633904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_019b096a-61dc-7c9c-a917-1eea7f3bd9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_SellingAndMarketingExpense_019b096a-61dc-7c9c-a917-1eea7f3bd9ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_019b096a-61dc-70c8-a2d3-2bcbc96199af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_DepreciationAndAmortization_019b096a-61dc-70c8-a2d3-2bcbc96199af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019b096a-61dc-7d1f-809f-26cc3954e08e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019b096a-61dc-7d1f-809f-26cc3954e08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019b096a-61dc-781d-b6bc-6e177fb5b5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019b096a-61dc-781d-b6bc-6e177fb5b5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_019b096a-61dc-777e-a85c-a10341de9408" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_019b096a-61dc-777e-a85c-a10341de9408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019b096a-61dc-7a61-979d-c46216704700" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_OperatingIncomeLoss_019b096a-61dc-7a61-979d-c46216704700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019b096a-61dc-7c49-9b43-680e514d75e4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019b096a-61dc-7c49-9b43-680e514d75e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019b096a-61dc-7acf-88d3-425e6d1b1070" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019b096a-61dc-7acf-88d3-425e6d1b1070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-61dc-7ad2-883f-b75f299cc214" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-61dc-7ad2-883f-b75f299cc214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-61dc-7247-9885-13be35815545" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-61dc-7247-9885-13be35815545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract_019b096a-61dc-7f2f-94ac-8fef0ffd829e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract_019b096a-61dc-7f2f-94ac-8fef0ffd829e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b096a-61dc-7e8f-9d37-0cdde7a11cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract_019b096a-61dc-7f2f-94ac-8fef0ffd829e" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b096a-61dc-7e8f-9d37-0cdde7a11cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_019b096a-61dc-76aa-8ba0-0e66528854df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract_019b096a-61dc-7f2f-94ac-8fef0ffd829e" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_019b096a-61dc-76aa-8ba0-0e66528854df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-61dc-7cb4-ab4d-5a5a8958bee0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract_019b096a-61dc-7f2f-94ac-8fef0ffd829e" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-61dc-7cb4-ab4d-5a5a8958bee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_019b096a-61dc-70a9-bc83-80d62d08c94e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_ProfitLoss_019b096a-61dc-70a9-bc83-80d62d08c94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract_019b096a-61dc-7577-bf74-1e8eaeaeaa64" xlink:href="jynt-20251231.xsd#jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract_019b096a-61dc-7577-bf74-1e8eaeaeaa64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_019b096a-61dc-7749-89f8-bfd78fcecbf3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract_019b096a-61dc-7577-bf74-1e8eaeaeaa64" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_019b096a-61dc-7749-89f8-bfd78fcecbf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_019b096a-61dc-7107-9cee-be911c56911b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract_019b096a-61dc-7577-bf74-1e8eaeaeaa64" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_019b096a-61dc-7107-9cee-be911c56911b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract_019b096a-61dc-7685-91cc-35228aaa51b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract_019b096a-61dc-7685-91cc-35228aaa51b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_019b096a-61dc-74c6-9207-38657488ff66" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract_019b096a-61dc-7685-91cc-35228aaa51b3" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_019b096a-61dc-74c6-9207-38657488ff66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_019b096a-61dc-7f65-a00d-723f6ca2ba10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract_019b096a-61dc-7685-91cc-35228aaa51b3" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_019b096a-61dc-7f65-a00d-723f6ca2ba10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019b096a-61dc-7d9c-bb49-52e33cefb9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_EarningsPerShareAbstract_019b096a-61dc-7d9c-bb49-52e33cefb9b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_019b096a-61dc-705c-bcb3-b44d5e9de0fb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019b096a-61dc-7d9c-bb49-52e33cefb9b9" xlink:to="loc_us-gaap_EarningsPerShareBasic_019b096a-61dc-705c-bcb3-b44d5e9de0fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_019b096a-61dc-7275-80ae-d60b6ef37520" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019b096a-61dc-7d9c-bb49-52e33cefb9b9" xlink:to="loc_us-gaap_EarningsPerShareDiluted_019b096a-61dc-7275-80ae-d60b6ef37520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019b096a-61dc-74df-aafb-07c04cc5be84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019b096a-61dc-74df-aafb-07c04cc5be84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019b096a-61dc-7278-b29f-d09e8a81fabb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-61dc-7f0e-be73-21d6a95f3180" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019b096a-61dc-7278-b29f-d09e8a81fabb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="simple" xlink:href="jynt-20251231.xsd#ConsolidatedStatementsofChangesinStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_019b096a-62ab-7ae7-9347-f421148a52d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019b096a-62ab-7854-a2e9-c3826ebacf44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_019b096a-62ab-7ae7-9347-f421148a52d8" xlink:to="loc_us-gaap_StatementTable_019b096a-62ab-7854-a2e9-c3826ebacf44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019b096a-62ab-7a7c-ace8-3596a46ccfdb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019b096a-62ab-7854-a2e9-c3826ebacf44" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019b096a-62ab-7a7c-ace8-3596a46ccfdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019b096a-62ab-7768-88a3-33db9bd72422" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019b096a-62ab-7a7c-ace8-3596a46ccfdb" xlink:to="loc_us-gaap_EquityComponentDomain_019b096a-62ab-7768-88a3-33db9bd72422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_019b096a-62ab-7300-bf62-e0375b429f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019b096a-62ab-7768-88a3-33db9bd72422" xlink:to="loc_us-gaap_ParentMember_019b096a-62ab-7300-bf62-e0375b429f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019b096a-62ab-7ff6-b941-b2f72c0ac014" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_019b096a-62ab-7300-bf62-e0375b429f9c" xlink:to="loc_us-gaap_CommonStockMember_019b096a-62ab-7ff6-b941-b2f72c0ac014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_019b096a-62ab-72b8-910a-d2681e48e148" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_019b096a-62ab-7300-bf62-e0375b429f9c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_019b096a-62ab-72b8-910a-d2681e48e148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_019b096a-62ab-7d81-bbff-b355b6d67d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_019b096a-62ab-7300-bf62-e0375b429f9c" xlink:to="loc_us-gaap_TreasuryStockCommonMember_019b096a-62ab-7d81-bbff-b355b6d67d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_019b096a-62ab-7f60-81bb-96794e23a1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_019b096a-62ab-7300-bf62-e0375b429f9c" xlink:to="loc_us-gaap_RetainedEarningsMember_019b096a-62ab-7f60-81bb-96794e23a1ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_019b096a-62ab-7add-9ac5-2e4f7ced1faa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019b096a-62ab-7768-88a3-33db9bd72422" xlink:to="loc_us-gaap_NoncontrollingInterestMember_019b096a-62ab-7add-9ac5-2e4f7ced1faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019b096a-62ab-756f-bfb5-69afdff76325" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019b096a-62ab-7854-a2e9-c3826ebacf44" xlink:to="loc_us-gaap_StatementLineItems_019b096a-62ab-756f-bfb5-69afdff76325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019b096a-62ab-756f-bfb5-69afdff76325" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019b096a-62ab-779a-a228-eb90802750a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019b096a-62ab-779a-a228-eb90802750a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_019b096a-62ab-7886-8742-9dd2e9ff1081" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_019b096a-62ab-7886-8742-9dd2e9ff1081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_019b096a-62ab-7d01-9680-8440cb38547f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_TreasuryStockCommonShares_019b096a-62ab-7d01-9680-8440cb38547f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019b096a-62ab-7ae5-bf90-164c5d53b87d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019b096a-62ab-7ae5-bf90-164c5d53b87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_019b096a-62ab-7d26-9ce1-c92f9d90a7e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_019b096a-62ab-7d26-9ce1-c92f9d90a7e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_019b096a-62ab-77c3-8362-f803f658ed39" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_019b096a-62ab-77c3-8362-f803f658ed39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019b096a-62ab-7b2d-ade5-73d4e15a237a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019b096a-62ab-7b2d-ade5-73d4e15a237a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019b096a-62ab-7942-b808-68fef78f25bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019b096a-62ab-7942-b808-68fef78f25bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_019b096a-62ab-7938-9e7b-2bf384ffa21a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_019b096a-62ab-7938-9e7b-2bf384ffa21a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_019b096a-62ab-748b-9400-ee150578f385" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_019b096a-62ab-748b-9400-ee150578f385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_019be491-de24-7472-80ad-73eeb8d7d07c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_019be491-de24-7472-80ad-73eeb8d7d07c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_019be491-de24-7946-b831-73ec6131abba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_019be491-de24-7946-b831-73ec6131abba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_019b096a-62ab-7e8c-ae7f-271620bd8346" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_ProfitLoss_019b096a-62ab-7e8c-ae7f-271620bd8346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019b096a-62ab-7eb0-8320-14bfcd3b7d99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019b096a-62ab-7eb0-8320-14bfcd3b7d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_019b096a-62ab-7bbc-a2d8-8e601e52eace" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_019b096a-62ab-7bbc-a2d8-8e601e52eace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_019b096a-62ab-7214-9d14-73b8fb3674b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019b096a-62ab-729e-b56f-ef7971c99b46" xlink:to="loc_us-gaap_TreasuryStockCommonShares_019b096a-62ab-7214-9d14-73b8fb3674b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="jynt-20251231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_019b096a-62ab-7828-98e5-a6baa6609397" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019b096a-62ab-7ba2-a9a3-16112464a980" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019b096a-62ab-7828-98e5-a6baa6609397" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019b096a-62ab-7ba2-a9a3-16112464a980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_019b096a-62ab-705d-b49a-11c57d012035" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019b096a-62ab-7ba2-a9a3-16112464a980" xlink:to="loc_us-gaap_ProfitLoss_019b096a-62ab-705d-b49a-11c57d012035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019b096a-62ab-7e0f-9210-2141b2a4a031" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019b096a-62ab-7ba2-a9a3-16112464a980" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019b096a-62ab-7e0f-9210-2141b2a4a031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_019b096a-62ab-776c-986d-dd74f03260a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019b096a-62ab-7e0f-9210-2141b2a4a031" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_019b096a-62ab-776c-986d-dd74f03260a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_NetGainLossOnDispositionOfAssetsOrAssetImpairment_019b096a-62ab-7d03-b123-ca641d42d871" xlink:href="jynt-20251231.xsd#jynt_NetGainLossOnDispositionOfAssetsOrAssetImpairment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019b096a-62ab-7e0f-9210-2141b2a4a031" xlink:to="loc_jynt_NetGainLossOnDispositionOfAssetsOrAssetImpairment_019b096a-62ab-7d03-b123-ca641d42d871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_GainLossOnTerminationOfFranchisingAgreements_019b096a-62ab-760d-bbe6-350b9037785d" xlink:href="jynt-20251231.xsd#jynt_GainLossOnTerminationOfFranchisingAgreements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019b096a-62ab-7e0f-9210-2141b2a4a031" xlink:to="loc_jynt_GainLossOnTerminationOfFranchisingAgreements_019b096a-62ab-760d-bbe6-350b9037785d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_019b096a-62ab-753b-bce1-a2e63ab78227" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019b096a-62ab-7e0f-9210-2141b2a4a031" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_019b096a-62ab-753b-bce1-a2e63ab78227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_019b096a-62ab-79d1-af60-4e6bc619541d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019b096a-62ab-7e0f-9210-2141b2a4a031" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_019b096a-62ab-79d1-af60-4e6bc619541d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019b096a-62ab-765e-bb17-63db638a8e40" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019b096a-62ab-7e0f-9210-2141b2a4a031" xlink:to="loc_us-gaap_ShareBasedCompensation_019b096a-62ab-765e-bb17-63db638a8e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019b096a-62ab-7d46-8cad-912123c140e9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019b096a-62ab-7e0f-9210-2141b2a4a031" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019b096a-62ab-7d46-8cad-912123c140e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_019b096a-62ab-7f7b-92cd-079cc2194a01" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019b096a-62ab-7d46-8cad-912123c140e9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_019b096a-62ab-7f7b-92cd-079cc2194a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019b096a-62ab-731d-8c62-1736773d9b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019b096a-62ab-7d46-8cad-912123c140e9" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019b096a-62ab-731d-8c62-1736773d9b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_019b096a-62ab-7b72-92b4-d87443ef2e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019b096a-62ab-7d46-8cad-912123c140e9" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_019b096a-62ab-7b72-92b4-d87443ef2e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDepositOtherAssets_019b096a-62ab-73f1-b868-e26901a37d68" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019b096a-62ab-7d46-8cad-912123c140e9" xlink:to="loc_us-gaap_IncreaseDecreaseInDepositOtherAssets_019b096a-62ab-73f1-b868-e26901a37d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019b096a-62ab-7ca2-a276-12328fc560d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019b096a-62ab-7d46-8cad-912123c140e9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019b096a-62ab-7ca2-a276-12328fc560d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_019b096a-62ab-77af-9806-c136703d1ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019b096a-62ab-7d46-8cad-912123c140e9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_019b096a-62ab-77af-9806-c136703d1ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_019b096a-62ab-7d24-a0b2-ba2fb8ca516b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019b096a-62ab-7d46-8cad-912123c140e9" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_019b096a-62ab-7d24-a0b2-ba2fb8ca516b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019b096a-62ab-755d-9e45-d849acebb002" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019b096a-62ab-7d46-8cad-912123c140e9" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019b096a-62ab-755d-9e45-d849acebb002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019b096a-62ab-787b-8483-1eb3f0c8d4f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019b096a-62ab-7d46-8cad-912123c140e9" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019b096a-62ab-787b-8483-1eb3f0c8d4f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_IncreaseDecreaseInRegionalDeveloperFees_019b096a-62ab-7e00-a21a-5b2b13e492b7" xlink:href="jynt-20251231.xsd#jynt_IncreaseDecreaseInRegionalDeveloperFees"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019b096a-62ab-7d46-8cad-912123c140e9" xlink:to="loc_jynt_IncreaseDecreaseInRegionalDeveloperFees_019b096a-62ab-7e00-a21a-5b2b13e492b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_019b096a-62ab-78ee-a836-7d866e6c5fff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019b096a-62ab-7d46-8cad-912123c140e9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_019b096a-62ab-78ee-a836-7d866e6c5fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b096a-62ab-71b4-9be7-f8193c489523" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019b096a-62ab-7ba2-a9a3-16112464a980" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b096a-62ab-71b4-9be7-f8193c489523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019b096a-62ab-76fe-b5f8-c98edf37301c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019b096a-62ab-7828-98e5-a6baa6609397" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019b096a-62ab-76fe-b5f8-c98edf37301c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_019b096a-62ab-7e32-85b4-3fc8cd8d15c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019b096a-62ab-76fe-b5f8-c98edf37301c" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_019b096a-62ab-7e32-85b4-3fc8cd8d15c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019b096a-62ab-726a-a2b2-895a8c2d34af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019b096a-62ab-76fe-b5f8-c98edf37301c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019b096a-62ab-726a-a2b2-895a8c2d34af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019b096a-62ab-7551-a1f9-693fa9e3fe6c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019b096a-62ab-76fe-b5f8-c98edf37301c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019b096a-62ab-7551-a1f9-693fa9e3fe6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019b096a-62ab-7f59-926c-007132de0e60" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019b096a-62ab-7828-98e5-a6baa6609397" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019b096a-62ab-7f59-926c-007132de0e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_019b096a-62ab-7320-95b8-295b1041c5b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019b096a-62ab-7f59-926c-007132de0e60" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_019b096a-62ab-7320-95b8-295b1041c5b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_019b096a-62ab-7123-82dd-ecbac18b200b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019b096a-62ab-7f59-926c-007132de0e60" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_019b096a-62ab-7123-82dd-ecbac18b200b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_019b32be-d502-7284-a74f-972eedf51487" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019b096a-62ab-7f59-926c-007132de0e60" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_019b32be-d502-7284-a74f-972eedf51487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_019b096a-62ab-712f-8f90-00c6abd70a65" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019b096a-62ab-7f59-926c-007132de0e60" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_019b096a-62ab-712f-8f90-00c6abd70a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_019b096a-62ab-7c06-857b-970b56e5f724" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019b096a-62ab-7f59-926c-007132de0e60" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_019b096a-62ab-7c06-857b-970b56e5f724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019b096a-62ab-7ec4-aa07-aa60c4af5bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019b096a-62ab-7f59-926c-007132de0e60" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019b096a-62ab-7ec4-aa07-aa60c4af5bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019b096a-62ab-78e7-bb77-e27ab1dc3d37" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019b096a-62ab-7828-98e5-a6baa6609397" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019b096a-62ab-78e7-bb77-e27ab1dc3d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019b096a-62ab-77ee-acaa-f4d0aa3bda2e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019b096a-62ab-7828-98e5-a6baa6609397" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019b096a-62ab-77ee-acaa-f4d0aa3bda2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019b096a-62ab-7e75-aa49-6307a93b3ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019b096a-62ab-7828-98e5-a6baa6609397" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019b096a-62ab-7e75-aa49-6307a93b3ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_019b096a-62ab-7ab7-93ee-cf8a193e519f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019b096a-62ab-7828-98e5-a6baa6609397" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_019b096a-62ab-7ab7-93ee-cf8a193e519f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019b096a-62ab-7280-9f2a-7d7dd4353fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_019b096a-62ab-7ab7-93ee-cf8a193e519f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019b096a-62ab-7280-9f2a-7d7dd4353fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_019b096a-62ab-7ee8-a5f5-fe0a62412f06" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_019b096a-62ab-7ab7-93ee-cf8a193e519f" xlink:to="loc_us-gaap_RestrictedCash_019b096a-62ab-7ee8-a5f5-fe0a62412f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019b096a-62ab-74ae-8600-1734c516748c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_019b096a-62ab-7ab7-93ee-cf8a193e519f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019b096a-62ab-74ae-8600-1734c516748c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_019b096a-62ab-767d-8637-9ddce02284f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019b096a-62ab-7828-98e5-a6baa6609397" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_019b096a-62ab-767d-8637-9ddce02284f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_SupplementalCashFlowNetCashPaidAbstract_019b096a-62ab-7e2f-b389-2ce85aa7b73e" xlink:href="jynt-20251231.xsd#jynt_SupplementalCashFlowNetCashPaidAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_019b096a-62ab-767d-8637-9ddce02284f6" xlink:to="loc_jynt_SupplementalCashFlowNetCashPaidAbstract_019b096a-62ab-7e2f-b389-2ce85aa7b73e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_019b096a-62ab-7f8c-a2b8-309078413532" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_SupplementalCashFlowNetCashPaidAbstract_019b096a-62ab-7e2f-b389-2ce85aa7b73e" xlink:to="loc_us-gaap_InterestPaidNet_019b096a-62ab-7f8c-a2b8-309078413532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_019b096a-62ab-7069-b1e4-dc5954aaeae3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_SupplementalCashFlowNetCashPaidAbstract_019b096a-62ab-7e2f-b389-2ce85aa7b73e" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_019b096a-62ab-7069-b1e4-dc5954aaeae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_019b096a-62ab-7faa-bea5-12bcfc4de5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_019b096a-62ab-767d-8637-9ddce02284f6" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_019b096a-62ab-7faa-bea5-12bcfc4de5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_019b096a-62ab-7a26-9cf9-32d03e8b2e01" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_019b096a-62ab-7faa-bea5-12bcfc4de5ef" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_019b096a-62ab-7a26-9cf9-32d03e8b2e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_StockOptionExerciseReceivable_019b096a-62ab-778a-abb9-adce8968b320" xlink:href="jynt-20251231.xsd#jynt_StockOptionExerciseReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_019b096a-62ab-7faa-bea5-12bcfc4de5ef" xlink:to="loc_jynt_StockOptionExerciseReceivable_019b096a-62ab-778a-abb9-adce8968b320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="jynt-20251231.xsd#NatureofOperationsandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-7655-9b72-6e77f714c8ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_019b096a-62ab-75e2-afc3-b0e45c814001" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-7655-9b72-6e77f714c8ba" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_019b096a-62ab-75e2-afc3-b0e45c814001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/RevenueDisclosures" xlink:type="simple" xlink:href="jynt-20251231.xsd#RevenueDisclosures"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/RevenueDisclosures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019b096a-62ab-7323-934d-d1a0776094ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_019b096a-62ab-767e-a845-252306fd7759" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019b096a-62ab-7323-934d-d1a0776094ba" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_019b096a-62ab-767e-a845-252306fd7759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/Divestitures" xlink:type="simple" xlink:href="jynt-20251231.xsd#Divestitures"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/Divestitures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_019b096a-62ab-7e85-9ea2-2bc4b846c55a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_019b3303-d92e-7c4d-8fa0-1e2f02ccd2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_019b096a-62ab-7e85-9ea2-2bc4b846c55a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_019b3303-d92e-7c4d-8fa0-1e2f02ccd2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/PropertyandEquipment" xlink:type="simple" xlink:href="jynt-20251231.xsd#PropertyandEquipment"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/PropertyandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_019b096a-62ab-7f49-b6eb-d166334e7af6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_019b096a-62ab-7d96-a8b4-1213a32da0d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_019b096a-62ab-7f49-b6eb-d166334e7af6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_019b096a-62ab-7d96-a8b4-1213a32da0d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/FairValueConsideration" xlink:type="simple" xlink:href="jynt-20251231.xsd#FairValueConsideration"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/FairValueConsideration" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019b096a-62ab-76b3-9da7-bebd9b9937aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_019b096a-62ab-7dca-8aa9-77750773366a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019b096a-62ab-76b3-9da7-bebd9b9937aa" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_019b096a-62ab-7dca-8aa9-77750773366a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/Debt" xlink:type="simple" xlink:href="jynt-20251231.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_019b096a-62ab-7e4e-9091-4731df50e5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_019b096a-62ab-7935-a3a4-03318d7917aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_019b096a-62ab-7e4e-9091-4731df50e5a2" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_019b096a-62ab-7935-a3a4-03318d7917aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/StockholdersEquity" xlink:type="simple" xlink:href="jynt-20251231.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019b3338-b6e2-7617-8923-19d04e1137fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_019b3338-b6e2-7c31-88bc-a3ee51c2285c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019b3338-b6e2-7617-8923-19d04e1137fe" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_019b3338-b6e2-7c31-88bc-a3ee51c2285c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="jynt-20251231.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019b096a-62ab-7326-b725-c96490df5fef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_019b3344-7cfe-7818-9f3c-5c213f701a34" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019b096a-62ab-7326-b725-c96490df5fef" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_019b3344-7cfe-7818-9f3c-5c213f701a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/IncomeTaxes" xlink:type="simple" xlink:href="jynt-20251231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-756c-af5a-4fe4e54e441e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_019b096a-637d-7977-8644-619b351999c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-756c-af5a-4fe4e54e441e" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_019b096a-637d-7977-8644-619b351999c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="jynt-20251231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-792c-8cbb-fb96e44c8394" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_019b096a-637d-7bd3-972f-bc1ef62a668f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-792c-8cbb-fb96e44c8394" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_019b096a-637d-7bd3-972f-bc1ef62a668f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/SegmentReporting" xlink:type="simple" xlink:href="jynt-20251231.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_019b096a-637d-717a-b2fd-04a0fd58564a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_019b096a-637d-72d6-b716-cd338017405f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019b096a-637d-717a-b2fd-04a0fd58564a" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_019b096a-637d-72d6-b716-cd338017405f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="jynt-20251231.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_019b096a-637d-73a1-9ce4-b4119b4526fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_019b096a-637d-70ae-917a-c3b70a2da34a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_019b096a-637d-73a1-9ce4-b4119b4526fe" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_019b096a-637d-70ae-917a-c3b70a2da34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/QuarterlyFinancialDataUnaudited" xlink:type="simple" xlink:href="jynt-20251231.xsd#QuarterlyFinancialDataUnaudited"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/QuarterlyFinancialDataUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_019b096a-637d-72a9-b755-d960b39cdae1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_019b096a-637d-7d0f-8a1f-a18d2b2cf72c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_019b096a-637d-72a9-b755-d960b39cdae1" xlink:to="loc_us-gaap_QuarterlyFinancialInformationTextBlock_019b096a-637d-7d0f-8a1f-a18d2b2cf72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="jynt-20251231.xsd#NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_019b096a-62ab-719d-bc78-6eff874665d5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_019b096a-62ab-719d-bc78-6eff874665d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_019b096a-62ab-7508-8af2-21ce4c8c5810" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_019b096a-62ab-7508-8af2-21ce4c8c5810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_019b096a-62ab-7638-a869-b8f99d9c1888" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_019b096a-62ab-7638-a869-b8f99d9c1888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_NatureofOperationsPolicyPolicyTextBlock_019b096a-62ab-7a77-88e7-38cb01ae29fa" xlink:href="jynt-20251231.xsd#jynt_NatureofOperationsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_jynt_NatureofOperationsPolicyPolicyTextBlock_019b096a-62ab-7a77-88e7-38cb01ae29fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_019b096a-62ab-7df4-b05e-5fc37e28116a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_019b096a-62ab-7df4-b05e-5fc37e28116a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_019b096a-62ab-7a3c-93da-25b07cc633db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_019b096a-62ab-7a3c-93da-25b07cc633db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_019b096a-62ab-7bae-b960-c89688ed599e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_019b096a-62ab-7bae-b960-c89688ed599e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_019b096a-62ab-7d4e-b581-44bb1aea80d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_019b096a-62ab-7d4e-b581-44bb1aea80d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_019b32c9-9b43-7643-871f-1d887a15b457" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditLossFinancialInstrumentPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_019b32c9-9b43-7643-871f-1d887a15b457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock_019b096a-62ab-77dd-aa20-be8bf97d6156" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_DeferredChargesPolicyTextBlock_019b096a-62ab-77dd-aa20-be8bf97d6156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_019b096a-62ab-72d8-b29d-fb4e2fdca782" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_019b096a-62ab-72d8-b29d-fb4e2fdca782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalUseSoftwarePolicy_019b096a-62ab-734e-9566-6528964f0295" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_InternalUseSoftwarePolicy_019b096a-62ab-734e-9566-6528964f0295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_019b096a-62ab-7fb6-a5b2-80b72eef3a76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_019b096a-62ab-7fb6-a5b2-80b72eef3a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_019b096a-62ab-7926-b567-bfe55556824f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_019b096a-62ab-7926-b567-bfe55556824f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_019b096a-62ab-78ad-b2a0-33a483f60bab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_019b096a-62ab-78ad-b2a0-33a483f60bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock_019b096a-62ab-7454-b19e-00ab796c9811" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock_019b096a-62ab-7454-b19e-00ab796c9811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_019b096a-62ab-7fd2-8124-1c3c4445da8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_019b096a-62ab-7fd2-8124-1c3c4445da8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AdvertisingFundPolicyTextBlock_019b096a-62ab-79ce-b438-aaa73ca4949c" xlink:href="jynt-20251231.xsd#jynt_AdvertisingFundPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_jynt_AdvertisingFundPolicyTextBlock_019b096a-62ab-79ce-b438-aaa73ca4949c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CoOpMarketingFundsPolicyPolicyTextBlock_019b096a-62ab-795d-94a2-c96351ae2fca" xlink:href="jynt-20251231.xsd#jynt_CoOpMarketingFundsPolicyPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_jynt_CoOpMarketingFundsPolicyPolicyTextBlock_019b096a-62ab-795d-94a2-c96351ae2fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_019b096a-62ab-76bc-a1d2-3f57f2f46b28" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_019b096a-62ab-76bc-a1d2-3f57f2f46b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_019b096a-62ab-700e-8f5a-b1cfd8b1cbbb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_019b096a-62ab-700e-8f5a-b1cfd8b1cbbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_019b096a-62ab-7c41-863b-bb8221d4dcf8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_019b096a-62ab-7c41-863b-bb8221d4dcf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_019b096a-62ab-7a9a-9360-2966a1ecf807" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_019b096a-62ab-7a9a-9360-2966a1ecf807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_019b096a-62ab-702f-8dbd-7211862f7ced" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_019b096a-62ab-702f-8dbd-7211862f7ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitPlansPolicy_019b096a-62ab-7dba-9468-a20ec72c58a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PostemploymentBenefitPlansPolicy"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_PostemploymentBenefitPlansPolicy_019b096a-62ab-7dba-9468-a20ec72c58a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_019b096a-62ab-7c82-8908-4f6b0c742c23" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_019b096a-62ab-7c82-8908-4f6b0c742c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_019b096a-62ab-7752-81ae-2053ed5b6553" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_UseOfEstimates_019b096a-62ab-7752-81ae-2053ed5b6553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_019b096a-62ab-7d04-81f6-0654416db356" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_019b096a-62ab-7d04-81f6-0654416db356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_019b096a-62ab-7577-adc9-5c464363d5d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-70f1-81d4-52f8b34ee00d" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_019b096a-62ab-7577-adc9-5c464363d5d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="jynt-20251231.xsd#NatureofOperationsandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-797b-8d82-b8fb8d58161d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock_019b096a-62ab-78df-9c1e-f2ffac08c514" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-797b-8d82-b8fb8d58161d" xlink:to="loc_us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock_019b096a-62ab-78df-9c1e-f2ffac08c514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_019b096a-62ab-7a7e-b08a-5323d24ed909" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-797b-8d82-b8fb8d58161d" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_019b096a-62ab-7a7e-b08a-5323d24ed909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_019b096a-62ab-7cf4-a561-e31514006982" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-797b-8d82-b8fb8d58161d" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_019b096a-62ab-7cf4-a561-e31514006982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock_019b096a-62ab-7d0e-8ca3-038a98a2813b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-797b-8d82-b8fb8d58161d" xlink:to="loc_us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock_019b096a-62ab-7d0e-8ca3-038a98a2813b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_019b096a-62ab-7b0b-9241-23c1d7f4bbc1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-797b-8d82-b8fb8d58161d" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_019b096a-62ab-7b0b-9241-23c1d7f4bbc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_019b096a-62ab-7432-bb76-ff33b2abe0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-797b-8d82-b8fb8d58161d" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_019b096a-62ab-7432-bb76-ff33b2abe0c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/RevenueDisclosuresTables" xlink:type="simple" xlink:href="jynt-20251231.xsd#RevenueDisclosuresTables"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/RevenueDisclosuresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019b096a-62ab-725b-be99-15b57348cca1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_019b096a-62ab-74c5-83c1-7bc69f04cfad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019b096a-62ab-725b-be99-15b57348cca1" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_019b096a-62ab-74c5-83c1-7bc69f04cfad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_019b096a-62ab-7414-b1ed-5230258362dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019b096a-62ab-725b-be99-15b57348cca1" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_019b096a-62ab-7414-b1ed-5230258362dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_019b096a-62ab-7159-aede-74f265fe1f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019b096a-62ab-725b-be99-15b57348cca1" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_019b096a-62ab-7159-aede-74f265fe1f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_019b096a-62ab-7500-b2db-7985cd46ae7c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019b096a-62ab-725b-be99-15b57348cca1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_019b096a-62ab-7500-b2db-7985cd46ae7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/DivestituresTables" xlink:type="simple" xlink:href="jynt-20251231.xsd#DivestituresTables"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/DivestituresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_019b096a-62ab-7238-8c1c-90d5358cd3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_019b096a-62ab-7941-9770-c876def66b57" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_019b096a-62ab-7238-8c1c-90d5358cd3b7" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_019b096a-62ab-7941-9770-c876def66b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="jynt-20251231.xsd#PropertyandEquipmentTables"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/PropertyandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_019b096a-62ab-75bf-bb42-9d7ed198498c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_019b096a-62ab-7922-ae58-f3b0863c4960" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_019b096a-62ab-75bf-bb42-9d7ed198498c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_019b096a-62ab-7922-ae58-f3b0863c4960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="jynt-20251231.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019b096a-62ab-73d8-90ff-f5ba096f18bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_019b096a-62ab-7512-9bbd-29f9fb402304" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019b096a-62ab-73d8-90ff-f5ba096f18bc" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_019b096a-62ab-7512-9bbd-29f9fb402304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_019b096a-62ab-756c-ac0b-1344c58dd926" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019b096a-62ab-73d8-90ff-f5ba096f18bc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_019b096a-62ab-756c-ac0b-1344c58dd926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_019b096a-62ab-7937-b86a-b58fee0d7966" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019b096a-62ab-73d8-90ff-f5ba096f18bc" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_019b096a-62ab-7937-b86a-b58fee0d7966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="jynt-20251231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-714d-9c09-42bfbf9fc22a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_019c6638-88fa-73de-b1c8-9503a07fd52b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-714d-9c09-42bfbf9fc22a" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_019c6638-88fa-73de-b1c8-9503a07fd52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_019b096a-637d-7f0a-abb3-10c0654bfd13" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-714d-9c09-42bfbf9fc22a" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_019b096a-637d-7f0a-abb3-10c0654bfd13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_019b096a-637d-7916-9935-a21a6c1b6657" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-714d-9c09-42bfbf9fc22a" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_019b096a-637d-7916-9935-a21a6c1b6657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_019b096a-637d-7ba0-8fd9-d61bda6044f7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-714d-9c09-42bfbf9fc22a" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_019b096a-637d-7ba0-8fd9-d61bda6044f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_019b096a-637d-747f-abdd-dfd6755c2987" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-714d-9c09-42bfbf9fc22a" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_019b096a-637d-747f-abdd-dfd6755c2987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_019c6694-0101-788a-a978-0a8a2da531ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-714d-9c09-42bfbf9fc22a" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_019c6694-0101-788a-a978-0a8a2da531ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="jynt-20251231.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/CommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-7de2-86ac-479f753d836b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_019b096a-637d-78f0-b85a-18fe08d65faf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-7de2-86ac-479f753d836b" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_019b096a-637d-78f0-b85a-18fe08d65faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AssetsAndLiabilitiesLesseeTableTextBlock_019b096a-637d-72b1-9f16-f41f882bf53a" xlink:href="jynt-20251231.xsd#jynt_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-7de2-86ac-479f753d836b" xlink:to="loc_jynt_AssetsAndLiabilitiesLesseeTableTextBlock_019b096a-637d-72b1-9f16-f41f882bf53a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_019b096a-637d-729e-a939-288f574e5dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-7de2-86ac-479f753d836b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_019b096a-637d-729e-a939-288f574e5dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="jynt-20251231.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_019b096a-637d-7e99-9eb4-853a3821d89b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_019b096a-637d-7def-ab99-1052ec4d17d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019b096a-637d-7e99-9eb4-853a3821d89b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_019b096a-637d-7def-ab99-1052ec4d17d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedTables" xlink:type="simple" xlink:href="jynt-20251231.xsd#QuarterlyFinancialDataUnauditedTables"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_019b096a-637d-7831-98b8-7dfe0cacc038" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_019b096a-637d-775a-aacb-0ba4cad66f67" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_019b096a-637d-7831-98b8-7dfe0cacc038" xlink:to="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_019b096a-637d-775a-aacb-0ba4cad66f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-7655-b7e0-c33cc47cdfd8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-7553-b4e9-1b31f9021a10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-7655-b7e0-c33cc47cdfd8" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-7553-b4e9-1b31f9021a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisorDisclosureAxis_019b096a-62ab-7a17-9ab3-cbde2aa6d0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisorDisclosureAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-7553-b4e9-1b31f9021a10" xlink:to="loc_us-gaap_FranchisorDisclosureAxis_019b096a-62ab-7a17-9ab3-cbde2aa6d0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisorDisclosureDomain_019b096a-62ab-7799-9614-d544c6e054c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisorDisclosureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FranchisorDisclosureAxis_019b096a-62ab-7a17-9ab3-cbde2aa6d0d5" xlink:to="loc_us-gaap_FranchisorDisclosureDomain_019b096a-62ab-7799-9614-d544c6e054c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisedUnitsMember_019b096a-62ab-75c4-bde2-ea9d8aff6316" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisedUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FranchisorDisclosureDomain_019b096a-62ab-7799-9614-d544c6e054c6" xlink:to="loc_us-gaap_FranchisedUnitsMember_019b096a-62ab-75c4-bde2-ea9d8aff6316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityOperatedUnitsMember_019b096a-62ab-73db-8c1d-c6d3f449407c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EntityOperatedUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FranchisorDisclosureDomain_019b096a-62ab-7799-9614-d544c6e054c6" xlink:to="loc_us-gaap_EntityOperatedUnitsMember_019b096a-62ab-73db-8c1d-c6d3f449407c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-705c-acb8-4b85791574ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-7553-b4e9-1b31f9021a10" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-705c-acb8-4b85791574ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-77c4-9c58-bc2f348d2816" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-705c-acb8-4b85791574ab" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-77c4-9c58-bc2f348d2816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019b096a-62ab-79c3-b59a-8b86b4c7b8be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-77c4-9c58-bc2f348d2816" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019b096a-62ab-79c3-b59a-8b86b4c7b8be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-76c2-9956-ccd50926ac84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-7553-b4e9-1b31f9021a10" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-76c2-9956-ccd50926ac84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-714c-ab3b-5b39263297d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-76c2-9956-ccd50926ac84" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-714c-ab3b-5b39263297d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019b096a-62ab-795b-998c-cf289781c2a1" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-714c-ab3b-5b39263297d7" xlink:to="loc_jynt_CorporateClinicsMember_019b096a-62ab-795b-998c-cf289781c2a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_019b096a-62ab-7f4c-93e6-554a7395f818" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-7553-b4e9-1b31f9021a10" xlink:to="loc_us-gaap_ProductInformationLineItems_019b096a-62ab-7f4c-93e6-554a7395f818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward_019b096a-62ab-7b33-ba4a-79aafa9b20ae" xlink:href="jynt-20251231.xsd#jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019b096a-62ab-7f4c-93e6-554a7395f818" xlink:to="loc_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward_019b096a-62ab-7b33-ba4a-79aafa9b20ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_019b096a-62ab-75cd-8ef0-9e8196484ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfStores"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward_019b096a-62ab-7b33-ba4a-79aafa9b20ae" xlink:to="loc_us-gaap_NumberOfStores_019b096a-62ab-75cd-8ef0-9e8196484ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ClinicsOpenedDuringThePeriod_019b096a-62ab-7829-a6d9-8b4fcf2e04a0" xlink:href="jynt-20251231.xsd#jynt_ClinicsOpenedDuringThePeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward_019b096a-62ab-7b33-ba4a-79aafa9b20ae" xlink:to="loc_jynt_ClinicsOpenedDuringThePeriod_019b096a-62ab-7829-a6d9-8b4fcf2e04a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ClinicsAcquiredDuringPeriod_019b096a-62ab-7ec8-8c02-6194d4e91225" xlink:href="jynt-20251231.xsd#jynt_ClinicsAcquiredDuringPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward_019b096a-62ab-7b33-ba4a-79aafa9b20ae" xlink:to="loc_jynt_ClinicsAcquiredDuringPeriod_019b096a-62ab-7ec8-8c02-6194d4e91225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ClinicsSoldDuringPeriod_019b096a-62ab-7eae-9fc5-9ff373dcc230" xlink:href="jynt-20251231.xsd#jynt_ClinicsSoldDuringPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward_019b096a-62ab-7b33-ba4a-79aafa9b20ae" xlink:to="loc_jynt_ClinicsSoldDuringPeriod_019b096a-62ab-7eae-9fc5-9ff373dcc230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ClinicsClosedDuringThePeriod_019b096a-62ab-71b2-8701-985769708eaa" xlink:href="jynt-20251231.xsd#jynt_ClinicsClosedDuringThePeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward_019b096a-62ab-7b33-ba4a-79aafa9b20ae" xlink:to="loc_jynt_ClinicsClosedDuringThePeriod_019b096a-62ab-71b2-8701-985769708eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_019b096a-62ab-7b74-99cd-a9bfb020e925" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfStores"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward_019b096a-62ab-7b33-ba4a-79aafa9b20ae" xlink:to="loc_us-gaap_NumberOfStores_019b096a-62ab-7b74-99cd-a9bfb020e925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ClinicLicensesSoldButNotYetDeveloped_019b096a-62ab-7a57-ad12-884126c648ed" xlink:href="jynt-20251231.xsd#jynt_ClinicLicensesSoldButNotYetDeveloped"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019b096a-62ab-7f4c-93e6-554a7395f818" xlink:to="loc_jynt_ClinicLicensesSoldButNotYetDeveloped_019b096a-62ab-7a57-ad12-884126c648ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ExecutedLettersOfIntentForFutureClinicLicenses_019b096a-62ab-7c67-85db-2651eea41da4" xlink:href="jynt-20251231.xsd#jynt_ExecutedLettersOfIntentForFutureClinicLicenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019b096a-62ab-7f4c-93e6-554a7395f818" xlink:to="loc_jynt_ExecutedLettersOfIntentForFutureClinicLicenses_019b096a-62ab-7c67-85db-2651eea41da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-7c60-b928-0f13f9ddc1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-77a1-8051-051799d4fc01" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-7c60-b928-0f13f9ddc1b6" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-77a1-8051-051799d4fc01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019be4a5-e4b7-733c-8cf4-3d945e3676b2" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-77a1-8051-051799d4fc01" xlink:to="loc_srt_RangeAxis_019be4a5-e4b7-733c-8cf4-3d945e3676b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019be4a5-e4b7-734e-aec2-5bb59fd2d038" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019be4a5-e4b7-733c-8cf4-3d945e3676b2" xlink:to="loc_srt_RangeMember_019be4a5-e4b7-734e-aec2-5bb59fd2d038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019be4a5-e4b7-76ff-aec9-6425ae69acab" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019be4a5-e4b7-734e-aec2-5bb59fd2d038" xlink:to="loc_srt_MinimumMember_019be4a5-e4b7-76ff-aec9-6425ae69acab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019be4a5-e4b7-7125-97c7-5bf2b8b2422f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019be4a5-e4b7-734e-aec2-5bb59fd2d038" xlink:to="loc_srt_MaximumMember_019be4a5-e4b7-7125-97c7-5bf2b8b2422f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_019be4a7-8dfc-7099-ab1a-92f94bc80214" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-77a1-8051-051799d4fc01" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_019be4a7-8dfc-7099-ab1a-92f94bc80214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019be4a7-8dfc-7f0b-a9e7-4ebe54f2bfc7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_019be4a7-8dfc-7099-ab1a-92f94bc80214" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019be4a7-8dfc-7f0b-a9e7-4ebe54f2bfc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_019be4a7-8dfc-7436-8e17-2b704ca955cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019be4a7-8dfc-7f0b-a9e7-4ebe54f2bfc7" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_019be4a7-8dfc-7436-8e17-2b704ca955cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchiseRightsMember_019be4a8-1ab8-7b5a-a190-67f94c06d5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchiseRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019be4a7-8dfc-7f0b-a9e7-4ebe54f2bfc7" xlink:to="loc_us-gaap_FranchiseRightsMember_019be4a8-1ab8-7b5a-a190-67f94c06d5e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_019be4a8-1ab8-769c-aeed-09468865037d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019be4a7-8dfc-7f0b-a9e7-4ebe54f2bfc7" xlink:to="loc_us-gaap_CustomerRelationshipsMember_019be4a8-1ab8-769c-aeed-09468865037d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019be4a7-f034-7c8f-83df-f3efb0a2da6b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-77a1-8051-051799d4fc01" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019be4a7-f034-7c8f-83df-f3efb0a2da6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019be4a7-f034-79c7-951a-aabc092f876e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019be4a7-f034-7c8f-83df-f3efb0a2da6b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019be4a7-f034-79c7-951a-aabc092f876e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019c65ca-fa2e-79e6-8168-2f417a472950" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019be4a7-f034-79c7-951a-aabc092f876e" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019c65ca-fa2e-79e6-8168-2f417a472950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_019be4a7-f034-7afe-96df-2dadf3d808d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019be4a7-f034-79c7-951a-aabc092f876e" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_019be4a7-f034-7afe-96df-2dadf3d808d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_019be4a8-c413-76be-bb35-4df5e7ef4563" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019be4a7-f034-79c7-951a-aabc092f876e" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_019be4a8-c413-76be-bb35-4df5e7ef4563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_019be4a7-f034-7bc1-b87d-d9dc58e58b60" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-77a1-8051-051799d4fc01" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_019be4a7-f034-7bc1-b87d-d9dc58e58b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019be4a7-f034-74a4-8cb2-6a3e6e3a3fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_019be4a7-f034-7bc1-b87d-d9dc58e58b60" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019be4a7-f034-74a4-8cb2-6a3e6e3a3fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_OperatingLeaseRightOfUseAssetMember_019be4a7-f034-7b4c-97b0-ac8d51bc63ee" xlink:href="jynt-20251231.xsd#jynt_OperatingLeaseRightOfUseAssetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019be4a7-f034-74a4-8cb2-6a3e6e3a3fd0" xlink:to="loc_jynt_OperatingLeaseRightOfUseAssetMember_019be4a7-f034-7b4c-97b0-ac8d51bc63ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019be4a7-f034-7036-a95e-929e8a13fcf3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-77a1-8051-051799d4fc01" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019be4a7-f034-7036-a95e-929e8a13fcf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019be4a7-f034-7c91-8fad-9a68dd6c60c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019be4a7-f034-7036-a95e-929e8a13fcf3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019be4a7-f034-7c91-8fad-9a68dd6c60c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019be4a7-f034-766b-8dd0-15695c6809e6" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019be4a7-f034-7c91-8fad-9a68dd6c60c3" xlink:to="loc_jynt_CorporateClinicsMember_019be4a7-f034-766b-8dd0-15695c6809e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_019c65ca-fa2e-76a9-9023-45610a3f00b6" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-77a1-8051-051799d4fc01" xlink:to="loc_srt_StatementGeographicalAxis_019c65ca-fa2e-76a9-9023-45610a3f00b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_019c65ca-fa2e-715d-882e-59a512003f9d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_019c65ca-fa2e-76a9-9023-45610a3f00b6" xlink:to="loc_srt_SegmentGeographicalDomain_019c65ca-fa2e-715d-882e-59a512003f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_KansasAndMissouriMember_019c9094-1709-78a0-b719-b5fdf89cd8ec" xlink:href="jynt-20251231.xsd#jynt_KansasAndMissouriMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_019c65ca-fa2e-715d-882e-59a512003f9d" xlink:to="loc_jynt_KansasAndMissouriMember_019c9094-1709-78a0-b719-b5fdf89cd8ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisorDisclosureAxis_019c65ca-fa2e-7c3c-90a2-9c63e49c527e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisorDisclosureAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-77a1-8051-051799d4fc01" xlink:to="loc_us-gaap_FranchisorDisclosureAxis_019c65ca-fa2e-7c3c-90a2-9c63e49c527e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisorDisclosureDomain_019c65ca-fa2e-7d4e-bcdb-6e91e31d98c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisorDisclosureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FranchisorDisclosureAxis_019c65ca-fa2e-7c3c-90a2-9c63e49c527e" xlink:to="loc_us-gaap_FranchisorDisclosureDomain_019c65ca-fa2e-7d4e-bcdb-6e91e31d98c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityOperatedUnitsMember_019c65ca-fa2e-73f8-9c70-3fb53d9a8887" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EntityOperatedUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FranchisorDisclosureDomain_019c65ca-fa2e-7d4e-bcdb-6e91e31d98c9" xlink:to="loc_us-gaap_EntityOperatedUnitsMember_019c65ca-fa2e-73f8-9c70-3fb53d9a8887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_019c9083-23cc-766c-a7ee-d917bff32fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-77a1-8051-051799d4fc01" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_019c9083-23cc-766c-a7ee-d917bff32fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_019c9083-23cc-7a92-a720-4c4f9c8f5509" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_019c9083-23cc-766c-a7ee-d917bff32fbe" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_019c9083-23cc-7a92-a720-4c4f9c8f5509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_019c9083-8cbc-7840-afb2-a5d840d3a9d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_019c9083-23cc-7a92-a720-4c4f9c8f5509" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_019c9083-8cbc-7840-afb2-a5d840d3a9d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductInformationLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019b096a-62ab-77a1-8051-051799d4fc01" xlink:to="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ManagementAgreementNumberOfProfessionalCorporations_019be4a5-36c8-7242-bed4-adcaa1328ade" xlink:href="jynt-20251231.xsd#jynt_ManagementAgreementNumberOfProfessionalCorporations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_jynt_ManagementAgreementNumberOfProfessionalCorporations_019be4a5-36c8-7242-bed4-adcaa1328ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ClinicsSoldDuringPeriod_019c65ca-fa2e-7778-af98-e54f4a77621f" xlink:href="jynt-20251231.xsd#jynt_ClinicsSoldDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_jynt_ClinicsSoldDuringPeriod_019c65ca-fa2e-7778-af98-e54f4a77621f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ManagementAgreementTerminationNumberOfProfessionalCorporations_019c65ca-fa2e-7fda-85d8-227e40bf9e30" xlink:href="jynt-20251231.xsd#jynt_ManagementAgreementTerminationNumberOfProfessionalCorporations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_jynt_ManagementAgreementTerminationNumberOfProfessionalCorporations_019c65ca-fa2e-7fda-85d8-227e40bf9e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_019be4a5-6dd2-742b-b19a-5e9173c1e15c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_019be4a5-6dd2-742b-b19a-5e9173c1e15c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019be4a5-97db-71e1-b91a-ccd15a411127" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019be4a5-97db-71e1-b91a-ccd15a411127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_019be4a5-e4b7-7d24-a360-a562b3a12aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_019be4a5-e4b7-7d24-a360-a562b3a12aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_019be4a5-e4b7-791f-aa0a-9fbe6fdd7787" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_019be4a5-e4b7-791f-aa0a-9fbe6fdd7787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_019be4a7-8dfc-7f01-a717-baeb83919e11" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_019be4a7-8dfc-7f01-a717-baeb83919e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_LesseeOperatingLeaseNumberOfRenewalOptions_019be4a7-b2f9-7c9e-80cc-1dd9a0279bb4" xlink:href="jynt-20251231.xsd#jynt_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_jynt_LesseeOperatingLeaseNumberOfRenewalOptions_019be4a7-b2f9-7c9e-80cc-1dd9a0279bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019be4a7-f034-78a3-a98d-a20d0563dad3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019be4a7-f034-78a3-a98d-a20d0563dad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_019be4a8-4d14-7452-91f2-f564f5c1c637" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_019be4a8-4d14-7452-91f2-f564f5c1c637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_019be4a8-c413-715d-a62d-3ea9eecf5746" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_019be4a8-c413-715d-a62d-3ea9eecf5746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage_019be4ac-75fa-767f-822f-e2be2cf2e0ed" xlink:href="jynt-20251231.xsd#jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage_019be4ac-75fa-767f-822f-e2be2cf2e0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_FranchiseRoyaltyGrossSalesPercentage_019be4ac-9c07-7035-8f6a-5415e1a3c6f1" xlink:href="jynt-20251231.xsd#jynt_FranchiseRoyaltyGrossSalesPercentage"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_jynt_FranchiseRoyaltyGrossSalesPercentage_019be4ac-9c07-7035-8f6a-5415e1a3c6f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_RevenueRecognitionFranchiseAgreementTerm_019be4ac-bff5-76d4-8479-7ab125b9e07a" xlink:href="jynt-20251231.xsd#jynt_RevenueRecognitionFranchiseAgreementTerm"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_jynt_RevenueRecognitionFranchiseAgreementTerm_019be4ac-bff5-76d4-8479-7ab125b9e07a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage_019be4ac-e011-7b25-8d21-bb0184b6a556" xlink:href="jynt-20251231.xsd#jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage_019be4ac-e011-7b25-8d21-bb0184b6a556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_019be4ad-00f3-76b6-bab6-6cf1adef847f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_us-gaap_AdvertisingExpense_019be4ad-00f3-76b6-bab6-6cf1adef847f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_019be4ad-2371-7872-9b96-115557c6e37a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_019be4ad-2371-7872-9b96-115557c6e37a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage_019be4e0-d6f8-762c-9fa3-7f3a445d10c6" xlink:href="jynt-20251231.xsd#jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage_019be4e0-d6f8-762c-9fa3-7f3a445d10c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_019be4ad-4f44-79ad-b0ca-606bfbeaba8c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_019be4ad-4f44-79ad-b0ca-606bfbeaba8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_019be4ad-4f44-7030-bfca-b23a2045630c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019be4a5-36c8-7be0-9c67-8fbd5bb4a0de" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_019be4ad-4f44-7030-bfca-b23a2045630c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEIncomeStatementDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEIncomeStatementDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEIncomeStatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-751e-9306-0148ac6a7f07" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_019b096a-62ab-710b-a798-f67b2a1beac1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-751e-9306-0148ac6a7f07" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_019b096a-62ab-710b-a798-f67b2a1beac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_019b096a-62ab-702f-bc9e-c22dfdfe75b5" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_019b096a-62ab-710b-a798-f67b2a1beac1" xlink:to="loc_srt_ConsolidatedEntitiesAxis_019b096a-62ab-702f-bc9e-c22dfdfe75b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_019b096a-62ab-7336-98e8-683affeda9b0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_019b096a-62ab-702f-bc9e-c22dfdfe75b5" xlink:to="loc_srt_ConsolidatedEntitiesDomain_019b096a-62ab-7336-98e8-683affeda9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_019b096a-62ab-7bed-ad8f-7394c51045d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_019b096a-62ab-7336-98e8-683affeda9b0" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_019b096a-62ab-7bed-ad8f-7394c51045d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-77a6-905b-9e5a7d72c548" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_019b096a-62ab-710b-a798-f67b2a1beac1" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-77a6-905b-9e5a7d72c548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-75f7-88f3-790df5e423f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-77a6-905b-9e5a7d72c548" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-75f7-88f3-790df5e423f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019b096a-62ab-7530-a276-c339413f4415" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-75f7-88f3-790df5e423f0" xlink:to="loc_jynt_CorporateClinicsMember_019b096a-62ab-7530-a276-c339413f4415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_019b096a-62ab-7f4d-93db-578083d33fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_019b096a-62ab-710b-a798-f67b2a1beac1" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_019b096a-62ab-7f4d-93db-578083d33fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b096a-62ab-797a-a28b-f9780e161754" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_019b096a-62ab-7f4d-93db-578083d33fc2" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b096a-62ab-797a-a28b-f9780e161754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_019b096a-62ab-7a6a-a278-4c0b64f2eea8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_019b096a-62ab-7f4d-93db-578083d33fc2" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_019b096a-62ab-7a6a-a278-4c0b64f2eea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-62ab-77c5-8b8b-08d10b60b750" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_019b096a-62ab-7f4d-93db-578083d33fc2" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-62ab-77c5-8b8b-08d10b60b750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-74a3-b4c2-9608dc1675d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_019b096a-62ab-7c8d-9801-92347c69f7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-74a3-b4c2-9608dc1675d3" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_019b096a-62ab-7c8d-9801-92347c69f7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_019b096a-62ab-7cba-affb-c56aadc91aea" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_019b096a-62ab-7c8d-9801-92347c69f7a8" xlink:to="loc_srt_ConsolidatedEntitiesAxis_019b096a-62ab-7cba-affb-c56aadc91aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_019b096a-62ab-7129-b7af-f1eb1b84afd4" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_019b096a-62ab-7cba-affb-c56aadc91aea" xlink:to="loc_srt_ConsolidatedEntitiesDomain_019b096a-62ab-7129-b7af-f1eb1b84afd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_019b096a-62ab-7d56-b68c-0c6271b98447" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_019b096a-62ab-7129-b7af-f1eb1b84afd4" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_019b096a-62ab-7d56-b68c-0c6271b98447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7ed3-896d-775b2a5db644" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_019b096a-62ab-7c8d-9801-92347c69f7a8" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7ed3-896d-775b2a5db644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-73dd-b30d-905af9008c16" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7ed3-896d-775b2a5db644" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-73dd-b30d-905af9008c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019b096a-62ab-74a4-995c-62be4b98b7a9" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-73dd-b30d-905af9008c16" xlink:to="loc_jynt_CorporateClinicsMember_019b096a-62ab-74a4-995c-62be4b98b7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_019b096a-62ab-77d6-85d0-1563a3b4f93f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_019b096a-62ab-7c8d-9801-92347c69f7a8" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_019b096a-62ab-77d6-85d0-1563a3b4f93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-7b3c-b0d0-367881a051a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_019b096a-62ab-77d6-85d0-1563a3b4f93f" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-7b3c-b0d0-367881a051a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-706b-9cb8-64c763eeea4f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_019b096a-62ab-77d6-85d0-1563a3b4f93f" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-706b-9cb8-64c763eeea4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesReconciliationofofAccountsReceivableAllowanceforCreditLossesDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#NatureofOperationsandSummaryofSignificantAccountingPoliciesReconciliationofofAccountsReceivableAllowanceforCreditLossesDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesReconciliationofofAccountsReceivableAllowanceforCreditLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-77ac-b979-91c3baa97659" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_019b096a-62ab-7e0e-96d6-7cf7a2351189" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-77ac-b979-91c3baa97659" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_019b096a-62ab-7e0e-96d6-7cf7a2351189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019b096a-62ab-7cf5-b793-60f8513faa0d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_019b096a-62ab-7e0e-96d6-7cf7a2351189" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019b096a-62ab-7cf5-b793-60f8513faa0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_019b096a-62ab-7119-829a-e3d785faa18e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_019b096a-62ab-7e0e-96d6-7cf7a2351189" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_019b096a-62ab-7119-829a-e3d785faa18e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_019b096a-62ab-74ad-9284-1e321b3cf3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_019b096a-62ab-7e0e-96d6-7cf7a2351189" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_019b096a-62ab-74ad-9284-1e321b3cf3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019b096a-62ab-7896-88cb-606e4ca22109" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_019b096a-62ab-7e0e-96d6-7cf7a2351189" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019b096a-62ab-7896-88cb-606e4ca22109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNetLossGainonDispositionorImpairmentRelatedtoContinuingOperationsDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#NatureofOperationsandSummaryofSignificantAccountingPoliciesNetLossGainonDispositionorImpairmentRelatedtoContinuingOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNetLossGainonDispositionorImpairmentRelatedtoContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-7829-bee3-0b204369c59e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_019b096a-62ab-7f03-8276-57a47c2393e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-7829-bee3-0b204369c59e" xlink:to="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_019b096a-62ab-7f03-8276-57a47c2393e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_019b096a-62ab-7c39-810a-fba93e65a221" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_019b096a-62ab-7f03-8276-57a47c2393e3" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_019b096a-62ab-7c39-810a-fba93e65a221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_019b096a-62ab-7b75-840e-acc2ec70c2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_019b096a-62ab-7c39-810a-fba93e65a221" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_019b096a-62ab-7b75-840e-acc2ec70c2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_019b096a-62ab-7601-be12-7388ab5fae50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_019b096a-62ab-7b75-840e-acc2ec70c2d0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_019b096a-62ab-7601-be12-7388ab5fae50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_OperatingLeaseRightOfUseAssetMember_019b096a-62ab-7001-bb90-4b9b101e16dd" xlink:href="jynt-20251231.xsd#jynt_OperatingLeaseRightOfUseAssetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_019b096a-62ab-7b75-840e-acc2ec70c2d0" xlink:to="loc_jynt_OperatingLeaseRightOfUseAssetMember_019b096a-62ab-7001-bb90-4b9b101e16dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMember_019b096a-62ab-7d3a-9c42-e34e7cf1dd28" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_019b096a-62ab-7b75-840e-acc2ec70c2d0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMember_019b096a-62ab-7d3a-9c42-e34e7cf1dd28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_019b096a-62ab-75e1-b7e9-63404224d269" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_019b096a-62ab-7f03-8276-57a47c2393e3" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_019b096a-62ab-75e1-b7e9-63404224d269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_019b096a-62ab-7676-bebc-860a4808d015" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_019b096a-62ab-75e1-b7e9-63404224d269" xlink:to="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_019b096a-62ab-7676-bebc-860a4808d015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment_019b096a-62ab-71f8-b3f4-5f5da0c38a23" xlink:href="jynt-20251231.xsd#jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_019b096a-62ab-75e1-b7e9-63404224d269" xlink:to="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment_019b096a-62ab-71f8-b3f4-5f5da0c38a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment_019b096a-62ab-7e2d-bbc5-93a2a6dabe54" xlink:href="jynt-20251231.xsd#jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_019b096a-62ab-75e1-b7e9-63404224d269" xlink:to="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment_019b096a-62ab-7e2d-bbc5-93a2a6dabe54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_019b096a-62ab-7d40-a6ab-699a6ff18c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_019b096a-62ab-75e1-b7e9-63404224d269" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_019b096a-62ab-7d40-a6ab-699a6ff18c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-7431-b202-b49fa15f56fb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_019b096a-62ab-77d6-b748-dcfca1eb3852" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-7431-b202-b49fa15f56fb" xlink:to="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_019b096a-62ab-77d6-b748-dcfca1eb3852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-7662-a2e3-f4f0ea448698" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_019b096a-62ab-77d6-b748-dcfca1eb3852" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-7662-a2e3-f4f0ea448698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-756d-899f-ddd41de3cef1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-7662-a2e3-f4f0ea448698" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-756d-899f-ddd41de3cef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_019b096a-62ab-76af-afb3-bb2af36f5fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-756d-899f-ddd41de3cef1" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_019b096a-62ab-76af-afb3-bb2af36f5fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DiscontinuedOperationsHeldForUseMember_019b096a-62ab-7447-8edb-54c7326c3fcf" xlink:href="jynt-20251231.xsd#jynt_DiscontinuedOperationsHeldForUseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDiscontinuedOperationsMember_019b096a-62ab-76af-afb3-bb2af36f5fb0" xlink:to="loc_jynt_DiscontinuedOperationsHeldForUseMember_019b096a-62ab-7447-8edb-54c7326c3fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_019b096a-62ab-7adb-856c-b96aaf7127e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDiscontinuedOperationsMember_019b096a-62ab-76af-afb3-bb2af36f5fb0" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_019b096a-62ab-7adb-856c-b96aaf7127e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_019b096a-62ab-723b-add8-ccdf99ca9fda" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDiscontinuedOperationsMember_019b096a-62ab-76af-afb3-bb2af36f5fb0" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_019b096a-62ab-723b-add8-ccdf99ca9fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_019b096a-62ab-73d7-b659-e60195bda422" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDiscontinuedOperationsMember_019b096a-62ab-76af-afb3-bb2af36f5fb0" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_019b096a-62ab-73d7-b659-e60195bda422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_019b096a-62ab-7efa-913a-f8aac622e62f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_019b096a-62ab-77d6-b748-dcfca1eb3852" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_019b096a-62ab-7efa-913a-f8aac622e62f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019b096a-62ab-7e60-bd73-6157dc41f7ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_019b096a-62ab-7efa-913a-f8aac622e62f" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019b096a-62ab-7e60-bd73-6157dc41f7ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_019b096a-62ab-7640-9270-c4ab09545a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019b096a-62ab-7e60-bd73-6157dc41f7ff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_019b096a-62ab-7640-9270-c4ab09545a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_OperatingLeaseRightOfUseAssetMember_019b096a-62ab-79aa-bca2-a69be272e486" xlink:href="jynt-20251231.xsd#jynt_OperatingLeaseRightOfUseAssetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019b096a-62ab-7e60-bd73-6157dc41f7ff" xlink:to="loc_jynt_OperatingLeaseRightOfUseAssetMember_019b096a-62ab-79aa-bca2-a69be272e486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMember_019b096a-62ab-7194-9dda-0cdfdcc1fea9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019b096a-62ab-7e60-bd73-6157dc41f7ff" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMember_019b096a-62ab-7194-9dda-0cdfdcc1fea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AssetsHeldForSaleMember_019b096a-62ab-7601-9a8d-375a92906cca" xlink:href="jynt-20251231.xsd#jynt_AssetsHeldForSaleMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019b096a-62ab-7e60-bd73-6157dc41f7ff" xlink:to="loc_jynt_AssetsHeldForSaleMember_019b096a-62ab-7601-9a8d-375a92906cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b32ea-7e1b-7640-a1fa-9b0044041181" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_019b096a-62ab-77d6-b748-dcfca1eb3852" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b32ea-7e1b-7640-a1fa-9b0044041181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b32ea-7e1b-786e-8144-dec28161e4fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b32ea-7e1b-7640-a1fa-9b0044041181" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b32ea-7e1b-786e-8144-dec28161e4fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019b32ea-7e1b-7431-a642-e083507e1d2e" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b32ea-7e1b-786e-8144-dec28161e4fd" xlink:to="loc_jynt_CorporateClinicsMember_019b32ea-7e1b-7431-a642-e083507e1d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_019b096a-62ab-7272-8bf5-3a9c431714b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_019b096a-62ab-77d6-b748-dcfca1eb3852" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_019b096a-62ab-7272-8bf5-3a9c431714b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment_019b096a-62ab-7189-9486-474396109c95" xlink:href="jynt-20251231.xsd#jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_019b096a-62ab-7272-8bf5-3a9c431714b2" xlink:to="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment_019b096a-62ab-7189-9486-474396109c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment_019b096a-62ab-7ce6-a714-e9ace7c78a35" xlink:href="jynt-20251231.xsd#jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_019b096a-62ab-7272-8bf5-3a9c431714b2" xlink:to="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment_019b096a-62ab-7ce6-a714-e9ace7c78a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019b096a-62ab-73ec-a348-233731d6a5b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_019b096a-62ab-7272-8bf5-3a9c431714b2" xlink:to="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019b096a-62ab-73ec-a348-233731d6a5b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-7c22-aa6a-3169e32c32c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-62ab-7db0-ab09-71a86dc8f1e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-7c22-aa6a-3169e32c32c4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-62ab-7db0-ab09-71a86dc8f1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-62ab-7ef2-bf16-4f118fdef012" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-7c22-aa6a-3169e32c32c4" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-62ab-7ef2-bf16-4f118fdef012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_019b096a-62ab-7e68-a213-2302880a656f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-7c22-aa6a-3169e32c32c4" xlink:to="loc_us-gaap_ProfitLoss_019b096a-62ab-7e68-a213-2302880a656f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019b096a-62ab-7289-8d48-0a4f7ab0a40f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-7c22-aa6a-3169e32c32c4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019b096a-62ab-7289-8d48-0a4f7ab0a40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_019b096a-62ab-7233-a660-2994a5207e61" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-7c22-aa6a-3169e32c32c4" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_019b096a-62ab-7233-a660-2994a5207e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_019b096a-62ab-7489-8e36-64fd1ecbdacb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_019b096a-62ab-7233-a660-2994a5207e61" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_019b096a-62ab-7489-8e36-64fd1ecbdacb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019b096a-62ab-7c28-b458-f8541f53751a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-7c22-aa6a-3169e32c32c4" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019b096a-62ab-7c28-b458-f8541f53751a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019b096a-62ab-7b32-84d7-f37ae3837eba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019b096a-62ab-7c22-aa6a-3169e32c32c4" xlink:to="loc_us-gaap_EarningsPerShareAbstract_019b096a-62ab-7b32-84d7-f37ae3837eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_019b096a-62ab-7038-b52b-0e7317ffabfa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019b096a-62ab-7b32-84d7-f37ae3837eba" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_019b096a-62ab-7038-b52b-0e7317ffabfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_019b096a-62ab-791c-b6a5-0b1c4fd4ee6f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_019b096a-62ab-7038-b52b-0e7317ffabfa" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_019b096a-62ab-791c-b6a5-0b1c4fd4ee6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_019b096a-62ab-7e51-ba26-a66d46c8a396" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_019b096a-62ab-7038-b52b-0e7317ffabfa" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_019b096a-62ab-7e51-ba26-a66d46c8a396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_019b096a-62ab-70dc-a2db-a92da7915d26" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_019b096a-62ab-7038-b52b-0e7317ffabfa" xlink:to="loc_us-gaap_EarningsPerShareBasic_019b096a-62ab-70dc-a2db-a92da7915d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_019b096a-62ab-76af-ab4f-975a0d9c2e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019b096a-62ab-7b32-84d7-f37ae3837eba" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_019b096a-62ab-76af-ab4f-975a0d9c2e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_019b096a-62ab-7d93-b7b2-7d242d797379" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_019b096a-62ab-76af-ab4f-975a0d9c2e3b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_019b096a-62ab-7d93-b7b2-7d242d797379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_019b096a-62ab-7115-994c-b231c984a18f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_019b096a-62ab-76af-ab4f-975a0d9c2e3b" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_019b096a-62ab-7115-994c-b231c984a18f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_019b096a-62ab-7718-ac62-0854c2b9c7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_019b096a-62ab-76af-ab4f-975a0d9c2e3b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_019b096a-62ab-7718-ac62-0854c2b9c7c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_019b096a-62ab-7167-bff0-7a3f9b8b7e59" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019b096a-62ab-7b32-84d7-f37ae3837eba" xlink:to="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_019b096a-62ab-7167-bff0-7a3f9b8b7e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019b096a-62ab-7089-b0c7-b7292d44191e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_019b096a-62ab-7167-bff0-7a3f9b8b7e59" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019b096a-62ab-7089-b0c7-b7292d44191e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/RevenueDisclosuresNarrativeDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#RevenueDisclosuresNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/RevenueDisclosuresNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019b096a-62ab-7fa4-a746-f8b8c1d60f90" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_019b096a-62ab-79b8-99eb-b85cf96b3881" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019b096a-62ab-7fa4-a746-f8b8c1d60f90" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_019b096a-62ab-79b8-99eb-b85cf96b3881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisorDisclosureAxis_019b096a-62ab-7602-a76e-6567a28cd3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisorDisclosureAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019b096a-62ab-79b8-99eb-b85cf96b3881" xlink:to="loc_us-gaap_FranchisorDisclosureAxis_019b096a-62ab-7602-a76e-6567a28cd3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisorDisclosureDomain_019b096a-62ab-750e-9600-92fd6b885951" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisorDisclosureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FranchisorDisclosureAxis_019b096a-62ab-7602-a76e-6567a28cd3c3" xlink:to="loc_us-gaap_FranchisorDisclosureDomain_019b096a-62ab-750e-9600-92fd6b885951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisedUnitsMember_019b096a-62ab-7438-8902-e9e8795c4ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisedUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FranchisorDisclosureDomain_019b096a-62ab-750e-9600-92fd6b885951" xlink:to="loc_us-gaap_FranchisedUnitsMember_019b096a-62ab-7438-8902-e9e8795c4ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-7e3f-afd1-85343617d84e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019b096a-62ab-79b8-99eb-b85cf96b3881" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-7e3f-afd1-85343617d84e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_019b096a-62ab-74ff-a652-0007db17220f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfStores"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-7e3f-afd1-85343617d84e" xlink:to="loc_us-gaap_NumberOfStores_019b096a-62ab-74ff-a652-0007db17220f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ClinicLicensesSoldButNotYetDeveloped_019b096a-62ab-79ac-9305-944e2d9520b2" xlink:href="jynt-20251231.xsd#jynt_ClinicLicensesSoldButNotYetDeveloped"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-7e3f-afd1-85343617d84e" xlink:to="loc_jynt_ClinicLicensesSoldButNotYetDeveloped_019b096a-62ab-79ac-9305-944e2d9520b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ExecutedLettersOfIntentForFutureClinicLicenses_019b096a-62ab-7f9e-a15e-16958a39697d" xlink:href="jynt-20251231.xsd#jynt_ExecutedLettersOfIntentForFutureClinicLicenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-7e3f-afd1-85343617d84e" xlink:to="loc_jynt_ExecutedLettersOfIntentForFutureClinicLicenses_019b096a-62ab-7f9e-a15e-16958a39697d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/RevenueDisclosuresDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#RevenueDisclosuresDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/RevenueDisclosuresDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019b096a-62ab-708d-bbb8-efccacf706c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_019b096a-62ab-7aee-bbdc-03fdb0d6a95f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019b096a-62ab-708d-bbb8-efccacf706c3" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_019b096a-62ab-7aee-bbdc-03fdb0d6a95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_019b096a-62ab-7a59-bd29-77946fa6f2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019b096a-62ab-7aee-bbdc-03fdb0d6a95f" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_019b096a-62ab-7a59-bd29-77946fa6f2dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_019b096a-62ab-75ca-99d9-fb38e7c061b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_019b096a-62ab-7a59-bd29-77946fa6f2dc" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_019b096a-62ab-75ca-99d9-fb38e7c061b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredAtPointInTimeMember_019b096a-62ab-7388-89dc-47273ea2a87b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransferredAtPointInTimeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_019b096a-62ab-75ca-99d9-fb38e7c061b0" xlink:to="loc_us-gaap_TransferredAtPointInTimeMember_019b096a-62ab-7388-89dc-47273ea2a87b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_019b096a-62ab-772c-b67a-5289b3b6648c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_019b096a-62ab-75ca-99d9-fb38e7c061b0" xlink:to="loc_us-gaap_TransferredOverTimeMember_019b096a-62ab-772c-b67a-5289b3b6648c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-7596-936f-4c1130a5bd1c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019b096a-62ab-7aee-bbdc-03fdb0d6a95f" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-7596-936f-4c1130a5bd1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_019b096a-62ab-73a3-aa0a-a915a5647057" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-7596-936f-4c1130a5bd1c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_019b096a-62ab-73a3-aa0a-a915a5647057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/RevenueDisclosuresRollforwardofAccountsReceivableDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#RevenueDisclosuresRollforwardofAccountsReceivableDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/RevenueDisclosuresRollforwardofAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019b096a-62ab-72d4-8ce7-d7fd92c1bad4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward_019b096a-62ab-754d-be51-27a537dc1c47" xlink:href="jynt-20251231.xsd#jynt_AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019b096a-62ab-72d4-8ce7-d7fd92c1bad4" xlink:to="loc_jynt_AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward_019b096a-62ab-754d-be51-27a537dc1c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_019b096a-62ab-7554-aff6-9f2f4a989328" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward_019b096a-62ab-754d-be51-27a537dc1c47" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_019b096a-62ab-7554-aff6-9f2f4a989328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance_019b096a-62ab-74f1-a794-8ab1c61866ad" xlink:href="jynt-20251231.xsd#jynt_AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward_019b096a-62ab-754d-be51-27a537dc1c47" xlink:to="loc_jynt_AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance_019b096a-62ab-74f1-a794-8ab1c61866ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance_019b096a-62ab-7072-bc0d-61a203097157" xlink:href="jynt-20251231.xsd#jynt_AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward_019b096a-62ab-754d-be51-27a537dc1c47" xlink:to="loc_jynt_AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance_019b096a-62ab-7072-bc0d-61a203097157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019b096a-62ab-78b6-a0ee-fd7723e0d389" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward_019b096a-62ab-754d-be51-27a537dc1c47" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019b096a-62ab-78b6-a0ee-fd7723e0d389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_019b096a-62ab-7a15-8927-0bd6f9daf524" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward_019b096a-62ab-754d-be51-27a537dc1c47" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_019b096a-62ab-7a15-8927-0bd6f9daf524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/RevenueDisclosuresRollforwardofContractLiabilitiesDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#RevenueDisclosuresRollforwardofContractLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/RevenueDisclosuresRollforwardofContractLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019b096a-62ab-774a-9b79-f1e5f4c20392" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ContractWithCustomerLiabilityRollForward_019b096a-62ab-7f80-aaf0-3e1300a59c0f" xlink:href="jynt-20251231.xsd#jynt_ContractWithCustomerLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019b096a-62ab-774a-9b79-f1e5f4c20392" xlink:to="loc_jynt_ContractWithCustomerLiabilityRollForward_019b096a-62ab-7f80-aaf0-3e1300a59c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_019b096a-62ab-7bd3-890c-701944943ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_ContractWithCustomerLiabilityRollForward_019b096a-62ab-7f80-aaf0-3e1300a59c0f" xlink:to="loc_us-gaap_ContractWithCustomerLiability_019b096a-62ab-7bd3-890c-701944943ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_019b096a-62ab-7a63-8d60-84a749a76c81" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_ContractWithCustomerLiabilityRollForward_019b096a-62ab-7f80-aaf0-3e1300a59c0f" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_019b096a-62ab-7a63-8d60-84a749a76c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_019b096a-62ab-79dd-ac1b-4f2ec2279aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_ContractWithCustomerLiabilityRollForward_019b096a-62ab-7f80-aaf0-3e1300a59c0f" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_019b096a-62ab-79dd-ac1b-4f2ec2279aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_019b096a-62ab-75e6-a002-598f790a4007" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_ContractWithCustomerLiabilityRollForward_019b096a-62ab-7f80-aaf0-3e1300a59c0f" xlink:to="loc_us-gaap_ContractWithCustomerLiability_019b096a-62ab-75e6-a002-598f790a4007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/RevenueDisclosuresRollforwardofDeferredFranchiseandDevelopmentCostsDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#RevenueDisclosuresRollforwardofDeferredFranchiseandDevelopmentCostsDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/RevenueDisclosuresRollforwardofDeferredFranchiseandDevelopmentCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019b096a-62ab-71ef-9729-b9bbddffa7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ContractWithCustomerAssetRollForward_019b096a-62ab-7319-8671-7260b5ac84b7" xlink:href="jynt-20251231.xsd#jynt_ContractWithCustomerAssetRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019b096a-62ab-71ef-9729-b9bbddffa7e0" xlink:to="loc_jynt_ContractWithCustomerAssetRollForward_019b096a-62ab-7319-8671-7260b5ac84b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_019b096a-62ab-7490-bfbb-b33c54c8eb8c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_ContractWithCustomerAssetRollForward_019b096a-62ab-7319-8671-7260b5ac84b7" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_019b096a-62ab-7490-bfbb-b33c54c8eb8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ContractWithCustomerAssetRecognizedAsCostsOfRevenue_019b096a-62ab-7d09-a314-708a6eacf94c" xlink:href="jynt-20251231.xsd#jynt_ContractWithCustomerAssetRecognizedAsCostsOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_ContractWithCustomerAssetRollForward_019b096a-62ab-7319-8671-7260b5ac84b7" xlink:to="loc_jynt_ContractWithCustomerAssetRecognizedAsCostsOfRevenue_019b096a-62ab-7d09-a314-708a6eacf94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CostsIncurredAndDeferredDuringTheYear_019b096a-62ab-7b59-9695-7d6dae974a44" xlink:href="jynt-20251231.xsd#jynt_CostsIncurredAndDeferredDuringTheYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_ContractWithCustomerAssetRollForward_019b096a-62ab-7319-8671-7260b5ac84b7" xlink:to="loc_jynt_CostsIncurredAndDeferredDuringTheYear_019b096a-62ab-7b59-9695-7d6dae974a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_019b096a-62ab-7cd0-bdd1-0c4ba0d04c67" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_ContractWithCustomerAssetRollForward_019b096a-62ab-7319-8671-7260b5ac84b7" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_019b096a-62ab-7cd0-bdd1-0c4ba0d04c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/RevenueDisclosuresEstimatedRevenueRelatedtoPerformanceObligationsDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#RevenueDisclosuresEstimatedRevenueRelatedtoPerformanceObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/RevenueDisclosuresEstimatedRevenueRelatedtoPerformanceObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019b096a-62ab-750f-a2ab-761dcfdea06b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_019b096a-62ab-72bc-850d-a5b3eff7aa04" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019b096a-62ab-750f-a2ab-761dcfdea06b" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_019b096a-62ab-72bc-850d-a5b3eff7aa04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_019b096a-62ab-7e3d-b7f3-ddae9ba58401" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019b096a-62ab-72bc-850d-a5b3eff7aa04" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_019b096a-62ab-7e3d-b7f3-ddae9ba58401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-75bb-8c0d-6b21b4088740" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019b096a-62ab-72bc-850d-a5b3eff7aa04" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-75bb-8c0d-6b21b4088740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_019b096a-62ab-781c-b8d5-75acd8a6687f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-75bb-8c0d-6b21b4088740" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_019b096a-62ab-781c-b8d5-75acd8a6687f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_019b096a-62ab-7165-b7f7-7e93ddef8de9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019b096a-62ab-75bb-8c0d-6b21b4088740" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_019b096a-62ab-7165-b7f7-7e93ddef8de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_019b096a-62ab-76ce-bbfe-a1b3451174e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-70d9-a1e2-61e9508201f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_019b096a-62ab-76ce-bbfe-a1b3451174e0" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-70d9-a1e2-61e9508201f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-79a4-a251-eb03372ed062" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-70d9-a1e2-61e9508201f9" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-79a4-a251-eb03372ed062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7df4-9075-86ec71b7420e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-79a4-a251-eb03372ed062" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7df4-9075-86ec71b7420e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019b096a-62ab-7cf1-91d5-5f5b9de25236" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7df4-9075-86ec71b7420e" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019b096a-62ab-7cf1-91d5-5f5b9de25236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7b5a-a529-f13154e7c34e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-70d9-a1e2-61e9508201f9" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7b5a-a529-f13154e7c34e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-79ee-9951-4529d1f6f91f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7b5a-a529-f13154e7c34e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-79ee-9951-4529d1f6f91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019b096a-62ab-7cb7-876b-777193823415" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-79ee-9951-4529d1f6f91f" xlink:to="loc_jynt_CorporateClinicsMember_019b096a-62ab-7cb7-876b-777193823415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-70d9-a1e2-61e9508201f9" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_019b096a-62ab-75b5-b944-9f98edcb2f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_us-gaap_RevenuesAbstract_019b096a-62ab-75b5-b944-9f98edcb2f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_019b096a-62ab-7342-8b4c-acd88cdb8c25" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_019b096a-62ab-75b5-b944-9f98edcb2f2a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_019b096a-62ab-7342-8b4c-acd88cdb8c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_019b096a-62ab-7023-b260-41855aa16c44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_us-gaap_CostOfRevenueAbstract_019b096a-62ab-7023-b260-41855aa16c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_019b096a-62ab-7b75-9537-764a16bc6dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_019b096a-62ab-7023-b260-41855aa16c44" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_019b096a-62ab-7b75-9537-764a16bc6dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses_019b096a-62ab-7f34-bf5d-7a8f73cb11cc" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses_019b096a-62ab-7f34-bf5d-7a8f73cb11cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_019b096a-62ab-7d14-97b8-7a79cddd200a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_019b096a-62ab-7d14-97b8-7a79cddd200a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_019b096a-62ab-7bb2-989a-3338a8b70683" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_019b096a-62ab-7bb2-989a-3338a8b70683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses_019b096a-62ab-7dad-9537-97e4d962c943" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses_019b096a-62ab-7dad-9537-97e4d962c943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019b096a-62ab-704d-a530-971dec2c5c16" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019b096a-62ab-704d-a530-971dec2c5c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_019b096a-62ab-7f4f-9778-14bd7b608079" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_019b096a-62ab-7f4f-9778-14bd7b608079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_019b096a-62ab-7425-9ca8-3738318f9be6" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_019b096a-62ab-7425-9ca8-3738318f9be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b096a-62ab-7649-9d66-cdf141924078" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b096a-62ab-7649-9d66-cdf141924078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_019b096a-62ab-7973-96af-2d291fa25361" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_019b096a-62ab-7973-96af-2d291fa25361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-62ab-7c93-becf-4d75c9b00491" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-72e0-943f-4bcd3537183a" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-62ab-7c93-becf-4d75c9b00491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_019b096a-62ab-770f-8a2a-73e4c959f20f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-77f5-885a-eb44f526c8ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_019b096a-62ab-770f-8a2a-73e4c959f20f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-77f5-885a-eb44f526c8ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-717d-b266-0d9e36baf10c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-77f5-885a-eb44f526c8ec" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-717d-b266-0d9e36baf10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7a52-8a9f-02e63fd2b5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-717d-b266-0d9e36baf10c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7a52-8a9f-02e63fd2b5ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019b096a-62ab-7b5d-b205-d465656316ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7a52-8a9f-02e63fd2b5ae" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019b096a-62ab-7b5d-b205-d465656316ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_019b096a-62ab-725c-9cdd-b3d63a2e391a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7a52-8a9f-02e63fd2b5ae" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_019b096a-62ab-725c-9cdd-b3d63a2e391a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7dd6-8d93-802249ec5c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-77f5-885a-eb44f526c8ec" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7dd6-8d93-802249ec5c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-78f0-b769-88f84bcb6e01" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7dd6-8d93-802249ec5c1d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-78f0-b769-88f84bcb6e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019b096a-62ab-7270-97f6-dd783b914d4f" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-78f0-b769-88f84bcb6e01" xlink:to="loc_jynt_CorporateClinicsMember_019b096a-62ab-7270-97f6-dd783b914d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_019b096a-62ab-786c-b75f-bd519a3cc116" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-77f5-885a-eb44f526c8ec" xlink:to="loc_srt_ConsolidatedEntitiesAxis_019b096a-62ab-786c-b75f-bd519a3cc116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_019b096a-62ab-7dc9-b173-1cc731793e27" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_019b096a-62ab-786c-b75f-bd519a3cc116" xlink:to="loc_srt_ConsolidatedEntitiesDomain_019b096a-62ab-7dc9-b173-1cc731793e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_019b096a-62ab-7b4d-9bd0-9e78094eb0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_019b096a-62ab-7dc9-b173-1cc731793e27" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_019b096a-62ab-7b4d-9bd0-9e78094eb0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-75b5-9a4d-df88728b27b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-77f5-885a-eb44f526c8ec" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-75b5-9a4d-df88728b27b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7c38-bb0d-bf4aff1d0b70" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-75b5-9a4d-df88728b27b7" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7c38-bb0d-bf4aff1d0b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_019b096a-62ab-7c06-88b2-05e9038c326e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7c38-bb0d-bf4aff1d0b70" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_019b096a-62ab-7c06-88b2-05e9038c326e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_019b096a-62ab-794e-9dbe-a5c758ddcfde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7c38-bb0d-bf4aff1d0b70" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_019b096a-62ab-794e-9dbe-a5c758ddcfde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-7433-ab53-5f60fe425c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7c38-bb0d-bf4aff1d0b70" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-7433-ab53-5f60fe425c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_019b096a-62ab-7da4-a36f-7b6045018a45" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7c38-bb0d-bf4aff1d0b70" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_019b096a-62ab-7da4-a36f-7b6045018a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent_019b096a-62ab-7728-999b-46e8bcc4dd47" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7c38-bb0d-bf4aff1d0b70" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent_019b096a-62ab-7728-999b-46e8bcc4dd47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_019b096a-62ab-7e24-8b91-0cd345d9b94d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7c38-bb0d-bf4aff1d0b70" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_019b096a-62ab-7e24-8b91-0cd345d9b94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_019b096a-62ab-767a-b588-f245221d913e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7c38-bb0d-bf4aff1d0b70" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_019b096a-62ab-767a-b588-f245221d913e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7962-9d3e-6a6f1423e975" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-75b5-9a4d-df88728b27b7" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7962-9d3e-6a6f1423e975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_019b096a-62ab-79d1-995e-af70e60728b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7962-9d3e-6a6f1423e975" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_019b096a-62ab-79d1-995e-af70e60728b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_019b096a-62ab-720e-bdfb-a8fd0434cc26" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7962-9d3e-6a6f1423e975" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_019b096a-62ab-720e-bdfb-a8fd0434cc26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent_019b096a-62ab-7163-becf-e022778f39f8" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7962-9d3e-6a6f1423e975" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent_019b096a-62ab-7163-becf-e022778f39f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_019b096a-62ab-71aa-978d-4630490dc40f" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7962-9d3e-6a6f1423e975" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_019b096a-62ab-71aa-978d-4630490dc40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent_019b096a-62ab-78a7-b971-f31792ef6f8d" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7962-9d3e-6a6f1423e975" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent_019b096a-62ab-78a7-b971-f31792ef6f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_019b096a-62ab-7fd1-a715-5e1655674f36" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7962-9d3e-6a6f1423e975" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_019b096a-62ab-7fd1-a715-5e1655674f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-7e8b-9996-d95c0a304784" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7962-9d3e-6a6f1423e975" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-7e8b-9996-d95c0a304784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_019b096a-62ab-7550-a502-d8e7037667a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7962-9d3e-6a6f1423e975" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_019b096a-62ab-7550-a502-d8e7037667a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/DivestituresKeyComponentsofCashFlowsfromDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#DivestituresKeyComponentsofCashFlowsfromDiscontinuedOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/DivestituresKeyComponentsofCashFlowsfromDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_019b096a-62ab-7088-885e-c5172c45b64e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-73a3-b1e3-cc1dc4d5e312" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_019b096a-62ab-7088-885e-c5172c45b64e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-73a3-b1e3-cc1dc4d5e312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-792a-8237-e4f4230494be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-73a3-b1e3-cc1dc4d5e312" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-792a-8237-e4f4230494be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7b05-b89e-b12d4b01fa63" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-792a-8237-e4f4230494be" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7b05-b89e-b12d4b01fa63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019b096a-62ab-7013-bc0e-cfbf760926bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7b05-b89e-b12d4b01fa63" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019b096a-62ab-7013-bc0e-cfbf760926bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7f13-a938-239dd8cc3d37" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-73a3-b1e3-cc1dc4d5e312" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7f13-a938-239dd8cc3d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-7368-8a8f-385dcda78412" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7f13-a938-239dd8cc3d37" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-7368-8a8f-385dcda78412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019b096a-62ab-7e49-b3ac-c6cd070d90b2" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-7368-8a8f-385dcda78412" xlink:to="loc_jynt_CorporateClinicsMember_019b096a-62ab-7e49-b3ac-c6cd070d90b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-758e-b066-07761b31aafe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-73a3-b1e3-cc1dc4d5e312" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-758e-b066-07761b31aafe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAlternativeCashFlowInformationAbstract_019b096a-62ab-703e-9602-b55a868f4204" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationAlternativeCashFlowInformationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-758e-b066-07761b31aafe" xlink:to="loc_us-gaap_DiscontinuedOperationAlternativeCashFlowInformationAbstract_019b096a-62ab-703e-9602-b55a868f4204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortizationDiscontinuedOperations_019c92a7-3fba-7237-b868-82a70b802628" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortizationDiscontinuedOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationAlternativeCashFlowInformationAbstract_019b096a-62ab-703e-9602-b55a868f4204" xlink:to="loc_us-gaap_DepreciationAndAmortizationDiscontinuedOperations_019c92a7-3fba-7237-b868-82a70b802628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019b096a-62ab-75df-a8bd-94fce59e6e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationAlternativeCashFlowInformationAbstract_019b096a-62ab-703e-9602-b55a868f4204" xlink:to="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019b096a-62ab-75df-a8bd-94fce59e6e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CapitalExpendituresDiscontinuedOperationsAbstract_019b096a-62ab-7cbf-b99e-f96df9198ef2" xlink:href="jynt-20251231.xsd#jynt_CapitalExpendituresDiscontinuedOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-758e-b066-07761b31aafe" xlink:to="loc_jynt_CapitalExpendituresDiscontinuedOperationsAbstract_019b096a-62ab-7cbf-b99e-f96df9198ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpenditureDiscontinuedOperations_019b096a-62ab-77f2-9e64-17b62fb88d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalExpenditureDiscontinuedOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_CapitalExpendituresDiscontinuedOperationsAbstract_019b096a-62ab-7cbf-b99e-f96df9198ef2" xlink:to="loc_us-gaap_CapitalExpenditureDiscontinuedOperations_019b096a-62ab-77f2-9e64-17b62fb88d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/DivestituresNarrativeDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#DivestituresNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/DivestituresNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_019b096a-62ab-7117-a1ec-950632f6b8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-71e0-9ba4-afd69ecd4586" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_019b096a-62ab-7117-a1ec-950632f6b8f5" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-71e0-9ba4-afd69ecd4586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019b3317-fa4b-7fc9-b4a8-bab3ae155e53" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-71e0-9ba4-afd69ecd4586" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019b3317-fa4b-7fc9-b4a8-bab3ae155e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019b3317-fa4b-7092-958d-3c311f35a144" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019b3317-fa4b-7fc9-b4a8-bab3ae155e53" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019b3317-fa4b-7092-958d-3c311f35a144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_019b3317-fa4b-744c-86e4-2a4c728dcb87" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019b3317-fa4b-7092-958d-3c311f35a144" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_019b3317-fa4b-744c-86e4-2a4c728dcb87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_019b3317-fa4b-7744-b568-b19680c7bd59" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019b3317-fa4b-7092-958d-3c311f35a144" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_019b3317-fa4b-7744-b568-b19680c7bd59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b3317-fa4b-703b-98bd-961111018b65" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-71e0-9ba4-afd69ecd4586" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b3317-fa4b-703b-98bd-961111018b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b3317-fa4b-7741-a582-b566b4a2741b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b3317-fa4b-703b-98bd-961111018b65" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b3317-fa4b-7741-a582-b566b4a2741b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019b3317-fa4b-7c67-a3e7-5ff4faf73ad9" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b3317-fa4b-7741-a582-b566b4a2741b" xlink:to="loc_jynt_CorporateClinicsMember_019b3317-fa4b-7c67-a3e7-5ff4faf73ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_019b3317-fa4b-7e97-8efb-d99ff17fc259" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-71e0-9ba4-afd69ecd4586" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_019b3317-fa4b-7e97-8efb-d99ff17fc259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019b3317-fa4b-786c-a270-725463d7de5b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_019b3317-fa4b-7e97-8efb-d99ff17fc259" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019b3317-fa4b-786c-a270-725463d7de5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AssetsHeldForSaleMember_019b3317-fa4b-7c7a-bb98-4817464467ad" xlink:href="jynt-20251231.xsd#jynt_AssetsHeldForSaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019b3317-fa4b-786c-a270-725463d7de5b" xlink:to="loc_jynt_AssetsHeldForSaleMember_019b3317-fa4b-7c7a-bb98-4817464467ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b3317-fa4b-7555-bd1d-61df467eb2f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-71e0-9ba4-afd69ecd4586" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b3317-fa4b-7555-bd1d-61df467eb2f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupHeldForSaleClinicsExpectedToSellPeriod_019c5395-8c72-7a55-a4a1-425ba8af1f8d" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupHeldForSaleClinicsExpectedToSellPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b3317-fa4b-7555-bd1d-61df467eb2f1" xlink:to="loc_jynt_DisposalGroupHeldForSaleClinicsExpectedToSellPeriod_019c5395-8c72-7a55-a4a1-425ba8af1f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue_019b3317-fa4b-73e4-8e70-72b94e3a6019" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b3317-fa4b-7555-bd1d-61df467eb2f1" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue_019b3317-fa4b-73e4-8e70-72b94e3a6019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019b3317-fa4b-7e8b-aa9f-829ac20ad167" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b3317-fa4b-7555-bd1d-61df467eb2f1" xlink:to="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019b3317-fa4b-7e8b-aa9f-829ac20ad167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_019b3317-fa4b-7067-a57a-e1cbbf882cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b3317-fa4b-7555-bd1d-61df467eb2f1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_019b3317-fa4b-7067-a57a-e1cbbf882cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold_019b3317-fa4b-7d50-aca1-18d0bd0d0272" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b3317-fa4b-7555-bd1d-61df467eb2f1" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold_019b3317-fa4b-7d50-aca1-18d0bd0d0272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_019b3317-fa4b-78e9-8af1-a17a5ad00b2c" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b3317-fa4b-7555-bd1d-61df467eb2f1" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_019b3317-fa4b-78e9-8af1-a17a5ad00b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold_019b3317-fa4b-7f1d-bc80-4e94996f6fb9" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b3317-fa4b-7555-bd1d-61df467eb2f1" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold_019b3317-fa4b-7f1d-bc80-4e94996f6fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b3317-fa4b-7515-8fce-a9e8d8ebcec6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b3317-fa4b-7555-bd1d-61df467eb2f1" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b3317-fa4b-7515-8fce-a9e8d8ebcec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_019b331a-2308-790d-834c-ca0d5f4e1cff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b3317-fa4b-7555-bd1d-61df467eb2f1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_019b331a-2308-790d-834c-ca0d5f4e1cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_019b096a-62ab-7d1f-b4a1-0fdea4a3af5b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-7d56-9bae-f0bbebef1fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_019b096a-62ab-7d1f-b4a1-0fdea4a3af5b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-7d56-9bae-f0bbebef1fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-76d7-aea3-74af76c2f010" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-7d56-9bae-f0bbebef1fc3" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-76d7-aea3-74af76c2f010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7d4f-8f22-c080bcaadd50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-62ab-76d7-aea3-74af76c2f010" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7d4f-8f22-c080bcaadd50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_019b096a-62ab-7d8a-b384-845b540f61f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-62ab-7d4f-8f22-c080bcaadd50" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_019b096a-62ab-7d8a-b384-845b540f61f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7f67-9ea8-206c7464e57f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-7d56-9bae-f0bbebef1fc3" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7f67-9ea8-206c7464e57f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-7c7d-94e8-9b97044d7422" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-62ab-7f67-9ea8-206c7464e57f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-7c7d-94e8-9b97044d7422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019b096a-62ab-79ed-837f-1c367cc17cbd" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-62ab-7c7d-94e8-9b97044d7422" xlink:to="loc_jynt_CorporateClinicsMember_019b096a-62ab-79ed-837f-1c367cc17cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-74cd-9895-6c92f66d7e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_019b096a-62ab-7d56-9bae-f0bbebef1fc3" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-74cd-9895-6c92f66d7e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-72bf-8b1b-35b421dfb7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-74cd-9895-6c92f66d7e8a" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-72bf-8b1b-35b421dfb7b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_019b096a-62ab-74e4-8b95-05f37f7bc427" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-72bf-8b1b-35b421dfb7b1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_019b096a-62ab-74e4-8b95-05f37f7bc427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent_019b096a-62ab-70c7-bab4-a0ae2de1278d" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-72bf-8b1b-35b421dfb7b1" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent_019b096a-62ab-70c7-bab4-a0ae2de1278d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_019b096a-62ab-70a0-a64f-9599c0f4c53b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-72bf-8b1b-35b421dfb7b1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_019b096a-62ab-70a0-a64f-9599c0f4c53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent_019b096a-62ab-753d-9673-b05abedb3abe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-72bf-8b1b-35b421dfb7b1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent_019b096a-62ab-753d-9673-b05abedb3abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_019b096a-62ab-7074-b481-ea4693a686e7" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-72bf-8b1b-35b421dfb7b1" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_019b096a-62ab-7074-b481-ea4693a686e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-730d-98fd-253ca4d55291" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-72bf-8b1b-35b421dfb7b1" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-730d-98fd-253ca4d55291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7908-ba89-81f7d45ae7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_019b096a-62ab-74cd-9895-6c92f66d7e8a" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7908-ba89-81f7d45ae7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_019b096a-62ab-7f01-a8c7-413602355d18" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7908-ba89-81f7d45ae7bc" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_019b096a-62ab-7f01-a8c7-413602355d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent_019b096a-62ab-7e55-981e-14dcd3988e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7908-ba89-81f7d45ae7bc" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent_019b096a-62ab-7e55-981e-14dcd3988e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-7ffd-80a2-fc1e60159d51" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_019b096a-62ab-7908-ba89-81f7d45ae7bc" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019b096a-62ab-7ffd-80a2-fc1e60159d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#PropertyandEquipmentSummaryofPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_019b096a-62ab-7152-979c-563205ca2224" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019b096a-62ab-7e21-bbea-22b750e987b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_019b096a-62ab-7152-979c-563205ca2224" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019b096a-62ab-7e21-bbea-22b750e987b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019b096a-62ab-74ba-ae3b-9796439ad2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019b096a-62ab-7e21-bbea-22b750e987b0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019b096a-62ab-74ba-ae3b-9796439ad2cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019b096a-62ab-7cb4-b6a6-c9d43ab36660" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019b096a-62ab-74ba-ae3b-9796439ad2cc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019b096a-62ab-7cb4-b6a6-c9d43ab36660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_019b096a-62ab-7e1c-93aa-00f6dfcee395" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019b096a-62ab-7cb4-b6a6-c9d43ab36660" xlink:to="loc_us-gaap_OfficeEquipmentMember_019b096a-62ab-7e1c-93aa-00f6dfcee395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_019b096a-62ab-7cb6-a9dc-ec90de7b0398" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019b096a-62ab-7cb4-b6a6-c9d43ab36660" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_019b096a-62ab-7cb6-a9dc-ec90de7b0398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_019b096a-62ab-77c1-8922-2503c1aae069" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019b096a-62ab-7cb4-b6a6-c9d43ab36660" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_019b096a-62ab-77c1-8922-2503c1aae069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember_019b096a-62ab-709d-b552-d7e1953d7d79" xlink:href="jynt-20251231.xsd#jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019b096a-62ab-7cb4-b6a6-c9d43ab36660" xlink:to="loc_jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember_019b096a-62ab-709d-b552-d7e1953d7d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019b096a-62ab-7202-b466-e030049a9b73" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019b096a-62ab-7e21-bbea-22b750e987b0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019b096a-62ab-7202-b466-e030049a9b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_019b096a-62ab-7dc3-9a0e-b3c237d07ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019b096a-62ab-7202-b466-e030049a9b73" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_019b096a-62ab-7dc3-9a0e-b3c237d07ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019b096a-62ab-7d60-a18a-06bd09ef269a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019b096a-62ab-7202-b466-e030049a9b73" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019b096a-62ab-7d60-a18a-06bd09ef269a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019b096a-62ab-7d08-827d-ccf7b12161fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019b096a-62ab-7202-b466-e030049a9b73" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019b096a-62ab-7d08-827d-ccf7b12161fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_019b096a-62ab-7b56-94ec-45735d2bc2a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019b096a-62ab-7202-b466-e030049a9b73" xlink:to="loc_us-gaap_ConstructionInProgressGross_019b096a-62ab-7b56-94ec-45735d2bc2a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/PropertyandEquipmentNarrativeDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#PropertyandEquipmentNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/PropertyandEquipmentNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_019b096a-62ab-73b3-b6cf-f40fd8f2ceb9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_019b096a-62ab-7004-bf19-205da5a14077" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_019b096a-62ab-73b3-b6cf-f40fd8f2ceb9" xlink:to="loc_us-gaap_Depreciation_019b096a-62ab-7004-bf19-205da5a14077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/FairValueConsiderationDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#FairValueConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/FairValueConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019b096a-62ab-747d-9df6-ee0c2b8f32d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019b096a-62ab-7968-b17e-b149817702c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019b096a-62ab-747d-9df6-ee0c2b8f32d9" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019b096a-62ab-7968-b17e-b149817702c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_019c661d-986d-7a16-ba3e-d4663d1476d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019b096a-62ab-7968-b17e-b149817702c6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_019c661d-986d-7a16-ba3e-d4663d1476d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019c661d-986d-72e5-af27-70d780b7bbd8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_019c661d-986d-7a16-ba3e-d4663d1476d0" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019c661d-986d-72e5-af27-70d780b7bbd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_019c661d-986d-708a-b267-006a50b43e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019c661d-986d-72e5-af27-70d780b7bbd8" xlink:to="loc_us-gaap_MoneyMarketFundsMember_019c661d-986d-708a-b267-006a50b43e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019c661d-986d-7e43-ac92-7252df9a02e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019b096a-62ab-7968-b17e-b149817702c6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019c661d-986d-7e43-ac92-7252df9a02e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c661d-986d-7ec4-9e98-ea11f33ea9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019c661d-986d-7e43-ac92-7252df9a02e2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c661d-986d-7ec4-9e98-ea11f33ea9f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_019c661d-986d-7481-9452-079c3bccdbda" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c661d-986d-7ec4-9e98-ea11f33ea9f4" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_019c661d-986d-7481-9452-079c3bccdbda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_019c661d-df28-7011-9485-092e5b7b8a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c661d-986d-7ec4-9e98-ea11f33ea9f4" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_019c661d-df28-7011-9485-092e5b7b8a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_019c661d-df28-7a66-aca7-3e8b6acef3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c661d-986d-7ec4-9e98-ea11f33ea9f4" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_019c661d-df28-7a66-aca7-3e8b6acef3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_019c661d-df28-75b6-8d8a-7805d0459b76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019b096a-62ab-7968-b17e-b149817702c6" xlink:to="loc_us-gaap_ValuationTechniqueAxis_019c661d-df28-75b6-8d8a-7805d0459b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_019c661d-df28-7639-9e0e-f21a7f943efb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_019c661d-df28-75b6-8d8a-7805d0459b76" xlink:to="loc_us-gaap_ValuationTechniqueDomain_019c661d-df28-7639-9e0e-f21a7f943efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_019c661d-df28-7316-954b-ef3b91f6eb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_019c661d-df28-7639-9e0e-f21a7f943efb" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_019c661d-df28-7316-954b-ef3b91f6eb1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_019c661d-df28-77de-92f1-aeae03da6640" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019b096a-62ab-7968-b17e-b149817702c6" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_019c661d-df28-77de-92f1-aeae03da6640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_019c661d-df28-7afd-b103-7fca4f4bdecf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_019c661d-df28-77de-92f1-aeae03da6640" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_019c661d-df28-7afd-b103-7fca4f4bdecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_019c661d-df28-7eb5-a39d-51eaba81e583" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019c661d-df28-7afd-b103-7fca4f4bdecf" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_019c661d-df28-7eb5-a39d-51eaba81e583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019c661d-df28-7428-81f4-cb1d02923e04" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019b096a-62ab-7968-b17e-b149817702c6" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019c661d-df28-7428-81f4-cb1d02923e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019c661d-df28-7d99-8ad2-26cf312692fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019c661d-df28-7428-81f4-cb1d02923e04" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019c661d-df28-7d99-8ad2-26cf312692fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_019c661d-df28-7923-b4c3-9836a097cbab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019c661d-df28-7d99-8ad2-26cf312692fe" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_019c661d-df28-7923-b4c3-9836a097cbab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DiscontinuedOperationsHeldForUseMember_019c661d-df28-75f3-8e23-5f4afaec9586" xlink:href="jynt-20251231.xsd#jynt_DiscontinuedOperationsHeldForUseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019c661d-df28-7d99-8ad2-26cf312692fe" xlink:to="loc_jynt_DiscontinuedOperationsHeldForUseMember_019c661d-df28-75f3-8e23-5f4afaec9586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019c661d-df28-7294-b3c5-c2e8817ec58d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019b096a-62ab-7968-b17e-b149817702c6" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019c661d-df28-7294-b3c5-c2e8817ec58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019c661d-df28-7455-b079-0c4719402e15" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019c661d-df28-7294-b3c5-c2e8817ec58d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019c661d-df28-7455-b079-0c4719402e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019c661d-df28-717c-a34f-2f1667541fda" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019c661d-df28-7455-b079-0c4719402e15" xlink:to="loc_jynt_CorporateClinicsMember_019c661d-df28-717c-a34f-2f1667541fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_019c661e-024d-7522-a0ec-80df995ec952" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019b096a-62ab-7968-b17e-b149817702c6" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_019c661e-024d-7522-a0ec-80df995ec952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019c661e-024d-758e-8f6d-5de1fe51cba7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_019c661e-024d-7522-a0ec-80df995ec952" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019c661e-024d-758e-8f6d-5de1fe51cba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_OperatingLeaseRightOfUseAssetMember_019c661e-024d-7cbd-8c6f-1367a22c8a88" xlink:href="jynt-20251231.xsd#jynt_OperatingLeaseRightOfUseAssetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019c661e-024d-758e-8f6d-5de1fe51cba7" xlink:to="loc_jynt_OperatingLeaseRightOfUseAssetMember_019c661e-024d-7cbd-8c6f-1367a22c8a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_019c661e-024d-7c6d-8c6c-911270663384" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019c661e-024d-758e-8f6d-5de1fe51cba7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_019c661e-024d-7c6d-8c6c-911270663384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMember_019c661e-024d-78e6-933f-47e3e3ea6eef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_019c661e-024d-758e-8f6d-5de1fe51cba7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMember_019c661e-024d-78e6-933f-47e3e3ea6eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c661d-986d-79c9-bb4b-39d4cb0e73f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019b096a-62ab-7968-b17e-b149817702c6" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c661d-986d-79c9-bb4b-39d4cb0e73f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019c661d-986d-7be9-8b53-a4b91ed1b207" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c661d-986d-79c9-bb4b-39d4cb0e73f0" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019c661d-986d-7be9-8b53-a4b91ed1b207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AssetsHeldForSaleCashFlowForecastPeriod_019c661d-df28-74b4-8ae7-c6ef0532d330" xlink:href="jynt-20251231.xsd#jynt_AssetsHeldForSaleCashFlowForecastPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c661d-986d-79c9-bb4b-39d4cb0e73f0" xlink:to="loc_jynt_AssetsHeldForSaleCashFlowForecastPeriod_019c661d-df28-74b4-8ae7-c6ef0532d330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AssetsHeldForSaleMeasurementInputPositiveCashFlow_019c661d-df28-7230-9c64-3b594a84670b" xlink:href="jynt-20251231.xsd#jynt_AssetsHeldForSaleMeasurementInputPositiveCashFlow"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c661d-986d-79c9-bb4b-39d4cb0e73f0" xlink:to="loc_jynt_AssetsHeldForSaleMeasurementInputPositiveCashFlow_019c661d-df28-7230-9c64-3b594a84670b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_AssetsHeldForSaleMeasurementInputNegativeCashFlow_019c661d-df28-7c86-a655-dcb050a0e631" xlink:href="jynt-20251231.xsd#jynt_AssetsHeldForSaleMeasurementInputNegativeCashFlow"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c661d-986d-79c9-bb4b-39d4cb0e73f0" xlink:to="loc_jynt_AssetsHeldForSaleMeasurementInputNegativeCashFlow_019c661d-df28-7c86-a655-dcb050a0e631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019c661d-df28-78fc-908c-4258023a0d07" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c661d-986d-79c9-bb4b-39d4cb0e73f0" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019c661d-df28-78fc-908c-4258023a0d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_019c661d-df28-7699-9879-c7e96824c2f5" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c661d-986d-79c9-bb4b-39d4cb0e73f0" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent_019c661d-df28-7699-9879-c7e96824c2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019c661d-df28-7730-ac3e-36f588946830" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c661d-986d-79c9-bb4b-39d4cb0e73f0" xlink:to="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_019c661d-df28-7730-ac3e-36f588946830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment_019c661e-024d-78bd-a28b-a14c3835f481" xlink:href="jynt-20251231.xsd#jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c661d-986d-79c9-bb4b-39d4cb0e73f0" xlink:to="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment_019c661e-024d-78bd-a28b-a14c3835f481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment_019c661e-024d-7e6c-ae60-24ed2414567a" xlink:href="jynt-20251231.xsd#jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c661d-986d-79c9-bb4b-39d4cb0e73f0" xlink:to="loc_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment_019c661e-024d-7e6c-ae60-24ed2414567a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/DebtDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#DebtDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/DebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_019b096a-62ab-7af7-b770-bdc570ada2b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_019b096a-62ab-79ca-8601-8b4e7b9c4096" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_019b096a-62ab-7af7-b770-bdc570ada2b4" xlink:to="loc_us-gaap_DebtInstrumentTable_019b096a-62ab-79ca-8601-8b4e7b9c4096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_019c66ac-a438-7c9b-960a-b4b44786ef81" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019b096a-62ab-79ca-8601-8b4e7b9c4096" xlink:to="loc_us-gaap_CreditFacilityAxis_019c66ac-a438-7c9b-960a-b4b44786ef81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_019c66ac-a438-742b-97bc-bbebe7349617" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_019c66ac-a438-7c9b-960a-b4b44786ef81" xlink:to="loc_us-gaap_CreditFacilityDomain_019c66ac-a438-742b-97bc-bbebe7349617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_019c66ac-a438-7daf-8588-159cf7e9a86b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_019c66ac-a438-742b-97bc-bbebe7349617" xlink:to="loc_us-gaap_SecuredDebtMember_019c66ac-a438-7daf-8588-159cf7e9a86b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_019c66ac-a438-7b12-a70e-d29f1b4c0ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_019c66ac-a438-742b-97bc-bbebe7349617" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_019c66ac-a438-7b12-a70e-d29f1b4c0ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DevelopmentLineOfCreditMember_019c66ac-a438-7d53-9126-fb05f583e538" xlink:href="jynt-20251231.xsd#jynt_DevelopmentLineOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_019c66ac-a438-742b-97bc-bbebe7349617" xlink:to="loc_jynt_DevelopmentLineOfCreditMember_019c66ac-a438-7d53-9126-fb05f583e538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_019c66ac-a438-7e23-b78f-8d713743198c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_019c66ac-a438-742b-97bc-bbebe7349617" xlink:to="loc_us-gaap_LetterOfCreditMember_019c66ac-a438-7e23-b78f-8d713743198c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019c66ac-a438-76e0-972b-c0ba288685f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019b096a-62ab-79ca-8601-8b4e7b9c4096" xlink:to="loc_us-gaap_DebtInstrumentAxis_019c66ac-a438-76e0-972b-c0ba288685f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019c66ac-a438-7ab0-ac2c-e38e0aee282d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_019c66ac-a438-76e0-972b-c0ba288685f6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019c66ac-a438-7ab0-ac2c-e38e0aee282d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_SeniorSecuredCreditFacilitiesMember_019c66ac-a438-70d6-b263-1cad781ebc4d" xlink:href="jynt-20251231.xsd#jynt_SeniorSecuredCreditFacilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019c66ac-a438-7ab0-ac2c-e38e0aee282d" xlink:to="loc_jynt_SeniorSecuredCreditFacilitiesMember_019c66ac-a438-70d6-b263-1cad781ebc4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_A2022CreditFacilityMember_019c66ac-a438-7f87-8f7a-449c37371214" xlink:href="jynt-20251231.xsd#jynt_A2022CreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019c66ac-a438-7ab0-ac2c-e38e0aee282d" xlink:to="loc_jynt_A2022CreditFacilityMember_019c66ac-a438-7f87-8f7a-449c37371214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019c66ac-a438-76c3-b47c-9a22c90366c0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019b096a-62ab-79ca-8601-8b4e7b9c4096" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019c66ac-a438-76c3-b47c-9a22c90366c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019c66ac-a438-7a11-9545-da2fcabe28ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019c66ac-a438-76c3-b47c-9a22c90366c0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019c66ac-a438-7a11-9545-da2fcabe28ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_019c66ac-a438-76ad-a537-ab0fddaec703" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019c66ac-a438-7a11-9545-da2fcabe28ad" xlink:to="loc_us-gaap_LineOfCreditMember_019c66ac-a438-76ad-a537-ab0fddaec703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019c66ac-f58b-7dd3-8d4c-cb50bec7adc4" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019b096a-62ab-79ca-8601-8b4e7b9c4096" xlink:to="loc_srt_RangeAxis_019c66ac-f58b-7dd3-8d4c-cb50bec7adc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019c66ac-f58b-7461-ac5c-4b6fce5656f2" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019c66ac-f58b-7dd3-8d4c-cb50bec7adc4" xlink:to="loc_srt_RangeMember_019c66ac-f58b-7461-ac5c-4b6fce5656f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019c66ac-f58b-7d9c-b652-314e412306eb" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019c66ac-f58b-7461-ac5c-4b6fce5656f2" xlink:to="loc_srt_MinimumMember_019c66ac-f58b-7d9c-b652-314e412306eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019c66ac-f58b-7c1d-a544-ca7841cfebac" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019c66ac-f58b-7461-ac5c-4b6fce5656f2" xlink:to="loc_srt_MaximumMember_019c66ac-f58b-7c1d-a544-ca7841cfebac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_019c66ac-f58b-7cbb-9b1f-34decf490eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019b096a-62ab-79ca-8601-8b4e7b9c4096" xlink:to="loc_us-gaap_VariableRateAxis_019c66ac-f58b-7cbb-9b1f-34decf490eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_019c66ac-f58b-7d45-8f38-5e6a13cd9619" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_019c66ac-f58b-7cbb-9b1f-34decf490eb9" xlink:to="loc_us-gaap_VariableRateDomain_019c66ac-f58b-7d45-8f38-5e6a13cd9619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrMember_019c66ac-f58b-7697-917d-e4d73a9078cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SecuredOvernightFinancingRateSofrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_019c66ac-f58b-7d45-8f38-5e6a13cd9619" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrMember_019c66ac-f58b-7697-917d-e4d73a9078cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_019c66ac-f58b-71e2-b567-b85fb9d0a195" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_019c66ac-f58b-7d45-8f38-5e6a13cd9619" xlink:to="loc_us-gaap_BaseRateMember_019c66ac-f58b-71e2-b567-b85fb9d0a195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_FederalReserveBankOfNewYorkRateMember_019c66ac-f58b-7ab4-ba77-a3451a4523e1" xlink:href="jynt-20251231.xsd#jynt_FederalReserveBankOfNewYorkRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_019c66ac-f58b-7d45-8f38-5e6a13cd9619" xlink:to="loc_jynt_FederalReserveBankOfNewYorkRateMember_019c66ac-f58b-7ab4-ba77-a3451a4523e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_019c66ac-a438-7b6e-8774-65d1f3b11952" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019b096a-62ab-79ca-8601-8b4e7b9c4096" xlink:to="loc_us-gaap_DebtInstrumentLineItems_019c66ac-a438-7b6e-8774-65d1f3b11952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_019c66ac-a438-75c7-9ea8-0fc5795e7601" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019c66ac-a438-7b6e-8774-65d1f3b11952" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_019c66ac-a438-75c7-9ea8-0fc5795e7601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_019c66ac-a438-76f3-923c-ec5c5bce6486" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019c66ac-a438-7b6e-8774-65d1f3b11952" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_019c66ac-a438-76f3-923c-ec5c5bce6486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount_019c66ac-a438-777b-bfc2-93b92c8a33c5" xlink:href="jynt-20251231.xsd#jynt_LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019c66ac-a438-7b6e-8774-65d1f3b11952" xlink:to="loc_jynt_LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount_019c66ac-a438-777b-bfc2-93b92c8a33c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_019c66ac-f58b-70d6-aa6d-abf88e88893b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019c66ac-a438-7b6e-8774-65d1f3b11952" xlink:to="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_019c66ac-f58b-70d6-aa6d-abf88e88893b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_019c66ac-f58b-776c-a634-29bac83ebbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019c66ac-a438-7b6e-8774-65d1f3b11952" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_019c66ac-f58b-776c-a634-29bac83ebbe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_019c66ac-f58b-7fb2-a9c5-13c839ff25e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019c66ac-a438-7b6e-8774-65d1f3b11952" xlink:to="loc_us-gaap_LongTermDebt_019c66ac-f58b-7fb2-a9c5-13c839ff25e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_019c66ac-f58b-78c3-952f-f2319694e26a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019c66ac-a438-7b6e-8774-65d1f3b11952" xlink:to="loc_us-gaap_LineOfCredit_019c66ac-f58b-78c3-952f-f2319694e26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_019c66ac-f58b-7010-b6f2-e50d2866195d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019c66ac-a438-7b6e-8774-65d1f3b11952" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_019c66ac-f58b-7010-b6f2-e50d2866195d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_019c66ac-f58b-758d-9137-c92bc71e0433" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019c66ac-a438-7b6e-8774-65d1f3b11952" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_019c66ac-f58b-758d-9137-c92bc71e0433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#StockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/StockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019b3338-b6e2-7686-b4fe-3ceaa62b3f26" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1_019b333f-5f94-7c60-9c78-caa44b82c37d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019b3338-b6e2-7686-b4fe-3ceaa62b3f26" xlink:to="loc_srt_StockRepurchaseProgramAuthorizedAmount1_019b333f-5f94-7c60-9c78-caa44b82c37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_019c6624-77e3-782f-a496-ccf8794cf779" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019b3338-b6e2-7686-b4fe-3ceaa62b3f26" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_019c6624-77e3-782f-a496-ccf8794cf779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ShareRepurchaseProgramAdditionalAuthorizedAmount_019c8ad0-847c-7113-8d36-32079086b803" xlink:href="jynt-20251231.xsd#jynt_ShareRepurchaseProgramAdditionalAuthorizedAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019b3338-b6e2-7686-b4fe-3ceaa62b3f26" xlink:to="loc_jynt_ShareRepurchaseProgramAdditionalAuthorizedAmount_019c8ad0-847c-7113-8d36-32079086b803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_019b3343-1ca6-72ca-a733-eb79915c0582" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019b3338-b6e2-7686-b4fe-3ceaa62b3f26" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_019b3343-1ca6-72ca-a733-eb79915c0582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_019b3343-1ca6-75ef-9efe-c267fd89bcb1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019b3338-b6e2-7686-b4fe-3ceaa62b3f26" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_019b3343-1ca6-75ef-9efe-c267fd89bcb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_019b3343-1ca6-7044-b827-9145ddef1374" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019b3338-b6e2-7686-b4fe-3ceaa62b3f26" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_019b3343-1ca6-7044-b827-9145ddef1374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_019b3343-1ca6-7ee8-a3be-056e2b19d0ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019b3338-b6e2-7686-b4fe-3ceaa62b3f26" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_019b3343-1ca6-7ee8-a3be-056e2b19d0ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019b096a-62ab-702b-9ae6-ef3582f274c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ab-7950-88ef-6df5b2df7d32" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019b096a-62ab-702b-9ae6-ef3582f274c6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ab-7950-88ef-6df5b2df7d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019b3352-44d3-7fe0-ba13-7fff13044628" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ab-7950-88ef-6df5b2df7d32" xlink:to="loc_us-gaap_AwardTypeAxis_019b3352-44d3-7fe0-ba13-7fff13044628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b3352-44d3-7e47-8a90-92dc3746bd40" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019b3352-44d3-7fe0-ba13-7fff13044628" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b3352-44d3-7e47-8a90-92dc3746bd40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019b3352-44d3-7ae3-a6c6-2668b16740e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b3352-44d3-7e47-8a90-92dc3746bd40" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019b3352-44d3-7ae3-a6c6-2668b16740e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_019b3352-8e51-734f-9b24-08fdf64c0e17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b3352-44d3-7e47-8a90-92dc3746bd40" xlink:to="loc_us-gaap_RestrictedStockMember_019b3352-8e51-734f-9b24-08fdf64c0e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_019b3352-8e51-7b08-a352-1c7f278164b6" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ab-7950-88ef-6df5b2df7d32" xlink:to="loc_srt_TitleOfIndividualAxis_019b3352-8e51-7b08-a352-1c7f278164b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_019b3352-8e51-7624-b890-d777c3f35f25" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_019b3352-8e51-7b08-a352-1c7f278164b6" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_019b3352-8e51-7624-b890-d777c3f35f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_019b3352-8e51-7428-a37a-5cc606a5d518" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_019b3352-8e51-7624-b890-d777c3f35f25" xlink:to="loc_srt_DirectorMember_019b3352-8e51-7428-a37a-5cc606a5d518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ab-7950-88ef-6df5b2df7d32" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019c8ad7-2467-7f6e-8700-b3b56f101be1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019c8ad7-2467-7f6e-8700-b3b56f101be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_019b3352-44d3-7691-a305-376fbc1c1af7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_019b3352-44d3-7691-a305-376fbc1c1af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_019b3352-44d3-7275-a94e-c961e255fdb1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_019b3352-44d3-7275-a94e-c961e255fdb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage_019b3352-44d3-7de4-a2d5-050050a431a3" xlink:href="jynt-20251231.xsd#jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage_019b3352-44d3-7de4-a2d5-050050a431a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019ca0bf-18e9-75af-b00e-198cdbd4ae68" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019ca0bf-18e9-75af-b00e-198cdbd4ae68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019b3352-6924-7cde-9258-c65884b5a8fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019b3352-6924-7cde-9258-c65884b5a8fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_019b3352-6924-7e0f-bc6b-3bd743e57602" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_019b3352-6924-7e0f-bc6b-3bd743e57602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019b3352-6924-7c6b-bafa-8b534e1f9f62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019b3352-6924-7c6b-bafa-8b534e1f9f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_019b3352-6924-7ea9-b33d-95d9b19d8348" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_019b3352-6924-7ea9-b33d-95d9b19d8348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019b3352-6924-7bd0-b5d6-e19a4ac929f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019b3352-6924-7bd0-b5d6-e19a4ac929f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments_019b3352-8e51-793d-800a-adc2b8dae57f" xlink:href="jynt-20251231.xsd#jynt_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_jynt_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments_019b3352-8e51-793d-800a-adc2b8dae57f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019b3352-b010-7e38-958c-e9c841503ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_us-gaap_ShareBasedCompensation_019b3352-b010-7e38-958c-e9c841503ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_019b3352-b010-7f54-ac93-7805842425ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b3352-44d3-7ff8-8954-4a69ab37b78a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_019b3352-b010-7f54-ac93-7805842425ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/StockBasedCompensationValuationAssumptionsusedforStockOptionsDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#StockBasedCompensationValuationAssumptionsusedforStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/StockBasedCompensationValuationAssumptionsusedforStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019b096a-62ab-70c1-b90f-11b8e0521db1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ab-7971-a978-c34fd1e11233" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019b096a-62ab-70c1-b90f-11b8e0521db1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ab-7971-a978-c34fd1e11233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019b096a-62ab-756b-80b4-8a5229c0823e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ab-7971-a978-c34fd1e11233" xlink:to="loc_us-gaap_AwardTypeAxis_019b096a-62ab-756b-80b4-8a5229c0823e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-62ab-700f-96a9-da1487406227" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019b096a-62ab-756b-80b4-8a5229c0823e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-62ab-700f-96a9-da1487406227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019b096a-62ab-71e2-98c2-860337c25732" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-62ab-700f-96a9-da1487406227" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019b096a-62ab-71e2-98c2-860337c25732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ab-73ae-a6c9-ad17f0685c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ab-7971-a978-c34fd1e11233" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ab-73ae-a6c9-ad17f0685c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_019b096a-62ab-7e83-8c72-2e399e7ead55" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ab-73ae-a6c9-ad17f0685c4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_019b096a-62ab-7e83-8c72-2e399e7ead55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019b096a-62ab-74ce-a5f3-6ae8c6e47f19" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ab-73ae-a6c9-ad17f0685c4c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019b096a-62ab-74ce-a5f3-6ae8c6e47f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_019b096a-62ab-7dee-866a-5995cd656a08" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ab-73ae-a6c9-ad17f0685c4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_019b096a-62ab-7dee-866a-5995cd656a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#StockBasedCompensationStockOptionsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019b096a-62ab-76d9-b3de-cab81822f694" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ab-740f-87aa-ffcd2eea5be0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019b096a-62ab-76d9-b3de-cab81822f694" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ab-740f-87aa-ffcd2eea5be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019b096a-62ab-7034-8280-55f0fc88b20c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ab-740f-87aa-ffcd2eea5be0" xlink:to="loc_us-gaap_AwardTypeAxis_019b096a-62ab-7034-8280-55f0fc88b20c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-62ab-7dd3-aedc-5fce32ad5a05" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019b096a-62ab-7034-8280-55f0fc88b20c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-62ab-7dd3-aedc-5fce32ad5a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019b096a-62ac-759e-a2b3-74fe2a83af3d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-62ab-7dd3-aedc-5fce32ad5a05" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019b096a-62ac-759e-a2b3-74fe2a83af3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-751a-a6ed-483eb2e27e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ab-740f-87aa-ffcd2eea5be0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-751a-a6ed-483eb2e27e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019b096a-62ac-727b-addf-67571c34b3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-751a-a6ed-483eb2e27e2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019b096a-62ac-727b-addf-67571c34b3a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019b096a-62ac-751c-b765-0a12758ece3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019b096a-62ac-727b-addf-67571c34b3a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019b096a-62ac-751c-b765-0a12758ece3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019b096a-62ac-79b2-bcc6-2302afedb11e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019b096a-62ac-727b-addf-67571c34b3a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019b096a-62ac-79b2-bcc6-2302afedb11e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019b096a-62ac-7c79-a57e-3e9fed0eece9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019b096a-62ac-727b-addf-67571c34b3a0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019b096a-62ac-7c79-a57e-3e9fed0eece9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_019b096a-62ac-7054-b325-44d6e7b06fed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019b096a-62ac-727b-addf-67571c34b3a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_019b096a-62ac-7054-b325-44d6e7b06fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_019b096a-62ac-7b80-848f-a5aa10ec7a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019b096a-62ac-727b-addf-67571c34b3a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_019b096a-62ac-7b80-848f-a5aa10ec7a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019b096a-62ac-77cf-99a7-919a182f4005" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019b096a-62ac-727b-addf-67571c34b3a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019b096a-62ac-77cf-99a7-919a182f4005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_019b096a-62ac-77ff-838e-d187c5c21a14" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-751a-a6ed-483eb2e27e2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_019b096a-62ac-77ff-838e-d187c5c21a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_019b096a-62ac-78d9-ad94-4d82705bc025" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-751a-a6ed-483eb2e27e2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_019b096a-62ac-78d9-ad94-4d82705bc025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019b096a-62ac-71af-a0f7-3d4ed08459c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-751a-a6ed-483eb2e27e2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019b096a-62ac-71af-a0f7-3d4ed08459c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019b096a-62ac-7517-a7e4-6e568c75e907" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019b096a-62ac-71af-a0f7-3d4ed08459c9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019b096a-62ac-7517-a7e4-6e568c75e907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019b096a-62ac-749e-803c-d76fa31dbaee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019b096a-62ac-71af-a0f7-3d4ed08459c9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019b096a-62ac-749e-803c-d76fa31dbaee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_019b096a-62ac-75f4-8a6c-fb8a7cafd318" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019b096a-62ac-71af-a0f7-3d4ed08459c9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_019b096a-62ac-75f4-8a6c-fb8a7cafd318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_019b096a-62ac-7c63-bf14-c5ffc96fdc27" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019b096a-62ac-71af-a0f7-3d4ed08459c9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_019b096a-62ac-7c63-bf14-c5ffc96fdc27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_019b096a-62ac-771e-8242-b488bddc51ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019b096a-62ac-71af-a0f7-3d4ed08459c9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_019b096a-62ac-771e-8242-b488bddc51ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019b096a-62ac-7ed3-a6c3-540b118f36c8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019b096a-62ac-71af-a0f7-3d4ed08459c9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019b096a-62ac-7ed3-a6c3-540b118f36c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_019b096a-62ac-7a01-a4a5-816dceee316c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-751a-a6ed-483eb2e27e2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_019b096a-62ac-7a01-a4a5-816dceee316c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_019b096a-62ac-7b06-92f0-b11bcd8818dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-751a-a6ed-483eb2e27e2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_019b096a-62ac-7b06-92f0-b11bcd8818dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_019b096a-62ac-792b-9672-fe1c642b957a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-751a-a6ed-483eb2e27e2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_019b096a-62ac-792b-9672-fe1c642b957a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_019b096a-62ac-726c-8682-babfd0dd8919" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_019b096a-62ac-792b-9672-fe1c642b957a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_019b096a-62ac-726c-8682-babfd0dd8919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_019b096a-62ac-79e0-aefc-5f15159d39eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-751a-a6ed-483eb2e27e2a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_019b096a-62ac-79e0-aefc-5f15159d39eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_019b096a-62ac-747b-aab2-06ee7f041bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-751a-a6ed-483eb2e27e2a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_019b096a-62ac-747b-aab2-06ee7f041bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_019b096a-62ac-748b-9b1a-967a6c6f08a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-751a-a6ed-483eb2e27e2a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_019b096a-62ac-748b-9b1a-967a6c6f08a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_019b096a-62ac-7b54-9de0-e0c76d8c0a30" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_019b096a-62ac-748b-9b1a-967a6c6f08a6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_019b096a-62ac-7b54-9de0-e0c76d8c0a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_019b096a-62ac-78e0-9180-3dac6fc65b17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_019b096a-62ac-748b-9b1a-967a6c6f08a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_019b096a-62ac-78e0-9180-3dac6fc65b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_019b096a-62ac-76e0-9de8-02352fc367aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_019b096a-62ac-748b-9b1a-967a6c6f08a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_019b096a-62ac-76e0-9de8-02352fc367aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_019b096a-62ac-79c3-89fa-09d03c36ba03" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_019b096a-62ac-748b-9b1a-967a6c6f08a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_019b096a-62ac-79c3-89fa-09d03c36ba03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/StockBasedCompensationRestrictedStockActivityDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#StockBasedCompensationRestrictedStockActivityDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/StockBasedCompensationRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019b096a-62ac-73d0-98fb-2056c523be71" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ac-7052-9d11-91563b7d1fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019b096a-62ac-73d0-98fb-2056c523be71" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ac-7052-9d11-91563b7d1fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019b096a-62ac-72ca-ba49-58805ee0a0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ac-7052-9d11-91563b7d1fe1" xlink:to="loc_us-gaap_AwardTypeAxis_019b096a-62ac-72ca-ba49-58805ee0a0e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-62ac-7298-96fa-f5406fc8303b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019b096a-62ac-72ca-ba49-58805ee0a0e0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-62ac-7298-96fa-f5406fc8303b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_019b096a-62ac-7a88-a0b0-e0d88cc751c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019b096a-62ac-7298-96fa-f5406fc8303b" xlink:to="loc_us-gaap_RestrictedStockMember_019b096a-62ac-7a88-a0b0-e0d88cc751c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-7a6b-a02d-17e1caa816c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019b096a-62ac-7052-9d11-91563b7d1fe1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-7a6b-a02d-17e1caa816c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019b096a-62ac-7df8-b43c-63befb45a351" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-7a6b-a02d-17e1caa816c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019b096a-62ac-7df8-b43c-63befb45a351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019b096a-62ac-7ee7-900a-02c8620ee866" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019b096a-62ac-7df8-b43c-63befb45a351" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019b096a-62ac-7ee7-900a-02c8620ee866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019b096a-62ac-7f8d-9301-e8cc7793f52a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019b096a-62ac-7df8-b43c-63befb45a351" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019b096a-62ac-7f8d-9301-e8cc7793f52a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_019b096a-62ac-7a04-ab8d-b8e75e76bcd5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019b096a-62ac-7df8-b43c-63befb45a351" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_019b096a-62ac-7a04-ab8d-b8e75e76bcd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019b096a-62ac-7e9c-9e84-fa7d41ecbd57" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019b096a-62ac-7df8-b43c-63befb45a351" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019b096a-62ac-7e9c-9e84-fa7d41ecbd57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019b096a-62ac-7a57-b890-f192bd919377" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019b096a-62ac-7df8-b43c-63befb45a351" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019b096a-62ac-7a57-b890-f192bd919377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019b096a-62ac-7e7c-92e4-5d1e1c92628f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019b096a-62ac-7a6b-a02d-17e1caa816c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019b096a-62ac-7e7c-92e4-5d1e1c92628f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019b096a-62ac-7710-917b-f52175490082" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019b096a-62ac-7e7c-92e4-5d1e1c92628f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019b096a-62ac-7710-917b-f52175490082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019b096a-62ac-711a-8c91-31372561edcb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019b096a-62ac-7e7c-92e4-5d1e1c92628f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019b096a-62ac-711a-8c91-31372561edcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_019b096a-62ac-78d6-bbfd-fe6cffe0f70c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019b096a-62ac-7e7c-92e4-5d1e1c92628f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_019b096a-62ac-78d6-bbfd-fe6cffe0f70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019b096a-62ac-7da8-8486-cd5d078e2634" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019b096a-62ac-7e7c-92e4-5d1e1c92628f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019b096a-62ac-7da8-8486-cd5d078e2634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019b096a-62ac-72dc-898d-083fb269cb4e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019b096a-62ac-7e7c-92e4-5d1e1c92628f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019b096a-62ac-72dc-898d-083fb269cb4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/IncomeTaxesLossFromContinuingOperationsBeforetheProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#IncomeTaxesLossFromContinuingOperationsBeforetheProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/IncomeTaxesLossFromContinuingOperationsBeforetheProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_019c6636-e0ca-7195-b2a1-2d13bdb791ce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_019c663b-3d88-7dca-90f4-241a5057da26" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019c6636-e0ca-7195-b2a1-2d13bdb791ce" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_019c663b-3d88-7dca-90f4-241a5057da26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019c663b-ec2a-7916-a528-3440a411450b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019c6636-e0ca-7195-b2a1-2d13bdb791ce" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019c663b-ec2a-7916-a528-3440a411450b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/IncomeTaxesIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#IncomeTaxesIncomeTaxExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/IncomeTaxesIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-74c7-8bab-ec307d185eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_019b096a-637d-7eb7-b286-908a1480d243" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-74c7-8bab-ec307d185eb4" xlink:to="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_019b096a-637d-7eb7-b286-908a1480d243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_019b096a-637d-73c6-bccd-c98b9b10cd42" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_019b096a-637d-7eb7-b286-908a1480d243" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_019b096a-637d-73c6-bccd-c98b9b10cd42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_019b096a-637d-7b79-b337-9ef7f0bad86e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_019b096a-637d-7eb7-b286-908a1480d243" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_019b096a-637d-7b79-b337-9ef7f0bad86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_019b096a-637d-73db-ac64-8167311649fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-74c7-8bab-ec307d185eb4" xlink:to="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_019b096a-637d-73db-ac64-8167311649fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_019b096a-637d-7c64-ae7e-f97154f7f80f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_019b096a-637d-73db-ac64-8167311649fe" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_019b096a-637d-7c64-ae7e-f97154f7f80f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_019b096a-637d-7c93-99fb-ec5e298911ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_019b096a-637d-73db-ac64-8167311649fe" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_019b096a-637d-7c93-99fb-ec5e298911ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-7961-8a47-3dca1412d4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-74c7-8bab-ec307d185eb4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-7961-8a47-3dca1412d4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-74f7-8834-64e7217545f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract_019b096a-637d-7518-a2ff-22bd2095a626" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-74f7-8834-64e7217545f5" xlink:to="loc_us-gaap_DeferredTaxAssetsGrossAbstract_019b096a-637d-7518-a2ff-22bd2095a626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_019b096a-637d-7a79-b49b-295bdd2d3594" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_019b096a-637d-7518-a2ff-22bd2095a626" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_019b096a-637d-7a79-b49b-295bdd2d3594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_019b096a-637d-72b0-acb6-44526905c5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_019b096a-637d-7518-a2ff-22bd2095a626" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_019b096a-637d-72b0-acb6-44526905c5b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DeferredTaxAssetsOperatingLeaseLiability_019b096a-637d-7289-a635-234f0ea462dc" xlink:href="jynt-20251231.xsd#jynt_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_019b096a-637d-7518-a2ff-22bd2095a626" xlink:to="loc_jynt_DeferredTaxAssetsOperatingLeaseLiability_019b096a-637d-7289-a635-234f0ea462dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DeferredTaxAssetsGoodwillComponent1_019c6641-9572-7f60-a9d0-15234f15ce6b" xlink:href="jynt-20251231.xsd#jynt_DeferredTaxAssetsGoodwillComponent1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_019b096a-637d-7518-a2ff-22bd2095a626" xlink:to="loc_jynt_DeferredTaxAssetsGoodwillComponent1_019c6641-9572-7f60-a9d0-15234f15ce6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DeferredTaxAssetsGoodwillComponent2_019b096a-637d-725e-a9bf-ee075c7c04e8" xlink:href="jynt-20251231.xsd#jynt_DeferredTaxAssetsGoodwillComponent2"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_019b096a-637d-7518-a2ff-22bd2095a626" xlink:to="loc_jynt_DeferredTaxAssetsGoodwillComponent2_019b096a-637d-725e-a9bf-ee075c7c04e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_019c6648-0b86-7091-afbf-53c2c08961de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_019b096a-637d-7518-a2ff-22bd2095a626" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_019c6648-0b86-7091-afbf-53c2c08961de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DeferredTaxAssetsNonqualifiedStockOptions_019c90ac-912b-7ca6-ab80-1bf0ba772c39" xlink:href="jynt-20251231.xsd#jynt_DeferredTaxAssetsNonqualifiedStockOptions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_019b096a-637d-7518-a2ff-22bd2095a626" xlink:to="loc_jynt_DeferredTaxAssetsNonqualifiedStockOptions_019c90ac-912b-7ca6-ab80-1bf0ba772c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_019b096a-637d-73e1-8535-d137fa822ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_019b096a-637d-7518-a2ff-22bd2095a626" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_019b096a-637d-73e1-8535-d137fa822ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_019b096a-637d-7d4d-991d-88b4c455d8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_019b096a-637d-7518-a2ff-22bd2095a626" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_019b096a-637d-7d4d-991d-88b4c455d8dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DeferredTaxAssetsIntangibleAssets_019b096a-637d-707e-9d0c-fd4bbf9c9b7b" xlink:href="jynt-20251231.xsd#jynt_DeferredTaxAssetsIntangibleAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_019b096a-637d-7518-a2ff-22bd2095a626" xlink:to="loc_jynt_DeferredTaxAssetsIntangibleAssets_019b096a-637d-707e-9d0c-fd4bbf9c9b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_019b096a-637d-76c0-83b1-c8e6ad4434f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_019b096a-637d-7518-a2ff-22bd2095a626" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_019b096a-637d-76c0-83b1-c8e6ad4434f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_019b096a-637d-712d-91b9-3eb04fe55da8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_019b096a-637d-7518-a2ff-22bd2095a626" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_019b096a-637d-712d-91b9-3eb04fe55da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_019b096a-637d-765a-a998-e7f30ea14861" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_019b096a-637d-7518-a2ff-22bd2095a626" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_019b096a-637d-765a-a998-e7f30ea14861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_019c664b-e01b-7680-8450-5650bce92cab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_019b096a-637d-7518-a2ff-22bd2095a626" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_019c664b-e01b-7680-8450-5650bce92cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_019b096a-637d-7508-9295-af80341fc346" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-74f7-8834-64e7217545f5" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_019b096a-637d-7508-9295-af80341fc346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_019b096a-637d-7c6f-b149-06660d4cb1e2" xlink:href="jynt-20251231.xsd#jynt_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_019b096a-637d-7508-9295-af80341fc346" xlink:to="loc_jynt_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_019b096a-637d-7c6f-b149-06660d4cb1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DeferredTaxLiabilitiesDeferredFranchiseCosts_019b096a-637d-77a8-a379-8575cd7c174b" xlink:href="jynt-20251231.xsd#jynt_DeferredTaxLiabilitiesDeferredFranchiseCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_019b096a-637d-7508-9295-af80341fc346" xlink:to="loc_jynt_DeferredTaxLiabilitiesDeferredFranchiseCosts_019b096a-637d-77a8-a379-8575cd7c174b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_019b096a-637d-763a-8da0-e10330e0a7fb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_019b096a-637d-7508-9295-af80341fc346" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_019b096a-637d-763a-8da0-e10330e0a7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_019b096a-637d-7ba6-bf91-e65f438c001d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_019b096a-637d-7508-9295-af80341fc346" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_019b096a-637d-7ba6-bf91-e65f438c001d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_019b096a-637d-7215-b023-8a1574e05236" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_019b096a-637d-7508-9295-af80341fc346" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_019b096a-637d-7215-b023-8a1574e05236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_019b096a-637d-7633-90f3-4116e3e9329d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-74f7-8834-64e7217545f5" xlink:to="loc_us-gaap_DeferredTaxLiabilities_019b096a-637d-7633-90f3-4116e3e9329d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-7d5d-9924-81cab8c36e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_019b096a-637d-722e-8d0d-8c6793f59081" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-7d5d-9924-81cab8c36e1f" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_019b096a-637d-722e-8d0d-8c6793f59081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019c669b-f797-793d-ba68-767980976ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_019b096a-637d-722e-8d0d-8c6793f59081" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019c669b-f797-793d-ba68-767980976ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019c669b-f797-7954-a093-86c8e80f7c88" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019c669b-f797-793d-ba68-767980976ddd" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019c669b-f797-7954-a093-86c8e80f7c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019c669b-f797-789a-8e86-8c5f9c74cda4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019c669b-f797-7954-a093-86c8e80f7c88" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019c669b-f797-789a-8e86-8c5f9c74cda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019c669b-f797-7e6c-a89a-f8f992cd9823" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_019b096a-637d-722e-8d0d-8c6793f59081" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019c669b-f797-7e6c-a89a-f8f992cd9823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019c669b-f797-73f2-b392-931d06a31b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019c669b-f797-7e6c-a89a-f8f992cd9823" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019c669b-f797-73f2-b392-931d06a31b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019c669b-f797-729d-aa3e-889c73c451f9" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019c669b-f797-73f2-b392-931d06a31b8b" xlink:to="loc_jynt_CorporateClinicsMember_019c669b-f797-729d-aa3e-889c73c451f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_019c669b-f797-70a1-989b-adc693b783d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_019b096a-637d-722e-8d0d-8c6793f59081" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_019c669b-f797-70a1-989b-adc693b783d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_019c669b-f797-7e30-83b9-faa67d2c5066" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_019c669b-f797-70a1-989b-adc693b783d7" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_019c669b-f797-7e30-83b9-faa67d2c5066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_019c669b-f797-7cea-91c4-242b1312644f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_019c669b-f797-7e30-83b9-faa67d2c5066" xlink:to="loc_us-gaap_DomesticCountryMember_019c669b-f797-7cea-91c4-242b1312644f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_019c90ae-93eb-7f74-80b5-36d0bb9fdd1f" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticCountryMember_019c669b-f797-7cea-91c4-242b1312644f" xlink:to="loc_country_US_019c90ae-93eb-7f74-80b5-36d0bb9fdd1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_019cc457-7737-7cbb-b12a-4cac2f732829" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_019c669b-f797-7e30-83b9-faa67d2c5066" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_019cc457-7737-7cbb-b12a-4cac2f732829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_019c669b-f797-76f5-a8ed-3df5c5846ced" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_019b096a-637d-722e-8d0d-8c6793f59081" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_019c669b-f797-76f5-a8ed-3df5c5846ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_019c669b-f797-7674-8211-d351d68af05e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_019c669b-f797-76f5-a8ed-3df5c5846ced" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_019c669b-f797-7674-8211-d351d68af05e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_019c669b-f797-7fc7-9c38-2910dc7c4a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_019c669b-f797-7674-8211-d351d68af05e" xlink:to="loc_us-gaap_ResearchMember_019c669b-f797-7fc7-9c38-2910dc7c4a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CaliforniaAlternativeMinimumTaxCreditMember_019c669b-f797-7ce2-a744-dc15fa7e6083" xlink:href="jynt-20251231.xsd#jynt_CaliforniaAlternativeMinimumTaxCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_019c669b-f797-7674-8211-d351d68af05e" xlink:to="loc_jynt_CaliforniaAlternativeMinimumTaxCreditMember_019c669b-f797-7ce2-a744-dc15fa7e6083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_019b096a-637d-722e-8d0d-8c6793f59081" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_019c669b-f797-7718-b8e9-9b06756c330a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_019c669b-f797-7718-b8e9-9b06756c330a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_019cc53f-6adb-7a01-82a4-84ae07807ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_019cc53f-6adb-7a01-82a4-84ae07807ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent_019c669b-f797-7a42-9c4a-87ae7dca8497" xlink:href="jynt-20251231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:to="loc_jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent_019c669b-f797-7a42-9c4a-87ae7dca8497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_019c669b-f797-7d06-b923-f8d4902513c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:to="loc_us-gaap_OperatingLossCarryforwards_019c669b-f797-7d06-b923-f8d4902513c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_019c669b-f797-73c0-820f-0cd55a21f622" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_019c669b-f797-73c0-820f-0cd55a21f622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_019c669b-f797-718b-9c5f-9175f19ad489" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_019c669b-f797-718b-9c5f-9175f19ad489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_019c669b-f797-7c7b-9f18-917ba345b1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_019c669b-f797-7c7b-9f18-917ba345b1f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019c669c-7f76-7e38-a2e8-c1484597a876" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019c669c-7f76-7e38-a2e8-c1484597a876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_019c669c-7f76-73bb-a69f-7fc08e64b69e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_019c669c-7f76-73bb-a69f-7fc08e64b69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_019cb99e-c6c2-7e54-bb4d-601397c64dca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_019cb99e-c6c2-7e54-bb4d-601397c64dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_019c669c-c052-74bd-a52f-3cc6b327294b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019c669b-f797-7195-b8bf-78e61a0b68fe" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_019c669c-c052-74bd-a52f-3cc6b327294b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#IncomeTaxesEffectiveIncomeTaxReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-7901-b022-5db766b1b454" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019c6677-8112-7c59-9b3e-ce553a150758" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-7901-b022-5db766b1b454" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019c6677-8112-7c59-9b3e-ce553a150758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c6677-f150-7265-8176-f4cde5cc8c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-7901-b022-5db766b1b454" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c6677-f150-7265-8176-f4cde5cc8c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_019c6678-340e-7f73-b575-7d26f714ba15" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c6677-f150-7265-8176-f4cde5cc8c3e" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_019c6678-340e-7f73-b575-7d26f714ba15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_019c6678-340e-747d-8a62-90b5cf34374a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c6677-f150-7265-8176-f4cde5cc8c3e" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_019c6678-340e-747d-8a62-90b5cf34374a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_019c6678-340e-7bd2-a16a-68d2f59f2e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c6677-f150-7265-8176-f4cde5cc8c3e" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_019c6678-340e-7bd2-a16a-68d2f59f2e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount_019c6678-340e-7834-8746-95b880e15dc7" xlink:href="jynt-20251231.xsd#jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c6677-f150-7265-8176-f4cde5cc8c3e" xlink:to="loc_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount_019c6678-340e-7834-8746-95b880e15dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_019c6678-340e-7ede-b8e4-0049ae3ef67c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c6677-f150-7265-8176-f4cde5cc8c3e" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_019c6678-340e-7ede-b8e4-0049ae3ef67c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount_019c6678-340e-7115-872f-72e6d281c3f9" xlink:href="jynt-20251231.xsd#jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c6677-f150-7265-8176-f4cde5cc8c3e" xlink:to="loc_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount_019c6678-340e-7115-872f-72e6d281c3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_019c6678-340e-7aed-95ac-1b8ec216a424" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c6677-f150-7265-8176-f4cde5cc8c3e" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_019c6678-340e-7aed-95ac-1b8ec216a424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_019c6678-340e-7ec5-aa02-86951dc621b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c6677-f150-7265-8176-f4cde5cc8c3e" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_019c6678-340e-7ec5-aa02-86951dc621b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_019c6678-340e-78c6-bf8f-3920394a06ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c6677-f150-7265-8176-f4cde5cc8c3e" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_019c6678-340e-78c6-bf8f-3920394a06ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItemsAbstract_019cb999-9315-7ea8-9cea-5a1361280839" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItemsAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c6677-f150-7265-8176-f4cde5cc8c3e" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItemsAbstract_019cb999-9315-7ea8-9cea-5a1361280839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount_019cb998-a3d7-72b6-a839-992c4e8411c8" xlink:href="jynt-20251231.xsd#jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItemsAbstract_019cb999-9315-7ea8-9cea-5a1361280839" xlink:to="loc_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount_019cb998-a3d7-72b6-a839-992c4e8411c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_019cb98e-bf42-7c9e-a4a1-bf7a7712d24b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItemsAbstract_019cb999-9315-7ea8-9cea-5a1361280839" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_019cb98e-bf42-7c9e-a4a1-bf7a7712d24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_019c6678-340e-7707-b719-8741598cf215" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItemsAbstract_019cb999-9315-7ea8-9cea-5a1361280839" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_019c6678-340e-7707-b719-8741598cf215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019c6678-340e-781e-9b76-b3cd900fbee5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c6677-f150-7265-8176-f4cde5cc8c3e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019c6678-340e-781e-9b76-b3cd900fbee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c6679-aa52-76f1-bc3d-85d00cb89bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-7901-b022-5db766b1b454" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c6679-aa52-76f1-bc3d-85d00cb89bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_019c667a-0219-7e66-bef9-01a9fd064f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c6679-aa52-76f1-bc3d-85d00cb89bc1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_019c667a-0219-7e66-bef9-01a9fd064f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_019c667a-0219-7260-b43a-c9227cfdedc0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c6679-aa52-76f1-bc3d-85d00cb89bc1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_019c667a-0219-7260-b43a-c9227cfdedc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_019c667a-0219-73bb-be92-78e4fbaec114" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c6679-aa52-76f1-bc3d-85d00cb89bc1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_019c667a-0219-73bb-be92-78e4fbaec114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent_019c667a-0219-7750-a8ea-5f45bae2a6d3" xlink:href="jynt-20251231.xsd#jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c6679-aa52-76f1-bc3d-85d00cb89bc1" xlink:to="loc_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent_019c667a-0219-7750-a8ea-5f45bae2a6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_019c667a-0219-7a51-8a05-1f287886a62e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c6679-aa52-76f1-bc3d-85d00cb89bc1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_019c667a-0219-7a51-8a05-1f287886a62e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent_019c667a-0219-7f79-a028-99c78fb9cd20" xlink:href="jynt-20251231.xsd#jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c6679-aa52-76f1-bc3d-85d00cb89bc1" xlink:to="loc_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent_019c667a-0219-7f79-a028-99c78fb9cd20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_019c667a-0219-7074-b315-2b8c6f3ccb1b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c6679-aa52-76f1-bc3d-85d00cb89bc1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_019c667a-0219-7074-b315-2b8c6f3ccb1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_019c667a-0219-7144-97b6-acc0552abc30" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c6679-aa52-76f1-bc3d-85d00cb89bc1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_019c667a-0219-7144-97b6-acc0552abc30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_019c667a-0219-7058-9ef4-72e4bf4bf406" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c6679-aa52-76f1-bc3d-85d00cb89bc1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_019c667a-0219-7058-9ef4-72e4bf4bf406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercentAbstract_019cb99a-3842-7743-8236-bc836f6c28c1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercentAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c6679-aa52-76f1-bc3d-85d00cb89bc1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercentAbstract_019cb99a-3842-7743-8236-bc836f6c28c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent_019cb998-f761-77df-82a3-903e79313e45" xlink:href="jynt-20251231.xsd#jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercentAbstract_019cb99a-3842-7743-8236-bc836f6c28c1" xlink:to="loc_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent_019cb998-f761-77df-82a3-903e79313e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_019cb991-23e6-74f4-b7a7-d2f9d52e547e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercentAbstract_019cb99a-3842-7743-8236-bc836f6c28c1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_019cb991-23e6-74f4-b7a7-d2f9d52e547e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_019c667a-0219-7735-be17-e5e3822f5e68" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercentAbstract_019cb99a-3842-7743-8236-bc836f6c28c1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_019c667a-0219-7735-be17-e5e3822f5e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019c667a-0219-7d18-a830-2aee0746e503" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c6679-aa52-76f1-bc3d-85d00cb89bc1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019c667a-0219-7d18-a830-2aee0746e503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/IncomeTaxesUncertainTaxPositionRollforwardDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#IncomeTaxesUncertainTaxPositionRollforwardDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/IncomeTaxesUncertainTaxPositionRollforwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-7c50-ab51-a1d64d8337ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_019b096a-637d-7e3e-9c6a-ce9106e97313" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019b096a-637d-7c50-ab51-a1d64d8337ca" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_019b096a-637d-7e3e-9c6a-ce9106e97313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-637d-78e8-a394-221cecf2b25a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_019b096a-637d-7e3e-9c6a-ce9106e97313" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-637d-78e8-a394-221cecf2b25a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-637d-7dd7-bb85-1490be1826cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019b096a-637d-78e8-a394-221cecf2b25a" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-637d-7dd7-bb85-1490be1826cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019b096a-637d-7706-9e41-a5acda33c19a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019b096a-637d-7dd7-bb85-1490be1826cb" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_019b096a-637d-7706-9e41-a5acda33c19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-637d-7cc8-bf25-b66e8e2195c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_019b096a-637d-7e3e-9c6a-ce9106e97313" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-637d-7cc8-bf25-b66e8e2195c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-637d-7cf1-813f-34b521a06fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019b096a-637d-7cc8-bf25-b66e8e2195c7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-637d-7cf1-813f-34b521a06fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CorporateClinicsMember_019b096a-637d-7536-9fd7-0396c4362d91" xlink:href="jynt-20251231.xsd#jynt_CorporateClinicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019b096a-637d-7cf1-813f-34b521a06fd6" xlink:to="loc_jynt_CorporateClinicsMember_019b096a-637d-7536-9fd7-0396c4362d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_019b096a-637d-708e-89ac-01a27cd7d97b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_019b096a-637d-7e3e-9c6a-ce9106e97313" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_019b096a-637d-708e-89ac-01a27cd7d97b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_019b096a-637d-7451-afa5-9ee6e450caeb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_019b096a-637d-708e-89ac-01a27cd7d97b" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_019b096a-637d-7451-afa5-9ee6e450caeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_019b096a-637d-7151-89d1-2f63a516b153" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_019b096a-637d-7451-afa5-9ee6e450caeb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_019b096a-637d-7151-89d1-2f63a516b153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_019b096a-637d-7eca-8df8-5a5da16726a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_019b096a-637d-7451-afa5-9ee6e450caeb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_019b096a-637d-7eca-8df8-5a5da16726a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_019b096a-637d-7516-9c7e-8a4829b2331f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_019b096a-637d-7451-afa5-9ee6e450caeb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_019b096a-637d-7516-9c7e-8a4829b2331f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_019c6695-59af-7a02-b2fb-b6669f188052" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPaidByIndividualJurisdictionTable_019c6696-3a1e-700f-b311-f41a99d0b24b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPaidByIndividualJurisdictionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019c6695-59af-7a02-b2fb-b6669f188052" xlink:to="loc_us-gaap_IncomeTaxPaidByIndividualJurisdictionTable_019c6696-3a1e-700f-b311-f41a99d0b24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_019c6697-c97b-715b-8d6d-6b977828dbc8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxPaidByIndividualJurisdictionTable_019c6696-3a1e-700f-b311-f41a99d0b24b" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_019c6697-c97b-715b-8d6d-6b977828dbc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_019c6697-c97b-7eee-b7c0-dfab71e995e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_019c6697-c97b-715b-8d6d-6b977828dbc8" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_019c6697-c97b-7eee-b7c0-dfab71e995e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_019c6698-526c-72a1-b171-3e3e5f9801b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_019c6697-c97b-7eee-b7c0-dfab71e995e2" xlink:to="loc_us-gaap_DomesticCountryMember_019c6698-526c-72a1-b171-3e3e5f9801b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AZ_019c6698-9038-74f3-b940-399cf31b87c9" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_AZ"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticCountryMember_019c6698-526c-72a1-b171-3e3e5f9801b4" xlink:to="loc_stpr_AZ_019c6698-9038-74f3-b940-399cf31b87c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_019c6698-b839-7e9a-8312-ce31169c731a" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_CA"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticCountryMember_019c6698-526c-72a1-b171-3e3e5f9801b4" xlink:to="loc_stpr_CA_019c6698-b839-7e9a-8312-ce31169c731a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_019c6698-df18-7266-a56e-fc612d4f5d4d" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_TX"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticCountryMember_019c6698-526c-72a1-b171-3e3e5f9801b4" xlink:to="loc_stpr_TX_019c6698-df18-7266-a56e-fc612d4f5d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalTaxJurisdictionOtherMember_019c6699-1dec-7588-b695-05c9d73776b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StateAndLocalTaxJurisdictionOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticCountryMember_019c6698-526c-72a1-b171-3e3e5f9801b4" xlink:to="loc_us-gaap_StateAndLocalTaxJurisdictionOtherMember_019c6699-1dec-7588-b695-05c9d73776b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems_019c6696-ab89-7b73-8641-dabc37395426" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxPaidByIndividualJurisdictionTable_019c6696-3a1e-700f-b311-f41a99d0b24b" xlink:to="loc_us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems_019c6696-ab89-7b73-8641-dabc37395426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPaidFederalAfterRefundReceived_019c6696-ab89-7740-b510-5424a2af265a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPaidFederalAfterRefundReceived"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems_019c6696-ab89-7b73-8641-dabc37395426" xlink:to="loc_us-gaap_IncomeTaxPaidFederalAfterRefundReceived_019c6696-ab89-7740-b510-5424a2af265a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPaidStateAndLocalAfterRefundReceived_019c6697-2ef4-7b54-b3d2-b5b669b8b7fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPaidStateAndLocalAfterRefundReceived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems_019c6696-ab89-7b73-8641-dabc37395426" xlink:to="loc_us-gaap_IncomeTaxPaidStateAndLocalAfterRefundReceived_019c6697-2ef4-7b54-b3d2-b5b669b8b7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_019c6699-c29d-7a0e-aa0e-07ddbc37ab16" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems_019c6696-ab89-7b73-8641-dabc37395426" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_019c6699-c29d-7a0e-aa0e-07ddbc37ab16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-7eb8-b0a0-ee11c5a7a711" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeAndExpensesLesseeAbstract_019b096a-637d-7006-b116-c7445f1cff85" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeAndExpensesLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-7eb8-b0a0-ee11c5a7a711" xlink:to="loc_us-gaap_IncomeAndExpensesLesseeAbstract_019b096a-637d-7006-b116-c7445f1cff85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_019b096a-637d-7cc6-ab9c-b1c7ddd109d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAndExpensesLesseeAbstract_019b096a-637d-7006-b116-c7445f1cff85" xlink:to="loc_us-gaap_OperatingLeaseCost_019b096a-637d-7cc6-ab9c-b1c7ddd109d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_019b096a-637d-7a98-85c4-dd10d546646e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAndExpensesLesseeAbstract_019b096a-637d-7006-b116-c7445f1cff85" xlink:to="loc_us-gaap_LeaseCost_019b096a-637d-7a98-85c4-dd10d546646e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_019b096a-637d-77f5-96a7-d13eac01ce7c" xlink:href="jynt-20251231.xsd#jynt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-7eb8-b0a0-ee11c5a7a711" xlink:to="loc_jynt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_019b096a-637d-77f5-96a7-d13eac01ce7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019b096a-637d-74fd-b177-4861d8da29e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_019b096a-637d-77f5-96a7-d13eac01ce7c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019b096a-637d-74fd-b177-4861d8da29e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019b096a-637d-79cd-9d04-7c0afeea27a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_019b096a-637d-77f5-96a7-d13eac01ce7c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019b096a-637d-79cd-9d04-7c0afeea27a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019b096a-637d-70f8-bfc9-c5d114a151c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_019b096a-637d-77f5-96a7-d13eac01ce7c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019b096a-637d-70f8-bfc9-c5d114a151c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_019b096a-637d-759f-a6a6-347164bc1c51" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_019b096a-637d-77f5-96a7-d13eac01ce7c" xlink:to="loc_us-gaap_OperatingLeaseLiability_019b096a-637d-759f-a6a6-347164bc1c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_WeightedAverageRemainingLeaseTermAbstract_019b096a-637d-7e32-964b-956dfacb6239" xlink:href="jynt-20251231.xsd#jynt_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-7eb8-b0a0-ee11c5a7a711" xlink:to="loc_jynt_WeightedAverageRemainingLeaseTermAbstract_019b096a-637d-7e32-964b-956dfacb6239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_019b096a-637d-7ef4-a01d-e930f5c2c113" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_WeightedAverageRemainingLeaseTermAbstract_019b096a-637d-7e32-964b-956dfacb6239" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_019b096a-637d-7ef4-a01d-e930f5c2c113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_LeasesWeightedAverageDiscountRateAbstract_019b096a-637d-7138-a449-b507f05593fb" xlink:href="jynt-20251231.xsd#jynt_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-7eb8-b0a0-ee11c5a7a711" xlink:to="loc_jynt_LeasesWeightedAverageDiscountRateAbstract_019b096a-637d-7138-a449-b507f05593fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_019b096a-637d-7725-abed-7aaf87fb6081" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_LeasesWeightedAverageDiscountRateAbstract_019b096a-637d-7138-a449-b507f05593fb" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_019b096a-637d-7725-abed-7aaf87fb6081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_CashFlowLesseeAbstract_019b096a-637d-77ac-96cb-0d5cc92516ed" xlink:href="jynt-20251231.xsd#jynt_CashFlowLesseeAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-7eb8-b0a0-ee11c5a7a711" xlink:to="loc_jynt_CashFlowLesseeAbstract_019b096a-637d-77ac-96cb-0d5cc92516ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_019b096a-637d-7544-a5c6-6855bbe48734" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_CashFlowLesseeAbstract_019b096a-637d-77ac-96cb-0d5cc92516ed" xlink:to="loc_us-gaap_OperatingLeasePayments_019b096a-637d-7544-a5c6-6855bbe48734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_019b096a-637d-7538-bf5c-f841c68b7483" xlink:href="jynt-20251231.xsd#jynt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-7eb8-b0a0-ee11c5a7a711" xlink:to="loc_jynt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_019b096a-637d-7538-bf5c-f841c68b7483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_019b096a-637d-7d68-91af-3a478eb834a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_019b096a-637d-7538-bf5c-f841c68b7483" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_019b096a-637d-7d68-91af-3a478eb834a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-7c68-be93-6f5df36f0189" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019b096a-637d-7526-98dc-36d88f6d62b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-7c68-be93-6f5df36f0189" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019b096a-637d-7526-98dc-36d88f6d62b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019b096a-637d-797d-8d63-0f99e172ae88" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-7c68-be93-6f5df36f0189" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019b096a-637d-797d-8d63-0f99e172ae88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019b096a-637d-764c-97f1-523e4ef3f341" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-7c68-be93-6f5df36f0189" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019b096a-637d-764c-97f1-523e4ef3f341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_019b096a-637d-7db5-87d9-df713e46b242" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-7c68-be93-6f5df36f0189" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_019b096a-637d-7db5-87d9-df713e46b242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_019b096a-637d-732f-bcbf-912683ff1588" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-7c68-be93-6f5df36f0189" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_019b096a-637d-732f-bcbf-912683ff1588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_019b096a-637d-7c7a-89bf-a713ac31c571" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-7c68-be93-6f5df36f0189" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_019b096a-637d-7c7a-89bf-a713ac31c571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019b096a-637d-75e2-a2bd-b71c419868a4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-7c68-be93-6f5df36f0189" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019b096a-637d-75e2-a2bd-b71c419868a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019b096a-637d-71bd-b615-ec6cfcf6fb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-7c68-be93-6f5df36f0189" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019b096a-637d-71bd-b615-ec6cfcf6fb8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_019b096a-637d-787b-a26f-b146d8344cae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-7c68-be93-6f5df36f0189" xlink:to="loc_us-gaap_OperatingLeaseLiability_019b096a-637d-787b-a26f-b146d8344cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019b096a-637d-76b6-a9a9-65d005b74fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-7c68-be93-6f5df36f0189" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019b096a-637d-76b6-a9a9-65d005b74fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019b096a-637d-72cc-988e-adc8de2ee152" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-7c68-be93-6f5df36f0189" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019b096a-637d-72cc-988e-adc8de2ee152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-722a-b40b-355d69a3ec0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_019b096a-637d-7e4d-94d9-6b763b724a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019b096a-637d-722a-b40b-355d69a3ec0c" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_019b096a-637d-7e4d-94d9-6b763b724a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_019c66aa-9479-7d9b-996f-230226890a62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_019b096a-637d-7e4d-94d9-6b763b724a5b" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_019c66aa-9479-7d9b-996f-230226890a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_019c66aa-9479-7895-9f52-37c69a84140f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_019c66aa-9479-7d9b-996f-230226890a62" xlink:to="loc_us-gaap_LossContingencyNatureDomain_019c66aa-9479-7895-9f52-37c69a84140f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_EmploymentMattersMember_019c66aa-9479-7e0f-80b5-dd102adfd1e1" xlink:href="jynt-20251231.xsd#jynt_EmploymentMattersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_019c66aa-9479-7895-9f52-37c69a84140f" xlink:to="loc_jynt_EmploymentMattersMember_019c66aa-9479-7e0f-80b5-dd102adfd1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_MedicalInjuryClaimMember_019c66aa-9479-70c4-a64f-0181ee1109c2" xlink:href="jynt-20251231.xsd#jynt_MedicalInjuryClaimMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_019c66aa-9479-7895-9f52-37c69a84140f" xlink:to="loc_jynt_MedicalInjuryClaimMember_019c66aa-9479-70c4-a64f-0181ee1109c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c66aa-756e-7651-a786-fe641de37607" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_019b096a-637d-7e4d-94d9-6b763b724a5b" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c66aa-756e-7651-a786-fe641de37607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_NumberOfFutureOperatingLeasesCommitted_019c66aa-756e-7f33-98f0-47704ff75f60" xlink:href="jynt-20251231.xsd#jynt_NumberOfFutureOperatingLeasesCommitted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c66aa-756e-7651-a786-fe641de37607" xlink:to="loc_jynt_NumberOfFutureOperatingLeasesCommitted_019c66aa-756e-7f33-98f0-47704ff75f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_GuarantorObligationsRemainingExposureUndiscounted_019c66aa-756e-7223-8d7c-ac0fc7c16567" xlink:href="jynt-20251231.xsd#jynt_GuarantorObligationsRemainingExposureUndiscounted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c66aa-756e-7651-a786-fe641de37607" xlink:to="loc_jynt_GuarantorObligationsRemainingExposureUndiscounted_019c66aa-756e-7223-8d7c-ac0fc7c16567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_019c66aa-9479-78b8-b58c-139a76bdacdc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c66aa-756e-7651-a786-fe641de37607" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_019c66aa-9479-78b8-b58c-139a76bdacdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019c66aa-9479-7205-8218-65411eb796f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c66aa-756e-7651-a786-fe641de37607" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_019c66aa-9479-7205-8218-65411eb796f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019c66aa-9479-7da5-9234-ae3a12246166" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c66aa-756e-7651-a786-fe641de37607" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_019c66aa-9479-7da5-9234-ae3a12246166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_019c66aa-9479-78a4-a149-c2f5a0619e76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c66aa-756e-7651-a786-fe641de37607" xlink:to="loc_us-gaap_LitigationSettlementExpense_019c66aa-9479-78a4-a149-c2f5a0619e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#SegmentReportingNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/SegmentReportingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_019b096a-637d-7038-944e-334f90ab0773" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019b096a-637d-7e8e-be04-98a24a1f4e21" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019b096a-637d-7038-944e-334f90ab0773" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019b096a-637d-7e8e-be04-98a24a1f4e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisorDisclosureAxis_019b096a-637d-7857-9afa-445516ad00a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisorDisclosureAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019b096a-637d-7e8e-be04-98a24a1f4e21" xlink:to="loc_us-gaap_FranchisorDisclosureAxis_019b096a-637d-7857-9afa-445516ad00a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisorDisclosureDomain_019b096a-637d-7000-8dac-dcacf0fa3776" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisorDisclosureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FranchisorDisclosureAxis_019b096a-637d-7857-9afa-445516ad00a1" xlink:to="loc_us-gaap_FranchisorDisclosureDomain_019b096a-637d-7000-8dac-dcacf0fa3776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchisedUnitsMember_019b096a-637d-794f-b1b6-6e8d96a246e9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchisedUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FranchisorDisclosureDomain_019b096a-637d-7000-8dac-dcacf0fa3776" xlink:to="loc_us-gaap_FranchisedUnitsMember_019b096a-637d-794f-b1b6-6e8d96a246e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-73c8-9d39-82b6e26eb250" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019b096a-637d-7e8e-be04-98a24a1f4e21" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-73c8-9d39-82b6e26eb250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_019b096a-637d-794c-8154-9fc4ba4695ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-73c8-9d39-82b6e26eb250" xlink:to="loc_us-gaap_NumberOfOperatingSegments_019b096a-637d-794c-8154-9fc4ba4695ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_019b336b-c94c-7dff-b0ed-b0512ba204f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-73c8-9d39-82b6e26eb250" xlink:to="loc_us-gaap_NumberOfReportableSegments_019b336b-c94c-7dff-b0ed-b0512ba204f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_019b096a-637d-7aad-9ad2-3cfa313fff8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfStores"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-73c8-9d39-82b6e26eb250" xlink:to="loc_us-gaap_NumberOfStores_019b096a-637d-7aad-9ad2-3cfa313fff8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_019b096a-637d-7ef3-a914-55c784092905" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019b096a-637d-7c98-9c9e-9365d24b4643" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019b096a-637d-7ef3-a914-55c784092905" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019b096a-637d-7c98-9c9e-9365d24b4643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_019b096a-637d-7439-a548-200cd6e040d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019b096a-637d-7c98-9c9e-9365d24b4643" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_019b096a-637d-7439-a548-200cd6e040d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_019b096a-637d-7a0b-a787-6290355c7eba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_019b096a-637d-7439-a548-200cd6e040d8" xlink:to="loc_us-gaap_SegmentDomain_019b096a-637d-7a0b-a787-6290355c7eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_FranchiseOperationsMember_019b096a-637d-73f0-ba10-e11b6af8ad7e" xlink:href="jynt-20251231.xsd#jynt_FranchiseOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_019b096a-637d-7a0b-a787-6290355c7eba" xlink:to="loc_jynt_FranchiseOperationsMember_019b096a-637d-73f0-ba10-e11b6af8ad7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019b096a-637d-7ef8-9233-21d00c3b513a" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019b096a-637d-7c98-9c9e-9365d24b4643" xlink:to="loc_srt_ProductOrServiceAxis_019b096a-637d-7ef8-9233-21d00c3b513a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019b096a-637d-75f4-8d37-c36336022167" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_019b096a-637d-7ef8-9233-21d00c3b513a" xlink:to="loc_srt_ProductsAndServicesDomain_019b096a-637d-75f4-8d37-c36336022167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FranchiseMember_019b096a-637d-7179-abf6-5d8b38502bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FranchiseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019b096a-637d-75f4-8d37-c36336022167" xlink:to="loc_us-gaap_FranchiseMember_019b096a-637d-7179-abf6-5d8b38502bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyServiceMember_019b096a-637d-7a99-9a61-df4fc5fc289c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TechnologyServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019b096a-637d-75f4-8d37-c36336022167" xlink:to="loc_us-gaap_TechnologyServiceMember_019b096a-637d-7a99-9a61-df4fc5fc289c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-7b18-a1d7-39ad51018b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019b096a-637d-7c98-9c9e-9365d24b4643" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-7b18-a1d7-39ad51018b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_019b096a-637d-750f-b0ae-ee9672c752ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-7b18-a1d7-39ad51018b1d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_019b096a-637d-750f-b0ae-ee9672c752ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_019b096a-637d-70c4-8753-44a820a64698" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-7b18-a1d7-39ad51018b1d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_019b096a-637d-70c4-8753-44a820a64698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_019b096a-637d-7a39-8644-fbdf72e9d0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-7b18-a1d7-39ad51018b1d" xlink:to="loc_us-gaap_SellingAndMarketingExpense_019b096a-637d-7a39-8644-fbdf72e9d0b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_GeneralAndAdministrativeExpenseAdjusted_019b096a-637d-7c9e-b703-4c7cf4f79752" xlink:href="jynt-20251231.xsd#jynt_GeneralAndAdministrativeExpenseAdjusted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-7b18-a1d7-39ad51018b1d" xlink:to="loc_jynt_GeneralAndAdministrativeExpenseAdjusted_019b096a-637d-7c9e-b703-4c7cf4f79752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019b096a-637d-7345-a070-abb98800af76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-7b18-a1d7-39ad51018b1d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019b096a-637d-7345-a070-abb98800af76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_019b096a-637d-7377-bc1c-60300288ffaa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-7b18-a1d7-39ad51018b1d" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_019b096a-637d-7377-bc1c-60300288ffaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_019b096a-637d-7457-a23a-632a6ae236f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-7b18-a1d7-39ad51018b1d" xlink:to="loc_us-gaap_DepreciationAndAmortization_019b096a-637d-7457-a23a-632a6ae236f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-7bc0-80c8-b3deaffeb4a4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-7b18-a1d7-39ad51018b1d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-7bc0-80c8-b3deaffeb4a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-637d-784e-ab75-73e951bacdf4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-7b18-a1d7-39ad51018b1d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-637d-784e-ab75-73e951bacdf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_019b096a-637d-7e5f-b207-9986bffb891f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019b096a-637d-7b18-a1d7-39ad51018b1d" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_019b096a-637d-7e5f-b207-9986bffb891f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-637d-7b06-bee6-9a228cda2552" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_019b096a-637d-7e5f-b207-9986bffb891f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-637d-7b06-bee6-9a228cda2552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-637d-7136-8cb1-376158009d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_019b096a-637d-7e5f-b207-9986bffb891f" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-637d-7136-8cb1-376158009d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_019b096a-637d-7fea-88c8-a0a2ed9ffe9f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_019b096a-637d-7e5f-b207-9986bffb891f" xlink:to="loc_us-gaap_ProfitLoss_019b096a-637d-7fea-88c8-a0a2ed9ffe9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#RelatedPartyTransactionsDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_019b096a-637d-7e4e-9c9c-512743ab76df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019b096a-637d-78d4-88f7-551db85472c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_019b096a-637d-7e4e-9c9c-512743ab76df" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019b096a-637d-78d4-88f7-551db85472c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_019b096a-637d-7203-a0e2-dbfe9bd00d30" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019b096a-637d-78d4-88f7-551db85472c4" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_019b096a-637d-7203-a0e2-dbfe9bd00d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_019b096a-637d-7605-b31a-1561cef6923d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_019b096a-637d-7203-a0e2-dbfe9bd00d30" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_019b096a-637d-7605-b31a-1561cef6923d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_BanderaPartnersLLCMember_019b096a-637d-739b-aba5-55d5dc161fa4" xlink:href="jynt-20251231.xsd#jynt_BanderaPartnersLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_019b096a-637d-7605-b31a-1561cef6923d" xlink:to="loc_jynt_BanderaPartnersLLCMember_019b096a-637d-739b-aba5-55d5dc161fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019b096a-637d-70e2-8468-36fd0ed8026e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019b096a-637d-78d4-88f7-551db85472c4" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019b096a-637d-70e2-8468-36fd0ed8026e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_019b096a-637d-7b0a-8a36-db8d2c7b630c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019b096a-637d-70e2-8468-36fd0ed8026e" xlink:to="loc_us-gaap_RelatedPartyDomain_019b096a-637d-7b0a-8a36-db8d2c7b630c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_019b096a-637d-7ecd-b6b4-87b5ea569be3" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_019b096a-637d-7b0a-8a36-db8d2c7b630c" xlink:to="loc_srt_DirectorMember_019b096a-637d-7ecd-b6b4-87b5ea569be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_019b096a-637d-7ef0-82ac-a1c8567202d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019b096a-637d-78d4-88f7-551db85472c4" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_019b096a-637d-7ef0-82ac-a1c8567202d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_019b096a-637d-74b5-8618-d2d4f555274a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_019b096a-637d-7ef0-82ac-a1c8567202d8" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_019b096a-637d-74b5-8618-d2d4f555274a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_FranchiseLicensesMember_019b096a-637d-701e-bbd5-f76e1796fad3" xlink:href="jynt-20251231.xsd#jynt_FranchiseLicensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_019b096a-637d-74b5-8618-d2d4f555274a" xlink:to="loc_jynt_FranchiseLicensesMember_019b096a-637d-701e-bbd5-f76e1796fad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_FranchiseLicensesOneMember_019b096a-637d-7326-869b-2c58aaaaa33c" xlink:href="jynt-20251231.xsd#jynt_FranchiseLicensesOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_FranchiseLicensesMember_019b096a-637d-701e-bbd5-f76e1796fad3" xlink:to="loc_jynt_FranchiseLicensesOneMember_019b096a-637d-7326-869b-2c58aaaaa33c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_FranchiseLicensesTwoMember_019b096a-637d-7f9c-b1cf-b94d49323999" xlink:href="jynt-20251231.xsd#jynt_FranchiseLicensesTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jynt_FranchiseLicensesMember_019b096a-637d-701e-bbd5-f76e1796fad3" xlink:to="loc_jynt_FranchiseLicensesTwoMember_019b096a-637d-7f9c-b1cf-b94d49323999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_019b096a-637d-7349-b069-414f852f18b4" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019b096a-637d-78d4-88f7-551db85472c4" xlink:to="loc_srt_CounterpartyNameAxis_019b096a-637d-7349-b069-414f852f18b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019b096a-637d-77d0-a0c5-4f2c87e4504c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_019b096a-637d-7349-b069-414f852f18b4" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019b096a-637d-77d0-a0c5-4f2c87e4504c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_UnaffiliatedFranchiseeMember_019b096a-637d-788d-b23c-8c02cbe4912a" xlink:href="jynt-20251231.xsd#jynt_UnaffiliatedFranchiseeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019b096a-637d-77d0-a0c5-4f2c87e4504c" xlink:to="loc_jynt_UnaffiliatedFranchiseeMember_019b096a-637d-788d-b23c-8c02cbe4912a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019b096a-637d-729d-b41d-6fcdb038b5d0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019b096a-637d-78d4-88f7-551db85472c4" xlink:to="loc_dei_LegalEntityAxis_019b096a-637d-729d-b41d-6fcdb038b5d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019b096a-637d-746d-a416-679c924b0d3d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_019b096a-637d-729d-b41d-6fcdb038b5d0" xlink:to="loc_dei_EntityDomain_019b096a-637d-746d-a416-679c924b0d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_MrJeffersonGrammMember_019b096a-637d-7226-a65c-d1c72985f28e" xlink:href="jynt-20251231.xsd#jynt_MrJeffersonGrammMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_019b096a-637d-746d-a416-679c924b0d3d" xlink:to="loc_jynt_MrJeffersonGrammMember_019b096a-637d-7226-a65c-d1c72985f28e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_UnaffiliatedFranchiseeMember_019b096a-637d-776c-9c1b-4f4dfb6f5103" xlink:href="jynt-20251231.xsd#jynt_UnaffiliatedFranchiseeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_019b096a-637d-746d-a416-679c924b0d3d" xlink:to="loc_jynt_UnaffiliatedFranchiseeMember_019b096a-637d-776c-9c1b-4f4dfb6f5103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_019b096a-637d-7831-9250-6daa9cdd1dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019b096a-637d-78d4-88f7-551db85472c4" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_019b096a-637d-7831-9250-6daa9cdd1dd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_019b096a-637d-7e3c-a1d8-e9ed09b5ce8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b096a-637d-7831-9250-6daa9cdd1dd2" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_019b096a-637d-7e3c-a1d8-e9ed09b5ce8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangesFranchisesSold_019b096a-637d-7dda-af06-59c29c6d8954" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantChangesFranchisesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b096a-637d-7831-9250-6daa9cdd1dd2" xlink:to="loc_us-gaap_SignificantChangesFranchisesSold_019b096a-637d-7dda-af06-59c29c6d8954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_019b096a-637d-73dd-99f9-65414670960b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b096a-637d-7831-9250-6daa9cdd1dd2" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_019b096a-637d-73dd-99f9-65414670960b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_RelatedPartyTransactionAmountsOfTransactionDiscount_019b096a-637d-71b9-bc8a-d1a0dd06052c" xlink:href="jynt-20251231.xsd#jynt_RelatedPartyTransactionAmountsOfTransactionDiscount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b096a-637d-7831-9250-6daa9cdd1dd2" xlink:to="loc_jynt_RelatedPartyTransactionAmountsOfTransactionDiscount_019b096a-637d-71b9-bc8a-d1a0dd06052c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_RelatedPartyTransactionCoPartnerPercentage_019b096a-637d-76c8-91f0-0d2b2b4981ba" xlink:href="jynt-20251231.xsd#jynt_RelatedPartyTransactionCoPartnerPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b096a-637d-7831-9250-6daa9cdd1dd2" xlink:to="loc_jynt_RelatedPartyTransactionCoPartnerPercentage_019b096a-637d-76c8-91f0-0d2b2b4981ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_RelatedPartyTransactionCoPartnerPercentageDivested_019b096a-637d-7ab4-97e3-9ca2f4c1c868" xlink:href="jynt-20251231.xsd#jynt_RelatedPartyTransactionCoPartnerPercentageDivested"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b096a-637d-7831-9250-6daa9cdd1dd2" xlink:to="loc_jynt_RelatedPartyTransactionCoPartnerPercentageDivested_019b096a-637d-7ab4-97e3-9ca2f4c1c868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_019b096a-637d-7aef-9a28-0206fe5d6070" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesReceivableNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b096a-637d-7831-9250-6daa9cdd1dd2" xlink:to="loc_us-gaap_NotesReceivableNet_019b096a-637d-7aef-9a28-0206fe5d6070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jynt_NumberOfClinics_019b096a-637d-7b29-810b-47f08e40f8cf" xlink:href="jynt-20251231.xsd#jynt_NumberOfClinics"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019b096a-637d-7831-9250-6daa9cdd1dd2" xlink:to="loc_jynt_NumberOfClinics_019b096a-637d-7b29-810b-47f08e40f8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails" xlink:type="simple" xlink:href="jynt-20251231.xsd#QuarterlyFinancialDataUnauditedDetails"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_019b096a-637d-7f2d-b021-180985219ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_019b096a-637d-7943-b0a3-ae20dc65eddd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_019b096a-637d-7f2d-b021-180985219ee1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_019b096a-637d-7943-b0a3-ae20dc65eddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_019b096a-637d-77ec-bef8-15ce6d0b5484" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_019b096a-637d-7f2d-b021-180985219ee1" xlink:to="loc_us-gaap_CostOfRevenue_019b096a-637d-77ec-bef8-15ce6d0b5484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_019b096a-637d-796c-bec4-dd4423cc7e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_019b096a-637d-7f2d-b021-180985219ee1" xlink:to="loc_us-gaap_SellingAndMarketingExpense_019b096a-637d-796c-bec4-dd4423cc7e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_019b096a-637d-7b7a-a831-805841c2e1bd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_019b096a-637d-7f2d-b021-180985219ee1" xlink:to="loc_us-gaap_DepreciationAndAmortization_019b096a-637d-7b7a-a831-805841c2e1bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019b096a-637d-784c-93cd-ab04fca1893c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_019b096a-637d-7f2d-b021-180985219ee1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019b096a-637d-784c-93cd-ab04fca1893c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019b096a-637d-750b-8699-7ce401950faa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_019b096a-637d-7f2d-b021-180985219ee1" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019b096a-637d-750b-8699-7ce401950faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_019b096a-637d-7ffb-88d2-e43c9754e0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_019b096a-637d-7f2d-b021-180985219ee1" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_019b096a-637d-7ffb-88d2-e43c9754e0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019b096a-637d-7fb9-b616-928f12794dac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_019b096a-637d-7f2d-b021-180985219ee1" xlink:to="loc_us-gaap_OperatingIncomeLoss_019b096a-637d-7fb9-b616-928f12794dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019b096a-637d-7cd0-bca0-d4859dfca774" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_019b096a-637d-7f2d-b021-180985219ee1" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019b096a-637d-7cd0-bca0-d4859dfca774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019b096a-637d-7710-b9a9-49c1448c1f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_019b096a-637d-7f2d-b021-180985219ee1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019b096a-637d-7710-b9a9-49c1448c1f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-71f6-b770-26dc5a14b721" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_019b096a-637d-7f2d-b021-180985219ee1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019b096a-637d-71f6-b770-26dc5a14b721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-637d-744a-a090-95a2c0997cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_019b096a-637d-7f2d-b021-180985219ee1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_019b096a-637d-744a-a090-95a2c0997cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b096a-637d-7c3c-8cca-5bb02581cb62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_019b096a-637d-7f2d-b021-180985219ee1" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_019b096a-637d-7c3c-8cca-5bb02581cb62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_019b096a-637d-78d0-bee2-99df44594547" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_019b096a-637d-7f2d-b021-180985219ee1" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_019b096a-637d-78d0-bee2-99df44594547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-637d-7099-836b-0e99bdd80dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_019b096a-637d-7f2d-b021-180985219ee1" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_019b096a-637d-7099-836b-0e99bdd80dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_019b096a-637d-79de-b664-ae9be4d3d2df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_019b096a-637d-7f2d-b021-180985219ee1" xlink:to="loc_us-gaap_ProfitLoss_019b096a-637d-79de-b664-ae9be4d3d2df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract_019b096a-637d-785b-9959-f02bc67ae455" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_019b096a-637d-7f2d-b021-180985219ee1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract_019b096a-637d-785b-9959-f02bc67ae455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_019b096a-637d-7261-a710-cd47212b2025" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract_019b096a-637d-785b-9959-f02bc67ae455" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_019b096a-637d-7261-a710-cd47212b2025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_019b096a-637d-73f3-b048-02842b7b0913" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract_019b096a-637d-785b-9959-f02bc67ae455" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_019b096a-637d-73f3-b048-02842b7b0913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract_019b096a-637d-73d6-843e-fb66dcbcb350" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_019b096a-637d-7f2d-b021-180985219ee1" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract_019b096a-637d-73d6-843e-fb66dcbcb350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_019b096a-637d-7363-a515-93bb8010b2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract_019b096a-637d-73d6-843e-fb66dcbcb350" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_019b096a-637d-7363-a515-93bb8010b2e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_019b096a-637d-7152-a967-5e3bf3fc4687" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract_019b096a-637d-73d6-843e-fb66dcbcb350" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_019b096a-637d-7152-a967-5e3bf3fc4687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019b096a-637d-719b-b593-4a6b8dea8d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_019b096a-637d-7f2d-b021-180985219ee1" xlink:to="loc_us-gaap_EarningsPerShareAbstract_019b096a-637d-719b-b593-4a6b8dea8d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_019b096a-637d-7c25-9a36-4e1ac07013c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019b096a-637d-719b-b593-4a6b8dea8d3c" xlink:to="loc_us-gaap_EarningsPerShareBasic_019b096a-637d-7c25-9a36-4e1ac07013c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_019b096a-637d-7fbf-b18a-2a9f61620524" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019b096a-637d-719b-b593-4a6b8dea8d3c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_019b096a-637d-7fbf-b18a-2a9f61620524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>jynt-20251231_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 jynt-20251231_g1.jpg
M_]C_X0 817AI9@  24DJ  @              /_L !%$=6-K>0 !  0   !D
M  #_X0,B:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@
M8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \
M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!
M9&]B92!835 @0V]R92 Q,"XP+6,P,# @-SDN9# T8V,Q-CDX+" R,#(U+S W
M+S R+3$R.C$X.C$S(" @(" @(" B/B \<F1F.E)$1B!X;6QN<SIR9&8](FAT
M=' Z+R]W=W<N=S,N;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/B \
M<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(B!X;6QN<SIX;7 ](FAT=' Z
M+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\B('AM;&YS.GAM<$U-/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(B!X;6QN<SIS=%)E9CTB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(@>&UP
M.D-R96%T;W)4;V]L/2)!9&]B92!);6%G95)E861Y(B!X;7!-33I);G-T86YC
M94E$/2)X;7 N:6ED.C-"-D5$13 W1D$T13$Q1C Y-$%$0D8P,C1"04,Q041%
M(B!X;7!-33I$;V-U;65N=$E$/2)X;7 N9&ED.C-"-D5$13 X1D$T13$Q1C Y
M-$%$0D8P,C1"04,Q041%(CX@/'AM<$U-.D1E<FEV961&<F]M('-T4F5F.FEN
M<W1A;F-E240](GAM<"YI:60Z,T(V141%,#5&031%,3%&,#DT041"1C R-$)!
M0S%!1$4B('-T4F5F.F1O8W5M96YT240](GAM<"YD:60Z,T(V141%,#9&031%
M,3%&,#DT041"1C R-$)!0S%!1$4B+SX@/"]R9&8Z1&5S8W)I<'1I;VX^(#PO
M<F1F.E)$1CX@/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[@ .
M061O8F4 9,     !_]L A  ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! @(" @(" @(" @(# P,# P,# P,# 0$! 0$! 0(!
M 0(" @$" @,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,# P/_P  1" ;8"P@# 1$  A$! Q$!_\0!0@ !  (" P$! 0$
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M  (1 Q$ /P#W\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M0
M
M
M
M
M
M
M
M
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MDC_@$++].4
M
M
M
M
M
M
M
M
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MA+C^@
M
M
M
M
M
M
M
M
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MV7+6NZFR%M4TFTW"R#E"2U36L6UJFO5&3#XG.
M
M
M
M
M
M
M
M
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MN49PDOMC*+<9+[TVCO!\SD@
M
M
M
M
M
M
M
M
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M95*4'K"49+1]8RC+T:9FHXIEP
M
M
M
M
M
M
M
M
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M<CO-/M\\=;+B'4<\$KCJ0:D\]*B/_(,80L(^H
M
M
M
M
M
M
M
M
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MM=5=4EK&;PZY5XMBU[TZXRG&/N1UIH+$-5P
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M]4T_5%]8^11ET0RL6<+<6V"G"<&I1G&23C*,DVI1DFFFFTTTT]#N!Z'V
M
M
M
M
M
M
M
M
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M=E55DX676W60A&=MLXP2@H)2A77"3BXMSFW)I0H6+.-0
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M0S8,=3)DAM:TO<J)+:FR=22N3]%*(OQ,N<-D8.;B/3*JLK_JHM?;Z:KKZ/\
M>)SMF_;'O47+:,S%RDEJ_:MA8UZ:ZJ,FUIW1U3T:U6OJ9XVZT\GK9<;=1R9=
M;:TK3R7XEU),RY(<4RQ]
M
M
M
M
M
M
M
M                                                  8-LW[Y^SK.
M/RSU?F'\JWGV3I]KS]S^W2/9_P#'W])=/?XY[WZKC^-]/(Y6%^'_ !M/XS_,
MGNP[_7\SN7=^;\WYNOIU^SJ8CD'ZU_4.;^HO]F_PEWX?\S^7]N7L_P I^C_E
M.W\_Y/XWRZGA!=:<9<<9>;6T\TM;3K3J%-N-.-J-*VW$*(E(6A1&1D9$9&0[
M((R4DI1:<6M4U\3\H%E=E5DJK8N-L6TTTTTT]&FGU33Z-/JF?@>3T
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MK;TC579.,(ISLE/6^+=-&P
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M="2DM5Z]4VC(1Z'W
M
M
M
M
M
M
M
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MP:T?[S)M1?1DU*_&G"RF6NDHM2B]'H]&M4]&FG]ZT.\'H?4
M
M
M
M
M
M
M
M
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MA23-)\&1E_DCX'./V
M
M
M
M
M
M               X$JUJX+A-3;*!#=4@G$M2ID>.XILU*23A(=<0HT&I!ESQ
MQR1_P #ZQ9L*<E2X4N+,0DR)2XLAJ0E)GSP2E-+61&?!_P#@ #E   .HOITF
MLIK&PALM2),.,M]II]:D-*-'!JZS3PHR2CD^",NHRXY+GDB!5]>Y\O4ZVM*X
M3;2#/K93%:,G2_01K6A2TF7\SCD?3M1Z=Q+&/[BQZQ:;1<*.IEDDNXKH<<B*
M7TGR:.DEO(ZE%P2>%\<ERH>KB_@>VJ)6B38D]A$F%)9E1U_Q76'$N(,^",TF
M:3/I6GGU2?!E^DAZGDY(
M
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M0[9RA3+2C=L?O^$<653NM::Z8+4H]VB7I?&V)TG
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MI_>M#O2,C(C(R,C(C(R/DC(_4C(R]#(R'H?4_H
M
M
M
M
M
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M/4S,>#R
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MFD:8OMI@M/A"I0BGZO35MO5G1#EF&
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MM:N4\F1<_@.,9,Y0
M
M
M
M
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M]+J#,N?52B;Z2X_X;_@EZR]#VB6O'H>X
M
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MT\*W+!SL['A7BWJF^J<IX&3WWXM[K[^^,:;YR@UV=VN8NY)0>F_<;)G4P
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MG[CA&6QX5";]
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M2M/)?B74DS+DAZ'U/H
M
M
M
M
M                                         KUO*[Z45="TO^/U3I22
M5R1ER;;"5)+T0M!$H_7U-*_X#]?>*^)ZR?P*YCV/0           #MJ&Q=J;
MFML65=*XLMATCYX+A+B>>HN%$I)?B9&1D? ,\KU+ZQWVY4=B2T?+4AEI]H^4
MGRV\A+B#Y2:DGRE1?@9D/D?0^P
M
M               .$W81G9\BM;4I4J*PS(?(DF:&T/J6325+_ G%$CJZ?QZ3
M(P!YA/D+\SO)%&[=RZ.9R5_#=<LPF<-L\)BQ,;M&K:HN:"-+DS)=L_52K**_
M=UMPDEMQY#?9;X3Z.=Q2MM/%?C_BE_'<#DU]7XC=W8[8V.5L5"==CBHJ"FH/
MVY0]91?<]7Z:)=)?UG?4YYJV[RGR7Q!MV:MLX-'%AA6XL*L.Z631E8L+)VSR
M)T3OK>53D+6NJV'M5M0>EBLE+4:+W.MH
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M?<;U>OM:%MA S:
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MDLN]9$1F9H[:U=1$1&?I_ /B<TY8
M
M
M
M
M                                   #^&9$1F9D1$1F9F?!$1>IF9GZ
M$1$ *.9S=*OLFM)W4:F?<+8C$?47$=DS;:+I4?TJ)"2(_P /P_ OP'T2T1Z/
MU,2'D]0             N=J^X*WQ"OZE];\ UP7^5$:OU:NMH^G@E)03:R0D
MSYYZ#]3]1\Y+1GT3U1(8\'D
M
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MKG)RE71%*K&JE)REK*O'A56^UJ&L6JXPAVQ43C/%:@
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MHT_0_ \GH
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M4;4Z,X23/UX,T.F1'P..9([ C(R(R,C(R(R,CY(R/U(R,O0R,@!_0
M
M
M
M
M                                           !A>P+LJ'%;.62NEY]
MOV,<^>/ULHE)/A1*2I*B9)9I,O7J(AY2U9X?1%(S,U&:C/DU&9F?\)F?)G_P
M3'T/F?P              $^:-N#;FV=(XK]7):3+8(U?@\QR2DI3^'U-*49G
M^/TE^/Z/62^)[Q^PLJ/0]@
M
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M,E5E>^NZ3KRI?HK[XM04G?&Z,5"V)SQZ'-
M
M  #GQ;2S@MFU"L9\-I2S<4U%F2([:G#2E)K-#3B$FLTH(N>.>"+^ ?*S'HM?
M=;"$I:::M)_W*.;C;EN.'!U8E]U5;>K4)RBM>BUTBTM=$EK]R,L@[0V-6O'(
MB9QE*73;4WU.W=A*(D*-*CZ42GWVTJ,TE]1$2N.2YX,^<?9L6S6Q[98M&FOP
MA&/]&*3_ '"28WD+G6+-V5;ON+DUI\]]EB^#_-LE))]/5+7U6NC9FE=Y'[LK
M$,-1\_MEL,.=SL2&X+Z7?UG=6A]U<0Y+B'#/@_UA*)/H1EP7'"LXGL%K;>.E
M)KX2FM/O24NW^A^74S^+YE\D8BA".Y.=<'KI.FB?=UU:E-U>XT_3\]-+I%K1
M:9U7^8^ZX)NFNQH[ W"01?<*@W":Z>KGM$Q+CD1KZBY-75^!<<>O/ LX-LL]
M.UWPT^R2Z_W:,OZ&A(<;Z@N>4=WNPP+]=-.^J:[=-?3V[:_7XZZ^BTTZZYI7
M><^Q8Y1BLL=QZQ-M1'*-HY$ Y)=1J-*.E,DHY&7!?SQ\?IY]1P;> 8;U]G(M
MC]FJC+3\NG;K_0,_B_4AO<.S\;MN+9I^=V665Z_U/=[O;^[W%P?VXVK$B0S*
MIJ]PFG%M(..N2T:C;6I)J5W'G2(C(OP+_P $5AVFW'<=FQOB+TME(Q][K,^'
M%M34);(C5^*6U,+7]*?YOJ?\ =H[D=TQN_&%J,I$.S802>24AMI]1JY+A/3U
MMD1<<^O/_ 'CM9Y[D=LQN#"WD&M4F:Q]1IZ'XG"S(B+ZB)MUPNDS/CU,C]/P
M'CM8U1W3.R,)?6AM&01>M?X)4W*3P?')DI:F";+@B]3YX#1C5';,9;C,DU$S
M>U9F@B-77+::(N?PX-Y2",SX_ @T9Y.Q;MJIY/6S95[J.3+K;F1EIY+\2ZDN
M&7)#P#GI4E:4K0I*D*22DJ29*2I*BY2I*BY(TF1^A@#^@
M
M
M
M
M                 *V;PO.[+KZ%I1=,5!RY/2HC5W7R2:&W$^O226B0I/Z3
MZC_F#WBOB>LOL(!'L>@              !E.%6QTF3U$\UFAI$IMN0:>>HX[
MQDAY!=/K]:#X_3R1_@8/JCRO4O.1D9$9&1D9$9&1\D9'ZD9&7H9&0^1]#^@
M
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M[Y5UQ<['".1A8U<G&,6^WW5.6FD(RDTGK3%P&B8
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MLXYC8&1N]/R-9->8[]LPINJ<9+OKLI]MY%5L9QC53*VOVYQ;E<,5^;5
M
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M2A1F22,R]?YH ^X
M
M
M
M                     I+L=4E6:7WNE&I137$L\FD^(Q*/VZ?I]"(FN."_
M'C\?7D?1>AZ2]3"!Y/4               _J5&E25)/A23)1'Z'P9'R1\'Z?
MB +R8/;%<XM3S>3-91$1GN>HU=R*79Y4I1JZUK0@E&9&?J?_  !\WT9]498/
M
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M#R,'><>7;93=!PG'['H_SHR]83CK"<=)0DXM,Z <LP@
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M+9EY>5GY5N?GVV7YU]DK+++).<[)S;E.<YR;E*<I-RE*3;DVVVVSY#[''
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MUK.46KWD/']U.CV2R(B!?X
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M^3BW=OO8]L4I14NUN,Z[*Y1G7;'Y9?-!Z65V0A:X1(NP
M
M
M
M            *<;:80QG%F39&1.-0WE&9F?+CL5MQS@S_FJ_#]!#Z1]#TEZD
M:CR>H                %E-&6_<AVM*XOE4=Q$Z.C])-N<,R%*/JY]5=LB]
M/T'Z_@0])?:>\?0GT>I[
M
M     &NCS?V'D$"51X#6RW8-/95SUA<)95TKL"[J6F8ZG$]*TQS2:B<1Z]9$
M1<DE2TJL'@NVXU]ENX7I2LJDE#7T3:;<M/M].W[.K]=&M;/J#Y5NFW8V+QK
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M4(2<)KNC%ZI8*,H0T
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M@E5N.!-N[=+JJ9_B974YV1K9G8LYU1R+ZL14RQW56K\5444W.1QBR>@
M
M                             $LZ2CK>V)5/))!H@P+Z6X:S3])?8[",
MRI!*(R4XF5);X_27X_H$:Y?8H;!<GKK)P2_N\7_<)EK^$\:61Y'P9I)PIA?.
M6OV>Q9%-?>I2C^3U^!<@4P;W
M                   'G@\_*1VF\J-B/' <A1+Z)AF00'%-FANR3.PK'VK2
MR8,S,G$OY#%FI<47IWT.%^@;M^(<M97C_!7>IVU.VN7VQ[;K'&+^S2MP:^YH
M_/']=&RV;-]3O(I+'=&'F1PLFIZ:1M5F!C1MMC]JEDPO4GZ>Y&:^!3466:C@
M           2=K?=&U]0/V+^L=@9/A2K=MMNS:HK-Z-%G]E7+#LJ$9KAO28Y
M&I+;RFS=;0M:4J)*UDK";QQO8>01A'>L2G)]MOM<XIN.OJE+I))_%:Z-I-K5
M+2P>!^5_)'C"S(LX!O6X;4LI)71HM<:[>U_+*=;UKE.'50FX]\(RG&,E&<D^
MNV#M'8NUK=N]V1FF19I:L,^WBR;^SDSRA,=+9+8KX[B_:U[+JFB6XEA#:7'.
M5J(UF:C^VT['L^Q4/&V?&IQJ9/5J$4NY_;)^LFM=$Y-Z+HNBT.#S;R+SKR1N
M4=WYYNV=NN?7#LA+(ME8JX]-8U0;[*HMI2DJXQ4I:SDG)MN;_&OS(W'XJ*ND
MZO<QMR)D4J/+N:[)JJ7:PICL2*_%C?3$M*Q^.EKO=9]IQ"G%H02S4A/0(YR_
MQ_L/-956;N[XW4Q<82JE&+2;3?YT)IZZ:=4]$WIHWJ6MX,^IWR3]/M>7C<(C
MMUV!G71LOIS*;+:YRA7.N#7M7T3AHI]WZ.<7)QBIN48]IZ1OCY\P;WRVP7,;
MC,H6.4>68KDD>G524+DDR=J5TU=,:O'FY2EN,)L;%^2TVCJ,B*,K@SX48U1\
MD\(IX/NU.'B66W85]'>IS27S*<XR@G'1/MBH-O1?G^AW4?29]0V;]1'!\_?]
M[QL+!W_;]R_#V48\YR7M/'ILJO:L;E!6V2R(17=):4M:MILV$"NC:@
M
M
M
M                    "GFVK2):9:\<-PGFXD=F*MU"DJ;6XA/*NA23,E)(
MS_'\#+U+\1](K1'I(C$>3U                 SG7=^C'LGA2WB6<5WKCR"
M;(U'T.H4CKZ2]5=OJZB+^$B_0/#6J/:/J78'S/<
M
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MRC)QDFI)Z-/U3/R!X
M                                                 G+0+#3N86KS
MAN$J%BU@^T2#3PIUZQJ('#A*(S-LFYJC]#(^2+]')'#N<6.&S1BM-)WQ3_NL
MY=/W4B\_I\QH7\YMMFWW4[=;..GQ;LIKZ]/32;?33JEUTU3M>*D-T@
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M)66*N*<IN$6HQ3<M$C,!QC*
M
M
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M/T'R/H<T
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MZRMOQ,JER[+8>Y)2C*,XPLINKE\EU%L(6U3^6<4_7J!R3%
M
M                  6/\>6'#?S&6EM)M-0*B(X\?1U(5*FO/MMI(S[G#I0%
M&?!<?07/KP(!SZQ+&QZM?F=DGI^1)-_9T[E^_P#E-D_IPQYRW7=,M17MPQZH
M.735.<Y22^WJJV^G3Y5K\"R0K(VR
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MG79V5N5<H7UN.L$TVXO5QU=R1"R_0
M
M
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M98]H^@.\HNO\HS>WU=SL6?1T<]?7VE]/1T_5U=7X<>O(\/U!@7^>_P#\4O\
MWZ'GH#Y/+L$IZ9"YB4+].'E/DE?Z>.%GPH>>GP/!PP   CX]2]#+U(R_0 )X
MH-RE61*>LD5AKBQ&6HTR2;JER%(3Z=QDNK@S0G]!D?/'Z/T>KB>_<28[MS#$
M,]U,Q]U9MFLF4L<.=1&9=M1FLD)5Z?PF7'X<CU[6>=4=UA68Q<QKG93+1QY$
M1TF9;!GU)0:^LV5H5^/2XA!^A^I&1_HX,S6@3U,S'@\@
M
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M">['T?;-:QB_E4 "6E(
M      3KJQ7V+7F^<S4OM.IPNBUM3.]SM\7NQLJKWY;7'O(WN/<:_P 0R!OM
MDA\_J[G026U+1%=]7XK>-IVU+6/XF>3-?TF/5))^CTTR+L=ZZQ^S75I.YO&T
MOU+P3FO+9/ML6T8^U4/73^N-US*I37Y\.[OVS!W./8HV/KW]B4'.$%"5%,@
M           !?7PEV M<_*=+6LZ*B#E,21E>!LSE&RAC8=.FO.RB19I()J*K
M)\(@RFE(?6EF1+@0FRX=-OFJO)>TJ->/R:B,O<HDJKW'KKCS[NUN/J_:OE%Z
MQ6L83M?YNINM]('.)3S-R\1;G=4L/<JI9NVQL?:H[I0JO=A"S32#S-OKN@XV
M24+;\;$@M+.S6Z8KHVY
M                                                   M-X_1T(HL
MJE]:C<DVU-'-O@NE*(,.T=)9'^/4M5B9&7_C2%:<^L;OQJOA&$W_ '9Q7_L3
M:_Z;\:,=OW;,U?=.ZB&GP2A&V2?[ON/]Y$]BOC98
M                                   T<?*!_9TP/^1BD_N@;*&W'@3_
M ('Y/]DK/\@QSH[_ &F'_/MM/_)'%_WQW0UNB[CKO
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MMU"7&UI/E*T+22D*2?Z24D^2$.+X/V
M
M
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M?JZHBZ^H^3-*2_ BY,_26O[A[Q]"=1ZGL
M
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M2S*52P[(N%L+(][JKJD)X:S@
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MBY/',R[*ONNE&:G=38HQ4=4TJJX-=>FK;1O3$M*6
M                      N+HUAQC7[CBVDI3.RFUD-.?0:W66*VDBI,S2HU
M)2F0ATNE7!\ER7H?)U-SF:EO$(I_FT13^YN4W_<-&Z'T]X\Z>$7W3BE[NXVR
MB^FKBJJ(?#KTE&:T?WO31ZN7!#"]0
M                       #1Q\H']G3 _Y&*3^Z!LH;<>!/^!^3_9*S_(,<
MZ._VF'_/MM/_ "1Q?]\=T-;HNXZ[P
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MS3T<6G&24DTLL'&,N
M
M
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MZ>"_29<EQR/$O0]H^I=$?,]P
M
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M'^-;;B-Q<7'W\BE[KFI.,8Z]FX;CEP;DYN3CW=RBXPA!0E13(
M   !M7\5LFP?(M.T6O\ %YA1<]Q%[+LGS/%Y<-YB9D+UM<M-KS*@GF_)BVL6
M'BL2EKY$-)QY4=4!QXHZVC<D*HGG.'N>%R.W=L^/=M62J:J;4TU6H0>E-D=$
MX-VNZR,_FC+W%'O4M(+LM^FOD/#M^\487!^-V^WS;:YYV9GX<X2C9E2NOBGG
MXUG=.%T(8<,#&MH7M75/&G<J)5.=\IQ$;+B
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M_P#9#9#ZE?\ XR__  S_ .Y3UQBR#5H
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M=N$+OU7D;%B_A9R;E6X5SNC;"MZM1[;W9*=?RM.SW''2V,I:\Q<IH*
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M>$IQ:G%$W.BLMDI:C49-LLPT--((S]$I224EZ$1$,XO&G XI16V8VB7V2?\
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M1^@K<VN.6
M
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MGGA1?B1D9#YGN<D
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M]IX#32G.DV:VECY-E4EI).2$.*L)3%/6T['4EMM;91Y4M2DN<.$TI/2>'O\
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M_P!%5?Y)$\O'[K#_ .QU_P#TL7_Y0H@'CW_WY_XK_P"R&R'U*_\ QE_^&?\
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M4HN5<)1\]HW,.@<
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M7L1%;FUP
M
M                                                   0;M38!UC:
MJ"EE$4]9]-@\T:NJ.CTYCI61$74HCX7TGZ']/Z%I'M%?%GJWI^4K"I2EJ4M9
MFI2U&I2C]34I1\F9G^DS,Q[GH?P                          ?5AAV2\
MU'80;CSRTMM(3ZJ6M9\)21?I,S \EN=88[DV/P9+5[(+VSQ-*AP3=[RHRO7K
M4?XDUU)X^GGD^?J(C+@O233]#W2T)3'J>0
M
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M0EDV2ZNJ28?+N78&BCE5Y52T7;D51<M.G164NEZZ)Z2G&QZR;DI/32HM_P#
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M)EQQ,JSNE+W\[#IJQ-PRNZ:4G^+SJ<C)ZKI[NBZ)$%"5%,@
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MR7]5?J++JRO9_%=_8V^WO_#]NNJ7YW;+3\C/2P)V:\@
M                         !L4K(Z8=-004.&ZW!QV@AMK5QRI,:GA-<F2
M?0E&:3,R_08H#<;';N%]KZ.5TW^_)L[*>+XT</C.W8<6Y1JP,>";]6HU0CK^
M[H<T<(S@
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M/\ZJZF<J[:Y::KNA.,HO1OJF=6/N8X
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M"$$HQA&*2C&,4DHQBDDDDDDDDM#LAZ'V
M
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MEMQWDS<6DO4SY/@SZ2,R(C/U?KT/<R$>
M
M &KSS=V!-FY568!$F.(JZN U963#+O#,F9*<5[=N2E#AF;D;L&HT+21>K:BY
M,B,6;P/;J_:LW.R*=CEV0;7HDM9-?EUTU7V-?::I?41R?(_%XO$\:QQQE4K[
ME%])2E)QJA/1_P #L<^V2T^>$NK2:H@+$-8@
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M;:W*R3;;;U;;ZMMOJVWU;?J?@>3T
M                                                   #ZLLNR'FH
M[*#<>?<0RTVG^,XZZHD-H3_-4M1$0\2E&$7.3TBEJ_R(^E55E]L:*4Y6SDHQ
M2]6V]$OW6;)IR6T2Y#;+:6FFG%,MM-I2AMM#/ZI*$(21)0A)(X(B+@B&NK;D
MW*3;DWJV_B=G\(0J@JJHJ-<4DDEHDET2271)+HDO0XH\'L
M      =J[26C,)-@Y%,H:FVGB>)UA7ZM[I[:S;0ZITB5UE^*?3GUX#5>@.J
M'80*FPM.[[&/W^QV^[^M9:Z>[U]']&<;ZNKMG^'/' :Z X?9<[W8Z?UO<[/1
MRG^B=71T]7/3_&].>> !WOY4O_\ SP_]^H7^:1XU1Y/D]C5XPGK77.J+^!E;
M,A7_ )".ZZO_ ,(-4>#I%)-)FE1&E23-*DJ(R-)D?!D9'ZD9&/(/X
M                 #2?\E6F6\;SFBW/2QT-U6Q4?9\I::)*4QLVHX;26IYH
M+H0A&2T#;:^$)4:I4*2ZXKJ>3SMAX-Y1+<=GMXWE-O)PGW5M_&F;?3_Q<VUU
M?YLX1BM(LZ3_ -HUX<KXMSS#\M;-6H[3R%>SEJ.B4-PQX)*S3HDLK&49:13;
MMQ\BVR7=:M=8PO8ZVP
M      MWXD^'6R?+/+G:S&D'1X72O-%EF<SHRW*^M)9MK.MK6^II%I>N,.$Y
MV"<0AILR4ZM)K90[ ^=<_P!JX1A*>0O>W2U/VJ$]&_Z>;Z]E:?3NT;D^D4])
M..RGTX_3+S/ZA]_G3MC_  '#<.<5F;A9!RA!O1^Q1'6/OY,HON]M2C&N&D[9
MP[JU9ZBO'3PLT5XU5<=G"L7CV&2%'[-AFF0LP[3*+%2CZEF]8^T8)EHU<<-1
MVV(Y&DE):2KDQI[R?F_(N77NS=KW^'UUC3#6-,/R0U>K_IIN4OZ8[V?#_P!/
M7BOP?ML<3@^W06Y]G;9G9"A;G7Z^ON9'9#MB_P#"J854]-56GJW;41(NP
M             #\K6AM*EN+2A"2Y4M:B2E)?PJ4HR(B '4_F&@_T<I_^:<+_
M (N/.C!_2R"A,R(KNH,S,B(BLH1F9GZ$1$3W)F9AHP=N/
M
M                            XTR(Q/B2H,E'<C3(S\20CGCK8D-*9=1R
M7X=3:S( 5BUW)D8;L*=C,QPTL3G7JISZN6UR&34_52^$IY4;Z#-"/0N"D>I%
M^CW?5:GHNCT)6VY?%3XE)BMK,I=XLJUDDKZ5)CJ+N3W%%R2EM'&2;2N/TO)Y
M].1ZQ6K/:7H<73N/_:<8^Y.HZ9=\XF6KUY,H3'<;@),B+@NHEK=+U/T=+GU]
M"\R?4\170EH>I[%9<U_LQX]_Z,<4_P O,#W7YIZ/\XLT/0]P
M                   ,)S7*:?'(L5B[B/2X5N<B,ZAI*5)2TV37=ZR-23Y,
MGBZ>#3ZE_&(^!Y2;]#PWIZE7,SJ\9ANQIN,6J9T*;U&J*M)HD0UI+U0OE*$K
M21\EU)(BY]/T<J]UK\3U:7JC!QY/4                          #L(-3
M8V2)+D&&_)1#:-^2MIM2TLM)_%;AD1DE)?PGZ%_P0/.C9F>LJ%ZZRJO631JB
M5[J9LI9I,VB2P9*)"SX,OUBN$EQZ\J+\/Q'B7H>8^I<X?,]P
M
M                _BE)0E2UJ2E"4FI2E&24I2DN5*4H^"))$7J8 T6[[R%G
M)]NYQ;1G5NQ'+=4:,2GC>2TB$PS%=::5_%2V4IIP^"(BY49_B9B\^,8TL78L
M>N:TFXN3Z:?G2<EK]_:TOW#K\\M[G7NWD+<LBF3E1"V-4>NJ7LUPKFH_!+W(
MS>BZ:MOU;9$ SQ7
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M+)=TU*>'BO'P9=DO:5F/;.M:VSE/OAQS,@
M        'Z2E2U$E"5+4H^$I21J49_P$1<F9CX967BX.//+S;:Z<2M:RG.2A
M"*^V4I-)+[VSD8N+E9V1#$PJ[+LJQZ1A"+G.3^R,8IMO[DCE.UU@RT;ST&8T
MRDDFIUV,^VTDE&24F;BT$DB4I1$7KZF8A>T>4O&/(-WAL&P\CV'-WVQS4,;'
MW#$NR).N,IV*--=LK).$(3G-*+[8QE)Z*+:F.[>,?)6P[5/?M\X]OF%L=:@Y
MY%^!E4T15DHP@Y7651KBISG&,&Y+NE*,5JVD^&)V08
M                           R/#XOOLNQ:#W.U[S(Z2+W>GK[?N+.*SW.
MCJ1U]'7SQR7/'XD.%N5GL[=D6Z:]M$WI]ND6S/\ %,;\;RC;</N[?>S\>&NF
MNG==".NFJUTUUTU6OVFP24HUR9"C_%3[JC_R3<49_P#AF* .R=^I\0/
M               !.-<;/V:K;?-!(?KX3'2X9$EPW8K:2:]?0S<+T(OT_@/1
M^IY(OR*D742C4TE2H+YFJ.YZJ)LSY-4=:C]>M''IS_&3Z^ID?'LGJ#(L"_\
MAK_[P_\ P8/$@8;_ /#?_P!*7_P4//P!(^57,VH]A[,VR]Q[KN=QLE_T+V_1
MQR9<?T4QX2U!C$?-K1MPC?:C2&N?J;)"F5\?^,<2:B2K^::5%_,'GM!WMS#A
MY!4?>(#9%*;0ITSZ")YU#1=+\9XDG]3C:4\H/ZC/I(D^BN1X71Z,$8CV/
M                     4X\^J>/:>*^P93RC)>.6>#WT0NA"R5)<S&FQHT\
MK(S:/VF2.GUIX5Z=/\52A:?AK*GC\_Q:H_FWU7P?7X*J=G[O6M='^7U1II]?
M6ST;G],>\YMSTLV_+V_(AT3UE+-HQ6M7UC\F3-ZKKT[?1L\[HW3/S[
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M1):OJWI\6_BW\3L1X/<
M
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M]^(BR@2<=O,@K9,=J9'4TZ7?)UI9IZD$2T&HU\?@-3-QX/(
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M6JBIC-..*=</DUN+4:E&1*<5RHT-DHR27X$7\TS,_#>I['<#P
M
M                  KIY/[%D:\U?9OULA,>[O'$4U8LU)2M"I1&F2\T2N>M
MV/&ZG"2:5)62%$HNGD9WCFVQW3=J\>U-X\=9S_J8_!_=)Z1;^_IU*^\G\IMX
MCPW)W/%DH[C/2FAO3I99T[EKJG*N"G8DTTW#JM-32TI2EJ4M:C4M1FI2E&:E
M*4H^5*4H^3,S,_4Q>B22T7H=>\I2E)RDVY-ZMOU;/R!X
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MKLE*6$U?''A;H[+*Z<NN6L&K8N<73^F4"]0K,W,
M                SG%[N!7151I"%')=E\,FRR@W%-O$RCI6X?;+I2X1GZJ,
M^/T>A$?71]8GT[>2?*?+JN5<5R:H<4Q-E[LF&5E6QIA=BO+M[ZJ8^\^^RF:K
MTKHA!3:E*;]RZ4.PKZ1?J"\<^,.)V\8Y1C6SY3E;SVXT\;&JE=.G)6+7V6W2
M]E=D+H.S6=\YN"<5!>W5&>697_R@G_\ O+_EV,-)OHK_ .LSQK_SC_O5G&YW
MUE?]6[D?_F__ 'TPB&AWX'1.
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MK.?27LQ?I57+T6B_E)1_/EJM90C%EPA%2W0
M
M                   #',MH$9/C]C3*4AMR2T2HKSA<I8F,+2]&<,R2I:4=
MU!)6:2ZNVI1?I'E/1ZGAK5$?ZWUK-Q&PFVEO(KY,I<4HD%,%;[R&4..$Y)=6
MJ3%C*0ZKM(2GI(_I-1&?KP/+>IX2T)C'J>P $/Y#K^YML^JLIC2:Q%?!ETC[
MK+[TI,Q2*V2V\^3;;<)Q@U+2@^CEPB,_QX'LGTT/73KJ3 /4]@
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M;AV4V26DL+.*RZDFVE-K03J#625=*NHT<&1])CPY? \I$[#U/(
M
M                     &HKS&V&YE6QSQ>,ZE55AS7M22V9J2Y92D(>D.&L
MB)#A)94CI-//'6:3,^/2VN#[<L?;Y9\U^EO?3^HBVOZ,M?W$C37Z@>3RW+DE
M7&Z&OPNWP3GI\;K8J3U^WMK[$M/1RFGUZ*H0FYK^
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MQKR'=LJUO9<W>,2C&I;37XG$HMMR[TG'6+A3EXE3[))6*Y.U?H:2T A9L6
M                                  !R8?\ QW%_]V6/_.J1%N=?\"=X
M_L5E_P"I["4<(_X9[1_93%_R>LES*_\ E!/_ />7_+L8=''T5_\ 69XU_P"<
M?]ZLX[L/K*_ZMW(__-_^^F$0T._ Z)P
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MM[]?X/;W:K34\RXWO/S9
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ML'@W$*/8V+ I4()Z.<Y-]UEULDHJ=UTW*RV>B3G)Z1C'2*EP8HF8
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MS@^[37]-W*QI/M<%4W\R:5\!"2^0
M
M                                       (>R5O]G62/[$C$XG$[SV<
M+9$%AOK17O-%[6JV$AKJ-1?;4]N):$TDC7 4B2ODH7!^RZK3XGCTZDOH6AQ"
M7&U)6VM*5H6A1*0M"B)25)4DS)25$?)&7H9#U/)^@       '39'T_E^\ZNG
MC[38\=7''5[1WH_'^>Z^./YH\KU!YYAL@=6IW./6[N/WU/>,D:G*FSA3R;)2
MDD\F+(;=<CK-"T*-J0VDT++DNI*C(_0QQLW&CF8EN)/\VRN4?R:K37\J]5]Y
MEMAW6W8]ZQ-YIU=F+D5VZ:M=RA)2<7HT])).,EJM4VOB;"34RYTNQG">BOH;
MD17B)1$]%D-I?C/$2B)1$ZPXE1<^OJ-?[(3JG*JQ:61;37V-/1K]\[*<?(IR
M\>O+QI*>/;",X27I*,DI1?7KU33ZG\'H?8                #](;6X9DVA
M:S2DUJ)"34:4I_C*,DD?"2_2?X #\@#ZE'>-E4@FEFRA1)4[Q]!*,R(B,_\
M)47_ (('DE37VO*_,6),E^T?8]FMI+\=J,1\]\G>@DNJ<+U_5'ZD1\<%_#Z>
M&]#RDF=+<8K54.9*Q^QL7T5Z3C*]XTSW'4IE$TX@E-<ESTMK]>#Y]/0S/\2>
MJU&B3^XM#BF%TF*-K74F^XN6TV3S[KR72>27UI6@DI))),SY3ZGZ'^)CT;U/
M9+0S$>#R
M                                       !TF2W,;'L?N;R6\F/'JZZ
M5,<>7_%;[+2E(4KZ5^G7Q_.J_P @_P ![UUSMLC56M;)-)+[6WHCX9.13AXU
MF7DR4,>J$ISD_11BG*3Z=>B3?0T 9#</Y!>W%Y)4XM^VLIE@ONJ-:T^ZD+=0
MUR9GPEE"B0DB]$I21%Z$-AL/&CAXE>+#3MKA&/[RTU_=]6=:.^;I=O>\Y6\7
MMNW)R++'KUT[Y-J/Y(IJ*7HDDET1TXY!B@
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M!OKA%-M+NG.480CZRE)12;:1Y;AO^?F*
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M1+2,F9!=-^,M3B$.]IYI*S:6;:S03S;:E)2M)EU$7!F1\&/0^YS0
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M9V.*94
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MOEX:WU[YP'%5CUOPG+%ET>GZ)1=:Z_93.M/3IKKZ>BSX1LM,
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M/4\G]
M                                      4B\T]EJQW$86"USIHL<L-U
M4U:#^IFGC\(EH,RY)*I1.I:-"B+K:=49'RD3+A>UK-W)YEJUHQ]'^6;U[?WM
M'+[FE]I1_G;ELMAXLMDQ9-9^YN5;:_@T1T]Y_P#?]T:M'ZPG-KK$U5"WS24
M
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MW*V&//#PZL3$PIUQK=6-C8^-6JH2A*%2C176E5"5=;C6OD3A!Z:Q376#[F/
M
M                          LOX[Q^49Q,Z_Z%&H(7;Z?XWO)<^3W.OJ].
MW]NZ>./7KYY+C@Z]Y]9I3BU:?G2F]?ZE17]'N_H&S/TW8W?F[MF=W\G5CPTT
M]?<E;+777II[>FFG7N]5IUL4*U-K
M                           K]Y6_XMFZ?^L:?_EJ$)OXW_X=;9_HE?W#
M->/JR_ZN'+_[$3_O=9YEQO>?FR
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MYW.:=;?:;?96EUEYM#K3B#)2'&W$DM"T*+T4E:3(R/\ 20B)<Q]
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M<0AQM:7&W$I6A:%$I"T*(E)6A23-*DJ2?)&7H9 #]
M
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M)*$I+\"(N"'J>3Z
M                                                /XI24)4M:DI0
ME)J4I1DE*4I+E2E*/@B21%ZF -)_DUG!9SMO()##JW*ZD65# )1J2GB I292
MS8-*4M/%*4II?XFKM$9F?IQ=7$,#\%LL)R6EMS]Q_D?YO7[.U)_=JS1'S7R%
M;[SJ^BJ3>)@16-'J].Z#;M>GP:ME*#?750CUTT2K\).5&
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MV#CUWY.#')IEFXU%LHPA;?BQF[:X]TZE-2BIU>]0[80C=6Y=6.08T
M
M                +8^/\<F\5R:631I5*OZ^*I_I,B?1"KY#_9)9_2KVRII*
M,B]4]TN?Q(5CSVS7+QZM?2N3T^S66FO[O;_0-MOIQQE'9=SR^QISRJX=VCTE
MV5N7;KZ/M]S5KU7>M?5$X" FQX
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M;UP>ZSW9[3NF3B>YT7N1HNG7&S1-Z>Y&*GV^L>[1Z--&"C*D,
M                          N?X?\ A;L;RMRZ(W AS:+6E?+<+*LZ<9)$
M=M$/V[DFFHE/H6U,O9#<E!$9I6S%2ON.$I7;9>KSGOD/:^%84H:QNWR<?T5&
MOVZI3LTZQK33^R4VNV.G64=I?IJ^EOF/U [_ %W]EV!XYHN:R]P<5H^SM<L;
M%[EI9DS4H]='71%^Y;JU"JWU8Z+\:M/^/&.P:/6N&T]-*9@M1++(41&G,AO5
MI4MQ<FYN'$JG6#ZW'5<&XM70@R;1TMI2@M-=^Y-OG)LN67O.19=)R;46W[<-
M?A7#\V"T^Q=?5MMMOOM\;>)/'GB/9*]BX#M>+@TQKC"RV,(O)R&FWWY.0U[M
M\VVWK9)J":A6H5QC",]# ECGR??9C,N2)#K;##236ZZZHD-H27XJ4I1D1$ *
M19]\C?A]K?(IN+9'MF*];USST6>WCE%D.5QH<R.OM284J;CE99Q8\V*Z1H=:
M6I+C;A*0HB4E1%.]L\9\ZW?%CFX.WV/&FDXN<JZNY/T:5LX2<6NJ:6C6C3T:
M-<>7?5S].?!MYMX_R+E&)'=J)RA9#'IR\U5SB])USLPL?(KA9"7RSKE-3A)2
MA**E&26GWY ODI+<<>NUQXZY-DU)@J/<O9=E#$>?C5CE"E=I,&MK%N*AWD"H
M)HW?>I<;97)ZDM%^I[R7[P\9>));/;/=^7T4SSEHJ:6XV1K]>Z<TNZN4_3LT
M<E#K+\[M<>NWZN_K>IYSA4\%\&;CG8_'9=[S\Z$+<2S*3[57CX[E[>37CZ=[
MR>^NJ5^L*M/95BNRCX;M?[7F;5S;;KAS&M;3Z"RH;BRLG9#Z\HRY5E!GL28Z
M%NI7+=K&5RT/3'5*)+DQ2$$XOO&SP_/.Y[)';<38*^U[Q5:K(QBDE53V2BT_
ML[WV=L%IT@I/1**EG_V:W$/(=G*]]\F9;LCP/,PIXMEELI.69GJ^FY603>LW
MCP]]6WSU2E>ZX]\Y6NGT>#6 [@0    "$=Q[UQ/3U<TNT4=C=S"7]NHXJTG)
M>-".KN/GS_2[!<ERL_0NHOTJ22LOM&RYN\W.O&25<=.Z;_-BO^V_L2ZO\FK(
M7S3G>Q<&P%E[M)RR+-553#1V6-+KHG^;!=%*;Z1U2ZR:BZ0V?G5G4AU\ZO%Z
M.O94GI8)Y]^8XTHBX)PS4TVE1*,N30?/')D2OP,3BKQ_C**][(FY?'MBDOZ+
M?[_] H#+^I'<Y62_ ;71"K3Y?<MG-Z_:^V-:_P"]7Y.Y^I&%_P"6VZ;YAZ.=
MY J&WV"8<*FK41S-/4KN*+W3LPB4\VKH5Z<=/X$2OJ&5Q^%;'2TYJVW1Z_-+
M^A\JCT^/]SJNA$-Q\]<_SH.%$\3$UCIK33JUUU;3NE;HVNGV)=4E+J5QF3)5
MA*D3ITAZ7,EO.2),F0XIUY]YU1K<==<69J6M:CY,S$JKKKIKC55%1JBM$ET2
M2]$D4_E963G9-F9F63MR[9N4YR;<I2;U;;?5MLXP]SC@  !,6 [5D8/@VQL5
MCMR3DYI#@0X<A@FFT0R+W+=@^[*-U,AIPF5-&R3:%<J2?*D?B(]NNR?K+<\3
M,;BJJ&W-/5N6C3BDM---4^[5KI\&69P_G_\ -;BF\['&%CS=PA"-,HZ*-;<;
M*[I2EKW)J$HNM1B_F3U<>C(=$A*S     -L7B=O*)F&/1L%R&:VWE-(SV8:G
MWC)=M7-=IN.ZV3OJI])*Z7")2N7",SZ2<;2=.<KV*>V9CRJ(O\!:]4_A&3ZN
M/Y/C'TZ=.KBV;R>'O(5/*]DAM&X617(\."C)-_-=5'11N6OJ]-(VZ-M37>^U
M612N@(B7,      !@V>;$Q?75)+O,DL68S,9LU(C]Q'NI#AI4;333/)N*4Z:
M>$D25*4?HDE*X(^5AX>3GY$<;%@YW2?HO[EOX)?%OHC%;UO>U\>VZS==XNA1
M@U+5RD_5_",5ZRG+TC&*<I/HD:BMJ^1&:Y_EAW51;W&-U,,VVZJOA37(BNVR
MZMU+\Y$9Y3;JW347+)J<:2E)$?6HUK7;NS\5P,'#]O-KKORI?G2<=4M?A#5:
MI+^-TDWUZ=$M+.;^8N1<@WI96P9&5M^T4Z*JN%CA*>C;[[NQZ2E+T=;<JXQ2
MC\S[I2@ZUNK>\D>[N;2PM9)$:4OV,Q^8ZA!GU=MM3[CAMMD9^B4\)+]!"1X^
M+C8D/;Q:X5U_9%**_H?'[RKMRW?==YO_ !6[Y-^5D::=ULY6-+[$Y-Z+[$M$
MO@CK!]S'     &U?Q3V3@F-Z4@0[_*:>HDUEK>+G-3Y:(ZF$RK)QYDU$O@S(
MV74+,RY(DJ(S%/<KP,VWD%LJJ;)QFH./;%O72$8]-$_BFOW#=_P[R+8<3QMA
MU9F;BTV8\KXV*RV$.QO(LL7=WM::PG"6OII)==2V2\UQ1% K*"OJU="3/N"L
MD2FCCJ;_ !(TJ4I/!G_-XX+U/@O413V+O=]CLE[^NG;H^[7[-/77[BX?QV#^
M#_6'O5?@.SN]WOC[?;_&[]>WM^_70C36WD)@&TKZ?CN-R)7W"$T\^A$MDV/>
M1F%FA<F*E7"G&"+@S,B^GJ22N#4GG)[CL6Y;55"_,AVUSZ)IIZ/37M>GH]/W
M]'IKHR*<8\@\6YAF7X&Q9#LRL=:N,HN#E#N[?<AW:=T-=$WZKNCW)=RUK9Y'
M>4MWBN2GA^NY<9N15J0JYM%LHDMI?4A1E"9(SX=6:%)6:B/MDA2?XRE'VI'Q
MGBE6XX[SMQ[ECRU4(IZ-Z>LF_LUU27JWJ_336K_*_F#*XMN,>/<:5<MSK2E?
M9-=T:^Y:QJC'HG-IJ<I=5&+45K)R[*9[*WAGVU6ZEG*)L5+-.G^EVJME^"U(
M>+@VY4QLY3Z7Y3)]70OA)EUJ_F<3G:>.;=L\YV8RE*R:TUGHVE]BTBM$_CZZ
MZ(U^YCY/Y/S>BC%W1TU8^/)R4:%."G/II.:E9/64='V-=JCW2T74W1:]CR8F
M#8G&FI4B6S0UJ9"5K2XHG?;(-1FXE2TK,S/GDC,C_'D4EDRA/)LG7_)N<FOA
MT;>G] WXVNJ^C;,>G)U63"BN,]7J^Y02EJTVGUUZZO7[3,1\#G
M
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MY]1\V]7J?0[P>
M                                                    $8[E5D:-
M8YBO%%]%ZBFE*A=*.X\I?1QT1D']"I*S,B1U_1S_ !B,N4GS=M6*\^E9O^9/
M<CW_  ^77KK]WVZ==-=.I@^3O=H\=SI;%_LRL6UT]-7[B@^WM7HYM](:ZQ[M
M.Y-:IZ'5*4M2EK4:EJ,U*4HS4I2E'RI2E'R9F9GZF-A$DEHO0ZTI2E*3E)MR
M;U;?JV?D#P
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M_@\G@
M                          "YFD8YQM<I6I1*^X9/;S4$1&7;2S"J8!H5
MS^*C7&-7I^@Q4G.+%/>8Q7\"B*_\*4O^V;J_3]C2HX)98VFKMPMFON2KIKT?
M[L&_R,E40XO
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M^O\ AD/DM_>LC)+[5ZI/H3 ,:2@
M                                                    ^;KS,=!N
MONMLMI_C..N);07^2M9I20 C'*]U:QPQ+GWW+ZAE]HC5[)B4S(FN$E*%'V([
M:^M\^'4>B.3X61_Q>3+GXFU[CG-?A*;)I_%1?;\?67YJ]'ZOX$?WCEG&N/Q;
MWG.Q<><5KVRLC[C]/S:TW9+I*+TC%O1I^G4K/EGG-AM?W6L2Q^ROW2-SLR9G
M-;"<(DK[9N)=2F8T:UDDCX;5PDS/\2(E2?#X+NEVCRY5TQ_+WR_>C\O_ (7_
M '54V]?4'Q#!3AL]63GW==&H^S6^CT^:Q>XM7HOY)Z+5^J2=9\J\Q]N7YO-5
M4BOQF&LU$TF!&3(G-H5T_2Y,?2EE\^$%ZFP1&9GZ<'TB3XG!MII2>5*RZ?QU
M?;%_N1^9?W9E3;S]07,<Z4H[35BX-#;[6H^]8E\-96?HWI]OLQZ_#X+O=09/
ME.4T.03LEL["VZ;V*W$G3Y"GU..+KD^_BMDI!$AN*AF,X:24:>M\U=*5*4I<
M:YE@X&#DT5X4(5R=;[HQ6G3N^5OKU;?<M?LCIJTDE;'@KD'(^0[5N&3OMUV3
M5'*@J[+):_-[:]R$>B45%*N6B>FMCEVIRDYRH(87J     8='/\ +5JFO5PB
M@N7S^TF1$ENLN'36X]4I0@N$1+ B4\QZ)2VZ2V_Y]LB\^OY09B/    #^I4I
M"DJ29DI)DI)E^)*(^2,OYI&0 JIO'$85/:0<EKDI98R9ZP]_#2DR0Q;1/:O2
MI+2E+/\ 567O>YT)226EI41?2:2*V>&[M;G8DL._K9CJ*4OMB]4D^GK'337X
MIKXILTQ\Z\,P^/;W5ONW:1QMRE;*=:](70[7.2;;Z6]_=VI)1DI:='%*"!,R
MB  +\8/<)O\ #,:M.3-TZMFNF&KCK.=3_P"=LA:^#,NJ2F.A[^:3I>A'R14;
MR'#>#O%]/\!S<X_DG\R7[FNG[AV%>,][CO\ P?;L[5N^%"ILU]>^G]$V_P"K
M[5/\DEZ>BRD84G8             =O06)5%W5V9^I09K$D_IZO1M9&9])>I\
M?_GR#]#RNC+R4UW67\)$^KDIDQU'TJ,B-*VG.E*E-.)/\%HZOT<I/]!F7J/D
MUH?0[8
M                                           !^''$,MN.NJ)#;2%.
M.+4?"4(0DU+4H_T$E)<F -/OD1OC+\IS+)L;I\CE1L-A2U5K,.N6J,F9[=)M
MRSDO)X?47>6XRM*%);=0CZDGR8MSB_'<*G!JS\NI2SIKN7=U44W\ND?37326
MK3DF^C1ICY;\G[]F\@S..;-ENKC]+]F2J^65LE'2WOL7SN/>YUN,9*N4(KNC
M+5MU2$U*#
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M[
M                       7HU;']MK+$"-E3*Y";N6X2D&A3JGKR<AI\R41
M&:78;+72?X&@B,OQY.E^6V>YO]_76,>Q+[M(1U7[^NOWZF^GA?&6/XVVYN#A
M98[YRU33EKD6J,NOVP4='Z..C1G(C9:(
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M[L6P1DO#_P#S=;=_X_\ U5<1'ZZO^M1RG_S;_O1MY?\ %EFI(
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M%VY<.WC&W;B]4I0OKVZ&54J6NNF51DT8^:JW%Q[;;JWC3::KF[(S2B$9\KH
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M,H6Q>C3337Y4^J.3BY>+G8\,O"MKNQ+%K&<)*<)+[8RBVFOO3.['S.0
M
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M\YMUUN<U&5&:82EA*TN..@;W@
M                                             !\')4=EZ-'=>0A^
M6IU,9I1_6\;+9O.D@OT]MLN3_F "K7EIM"7@&OSK*:5[:]RAPZYEYM:T2(D)
M25')DM*;Z5(6;3:R0HE)Z7"+GDN4JDO%=JANFZ)7K7&J7?)?!Z>D7]S?JOBD
MU]Y5GE[E]_$>(V68$NS=<N?LU2U:<.Y-SLCIU4H03[7JNV<HRZZ:/3R+L-"
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M>W2W/AF9/*[8N2JM[).R*CKI7;5&,7-M-1BX*,M4N^+C\WJO%AFLH
M                      ! OEGG5/@6L)VLEOLSL\VC$H9-E61I+2U8;@];
M=4^707[Y)$YVKG+K*KA.0XI=+K,%A;KIH)YE#DGX%MF1NV^1WJ*<=IP)6*,F
MG^FOE"=,E7]L*8RFIR]'.2C'7MDU2OU.\SVKA/CJ[QY.<+N:\DJQIVTPFG^
MV^K(HSJY9*ZZ7YMM./.BE:3ACUSMM<5=5&>K$7F=;0
M      !N'T?92[GQ\U%83IR+65$A95C9RT<&Y B8_E$]JJQR>ON&;D^IIY<=
MU!FA/37RXJ"-1)(DZ\\DIKQN7;C35%UPE.JS3^,[*HN5D?LC.:DGUZV0L>BU
MZ]JWAW<,G=O!G%L[,NCDY-5.9B=Z]:X8V9:J<6UZ];**)U3CK%=N-?C03:BE
M&01BR<@
M                            ; \1CG%PK"6362U?E6ID&:2,B(IS2IZ$
M>OXFAN423_FD**WZQ6[UE2732Z2_NK[?^T=B7CK&EB<$VBJ33;P*I_N615B7
M[BEH_O1WPQ!,P
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MP9?_ .D#^M>D$:X?_P ',?\ \9_DLRV_.O\ SJ;K_P#!O]1XY"XDI4@
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M1*2_F$*<-WCZ@
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M(KEVXIGVZ^O;?IH[*Y"V8ZU$2EI+A)^H CC]RI_WK+?G^S_VG_M=?%4 >OT
M
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MLRI+^"[\&4[I27YTL"F#]5I= 5V;;
M                                                   ;'(K"(E;2
MP6VC9:@T5)#::/K-33;%7%2AM9N*4X:D%Z?4?/IZ^HU]SK';FW6R>LI6S;?V
MZR;UZ'9=Q['AB;!@XE<7"NK#H@HO75*-<4D]>O333KU^T^HXIEP
M                                                  #6_P#(!XT0
ML[Q"QWAB<7M9Q@U2A[,(K7=464X36(0AVQ[?U,MVN&P2-Y2_U?=K&W"4I2F&
M$'>_AKGEFV9\.)[C+7;,F>E+>GZ.Z7I'[>VU_*EUTL<=$E*3.MKZ^?ILQ.8<
M9R/-O%*NWEVT8REN$(Z_UW@5))W:=8J[!KULE+Y>_%C8I2E*FF#T;#:\Z4
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MACFL#X0?[%F\/Y0,=_K<<%0_3[_L/N'^B8?W@WD_:??\/.+_ -B,C_5"*_\
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MV+8(V(\/_P#-UMW_ (__ %5<=67UU?\ 6HY3_P";?]Z-O+_BRS4D
M   ":_(!Q3^P8$QPD')LM4: MISJ&VVCE6=MH;6MG:3GDM(0A4JPL);K[R^.
M7'7%*/DS,Q&>))0VB=<=>R&X9\(K772,,[)C&*U^$8I12^"22+>\X3E=SFC*
MLT_$9'&>-76-)1[[;^-[3;=9))).=MLYV3EIK*<I2>K;9"@DQ4(
M     !:+7GEMLS Z.HQ:=!Q7/L:HV$P*JOS.MG.V%;5)>)YNK@9+06E#DC<&
M(?)16793S$5!]MMLFN6S@V[\ V7=,JS.IGD8F;:^Z<J91492TT[I5V1LK[G_
M  FHJ4GU;[NIL=P3ZH/(?"]GQ>-YM.V;WQ["A[=-6?58[:J5+N5->7C78V6J
MX=53"=UE=,7V0@J]:W8&D\T]9V)I;RS6678NL^ONV6'9/6Y3#+J6^;?8QG(J
M['I:.RVIHE==VON&E7';ZBZ8ID^.-\IZX&;CWKX1NJE4_AZVURL77KZ4+35>
MNG6\=G^KCQYGM5\GX[NFVSZZVX.75F0ZN6G;B956+-=J<->[<)=[4M.SN7;+
MM+O30.1DRFOVM%I)3R.M%=G>,9'CDHC]J4I33EA50\HQ9AYGI6VONV2$*=22
M6EN]:>8_D\9Y9AZN[;Y6P3_.HMKL7KIKVR=5K3Z-:5MZ:N2CHRTMH\R^$-_4
M8X/)J\/)FM55N.)E8L_S.]Q=M->9AQE'24)=^7&+FDJY6=T28:NDE9"2U8G+
MH\X;0AQTW<"R.@SE'9:?3&==/\J65NM"&GG$)7U$DVS6GJ)/4GF/WYE6)TW!
M6XK;TTOKLHZM:I?I8P]5KIIZZ/371EJ;;L^3ONLN,6X>\P2<M=MRL;<5VQDH
M.7]96WM)2<5+5)Q[H]R7<M>NDQ94-TV9<9^*\1$HVI++C#I)5_%4;;J4KX5^
M@^/4<B%E=D>ZN2E'[4]5_0.!D8V1BV>SE5SKMTU[9Q<7H_3HTF<<>Q\
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MY[3I/DDG>IOGT]?0>5*4?1M:K3]P])UPGIWQ3T>JU6NC7HU]C7VG;CP>X
M
M      !#6ZMP4NHL6>M)JS?MY1>WIJULB4]*E.$X:#4:B-#+1)96?6LC2709
M]*N.D\IM&U9&\9BQ<?1+364GZ1C\7]_KHE\7]BU:B?,^8;7PG99[QN6LGKV5
M5Q_.ML:;C!/JHK1-RD^D8IO1O2+TKY;EEWFU_89'D$UZ=8V#RW%+=6:TL,FM
M2FHK!'Z-L,$HR(B+U,S4?*E*,[QP,#&VW%CB8L5&N*_=;^,G]K?_ -)=$D=?
MO(^1;IRG=[=YW:QV95CZ+^#"";[:X+T4(I]$O5ZR>LFV\:',,&
M !R8<N37RXL^$\N/,@R6)<20WP3C$F,ZEYAY!F1D2VG4$HOYI#TMKA=7*FU*
M54XM-/XIK1K]U'(Q,K(P<JK-Q)NO+ILC.$EZQG!J49+[TTFB\&!9["SVK<D=
ME,*^K4LE=P6D**(ONF:&K* HS/IC27$F2FC,ULK]/5)I4=,\AV&S9<A.#[L*
MQOL?Q7VQE]Z^WT:Z]'JEO=XR\C8W/-ME"^*JW[&C'WH)/LDGT5M;_BR:ZQ;[
MH2Z/6/;*6<".%G@       !&6V,MN,1QN$_1.LQ9UI9.P7)RXZ'Y,2.U&)_F
M";QK89>=,S2I9MJ6E/J@TJX44LXCM>'N>99^,BYPJ@I*.NB;;TZZ=6E]FJ7V
MZKH4SYJYAOG$]BQWL5D:;\JZ5<K.U2G&*CW?)KK&+?HY.+:76+C+22IM-G3;
M*0Y,L9DJ?+=,U.RILAZ5(=49FHU./OK6ZLS49GR9GZF+<JJJH@JZ8QA6O112
M27Y$NAI3EYF9GWRRL^VR_*D]93LE*<F_75RDVW^ZSB#Z'&   #Z(=4V:5(X2
MM!DI*RY):5)/E*B41D9*2?X&.%;@JV;D[;HI_!2Z?O:,D.%R&6%1"E8>!9.'
MI.=.LWUU3<E):M>B>FNB6NKZEZJ2,WD%'37S=[?J*WK8TU[BU2[T332;-DR:
MTQT)4<>R9>;_  (_I]2(^2%';GAO W"[#?I7-I??'UB_W8M/]T[!.)[Y#DG&
M\+?(::Y&/&4M'JE8OEMCJOXMBE'T7IZ+T.S^P?\ Q;R#_FE_]Q'!) /L'_Q;
MR#_FE_\ <0 ^P?\ Q;R#_FE_]Q #[!_\6\@_YI?_ '$ =E4X187DQ$"LL\BD
MRUH6M#2;,B-26TFM?!FR1<D@C/\ R"!O0\I:G]=P>P9;=<<M,A234TJ]9*L3
M2923+T1RJ.2"]?3@S(^>?3T/AJ-&313:\1L6IK6"RO+X9X^^B+8PIMLMUE#+
MJ%DE^O0F-TM/K-DR4@_1721FI// ]6]#VTU1*U3IFFHW'W:O*\^B*DH9;<)G
M(6VR-+*>E/\ $KTF?5QR?)GZ_AP7H/#DW]AY2T.\_9[_ -7&Q/ZIO^0AXU/(
M_9[_ -7&Q/ZIO^0@U!EM)4%20SAE96]J:GEOJEW<]=A,,UI0GMD\I+:4,H2V
M72A*2(C,S_$S,_ -#'[T=_O%'G-_]+-_MP_'T 5/_=3M?8/M?X-6-9[,Q+'\
M\U[GFX/(K%,SPS*ZN)=XWD^-W=C7P+:ENJF>T]$GU\^(\I#C:TF1D?\ #P8
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M?'7%;N77FU-49HC6,1SJ(N'"+DC O?\ N5/^]9;\_P!G_M/_ &NOBJ /7Z
M
M                 #A6,^+509=C-<)J+#86^\LS27"$%SP74I*>I1^A<F1&
M9CRDV]%ZL\2E&$7*32BEJV_1(T=[RV9(VIL"TR#^AUD=2JVE9)Q:TE7QG7.B
M0?5TI-R4I1JY)"3[9(2KDT]1WEQS:5M&VQIG_FB?SS^Z32^7\D5T_+JUIKH=
M?GE#F;YKRFS-IZ;7CKV:%J^M<9-NQ_#NMDW+HDU#L@]7#N</#/%<@
M               !X@*S/JWX[_W@[9F3;9>9J-=['W%L"PO<LO4'"KZC#_*&
M'(S.GRV-:./0ZYFBQ/*<JBLV4Q??9CPX,YM9$^V:FZGC='9.:669/2BRV3;?
MHHV_,GKZ:)M:OX)/XFY%F#9SWP3CXVUISS\?$J481ZN5F&U7*#CU?=.$&X1Z
M-RE!KY7H_;^+8--R+]U[CP'Q\U/GVZMHW'V+ =;XY-R7)+!+1R)/M(A)0Q!K
MHA*0J=;VTYUJ)"CI,E2);[;:3Y40X^7E4X6-/*R'I37'5O\ [GWOT2^+,EL^
MTYV^[I1L^VP[\[(L4(+T6K]6W\(Q6LI/X13?P/)G^[8X7E.QO*;RY\J;:)[&
M#^17L+G>RB2(]#*RG<>Q:[8UC$J')CDIYW["SKDNIHGWG([,YDWC,W6U*KG@
MM5E^X9.XR6B[.W[M9R4GI^3M_<U6IM!]0F9C8'&MJXU4^Z?O^XM6G)0HJ=2<
MM-/SO=]=$FXO3T9%W[Q747U_\EWC?0XK9_9,HN_'33U1C=S[V;6_:+ZRW[NZ
M'3V?W&N:>L('L+!YMWO,(6\UT=2$FHB(<?FT9SWZB%;TL=$$GZ:-V6:/5=5H
MS)> [:*/'FX7Y,>_&AN%\IQT3[HK&QW):/H]5JM'T?HS--Y?'7\[NC=29YMZ
M5Y\[ V5 U]1.Y):89JWR[\J[G/;2G@O,'<R<>J,CQK%*NS>I*M;T]Y@YS<AV
M-%<3&0_)-J.[]<O9.7XF-/)>9.Q06KC"ZYR:^.B:2>BZZ:ZZ+IJ]$</9N?>%
M=ZW2C:H['1CSOGV1LNP<*-2D_P U2E"<Y+NEI%/M:3:<G&.LE!?PG^+OCAYY
M>0F;;)\L=Q; V9OS +VLV17ZERZ:N;'VM6P55Z/SYF6P+NXN<KV"S27ZVV;&
MD)JO-I*83CTR?%E283/$XIM^#O&;._<;9V9D&I*$OX:_C2DVW+1^L>GPU;3:
M6:\P<DY!PG8:=OXQB48^QWP=3O@M'2WK^CKJC&,*NZ.KA9K+7YTH0E&,W[K1
M;AI:                          !&?D!LN-I7 L@JUS"A;7S6F>H,9H4&
M7W?&:"]8]OD.97+*5(D4;C]"^[#J26;<IR3*.4TGHC&I67XKLT^3;K3=&/=L
M&-:K+;/X%ED'K73!^D]+$IVZ:Q48^W)ZST5>^</(./XBX5G;;.WV?)F[XDL;
M$QE_+XF-D1[<K/OBFI8[EC2G1A*7;=.VYY-:[,=REJ#&P9U9
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M.JZF>DZ;Z[*9KN@SCCW/@
M                                       '+@Q53IL.$A9-KF2H\5*U
M$9I0J0\AE*U$7J9)-?)CTML554K7U48M_O+4Y.'C2S,RK#BU&5MD8)OT3E)1
MU_<U-DEFHEV$LR/GAY2>?7\4<(,O7^ T\#78[/7ZG! \
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MG**E)Z)-I:_D^WU.!3B961"=M%=DZZUK-QBVHKJ]9-)J*T3>KT]']AQA[G'
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M$N<<>YK3=;L-ED_8<58IUS@X]_=V]6NV6O;+\V3:T7<EJM9G&*)>
M
M       8]E63U6'4%ED=R^F/7UD9V2\M1F7)--J<Z2Z4K69FE!F?"5'P1\$?
MX#ZT4VY%T:*4Y6SDDE]K?1'%SL[$VW"MW#.FJ\.BN4YR>ND8Q6LGTU;T2]$F
MWZ)-FCW;>SKC:V7S<CLEN-Q2-<>HKU'PB# )9F@NVE:T%(>(B-PR-1^B4=1I
M0GB\]CV>K9L)8\-'?+K.7\:7W?TJ](K\KTU;.OGR#S?,YUOTMRM[H;?6G#'J
M?\"O775I:KW)OYK'UZZ13<81TC 9D@H              !9[Q[BL>QR^8A9.
M3>[31ELEU$N/ (I[RGE$3G#C<J5T)YZ/H-G\?KX%<\^LL_K:K1^S\[U^V7RK
M3]Q??UU^XVC^F_&Q?_*N8Y)YWZ""CUUC7^DDY>NC4Y:+TUCV>OS-%@Q7)M$
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M'G]/BF;1HL6UL,-M-'^.N.U^0QVX<N8T=?+N\5L8R%&HE=R(X7'!$9@>FX
M
M                 %'/,?;L&DQ=>NJJ6ER[R%O_ #S0PM75#J26II]+YH41
M=,OI6UTGR2E$K]+:R$SX;M%F9GK<+%_6M$M=7\9^L4OZGI)_9T^U%&^<>:X^
MQ<<GQS&G_P"6-QK[6D^L,=O2R<M'Z6:2JBGTEK/^*T:L!;QI.
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MD=/F\;MN6_[ME;[O-T\C=\W)LOOMG^=;==.5EMDM-%W3G*4GHEU;.K'W,<
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M'E49%N*[GCNVS==QR^VJ613CV34:\FN,I.J,7-24'.*4Y=F/F9
M
M         ,KP6,B;FV(1'6S>9D9/0M/MI-9&MA=I%)\NILTK27:YY,C(R+UY
M(8_=K'5M>39%Z2C18T_O['IZ_>27AF/#+YAM6+;%SJLW'&C)=>L7=#NZKJOE
MUU::T775&O3.?.'R9I=B[&CT.R'J^I7G>5G7U$S&\-R*/3P47D]$.LKG\DQN
MTE,0X48DM)2E9=24$:N3]1:NV>*^"Y>SX4\S!C9D?A:NZ:LNK<Y.$>Z4E79%
M.4GJWT^/0T=YA]9_U'[)SS?\?8>1W8VU/>LSVJ)XV#DQHK618JZ:I96+=.-=
M<-(12:U44WJ^I^*[Y$_)R%&2Q,R#%+IXEK4<ZQP?'8\E25'REM3='$IX/0W^
M!&3)+,OQ,QXO\+\"ML[Z\>ZJ.GYL;K&OR_.YR_HZ'OMW[0'ZE\+&5&3N>WYE
MNK?N7;?BQFT_AI1"BO1?#2O7[6S,H/R<;\B1&8\K%=1VS[?<Z["=CV6L2Y'6
MZMQ/>:I\ZJJY/:0LD)[;".4I+JZE<J/%W>!^&VV.<+MPKB_X,;*FET^'?3*7
M7UZR?5]-%HB88/[2?SYB8L,?(P.+Y5T==;;<3,4Y:MM=RIW"FKY4U%=M<>B7
M=K+63S&)\I&?IC,IL-3X-(FD@BDO0;7)($1US]*V(<F7:/QT&7\ZJ0Z?/\]^
M@8RWP!L;L;IS\N-6O12C7)K\K2BG_=5^0F&)^TZ\C0QH1S^-;)9F)?/*NW*K
MA)_;&N4[917W.R;^\S1OY5(I(1W=!/*=Z$]U36V$--*<X+K4TTYK-];;9JYZ
M4J6LR+T-1_B,5+Z>EW/MW=J.O37%U>GY?Q"U_>7Y"9U_M2)JN*MX,G;HM6MY
M[4WIU:3VJ32;]$Y2:735^IFK?RB:O-U!.ZPSUMDUI)Q;=KCSSJ&C476I#:E,
M)=6E/)DDUH)1^G)?B,5+Z?\ >M'V[ABN6G36%B_H]?[A_D)G7^T[\?NR*MXQ
MO$:M5JU?C2:7Q:3[4VEZ)RCKZ:KU,QC?)AXZOR&&'*/<,-MYYIIR9)Q/$%1H
MJ'%I0J3(3#V)+EJ882?4LFFG7#21]*%*X(\9/P-S&$'*-^W2DDWHK+M7]RUH
M2U?HM6E]K2ZDPQ_VE?@6Z^%-FV\KJKG-)SGB8+A!-I.<E#<IS<8KK+LA.6B?
M;&3T3R^/\A'B^_(89<RC*(;;SS33DN3A=NJ-%0XM*%29"8?NY:F&$GU+)IIU
MPTD?2A2N"/&3\*\[C!RC3CRDDWHKHZO[EKHM7Z+5I?:TB6X_[0?Z;+KX4V9V
MZ55SFDYSP+G"";2<Y*'?-QBNLNR$Y:)]L9/1/,8?FWXISI+,1C<E8EY]?0VJ
M9B6QZV,2N#,N].LL,B08J#X_C.NH1S^D8RWQ+Y"JK=DMNDXI?P;L>3_<C&UR
M?Y$FR88GUO?2YFY,,2GE54;9O1.S!W2J"?\ 366X4*X+[YRBOO,OA^47CE.D
MLQ&-UZ]2\^OH;5,O$5L8E<&9=Z=9-Q(,9!\?QG7$((_Q,8VSQWSBJMV2VO+<
M4OA#N?[D8MR?Y$FR78GU4?3KFY,,6GF.R*V;T3LO]J"?]-9:H5P7WSE%?>9C
M W)IRVEM5]5N'4UI/?[G8@UNS,'GS7^RTM]WL1(EZ](>[3+2EJZ4GPA)F?H1
MC%W<3Y5CUN[(VS<*Z5ZRECW12U>BU;@DM6TORDPP/-OAC=,J&!MG+^+Y.=9K
MVUU;K@V62[4Y/MA"]R>D4Y/1=$FWT3,O@9%CMK+:@5618_:3W^YV(-;>54^:
M_P!II;[O9B1);TAWMLMJ6KI2?"4F9^A&,;=MFY8];NR,>^%2]92KE%+5Z+5M
M)+5M+\I+<'EW$]TRH8.V;IMV3G6:]M=63399+M3D^V$)N3TBG)Z+HDV^B9D)
MPIB2,U1))$7XF;#I$7^29HX(<$D6C/D;+R2,U-.$1>IF:%$1?Y)F7! -#Y@>
M                                       _;3BFG6W4_P 9IQ#B?_;D
M*)1?P_I(#R>7OR*UXSJK=^S,#B-K:K*3)YCE&TX2>XC'+A#-[C:7#0E#:UE0
MV<?E24I2H_4B(C(B[ .&[S+D'%L'=YM.ZW'CWM?X9#6%G_AQE^0_,1Y\X%7X
MQ\R\CX/CQ<,#"W*S\.GIJL6Y+(Q4]$DW^&MJU:23?5))Z$+B3%0@
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MG-<_U19.&76_FIN486I?"2C&4XRB]/6$I=O3N[6UK/HPI.@
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M%<Q:5KBEQG^HB)9$EUM:3X4VZE*EDE9<D?')^AD/DUH?0[8
M
M                            0?Y ;.G:IP"5D59#]W8O268$0U$1LQWI
M!]"'Y')\DRA:BYX(S5_%+I-1*3E]CVQ;ON,,*4^R#U;?QT75I?>_A]GKUTT<
M-Y]RN7#.,7[[72[[X.,(1](]\WVQE-KJH)]7IUETBFN[N6E6_O[?*+>=>WLY
M^QM+%]3\J4^HU+6M1^B4E^#;39>B4EPE*2X(7EB8F/@X\<7%BH4P6B2_N7]K
M?JV^K9U];SO.Y;_N5N[;M;*[/NEK*3_H)+TC&*Z1BM%%))+0Z<<@Q@
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ML&6%GVT1NJ:LIOJNJGKI93D8]EV/=#5.$I56S4)QE7+MG&45@ RQ"
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MXMQG%Z-=T6UJFM=4TN$/H<0
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M*&)3WW3R;*U/)E+(CCS5W=BU3*X"9E!
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M,_4B,T&9$? QY(SZ@
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MC67AY>WY,\+/JLHS*WI.NR,H3B_LE&24HO[FDSFC('&
M
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MF^FO(Q[?;E\U4K,>ZJ<ZI-RJE)UR;E%LC09LKT
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M'OHDI..EE<X/N7K'YDNJ^*]4=</L<$
M                       ,FH)L>GJMD9')BNRV\7U%M'(.TRHT.&4##+;N
M$E7)-DIYAU;9&OE)*61_CP,?G53R+L+"A)1=^XXM>K_IKH:?O-)].O0D6QY=
M&U;;O^_7URMAMW%MXR=(O1_H\"_7KZ:RBW!=W362^.AH1&U1TG
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M:^4^08W+/)W(^58:2P]SW[<,NM*7<E#(R[;HZ2[8]R[9K27;'5=>U>A'8S!
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M*]_E:,.V7Z-O^J]PK^PL/\DL.CWZ_O\ KE^0_P#E!9_D51" V9-/@
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M6-QV#6-MV+'55X>W8R]K"QJXOI%0IC&5C2C[E\[;I1]RV;<7#.E<
M                              !>;P)>9C[-S*0FPOVIT+6F1SF:6%)A
MQL6R. A<6);0,T]U#GG+A1HTTI,%A"&E.V+3/#[:R0AVK_*T93V7&@X5.J6=
M7%S:;MKEU<)4Z..DFX]LY-O2MRUBUJX[D_1/;51Y$W:]7YT<RGCV59''KG"&
M'E5IPA=7G]\+.^N$+%;CUJ,'/*A5I=":A"R\0K4W&  L%XUZQ/9>R*YB7'[M
M!CZFKBZ-:"6RX32S.#"<(R4@_<OMFHTK(T.(:4@_XQ",<LW5[9MCA4],J_6$
M?M2_A27Y%T375.2?P+;\-<.CRKED,C,@I[1@)76IK6,IZ_H:WZI]TTYN+3C*
M%<XOU-U;##,9EN/':;88:22&FFDDAM"2_!*4I(B(A2IO>?4 =+=8[1Y$TRS=
MU<2Q1'?:DQSD-\N1WV'$/,O,/)-+S+C;S:5$:5%PI)'^)$/>%DZVW!N+::>C
MTU36C7Y&NC7Q/E=11D)1OA"<8SC)*23TE%J49+77246DXM=4TFNIW)%P1$7/
M!$1>IF9^G\)F9F9_S3'H?4_H         .#9UT:VKIM9-;2[%GQ7HDAM:4K2
MII]!H41H41I47!_@9&1_I'F,I1DI1;4D]4_L9Z65PMA*JV*E7)---:II]&FG
MT::Z-/U-96;^$UW6R[:RH,HI6<>:2[*C-6RG67HJ.%K.*J0MQ1.H;(OI4KZ^
MD^D^M1=2[*PN>Q]F%>;1*61Z.4&M)??VO31O[%TU]--=%JUOOTZSEG79&PY]
M56V/64:[HRUK]7V.Q-]T%\)M*2722DUW2HJ\T;+SK)K;<-IQ;1N,N)=96;:C
M2:VG4&:'&U<<I47H9>I"Q8R[HJ6C6JUZ]'^ZO@S6&VMTVRJ;C)QDUK%IQ>CT
MU371I_!KHUU/D/)\P    #M:N\NZ-QUVEN+2G=?0EM]RKL)=>X\VE74E#JXC
MS*G$)5ZD1F9$8^&1B8N6E'*JKMBGJE.*EI^35/0R6V[SN^S3E;M&7DXEDUI)
MTVSJ<DNJ4G"46TGUT9F.(;9V%@\],^@RBT:677UQI4N1,A.FX@D*4N,^ZI'7
MPE/)IZ35TD1\I]#Q^=L.U;A#LR*8*7PE%*,E]VJ^'W/5=?M))Q_R)S'C5_O;
M=G72K>NM=LI6U-M::N$VTI=%\T=)=$FVNA9_"/-C8"+^*WE=-6W=9,4Q#.+1
MQ),:P0ZXZA#;L5ER5,]X^KJ-)-)[:EJ41F:C(DG$\_@F'#&E9A73C;%-_I'%
MQ:2^+48]OV]W5?=\5<?'/J&WJ_=*\;?L"BW$MDH+\+&Q7*4FDG&$[+5;KZ*M
M=C;:TET[7LUQ^Y9R&EK;MB/*BM645$A,::RN/*8-1FE;3[+B4.-N(6DRX4E*
MOX2(_05I9!US=;:;BVM4]4]/L:Z-?8UZFUE%RR*(7Q4XQG!22E%QDM5KI*,D
MG&2UT<6DT^C6IW ]#Z@
M                     !0CSARW&',4IL3]S'E9(5PB>S&;[;SL&.TAUJ1(
M<5SS')72;1F7U&I1I(C(G.F<<%Q<F6Y2RX)K%C6XR?HFWII'[W_"T^&B;ZZ:
MT!]0>[;53Q6K9KIPENUV3"RN'1RC&"FI6O\ BQZNM2]9.3BDTIN.L06R::
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M[*R[Y34->[M3Z).6BU>B6KT2;UT2,S%@$<
M                                                      (_VL^S
M&UMFS\AUMAEO'+,W'75$AMLCCJ3U+6HR2A)&?J9^A#EX$92SJ8Q3<G;#1+^J
M1B.0V0JV#.MM:C7'#N;;>B25<FVV^B275M^AH-&PQUF
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M*73[]7U^Y_>;.?3?@]V3NNYR3^2NBJ+TZ/O=DYI2^U=D-4OXR;^!8P5L;4@
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MD8[4NU^[7.O26FNGS1771-Z>NB.L'W,<
M             !^\CERZG27D7<19;,,DZ<O*!U;O:-3C>4V=14O1T)?;6S_3
MD-;S!'R3A+=3V_KX-/SQJZ\CDNS8TXN7_E*%BTU_P*,YI]'KT>DOLT3UZ>OO
MOV5E;9X@Y[NN-;"I+B>1C-OMU:S+J*)12DG'YZW.O7I)2G'L^;1K1H-GCIM
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M6+BTY639UR<FK*5,IQQ6Z[*VB:&OX
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MQ?HK.U.5E?W2G#Y=8PNZ(>78
M                         !#6V]SXAJVBF2+.T:7<.,/-5U5#6T_8.RNA
M1((F"<(VS0K]*N$I,R-7">5%D]KVG-W;(5&+%M:_-)_FQ7VM_P#:]7\$R+<L
MYCL7#=NEN&\VJ,M'V5)IVVR^$81]7J^CD](1]922-(UU<6&06UC=VKZI-A:2
MWIDIU1J,C<>6:NALE*4:&&D\(;1SPA"227H1"]\7&IP\>&+0M*:XI)?D^W[6
M_5OXO5G7?NVZYN][G?N^XS<\W(LE.;^]OT6NND8K2,8^D8I171(ZL?<QP
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MNO\ VC1;SAG3S/(F53)ZUXU5%4>NNB]J-K7V+2=DM4OCJWU;(B$G*C
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MCX]R]MO1R]NR$;:U)KHY*$XJ3T6K3>BUT4CBVB'
M                                                           &
MO;S7VK85C<'6E2^EE%M#]]?FAPN_[-2TE&CF@BZB:FGU$9F9%TMJ3PKJY3/>
M$;17DWRW.]-QIDE!?!STU;_[U::+[6G\.NNWGWFF1M.VU<4V^2C=G5RE>]?F
M5"?;&*7V6R4TY=/EKE'1]STUK"U#3X
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MV*+:]5W1DOM370Q>9HW!9)+5%>R*M=-*2035A"EQ4FE1=2C8DUON5FM')?\
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M>XQRI.>K6B[<1I-*3[G%::-RCIF&QIU,@
M                                %C->1+6WT;MZFP=2%Y6U84.5YW"C
M'):OING<7A6BK,ZYQ"4L3,<K,GM(DZ[B=9N**+"E=M3,-Y;4-WBRC'Y3MV3N
MFJP'"RJB3T=<<RV4>WN7JK)51G"B>FB[K:]5*R*E?7!,7<]U\-\IVGAK4N31
MOQLS<:X=\<FS8L.N[W?::7;/%IR[J<C<*.[O:IQ,GLE5BVSKKF)D4*
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ML9Q<7W^KG+1O2QOW--5WN+<7/PQ!,@
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M1A'7KVPBE".K;T2U;>K,F$P,*
M                                             :5/*BTDV6\,R;D&
M9E5/0JN-];BB*,W#9EI)*5J439=R8KE*>$\\GQZF+HX;3&O8*IQ];)3D_P O
M<X_N](K^X-$_.>;;E>1LNBS7LQJ:*X]6_E=4;>FOI\ULNBZ:ZOU;*\"4E0@
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MN=T7=&,;LK)[95J^44Y^U75"5D*(*7=)6SG<E*4*Z<5&YAIZ
M                &.; RA[!-4;4S2)*=@VE;A[]%02XSZX\YB^S>=#Q!A^O
M>:?9>CSJ^IMYLUMY/*F3B]232YVS+E;7@QW7?L#;+(J5%F2IV)K6+KHB[FI)
MIIQE.$(-/U[M'K'5&!YQR2[A?C/DO+<6V5.Y8^U2Q\:<).-D<G<+*\&,JI1E
M&4+*J;[\B%BU<'3W1TL[&M+0V0.HX
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M#QIZZN455@Y64W'1I)N<*UJ^Y.+FNU/MDM0 V%.J\
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M+Q)EV3NV_<,>FV^A8TY.4*<FROW5CY6,M:,FC(G&V%U5G24=)N 1+2D
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MT<\D<+?!>2SVFN<[-OLKC;1.6G<ZY:K2?:E'OA.,HO1+N24^V*DHJ-!FB @
M          ?I*E(4E:%&E:3)25),TJ2I)\I4E1<&1D9>A@TFM'Z'F,I1DI1;
M4D]4UZIE]M.^8>4,3,8PW+JV!:19,ZOI_P P&\[%EQV'#3&8-V,TPXT\ZX\I
M*5+-2&T$?)))*>!6V]\+HJINS\"R48PBY^VUKZ=6E+5-)+71-2?334VGX%YW
MS\[.PN/<CQZYVWVPI_%1FX/67RPE95V2C*4IZ*4HRKBM7+M21LY2I*TI6A25
M(4DE)4DR4E25%RE25%R1I,C]#%;FT1_0
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M+DS/A*2(A@B>'T
M                                                         :,O
M(2>FSW1L&8ELV2<O.UVU*)9I5%A1(JSZB)/)*4R9EZ%Z&+QXM6ZM@QHOKK&3
M_NTY2_[9U_>7\F.7Y'W2V*:2MKAU^VNBJMO]UQU7W,AH2 K8
M                                                     K3YD7Y5
M.H,*Q9#W1)S7/K'(94=I:#6JLP*C365[LM!22=:C2;'.)1,%V30\Y%<,U$;*
M"$Q\>8OXCD>3G-:PQ<2-:;_C7S[I)=-&U&B/=UU2E'1:29KY]5^]K;/%>T<;
MA/2_=][MRIQ36KIVW'5-3FN_N4)V[C<J_D<;)TV-R3JBC6:+I.O,
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MR\3$\(\4VM6267F<@W')]OYM)+'Q\>B4_3L3@KJHI-]S]R3BFN_35D+T.ML
M
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M>TX,;'%WSHQ\K)NG?D2@E!Y&5EY&3E6Q@NRIW>S!RA7&3AX2,JH
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M6AJQ]0V'CX=&PUTM2E73D5.7Q:J_#))Z=.C<NGP;93,6":T
M!^DJ4A25H4:5I,E)4DS2I*DGRE25%P9&1EZ&#2:T?H>8RE&2E%M23U37JF;W
MM+9)#RO6&'V\.0[)2NGBQY"WU&N0F7&;2W);D*-2S-Y#A<*]3]?P,RX,]?=T
MQIX>XW8TTDXV2Z+TTUU6GW-:-?<=E/$]UIWOC6#NF/.5D+L6MMR_.[E%*:EK
MKK)34E)ZO5IZ-KJ2D. 2
M                   /RM"'$J0XA*T*+A2%I)25%_ I*B,C( :\_(;R2P&Z
MQ3*<$JJ5R?D#DF9CKJK.M[;=<W'4;;D]AYUM*4FT]]4<VU+/NMD?!)-+@G?&
M^,[C^,Q]RL:KQ$HV)J2;DO51T75:KI+71=K:]=4:]^4?*W%X['N7%L:,\C>9
M.S%E"=4E"MKY96]TDD^QZNIQU?N0C+11TD];8M8TY
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M^_W/]XV7^G#:93W/<M\EJHU40HC]C=L_<E_=?:A_=E]YM,%8&V8
M
M                                  :;O+?"7<4VU9V2&NW7Y6VBVB*0
MWT,]]MMEB8RUPTVE1M_JU+/E2C<<,S/U%P\*SED[1^&;_2T2<?O[9-RB_P"Y
M2^Z)I)YZX_+:N9_K:$=,3<:HS6BT7N5J-=B6B2UT4+)=6V[&WZE7A,"D
M
M "@/F]?E,VECF(M+6EK -=8S52HQ.OJ91<Y*<S/K)Y3+O2AJP2SED>+(Z4DI
M)Q$M*,^T7%J>,L7V]DOW&27=EYELD]%KV5=N/%:KUCK5*4>O\-R7YQI#]8>]
M_BO(^W\7K;5>Q[#B4SAW2<5?E^YN5LNUZ)6J.;53;HDTZ(UR;]M:4U%C&IP
M             !7_ ,L?\5CR6_V/^Y/[G61B-<T_X';M_8S*_P @F6WX!_Y]
M^$_\KMG_ -\,<U@?"#_8LWA_*!CO];C@J'Z??]A]P_T3#^\&\G[3[_AYQ?\
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M#]/Y^0
M !]$O.I(DI=<2DOP)*U$1<GR?!$?'X@>=3].R'Y#:F9#JY+*^.MF2?N65]*D
MK3ULO]QM72M)&7)>AER/:$YUR[ZVXS7Q3T?[Z/E?33DU.C)A&RF6FL9)2B]'
MJM4]4]&DU]ZU-.ORG6BEVFC\?3'9:C5E/G=LRME*6BZ[NRQR(\P3+:$--M-'
M0I61D7*ENJY_0-G?I_J<L3=,V<I2MLMH@]>O2$;&GKZ]>_3\B1T^?M.\V$-\
MX=Q^BJNK$QL+<+X]J[>N1;BPE'M244E^&4EIU;G+4U-#8<ZL@
M                                                    FZDDR5>-
M^S(:I#ZHC&[M&R6(JG7#C,R9>">0S4J0TP:NTV_):A,I<61$I:6D$9F24\1C
M*A!<SP;$E[CVO.3>G5I7[>TF_71-O1?#5_:RX=GR+Y> >18LIS>+#F''IQ@V
M^V,I[=R=3DHZZ*4U7!2:6LE"";:BM(1$G*>
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MB^O5R>K<Q#&$I
M             -?GFYKJK1CM3G=76L1I\:V]K<28[)MF_&GH)I+LI33:B=<.
M6EA*#6:4H(E$1FI?!SO@VX65Y\MOG)^Q96W%-^DH]>FKZ:Q<M=%UZ-^AKU]0
M7&\7)XW5R2BJ*S\7(C&R:6C=5J[/G:C\VEBJ4'-I13DD]9:/6@+6-.@
M                  RS!+'[5FF+3S(U-L7M:3Z4I)2U17I3;$I#9*4A/<5&
M=42>5%PHR]1CMWH_$[7D4?&5,M/RI-K]S5+4E'"=P>U<OVS/ZN->;3W:)-N+
MFHS23:6KBWIJUUTZE]UIZ%K09\]"E)Y_AZ3,N?\ PA0AV/'Y \   !7??V/.
M.M466LF:D,-IQNQ;X27;63LZQJY!=)=:R?;<?:6I7HCLME_/"R.";A'LMVR7
MY^ON1^]=(R7[FD6OMU?V&K'U$\;M][#Y;3UI<%BVKITDG.RJ7VON3LC)OI'L
M@OX1686(:P@         &?M1H.*T57:V-.Q9WV0E*E5D.W)_[?74#9HC,6JZ
M]M<5R9*M927TQU.*5&2TR:R2M:DFWB)66[AEV8]%KKQ*=%)PT[I6>KAW/514
M%V]VB4FWIJDFI3>O'P^-;+C;EN&)#(WO/4YTPO[O:JQEI"-SJ3@[)W3]Q5.3
M=2A!S49RE%UW1\+]EU2KR^PV765%186Z&["O>K8:83<LHJ4,O1G3-UPW7DFI
M)H27J9*,R]"/B#\VVJZJ-6?&=EE*^1]TNYQ;U::Z=$^J;^U+[2_O O,,+-GF
M<=LQ\7&SY/WX>S6JU9%*,)I_,]90^645_%<WZ)FR(5Z;*@           4 \
M@OE1^._Q2VL>C_(_RXU!IK:J:^CMG<.SJ[E4\^+59*1JI+.;*<@+K(-?.0DU
M$\\^AMM"34LTI(S %_P!U]M;55!56=[>V=?2TE+7S;:YN;:;&KJJIJJZ,Y,L
M+.SL)CC,2!7P(C*W7GG5H;:;0:E&22,P!2#Q?^3OP#\T\_M]6^*_E+K#=^PJ
M##[#/[C%,*G64JUK\-JKK'\=L,AD-S*R$T5?$N\JKHRS)1J[DMLN.#,R O>
M(/\ (?R4T+XF:OM=T>2.U</TWJVEL*>IL,SS6R*NJF[7(+!FLIZR.E"'I<^P
MGRWBZ&8[3KA-H<=41--N+2!T_C+Y:>-GF9KR9M?Q:W+@^\-=UN466$V658):
M?<J^LRZH@5-M98Y9I<:CRJZXBU-_!E&P\VA9Q9C#I$;;J%* L0
M
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M*-)X[:465I7ZI:I;#MV7"EH0V1TENU5W2UN+<)/#;#A$LR29\FGJ\+=J:_\
M-M=V._MG'6/W_/!SA\/C)=.OVZ>9<+SLAI[#DX6YQ?HL>W2WJTE_6]\:<AMM
MI?)7)*7375QUQ.=7SZR0J+909E?*1SUQIT9Z)(3TK6VKJ9?0VXGI<;4D^2]%
M),OQ(9&JZF^'N43C.M_&+37V^JZ>A&,S!S=NO>-N%-M&2O6%D)0DM&T]8R2?
MJFO3U37JCACZ'%
M            #M:.L7=7=/3MJZ%VUI7UB%\D72N?+9BI5RKZ2Z3=Y]?0?#+O
M6+BVY+ZJNN4O[JF_^T9+9MNEN^[XFTP>D\K)JI3^QV3C!/\ \(TV;CS-K8>U
MMAYM&,O89)E][95#:4="8]$Y8/(H8B>J)!<64.F;8:);C+;J^CJ<+K-0V'XY
MMLMGV##VR?\ +4X\(S^^?:O<?K)=9]ST3:6NB>FAU/>5^6U\[\E[]R_'T_!;
MANN3;0DM%''=LEC07R5M^W0JX=TH1G+M[IKO<B-1FBOP              "O
M_EC_ (K'DM_L?]R?W.LC$:YI_P #MV_L9E?Y!,MOP#_S[\)_Y7;/_OACFL#X
M0?[%F\/Y0,=_K<<%0_3[_L/N'^B8?W@WD_:??\/.+_V(R/\ 5"*__*G_ (_7
MCM_)_J/^[1L,1KS'_P Y.U_Z&QO]57EM_0;_ -4SF/\ 9?=O]YMO/1^-J#IE
M-4GR?^7^":PTEFNE<;R2KN=M;.JY.'3*&KFLSI&(XK:);8RNQRAJ(]U53EE0
MONPH<=Y3;[SLKO);<99=(4UY=YQMVT<?R-@Q;86;UEP=3A%INNN72R5FC^7N
M@W",7HVY=R3C&1OQ]#?T[\JYQY.VSR7O6%?C>/\ 8[XYD+[8.$<O*J;EBUXK
MFOTJKOC&ZZR"E"$:O;<H66ULRCXH=*6^H_%F%=9+6.5>1;:R2=L%466TMFQB
MXR]!KZ;$V);:T(Z&YM?6+LV"Y49,V1=1DHS0CE^&=@OV3A\;\N#AE9MKNT?2
M2K:C&M/\L8^XONLZ]>BP7U]>3=O\A>=K=MV2]7[/Q_"A@=T&G7+)4[+LN4&F
M]7"RU8TWT7?C/1-:2ELS%M&D@                       74^/S&RO_)_#
M9;K:'HV*U&79.^VMI;I=R-CEA55KQ&CZ65Q+JWC/)4OZ>ILD^IF1'6'F'.>%
MP++A%M67SJJ3U7QLC*2^_6$)+1=>NOP-Q/H.XXN0?4OLM]L5/&VVC,S)IIM:
MPQ;*JGJOS7"^ZJ:<NFL4O5I'H5&E!^A
M                                T?\ R@SWG=U8#5^YZXL#4E;+*(E:
M%)C3K+-,W]RXM*?J0_*@PHAF2O4VT(/C@_7;7P)3&'$\J_MTLGN$UK]L8TTZ
M?E2;E^ZV=(/[3#/MN\V;/MWN]V+1Q>B2AJFH66YV?WMKU4IPKIU3_@J+]'UU
MK"\3KI
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M4?8+U4I1F9F* WE);OE)>GXFS^]L[(N#RE+A>T2DVY/:\5MOU;]BLEP8TE
M                                                          !#
MN_Z%&1:@SF ;1//-TDJ;#2I3:$IF1$&['<4MQ)])-J+J/C@_3@OX#R>RY#QM
MVQKM=$KHZ_D;TE_0;(ISK;H[MPW<\!I2E/!N<4^B[XP<ZWK]TXQ9HO%_'7
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MLJK:\+&RX;Q8WW5N*E"$(Z.5CM3T4%'XRC&3GI!1;E#NN6(L6X
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M'A2*J2],^V5]/MW5M99^VF-.2$7DB!0LQ5/%(84H#_1T
M
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MPEI)=/M2,9N7&.0;15^)S\2Z&$WHKDN^B77M^6^ONIGUZ:QFU^^8Z.88$
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M&_TSE?Y0; ?]/+Z3/^)V[_[D[-_Z0+0>.WPX:SU_>5^6;RR_]KLVMD>[AX3
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M%YF3[RBX:]TG+\ VI)-14&FTYQUW-#5D[F0
M                                  #S\?(C:1Y_D]DD)E#R7:'%\&JY
MBG4H2VY(DXS OT+C&AQ:ELIAW;23-1(5W$K+CI(E*W1\,8\Z> X]DFNVVZZ:
MT^"5DH=>GKK!^FO33KKT7Y_?K_W.C/\ J8W7%I4U9A8.WTSU2T<I8E>0G#1M
MN/9?!-M1?>I+31*4J.BU32T
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M)D$\F[3@[OP7<Z\Z'<J,.V^#]'&VFN5D))_E6C^V+E'XFD\7L=>
M             '85-9+NK2NIX""<FVDV- BI4KI0;\MY##9N+X/H;2I9&I7X
M)21F?X#XY%]>+1/)N>E5<7)_D2U?[OV'.VS;LK=]QHVK"2EF9-T*X)]%W3DH
MK5_!:OJ_@M6;S=*8K>X3K7&\7R13:K:HBG%>-F2J6QVT*X82PZM*%]E#7"4I
M-*321<<$*$W;*IS=RNR\=.--DW))I)]?75)M:MZM]6=C'#]ISMAXQ@[-N,X6
M9F-CQKE*,I2B^WHE%R49=JCHEK%:):):(E48\D@
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M!JERGD>;RO?<C?<_56WS;C'755P72%<7TZ0CHM=%J]9-:MED!SB/@
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M$[I>E-IN, SRKLJ.<E#SS:9M>Z2'7$D2U 6G
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M)*TG_,,ADXRC.*E!IQ?Q75$3MJMHL=-\90MB]'&2::?WI]4?(>3Y@
M                                       0MY17BL?\=[R*T]TR,^SK
M%,54P27B[U+1,6696[BG"C*8_47-93DE!NI4KK-72?1R4AX3C++YA5.2^3$Q
M;;=>G2<W&F'377K"5W73X):]2I/J.WF6Q^",S&KGI?O>]86'VZ2^;'QHVY][
M;[.WY;ZL#2/>F^YR[7VZK5 +Y.LL
M                   #>'\8>/-PM-Y[E!H0B1D6R#IS,X26GG8>*8W4RHSA
MS^KN3(Q2LLDH;;Z20PXATR,S<42=4O/N;*SD6%M^K<*</O\ SM4I6V23^7X/
M2J+;]9)Q^Q:]UG[,KC]>)XKW_D[261G;\L?^3TDZ\/%IG!^YKK9#OS+8QCIV
MURC8TVYR2V3"ACLH
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M&_\ &.2\4S?U;RG;L[;=Q6OZ+*HMQ[.GK\ET(2Z?'IT,H',,&
M                 $UP";A>.>5J-:W'<DW7K\D()M*6XC>$X+LPW5J=[AJ>
M78*V @DI)"2;**9F:NLB3&;6[>98ZZ*-.V9'[OO7XVG33IV_AW\>O=Z+3K;V
M$J\3P)N;;<K=PY?MFBT24%M^W;MJV]=9.U[G'1=J452VW+O2C"@DQ4(
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MVB%>1\F6)P/=[8I-O MAU^RR+K;_ '%+5?>C2 +Y.NH
M    #:QXOZAQJ1JS&,CFPX;US,O4Y"<]45MR2EN'(<*/#:D&33\8C;))*,E*
MX-)\>BU$*;Y7N>5;O-U$9RC1!>WVIO1K1:ZK71ZMOX?9]AO-X>XKM&)P;!S[
M**;-QOD\AV.$7.,N]JOMEIW+L@HK37U<_A)HNT(D7(
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M*3,AT6\=?U\>:U%?KK#'LF>K;UBM0I]Z3]SN)/:93#?6X![S
M
M      &D'R7,CWIL4R,C([>*9&1\D9'45QD9&7H9&0N[B/\ P>Q_^_\ \DF:
M$>:O^<S<_P#X/_J6@@L2,JP           #])4I"DK0HTK29*2I)FE25)/E*
MDJ+@R,C+T,&DUH_0\QE*,E*+:DGJFO5,S"/GF2H91%L);.0PFT*;;A9/$C9
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M%%4DG&<H/LDI)-.-FCA)--=8R?7IZG0CEF%
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MEW?$M>*V-M
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MBZ:EI/7O4'_-]_8LT?\ R@9%_6XV(]]07^P^W_Z)G_>"T/V8/_#SE']B,?\
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M /;H_P#6'$:_^?'_ ,V?_9RV_P#\Q'_XW?\ RO(7$E*D
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MZPP. SP7H[,W)JJ2^.D)>^Y):IZ)U1BWI+3N2:7<FM38N(T?
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MI-JF^*A.45ZN#C*<):+JXJ?>DG)Q[4V61& +&
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M,SOU_P!C^W$M[K0PE:4*2!L_
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MUJFOB16RN=4W5:G&R+:::T::Z--/JFGT:?H?@>3T
M             #]MMN/.(::0MUUU:6VFFTJ6XXXM1)0A"$D:EK6HR(B(N3,>
M)244Y2:44M6W\#WKKG;-55)RLDTDDM6V^B22ZMM]$EZFK_RQR+\Q>0&Q$M24
M2(6,643 J[L./KAMQ<!K(6(N>R[[KOZB7-IWI*EHZ$/O/K>)*>YP5U<!P_PG
M$L-RBXVWP=\M=-=;Y2N^;1+JHS44GJXJ*CJ]#KG^IO?OU[YPWZ-=BLQ-NR(;
M;5VN3K4-MIKP7[?<W\L[*)VN4>V-EED[5&/N:*N@F)0H
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M;;A.4XRE.+;DI-J3;U9G PI8
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MXVTXE;DFEE3ELDAU*)2.MSI7VR-&K'@].GFNY8^(W+;5BV:-?-%]M]:J??\
M?!S:T?S+5]=.G<O^T2E'.^GWB>Z;Y%5\MGO&*Y0EK79%6[;E3RU[#::4;HT*
M>L6ZI=L-8][4O2&-J3IB                           FC_V'?_MT?^L.
M(U_\^/\ YL_^SEM__F(__&[_ .5Y"XDI4@
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MZ>JMOVL>W^YUL&Q]O^1.[V/>Q6I/9[OYR:[O:[O3U=*>KCG@OP&LW(_VK?\
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M^/\ UI^H=PEB_B_8_#>_VQC+O]CWLCVM>[3M]ZST_.ZF#BS"GP
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M[RH]QW/<=WRGF[K?=DYDEHYV3E.6B]%K)MZ+X+T7P1UX^QP0
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M&N4I=]>EPT+0XA#C:TN-N)2M"T*)2%H41*2M"DF:5)4D^2,O0R$=+*/T
M
M                           *7^9>S?RMAD?#JV3T6^5=UN0EM7#C%4@B
M3)<,TGR7=2LV^#X,C<2HOP$NX=M7X_<OQ-BUQ\?23^^7\%?O_-^YI\2F/-_+
M_P";O%'M>++3<]Q[JHZ>L:DE[T_W4U6OZO5?FFIT7&:.
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M_4N>1UW'ZHCY >
M             Z?(9\NJQW(K6O=[$^KQZ]LH+_;:>[$R!52Y<5_M/H=9<[+[
M*5=*TJ0?'!D9<D.=ME->1N6/CW+6J=]<9+JM5*236JT:U3^#U(]R[/RMKXGN
MFYX,_;SL;;LFVN6BEVV5TSG"6DDXO223TDFGZ--=#R7#L8/RF
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M*V#OKEK3DYMW9[\ZW%N-M5$:X456:=9_B95.5-D)SVMBY30<
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M)B;-QNC'QN/XV/77CU41C&FNF,4JXU1A\J@HZ=O;TTZGXR^3;WR+DG(L[?\
MEV3E9G*,S*LMR[\F4YY%N1.;=L[I3^=V.>O=W==>AUXRQ@P
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M52_+VE#>=>;QV/8OYL84O_*NX5_/H^L,=MJ3_P#':2J2_B^YZ-(U>BVS2X
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M\7V9&=/UG-ZO1>B2](Q7PC%**^"1U(^YC0
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MX/OHLMKZI>BGJOBD<03,AP           &7XC_\ '/\ ]:%U_P# PQVX_P"
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M3CK?)KNC!R6JTZ]4;6QW;FAX
M                                          =5>VT>AIK2ZE<^WJX,
MF:]PE2OHCM*</Z4$I9EZ>O!&?\P>T(2LFJX=9R:2_*^B/E??5C43R;WVTUP<
MI/1O2,5JWHM6]$O1)O[#1WN;:<[;N9R,GDQE0(J([<"M@&[W.Q$86XI#BTI(
MFD2'R6762>K@DI2:U]/6=Z;!LT=EP?PW<IW2EW2DEIUT2T7QT6G37UZO1:Z'
M7SY'YQ9SS?\ ]:1KE1@U5*JFMR[FHJ4I=\M-(J<W+626NB48=TNU2<3#-D
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MVE<'1SJ+)25T]#=+;QE3U]?:Z.FDL?MU^KK4\E/_ !KZ+/H/A7H/O^ML>O\
MS7"ZC^K@^WX_PX]U?P;_ #_3KZ=3@KAFYY.CV:["W!/318]\'8]>W33'M]K)
M>KDE_(_G/M>DNAC-A5V=2][:UKI]9(+GF/81)$-[Z3X/]5);;7Z&?KZ#G4Y%
M&1'OQYPLA]L6I+]]-D>SMMW';+OP^Y8]V/D?Q;82KE_=9I/^@< ?4X0
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M1;*^^4IWSDY2E)MRE)O5RDWJVVWJV^K?5GX'N?,
M"V_@OC:LD\HM8H4VM4:BE7F52W4(;64;\N8W;6=>XYW?1"7KIF*R2R(U(6ZE
M2?4B%=^5LY8' L^::5EL(5):Z:^Y9",DM/L@Y/3XI-,VH^BKCDN2?4OQFF46
M\;$OOS)M)24%BXMUU;:?HG?&J&JZQ<TUU29Z,AHZ?HL
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M )L_^SEM_P#YB/\ \;O_ )7D+B2E2
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MJ/>Z,BJ:A?A9<8Z]^-E5US?99*AWTP]UQ6,\5J          64\0O\8C7O\
M\EG]8^3#3/\ :"_]4/EW_FO_ 'ZVX[ ?V6O_ %[N"_\ GK_\GMV+?^>\63-Q
M?6T*%'?ES)>638L2)%:<D294F17MM,1X[#25NO/O.K)*$)(U*49$1&9CKW_9
M4YN'MO-N9[CN-U6/M^/L--EMMDXPKKKA?*4[+)R:C"$(IRG.348Q3;:2.TW]
MMAMVX;OX[\?[3M-%V5NN5R;(IIIIA*RVZVS&C"NJJN"E.RRR<E"$()RE)J,4
MVTB*,=\5?(#7V.UV;:^R-BMSVSKY42^QB),B5T^%52WX$N+6Q[>:M53.F=Z(
ME<M*W([;2T)2VX[P:COGE_UV?2=Y9YAF>-?+6SVYGBO"RZ[<'<K:;<BB[*JA
M?5;D3Q*8K*IJ[+90Q90A?99"<YW54=RC'6?@?[-7ZW_!W \#R[X.W^G \U;C
M@W4[CM%%].+DT8=UF-=3BUYM\GA9%_?3&S-A99C5565UPHNR5&4Y71\=X.[:
M_%+1C=TGOVY6ZOLC<B736%FS5FPVM[WLVB4]#?:<F+4;/6\Z^DB-)]*";2.M
MWZO=T^FC=N=X.3],U/M<?>WK\;*NK,HQIY/?)0]FG-4+82C4HJWLJKIDW&4>
M^QVR?;;]".S?5]L?C3<</ZP,CWN4+='^KXVWX&3EPQ/;C*?OY&W.RBR$KY2=
M'N7VY$(J<)>W5&B"U3>2_P!D_;OLO[!VO8_F#]?V>WT?>_8P_P R\]KZ>[^8
M_==?/U=?/5]7([WOHN_G+_T6^%_SK[_UI^J?D[N[7\'[]WZNT[NO;^K_ ,+V
M?P>SM[/ET/S2_M!_YH_],_R%_,CV_P!3?KS])V=NGX_\/1^M=>SIW_K3\9[F
MOS=_=W_/W$%C9\TV             #U,_#]JY>&>,LC-IK/;L-H9;:WC7=9?
M8E,T]2I&/5[#J7FVDKCR#JUS&%I):5-2B4E9DKI3IIYNWA;ES26%6]:<*B%7
M1IISE^EFUHWU7>H271IP:TZ=>^_]GIP67%/I_JY!DQ[<[D&XY&9UC*,U16UB
M41DI)?++\/9?6UW*4,A24FI)+;"*?-Z@      .LN:B#?5<ZHL6&9,.PC.QG
MV7VDO-*2Z@T_6TOZ7"(SYZ3]#_ _0Q[0G*N2G!M33U371IKT:?VGSMJJR*I4
M7QC.B<7&49).,HM:.,D^C371I]&NC-"NQL7/"\YRC%^A;:*>WE1XZ'#6;B(:
MU%(A)6IPDK6LHCR.5&1&H_7@A?VSYKW#;*<R6G?."[OZI=)?^$F=<7-MBCQG
MEF?L=::HHR'[:;U?M2TG5J_B_;E'5_'U,*&1(L                  %U/"
M7+ZG'\]O:.R<;8?RFLB-5SKKB4).16.RGEL()7'4XXS)-7H?*6VUGQQR90'G
MN);;ATYD$W73*2E]RGVZ-_8M8Z?E:-COISWK$P]YS]DO:CDYM54Z]7IW.CW7
M*"7QDX6.?KTC7)Z-:Z;7A5AMX11N/:E;J/#Y.2S&DS)9N(C5E;W"0N;+=Y)M
M/\9*NTE7\<R/E*.5$1])D,CM6VW;MFQPJ-$Y=6WZ1BO5O_M+XMI:K4C',.58
M'#=ANWW<$YPKTC"":4K+)=(P3?IKZR>C[8*4M'IH]+>Q<YL=CYA;Y?:-)CR+
M1U"D14.J>1%89:0TTPEU2&^LR)/4HR2A)K4?2E*>$E=^T[;7M.!#!KDY=NK<
MM--6WJWIUT^Q+5Z)+J_4T%YGRG)YGR*_?\FM4NWM4:TW)0A"*C&/<TNY]-9/
M1)R<FHQ345A R)%@   DO4&;'K[8F-9.LS*)#G)9L"+@OZ1E?J7EFKI4HDL&
MHG#)/JHD=/J1F1X??]O>Y[5;BP_EM.Z/]5'JE^[Z?NZDY\<<EAQ/F.'N^1_F
M+O==OW5V)PE+TU^1M6=-&^W3T;1O=@S8UE#BSXCA.Q9C#4EAQ)D9*:>02TG]
M)F1*(CX,N?0_04.TT]'ZH[$(RC**E%IQ:U37HU]IRAX/(
M             :BO,^B54;3:F%/F26;NL38(AR9#S[,![N=N04)#BS;B,R#)
M)FVVDD]2369FI9\6SP2Y6;;95VQ4J[/SDDG)-:KN^+:ZZ-OTT7HC3;ZA\&6/
MRG%S/>MG7D8NOMRE*4*Y0EVOVTWI",THN48I)S4IMMS>E0A.#7X
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M5JRE5[D*[)QNIOCV]T579%*47-=8R;LA)N*T@FYK9 .VPTX
M
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MYJBE9K6H-N'Z9-:VQ<AH
M            !LI^,/'43]QYQDKZ6%MXUKB7&B$IV2B0U:9!D%%%:DM--$EA
M]E-1#G-.$ZHR2IY!I0:OJ11WGG.='%L;"CJI7YL6^BT<:X3;3;ZI]S@UI]CU
M>G1]BW[-/CT-P\S;KR&Y0E7MNP61AK*2E&[)R,>$9I+Y915,,B$E-]'.#C%O
MYH;P!J4=WP
M         !63S-M5TWBWN::VTA]:Z"DJNA:C2DD9!FF,8^\[RDC,UQV+13B2
M_ UI(C].18/BO'CE<_VVN3:2LLG^[7398E^ZXZ/[F:O_ %H;I9M'TQ<LRZX*
M<IXN-1H]4M,G/Q<:4NGQC&UR7P;23Z'FQ&\I^<L
M                                            FC_V'?\ [='_ *PX
MC7_SX_\ FS_[.6W_ /F(_P#QN_\ E>0N)*5(
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MU?[IH;YMOQK_ "/G?ATM81IC-II]TU3#5]/C%-0:]4X-,@028J<
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M]]CHSSAPFC?MAGR6-LX9^VT2:BEW1LK<DY)_&+BM9*2Z>JDM.L=5XMXTH
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MF=E2SLV[-FE&=ULYM+T3G)R:7Y-3GC)G%
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MA8VHM3@Z^WMKBW3P6(:J
M            ;IOBWH%1-?[;RGHDDF^S'&<?)Q:F_9N'B=+962FXZ"03WN&_
MSFDWC4I2>E3721'U&K5WZ@<SOW3;MOUCK5CVV:?POTLXQZ_#1^STZ>JEKKTT
M[D/V8.PRQ^'<KY/VV=N9N>)BZO3VV\.BVUJ*T[N]?CDYZMIQE7HDU)O:&->S
MM$
M  *0_(;8>Q\8<@C^^]F5QE^%U?8]U[?[H:)TFX*O[7<1[[H*H.5VN%<>U[G'
MZOJ*W/"=/N\ZKGV=WMXUTM=->W5*'=K_  ?S^W7I^=V_'1Z/?M"]P_!_3AE8
MWO\ M?B]WP:NWO[?>TG*_P!OMU7N:>S[W9H]/:]S3]'JO/H-RCH,
M                                                         )KE
M)3$\<Z-;KB.K(-UY4F R@G#<).'X+AQVSD@S;)IM"CSB$3/"E*69.<DDDD:H
MS6W9S*U13TIVRKN?^+7W=B7Q_P  GKTZ?+ZZ]+>R8QQ? F'.V2[L[E^8JXK7
M73!V[!]YRZ=J3_6..H:-N35FJBHIRA028J$
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ML^_96/1\DU%4VUX^9V^X_P!'.?XC)R)2C!]T(RK<X+OC*>WT4N;_
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MMS:GB;KM_17QLIL]5JXRC.+T7K\KBNY^B[H_:;(Q71LX
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M8LHBP
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M=&I/2]X<7+7U;KQ(.+71UN&GVNYXJDW3
M                                -</R=V<=C1V$TRD/'*L]K5UFPM*4
M''1'H\0RZ+*0ZLW"<)YQS(63;(D*2:4+Y-)DDE7KX"QYRY/F92:]N& X/[=9
MVU-:?#32MZ]?BO7KIUO_ +33<Z*O#VQ;-)3_ !61R6%T6DNU1Q\+,A-2>NO<
MWDP[4HM-*>K324M&@VQ.DL
M                           FB]_Q>-7?RS[Z_K'\<!&L7_AAG?V-P?\
M)]Q+;WG_ )B.-_\ *[DG^]_%2%Q)2I
M              GO<BWK7$]$Y9<,>WRJ_P!8NP;5Y;J7)5_2X9EV1X7AN43$
M\=YE]S'J-NH23AFIUJE0]ZDZ1G$^-J-&X;K@8SUP*<Y2@M.E<[J:[KJE\&O<
MF[>GH[G'^"79Y8G;N?&.%\FW6'9R7.XZZ[I-ISR<? SLK P,R:_.C)XN/'!2
MEUG# A=Z6IN!!+"DP                            ]AOQU:&9T/XU8K
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M=>?D3B$N$\HNV>,G/"DE;1)^KIFWVJ7VR@XRKD]%W.#DDDTE&(S!!@
M  _S&O-!_,*KY#/-#+<'3>L7V!>7_D)F[%YC\>6[,Q1=!OC)'H.3N2HC3AU;
M-7<.1C3*<-#;;ZVRZB4I)'0FZ.V.]95E.O?#)LEJOAI8^OW:/3J=C'$(XEO
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M\>UQ7\*2+Q?NO?\ 8&\HOY7</_K-=&6X!_F/(_Q6/]Y(;]2'^S>V_P"A;/\
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MFKER7CCG4E:DFC)8$O'UDKMJ0XE*DV7!J29*3SR7J0QF\ZQVVVV/YU25B_\
M%25GQ_J?W?0EO!>RSE>'AV-*O+E/%>J;6F75/&?HTUTM]4TUZKT,.4E2%*0M
M)I6DS2I*B-*DJ2?"DJ2?!D9&7J0R:::U7H1.491DXR34D]&GZIGY \
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MWH]47'QF>^SV'%ER:%<-^]I>\H-./<M5KK'Y>YK1S4-8*;DH-Q2;DH<(S@
M
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M?"$:X*N'2$4DOR+HB-WWVY-\\F]]UUDW*3T2UE)ZMZ+1+5OT22^P^(]CY
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MKZYU61_JH61C)>C]4=6/N8X
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MZ<&:3+GG@C\:GDXMM23*93*91LK2^E1H<84M:.4&1*09N-M*)9$HC_#C@_\
M)'E/4\'4 #(WL8GQH'W&2]#CLDTETVW''^^77P3;9H1'6GNK-1%QU>AGZF7J
M/&OP/)C@\G@                         U2?*?926<>T=4(-!0["YV/92
M2-'+AR::#@T6$:%\_0A+5[(ZBX^HS3_PI#8WZ?**Y9&ZY+U]V$,>*_)-W-_T
M81_H_:=4G[43<<FK;.%[3%K\'??NETEIU[Z(8$*]'\%VY%FJ^+:^PTXC9DZA
M@
M     ":+W_%XU=_+/OK^L?QP$:Q?^&&=_8W!_P GW$MO>?\ F(XW_P KN2?[
MW\5(7$E*D                                           "?\ 8)5F
M7:@U3G\):(5UBZ)FF<MJ>W,Z)CE!W\EQ'*X#[KLF.:+/';M4"6P2FC:DU?>2
M@TR?HB6T>_M_(L_:+=98U[695/IT5FE=U4DDG\MD/<A+1ZQM[6]8=;OYRMNY
M1XLXSS?$:IW?;E9L.;1I/2;QN[+P<VN4G..EV+D/&OK3@X6X?NJ#CD?+  EI
M2                           '[::<><;99;6Z\ZM#3332%...N.*)*&V
MT)(U+6M1D1$1&9F8\2DHIRDTHI:MOX'O779;9&JJ+E;)I))-MMO1))=6V^B2
MZMGO!UM*MIVOL+F7T-%?=2L8I9%K!;:6PW$GNP&%RF&VG''G$(;>,R+J6LS+
MU-2OQ/K>S(45Y=M>-)RQHV24)?;%2:B_1>JT?HOR'ZPMCR-PR]EP\K=ZU3NM
MN+5.ZM)I0ME7%V02;DTHS<HI.4FDNK?J9L.,90        ->OG%KIZ5#H]C5
M[!**O+[1=J;09K[#ZT^RD.JYX-++A="2(N>%J,SX27$^X+N2IRK-ML?RVKNC
M_5175?\ ?1_O/WFNGU"<6GG[1C\HQ8ZVX3==VGJZK&NR7Y*[.G1?X*V^D>FM
M<6F:@        !XF/!3"<3V3\\GFWK_.Z"NRG"\SS_SZQG*<<MV"D5MU17.Q
M,I@V5=,:Y2HV9,5Y23-)I6DSZDF2B(RJK:*J[^89=-T5*J<\A-/T:<GJC</F
MF9E;?X3V?.PIRJS*:-LG"<>CC*-4&FOR,K=OZG\H?@B\Q=N4>B,CMXNLMX:Z
MS"NU;DU]%;LJK(L%R%B:QC=C*1^MI9&W- Y7);-$AQEMY3C27G(C=7=JBR.!
MF1W#B&YV0PY-8]L)*#?5.+]']G?6_C^[IVST<@V.WC?FKB>+=O=<'N.'D5NZ
M$7I*%D6G-+^$J,F">J3:T>BD[:>Z-_O /X[9>E?C%\XO,S<U/,3N7>'A?Y*%
MKVMR&(VY9X;JNSU!E]@G)#=D]V<QD>T%=$I;BC2ZBH2PGDCE24#,[-LCQ=@R
M]TRD_P 5=BV]J?K&#A)Z_EGZ_DT^UD&YQSV.\>1MFXCM$U^J</=\3W7%]++E
M?6NSIT<*?S=/3O[OXL63I^Z]_P!@;RB_E=P_^LUT<S@'^8\C_%8_WDPWU(?[
M-[;_ *%L_P D*C?O0G]GCQ<_DCS'^O)D8WG_ /FS'_Q.7]Z)3]-_^PFY?Z*K
M_P C/9^+1-10             _;;CC+B'6EK:=:6EQIUM2D.-N(42D+0M)DI
M"T*(C(R/DC'B45).,DG%K1I_$]Z[)U35M3<;(M--/1IKJFFNJ:?5->AN:\:]
MTP]J8HU725*1E6-P8C-VSVUDTX@^8[$UISH)HD2E,F:4$9F@OI/DTF9T=R'9
M+=FS7'UQ+&W6_N6FL7\=8ZI-_'U^.B[ ?&G/<7G6Q1N;TWK&A".3#31*;4DK
M(]$NRWLE**6KAUB_1-V5& +&                           QW+<BBXEC
M-YDLU1)BTM;)GO*4E:D)2P@SZEI1]9H)7'/'!\?I+\1]:*;,BZ%%2UMG)12^
MUMZ+^B<7.S<?;<&[<<N7;B453LF_LA"+E)_N)-FB_8FR<GV9?2+K(9S[B%.N
M*@UI/N+A5S*S_B,-GTH4\M)%W'>E*EF1$1)0E"$WOM.SXFSXRHQDG8U\TVOF
MD_O^[[(^B^]MM]>'-.;[US?=)9^YS<<6+?M4*3]NF/V17HYM:=]C7=-_9%1C
M&/QE2'                                               <F'*<@S
M(LUHD*=AR6)327"4;:G([J74$LDJ0HT&I!<\&1\?I(>EM:MKE5+7ME%IZ?>M
M#D8F3/#RJ\NI)V561FD_36+4EKHT]-5UT:_*9!F\5J'F&2LQSZHIW5A(A*Y4
M9K@RY*Y<%:NM*%DM41]!J(R(R,S(RY'#VJR5FVT2G_*>U%2_JDM)?T4S.<PQ
MJL7E6X58[UQ?QELJWUZUSFYUMZI/5PE%M-)I]'U,6'/(V           !E^
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MB1VX]3Z@ ?-#++2G%MM--K=5U.J0VE"G%<F?4XI)$:U<J/U/G\0!]
M
M                  ?"4WWHLEKJ2CNQWF^M7\5'6VI/4K_QJ>>3 'GWS"+[
M'+LI@]SN^SR.[B]WIZ.Y[>SE,]SHZE]'7T<\<GQS^)C83;;/>V['MTT[J(/3
M[-8IG6IRO&_!<HW+#[N[V<_(AKIIKVW3CKIJ]-=-=-7I]IC@YI@
M                              S:A)-?BN8W*DJ)Z4W5XK7K/CI)ZVDK
ML[%Q"5L.(=-NKHULK,EI-OW23_%23+%Y>MVX8V,OS8N=LOR07;%>O36=BDNC
MU[']C)ALBC@\:W7=I)^[9&G#J?P4KYNZUI.+3TIQY5R^9.'O1?JXM82,H0\
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M*'EL'\RVX.?,]DRKF)"69<I5REZ3QTK</CZ3)KDT)_'^>/G@_0D#$AY/
M                     !I>^4FS8<S_ %/2%)6N5!P6UMW89D_VV(UQDLN#
M&E)4I!1C7+>H'D*)"C61,)ZR(C1SM3X HG'8\_*<5[<\N,4^G5PK3:^WHII]
M>GS=/B=,'[3K<Z+?(W&MGC8WDT;);=*OYM(QORIPA--KLUF\:<7VMR_1KN23
MAKJW%^G64
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M8^X<>S(REC9>/)RIOC&3A/M;490G"2[;:;(PMJE\MD(MK7XCW/B
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MA.4STM$VY+<[G342EJ(Y32#CK+O-)<D>K^;K\3SZ="<1ZGD
M   "._VL8!_H_P#^FJZ_TN'GM9XU1^D;5P%:TH3?I(UJ2DC76V[:"-1D1&IQ
MRO2VA/)^IJ,B(O4S#M8U1FT"P@VD5J;72V)L1XC-N1&=2ZVK@^%)ZDF?2M"B
MX4D^%),N#(C(>#R=;?9-1XRS'?O)OLFI3BFF%>VER>MQ">M2>F)'D*3PGUY,
MB(>4F_0\-I':PY<>?$BSHCG=BS8S$N,[T+;[L>2TEYESH=2AQ'6VLCX41*+G
MU(C'@\G)
M                   &(Y["N;+#,F@X]+]A=R:B8W6S.%*[$HVS-"S0@R6X
M7!&1I+^,1\?I'VQI50R(3OBY4*:<E]L4^J_=70X6Y59E^W9%&WV*K/G3.-4V
MM5"QQ:A-KXJ,M&U\=#05:1[&+93X]NB2BT9F2$6*9BE+E%-)U7N3D+6:EN/*
M>Y-2C,^HSYY/GD;#8\Z;*(3QNUX[BNW3T[=.FGW:? ZS]RHS\;<+Z-T5BW*%
MLE:IMN?N=S[^YO5N7=JVVWJ^NK. /J<(
M          ,UNB^WXCB-7QT/62[C*I1&GAPVY<I%'6(=,VFU$AMBB=>:3RLN
MF4:R/A9$6,Q?TVY9-_K&"A4OLZ+W):=?B[$GZ=8Z? EV[K\#Q;:]NTTMR'?F
M3Z==)S6/2G\J>BCC3G!:RZ7.2>DTEA0R9$0
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M]%&3TA="$GI&<)>GI.+])+7&!SB.@
M67\.<=+*/)W3->:264#+V<JX-TV2+\CP9N:=9J(C-1-_8.KH+^B<='\\(1Y)
MSOU?P7<[_3NQG5Z:_P LU3_]D]?AZ_ V(^DOCW\Y_J/XAMNFOM;O#+_.[?\
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M:]VO?W7Y>3W::+MT_$=G;K+\SNU^;MCKT%RF@H
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MFU_]\-S_ ,?_ /K1_;9__!GB/^YW_P!N'[9O_74:7_J%_P#4H'\VO_OAN?\
MC_\ ]:/[;/\ ^#/$?]SO_MP_;-_ZZC2_]0O_ *E _FU_]\-S_P ?_P#K1_;9
M_P#P9XC_ +G?_;CL+/R&R^?*.1%PS0](R:$(*#6>.FC78J5)(R4Z2[G ;>;U
MN?SW+QI_@(A\:.'[=57V69.ZVRU_.EN.<G^3Y+X1Z?D.=N/G;E6;DN_&VGA6
M'5HE[=/%N/2@FOCK?MM]FK^.MFGV)'7_ +>LX_T"TQ_WN'CQ_>N'V_FIM?\
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MZ?E[2A_.W"[-^V*'(-OK<]RV]/O2766.^L_O?M/YTOA%V?%FKH6X:6@
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M"?7XM-F(^4/QZ^'_ )G7V+9/Y*ZA_:1>8743*'&9WY^VAA_VVJL)A6$N+[;
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MTHP7P2T7[R-.K[[\FUWY,YV72TUE)N4GHM%JWJWHDDON6A\1['R
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M5P3ID?/!&7E]5J>%T>AE&]_^5-#_ .C&3_E8AXCZGF1*V(?]*6+_ /6[2?\
M.R,/#]3RO0R(>#R
M                          !K)\Q]+RH-L6R\:JB^TR8[;.1,P(S:41)#
M/696;R6_UBB<0?2XKCA#:4\<(0LTV1PG>X1B]HRI:-RUK;?V^L%\%UZQ7Q;:
M]6M=7?/7 ;[IQYIM%7=&-?;E1A%:I1U[<B6G671]ECZ]L8P;^52:H&+)-5P
M                                   /JRR[(>:CLH-QY]Q#+3:?XSCK
MJB0VA/\ -4M1$0\2E&$7.3TBEJ_R(^E55E]L:*4Y6SDHQ2]6V]$OW69;GK["
M\HGP89H.#0HB8W#-LT&TXUC\5FJ<DM*;-27$3Y45R1U\\K-TU'ZGP,=M$)K
MA;;K[MS=LM?5.QN:3_J4U'3X::$HYM=1+D=^'B:/#PE#$KTT[7'&A&ES36J:
MMG"5NOK)S;?5F&C)$3
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MWKC^7^ W[#RL'/TU]O(JLILT[I1U[+(QEIW1E'733NC)>J9U Y!BP
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MYQU23E^ENLEK)M_-VZ]JBE2X6<:?
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MCDM8JS1Z2:U7J_4P@90AX
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M_P#*FA_]&,G_ "L01]1(E;$/^E+%_P#K=I/^=D8>'ZGE>AD0\'D
M
M  #%\UIW\@Q+(J6-V_<V53,BQ^\7+9/N-'VE&1$H^I+A$9?^.X_#\1]<>Q4W
MPM?51FG^\]3A[AC2S<"_#BU&5M,X)OT3E%QU_<U-!M_16>,W-C0W,9<.SJY*
MXTMA9&72M)$I#B#4234R^TI*VU<<*0HC+\1L)B95&=C0R\9]U,UJG_<I_>GJ
MFO@TT=:F\[/N&P;I?LVZ0=>?CS[9Q_>:DG\8RBU*,O246FNC.G'(,8
M                             9E@2&TY/"LGTH7&Q]F=DSY.=)MK_+\)
M^UC,+2IQDG/>38S3"4=2>M3A)Y+GD8W=VW@3HCKWW.-2T]?TDE!OT>G;%N6N
MG1+4EG"80CR*G<+DG1@PLRY:^C_"URNA%IN.ON60A6HZKN<U'5:F(.../.+=
M=6MUUU:G'77%*6XXXM1J6M:U&:EK6HS,S,^3,9&,5%*,4E%+1)? BUED[9NV
MUN5DFVVWJVWU;;?5MOJV_4_ \GH
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M4HRBZDXRBTTTTFFFFM3!!E2&
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MV*LG"GC6>U3D_ALVI9JKA?&ZRJ>#=&>39K"4H'$K*6
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MZZFB?G':8[7Y R+8)JO,IKO777K).N;75M:SKD]'IHWT7;VE>A*2H0
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MB/,I2D]9-MZ)?N+HOWET1Z0KA6NVN*C'5O1+3K)N4GT^+;;;^+;;ZL[D>#W
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MU6D)6,V;BON=4V?LUO*(G),!LR1V.%<+-Z!Z),O4S;X_X4PDOB>(OX'"WO\
M\J:'_P!&,G_*Q!'U$B5L0_Z4L7_ZW:3_ )V1AX?J>5Z&1#P>0
M
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M)+31455RUB^Z-SBGIW&$C*$/
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MNLH*>+9IKZ3=B2T];V"G3?
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MXV=?+'E.RRS+GE69+]JMU4PK@)F4$
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MS8_LTE_UHT7_ )WLQ;? _P#8>S_1,O[Q6:8_45_PVQ?[%5_Y/DE1!-B@P
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M@0#G[7X/'7Q]R7]Y-DOIOC)[UN<M'VK%K6OPU=CT7[NCT_(S:B*M-N
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M_>D4OR3G?..924N7[SNNZR333S,O(R6G%.,6O>LGUC&4DGZI2:71LPX9$B@
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MV]TE&9?M"$-H0VVA+;;:4H0A"22A"$D24H0E)$E*4I+@B+T(A!R_C]
M               #HJG&:&A<>>IZN- <?0EMY;"5$;B$JZDI5U*5Z$KU'G5G
MC1([T>#R8VWB&-,V16[-/#8LBD*E%,92MEWOK,S<<_5K2GEWJ/J+CA1&?//)
MCSJSQHO4YMM0T]\VRU<5[$]N.M3C*'R49-K4GI4I/2I/J:?0>-3SIJ=C&CL0
MX\>)&;2S&BLM1X[*.>AIAA"6FFT\F9]*&TD1?S" 'V
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MIW=S>$C*$/
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M*4[Y2Z+L3;5?R*),8B1=H
M                    !]&7X\5UN5+?9C1(JRE2Y,EUMB-&BQC[TB1(>=4E
MIEAAE"E+4HR2E)&9GP/:$)V35=:<K)-))+5MOHDDNK;?HCY7Y%&)1/*RIPJQ
M:H.<YS:C&$(K64I2;2C&*3<FVDDFV]#R,R9,F;)D3)DA^7+EONR94J2ZX_)D
MR7W%.OR)#[JE.O/O.J-2UJ,U*49F9\CLBA"%<%76E&N*222T22Z))+HDEZ(_
M)MD9%^7?/*RISMRK9N<YS;E*<I-N4I2;;E*3;;;;;;;;U/@/8^(
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MYRHLTAD**?X>4H1N['.">/SL SNK>MH]GA.75TB@[OWUB=C=S$>I?;H<<?\
MNS4B$VNN[*&5FOO$CI))F?X&.95N^U7QKG1E8\X7:=CC9!J>NFG8T_FUU6FF
MOJC!YO".:;;;E4;CM&Z8]^#W?B8V8M\)8_:FY>^I5IU=JC)R]SMT2;?HS*G-
M#;R:K2NG=,;7;ISBM32MG-=9>BM.&\A#C,LIZJ<HIQ76W$J2YU]"B41D?J.
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MO/Y)GYNX9[<F[,F^V^QN<NZ;<[93EK*3<I/764GJ]6=$.484
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MR^Q<;V;CFWT[9M-$*\?'4E%M=T]9Z.<G-_,Y3:3D]>NB6BBDE8D<$SH
M
M                                         %-_-N' D:HB29+B43(%
M_"=K4&VXM3KKZDQ9*4*2HD,FF*ZI1J41EP727!J$MX3.R&^QC!:QE7-2Z^BT
MU_=^9):?N_ IGSSCXUWCVVR^25M653.M:-ZS<G!I-?F_HYS>KZ:+M]9(U*BY
M#1L                                 .3#B/3Y<6#&3UR)DEB)'1_P[
MTAU++2?0C/ZEK(AZ6V1IKE;/I",6W^1+5G(Q,:[-RJL/'6N1=9&$5]LI-1BO
MW6T9+G4QJ7E=PF,LUPJU]%'6F9=)?;*!AJFKU);-MHVDN1(*%=)IZB-1]1FK
ME1\'::Y5[?4YK2V:]R7]58W.7Q>O636O[VBZ$@YGE5Y7)LN..V\/'FL>KX?H
M<:*HJT6D=-85Q>FFJ;>K;U;Q$9$BX
M                      9GEYE'9Q.G2M1IJ\2JWW$=2E$4G(G).5*<,NAM
MLW%Q;ME/*2,R;;0E2C4@^,9MOSRR,E^MF3)+\E:56GVZ:PD_RMM+1DMY2U15
MM>U1;TQMKIDUJW\V4YYC?HEJX9%<=5K\L8Q;;B],,&3(D
M        'U99=D/-1V4&X\^XAEIM/\9QUU1(;0G^:I:B(AXE*,(N<GI%+5_D
M1]*JK+[8T4IRMG)1BEZMMZ)?NLV/+93&,HJ%FXB(AN&APS(S<1$;3&0X?'H7
M6EHCX+T+D:\6V.VV5KZ.4F_WWJ=G.'C1P\2K#@VXU5Q@F_5J,5'5_ET/R/F<
M@
M P?9]HW1:PV;>/-+?9I-;Y[<NL-&E+C[=5B5Q/6PVI7TI6\F.:2,_0C/D9KC
M>.\OD6!B1:4K<VB";^'=;%:_N:E?^6=TKV/Q5R;>K8.=6'Q[<;W%-)R56'=8
MXIOHFU'1-]-3RG#L,/RU@
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MK;\['Q<S&Q]QQ[K,>RNI^S)X]\?=G%*4K%D8TJHIOY86R70]"XUK.V<
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M9[:G5')L]JV$-6E7;5V65Z2E%URBXRE%IN,1G"NP
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M1]F5$E,M28LJ,ZA^/)COH2ZR^P\TI3;S+S:B4E23-*DF1D? ]3R?8
M
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M_P"Z_4SW,\FO+Y7N%E+UQHY5E=;Z]:JG[56O=UU]N$===.OP7HL3&0(P
M                   &9Z[@HL<ZQ.*Z239.^KGWT+(S2ZQ$D(EOL\$9>KS3
M!H+U_$QC-[N>/M&3;'7N5,DON;6B?[C>I+N X,=QYMM6)9HZY9U+DGZ.,)J<
MH_\ ?*+7[I>]2C4I2E'RI1FHS]"Y,SY,^"]/Q%#'8N?P
M                                             0;Y-V,FJ\=MV2XG
M03RM;Y+7*-:.M)1KN&='.^GDB):H-BXE)_SJC(_Q(3'Q]17D<WVNNS7M697+
M]V#[X_\ A110WU1;CD[7]/',<G%:5LMAR:7JM?DR(>Q9^ZZ[))/X/1_ \Q W
MU/S2
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MMNK>KUA.)APR)%
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MG%?K75&/[L8I,ZS^1;DMYW_-W=:]N5EVVI=>BLLE)+KUZ)I+[$M#HQRC#
M                      &W?P[P.OQ_6D'*E0%1<@R9,@YLDUG_ $Y5IEKD
MTZS;,B-))C.D:?YBC,O0^3I?E^?9E[Q91W]V/2^V*^"?;'O_ '>Y/7\AO=X6
MX[C;+P?%SO95>YYT/=MEUUG'W+'1KK\%5-..G\9OKJ6[$6+<
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M%R*KL[-WX[LV7)1[OY>6VXU.8VI:]O=FT9,X1BY05<H=O:ODC" DY3P
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M(QS)N\#4XZ?<4]0DI4JO3U.&JM4MLNA$3@_9]5K\3QZ="8QZGD
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M3VL=01<;;CWNHLFRK&XE>6=PLD-$1^0B<VX;CBVR:=94L#=<
M
M Q[+;QO&L9O;]TR2BIJY<WD^WP2F65*0?#JVVU'U\>AJ(E?ASZCZ4U2ONC3#
M\^<E%?E;T1QLW+JP,.W.OU]BFJ4Y:::]L(N3TU:7HOBTOM:-!>2Y%:97>V>0
MW$EV586DMZ4\MUUQXT$XLU-L-J<4I1,QT&2$%^A)$-@\+#IP,6&)CI*J$4OR
M_:W][?5O[3K5W[>\_D>[W[SN4W/+OL<GJVU%-_+".OI""TC%?"*2.B'*,0
M                               &:P"]A@V03C+AV^MZK'HZNGCJA5R5
MWUPGK-KUZ)C=8?2E?'KRLO1!C&7?IMVIJ_@TUSL?]5+]'#X_Q7;ZK\C]278*
M_ \-SLQK])FY5.+%Z>M=6N3>M>WX6+$Z*7QUDOS&84,F1$
M                                       ,SU^GIRVKGFDE(HBG9,OJ
M)TT$G&*Z7?EUDU]:B4NN)))Y3UF9)ZD\\EC-X>NW64_&[MJ^'^"R5?Q_JOW/
M71DMX-'MY1C9NB<<)69;UUTTPZIY/7MZO5U)::KN;4=5KJL.4I2U*6M1J6HS
M4I2C-2E*4?*E*4?)F9F?J8R:22T7H1.4I2DY2;<F]6WZMGY \
M            !,FBH1R<\1,(E_YT4ES.,TK0@D^YC%2)-9*^I:>NW(B)'U=1
MD?\ %)0BO,[E5L<Z^GZ6R$?WGW]/[I\?[G0N3P1@/,\A4Y"3TQ,:^UZ-+36'
ML==>K6MR6D>NNC_-3+>BG3>$
M                         "HGGA.B0_%+:3,E[M.VKF#5M>CMNK]Q-3L/
M%;=3/4VA:&N*^ID.=2S2GZ.GGJ4DCL[P]39;Y"PIP6L:XWREZ=$Z+8:_?\TH
MKIJ^NOHFS3_Z\<[%Q/I=Y#CY$^V[*MVZJI:-]UBW+$N<=4FH_HJ;):R:7RZ:
M]SBGYT1NP?GK
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MJYIO(G-N5DW4D6":P
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M)^C:*=\U\OJXYQ*S;:9:;MN*=4$M=8U]/>L>GP47[:ZI]UB:349::E!<IHN
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MO_[H;_O-N%_[(#>W_/RK 'I^
M                                      !$._?["VS/^M&V_P#.!C)[
M+_LQB?Z)J_O<2+<Y_P"!.\?V*R_\@L-%8OXZW@
M            #-LH)$"GPVB0I)N,4SF0STET$:+#*'4RV24E"25U*QZ)7GRL
MS49&7\[TD6+P-;LG)RWZ.WVX_P!34M'_ .Z.STZ?NZDPY(H86T[3LT&G.&(\
MJU=.EN9)3CKHM>N+#%>LFVT_XO:EA(RA#P
M                           S3&R*+0YO:J29FBF@TD9?2HT-S+RWAJ6:
MU=:$<JJ*V8E*3ZC,SZB3]!J3C,[])EXN.GZVRF_ZF$)?^SE#7T^S7KHY;Q]+
M'V7>-RDFVL2O'@]'HK,B^MO5ZI=:*KTEU>K[DOE<HX6,F1(
M            LCX]PN5Y=9FE/ZJ/3U:%FWRL_>R)<UQ"'C+Z6R^U(-:2/U/H
M,R]"%?\ /KM*,;'Z_-.4O7^*DEJO^^>C_*;+_3A@]^X;IN;2_1TTU)Z=?TDI
MS:4OL_1+N7Q?:WZ(L@*S-K@
M                        *%?)#:_;?&U$7V_>._V7B%+W.[V_:=NJRO(#
MD]':<]QU?8.ST<HX[O5U?3TJN7P7C^_S65NNGLX-L]--==9U5Z>O3\_77KZ:
M:==5H/\ M'=U_5_T^4XGM]_X[D6'1KW:=G;3EY/=IH^[7\/V=NL?S^[7Y>V6
M@L;@G1&
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M7DGE=W+N6Y6X.:E@53=..D]8JFN349+[?<>MC>KZST3[5%*+QFB!
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MTR\@V/<N,;]F\:WFOVMWV[+NQKX:Z]EU%DJK8ZKH^V<)+7XZ&0#DF(
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M%H<0EQM25MK2E:%H42D+0HB4E25),R4E1'R1EZ&0]3R?H
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M_L@-[?\ /RK 'I^
M                             !$._?["VS/^M&V_\X&,GLO^S&)_HFK^
M]Q(MSG_@3O']BLO_ ""PT5B_CK>
M#GU=>];6==51O619SXE?'+@U?KIDAN,UZ%P9_6X7H/ED71QZ)Y$_S*X.3_)%
M-O\ N#F[;@W;GN./MN/_ )HR+H51_JK)*$?Z+1V^96+-KE-Y,BJZH/OW(E:?
M63G%37$FOJD]9.O(/HKHK1?0HT>GT\)X(N-ME,L? JKL_E>Q.7]7+YI_!?PF
M_5:_;U,IRS/IW+DF9E8SUPO><*>NOZ&K2JE:ZR72J$%T;CT^72.B,9'.(\
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MSI+Y\C.GIU_@5UUQ73X/N=GY5H3"(47R
M                                 !K*^4.>\UJS656F3T1Y^P+&>[#Z
MDE[EZIQU^.Q)Z#^M?L473B>2]$^X]?XQ"_O %,9;WGY#CK..+&*E]BE8FUK]
M_8G_ -[]QUD_M.L^VOQWQG:U;I1=O5UKKU7S2IQI0C/3U?MJ^4=5T7N=?5&D
ML;4'3"
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M=R/:>-)+CF+OVX4XB3;7X:O+MA1HWU:]J,=&^K7J1V,P0,
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MY6ZW;UDQ4M&J9NZ5$4^Z54<NB"34>Z/T^1'%+[Q$\W->^5& Q6SK\VM(.=E
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MG[IQ3:%8]YY!QK%E4EWPGN^W3NBY-)1>-3D6Y*E\R[H^SK!:RGVQ3:^5#D>
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MG#JZW9=96Y=KLIE%2A/8!YH[:I?$OQ(RN?A$:'B4QNCC:OU16T28E2U1WU[
MDUM._1QTI2RVYBE3&DV;32$*Y* ?)<=1E9?/=ZQ^%<)NLV]1HL5:Q\:,-(]D
MYIQBX+T_1Q4K$DOX!J3]-7C_ '/Z@?J#P,7D\[-PQGE2W/=;+^^UWT461LNC
M?)ZMK*ME7C2DY+1WK1ZZ)^?SP[Q_SMU+7S-L^-^F+"\K=C4Z:N/ED[%X=TQ+
MIJJXE(E,5)3;*(3,>1;P?UJC;,W%1D&DR3SU:T<&QO(NRU2WKBN!*RK*K[58
MZU-.,9/51UDM$Y+KTZ]JTZ>O;?\ 49N_TK>0,NOQ_P"9^2TXN;LV3[LL6&3.
MF4+K:8N,K>RN>LHTS^1=R[59+N7=^;*_DK'^2[R)P-FCW5H20]CF(V#N8QK:
MOPJJIK*E<KZR<Q/D(LHMNIXJ]VMD.>X842VG#0VLTFXTTI&:Y9'RQRC;EC[_
M +:WBT2]U2C5&,H=L6F^Y2U[>UON75/1/35)J >%+OHG\.\JENGC/ED([SN%
M*PY569MMU=RLLA*$77*I1]Q61C[<TU*/=.*EV634M@GPZ;Z5GVCK[3-U.<?R
M#3-HVNF]W(:6])P3+9%A/K68Q+XF2&Z&\CS6%F?6B-'?B-$I*#;05F>#.2/<
MN/6;#D2;R<"?RZM:NFQR<4OB^R:DGZJ,7!=%HC4;]HUXHCQ/RCB>2=MJ4-HY
M)0U=V1:C'.Q(UUV.6GR1=]$J9Q_-=ED,B;4I*<GN#%XG76
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M=_AJZK,;&%,K([-AF>%8!=JL&&HZB?0JN2VE1ET.++U(#<>
M
M "L_E+L''\5UADF/V$I/W;*Z>955L))\O.*DMJ;)XDER?0TKA2S_ (J4%ZF1
MJ02L_P :P,G-W>F5,6ZZ;(3F_@E&2?7[WIHEZO\ (GI7/E3D6U[#PO.KS[%'
M(S<6['IA_"G.RMPZ+^+#N[IR]$M%KW2BGIE%Y'7V
M             &;8(:8EG8WRU&@L7H;2[94G@C*Q-#=31GU$_'<02+ZUBJ,V
MS-PB+T(OXQ8O=M;*(8BZ_B+H0?\ 4]9V?!K^3A/UZ?;]CF'"W'&W'(WN3:6V
MX5V1%K_#=%1CO7NBUIDW4MN+<M%T7Q6$C*$/
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M)-O_ %;X\VRIK2RRJ5K?;VM^]9.R+?V_)**4G^=%1:T6B6:# %C
M                                                     :A/E1LX
M[DK1E(E#WNX,38MP\XI*"CJC7,C"X$5MI9.&XI]#N/O&X1H2DDK1P:C-1)V:
M^GS'G'&W7*;7MSGCP7VZP5S>OPTTL6G7X/HNFO4+^U$W.BW=N&;-%3_%48^Y
MW2;2[7"^>#7!)ZZ]R>--R3BDDX:-MM1U(C8PZI0
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MF\X':H*Q.S*VG,KQ9.#]55F/'OUC\\74I5ISC%.#1*2FP
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MY+BC=*0A*DJ2GMD:34OQT^!Y.Y
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MSU<>G;T;U:6%#)D1
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M6U[/B;8DHK'Q:JM$VTO;KC#1-]7IIIJ^K]3[#CF2
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MWC:,)J6!LUE.SU37I95LF-3M%5WY\^MU>%&U_.UK-Z:+HH4$F*A
M           -NOQ8>7=QJ?.Y&E<F?3(UIED;)\H8DR5)3^4;;'<<E9'=V"I;
MKZ.Q12<?QZ2MULD.]$M*%(2@GI"SHCS5PFG=-OCR?!36[TRJJE%?X-"RQ5P2
M276R-ED4GJM8-IM]L$NR7]GY]0F=P_D]GA[D<T^$;A7F9M-LM%^!OQ<2>5D3
ME.4EVXMF-BVN<$I=E\83@H*S(E+T]09T.SAQK"ODLS(,QEN1%E1W$NLOLNI)
M2'&UI,R4E1'_ , :F2C*$G&2:DGHT_5,[L:[*[JXVU24JI)------:IIKHTU
MU371HY8\'N53\G_,'4?BOC16N<62K#(9S3QX_A=.Y&?R&[>9=C-/=B.Z^RVQ
M'B^[2X\ZZMMM"/0U=2VTKEG$^&;YS+-_"[36O9BU[ELM576FFUW-)O5Z-1BD
MVW\$DVJ6\U^?/'G@;CZWKFV2WFW*7X;"I[99>5*+C&7M5RE&*A#OB[+;)0K@
MNG<YN$)>9_RS\_MP^4DIZG?E/X+K,C236!4M@XMBR-I]UYN1DEBVS$?N#,U-
MG[91%$2IEI9MK=;)T;9\(\7['PY++GIE[W_ATXZ=FJ2:JAJU#X_/UFTVNY1?
M:=)?U$?6+Y%\[RGLF.Y[)X]>G_D^BUR>0XR;4\R]1KE?ZQ:HTCCQE"$U5*V"
MM=$19AJ&               3EXXL/3MO4-,Q#78*R>BV%AKL)EN0[)E1<TUS
MEF*3683<527U6"X=RY[?IZN'^@S2LN4G%N9RC5QVW)G)05%N/<I/1).G(JMB
MY:].W6"[OZ77JO4N3P%3=F>4L+::*G?+<<+<\!UQ4I3G#/VK-PK(UJ#4G:Z[
MY>UIK^D[?EDOE<&B4E-@                                    9WJ[
M)F\*V9KK,G5LMM8EG6(Y,XY)9D2(Z&Z'(*^U6N1'AF4M]E*8AFM#1DXI/))^
MHR&*WW!>Y[)F;;'5RR,6VI:-)_I*Y1Z-]$^O1OHOCT)GXXY%#B'D/8>66.$:
M]KWK"RVYQE**6-DU7-RC#YY12AUC#YFM5'KH?#9&,_DK8F>X;T=O\I9IE.,]
MOO>XZ/L-Y.JNCW'!=_I]IQU\%U?C^D>^RYWZSV?$W+U_$8U5OII_*0C+T^'K
MZ? ^//\ CO\ -#G>]\3T[?U7N^9B:=W=I^&R+*=.[^%IV?G?'U,+&2(D
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M
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M\FK?<Y)82,H0\
M      ,PP%#7YNII3Y$;%0Y*R)]*OXBF<:@RL@=2XDFW5+;4W6&2DI2:E),R
M+U,C&-W=R_5UM<?SK$JU^6V2K7Q77671^B]62OA$:_YTXF3=HZ<64\J2?HXX
ME<\J2?23::I::2;:U2ZM,Q)QQQYQ;KJUNNNK4XZZXI2W''%J-2UK6HS4M:U&
M9F9GR9C(QBHI1BDHI:)+X$7LLG;-VVMRLDVVV]6V^K;;ZMM]6WZGX'D]
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MY')$/D<P_('@
M     - _R.6A3_)6="*:N4=#A&&5:HZGG'4U9R:]V_3";0LS1'0ZW=E*-".$
MFJ2:C^I2AN7X3QW3P6NQP4?=R;IZZ)=VDE#N?V_F=NKZZ1T]$CH+_:%;G'/^
MI#+Q5<[7A;3@TN+DVJ7*IY'MI/I%-9"N[8]-;7+\Z3*'"VS1\
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M_P L:YX>1CJJ&9M5M:T:GM[LIC78N^-^+;C7*VV<[&JZ"8E"@
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M\OYSG79^^W]'.;2C"";<:J:XZ0II@Y/LJKC&";D].Z4F\"&5(8
M      !*.C[9N@W5J"]>97(:I=HZ_MG6&U)2X^W6Y94S%LMJ5]*5N)9-)&?H
M1F,%RC'>7QG<<6+2E;@Y$$_L[JIK7]S4L?PYNE>Q^7>*[U;!SJP^2;9>XII.
M2JS:+'%-]$VHZ)OIJ81DE/\ E[(K^@]Q[O['=6E/[OL^W]U]LG/PO<=CNO\
M8[_8ZNCK7T\\=1\<C*861^,PZLO3M]VJ,]-==.Z*EIKHM=-=-=%K]A#^0;5^
MHM^S=D]SW?P>7=1W]O;W^U9*ON[=9=O=VZ]O=+3735^ITHY)B
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M<+Q>?>5<?:Z>/9FZ5[?6\;,AD3>1;1DY,$X1BFH>UB7-RUT345_"(+&SYIL
M                        6"\?=#V6ZK^R7,D6%#@&*0SL<SRV)7(G*A$Z
M2FZBAK&Y,F%#D9!D=ATL,(4[^I9[LE2'$,*;5$>6\JIXUBPC5&%N[Y$NVFIR
M[==.L[)-*35=<=92:75]L$TYIJ\O!OA7</+N]Y$\NR_"X/ME7NY^;"I6>WKJ
MJ,:I3G77+)RK=*ZXN?Z.'N9#C.%,H2VE-L0*VFQK&ZAV\DU&)43./ULW)K4[
MO()T9F;/L%2K2Q-F.A3BY-BX3++:"9B1DMQV_P!6TD4AK;;D7YF0JED9%KLD
MJX=E<6XQCI&.KZ:16K;UG+NG+K)G9#"K"V_:=OX_M<LRS:]KPHXM5F7=^(R;
M(1LLM<[K>V*;<[9*%<8J%%2KHK^2J)\Q[GS  RC"8[<S,\1B/$9LRLGH([I)
M/I4;;]K$:<)*OYT^E1\'^@<#=9RJVS)LC^=&BQK\J@V2/A^/7E\MVO%NU]JW
M<<:$M.CTE=!/K^1GH&9:2PRTP@U&AEIMI)JX-1I;22$FHR(B-1D7KZ$-?3LG
M/H    #_ #J_BE_>XO(W)_+S#M<?);?:H;\<=GQSPE.RL4PB!KUS3F>V=C7?
ME7.\ML69TB#-UNI2'J^[)Y+/VYJ8W9^X2S!?CR@/]$R)+BSXL:=!DQYL&;'9
MEPYD1YN3%EQ9+:7H\F-(94ME^.^RLEH6@S2I)D9&9& /'E\Z7S4><7@+\J_B
M'XC^/-]K>MT[N74^@<OS:%E6O*_)[]^YV'Y';=UGDBZZ]E2V7Z^.[BV&PD,M
MI29-/)6X7)K,@![%0  'CJTQ\U'G%G'[RQ<?%[?7VMW/%.%MC?6(,5$;7E?&
MS8J;7OC-L7:6.(5F:99S52&LLQJ*MYSM\NL$IL^"5R /8J
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MJ4M%W2UEI'719L+%(R
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M&AM!&I*5'T\J+DS'IM]$L7"JQY];(UI2?VRT^9^K]9:OUT^SH<CDFXU[OO\
MF;E0DL:W(FZTO2-?<U7%=(OY:U&.K2;TU:UU.@'+,(
M                                   &:XOU1*;-[8OQ9Q]BG9_HO_'-
M];P(SG5V^E/1]I8E\=2B^OI^E1<D,9GZ696+C_;<YOT]*X2?Q_IW#X>FO5="
M7<<[L;:=XW->L,&-$?SOS\F^J#UTT6GL1O\ 5_G=O22U1A0R9$0
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M_%)4@^%I4D_QX41I/_P#X,?,Y!_
M          'G'\Y+1NW\J=M26FEM)C3\:IC2X:34MS'L)QJA>?+I]"1)=K5.
M)+\22HB/U(;R>*L=XWC_ &VN33;KLG_CEUDTOW%+3]P_.;]:6Z5[O]3O+,JN
M+A&&5C4:/1O7&P,7&E+I\)2J<DO5)I/J5.%A&KH
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M:"CCW[?N>[62Z=TLK,W;*VN?HE\D<;8L-13U?<['KHTE!PE!3@
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M-V/!R=_SLFEQ3C%X^7D3R<=J+47'6FVMN#BG!_*TFB%Q)2I
M                        )OVKT6.$:"R1OL&[*UC98Q;*:]PA1W&';'SB
M!&0ME_\ 5)Z,-F4Q=;/ZIQ?49_K2<$8V'6G<]VPGKVQSHVPUT_,NQJ)/JNO\
MLKNDNJ6G\'M+A\E=F?P_A&_P['99QVW$O:[D_?P=UW"N"<9=.F!/ ^:OY)2[
MF_TBL(0$G*>                  #(\3Q/(,XR"MQ?%ZU^UNK5\F(D1@B(B
M(B-3LB0ZHR:C0XS1&XZZX:6VVTFI1D1"'\]Y[Q/QCQ/,YOS?,JP.-X%7?;;/
M]Z-=<5K*RVR34*JH*4[)RC"$6VD3SQEXRYQYBYQM_CGQSM]VY<NW*Y5TTUK]
MV=MLWI"JBJ"=EUUCC757&4YR44V;J-7X1@'CGCF.8:JU8<R3-;EF*Y/>;)-I
ME>0G'3W2BQD=QV/35$9)]M!J-F,A7*E&^^9N_FU\W>3/*_UA<QWCR+# MAP[
MC6VSMC1"3>-M> K'VNVR7;&S,RK&N^:BK<B<4H0CC8T8T?KD^G3P_P"$?H*X
M#L/BBS<J;.?<NW:NF63."69O.YNM=ZIJCW3JP,*I-UP<G3B0FY662R\R4LB)
M?/?^P_C?\I5/_6OF(OS]E3_UA=Y_Y&9?^^6T&L7[:_\ ZJ^P?_I P?\ >C?3
M4<._X_+X                       %@/'S1DW<^4J*S?GT.NL>4U*SG+HL
M=EY<",MMYR%1U"92VX\S)\B=CFQ$9+N&TGKDN-J8CN\1+EW**^.8/Z!0MWF[
M545-M=SZ*4YZ=556GW3?37I!/OG$O#P9X:R_+7)&MQG=A<"P&I[CFPC&3K@U
M)UX]"FU&>9E2BZZ(?.X+OR+(.BBW3:;!8IL=QFHP7#JM&/83CZG7:VH;6EZ5
M-GOI2W+R'([ FVEW>2V*&R[TE:4H0DB:8;982EI-'S>1EYMFZ[C8[MTN24IO
MHE%=577'KV51^$5JW^=-RDW)]DF'5M.P\>Q>%\4QE@</P6W50GW3LLDDIY65
M;I%Y&7:DO<MDE&*_1TPJIC&M?(>Y\@   [[%VWG<FQUJ,2U2'+VH;82V?#BG
MEV$=+1(,C(R6:S+C^:.)GN$<&Z4].Q4SUU^SM>IFN-PNMY#@5XZ;R)9M"CIZ
M]SMBHZ??KIH>@J E2(,-"TJ2M,2.E25$:5)4EE!*2I)\&2B,O4AKR=F!R@
M  ?XNOQ@_%5G?RBX7YIUFE[:P/??CCI_%=MZJP!!4Z:C;LF1D\NGR+7<J?;2
MZQ%%D%K6$EVFG*E)BIFLE&DM]N3[F(!Z_OW5OYPYFS*J@^*WR^R"P9W%@5?,
MI_%#/,F=O9UUL'%<;C9!<Y!I'.9]N]+=J\PU=25IEC2W#9C3*"*JL-+$JMBE
M9@4/_>IO]_S^.[_8_P#B1_MS_(< ?Z/@  #_ #@_&C_VMIR/_9 >67^T@W*
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M!F[;M,8PV^2KMC7'TK]V"E*"7P2EW.$5TC!Q2Z(G0;)%7@
M
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M^E*_[&2Z45B\$B_2>;NTO@^L</'23U]-$\Z2Z+5O75_*M,*&3(B
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MQ[%NAYOUZ6_J2O\ 2M(C&5]/N?#_ #%N=-G3^'3*OK\%\MEG3[_A]C+@V?\
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MU-2JDDTT]4TUJFFNC375-=&CY*2I)FE232HOQ)1&1ER7)<D?K^ \'L?P
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M+:>?VX5F'@7RNJ5&/&EJ<X=DNYION7;Z+[2V8FIK^
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MV\G?%AYOC/D>-L$I]JR7N>?.R*;24[,:&]/2*U;FJ[K9J*^2-DFHD7W/PO\
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M*J;I5/)6-3DW6SK=RK=2=U^1*%-MD.Z;:FH'$K*6
M   #E09LJMFQ+&"^N--@2H\V'):,B<CRHKJ'X[[9F1D2VGFR47I^)#YVU5W5
M2IM2E5.+BT_1IK1K]U'(P\O)V_+JS\.;KS*+(V5S7K&<)*49+[XR2:^]$M>1
M4)NNW]NR(Q$1!AHVOL%VNC,QTQHR:J3E5K)J7(3*$(:37R*UYIR.;9=M;"D*
M1RDR,1_AUKNXEMEDY.5GZOQU)MZOO545/N?KW*2:EKU4DT^NI:'GG#KP/-_,
M,:BI4XBY-N;JA&*A!4SS+ITNN*27M2JE"53BNQUN,H:Q:9#8DA4X
M             $W>025O;!@W"H_9_,VL=*Y0ZZA+Q19ME>Z>P>=D,N&IU;A*
M85DSDU"DH4;;+K:V2)/;Z$QCB+4=HECIZ^QG9M2736,89=\:T]/C[78]7UDF
MI===7</G.,K><T[K*OL_6/'=@S&UW=EEN3L>W694X.3>L7EN^+46XUSC.I*/
M9VQA$2<IX                                    "<IIJN/'#'W5*6Z
MY@.Y,DKEK.6V^<>!LW#L>L*R$Y%47N($5,_65D]&X,V7W7Y1DE*T+-<7J_K;
MF=T5HHY>VUR]--98UUD92U])/MR:XR^,5&OJTUI<F8Y;MX!P;&W*S9.69=3?
M>I=M>[X.+;36X/YJX*S:,NRK1]ED[,EI*<9.<&B4%-@
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M&*ZZ1A%1A%-MJ,4FV^ID@EIA@
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ME^ X0Y-:7;CN*2Z=?:PZ]9:?+^9.W*CJU)J4J=-$X/7"ADR(@
M          >(;']9X#N7]X[V)J[:.*5&;Z_S?8OD11Y1B]Y'.176M=(\7=C+
MZ5="FY$29$D-H?BRF%M2H<IIM]AQMYM"TU1#'IRN<3Q\B*G3.=B:?HU[4O\
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M+=TW/ G[F#D[CDVURT<>ZNRZ<X2TDE):Q:>DDFO1I/H8P.<1T
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MV1LO R6VX3;1FB:UB29/29<MJ?-'*B22CC/'4Z\O=<9Z-5[G+1^FONX^-?\
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ML^=@\DQ]SE=DWT6PE"G"W#%=2C4E)3E+,C--]-(27JT4O'8^=2P
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M.S'GYQLQ /8:
M                                                          (]
MVPQ:2M;9K'I8I3;5['Y[<"*I!N)>D*;X0E:4J2KH+\3,C(TD7/)<#EX$JHYU
M,KVU2K8.37PCW+5_O&(Y!7EW;!G5;?%3SY8=RKB_25CKDH)]5T<M$^J_*:&)
MD.57RI$&='>B3(CSD>3&D-J:>8>:4:'&G6UD2D+0HN#(QL'797=7&VJ2E5):
MIKJFGZ-,ZU,K%R<')LP\RN=675-QG"2:E&2>C33ZIIG&'N<<
M              #.<F);^.83)AJ;=IXE3*JS-KK-<6\^YS;*U8L.I)$B4^4Y
MM;7!]*XQ(X]4JXQ6#I#-RH6:K)E8I]?C7VQC!Q^Y=K3^*EKKZHF7(5.[8-GR
M,5QEM56+.GY==89'O66W1MU])R]R,H:=)5=FG6,M,&&5(:
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MXL(XT''MU7:X51<>K>FFK;U;Q 9$BP
M             87MF<FIT=NNU<:-Y+>#Q*EI!NDPAR5D^9XIC:$]U3;I*=C1
M;-Z631%U.IC*+E)=2TY#8ZGD<GVS'3T;RG-]->E5-MGIJNC<8PU]%W+U>B<2
M\FYD=L\.<OW.<7)1V:%,5KVISR\_"Q%UT>KA"ZRY02UFJI+6*[I1TUC8HZG0
M                          .^J,IR:@;>9H<BO:1F0M+K[51;V%:V^XE/
M2EQY$.0REQ:4^A&HC,B'$R,#!RVI9=-5LDM$YPC+3\FJ>AFMKY)R'8ZYU;+G
MYN'5-IR5%]M2DTM$Y*N44VET3?70EZJ\J/)&G6ZY%WCL^2;R$H6FYS"YR%I)
M),U$IEB_E63,=SD_53:4J,O0SX$=R.!<*RHJ-FU8*2?\"F%;_==:BW^1ZHM7
M:_J6^H+:+)V8G,^23E-:/W\_(R5HGK\L<F=L8O[XI-KHWH2E3?(!Y35*HZ9&
M?5M]&CQDQ4Q;S"<*>[I-MH;:?DV,"AKKJ5*02.3<<E*4XHS-SK,S$?RO#_C_
M "5)QPI562EKK"ZY?'5I1E.4$ON4>BZ+0L_9OKM^IW:95QMY!7FXU=:@H9&#
M@2UT22E.RO'JOG-::N4K6Y/5S[F]24J7Y.MWPBALW6':MOV65+]Y).IR>IMI
MC:W'%I2E^ORM-1&<:2LD)4F HNA!=25*,U''\KP/Q&[NEC7YU,FNB[ZY0B]/
MLE5WO7U?S^KZ-+H6?LO[2GSC@JJG=]MXWGTP;]R3Q\JFZQ-MZ=U>8J8-)J*:
MQVNV*[E*3<G*-/\ *@\ALD9#H^/*=.3R<FCV"]6-M0S2T1I]A8X?=+D2FU$M
M75[EI"R-*>E/!J5'\GZ?*)/7#W2<8]OI.A2;?7^%&V&B]/X+:ZO5^BM#:/VH
M>Y5U]F_<-HNM=GY^/N4Z5&O2/3V[,*]RFGW/7W81DG&.D=')RI5?)[I9_P!Q
M][P/:-6:>U[7[5&Q.^[_ %=WO^X*7DF.>U[?".CI[W7U*YZ.DNJ.Y'@+DD=/
MPF9@S]=>_P!V&GIIII79KKUUUTTZ>NO2TMK_ &FOB6[W/UWL'(L?3M[/86'D
M=WKW=WN96+V:?+VZ=_=J]>WM7=*M1\@/BW:.=$K-+W'4^V[Y/7N$Y(XWW.IH
MO9*+'(>1/%+)+AGR2#8X;5^LYZ>J/9/A?GM"UJQZ;GW::0NK73K\WZ1UK3]W
MNZKIZZ6EM'[0#Z:-RL[,S=-PV^/M]W=D8&5)=WR_H_ZUADR[^K>NGMZ1E\^O
M:I233^6GC1>HA.0-U86VBP>)AC[P[:XVMMQ4A47F:UDE74O5C).IY-R2EILF
M^'.KMF2A@LGQISO$<HV[9D-P6K[.VSX:_*ZY24GI\(ZO7IIKT+'VCZN?IMWJ
M%-F'R_:X1OGVQ_$>]BM/N[-;%E54NJ.JU[[5"/;\^O8U(D*MW!J"YDE"I]NZ
MIMYIH6Z4.JV3A5C+4VWQW'$Q85X^^I#9']1DG@B_$86_BG*,6OW<G;=PKJUT
MUECW177[W!(L';O-/AS=\E8>T\MXSE9C3:KIW3!LGHO5]L+Y2T7Q>FB,TJ[:
MIO%NM4=O4W;K"$N/M4UG!M76&UF:4N/-0)$A;3:E%P2E$1<^@Q61@YN)%2RJ
M;:HMZ)SA**;^[5+4F>U\BX]O=DJMES\+,M@DY*B^JUQ3>B<E7*32;Z:OIJ<N
MU=L:2KL[EFMD29%36V-I%BK9?2F7*KH3\V/%/H0:S]PZP2.$EU&1^GJ/&%3#
M)S*L>R7;79;&+?V*4DF^O3HGJ>^_Y^1M.Q9NZXM?O9.-B76PKZ_/.NN4XPZ=
M?F:4>G7KTZGDUN,;R+'O;_?Z"ZH_=][VGWBKG5GNO;]KO^W]ZPQW^QWT=?3S
MT]:>>.2'8ICYN'F:_A+:K>W37LE&6FNNFO:WIKH]-?71GY5]UX_OVQ>W^N\+
M+P_=[NSWZ;*N_MT[NWW(Q[NWNCW::Z=RU]4=*.28@
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MRV5$U;5?CW4SG/LOHM5=EU/MW618+S-;@
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M5:H1E9*,(UP2A7&%5===4(54TU0A535"%54(5PC%=")20L
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M*;-OS)))KM]MU[C2XN+ZV>ZG%:)RA 2<IX
M          "\V..NWIZ>H52%OS,^\,]OXPJ4])A5,F=9XUEOD!*PRK>DR7%1
M)2/?X'4U$<GUD:XB&DI-M26R15N;&.*MQRTDJ\3DF);HE*:C&RK 5TDDM5\M
M]MTNU=)N3?<F]=RMAMMWE\4V65CGE[WXEWS$<Y3KIG9;B9O)IX%,IS;A->YM
MN%@UJR2<J8UQBZY1@H49%I&FH
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MK2[4E'1))*0AQ3+
M
M                 ?Q2DH2I:U)2A*34I2C)*4I27*E*4?!$DB+U, :=O,:L
MBUNZ9QQHK$55A155C)-A2U>ZD/.36?<O$I".AXX\=M!I+E))07!BW^#63LV5
MQDVU"^27W+2,M%]VLF_RMFE'U!XM./SNNVJ$8SOV^J<VO6<E.ZM2E]ZA7"'3
M7Y8KXZE5Q,BC                           ,MQ:VB,*ET-TMPL>OB:9F
MF@_6MGM&K[9>M),CY<K'G#[B2]78RW$?SQ<8[<,>R:CEXJ7XVG5Q_IHO\ZM_
M=)+I]DE%_ E'&]SQ:96[+N\I?J'-2C9I_@5D=?9R8K[:9-]R76=4K(?PEITE
MO53*2RF54]*$RX3QM.]IQ+K+A<$MI^.\GZ'HTAI27&UEZ+0HC+T,<O&R*\JB
M.13K[<UJM>C^]-?!I]&O@UH8?=-MRMGW"W;,U)9-,^UZ-2B_BI1DNDH2BU*$
METE%IKHSK1]C'@                   &I3$/B5UWB'R*R_D4C;;S29FDO*
M,XRA6N7Z2C;Q=$C.-<9!KB5%3:MK^ZFS!A9 N2VKCJ4ZVE)_29B.5<;HJWM[
MVK)NURD^W1:?-%Q]?7XZEHY?E'/R^ K@,L6E8BJKA[JE+OTKMC:GV_F]7'1_
M<S;6)&5<:J_D4^);0_R(V6"9;EN07NKMCX0S-J%YWA5/C\NRRK$YA$\QC>4M
MV<4GK)FBLD&_6.G(+V129:"0LI'+<>WOCF'O<H662==\.G=%+5K['KZZ/TZ]
M-7]I9G ?*.]<"KOQ<6N&3M]S4O;LE)*$UZSAH]%W+I-:?-I!ZKMZ[!-'ZN@:
M/TKJ#2U5:3+RKU!J[7^KJV[L&68\^X@8!B=3B<.TG1XQG'8F6$>I2ZZAOZ$K
M69)]"(9G$QXXF+5BQ;<:JXP3?JU%):_NZ$%WG<I[SO&7N]L5"S+R;;G%=5%V
MSE-Q3?5I.6BU)%L*^!;0)U5:P8=G5V<.37V5;81F9L"P@365QID&=#DH<CRX
M<N.XIMUIQ*D.(4:5$9&9#[RBI)QDDXM:-/XG KLG5.-M4G&R+333T::ZIIKJ
MFGU37H:2/$OX)/&OQ+\H:[R6QW.LZS5>)3,LL-;Z_P KATKM'AL_(6Y=;43G
M[-#;D_(YF)T%E(8B.R$H7[PVIO*7V4"*;;Q# VW<%GPG.?:VXQ>FD=>BZ^KT
M3Z:_'KZHN+E'FKD/*.-RX]?132K5!6VP<NZQ1T<DEZ04Y).26ORZP]&S>$)8
M4T                    9?@333F74CTAM#L:LDNWTMIPVTM.P\=BOWTMMT
MW4K1V5QJY1+^E1])GPE1\$>.W>4EMML8-J=D56FM=5*QJM-:?'62T].OQ1*>
M%55SY3AW7Q4\?&L>3.+T2=>+"63-2[M5VN%4E+HWIKHF]$\5>>=D/.R'EFX\
M^XMYUQ7\9QUU1K<6K^:I:C,QD(QC"*A%:12T7Y$1JVVR^V5]S<K9R<I-^K;>
MK?[K/D/)\P                                           @ORILRJ
M_'RRCE[?OY1LG"Z9M#QJ4\JMJZ?,+ZU?BMMNHZ'8UA&K$*6X2D]N0I*2-1]2
M)+P>GW^7URZ]E&%=-Z>G=*=-<$^GHXNUZ+KK%-].CIKZE-P6V^#,BE>W[^X\
M@P*$I:]SJIHSLFZ4$FM'"V&)%RDFNVV22[GW1U5B]3K5
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MU3_=14V9B9.WY=N!F0=>919*NR#]8SA)QE%_?&2:?WHXH^AQP
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M\EO,V[CO*-GC5AX>1=-W[B[LFK+6[95#DW#M4+(8=F3ID6PR\FZ,(T6UVY$
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M3JOQL*JRV_$OLG.QPEEP5UG?.J8GIK0
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M1?R?QS$X=Y*Y#Q' >N#M6^9^'6^JUKQLJVF#TE*<EK&"_.G-_;*3ZN/AER#
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MT?1FKO(-GOX]OV;L&4]<K!R[L>;T<=94V2KD^U]5UB^CZKT?4Z4<DQ
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MV/?^;I'^9P_Z5'T\_P#&S:O[O/\ O@_M1^2?]I\S]Z/]^)E&P!7(
M
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M99R?%V^G?,'*PN88<9PO[X]M=D'II.,9:2BW.,GHHJ*4FN^>D>V"A*"H0
M                         S]HCR_'BBD1N9+BD):H:6VD]RWQ:/U.R&%K
M+A3LW'N3<;_$U0S6G\&4D,1+_P FYON>F#D2Z]?S+7T3^Z-GH_LGH_X3)O4G
MRG8OP_67(=LI;@DEK?AQZRBWZRLQ>LH_%T.2]*8HP 9<A
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MKK&,,''QFYM:IPE',^6+[=+(REJ^WMUUBWS0T
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M^:.7[IMML+MNR>4;K;59!ZQLKLSKYPG%_&,HM23^*:(D$@*O
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M*E=+:%+5QPDC/@A\KKJ\>F>1<]*:XN4GU>BBM6]%JWHE\%J<O;\#+W3/HVS
MA[F=DW0JKCJH]UEDE"$=9-16LFEK)I+U;2ZGF<\ ]65_G%Y;[9WMNNK;R>@Q
MF8><6>+6K;%M0V61Y;/L(>%8U=M28Z&;'&\>J:J0IJ*;:&I'VYAMU"H_=9<U
M-\:[/5Y"YMF\CW^"NQJ9>[*N6DH2G8Y*JN>JTE7",9:1T2EV133CW1?=I]6G
M.\OZ7OI\X_XK\9WO!W;.K_!5953E5?7CXE=<\W)H<9-UY.1;;6IVJ3E7^(MG
M"2N]NV'IO99:CM-,,--L,,-H99990EMIEIM)(;::;024-MMH21)21$1$7!#;
M:,5%*,4E%+1)? Z0[+++;)6VR<K9-MMMMMMZMMOJVWU;?5LU<?*3XJXMMW1>
M6;AJ:B'#VIJ2C/)D7L>*TW+O\'H3?EY)CUS*;97(?AU=/(EV$0SY-N0QT<H;
M><45/^8.&X>]\=NWRB$8[SA5^YWI=9U0U=D)/35J,7*<?LDM.BDV;T_0IYYW
MWQ[Y3V_QUN&199P/D.5^&=$I-PHS;^V&-D4Q;48SMNC5CV^G=79W:2G7!-\1
M6WK#9'BRG$[N8Y+MM099/PJ(IY3SSR\2DP8-]C"UOJC-,);AG8RZ]EE+CJVH
M\!LU=*5-I#PEOENZ\/\ P61)ROP;G4M=6_;:4Z^NFG3NE!+5M1@M=$T/VA7C
MS$X9YV>_[96J]OY%M]>;-)145EQG.C)2BI.6L_;JR)S<8J5E\].YQDS7/OK+
M\9P'YD'\RS*YAX]B^/9IJFPNKJP4M$*NA(TEA3:I$A3:'%I;2MPB]"/\15O)
M,[$VWSJ\_/LC5AU9&/*<Y>D5^$JZLW(\4<=WOEG[.*''..8UF9OF9MFZUTTU
MI.=DWO6:U&*;2UT3^)ND_P /SPU_[H77_P#Z&3O\P"^_[97!/]L\;]]_]PZU
M/^B7]2'_ !0W?^Z0_P L-+_R\;^TUO+_  >_V2;"Q_//RO\ M8_,'V)Y]W[5
M][_9I]J]UWH['3[[[1)Z..>>RKG@4+YNY+L7(?U9^I,JK)]G\3W]C;[>_P!C
MMUU2]>V6GY&=E'[//Q+Y(\6_SO\ [8.SY>U?COU5^']]17N^S^LO=[>V4OS/
M=K[M=/ST>A_4W]BS6G\G^&_UN5HV?V7_ &'Q/]#5?WB)T]\__P"'F]_V7S/]
M46$@#)D2            F_R(?4K:EE7D71$QS&-<XE5L]QYPF:C$]<XKCU8D
MS>==4;SD2N2X\9&E*WUK624DKI*,<.BEL,+O\$NOR+9/IUG;D6V2]$NB<FE\
M5%):O34N'SO=*7DG(P5TQ<#;MKPJ8ZR?;1A;7AXM2^9M]SA4I6-:*5DIR48J
M6B_GD>7>W7G=T2&4)S*;6;&0<5WO1'D;,H:K8+<N&HWI"VX4U&2D\RVM:G&F
MEI0OZTF0<,^7C.)C:MO&C+'ZK1K\-9/'T?1?,O;T;2T;3:Z-#SZO=\O;UN_;
M"*W:ZG=5V2[H26[8U.YJ=;[I-5V++4ZXRDY0A*,)_-%HA$2<IX
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MF_-.7S=G+-WW3=+)3C-O+RK\EN48]D9-W63;E&'R1?JH_*GIT,1&0(N
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M%\96\6S>-QW3BF$\'$OEI9!J6ON02C+YFW[BB]8JQ?G:/5*2:5G!@"Q0
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M9Y4V;Q[M\J]89')+(:TX^OVZI66Z=8U)I_%2FUVQT^:<-SX_0>=<
M
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M\+[SX/Y7#C&\YN#G2NI]ZJ=$GW^TY.,7=3+YZ92<7I%N<7H^RR239U(NHIH
M                   S-!E#U^^9+4ES(,M98,B4HNN-BU2M]YLR2@B[:I&5
M,J42U&2E-H-*>4&8QC_2[PE\*<9O]VV>B?Y=*I):+HF]7U);!K$X--IM3SMT
MC'U?6.'0Y271>CEFUMJ3ZN,'%:P;,,&3(D
M                   4,\XK%QS/==T/5*)C']4U!FTZI28SDW(LGRW)GIL>
M-UJ0VMR!:Q8ZW..MY,5!G])()-H>,:8K:\W+^7NNSY]5ZZ5U55*+?]5"4DO1
M=[^.K>E?UC9]D^:[#LNMBIP>,T=&VH.S*S,W+E9&&K2;KNIJE+\Z:IBW\JBE
M2H64:B
M        37XW(3^W_3,MQQ#,6FV5AV26+[A.*2Q4XO>0\BN'R0RVZ\ZMFKJW
ME)0A*EN*(DI(S,A&>:/_ .9+<JTFYV85U<5]L[8.N"ZZ):RDDVWHO5EO> (Q
M_MX<2RK)*&-B<AP<JV3U:C3AY%>5?+2*E*3C33-J,4Y2:44FVB%!)BH0
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M[<*UIVTV2A)K71N$G%Z:I/35=-4GI\$<T9 XP
M
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M=C]9,XBZ6_?=7+5?.Q7E.*<;B-$ZN*TDSY0T?ZY#:B01\'RVKGC\3$WP_/\
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MQMIV?;'ZPP97R_._/R;[9K371:>Q&CT7YW=UDM&84,F1$
M                              UG>8%DJP\AL]9,G$)H&L2Q%#3L@WU-
M*P_"L<QF1R7;:*,X],JW'7&"279=<6@S4HC4=R^/*55Q#%ET;N=UVJ6FOO7V
M6K[=4E))2_A))]$]#KT^JC<)9_G7>ZFI1CA1PL%1<NYQ>#M^+B3^"['*RF<Y
MUZ?HYRE!MM.3K0)J:]@
M                    37X\I26U:F<XXAF-18YL?*9RUDXHRK,2UKEV36B6
M4--N+<E+KZEU+*.");II(U)(S449Y@V]@LJBFYVW8]4?ZJW)IJCKK\.Z:U?P
M6K2?H6]X*C%>2\7,LDHX^%M^ZYEC>O\ )86TYV7<HI)MS=5$U!=%*;BFXIN2
MA028J$
M L%HR,JMJ=SYY/<9BX[CVI,LQ61(>F/07IV3;/K)F'8E05;T1#DQVSE/295@
MMA!$W(K*N8A]28YN\Q'E,U?D;;M52<LR[<*K4DE)1JQI*ZVR2>D5%)1K4GUC
M9;6X)S[2\O#6/+;]LY;S3-E"O8<#B^;ARE*<JY69>[TSP,+&IE!.R5TY3NR9
M5Q2A;B8>7"Z4:';K7T2XHT
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M'MQ,O)HG=&R$\E47W=JN7;9*;4IP;]R/XV;K^KPUZCM\5RJ+FN"9C%LY^)Y
MB!,I;0V:JVE5%A59'0ST$_4WM>_'2IQ+2Y,1UE]I;+Z^I:&_.R;O?N4;<?/Q
MY8NZXTHQMK[E..LX*<95V1Z3A)-I:J,TXR4HK1-^GD3@VW<3MP]TXUN=>\<+
MW6NVW"R57.B[MING1;3E8UB[J,FJ44Y*$K:9PLKG5=/6<:XN&=*X
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M(SY5]E=SKE512M$M8PFH62E!:J$>R,%))MRBNV6S(=PAI6
M
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M[>LK!WC5[I7?-6MONUGW-REW?'N;[D_BGJ=(.28D
M      "1F_\ HTQDF/X^4X= /VR2]7KS$8_*G&/J^IV?BY'U((CZE0#,B3Q'
M,SPK_P#)>=W^FWY,^OV5W/X_=&WX_99ZOYR?0_\ FNX\J?7DNTT_)_&R,*/5
MQZ_G68?K%)ZO&;2CI1JXY&:("                  ')A_\=Q?_ '98_P#.
MJ1%N=?\  G>/[%9?^I["4<(_X9[1_93%_P GK)<RO_E!/_\ >7_+L8=''T5_
M]9GC7_G'_>K..[#ZRO\ JW<C_P#-_P#OIA'YQ24F32QDD9=<8W([A%Z<&A9J
M;].3/ZFEI,S]/7D<KZU>'9G%/J W;*MC/]7[O"G.HE+KW1LJC7<M>V,?DR:K
MHQBNYJOV^Z3DV<7Z->78G*? NU8M<H_C]IE=A7QCT[779*REZ=TG\^/93*4G
MVIV=_;%12.DHX.1,W2G9RWO;_P!,>Y6MXELR.I*B;[*/4OZ*:5%PE/2DC+T_
M ]A_J+\C?2QO_P!/M.R>.J=O7)W^#_5]-.,Z\K"[)UN_\59HI=,974V]]M_O
M7SA8O<:5\-?_ *>_'GU/[%Y\NWKR%=GOC2_&?C[K<A68N9WPL5'X6O5K_-#I
MNK[*J/:HA.#]M/V)_C.W&>FN9_%\E/N%^'*&5$VD^?7DNXM)<>GKTF.9^S;V
MK>XY7*=[6L>.3KPZ'KKI9DP=]B[>FC=-4Y=_S)Q_$5Z*2DW'A_M%MTV:6+QC
M97I+D,;,R]:::UX\E36^[KJE=;!=GRM2]B>K3BE*.AVIG5Z
M     '[;;<><0TTA;KKJTMM--I4MQQQ:B2A"$)(U+6M1D1$1<F8\2DHIRDTH
MI:MOX'O77.V:JJ3E9)I)):MM]$DEU;;Z)+U,MSY;7YNN8K!D;%0Y%QUA2?XB
MF<:@Q<?:4VHW'5+;4W6$:5*4:E),C/U,R&.VA2_5U5DOSK$['^6V3L?P7767
M5>B]$2CF\J_YTY>-3HZ<64,6+7HXXE<,6+763::I33;;:T;ZMHP\9(B@
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MQU;?;IJV^I@(RQ"0
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M64>]=C60OI5EL:LC'RL:^BV$;;$^R-D9=ED2,1G"NP
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MAY*_X";G_H9_W*.N[Z2_^LAQ#^R\/[Q84_\ A3_Q6,^_V0&5?W.M5"#^ O\
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MH_<3;A&U>3> \"_+Q<'Q=O-.[[_?M&VYMFU9,8X>YI[CM^-N%<,2,YO&W/\
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M/&33EW663T=ED_3NDTDNBZ1BDHQ7PU<FY<&,)6
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MZ*XXIN4;1(DD7*3/@ ;9P
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M%E<KY7E69>^9=G=99+]Z,(17RPKA'2-=<4H0@E&*21QQ)B-
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M-P>!AWYBFH-24I1=/=",DXRDDI=&S1&-HCI?
M                                       ":]/DW'I=Z7+JE]-+I2S,
MH[;:5*E.9-G^N\#92;BG$$PB*]EJ9*E<+-26#01$:^I,9Y%K/)VK&CIK;N<>
MOV>UCY%[^'755=J]/SM=>FCM[Q6JZ-HYGNUC?;A\0N^5)-S>7N>U[;%:MKM4
M)9JM;TDVJW!+67=&%!)BH0
M                  +<Z/VQFF/:KW-3_>HLC&\1PAJ\QJJF4E;=7%+D^0YW
MB./1I^/V$R)(GXY1,R+A<F?]?VYY]2&5MG(FI-=>\HV#;,S?MMR/:DLW(RG"
MR2G*$)U5T6V.-D4U&R;4%&OI[BCK)/LJ>FT7AWR=R[8_&O+=J_&5V<?VO9UD
M8E,\>K(OQ\O*W'!Q8V8ULX2LQ<:,KY6Y/S?A9V.%4Z_?S(N48N>0&P7U$Y,@
M:HLI)H;0[.MM :&MK.4;3:&DO3K2SUK+L+"4I""ZWGW7'7#]5*,S,QG%Q+:(
M+MKGN$(:O2,,_.A%:]=(QCDJ,5]BBDEZ)%=S\X<YNE[F51QG(R-$G9=QKC=]
ML^U)*5EUNTSMMFTEW3LG*<GUE)MMGX_;UG'^@6F/^]P\>/[UP\_S4VO_  W<
MO]T=P_UT>G]NOF/^<N(__0KQ?_T./V]9Q_H%IC_O</'C^]<'\U-K_P -W+_=
M'</]=#^W7S'_ #EQ'_Z%>+_^AQ^WK./] M,?][AX\?WK@_FIM?\ ANY?[H[A
M_KH?VZ^8_P"<N(__ $*\7_\ 0X_;UG'^@6F/^]P\>/[UP?S4VO\ PW<O]T=P
M_P!=#^W7S'_.7$?_ *%>+_\ H<?MZSC_ $"TQ_WN'CQ_>N#^:FU_X;N7^Z.X
M?ZZ']NOF/^<N(_\ T*\7_P#0X_;UG'^@6F/^]P\>/[UP?S4VO_#=R_W1W#_7
M0_MU\Q_SEQ'_ .A7B_\ Z''[>LX_T"TQ_P![AX\?WK@_FIM?^&[E_NCN'^NA
M_;KYC_G+B/\ ]"O%_P#T.?MSR'VT:B]OD%15L(0VTS HL&P''JF*VTVAI#<*
MGH\8KZJ$CI1RHF64$I9FI7*E*,_"X?Q_^'399/5MRG??9-Z]>LYVRE+]UO1=
M%T2/>?G;R?*7Z#.Q<:E)*->-MVVXM,%%))5T8^'536M%JU"N*<FY/64FW^/\
M(;<'^J__ -,&+_Z2#S_,_CG^=_\ W2W^_GI_;U\J?[:__$V'_K<_:?(W>+"7
M/MNRLCH'7D$T[-Q9Z/B=FM@G&WCCJM<:C55D<5;K2%+:[O;6:$FHCX+CP^&\
M7DU[V%3;%/51M3MCKZ:]MCG'71O1Z:K5Z,]X^?/,=$9?J_D.X8-LUVNS#E'"
MM<=5+M=V)&FWL;C%N'?VR<4VGHC\?X1_D/\ V^MS_P"NCG'^G@\_S,X?_M3M
MO^E:/[X>G]O[SO\ \=N7?[L;A_K@PYS9NR'G''GM@YNZZZM3CKKF5WRW''%J
M-2W'%JGFI:UJ,S,S,S,S&16R;+%*,</%44NB]JO^^D4L\A\_MLE;;OF\2MDV
MVWFY+;;>K;;LU;;ZMOJV8K8V5C;S'K&VGS;2PD=OW$ZQE/S9C_::0PUWI,EQ
MU]WM,-)0GJ4?2E)$7H1#GTTTX]:IQX1KI7I&*44M7J]$M$M6V_RD:S]PS]TR
MYY^YWW9.=9IW66SE99+M2BNZ<VY/2*45J^B22Z)'"'U.(           !.NL
MLKP.?CKNIMI(R"!BUSFE/DE1F6.6$5$G![AV#(QVVL;6AL(4J)DN/RJZ5'?E
M,-/09B55S?:?(EN(5%M[P-UJS%R#8O9GGUXTZYTV1>E\.Y60C&R,DZ[%)2C&
M34X/W'W0U2:N;QYR7A6;L,O&/DA9U/&\O=Z,JC/Q;8*6W7NN6+=;=C6USAEX
MTZIU675PGCWIXL/:O2E.$LFUC2WNF/*;#<1R5[[<U!V=6X-E;S\57VF_P6_O
M4XIE"TMS&%(L,8RC%9TCMO)2I+L9]+K2NKH67!WS)Q>2<$R=PPEWRE@ROJ2?
MSUWUP]VKT?RVU6QCJOA*+C)::HD7CK:-Y\2_4EM/%^0R_#UT\BJV[-E*#]G)
MV[)R5A9C2LBU;B9F'9;V6)-3IL5E4M>R:KC95TRHL9]38L^WL*N;*KIT?N-.
M]B9"?<C26>ZPMUAWM/M*3U(4I*N.2,R]1,J;J\BF&12]:;(J47U6JDM4]'HU
MJG\5J4%N&!E[7GW[9GP]O.QKIU61U4NVRN3A..L6XO22:UBVGZIM=3A#ZG$
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M"S<K<JWY*/QN+5._;,.$Y3KC9DY6?'%JJHC*4VINR5<ZHSBZX"9E!
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M3ZG(P\F6'EU9D85V2JLC-1LBIUR<9*7;.$M8S@]-)1?246T^C/7!X"^3=_Y
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M1/=U\MMSM/M-/-]72M"5$9$!D
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MCA)?!Z>DHO\ A0DM)0DNDHM271HZT?8QX
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MW_9X\H_Y(\._KR>%7< _S9D?XG'^]&W7U(?[";;_ **L_P C/9^+1-10
M              Q;95DFETSNRW4]+8.-K>76H."1%(<5EV28S@_94X<B/VXC
MR<G-,G@U=<8W$="^KI/F;12\GD>V8R47W9JE\WI^AKMOU]'JU[7R^FDM'JM-
M2-^0=PCM'B7F&ZN=L'7Q^=2]O\YO-R\3;NW7NCI"2RVK>K[J>^';+N[7I@&Q
MQU*
M      !->NC;AZO\@[$TK=>G8?@^(H03B6VV&[3:V&96[.67;<4\MM6"(82V
M1H+B2I9J^@DJC.\ZV;[M%/11ADWV_E[<6ZI1]>FOON6O7\U+3KJK>X$Z\3QS
MSG/:<K;MJV_"2U245=O.!FNQ]&Y-/;HUJ.L5I:Y-_(HRA028J$
M                                              ">/'.9*+84RBZT
M?8,NP+8V/YK'?>*/$?P]O"[G(;63+D&\P49% ]0LVK;IK)++\!M:R4A*D*BG
M,JX?J>.7H_Q>/EX]E+2U:N=T*XI+1Z^XK'4UIJXV-+1M-73X$RLE<ZMV75?J
M3=-DW7&SXREVPE@K ORKISEW1[%C2QJ\R,W)*%F-"<E*,90E XE92P
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M+=^G&W==@W;)PIVQBXPN5%LH0OKC+64:\BM1NK4OF4)Q[NNIC FQ78
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M9'R1D?J1D9>AD9" FQ9_0
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M3(1!A();AD1K5R?Z0!E
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M:77C7+L:BU%JJQN6DZYU+M@^Q2]R":<EW-.MXF!2
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MXH2Q:8N.J47=";>JBI:H!?!UF
M                            !->+&W#T+N*P)"W),_/=+8F1&XE+#,*S
MK]M93)DFWVS<<E)E8/':1]:4$V\YR2CZ33&<].SEFW4]%"&)FV_>Y1EB5)>O
MII?)OIKJH^BUUM[C;KQ?"G*\Y)RR+M[V#"]4HQKNJWK,G/335S4]NJA'YE%1
MG9JF^UQA028J$
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M_CNO"?)1V!DA-GD:6'C3)B4+"^5-,=2#;7-=3V4*,R;2\I#B4:%?5E]<O#?
M=&3PSB7M;OY==6GL+5XVWN<-:[<Z:T4IZ-60PZY>[.*3NECPLJG9V:_0_P#L
MW^?_ %.9&)Y!YPKMB\$J[5Y+T67NBKFU;3MU<M7"O6+KGGW0]B$VU1#*LJNK
MJNWMC=NO_&O"8> 8"Q62LGKX)P:'&8[JI,:B)U3KKMQDKR'#<[BY+JWU-+64
MJ:^YU'TI4MU/6AX%^FCRS]9GDO(\L>5[<VCA.7E>_G;C9%5V9KBHQCB;=!Q4
M>U5QA3&V$'C8=-:A'NG"NB?;]]37U?>#_P!G[XAQ?"'A*G;\GR)@X;Q]NVFJ
M;MJVY3<YSSMVG&3EWRMG/(G3.Q9F?D6N<W"NRW)A6OP-MV7]F9VB>]W;FWQ9
M=BV^ZE/<D=F\AKL_UI\'W77IK;AH+^,235_.#<S]J?L&1B^%>+6[57V<=V_?
M5CRA%OMK[\*Z.-\O7Y8PIL@I/\URC'76?7K^_8L\HQ<WZA>9T[W;[G*]TXW+
M)C9-+NM[-PHEE_/T^><\BJQPC^>HRGII7T^'GW5V;>Q<.NG&7_LTO"FJN+(,
MG#C'9U][=R[!E*C3V4OE%LXRC(CZC29<EP1#D_LH]\V2WP_R+C=5E7\XZ.2R
MR;:]8^Y^&OPL.JB;6O>X>[C9$4VNU23T>K9P_P!MMQSD5'GGBO+KJ;OYIY/$
M88=-ND_:_%XVXY]V36GIV*Q4Y>)*23[W%QU6D8LFWP%KK"/KK+[&0VZW76.7
M);KS<ZTH><@U,-$Y]E"B)*FC4^ALW$\DI;:DF?*#(M:OVK.[[1E^7^/;/BSA
M/=\/C[ED=NC<(W95KIA-KJI:0G8H2T<861FEI8F]O?V)FQ;Y@^!^5;]FPLAL
M6?RA1Q>[N2LGCX=$<BRN+23AK974[(ZJ4ZIUM]U+2I)Y53H5AY ;'?KS2;#=
MA4P7#0E*2][68Y35MD1DGT-16,1TE'^)JY,_4S'9=]"FV;EM/TG\.Q=V4EE3
MQ,JZ.K;?LY.X9F1C]7\'CVU-+T2T2Z)'4#^TIWC:-\^M[GV;LCB\*&=A8\NU
M)+\1B;5@8N6M%TU653<I/UE+64NK97L;;&C0      &=8+K3.-E2+:+A% _>
M/4=8Y;V9(E5\%MB*A:6FFFWK.7"8EV<YY7;B0F5.39CG*&&G%$9%BMTWO:]E
MA79N=JJC;/LCTE+5^K>D5)J,5UG-Z0@NLY)$SX9X]YCY!ORL;A^#/,NP\9WW
M:3JK48)J*BI73KC.ZR3[:<>MROOEK&FNR2:.-AF 9CL*?*K<.HI5U)@Q43K!
M;;D6)!K(3DN- ;EVEG8/Q*VMBN3IC3*7'WFT*=<2DCY,B'TW+=]NV>J-VXVQ
MJA.7;'75RE+1RTC&*<I/M3>D4WHF_0X_$N#\KYUFV;?Q3"LR\BFM66M.$*ZJ
MW.%:G==;*%54'9.$%*R<8N<HQ3U:1,.T\HH<"IK#1.LW:^34L+JVMJY[!=5+
MF[-RZH]K,FUD>Q/AA.N\2R=MU%6Q$2B//7';G.JD+[#J8YL6#E[MDPY5O:G'
M(:D\6B2TCC53U49./K^(MJ:=LIZR@I2JBH+NB[5\D\CV3A.TW^&/'DJ+-K@Z
M8[SN5;<[-WSJ.RRRJ-OYJVO"RU..'72HU9,JJ\RV5\_9LC6T30U_
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MW;:<7=*]/;R<>NU::Z:60C->NC]'\4G]IF@XYD0
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M.=ME$HWVB]'$I,R &V<
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M,.[N>/='3WL63]?T3E&53EUGCV53;[W-1Q 9$BP
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MC2U+=\D>5/[8.#C8?X#\)^'ME/7W_=[NZ/;II[->FGKKJ_R&Y\2@J(
M            *I>:UF437FIJ%/M^[<97GV12TF:E2VX=168?3TKS9)=[3,>5
M*L+-"R6@UK5'29&E)?7.?&U/N;SGY3U[:L>BM?9K.5TYKTU;2C4UH]$I/U?I
MK1]7>X+&X)QC98^W[N7N>Y94UU<U"BG!HQY+1Z1C.=N6I)Q<I.J+3C%?/KD%
MPF@X
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M-=&1K+P\O;\F>'GU649E;TG79&4)Q?V2C)*47]S29Q1]#C@
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MN>SX6XPQ<JV-]V+^-I5WL^_&G']VI1<9X]DJ83LQYU3EW-]\HA$B*M
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MK]^NI]O(^!;M7D/?MKOJ]F_&WK-JE7HE[<J\FV#AHNB[6NW1=%IHC!!E2&
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M.+\=^&_5E^9=V?@/P?O>_P#B\'"[>[\;5[7M^[KVV=W9I'OA ;,FGP
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MT;7DWPR,V.VXBQ%N&34[75?F*,Y1DZO?M]JBE48E3LE*&/&>DE#0DA4X
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MH;/L%%,L^JKY87;[94Y[A;DZ-^_DX-ET]IKLFVJJ<24:8UJVWW*]"7E%
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MJC)IRC4IR5<6H*344S/1Q3+@
M
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M\4UTE&2TE&2UC*+4HMIIG7C['!
M      ,VV(:49=9P&UDMNB;K<91TJ>6A)XS50J%TD*?0VX9&_7J,SZ2)2C,R
M]#&+V75[;7<_6YRM^'^"SE8O37X21,.>.,.4Y.#!IPPHU8BT<FOZTIKQGHY)
M/\ZIO71)MMKHS"1E"'@
M   %$O.&T->8:SQUMXE,T6L(\V4REE*4(M\ER[*[5UY+YMI??-R@^VMJ(S-M
M"V5$@N>I2K.\8T:8&=F-?-;G.*>O\"NFJ"6FNBTL]QKXM-:_!+3#ZQ=R<^5<
M=V&$DZL+CD;)Q44DK\O.S;G+NT4I:XWX2+U;C&4&HK7NE*D@LPT_
M                                                       #:1XC
ML1V/'V1);804JUW'F#$R2:WC<7'H,)UNY6L);-WV[:&G,DEJ49():S61&HR2
MDBH_GTISY>H2;]NO;:6ET];+LGN?IKU]N'QT6CZ=6=C_ -+U-%/@V>17!+)R
M>69T;)ZRU<<;;]J=44N[M2B\NYMJ/=+N6LM(I*P BI>
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MW+O]9BF_OTA_;*W?_:S&_P!.3_UD/^A_PG_CANO^X-'_ *?'^!)@7]NW+O\
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MOB72JNIMBX6560;C.$X22<91::::.K'W,<
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M_P!V&/3"C'L5%,OD+_\ F0__ "?_ /K%#L<_9&__ )P?_,7_ ,N3J9_;I?\
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MKKI&*BNOW))%)[CNFY[ODO,W;(ORLQI)V763LGHO1=TW*6B^"UT1UP^QP0
M                   );I=%;6R+&4Y;28D_8U;M987L6''M*(\HL<>JI/L[
M+):G"%6B<SM\8@3"4R[918#T%#S:T&[U-K),?R>4[!AYWZORLA0O4XP;<9^U
M&R:UC7._M]F%LEHU7*Q3::?;HUK:&T>&/)F_<=7)]GVN>1MLL:W(A"-V/^,M
MQ:9^W;ET[>[EGWXE=FM<\NG&GCQG&<';W0FHYHW;7.J=%5+-/;3:+*=W9 63
M2WZN3+K;=G6F O6E%0QW)C$F/*3697FTNR?<:2V;+RJ*,YW%&GH1C'CXV_\
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M9M^U\>X]E?BX7I2A*.YT7X2[9PG*FZBW#>X/WH/(I?LRBDYZ2AJO%Y'7*
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M]< YEQW!>Y;WMV1C8*DHN<TNWNEZ+HWZDBBV"'@
M
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MDDM'C;=BUV]J3?R3R%=;%M]S5FLE%MQ57Q.#7,
M                                         -L?C/'CQ/'?#4QVB;.Q
MS'8-S-5UNK5(L77,=I5/GW%K2V15M!%;)""2C]6:N.I2C.A>93G9S#*<WKV8
M^/"/ITBE9/3[_FLF]7J^NGHDCLV^GJBG&\$;3&B*C[^Z[G?8]6W*V3Q<=RZM
MI?HL:F*C%*/RN6G=*3<RB/EL@
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M]Y+XPY1=Q/E5=4=QKA"R,ZK874W4VKNIOIL@VI56PTG'N4;(Z]MM==D90C@
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MNQ<'-Q59+OLCB[E@XVXX]=L_;J4[:J<J%=DE7!2G&32T:(T&;*^
M    #9+X9[;V%FV>O8CDF1OV&-XSJYUBFJ?:P([$8ZBVQ&IA2'78T5F5.EHA
M.K2;K[CKA]Q7KZCIJ_:-> ?$GC7Q57Y X;L]6)S+>N<1GF97NWV3L_%XNZY5
MU<8V6SJIJE=&$E51"N"[(?+TZ]_W[)OZG_.?E[S7;XO\@;]=G< X]XYG7@87
MLXU5=7X+-V3"Q[9SJIA=D7QQYV0=V39;9+W)MRZZ+Y^:]\_BNU]-Y1%:2_)Q
MMEN^CL+5T(>?I\DB6#+2U&APDI<<CD1GTJX(_P #_ ??]FKQ7%YUX&\B\(SI
MRJPMYME@V32U<(9>W6X\Y):QU<8V-I=T=6O5>IQ_VO'-<WQM]3/BCR+MM<;M
MQV"F&Y55R>D9V8.ZTY4(2?;+12E4HM]LM$]>U^A9?<>&6'D?IFF8PJU?QW[S
M+ILIBLY)&M:5N?";BS$IJ[R*U&D2D,=Z6B0A26GV5NQVG6S6@T.'I9].WD;:
M?HY^HS<<KR3@5;Q^KL?+VRV>W68N9*BZ5M+>3A6RLKJ<^RJ=$XNVBZ%=]U%R
MJL5M2["OJL\3;Y]?/TG;5A^(]RNV%[KE8.\4PW6K,P(Y-$:;TL/<*84V71K[
M[J\FN4:<BBRW&Q\FB5U3IO?UP>LE>-.@UIR^;,RJ1B4.VM9;5$S96+"%29+L
MEFKJS<B]^+5,+677)>:989ZG'7";1SQ\?)V]8/UG_57&7C[&Q]BQ-_R,7%JE
MFSQ\>;5=<:YY.2HV]EN5-)]F/3;==;VU45.VS37[^'>/;E^SZ^BB</*67E<D
MSN,8N;F70VZO+RJXNVV=M>'B.5/N4X=;DO<RKZ:,>CONR;HTU*6FDZPG/V<^
M=92C2<JPF29TDT))"#?EO+?>-""]$)-QP^"_00_2OM.V8NR[5C;-@J2PL3'K
MIK3>K4*H*$-7\7VQ6K^+ZGY#-\WC-Y#O69O^XN+W#.RK<BUQ7;%V762LFXQ^
M"[I/1?!=#AC(&+          )K\@5I?V,S8=M#3]WK71V23R:-SMKMLFTEKS
M(+A]M+KCJFD2;6R><)!'T-DKI21)(B*,\179LSIU;A5FYM<=?XE>;D5P7337
M2,4M?5Z:OJ6]YQE&[GT,[M4;LSCW'LJS371W9?']KR;Y)-MI3NMLDHI]L4^V
M*44DH4$F*A       WP9I_BWY9_(C>_UARA^6CQQ_P!<C8?_ -)N%_OY4?M#
M\L_]0/DW_P"A[<?_ ,G+B+O$B7K/'M+X[*K[*AJKJZ5/D94Y8VE4Q<RK:':6
M$)"9J522=:AQX[:?9-&223&6EPT];KBE7A]?N!YIY=]2&[X.[86ZY_&MMC17
MMD<?&RIX=6+=C47-TM5]LK;+)/\ %V)R;R(3J4O:HJA#7/\ 9@;I]/?!?I*V
M'<MCW#9=MY=N\LFW>)969AUY]V;1F9./%9"=JG"BJJ$?P-,E!1Q;(7.'O9%U
MEF9X?J;7<':T[:,#8M]EV:V3%DV]&L<FQBTB)B3$(;4S%@5=-#EL0ZYA"6V$
M)<)MEM))X,B%<^0O/?E_<_!&+X/W7A^U<?\ &V%;CRA9C[;N6-:[:6Y*=E^3
MEW53MR)N5E\Y5NRVR4I:ILMCQ7],O@?9_J6S/J-V3GN]<H\N[A3E1G5E;MM&
M92J;XJ+KIQL/!HNKHQ:XQKQJX6JJBJ,8=K21T/E=K7"<WPF1D&47TZIN,#Q7
M/+G$X46TJ8#-Q9*J8<TXLN-8P)<JP:*53QD=$9;+G#JBZN5)-,I^@[S-Y+\9
M^2ZN)\'VK%S^/<IWW8\3=+K<;*OGB8ZRK:5;59CWU542]K+R)=^1"V&M49=O
M;":E"_VF'T_^(/+_ (AOYQY'WK,VSE/"^-\CSMEQZ<S"QH9V6\*C(=-]65CW
M79,/>P<6'MXEE%FETX]_=97*&EL?I$/R2       3=1]RP\=]D1?U+Z\=VWJ
M6ZBM?TNF7"KKS%=N4^0SD?Q93T*18PJ1ET_K0TZ;/!)-P^J,96E/,<*SJE=M
M^7!OKI*4+<2=<?L4E&5S7HVN[U[>EP[-WYW@?D&-\DYX'*-EOA'Y5.NK(P][
MHRK%Z3E7*VO;ZY_G1A/VM.UV/NA$2<IX                          "U
M.YL/C:KU1K;7[]S^;9V1VDC;=?D-93H1AL.NRC%L=J;"LQ3*ES'WLE>=F4S+
M5D:&8J&'ZYI*DJ5TFF!\;W&>_;_F[O&O\/536L25<I_IG*JVR<96U:)5I1FW
M7JY.4;)--+7793RSQ6CQKXRX_P 'NR_UIF[ADRWNK*IH2P(59F'BTVTX68[)
M2RY2LHKAE]M=,:[,6N,HREVN.J_S.VUM#1/C[F&V]356'W=_A,BEL;6JS2ON
M[*NDXQ+LX]3;NPV*&\QZ4FPKE6#4HUKDDT45A[Z5+-!#E\\WK=^.\9OWO984
M69..X2E&V,Y1=;DHR:4)P?='N4M7+3M4NC>A@_IL\?\ !O*GEW;O'W/[]QQ=
MIW.%U=5N'9379')A5*VI3E?1D1]NSVY5:1K[G;.OYE%29'?Q^^6%[Y;Z>NLQ
MS*!C=/F^,YI88S>U6*P+*NIT0CKZVTI+")'MK_(YZFYD:<MM2W)">7X[I$VE
M))4O%^,^:9/-MBLSL^-4-PIR)5SC6I1CIVQE"24IS?5-K5OUB^FFC<P^KCP#
MM7T^>1<;CG&[<W(XQG;97DT6Y5E=ESG[EE5]<Y548]>L)0C)*-;TA9!N;DVH
MSGY/;A7H+0.T]NQV*^3989B[\JBC6R7W*J3D]E)C4>+1K-J+)A2WZ^1D=I%0
M\VT^RZXVHTH<0HR44BY=OCXUQK,WN*B[:*6X*6O:[)-0K4DFFXN<HII--KHF
MGU*L\'^.H^6?+6P^/+I70PMRSHQOE4XJV.-7&5^5*MRC.$;(X]5KA*<)QC)*
M4H2BG%TP^.;SQS#R[E;-QS9M3@^/Y?AT>ANZ&)A5;D%=%ML;L')L"WDR&[S(
MLF6J13V;<1*U$\R2DS6R2A72M10+Q;Y&SN;SR\7=H8]6=0H3@JHSBI0EJI-]
M\[.L9=NO5?GKH^ILI]9'TI\=^GJC9-YX1D;IF<>W&=]-\\VS'LE5D5J$ZHQ=
M&/C+MNJ=K2<)M.F>LEK%/97D^1U&'XUD.6Y!+;@4.+4=MD=W.>6AMJ%44D"1
M9V4MU;JVVT-QH<5:U&I24D2?4R+U%L9>51@XEN;DR4<:FN4YM^BC!.4G^XDV
M:5;'LVX<BWK#X_M%;MW7/RJL>F"3;G;=9&NN"23;<IRBDDF]7T3-5GQ\><'D
M+YAYYL>#EN+ZGQO \%Q>-,7.QFBS$KQ&3Y'9N,8G D/VF;6-=)KU5U39.R32
MRPZXN.@F^@E*-%.>,O(/)^<[CE5YM.%5MN-2GK7"WO\ <G+2M-RME%Q[8V.7
M1-N*TTU>F^7U>?2_X@^G3BNS97'\[?\ -Y7NN=*"ADWX?L/&QZU+*LC&K"KL
MC9[EN-"O6<XQ5DG/N<8J6)^./R*;NR?R\F^,'D/AVL\7<1:9?A<2=A]+EM/8
M(SC'G''ZM3KUWF.609E'>P:V0B/VVT$\N3&=;D&W]+O"XKY1Y!F<WEQ'D]&)
M2^^VI.J%D9>[#K'5SML3A-1DHZ):N4&I:=)9_P R_1UXQV/Z>:O./A_<=[SH
M.C$S)0R[L2ZMX60E&W14X>+.%]$[*W9W2EV1KNKG2I]:]S8O@ZVC6Q\BWF_D
M7B#0:YAZ[K,/OM@9U<6LER!F,2TM*J!AU#"2U/F.PJ'(L<LXUA/N[2&B&ZMU
M3#C<>6GH4M)&BJ?*/D'*X/C8L-KA19N>19)]MJE**J@OF>D)PDI.<HJ+;T:4
MUHVNFZ?T<?3!L_U$;MO.1S"_<<3B.U8U459ASJJMLS+YMUP4[\?(KE7735=*
MZ,8J<968[[E&6DK;^-V7;-V!I#76=[@J<?H,\S+'X^365'C-9:5%94P+I;D^
M@AJ@W-[D5DS8)H7HRY279!+1(6M!MMFDT%->*YV[[GQ[%W'?(55[E?4K)0KC
M*,8J?6"TE.<E+L<>[66JEJM%IH:^>9^/<(XCY/WGBOCO(R\OBFVY<L:N_)LJ
MMMMLI2KOGWTT8];K]^-BJ<*])5J,E.:DI.<!(2KP    #FUJX#5C =M&'Y58
MW-BKL8T9TF),B A]M4MB.\9&3+[T<E)0H_1*C(Q\KE;*F<:&HWN+[6UJE+3H
MVOBD_5'+V^>%7GT6;E"=FW1N@[80?;*5:DG.,9?P92CJD_@VF3KOO(<KIM^9
M?)AW[]<_A63R*S7<[%GET$/&\-IYCKN!-8:Q5S7%XW61J%V.]&::>-]I3JEO
M+5(4ZM46XGAX&3Q/'A94IQR:%+(C:O<=ETTE>[G)?I).Q2C)M=K22BE!12N?
MS9OO)MI\V[KD8N=.B[9]QE3M=F')XT,3 HFWML<"--C>)3#&=5E4(6>Y!S<K
M9ROE;.43YEF^5[!O'<DS*ZE7UT[%APE39*6&C3%@1T1HK#4>*S'BL(2A'4KH
M0GN.J6ZOJ<6M2L_MNV8&T8JPMMJC5C*3EVK5]9/5MMMM_NOHDHK1))5ERSF'
M)>=;S+D'+,NS-W>5==;LFHKY*HJ$(QC",8122U?;%=TW*R?=9.<I8J.>1H
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M:V4[*Q:KV/H_:V(Z4RFWH#G1H%@C\XU^Q8:5NJCLJD1J>-WD(4TA) ?Z'@
M                   H+Y,^/=]E6293M*MM*B'1U.#.6]JQ,<F+LY5AC==8
M..Q8,9F*N,3+U= 8(G%O-\.+/Z3X,QUA?6']*_)N:\NWKS1M&;@8_&\'C<LK
M)A;*UY%E^!1?*5=-<:W7V2HII7?.V&DY2^223;VM\*^7-JV+9L'@V91D6;G?
MNBJJE!05<:\BRM*4Y.2EJK)S?;&$M8I?,M=""/#G^S5!_P"MZ_\ \KM#6CZ
M_P#K#8W]BLW^\1+3^HG_ )MK?]&4?WIFW$=ZAU_@
M
M  !U-I0TMVRXQ;U4"Q:=1VUIEQFG5&@S29I):D]Q)&:"YX,N>![0G.$E.#:D
MOBNC/G;55?6Z;XQG5):.,DFFOL:?1FOGR@\;<9Q[%7<WU[1G7N5TE<F_AQ7E
M%#15FVHW7H\(S[+"8JR[A]LD$E!*(^KE!(G_ !7DV9/.C@;E:YTV+M@Y=6IZ
MK1.7J^[TZZ]=/3KKKAY?\5;)5Q^WD/%\.&/GXTW9=&MN,)4:-V-5Z]D76])_
M(H)04]5+2/;KI%H&I            'A>U[@DCYMOF$V;/V#D5C,T!KQ[([EJ
M-!L5J0KQ[U=ET3&,'P;&[*KL94*G>V):Y"U.G.P)9DERTM)L1Q3A)6=244OE
M?)K'=)O#AJ_7_ X/2,4T^G<WJ]'\9-&Z&?FQ\.^*<:&#7%;Y>H1U:_\ ?5T'
M.RR:DDY>U&+C%2CZ0KA))=#VQ:RU3K72^'U>O]38+B^N\+IF66:_',2IH5+6
MMFQ$C02E/M0VFU3K%Z+#:2]*?-R2^:"4XXM7J+5Q\>C%J5.-",*EZ**T7_U?
MO]33W<=SW'=\N6=NEUN1F3?6<Y.3ZMO1:^BU;TBM$O@D4>V!\3O@YL'R'UGY
M+R]+8Y0YUKNW*ZFTN+1&:# =@SX++KV-6&<X36(BT5G;XO>FU.9E-M-+G]OL
M6138Z6&V,3=QS:;LVO/=48W0>NBZ1D_@Y171M/KK\?26JTTF>#Y/YG@;#D\>
MAF63PLB':I3?=;4G^>J['K)1G'6+BV^W7NK[):N6R 9PKX\G/[R/Y(V^4V^@
M? G6AO7F391>T^T<WHJ)Z2_;V%O9R;'"M184[&B=,>0]<6$^QGJ@/*6Z;J*V
M1VT$;#BZZYSG2LE3L]'6R34Y)>K;UC"/[KU>G]2_L-G_ *?>/U8U6=S?<=(8
M]<)4UREHHJ*2LOLU?5=J48]RZ:>Y'5]4M:?E%XWYA\)OF?X9[IP^18Y!5?DO
M LUG.]Z7#9O,WQ>BJ\+\EL(A62'G&T5V4MW+\A#29#Z8<')&HZ^MM"3<P.X8
M-O%-TQ<JK64>R,ORR24;8Z_8]=?N4M"P^-\@Q/,/$=WVC+4:[?>MK7H^VN<G
M9B6-?;#M2UT7=*IR6C?3WH8?EV-Y_B6+9YAEQ#R'#\VQRDR[%+^O4M<"\QO)
M*R+<T5Q!6XAM:X=G5S6GFC-*3-"RY(A<%5E=U<;JFI53BFFO1IK5/]U&DN7B
MY&#E6X67!UY=-DH3B_6,X-QE%_>FFF9$/<XX        =G36\ZAM(-Q6N):F
MU[Z7V%+23C:C+E*VGFS^EUA]I2D.(/T4A1D?XCX9.-5EX\\:]:U36C^W\J?P
M:?5/X/J9':=TS-DW*G==ODHYE$U*+:U3^#C)?&,DW&47T<6T_4R#+JB"RJ%D
M5"V:,;R(GGX3)J-:JBR8-'W;'WC5^LYK7W4FPI75W8CC2NI2NOCA[;DVR4\+
M+>N=1HI/^/%_F6+^J2^9?":DM$M#.<IVO#JE3OVRQ:X_GJ4JXZZNBV.GOXTM
M>OZ*4DZV]>^F=<NZ4N_3#!DR)
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M^
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M_9G[?[IA$_#?N_YS[O8][0NTGW+V'Y4:[O:[O=[/?3U<=/67\8=6G'/V:?\
M-_S)@>6_YZ^]^!Y-1N_X3]4=G?[.='-_#^_^M)=O=V^W[OLRTU[_ &G^:=T7
M+/VO?\Z/ .Y^#?[7OL?K'A^1L7XW]?=_M_B-NGM_XK\-^IH=_9W^]['XB/=I
M[?O1U[U0\=I9TNDNZ2VI^QS.F,U^Q?F/L5EC7?;?NGVCJ]^VAOO>\^W6G3VN
MCGI[1]7\)"@/J7\&?](GQ?;XV_6GZG]W-Q\C\3^&_%Z>Q)R[/9_$8VO?KIW>
MZNW^*S:'Z0?J2_Z*?F6CRY^I?U][.WY6+^$_%_@M?Q,8Q[_?_"Y>G9IKV^R^
M[73NB9OY#>0W[>?RA_T(?E3\J??_ /X?_?/?_?/LG_Q$I_:^U^S_ /VSK[G\
M[T_567TC?2-_T6/YP?\ S0?KW]>_@?\ WC^"]C\%^,__ &S+]WW?Q?\ [7V>
MW_#[_EN#ZZ?KI_Z:?\UO_F6_FU_-K]9?_'+]8_B?UC^ _P#V#!]GV?P/_MON
M>[_ [/GK6-S#K^       G74L-[(<)WMB$*,],MY6OJG,*.'$6GWD^7@V<XS
M-NHK493:U2V86#V5Q9.I;-+I)KNHN2)2%17D%D</<]JW&V2CCQS)TS;](J^B
MR,&W\'*^--:;U6MFC^#5S>,,6W?>(<TXMB5SMW6S8Z<['K@U[ED]NW'$LR(*
M#3[XU[=;G9<U%J:6+W+5*4904)44R                       $_:CK\3Q
M;'\CW/F]7%R6/B]A$QK ,)GQH5A2Y7L2UK;*PB2LO@RNY[G",0A0BESHIH2J
MQ?>C1DK)M<A2(ER&[<,_,IXUMDY43O@[+[HN49U8\91BU3)::772EV0EJ_;B
MIS:U4$[O\78/&.-['G^6^88U>X4;;?#$VW;[(5VX^9NEU5ML)YU<]>_;\&NM
M79%.B>599CX\9*N5\H=U8UVN=Q8QG.:8YC4K5N=X51/YIE]97*C2M0Y#$EY#
M453GY=:<]I::UMY-KD*&8%0G[I72.$,,+A\$E7&INWGCF=B[;FWQS]JR;533
M*6JRZVJYR_2/K')@HUN5EK]JR/64E9ZK+Y^!P'RMQW>>7;!M]G&^:;1A2S\Z
MFIPGL>5">512_P +%]EVTWSNRHUXV$OQF+;I"FF>+HHR['=&+1]>ZHUWK:VS
M['\DS'&,ZSS()..T:[^0]C57G6+:S*14VS=W4U!TLVIN\2>7VFT.LS2L.^TO
ME+I#X\:SY[QO^9O6/B74[=?BT5JR?MI62HMR=)P[)S[U.%J6K:E#V^V2ZQ.=
MY;XW1P7QEL/C_<][P=PY7MV];EE3Q<=Y,I8E.XX>T]U%RR*:/P]E&1A62[(Q
MG7>LGWJYZQM13+,L4J,[Q#*L'R!MQZAS+&[S%+MEE2$.NU&0UDJHLFVE.MO-
MI<7#F+))J0M)&?J1EZ"8Y^'1N.#=M^2F\:^J=<TOC&<7&7V_!OX,H7C>_;AQ
M7D.!RC:)*.Z[;FT95+>K2MQ[8VUMI--I3A%O1IZ>C7J><CXLLJM_'WS)V?XW
M9BXW"?R]O(\)ELJ2LDO9_JFPMIU6XV^VX]#]G(HTW1-*,U)?6^SVG#ZB2[JU
MX>S+^,\[S.*YS497J=37VW8\I./7JM'#W=/M;CH^NC[E/KMV';_+OTX;'YGX
MY%V5;<\?-@^FJP-TKJA:G%I3[XWO"<TDG!0L[X+1N%E/FJVVN%A6I]#4[O>L
M\SR"1G=_#C-/KFE4XZVNEQJ&:4_JGH]Y=V\EQ*$)6[WJM/J@C(G)7Y]WMU[?
MA<<H>MV1:[II:Z]L/DK7WJ<Y2>BU>M:]/C2W[,_Q]')Y-O\ Y6W&/;@[;B1P
M:)R<5#W<AJ[)G]JE1357%MN,>S*?YSZPI7H:@R/X_P#Y"M9X3F$MR/5Y91X9
MB>33GK&+&KY]?M7&J=F;(=EQE+B)H\6VJW]1O<HZ*GJ-PRZ9 @/',;*\:>3L
M3;\Z35-U=5=C<DHN.17%-ZKIV5Y'V]-*]=?21LMY6W;9OJW^D'>^3\<K4\_;
M\K,RL:"KE*RNS:\FYPBH2TF[\K:WT[-)=V7HH:ZTFVCY8MP*UCXG7F-U\ER/
M?;?O*S7T-3!-*=:I%=R]RQ]Q+Q])0Y5+4JKG32E:TG8IZ2(_UB+I\T;X]HX7
M9BU-K)SK(TK3350_/L?7X.$>Q^K^=:?:NO\ ^@+QU'G'G[%WK+@I[5QW%LSY
M]VJ3O6E&+%:=>^-UJR(IM1:QY:M_F2?$[I]6L?$ZCR2PC.1[[;]Y9[!F)?-I
M3K5(KMT6)L-J9+I*'*I:E-BT2E+6D[%749'^K0\+[&]HX77E6IK)SK)7/735
M0_,K73X.$>]>K^=Z_8GU^^18\X\_96RXDU/:N.XM>!#MU2=ZUORI/7KWQNM>
M/)I*+6/'1/\ /EKO^6_4MOI[?^L_*;!5N5R\OF53TR;$86R=)M#6[E=,I;5<
MN,F.EMR\I8\5<=)+-\WJJ4X:^#02:P\U[+?L?)<3F.W:Q=\HMM+3LR*.UPEJ
MM/SX*+7776N;U]--POV?/D#;_(WB7>_!/*DKH[=7:H0G)/WMLW%60NJ4).3:
MHNE:K'HH*&51!1U4F]^>E-HTVZM3:^VK0'Q6YSB]9>E'-*D+KY[[)-W%0\E2
MG"]Q36[3\1PTK6@W&3-*UIX4>R6P;Q1O^RXV\XW\ED4QGI_%;7S1?WQDG%^J
MU71M=3J;\F<&W+QGY W?@6[?YMVO.MH[M=597&6M-J]/ENI<+8ZJ+[9KNC&6
ML5YU-BPW?D ^3T\18><DZXQ&\;Q61*0TJ0S$UGJ=<J;E1I>]JGM-YAE"I[4)
MUUI;;4BX82KK0GE6KNZ0EY+\N_@8MO:J+/;;TU2HQM79UT_P6SO46TTI6Q3U
M7KW&<.R*_I)^AW^<-L5#F>X8KRHQ;493W+=5&&+\O=U>)C*B5T(R4IUXEKCV
MR>B].[++4=IIAAIMAAAM#+++*$MM,M-I)#;33:"2AMMM"2)*2(B(BX(;<1BH
MI1BDHI:)+X'1[999;9*VV3E;)MMMMMMO5MM]6V^K;ZMGT'D]     "8M*5]*
M]DE_?7M+"R2+@V"99FT/'[3N*IK>ZI8"443%XRTI#DZEBV\QF3)B=24S6F#C
MK4E#JE%'.379,<*G$Q;)4SRLNJEV1_/A"<OTC@W^;-P3C&?7L<N])N*1:OB'
M!VBWD&=O>]8E.X8VS;+F[A7BW:NB_(QZ],:.1&+3LQX7SKNNIU2R(5NB4HPL
MDU&^19%=9;>VN2Y'8/VMY=S7K"SL)!-I<D27U=2C2TRAJ/'8;+A#332$-,MI
M2AM*4)2DLUAX>-M^+7A8<%7BU148Q7P2^]ZMOXMMMMZMMMMD!W[?MWY1O.3R
M'?[YY.\YETK;;9:)RG)ZO112C&*Z1A"$8PA%*$(QA%)=*.28@
M  -IWQM^9V"^.TG.M;[H>DM:GSQ)V_NVJB9>1ZK(F8*(4LYU;6L2K*1'NZZ)
M'92IMIWM.LIY)*5J<12GESQ_N7*5C;QQ^*GO&.O;E'OC!SK[NZ+C*3C%2KDY
M/K*.JD]&VDGV#?0_]3W$_#3W7@GDVZ>/P7<Y_B:[E19D0HRE6JK8VU4PLNE7
ME4PJAK"NSMG5!2BH3G.$Y[I^0?0VG-?WFKO!#%XM*WFCDVPO<Q30SL?KJ2?-
M:A1G9E90759%DV%TN(RII*G$(C,)98_H[:>PF,<>\5<FY!NL-X\DW3G"A1C&
MJ5D;)V1BY-1E.$G&%:D]6DW.?=+\QON=P^4?K0\1>+^&7\%^DS"QJ<C<)VW6
M9M>+;B8^)=:JX2NJQLBFNS(R77#LBYPA30JZ=%?"/M1LSX?%J/SC\.J?36X+
MB!FFR\09N8,UVQ<0YF.-)^Y6C.*W]=9OE(L&;!=#&;_IT^LWU$\EPGD&^TJ(
M\YKWKQUSZW>M@A+$VZ^49U]J?LVKL@[JI16D7'W')^WT[4XRCVM1:O'Z=,KQ
M_P#53],^'P'R;?3O7*=NIMIR_<E%Y^))7WPP<NJV?=;"YXJK2R>JME&VN[W(
MRMA*1=W>'NSLI\2L"U1D$^MVYG.M=A4LV/D-H@D6M]@L')W&T1CDSG'G8]L>
M'2.S)6N0HWWB=(U]+IJ&(V#FVV[;S7)W_&KG@;=E8UD?;K>L:[9U+KI%+6'O
MIRBNWY4T^WIH3?R;]/?+>6_3]M'C/=<JCDG*MFW7%M63DQ4+,K$HS9KM=ELI
M.&2]MG&JZ3M_33A.+L:L[B)/*WXM*BWU],5XT8EC%;F5[GU)EUW%NI#=:BJH
MJW%;FGDXOB$I$&:[ AV=W:-3GH?4Q$4XUU&I*68[:,_PGS!G8>ZURY?D9%VV
MUX<ZH]B[F[)6US5ER[HJ<HPC*"FDYI/31N4Y.LOJ#^A;C>_<,RJO!FV;7@<L
MRM\Q\VU7S=<(8U6)DT68F#-4V.BNV^VK(G0Y0HE.+DYQ56/5'6]I7%?.#QQ\
MD\7U'B]/G%ED6'N'GDO5<7+G&L!O\1D]46XN^S/N:[#E1)9/+89FO=)M6J6T
MES)0E M;DF=XUY;Q&[D&=/&KIN?L1R73KD5W1^:$/EA*[5:*3A'76IM_F-LT
MO\2\>^K;PCYRV_QCQ['W7+SMO3W&S:(9[CM>5@6:UY&1^ER*L#LGW2JA?9HZ
M\U0BOZYA&!Z6O'WR+P#R+Q>=?89(E,SZ"T?Q_+,?LF$QK;',B@MQU6-5.;:>
MEPG7(JY"4F[%D2HBS/\ 5/NIX6>JG(>.;GQG,CB;E&/Z2M65SB]865RU[9Q;
M2DD]/2<8S7\*,7T.Z#QCY5XAY;V*W?>)6V-8N5/%RJ+8J%^)E5J+MQ[HQE.M
MSAW+])39=1/JZKK(K4GT8$L<@3R%U=EVX<0K<'QG.KK7U?9WT(LRNL==;CWC
MV)M<O6=753%'W:^;9]I+"9+7ZV.3AK21\&D\UL&Z8NSY_P"L,G&JRYPKE[<+
M.M:M?2$YQ_AQAUEV/I)I)Z>J@'DGB&[\[XW_ #9VK=\O9:,C)J_%9&+I')EB
M1;=^/1:UK19>M*_?C\]47*45+3LEJ(\I=4:^U3J/>FJ-4:,QG%\)Q3&E7>:;
M[VG*MW;&US%:HDZMQ? Y%Q FVF99%>SEQX[$M,YJMK9LE+27')#:H@N+AV^[
MGO/)-LWG>]SOR-SNR?;IPL912C4NZ,[+U"4:Z*H+NDX.N5ML(]ST@U8:)^>?
M''$> ^)^7<#\>\1VW;.(X.U?BL[?]UE:Y6YDW7;1B;?/(JMR=PS,B;IJAD1R
MJL/$R+O:BYY$)8IY]QM>=*)*^!(1F&0XE@5+K+";K(\EMZ?&:V596.PXSDZS
MM9C%?'DV*Z[.H<"*V;SY+>6VPVTT@E*Z220BF\XV1@8V3O&1NVX48--<[91A
M#":A"*<G&'?ASF]$M(J4Y2;T6K9=G =VVODF[;1P3;.#\7W'D6=DX^'7=D9'
M(83NNNG&J-E_X??:*(:RDI62JHJJ@NZ2A&*T/9E@>G7L$P[',2QG8&:8U2T=
M1 @0:2LJM6)A5S4>,TT45@W]:OOK;8Z>A)N.+7TI+E1C0G,S,C/RK,W,D[,J
MV;E.4FVY2D]6W^5GZ6-DV3:N-[/B\?V*BO%V;"HA3136M(5U5Q480BOLC%)=
M=6_5MO5F7?DK)/[;NP_^9FI_[V XVJ^Q?T3*:#\E9)_;=V'_ ,S-3_WL U7V
M+^B-!^2LD_MN[#_YF:G_ +V :K[%_1&@_)62?VW=A_\ ,S4_][ -5]B_HC0?
MDK)/[;NP_P#F9J?^]@&J^Q?T1H9^RA33+3:WG)"VVT(7(>)E+SZD))*GG4QV
MF&"<=,NI1(0A')^B2+@AX/)_G#_,A_[5P>!/^R ^,#^[;A@ ]3WS^_$/5?*Y
MX?S*C JK'XOEKI'[EFGCIE5HN/7+N9#C+3F5Z<M;R3)AQ(&/[.B066F7I;B8
ML"YC0I3JVV$2.L"8/A+^+##?B@\*L1TSV,?N=^Y[['8GD[L>G86[^:MH3X"$
M%B]1;3.;"7K_ %;7N?9J-'3$CR>W*M?9Q)EK-0H#R _NK/\ O^?R(_['_P M
M_P#;G^/  O\ _OO/^*SX/?R_[$_N=1P!Z?OB=_WK+XT_]@!X;_[777( B_Y7
MOE>\<?BP\<<WV5LK-\/G[RGX?<N^/WC\[<Q7L[VSG;T6="Q92L6A3F<B@:O@
M9$RC\PY#T(AUL-#B$..SW8<.2!Y@OW,/Q(V/867F%\E&TZJP[>V.WHK5V8W,
M=UBRSZ2_EB=D>0.1Q._&C%,Q_P#-U7C,1$^*;L25;1+&+U(>KG4$![S
M                !'FW?[$^S_Y/,U_K;LQ57G;_ )D.9?\ )3=O]09!+O'_
M /P]V3^R^'_JBLUH^'/]FJ#_ -;U_P#Y7:'4!] ?_6&QO[%9O]XB;I?43_S;
M6_Z,H_O3-N([U#K_
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MO'V."                                   9G'_ *2P&R>Y(G+[)ZZ
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MTE_ET-J'&@JD/RZC#FGW'7K]G#(DA:RI8>1/]E;K1&LHR6S9BFQ%6<<HGL7
M.,\<WB_>MIH5>3?'1+5N-2?6:J3_ #%-Z-KKVZ=L.V#[2[/(_P!3?E[RMP/;
M?'W-=R>3M.WV.<IJ,86YCBDJ'F3BE[T\>/>HS>CL<E;>K;X^\]1_RH;!S#=W
MD]J7P[PJW<CUC4S#(EK7)EJ^WR=B['L66:N9D$6%)?ZX>,XO.AR&52&VW8Z)
MTEPD]M:'%TGYBW/.Y!R["X-@3:I4JE*.ORN^^247-)OI76XR7<DTIS>FC3?8
M-]!_$>.^,?!W(/J,Y-CJ>;*O,G58X?I([?MU;E;#'E.,=)Y.3"ZN:KE*-DJ*
M(-]\90CN/\<O%#3/C'B=?0:\Q2K3?)AQ49%GLZ"U(S#*;)N&W&ESY]O(.3,A
MPY+I..-U\=QN!%-Y9--)-:S7>O%N&;#Q'"CC;73#\3VKON:3MLEIHVY/5I/J
MU"+4(ZOM2U>O7%YD\^^2/-^_W;MS#/O>U.R3Q\"$W'$Q:W-RA7"F/;"<XKMC
M+(LC*^WLC[DWVQ4?AY+^)FH?*'#+3'<YQVKC9,J'(+%]B0JR-^;<4M3C*9AS
M(U@TJ),LJMMPD')K7G_:2T-I)1)6AIUOUY9PO8^7X$\7<:H++[7[=ZBO<KEI
MHFI='*/IW0;[9)+71I-?;PG]0'D/P9R6C>.+9E\]D5D?Q.WSME^$RJNY.<)5
MOOA7:UW*O)A#W:G)N+<960GIO^*38N<:7\E-H>(.?SG&XTIS+&(=&JP*37U>
MS->3'&[I>/HDR([;D._QN'->>=BM..2D0(SO3VD+<117AG=-PV'E>9P?<Y-0
M;L2AW:QC?0_G[-6NDX*;;BFY*$'IHFUV._7QP[B_DKPML7U$<2J4KZUB2G>J
M^VRW;=P@G2LAQC)J=&1.F$(VRC&J5]\.[W)1A+T5C:(Z<P
M              W0:X0VSI_3,=EIIAAK6U4MMEAIMEM+DZTNK.:[T-I2DW9=
MC.>?=4?U..NJ4HS,S,:X[LW+D&Y3DVYO-GJV]7\L81BNOP48J*7P227H=M?
M80J\5\2HIC&%,./TM1BE%)V79%UCT276=MEEDWZRG.4FVVV90.&20
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M):+-HVBOI\U<+Z+=USYKN3]JFJ$<"E.,HV7Y=LUVRPWK7H2\HH
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M
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M/)WB&,<C(J_G#15W*,IQ4WE8\6M-)2ZN^#>C;]+DWHTTO;$+5-/0
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M2?5MG+'J<D
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MFE#<\)NRB+E+MA7F5M*_;\AMQBZ,RNJ3F]*W;%QE*'A(BJ@
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M8'+.=[WRK:L?\'MFY[OF9=-'RKV*LC(LNKIT@E!>W":A\J4?E^5::&%C)D2
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M%^)8];MISYPG=^"G/MC&_&NKA;;M^3%*5E-5E5\(7X]CG"XDI4@
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MD&=551%_FRHVWWZ_=C\JU[LC(R*FU*2UHTTBU+7=R*%.R@
M
M                                                           -
M7/G+E\B9F-#A/MTMQJ:M:NCDDM1JD.67>991V_1*#CDR[R9]742T\=/"NJSN
M X453=N#?S2E[:7V))2;U^_N7[WQZ::H?4=OLY9V!QJ,-*X5/*E+7\YSE.J$
M4O1=JKFVWKKWI+MT?=1,6&:R
M  !V51:S*2RAVL!2$RX3Q.M=UM+K+A<&AUB0RKZ'HTAI2FW$'Z+0HR/T,?')
MQZ\JB6/=K[<UH].C^YI_!I]4_@UJ9#:]RRMGW"K<\)I9-,^Y:I2B_@XRB^DH
M2BW&<7TE%M/HSN\IJ8C"HE]2H<+'KXG7H1++UK9[1I^YT3JB,^7*QYPNVH_5
MV,MM?\\?'$V_(LFI8F4U^-IT4OZ:+_-L7W22Z_9)27P,QR3;,6F56];1&7ZA
MS4Y5Z_X%9'3WL:3^VF37:WUG5*N?\)Z8D,B1<
M          ,SS[]5DLFL21)1C\*IQOMI4THD/T57$K; S-E*6S<>LX[SKG'4
M7<6KZE?QCQFS_-@QO?5W2G9KU]+)N4?7KHHN*7W)=%Z$MYO^BY#9MR24<&FC
M%T33TEC4PJM_-26LKHV3EIK\TI?-+U>&#)D2
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MO&V&577>I*Z&'BQ:EJFG'%ICVM/JG'331^FFATXY1BP
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MW3=LB6%DU^U9BY4.DHW0MQ]:5;DUN.590VKJI72C;'OC)E5A/#6L
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M/MEI+ O @0
M
M &GSS,G-3=U2DM$HE0L=IX+Q*+C]:TY.<Y2?\\E33R3_ .#Q^@6]P6$H;+*3
M])7R:_)VP7]RF:5?4+D5W<YJKAKW5;=5"7Y7;?/I]ORSC^[T*H"9E%
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MQ\U8G;*KXQC%_P!V<E_[$Y,\:4,.O,U7;9;9#3XIUQKDW^[[BT_(S*!]#C
M   '#GV-?5QSEV<^'7126E!R9\IB)'):_1"#>D+;;):S+T+GDQZSLA7'NLDH
MQ^UO1?T3[8^-D95GLXM<[+=->V$7)Z+UZ)-GYKK6LMV52:FQ@6<=#JF%R*Z9
M'FLH>2A#BF5.QG'4)=2AU*C29\D2B/\ 20\5VUVKNJE&4==-4T_[@]LG$RL.
M:JRZ[*K&M4IQ<7IU6NDDGIJFM?N9SA[G'        #,,6L(2TR\9NG6V::]-
MHDSG^XI%#<-$I-?>(2CDR;;-9LRB(N5QG%?BI*.,;N%-J<<[%3>53K\J_P $
M@_SH?E?K'[))?!LE7&\[$G&WCV[RC#:,UK2R6K6-?'559"2^"U<+DOSJ92]9
M1CICMC7RZF?+K9S1L2X3[D=]L_T+;5QU(5^"VUEPI"B]%),C+T,AS:+J\BF-
M]+UKFDT_R_\ ;^U?!]# Y^#E;9FV[?FQ<,JF;C)?>G\'\4_6+71IIKHS@CZG
M#                              ,FPR$S899CL64KIAKMX+DY?')HKXS
MZ),]:4FV[UK1#96:4]"NHR(N#YX'!W.V=.W765_RJKDH_P!4UI'XK^$U\42'
MB6)3G<GP,;)>F(\JMV/[*HR4[&EI+5JN,FEVO5]-'Z'3V4YZTL9]G(,S?L9L
MJ<^:EJ<4;TM]R0X:G%F:W#-;A\J/U/\ $QR:*HT4PHA^9"*BOAT2T70Q6X9E
MNXY]^X7ZN^^Z=DM6V^Z<G)ZM]7U?J^K^)P1]3A@
M                       %7?-*R5#U9J^DZ7/^B#.\VNU\OFVAMG%Z'%*V
M([[/MG[A,Q[*I*$/&HB;5%6A)*-2^B:^.*5;O^=D]/T.)3#T^-MELFM?AHJH
MMK3KW)O31:ZX_5QN$L3QMQS9]):YV];AD/YM$HX>-A50EV:?-WRS+HJS5*+I
MG%*3E+MULBY3K^
M                 #[QHTF;)CPX<=^7+EOM1HL6,TX_)DR7W$M,1X[#25.O
M/O.J)*$)(U*49$1<CUG.%<'98U&N*;;;T22ZMMOHDEZL^V/CWY=\,7%A.W*M
MFH0A!.4IRDTHQC%)N4I-I))-MM)+4WW9\I*\[S5:%$I"LMR-25),E)4E5Q,-
M*DJ+DC(R/T,:K;.FMIQ4_7\-7_>(G=CS>49<TW>46G%[IE-->C7OV&)#(D7
M
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MC3[:E8JN_P#"W3HW#MUE"3?X3Y83BY]KC8H5G$U->@
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MLFX[GK/=]CWC*VRJYR<I2V^ZFO-HQI:]5##R'F3IZM=N9*&D8UPU@<2LI8
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M5D_YHQK[*I_U5<W"7]%,[49LX
M
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M^$B;VM\IV+\1UER';*4IMM:WX<>D9)>LK,7I&7Q=#B_2F3, &7(0
M                      9KAG5&_--R7T_9\1N>ES];]#U_[?$FN@VN/UQ?
MF U)Y4DD])J]>GI/&;GI9^'Q7_@N3#[/2O6Y^OP_1Z/\NGQU)=Q+NQ_UENT>
MGX3:K]'\W263VX2TT_A?UTVM6DM'+KV]KPH9,B(
M                         %&?.*S+\R:IQQ'MS^U:V<N9A(-2Y+5EDN9Y
M2XEA]9.J9)I5!65S[:$I)23?5UF9F2469XQI_K3<,QZ_I,U0C]CC735U7377
MW)61;UT?:M/M>FWUC;@OU_QG88>W_6W'W?9IJYQMR\_,?;)ZN.GX:G%LC%)-
M>Y+N;;48T=%G&G(
M                  9]JF%*L=HZVKX+"Y,V?GV'PH<9HB-R1*E9#7,1V&R,
MR(UNNK))?S3&)W^RNG8LVZUJ-4,2YMOT25<FW^XB;>-,3)W#R/Q_ PX.S,OW
MO!KK@O64YY548Q7WRDTE][-S]ZXV]=W#K2T.M.VM@XTZVI*VW&URWE(6A:3-
M*T+29&1D?!D-=,2+CBU1DFI*N*:?PZ([:]YLA;N^5;4U*N63:TT]4TYR:::Z
M--=4UZG5#[F-
M                   XEU]6%;3:5]3;FF-T=QM7JASL:LRZ6QUH/Z5=F7';
M=1S_ !7&TJ+U21E[4]-QP9+\Y;EA:?NY5*?[Z;3^U-KT9QMV^;B/)*Y=:Y<2
MW_5?!]NS9TXZKT?;.,9Q^R48R75)FD(;,'3R
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MEN/F;1M6;F3JG%_+;C9F-19CV0^2=5SQ\B$W&JRFZ!!+"DP
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MJ_DVXYVXWT4QJJEE7VY$JZH+2-=;MG-PKBDE&$=(I+1)&/#F&#
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M7(=TG=79U]VW!QX0HQE8GIVQCD+-LJ6GS5W*Q-QLCIN#%*G8
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M/L.OSDFYPWKD6?O%:TKR\V^Y+[%;;*:7[G<9,)@84
M
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M;^>G.I-ZNFQ?RV+-Z+YZ)/2+:7?4Z[$M)F&C)$3
M       #-81>TP&^DFVA2[C(Z&K8<,GC4B/6P[:SL23P:&"6M]Z%P9]:NGK]
M$\D9XRW])N],$WI719-^GK*4(Q^_T4_L^'J2[#2Q>$YN0XISRL_&IB_FZ1JK
MNMMT](ZN4L?37N>G=TCKJ\*&3(B
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MQ[;*NYO2%FGR-N.DDXM-IZN$5IW;&AFR
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M[\BY9&%*7;"G%6P84)SOE)-V6VWQY"Z(5=L:H0A9;*4K%4E (EI2
M    %E/$+_&(U[_\EG]8^3#3/]H+_P!4/EW_ )K_ -^MN.P']EK_ ->[@O\
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MXK=<\;R'NWMY>^R[FK<?'ZSV_99I?FZ1<-RSJT])76X=-Z][!<*ZU":FO@
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MG*!
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MO%WXK#H_!XKIVN]6^WDY%-N1^BP<J?9BUWV?HNWL[IUJ>J$=\A^9P
M                     +(>(L)V=Y$:X0TII!0Y&1W,A;R^VVW H,/R&\LG
M#5P?*FZ^O=4DOQ4HB+](AGD&V-7#\QRU^95P6G\:RZN$5^[*2+^^EW#MS?.^
MP0J<5[4\J^3D]$J\;!RLBUZ_:JJIM+XM)?$V<"F#L1
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MO4K+(MR+K7/+E.=Z2BW-MRTBE%1;?7Y8I12^"22Z([P>Q\
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M&Y6>ZJ8*SODVW*??W=S;;<M6VR1APC/@
M
M                                                8AG\EJ'A&52G
MXK<UEBBL7'(CW!-/I3&7RVOE#B>#_FI47\)&7H/MCQ<\BN$6XR<XI-?#5KK\
M/0X6Y70Q]NR,BV"LKA1.3@_22C%MQ>J:TDEH]4_7T9Y_!L6=80
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M,S,S&TT8J*48I**6B2^!TJV666V2MMDY6R;;;;;;;U;;?5MOJV^K9^!Y/0
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M:]_V_?EA9.%NLZL>VC!QJ%WXU]CQ)VU96:JY22=C@W'7V7IJW'>*?G%
M                       "U?AA#=?WO6SDFA,>FP;:TR:I9GU$U/UIE6.1
M2:0E*E.+<M+R.CCT)*5&HS(DF('Y(LC'BTJNO?9EXJC^6.358]?R0A)_T/5F
MRWTE8MEOFC'S4TJ,39MYG8WZZ6[3F8L-$D]6[LBJ/W)N3:29L=%0F_(
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MGN.,8NN;2Z=R7=&4GU:[%_!/5>+#-90
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M_DK+X;BN?ZHXK"&QX\9**TCMFN/D6)1T7]=YRR\Z;T3E9E3DXPU[(P4)24R
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MIK5E^V[/CX>WVXE>6J8NS\%.Z_,>/D9/Z/&>/;378E:X1K()N:[@
M         !:75N&.YIIO)L7P)ZBN=HYOGM526&*W.P<0Q"P9Q>AB5USB\O$\
M?RERHD9K;9)D,N?%>1!GNOPTPVDG$6<M#B()ONY1VSDE&=NRMJV+%Q)3C;#'
MNNB[;'*%JMLJ[U3"NM5R3G6HS[Y/W%[;B]D?&_$K.7>*-PXYPF>%E^1]XWNG
M'MP[]SP<&V.'C0JOPYX6+F.B6X7Y>5/)IG''R9V4*BJ+Q9O*A9"K0G9K<
M   !FN*ZWS[.#/\ *.'9'D#25&AR76U,Q^O862'7"1)LB:*!%4LF%DDG'$FM
M1=*>5<$*VYUYC\4^,HK^V!R+9]IO<=8U9.55"^:UC'6O'[O?L2<XN3KKDHQ?
M=+2.K+<\;> O-GF&3_M7\4W[?,:,G&5V)A7V8U<NV<NVW*4%C4N2KFH*VV#G
M*/9#NFU%_/,-?YGK^3#AYGCUACTFP8<DPF;!#:%R&&G.TXZWVW'"-*'#X/\
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M[3;#+9=+;++:6FFT_P#"H;024)+^81 #Z
M
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M94_YOYZ<ZDWJZ;%_+8LWHOGHD](MI=]3KL2TF8:,D1,
M      ,CQ"O:M,IQZ!()'M9%O *:;A-J;17MR$.V#JT._JW$-0FW%&D^>HBX
M(C,^!PMRNEC[?==#7W(UR[=-?SM-(KI]LM%K\#/\5P:]RY)@X5^GX:S*K]S7
M315*2=K:ET:C6I-I^NFFC;T.LMK!RWM;.U>(R>L[";8.DI?<43DV2Y)<)3G2
MCK,E.'R?27/X\$/OCTQQL>O'C^;7",5^2*2_[1CMTSK-TW+(W.[7W<B^RV6K
MU>MDW-]=%KU?KHM?L1UX^QP0
M        #H<YLBH]5[CNU>W24+5F6UO<E*43*#S2.SKU'"4.M+<D/+RXFV"(
MS(GUH4I*D)40Y.W4_BM\V[%6NL\^F73U_0MY'V/HO9UE_2II--HPO,=P6S^-
MN5[P_;2IXUFU:SU[5^/C';%T3BW*3S5"OU2LE"4DXJ2-*HV1.HH
M                                                        N5X1
M0G']F9I8$XTABDU1DLV42S<[CC=E>8KC$9N.E#:TK=^XY PI74:$DTE9\\D2
M55SY,L4=FQ:=&YV[A6E]B[:[;7K]W;7+TUZZ+[UMA]'N'.[R%N^<I15.'QG+
MLGKKJU;D8>'!0233?NY-;>KBE!3>NJ497^%5F[X
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MP,.7=D;9QW#QKUK%]MLK\O,2^63:_0Y=,M)J,OFU4>QQE+:^+G-!
M    )QTU7T=$JSW-E?1-Q_5=[B95^+H:D.2<RSZ];R*WPK'I#K1M-5F.<X9-
MEVLM;G6F+%-AE"WI#?3%^27964H<;P-8Y>?5;W6ZK2FB'MPNL2>KE9^FA"J"
M6G=+NDU&#UN/Q-@[-LTLCRUR;2[8^-9N%[6&HR<\_<LA95^WXLI+MC5B_P!8
M9%^9=*7<J:735"=M\.V&[*QF6]C/MK%[W%A:395C.D=MIKOS)K[DF2]VF$-,
M-=U]U2NE"4I3SP1$7H)'337CTPQZ5I37%1BNKT45HEJ]6]$OB]2I]PS\O=,^
M_<\^?N9V3=.VR6BCW662<YRTBE%:R;>D4DO1)+H<(?4X@
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M<G%X[L>T+ H_$6QMR+E+,S,^Z^YUPA7&5F3G7]E4$XU5*N#G9*,K)1B,X5V
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M[IV['E]Z2LCV6UV5SE795=7J^RR$HOIJU*+C9"4JYPG*:AA2?@
M
M
M       !1[S8UU/R3%J;,JN,_+D8HJ0S-:80XZM%7-4A3[I--J/DD.MI6M1I
MX0AL_4N>#F?"MSKPMPEBW-1JR$DF_P"/'7MZ_?JTOM;11GGGBF1OW&:MVP82
MLR]MG*;C%-MTV**M:2]>UPA-O3I",WJNNNJX6\:4
M                       !FV)V<1UF=B=T\VU37YH.-,DKZ6,?R%I*FZR\
MZC(S9BF:_;S>GCJBN&LR6IIM(Q>XT61E#<<5-Y5/K%>ME;_.K^]_PH:_PUIT
M4FR8<8W'%MJNXON\XQVC.:[+)O2.-E)-4Y&O\&'7VLC336F3DU*54$8K80)E
M5.EUM@PN+.@27HDN.YTFMF0PXIMULS0:D*Z5I/U29I,O4C,O49"FZO(JC?2U
M*J<4T_M3ZHC.=A96VYENWYT'7F462A.+TUC*+TDNFJ>C7JFT_5-HX8^AQ0
M                   )"UQ#E2+6ZEP65/3*O$LCDQ4E(C1B1*GPCQ^*^I<H
MNA1L2;I"T)(R4;A)]2+DQA][MKACU5VO2NS)K3Z-](R]QKI]J@TWZ::DZX!B
M9-^YY>5AP<\K&VO*G#YH0TG;7^%A+6?1]L\B,HI:-R4>J6K,=M,3RBD-PK?'
MKJN)KK-;DRLF,,=+:^A;B'ULDRXR2OP6E1H/]!F.9C[C@96GX:ZJ;?PC*+?7
MX::ZI_<^I@=RXQR/9W);I@9F.HZZNRFR,=$]&U)Q[7'7^$FXOX,Q\<PP8
M                                         !$GD;:(I_';8BE.--*R
M6[P#"T=;;SKCYR;Q_-U1&NVE33"E)U_WC=<X(DL&V1\N$2L[Q&AY',,))-JF
MO(N^"TT@J-7\7_FC31?QM=-(ZJL//>XQVKP/OTG*,9;AF;;@+52;EWY$MP[(
MZ:J+:VSO<Y:)*OL3UL2>I(7Z=7X
M                               !>CP<A&5QN*Y4Y^K:UO68^E@D<K7(
MN-B89<MOFLU))#++&*.I5Z&HUNHX+CDRJ_R=9K1MN,EU>;*S7[H8]T-/RMVI
M_D3^XW+^CC$TW7E>ZRE\D>/U8JCIU<K]TP+U+77I&,<*:?JW*<>FFK5X!6IN
M(
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MW#/NPJMMNONGMU$[)U52G)UURM[/=E7!OMA*SVZ_<<4G/LAW-]L=-"'SG_\
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MS;,F4X^_9OF/&J-F#31'6ZZG(V[*E/)G*,:<:=6)<KHZ64Y%:A-37P
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M5X63/"I@[+[<._'SL['S)XE:<[Z[/P5UE496X]%G;.N$ B6E(
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MR%S6#O63[^WV:MQKS(UZ743CU2CDU5PE7-=JC;4XR4W?%U^F0:J'=
M
M
M            'R?89DLN1Y#3;[#J30ZTZDEMK2?XI4E1&1D -)_DOAS.&;<R
M*%"A-0*RQ]O:UL:.R3+#<=YOL+Z2(_J<=?CJ=69DDS4YSP9&2E75Q#-EF[+#
MW).5U4I0;;;?KJO7[(M)>OIZ_!:'^:]AKV/G=[QJH586757=",(J,5K'LLT4
M7IJ[(3G+I%ZRUTT:;@(2<J4
M      ,_DD>7X]]P21N9+BD)ABU2AI/<M\6C]N+!MC-'"G9N.\MQ9)F1FJ&;
M"_P9>6,1#_R;F^R^F#D2;AU_,M>KE#[HV=9Q^R?>OX443?(3Y3L7XZ.LN0[9
M3&-R26M^''2%=W3K*S%^6FUZ:NATS]*;I& #+D(
M S2N,H>#9))ZC)VWN:"D;0E2B)<.,BQNK$W"2CA1-RXD'I2I1$HU&?29H(TX
MR[]+NM$-/EKJLF_ZI]L(Z?N.SX?=JM>LMP&L3ANX9&K5N5EXV.DF^M<%;?;K
MHOA.&/HFTFVWHW%./05UY=TYDJIN+2K4E:W"576$N$9..-]I:R.,\T9+6T72
M9_B:?3\!S+\3%R5IDU5V+33YHJ7W_%/X]3"8&\[OM34MKR\G&DFWK5;.OJUV
MM_))=6NC?Q73T.^//<B>,_N2JF[2HW5+^^8_1VKZS?3TO*3/EU[EDPX\9$I2
MVGD.*41*-7)<CA_JC"C_ "'N5/I_)V6073T^52[6E\$XM:=--#-OFV_6M_K!
MXN8FVW^(QL>Z3[EI)^Y.IVQ<O5RA9&3DE+77J?I.1XW)5S:8+5\GT=;U#;7=
M,^YPVI#BU(F3+NM;6M72HB:C-H2HC^DR,B(\+.@OZWR[/R60A-+^ZQKD_LZR
M;^\\QW_C^0]=RV7&^&LL:[(HD^FC;5EF14FWHUV4QBGK\K3T1#6O9BT)]WEU
M!UK9(U.Q*C*&F4F70\3CC,G%GEH2L^LEI:-1)(T]M1\*!RWFI:]N-=HGZ.=3
M?V:)JU?=HWZ]=5Z"-?!<N2B[=UP4W'K*%&8H_"6KC/#DTG\W<H-Z?+V-]3\I
MQ>IEFG[;F^-NJ4DC]O9MW5))3^L[1];LRJ.HX+DE%Q+4HT'STEPK@\_(K_E\
M6]+[8]DUZ:^D9]_W?F::_'JCQ'CFV9.GZOWC;Y2:_,N61CS773K*RGV/L?2]
MOM>NBTEI_/R!EKB>J%5HN2Z.LOR[95.2J41.=M1(3C\ZR4M;:O5:2(U(3]2B
M)/J//ZXVY/2VQU=?\$C.K[_\$C']Q_'T74\?S'Y/-:X>,LM::_UK;3E_'1Z+
M&LM;:?YR76*^9I+J8W.K;&K>./9P)M<^1K2;$Z*_$>)3:C0XDVY#;:R-M9<*
M+CT/T,<VJ^F^/?1.,X?;%IKKZ=41_,V_/VZWV-PHNHO3:[;(2A+5/1K223Z/
MH_L?0X(^IPP                                  "LGF9:>RU!@%(2W
M2_,VR<CM%H;;:[#GY&QBFB-KEO&LGC=:_:&HHZ22I)$M\S-)FDE3/QU1[O(\
MO)Z?H,*N/J]?T]LWT7IH_P .NY^O2/KUTUW^K+<OP?BO8]H3DOUCR#*N:27:
M_P!78=$$YRU[NY?K1^TDFDI7-M-KNUI"YSKX
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M -)VT/Y&-V_W),T'M3_LA@_V2PO]5TG&W7_@IR/_ )(\@_WDSS2"-F#IY
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MB/*<=XV^X5BA;6VI+YHQG"<)Q;C95;7*%M5D&X653A9!N,DWBHYY&@
M+9879W&L= 6&4O5=13V64;$IUXU&S/$<=OZ[;.',4=S7936QJV^@3+"318U8
M.,+.<VVB$B3)6AF2B:A)% -RHQM\Y;#!C99931AS]QTVV5RQ+G.$JI.4)**G
M9'N78VYN,4Y0=39LYQ+<-U\=>#[^26XV+B;AN6_4/$AGX.+DU;U@QQ\BK,JA
M5DUV6SQL2UUR>1&,:(VW3A5D0S(12B'--KS\LH(>(56*XEKW#8MT_DS^*X.U
MDB*RTR=^.Y!3D%M)RS)<LNYLV'6NJC1&CEE#A,..%'9:4^^IV0[9L%6WY<MQ
MOOR,S<I5*I6WNONC4GW>W!55U0C%R2E-]G?.2CWRDHP4:MY=Y,S>3;'5Q;;=
MMVO8N)UY<LN6'MZRU3=F2BZ_Q-\\W+S<BRRNJ3II@[U1CURL5%-;NNE9%8SQ
M6H         !9CQ5VEB>I-A7.29B].8K)N&6-(PN!"7.>.?)N\=GM)4RVI)I
M:./6NF:OP(R(OTC2WZZ_!W///WB/;N'>/*\6S>L;D>/FS5]RHA[%>%N%$FIR
M33E[F17I'XIM_ ["?V:_U'^,_I@\Y[MS[RK;F5<>S.)Y6WUO&HED6/(MW#:\
MF"<(M-0]K$N;EKHFHK^$=YY7;@PG;V28A98@[9285-43(5@4V&NL>[C\],A*
M&#>)\CZF2/ZNE1)/]!_@(Q]!_P!/7DOZ?>&\AV7R!#"IW/<=PJNQW3<LF';"
MAUMS[>STGI\O<G)>DEZDP_:7?5/XA^J3G_%N0^+K-PR-HVG:[\?*5]#Q+.ZS
M)5JC7W^XNL-?G[9*+]8R]';3!/+/QXLL4I<>R.H=PB)1P8T6)C]M1R\KIH)5
M[#42(W6SZV!9R9G3&=4E+[\:.ZKI<ZR(U)-S0?RC]!'U=[-SO<N7<.W"')L_
M<\JRVW/Q<VK:\N[WYRMMED49%^-75K9",I4T9%]4>ZKVVU&2J[.O#/[3?Z$]
M_P#&FT\%Y]M5G#]LV?#JIIVW-V^[><''_#5PIIAB9&+C9=M^E4Y1CD9.)C72
M[+_=2<X2NZC:OFQ@]3CTNBU$U)N+=V"4&MNW*N138_1M*9;:)^+"G-P;*1)A
M-*-++1QVF4N()1J6@NA<@\%?LU?)V_<MQ^4_4#.G;N/UY3OR,..37EY^;)3E
M)PMNIE=CUUW22E=:K[;I5RE%1KLE[E<7^I3]KQX<XSP;*X9]+M>1NO*+<-8V
M+GRP[<';=O@ZXP5E-&1#'RK;<>#<**7C4T0MA&;G95%56ZLWGGI+SLB0Z[(D
M2'7'GWWG%NO//.K-;KKKJS4MQUQ:C-2C,S,SY,=Y>-C8^'CUX>'7"K$JA&$(
M0BHPA"*48QC&*48QC%)1BDDDDDM#\WF7EY6?E6Y^?;9?G7V2LLLLDYSLG-N4
MYSG)N4IRDW*4I-N3;;;;/D/L<<C_ %I_TN67\H&V?[J>9#&;3_F6?^B<G_5%
MI+>;?[,T_P!B-J_WKPR0!DR)$:9E0Y%D$QI,5#":Z(@R90Y(0A3CSG'>?6DB
M,_P(DI(S]"(S].HQ0_D_A_-N9;G77M\*5LF-'Y%*R,7*<M.^QKK]BC%-]$FT
MDYR1V5_1UYX^GCP#P_+R>4WYT_(>[7)Y,ZL2RR%./4VL?&KFW%>LIW72A%*<
MYQA)SC17)91BU&FAJFHJB2<MT^_-<2?42I"R(NA*O_<;*"))<>A\&?XF8L'Q
M_P 2KX?QVO FH_K&Q^Y?)/76QK\U/^+"*4%IT>CEIK)ZZO?5#YPR?._E7*Y-
M1.Q<4Q5^%VVJ2[7#%KDW[DH?"W(L<[IN6LXJ4*7)QI@HY&)N:Z@
M     &P/XP/RVKS+UFWD3,9Y3D7*/L293#CS:+QC'YTIMY)I0IIA;-9'E+ZW
M32@B(RYZC21U7YF_%+@&5+';4%93[FCT^1V16C^U.;@M%_<:FYOT"K:)?4SL
M]>Z1A+)EB9_X;NBY:9$<2V>L=$U&2HC>U*6B6FB?>XI^O<:4'Z#
M
M
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M(VPZ*,8N5$Q:1I@
M                    ;)?"^&W&U7LVP)2UO76P,(AK09I)MAO&,<S%]I2"
MZ34M<M67+)7)D2293P1]1\4UY&L<]_PJNG;5AWO\ONV4I_O>ROR]S^P[ /I)
MQ:\?QKR+.3;MS-\V^#732*Q,7.DFNFK<WG2UZI)5K1/N>EHQ"C8\
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M3R%/^%.-5[QG7KK&IW6Z:.YZQJ.VHZIP
M     [2I4I+\TTJ-)G0Y,GE)F1]*\<M4+3R7Z%)49&7Z2,<?*2=<=?\ #:_\
MDB9';)2C=<XMI_@LM=/L>+<FOW5T?W&B,;1'2^
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M3;,[9=SR-GW2MT[GB7V4W5O1N%M4W"R#:;6L9Q<7HVM5T;1UX^QP0
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MMA?6W^&K6FLXJ#NE+2JQ1AWRON6Q\'\0[37C>1=KPN0^1<S*B[=N_'7QJVO
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M1M]/)L65BQ??S<G*S82Z=URIMN6,HQA)1KMKQ5;&2F_=6NANH%,&^8
M
M
M               &H'S1?CR-S&J,ZTZA&+4[2U,J2M*7FY5HEY"C29D3B7.>
MHOQY%N<#36SV:_')E_>*S2_ZB91?-\9)IM;74G]S]_)>C_<:?Y&5+$U*%
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M_+ZZOU);S5*C>EMJ3BL+$QL=III^Y71!7:IMM:WNUZ/1Q346HZ=JPL9,B0
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M^-C[I+W*\F^ZN27;V=B@X]T9-U4$\-:0
M                                    #:'XBQ&8VA)\]!NJD7.WLFB2
M"4M'9;9QK#,">AFRV39+)U]>6/\ =-2U$9-MDDD\*-5(<^LE/ED:GIV5[=4U
M]K=EV0GKU]%[4=.GQ>K?33L:^ES%IQ_"=V;#N>1E\IRX2U:[5'$P-ME7VK37
M63S;.]N36D8:):2<K"B*%Z@                           !(F%U2#0JV
M<6Z2R<<88;0YT-J024]Q;I(/ESE9\$DSX^GDR/T,NK+]H#YIS:,RGPGME&'/
M;YXU.9F76TJRZ%LIV*FK'E8G&EJN/?9=5%VN-JJA;7'WX3[/?H+\-X=^)=YF
MW*[+AGPR;L/$JKN==,ZU"MW6WQK:E<G9+LKILDJTZG9*J;]F<.R=R]AJU57'
M#<-M$HXBY/=(E$XE?:49,=L^I"72XYZR,T^O'Z!4FR_0MR3>?#57E*&^XL-V
MR-H6XU8#QY.$J)U+(KA+,]Y.%L\=J7;^%E"-K53GVZVJUMY^MWCFS^8+?&4]
MCRI[5C[L]OMSOQ$5.-T+'CV2CA^RU.J&0G'N_%1G*I.Q0[M*GQ<SJDN1_NR%
MN=QCM-.MJ6:FNTM?;2IM*C_5J)Q9<DGT/GGCGDSFGT!^:LK;.3+PIGX^+^K-
MR_$9&-="I0R/Q-53NG7=9"*]Z$J*K90G=K96X1JC8ZW77"'?7?X;QMRXV_,V
M#?E?K+;OP^/DTSM<Z/PUMJIA937.3]F<;[:U.%.E=BG*V5:L5EDXS';H=3H
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MOHEB[K@8\IPK_$74*5N/D8U=ME=-F3B9%BC*RNRZFB,W&N"A*2F0
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M5;4E*BC.ABX-6#1)3<;/P.'C9-T/T61DW4MUN!Q*BE@
M                     E#$=)[>SUAN9A^M,VOJUPE**ZA8[9_8&TI9<?)4
MC('H[5+%)Q#1]!N/H[BN$IY49$>#W#DW'MJFZ]QS<:J]?P'9'W'U2Z5IN;]>
MND7HNKZ%C<6\0>4^:TQR^*\>WC-V^2;_ !%>+=^&247+663**QX:I/M[[(]S
MTC'632<YT/A)MF:?5E5UKO7[:5F2T7N7,Y%/Z4KC)4DJW7,7-Y,>3P^OAJ5[
M925,+)SM\H-<7RO)FPU],"K,RWI_ J=<?C_"R70FNBZQ[D^Y::]=+EV7Z/\
MR=EONY+F;#L=:?59&;'*LT3@FO:VJ&X3C/YI?)=[33KFK.SY.Z7:/PLUM![#
MN5[.RW(7#6VJ378EB=9CL9+27W#<1'R*_N;N2X\_%2@B-5.A++BS/]<E!$O
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M9ML*+,3=JZ_<[)24X2@G&+<+$HZN+DM8RA%Z-./<E+MM@(P6L
M
M
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M-_A=<8_W5)?]HX^][@]WWG+W5ZIY65;;U23_ $DY3]$VEZ^B;2^UG4CD&,
M                         YD.PGUSANU\Z9!=/IY<AR7HKA]"NI/*V%H4
M?2KU+U]#'SMIIN7;=",X_9))_P!R<K$SLW G[N#=;39TZUSE!].JZQ:?1]49
M-^T#+W$],VX7<IZ.V:<BAU^2I4V3G=2A99!$LB6AMWZD$?)(5ZIX,<']3[:G
MK54JGKK^C<JON_P-Q^'1_;\21?SXY3-=N9EO+CIIIE0JR^FO<D_Q,+=4GUBG
M^:^JT9^RRRNDJ/[MA6+325WS-V"U:4$EM;S9EULE3646M+H=(EI2Y%<;3P:4
MI2DS(>/U==!?UOE9$?3I)QL73[>^+EZ=-5)-^K;9[+D^!D-_K/:-MN3[OFK5
MV--.2]8_A[85=):22E3.*ZQC&*>A^RE:[EJ2<BGRRE4:XI.'77-9=1NV39HE
MJ8ASZJLDM+-9$M"5RW2/DTF9%P8]77O5:^2W'M6CT[H2@_NUE&<D_L>D%]NC
M]#W63P/*:=^)N>'+6&KJR*<B&FFDW&NRFF<7KI**E?/U<6TM&?C['A\E'5"S
MGVJS9ZR;R+&;2!PZ4CMJ96K'WLL(NIC]8A1=1'_%5TF/;\7N4'I;B=RU_P #
MMA+IIKK^D5/QZ-?NK4]/U/Q3(AKA[S[4NS73*Q+JOF[M'%O&EF_P?FBUJG^:
M^UGY/")[QF57<8K<^KI)3#R6KB2'";3UH-B!=/U-C(4^CDT(;94YR7"DI5P1
MOUK3'^7JR*O3\ZJ;2_+*"G%:?%MI?%-KJ>'P_-M;_5V7MF7U?2O+IA)Z+5=M
M61*FV7<NL8Q@Y=-)1C+1/B2\*R^"A+LG&;Q,=9H2W+;K93\%Y3B#<2EB=':=
MAOF:"/T0M7!I,C]2/CZ5[IMMK[:[ZG->J[DI+X=8MIK]U'%RN(<IPH*W(V[,
M5#:2FJIRKDVM5VV13A+IK^;)^C7JGIBXYY'     #D18SLR5&B,D1O2GV8S1
M*/I2;K[B6FR4K^=+K47)_H'K9.-=<K)?FQ3;_(NI]\;'LRLBO%IT]VR<81UZ
M+63277\K-2GD3>,9'OC;]M#=0]7.[%RR+4.MM/,)725=S+JZ-1MR23)2LZB$
MSU=PB<-7)J(E&9"^.'8L\/BNW8]B:N6'4YK5/YY04I]5T_/E+33I]G0ZPO/&
M\T[_ .:>5;GB24\"6_9L*&E**>/3?.G'>D])Z^Q77KWI2;U<DFV0T)(5,
M
M  ;8?&6*Q#\=\02PC@[/-=A7LM:E*4I<YXL7H5=/)]*&4P,;C$22+^/UF9GU
M<%0W,YRLYADN7\#&QZU_4KW;/W^ZR7[FB^!V:_3QCTXG@C:HTK3\1N^YY,VV
MVW9+\'C/3X**JQ*M$E^=W-MZZ*9Q'BV@
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MPY7PLNNO48W9<JFW"*JBY^U1&?;9%N?NS:CWQKT<'APWN-'0
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MY;Y/VRB.-M6][]F96/6H]C6/9=+V'9'NE^GG2H3R&GI*^5DDHIJ*P46@4V
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M&PO%M_?(MK_%W4RQMQJME3D42:<J;Z].^#:Z233C.$E^=7.$NFNBED8\D8
M
M
M                0_G^C=<[#1/D7>.5[ES,8[:;A+?:GH6@W%M?TXUTRD-D
MXX9J)"B(^3_29\Y+!W?<MN:_!W3A!/7MUUBW\=8O6+_>U(QO_#.+\GC);W@X
M]]TH*/N.*5R2U:4;HZ612;;24M.KZ=6:3<KH7<7R6]QYY9NJI[29 2\HFTJ?
M98>6F/(4AIQU#9R&.E9IZCZ>K@_4A>FWY:SL*K,2T]RM2T^QM=5\-='JM?CZ
MG7OR39I\>W_,V2<G/\+D3K4GHG*,9/LGHFTN^.DM-7IKH^J,?'+,(
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MEUJ;<.OLJ%U]Y:C,DJXF-IZ2Y(N2,E>?9W:'YE],UKZ3J:?Y.Z-B2^U?(_\
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MG79&4)Q?V2C)*47]S29Q1]#C@
M                          ;?]$QV(OCUI=,=HF_N%+FES-5U.K5(L'MI
MYU2J>/N+6ELBK:"*V2$$E'ZLU<=2E&>OG)IRLY=N;F]>RVF"].D5BT3T_NUD
MGJ]7UT]$CM/\,448W@KB,:(J/OX>??8]6W*V6\[CCN75M+]%C4Q[8I1^5RT[
MI2;DD8@L
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M9MV9PS>/=JTB[+7B4+<L9T]TH:2QLW!Q<VUQ[I?A<7(2C+70@H2HID
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MJLDK)54N^2IACPMO[9*ZZ-D_<MU]R4""6%)@
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M71=%T157(-XOY#OV;O\ E+3*SLN[(FM7+25UDK)+N?5]9/J^K]7U.E'),0
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MQMK7R*>K4JWV2BW&N4)9'",Z
M
M                                          &(9[EE?A&(WN2V4@H\
M>LKY+R5>AK6^EAQ33;+9J0;SQFGDD$?4KC@O4??%QK<O(ABT+6VR2BORM_'[
M%]K^"ZF/W7<\/9MMOW;/EV8>/5*R;^/;%-M)?&3](KUE)I+JS0=<6;UU;VEQ
M)2A$BVL9UG(0V7#:7I\EV4ZE!'ZDA*W3(OY@V$QJ(XN-7C0U<*X1BM?LBDE_
M<'6KNNXW;ONF3NV0DLC*R++I)>BE9-SDE]VLGH=:/L8\
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M.<_<JCVP44VY/2.B;UT1@(RQ"0
M              W/:V9:C:=TO$CMH9CL:WKWFVFTDE*7;2ZOKJP<,R+J6N5:
M6;[RC,S/J</CT(B+7+=Y2GR'<K)MN;S9)O[HPKA']Z$8I?D^T[:O']5>/XIX
MEBT14*(;!5))+1)W9&3D6O[W.ZZRQMZ]9/X:)94.$24
M                                                   .SJOZ-,_]
M$>2?UO6@X^5_)Q_Q6O\ R2)D-M_E;?\ 0>7_ *EN-$@VB.F
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MEU+"R&[,C;<W#6-9E87XC2*S,:%6=B6XN9VUV65VNJ^J%]%DK(;$D*G
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M9-F9ON=?.Z^ZQKNLLF]9-Z)1BOA&,5&$(I1A&,4DNB'*,*
M                =YC61W.(7]3DV/37:ZZI)S%A7RVC]6WV%<]#J#Y0_&?0
M9MO-+(VWFEJ0LC2HR.,\SX?QWR!Q3<.%<MQH9?'-SQ9T7U2_A0FM-8R76%D)
M:656P:LJMC"RN49PC)3#Q_SWE?B[FVU^0^#9EF#RS9\RO)QKH?P;*WKVSB_E
MLJLCW57TS4JKZ9V4VQE7.47L>P_S^IUQ66L_P6SC36VN)$_#Y$6=%E/<&?<9
MJ;J77O0&C/@NA4V29?CU'^!=.GD+]D_R&O.LO\4<HPKMLE/6NC=J[:;:H?Q9
MY6'5?"^2ZONCAXZ?YO8M.Y]^7BO]MYQ6[;:<;S;PW<,?=X5Z6Y.QVTY%-T_X
MU>%GW8T\:#>B[)9^4UIW>X]>U,P\_J=$5YK ,%LY,UQKB//S"1%@Q8KW!'W'
MJFEEV#T]HCY+H3-C&?X]1?@;Q[^R?Y#9G5W^5^485.V1GK91M-=MUML/XL,K
M,JHA1)]'W2P\A+\WL>O<GE3]MYQ6G;;L;PEPW<,C=YUZ59.^6TX]-,_XUF%@
M79,\F">J[(Y^*WKW>XM.UZX<ER.YR^_MLFR&:[8W5W.?L+"6Z?JX^^KGH:07
M"&(S"")MEI!$VRTA*$$24D1=Q?#.'\=\?\4V_A7$L:&)QS;,6%%%4?X,(+36
M4GUG9.6MEMLV[+;93LLE*<Y2?0;Y Y[RORCS;=/(?.<RS.Y9O&99DY-T_P"%
M98]>V$5\M=5<>VJBF"C513"NFJ,:X1BNC$F(>          <J%"FV<V)6UL2
M586-A*CPH$"%'=ES9LV6ZAB+$B16$./R94E]Q*&VT)4M:U$1$9F/2VVNBN5U
MTHPIA%RE*3244EJVV^B275M]$CD8>'E[AEU8&!59?GWV1KKKKC*=EEDY*,(0
MA%.4YSDU&,8IRE)I)-LG7?\ )E5EG@VM'+F+/9U7@-+C4ZLJ)I2L>H\PGKD7
M^:Q(),I;AJMBNK(VK5YM/4Y/CN(6MSM)4(KQ*$+Z,K>U7*$L_+G9&4XZ63IC
MI72Y:]>SLCK4F]%7)-)=S1<_F_(R=NW#9O'L\NN^KC6R8^)9319WXN/G6N63
MN$*^W2MW_B+>S,LBM99-<XRG/VXR( $M*0                       #]M
M-./.-LLMK=>=6AIIII"G''7'%$E#;:$D:EK6HR(B(C,S,>)244Y2:44M6W\#
MWKKLMLC55%RMDTDDFVVWHDDNK;?1)=6R6L?T#N_*2[E#J78<Z*EUYAVR/$KJ
M)31GX\<I3K,R[FPXU1"=2PM)DEU]!J-:"+E2TD<?R^6\7P.F5N&'&S1-1]V#
MFTWHFH1;G):_9%^C?HF6=L7A#S%R1>YLO%]]NQE*47;^"R(40E&/?*-F19"%
M%;46GI.R+;E%+5RBG-M-X0;5>D$WF%_KK VFEF4Q$_+(^5V+2&Y2([K3$+7C
M.7,N3S1UK0T\_'1^KX=<9ZDF<:R?)NQ*&NW4YN7)KIVU.J+Z:IN60Z7V^B;4
M9/K\JEH]+@VGZ._)5MZARK.V'9*XO](K<V.;;%*:BXQKVN.=%VZ=THPG95'Y
M=++*NZ+<R4WAEJ.K0D\GS_/LR?-EI3D?%ZBBP&$S(6RP;K3%M=KSV7.98>6X
M1.+KHJG"07T)ZN4QW(\B\BO?]98F)C0U>CMG9D2:U>C<(>PHMK3HK)Z:^KTT
M=K[3])GB[;HI\BWO>]VN<$W'#HQMMKC)QCJHW9#W*=D8R<EW2Q:7+M7R1[M8
MS12:GTABQI70:=Q%V4CKXLLQ>N<]F.<K?6WWZW);&5AZ^R3R4IZ:I'432>OK
M^KJCF3OG)L[IF;ED*#_@TJ%"^'I*N*NZZ?&UZ:O33II;>S^,O#W&VI['Q3:Y
M9,=?TN=*_<IOK)KNJR[9X+[>Y):84=5"/?W?-W2C$R>\K(9UU)-3C58;26#J
M\3B0L3JE,(81%:CJK,;C5<!4=F,V3;:#;Z&T<I21$9D>$GM^)=9[V3#W[]=>
MZURMGKKJWW6.<M6^K>NK?5ECXO(]YV[%_ ;/<MOVYQ473A0KPJ7%14%%TXD*
M:W&,$HQCV]L8](I)O7II$B1*=7(E/O27W.GK>D.K>=7TI)">MQQ2EJZ4)(BY
M/T(N!RH0A7'LK2C!?!+1?O(Q-]]^3:[\F<[+I::RDW*3T6BU;U;T227W+0^(
M]CY                    '94]F]2V]7<1DH7(J;&#9QT.%RVIZ!):E-)61
M>IH4MHB/^8/CDT1RL:S&GJH60E%Z?9)-/^Y,AM6XW;1NF-NV.D\C%R*[HI^C
ME7-3BG]VL5J7YV5@C'D9@V([5P:I<8S"PDMTUY$6YPP\33SL>2Z^26TDCLS^
MXI+J$$3A)4E*5&I/%9;3N<^*[C?M.X2[L..K6BU?<TG%K^KCHFF]$].JT>NV
M',N)T>8.,;?S+C52JWRQ1@U.7;%U*<X60F_C[-JDXSC'64%)=LNZ"C5U[Q^V
MHSF!X8>+SWYR7D(78Q6'G*7L&I).2F[%YN.RXAI!FKM^CRB+Z4'R7,Q7*ME>
M#^-]U+I^8_Y37[.U:OK]OYOWE'S\/<\AO_ZA_!SGU6N1'7\-V/36:NDH1>BZ
MN#TM>FB@WHC<#A6OL*Q2!!;IZ>KASZN' AS7(CRG5,2H41">AY9O+_6,DL^#
M7]72KD_Q,SIC)R\G+L=F3.4YMM]7\6]7HO1:_=T-Z=MVC;-GQXXFUT5441A&
M"4(I-Q@M(J3_ #I:+XR;?5MO5LP;8WDKK+72'&9-JF\M4*-!T]*XU(F)43:G
M")WZNF.2R(B2ISI;,U<=7)'QDMLX_NFZO7'K:I_CRUC#]QZ=?R13?W$6Y5Y'
MXEP^#CNF3&>:GI[%3C9=KIKU@I+LU^#L<(M_$[?4&WU;?BR[JMQ:SI,=9Y9B
MSK9U@I$R8TZ;<A,=J,IYEV*E1&DG"61]QMQ)D721J^.Z[79M&1^$OLKGD::M
M0U:BGZ)MI/5KKIIT6CU>O3G</Y;C<SVQ[SM^-DT;:YN,)7J,96.+:FXQA.Q=
MD7\JEW=9J<>U=FLN1N?<51IG'X5W;5TZR.SG*KH,>$374J4EE4CATW76DI;[
M2%&9\EZ)/\3X(VT;3D[SE/%QG",E!R;DVDDFE\$VWJUTT/'-.9;7P;:%O&ZP
MNLIG=&J,:TG*4Y1G)+YI1BEVPDVV^FG1-M)Y-KC8-)LO%J_)Z1Q/:ELH.3%Z
M^MR#)]2=C.GTIY6TXA23]/Q29?H'&SL*_;\J>)D+2V#T_*O@U]S75&4X_ONW
M\DV>C>MLFIXE\%)?;%^DH2^R4):QDOM7V&>#B&9
M
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MVVHI6>[7'L;E**2EHVVDNK1APR)%
M  W>42&V<(U7'9;:989TUIQ;;++3;+:7)VLL5LYKG0VE*3=EV,YY]U1_4XZZ
MI2C,S,QK1>W+<L^<FW-[EF:MO5_+DVQBNOP48J*7P227H=PNS0A5P_C5%,8P
MICQ+8FHQ2BD[-HP[K'HDEK.VRRR;]93G*3;;;.8/0Y0
M                                                   =G5?T:9_Z
M(\D_K>M!Q\K^3C_BM?\ DD3(;;_*V_Z#R_\ 4MQHD&T1TP
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M92K;K63CW*#T6BBX9TK@
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M!A\G,S,R2EF6V6RBM$YRE)I?=W-Z'$'N<8
M    M;XS;OJ-2RK].46%RJFF-1E0:>!&*3'<FK-TI4MPS-*F%MMM-$1$9DKJ
M/TY]1#.5[!D[M*JW!A#WXZJ4F]'IT[5]CZMO[5^Z7MX=\C[7PVG-Q.09&0MO
ML<)4U0AWQ[WW*R>OK%Z*M:)Z2ZMK5(F38_F^W.JY]5KVBFPI<IM<9N\M5LI.
M,E9J(Y<2*VIQ3CG;X)*7"1TJ/DS,BX5A=MX)?[L;-SL@J4]7"&K;^YRT27WM
M:]/31O53SE'U#[<L.S&XGC72SI)QC=<HQA#7^'&M.;L:_@J?8M>LE)+ME5?&
M_(#:&+QK]B!?JD.Y)).583+)"YTI"U,FPXB+W'BC,L+:Z2)LVU(02")!)+DC
ME65Q79LN=<I5N$:H]JC!]J:UU^;IJWKKUU3>KU;*>VCS%SK9Z<JNK)C?=E7>
M[*RZ+LG"6G:_;UEV1BTHKL['&*C%045JG#+CCCSBW75K===6IQUUQ2EN..+4
M:EK6M1FI:UJ,S,S/DS$BC%12C%)12T27P*QLLG;-VVMRLDVVV]6V^K;;ZMM]
M6WZEY_"><]/R'(:63?6J/MM<S9X[1)L9+=8[+-R6<YY<1*B94E"^TI2?0E=1
M\I5RHRKGGU$80HR*ZX=TY24YZ+NZ*/8M?7T[OWM-39_Z<]PMONW#;<C)N==%
M=<Z:'.7MI3E9[TU#\U-2]O[.LV]&WJJW;=RW/+G+,@I<QO)\Y-5D-FIFN<DN
M*KXJS?>2PMA@S+^)%<X;-PC>0E:B5PI2^93Q_!VRC IR\&N,9V4QUDU\SZ+7
M5_U2ZI=&TM.B14GDGD/*\_D6;LW(,J=F/C9MKA4I?H8=6H.$5ZZ5O2#GK-1D
MTVI2GK9KP7RHH63Y1BLF626;6#'GUT1QYM""F,*4B:\TT9=QUUYAMA!\'P1)
M27XF1'%^?XB<,?-C'JG*$GI\'HXIOTZ/NT_*RV?IPWEQNW+8+;/DDJ[ZX-KI
M):PME&/JW)>UW-=$H+734V?BM#:H
M
M                                            "@/G=)O&:'$68\LF
MZ"5/>9L(B21UO3R;<DPE+7W2<[!(B+/IZ#2I:",U$:2)4[X%#'EN-KFM<F-6
ML']BUTE^[UBM=?37UU>FO?U%7;G5Q?#ACS[=KLS.RZ.BUE+L<Z4WKKVKLL;7
M:TY*+;3BE+66+6-.0
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MU;T6OHM6WHNFK?VGR'D^8
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M*21UP^YP0
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MJ^7;I&M_+M^#C.WMU48WYBO]KNTTB[98<;$M5*2HDU\L9ET!71ML
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MGGRG)6?5>N18U,ITO62A"/\ )7*<%I\Z]R*7N=T>KTC&<8M[=14YN*
M
M
M          !IF\F[?9USFDMW-Z>RJ*2'/E1,<:<:5]O>CDISLRDR$<LJE2XS
M?639F2F4<IZ>HG%*N#AU.T582>'9&S/G%.SX27]+H^JC%O35=)/KKHTEI1YP
MS.9YF^N.^8UN/QVBZ<,73K58OA:[(ZQ=MD%W=C:E7'Y.U-3<JS"8E&
M                                            &:XO-BS8\K$;=]$>
MMN'D/UTY:$J^T9$V@VH,M3A^K4&<1^VE\>G:4EP_5I(QF?595..Y8R<KZEI*
M/\>OUDOOE'\Z'WZQ_A,EW&\O&RZ+.+;I-0P,N:E58TG[&4EVUSU^%=G\E?\
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MGHU]IT Y9A
M    S/(.J/C."0C-S]?675Z:%)-#:%6&0V%41I0:CZW'&<>0HW."ZD&A/J22
M,8S#TGG9=O3I9"O[_EKC/]Y.QK3X/5_$EN^]U''=EQ&Y?/CY&1H^B3MRK:>B
MUZMQQ8MRT6L7!=5%,PP9,B0
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M0U279&*C&/;\JBDET2,)&4(@
M                                '<4;#TJ<Y$C,NR)4NJO8D6,PVMZ1
M)E2J.Q8C1H[+9*<>D2'W$H;0DC4M:B(B,S(<7,E&%'N3:4(S@VWT22G%MM_!
M)=6WT2ZF5V>F[)S)8V/"5F3;C9$(0BG*4YSQ[8PA&*U<I2DU&,4FY2:23;-#
MXVD.EL                                                )4U!GM
M=KW)K:QN8^02Z3(L%SW KF)CELQ5RG:[.\3M<7>D2&Y<27$MV:I5DF:U$=[2
M%S(S#AN)[?!X'D6TW;O@UTXSICE4Y5%\'9!R2E1;&U)--.#EV]CFM6H2DM'J
M65XKYM@<%Y#E9^[0SK=HS]EW+;;X8M\:9NK<<*[#E*2G"<+XTNU9$*)]D97U
M4S<U[>CLE7Z-\:G-8PLZL]HYO%KKO8E#B%1E\9G$)<.KCW])D=H]#S[6;,EW
M,<3M\5E8\;5A)8G64&1%EQI4 Y9..LQH9=RCFJWR6U48.+*ZK#LNG2W<G)US
MKBG1DM*FV%JLUKC*%<XRA.NWV](RGL!@^&_I\GX[IYGN/)-XKP,S?L;!HSH1
MP9PICDX^5=*&Y;3&;SL*_#GB]F5;7D9>/;3=CY."\I66TX\5^3U#L.OV)8RL
MJU[>X%B%=*D8/K.+*I;*'C)X;ABSK:>/C5Y(C-UF3(=A&B;)G0W%M3I,QR6G
MA+Y$,[P?+V>[9X5X&95E[C.*OR6IQ=GO7?--V03<JM):PC":3A&"K?6#*U^H
MO9>=X//,C)Y+L6;LG%J+);?M,)X]L,3\!@/VJ(XF1*"IRTZ^W(MR:)2AD77S
MR5I&]%;1-#7\ #L*JVM:*PBVU'9V%-:PEFY"LZJ;)KK"(XI"FE.19L1QF3'6
MIM:DF:%$9I,R_ Q\;\?'RJ98^5"%E$EUC**E%_'JFFGU^U'.VS=-SV7.KW39
M\B_$W.EZUW4V3JM@VFFX60<9Q>C:UBT]&UZ,^][?WV4VTV_R:[M\BO;%:';"
MZO;*9;VT]QIEN.VY-L;!Z1,E+;890A)K6HR0DB+T(B'KBXF+@X\<3!JKIQ8+
M2,(14(13>O2,4DNK;Z+U>I]MZWS>N2;G=O?(LS*S]YR&G;D9-ME]UC45%.RV
MV4K)M1C&*<I-J*271(Z@<@Q8
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M0NX_54[6OE@[)J$6^YJ:79*8<UV9K*4XG'\<WEGV$:MI+9TL0U]IG5TB,PB
MA3T=%WEMED.Q==O9)F$BK:9;=N)B9TR0M2S[<=HB:..;9LF]P7XO,VO$RM]M
MK7O9&9E)ONZ/LJC7CY"KI4FVJ8=D(K3K.7S%J\O\A^.\FQ;'L/,M[V?QMAY3
M_ [9L.SRA%5IRBLC-MRMTVN65G3I4(3SKUD7VR<_T=%:53A2;DNA79A6MGCN
M[M@VS[R'94G(-DXMC+3B(C49J)&GJ9P/,[:W8>;;-MPVYE>XTRA*6U\F2VY-
M5A<KC7^'HNVO#QTM$J\:VU]6VW'6^F$&M=5K"Q-MMKX.H<OD/A2S+_66XX',
M-\W.<TYSR=UP\1-04%"%CCMN?=?&27;)QOQI0KBHURU:E#AHV?KRL2G[#X_Z
M^7)+W"TV.89'LS*9<=YUE++*HL&'FF-XR\S$,C<2W-KII*=4?6:D$2"^KV/>
M+W_7>[YBAT^6FO&J32>KUDZ;+$WZ-PLAHO31]3B0\B\%VZ*_4O!]C>1\S5N=
ME;MF3A*45&/977GXF)*,.LE'(Q<A.;^=R@E!?PM^YA"[?Y:Q[5>']MEUI$C'
M]1ZZ5<-N2.\F1)CY1>8[=99">?CO&R9,3VFR:+I2@NI9J?S2VZW7\;=GY.K3
MTLR\CLZ::)U0LA5))K7YH-Z]6^BT+S=RO#[5Q_ XUM7;"24L;9-K=Z<NY2G'
M,R,7(S:Y2C+L:KR814%I&*[I]W"M_(/>5Y#^VS]M[!*H[+$?[%7Y3;4^/DS%
M=2^PA-!428-,CMOH)9&3!'UI)1GR1&/IC\0XMBV>]5M^'^(U;[Y50G9JUH_T
MDU*?IT_.].GH</=/.?F7>,7]7YO*-\_579&/X>K,OHQNV#4HI8U$ZZ%I)*6J
MKU[DI>J3(HFSIME*?G6,N5/FR5F[)F39#LJ5(<,B(W'Y#ZW'G5F1%ZJ,S&?J
MJJIK55,8PJBM$HI))?<ET1667F9>X9,\S/MLOS+'K.RR4ISD_ME*3<I/[VVS
MBCZ''     /VTTX\XVRRVMUYU:&FFFD*<<=<<424-MH21J6M:C(B(B,S,QXE
M)13E)I12U;?P/>NNRVR-547*V3222;;;>B22ZMM]$EU;-IOBG@^?8+K78U?G
M6!W>$MW>1X'D>/SLCHG*&RR!F#!S"IFPE-V:XUO(BPDVC4B#TQ^QTN2U]9FI
M)"C.=;IM.Z;YAW;5EU93JHOKLC7/W(UN4J9Q>L=8)R[7&>LN[I6M.C.R3Z:>
M'<VX9X^W_!YGLN9L\,S<-MRL:S*QWC6Y,:Z\ZFRMJYPOE"OWH6X^E7MZ2RI=
M[;BB>!&2Z                   \;O[PKY3^36BO-O5./:6\AMW:FQR1XQX
M-D\O&==;3S?#<9GY"[MO=4%^ZLL=H+N!2V5C*@5$6.\Z^PXIZ/&::6:FT)25
M8<TW#/Q-UKABWVUP_#Q>D9RBM>^?5I/1OHE^1&V?@CC7'=ZX=E7[Q@8>5D+<
M;(*=M-=DU'V,=J*G*+DDG*3236C;:ZLWR_%A\C&)_(/H9F]F.5U+O?7C-92;
MLPF&T4*,Q;RF7?MV9XO#=GV,I6%Y:F*ZJ/W'#=BRV9$9?433;STPX]O=>]8?
M>]%F0T5D?O\ A)=7\K^'V/5?#5TGY+X#E<$WMT0[I[)D-RQ['U;BO6N;T2]R
M&JUT6DHN,EZM+X_,]L#/-6_&IY)9WK+-LNUSG%%^Q[[)F6"9)<XAE=/]SWYJ
MRFLOM618_-K[>O\ N%182(K_ &7D=V,^XTOE"U)-RFZ['V*^['G*%J[-)1;B
MUK9!/1K1K5-K\AY\1X.%N7D/;\+<::LC#G[_ '5V0C.$M,:Z2[HR3B]))26J
MZ-)KJB+O@AVALO;_ ( 8[F>V=B9UM#,']H[+KWLKV)EM_FV2/0(%E#;@P7;W
M);"SM'(<)"C2TT;IH;(S))$./Q#(OR=FC;DSG9;[DEK)N3]?M;;,GYKVW;MJ
MYS9B;7CTXV(L:E]E4(UPU:>K[8)+5_%Z=3!?F*^6]SP$JL9U-IBMQS*O)'8-
M0]D'.2L2[#&]68.J2[71,IN:R)*KE761Y%.CRFJ:#W^PT<)Z5.2IE,>-/^/)
M^2?J:,<;%499TUKUZJ$?35KIJWU[5]S;Z:)\SQ/XM7.+;-TW>5E7'Z)]OR-*
M=UFFKA%M/MA!-.R6FK[E&'7NE#3-AOQQ?.+YQX]7[FVCY%7NN6[QENXQG'=[
M;JVCA%DW!MVFV7Y5)J_7&)9-6Z\9EL5$9Q^(_!IWGB4TZ;*S-2DQ>K8^6[M!
M961>X:]4K)SB^OV0BFH^BZ:1_(6YE^0/#7#+Y;1MN!#(<'VSGC8]-BUCZ*5U
MLX.W3N:4E*Q+JM4=.W9_.;\5.U=<TEQ8[ WY@67Y0S@6'8[*O,I\@M*[!M;&
M3[*JPVF?G&UFFN+VX>24JICH+';*5VG%(:?81.9/T[N6\=R(0DYW4REVQ6KL
MA)OTBOX46_5+Y6_O6J/JZ_#'DS;,BZJ-&#G55^[9-1ABY%44M962T_1VQC^;
M-_I81U6K4G!GMCQ>=>V>,X[9910LXMDUA15$[(L8CW#.0Q\<O9=?'?MZ%B_C
MQ8#%XS46#CD=,Q##*)*6R<)""422M:MSE7&5B[;&EJM=='IU6OQT?37XFGV3
M"FO(LKQINW'C.2A-Q[7.*;49.+;<>Y:/M;>FNFK.\'L?
M      "PGC#ATC+]O8ZEON)BT2EWDUQ*"-':B\(0RIQ9*;2IQ;O423(S<2A2
M2X_C)BW,,V.)LLZ^CLN:@OW>K?[B7[C:_([>\([%9O//*,G62Q\&$KY-+U:^
M2$=?1=TYIZ>KC&6FGYRV\TNNL)QV]GY+1XY65=U9H6F?.AQT-.RC<=<><<=4
MDN5..+</D^?P]!3]F7E74QQ[K)RHA^;%R;4?AT3].GV&[6+LVT86;=N.'BX]
M6?D?RMD*XQG9U;UG**3DVVVVVVWZ^B,U'',D
M
M                                                    !"/D)@4?
M/]7Y)7%$9D6L&$Y94[BVNIUF=#2;S?;>01NL(4:?K-//*.2,C(S(\MLF?+;=
MTIRM6JU)*?WP?27Y>G5:_%)^JU(?SWCE?*N)YNT.$9Y,J92IU7YMT$Y5M/UC
MK)=K:ZN,I1T:;3TSN8'G+3:W7<,RMIII"G''',=N$-MMH2:EK6M4,DH0A)&9
MF9\$0NN.[[3)J,<K'<F]$E9#K_X1H99PKF54)6V[1N<:XIMMXMZ22ZMMNO1)
M+JV_0QN3%E0W39EQGXKQ$2C:DLN,.DE7\51MNI2OA7Z#X]1SH65V1[JY*4?M
M3U7] C^1C9&+9[.57.NW37MG%Q>C].C29QQ['P
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MROE%W2BHI1E8XI:(Q(9$BX
M               9EFY$Q9UE>1<'68MBL5WEQ#BRE/4,&RGM.&@B0E<6?/=9
MZ?Q23?!F:B,QC=J??19=_AF1:U\.BLE&+_=C%/7XZ].A+.8)4[CCX*]<?;<.
M#ZIOOEC5VV1>G1.%EDX:>J[='JTS#1DB)@
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MKZG)Q;]DW"QT;;O7&\O)2U]O'WK:;[6EIJU53FSL:6O5J+275Z)-G9_:GO\
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M_P!/N$_]=V-_\^80QV\_[$97^AK?[Q(E/!O^&VS_ -E<3_)ZS00-JSI'
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MGHTIE#C:OXR'$)41D9$8-)^IY4I1>L6T]&OW&M'^^NC^X^H'@
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M9*2KEJM-8N?S./K+5/7MBR[HAQ=P
M
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M6J]"N)1E&3C)-23T:?JF?D#P
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M;,_S3)JR^6[E=CZ?AOQML:]$TO;A-PKZ/JODC'UZ_;U,3&0(P
M                                             !KH\T9R7]WNUJ63
M;*AP'64'O*=)9RU6F#4F6+>Z":;[!,JR0V"3RODF>OJ^KI3;GC:IQXS[[>ON
MYF3+33T[+YU:>O77V^[7IZZ:=-7H7]7&9&[S#+;XQ<5A;)M%?<WKWN[;L?-<
MM-%V]KRO;2UEJH=VOS=L:G"?&L@
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M_P#.?'O](1_RP?X:^VO]!-9_U%,_YN#^UKL/^'9W^//^^C_I>>3_ /.?'O\
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MM%=BC;5MT+:Y.$FE95.%D'\T)1DDU0L6L:4@
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MIW63MDHIMJ*E.4FHIRDTD]-6WIJV=6/N8X
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M7!ABU6:./O3[I7961VOJOQ.9=D7I-)QA.,-/E1\Q[GS
M   /&!\]7^^U>''\D?CU_MEMPBKN8?\ "3%_Q.O_ "69MUX1_P":[=O]%97^
MI*#U:^5GB_JWS#T;FFAMN5GN\:RR'U0+B+&KW<@PS)(J'?LN9XG+L8<UFLR.
MD>=5VW209.L..QW26P\ZVNQ-QV_'W/$GAY*UKDO7IK%_"2U]&O\ NKT;-9.,
M\DW+B>\T[WM4M,BI]8MOML@_SJYI-:PE\5KT:4EI))K_ #Y-\1_)_P".H_+C
MX[-@/>[P+;GY%DV3,D[8\6O8F*Y]B.Q,$W1K5GWI5[$S)Z_$&ZR<OI>4ELWH
M,LBF5R4QZ7S%N&R?B=DNZTV]NOKH])1E&<?AU4='^ZGUCTWKV27&^??JOGN"
MM,[%]Q+3M[XN=4ZK,>[IJU!V.<?3KI./R6/N];'[N[_O;>,_RN;6_P">L$61
MPG_8*/\ BD_[DU<\]?\ .#9_H6G^X9I9\P+#)OBF^;V-Y32\6L9FGML91;[5
M9^WO6$2#EN)[9HYN,[M@*=B)1!G91AV;W=A<,UCJW?UR*J4^EM,IDQ%MSE9Q
MWEGZP<6\6R3GTU^936EG[L9-RT_J6_5%O<4AC^3?#CXU&V*W;%JC3UT;A.B2
MGCOKU4+*XQ@YI+I[L8ZN+/9=J?;FLMZX#CVT=/YQCFQ-?Y5#*91Y1B]BS8UT
ME)'T28<CH,I%;;UL@E,38,I#,V#*;6Q(::>;6A-H8V3CY=,<C&G&=,ET:>J_
M^DU\4^J?1K4U*W3:MQV7.LVW=:;,?.J>DH36C7V-?!Q:ZQDFXR34HMIIE=?*
MKY!/$_PQ<Q2%OK:M1CU[E^1T-% Q2J-.0Y? @7<LF'LTO,8JW7KFIP6AC)<D
MS;%QGH[;9M1TR)2VH[G!W'>MNVOM698HSE)))=9:/^$TNJBO5O\ >U>B,_QG
M@O)^7*V>R8T[*:JY2<Y?+6W%:^W&;^65DGHHP3]7K+MBG)6^I[BHR&HJ[^@M
M*Z\H;RN@W%)=T\Z-9U%Q46<9J;6VE790G7X=A76$-]#S#[*UM.M+2I*C29&,
MG&49Q4X-.#6J:ZII^C3^*9%+:K:+947QE"^$G&49)J49)Z.,D^J:?1I]4^C.
MQ'D^8           %I=<[&UED&,1=?[GK'W(]>@HV/Y9"91[ZMC)-!1HCDED
MD2F41NE*$&?+2FR(G%(0E1.0C==GW?#SI;MQ^6CF];*]?SG\7VOY9:]6UTDG
MUCJWTV!X=SGA>^<>JX9Y)JUC0NS'RG%MUUK\R#G#]+4X=(QDE*N4$E;I&+[L
MNAZ]\3+R5:1X&T;JH6EI4>*NY2W!@QY+7)G)9ERFOZ=;=-!ES]:#)9&DCX/G
MASW7FV/"$[<2,HZZ_+#N;3^#4)-K]Y-?$S./P_P)N=UU.)O%E5FCBO<N54(R
M7\*$KZ8*>O\ 5S@U^;]I(N(>)58I=5E^O=O19<V-(:F4MBU$:DPUO-&:CZT,
M/-O/,N,DLE)2:>M')<D7)C'YO,<BZ%F!N.''VY+MG%RE&2_?3T:]5TZ,DVQ>
M#]MP;\?D7&=[L>17)64VQKKMJ>G3^!.*G"2UC)*:33:U)YS;Q^QW:ESBMYFB
MXD/(:EOVU[%JI*"1?1T$3S:7BZ2E)+J-3G!+21&I2N/K4([MV_YVTTW8^$TJ
MK'JN[JXOT[E\-6NCU3]%]A9G)_'/'N99V%N>_5N67BK22@^V-L7U]NQZ=[A&
M>LH:2BUW37\)G:[%\8M:["<F6<N',A9 NI9K(-E&GR&FHWM&E-Q'G(B#[,IY
M)J/J6ZEQ1^G)*21)#;.1;IM453C37X93[G!I-/735:M=R3T_@M?;ZMCE?C3B
M/,;IYN[8[_6DJ?;C="=D)12[NV7:I*N<HN3T=D):K2+UBDE#M-X*X6Q]LD7&
M39!-=;0P[9P4G":A2'D=LWHZ%1X[4QN,_P#5ZI?);?H1*5_&&:NYWNUBE&J%
M$$]='I)RC]GK+M;7WQT?V? @F#]//"\>55F9?GY$X=KG%V5PKL:_.6D*E9&$
MGKTC;W)=.]OJ76H*"IQ>H@T5'#:@5=<PEB+&9224(0DOX"(BY/\ F$1$7H1$
M1$10VVVR^R5UTG*V3U;?5MOXLO'%Q<;!QJ\/#KA5B50480BDHQBEHDDNB21W
M ^9R
M
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MI^O31O5;R3XQW#@>6KZ7/(X_:]*[M.L9:?R=NG2,_5Q:TC-=5HU*,8($D*M
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M:?)Z?TNGW_;U)7SK3^>.Y>GO?C+/<TUT][N_3::_#WN_33I_%^70PT9(B8
M                                                 &8:_:2YFN-.
M+2:VX5M&M'6TMDZ;S-.H[5UGI,R21/-PS0:CY))'R9&1<'C=XDUM=\5TE*MP
M3UTT<_D3_<<M?O\ 0E7!ZXSY=MUDTY5TY4+FDM>Z-#]Z4=/Z95M-OHD]6FEH
M8DXXX\XMUU:W775J<==<4I;CCBU&I:UK49J6M:C,S,SY,QD8Q44HQ244M$E\
M",663MF[;6Y62;;;>K;?5MM]6V^K;]3\#R>@
M                                &LGR[F>]\AM@%V^TBM1B&/LEU]:E
MQ\8P7&,=C/N*Z4$;TF/5I<7P1)):C(BXX%S^/J_;XAB/75S=UC_+;?;8TON3
MDTON1UX?5)E_C/.N^?+VQQU@XT>NK<<3;L3%A)O1?-.-*E+1)=S>BTT*VB9F
MOX
M                    31XX?XP^A?Y9]7?U\48C7,_^!^[?V-RO\@F6WX!_
MY]^$_P#*[9_]\,<A<24J0
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MCVWU4V)6U4WIRD_>IA.-5C;^:<)2TCKVJ*AGBM0
M                            ";ZGQYVE<:PM-N1J5AG$JR%+M6TS)S,:
M[MZ6MF18-K>TE*O^G;"DJWY*N]*(DL],=\T*7V'21&,CE^QX^^5\?G8WN$Y*
M#TBW"$Y1<H0G/\V,Y)=(^OS0U2[XZW#MG@GR1NOCK)\HX^'"/%\>F=R4[(PR
M+\>JR%=V3CX[_26X],IOON24-*KW%R]BWMY7CMIUS<FP(]98*D0\(QQA.2;
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MOPR=KC*N%4=8P3:@X.4^LGJ_<[Y:=T5KLX%>&RP
M
M
M            8MF6(4N=8]8XW?1FY,"P86TKK;0XIEPR/H?;)9&1.-J]2/T,
MC+DC)1$9??&R+L2^.3CR<;H/5-?]GH_1KXKH<'<]MPMXV^[:]QKC;A7P<9QD
MM4T_R^C3T<7ZQDDUHTC2QN33M_J+(WJV<ER92R'E_9[DFU$U):/J6AB0?0A+
M<M+:3_ B2Z234DB,EH1=FP[]C[UCZK2&9!?/#_V4?MB_WT^C^#>A7D7QUN7
M]R[9=UVQW2?L7Z>OQ]NS3I&V*_(II=T?X480Z,\5P
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MN[Y>Z2;<LG)MM>J2?Z2<I]5'HGUZI=%\.AU0^YC0
M                               ,RPPB;>R.P47I6X=DI\J<0VTD[B K
M&4&Z:BY5U+O22VDC(U/&@O7DR/&[G\T:*5ZSR:OO?R2]WI_C?7[%J2SB25=V
M?G/TQ]IR_BDE[];Q%KKZ]<E**6C<W%?<\-&2(F
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MNCW::Z=RU]4=*.28@
M               )H\</\8?0O\L^KOZ^*,1KF?\ P/W;^QN5_D$RV_ /_/OP
MG_E=L_\ OACD+B2E2                                        '8U
ME1:W<HH--66%O-4A;J8=9"DSY2FVR(W'"CQ6W7C0V1_4?'!?I'QOR,?%K]W)
MG"NK7364E%=?O;2.=MVU[GN^2L/:<>_*S&FU737.R>B]7VP4I:+XO31'-M\6
MR:@;9>OL=O:1F0M33#MO46%:V^XE/4IME<R.REQ:4^IDDS,B'RQ\_!RVXXEU
M5LDM6H3C+3\NC>AS-TXWR'8ZX6[U@9N'5-M1=]%M2DTM6HNR,4VEU:770Z$<
MLPH &?:MM\2H-B8==9W4(O<0K+V%+OJIV$=FQ*A-+YYD516%45O%8>Z778:I
M+");:#94M*5F8Q.^X^X9>SY.-M5CJW&=4E7)/M:D_LEVS[&UJE/MDX-J23:)
MMXWW3B^R<\VK=^:8JS>+8^;7/)IE7[T9UQ?\*GW:??A&6DYT.VN-\8NJ4XQF
MV7UV%J/9^P<8T7;Y78U^<8+(S?.L\G[(AL3<4UAAVD<A+3]13U\N3(@45?K^
M+ 7C]O(^PPTD_&-Y:F&W7G%F=4;1R'8]HSMUQ]OA/%W58M%$<9M6Y-V;7^+G
M.22E.60Y>Y5'WYOMEHE-QC%&['.O%WD7G/'>&;IR;(HWGAEF\;CN5FZPC9A[
M1@<?ROU'115.<JL:K;(5/&S;/U;0E93WSE3"RZR;=>[[9FF7-IY3M>IF;[CY
M-<9;E>61YF*Y-BNO9Z;'(Y]G+=<K,DC4^16&/L+78JYZ8<APV#4T9%U&HI?B
M[)R2.Q4;!D1VEX->/54U;5;D1[:XQ24JW.N-C^5?PXKNTE\-'1>]>0_$UGDG
M<O)FV6\VAR'+W3-S8V8>7A[9:K<JRZ;=.5"C*MQHMVO72BR3K;K:7<Y+!9.8
MZ*DSYEQ*U?MJ]MYK\R;)>RO?-':Q;"QG&ZX_.N#JM'X[>3WUR7C>4I%@RMQW
MU6I1&I*LI#;>50JCC0SMOJQXI)*K!G%QC'32,._-LA%:+3K7))>B3T:A>1RS
MPQD9MNZY/'.49NZW3LLG+-Y)CW0MML[G*R_V>/8N19)SD[&UDURE/K.4DY1E
MQ6\_U+&4;T?0E1-?0APF8][L3/I=2MQ;:VT+FQJ.RQJU>0RI76E+,Z.9K274
MHT]25?1[3R"?RSW:R,-5JX8]"G^XYQLBM?3K"73T6NC7'AS?QACR]ZCA.+=<
MD^V&3NFY3I;::3LACVXETE%ON2AD5-R2U;CK%F]L8A'4;T/QVTI&E)0X4>2Y
M-WE:)C.K;6VB05=>;JM:>6M@U=:428S[)J(NI"B] >P;C-=MF\;G*O5:KMP8
MZK[.Z&%&:U]&XRC+[&A#R;Q6B7NXO ^(5Y*3[9NSD-RA)II2]K(W^ZB;CKJH
MVU65MI=T)+H&]V28ZC=AZOTI&E)0X4>2YK:JM$QG5MK;1(*OO';6GEK84KK2
MB3&?9-1%UH47H9\8A/Y;,[<Y5ZK5?B91U7V=T%&:U]&XRC+[&A#R_D42]W%X
MYQ"O)2?;-[53<H2::4O:R'=1-QUU4;:K*VTNZ$ET#6_\_8<;?C5>H8<EE:'8
M\N#X\Z A38K[:B6U)B38FLF9424PX1*;=:6AQM9$I)D9$82XEM,TXSLW&4&M
M&I;AGRBU\4XO)::?HTTTUT:T%?G#F]-D;L?&XM5D0:E&=?&.-5V0DGK&4+(;
M1&<)Q>CC.$E*,DI1::3/Q_A#;@_U7_\ I@Q?_20>?YG\<_SO_P"Z6_W\]/[>
MOE3_ &U_^)L/_6XD^1_D+,]P4C>NX7$2NZ3[/[2LR1&6E_J[K7MD7*8Z6%$H
MR[9))!)]"+CT"'#.(5Z=FU;<G'31_AJ=>GH]>S77[]=1D>?O.N5WJ_F?*Y0L
MU[H_K;/46I:ZKL5ZBHO73M24=.B6G0AZ3)DS9,B9,D/RY<M]V3*E277'Y,F2
M^XIU^1(?=4IUY]YU1J6M1FI2C,S/D2.$(5P5=:4:XI))+1)+HDDNB27HBJLC
M(OR[YY65.=N5;-SG.;<I3E)MRE*3;<I2;;;;;;;;>I\!['Q       TH>7'R
MG9_XX>0NP=,4FJ\/R2LPW\J>VNK2YNHD^;^8<(QK*WN_'B(..W[>1>+:3T_B
MALC/U,Q0/-O,6Y<5Y/D[#CX=%M-'MZ3E*:;[ZJ['JETZ.;7Y$=F?T^?0CQ+S
M-X@VCR3N>_;CA9VY?BNZFJFF=</P^;DXJ[93?<^Z-"F]?1R:71(K?_NWVT_[
M1^O_ .J+(_\ B8BO_2"WC_:_&_N\RY__ %8/ _\ C1N_^E\?_NF28;\T6SLG
MR_%<;?TM@<5C(<DHZ-Z2S?Y MV.U;6<6 X^TA:.A3C*)!J21^AF7J.5@>>MW
MR\ZG$E@8RC;;"#:G/5*4DM?W-3"\D_9J\'V/CV?O57)MUG;AX5]ZBZ,=*3JJ
ME8HMIZI-QT>G70V0>??F'DOA[B& 9)C>'4>8OYCDEG1R8UY/GP&H;4"L3/0^
MPN E2W''%JZ3)7H1"U/)/.<O@V#C9>)17?*^V4&IMI)*.NJT-,OI,^G39?J*
MY#N^R[UN65MU6W85=\940KFYN=OMN,E9T22Z].NI)GAUY68IY;:FBYS3M1Z;
M*Z>0BDV#AR9)OOXWD*62>0['[I(D2,?NX_Z^!)-)I6DG&34;\=]*,OP7F6%S
M795N-"5>;!]EU6NKKGIKT^+A-=82^/6.O=&24)^HSP)O_P!/OD"SBVXRGD[!
MDP=^WYG;VQR<?NT:EIK&.11+Y+Z]=4^RU155U3E8O,KQW&,0RK)&&&Y3^/8W
M>7C,9Y2D-2':FLE3VV'5H^M+;RXY)49>I$?H)1GY#Q,&[+BDY553FD_CVQ;T
M_=T*<XWM=>^<AP-EMFX59F;10Y))N*MMC6Y)/HVE+5)]-2@GQ]>;^5>97[6_
MS-@^/X9^SC\A>R^Q6-C/^Y?F_P#.GN?=?<$I[7L_RNWT='\;NJY_ A6WC/R#
MF<[_ !OXO'JH_"^SIV2D^[W?=UU[O33VUII]K-L_JZ^F#8?IO_F]^I-TR]R_
M7/X_O]^NNOV_PGX/M[?;]>_\5+NU].U:>K-CXM0TR
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M6-V7R@I2C3%]M5$)255<7.R4^4/4Y(
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MH^@
M
M                                   "OWDY"JG]-YE*L*MJQ>BU3_L%
MK0E2X<IQ)DS,1RE7)172)W]'2:"47JDAF>/2L6]XWMR<&[8ZO735:]8_]\M5
M^Z0;R7#&GP+=?Q5*N@L*QI-)]L^U]EBU]'7+2>OJNW4TG"^#KN
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M>)7]L\W)MS:9J*C?1C24:E1;-Q^>VO(JMBK(MN/LZPFXS24&B5E-@
M                                             !F5+TQ\1S:8?0E4
MK\MX^E9]Q2U>^LW;TV$)3RA/66+=9K47H3?21_7P>-RM9[CBU=?E]VS^ZQ5>
MO_NNFB^W7X$LVC2CB^\9;T3L_"8VO75^Y=+)[4ET6OX/N<GZ=O:G\VCPT9(B
M8                                                        '69
M/+9KM?;9L9!.J9CZAVA$Z&4(6XM[(<*N<6AGPMQI*6FIMZVXZ?)F32%&DE*X
M2?UQ*Y7;K@4PT[I;CBOKZ:5WPM?P?5Q@TOO:U:74QW(LJG X-R?/O[G57Q;=
MX:12;<LK;[\.OU<5HK,B$IO750C)I2EI%Z2ALJ=0(                &0U
M.6Y70QEPZ/)LAI8CCZI+D6INK*NC.25MMM+D+8AR66E/J:90DUF74:4$7/!$
M.'D;?@9<U9E44VV)::SA&3TZO35IO35OI][,YMG*.2[+0\79MQSL3%E-S<*;
M[:HN323DXPG%.348IMK71):Z)&85.\-U4#;S-%M_:-*U(6EQ]JIV!EE:V^XE
M/2EQY$.V92XM*?0C41F1#'9'%^,Y;4LK;L&V271SQZI:?DU@]"5[7YC\N['7
M.K9>5<DPZIM.2HW/-J4FEHG)5WQ3:71-]=#NC\CMZNMI:LMIYAD26EN.1SRZ
MT<S)R(IY+:7B@O94FX>@H?)E'<2RI"5FA)J(S(AQOYF<5B^ZG QJ6UU]J/LZ
MZ:Z=RJ[%+35Z-ZZ:O0R[\^^9[:U7N')=USXQ;<?QMSSW!R24O;EF>_*M2[8]
MR@XJ3BG)-I O(3:#C:F;&;A^0LJ6VZAK+M5:IS)N,XVEQ).0497A5RFO6XET
MR<-@FS<(D]?5TIX?S0V*+[J8Y-,M--:LK*IU]/SO:NAW>G3NUTZZ::L+SIY&
MG6ZL^[:L^IM-+-V;9L]0:36M:S=OO53:DU)U]KFM.[7MCH+>E](;6U<X+I2[
M3UMN1S/2VM\:<BJ2EQ+A(>P/'L2=E(?)9=29*GTI-!&@D&:NH^+8D'W8V5N=
M3TZ_UYD6:^GPOLM2T_I>WU>NO30O,V]7UNO=MEXAF1U3C_Y VK$<&DT]);;B
MX4IJ6JU5KL2<4X*+[NX6X:B0VIBXT?I2Y8-;;K39TV;XVXPZVEQ'6F;@N?8I
M8O(6ATR4T\\ZR9D2NCJ2E1/YN9$'W8VZ;G7+31_/39JNG\&^BV*]/5)2]5KH
MV@O*NUWUNG=>'<0RZ=4TO8W#$<9)-:JS;MRPK9)J3UA.<ZV])=G=&+6=ZUO=
M7;$RROPVXT%@5(FX1/.-<XEEFY(=A!?KZFQLDFZSD^S,OKYL5]<1*%H)EEPD
MF9I<(QBM[Q=]V?;Y[EC;MEVNMQUA;5AN,E*<8]'5C4RBUKJGJU]L29^/MY\<
M<\Y-1Q/=>$;)AQRU;V7X6;OL+:Y54VVKNCF;MG560DX*,HJ$)::]MB95D3LU
MN                                                  )H\</\8?0
MO\L^KOZ^*,1KF?\ P/W;^QN5_D$RV_ /_/OPG_E=L_\ OACC]@N<?Z.Z8_[X
M_P >/[Z(?SKVO_"MR_W.W#_6H_M*<Q_S[Q'_ .BKB_\ Z8'[!<X_T=TQ_P!\
M?X\?WT0_G7M?^%;E_N=N'^M1_:4YC_GWB/\ ]%7%_P#TP/V)6L?Z+?8.EZ>2
M?U(C?M:PS).XP?HE_P!]@UEE=2UU.)4GM.2$2$]/4ILD*;4M_.>B?7'P]SLA
M]OX2ZOK]G;?&J;^'51<>NBEJFD_M/[E1\FZ[YQ'$R'U4/UU@9>L?A+W-NMS*
M8ZO5=DK8VK3NE6H2A*3]C/\ Z]?2_P#5U_ZBP_G+_P#>_<_\8_\ KA_:F_\
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MTWA9&17C+(PECURQK)0OCEXF99.N*MBW6T30U_
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MH=\N\*VJ[?-HG@[YM]%;G.&*[(Y2C&+E.2Q[815B272--EELOX-1B8W6-,P
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MI*7=ZMMNU8CI98
M
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MI*B-*DJ2?"DJ2?!D9&7J0GB::U7H:ZRC*,G&2:DGHT_5,_('@
M                              #,LNY]OAW3T>V_)M?[7M=OM<?<[CWO
M3V_3K^[>X[G/U=[KY]>1C=NT[\G77O\ Q,M=?7\V';Z_TG;I]VFA+.4=WL;3
MII^'_5-?9IIII[U_N::?'WO=[]>O?W:]3#1DB)@
M                               !F2S*/KZ,DCX5;YC.-1);0746.4E>
M2#?=Y):N@\I5VD\&1=3A^G/KC5\^\2?^%XT?_=)R]%_XKK_WI+)M4<&K2]<K
M=K-=$NOX7'JT[GZO3\8^Q=4M;'TUZX:,D1,
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M;E7RTBI2DXTTS:C%.4FE%)MHA028J$
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M5M$LBR=%R<6XN-U,H6Q<6TXS370BL9XK4
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M3@Y;:UAD8KA:\=N<JHV^Y6I.G(5\+8?!A_[%'_VDO_HN"9_3Q_\ 'C_X)_\
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M\&VG:]DQK*73)XN-6LF=3Z.%F?:K<^U272:LR9*?5R6KEK\A[GS
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M;<G*MX57E\RC&%[V]RRXM=B4?;;L[HZKM?9KWI:*,M4NU+1>B<7J=<X
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MER?Z"Y_ O3\"%'RG*<G.;;D_B^K-_JJJJ*U31&,*HK11BDDE]B2Z([$>I]
M
M
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MR[Q)R_A^)+<LR%.1M<&NZVF;DH:M*/?&<836K>FJC**?1RZK6$1(BL
M                                 SUYB9<:^JWF#]Z>)W5\S/:0M*I%
M727#5%(JW5,%^L*N<N"G\N$1I0\[PHRZT$>(C*O&WFR,_E6156XOX3G!V*:U
M].Y0]OIZN*U7HR;6TY6Z\&QK:?TSVS,R8V)-.5./>L:5,G'U]IW_ (GY]&HV
M3TDUWP3P(9<A(
M      9GD1JCX[@D%1.$I5-:W*R<49="K+([2&VA+)I(T$N)3M/$LS_6)=(R
M]"(SQF%I/-R[5IHK80_NM<)/K^6;6GP:?QU);OW=1L.RX<NY-XEU[U?H[<JZ
MM)1TZ:PHA-2_A*:^"3>&#)D2
M                     B/R/E*A^.VP>)7M$6=_K^E4GW)1_N*W+>;>(J^W
MUH.;RG'U2^SPKCV?=X_5=19WB$%9S##^7N<*LB?IKVZ0C#N_I?Y10UZ?G]O\
M+1U=Y]R98O@??&K?:AD9VV8[7?V^ZW?9D*G35>Y_F9W]FC_D/<T_1ZK4F+].
ML$                          ":-"_P#3Q>_R,>1_^UXVB(URO_8NK^R6
MW?[X8I;?A3_ACF_\D>5?_DOO!"XDI4@
M                      $Y;W,K.WU_FJ4H(L^U#KVY?<;<BN(E6N,U;FK\
MDL%>V;8-$JRRC7\V1()U"7/<N.'RM)I<7%^*_H,?+VQZ_P!:;CD07KTA;+\5
M7'JWTC5D0C'1Z=J7H]8JY/-#6X[IL?+HI);WQ;;+Y-.#4[L2E[1EVOL4=)VY
MFV9%MJG%3]V=CUG%QLG!HE!38
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MNX[GQ_#_ %?L.3G7VXV+WNS\-CV6SG3C^Y+YK/9K<:^]]9=O<^K,>',,&
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MN(<;DGL6)EQ=,5-V>U"ZJN_V.^3E.3QW:Z&YRE9K6U9*4U*3ZH7*4^1'X_\
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ME)ZMDA#B&7
M
M                                                  (ZVW2(R'6V
M9U*V%R3E4-@E#3:>ITUDPLR[?H?2OIY(E?SO//Z!R\"YXV=3D)Z=EL7K^22?
M[WVF&Y%@QW38,[;91<U?B75]J]6Y5RBDOOU?1_!Z,T)#88ZS@
M                           S773[C.=8HVD_U4^]K:F:T9J[<FNMY;5;
M817DD9=;,F'*6A23]#(_48O>H*6TY$G^="F4XO[)03E%K[U))HEW KIU<SVR
MN/\ )WYM5%B^$ZKYJJV$E\8SKG*+3Z/7J84,H1$
M                                ,RSC]3;0*[I0G[3C.+0'"2KK4F6=
M! F63;CA+6A:V;28^CE'T]*2(N>.3QNU?-CSNZ_I+[9?N>Y*,=/RP47UZ]?W
M"6<Q7M;G1@I)?AMNPZWH]=)_AJK+4WJTW&Z=D>G31)+735X:,D1,
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MI)65PJL2:ZI3JLG7->DJYSA+6,FG"8DQ4(
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MWO)Q(469%4,B&/.HXL$U=
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M]^5=+(R9SLR)O64I-RE)OU;D]6V_M;/B/8^0
M    9?395]IA)A^P]QTN..=SW7:Y[A\\='MW/P_R1HYYZ^C'^W?Y!LYW_.3]
M6>YBTT^Q^K_Q.GLQ:[O=_'4:]VNNGMK3[6;L^"_K$_M+<!KX/_-W]9>WE77>
M_P#C_P /K[S3[?;_  5^G;IZ^YU^Q':?GW_XE?\ O]_R&*7_ /5I_P#X:_\
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M-_\ .[__ !Z&%_F#_P#M?_N7_P!L)Y_TD_\ [R__ !9__*C_ '-W_P!?-_\
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M$1$7H1$0X!(#^@
M
M                                                          PC
M8N6TN$XA<WU^YVZUF*\PY]!N$XM]EU*6C225FKN$1D1<&:C^DB-1D1\C%Q;\
MS(ABXZ[KIO1+_L^"]6_@C';MNN!L>VW;MN=BKP*(.4Y=7HE]B6K;;T44NK;2
M75FA"PD-RY\Z6TWV6I4R3(:9^DNTV\\MQ#?T\)^A*B+T]/0;"TP==,*Y/648
MI-_;HM-3K0SKX96;=DU1[*[+9R4?L4I-I=.G1/3H<,?0XH
M                      '.K9\BJL8%I#429=;-BSXJE$9I3(AOMR&%*)*D
MJ,B<;+G@R/\ FCY7TPR*9X]G\G.+B_R26C_H,YFWYU^V9]&Y8K2RL>Z%L&_1
M2KDI1^SXI?%'=YM!B5F6Y#!@([,6/:2DM1N6C.%U+[CE>KL_JR77N+-A1%QP
M;9EP1^@XNU6V7[=3;<];)5K5]?F_INO7YE\W[IF.886+M_*,_#PH]F-7DS48
M=/T>KU=3[>FM3;K:7HXZ=&8L.>1L
M                  Y,.*Y.F1831H2[,DL16E.&HFTN2'4M(-9I2M1()2RY
MX(SX_08]+;%57*V6O;&+;T^Y:G(Q,:>9E5XE32LMLC!-^FLFHK71-Z:OKHG^
M0R#-Y3<W,<GD,_\ &QWMFU#3T);[<&/+=CP&NA)%QV8;2$^O)GQZF9\F.'M5
M;JVVB$_Y3V8N7Q^9I.3_ '9-LSG,<FO+Y7N-]/\ F=YMRK6FFE<9N-:T_I:U
M%?;TZMO5F+#GD;
M           JMYJ37(^LM3US;;1M7&=[(FRG5$X;Z7,;Q_7;$!MDR<)I#2TY
M5)-WE"E*-+?!I)*B5-_&]2GON?<V^ZO$QHI?#])9D.6OQU_11TZ].OKJM-:_
MJZRYT>.^,8$(Q]O+WK=;)MZ]R>+C;7&I1ZZ)-9EKGK%MM0T<4FI:X!<9H(
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MZ?HY0E+88*3GI*N2K4-5=/2#1*"FP
M             #8UL-N-I?6]ME.!:TPZ+KC8=%;Z@J5[!Q'8V+[E;<R.AM),
M_*)+UXJ%C^7Q4^U]T3T)R;7UEA[1E+:%,,O.TWL\I\EWJO W;-R9;SAVPRY_
MA[L>W#TKLBHU)0[K*GU[=)J%EE?N2<FIRC'??G=>/XDX!E<EX5Q[:JN ;]A7
M['2]SP=UP]^3RL:Z=F9.60Z\;.@NSWE9CSR,7$R?PU4:X2IIMMURBY#0@
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M%SHO@FH703T?1]860?RVU2^>N?1ZIQE+H!RS"
M         2KJ/7T#9V12,3=MGJ>WEP5/4,DV4OP'9K+K:5Q9R"+NEWT.EVS)
M2$D9'U*_ CP>_;K?L^-#,KKC91[BC--Z/1IZ.+]/5=>C]5][5A>.N'[=SC=+
M]CR<BS&SWCNRB2BIP<H-=T;(]'UB]5I*/H]6WI&6V70NEH.GL7]DZ<:;D<]7
M>N+1II!&XLN>B.TZ:"=..SU&22,^../3JZC54>^;Q=O.:\B>L:5TA'7\U?W&
MK]6_W/1(W0X!PG"X+L4=LH<;,Z;[K[5'1V3_ +GL@GVP3?1:O\Z4M9X&&)P
M
M
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MR"]74YN<_<CU?9JU-?FZ224]?XLHU4
M     /JR\['>:D,K-MYAQ#S3B?XS;K2B6VM/\U*TD9#Q*,9Q<)+6+6C_ ",^
ME5ME%L;Z6XVPDI1:]4T]4_W&2B[.9V1%MV_L]'59?%<?OJU-)"<B*R-E3:G;
M^M=0N2^J39ET>]C%RI1]+S3:?K;2G 1JELEE<O=MLVV25<N^2?MOTKDNBTC_
M  )?#K&3?1MV1;F5>0,?*K_"8>-RFN4LFI8];@\J+3>35).<G.[I^(JZMO2V
MJ$?GA&,4B0%9@
M  &8:_:2YFN-.+2:VX5M&M'6TMDZ;S-.H[5UGI,R21/-PS0:CY))'R9&1<'C
M=XDUM=\5TE*MP3UTT<_D3_<<M?O]"5<'KC/EVW633E73E0N:2U[HT/WI1T_I
ME6TV^B3U::6AB3CCCSBW75K===6IQUUQ2EN..+4:EK6M1FI:UJ,S,S/DS&1C
M%12C%)12T27P(Q99.V;MM;E9)MMMZMM]6VWU;;ZMOU/P/)Z
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M63F5RE)8F0EHZZ*JHUW4U)>W=+OG*4Y41C3Z&QLZ=/X
M  !-^K.BSP;?>,K[!/2-<56651K]PEU=IA>P</E2F4NM]4=+!XA96[II=21+
M>::)*TJX2N,;]K1NFTYJU[5FSJEZ:=MV/<D]/77WHU+5>B<M4UU5P^-NS<.&
M\VX]/L]ZS8*<VG7N3=V!N>#.<=5K%1_ VYLVII=UD*U&:EI&<("3E/
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M?EZ+TBDNA)@X)GP
M
M
M      /D^PS)9=CR&TNL/MJ:=:67*5MK(TJ2HOX#(P!I\WWXWY3KZ[M;RB@R
M;K#Y;[T]J1"8<=>JD/K=?=CR6&R6OVL4B/ASU-MO^/Z%W%V]QSE.+FT0P\V2
MKSHI1U?13TT2:?HI/XQ^+_-]=%I9Y/\ $.[[%GY&^;!5/)X_9.5CC!.5F/W-
MRE&45JW5#U5BU[8]+-.WOE543,H@
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M1$P
M H3YQ2X[FPM=5S!O*=I-/TD28XZTAI"Y%KF>>Y4DHW0\\IQEF)D339J42%&X
MA?TDG@SM'QC7-;3FW2T[;=QFUH]>D*:*NO1=6ZV]%KT:ZZFE'UC95%G.MAP*
M>]V8?%<>$VTDG*[/W+,79I*3<8PRH0;?:W*,OE2T;I:+)-1P
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M5$_;>G>Z,ET9$8IQEWTQ[91EHU!HE)38
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MXO@\/V"C8\'JJUK.?QLMEIWS?Y7T2_@Q48_ EL8TDX
M
M
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MET2-.<[-RMRS+=PSINS,OLE.<GIK*4GK)]-$M6_1))>B21EP^AQ0
M           #,Z0D1\/S><:FTKDGC./(ZN\IQPK"R?OE--I0DV4D?Y5)2EK,
MC+H)*?XQD,9E:SW+%JZZ1]VSX:?+%5ZOX_X+IHOMU?H2W:%&CBN\9C<5*QXF
M*M>[5^[;+):27RK_ #%JY2T:[5%?G,PP9,B0
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MYU3Q;+,?*JC&BVRNC]'A0P)2JK[H7^]"-4*[=48[X3\T
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M1JK@H4T04G*V*4(V*%</TCUA"PDY48
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M*Q:;,16YM"
M
M
M        $.;ATUC&W*7VMQ&,K:"Q(*GL6G%-/Q'74F9$E1'T&1K]2)9*1U?Q
MDJ+T&3VO=LS:+_?Q):)Z=T7U4DO@_P#NK1KX,BG+>&['S3;OP&]5N3BI>W9%
MM3JE):=T'Z?!:QDG&6B[DS2ME^)76#Y#98U?Q'(EA7/N-'UMK0W*82XM#,R,
M:TI-<:02.4GP1I/E*B)25)*\MOS\?<L2&7C/6N2]/C%_&+^QKX_OK5-,Z_N2
M\<W/BN\W;+NL'')JD]'H^VR&K[;(-^L)I:I^JZQDE*,DL9',,"
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M_!:%K+3+W6YZ>BTQJ*$F^OS=<J2CT^72?7YFEA@R9$@
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MT7:E%4MMR[THPH),5"
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MQ,6CV*G'W:<3)_"RNOJ<I64V%CFIX
M          '?5&+9-?MO/4..WMVS'6EI]VHJ+"R;8<4GJ2V\N''>2VM2?4B4
M9&9#B9&?@XC4<NZJJ36J4YQCK^35K4S6U\;Y#OE<[=EP,W,J@TI.BBVU1;6J
M4G7&23:ZI/KH2U!\7_(B<EY?[&-AUJ63:2:LBQJPQ9+JG2=-*8AY(U5%--)-
M'UDSW.WRGKZ>I/. MYSP^II?K+#FWK_)V1MTTT]?;<^WUZ:Z:]=-=&6?A_3E
MYWS(RD^);]CQ@TM<K$MPU)RUT4/Q<:?<T[7W>WW=O3NT[HZY_ \*-VO*Z+=6
MO<:7[@F"39[)Q&T5TD:2=?66'V63FPTR:N#)SH=5P?0A7!C$V^2^-16N.LR]
M::_+C70_(OTT:M6_NU7VM$WPOI#\OVR[=T>Q;?+O[=+=UPKG\.Z3_ VYG:HZ
M]5+MF]'VQEHS.*[P<FET_?MS8(QU/)27Y:HL[O>B.71W'7OOF.X;P]]1]#:.
MXE73]2T>@QMWDZ#_ ,R[;E/I_@ME$.OV+LLNZ?:WI]R9,<'Z.,M:?KKENRPU
MFE_6F-N.1I'IJY?B,7 ^;J^V,>Y/3YIPZ&=UGACJ6&IM5SL?8N1H]PA;K59B
M.-86KVB#0;D9M^5DV>E[B07427S;Z6?0S:=]2&+O\C<AL36-AX5+TZ.5MMW7
M[=%51T73Y==7_&B3/;OI+\88DHO=M_W[/A[B<E3A8F ^Q::P4IY>Y?-+JE8X
MZ5]'[5G5&=5GC/X[57:YPS,LA[<HI*_S7L-;W?0GL\5[GY0QO"NFO7VCZNCI
MDGW%=+R?HZ,7=S+F%^O]=8U.L=/T6/IIZ_-^FLN^;KTU^7HM8OKK--O^GOP-
MMO;_ .2-VSNVSO?XW='+N2[?T3_ XFWZ5/1Z]NEOS2TNC\O;GE3K?3= IM5-
MI36K!M/KDE]V@7V9I4^MM#7+B<]R+*4NL(2V1I841QR5RKM]2E&>+R-VY%EZ
MK)W/.EJM/DE73T]>GL5U:/\ IOSOAKHD37;. ^*-DE&6T\0X]!QFY_IJLG/3
MDTEU6Y968G%)+2M_HM=9=G<VWG5;9'1]G\NU.+8M[8W%1OREAN)XG[5UWK[D
MF+^7*6L]M,5UG^O;Z7OP^KT+C%W8T<K7\9.^_N]?>NMMU2^#]R<M8_TKZ?<3
M+;]P>S=GZAQMMVWV]7#\%@X6%V2>NLX?A<>GLL>K_21TGZ?-T6G,G91DUGU?
M<LBO;#K9..OWUO82^J.KKZF%=^0YU,J[BN4G])]1^GJ/2K P:/Y"FF&CU^6$
M5U^WHO7[SE9G).0[CK^L,_-OUAVOW+[9ZQ>NL7W2?R]7T].K^TZ$<LPH
M  &38E4Q;>Y;18KZ*BNC2[FZ43J6G%552PN9+C1U&I*O=SR;*.ST\F3KJ3XX
M(QP=QR+,;%;H6N3.2A#IJN^;[4W]T=>Z7W)DAXOMF-NF[1CN#[=JHKG?D/51
M;IIB[)P@]5\]FBJKTU??.+TT3.'?WUAD=D[96#G*C0W'B1T?3&KZ^.71#KH3
M1$2&(D-GA*$D1<^JCY4I1G],/$IPJ%12NFNK?QE)_G2D_BV^K?[BZ)(XN^;W
MG;_N$MPSI:RT48072%54>E=5<?2,(1Z12^^3UDVWTHY1B
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MV>W/[NZE5O31:?%*6I8 84G(
M
M
M                       !3/S!U*SEF'.YQ6,MHO,497*EJ)"2<G52$I*0
MRI9$2S6TTGJ1SUFI2$(21=2C$MXAN\MOW%8MC?X6]J+^Z3Z1E^_\K].CU?H4
MUYJX7#DO%Y[KC17ZWVZ$K8O3K.I+6VMOUZ17N077YH]J2[VS4R+D-&@
M                       S;*5(CTV$5L5LD0?L#UV;I.(=.;:V]E+C6DM2
MFTI))LE4,P^CU-!0R(SZN1B\!.>5E7V/6WWE#3T[80BG!?N]\IZ_'O\ L)AR
M24*-HV?;\:*CA_@I9&NJ?N77VSA=-M):=OL5T=O5Q5'5ZZF$C*$/
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ME[IX^W+\%_,3&_#]GO>_^CE7W:^U[7JWKII9^37[S;B)(58
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M/=*]\\N\JWJJ#A5F<DW.]1;3<5;FWV*+:Z-I2T;734BX9TK@
M              ";%MN-^.<=Y;:T-2]URVXKJTJ2W)<K\%A*GMQUF1)>7"39
MQC>))F;92&^KCN)YC*:?,G%-.4=L6J^SNOEVZ_9W=LM/M[9:>C+>E79#P)"V
M<6JK>7S4&TTINK;JW8HOTDZU;4YI:N"MK[M.^.L)B3%0@
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MMXQR7<>-WV1MOV_.OQI3BFHSE1;.IRBGU2DX:I/JD^IUXRQ@P
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M\\JF%.4U"C+Q<J=D[)TSLG36X3G=W>]&R%J@G$W3B_#K1
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MD6'XHHNO\A;7&F+DXY'<]/A&,).3?W)+4WLBBSL'
M
M
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MFD_0EG-6J=SIVCW5;/;L.G&G)-N"M@G*Z$/Z6NZ=D-5TG*,IKI(PD90B
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MWU_6/XX"-8O_  PSO[&X/^3[B6WO/_,1QO\ Y7<D_P![^*D+B2E2
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MR5EEEDG.=DYMRG.<Y-RE.4FY2E)MR;;;;9\A]CC@
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MM_X.-,K8RG[V=GV9%>+"7=)3GB8DY.<*Y2C&O%L]M]D$STQC;,Z2P
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MR2EIJM=&TYT&')L
M
M
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M^+R3<Z=NG_'P:\V^&)+\R'YV/&M_F0]?S(^BQ43DK<
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M54X:ZQE"6XUW/Y7K%2=F-0^])3TAV=W9*<904)44R
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M;?S:)M+2*_@Q2Z$JC@$@
M
M
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MJ4M:C4M1FI2E&:E*4H^5*4H^3,S,_4QDDDEHO0BDI2E)RDVY-ZMOU;/R!X
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MS$EK\M5N[96)!2;27>[<"]M1[DH.MMZR<8PH),5"
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MGQMML'[6%9EO)GD9,YRG=GYUD*L:F_+MUC7%PQZZZ**J::H_+.RR'A(RJ@
M                FC"/[#^\?^UG_71+$:W3_A'M?_PG_(D6WP__ )J^8_\
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M^"]$NBZ'8/MVW8.T8-6V[;5"G!I@HPA%:**7]%MO5MMMR;<I-MMF3#XG-
M
M
M
M       -(/DAE+^6;ARV6ZM*F*V4BE@]+G>)$2 1_1W24:5D4EYSC@DD2>"X
MY(Q=O$L2.+L=6GY]NMC_ "R]/_!430GS-O-F\>0,R,M/9Q%''A]RK6LM>O\
MAL['\-$TFM4R"Q)"JP                       D&V=B2M?XTJN+VB:^UL
M(-W#.,T1SKAU*I<>Y*>2E/R$+K%HCDRLDI8-HS01DLS/#X\;*]XO5WS=]<90
MEJ_E@NCAV^B^;67<OSM>OHB<;G;BY'!]OE@?HE1DVUY%?8OTE\DYQO\ =U<I
M)TN-7MRT5;@W%/O;<?#,$'                       #O*!VT:G&=2VEZ0
M;+AN-K0A2%L)-*U)6I1H-"5+2DN24DS5P7/J->?J9V;PUO7CJ-'F[+MP>,+<
M*51?5;;"VO,LC957.J%<;(W3A5.^3C91?"%*NM=>D'); ?3;O'F#9O(4KO"V
M+5F\E>!:[Z;:JYU68E<H660MG.5<JH3MA3%2KOHG.YU5JS6:B\A9RJY<M&8R
MXC:"6^VRN%V7$O$2C(E$:EGW$K21]7)EP7'J7 U9W[Z+/ .U^'L_EFW[WE9%
ME.VW9-6ZK*HLQI.N+G!QA4E195.455VQL<Y=S4+/<<6MG=B^LGSQN?ES XKG
M[+BT5W;C3C6[7^&OKR8J;49J4[6[J[81D[>Z4%"/:G.OVU)/O\P89<IG77"3
MW8[K*V%'P2NIQU#2T)/T,R4VLS,OT])'^CTUD^@[D>_;3Y]Q-DVV5KV?=<+*
MKS(+5U]E./;DTVSCHXJ4+ZX5PL>CC[\ZXRTME&>RGUR\>V/=?!.5O6XJI;OM
M>9BV8DWHK.^Z^O'MJA+52<9TV3LG6M5+V8SE'6J,H<ZE<1.H8:4*(N8*8BC+
MZC0MEOVRN2/I/GE//'\!_CQZBO//^U[AXZ^I7?<O<:ISE'D4MSK3_1JVK)O_
M !U:C)>XNW2SVN]=VDHR[H1G&5<; \#[GM_D+Z<=DQ=OMC!2X_';;&OG=5N-
M1^"L<HOVWW:U^YV/36,H]LY0E&R43M54QRP*M-EQ,CO=IPN@U=M)+Z5O'QP1
MLI+UZN>DR]>1W:[OYEX%MOBZSRW5GXUO%?P+R*9.R,'=-U.RO%2>LHY-DM*O
M8<7;"S6$J^Z+2Z7]J\/<ZW'R;#Q1;@Y-7*/QWL6Q5<IJF"L5=F2VM(RQJXZV
M^\I*J=>DHS[9)DJ91(1'I)G69=3Y(CM),^#6MQ9<DGT/DT-I4KC]))'2]]&_
M&-PY-]0NQ/"C/\-MT[LW(FH]RKJHJFDY+NCI&R^=./W+7ME=%]LM-'W&?5]R
M7;^-^ -\69*/XC<(U8=$'+M=EMUL6U%]LM95T0NO[7IW1IDNZ.NI#([]CHB
M                   ,RPTNTO)K$TH,JW#<@,UN*Z4-_>H[>+$HTDM"G%K5
M?DA!%SPXM*C(TD8QNY_,J*>OSY-?I\>Q^[^Y_)ZO[DUZLEG$_P!%/<<_1:8^
MTY/5OHOQ$5A^FJ;;>3VQ2UTDXMII,PT9(B8
M                                 8-M^8[7:(WA.CDCW#6#5$-M3A&I
M*&KW9>O\<L#)!*2E2UU=P^A)GR25*)1%R1#);#7&[E.UU3U['ES;_+#&R+(_
M^'"+?VZ:>C(=Y3RK,#POS'-H2]^.S403?5)9&[;9BV]-5U=-]D5KKHVI::I&
MG ;$'5"                            $T;1_Z1_'#^1B]_VP^^1&MB_V
M4WK^R4/][\$MOR1_P.X!_P D<C_\J.2$+B2E2
M                              !-'D-_9@R__P!(']:]((UP_P#X.8__
M (S_ "69;?G7_G4W7_X-_J/'(7$E*D
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M0[.L[#OV[-NV_)6F31;.N:ZK24).,EHTGZI^J3^U)G#'T.*
M          'Z2I2%)6A1I6DR4E23-*DJ2?*5)47!D9&7H8-)K1^AYC*49*46
MU)/5->J9)#91-@1):G.XSG\2*Y*;6TWUQ\SC06'7YB7VFT&XWE3<5LUDXGE,
M\FS)2?<*-;F#D[-GLBHZ/9Y22>OK2Y-*.C]'5J]-/\#UZ/L6D;!K6+SC&M=G
M=#G%5;FFEK'/A7%RL4HI:K,4$Y*:U63VM2C[\G.R-1G"O0
M                    #;-X<:M5B6&/YC:Q39NLK-*V$O-FEZ-4LFHHZ.E1
M<I-TS-1_@I)J4D_P%-\PW5;AN7X>IZXU&L5IZ.7\)_\ L5^37XF\GA+ATN-<
M66XYD''=MP:LDFM)0J6OM0>O5=&[&NCUGH^L2Y@B1<P
M
M
M                                                      &ISR.\
M:KS"W[[8=-,3;8[.M)%C9,+(D3JM=B^MYYY9GTH>CJE.'Z)+EM*B+E7!F5J<
M6Y15D1IVC*CV7Q@H0DO27:M$FO@]%Z^C:^&J1J'Y=\2Y>W6YO-=HM][ MNE=
M?5+13J=LG*<XRUTG#OEZ:*4$U^>DY*F GIKB                       &
M=Y>@J.+586V3Q/4W=L[];B'&2>R.XC0UR(Z65JZNS30&&(J341&;R7UI(DN>
MN)VUO*LLW26G;;I&O3KI7!RT>OVSDY3Z?P7!/K$F?*8K9\;&XC7W^[B:VY+:
M<>[*OA6Y147U[:*XUTIM+6Q73BE&SK@@RQ#                        R
M.@OSI5.I5&0^T^:36I/"'TFDC(NESI/K1Z_Q3].?4C+D^=5?J8^F>'U 8N#D
MXN\9&V[SMT+(U0FI78=BL<7)SH4X^W;TT]^O64HZ0LC8H5]FT7TW?4C/P+DY
MN/D[31N.S[C*$K9P<:LRMUJ2BH7.$O<JZZ^Q9I&,M9UR@Y6=^;EF=,:.O^FR
M5TF?;-@NODOYWDG#;ZC_ /;N/YHZ[Y_0!Y\CG_@X_J26/[BC[ZS)>UHVD[-'
M0K^R.NK7L]^B?;!O1/L#A]>7@J6#^+E^NHY'MN7L/$C[NJ3:AJKW3W2TT3][
MLU:UFEJUAE_D:[@D,--&Q$;7W"2I7+KJ^GI)3G2?0DD<GP1<_CSS_!OW],GT
MI;?X'LR.2;QF0W+F^7C^Q*=<.W'QZN]3E"CO2LE*QQK=EDU'\U0C"*[G/1#Z
MD_JDW#SE71QW:<.6W<+Q+_>C"<^Z_(M[.R,[^U^W&-:E8JZX.763E*<GVJ'Q
MHL@D4RU(-!R(;JB4XP:S2:%<<=QDSY2E9E^)&7"B(B]/Q+.?4;]+_&?/>%5N
M%=RVSG.)6X4YBK4XVUZ]RHRH)QG96GK[4XS4J)3E.,;(N54\)]//U,\D\%9E
MNWV4O<N$Y=BE=B.QPE5/31WXLFI0KL:T]R#@XWQA&,I0DHV0S4\VJ";ZR:FF
MODR[79:)1>A\*-7?[9),R_09G_,'7U3^SS\X3W+\%=F<=AA*"D\A9.3*M]4G
M",/P:N<TFW\U<*WVM>XFUKOQ;]?WA6.W?C*</D$\QR<50\;'C8NC:G*?XMTJ
M#:2^6R=B[D_;:3TP6[O)%R\E2T]F,USV(Y*ZB29D74XM7">MQ7'X\$1%Z%^D
MS[(OI[^G;B_@/CUF+@V?CN5YFCR\Z4.QV*+;A357W3]JBO77M[I2LGK.R3TK
MA7UV>?OJ"Y+YVW^O*S:_P/%L/58F%&?>JW))3NMGVP]V^>FG=VQC7#2%<5^D
MG9T8V&-?P                   #,J8_;X?FDOJ0DY3V,4'\7J=6F=.FWIM
M$9H,FV3/%R6I1&2NI""+DE*&-R?GW+%KZ_*K;/N^6,:]?R_I=%]S;^")9M/Z
M#BN[Y6J7N3Q,;TU;]RRS)T].D?ZS3;U3UC%+5-F&C)$3
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MP<N7\U,.JG&EN>VU9MLJHW73KQ=NOS*\[(EI/NA#'QK';.3C6IS;14,6&:M
M                                                    !-'D-_9@
MR_\ ](']:]((UP__ (.8_P#XS_)9EM^=?^=3=?\ X-_J/'(7$E*D
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M !>-H_RSZ%_K'\CQ&LK_ (88/]C<[_)]N+;V;_F(Y)_RNXW_ +W\J(7$E*D
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MCL(/N
M
M
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M?<YX#9CU<UVG<-JLRZW.E9-,Z?<C%I34>]+YZI-1NK_E*9OLMC"?0P@90AX
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M^A?ZQ_(\1K*_X88/]C<[_)]N+;V;_F(Y)_RNXW_O?RHA<24J0
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MEY@
M
M
M                 'S<::>3T/-MNHY(^AQ"5IY+\#Z5$9<D .GFXQCEDT\S
M.HJF4W()*7B>KXJC=2GIX2M7:ZS(NDBXY_ N/P'M&<X24H-J2]&GHSYVU57U
MNF^,9U26CC))IK[&GT9@5GHK4-N;ZYVO\:<?D-=E4E-<RB0A'1T%V7$ERRI*
M?P-/!D?J7KZCGU;ONM.BJR;XQ3UT4Y:?O:Z/]U=2.Y?"^(9[E+,VO;[)RCVN
M3QZN[333I/L[EI\&FFO5-,CNU\0](V?<6C'YE<\I@V6EP+6;':9/ZS2\4=MU
M++KR5+YY62N>"(^2+@9*KEF_T]%D.2UU^:,):_=JXZZ?D:^[J1?,\.>.,W5S
MVV-=G9VIUV75Z>NC48V*#DF]=91EKT3U2T(ZL_!;7TE2G*W)<EK^&>AN/U07
MV5.D:C[KKDB,^]Z]1$9)X+A)<<'R8R-7.]X@M)PHGU]7&2?Y.DDOZ#(QE?3W
MP>^7=1;N%'RZ:1MK<=>OS/OIG+\J4DM%TT>K<=6W@78I2I=)GL59H869,V%4
MX:WI'U="$NL2&D,-'Z<J,EF7)GQZ<'DJ?($T]+\9-:^L9Z:+\CB]7^ZB*YOT
MVX[CKM^[3C)1?2RA23E\/FC;'M7P;[9->NC]".K/PDVS%Y.OF8U9-H:4XM2I
M[T19J21F33+7MY"G5*(OT]/KZ?S1DJN>[9+^5JOB]?@HR_?^9?W#(OE_3IRN
MOKA9NWVK1Z]SMK>OV+2J:>OVMQ_[9'EAXM[Q@+2DL*D3B4V;BG(,V MIHB,R
MZ7%OR8Y$K@N>"YX+\1D:^8[!-:RNE#\L)_\ L8LB^3X.\CT22JPZ[DUZPOH2
M7W/W+(/]Y-$>6&JME59M%-P;*$&\2S;)JGFRS,D=)*-11&GS;+E9<=7'5Z\<
M\'QDJ]^V6W7MRJ.GVS4?[UIK^X1?)\=<[Q.WW=HW!]VNG93.STT]?;4M/7IK
MIKUTUT9ATRKLZ[C[A73X/*U-E[R)(B\N(_C(+OMHY6G])?B0R-611=_(SA/I
MK\K3_N&1G+VW<<#_ #=CW4]6OTD)0ZKU7S)=5\4< ?4X0      'Z2E2U)0A
M)J6HR2E*2-2E*4?"4I27)F9F?H0-I+5^AYC&4I*,4W)O1)>K9F^>M'&L:>#(
M2:+6NQ7'8-TTM"4N1["/ 0EN(\:4I-3\*L]NRX2N5-K;-LSY1P6*VB7N46VP
M_P SSR+)0?P<7+JU]TI=TE\&GK\28\VJ>/GXF'>FMSHVS%KR$TDXVQK24)=%
M\U=/M5R3U<)1<'UCHL&&5(:
M                &99&11Z'!87'#AT5A;2"-Q"EMNV>16[3+9H07ZI"JZOC
MO))7*C)[G\#(AC<)]^7EV_P?>C!?>HUP;?W_ #2DOLZ:>NI+-_2HV79L/_!'
MA6W2ZIM.W*OC%:+T3JJKFD^K[]?1I&&C)$3
M.TK(W>>[JB_5LF1E_ IST-)?Y"?Q/_@#2_ZT?,RX!P+^9&RVI<KW^N5<M->Z
MG :E"^U-?FRM>F/7KZQE=.+[JD;K_11X6?D'G_\ /G>ZF^)\?LC9'73MNSTX
MSQZFG^=&I:Y%FGI*-,)+MM9R[:3PDHR#]5<*=X_0G\4)_P#LC]3_ ,@OX11/
MT(>&_P 9GY'F+?Z-<7&[L?;>[TE<^Z.3DI:K^2A^@K;[HN5M[T4Z8R5\_7MY
MG_!;?C^&N/WZ963VY&Y]OK&E=LL7&;T?\K/^N+$NV:C50M77=.+Z =HQU7@
M                          !53S5F.L:UU'7MD@F+7.=FS)BC(S<6[04&
MM&:TD*-72VAI&2R^HB+E9K3R?TD)QXWKC/?-PMEKW5XF,H_DLLR7+]_VH?DT
M?VLUJ^KO*LI\>\7PJTO:R=YW>=C^+>-C;3&K3KHDEEW:Z+YG):OY4:XA<1H*
M                              9/AV99+@&1UN5XC;S:2\JGB=CS(4AY
M@W6E?1*@3$M+04RLL8YJ9E1G.IF2PM3;B5(49'P=QVW"W;#G@;A7&W%L6C4D
MGH_A):^DHOYHR76,DI)II$BXIRSD/"-_Q^3<7RKL/><:>L9URE'5/I.N:BU[
ME-L=:[JI:UVURE7.,H2:<O+W9C-)9VF2:WT_BN#9;82ICT&]>L[/+6,4:GKD
M./\ Y0HKU*Z>GL(ZG4)B2W&I#T)M'ZCH<,G4QY<8SLJBO"WK<;\K;X12E!1C
M4[7'33WK*_GG%Z-S@G%3;^;6/RNTY>7^/;/N&3O_  #BNV[-RB^R<J\B5MV;
M'"C8Y.7X'&R4Z*+8]T51?*%MF/&/Z'LL:LCE51O_ !*TMJ'8>R,+FVVX\'XD
MT.9XZ]41*_.K.OKYB\9M-LTUK G,W.04.0HB/+M(IM/641M34MIUY*9 X&1Q
M+<*,>W9]ER8U\<RNEE-BFY41E)>['$G"47"NROOBJI:QKFU*N48ZP)+M?G#C
M&Y;GA<ZY_M%V3Y7V;Y\;/Q940JW&ZJJQXEV]475V1OR<;*5%DLRGLLRZ8NO*
MKMM4;SJ-29<YLF?,TAL:TE3J;;65-2L?R6:ZJ3,P+;UY+*/59FQWED@ZC);&
M2B!D3)&GOP'_ ')<R(<<<CD&WK9:H\GV:$8Y.WX[5E<5HK\2"UG2]/X=<4[,
M=]>VR/8_DLF8OQ?RBSR!FV^'N?9-EVT\HW-3Q<NR3G9MN^9$^VG/CW/3V,NV
M:QMTAJO<QK/Q"UOQ:"MTF-)A29$.9'?B2XC[L:5%DM.,28TEAQ33\>0PZE+K
M+[+J32M"B)25$9&7(FD)PL@K*VI5R2::>J:?5--=&FO1FO\ D8]^)?/%RH3J
MRJIN$X33C*$HMJ491:3C*+3332::::U/@/8^(
M                     !-'D-_9@R__ -(']:]((UP__@YC_P#C/\EF6WYU
M_P"=3=?_ (-_J/'(7$E*D            LIXA?XQ&O?_ )+/ZQ\F&F?[07_J
MA\N_\U_[];<=@/[+7_KW<%_\]?\ Y/;L6X^0'_I.U]_URV?_ #K2- /V3?\
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M*3DNV$=OV[<NQ*'9JY6/<IN4G/1*J"4-6V0@).4\
M     7.\(\B*+L?*,(>^IO8.!W<:O1P@NC(</-G.:]Q*BC//K>DU5!806F4J
M;2Z[-3SRI*"%;^3,/OV?'W2/KB9<'+_$[M:)+U2T4[*YMM/10?P;-M/H^WY8
MW/MRX=;UAOFRY$*ETZ96#V[C4T^R4G*=.-DX\()Q4YY$==91@B_0JTW;
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MFK*YPEJE93=%*-D.Z,H^D9+1.48MZ*=!C"4@
M
M
M
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M>B2^"1 +;;;[97WRE.^<G*4I-N4I-ZN4F^K;?5M]6^K/D/)\P
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MMR>M:MN<YMP[WIV=>)_J]\#^(/'6'PKC^U<DNRL>ESMLECX5:RLR<4[;IO\
M6%LJXV6)**[;'52H02GV+7IG'%.K4XL^5+/DS_\ K%_ 1%^ [#^)<6V7A/&L
M+B?':O9V7 HC55'75Z+UE*7\*<Y-SG)]93E*3ZLZZ.7<JWOG')LWEO([?>WK
M/OE;;+31=TNBC&/\&$(I0KBND81C%=$?,2$C@
M     4M\XI1$6EZQ4CEU&+97<IA]WJ[42RRR36,S>T2C2U[R5C[[7)\*5[;U
M]"29V+XRAK+<[DOE]^J&NGQC4I..OQT5D7]GS?;J:C_6-DZ+B.WRG^D6VYMZ
MKUUTA;FSIC9IZ+OGBV0^#?M=>BBRA(M4TH
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M5CJ4U99&-49V1AT2,JH
M  )H\AO[,&7_ /I _K7I!&N'_P#!S'_\9_DLRV_.O_.INO\ \&_U'CD+B2E2
M            2YHG/J?6&U<6SF_C64RIH_OGNX].S%D6+GW/'+BG8]NS-F5\
M9?1)L$*7U/(X;)1ER9$D]?\ ZH_%7(?-O@G??&'%+L+'W_<_P7M69<[:\>/X
M;<,3+G[DZ:;[%K71.,.VJ>LW%/MBW);0_1CYLXK].OU*<;\Q\VQ]PRN,;/\
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M.=SC3C0BZ=OP*I-X^WX:DY0HK;4799)OOR,F<5.^UM]M=4:J:HN%X&N0
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MMRVG\5@PIQ*\K%K>'7[5D<S.V[)A_6&[Y&19;7F^S=D59CIC=&R481G94H6
M:P                       !-'_L.__;H_]8<1K_Y\?_-G_P!G+;__ #$?
M_C=_\KR%Q)2I                         #/M5YJK7&R<$SLFG)+6)Y52
M7<R&VEM:K"M@SV';6LZ'5MM+19UI.QU)4I)&EPR,R_$L3OVV+>=ERMJU499%
M$X)_Q92BU&73K\LM)+H^J]";>->7RX#Y V7FBC*RO;-SQ\BRM)-VU5VQ=U.D
MFDU=5WU--I-3:U7J;H\@KV:N\MJ^*\U)AQ9\EN#+8=1(CS*_NJ5 F1WVU+0_
M'F0U(=;61F2D*(_TC7+"NED8E=TTXV2@G)-:-2T^:+7P:>J:^#1VW;[@T[;O
M.5@XTXV8E=\U7.,E*-E6K==D9)M2C.MQG&2;3BT_B=,.28H
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MBLI(W&T*^E))-7H1"#\MVG=-SNI>%!SJA%Z_-%)-O[)2773XHV%\*\UXAQ'
MSH\@R(X^;==#M?LVSE*$8OIW55ST2DW\K:ZMM(IO6^)?E73K<=J,,LJIQY!(
M><K<^PN"MU"3ZDH<7%RYI2T)5ZD1\D1B*U\8Y)4]:J91;^RRM?W$RYLGRYXH
MS(J.9FUVQB]4IXN3))_=W8[T+0>+NF?(G"-K1+W95=>1L8;H[F,Z[/S>DOHY
M39++289'7P<DLY"EFHCX631DG])D)%QS:=]P]S5V?&:Q^R2ZV1DM7Z=%-O\
MH%7>4N:>.=\XG/ XU91+='?7)*.-;4^U-]WSRI@OW.[K]C-EHL UE  G/Q\Q
M'/<DV'56& >TCV6-OMV#]I8LG(KH#;Z'XY%)82IM;QRF>ZE*24V?H9DM)D1B
M-\IS=NQMLEC[@I2C=TC&+TDW%IZIO5)1>C;::]%H]="U/$.P\GW3EE6Y<:=-
M5F"^ZRVV+G7"-D9P[)034INR/?%1C*+Z-J<&NY;L(413:&'YB8KUK[5J/+G,
M1T-+>Z>%*02^.YV>YZDGDD\^I)+\"I(WV.>
M
M
M
M             KQY1Y9;X=I^]M*&P^W6KTNL@,OH4DGR8FS&HTHXY&9*[B&7
M.2,N>D^#,N!G.-X=.?O5.-DQ[J&Y-K[>V,I+7[M4M?M]" >4=[S^/<%S]TVN
MQ5;A"-<82Z:IV75UR<=?X2A*3B_@UW? TLO//2'G9$AUQ]]]Q;S[[RU.O//.
MJ-;CKKBS4MQQQ:C-2C,S,SY,7I&,814()*"6B2Z))>B2^"1U\6VVWVROOE*=
M\Y.4I2;<I2;U<I-]6V^K;ZM]6?(>3Y@
M                         '.K82K&Q@5Z%&A4^;%A)6ELW5)5*?;8)26B
M4DW#2:^23R7/X<CY7VJBF=SZJ$7+[/1:^OP.9M^)+/SZ,&+:E?="M-+5ISDH
MZI=-?7TU6OH=UFLX[+,,HF\&E,B^M5,MJZ>68Z9KR(S!=!$GICQTI07'IPD<
M7:ZO8VW'J^,:8:_>^U:O]UZLR_+\Q[ARK<LS1J-F;<XIZ?+'W)*$>G3Y8I16
MGP1BXYY'
M       H-YP3&W=B:_K4)7U4>HJ.&\ZHDI2^Y:Y?G.5DIM)*4:4,-9&EGU/E
M2FC5P1&1%:7C*MQVG,N>FENXS:7V=E-%7]%UM_NZ? TE^L3+KMYWL>WP3[L/
MBV/7)O323NSMQS=4M7TC'*5?7JW!RT2:2I@+(-2@
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M-_9@R_\ ](']:]((UP__ (.8_P#XS_)9EM^=?^=3=?\ X-_J/'(7$E*D
M                          /O&C29LF/#AQWY<N6^U&BQ8S3C\F3)?<2T
MQ'CL-)4Z\^\ZHDH0DC4I1D1%R/6<X5P=EC4:XIMMO1)+JVV^B27JS[8^/?EW
MPQ<6$[<JV:A"$$Y2G*32C&,4FY2DVDDDVVTDM2P^'Z%VA1VJ<ESZ+D^A\1QV
M;#3D6<YA M\.M8,.<73-B8?4SVZV^S#)WJIY?:KZYMQ2B<1WU,LN=P0[<>5[
M'E4?@MIE1NNX71?MT4RA=&3C^:[IQ[JZ:E-+6RQI+1]BE*/:7OQ7PIY&V;<E
MR'F]>X\*XO@75K*W'.JOP;JZ[.ED,&BQ59.=ERIE+LQL6,V^Z'O2IJL]PB_:
MF8L;"V7G^=18:ZZ'EV89%D4* \4?W,.#;6LJ9"C378R$-S+!F*ZA,B0KJ=DO
MDMUQ2W%J6K.[#MTMGV3$VJR2G9CXU=<I+71RA!*3BGZ1;3[8]%&.D4DDDJX\
ME<KIYUY"WSF>-4Z,7=-URLJNN7;WPKNNG97"R4$E.V,)15MKUG;9W6V2G.<I
M/ 1EB$@                      !-'_L.__;H_]8<1K_Y\?_-G_P!G+;__
M #$?_C=_\KR%Q)2I                           -TNO,D>S?4>ILQD/N
MRIL[#(N-7$E]Q;TA=S@$F1AB_=NN/.N/2Y-)40):W#X-92B-7*^LSUOW3#CM
MF_[AML$HU0R79!+HNS(2NZ+1:)3G9!+X=G3IHCMPX+O]O,/%W&.69$Y6YEVT
MPQ+YR;E)W[9.6 ^^3E)RG/'HQKY2>G=[R<M9]S>1CBF?
M                RBDO8<2'+I;JO.RHY[[$IPHSJ(MK6S6$.--V%5+<:?:2
MX;3AI=9=;6T^C@CZ%$AQ' RL2VRV.5BS[,J":ZK6$HOJXS6J>FJU333B^O5:
MQ<CV?><3%Q+=HW>AY&SWSC-]DE"ZJR*:5M,W&23T;4X3C*%D=$^V2C9#^Y%0
MQZZ/3V]4N9)HKV&X]$D2VD)>C38DI^%85<M;',<YC#C!/$2>.6'VE<>O(867
M.Z=N-D*,<NF232?1Q:4HS6O71ZZ?U49+X'G?MEHP,?$W7;96V;-FU.4)324H
M60G*NVF;C\O?%Q4TE_@5E<M.IBPYY&P         #J'J&JD7U;D[T7KO*BHN
MZ&NG=^2GV]5D<S'["YB^V2\F&[[R9BT!?6MM3C?8X0I*5N$OU<(N:L:^=)I?
MD>C?]PCZJ^V-$L9/]#.<9-:+K*"DHO7UZ*<NB>CUZZZ+3MQ['R       V">
M+OC32Y)50-CYPVQ:0)2I)5..O-M2(3S!$N.<FR;<0M#RW",U-I(^&B]>.[P;
M5:\KY/DUY$]JP&ZU!KOFFU)OH](M:-)>C?J_3\W\[:OP[XGVK(VVGE_(X0R9
MWQDZ<><8SJC!]T.^V,DU.<NKA%_+6FI-.S3V[X8/K+#-<IM48C4-U:+B<[82
MT-JY;2ZZ39&S&01)1'BH)I));21)21%P('EY^9GRC/,LE9.$%%-^NB^_XOKU
M;U;^+-AMFX_LO'JK:-DQJ\:BZYVSC!:1<Y))M+TBM$DH1TA%+2,49\.(9D
M
M
M
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M-23T:?JF?D#P
M     &9:^(BS*@E*+Z:J8J]5RXAI"48_'>O%+><61I1&0FO,W3]#)LE<&1^I
M8W>.NV75KULC[?V_RC5?1?;\W3[]"6<&27+,')?YN-:\E]5%:8L99#<F^B@E
M5K-_Q==&GU,-&2(F
M                :Y?-*9(>WS9U[J$--4>#:HKXC26^VM#<S6>*7\OO\_4M
MY=I=R%&9\&1*(OT"W?&U<(\5A=%MRMR\N3>NOIDVUK3[NR$5_1-"?JYRK[?-
M61@VQ4:L/9MEK@DM&E/:,+)GW?;)W9%K;?VI? JB)Z:S
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MCN4=D>/.,I8LZGE5U0S/<<'N$\%+/6'934I8]E<*K[<J:QRMHFAK^
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M.6/++CCW5V9]N+&JFS+ML[JWDQR+;*QB;FNX
M!-=XZX7CIK!DG%DRYNO>SJVB6HFUN-8+XZ):<6CGI4MI+RR29ERDEJX_$Q&<
M6*_GEG2T7<MLP5K^6_<=?W]%^\BWMXLL7@3CE2D_:ER_D;:U>C<=NXLDVO1M
M*4DGZI2>GJR%!)BH0                          -D?A=D16FM=B80O\
MXXQ+**K/H">$*ZZ_*H4;$\D<^B,3[?MY]%2)Y6ZII7>X23:R_74WY'Q/8WO#
MW-?F9%$J)?U54G;7\='K&=_HM>G75?F[_P#TD;\MQ\?;]P^?\OM>Y4[E6NCU
MJS*X866^D.Y=MF/MZ^:;@_<T2A)?I;2B$FR
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M3E)1BI=JL.,*3H
M
M
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MV:2;3['-=7%(S9
M       ,RP_I9_--BKH+[;AUWTN+[A]M5U[7%2Z4-\]:W?O_ &RZB-*.OK/C
MIY+&[EK+\/0M?GR8?^!K;_0]O7[]-/B2SBFE/ZRSWHOP^TY'5Z]/Q'9A]$O5
MR_$]O7I'N[GIVZK#1DB)@
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M(UB_\,,[^QN#_D^XEM[S_P Q'&_^5W)/][^*D+B2E2
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M\W;L2B^C"OR'DX_N4N,JX2E6IT]\L;LMNE5C]M=-33LBXR6FCC<9L@
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M#MB^V4HI3GJ^Y]O;&-FQ@"Q@
M
M
M
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MI2BVM4UKJFC'QRS"@
M    !F5091\-S*5SPJ5,Q:B+I;0:S1,D6EXI"W%&2D1C5C*342>34XEOTX+D
ML;D_/N>+7\(QML_NJA7Z?;^E_>U)9M35'$]VR?X5MN'C=$M=+)79#3;ZJ&N(
MFTO62ATT6JPT9(B8
M              <ZMBIG6-?"6LVT3)L6*I:2(U(3(?;94M)'Z&:27R0^5]CJ
MIG:NKC%O]Y:G,V_&CF9]&')N,;;H0;7JE*2CK^YJ:=]V6_Y@W-MN^]O[3[WL
M[/;?VG=]Q[7[EE5K-]OW^TSWNSWNGKZ$=7'/27/ V#XQC_A.-[?B:]WM8-$-
M=-->VJ"UTU>FNFNFKT^TZJ/+^Z_KWRSRC>_;]K\9R+<K^SN[NSW<RZSM[M(]
MW;W:=W;'7371>A&(SA78
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ML7;MOG7'%OKKJRX=F0HK+HL4XPA;)5W$P*()H\AO[,&7_P#I _K7I!&N'_\
M!S'_ /&?Y+,MOSK_ ,ZFZ_\ P;_4>.0N)*5(
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M&O*/(^'9'D'8]DS<GA>)7?9=EPC%U5PQHN=\I-R3TJ@G*73T734FP2 K(
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MQ4*VGW1U?J;,X[#46.Q%83T,QF6F&4\\]+3*$MMIY_3PA)$*W-H3[
M
M
M
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M;4H-:IIZI_D:->;Z+\6Z6/DPG7D0>DHR3C*+7JG%Z--?8T?$>Q\@
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MDO1)+H<(?4X@
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MQE]AYM2FW676U$I*DF:5),C(^!=Z::U7H:!RC*,G&2:DGHT_5,^H'@
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M3LF].NGK[<&^JA%Z>G<Y-=Q8$84G0
M
M
M
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MZO18:,D1,
M       .;$D1X3%]8RW28A5.'9S<SWU(=<)BNIL-O;2P?[;*'7G39AQ%J)"$
MJ6HRX(C,R(?&Z$['536M;;,BB$5TZRG=7"*U>B6LFNK>B^)R\6^G$IS<_*DH
M8>+M6XWVR:;[:J,#(NMEI%.3[:X2:C%.3:T2;9HJ&T!TR@
M
M               $T:9_^:O_ "+YU_\ @L1KDO\ \;_[)T?^R+;\3?\ SS?\
MD=Q_^PD+B2E2                           3KXVL1V=QXCE=@[V*?6+T
MS;=P[W$-$Y#U?"?S5FL)QPEDA[(;.FCUC)DE:N_,024J/@CBO-)3EQS(P*5K
MD9R6)!>O7*DJ7+3[*XSE9+JEVP>K1<WT_4T4^6-KY-G2[-JX[.>]WO5+6O:*
MY;A&G5ZZ2RKJ*L2O12?N7P[8R>B<%"5%,@
M31F_]A_1W_;,_KHB"-;7_P (]T_^#?Y$RV^8?\U?#O\ SM_JR!"XDI4@
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M(0:LNMDZI2[)WV/T>BDIVN/YIZJ?\'_0_P#:3U'_ *V^&_Z3"P_P>'_A5?\
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M%F^W#O\ =[5[FFFNG73UTU]=->NAVH\'N
M
M
M
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MT?P;-3.3\0Y!Q#->#ON/*J3;[)KYJ[%_&A-='KZ]KTG'5=\8OH8>,@1H
M                                    S+.OU=VQ )2#148_B]61-IZ6
MR?BX]6G8F@S0AQQ#MJX^X2E%U&2_T%P18W:?FQ7<]=;+K9]?L=DNW\FD.U:+
M["6<S?M[Q#"33ABX.'3T6B[H8M7NZ=$VI7.R2;ZON^"T2PT9(B8
M                                                 =1EDU-9KG;=
MDIDY!Q]2;&A(9)TF2-61XM88F;REFT[Z0T7QO])$7<-HD=2>KJ+[85;OW?;Z
M$].[<,9ZZ:_R=L;=/5>OM]NOPUUT>FAB^3YD=NX%RC<'!S<.+[K6HZ]O7*P[
M<+N;TE_)K)=FFGS.';K'N[EI.&RAU"
M
M$UZ)6EW)<SJ76T.1;G2F]$23,W$NM*Q_4^79K7N1UMN(2E97&+1B7UDM*F36
MG@C42DQGE2[<+&R(MJRO<\'3['[F753)/_O+9::::2T?PT=O>%Y1MY!NVV6Q
M4L;+XAR)3]5)/%V7-W"IQ::T?OX=2EJI)UN<=$VI1A028J$
M             #,<'S>VP&Z=NJF-46!RZBWHK*KOZUFWI;6INX+L"="L*]XT
MI>1TN$ZVHE)6T^VAQ)DI)#';IM>/NV,L;(E9#MLA.,JY.$XSA)2C*,EZ>FC^
M#BVGT9*^'<PW/A&[RW;;*\6]VXM^-;3DU1OQ[J<BN5=E=M4M%):-3@TU*%D(
M3BU**)'W-"QXJ/4>1UV-XKB]]F^$3LFO8.$KOSQV1'1E=YC=3.[%W:6\:!>N
MN8[*1/C5[B(+#K9()IITG6TX7C=N9^*W##NNOOQ,7*C57*[V_<3]J%DXZPC!
MR@O<BZY6)SDGJY2CVMS[RUB;$MGXMOV!M^V[=O6\;/9EY->WO)_"RBLW(Q*;
M.W(NOA7DR>+=')JQ9QQZYQ4%55:K81@<2LI8      "O\GRI\=X6QTZAF;<P
M^)LI>01,41B$F<ZQ:KR2>ZRQ!I4DZPB.JPFR)+;;+9.<N..)0GE2B(XU/F/%
MZ]U_4EF=1'=O=5?M-Z2[WHE#TT[FVDEKU;274MNCP/YAR>&/R'C<>W&SA2Q)
MY3RXP4JECUIRG<]).7MPC&4IR[=(QBY/1)LL )*5(8_E>5XW@V-W67Y?=5^.
MXQCM?(M+N[M)"(T"N@1D=;K[[J_^ E*4D:W%F24DI2B(^-F9F+MV+9G9UD:L
M2J+E.<GHHI>K;_[&WT74R^P[#O/*-YQN.\=QKLS>\RZ-5--47*RRR3T48I?O
MMO112<I-13:C_5&_M-;R^_?LDV%C^>?E?[7^8/L3S[OVK[W]Q^U>Z[T=CI]]
M]HD]''//95SP,9LW)=BY#[GZDRJLGV>WO[&WV]_=VZZI>O;+3\C);S[Q+Y(\
M6_A/[8.SY>U?CO=_#^^HKW?9]OW>WME+\SW:^[73\]&>9;F.)X%0S\IS;)*/
M$L;K&^[87F16D.HJXJ?7I)V;.>88)QPRX0CGK6KT21F9$,EFYV%MN-+,W"VN
MC%@OFG.2C%?E;:7Y%\?@17C_ !S?^6;M5L7&,+*W#>;WI71CU3NMD_CI""E+
M1>K>FD5U;2ZE//\ =*_"#[S]A_;U3^^]Q[;O_E/87V;N=/5U?F/\H_E[V_'_
M )F]UVN?3JY$%_MK^/O?_#?K*OW-=-?;N[?[O[79I]_=I]YL7_T*OJ?_ %;^
MM?YJ9/X7L[NW\5M_O:>FGX?\7^([OZ3VN[XZ:%N\*SS"=D4,?*=?9=C>;8W*
M<<98O,5NJ^]JUR&.GW$4YM;(DL-S(IK(G65&3K2CX6E)^@F^!N6W[KC+,VR^
MK(Q6]%.N<9QU7JM8MK5?%>J^*->>3<4Y/PS=I[%R[;\W;-YK2E*C*ILHM49:
M]LNRR,9.$M&X32<9+K%M=3+!S3      $U[*6F-K;QWK66T)9DZ[R_*7W3-Q
M3[EG:;GV9C3Z3,W#:3%;K<*A]"$H(R<-Q1J5U$28SLJ[]ZWB^3?=',IJ2^';
M'#QK%]^O==/5Z^G:DEH];>\@RCC^/^![?5%*JS8<[,D^KD[;M^W;$DO71056
M!1VI13[G8VWW)1A028J$      #SV?,!N6TV+LG5GB+KHYEU<0[2JNLIHZUQ
MM:K;/,S]K5ZYQ4V3[3B;2'5V*Y?2I1LNHNHRB,EMGQK)YPWZ[=-UP^$[7W67
MQG&=D(_PKK=(T5Z?QE&3E]C]V'Q1V]_L[?&^#P[A>_?4)S'V\;;K*+:<6^Q-
M*K!P^ZW<<K7JO:G;7&K5+OB\.]=8S6LF1/A!UM[6-[[>&<>^]NS[SVF.T/M?
M==M/N/;=YSO>W[W/1U_5T\<^HRT/I]VKL7N;AD>YHM=(0TU^.FO737T(3D?M
M/N:>_/\ "\7VO\+WOL[\B_N[=7V]VBT[M--=.FNNG0B/R$^'S']7Z5V/L;7^
MS,LR[*,&QN3E4;';BJI8$&QJZ-UFPR4O<0^Y*5,C8RQ,>BM((U2)+;;1?QQA
M.3>#L;:-@RMTVS+NOS,>IV*$HQ2E&&DK.JZZJM2<4O622^)8/B']HIN_.?)F
MS<-Y;LFW[=L>Z9L<6613;=9.NV]2KQOEGI'LEDRIA;.3TKKE.?\ !+<?$-Y"
M-;,T'+U%=V+C^8Z4F-U\1J6\E;TW7MVY(DXQ(C*4EMQUNCF-2ZY;:2<*+'9B
M=2R[[:$S;PCR=;MQN6R9$V\[;Y=JU?5TSU=;7V]C4H-=>V*AJ_F2-?/VAOB&
MSA/EBOR%ME*CQSDU;LFX)J,-PH48Y,9::I.^#JR(R?:[;)Y&D7[4I.@?R 9?
M3:^^3S66?9&N0UCV#W'C_E]\Y$85*E-TV-9#!NK1<:*DTJDR$082S0V1D:U<
M%^D5KY+SJ-L\NXFY96JQ<>S"MGHM7VUS4I:+XO1/1?$VS^DGCNY<O^AW>^)[
M,H2W?=,;?L2A3EVQ=V3CSIJ4I/I&+G..LO@M6;*/]UZ\-?\ 1K8']0D[_-0M
M?^W=P3_#,G_&7_W32W_U>7U(?YVVC_3T/[Z3)HGY!/'3R,S^/K76MEEDK*)5
M797#35QBTJIA'"J6T.S%*F.ON(2XE#A=*>/J&=XYY,XMRG<EM.TSN>8X2DE*
MMQ6D>KZME<>5/I&\Q^&^)3YKS6G;X;'"^NENG*C;/OM;4/D44]-5U?P+MBP#
M6(        );T7L9.J=JXCFLE,AVH@S9%=DL6+VS?F8ID$&509/%90ZVZRY(
M<H[)\V24D^EXD*+A2244?Y3LSW[8<C;8:+(E%2K;]%;7)65-Z:/3OC'71_FZ
MKT>A9_AGGL?&GDO:^79"LEM5-TJLN$-.ZS"RJYXV9"*DI1<GCVV=FJ>EBA):
M22:W 6U<FME)0Q,BVE=+BP[2FN8"^[6WM':1FIU1=5CY<HD0+. ^AUI:3,C)
M7'/)&-?L:_WZ^Z495W1DXSA+I*$XMQG"2^$HR337W':CN>!';\E0IMKR<&VJ
MNZB^M]U61CW05E&13+TE5=7*,X23:T>FNJ9U@^YC@
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M-MM-ETMM(2VA/)GTH0DDI+E1F9\)+])\BOC9 _8
M
M
M
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M+LO\=RK<LM:J%F=>XIO7MC[DNV/Y(QTBDNB2271&,CG$>
M                                           #!MPR9,#0F\I\0^V\
MUA-#")\VFW2;9N]HZ]H[!HB=0XVE<NHL9+1'QUI)9J09*(E%DM@A"WE6U56=
M8O*G+3735PQ<B<7T^R<8O[.FCU3T(;Y5R,C"\)\RS<7Y;H[/C5]W:I:1R-XV
MO'M7S)I.=%ML-?SDI.46I)-:<!L0=40
M
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MVE!O&=LX^[7F5./>?!A_[%'_ -I+_P"BX/O]/'_QX_\ @G_W28O]J5_\XO\
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M*,M/WFSD;CL.^;/&,MWPLO%C)Z1=U-E2;Z^G?&.OH_3[&94.28D
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M99CH)IAIMEM/\5MIM+:"_P A""2DA#2[SZ
M
M
M
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M=-6[:EK\L>NMD'*.B[I*O715P$K*;
M  #,M?$19E02E%]-5,5>JY<0TA*,?CO7BEO.+(THC(37F;I^ADV2N#(_4L;O
M'7;+JUZV1]O[?Y1JOHOM^;I]^A+.#)+EF#DO\W&M>2^JBM,6,LAN3?102JUF
M_P"+KHT^IAHR1$P
M              "&O)B1'B>.^9*D.DV=CF.OJ:$GH=6J18NN9%=)8+MH6ELB
MK:"4X:UFE'ZLD\]2DD<@X;"=G,,506O9CY$Y>G2*5<-?O^:R"T6KZZ^B;*F^
MH6^G&\$;M*^2C[^Z[916M&W*V3RLA1Z)I?HL:Z3E)J/RJ.O=**>IP7T=9(
M
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MHQ3FG*32BFWH?C_!YW!_J0_]/^+_ .G8\_SPXY_GC_W.W^^'I_:*\J?[5?\
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MZ))9P.*98
M
M
M
M                    #YNM-/MK9?;;>9=2:'&G4)<;<0HN%(6A9&E:5%^)
M&7!@"H>W_$C$,Y]Q<8IV\7R-9J<<]NTDZ^>HS4KA^*3C+27#4HS-9=+BC,N5
M]*22)5LW+-PVO2FUN[$_BR?5?U,NK7Y'JOL2]2HN<>'.-<N[LS$2P-Z?^"UQ
M79-]?Y6I.,9-M]9Q[9O^%*221K0S_5F;ZTL%P,KIGHJ2,B9L8Y+D5<DE&9)4
MS+)"20:S2?"'4MN&7KT])D9VEMF][=N\.[$G^D^,)=)K\J^*^]-K[]343EG
MN3\+O]O>L=_AF_ENKUG3/\D]%VOI^98H3TZ]NC3<>#*D-
M               ,SPTD-%E=DI3:/MF&79H4YWE&2[M43%"2VAI*B6XZ60F@
MNOZ$$HUF9&DAC-SUE^'H6K]S*AZ:?P-;NNOP7MZ].K]/B2WB:C4MSW"3BOPV
MTY&C?=ZY#AA:)1UU;_%=OS?*DW+UBC#!DR)
M                                   %=O+V:F-HBIKB9-:[K;=)-4_W
M22F.G&,.S!A+),]HS=.:>7&HU=:>WV"+I5U\IEG *W/E<[M=%5M]BTT]?=NI
M>NNO3M]GTTZ]WJM.M#_5+F1Q_"^-@=C<LSE&/9W:Z**P\'.BH]NG7W/QS>O<
MNWVTM)=^L=8 NXZZ
M                                              ":_'HVW-IUM>^E
M:HV08KL[$Y9M.):?:A9AJ_,L6FR8SBVWFTRHL6X6ZUU(6CN(+J(RY(1GE^L=
MAG='3OIOQK5KU3E3DTVQ3ZKHW!)Z-/1O1ZEO>"W7/R3CX-R;Q\[;=WPI]K2E
M&O.VC/P[)Q;4DIPA?*<-8N/=%=R:U1"@DQ4(
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MVFT<TEQDQ4PX4*ARRDO\4QV'/;BFW75]ID%O>-V"*Y"G>WV'R:[C<9;R:/\
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M^3,RGWI*YN6/@X\NZ,++X5SC9.ZV2UII[H1[(RMLEV^W"W5O]GW^SSO^J_\
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M5U^_.^NM7867-S=FW6WTZ49EN/7[,KKZ:L>,+K;,2>/7=BVZP\-AC58
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MN%Y<N^W;<^ZA3Z?I(0FU79HFTO<K[9]NNL>[MDE)-+B"9D.(C\?_ .P/I/\
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M+2N$5%+[$EHOZ!I/G9F1N.;=N&7+NRK[9V3?VSG)RD_W6VSLQ]#B@
M     !L@\;=%;.P_)X=^]EU/&Q@UQYMC44ELN>5N9-K0EB:SV&%PU--O$KDB
M/N\$E1]!^M4<EY%M6ZXWLTT3_%IZ*<THN*U3>FDFWKIIH]--=?4W)\5^,N8<
M-W-YN?N..MFLAW2QZ)3LC=)PE&+FYUP4.SN4E*MR<G%1;[38D(*; @
M
M
M
M             '\)23-224DU)XZDD9&:>HN2ZB_$N2_  ?T
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MC\/W;)6J5V1AXWIZJ3OR'K+[$\6.L5ZMQ;:TZX4,F1$
M                                           JIYL29,?6VGH2#[<2
MTS;:<V4@VF^9+U)1ZOC5CI/*0;Q(B)O9J2)"B0HW3ZB,TIZ9QXVA">][C:^M
ME>+BQ77T4YY3DM/3KV0]>O3IIJ]=:?J]R,BCQ_Q3$A\N-D[QO%DUVKYY8^/M
M$:7W-=VD/Q%ZTBU%N;[DW&/;KB%Q&@P
M
M!-'CS_9@Q#_TO_UKW8C7,/\ @YD?^+_R6!;?@K_G4VK_ .$_ZCR"%Q)2I
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M-]ER7G^YY6Z;Q)=JG;)=M<-7+VZ*H*-./5W-R]JBNNM2E*2CK)MR8,L0D
M  FC<W_S*/Y%\%__  H(UQK_ ..']D[_ /V);?EG_P"=G_DCMW_V8A<24J0
M       )JT=EF40=B:QQB#D=Y"QR;M/#)DVBAVDV-4S94G(*.(^_-KV'FXLM
MUV+%;;,W$J^A/'X<C6SZG.!<'W3Q#S;FVY[/MF3S#&X-N]-.;;C4V95-5>!F
MVPA3?.$K:HQMMLL2KE'YY.3ZZ:;<_1WY-\C;-YV\=^.]GW[>,3@67Y(V*_(V
MZC,R*L+(NMW+;Z;++\:NR--TYTTUU-VPG\D%%:)M/99YM?V"[#_KEQW_ "RZ
M.F']FC_UH<7^PNX?Y' _05^U\_ZFF;_R@VO_ "69)V@*%N@T9KB#6*C,NS<,
MJ[PGU1%&R5ADD--ZZ[)CMRFG)7:DV/"^'6U.DGT-ODB32?U8<JNY7]3_ #'<
M][5UF/C<CR<+L5J[_P /MUSPHQKLE7*-7=7CZPUJL53EU5NC<]B?HAX51PGZ
M-^ [/QV6/5E9?$\3<%8Z&Z_Q.ZT+<9SMJC="5W9;E=MFEU<KE#Y94J24(#H_
M%71>0NV;=9LJ\R+8-5.3/O\ )J#,Z1Z_J<D]ZI]Z<_6U[,M-.ZNUC.]*'R5(
M;,E%W3<3W"VLY/\ 77]4'$J,*W>^&;9M'B7.Q71@[=G;1F0P<K;O94(40R+Y
MU/+BL6RKNG2XT33A+V%3/VI:3<._9K?1KSG)W"GCOD'>-]\Y;;F+)W+=MMWW
M;Y[EA;K[[LLR+,7&KN6#.695=V5Y$99-;5D%DRR*_?C0;?>GKO3>:G3VEM^8
M8EU&5=55^I#C4FQ9>D.MRRL6779"FK-B6A7=X==):5(<ZN5FE/:Q]*OU#\:^
MHOQJN1;'@?JC/VVY8>5@J495X\X5QE5^'G&-:ECSJ<?;UKK<)1G5VM5J<^DW
MZU_I5Y=]*'EU\4Y'N?Z\VO=L=Y^'N3C*%N57.V<+OQ5<YVN&77=&7NZ6VJR,
MZ[E-.UUUP@-F33X             +0>,&Y<8U1>93 S./<)QK.:JNJI=S1,L
MSIU#+J[-NR@3GJA]^&FWJUN$I$EIM]I]M)DZT3JF^P[!^;\<SM^QJ+MM=;S<
M6R4E";<8V*4>V45-)]DM.L6XN+_-EVI]\=C/IT\L\=\9[SN6%RV&4N/[SC54
MSOQHQLLQITW*VNR5$I5J^EO6-L(V0LBFK:_<E7[-FS%::]ZOH;JGM&;FCR>E
MC9#1V#<*UK'9%5->DLQ')5;=0:ZQ@ONE%-9)6V:'&EH<:6XTM#BJ9C*U6VXV
M16ZLJBUUSBW"24XI-Z2A*49):Z:IZIIQDHR32["YQP;<'"W?:LF&7L^XX<,K
M'M5=U3E39*<8.=6175;7*78Y)./;*$H65SLKG"<N,/H<<   ,^QFWI(D-<*6
MGV[SJC-]UY)O,2B,S)!&9)439(0?'2HB3^GDS,QUG?5[X+^H7FO/,?GW";OU
MGL>#5&.'CXMD<7,V]I)VRBI3@[Y6V14_>IME>VU6Z85TPD^R+Z2_-_@'AO!L
MC@G,Z?U;O>;;*67?E5O)Q-P3;549.,)JF-5;</9NJC0DG9[T[+9Q62-/XM7*
M7*8>JFEDDR-<=UIUWI/U42$,J<<]>/P27K^ U,W?CWUE^5L>GA_)-OYEF[<[
M(N->;CY&-CN<=%"5UV3"BEN.NJG?9\KUGJNK-JMJW_Z/O%N1=R[CN?P_#W!5
MR4K,/(Q\G(4):N4:JL:=]R4M-'&FOYEI#1]$8-D%ZQ:S8_0TMR!#,^&UJ-E<
ME2E)-U1J22E-H<2@B3_/$7)^AGP78W]+_P!.'(?"WCW=8;AF8^-Y+WV$>ZZN
M"R:\&%=<EC5J$W"%]M,[;;;FFJ;+'"O6VNF-EG7G]3'U$;!YCY_M<L#$OR?'
M&R2EVTV3>-9G3G9%Y%CE!3G35="JJNI-.Z$%.S2JRV5=>9,6N,VD5IA[VC+;
M1$2(TU+;'8Z2(B)M:C)M)<%Q]"O4O0_X!H3R+PQ]7WA[F69R78?UWG;GF62E
M=G[59=E_C/<E)MWU03OF^Z3DXY%&D)_/!](S-Z>/>8OI*\N\0P^.;[^I<+;,
M.N,:L#=*Z<3\)V1BDJ+9M4P7;%14L>_6<-8375P/H[=T%-%-N&Y&<_C+;C05
M(<);BN?X[C?6A')EZFH^2+\"/T(8K9?IZ^IGS[S"&Z<[Q=VQFW75?G[O790Z
M:8:=*L>Y56VJ,92E"NBM5SL<NZR#E9-93>//_P!-O@CB4MLX/D[5DI*RVG!V
MF==ZMNGKUMOI=E53E**C.RZQV0K4>V$TJX.*)4AR7)?E.GRX^ZMU7J9D1K4:
MNE//KTI(^"+]!$.[#AW%MMX1Q3;N(;.M-LVS"IQJ^B3E&J"AWST23G8TYV2]
M93E*3U;;.F7E_)MQYIRG<>6[N]=RW+,MR+.K:C*V;GV1U;:A6FH5Q](PC&*T
M22..)(1PB/Q__L#Z3_DCUO\ UFTPXV'_ )CJ_P 3C_>497??]F\S_15O^22)
M$R+[A^7[W[3W?NGV:S^V]CCO_</9/^S[//IW?<=/3S^D?2_W/8G[7\KV/3\N
MG3^B<?;?P_ZQH_%Z?A?>AWZ^G9W+NU^[374T,2O&OR(G2I,Z=K7+YDV8^]*E
MRY1-2)4J5(<4](DR9#TQ;K[[[JS4M:C-2E&9F9F8I>6P;[.3G/'M<V]6WU;;
M]6WKU;-]ZO)?CJBJ-%&YX<*(148QCJHQBEHDDHZ))=$ET2Z(S^%@7FU6Q(\"
MN+=M? B-)8B0H687D6)&907"&8\9B];99:07X)2DB(<Z&%RZN*A7^,C!+1)3
MDDOR+N(_?O\ X1R;I9&3^H[+YO64I8]4I2;]6VZFV_O;-MVDXV5P]4X-&SE5
MLO+6:-I%\J]E/3K@YY//&LY\N0](???Z#3RI2U'QQZBSMHCDPVRF.9W?BE#Y
MNYZRU^]O7J:B\WLVF[EF=;L2I6T2O?M>U%1K[=%^9%))+77HDB4AD2*@
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MN3AP"1
M
M
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M'!ER1D9XXDASP
M       1?L;3^#;/@KC9+3QW)?;4B/:L-I;L8IJ)1=33Z22ODE&1_B1GP1&?
M3R1\_ W/.VRWW<.R4'KU7\%_<UZ/_LT([R+BFP<KPWA[YC5W0T:C)K2R&OQK
MFOFB_CT>C_A)KH:Q]N^*>;Z\.3:433^58TVM2^_$:)RRA,*6DFBE1FDH5*47
M625*:;29J(S[9(+J%G[-S+"S]*,[2C*?QU^23^YO\W\DGI\.YLU,YSX-WWCR
MGN''7/<-I3;<4E^(KCKT[H1_E=->LJHZ^LG7&*;*KJ2I"E(6DTK29I4E1&E2
M5)/A25)/@R,C+U(3---:KT*+E&49.,DU)/1I^J9^0/
M      9E*(HV!4R#+];:93?2C)3B.4Q:NLHHL5U#1%UI1(DSY*#4H^#-CA)>
MBN<;6^_=[7_!KQZU^[.5C:U^Y1B]/Z;K\"69*6/PG$B_Y7)W+)GZK\RFK&A"
M2CZZ2G9;%M]&Z]%Z2UPT9(B8
M                       !2CSBD1TOZ:KNZ1S2P[)+E;!(=Y;KK',K2KA/
MJ<-!,F;\S'I:>A*C6DFR-1$2DF=C^,H3:W*[3]%^(KAKT_.C3&<EIZ](V0ZZ
M:/7IZ/34/ZQKZ8W<3P.Y/,_565>XZ/I5;GW4UR;T[?FLQ;EVIN24$Y)*4=:'
M"TS2P
M                                   FCQY_LP8A_P"E_P#K7NQ&N8?\
M',C_ ,7_ )+ MOP5_P ZFU?_  G_ %'D$+B2E2
M     9IK?*8V#;$P+-IE;]YB8=FF+93*J.ZVS]UC8]>0;9^M[SK,AIKWS40V
MNI3:TIZN329>AXW><">Z;/E[97/V[,G&MJ4]->QV0E!2T33?:WKIJO3U1+>
M<EHX9SO9.896/^+Q=JW?#S)T:J/O1Q<BN^57<XR4?<4'#5QDEKJXM="_.I\O
MIV<0V[8ZQPC967[;O:^#D2I.59% 1F6?4]FUE!39C%!7M17[G6N%/U!3K%BL
M5*L;:WD06U*8B1'#.IM_V[)EN.WT[YE86/Q^J<J]*JY>S1.+J[4[)-J&3<I]
ME<K%&NJJ-K2G98C=SQCRG:JN*\IS_'>S\AW7RAFT5Y3GF95:S]RHN69[ED<:
MI0E?M.WRH_$95>([LK-S;,*$I4XN--O6D+K.O8
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MN6XNZ>BTC%1C&,8J$(0A%*,*ZX1C"N$4HPA&,8I))'!'U.&
M  ='B^.UN(8SCN)4R7D4^+T51CM4B0Z;\A%;25\>M@I??41*>>3%C()2S(C4
MKDQZUPC57&N/YL4DOR):'WR<BS+R+,J[3W;9RG+3HM9-M]/RL[P>Q\
M           .7!@S+*7'@5\5^;-E.)9C18S2WGWW5?@AMILE*4?IS^'H7J/G
M;;516[KI*-45JVWHDOO9R</#R]PRH86#7.[+MDHPA!.4I-_!)=6;1=%^+^*8
MQ?0\LL+UK);&LJZYS[<AQ/;J[J;%4[)>=;;;;/M.1W2)EM9J4@NKJY,_IJ#>
MN69FZ8[PXP56-*;?37644_E3U^QK637J]%T2>N[?!/#FQ\0W*&]673R]UJIC
M%=VBA5<XM6S@DDWW1DE6IZN$6VW*4HN%XA$2Y@
M
M
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MW(J,7).$%[;5BDU)SE'2,JY(GH8DF(
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MM<MRI=FVN34<BO653Z].Y^M<GKTC/1MZ]KDDV18,T0(
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MRU4.[7YNV-,A8YJ8
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MDDNB271)=$C2JZZW(ME??*4[YR<I2DVY2DWJY2;U;;;U;?5OJS\#W/F
M        &TCQ*M566A'ZYXW%.XMM#(&HZUI;-)UN38WC$UF&TX7#J40K*FEO
M&E1*(U33,C+@R.C^>4*GEBNCIVWX-;?]579;%M_#YHS@OR0^)V/_ $P[E+</
M"D\"UR=FV\CRE%M+3VLO%P[(UI^J5=M%\]'JF\AM-:/6P BI>
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MQC>H:6.N7:I/5OM<IRFY*$.JTZV0&")^
M
M
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M9KX--/\ >9D<;+Q<VE9&';7=COTE"2E%_DE%M/\ ?.['S.0
M                         '6VU/5WL%^MN(,:Q@R6ULOQI39.-N-.I-#B
M#(_4B<09I/@RY(S+\![0G*N2G!M33U371IKT:?VGSMJJR*I47QC.B<7&49).
M,HM:.,D^C371I]&NC*![C\,&'RDWVKG4QG^%.OXU*,RC.\<*5]N6TT:X[G22
MN$$2D*4:4I0V74L3S9>;7X^F/NR=E/PFOSU_5+TDO3KTDNK^9]#7CG7@7;]R
M[]RX=*&)G/J\>72B?I_)M)NJ7KT^:MO1)5+61K[O,4R7&GWHU_16E2ZPOH<.
M;"?::ZNM;9&W(-'MWD*<;4DE(4I)F1D1^@LC%W#!S8J>);78G]C6O[J]4_N:
MU-6]WXWO^P6RIWG#R,:47ZSA)1?5I.,].R2;32E&33T>C9CXY9A
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MRR$M*I;=9#3U=MU;3Z]-%CVZKTZ]R^*TZ:O/8OU1^$\BGOS:>4XF0I-=L,3
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MOOMFW+66L^W7M44JJ">&M(
M                                                   !-'CA_C#Z
M%_EGU=_7Q1B-<S_X'[M_8W*_R"9;?@'_ )]^$_\ *[9_]\,<A<24J0
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M7"-<4_V+M_LEN/\ OAE%M^:_^&.%_P D>*__ )+[.0N)*5(
M                  !N=UK@E?JS5^'X5$:5]XG08&<YS,<.,ZY(RW*:6LE'
M5LOQU.DJNQ:H)B"VDEJ;.4F4\CT>Y/7'=]TNWW?,G=+'_6\9RHH75:4U3DNY
MIZ?-;/NFWIKV>W%_FZ';5X^X7@^-O'.U<0Q8O]:W4U[CN-C[&Y9N9CTS]F,H
MMZU8='MX\4I.+N63;'I;J\K'#)*
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MG*3FX]SZRC7W>W&3T;C%/1:Z*6!P"1
M
M
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M[DCZ9.3?F9%F7E3E9E6SE.<I/64I2;E*4F_5MMMOXMG''L?
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M?OIIEY;1N^W[]MM6[;58K<"Y-QDOCI)QDNOQC*+B_O3,O'',D
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MJ1R*<CSORJ-+[O8W>[&D]&E[F+IC6Z:Z-Q]VJ?:]%K'1Z+70@(2PI(
M
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M*U_E\25NVY,DFEHK<C"MMC%:J,;(Q3:1V@^1D0
M            #[1V?<2&(_=98[[S3/>D+[4=GNK2CNON<*[;+?5RI7!\)(S'
MK.79!ST;T3>BZMZ?!+[?L/K15[]\*.Z$.^:CW2>D8ZO363^$5ZM_!=38!X]Z
MHF8ID<>]BYUK_)L>LF(T:_K(UBVXKL+=4IA]AYUQHN_'>0XE)ESUH4LTI,^D
MRJOD^]T[EC+'NQLBG)A/6#FM/NDFGUZK1]/1I==-==P?$G <_BNZ3W/!W;;L
M[:KZ5&Z%#<_M=<XSB]-5)22;Z2@Y].[1K98((;"
M
M
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M^J;UZZ*[8AI>0
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M1,LOIARHK?2:>ZMPULG)<4LN>"):2(S+^#@\I3SO=H:*ZNF<?CTDG^^I:?\
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M0[I=L6HQSJ.VO*3]8ZVQ=.0WJG*RVW6*[>Z>KL7.:!
M
M                                               &::W_ +(F!?\
M7IBW_/R",9O7^P^7_H:W^\2);P#_ (>;)_9?#_U16-D?V1,]_P"O3*?^?DX-
ME_V'Q/\ 0U7]XB.?_P##S>_[+YG^J+#"QDR)
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M6$XJ>7F8,^NCJOA"_(Q](]\<ONK4I+(48VW$#-H
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M/J
M
M
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M9@
M   <*16UTOJ.7 A2C4:35[B*P]U&DB))J[C:N321<%_  ,)M]2ZTOE*5<8/C
M=@:WSDJ]Q6,*ZGS)2>Z9$DB-1)69%_ 1\%Z#ET[AGX_^9[K8=-/EG)=/LZ/T
M,-G<=X_N;;W+!P\AN7<_=IKLUEIIK\T7UT;6OKHR+;;Q*TC:ES^67H#B4O$V
MJML9<)!./<?K%M1W&T.DVI)=*3^E)<D1%R8RM/*=^I_-R)-=/SE&7I_5)O\
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MW7*QI3BVD_Y]0S<A_4HD(-_K/^*1E/?&O)9\8Y;C94I:8-\E3=]GMV-+N?\
MB<NV?1:_*TO4UK^K/Q+1Y@\);MLU5??R';Z99^ TEW?B<:$Y*J+;2_KFKW,?
MJU%.V,W^8M/'D-[C\W0
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M]M1<U&,Y2BHPDU8 24J0
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M%>.\+&Q,+;L6^VQ1AB8&-5BT3EC^[937=?[4LJ]0^5Y-]UGYTY-PN)*5(
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M
M
M
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M/(LS\?OF3;DY6FB<WKVK^+&/2,(ZZOMBDM6WIJVSHQRC$
M                      3MXU7YX]N?#9"CXCS9CU9+,DFI79E1W%))!=QM
M'4<EIOU5RDBY/CDB,HUR['_$;#=_&K[9K]R2U_\ !;+5\+;D]N\B82?\ED*R
MF7K_  ZY./HU_@D8:ZZI+5Z:Z-;O!29OJ
M
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MQEC;U0E-.,XV574S;]N^FR/255BBW'51G%IPMA7;&<(Q@,T5\
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M/7L7'[]?&NR73KPU!OLR[OS;<Z:T7=W:.O&[M?;HUE#ME?=W;'Q:AID
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MX>AU"\CX_NW$]_S>,;[4Z-YV_*MQ[ZWZQMIFX36OQ7=%Z-=)+1KHT9(.484
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MC+^#*F6VYS<'W/\ 1RCN4%II%JR-O31J4H1$G*>
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MQM1=BJL<%KK*,5-+LG!RE\<$D
M
M
M                             ?"2AYQAUN,^49]:>&Y!M)?[2N2^OM+4
ME*S(OP(SX &NOS%P[8$?&H%_9Y:N_P <C7BR=K45C,), Y229A2'763,U(2Z
MLT$@_HZG?X4IYGW",K!CGO'=2CESK:4^YO73K)*+Z+5=>G\7[V:Z>?=HY!;Q
MV.Y1RW9LM.5%SH548]G>NRN;L762C)]FDM$W:GZI&N@6F:@
M                             =M0V1TUY2W!$HSJK:NLB)*4K49P9C,H
MB2A:D(6H^UZ$9D1_I,AQ\NC\5B6XW^&5RC_=DU_VS)[)N#VC><3=5JWBY55O
M1)O]'.,_1M)^GHVD_M1Z"ZB:FRJJVP2XETID&+)ZT*0I*E/,(6OU;_5\DHS(
M^/0C&N[33T?JCLVC*,HJ46G%K5->C1V(\'D
M
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M]\=\OW'A')JU7OFV94Z+5%MP;B_ELK;47*JV#C95)QBY5SC+1:Z&&C(D4
M                                                           U
M ?-9_BL8#_L@,5_N=;5%'^??^!V-_9.O_(,@[$?V9W_/ONW_ "1RO]\-K+@>
M ?\ B:^/7\G\/_+T\3CQK_P$VS_0R_N6:[_5I_UD.7_V7G_>*RWXG!KL:N/E
MM_8Q_@NS/VD^W_//WB-^QOV?VW\T?FCO1/NWL?=_TU^5_M/_ "Y[?ZOM]CG^
MF/:BG_-?ZA_FA+]:Z?K'O7X73M]SW-5W::]?;[?Y73IIV_PNPWI_9]?VR?[>
M=?\ ,OO_ )K?AI?KCO\ <_#?A>V?M=_9\OXGW?\ ,?=\W=[NGZ+WS2A\:K^H
MX_EWKY[=ZI#+S,=+^LI5O(@LX_'V.S'A*PA60)MF^KV_L>I5*XRXA;=PBOZ"
M4E1&B@?%$MDCS?&ER'522UQW)I05Z2]KO[OAI_)--:6JK377IV:?6K5Y"N^G
MK=Z_&"A*N4W'<HTQF\B6W.4UF_A_:>G=WZ+,C.+4L1Y?<TTU+U[#=X_/$
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MNCA)Q_-O_5#5D8R]<:ISBOD;A$2<IX
M "UGA?*AL[YIX;[:3GW>*;"HJ&0I+:O;7=EA%XU':2EU24]VYC$]6H5S]"II
M*_1R('Y)A9+BMEL7^AJR,>=B^V$;X-OI\(/2Q_:H:?$V7^DG)Q:O-6)B717X
MW,VS<\?&EHGVY%NWY"BDGHM;X=^+%_P7D*7P-C@J$WX
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MFD8=J@E\WJ3^,03<
M
M
M                     Q_*<8ILRHK''+^(B;5V;"V)#*^2,B6DTDXVHC)2
M'$=7*3(R,C'UHONQKHY%$G&Z#U37P:_[/R/XG#W# P]UPK=NW"N-N%=!PG"7
MI*+Z-?:ON:::>C3329J0\BO'B7J.:U=4JW9^&6+J6F75=2Y-5*,BYCRS,UK.
M,XOT;=49\*42%&:C2:K<XQR9;LOPF9I'/BM=?132^*7PDOBOLZKIJEIAY8\4
MOALEO>R=\^-V347%MRGCS?HI/U=<FM(3?52:A-]SA*=7!,"D
M                              -X_COD/YET[A$Y3J7GV*IJMENI6TKK
MEP/U$@S)E*6VE$X1ET$7T<<'P?)%0F^X_P"%WC)HTTBK9->OI)]R]>OHUU^/
MJ=C7C_<_UQPG:\]R4IRPZXR?3K.M>W8_EZ+YX2U2T[7TT36A-8Q),
M
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M"46I1DM8SA*,XMQDF^B'*,*
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M9U.'MV%WR5LJL6RJB>5?;*J$O<KQ\2F5:M=/18IJH
M         $W807O]*;TJC0R^59-U3G)-=WHEQ7*:^O,**V0TEYM;T)A&R51'
M2-#C:79S)F1+[9E&-T_1<FVJ_5KOCE4:Z='WUPN[-=.DG^&4UU3TA+X:EP\/
M7XWQ#S/;7&$UCW;-N.G=I.#HR<C;_>24DY5Q6[.F>L914\BIM*78R$1)RG@
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M9DR7SW9$(672;^*GVKV]%TBJ^Q126G7J=>O)_JF\U;]O:W/9]ZS=AVJJ2]C
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M+\315&:CV=C]J5BBTM7I*+=OA$2[@
M
M
M                                   ,>RG%Z;,:2=07L)B;7SF'&7&W
MFR<)!K2:2<01\<*3S^@RY'UINMQ[8WT2<;8O5->J9Q<[!P]RP[,#/KA=AW0<
M9PDM8RB_5-?W#]4^JZFE+=.G[O4.2JKIZ4N5-D[,D4$M"U.J<@-OFEIJ4OM-
MM^[;:4GJ-'*5?C]*B4A-V\?WVG>L75)QRJU%37PU:_.CU?RMIZ:]5Z?8WH/Y
M)\>YO ]V4')6;/DSL>/--N2A&7\G9K&*]R,91U<=8R3[EIUC&&QGRMP
M                                  #:OX-Y#[_7=W0..'UT-\Z;#)N*
M7Q&GMIF+>2CH2AE*I#RD\<F:C29\\>A5!SG&]G>%<O2VJ+_=CK'^X2_?1NQ]
M/^Z?C>#RP9/Y\/,L@EKK\DU&U/31:)SG-::OJF]>NBNV(:7D
M
M                     &EGY?O&VIR75U?O?%<82K,L'L8T3++&KC?TU,P>
M4E]M]R>Q'1W)C=+8NM2.Z?44.-[EPR)"W5IO/P?RJW;M^?'<N[3;<N+]N,G\
MJO6CCVM](NR*E%KIWR[%U:2?71^T0\,87*O&L/*>R8/?RW8[JUDVU1ULGMD^
MZ-GNJ*[K(XUTJKHR?=[%+R9M*MSE'S5C;@Z/0
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M2.0K4XK6U6JV6LE*;4Y:VS$U-?P
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M
M
M
M        !5CR^Q:)?ZAL[%Q;#$K'9,>UC/O-FKGM&M+C"5-L/NDY(:<6TWQT
M))3G*E$CJYDG$LJ>+OE*BFXV:P:7V2^/JEHFDWZ]%T3>A5WF3:*=V\?YKME&
M%F*HY$'):KNK>C72,FG.$IPBUII*2[I*'<:=!=IH,
M                     7G\%L@.)G.3XXIPS3<4;<UEE1O*2E56\KW#K:2/
ML-K64ELE*/ZE$1$1'QR5>\_Q^[&Q\M+\V<H-]/X2U7W].UZ?#J_M-E_IOW/L
MW/<]FDW^EHKNBNNB]J;A)I?FK7WH)^C>D?5)Z;2Q6!MF
M
M                 '!LJV#<0)=991FI<"<RN/*C/));;S2R]4J2?)'Z^I?P
M&0\QE*$E*+:DGJFO5,]+*Z[JY56Q4JI)III---:--/HTUT:?1H\P/R0^ C/C
M_+=W+K%#"=6WUJEBYQQ'#2L,M[!_HCKK$>B#QZPD.)0E@N#AOK2EHC842(VV
MWB;R9;R)1XWOC<MYK@W7;_AT(KJI_P#ML5U[O2<4V])IN?2-];7TCX7BZ5GE
MGQU"%7 \G)C'*PET_ 7W2TA/'7H\2V;[55ZX]DHP@G1.,:-2(O0ZX@
M
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MM4W?0TZ;G*N,O=I<6XNJS7OK:;3@UHVNIG XQE
M
M
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M>\;,MV^[$R%FT]ON04)2E#OCW14E%/M;3UT>C]5ZIG2#E&(
M                        G;QJOSQ[<^&R%'Q'FS'JR69)-2NS*CN*22"[
MC:.HY+3?JKE)%R?')$91KEV/^(V&[^-7VS7[DEK_ ."V6KX6W)[=Y$PD_P"2
MR%93+U_AUR<?1K_!(PUUU26KTUT:W>"DS?4
M
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M2E%_'JNJ::Z-,Z@<@Q8
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MY]L*T^Z<FE%-]#5X.[X_.:
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MQL='&]AQ<-66)*=UF39?O&39VKI&K\5NE]>-_"EBUT3L_22F0:)04V
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M:<\O%<IN2G@WSA&<(QE-RC^'R9MR[(QK[<FI:*?=*>\L4 =F@
M
M
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M+7ZM_J^249D?'H1C7=IIZ/U1V;1E&45*+3BUJFO1H[$>#R
M
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MXMQDHV0DE*+<9):IM,Z(<HPH
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MLMJ]YUT0RL['LMM>=;.=OX=YL+9^VI2E#%PJ+K8FMP=R1T"@
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MIW5752G5;'2=<Y0:;Q@<XCH
M                        %O?!C?3/CMY(81G%FZAC&+1;N&YB^MPV41<<
MR)^(AVQ=>)1$B)4V<6++D<I6:HS#B4IZS290'R7QFSE7$LC!QTWGU-74KU[K
M*T_E2^V<'.$>J^:2;>FJ>R_TD>7<;PSYOVSD>ZR5?&\U2V_.FWHJ\;*E#],W
M\(8]]=&19TDW55.,5WN+7LVBR69L:/+CKZV)++;[*^#2:FW4$M!FD^#2K@_4
MC]2/T,:)'Z0C[@
M
M
M             XLV=#K8SDN?*8AQ6B-3C\EU#+22(C5ZJ69$:C(CX(O4_P!
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M/74D&1Q+E6'BRSLO;-PJPH1[I63Q[HPC'^,YR@HI?>WH60'.(^
M   &\?QWR'\RZ=PB<IU+S[%4U6RW4K:5URX'ZB09DRE+;2B<(RZ"+Z..#X/D
MBH3?<?\ "[QDT::15LFO7TD^Y>O7T:Z_'U.QKQ_N?ZXX3M>>Y*4Y8=<9/IUG
M6O;L?R]%\\):I:=KZ:)K0FL8DF
M
M     :#OEV\6, H,+A^06%8_#H\GD9A%B9Y(A]]IJ[AW,;V3,V3&;)R-[^/9
M,Q4I<Z6NI#KO<<4LVDGL1X/YAN<]U?%<ZV5FW/'DZ8O1^W*#[G&+>C[91<NF
MKT<8Z)+5G5K^T1\%\1IX4O,W'<*G%Y57NE4-PLK4HK*IR(.J-ED8ZP]ZNZ%*
M4]*^^-ECG.<^Q/S[#:,Z<
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M\;LV3#679%Y&=GY6-^%JOBIJR5N11)O<K'%.45CSM[X./N1T;#].Y^.0
M                                                 +$;VGKEX[X^
MLV*>SD432-*W:Q8;3T.G8JRR/)6<,=8A.\M?>K'#8\*58R6.EF6Z^A:D^X*0
MXY#^*U*O,W>5/7#END^UMIS<O;K=R<EU[(W.<:XR^:"BTGV=BC>_FC-EE;#P
M:K/79OU7#\=70A&4*(T_BLN. XUOI^(MP(X]V5;7I7=.R,W'WU?.RNXF!1
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M94*G%3QMA2G3>G!=:X;A-2PJWVJ,Z*LZ$6I0Z:CAW_'Y?
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MZV#=-LPK-.VZZB:H;;:4/?BI4^Y\K?MN?N):2<>V46XG&>*U
M                                      /8=\<VZ8VY?%G7DE^PCRLD
MPV >"Y*PAQ2Y3,_&$LPF'II+4H_=652N+-7TF:"3+1P2"42$Z(^3-AEQ_F>9
MC*+CBW3]^K['"W67R_TL)]]:_J'Z^K_2+](WDFKR?X"V'>)VPLWC!QEMV6EK
MW1R,)1J3LU;_ $EV/[&5+1Z:7II1U[8WL$"-E
M
M
M                                #K[6Q8J*Z99R24;$)A;[I(-!*Z$?
MCZN*0@B+GU,S(B(>4FWHO5GB4HQBY2:44M6WZ)%3MH^6>%4>/6R\"O:N[R*(
MZF-$942GXTI;BV$ID15M$ME^,TT\IQ2E*3_0^G^,?!2C;.*[GEY5<,NJRK$E
MJY2:2:23^#ZIMK1)KXZZ:%3<L\O\4V;:,F_9LS%S=YJTC75&3E&<I.*U[H?+
M*$8MR;C/1]KBI=W0H?M_R(RW;C,*%+830UD=AIN5!KYK[B+-QLB^N::416G&
M>\:G":-LR)9D?)DE!)L#9.+8FSVRR)2][(?YK<4NU?TJU?5^C>OIT6FKUULY
M]Y>WGF^)7MM=7X';%ULA"V4G=+I_*/2"<$UK&MQ:4M&W)J+4#1I4J&Z3T22_
M%>(C23L9YQATDJ_C))QI25\*_27/J)-.NNR/;9%2C]C6J_HE4X^3D8MGO8MD
MZ[=-.Z$G%Z/UZIIGYD2)$MYV3*?>DR'EFX](D.K>>=<5ZJ6ZZXI2W%J/\3,S
M,PA"%<5"M*,$M$DM$OR)'K???E72R,F<[,B;UE*3<I2;]6Y/5MO[6S]PYDJO
ME1YT&0]$F1'FY$:3'<4T\P\THEMNM.(,E(6A1<D9#Q977=7*JV*E5):-/JFG
MZIH]\7*R<')KS,.R=675-2A.+:E&2>J::ZIIFQG7?FSC=7CU+29;CER4^#&;
MBR[6 J,]"=[,=)JDFTMWW?<D2"5PDDJZ24GE1\*4*OS^"YWO3LP9U2H<FXQ;
M<9)-]%Z./1?'5:_9\#;?CWU"<=E@48_(*,RO<8UQC99",+*I2C!:S_/5B[Y)
MZ1[)=NJUD^K4^87Y5ZER[WI2+IG%U17DM,HR&0Q#7-)Q:TM'%;-1..J6E!&9
M))1)Y(E&1F1'@,WC&\X+2G3*Q-:ZUIS2T]==%T_=]?@6+L'E;@W((SE3G58T
MX34>W)E"B4M=='!3G\Z>G\'5K5*23>AV&R=_85BVO9N<8[;U>0ON.+JJ-<%U
MMUN99*(U%';?4@TN--K;Y=Z>OH2E2NE7;4D?';MDS<[<H[=.$ZK/6?=%IQA\
M9-/1^C6FNFK:6JUU,AR;G>Q\?XK;RBF^G*QEK"GVK(3C=<]5&N,XMKU3<VM7
M"$9R[6XZ&O#9NZZS.:3%<JJ*]&([,JK=Z+-G4CGMGI=:W7(7(F.N16XZ4L2Y
MDA"$-J(R7T.D9<<]5A[1QV_;\N_"R6K]FG4FE)=._NZ+1Z_,HIMM:>L7Z^FL
M_-?)^W\DV7 W_:HSV_G6/F.#E5+YO85*[V[$HMUSLE&,(3[ND;4]4WW09DF<
MY?F"(K>3Y%:7;<)3BXJ)\A3J&5O$E+BT)X)/4I*"+D^3(N>/Q/F3X>V;?M[E
M+#JA7*26K2]="I-[Y9R3DD*ZM\S+LFNIMP4WT3>B;T22UT6FK].NGJS$QSB/
M        !#OD'NO$_''2&TMZ9P\RUC.KL+N\MG,O2BA':2*Z*LZJ@BR>Q*-N
MQR2X7'KXI$TXI4F2VDD*,R(^-FY=>#B69=W\G7!O\NGHORMZ)?>S+;%L^5R#
M><;9<--Y&3=&"Z:Z)OYI-:KI".LI=5T3ZG^:_DD_RESV7EWR737;>+(+RBJR
M<VQ6H?:;J=\6#<[;%9'QMI:)T>KAX5'K(2X[+BTLP6I$".RE:.4MT58]PN<M
M^>J?XA?.OA8_G6GV=NBT^S6*1V$8\.-8,:O'D%!Q_5K_ $#_ (6,M*&Y^C;L
M;EJUUDU.3T?K_HS^&GDE1>7/C#IKR$HSKF7-B8766&35-4\\_#QK.X2#J\\Q
M5E<G^FU,X[ET*9%:6Z1+>8;0[QPLC.[]KSH;E@59L-/G@FTOA+TDOW):HT$Y
M;Q^[BW(\O8KNYK'N:A*7K.M_-5/IT^>#C)Z>C;7P,_\ (#^P/NS^2/9']9MR
M/MF?YCM_Q.7]Y9P=B_V;P_\ 157^21/+Q^ZP_P#L=?\ ]+%_^4*(!X]_]^?^
M*_\ LALA]2O_ ,9?_AG_ -RDH_+M\NV4V.4S/ ?P'F6^5[>RNW3KW9&R->ID
M6=U6W5G(^U/:EU*]5=R1+SJ7(<.-:VL8S.I,U18JO?\ >>K^1R7DMCL>S[.W
M+)D^V4H]6F^G9#3^%\&UZ>B^;5QQOBOQ7C5XRYOS=0JVJJ'NU56Z*+BEW>_?
MW=%6EUA!_G_G2^3167A^'[XH*CP(PB3LW:7V[(?*/8]%'A9-)B+C3J?56,ON
M-3UZ\Q:Q:):;&QDRFF7+RR;6<>5(CM,1>8\?W$S+<9X['9ZOQ&1I+<+%U^R"
M]>U/XO\ C/T;22Z+5PWRMY.MYOF+;MM[J^-X\VX)ZJ5TUT]V:^"2U5<'U2;E
M+YI=L-V(E13P             ;7?![("L-:VM&MTNY07TA#3)N-FHF)Z2GJ=
M2RA)*2VI^2HNM7)K41D7HDB*G^<8_L[U[R72VJ,M>OJM8?OZ17I]J^TW<\ [
MG^-X)^"E)=^'EVUI=-5&>ER>BZZ.5DTG+U:DD]%HKJB'%W
M
M                        !1[Y'<?:R/PUW3$=@R; H%#&R!+$8I!J;=QV
MQB734YTHO#OMJQR$4EPS,FR0T?<Y;ZB.=^,LEXG/-LMC)0;R.S5Z?X)&5;CU
MZ:R4NU?'5K3KH:X_5WM$-Z^FSEV'93.^,-K_ !';'NU3Q;JLI6/LT?;4Z5;/
M7Y>V#[]8=R/',-\#\V@
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M7,KLG>L&Y0E#2.5F9'XG%L4ETR,#+C?B7)-J?MPOCI7=65]$N*-
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M8JN47X&;#C-]\J*\N5%JQ;+HIRE3#(<?:G;%)N5<9N:2;:T1T0Y1A0
M                                      #:/\2^XD:Y\F$8G<7DB!C6
MR\;LJ5-<N1V:N3E<!<>RI9LDEH4VF1'K(\]IKZD&ZM]+9=2S;2=+><=C_6/$
MX[I16I96%?&3EI\RIFG":7W=[KE+UT4=>BU9V ?LZ?(O\U?-=O#MPRYU;-R#
M;K:JZG+2J>=1*%^/.6JT5GL0RJ:^L>^5R@NZ;A%^K,:>G>R
M
M
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M.0\*HW?C60[-@IC[UU5?YMM.D90N32U<:4G*4'\JB_<:3J/<L+:-,@
M        "]W@ID/M,QRK&UN&:;:G8GQV3<422<KGEE)<2TE!I4I2'VR-2E%T
MD7!$9J%><_QM:<?+7\&4H/\ [Y)KK]W;+]\V;^F_=.S.W/9I/^4JJNBM?3VY
M2KFTM.NON5ZO7IVKH]>FT05B;7@
M
M    !T^045;D]';8]<1TRJNY@2:Z='67*78\II33A&7\)$KDOYI#Z56V46QN
MJ;C;"2DG]C3U3_<9QLS$QMPQ+<#,@K,.^N5=D'Z2A.+C*+^Z46T_N9XO_,+Q
MWL/&;>>4Z\<0\O'7G3O\)FO$X9R<5M'GEP([CSBW3D2JA;:X;KAF2GE,$]TH
M)U*2WRX!RN',.-T[G+19T/T=\5\+8I:M+X*::G%?!2[=7VMGYLOJ<\*W^"O+
M.=Q&KOEQN_\ KK;K):ZRP[I2[*Y2;?=9CRC/'LDVG9*KW>V*L455T34U\
M
M                                                    +$:9D5.N
M*>TWY:1'K2\PO)Z>AU;2DY6?;I.PIU-?V\;*+]N9'FR'*77QUT2<3#3;;DR<
M]&:2ZVCO.M0_DD+]YR8<3HDH8N31.S*G\W<L>,ZX.JMIQ7?D=TX=S;4(*<G%
MOMC*]_$M^V<!VK)\V[C5/)WG:-QHQMGQ]:?:GN=E&3?#,R59&R3Q]L]JG(]N
M$(ROR+,>J-M</=LKKN)@40
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ML)2@I+K5*$TY1E&3L^(P6\
M
M
M                 ?)\G38>)@R)\VG"9,^."=Z#[9GU$:>"7Q^)&0 UM>5F
MYZ.?42-;M4L4\N9DPV<K>D0%=,)2&?>(]E-0MDUR$NFRZDB-YLB<,C/J09*L
M#ANQY4LB&\6-PQ4I=FC6LGKVM-=?E_.3UT>J6G3J:X^<O(&TT[9D<(QHJ[=Y
MSJ]Y3A+LJ@XJV+C/6.MO\DXZ=T%&4E)]R<37N+1-0P
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M<4D]%W-2]8F[$4L;W@
M                                                         &EG
MYJ\8QE_2FM,OEL-LY36['324T],0WWWX-MC]K)MJA3Y/M)AQY2:AB2MPT.FM
M<%IO@NKJ*]/ >7EU\IRL*IMX=N%*=BUT6M=E:A/31]SC[DHI:KI9)_#1]<O[
M2_9=DR?#6T;_ )D5'?,3D-=.-9V.4G#)Q<F611W=R5<+%C572DU+66-7!)=W
M<O-6-MSI
M
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M2HN4J2HN2-)D?H8U'.[\_H
M
M
M                  U0^;ZZ!&QZ6)70#C73=&J7>2^A)(G-SGTG6&A9.*-1
MLFS(ZB-*>%*YY/J]+3X#'(_!7SG+7&=B45KZ22UF]/O3A^]^_J']1UFW?KW;
MJ*:]-U6+.=L]/SJI3[:8ZZ]7"4+_ (+1275ZZ*E8GQKB
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M1&DOU[*'?1)FHR+Z_P #,QKR=EYRP
M
M        :(/F\L[E&,:-IFXSYX_*OLDLYLM,\FXS=S KV(M9&<JS/F6^["L9
M:D2"_P"-TH6@_P"C$-A?I\IHENNXY$FOQ4<>N,5V]7&4VYM2^"3A#6/\+5/^
M"=77[3_.W*OA?%=MJA-[1;NF5;;)6:15U5$(41=/K.4H79#C9_@2A.+_ )9'
MGD&TQTU@
M
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MDV39^-[3C[%Q_%HPMFQ:U7313"-=5<%Z1A"*48KX]%U;;?5MF7#C&4
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M7FWQ#AYNX7^[S;:80P]R3;<Y6P3565)O3N_&4Q5TI)**O]^N*TK-@XKLVE
M
M
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M5XJN)<QOPJE7' OBKZ(PU2A5.4XJ#3]'&4)1]7JDI:ZMI0\,\5P
M                             &]C15X>1:EP:S6HEON4,)J4I*'$(]VR
MT29"6R=4ITTMN<IZE&9J-)GR9<&>O^[T?A=TR*$M(QNGIZ>FK:].GII_]([)
M.&;C^MN);;N+:E9;@TN36J7?[<58OFZ])J2U;>NFNK]7+0QQ)@
M                                  #@S[*!5L>YL9D>&QU$@G)#B6R4
MH_YU!&?4M7'KP1&9$1G^! #C2+^EB1F)DBTA-Q9*NEA_OH4AU1$1F2#0:NKI
MY(C_ (#,B/U,@T8/@648X;S4<KNL-UY/4VDIC)D9>OH:R7VT*]/XJC)7/'IZ
MD/.C!WI&1D1D9&1D1D9'R1D?J1D9>AD9#P#^@
M                      #4E\Q&K9.9>.%5G-='=>FZPRV#<339;D2'%4-N
MVY16#266GDM-H9DV#$MUY3;AM,Q5?Q$&M0N3P?O$-NYC^!M:56;CRK6NB7N1
MTL@]6OBHS@EJM7->K21H;^T1X'=ROP-_./"@Y9O'MSIRI:*4I/&N4L6]**DD
ME&=U-TYN,G"NF?YL7.2\N0W'.A@
M
M                      L?M7)I.5:BT[=Y+&J[?.K6SSW[EG)U$2OR:SQJ
M@1B>-XW29%;0%LN9=-KW:^6ZJQLD/SS;>:9)TDMK-V&;#A0P.0[EC84K*]KK
MA1VT=[E5&RSW;+)UPEK[2DI07MUN->JE)QU:[;]\E\BR.2^+N*;OR&O&RN9Y
M.3N7N[C[$*LN[$QEA8F)CY5U;B\ZRIU7S>5EQLR>R=52M483=E<!,R@@
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MN3,S_P D8TE!^P                                          %/\
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M\D9>AD-*S] A^@
M
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MG\B^?Y2<$+0XA#C:TN-N)2M"T*)2%H41*2M"DF:5)4D^2,O0R&))B?H
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M5X>3=3\?BU<NK;UT5R2TT222TZ:NXPB1<H
M                 0[ENW*ZBDS:NOB.3;",9LF\M24Q6WBZB5Z)-2W2;,B+
M@S1SZG^''5[*.IX;T*Y9!E5UDT@W[28MTBY)M@N$,M(ZNHDI;224\$9%^@BY
M+GCD>Z21Z-MG0J>>4VEI3KJFD_Q6U.*-M/\ [:@SZ2 'X(S29*29I4DR-*B,
MR,C(^2,C+U(R,#P6)TQE;SSLK'I\MU]2T]^M2ZKK-!,H4J0VE2OJX4@NK\3(
MC3^@S]?62^)[Q98<>A[
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MQOQ=>YR;?X>VK5MMM]=>I"HDA4X
M
M                    3WF#C51X_:9Q^4\],L\BR?9FRX"'RADS1XU-ETFN
MV6:Y3+KTU7W_ "'75@Y*3([:$G!9-ELNIUQZ)[<I9'+MRRZTHT4T8V-+376=
MD5/(;EJDOT=>16H]NK??+N?2,8W9RJ=>U^#N);'DSG;N.?N.[;M6I=G;CXED
M\?:XQJ<92L?XG*VO)E<K.R*>/4ZJUW666P()84F
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M'*E">4H)3E"+A&4M%W.,'.QPBWJU%SFXK1.<FM7D8]#[
M                        '%FPHEE$D0)\=J7"EM+8E17T$XQ(8<+I<:=;
M5RE;:TGP9'Z&0\QE*,E*+:DGJFO5,]+*Z[JY56Q4JI)III---:--/HTUT:?1
MHBVSTUBC.$9-AN ,IU4>1LV)G=X!"JJ>UKY]FV:)5G!4[7383<]?/42UL.I)
M:4J-*NDB&0CN>3/.JSL_^NYU./RWRG.,HQ>JA+YE+L^':I+ITZ$:MXCM5''L
MOCO'%^HZ,N%J]W;ZZ,>VJRZ/;+(JUIG2LCTDK)U6?,DVGHCK?'C55_I?55#K
M[)\_OMG7=5)MY,W-<FES9UU;*L[.3/0F7*L)4R6XB"T^3#)+<7VV&T(Y,D\G
MR.0;IC[UN]VYXN+3A8]G;VTU)*N"C",?E245\W;W2TBM9-O3J8OQEP[<^ \'
MP>);QO.X<@W/$5ON9^;.=F3D.V^VY.R4[+9Z5JQ4UJ5DW&JN$==$3<,,3P
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M?(,;NO\ U;?.&1"ZI:.5&'*-5=\;H1[I51MLR97M*I.,Y*1H3&S)U#@
M              '[:=<9<;>9<6T\TM#K3K2U-N-.-J)2'&UI,E(6A1$9&1D9
M&0\2BI)QDDXM:-/XGO79959&VJ3C;%IIIM--/5--=4T^J:ZIGJ^^,'RIR?R*
MU':46>&Q)S'6,JOH)5TAY'?R.I>@H<JK>9'-9O(LW>T\W),D]I;C7<0?#ALL
M:4^6>&XG$M_A+;=5MN9"5D(?X7)2TG!/T<%K%Q^*3[7Z*4OT&?1-YZWOSAXR
MNARQ*?+=BOKQ;[TU_75<JE*C)LCKW1OGVV0NZ=DYU^[!KW)55;.159N4
M
M
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M[MUVJ6NFE-L>BT_APGJ]=>NL.U::=)=5TUV;"M3:8
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MR>-0HNR<8R<:U*2A%SDEI!2FU&+DTG)J*ZO0XH^AQP
M
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M)UM4V^JMIM++3;*.>AIM#:.3Y/I0DDIY/])\$-/SO3/H
M                                                #\.-H>;<:=22
MVW4*;<0HN4K0M)I6E1?I)23X, >=;Y OC8Q?66%[*\B]=9/D4IQ.0IR2YP5Z
MHAS8;#&29"\N\=I5U$2$Y4T]&S8E*,G4O-QXL5WE1(-)M;->,?*^X;AN&%Q+
M=ZJ?:=?M0O4I1EK77^C5G>Y*<Y]G9JG%RG..BUU[NHKZOOHIXQQKC'(?-W!L
MO</QL,K\;D;>ZJ[:5')R],EXSIKJG11CJY7]LXVQJHIM[IJ+3KT8C9$ZFP
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M8
M
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M2[5KZ??J=:/)[,*WDNXV[:U+;I9U[J:;:=;MFX--]6G'1IOJ_B8^.88,
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M,:ZGX?"*N75M::NE)::MMI:==5NA%,F\H
M       !^''&V4*==<0TV@C4MQQ24(0DOQ4I:C)*2+^$P!#CFQK*QS>/CV-L
M0IL!"^W(=<4?+Z6_68\VX2DDE+".HT\&?))Y]>>D>VG35GC7KH3,/4\@ 81G
MN)GEU+[)ITFI4=WW$8U^B%K))I-M1_SAJ]#(_P .2X/@C,R\IZ,\-:E2;?$<
MAHU+*QJY33:/_,Y-*4PHO3U2XDC2HBY]3+DOQ_@,?35,]-&8V!X   "Z&KF7
MV<*J"?0E!K)];:202%=OO+27<+I2HW.I)^JN3XX]>.!\Y>I]%Z$@CP>0
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M\-W_ "^+\HQ+L'?\&YU7T6K2<)K]]2C)-2A.+E"R$HSA*4)1D\>'+,&
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M\>;;X]X[\V)@T_I+7'MGD9$VYWY$UW3:E;:Y24.^2JAV4P?MUP2GX8 LH
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M
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M[IRUE+1:MZ'?#Y'+
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M;:]GQ>=X.;"^J:JIQ9WT*NV%N)[\*^BG*R%D8V2C7[E47*<%JSRK#=,_/X
M                &S[XJMW6^JM^3Z J'*\DQ3.J$H=^SC%3?7WY;DQ+&&S5
MY7;UM,S.*/21W[$X<B6XQTQURV5+=::)SJICS;L&/NG&J]P]W'IS<6W6'NSA
M7[D91;G5"4VM9M1[XP4OF4))1<M--_?V>GDK=.'^6LKBZP]SSN/;UA*-ZQ*,
MG)_"6U6P5&9?51&SMQE*UXUM\J]*GD52E9"M6*7JVCR&9;#,F.XEUB0VAYEQ
M//"VW$DI"B(R(RY(_P #(C+](T[.]P^P
M
M
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M9'63[.=9K;7-?[ZFDFA!]MEOI2H^3+AEMLCY/^$6[XW\1>//$>%D[=X\V_\
M5^'F6QLNC[^3?WSC'MC+7)NNE'2/32+BGZM:E3>1?+'D#RQFXVX<_P _\?F8
ME4JZI>QC4=D)2[I+3&IIC+67762;7HGH< 605T                  &58/
M<*Q_,L7NDNDP5;?5<EUTS:228R)C12N5O$;39*C&LNL_XO//)&7(X&Z8_P"+
MVV_&2UE.J27KZZ/3TZOKIT^/H2/B&Y_J;E.W;HY*-=&95*3>B79WI36LNBU@
MY+5^FNNJTU/0!$D)F1(LM'!(E1V9".#ZBZ7VTNIX5PGJ+A7X\%R-?3LG.0
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M;::;22$-H07"4I27!$1$0]#V/H
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MMGJ.%]'6H
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MT
M             /PXVAYMQIU)+;=0IMQ"BY2M"TFE:5%^DE)/@P!Y]/D&^,W*
M)N2Y%N_Q[IF+2%:$_<9AKJ 3,>Q:GMMLJFW&+1TLLLS5SDI=D2HJU^X=?2I;
M2GGY!,%LCXQ\MXN'B5<<Y5.480:C3D/6247KI"YZMQ4>D832<5'13[(P[WU0
M_6!]$&\\@WO,\K>&<>N[)R$[L_:X*-<YVI+OR,"*C&%D[4I6WX\FK;+E.=#N
MLN5,="8V:.H0                #83\8&QH.O?+K"VK5V)'J\]J+[7\Z1-[
M/MFRMFXUO";7WD+(US;2A8C-I274MQY*2XYY*J?,VU3W/@MUM2<K,2ZN])?9
M'6N;_)&%DI/[%%LW3^@3FE'$/J-P,/+G"O%WS!R=N<I-)*5BADTQ3?\ "MR,
M6JF"75RL4?1LW:;P^276WC-NZ5I3+\#R(Z:KKJ^<K)*-R-,1&*U;?DI)==(?
M9EJ92[^/;)9I+^*2B/Z=>^->*MZY7Q[]?;7?1W.R455/NBWVM)_,DX_DUT^]
MH[0?+7UH>/\ POY1?C?F6W[E[4<6JZ690J[815T7**=+G"QI::2<7)KII%E\
M-2[9Q3=&&UV=8:B\31V:"7&5?X]<XW+<_$E*1!O(4"8Y'-23[;Q-]MY'"VS4
MA25'7^Z[7E[+GV;;G>VLJIZ24+(6)/\ JJY2CK]JUU3Z22::-G>&<PV3GO&\
M;E?''DRV;+AW5._&R,6QI-K7VLFJJWM;3[9]KKL6DZY3@U)R:,<2@
M
M
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M][?Q;^TJ+?=_W7DFY6;KO%LK<NR3?7\V*^$81](Q2222^"7J^IT(Y1AP
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M/@>TGKZ'JEH3F/4]@
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MQU[;+&EIY%]G6B
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M?C_?\'<=QC3[KH3G5D*O71S_  ]\*K^V+T4W[?Z-RAW]O?#NLR(R6V
M
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MHMY#NSORH*JI4PKQ;;YO%K48I)J-/;V2?=-UN'N666=]DKI"&%]@
M
M
M                                       !%FV=L8[J7&W;RZ>;<E+,
MFZVJ0X12[%\^KAIALO4^>D_4^$EP9F9)2I2<AMFV96[92Q<5:R?JWZ17Q;?V
M?T6^BZLC?*N5;1P_:)[QO$^VJ/2$%IWVSTZ5UKXR?[T5K*344V:U/(S/XN>M
M5675-)2>SRFLIF)MT4J)/NJV36MO2CQ<VTN+<JCCK<)Y]22Y=6KH-1I07-B\
M3V^W!R;L7*LM5U-DFJ])1KDFE'W==%WZZ:13_-7735FLOF3DN)OVU86[[1C8
MD\'.QZHSR7*NS)JE"4[?P;BI-T]CGWV./\I)]K?;!:U+$\-<P
M                                      #;UX89#]XU"W6+<-U[';B=
M <-3BEJ2W(6<N,WP:$H:2W&<21)(U>A=1G]7 I?F6-^'WVR2Z1MC&:_>[7^7
M5Q;-[?!^Z?K'Q[C52>MF);;2WKKZ3]R*]%II"R"2Z]$GKUT5N!%BW0
M
M   #&LDRREQ:,3]I(Z5K+EF*T1.27?Q(C2WR72@S29=1\$?!\<F7 \I-@X&(
MYS4Y@F04%+K$B,1*<C2#;[AMFKI[C?2HS4E)F1*]"X-1?P@TT>$]3-!X/(
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M5>%DPKRLS6BQ3OIE"%V%3*/NVN2;I=G;"GV+K7&V4DH2].PU0.ZD
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MZ)N"JAV9M4'UG*N-5U<)1UHLA"V]:E!>9UR@
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M5;C9GL]L-91EW4VRI6BI=M,H:J/Z.<X3E7VINJO8**\-H@
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MU49NMR2?5)I/J3 ,43,
M
M
M     #"]A9E$U_AM]ETQHY#5- =E)C)/A4EY*?U3"#,R3UN*]"(U))1^G47/
M(Y.%BV9V77B5:>Y9-16OHM7ZO[EZO[C%;YN^-L.SY.]9FKQL6F=DDM-9=J;4
M8ZZ+ND](QU:6K6K1I!V1LC)-H9)*R/(Y2EK6I:($!"U'$K(AJ+IC1D\)2:C2
ME/6OI(UF1>A))*4WIM.TXNSXJQL9:R?64GZR?VO[OL7HE]K;;Z^>:<TW?F^[
MRW/<Y=M4=554F^RF&OYL?MD^CG-K6;^R*C&,?C*$0
M                                 V'>!M\29N<8VXX:26U MH[9N.*)
MUU1JC/FVR1=IHVVHR>M9GROJ27IT^M9^0,?2W&RDO6,H/I]C377]UZ+X:/[3
M:[Z;MR4L/=-HDWK"RJZ*U>C[XRA-J/HM/;AW/766L5_!1LD%=&S@
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MC=*R5=/H.889C,MQX[3;##220TTTDD-H27X)2E)$1$-;#MD/J
M        #YO,M2&G&'VT/,O(4VZTXDEH<0LN%)4D^2,C(P!Y=/EL\=,+TUM?
M#LWP6L33P=LP\BL+ZLB$LJYG(J615>YLD-DTEF)*O2ME+<2A1)=<84Z:>XIU
M:]N/!W*-PWK:,G:-QL=DL!U*N4OSO;L4TH-ZZR4'#1-]4I*.NBBET@?M%?#W
M%^ \WVGG/%<98D.2++>756M*?Q>-*B4KXQ2[:YY,<C6<8M*<ZIV]JG*R4M2@
MO,ZY0
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M9QDOW5*,D_O33^P[YEEF.TAB.TVPRV72VRRVEIIM/_"H;024)+^81#T/L?0
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MIQ=FL+>Z&3&/;!R4UZC$GU)2KA2>I)'TJ+A1<ESPHOT*+](U+.[0_H
M
M #QW?))F*<R\Q]N/LH0B'03:C&(9DPMAY::JE@JFJE)4\ZAQY-K)D(2M'2E3
M24'QSRI6[_B' _ \!PG+7W+O<M?75?-9+MTZ?Q%%M/7YF^NG1?G?^N;DD>1_
M4OOZJ2_#;>L7#@]'&3=.+4[7+5O5J^=L8M**=:ATUU;HL+,-1@
M      ,NP+.<DUIF6.9[B$XZ[),6M(]M52NGN-D^P9DMB2URDGX<QA:V7VS,
MB<9<4D_0QC]UVO#WK;;MJW"/?AWUN$EZ/1_%/X23T<7\&DR4<*YCO_C[E>!S
M3B]WL;]MN3&ZF>FJ[H]'&<?X5=D7*NR#Z3KE*+Z,]J/C-NZF\A=+X1L^I<:)
MV\J&2NH*'$K<J[Z)U1+BO=XX5U1;&.ZWU=*4K-!FGZ>!H%R;8<GC.^Y.RY6K
MG18U&7\>#ZPFOZJ+3^YO3X'Z:O$?DC:?+?CG:?(.SZ+'W'%C.=:>KIOCK#(H
M;]=:;HSAJ_SDE)=)(GL8$L<
M
M
M        ^3[[49AZ2^LFV([3C[SAD9DAII!N.+,DD:C)*$F?H1F -?OD1O.T
MA5]YCL7\BY?B60QTMPW8UVRW<PH\DGVW&I5.HSERU()2?UK9)[9D9+3P9*.:
M\;V*&7?"Z<LFG*JGW?R;['HTUI/HHO[5+77X/X%$>4_(-NR[??@X]>V9^U9E
M/M],J"NAWQE"?=0FY61ZIQLK:4/2:])/6H+<-+
M                                M#X@Y =)NBFBFX9-W\&?3DT9O&VX
M^MM,IM9H;/H-QIJ,YTJ7Z))1_I/@XAS?'][97:EUJMC+7IZ/6'[S<EZ?8OL+
MN\!;G^"YXL)M]F9B6UI=='*&ER>BZ:J-<TG+T3DD]7H]R(ITW<
M                                                         K%M
M_%FJB0B^B39!?=93ZGXJW%&2'U+-YU;)I(DDT:GBX(^#+^;SR7O%Z]#UE]I!
MRG75EPMQQ1?P*6I1?^ 9F0]CU/P!X!'QZEZ&7J1E^@ 6:TSD-[:-S*Z<I<FM
MKHR"CR5D:ELO&MM+<93A\GTJ:ZC21GQPD^"+@^?221[Q;9.X]3V
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M*[?@86U8%&U[;5"G;L:F%55<%I&NNN*A"$5\(QBE%+X)([H?(Y8
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M92:<I8UT(9&*Y.+:[WCW5.?Q4M4TGJE"HDA4X
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MB[+INRR;2]92DVVWKHM(K2,8I2"."2(
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MX]]'TGF6U"Q9J5+54*L,8H+RX8JCF++WA0Y3E2E"U\=9)69EZD0O/#Y3D97
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M2M*5H4E2%))25),E)4E1<I4E1<D:3(_0QJ,=X1_0
M
M
M                        ?-YEJ0R['?03C+[;C+S:OXKC3J30XA7\Q2%&
M1@#4+Y;4%)C^90JW&<!:Q2JKVGD/W,"$;%??2YY-/-H.0EA#:I<0HKIFE3BE
M]*^>"+U.V>$Y%U^-;/)R7=:VM*Y2<I04=4WHVWI+5>BTZ?::;>>]LPMOW3$J
MVO:886)"$G/(JIC75?.WM<8:PA&+G7[<VU*3FU-O1+JZEB<&OP
M                                           9MKBY<Q_/L/MVS(O9
MY#5FX9I4OB.]*;CRC)"%H-2O;/+X+G@S_$C+DCQF\XZRMIR*/BZ9:?E2U7]%
M(EG!-R>T<RVS</2$,VI2]?S)R4)Z:-/7LE+3X:^J:U3W[L/(D,,R&^>V^TV\
MCGCGH=02T\])J3STJ_09D*!.QX^H
M                                  Q#-L8CY322(;O64B.AV1"6CE1E
M(2VKI0:")743O!%R1&HCX,N?5)^4]&'U*0.MJ9=<:5Z*;6I!^G'JDS+_ ,/@
M?0^1^   &=X+FLG#YZUH9:?B3#;;EH<ZN4H)23[B#29&2D<?Y'\)'Z$/#6I[
M)Z%BJ#/?O^5S*B(NL=IVH:),68A;[<MY;A-]+/2^I"5N),U=24H+T]2,R+D_
M1K1:GMKU),'@\@
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MWZQC"SULH0AM"&VT);;;2E"$(224(0DB2E"$I(DI2E)<$1>A$-,#OX/T
M
M
M         JCYP;$/5WBMN?*V9CE?8%A\^EI9S1H)R)?Y$14M%(;)UIYE:V[6
M:UPE9=*OP_3P<LX+M:WGF&W;=**G5/*A*<?MKK?N6+IH^L(2_)ZE+?49S*7
M?!?*>4U6NG,HV>^NBQ::PR<I?A<6:[DTW'(NJ:333:T^)XLQO^?F/
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M:>ECTCD]D5"O(UTC77;3 V:BKC<4
M
M
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M1-U5J263[;<VK+*E",(P^5Q[H/M[M$HQU[8P^)$5>
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M  NV4?WFT=F?']R6\[%A;LO_ 'SBU6_!=9PC)II-I--M-)O1]-20AQ#+@
M
M   5LW%AT* AG(JYGL^YDFS.;1_0^\X1N(<0G^=[G"C,B]$]/H7!_3[Q?P/6
M2^) :&UN*Z6T+<4?X)0DU*_$B_!)&?XF/8]3[*ART*2A49\EK+E*>TOJ5Z$?
MTET\F9$?K_!^D ?!25(4:%I4A23X4E1&E23+\2,CX,C(#P=I23OMMM F*6M#
M;$MAUWMJ,C-"'$J/G@_T<<_S/Q!^AY7J7CI+^IR*)[RIEHE-$:4NI+E+C#BD
M]7;=0?J1EZER7*3,CX,^#'S:T/H=R/
M                               -6GRE>+E3N32MIM&K:3%SS4=39Y#'
ME-L-J<N,;A1ER[JCDJ2CW+O<CQ^Y&(C4926T)21$XX9VQXBYA?QSDE>VVMRV
MO<+(536O2%DGVUV+X+1OME_2-M_FHTI^N+P7M_E7Q1E<LQ(JOF/&<6_,IFHI
MRNQJX.S*Q9-+N:E7!VTI:M7044DK9Z^5 ;IGY_
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M4$XU50@G*4,>B,I>U"=DW[EEUFL?=<(W8$&-B0
M
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MN-"FHRZ64V)N%U%J716T6QG5/M;@Y1[JY3KE&<IH&&)X
M
M
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MMK(R/^:0\M-='ZGB,HR6L6FM6NGVIZ/]Y]']YS!X/(
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M)47*5)47)&DR/T, ?T
M          !T>34T/(<=O**?'3+A6]3/KI457/3(9EQG&5LJ)*DF:7"7P9<^
MOX#Z56V46QNJ;C;"2DG]C3U3_<9QLS$QMPQ+<#,@K,.^N5=D'Z2A.+C*+^Z4
M6T_N9X9-L:[O=4[%R_ ,BJ+:DL,;O+" W#NFT(GKKFY+GVN:MQIMN-*;GP.V
MZAYDNRZE?4CZ3(=B&P[OC;[L^/NN)9797=5%MP]%+3YXZ/JG&6J<9?,FM'U/
MRT>2N#;OXWYUNG"]ZQLG%R\'+LKC"]+W)4]S=-O=%*%D;:NRR-E?Z.:DI0^5
MHCP9<@P                                      2=KG4F7;1A[$GXN
MW"]MK'7UWLC)';!V3&:514+L1,Z) D-1)$9=TY&D.2&([RV"?9BO="S6DD*P
M>\\@V_8K,.K.<N_.S(8U:BDWWV)]KDFT^S5*,I)2[7*.JT;:L3@/B_E'DC$W
M[-XY&G\/QW8\C=<IVRG!/'QG!60KDH2@\APE*VNNR5:LKIN[9.<5"48C.%=@
M =[88S?U-+CV1657*A4N5HM'<<GR$I0U<,4LXZRSD0DFKNNQ8EDE<<W>DFU/
M-N(29J;62>+3G8F1DW8=-D99..XJR*]8.<>Z*E\$W'26GKVM-K1K7-9W'=[V
MS:,'?=PQK*=HW-72Q;9)*-\:+/9NE6M=7"%JE4YZ=KLA.";E7-1Z(<HPIW6/
MXWD666D>CQ6ANLENY?5[6GQ^KG7-I)Z"ZE^WKZYB3+>Z$^I]*#X(<;+S</;Z
M'E9]M5&-'UG9*,(K\LI-)?NLR^Q\?W[D^Y5[-QK"R]PW>W7LHQJ;+[IZ=7VU
M51G.6B]=(O0M+C7@+Y@Y<RZ_1Z*RIQME$=QS[E,QV@7TR2<-LD-7]U6.NK1V
MS)Q*"4IDS(G"2:DD<(RO*? ,.2C=N53;;_,A;;Z>O6NN:7W-]'\-=&;"[-]&
MGU-;[7*S"XEFPC%1;_$78>(])IM:1R\FF4FM'W**;@]%-1<EK?GQ[^'#/[NY
M9MO(2_A8MC,21U+QG%)I3KZY0A/4E#]L[%*)4Q5.&GK)MMYUUKJ2EQASA::V
MY/YYPJ\=T<4HE9E27\K='MA#^IK3[IRT].YQBGHVIK5/;3P_^S8W_)W*.Y>:
MMPIQMFKG_F+ L]R^_3T5F3*'MT5N6G<JX6V3AW14J)M36_G5NHM=Z7Q6#ANM
ML6J\6H8*5=,:NCI;6^\X9*>E3)"NJ1+ER%D1N.N*4XX9<J49^HUNW3=MRWO-
MEN&ZW3OS)^LI/5Z+T27HHKX1227P1VP\.X5Q3Q]L%/%^%X&-MNPT:]E-,>V.
MK_.G)O65EDO6=EDI3F^LI-DDC'$H
M
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MY>/!KYI->_CT0JBIWS<O3H-3SNK
M
M
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MP['Q[)AM^U;DMQS8N<<CLIE775.+BE"$Y2E[W7OUG%*.BCIU;2PH9,B(
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MXQ'(Z\*G?,K&VZB6-B4W2KC"4W9)=C<6Y2:CJVTWIVQ2]-'IJ^@'+,(
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MF
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M=1UI(U$2NE9<ER?J/0]CD
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M+"
M
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MI4.R=E%C+L"#FPP
M
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M&1D(D7,?T
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M7+[#RHZ$[$1$1$1$1$1$1$7!$1>A$1%Z$1$/4]C^@
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M:_Z]VV=D7?CRCVQE9!=)78LI2C[>1&/:^Y0L5=RE7&[8@YL,<*-65T-QQV)
MAQG734IQUB,RTZX:E*49K<0@EJ]5G^)_I '-
M
M
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MK(LM[OD<)^O%A]F2RU(CN)=8?;2ZTZ@^4K;61*2I)_P&1C2<_08?4
M
M
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M26V$=M+CRB(WGU)-2S[C[G*U&9FI2C-2C4HU*.H<G)OR[Y9.3)SOF]6WZO\
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MDTI.,;M5*/?5%J>R::)9.$VV3A-DT2R0DEDT1]1-DHBZB;)7KQ^'(QQ(SZ
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MFG"ZIR6JC;7+24&^NC:[9I=T)2CI)R>."9X
M                                              "#MKYY8T+\:FI)
M28\AV.MR<\V2%/-$Z7#3:5^KD=TD&2R,NE7"DF1CVBM>K/#>A$6,;'R&AG-N
M/3GY\%;A>YB2G%.-J0HRZU(Y)1MN<$7U)+J+@B]2Y2?LTF>J?VEP*RQC6T"+
M8PUDY'EM)=;41\\>II6@S+TZFW$FD_T<D/F>YS@
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MC3L_0Y,:VZL*GLBG'%5J[E?.3L]S)[83=3C3"-<7=[VU05(;M@
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MR&UAW7BY18)(R=\Z:\EIK\=EYY/42V&''$-RW3)MQ72D 0?_ +E!^]O_ /\
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MU4>9*A-19"R,FG%F1@"VX
M                    /RLT$A9N&DFR2HUFLR)!((C-1K-7TDDD_CSZ< "F
MOGAF#N,^(6Z+C';:-#?<P^;419T.8TT;2;9**M283[+J#1+)$PB9-M1+0X:%
M)]2(3+Q]AU9W-MMQKX]]3RH2<=-4^SY^J^,?E^9/HUKKT*'^I_?<WCGT^\MW
M;;KO8S8[+?7&S7M<7D)8^L))IQLTM:KDFI*QQ<?F2/&B-^3\SP      &\N0
MYB?C?HB1=8K2IN:[&Z&KDI5";;C2\HLK)^# :NK25PM9)F3;!,B0OZ_;Q^I+
M2.E"&Q^87%IY[]8_U2T\;YUN4MNW?>=UR:VKI2LJVS'QX77RP\:OY8ZTTX[H
MHA\GOY';*ZSOLLM/V09N1XR^@7Z+[^6^-MICNVQ<?V7#M3QXQJNW?*RK,?&A
MGYEVDI:7WY4<G)L_2?AL7OACU^W552N#HS:\+R,P/(%9-B$2*W%L':&ZK'R3
M9T-JP_';F,]DI;?6I2&74DZVM*NA1)6E7UD2,G]3_@;<OH]\J;3#A?(,BZV_
M$CG8>3#7&SL6<)RJGWNJ6B3G&3JLA)=\7.N4/T;E9AOHV^IC:/KU\+;Y/R%Q
M;%QZ,?.GMV?B6)9>VYE=E<;X=BNCW-QKG%7561EV35=L+'[BA52+66R=?^,N
MYMPU<UC([J@182\<I?L46OF2XQ5ER\XJ+.5:7%8E:H">8ZG4J4IUQHU=*>>"
M[,O-7AKRQ]:OTX^/-[VVW9]MY7+$JW#,_&V7TU6/)Q(15M"QL3)<5>]+XURC
M%5UV1@IS<=7T^_3SY_\ "'[/+ZL_*G'=WIW[=N$QSK]KP/U=3C7W5+$SK).G
M(>7G8BD\9:XT[8SE*VVJ4W76I:*W^">8&OMC9938;C.*;%>M[J3V&52*O&68
M<1AM"GYEA/>1EKSC4&!%;6ZZ:$..&E!DA"UFE"NO;RE^SV\M^'N![CY%YIOW
M#Z]@VVGOFJ\G<9W6SDU"JBB#VJ$977VRA54I3A6I24K;*ZU.R/:=X8_:G^#?
M/7DS:?%'CWC//+N3[OD>W!VX>TPHHKC%V7Y.39'>IRACXU,9W7.%=EKA!QIJ
MMNE75/O/+/*JK&='Y;'L'/Z:R9J/C=1&29$Y)GS7D/K,B/\ !J+"BNO+/\.$
M=/XJ(1GZ!N"[YS3ZF]@R]IA_6.R3LW#+L:?;713!PCK_ $UMUE54%]LW+\V$
MB8?M.?)/&_'WT><GP=\L_P#*7(:ZMJP:DUW6Y%]D;)-:_P "G'INOF_32M0U
M[IQUTB#],A^/P      #U+_%+Y1%M_4!ZJRJW7,S_5;;$!*ISSKDZXQ-[N_8
MIZ7GS/WBXC+"XKW2:W$*CDX\9=]OJTS\Q\0_F]R+]:8<%':<]N<=%\L+5I[D
M-%Z:MJ<?1-2:C^8]._+Z#_.<?*7BQ<0WS(=O-^-J%%G>V[+\.6JQ,CNE^>X1
MC+&M:<I1E5"=NCOAW;8Q4!O.
M
M
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MJ<6HVU2T]RJ?V22]4]&X37RR6OI)2C&8QBR6@
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MZO57HX_8>Z>OY2;4J2M*5H4E2%))25),E)4E1<I4E1<D:3(_0QZGD_H
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MS&A.:KC9V1E;7D4Q<H^[9&54ZU+N=#JA9;#5T+F-!0
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MJ+:0+"MDUU?MS"<:GXK8/DMQ#5?<OJ6Q)02HSH&'_O+OPS^%?Q;Z"\8_-GP
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M6\YZUA]R=#FJ ]=H
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M'&UI2M"TF1D1D-N*K:[ZXW4RC.F<5*,HM-236J::Z--=4UT:.CW,P\O;\NW
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M
M
M                                            #&LQO4XQBM_?J/C[
M55RY:#^G@G4-&3)GUD:"23RD\]7T\?CZ#ZT5.^Z%,?SIR45^Z]#BYV7# P;L
MZWK735.Q]=.D(N3ZOHNB]6:(LVSK)=@W;U]D\]4R8Z:B:;3UIBPVE*-78BM+
M6XI""/\ %2E+<7P1J4H_47YMNUX>U8ZQL..D?5M]92?VR?V_DT2^"1UR<JY;
MO?,MS>Z;W8I6Z:0A%=M=<==>RN.KT7WMRE+UE*3ZF'C($:
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MV[M75*=5<$YUWU2]Y2K?5N%UO;9;#1]S4M)+HHU'8NKO0^<*5B>2N3+.O?\
M;V\5ZL>@1'DLH8>:;?:5*DMR67R?6;3B%DM+?X]).*0+ 5./RG;5/-I[*Y+6
MN2DI26NJ>CT6C6B[DUHW]NB9K7+.W+Q!RJRC8<YY&57+LR*ITRKKFDHR2E'O
MFI*7<W7.,E.,>OR]\HFU'2&]<>W#3J4PI-=D<$B3:4KSB.^G^-T2&..">9=2
MDS)22X/@_0C):459O.R9>RY'M7_-5+\V:])?]QKXK^Y33>WO!N>[-SO;7F;<
MW7F5O2VB33G6WZ/IIW0EI\LTM'U32DI14\##$W
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M%RM>PPS&9;CQVFV&&DDAIII)(;0DOP2E*2(B(1XLT^H
M          "NWE%BV0YCJF72XQ4R[JU7>4TA$&$E*GU,1WG5/.$2U(+I;(RY
M]1JE]9G"N5<^\)7\>X;@W[AO<MQQ)JFI)S<(3DYRZM+2*?7J6_X/WW:..\[K
MW+>\BO&P5BW1<YZJ/=)+1=$_4UI_X/>ZO[7.1?\ FAC_ #0.H/\ Z*_U#?\
M%/=?[I#^_FY_]MOQM_MQA_W:7]]'^#WNK^USD7_FAC_- ?\ 17^H;_BGNO\
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MU5JB779!2>*&@]3^1N)9C)?VI;)NIO&89-]TN\FL$KDSK&)#6U'DE$4PW50
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MY!L%K-_89#/<QRNJRQ*L3&>D2I3[)2P/=X
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M;S+B?XKC3J26VM/\Q2%$9#2X[^SZ
M
M
M             ^$IA$J,_'<;9>0\VM!M2$=QA9F7TDZCTZD=7')>A_P #17N
M/(:^ZS6YAUF*X_B\6BM[BL)%)%[+M@['FG&?F6#YGUR%NO1C6V2N5-$X:36L
M_J.\N-XEN/MM=UU]MT[JX3^=MJ"<=5&*;>B2>CZ]=$]%Z'7]Y3WK#W/E63@X
M.WX>#1@Y5].M,(QG=*-G;*RZ45%2<I0<HKMU@I.+E-_,^JP35^:;$MXE3CE+
M,=*3TK78O1WVJV,PI1D;[LHVS;4G@C,DHZE*)*CXZ4J,N5N>];?M5+MR;$YK
MHH)IS;^Q+7I][>B7Q?5&(XIP/DO,,V&+M>/-8[2<KIQE&F$6_P YSTT>O7MC
M'NE+1Z+12:[K<6J96H\@@T$NT9M7I-6Q,>>98=8)F4HS*1&X62FE$T9I(C0X
MO]//ITF?'V#>UO>/9>J_;<+.W377IIJG\'K]O1+[->IDO(W 9\ W+'P'D+)C
M?CJSN['#22DXR6G5::I:?,WI^<ETUBAUEYDT$\TXT;C;;S9.H4V:V74DMIU!
M*(NIMQ!\I47H9>I#.1E&6O:T]'IT^U>J_*BO[*K:6E;&47**DM4UK%K5-:^J
M:ZI^C7H?>OANV,^#7L-O.OSID:&RU';2[(<=E/(8;;8:6ZPAUY:UD24FM!*4
M9$:B_$>EUL::9W3:4(1<FV]$DEJ]7H]%]KT?Y#[8.);GYM.#1&<KKK85Q44I
M2<IR44HQ;BG)MZ).44WT;7J9SG6L,GP)]Q=C'3+ISEN18EY"4AV#(4E;B4(=
M)"W%PY*DM'RVY_/$9)4LBY&)VG?L#=XI4R[<GMUE7+I)>GI\)+KZK[M4M29\
MS\=<BX5:YY]:MVEVN%>17HZY/5Z*23;KFTGK"7Q347)+4CH9H@0      %^O
M"'#695GD>66#L$XS28E5!CJ?A//.22<4^\W(BN)6ZP2U*96UP:5*-LS-/!H4
M=:\^S$Y48$4]5K.6J:77I'1^C_A:].G3KZHVK^G+8Y0IW#D5C@XV.%$$I1<E
MVZSL[XI-QUUK[-6G+23<=.V3V-/TE996M??J=>>?@,N,Q":E&<(^IPU&ZII!
MFAQYM9&1*Y_F'R*YU>FGP-GNU=REUU2:]7IUT^'I\/7U773U9WP\'DZ'**F5
M>X]<4\&P=JY=A!>C1Y[)\.1G%E]*B^E9=*N.E7*5ETF?*5%])^]<E"R,Y14H
MIIM/T>GP>GP9\<FJ=^/937.55DX2BIQT[H-II2CJFM8OJM4UJNJ-?. ^$MBU
M/M)F8VT5QNOG&W10TL=<.W89=6VI^XC]2WFF9+?U);:=Y1])]:^3)$_W+G-E
MU,:L"MURE'YY-]8M_"#73I_&E'K_ !5ZO7'BWT^XN#FV9?(\F.377=^@KC'2
M%D$W\V1%ZOYUZ5UV?+T;LEJXJWFMM*8MKME]N!!CM]V= LVFH[\U:(TV+!8B
M+63LETWGTK5&0KZ^>I:>LRZE+YAF?N69N5BMS9N=D8Z)Z)=-7+T22]6_W-%Z
M)%Z\>XOL?%<6S"V&A8^+98IRBG*7S*$*]=9N4OS8)O5O63E)_-)MS0. 9\
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MG"73OK;U2>B::TE%:Q<K&# EA
M                           81DVO\>RN4U,LT2T26F^UW(CZ63<01\H)
MSK:=YZ.3XXX_'UYX+CRFT>&DS[8]@>-XTLGJZ&:Y22,DRY2R>D)+ZB^DTH;;
M)1)49=73U<?I]3Y-MC1(S$>#R   $<[5C>XPFT7]']*FQ)Y47*BX<)G]7Z'P
ML^_QSR7TF?\ D'YCZGA^A30?0^8    !8O25#917[*ZDLK9AR890X_<2I)NN
M>X;<6MOG\4H[)DK^ ^"'K)_ ]XHL,/0]@
M           U6_+?IAS9'C:>;5Q\6^I+A&4&WR^9RJ)^.[ O(Y(0KL()F,^4
MLUJ0:R.*24FE*U\VYX7W];/S&&';_F?/K=+].D]5*M_;ZIPT3_AZM/1&D/U^
M>-)<\\#W[[A]-UXWDQSX_G?/C]LJ<JO1/MZ5SC?W.+:]CM3BIRU\JXW/.@0
M                         "2-1;2R?2VQL4V;A[R6[W$[1JPCLO.240[!
M@B-N966!1'X[SL"PBK6TZ@EERE0P^_['A<CVB_9L]/\ #7PT;6G=%^L9QU32
ME%I-/3U1//&7D3?_ !3SK;N?<9DENNW7J:A)S5=L&G&RFWLE"3JMK<H32DM8
ML]/GQ[Z#R6J:S7RGV[#<C[?W_/DY JIDH=)>&8A,D')I<>CIENR+",Y[12.Z
MV^X3S32&([K:78JEN:=^1^0X>1/&X?L4E+CVTP]N,E_@UR6EEKTTB^NJBTM&
MW.<6XS27>]]*OB[?=LHW;SGY'J=?E/FU[R[:9)K]7X,Y>YBX,%-RL@U#LE9"
MR2G7"&/CV0C;C3E.Q:_%'";GR-LO)#,GEY3E+%#68SAE?8MMO5V(5<%5@\^Y
M7-J0GIGS7[1Y*W5&XM+2C0VIM+CR7(LN5[E5QA<4Q6J=ME?*VUQU4KI244E-
M_P 6*@M(KHVDY:Z1TN27AGB.7Y>EYIWB,\WEE6W4X6$K5%U8%5;NE9+'CITN
MNE?9W6R;E",I0K[%99WVJ(B(B(B(B(B(B(N"(B]"(B+T(B(1DML_H
M
M
M                             HC\BFA6=Z>-.:1(%<Q+S'#XOYOQ)TVF
M3EJG4W,A^OC/N-+4T[;0>[%2?4A!=\^I24&I13WQKR-\9Y=BY5DG'!NE[-WK
MIV6=.YI/JH2[9_'\WHFS6OZM/%,?+G@_>-DQ:86\BPJ7G8+:CW?B,9.QUPDT
M^V612K,==8INQ=THQU:\>8WN/S=                         'NZU30+Q
M76F"8V[;RKYVCQ6EK';J<LW)MF[$@LLNS):E./*]R\XDS61K69*Y(S/CD=;^
M?DK-SKLR,(UQMMG-0C^;'NDY=J].D==%T71'ZO\ C>TV;!QW V*W(LR[<+"H
MH=]FON7.FJ-;MGJY/OL<>^6LF^YOJ_4D <0S0
M
M
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MXAR7$Y/L.)N-=V/9G68M4[H5235=LH1=D.WNE*';-N.DFVM-&WZDQ#&DH
M
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M[43*VVAEMMII)(;:0EMM"2X2A"$DE"4E^@DI+@AZGD_8
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MTTT@N$H;01)2E)?P$1"I#=L^H
M
M
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MVWO(MCM4<=S<7%ZX=EF&XO6,7)UNCVW-INQQ[^Z?=WRNJ(0;#
M
M
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MC.482EI'1.3A#N>K48IZ+/1\CE
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M23+\#_2E23]#(_4C' ::>CZ-$BC*,HJ46G%K5->C1S1X/(
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MR"E[=T8RG&-M>O;9%2DE--*32U>2CXG.
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M<Y767TG&K7N24LUF54S#R;O%;":U$6_&9L8T5R5%-,ADEL.(<4!9
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M^VQ_-JN1[IF(Y#7[KH0ZIQMU#8%OP
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M*_'4_@9RAF^[#VY1DXN,^Y=LE)=8M2T:DNJ?5'89R1[.N.Y[Y#37D; L*_\
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M[ON:?I-7M8%0F\@
M
M
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MC_=%,*GFE2I/MDFEE*EK4I+;9&:C,FFS))GS]1ES^D1LLXYP
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MQ'2S
M
M /(#\G&*1,5\R]HE!]NW&OVL:R%,2-$3%:AN2<>KX#[9]#BBE/29%:J2Z\9(
M4MQ]741F1K5NUX;S)Y? ,2%FO=3.VO5O75*R4E^1)244NNBBM.G1?GM^O78J
M-E^IG>K\;L5>?C8.4X1@H*$I8E5,]='I.5DZ973GI%RE:]4VG*5 Q:)IP
M                 ;!?C7\>'M\>1^/3[&.ZK#-6R(&;Y'()*^T]:0Y"W\2I
MU.)ZDH=FVL%4HT.)-I^- >:49&M/-5>7^4KCO%+,2F26X[@I4P7Q4&OTT_W(
M/L33UC.R$EZ,W0^A?PW9Y3\TXV]Y];?%>,.K<,A]>V>1&;>!CM]>L[X.^49)
MQLIQ;ZWHY(]>3;:&6VVFDDAMI"6VT)+A*$(224)27Z"2DN"&E)^@D_8
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M6&W&ZIK+*N9B636V'W,II%?(*>YC\B_HY::]^R@U$^9&;3)."TR\PMP"YX
M
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M[9V3P:Y=MR:BG"B.3=5)=E=%$(QIMC;;9.<*HRU="[CKQ
M  ]$?PB9><C#=WX%UJ,JC)J#+S;["22D\BJCIB6<HSZW%*_*QD39%PC@S/\
MC$-5_J"P?;WC;]R_PW&G5Z_X5/N]/A_+>OQ_<.YK]F#R+\3P3E'$]?\ ,6[X
M^7IV^GXW'=.O=\=?U?\ F_P=-?X1O7&OAV?@
M
M
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M<;6EQMQ*5H6A1*0M"B)25H4DS2I*DGR1EZ&0JHW /T
M
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MF&VMK%B3YF+Y3AV94URPP[WW:IRQ<K7)4YR$N;( VS@
M                                                     #6EGGA)
MH_&MYY[Y=[%C9%F<UR;!R''\$IJ>1<1(=M28U#@QW(..4U7+M;VZ<<J#D,EQ
M(,I*B6VWWDH45D8?/^1V<:Q^"[?.G'Q'W5RME-0E*-EDI]LK9R4*JUW=LGT^
M1:.7:VC53?/IE\58OES=/J-Y/1G;IOD?9R:L.%#R*:;,7$JH5E.'CU3OR\F3
MI5M::GI=)2A6[(QFO.=Y89-FNU=W[,V]D&M\JP&)DF0,,(K;W'[6I55LTU;
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MY.V4Q2;[E*B&=.;:TT[6LF':U)MM3U223EO^&N!VN
M
M
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M*4YZMUM-)+VW)2FI)JSXP18(
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MCMQ(T>*R1DS&8:CM$?')-LMI;01\$1<DE)?H&O9V5'W
M                                                      $8;"V&
M6&^UB1(K4RQE([_2^:R8:8)2DD:B;4A2EK-)_P \73Z'P?/I[):GAO0Z''MT
MT\QI#5\PNOF*<-/<BMJ<A=)\FE2NMU3S?'H7IU\GZ^A>@.+^ 4D3-&DQYC#4
MF*\V_'>3UM.M*)2%I]2]#+])&7!E^)&7!^H]3R?<
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MI"$%^^Y2DVY3G)RG9.4ISE*<I2>:#AF=
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MWU-QVF(<.,TS$BLLQF&6D 7/
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M]H:]G:$
M
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M$VE+72B,81LK:7517;):PD^C+1#%$K
M                  #A61350)::Y1(GFPX41:NV:4OFDR;4HG4J;X2KU/DC
M+^8 *U/9HNMM+F1F"U64Z";V$-)9=9IZ^QMYD:"I<&,IZ0<=+DU,I1,%RVX;
MRDM_SQN'S5C3LT]F+['%S^,G&*E)-O2.ND4M9:+T6OW+#2W7'QE+\;9%7PNC
M0O2M673KKG&$%.QQ<K')1K4Y)]S[$WKW2IS9:'RH[%B]PINPP.NMIK+-DS&R
M-ZP>B/2Y92(<*NC54& A;%:[%2^LCGR#3U(-)(4WTJG=/*L+\.\?<U'+L@OD
M;J45+2.C<I3E+K)-Q6E<?1ZZ]QKQG^'M^6YPW+B<K=EQ\B:]^$<MV3K[K$X1
MKA374NRJ458]<FSUBX*+KT?3:NV3EVL<NOL;MWLQM\SG7+%1'BN3WI=82U$Z
MTNS<:LR.8X3Z%-.(=)'0]$,G#Z>A!GR]ZVG#W; IW'!_#T[?"IS;44I:?Q/E
M^7IU33ZQGT^+,+P3F6]\-Y%F\8Y"MSS^37YD*80E9*=.O5>]^E_2?,NR49Q6
MEE#4GHHQ;V!9+JR;;XQ:GBEVU06]Q8PKN/,?CRC:H'$=$FVCQ8L&9'-U4R6S
M];2E(;)9KZR7RM*ZZQ<NNK(A;E5JZJ$6G'5+N6C2UDU+TU6CTU222TT36SN[
M;3E96V9&'M&2\+,NLC.-JBYJN2G"4FJXV5:J?:^Z/>HRE.<IJ:E*,L;LX53O
M'!\JQR9%?BY!C\%ZN.Z342FS=G'7K.8J"J<U'.6A^:XLS6ROH>5_/<=1'R,:
MZ_9\RG,AHX-J:CW)ZQUZ*?:WVOIZ-:KUT,;NN!M_-=ES=DO4X6I3HE8Z9Q[+
M7!:SI=D8^Y!-Z=T'VS2<>[1ZE0O'GQQRR?G=->Y?5+K*&EYMTDZN,\Y)GPYJ
MX[$93:3=2CMN,]U*R,_4VU(ZB)SHG7).58-NWSPMNGWW6?+)I-)0:3;3Z:MZ
M]NG]5KITUU[\6>']_P /DE&_<HH5&%BKW*X.4)2E?&;C!.*<NU0[?=[OC^B[
M&]9=FV 5>;9@
M                       5:WC&)O(JZ0DEG[BK2:U'_$);;[K24),B(B^A
M!'P9F?)_P#WCZ'K(A,>QZ$B8ELFZQ5M45LFIL):DJ[$GK439EZ*4WTK09+-/
M!>AD1\%SSP7'AI,]D]"T]%EU)?5S5A'FQF>4EWX[\AE#L9SCZDKZE)Y01D?"
M^.#(OT&1D7HUH>^NID3+S,AI#\=UM]EPNIMYEQ+K3B?^&0X@U(47\TC'@'T
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MWXE>-V.6N9-J52G)PBE??+WYMN$;&['&7JZ&H!WH
M                                     8/@^L=;:RBSH.MM>X/KV#:2
M&Y=E#P?$Z'$XMC*9;[+4F='H8$!F7(:9/H2MPE*2GT(^ !G
M
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MX)Z/AJ\=Q(
M
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M)2E)<$22(O0APC.G]
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MVVA'6M3B^A*4];BN.IQ721=2U<>IGZF,42\_8
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MI9=Q'/X=QH^'$>O\)<'^@>FFA[':@
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MB_*,2[!W_!N=5]%JTG":_?4HR34H3BY0LA*,X2E"49/'QRS!@
M     >ECXFM.>06DF,_JMJ:SM<1P_-8=!E6+6MA-J'77)[D5QFPB3*^%;S9]
M7)=@HAF3<B/%<0I#B'>5I0AO43S/R#B_(\K$R=BRXY&91[E5J4)J/:FG"49R
MA&,UW=ZUC*2::<>FK?>5] ?C'S%XHV7>]G\C[+9MFP[D\7-PYSOQY6.QURA=
M7;17D66TS=?L/MMIIG"4)PMUDHPANB%'G8>
M
M
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M&G%<$W+HTL>5#2K^1.3_ ,$=AM^%+F_P
M
M
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M4K/<?=W+112A!0]7WZ])-'P.:
M                    <6;!AV45Z%/C,RXDA!MO,/H2XVM)EQZDHO11?H,N
M#(_4C(QY3:>JZ-'B48RBXR2<6M&GZ-'1XKB5/AM8FHHVWV8#9EV6'GC=2PV@
MNAIAA/"4LQV&N&VT)(DH;2E)<$1$/>ZZR^QW6O6V3U;^U_%O[6_5OU;ZOJ<?
M#P\;;\6&%AQ5>+5'MA%:Z1BO2,=6](Q72,5\L8I1BE%)+)A\SD@
M
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M-O',=+D6U.NK<?;C%._"FU7"^?:NZRW%L=4.YZZ8LYN<E7CP2\ZHVK.ET
M             #W9:>1DS>J]>M9F;9Y8UB%$UD1M/%(:.W;@,HFFV^EQU+J#
M>2?!DHR/]'H.N'<WB2W'(E@:_@7?/V]5H_;[GV=/A\NG0_5UQ.&]U<6VVODN
MCY'';\=9>C4E^)5,%?I)-J2]WNT:;3775DD#A&?
M                IQYU^0N:>,.@K#:F!5F+V^0Q,HQJD;AY?"MI],J+<R'V
M93BX]-=4$XY#:6R[9E())'^*5"=>.N,8'+N2QV;<IW0Q94V3UJ<5+6*3764)
MK3[?E_=-<?JH\O\ )?!WB6[GG$Z,'(W>O.QJ5#+A;93VW2:DW&FZB?<DOE?N
M)+XIFDK_ ':KRF_U Z _J6V+_?5&P/\ :"X=_GG<_P#'*/\ 6YUB_P#K,?._
M^U/$?]*[A_Z4'^[5>4W^H'0']2VQ?[ZH?V@N'?YYW/\ QRC_ %N/_68^=_\
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M[+\?\\<A2<JQ^H-RJA_G'&[ZIZJ?,]?R+BV1":GI3"FHDIZ9<")W&.\!N.
M       !I(_>!_.S?WQT?'7DGDIXU6.+U>SZS;&KL0BR\OQJ-EE,5-EEG.BV
MZ%U$MYAE<A;,=/;<ZN4'ZD -A'@9M[,O(/P:\,=][&?KY.PMW^*'CKM[.Y-3
M ;JJJ1F6RM08?F>4/UE8TI;5=7NW=T^IEA*C2RV9((S(@!:\
M  &N#Y/_ )/_ !Q^*KQQM-\;XM/NN06OW"ETUIJEL(L;.]T9W&BMOMX]CS;[
M<G[5C]5[EEZ]O7F7(=+#<2I27Y;\*%+ B_P#\]?)WR:^-S*_-OR/\3?\&'.6
ML?W!L?6>M[')G+6!L34./XX_F^JL^3'?0QE>,5^3U3WVQQ%I&AR[)=8Y<Q(S
M%99U[:0/,CI3]Z<^7?R4Q6PSKQT^&2_W]A-3D$K$[3,=*8)Y.;4Q6MRJ#755
MQ.QJPR'!<,O:B'D$.HO8,IV$X\F2W&F,.J02'FU* NQX?_O1.QY7E/K#Q&^4
M7X_MD>!.7[LRBGQS7NP<IB;"Q"FKYN6R(-'AS6<Z[VY@^+Y/3XO:Y.[[9W*(
MUA)KXAS&E2HL:+'E3B V'_/I\PNR?A\U%H'9&MM.X/N*=N+9&38195N<7M]1
M1::+18PW?-3H+M"A;S\A]Y?;4ESZ23ZEZ@#3Q_[,?_-MA7_15M/]W]W_  ]>
MT?\ 3N5ROV4>6N ]FJ3]#B_SCD6E\CI,>X=6G^F),&2V7X&@S,C(#??\2GS;
M>)ORZ8;>+U$WD&M-X8)7IL]E^/\ GCD*3E6/U!N54/\ ..-WU3U4^9Z_D7%L
MB$U/2F%-1)3TRX$3N,=X"I^_OGRG^#ORAO>&'GSXS6'CMXJ;4^U(\9/-*5E;
M-IBV1H;A5E=<WVPH,&/8T59A\C,YCD65)9L8UEB$94&1<UY0YZIT,#T;1)<6
M?%C3H,F/-@S8[,N',B/-R8LN+);2]'DQI#*ELOQWV5DM"T&:5),C(S(P!'^Y
M,XE:RU#M79,&#'M)VO=;YSG$.MEN.,Q;&5B>,6E]'@R76>7FH\MZ 3:U(^I*
M5&9>H \-6E/WISY=_)3%;#.O'3X9+_?V$U.02L3M,QTI@GDYM3%:W*H-=57$
M[&K#(<%PR]J(>00ZB]@RG83CR9+<:8PZI!(>;4H#9Q\:?[RTQY*^4]'X&^>_
MB/G'@7Y4Y7(53X-$RX\NBX[F.839#DJAP2YQ#.\,Q3.=6Y1>U#B6ZLIZK&#;
M2XZT)DQGY,.&X!ZI0               !IXQ/YA=;97\OVS?B"CZ=SB)L?66
M#P,WG;@>OJ%>$V<6?IW7VXD08E$A'WUF0W6[!9AFI:NDWXZU?Q%) &X<
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M@@AL<
M
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MD8M==E<Y5RC&247/248*6KFF^DNSKT32CI;X1LM
M
M
M      #X/R8T5'<E2&(S9$HS6^ZVR@B274H^IQ24\)27)_P$ *F[6RUVZNW*
MV+(2NJK3-IKLJ2IM]U1)[SO<3_1$+4DND^32:2(R_A/Z16B/23^!$X\GJ
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M;KL.-3/'S9/NMNQIRE7[62V]9W4N,%"[K*ZN3][2RMV7[IA1AV+@
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MXF8QL@L>O=CY[7Y3=?F+8$+%:C.,4G76#UR:G&U-G+HLG]M<(FNIE5J5MH<
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M9/D*,BS#/[M-@^U(2V92;FP<Z6BY=,N"("R
M   #':W%,>I[N]R*MJH4*YR7V1WD^/&8:D62Z]#K<5R6\VVEZ0MMMTR+K4HD
ME_%XY/GZSONLKA3.<G37KVQ;;4>YZOM7HM7U>GJ_4XE.WX&/EW9^/137G9/9
M[MD81C.WVUVU^Y-)2GV1;C#N;[5T6B.!)UY@LO*H><R<2Q]_,:^%(K863.5D
M55U%KYDAJ7+A,V';]PB+)E1VW7&R5TK<0E1D9I(R^D<S+CBRP8VV+"E-3E6I
M/L<DFE)QU[7))M)M:I-I>IQK-CV6W>*^0VX>++?Z:)45Y+JK>1"F<HSG3"YQ
M]R-4Y1C*5<9*$I1BVFTF4-^1;QNK-BZ V9<Z[U149/NF\D80U&N:VBJW,ODU
M]3E=1+GM,7#[;4M#3-2S(+I[Q&I*U-H(S=-"[!\9<HGLO*<*.YYMM/'ZY7.4
M7.?LISIL2;K3<>LW#KV^NC?IJM7_ *O/#]'D#PUR&?$>/X6X>3LBO!C3=#'Q
M_P =.%&?C63C#)FHVZ0QE?I#W.L'.$4W/M>ACR3\(U>,>K,$R_-MLT3VQ\T1
M7K7J!JB4W;U278AOW#A7L:^L6)\>D=6VA3_M66'>XDR6E2VD.[(\/\D/F6^9
M.W[=@6+9Z.[^NO<^5Z/2O6MUQ<78M9*/?*22ZK1-KJ>\[?2;7X#\=;5RCE')
ML6?.MR=2>S+&2L@W7W9+KR895RNAB3<:YV^Q75.4EVV=TJXSH>+0-.P
M +0^%^K*7<_D[J37F2Q_=8[<7\F7=QUL.2(TF#14]E?'!FH;=9-,*SD5K<5P
MS41$E[\%&9).%>1=ZR>/\,SMSPI=N9&N,8/71J5ED*^Z/1_-%3<UT_@_#U-@
M_I7\?[1Y.\^<=X?R&KWMAMR;;LB#BY1LKQ,:[+]JS1QTKNE3&F;U6BL]&](O
MVIQV&HL=B*PGH9C,M,,IYYZ6F4);;3S^GA"2(:$GZ5C[
M
M
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MGKH?'&_$_AJ_QC@\OLCW]FJAWZ+N[%)N2CW:]NK;TTU>ID(]#[@
M
M
M       <.PFL5L&7/DGPQ#8<D.?PFEM)JZ2Y].I1EP7\TP!2[,LSL,LL3D.N
M+9B,FM$2,A:R;:;4?\'T\J41>JC+J4?X\%PE/T2T/1O4PL>3U
M S37;!R,SQ]*5]';L&7SY(S)1,*)PT>AE^))]/YH\/T/:/J7='S/<
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M"65CSTT^:3E1+'BOMR&WZ'K6&F)WZ@
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MR8\V#-\=]O2X<R(\W)BRXLG6N0O1Y,:0RI;+\=]E9+0M!FE23(R,R, >./\
M='_!GPJ\H?C1WMEODCXC>-&^LQB^:^S\)@9IN#1NL]B9I58BQH+QMLXN.4V7
MY7C-KDE-3P;3()TN.Q%E,HCRYCS[1(==6LP(?\=;C*/W77YB\@\<-IS+B/\
M%3\A5PR_JS8^16T>12ZZE55BW!Q7+[O(;AB+%CW&D;;,&\<SLBEQ%/8K:P,@
ME%(5&K8B@+#_ +[S_BL^#W\O^Q/[G4< 31D'[Z[\:,:FL7\6\</.>YR%J.:J
MFKR#"-!8U33974GI9L;ZN\B,LG5<<TF9FZW73%$9$7;/GD@(?^+;QM\U_F(^
M4?%/G(\Z]22/&S2>BL7K\4\2M+RXV45%IF2:NHR5S#)E.=]'I\DN=;XI:[#L
M\EE9$\B'"R'(Y3<:%&=KD3H\4#>_\\'R$:N^/GXY]_9/E.14Z-N;FUOG6F/'
MC7[LR,>19KL7.J!S%%WE?3.H=5/Q?5D'(RR"]><)J*42*B'WDS)\%I\"N_[K
MMXBY5XC_ !&ZA:SNB_+>9^1V897Y27-0Z[8JGM56RJS%Z+7DNUCSWW&J^PM-
M58112E1H[;#;*'DDXW[GW"U@;GO++_%8\E_]C_N7^YUD8 \(?[K_ /#/\;/R
M)> NW=U^8OCA^V#9N+^7^?:MHLE_;!OK7_L<$I-+Z RRLHOLVK=HX3C\GVV0
M9M:2/=/1')B_=="W5-MM(; ]LOAW\<G@[X TUG3>('C5K?2BKV.U"R#):6%8
M7VP\CKF%1W(U5DNT,SL<DV/D5/$D1DO,PYMJ_%9D*6ZAM+KCBU >5'=L2+-_
M?9?$UF9&CRV4:(N):&I++;[:)4#PI\CYT&2E#J5I3(A3HS;S*R+J;=;2M)DI
M)&0&X?\ >6O O:WR!?%_F& Z+Q6PSW<6E]H83Y$X)@5.\2+O,WL+J,NP_+*.
MAB*<;3<Y!^S[85Q)@5R>I^QF1VXT9#DIQAM0'DB\0]I_NC=MXFXM>>:?B1L#
M4_E[@N'PZ';FHZC-?/[(WMC['QN$5;?Y!K*UQG<"\!H:_,[&(J8W69#9T2Z9
M^2N"MQYJ.F:^!Z)OC.V?\<OAU\5/ES\FWAA\8GDOX]Z^R^G4_D^F<KO-M[6R
MCR2HM97V5X]IF\PY6=YSMM3&M[2%M=QV]OX%:BGJ&Y=J;SMM%I#E&!YV?D*V
MY^ZM>:'BYMGR'TM6;0\/_.V?K_,,BP72&N=7[)Q2'E6XBK$*Q'&\YQZDQC-O
M%2KP^PR1LCGV%#;44Y<"1(D.+7+)B.0&R_8'AA\AWR8_NJ^CL?VWC6P-F>6>
MIM@1O(_36/YC*NU[GVSJ#$K?8V+XFY>IR.6JSRC,)^D]D6<C'F5D4N^JHE43
M2),^2AR0!K0\0]I_NC=MXFXM>>:?B1L#4_E[@N'PZ';FHZC-?/[(WMC['QN$
M5;?Y!K*UQG<"\!H:_,[&(J8W69#9T2Z9^2N"MQYJ.F:^!Z5?B8UMX!G\7OFG
MY/>!G@?NCP8Q;R)U/M:HR"JW+G.SLVD;9QK4N'[91JO/,,F[)V=L I&+R,>V
M!*><EU;,."JTFRX*)-FFN1+,""/W*G_>LM^?[/\ VG_M=?%4 5_TW_[6U>6'
M\@&.?[1_QJ %</([RKU#\:G[WIN[R:\P9^0:VT5LK2&!QZ'8%?C-MFL9BHO?
M%#56NH65S<>PUB[S!['T; UE;4[GLJZ9-1*9)?MCC&I]('ND\>/('5?E3I;7
M_D)I#()&6:DVG3NY%@.3R:2ZQQS(<=*RG5L2Y319) JLAJX]D<!3S+,Z+%EI
M:6GO,M.=2$@30                                 U:?)9X8UF^M>6&
MS<-HIDS<V%5S7VG[:MA+V144>0;\S'IK3YMHDLMM//OQ2ZR6U+5RV9$\^EVU
M_%?/+N*;O';LVU1X[DS_ $JEJU7-K2-L=.J>JC&?P</7K&+6EGUF_39@>:N#
M6\GX_ASL\J;1C?UG*IQ4\JB-G?9A6*32LCI.VW'6JG"]M0>EUL+/*O)C284F
M1#F1WXDN(^[&E19+3C$F-)8<4T_'D,.I2ZR^RZDTK0HB4E1&1ER-TH3A9!65
MM2KDDTT]4T^J::Z-->C/S_Y&/?B7SQ<J$ZLJJ;A.$TXRA*+:E&46DXRBTTTT
MFFFFM3X#V/B     ;C/B+BZ9QG-<^VQLW.<4QG(,?9I<9PV'?Y#$J7R+(GUQ
M[&8B%)?:.3]PFNP8L=POP=);1$HW>"H#SI;ON5BX>R;7CWVX-CG;:ZZY33=:
M79'NBGIVQ[YR7V:2](G9M^SCPO&^S[QOWD'F&Z;;A\BQECX6%#)RZ:)1ADR:
MOL5=LX=[NL_#8]4DGI)V5K65J1Z:6'V9++<B.ZV^PZDEM.M*);:TG^"DJ29D
M9#5,[HSZ@
M
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M(>#R?T
M
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M^_D _M ^"/\ B3Q'_<?;_P#6X_P3_%G_ +FG0'^LWKK_ +' _GIS'_;;<_\
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M&@P8T>%!A1V8D.'$9;C18D6,VEF/&C1V4H98CL,H)"$((DI21$1$1 "J%WX
M^!^2YZWM3(_"?Q(O]GM2$RVMCW?C?IRUSUJ4@W31);S"=AC^0HD(.0YPLI!*
M+K5Z^I@"VX K!FOA%X7[*V/'W'L;Q#\7\_V[$[7M=J9KH+5.5;'C=AV6^Q[?
M.+W$Y^3,]EZ>^M'3*+I4\X9>JU<@6/\ M-5]J^Q?;*_[)]O^T_9O91OM7VKV
MWL_MGV_M^T^W^T_5=GH[?;^GCI] !C^$Z\P#6M5(HM<X/A^ 4DNP=MI5-A.,
MTN*U4FU?C1(;]G(KZ*% B/6#T2 PTMY2#<4VRVDSZ4)(@..SK'6T;-Y>S(^O
M<'8V1/CIB3M@,XG0M9O-BH@QJQ$:7E:(";Z3'16PF8Y(7(4DF&4-\="4D0&#
M[O\ &3QM\FJJCHO)'Q\T?Y!TF,6$BVQJGW?J? ]KU6/6LR,4.79T=?GE!?Q*
MFPE1")IQZ.AMQ;9=*C-/H )8Q_'J#$Z:NQS%J.GQK'JB.42IH<?K(5-35<5*
ME*3&KJNN8C084=*EF9(;0E)&9^@ [@
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MJP([9LDH/ P-,5*,G-5NB,8>TYMR<I5I*$]92DI)QF^^,DI2'%,N
M
M
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M7R-Q*#XX(RZOJ-1%6=M]LKO>[];=%UC\NG1+1:)::>G3[.FJZFUF+@8=6%^
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MB]"'H?0_H
M
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MBHV1+!"/EF@
M
M
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MQ48MMZ))+63<I/I\92;;?JVVWU9D8]3W
M
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M(_YOX?S1ZM:/1=4?:+;BFTTVO1Z:K[GIJOWFT<X>#R
M
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M+_Q<-5]@'Y;S_P#ME?\ JG4O_%PU7V ?EO/_ .V5_P"J=2_\7#5?8!^6\_\
M[97_ *IU+_Q<-5]@,4S;%<K<QJR=M<O._CQ&TR6ZXL;K*]2Y"5DTVZF5'>4X
M@V4NJ5QP9&7I_-+RFM3P_0JZ9&1F1D9&1F1D9<&1E^)&7Z#(>Y\P
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MGM^/D[EXNE<WC9\>VR55<FW&G.C6HNJZM:0E>ZJ\:]]LJG"4I454:%E&I(
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M+&OH]-/FO5$B2]624-HD$VI:H[I$1FVK@#.
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MUHVPS+[BF&934I3*5]+<A3!+-MJ07!FXP3BB7TD9<J07/IR1@=@
M
M
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M"5EZ$I*7$J(CX/C^:1F7X& .21$1$1$1$1$1$1<$1%Z$1$7H1$0 _H
M
M
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MSVVDZ[KHRE"7;W]LG!*R&DVVTKPB"&QP
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MNZSW +_@
M
M
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M$?7"V;:=MMMNV_&IHLOL]RQPA&/?/1ISEHDG-IO67J]7JWJ2".,9(
M
M
M                                              *V[UB1T2Z6:DT%
M)>9=8=02>%J;:4:FW5*X(E<FHT_I,B27/!<<^\3UD0 /8]          #D18
MDF:ZEB(P[(>5^#;2#6K_ ,+\" \DKXQJ"^M'6WKELZB"1\N)?(_=K+CGH1'(
MTK2HC,N35TIXYX,S+@>')'E1^TM!4U,"D@,5U<PEB,PDB2DB+J6K@B4ZZHB+
MK=7QZG_P"X(B(OFWJ>YV0
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M8]^\G_%SX/9;\76^-]T.CM/Z4W+XOX?C>6ZNV7K?7^)8'9'55N84=3(U7?\
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MNW\I[6^OV$U\=R*YE&.:ES"OQ!UZU5%7*AR&:G*;PFHZ'VVY*5N+6APV&U-
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MZ_L+TWKK4GYP_+/W?\N?FG\@8YC_ .8/R_\ F"?['W?>]I[Z1VNGO.=0$_@
M
M
M
M
M
M                                                           "
MJF[9ZG\EC0NLC1!@-$;:5']*WS-_J6@S,B6:7/Q+CE/!?H'O'T/61#(]CT
M   /ZA"W%$A"5+6H^$I0DU*4?\!)(C,S $[8/J+[I&.PR7W46.\VDXD5A9,R
M%DLDK2\I2DN$EOH/TY+ZN?3T(C5ZN7V'NH_:9F]I#&5N=3$VR9;X+]6M;;QF
M9?B9KZ6_Q_F$0\=S//:C/L=PV@Q=!E5Q.'CY(Y<@TNRC(R))EW"0@DDHB]>"
M(S_3SZ#PVV>=-#*1X
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M'/EM\ 'EAOOXFOB]UE@&7X/@GGS\:=//EXK06MS"M-:93-R[),2M<MIT94Y
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M.)<7SC6.OQ6J9=17H6Y*)JOC()+:0-PP
M
M
M
M
M
M                                 IEM66U,S>V6T?),^WB+]2/AV*RE
MAPO3\/J1^D?2/H>DO4CL>3U   #+L;PB_P H49UT0RCH/AR6\9-L(Y+DBZE&
M1*49?@7XF7X<CPVD>R39:'#=>U.+PV^^Q&GVJNE;\QQHG$MN%P9)BDZGE"4'
M^"^"6?\ ,+T+T;U/9+0D(>#R
M
M                         !5CRT\(O$_SLUXSJSRWT7@^\,+A2)TVFAY5
M%FQKG&+"R@.U<ZUPW+Z&;3YCA5Q)@.FVJ94SX4G@DF3A&A!I TT8W^ZA?"GC
MV<O9C(\>]@9-6'83K"%KS)-];;D8-6>XEG*@PF4UN3U67V-?2EPTPW86\WOL
MIXEG),U*4!OVU#I_5V@=:8;IO2N!8OK#5FOJ=JAPS!<-J8U+CM!6-NO27&H<
M&*A*52)LZ2[)E2'#7(F2WG9#ZW'G7'% 20
M          -='E/\6OB?YC>3GBWY<[IJ,XG;C\/<HQ7+],3<=S2904$*YP[8
M-/LVE7D-$Q&=8OHZ,IHXZW&W%()QDE-GZ'R -BX           B]S26G7MN0
MM^N:MU^K>%?A]GKZ'MW\I49;'9P>XG5-E8XE^<DPBOG,?D3J.*[[53ZF4*:^
ME*>I?4!*        "+]DZ2T[N23@DO;6K=?[,D:PS!G8.NW,\Q*CRO\ )6<1
MJJSI(N6XTB\A345.01*RYDM-2F22\UW.I"B6E*D@2@
M
M
M
M
M
M
M          K5N7$C8ELY' 86IN8HVYZ6T&HFY*2Y)TR2GDB?27/Z?J2LS/@R
M(O>+^!ZR7Q(#,C(S(R,C(S(R,N#(R_$C+]!D/8]  .9717)T^)$::6\M^0RV
M3:"Y4HE.))1$7\/!@>5ZE]ZRNBU,"+7PVTM1XK2&D$E*4=1I(B4XHDD1&XXK
MZE'^DS'R/H<X
M
M
M
M
M
M
M
M
M                                                   'Y6A#B5(<
M0E:%%PI"TDI*B_@4E1&1D ,%RO7U)DT(V$,1ZN63I/(G1(C*5FHS,W$NH039
M.$[SZJ/ZB,OTER1^4VCPUJ5<R["+;$)334PD/QY)J]K*8Y-MXTF1&C@R)1.)
MY+DN"/U+T+DN?=/4]6M"8]085(@DK)+-GM+?:Z:UEU!=SH7_ !I1DKU;(T^B
M?TJZC/T(BZO63^!YBM.I/@]3V
M
M
M
M
M
M
M
M
M
M        #AS*^#8);1.AQIB&E]QM,EEMY*%\<&9)<2HO4OQ_0?Z0!RR(B(B(
MB(B(B(B+@B(O0B(B]"(B ']
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
(       !_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Mar. 09, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Joint Corp<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">90-0544160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">16767 North Perimeter Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Scottsdale<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">AZ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">85260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">245-5960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 Par Value Per Share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">JYNT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 172.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,114,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Portions of the registrant&#8217;s Proxy Statement relating to its 2026 Annual Meeting of Stockholders, filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) pursuant to Regulation&#160;14A within 120 days after the registrant&#8217;s fiscal year ended December&#160;31, 2025, are incorporated by reference in Part&#160;III of this Form&#160;10-K.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001612630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">BDO USA, P.C.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Phoenix, Arizona<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 23,601,810<span></span>
</td>
<td class="nump">$ 25,051,355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
<td class="nump">700,058<span></span>
</td>
<td class="nump">945,081<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">2,849,864<span></span>
</td>
<td class="nump">2,586,381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Deferred franchise and regional development costs, current portion</a></td>
<td class="nump">945,933<span></span>
</td>
<td class="nump">1,055,582<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,744,556<span></span>
</td>
<td class="nump">1,787,994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Discontinued operations current assets ($1.0 million and $1.1 million attributable to VIEs, respectively)</a></td>
<td class="nump">22,246,318<span></span>
</td>
<td class="nump">43,151,055<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">52,088,539<span></span>
</td>
<td class="nump">74,577,448<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">3,159,226<span></span>
</td>
<td class="nump">3,206,754<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="nump">1,572,173<span></span>
</td>
<td class="nump">555,536<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetNoncurrent', window );">Deferred franchise and regional development costs, net of current portion</a></td>
<td class="nump">3,827,129<span></span>
</td>
<td class="nump">4,513,891<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Deposits and other assets</a></td>
<td class="nump">319,460<span></span>
</td>
<td class="nump">300,779<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">60,966,527<span></span>
</td>
<td class="nump">83,154,408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,588,665<span></span>
</td>
<td class="nump">1,750,938<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">1,501,838<span></span>
</td>
<td class="nump">1,505,827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_CoOpFundsLiabilityCurrent', window );">Co-op funds liability</a></td>
<td class="nump">700,058<span></span>
</td>
<td class="nump">945,082<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll liabilities</a></td>
<td class="nump">4,055,752<span></span>
</td>
<td class="nump">3,551,173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current portion</a></td>
<td class="nump">194,179<span></span>
</td>
<td class="nump">483,337<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred franchise fee revenue, current portion</a></td>
<td class="nump">2,519,018<span></span>
</td>
<td class="nump">2,546,926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_UpfrontRegionalDeveloperFeesCurrent', window );">Upfront regional developer fees, current portion</a></td>
<td class="nump">277,394<span></span>
</td>
<td class="nump">288,095<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">611,231<span></span>
</td>
<td class="nump">603,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Discontinued operations current liabilities ($6.1 million and $7.1 million attributable to VIEs, respectively)</a></td>
<td class="nump">21,368,446<span></span>
</td>
<td class="nump">37,367,459<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">32,816,581<span></span>
</td>
<td class="nump">49,042,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, net of current portion</a></td>
<td class="nump">1,815,527<span></span>
</td>
<td class="nump">311,689<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred franchise fee revenue, net of current portion</a></td>
<td class="nump">10,899,271<span></span>
</td>
<td class="nump">12,450,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_UpfrontRegionalDeveloperFeesNoncurrent', window );">Upfront regional developer fees, net of current portion</a></td>
<td class="nump">355,556<span></span>
</td>
<td class="nump">672,334<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">45,886,935<span></span>
</td>
<td class="nump">62,476,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 10)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Series A preferred stock, $0.001 par value; 50,000 shares authorized, zero issued and outstanding, respectively</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 20,000,000 shares authorized, 15,471,715 shares issued and 14,142,626 shares outstanding and 15,192,893 shares issued and 15,159,878 shares outstanding, respectively</a></td>
<td class="nump">15,471<span></span>
</td>
<td class="nump">15,192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">52,026,407<span></span>
</td>
<td class="nump">49,210,455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock 1,329,089 shares and 33,015 shares, at cost, respectively</a></td>
<td class="num">(12,192,081)<span></span>
</td>
<td class="num">(870,058)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(24,795,205)<span></span>
</td>
<td class="num">(27,702,470)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total The Joint Corp. stockholders&#8217; equity</a></td>
<td class="nump">15,054,592<span></span>
</td>
<td class="nump">20,653,119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling Interest</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">15,079,592<span></span>
</td>
<td class="nump">20,678,119<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 60,966,527<span></span>
</td>
<td class="nump">$ 83,154,408<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_CoOpFundsLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of Co-op funds liability (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_CoOpFundsLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_UpfrontRegionalDeveloperFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Upfront Regional Developer Fees, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_UpfrontRegionalDeveloperFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_UpfrontRegionalDeveloperFeesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Upfront Regional Developer Fees, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_UpfrontRegionalDeveloperFeesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 42: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 47: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 51: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 52: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 53: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 54: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 55: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Discontinued operations current assets</a></td>
<td class="nump">$ 22,246,318<span></span>
</td>
<td class="nump">$ 43,151,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Discontinued operations current liabilities</a></td>
<td class="nump">$ 21,368,446<span></span>
</td>
<td class="nump">$ 37,367,459<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Series A preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Series A preferred stock, shares authorized (in shares)</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Series A preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Series A preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">15,471,715<span></span>
</td>
<td class="nump">15,192,893<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">14,142,626<span></span>
</td>
<td class="nump">15,159,878<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">1,329,089<span></span>
</td>
<td class="nump">33,015<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Discontinued operations current assets</a></td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Discontinued operations current liabilities</a></td>
<td class="nump">$ 6,100,000<span></span>
</td>
<td class="nump">$ 7,100,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Income Statements - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 54,895,592<span></span>
</td>
<td class="nump">$ 52,163,430<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Total cost of revenues</a></td>
<td class="nump">11,225,474<span></span>
</td>
<td class="nump">11,516,848<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing expenses</a></td>
<td class="nump">13,299,399<span></span>
</td>
<td class="nump">10,973,610<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,644,161<span></span>
</td>
<td class="nump">1,371,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">29,632,036<span></span>
</td>
<td class="nump">30,124,589<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Total selling, general and administrative expenses</a></td>
<td class="nump">44,575,596<span></span>
</td>
<td class="nump">42,469,588<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Net loss on disposition or impairment</a></td>
<td class="nump">7,898<span></span>
</td>
<td class="nump">66,019<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from continuing operations</a></td>
<td class="num">(913,376)<span></span>
</td>
<td class="num">(1,889,025)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">683,872<span></span>
</td>
<td class="nump">280,287<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss from continuing operations before income tax expense</a></td>
<td class="num">(229,504)<span></span>
</td>
<td class="num">(1,608,738)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">38,653<span></span>
</td>
<td class="nump">5,606<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net loss from continuing operations</a></td>
<td class="num">(268,157)<span></span>
</td>
<td class="num">(1,614,344)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract', window );"><strong>Discontinued operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Income (loss) from discontinued operations before income tax expense</a></td>
<td class="nump">3,200,629<span></span>
</td>
<td class="num">(3,972,286)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation', window );">Income tax expense from discontinued operations</a></td>
<td class="nump">25,207<span></span>
</td>
<td class="nump">210,263<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Net income (loss) from discontinued operations</a></td>
<td class="nump">3,175,422<span></span>
</td>
<td class="num">(4,182,549)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 2,907,265<span></span>
</td>
<td class="num">$ (5,796,893)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract', window );"><strong>Net (loss) income from continuing operations per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="num">$ (0.11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Diluted (in dollars per share)</a></td>
<td class="num">(0.02)<span></span>
</td>
<td class="num">(0.11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract', window );"><strong>Net income (loss) from discontinued operations per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Basic (in dollars per share)</a></td>
<td class="nump">0.21<span></span>
</td>
<td class="num">(0.28)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare', window );">Diluted (in dollars per share)</a></td>
<td class="nump">0.21<span></span>
</td>
<td class="num">(0.28)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income (loss) per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss) per common share, basic (in dollars per share)</a></td>
<td class="nump">0.19<span></span>
</td>
<td class="num">(0.39)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss) per common share, diluted (in dollars per share)</a></td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="num">$ (0.38)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding (in shares)</a></td>
<td class="nump">15,134,215<span></span>
</td>
<td class="nump">14,919,091<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares outstanding (in shares)</a></td>
<td class="nump">15,186,868<span></span>
</td>
<td class="nump">15,147,247<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 33,203,885<span></span>
</td>
<td class="nump">$ 32,144,796<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_FranchiseMember', window );">Franchise fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">3,371,504<span></span>
</td>
<td class="nump">2,997,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenues</a></td>
<td class="nump">9,500,559<span></span>
</td>
<td class="nump">10,063,644<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_AdvertisingMember', window );">Advertising fund revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">10,451,281<span></span>
</td>
<td class="nump">9,180,281<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_TechnologyServiceMember', window );">Software fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">6,037,385<span></span>
</td>
<td class="nump">5,687,326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenues</a></td>
<td class="nump">1,724,915<span></span>
</td>
<td class="nump">1,453,204<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 1,831,537<span></span>
</td>
<td class="nump">$ 2,153,177<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Continuing Operations, Per Basic Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477349/740-270-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 37: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 38: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_FranchiseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_FranchiseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_AdvertisingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_AdvertisingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_TechnologyServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_TechnologyServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Stockholders' Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total The Joint Corp. stockholder's equity</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid In Capital</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Non-controlling Interest</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, beginning common stock (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,783,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning at Dec. 31, 2023</a></td>
<td class="nump">$ 24,771,882<span></span>
</td>
<td class="nump">$ 24,746,882<span></span>
</td>
<td class="nump">$ 14,783<span></span>
</td>
<td class="nump">$ 47,498,151<span></span>
</td>
<td class="num">$ (860,475)<span></span>
</td>
<td class="num">$ (21,905,577)<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Balance, beginning treasury stock (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">1,679,005<span></span>
</td>
<td class="nump">1,679,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,679,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 181<span></span>
</td>
<td class="num">(181)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">33,708<span></span>
</td>
<td class="nump">33,708<span></span>
</td>
<td class="nump">$ 228<span></span>
</td>
<td class="nump">33,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Purchases of treasury stock under employee stock plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Purchases of treasury stock under employee stock plans</a></td>
<td class="num">(9,583)<span></span>
</td>
<td class="num">(9,583)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (9,583)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">$ (5,796,893)<span></span>
</td>
<td class="num">(5,796,893)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,796,893)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, ending common stock (in shares) at Dec. 31, 2024</a></td>
<td class="nump">15,159,878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,192,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, ending at Dec. 31, 2024</a></td>
<td class="nump">$ 20,678,119<span></span>
</td>
<td class="nump">20,653,119<span></span>
</td>
<td class="nump">$ 15,192<span></span>
</td>
<td class="nump">49,210,455<span></span>
</td>
<td class="num">$ (870,058)<span></span>
</td>
<td class="num">(27,702,470)<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Balance, ending treasury stock (in shares) at Dec. 31, 2024</a></td>
<td class="nump">33,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 1,297,433<span></span>
</td>
<td class="nump">1,297,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,297,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 155<span></span>
</td>
<td class="num">(155)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">1,518,798<span></span>
</td>
<td class="nump">1,518,798<span></span>
</td>
<td class="nump">$ 124<span></span>
</td>
<td class="nump">1,518,674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Purchases of treasury stock under employee stock plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">779<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Purchases of treasury stock under employee stock plans</a></td>
<td class="num">(8,440)<span></span>
</td>
<td class="num">(8,440)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (8,440)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Common stock repurchased under authorized stock repurchase programs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,295,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Common stock repurchased under authorized stock repurchase programs</a></td>
<td class="num">(11,313,583)<span></span>
</td>
<td class="num">(11,313,583)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (11,313,583)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="nump">$ 2,907,265<span></span>
</td>
<td class="nump">2,907,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,907,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, ending common stock (in shares) at Dec. 31, 2025</a></td>
<td class="nump">14,142,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,471,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, ending at Dec. 31, 2025</a></td>
<td class="nump">$ 15,079,592<span></span>
</td>
<td class="nump">$ 15,054,592<span></span>
</td>
<td class="nump">$ 15,471<span></span>
</td>
<td class="nump">$ 52,026,407<span></span>
</td>
<td class="num">$ (12,192,081)<span></span>
</td>
<td class="num">$ (24,795,205)<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Balance, ending treasury stock (in shares) at Dec. 31, 2025</a></td>
<td class="nump">1,329,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,329,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 37: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 38: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 42: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 47: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 51: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 52: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 53: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 54: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 55: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 2,907,265<span></span>
</td>
<td class="num">$ (5,796,893)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,713,719<span></span>
</td>
<td class="nump">4,722,137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_NetGainLossOnDispositionOfAssetsOrAssetImpairment', window );">Net loss on disposition or impairment</a></td>
<td class="nump">5,448,908<span></span>
</td>
<td class="nump">7,780,574<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_GainLossOnTerminationOfFranchisingAgreements', window );">Net franchise fees recognized upon termination of franchise agreements</a></td>
<td class="num">(347,097)<span></span>
</td>
<td class="num">(239,335)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income taxes</a></td>
<td class="nump">93,066<span></span>
</td>
<td class="num">(55,556)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for credit losses</a></td>
<td class="nump">286,232<span></span>
</td>
<td class="nump">220,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">1,297,433<span></span>
</td>
<td class="nump">1,679,005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">1,534,554<span></span>
</td>
<td class="num">(1,645,078)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(35,389)<span></span>
</td>
<td class="nump">101,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset', window );">Deferred franchise costs</a></td>
<td class="nump">547,192<span></span>
</td>
<td class="nump">499,285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDepositOtherAssets', window );">Deposits and other assets</a></td>
<td class="num">(5,276)<span></span>
</td>
<td class="nump">8,827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(391,127)<span></span>
</td>
<td class="nump">68,258<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="num">(2,994,297)<span></span>
</td>
<td class="nump">4,609,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Payroll liabilities</a></td>
<td class="num">(839,892)<span></span>
</td>
<td class="nump">2,398,765<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating leases</a></td>
<td class="num">(5,103,266)<span></span>
</td>
<td class="num">(3,796,648)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="num">(1,444,410)<span></span>
</td>
<td class="num">(597,489)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_IncreaseDecreaseInRegionalDeveloperFees', window );">Upfront regional developer fees</a></td>
<td class="num">(285,443)<span></span>
</td>
<td class="num">(421,213)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="num">(543,663)<span></span>
</td>
<td class="num">(121,408)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">1,838,509<span></span>
</td>
<td class="nump">9,415,050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of clinics</a></td>
<td class="nump">7,778,287<span></span>
</td>
<td class="nump">554,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(1,503,785)<span></span>
</td>
<td class="num">(1,185,647)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">6,274,502<span></span>
</td>
<td class="num">(631,547)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Payments of finance lease obligations</a></td>
<td class="num">(4,354)<span></span>
</td>
<td class="num">(25,484)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Purchases of treasury stock under employee stock plans</a></td>
<td class="num">(8,440)<span></span>
</td>
<td class="num">(9,583)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of common stock under stock repurchase programs</a></td>
<td class="num">(11,313,583)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">1,518,798<span></span>
</td>
<td class="nump">33,708<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of Debt under the Credit Agreement</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,000,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(9,807,579)<span></span>
</td>
<td class="num">(2,001,359)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">(Decrease) increase in cash, cash equivalents and restricted cash</a></td>
<td class="num">(1,694,568)<span></span>
</td>
<td class="nump">6,782,144<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, beginning of period</a></td>
<td class="nump">25,996,436<span></span>
</td>
<td class="nump">19,214,292<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, end of period</a></td>
<td class="nump">24,301,868<span></span>
</td>
<td class="nump">25,996,436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Reconciliation of cash, cash equivalents and restricted cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">23,601,810<span></span>
</td>
<td class="nump">25,051,355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">700,058<span></span>
</td>
<td class="nump">945,081<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">24,301,868<span></span>
</td>
<td class="nump">25,996,436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_SupplementalCashFlowNetCashPaidAbstract', window );"><strong>Net cash paid for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">50,694<span></span>
</td>
<td class="nump">69,445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes</a></td>
<td class="nump">626,752<span></span>
</td>
<td class="nump">610,492<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash investing and financing activity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Unpaid purchases of property and equipment</a></td>
<td class="nump">245,250<span></span>
</td>
<td class="nump">124,699<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_StockOptionExerciseReceivable', window );">Stock option exercise receivable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 896,766<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_GainLossOnTerminationOfFranchisingAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) related to the termination of franchising agreements with third parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_GainLossOnTerminationOfFranchisingAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_IncreaseDecreaseInRegionalDeveloperFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Regional Developer Fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_IncreaseDecreaseInRegionalDeveloperFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NetGainLossOnDispositionOfAssetsOrAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Gain (Loss) On Disposition Of Assets Or Asset Impairment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NetGainLossOnDispositionOfAssetsOrAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_StockOptionExerciseReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Option Exercise Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_StockOptionExerciseReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_SupplementalCashFlowNetCashPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplement Of Net Cash Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_SupplementalCashFlowNetCashPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDepositOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDepositOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 37: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 38: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Nature of Operations and Summary of Significant Accounting Policies</a></td>
<td class="text">Nature of Operations and Summary of Significant Accounting Policies<div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">These financial statements represent the consolidated financial statements of The Joint Corp., which includes its variable interest entities (&#8220;VIEs&#8221;), and its wholly owned subsidiary, The Joint Corporate Unit No. 1, LLC (collectively, the &#8220;Company&#8221;). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amount of assets, liabilities, revenue, costs, expenses, other (expenses) income, and income taxes that are reported in the consolidated financial statements and accompanying disclosures. These estimates are based on management&#8217;s best knowledge of current events, historical experience, actions that we may undertake in the future and on various other assumptions that are believed to be reasonable under the circumstances. As a result, actual results may be different from these estimates. For a discussion of significant estimates and judgments made in recognizing revenue, accounting for leases, and accounting for income taxes, see Note 2, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Revenue Disclosures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, Note 9, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, and Note 10, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The results of operations of the corporate clinic segment are reported in Income (loss) from discontinued operations before income tax expense in its consolidated income statements for all periods presented and the related assets and liabilities associated with discontinued operations are classified as discontinued operation assets and liabilities in the consolidated balance sheets at December&#160;31, 2025 and 2024. The consolidated statement of cash flows includes cash flows related to the discontinued operations and accordingly, cash flow amounts for discontinued operations are disclosed in Note 3, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Divestitures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">. All results and information in the consolidated financial statements are presented as continuing operations and exclude the corporate clinic segment unless otherwise noted specifically as discontinued operations. For additional information, refer to Note 3, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Divestitures.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements include the accounts of The Joint and its wholly owned subsidiary, The Joint Corporate Unit No. 1, LLC, which was dormant for all periods presented. We consolidate VIEs in which we are the primary beneficiary in accordance with Accounting Standards Codification 810, Consolidations (&#8220;ASC 810&#8221;). Non-controlling interests represent third-party equity ownership interests in VIEs. All significant inter-affiliate accounts and transactions between The Joint and its VIEs have been eliminated in consolidation. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income (Loss)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) and comprehensive income (loss) are the same for the years ended December&#160;31, 2025 and 2024.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Operations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Joint Corp., a Delaware corporation, was formed on March 10, 2010 for the principal purpose of franchising, developing, selling regional developer rights, supporting the operations of franchised chiropractic clinics at locations throughout the United States of America. The franchising of chiropractic clinics is regulated by the Federal Trade Commission and various state authorities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the number of clinics in operation under franchise agreements and as company-owned or managed for the years ended December&#160;31, 2025 and 2024. All company-owned or managed clinics operations are recorded as discontinued operations:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Franchised clinics:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinics open at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Opened during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Acquired during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Sold during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Closed during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinics in operation at the end of the year</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">885&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Company-owned or managed clinics:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinics open at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Opened during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Acquired during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Sold during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Closed during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinics in operation at the end of the year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total clinics in operation at the end of the year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">960&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">967&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinic licenses sold but not yet developed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Executed letters of intent for future clinic licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Interest Entities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Certain states prohibit the &#8220;corporate practice of chiropractic,&#8221; which restricts business corporations from practicing chiropractic care by exercising control over clinical decisions by chiropractic doctors. In states that prohibit the corporate practice of chiropractic, we typically enter into long-term management agreements with professional corporations (&#8220;PCs&#8221;) that are owned by licensed chiropractic doctors, which, in turn, employ or contract with doctors who provide professional chiropractic care in our clinics. Under these management agreements with PCs, we provide, on an exclusive basis, all non-clinical services of the chiropractic practice. We have entered into such management agreements with four PCs. In connection with the sale of five company-owned or managed clinics located in Kansas and Missouri, we terminated our management agreement with one PC as of June 30, 2025. For additional information on clinic sales, refer to Note 3, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> If an entity is deemed to be the primary beneficiary of a VIE, the entity is required to consolidate the VIE in its financial statements. An entity is deemed to be the primary beneficiary of a VIE if it has both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE&#8217;s economic performance, and (b) the obligation to absorb the majority of losses of the VIE or the right to receive the majority of benefits from the VIE. In accordance with relevant accounting guidance, these PCs were determined to be VIEs, as fees paid by the PCs to us as our management service provider are considered variable interests because the fees do not meet all the following criteria: (1) the fees are compensation for services provided and are commensurate with the level of effort required to provide those services; (2) the decision maker or service provider does not hold other interests in the VIE that individually, or in the aggregate, would absorb more than an insignificant amount of the VIE&#8217;s expected losses or receive more than an insignificant amount of the VIE&#8217;s expected residual returns; and (3) the service arrangement includes only terms, conditions, or amounts that are customarily present in arrangements for similar services negotiated at arm&#8217;s length. Additionally, we have determined that we have the ability to direct the activities that most significantly impact the performance of these PCs and has an obligation to absorb losses or receive benefits which could potentially be significant to the PCs. Accordingly, the PCs are VIEs for which we are the primary beneficiary and are consolidated by us. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The revenues of VIEs represent the revenues of company-managed clinics in states that prohibit the corporate practice of chiropractic. Our involvement with VIEs affects our financial performance and cash flows primarily through amounts recorded as revenues from company-owned or managed clinics and general and administrative expenses, which are principally comprised of payroll and related expenses, merchant card fees and insurance expense, all of which are reported in Income (loss) from discontinued operations before income tax expense in our consolidated income statements. The management fees/income </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">provided by the management agreements are considered intercompany transactions and therefore eliminated upon consolidation of VIEs. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">VIE net income (including the management fee) for the years ended December&#160;31, 2025 and 2024 is included in Income (loss) from discontinued operations before income tax expense and income tax expense from discontinued operations in the consolidated income statements as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.984%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations before income tax expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,011,689&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,641,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">210,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">986,482&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,431,062&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of the VIEs&#8217; assets and liabilities is included in discontinued operations as of December&#160;31, 2025 and 2024 in the consolidated balance sheets as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.276%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">994,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,087,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,079,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,125,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We consider all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. We continually monitor our positions with, and the credit quality of, the financial institutions with which we invest. As of the balance sheet date and periodically throughout the period, we have maintained balances in various operating accounts in excess of federally insured limits. We invest our cash primarily in short-term bank deposits and money market funds. We had $19.2&#160;million and zero cash equivalents invested in money market funds as of December&#160;31, 2025 and 2024, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash relates to cash that franchisees and company-owned or managed clinics contribute to our National Marketing Fund and cash that franchisees provide to various voluntary regional Co-Op Marketing Funds. Cash contributed by franchisees to the National Marketing Fund is to be used in accordance with our Franchise Disclosure Document with a focus on regional and national marketing and advertising. While such cash balance is not legally segregated and restricted as to withdrawal or usage, our accounting policy is to classify these funds as restricted cash.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Credit Losses </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable primarily represent amounts due from franchisees for royalty and software fees. Receivables are unsecured; however, the franchise agreements provide us the right to withdraw funds from the franchisee&#8217;s bank account or to terminate the franchise for nonpayment. We record an allowance for credit losses as a reduction to our accounts receivables for amounts that we do not expect to recover. An allowance for credit losses is determined through assessments of collectability based on historical trends, the financial condition of our franchisees, including any known or anticipated bankruptcies, and an evaluation of current economic conditions, as well as our expectations of conditions in the future. Actual losses ultimately could differ materially in the near term from the amounts estimated in determining the allowance. As of December&#160;31, 2025, we had a $0.4 million allowance for credit losses. As of December&#160;31, 2024, we had a $0.2 million allowance for credit losses on accounts receivable.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a rollforward of the activity related to our allowance for credit losses:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.351%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Allowance for credit losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt expense recognized during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">220,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Write-off of uncollectible amounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2024</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">220,893&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt expense recognized during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">286,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Write-off of uncollectible amounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(77,638)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2025</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">429,487&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Franchise Costs and Regional Development Costs</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Deferred franchise and regional development costs represent commissions that are direct and incremental to us and are paid in conjunction with the sale of a franchise license or regional development rights. These costs are recognized as an expense, in franchise and regional development cost of revenues when the respective revenue is recognized, which is generally over the term of the related franchise or regional developer agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost and relate mostly to the corporate headquarters leasehold improvements, its furniture and fixtures and other office and computer equipment. Depreciation is computed using the straight-line method over estimated useful lives, which is generally <span style="-sec-ix-hidden:f-425">three</span> to ten years. Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the assets. Maintenance and repairs are charged to expense as incurred; major renewals and improvements are capitalized. When items of property or equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is included in income. We recorded Net loss on disposition or impairment of $8 thousand and $17 thousand in our consolidated income statements related to continuing operations for the years ended December&#160;31, 2025 and 2024, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitalized Software</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize certain software development costs, including costs to implement cloud computing arrangements that is a service contract. These capitalized costs are primarily related to software used by clinics for operations and by us for the management of operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct, are capitalized as assets in progress until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. We also capitalize costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Internally developed software is recorded as part of property and equipment. Maintenance and training costs are expensed as incurred. Internally developed software is amortized on a straight-line basis over its estimated useful life, which is generally <span style="-sec-ix-hidden:f-430">three</span> to five years. Implementation costs incurred in&#160;connection with a cloud computing arrangement that is a service contract are included in prepaid expenses in our consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We lease property and equipment under operating and finance leases. We lease our corporate office space and the space for each of the company-owned or managed clinics in the portfolio. We recognize a right-of-use (&#8220;ROU&#8221;) asset and lease liability for all leases. The lease for our corporate office space is recognized as a ROU and lease liability in our consolidated balance sheets as continuing operations while all other leases for each of the company-owned or managed clinics are reported in discontinued operations. Certain leases include one or more renewal options, generally for the same period as the initial term of the lease. The exercise of lease renewal options is generally at our sole discretion and, as such, we typically determine that exercise of these renewal options is not reasonably certain. As a result, we do not include the renewal option period in the expected lease term and the associated lease payments are not included in the measurement of the ROU asset and lease liability. When available, we use the rate implicit in the lease to discount lease payments; however, the rate implicit in the lease is not readily determinable for substantially all of our leases. In such cases, we estimate our incremental borrowing rate as the interest rate we would pay to borrow an amount equal to the lease payments over a similar term, with similar collateral as in the lease, and in a similar economic environment. We estimate these rates using available evidence such as rates imposed by third-party lenders to us in recent financings or observable risk-free interest rate and credit spreads for commercial debt of a similar duration, with credit spreads correlating to our estimated creditworthiness.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For operating leases that include rent holidays and rent escalation clauses, we recognize lease expense on a straight-line basis over the lease term from the date we take possession of the leased property. Pre-opening costs are recorded as incurred in general and administrative expenses. Variable lease payments, such as percentage rentals based on location sales, periodic adjustments for inflation, reimbursement of real estate taxes, any variable common area maintenance and any other variable costs associated with the leased corporate office space are expensed as incurred in general and administrative expenses on the consolidated income statements. Any variable costs associated with the leased property for company-owned or managed clinics are expensed as incurred and are included in Income (loss) from discontinued operations before income tax expense in our consolidated income statements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2025 and 2024, certain leases related to discontinued operations were terminated early with the landlord as a result of corporate clinic closures. The net losses to terminate the leases were recorded in Income (loss) from discontinued operations before income tax expense in our consolidated income statements of $1.4 million for the year ended December&#160;31, 2025 and $0.4 million for the year ended December&#160;31, 2024.</span><span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist primarily of reacquired franchise rights and customer relationships. All of our intangible assets are reported in discontinued operations. We amortize the fair value of reacquired franchise rights over the remaining contractual terms of the reacquired franchise rights at the time of the acquisition, which generally range from <span style="-sec-ix-hidden:f-437">one</span> to nine years. The fair value of customer relationships is amortized over their estimated useful life of <span style="-sec-ix-hidden:f-439">two</span> to four years. Intangible assets are attributable entirely to discontinued operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill consists of the excess of the purchase price over the fair value of tangible and identifiable intangible assets acquired in the acquisitions of franchises. Goodwill and intangible assets deemed to have indefinite lives are not amortized but are tested for impairment annually and more frequently if a triggering event occurs that makes it more likely than not that the fair value of a reporting unit is below carrying value. As required, we perform an annual impairment test of goodwill as of the first day of the fourth quarter or more frequently if a triggering event occurs. Goodwill is attributable entirely to discontinued operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2025, we performed a quantitative assessment of the fair value of the reporting unit and concluded that the fair value of the corporate clinic reporting unit exceeded its carrying value. The fair value of the reporting unit was determined using Level 2 inputs, which includes a potential buyer agreed-upon selling price, or Level 3 inputs, which includes consideration of a market approach using a multiple of earnings assumption based on clinic-level historical financial performance as well as an income approach using discounted cash flow models that use significant unobservable inputs and assumptions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">No impairment of goodwill was recorded for the years ended December&#160;31, 2025 and 2024.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Discontinued Operations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In determining whether a group of assets which has been disposed of (or is to be disposed of) should be presented as discontinued operations, we first analyze whether the group of assets being disposed of represents a component of the entity or group of components of the entity. A component typically has historic operations and cash flows that are clearly distinguishable for both operations and financial reporting purposes. In addition, we consider whether the disposal represents a strategic shift that has or will have a major effect on our operations and financial results. This strategic shift could include a disposal of a major geographical area, a major line of business, a major equity method investment or other major parts of an entity.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We report financial results for discontinued operations separately from continuing operations to distinguish the financial impact of disposal transactions from ongoing operations. The assets and liabilities of a discontinued operation held for sale, other than goodwill, are measured at the lower of its carrying amount or fair value less cost to sell. When a portion of a reporting unit that constitutes a business is to be disposed of, the goodwill associated with that business is included in the carrying amount of the business based on the relative fair values of the business to be disposed of and the portion of the reporting unit that will be retained. See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Assets - Continuing Operations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recovered. We look primarily to estimated undiscounted future cash flows in our assessment of whether </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">or not long-lived assets are recoverable. We record an impairment loss when the carrying amount of the asset is not recoverable and exceeds its fair value. During the year ended December&#160;31, 2024, certain long-lived asset groups were determined to not be recoverable and were written down from their carrying values to their respective fair values resulting in the following non-cash impairment losses which are included in <span style="-sec-ix-hidden:f-447">Net loss on disposition or impairment</span> related to continuing operations. Net impairment losses on long-lived assets were not material for the year ended December&#160;31, 2025.</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.271%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net loss on disposition or impairment related to continuing operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">57,959&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">40,872&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">17,087&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">703,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">667,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">36,368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">12,564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Total Net loss on disposition or impairment related to continuing operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">66,019&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Assets - Discontinued Operations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2024, certain long-lived asset groups classified as held and used were determined to not be recoverable were written down from their carrying values to their respective fair values resulting in the following non-cash impairment losses which are included in Income (loss) from discontinued operations before income tax expense in the consolidated income statements. </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.149%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net loss on disposition or impairment related to discontinued operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,929,036&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,755,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1,173,718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">5,779,712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">4,347,457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1,432,255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">298,510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">252,746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">45,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Total Net loss on disposition or impairment related to discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">2,651,737&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets that meet the criteria for the held for sale designation are reported at the lower of their carrying value or fair value less estimated cost to sell. As a result of its evaluation of the recoverability of the carrying value of the assets and liabilities held for sale relative to the clinics estimated fair values, we recorded an estimated net loss on disposal, which is included in Income (loss) from discontinued operations before income tax expense in the consolidated income statements:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Net loss on disposition or impairment related to discontinued operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">2,734,726&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">4,540,530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A valuation allowance of $6.3 million and $5.1 million as of December&#160;31, 2025 and 2024, respectively, are included in Discontinued operations current assets on the consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the composition of our impairment losses and disposal gains and losses recorded in Income (loss) from discontinued operations before income tax expense for the years ended December&#160;31, 2025 and 2024:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Impairment on long-lived assets held for use</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1,173,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1,432,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">45,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Impairment on assets held for sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">2,734,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">4,540,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Loss on disposal of assets other than by sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">383,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">161,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1,396,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">406,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Loss (gain) on the sale of assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">926,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(44,807)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Total net loss on disposition or impairment related to discontinued operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">5,441,010&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">7,714,555&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising Fund</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have established an advertising fund for national or regional marketing and advertising of services offered by our clinics. The monthly marketing fee is 2% of clinic sales. We segregate the advertising funds collected and any unspent amounts, if applicable, are included in restricted cash on our consolidated balance sheets. As amounts are expended from the fund, we recognize a related expense. Such costs are included in selling and marketing expenses on the consolidated income statements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Co-Op Marketing Funds&#160;&#160;&#160;&#160;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Some franchises have established regional Co-Ops for advertising within their local and regional markets. We maintain a custodial relationship under which the Co-Op Marketing Funds collected are segregated and used for the purposes specified by the Co-Ops&#8217; officers. The Co-Op Marketing Funds are included in restricted cash on our consolidated balance sheets.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue primarily through company-owned or managed clinics and through royalties, franchise fees, advertising fund contributions, IT related income and computer software fees from our franchisees.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues from Company-Owned or Managed Clinics.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> We earn revenues from clinics that we own and operate or manage throughout the United States. Revenues from clinics that we own and operate are recognized when services are performed and are related to discontinued operations. We offer a variety of membership and wellness packages which feature discounted pricing as compared with our single-visit pricing. Amounts collected in advance for membership and wellness packages are recorded as deferred revenue and recognized when the service is performed. Any unused visits associated with monthly memberships are recognized on a month-to-month basis. We recognize a contract liability (or a deferred revenue liability) related to the prepaid treatment plans for which we have an ongoing performance obligation. We derecognize this contract liability, and recognize revenue, as the patient consumes his or her visits related to the package and we transfer our services. If we determine that it is not subject to unclaimed property laws for the portion of the package that we do not expect to be redeemed (referred to as &#8220;breakage&#8221;), then we recognize breakage revenue in proportion to the pattern of exercised rights by the patient.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalties and Advertising Fund Revenue.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> We collect royalties, as stipulated in the franchise agreement, equal to 7% of gross sales, and a marketing and advertising fee currently equal to 2% of gross sales. Royalties, including franchisee contributions to advertising funds, are calculated as a percentage of clinic sales over the term of the franchise agreement. The revenue accounting standard provides an exception for the recognition of sales-based royalties promised in exchange for a license (which generally requires a reporting entity to estimate the amount of variable consideration to which it will be entitled in the transaction price). As the franchise agreement royalties, inclusive of advertising fund contributions, represent sales-based royalties that are related entirely to our performance obligation under the franchise agreement, such sales-based royalties are recognized as franchisee clinic level sales occur. Royalties are collected semi-monthly, two working days after each sales period has ended.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Franchise Fees.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> We require the entire non-refundable initial franchise fee to be paid upon execution of a franchise agreement, which typically has an initial term of 10 years. Initial franchise fees are recognized ratably on a straight-line basis over the term of the franchise agreement. Our services under the franchise agreement include the training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. We provide no financing to franchisees and offer no guarantees on their behalf. The services provided by us are highly interrelated with the franchise license and as such are considered to represent a single performance obligation. Renewal franchise fees, as well as transfer fees, are also recognized as revenue on a straight-line basis over the term of the respective franchise agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Software Fees.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We collect a monthly fee from our franchisees for the use of our proprietary chiropractic software, computer support and internet services support. These fees are recognized ratably on a straight-line basis over the term of the respective franchise agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Capitalized Sales Commissions. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Sales commissions earned by the regional developers and our sales force are considered incremental and recoverable costs of obtaining a franchise agreement with a franchisee. These costs are deferred and then amortized as the respective franchise fees are recognized ratably on a straight-line basis over the term of the franchise agreement. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Upfront Regional Developer Rights Fees </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have a regional developer program where regional developers are granted an exclusive geographical territory and commit to a minimum development obligation within that defined territory. Upon granting of the exclusive rights to develop a territory, a regional developer will pay an upfront fee to us. Upfront regional developer fees represent consideration received from a vendor to act as our agent within an exclusive territory. The upfront regional developer rights fee is accounted for as a reduction of cost of revenues, in franchise and regional development cost of revenues, to offset the respective future commissions paid to the regional developer. The fees are ratably recognized over the term of the related regional developer agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Regional developers receive fees which are funded by the initial franchise fees collected from franchisees upon the sale of franchises within their exclusive geographical territory and a royalty of 3% of sales generated by franchised clinics in their exclusive geographical territory. Initial fees related to the sale of franchises within their exclusive geographical territory are initially deferred as deferred franchise costs and are recognized as an expense in franchise cost of revenues when the respective revenue is recognized, which is generally over the term of the related franchise agreement. Royalties of 3% of sales generated by franchised clinics in their regions are also recognized as franchise cost of revenues as franchisee clinic level sales occur. This 3% fee is funded by the 7% royalties we collect from the franchisees in their regions. Certain regional developer agreements result in the regional developer acquiring the rights to existing royalty streams from clinics already open in the respective territory. In those instances, fees collected from the sale of the royalty stream is recognized as a decrease to franchise and regional developer cost of revenues over the remaining life of the respective franchise agreements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:106%">Regional Developer Rights Contract Termination Costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, subject to our strategy, regional developer rights are reacquired by us, resulting in a termination of the contract. The termination costs to reacquire the regional developer rights are recognized at fair value, less any unrecognized upfront regional developer fee liability balance, as a general and administrative expense in the period in which the contract is terminated in accordance with the contract terms and are recorded within general and administrative expenses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Advertising Costs</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs are advertising and marketing expenses incurred by us, primarily through advertising funds. We expense production costs of commercial advertising upon first airing and expenses the costs of communicating the advertising in the period in which the advertising occurs. Advertising expenses, excluding National Marketing Fund costs, were $0.6 million and $0.8 million for the years ended December&#160;31, 2025 and 2024, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for using a balance sheet approach known as the asset and liability method. The asset and liability method accounts for deferred income taxes by applying the statutory tax rates in effect at the date of the consolidated balance sheets to differences between the book basis and the tax basis of assets and liabilities. Deferred tax assets and liabilities represent the future tax consequence for those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. The differences relate principally to depreciation of property and equipment and treatment of revenue for franchise fees and regional developer fees collected. Tax positions are reviewed at least quarterly and adjusted as </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">new information becomes available. The recoverability of deferred tax assets is evaluated by assessing the adequacy of future expected taxable income from all sources, including reversal of taxable temporary differences, forecasted operating earnings and available tax planning strategies. These estimates of future taxable income inherently require significant judgment. To the extent it is considered more likely than not that a deferred tax asset will be not recovered, a valuation allowance is established. We applied the intra-period allocation rules under ASC 740-20-45-1 to allocate the tax provision between continuing operations and discontinued operations. The tax provision amount reported as Income tax expense and disclosed at Note 9, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> is all related to continuing operations and the remaining provision amount is allocated as discontinued operations and reported as Income tax expense from discontinued operations for the years ended December&#160;31, 2025 and 2024.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We account for uncertainty in income taxes by recognizing the tax benefit or expense from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the position. We measure the tax benefits and expenses recognized in the consolidated financial statements from such a position based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution. We have identified $0.6&#160;million and $0.9&#160;million in uncertain tax positions related to our VIEs in discontinued operations as of December&#160;31, 2025 and 2024, respectively. Interest and penalties associated with tax positions are recorded in the period assessed as general and administrative expenses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">With exceptions due to the generation and utilization of net operating losses or credits, as of December&#160;31, 2025, we are no longer subject to federal and state examinations by taxing authorities for tax years before 2022 and 2021, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings (Loss) per Common Share</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per common share is computed by giving effect to all potentially dilutive common shares including restricted stock and stock options. Diluted earnings (loss) per common share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(268,157)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,614,344)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,175,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,182,549)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,907,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5,796,893)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8212; basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,134,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,919,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock and stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">52,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">228,156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8212; diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,186,868&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,147,247&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings (loss) per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive securities excluded from the calculation of diluted net income (loss) per common share as the effect would be anti-dilutive were as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">71,030&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">87,651&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We account for share-based payments by recognizing compensation expense based upon the estimated fair value of the awards on the date of grant. We determine the estimated grant-date fair value of restricted shares using the closing price on the date of the grant and the grant-date fair value of stock options using the Black-Scholes-Merton model. In order to calculate the fair value of the options, certain assumptions are made regarding the components of the model, including risk-free interest rate, volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. We recognize compensation costs ratably over the period of service using the straight-line method. Forfeitures are estimated based on historical and forecasted turnover, which is approximately 5%.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Retirement Benefit Plan</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our employees are eligible to participate in a defined contribution retirement plan, the Joint Corp. 401(k) Retirement Plan (the &#8220;401(k) Plan&#8221;), under Section 401(k) of the Internal Revenue Code. Under the 401(k) Plan, employees may contribute their eligible compensation, not to exceed the annual limits set by the IRS. The 401(k) Plan allows us to match participants&#8217; contributions in an amount determined in our sole discretion. We matched participants&#8217; contributions for the years ended December&#160;31, 2025 and 2024, up to a maximum of 4% of the employee&#8217;s eligible compensation. Employer contributions for both continuing and discontinued operations totaled $0.6 million for each of the years ended December&#160;31, 2025 and 2024.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Loss Contingencies</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ASC Topic 450 governs the disclosure of loss contingencies and accrual of loss contingencies in respect of litigation and other claims. We record an accrual for a potential loss when it is probable that a loss will occur and the amount of the loss can be reasonably estimated. When the reasonable estimate of the potential loss is within a range of amounts, the minimum of the range of potential loss is accrued, unless a higher amount within the range is a better estimate than any other amount within the range. Moreover, if an accrual is not required, we provide additional disclosure related to litigation and other claims when it is reasonably possible (i.e., more than remote) that the outcomes of such litigation and other claims include potential material adverse impacts on us. Legal costs to be incurred in connection with a loss contingency are expensed as such costs are incurred.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Items subject to significant estimates and assumptions include loss contingencies, share-based compensations, useful lives and realizability of long-lived assets, deferred revenue and revenue recognition related to breakage, deferred franchise costs, calculation of ROU assets and liabilities related to leases, realizability of deferred tax assets, impairment of goodwill, intangible assets, other long-lived assets, and purchase price allocations and related valuations. Deferred revenue related to breakage, goodwill and intangible assets are related to discontinued operations. Refer to Note 3,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Divestitures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for more information on discontinued operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Guidance and Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (&#8220;ASU 2023-09&#8221;), which requires public entities to provide greater disaggregation within their annual rate reconciliation, including new requirements to present reconciling items on a gross basis in specified categories, disclose both percentages and dollar amounts, and disaggregate individual reconciling items by jurisdiction and nature when the effect of the items meet a quantitative threshold. ASU 2023-09 also requires disaggregating the annual disclosure of income taxes paid, net of refunds received, by federal (national), state, and foreign taxes, with separate presentation of individual jurisdictions that meet a quantitative threshold. ASU 2023-09 is effective for annual periods beginning after December 15, 2024 on a prospective basis, with a retrospective option, and early adoption is permitted. We have adopted ASU 2023-09 for the 2025 annual period on a retrospective basis. Refer to Note 9, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for the revised disclosures. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (&#8220;ASU 2023-07&#8221;), which requires public entities with a single reportable segment to provide all the disclosures required by this standard and all existing segment disclosures in Topic 280 on an interim and annual basis, including new requirements to disclose significant segment expenses that are regularly provided to the Chief Operating Decision Maker (&#8220;CODM&#8221;) and included within the reported measure(s) of a segment&#8217;s profit or loss, the amount and composition of any other segment items, the title and position of the CODM, and how the CODM uses the reported measure(s) of a segment&#8217;s profit or loss to assess performance and decide how to allocate resources. ASU 2023-07 is effective for annual periods beginning after December 15, 2023 and interim periods beginning after December 15, 2024, applied retrospectively with early adoption permitted. We have adopted ASU 2023-07 for the 2024 annual period and have identified no material effect on our consolidated financial statements or disclosures.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (&#8220;ASU 2024-03&#8221;), and in January 2025, the FASB issued ASU No. 2025-01, Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date, which clarified the effective date of ASU 2024-03. ASU 2024-03 will require us to disclose the amounts of purchases of inventory, employee compensation, depreciation and intangible asset amortization, as applicable, included in certain expense captions in the consolidated statements of operations, as well as qualitatively describe remaining amounts included in those captions. ASU 2024-03 will also require us to disclose both the amount and our definition of selling expenses. The transition method is prospective with the retrospective method permitted and will be effective for our annual period ending December 31, 2027 and interim periods for the interim period beginning January 1, 2028. We are currently evaluating the impact of adoption of ASU 2024-03 on our consolidated financial statements and disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Disclosures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Disclosures</a></td>
<td class="text">Revenue Disclosures<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Franchising Fees, Royalty Fees, Advertising Fund Revenue, and Software Fees</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2025, we had 885 franchised clinics in operation, 82 clinic licenses sold but not yet developed and 57 executed letters of intent for future clinic licenses. The franchise arrangement is documented in the form of a franchise agreement. The franchise arrangement requires us to perform various activities to support the brand that do not directly transfer goods and services to the franchisee, but instead represent a single performance obligation, which is the transfer of the franchise license. The intellectual property subject to the franchise license is symbolic intellectual property as it does not have significant standalone functionality, and substantially all of the utility is derived from its association with our past or ongoing activities. The nature of our promise in granting the franchise license is to provide the franchisee with access to the brand&#8217;s symbolic intellectual property over the term of the license. The services provided by us are highly interrelated with the franchise license and as such are considered to represent a single performance obligation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price in a standard franchise arrangement primarily consists of (a) initial franchise fees, (b) continuing franchise fees (royalties), (c) advertising fees, and (d) software fees. The revenue accounting standard provides an exception for the recognition of sales-based royalties promised in exchange for a license (which otherwise requires a reporting entity to estimate the amount of variable consideration to which it will be entitled in the transaction price). </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the primary components of the transaction price as follows:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Initial and renewal franchise fees, as well as transfer fees, are recognized as revenue ratably on a straight-line basis over the term of the respective franchise agreement commencing with the execution of the franchise, renewal, or transfer agreement. As these fees are typically received in cash at or near the beginning of the contract term, the cash received is initially recorded as a contract liability until recognized as revenue over time.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are entitled to royalties and advertising fees based on a percentage of the franchisee&#8217;s gross sales as defined in the franchise agreement. Royalty and advertising revenue are recognized when the franchisee&#8217;s sales occur. Depending on timing within a fiscal period, the recognition of revenue results in either what is considered a contract asset (unbilled receivable) or, once billed, accounts receivable, on the consolidated balance sheets.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are entitled to a software fee, which is charged monthly. We recognize revenue related to software fees ratably on a straight-line basis over the term of the franchise agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In determining the amount and timing of revenue from contracts with customers, we exercise significant judgment with respect to collectability of the amount; however, the timing of recognition does not require significant judgment as it is based on either the franchise term or the reported sales of the franchisee, neither of which requires estimation. We believe that our franchising arrangements do not contain a significant financing component.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We recognize advertising fees received under franchise agreements as advertising fund revenue.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capitalized Sales Commissions</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Sales commissions earned by the regional developers and our sales force are considered incremental and recoverable costs of obtaining a franchise agreement with a franchisee. These costs are deferred and then amortized as the respective franchise fees are recognized ratably on a straight-line basis over the term of the franchise agreement.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the captions contained on the consolidated income statements appropriately reflect the disaggregation of our revenue by major type for the years ended December&#160;31, 2025 and 2024. Other revenues primarily consist of merchant income associated with preferred vendor royalties associated with franchisees&#8217; credit card transactions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows our revenues disaggregated according to the timing of transfer of services:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized at a point in time</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">45,486,703&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">43,478,254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized over time</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,408,889&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,685,176&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">54,895,592&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">52,163,430&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rollforward of Accounts Receivable</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Changes in our accounts receivable, net during the years ended December&#160;31, 2025 and 2024 were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.351%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Accounts Receivable, Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,580,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash received against accounts receivable included at the beginning of the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,387,577)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net increase during the year ended December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,614,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(220,893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,586,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash received against accounts receivable included at the beginning of the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,067,962)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net increase during the year ended December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,760,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(429,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2025</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,849,864&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Changes in our contract liability for deferred franchise fees during the years ended December&#160;31, 2025 and 2024 were as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.684%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Revenue<br/>Short and Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,113,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized that was included in the contract liability at the beginning of the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,841,085)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net increase during the year ended December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,724,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2024</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,997,105&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized that was included in the contract liability at the beginning of the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,006,059)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net increase during the year ended December 31, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,427,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2025</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,418,289&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our deferred franchise and development costs represent capitalized sales commissions. Changes during the years ended December&#160;31, 2025 and 2024 were as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Franchise and Development Costs<br/>Short and Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,251,366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Recognized as cost of revenue during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,221,140)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net increase during the year ended December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">539,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2024</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,569,473&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Recognized as cost of revenue during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,190,555)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Net increase during the year ended December 31, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">394,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2025</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,773,062&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates revenues expected to be recognized in the future related to performance obligations that were unsatisfied (or partially unsatisfied) as of December&#160;31, 2025. We have elected to exclude short term contracts, sales and usage-based royalties and any other variable consideration recognized on an &#8220;as invoiced&#8221; basis.</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Contract liabilities expected to be recognized in:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,519,018&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,413,277&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,254,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,899,640&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,630,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,701,180&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,418,289&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-15<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Divestitures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Divestitures</a></td>
<td class="text">Divestitures<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Clinic Segment Divestiture</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In 2023, we initiated plans to refranchise the majority of our company-owned or managed clinics with plans to retain a small portion of high-performing clinics. During the third quarter of 2024, we expanded the refranchising plan to include additional clinic markets of company-owned or managed clinics, marketing the clinics in clusters grouped by proximity to larger private equity firms. Because we have formalized a plan to sell our entire corporate clinic reportable segment, we have concluded that the overall refranchising plan represents a strategic shift that will have a major effect on our operations and financial results. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Since December&#160;31, 2024, the corporate clinics classified as held for sale are reported separately as discontinued operations in the consolidated income statements and consolidated balance sheets. As permitted, we elected not to adjust the consolidated statements of cash flows for the years ended December&#160;31, 2025 and 2024 to exclude cash flows attributable to discontinued operations. Accordingly, we disclosed the depreciation and amortization, capital expenditures and significant operating and investing non-cash items related to the corporate clinic segment below.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The key components of Net income (loss) from discontinued operations that were included in our consolidated income statements are as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from company-owned or managed clinics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">54,038,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">69,982,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">54,038,508&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">69,982,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">IT cost of revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47,817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,971&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47,817&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,755,830&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,850,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">69,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,350,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">39,450,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">54,988,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">45,276,306&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">66,190,144&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss on disposition or impairment from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,441,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,714,555&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,300,221&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,970,172)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income tax expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,200,629&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,972,286)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">210,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from discontinued operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,175,422&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,182,549)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the major classes of assets and liabilities of discontinued operations that were included in our consolidated balance sheets:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">315,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,484,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">581,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">549,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,051,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">38,395,986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">67,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">208,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets (attributable to VIEs)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">994,138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,087,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deposits and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">235,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">425,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets, discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">22,246,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">43,151,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">83,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">67,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,519,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,066,941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Payroll liabilities ($0.6 million and $0.9 million attributable to VIEs, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">988,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,333,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">651,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">153,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">38,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities (attributable to VIEs)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">756,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,079,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities to be disposed of ($4.7 million and $5.2 million attributable to VIEs, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,368,318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">28,629,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, discontinued operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21,368,446&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">37,367,459&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The key components of cash flows from discontinued operations are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Significant operating and investing non-cash items</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">69,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,350,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss on disposition or impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,441,010&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,714,555&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Capital expenditures</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">84,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">664,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The clustered clinics are in varying stages of sales negotiations with approximately all of the company-owned or managed clinics expected to be recognized as a completed sale within one year with an estimated fair value of $2.6 million at December&#160;31, 2025. Effective with the designation as held for sale, we discontinued recording depreciation on property and equipment, net, amortization of intangible assets, net and amortization of ROU assets for the clinics as required by GAAP. We reported the related assets and liabilities of the clinics as held for sale as discontinued operations in our December&#160;31, 2025 and 2024 consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets that meet the criteria for the held for sale designation are reported at the lower of their carrying value or fair value less estimated cost to sell. As a result of our evaluation of the recoverability of the carrying value of the assets and liabilities held for sale relative to the clinics estimated fair values, we recorded an estimated loss on disposal of $2.7 million and $4.5 million for the years ended December&#160;31, 2025 and 2024, respectively, in Income (loss) from discontinued operations before income tax expense in our consolidated income statements and a valuation allowance included in discontinued operations current assets in our consolidated balance sheets. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2025, in connection with the sale of company-owned or managed clinics classified as held for sale as of December&#160;31, 2024 for a combined sales price of $7.8 million, we sold $16.4 million assets held for sale, net of a $1.0 million valuation allowance and $7.4 million of liabilities to be disposed of in the consolidated balance sheets as of December&#160;31, 2024. As a result of the sales, we recorded a loss of $0.6 million included in Income (loss) from discontinued operations before income tax expense on the consolidated income statements for the year ended December&#160;31, 2025.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2024, in connection with the sale of company-owned or managed clinics classified as held for sale as of December 31, 2023 for a combined sales price of $0.6 million, we sold $1.3 million assets held for sale, net of a $0.1 million valuation allowance and $0.8 million of liabilities to be disposed of in the consolidated balance sheets as of December 31, 2023. As a result of the sales, we recorded a gain of $0.1 million included in Income (loss) from discontinued operations before income tax expense on the consolidated income statements for the year ended December&#160;31, 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The principal components of the held for sale assets and liabilities to be disposed of as of December&#160;31, 2025 and 2024 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,497,545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,457,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,111,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,643,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,288,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,906,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,482,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,459,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(6,327,644)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5,071,603)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,051,965&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">38,395,986&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,065,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,526,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue from company-owned or managed clinics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,302,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,102,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities to be disposed of</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,368,318&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">28,629,103&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The pre-tax income of the clinics designated as held for sale as of December&#160;31, 2025 was $4.6 million and $4.7 million for the years ended December&#160;31, 2025 and 2024, respectively, the results of which exclude the allocation of corporate overhead.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205-20/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text">Property and Equipment<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consist of the following:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Office and computer equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">982,766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">937,551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,594,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,585,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Internally developed software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,103,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,914,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,680,909&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,437,414&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(7,511,832)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5,982,533)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,169,077&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,454,881&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">990,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">751,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property and Equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,159,226&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,206,754&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $1.6 million and $1.4 million for the years ended December&#160;31, 2025 and 2024, respectively.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Construction in progress at December&#160;31, 2025 and 2024 related primarily to internal use software in development.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Consideration<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Consideration</a></td>
<td class="text">Fair Value Consideration<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments include cash and cash equivalents, restricted cash, accounts receivable, accounts payable and accrued expenses. The carrying amounts of our financial instruments, excluding cash equivalents, approximate their fair value due to their short maturities. Cash equivalents consist of money market funds for which cost approximates fair values. Cash equivalents have an approximate fair value of $19.2&#160;million as of December&#160;31, 2025, which was determined using Level 1 inputs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Authoritative guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The guidance establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability, developed based on market data obtained from sources independent of our company. Unobservable inputs are inputs that reflect our assumptions of what market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on reliability of the inputs as follows:</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level 1:&#160;&#160;&#160;&#160;Observable inputs such as quoted prices in active markets;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level 2:&#160;&#160;&#160;&#160;Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly;&#160;and</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level 3:&#160;&#160;&#160;&#160;Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its   own assumptions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2025 and 2024, we did not have any financial instruments that were measured on a recurring basis as Level 1, 2 or 3.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our non-financial assets, included in both continuing and discontinued operations, which primarily consist of goodwill, intangible assets, property, plant and equipment, and operating lease ROU assets, are not required to be measured at fair value on a recurring basis, and instead are reported at their carrying amount. However, on a periodic basis whenever events or changes in circumstances indicate that their carrying amount may not be fully recoverable (and at least annually for goodwill), non-financial assets are assessed for impairment. If the fair value is determined to be lower than the carrying amount, an impairment charge is recorded to write down the asset to its fair value, which is considered Level 3 within the fair value hierarchy. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The assets and liabilities resulting from acquisitions, included in discontinued operations, were recorded at fair values on a nonrecurring basis at the date of acquisition and are considered Level 3 within the fair value hierarchy.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets that meet the held for sale criteria are reported at the lower of their carrying value or fair value, less estimated costs to sell. The estimated fair values of the company-owned or managed clinics classified as Held for Sale (see Note 3, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">) were recorded in discontinued operations current assets at fair values on a nonrecurring basis and are based upon Level 2 inputs, which includes a potential buyer agreed-upon selling price or Level 3 inputs, which includes consideration of a market approach using a multiple of earnings assumption based on clinic-level historical financial performance as well as an income approach using discounted cash flow ("DCF") models that use significant unobservable inputs and assumptions. Key inputs in the DCF models included projected cash flows over a 10-year forecast period, based on clinic-level historical financial performance and management's expectations of future operating results. A terminal value was estimated using the Gordon Growth Model for locations with positive cash flows. For locations with projected negative cash flows, no terminal value was assigned, as these clinics were assumed to cease operations upon lease termination. The future cash flows and terminal value were discounted to present value using a discount rate of 13.5% for clinics with positive cash flows and 4.2% for clinics with negative cash flows, which reflect the risk profile of the underlying operations and market conditions as of the measurement date. The fair value measurement of the assets held for sale as of December&#160;31, 2025, which included all company-owned or managed clinics, was recorded as $0.1 million based upon Level 2 inputs and $2.5 million based upon Level 3 inputs. As a result, we maintain a valuation allowance of $6.3 million to adjust the carrying value of the disposal group to fair value less cost to sell as of December&#160;31, 2025. The fair value measurement of the assets held for sale as of December&#160;31, 2024, which included all company-owned or managed clinics, was recorded as $0.4&#160;million based upon Level 2 inputs and $26.9&#160;million based upon Level 3 inputs as of December&#160;31, 2024. As a result, we recorded a valuation allowance of $5.1&#160;million to adjust the carrying value of the disposal group to fair value less cost to sell during the year ended December&#160;31, 2024.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets classified as held and used where the asset group was not determined to be recoverable are tested for impairment. During the years ended December&#160;31, 2025 and 2024, in connection with the planned sale or determined closure of certain company-owned or managed clinics, we recorded an impairment loss of zero and $2.7&#160;million, respectively, included in Income (loss) from discontinued operations before income tax expense in our consolidated income statements for impairment of long-lived assets classified as held and used where the asset group was not determined recoverable. The asset group was determined to be the clinic level, as this is the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. The long-lived assets fair values were determined by the following: Level 1 inputs, which included observable inputs from executed lease termination agreements; Level 2 inputs where available, which included using a valuation multiple (e.g., price per square foot) based on observable prices for comparable long-lived assets; and Level 3 inputs, which included a multiple of earnings assumption using our historical earnings trend data, comparable historical asset sales by us and franchisees that were not exact matc</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">hes, and (for calculating the fair value of intangible assets specifically) our historical experience, future projections and comparable market data include future cash flows, long-term growth rates, attrition rates and discount rates. Generally, a change in the assumption used for the multiple inputs would have resulted in a directionally similar change of the fair value measurement where a multiple of earnings assumption was used.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of these asset groups impaired to their fair value during the year ended December&#160;31, 2024 included ROU assets of $5.8&#160;million that were written down to $4.3&#160;million determined by Level 1 and Level 2 inputs. The carrying values of these asset groups impaired to their fair value also included property and equipment of $3.9&#160;million that were written down to $2.8&#160;million and reacquired rights of $299 thousand that were written down to $253 thousand both determined by Level 3 inputs discussed above. The carrying value for nearly all company-owned or managed asset groups were reclassified to assets held for sale as of December&#160;31, 2024.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Agreement</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2020, we entered into a Credit Agreement (the &#8220;Credit Agreement&#8221;), with JPMorgan Chase Bank, N.A., individually, and as Administrative Agent and Issuing Bank (&#8220;JPMorgan Chase&#8221; or the &#8220;Lender&#8221;). The Credit Agreement provided for senior secured credit facilities (the &#8220;Credit Facilities&#8221;) in the amount of $7.5 million, including a $2.0 million revolver (the &#8220;Revolver&#8221;) and a $5.5 million development line of credit (the &#8220;Line of Credit&#8221;). The Revolver included amounts available for letters of credit of up to $1.0 million and an uncommitted additional amount of $2.5 million. All outstanding principal and interest on the Revolver were due on February 28, 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2022, we entered into an amendment to the Credit Facilities (as amended, the &#8220;2022 Credit Facility&#8221;) with the Lender. Under the 2022 Credit Facility, the Revolver increased to $20.0 million (from $2.0 million), the portion of the Revolver available for letters of credit increased to $5.0 million (from $1.0 million), the uncommitted additional amount increased to </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$30.0 million (from $2.5 million) and the developmental line of credit of $5.5 million was terminated. The Revolver will be used for working capital needs, general corporate purposes and for acquisitions, development and capital improvement uses. At our option, borrowings under the 2022 Credit Facility bear interest at: (i) the adjusted Secured Overnight Financing Rate (&#8220;SOFR&#8221;), which is the daily simple SOFR, plus 0.10%, plus 1.75%, payable on the last day of the selected interest period of one, three or six months, and on the three-month anniversary of the beginning of any six-month interest period, if applicable; or (ii) an Alternative Base Rate (ABR), plus 1.00%, payable monthly. The ABR is the greatest of: (A) the prime rate (as published by the Wall Street Journal), (B) the Federal Reserve Bank of New York rate, plus 0.5%, and (C) the adjusted one-month term SOFR rate. Amounts outstanding under the Revolver on February 28, 2022 continued to bear interest at the rate selected under the Credit Facilities prior to the amendment until the last day of the interest period in effect, at which time, if not repaid, the amounts outstanding under the Revolver will bear interest at the 2022 Credit Facility rate. The 2022 Credit Facility will terminate and all principal and interest will become due and payable on the fifth anniversary of the amendment (February 28, 2027). On January 17, 2024, we paid down the outstanding balance on our Debt under the Credit Agreement of $2.0 million. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Facilities contain customary events of default, including but not limited to nonpayment; material inaccuracy of representations and warranties; violations of covenants; certain bankruptcies and liquidations; cross-default to material indebtedness; certain material judgments; and certain fundamental changes such as a merger or sale of substantially all assets (as further defined in the Credit Facilities). The Credit Facilities require us to comply with customary affirmative, negative and financial covenants, including minimum interest coverage and maximum net leverage. A breach of any of these operating or financial covenants would result in a default under the Credit Facilities. If an event of default occurs and is continuing, the lenders could elect to declare all amounts then outstanding, together with accrued interest, to be immediately due and payable. The Credit Facilities are collateralized by substantially all of our assets, including the assets in our company-owned or managed clinics. We intend to use the Revolver for general working capital needs. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2025, we entered into a consent and third amendment to the Credit Agreement (as amended, the &#8220;2025 Credit Facility&#8221;) with the Lender. Among other things, the 2025 Credit Facility contains the consent of the Lender to our refranchising of all company-owned or managed clinics which would have triggered certain default events included in the Credit Agreement. The 2025 Credit Facility also extended the maturity date of the Credit Facilities to August 31, 2027.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2025, there are no outstanding balances under our Credit Facilities or the 2025 Credit Facility. As of December&#160;31, 2025, we were in default of our Credit Facilities due to a violation of our fixed charge coverage ratio covenant primarily due to stock repurchases under the 2025 SRP, which constitute restricted payments. This prohibits our ability to draw upon our $20.0&#160;million Revolver under the 2022 Credit Facility until the covenant violation is resolved.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the issuance of the Credit Facilities and the 2022 Credit Facility, we incurred debt issuance costs of $53 thousand and $76 thousand, respectively. Interest expense and amortization expense related to debt issuance costs are being amortized to &#8220;Other expense, net&#8221; and was $22 thousand and $79 thousand for the years ended December&#160;31, 2025 and 2024, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders<span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">'</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> Equity</span><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchase Program</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On June 3, 2025, our Board of Directors approved the 2025 SRP to repurchase up to $5.0&#160;million of our common stock, par value $0.001 per share, from time to time until June 3, 2027 or such other date as we have exhausted, or the Board of Directors otherwise terminates, the repurchase authorization. On November 4, 2025, the Board of Directors authorized an additional $12.0&#160;million under the 2025 SRP and extended the repurchase date through November 4, 2027.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The timing, volume, price, and terms of the repurchases will depend on market and business conditions, applicable legal requirements, and other factors. The repurchases may be made on the open market, in privately negotiated transactions, or in such other manner (e.g., accelerated share repurchase transactions, block trades, derivatives, or otherwise) that complies with the terms of applicable federal and state securities laws and regulations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">During the year ended December&#160;31, 2025, we repurchased $11.3 million of common stock at an average price of $8.73 per share, excluding related costs and fees. As of December&#160;31, 2025, we had a remaining $5.7 million authorized for repurchasing shares of our common stock. All shares of common stock that we repurchased are held as treasury stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Treasury Stock</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2025 and 2024, shares of common stock at a total cost of $8 thousand and $10 thousand, respectively, were netted and surrendered as payment for minimum statutory withholding obligations in connection with the vesting of outstanding stock awards. hares surrendered by the participants in accordance with the applicable award agreements and plan are deemed repurchased by us but are not part of publicly announced stock repurchase programs.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We grant stock-based awards under our 2024 Incentive Stock Plan (the &#8220;2024 Plan&#8221;). The shares issued as a result of stock-based compensation transactions generally have been funded with the issuance of new shares of our common stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may grant the following types of incentive awards under the 2024 Plan: (i) non-qualified stock options; (ii) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; and (v) restricted stock units. Each award granted under the 2024 Plan is subject to an award agreement that incorporates, as applicable, the exercise price, the term of the award, the periods of restriction, the number of shares to which the award pertains, and such other terms and conditions as the plan committee determines. Awards granted under the 2024 Plan are classified as equity awards, which are recorded in stockholders&#8217; equity in our consolidated balance sheets. Through December&#160;31, 2025, we have granted under the 2024 Plan (i) non-qualified stock options; (ii) incentive stock options; and (iii) restricted stock. There were no stock appreciation rights or restricted stock units granted under the 2024 Plan as of December&#160;31, 2025. As of December&#160;31, 2025, 1,725,057 shares of common stock remained available for issuance under the 2024 Plan.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our closing price on the date of grant is the basis of fair value of its common stock used in determining the value of share-based awards. To the extent that the value of our share-based awards involves a measure of volatility, we use available historical volatility of our common stock over a period of time corresponding to the expected stock option term. We use the simplified method to calculate the expected term of stock option grants to employees. Accordingly, the expected life of the options granted is based on the average of the vesting term, which is generally four years and the contractual term, which is generally ten years. The risk-free interest rate is based on United States Treasury yields in effect at the date of grant for periods corresponding to the expected stock option term. Forfeitures are estimated based on historical and forecasted turnover, which is approximately 5%.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We did not grant any options during the year ended December&#160;31, 2025. We have computed the fair value of all options granted using the Black-Scholes-Merton model during the year ended December&#160;31, 2024, using the following assumptions:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">64%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.25</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.86%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The information below summarizes the stock options activity:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual Life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">486,334&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8.88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,903,699&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted at market price</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">38,059&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.51&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(227,952)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,435,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(9,201)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">26.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5,263)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">41.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December&#160;31, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">281,977&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11.80&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">777,566&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(123,460)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.04&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">656,751&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(89,604)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(432)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">45.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December&#160;31, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">68,481&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14.33&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">59,412&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December&#160;31, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">39,936&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17.06&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">59,412&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at December&#160;31, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">66,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14.47&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">59,412&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant-date fair value of our stock options granted during the year ended December&#160;31, 2024 was $6.21.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate fair value of our stock options vested during 2025 and 2024 was $157 thousand and $319 thousand, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We recognize compensation costs ratably over the period of service using the straight-line method. Forfeitures are estimated based on historical and forecasted turnover, which is approximately 5%. For the years ended December&#160;31, 2025 and 2024, stock-based compensation expense for stock options was $73 thousand and $141 thousand, respectively. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Unrecognized stock-based compensation expense for stock options as of December&#160;31, 2025 was $166 thousand, which is expected to be recognized ratably over the next 2.8 years.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock awards granted to employees generally vest in four equal annual installments.</span><span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock awards granted to non-employee directors vest on the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting of the shareholders of our company occurring after the date of grant.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The information below summarizes the restricted stock activity:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.445%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant-Date Fair Value per Award</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at December&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">231,901&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17.32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">285,656&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(107,103)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(104,472)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at December&#160;31, 2024</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">305,982&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11.97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">301,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(107,854)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(146,534)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at December&#160;31, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">353,490&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.86&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2025 and 2024, stock-based compensation expense for restricted stock was $1.2 million and $1.5 million, respectively. Unrecognized stock-based compensation expense for restricted stock awards as of December&#160;31, 2025 was $2.9 million to be recognized ratably over 2.9 years.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax Benefits</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) for 2025 and 2024 included pre-tax expense related to stock-based compensation of $1.3 million and $1.7 million, respectively. We recognized federal income tax benefits of zero and $0.1 million from the exercises of stock options and restricted stock awards for 2025 and 2024, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The components of loss from continuing operations before the provision for income taxes, by taxing jurisdiction are as follows: </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Domestic </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(229,504)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,608,738)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(229,504)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,608,738)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense reported in the consolidated income statements is comprised of the following:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Current expense:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">State, net of state tax credits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">38,653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">62,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total current expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">38,653&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">62,759&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Deferred expense (benefit):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(57,153)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(57,153)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">38,653&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,606&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The tax effects of temporary differences that give rise to significant components of the deferred tax assets and liabilities are provided below:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">757,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,607,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,535,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,909,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,795,895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,710,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill - component 1</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">383,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill - component 2</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">49,829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">55,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">471,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonqualified stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">117,962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">322,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,261,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,029,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">35,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">35,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,416,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,921,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">141,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">139,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,968,588&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18,730,802&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(11,327,659)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(12,307,555)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,640,929&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,423,247&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Lease ROU asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,320,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5,392,996)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred franchise costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(320,837)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(75,284)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill - component 1</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(807,824)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(147,143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,640,929)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(6,423,247)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income taxes</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A valuation allowance of $11.3 million and $12.3 million was recorded against the deferred tax asset balance of The Joint Corp., without its VIEs, as of December&#160;31, 2025 and 2024, respectively. During the year ended December&#160;31, 2025, the valuation allowance decreased by $1.0 million. As of each reporting date, we consider new evidence, both positive and negative, that could impact our view with regard to future realization of deferred tax assets in each reporting jurisdiction. A significant piece of objective evidence evaluated was the cumulative loss incurred in each jurisdiction over the three-year period ended December&#160;31, 2025. Such objective evidence limits the ability to consider other subjective evidence, such as projections for future growth, in evaluating the need for a valuation allowance. As a result, we determined that it is more likely than not that The Joint Corp. will not realize its deferred tax assets as of December&#160;31, 2025, and has recorded a valuation allowance after consideration of any recorded deferred tax liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, deferred tax assets attributable to its VIEs of $1.0 million and $1.1 million were classified as discontinued operations as of December&#160;31, 2025 and 2024, respectively, and are related to deferred revenue. See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for more information on discontinued operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Joint Corp., without the VIEs, has federal gross net operating loss carryforwards of $10.2 million and $12.3 million as of December&#160;31, 2025 and 2024, respectively. The federal tax effected impacts of these net operating losses were $2.1 million and $2.6 million as of December&#160;31, 2025 and 2024, respectively. $7.8 million of the federal net operating loss as of December&#160;31, 2025 is subject to a 20-year carryforward, with a portion beginning to expire in 2036. $2.3 million of the federal net operating loss as of December&#160;31, 2025 has an indefinite carryforward period.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Joint Corp., without the VIEs, has state net operating loss carryforwards of $10.2&#160;million and $3.6&#160;million as of December&#160;31, 2025 and 2024, respectively. The determination of the state net operating loss carryforwards is dependent upon apportionment percentages and state laws that can change from year to year and impact the amount of such carryforwards. If such net operating loss carryforwards are not utilized, a portion will begin to expire in 2026.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have research and development credits of $14 thousand that will begin to expire in 2031 and California Alternative Minimum Tax credits of $22 thousand that do not expire.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes differs from the amount calculated using the statutory federal corporate income tax rate of 21% due to the following items:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.162%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Percent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss from continuing operations before provision for income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(229,504)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,608,738)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected federal tax expense at U.S. federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(48,388)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(337,835)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes (net of federal income tax effect) (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(128,782)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">56.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">79,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Changes in valuation allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(507,419)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">221.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">66,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nontaxable or nondeductible items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Section 162(m) officer compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">85,992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Share based compensation (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(28,302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(119,263)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Payroll tax penalty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(45,749)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Meals and entertainment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">23,549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(10.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">30,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">26,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Changes in unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">300,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(130.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">212,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(13.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Other adjustments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Deferred true-up to deferred franchise costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">285,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(124.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Current year expirations of non-qualified stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">217,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(94.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(47,819)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(39,286)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax expense and effective rate</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">38,653&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(16.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,606&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">___________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(1) State taxes in Arizona, California and Texas made up the majority (greater than 50%) of the tax effect in this category.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(2) Share based compensation includes incentive stock options, non-qualified stock options and restricted stock awards.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Changes in our income tax expense relate primarily to state income taxes (net of federal tax and permanent differences), changes in tax rates, stock compensation, shortfall/windfall on stock compensation expense, change in valuation allowance and uncertain tax positions during the year ended December&#160;31, 2025, as compared to the year ended December&#160;31, 2024. For the years ended December&#160;31, 2025 and 2024, effective tax rates were (16.8)% and (0.3)%, respectively. The difference between the statutory federal income tax rate and our effective tax rate was primarily due to the uncertain tax position net impact and state taxes (net of federal taxes) for the year ended December&#160;31, 2025. The difference between the statutory federal income tax rate and our effective tax rate was primarily due to the valuation allowance, change in tax rate and uncertain tax position for the year ended December&#160;31, 2024. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We apply a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit or obligation as the largest amount that is more than 50% likely of being realized upon ultimate settlement. We consider many factors when evaluating and estimating our tax positions and tax benefits, which may require periodic adjustments.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2025 and 2024, we had gross uncertain tax positions attributable to the VIEs, recorded as discontinued operations, of $0.6&#160;million and $0.9&#160;million, respectively. </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">948,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,175,766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for expiration of the statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(314,468)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(227,584)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">633,714&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">948,182&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2025 and December&#160;31, 2024, there were $20 thousand and $22 thousand, respectively, of unrecognized tax benefits that if recognized would affect the annual effective tax rate.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Interest and penalties associated with tax positions are recorded in the period assessed as general and administrative expenses. Accrued interest and penalties were $178 thousand and $202 thousand for the years ended December&#160;31, 2025 and 2024, respectively, and recorded as other liabilities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The amount of cash paid for income taxes (net of refunds received) was as follows: </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">321,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">285,510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">State:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Arizona</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">62,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;California</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">168,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">182,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Texas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">62,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">51,026&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other state jurisdictions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">91,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid (net of refunds received)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">626,752&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">610,492&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">With exceptions due to the generation and utilization of net operating losses or credits, as of December&#160;31, 2025, we are no longer subject to federal and state examinations by taxing authorities for tax years before 2022 and 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the components of lease expense and income statement location for the years ended December&#160;31, 2025 and 2024:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.423%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Line Item in our Consolidated Income Statements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Operating lease costs:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">355,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">325,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">355,912&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">325,396&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information and balance sheet location related to leases for the years ended December&#160;31, 2025 and 2024 was as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of -use asset</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,572,173&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">555,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability, current portion</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">194,179&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">483,337&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,815,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">311,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liability</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,009,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">795,026&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining lease term (in years):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.6</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases for the years ended December&#160;31, 2025 and 2024 were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in measurement of liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">460,056&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">505,577&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash transactions: ROU assets obtained in exchange for lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,554,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of December&#160;31, 2025 were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.789%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">268,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">467,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">479,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">491,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">503,374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">211,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,421,699&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(411,993)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total lease obligations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,009,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(194,179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Long-term lease obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,815,527&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guaranties in Connection with the Sale of the Divested Business</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale of company-owned or managed clinics, we guaranteed 39 future operating lease commitments assumed by the buyers. We are obligated to perform under the guaranties if the buyers fail to perform under the lease agreements at any time during the remainder of the term of the lease agreements, the latest of which expires on December&#160;31, 2033. As of December&#160;31, 2025, the undiscounted maximum remaining lease payments totaled $5.0 million. We have not recorded a liability with respect to our obligations under the guaranties as of December&#160;31, 2025, as we concluded that payment under the guaranties was not probable.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we are party to litigation and claims from time to time. We maintain insurance to cover certain litigation and claims, subject to policy limits. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2024, we entered into settlement agreements from litigation related to employment matters of $1.5&#160;million that was outside the normal course of business which we have accrued for in discontinued operations current liabilities as of December&#160;31, 2025. The settlement is expected to be paid out during the first quarter of 2026.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, ongoing litigation related to a medical injury claim between a patient (&#8220;the Claimant&#8221;) and us filed on September 5, 2023 reached a settlement agreement on February 25, 2025. Per the terms of the settlement agreement, we and our insurance will pay the claimant $3.4 million. We accrued the settlement recorded in discontinued operations current liabilities for $3.4 million as of December&#160;31, 2024. The expense from the accrual was offset by a receivable recorded as discontinued operations current assets from our insurance providers for $1.9 million as of December&#160;31, 2024. The settlement was paid in full during the first quarter of 2025.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In 2025, we determined that the likelihood of a loss related to multiple lawsuits, including three cases consolidated into one class action lawsuit (but not yet certified), six individual cases related to each other by the court and two unrelated individual cases, all filed against us and a chiropractor employed by the professional corporation providing clinical services in 2024, 2025 and 2026 in the State of California became probable. The initial lawsuit was filed against us on June 6, 2024 with the Superior Court of California in Los Angeles County. The lawsuits allege, among other claims, an invasion of privacy, negligence, emotional distress, sexual harassment, unlawful recording, failure to provide a safe environment and trespass on person at one of our company-owned or managed clinics. The lawsuits are currently in discovery and trial is scheduled to begin in early 2027. We intend to continue to defend these cases vigorously, but it is not possible at this time to reasonably estimate the outcome of or any potential liability from these cases and therefore, no accrual exists as of December&#160;31, 2025. We also note that our exposure to these cases may be limited by our insurance coverage, but the potential exposure is undetermined as of December&#160;31, 2025.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2025, we incurred litigation expenses, including settlement costs related to employment matters that were outside the normal course of business, of $0.4&#160;million, included as Income (loss) from discontinued operations before income tax expense in our consolidated income statements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2024, we incurred litigation expenses, including settlement costs related to employment matters that were outside the normal course of business and a medical injury claim, of $3.0&#160;million, included as Income (loss) from discontinued operations before income tax expense in our consolidated income statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment Reporting<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">An operating segment is defined as a component of an enterprise for which discrete financial information is available and is reviewed regularly by the Chief Operating Decision Maker (&#8220;CODM&#8221;) to evaluate performance and make operating decisions. We have identified the Chief Executive Officer as our CODM.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we had two operating business segments: (1) Corporate Clinics, and (2) Franchise Operations. The Corporate Clinics segment is comprised of the activities of the company-owned or managed clinics. In the fourth quarter of 2024, as part of our refranchising strategy, all but one of the company-owned or managed clinics in the Corporate Clinic segment met the criteria to be reported as discontinued operations as of December 31, 2024 (Refer to Note 3, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for financial information on the discontinued operating Corporate Clinics segment). Therefore, since December 31, 2024, we have had one reportable segment: Franchise Operations. As of December 31, 2025, all company-owned or managed clinics in the Corporate Clinic segment met the criteria to be reported as discontinued operations. In accordance with Accounting Standards Codification 205-20, Discontinued Operations, expenses that in prior periods were partially allocated to the Corporate Clinic segment that are not wholly related to the activity of the segment have been recast to be presented in continuing operations, which is now Franchise Operations. Additionally, any expenses previously identified as Corporate Unallocated have been allocated entirely to the Franchise Operations segment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue primarily from customers by providing access to our franchise license, which represents symbolic intellectual property (See Note 2, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Disclosures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for additional details). The Franchise Operations segment is managed on a consolidated basis because all operations are located within a similar economic and regulatory environment, provide the same services and share the same business model and pricing strategies. As of December&#160;31, 2025, the franchise system consisted of 885 clinics in operation. The accounting policies for the franchise segment are the same as those described in Note 1, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nature of Operations and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. The CODM uses the following metrics to </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">assess performance and determine how to allocated resources; Net Income, Gross Profit, Operating Income, and Adjusted EBITDA. Net Income, Gross Profit, and Operating Income are reported on the consolidated income statements. Adjusted EBITDA is presented in </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations, Non-GAAP Financial Measures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and is reconciled back to consolidated Net loss from continuing operations on the consolidated income statements. The measure of segment assets is reported on the balance sheet as total consolidated assets. The CODM uses these financial measures to evaluate income generated from segment assets (return on assets) in deciding whether to reinvest profits in the Franchise Segment or into other parts of the entity, such as new products or services, expanding into new geographic territories, acquisitions or reacquisitions, or stock buybacks. Net Income and Adjusted EBITDA are used to monitor budget verses actual results. The CODM also uses Net Income and Adjusted EBITDA in conjunction with certain non-financial metrics in competitive analysis by benchmarking to our competitors. The competitive analysis along with the monitoring of budgeted verses actual results are used in assessing performance of the segment and in establishing management&#8217;s compensation. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes total revenue and significant expense categories and amounts for our reportable segment that aligns with the segment level information that is regularly provided to the CODM:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">54,895,592</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">52,163,430</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Franchise and regional developer cost of revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,500,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,063,644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">IT cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,724,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,453,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,299,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,973,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">27,256,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">27,359,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,297,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,679,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items, net</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">401,706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">871,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,644,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,371,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">38,653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Segment loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(268,157)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,614,344)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(268,157)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,614,344)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,175,422&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,182,549)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,907,265&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5,796,893)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">(a) </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other segment items, net includes interest income, acquisition related expenses, net loss on disposition or impairment, costs related to restatement filings, and restructuring costs.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">Related Party Transactions<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Jefferson Gramm, Managing Partner of Bandera Partners LLC, who is a beneficial holder of more than 5% of our outstanding common stock (approximately 28% as of December&#160;31, 2025), was appointed to the Board of Directors effective as of January 2, 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, we sold two franchise licenses at $40 thousand and $30 thousand each (which reflects the $10 thousand multi-unit discount for the second license per the Franchise Disclosure Document) to Marshall Gramm, who is a family member of Mr. Jefferson Gramm. In April 2020 and 2021, we sold two franchise licenses at $40 thousand and $30 thousand, respectively (which reflects the $10 thousand multi-unit discount for the second license per the Franchise Disclosure Document), to a franchisee of which Mr. Jefferson Gramm is a 50% co-partner in the business. In the fourth quarter of 2024, Mr. Jefferson Gramm divested his interest in the clinics to which he is a 50% co-partner in the business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">These transactions involved terms no less favorable to us than those that would have been obtained in the absence of such affiliation. Although we have no way of estimating the aggregate amount of franchise fees, royalties, advertising fund fees, IT </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">related income and computer software fees that these franchisees will pay over the life of the franchise licenses, the franchisees affiliated with Mr. Gramm are subject to such fees under the same terms and conditions as all other franchisees.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, Mr. Gramm loaned approximately $370 thousand to an unaffiliated franchisee that owns and operates one franchise clinic. The loan is not secured by the assets of the business and there are no foreclosure rights. As of December&#160;31, 2025, the remaining balance on the unsecured loan was approximately $196 thousand.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Financial Data (Unaudited)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Quarterly Financial Data (Unaudited)</a></td>
<td class="text">Quarterly Financial Data (Unaudited)<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Selected quarterly financial data for the years ended December&#160;31, 2025 and 2024 is summarized below:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.068%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.407%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Q1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Q2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Q3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Q4</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Q1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Q2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Q3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Q4</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">13,077,590&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">13,270,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">13,380,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">15,167,047&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">54,895,592&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">12,184,716&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">12,610,036&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">12,654,396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">14,714,282&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">52,163,430&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Total costs of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">2,972,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">2,772,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">2,661,234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">2,819,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">11,225,474&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">2,704,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">2,812,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">2,814,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">3,184,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">11,516,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Selling and marketing expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">3,505,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">3,483,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">2,816,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">3,494,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">13,299,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">2,237,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">3,440,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">2,504,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">2,791,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">10,973,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">361,930&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">402,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">446,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">433,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">1,644,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">329,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">342,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">345,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">353,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">1,371,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">6,914,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">7,745,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">7,295,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">7,676,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">29,632,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">7,339,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">7,793,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">7,478,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">7,513,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">30,124,589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Total selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">10,782,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">11,631,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">10,558,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">11,603,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">44,575,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">9,906,525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">11,576,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">10,328,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">10,658,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">42,469,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Net loss on disposition or impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">1,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">4,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">1,485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">7,898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">3,581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">61,501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">66,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(Loss) income from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(678,534)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(1,138,167)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">160,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">742,410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(913,376)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(426,596)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(1,779,325)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(492,820)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">809,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(1,889,025)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">185,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">159,922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">139,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">198,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">683,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">36,259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">80,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">83,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">79,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">280,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(Loss) income from continuing operations before income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(492,617)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(978,245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">300,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">940,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(229,504)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(390,337)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(1,698,854)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(408,992)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">889,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(1,608,738)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">13,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">11,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">10,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">3,513&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">38,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">8,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">11,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">5,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(19,536)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">5,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Net (loss) income from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(506,021)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(989,635)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">290,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">937,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(268,157)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(398,919)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(1,710,023)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(414,383)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">908,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(1,614,344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations before income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">1,577,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">1,183,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">664,269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(224,068)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">3,200,629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">1,516,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(1,719,222)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(2,693,562)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(1,075,745)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(3,972,286)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Income tax expense(benefit) from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">103,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">100,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">99,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(278,036)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">25,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">170,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">167,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">57,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(184,429)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">210,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">1,473,817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">1,082,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">564,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">53,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">3,175,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">1,345,898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(1,886,375)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(2,750,756)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(891,316)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(4,182,549)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">967,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">93,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">855,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">991,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">2,907,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">946,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(3,596,398)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(3,165,139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">17,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(5,796,893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Net (loss) income from continuing operations per common share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.06)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.06)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss) from discontinued operations per common share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.06)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.06)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss) per common share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 270<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/270/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our Chief Technology Officer (&#8220;CTO&#8221;) is responsible for cybersecurity within our company, including information technology risks, controls, strategies and procedures. The Cybersecurity Subcommittee of the Board of Directors oversees cybersecurity for our company and meets with the CTO at least quarterly to discuss the status of cybersecurity efforts as well as any security incidents. Cybersecurity Subcommittee materials are provided to the Audit Committee as well as the full Board of Directors. The members of the Cybersecurity Subcommittee collectively bring at least 40 years of expertise and executive-level experience in information technology and cybersecurity to successfully support the CTO to maintain a strong cybersecurity strategy within our company. The Board of Directors believes that a strong cyber strategy based on industry accepted best practices is vital to protect our business, customers and assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our CTO leverages more than 20 years of technology experience in the healthcare and financial services industries involving managing information security, developing cybersecurity strategy, implementing effective information and cybersecurity programs and managing within highly regulated global environments. He has managed technology compliance under the regulatory governance of frameworks such as HIPAA, GDPR, FDA, CCPA and TJC Hospital Accreditation. Management has the responsibility to manage risk and bring to the Board of Directors attention the most material near-term and long-term risks to our Company. The CTO leads management&#8217;s assessment and management of cybersecurity risk and regularly reviews cybersecurity matters with management. The CTO reports to our Chief Executive Officer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A dedicated team of technology professionals works throughout the year to monitor all matters of risk relating to cybersecurity. We completed our ISO 27001 Information Security Management certification project culminating in a primary and secondary audit against the standard. We received our ISO 27001 certification after the successful completion of an external audit and remediation steps and will complete a regular external audit in March 2026. Additionally, we operate and are compliant under the following provisions: HIPAA attestation for the HIPAA Security Rule and the Health Information Technology for Economic and Clinical Health Act (HITECH) Breach Notification requirements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Vendors that have access to our information are required to manage such information in accordance with laws and appropriate privacy and security standards. Standards are applied on a per-contract basis and include requirements to have an information security program and report to us any incidents in which its confidential information or systems are compromised. Depending </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">on the nature of the vendors&#8217; access to our information, we monitor and evaluate the controls and governance established with the vendors ranging from a continuous cadence to at least quarterly.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have not directly encountered any incidents from cybersecurity threats to date, but in November 2022, a breach was suffered by one of our vendors, which resulted in the release of certain information with respect to our patients and employees. This breach is discussed in more detail in Item 1. Business, under Regulatory Environment entitled "HIPAA and State Privacy and Breach Notification Rules". Based upon our investigation and the cooperation with our vendor, we believe the data breach did not have a material adverse effect on our business or result in any material damage to us and do not believe are reasonably likely to materially affect our business strategy, results of operations, or financial condition. Although we have not yet been materially impacted by any cybersecurity incident, we are subject to cybersecurity threats, as discussed in Item 1A. Risk Factors, including in the risk factor entitled &#8220;If we fail to properly maintain the integrity of our data or to strategically implement, upgrade or consolidate existing information systems, our reputation and business could be materially adversely affected&#8221; and &#8220;If our security systems are breached, we may face civil liability and public perception of our security measures could be diminished, either of which would negatively affect our ability to attract and retain patients&#8221;.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We annually assess our cybersecurity programs against third-party requirements, including HIPAA and the Sarbanes-Oxley Act of 2002. We test multiple aspects of cybersecurity regularly, including annual pen testing over our proprietary information systems and our technical recovery and incident response procedures annually.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a robust privacy compliance program. Employees receive periodic email communications, which train them to detect and report malware, ransomware and other malicious software and social engineering attempts that may compromise our information technology systems. In the second quarter of 2024, we implemented the KnowBe4 security training system and completed our first annual training in August 2024. In 2025, we completed a semi-annual security and privacy training cycle utilizing the SIMBUS360 platform. In 2026, we will re-engage the KnowBe4 system with a heightened focus on phishing awareness.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Currently, we rely on an established major incident management and communication process to address any potential cybersecurity incidents. This established process includes the use of third party partnerships to make available the distinct skill sets needed to assist in properly responding to any cybersecurity threat. We have established defined response procedures to effectively address any cyber threat that may occur regardless of the safeguards in place that minimize the chance of a successful cyberattack. The response procedures are designed to identify, analyze, contain and remediate such cyber incidents expeditiously. These procedures and approach to safeguard our information and assets will be continuously monitored by management and updated to evolve with the current cyber landscape in alignment with the ISO 27001 standard mentioned above.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Currently, we rely on an established major incident management and communication process to address any potential cybersecurity incidents. This established process includes the use of third party partnerships to make available the distinct skill sets needed to assist in properly responding to any cybersecurity threat. We have established defined response procedures to effectively address any cyber threat that may occur regardless of the safeguards in place that minimize the chance of a successful cyberattack. The response procedures are designed to identify, analyze, contain and remediate such cyber incidents expeditiously. These procedures and approach to safeguard our information and assets will be continuously monitored by management and updated to evolve with the current cyber landscape in alignment with the ISO 27001 standard mentioned above.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text">The Cybersecurity Subcommittee of the Board of Directors oversees cybersecurity for our company and meets with the CTO at least quarterly to discuss the status of cybersecurity efforts as well as any security incidents. Cybersecurity Subcommittee materials are provided to the Audit Committee as well as the full Board of Directors. The members of the Cybersecurity Subcommittee collectively bring at least 40 years of expertise and executive-level experience in information technology and cybersecurity to successfully support the CTO to maintain a strong cybersecurity strategy within our company. The Board of Directors believes that a strong cyber strategy based on industry accepted best practices is vital to protect our business, customers and assets.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">Cybersecurity Subcommittee<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">The Cybersecurity Subcommittee of the Board of Directors oversees cybersecurity for our company and meets with the CTO at least quarterly to discuss the status of cybersecurity efforts as well as any security incidents. Cybersecurity Subcommittee materials are provided to the Audit Committee as well as the full Board of Directors. The members of the Cybersecurity Subcommittee collectively bring at least 40 years of expertise and executive-level experience in information technology and cybersecurity to successfully support the CTO to maintain a strong cybersecurity strategy within our company.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text">Our Chief Technology Officer (&#8220;CTO&#8221;) is responsible for cybersecurity within our company, including information technology risks, controls, strategies and procedures. The Cybersecurity Subcommittee of the Board of Directors oversees cybersecurity for our company and meets with the CTO at least quarterly to discuss the status of cybersecurity efforts as well as any security incidents. Management has the responsibility to manage risk and bring to the Board of Directors attention the most material near-term and long-term risks to our Company. The CTO leads management&#8217;s assessment and management of cybersecurity risk and regularly reviews cybersecurity matters with management. The CTO reports to our Chief Executive Officer.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text">Our Chief Technology Officer (&#8220;CTO&#8221;) is responsible for cybersecurity within our company, including information technology risks, controls, strategies and procedures.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text">Our CTO leverages more than 20 years of technology experience in the healthcare and financial services industries involving managing information security, developing cybersecurity strategy, implementing effective information and cybersecurity programs and managing within highly regulated global environments. He has managed technology compliance under the regulatory governance of frameworks such as HIPAA, GDPR, FDA, CCPA and TJC Hospital Accreditation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text">Management has the responsibility to manage risk and bring to the Board of Directors attention the most material near-term and long-term risks to our Company. The CTO leads management&#8217;s assessment and management of cybersecurity risk and regularly reviews cybersecurity matters with management. The CTO reports to our Chief Executive Officer.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div>These financial statements represent the consolidated financial statements of The Joint Corp., which includes its variable interest entities (&#8220;VIEs&#8221;), and its wholly owned subsidiary, The Joint Corporate Unit No. 1, LLC (collectively, the &#8220;Company&#8221;). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amount of assets, liabilities, revenue, costs, expenses, other (expenses) income, and income taxes that are reported in the consolidated financial statements and accompanying disclosures. These estimates are based on management&#8217;s best knowledge of current events, historical experience, actions that we may undertake in the future and on various other assumptions that are believed to be reasonable under the circumstances. As a result, actual results may be different from these estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div>The accompanying consolidated financial statements include the accounts of The Joint and its wholly owned subsidiary, The Joint Corporate Unit No. 1, LLC, which was dormant for all periods presented. We consolidate VIEs in which we are the primary beneficiary in accordance with Accounting Standards Codification 810, Consolidations (&#8220;ASC 810&#8221;). Non-controlling interests represent third-party equity ownership interests in VIEs. All significant inter-affiliate accounts and transactions between The Joint and its VIEs have been eliminated in consolidation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income (Loss)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) and comprehensive income (loss) are the same for the years ended December&#160;31, 2025 and 2024.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_NatureofOperationsPolicyPolicyTextBlock', window );">Nature of Operations</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Operations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Joint Corp., a Delaware corporation, was formed on March 10, 2010 for the principal purpose of franchising, developing, selling regional developer rights, supporting the operations of franchised chiropractic clinics at locations throughout the United States of America. The franchising of chiropractic clinics is regulated by the Federal Trade Commission and various state authorities.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable Interest Entities</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Interest Entities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Certain states prohibit the &#8220;corporate practice of chiropractic,&#8221; which restricts business corporations from practicing chiropractic care by exercising control over clinical decisions by chiropractic doctors. In states that prohibit the corporate practice of chiropractic, we typically enter into long-term management agreements with professional corporations (&#8220;PCs&#8221;) that are owned by licensed chiropractic doctors, which, in turn, employ or contract with doctors who provide professional chiropractic care in our clinics. Under these management agreements with PCs, we provide, on an exclusive basis, all non-clinical services of the chiropractic practice. We have entered into such management agreements with four PCs. In connection with the sale of five company-owned or managed clinics located in Kansas and Missouri, we terminated our management agreement with one PC as of June 30, 2025. For additional information on clinic sales, refer to Note 3, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> If an entity is deemed to be the primary beneficiary of a VIE, the entity is required to consolidate the VIE in its financial statements. An entity is deemed to be the primary beneficiary of a VIE if it has both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE&#8217;s economic performance, and (b) the obligation to absorb the majority of losses of the VIE or the right to receive the majority of benefits from the VIE. In accordance with relevant accounting guidance, these PCs were determined to be VIEs, as fees paid by the PCs to us as our management service provider are considered variable interests because the fees do not meet all the following criteria: (1) the fees are compensation for services provided and are commensurate with the level of effort required to provide those services; (2) the decision maker or service provider does not hold other interests in the VIE that individually, or in the aggregate, would absorb more than an insignificant amount of the VIE&#8217;s expected losses or receive more than an insignificant amount of the VIE&#8217;s expected residual returns; and (3) the service arrangement includes only terms, conditions, or amounts that are customarily present in arrangements for similar services negotiated at arm&#8217;s length. Additionally, we have determined that we have the ability to direct the activities that most significantly impact the performance of these PCs and has an obligation to absorb losses or receive benefits which could potentially be significant to the PCs. Accordingly, the PCs are VIEs for which we are the primary beneficiary and are consolidated by us. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The revenues of VIEs represent the revenues of company-managed clinics in states that prohibit the corporate practice of chiropractic. Our involvement with VIEs affects our financial performance and cash flows primarily through amounts recorded as revenues from company-owned or managed clinics and general and administrative expenses, which are principally comprised of payroll and related expenses, merchant card fees and insurance expense, all of which are reported in Income (loss) from discontinued operations before income tax expense in our consolidated income statements. The management fees/income </span></div>provided by the management agreements are considered intercompany transactions and therefore eliminated upon consolidation of VIEs.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div>We consider all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. We continually monitor our positions with, and the credit quality of, the financial institutions with which we invest. As of the balance sheet date and periodically throughout the period, we have maintained balances in various operating accounts in excess of federally insured limits. We invest our cash primarily in short-term bank deposits and money market funds. We<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash relates to cash that franchisees and company-owned or managed clinics contribute to our National Marketing Fund and cash that franchisees provide to various voluntary regional Co-Op Marketing Funds. Cash contributed by franchisees to the National Marketing Fund is to be used in accordance with our Franchise Disclosure Document with a focus on regional and national marketing and advertising. While such cash balance is not legally segregated and restricted as to withdrawal or usage, our accounting policy is to classify these funds as restricted cash.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable</a></td>
<td class="text">Accounts receivable primarily represent amounts due from franchisees for royalty and software fees. Receivables are unsecured; however, the franchise agreements provide us the right to withdraw funds from the franchisee&#8217;s bank account or to terminate the franchise for nonpayment.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock', window );">Allowance for Credit Losses</a></td>
<td class="text">We record an allowance for credit losses as a reduction to our accounts receivables for amounts that we do not expect to recover. An allowance for credit losses is determined through assessments of collectability based on historical trends, the financial condition of our franchisees, including any known or anticipated bankruptcies, and an evaluation of current economic conditions, as well as our expectations of conditions in the future. Actual losses ultimately could differ materially in the near term from the amounts estimated in determining the allowance.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">Deferred Franchise Costs and Regional Development Costs</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Franchise Costs and Regional Development Costs</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Deferred franchise and regional development costs represent commissions that are direct and incremental to us and are paid in conjunction with the sale of a franchise license or regional development rights. These costs are recognized as an expense, in franchise and regional development cost of revenues when the respective revenue is recognized, which is generally over the term of the related franchise or regional developer agreement.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div>Property and equipment are stated at cost and relate mostly to the corporate headquarters leasehold improvements, its furniture and fixtures and other office and computer equipment. Depreciation is computed using the straight-line method over estimated useful lives, which is generally <span style="-sec-ix-hidden:f-425">three</span> to ten years. Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the assets. Maintenance and repairs are charged to expense as incurred; major renewals and improvements are capitalized. When items of property or equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is included in income.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InternalUseSoftwarePolicy', window );">Capitalized Software</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitalized Software</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize certain software development costs, including costs to implement cloud computing arrangements that is a service contract. These capitalized costs are primarily related to software used by clinics for operations and by us for the management of operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct, are capitalized as assets in progress until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. We also capitalize costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Internally developed software is recorded as part of property and equipment. Maintenance and training costs are expensed as incurred. Internally developed software is amortized on a straight-line basis over its estimated useful life, which is generally <span style="-sec-ix-hidden:f-430">three</span> to five years. Implementation costs incurred in&#160;connection with a cloud computing arrangement that is a service contract are included in prepaid expenses in our consolidated balance sheets.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We lease property and equipment under operating and finance leases. We lease our corporate office space and the space for each of the company-owned or managed clinics in the portfolio. We recognize a right-of-use (&#8220;ROU&#8221;) asset and lease liability for all leases. The lease for our corporate office space is recognized as a ROU and lease liability in our consolidated balance sheets as continuing operations while all other leases for each of the company-owned or managed clinics are reported in discontinued operations. Certain leases include one or more renewal options, generally for the same period as the initial term of the lease. The exercise of lease renewal options is generally at our sole discretion and, as such, we typically determine that exercise of these renewal options is not reasonably certain. As a result, we do not include the renewal option period in the expected lease term and the associated lease payments are not included in the measurement of the ROU asset and lease liability. When available, we use the rate implicit in the lease to discount lease payments; however, the rate implicit in the lease is not readily determinable for substantially all of our leases. In such cases, we estimate our incremental borrowing rate as the interest rate we would pay to borrow an amount equal to the lease payments over a similar term, with similar collateral as in the lease, and in a similar economic environment. We estimate these rates using available evidence such as rates imposed by third-party lenders to us in recent financings or observable risk-free interest rate and credit spreads for commercial debt of a similar duration, with credit spreads correlating to our estimated creditworthiness.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For operating leases that include rent holidays and rent escalation clauses, we recognize lease expense on a straight-line basis over the lease term from the date we take possession of the leased property. Pre-opening costs are recorded as incurred in general and administrative expenses. Variable lease payments, such as percentage rentals based on location sales, periodic adjustments for inflation, reimbursement of real estate taxes, any variable common area maintenance and any other variable costs associated with the leased corporate office space are expensed as incurred in general and administrative expenses on the consolidated income statements. Any variable costs associated with the leased property for company-owned or managed clinics are expensed as incurred and are included in Income (loss) from discontinued operations before income tax expense in our consolidated income statements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist primarily of reacquired franchise rights and customer relationships. All of our intangible assets are reported in discontinued operations. We amortize the fair value of reacquired franchise rights over the remaining contractual terms of the reacquired franchise rights at the time of the acquisition, which generally range from <span style="-sec-ix-hidden:f-437">one</span> to nine years. The fair value of customer relationships is amortized over their estimated useful life of <span style="-sec-ix-hidden:f-439">two</span> to four years. Intangible assets are attributable entirely to discontinued operations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill consists of the excess of the purchase price over the fair value of tangible and identifiable intangible assets acquired in the acquisitions of franchises. Goodwill and intangible assets deemed to have indefinite lives are not amortized but are tested for impairment annually and more frequently if a triggering event occurs that makes it more likely than not that the fair value of a reporting unit is below carrying value. As required, we perform an annual impairment test of goodwill as of the first day of the fourth quarter or more frequently if a triggering event occurs. Goodwill is attributable entirely to discontinued operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2025, we performed a quantitative assessment of the fair value of the reporting unit and concluded that the fair value of the corporate clinic reporting unit exceeded its carrying value. The fair value of the reporting unit was determined using Level 2 inputs, which includes a potential buyer agreed-upon selling price, or Level 3 inputs, which includes consideration of a market approach using a multiple of earnings assumption based on clinic-level historical financial performance as well as an income approach using discounted cash flow models that use significant unobservable inputs and assumptions.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsPolicyTextBlock', window );">Discontinued Operations</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Discontinued Operations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In determining whether a group of assets which has been disposed of (or is to be disposed of) should be presented as discontinued operations, we first analyze whether the group of assets being disposed of represents a component of the entity or group of components of the entity. A component typically has historic operations and cash flows that are clearly distinguishable for both operations and financial reporting purposes. In addition, we consider whether the disposal represents a strategic shift that has or will have a major effect on our operations and financial results. This strategic shift could include a disposal of a major geographical area, a major line of business, a major equity method investment or other major parts of an entity.</span></div>We report financial results for discontinued operations separately from continuing operations to distinguish the financial impact of disposal transactions from ongoing operations. The assets and liabilities of a discontinued operation held for sale, other than goodwill, are measured at the lower of its carrying amount or fair value less cost to sell. When a portion of a reporting unit that constitutes a business is to be disposed of, the goodwill associated with that business is included in the carrying amount of the business based on the relative fair values of the business to be disposed of and the portion of the reporting unit that will be retained.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long-Lived Assets - Continuing Operations</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Assets - Continuing Operations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recovered. We look primarily to estimated undiscounted future cash flows in our assessment of whether </span></div>or not long-lived assets are recoverable. We record an impairment loss when the carrying amount of the asset is not recoverable and exceeds its fair value.Long-lived assets that meet the criteria for the held for sale designation are reported at the lower of their carrying value or fair value less estimated cost to sell.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_AdvertisingFundPolicyTextBlock', window );">Advertising Fund</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising Fund</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have established an advertising fund for national or regional marketing and advertising of services offered by our clinics. The monthly marketing fee is 2% of clinic sales. We segregate the advertising funds collected and any unspent amounts, if applicable, are included in restricted cash on our consolidated balance sheets. As amounts are expended from the fund, we recognize a related expense. Such costs are included in selling and marketing expenses on the consolidated income statements.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_CoOpMarketingFundsPolicyPolicyTextBlock', window );">Co-Op Marketing Funds</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Co-Op Marketing Funds&#160;&#160;&#160;&#160;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Some franchises have established regional Co-Ops for advertising within their local and regional markets. We maintain a custodial relationship under which the Co-Op Marketing Funds collected are segregated and used for the purposes specified by the Co-Ops&#8217; officers. The Co-Op Marketing Funds are included in restricted cash on our consolidated balance sheets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue primarily through company-owned or managed clinics and through royalties, franchise fees, advertising fund contributions, IT related income and computer software fees from our franchisees.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues from Company-Owned or Managed Clinics.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> We earn revenues from clinics that we own and operate or manage throughout the United States. Revenues from clinics that we own and operate are recognized when services are performed and are related to discontinued operations. We offer a variety of membership and wellness packages which feature discounted pricing as compared with our single-visit pricing. Amounts collected in advance for membership and wellness packages are recorded as deferred revenue and recognized when the service is performed. Any unused visits associated with monthly memberships are recognized on a month-to-month basis. We recognize a contract liability (or a deferred revenue liability) related to the prepaid treatment plans for which we have an ongoing performance obligation. We derecognize this contract liability, and recognize revenue, as the patient consumes his or her visits related to the package and we transfer our services. If we determine that it is not subject to unclaimed property laws for the portion of the package that we do not expect to be redeemed (referred to as &#8220;breakage&#8221;), then we recognize breakage revenue in proportion to the pattern of exercised rights by the patient.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalties and Advertising Fund Revenue.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> We collect royalties, as stipulated in the franchise agreement, equal to 7% of gross sales, and a marketing and advertising fee currently equal to 2% of gross sales. Royalties, including franchisee contributions to advertising funds, are calculated as a percentage of clinic sales over the term of the franchise agreement. The revenue accounting standard provides an exception for the recognition of sales-based royalties promised in exchange for a license (which generally requires a reporting entity to estimate the amount of variable consideration to which it will be entitled in the transaction price). As the franchise agreement royalties, inclusive of advertising fund contributions, represent sales-based royalties that are related entirely to our performance obligation under the franchise agreement, such sales-based royalties are recognized as franchisee clinic level sales occur. Royalties are collected semi-monthly, two working days after each sales period has ended.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Franchise Fees.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> We require the entire non-refundable initial franchise fee to be paid upon execution of a franchise agreement, which typically has an initial term of 10 years. Initial franchise fees are recognized ratably on a straight-line basis over the term of the franchise agreement. Our services under the franchise agreement include the training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. We provide no financing to franchisees and offer no guarantees on their behalf. The services provided by us are highly interrelated with the franchise license and as such are considered to represent a single performance obligation. Renewal franchise fees, as well as transfer fees, are also recognized as revenue on a straight-line basis over the term of the respective franchise agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Software Fees.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We collect a monthly fee from our franchisees for the use of our proprietary chiropractic software, computer support and internet services support. These fees are recognized ratably on a straight-line basis over the term of the respective franchise agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Capitalized Sales Commissions. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Sales commissions earned by the regional developers and our sales force are considered incremental and recoverable costs of obtaining a franchise agreement with a franchisee. These costs are deferred and then amortized as the respective franchise fees are recognized ratably on a straight-line basis over the term of the franchise agreement. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Upfront Regional Developer Rights Fees </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have a regional developer program where regional developers are granted an exclusive geographical territory and commit to a minimum development obligation within that defined territory. Upon granting of the exclusive rights to develop a territory, a regional developer will pay an upfront fee to us. Upfront regional developer fees represent consideration received from a vendor to act as our agent within an exclusive territory. The upfront regional developer rights fee is accounted for as a reduction of cost of revenues, in franchise and regional development cost of revenues, to offset the respective future commissions paid to the regional developer. The fees are ratably recognized over the term of the related regional developer agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Regional developers receive fees which are funded by the initial franchise fees collected from franchisees upon the sale of franchises within their exclusive geographical territory and a royalty of 3% of sales generated by franchised clinics in their exclusive geographical territory. Initial fees related to the sale of franchises within their exclusive geographical territory are initially deferred as deferred franchise costs and are recognized as an expense in franchise cost of revenues when the respective revenue is recognized, which is generally over the term of the related franchise agreement. Royalties of 3% of sales generated by franchised clinics in their regions are also recognized as franchise cost of revenues as franchisee clinic level sales occur. This 3% fee is funded by the 7% royalties we collect from the franchisees in their regions. Certain regional developer agreements result in the regional developer acquiring the rights to existing royalty streams from clinics already open in the respective territory. In those instances, fees collected from the sale of the royalty stream is recognized as a decrease to franchise and regional developer cost of revenues over the remaining life of the respective franchise agreements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:106%">Regional Developer Rights Contract Termination Costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, subject to our strategy, regional developer rights are reacquired by us, resulting in a termination of the contract. The termination costs to reacquire the regional developer rights are recognized at fair value, less any unrecognized upfront regional developer fee liability balance, as a general and administrative expense in the period in which the contract is terminated in accordance with the contract terms and are recorded within general and administrative expenses.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Advertising Costs</span></div>Advertising costs are advertising and marketing expenses incurred by us, primarily through advertising funds. We expense production costs of commercial advertising upon first airing and expenses the costs of communicating the advertising in the period in which the advertising occurs.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for using a balance sheet approach known as the asset and liability method. The asset and liability method accounts for deferred income taxes by applying the statutory tax rates in effect at the date of the consolidated balance sheets to differences between the book basis and the tax basis of assets and liabilities. Deferred tax assets and liabilities represent the future tax consequence for those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. The differences relate principally to depreciation of property and equipment and treatment of revenue for franchise fees and regional developer fees collected. Tax positions are reviewed at least quarterly and adjusted as </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">new information becomes available. The recoverability of deferred tax assets is evaluated by assessing the adequacy of future expected taxable income from all sources, including reversal of taxable temporary differences, forecasted operating earnings and available tax planning strategies. These estimates of future taxable income inherently require significant judgment. To the extent it is considered more likely than not that a deferred tax asset will be not recovered, a valuation allowance is established. We applied the intra-period allocation rules under ASC 740-20-45-1 to allocate the tax provision between continuing operations and discontinued operations. The tax provision amount reported as Income tax expense and disclosed at Note 9, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> is all related to continuing operations and the remaining provision amount is allocated as discontinued operations and reported as Income tax expense from discontinued operations for the years ended December&#160;31, 2025 and 2024.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We account for uncertainty in income taxes by recognizing the tax benefit or expense from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the position. We measure the tax benefits and expenses recognized in the consolidated financial statements from such a position based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution. We have identified $0.6&#160;million and $0.9&#160;million in uncertain tax positions related to our VIEs in discontinued operations as of December&#160;31, 2025 and 2024, respectively. Interest and penalties associated with tax positions are recorded in the period assessed as general and administrative expenses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">With exceptions due to the generation and utilization of net operating losses or credits, as of December&#160;31, 2025, we are no longer subject to federal and state examinations by taxing authorities for tax years before 2022 and 2021, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings (Loss) per Common Share</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings (Loss) per Common Share</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per common share is computed by giving effect to all potentially dilutive common shares including restricted stock and stock options. Diluted earnings (loss) per common share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We account for share-based payments by recognizing compensation expense based upon the estimated fair value of the awards on the date of grant. We determine the estimated grant-date fair value of restricted shares using the closing price on the date of the grant and the grant-date fair value of stock options using the Black-Scholes-Merton model. In order to calculate the fair value of the options, certain assumptions are made regarding the components of the model, including risk-free interest rate, volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. We recognize compensation costs ratably over the period of service using the straight-line method. Forfeitures are estimated based on historical and forecasted turnover, which is approximately 5%.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitPlansPolicy', window );">Retirement Benefit Plan</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Retirement Benefit Plan</span></div>Our employees are eligible to participate in a defined contribution retirement plan, the Joint Corp. 401(k) Retirement Plan (the &#8220;401(k) Plan&#8221;), under Section 401(k) of the Internal Revenue Code. Under the 401(k) Plan, employees may contribute their eligible compensation, not to exceed the annual limits set by the IRS. The 401(k) Plan allows us to match participants&#8217; contributions in an amount determined in our sole discretion. We matched participants&#8217; contributions for the years ended December&#160;31, 2025 and 2024, up to a maximum of 4% of the employee&#8217;s eligible compensation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Loss Contingencies</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Loss Contingencies</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ASC Topic 450 governs the disclosure of loss contingencies and accrual of loss contingencies in respect of litigation and other claims. We record an accrual for a potential loss when it is probable that a loss will occur and the amount of the loss can be reasonably estimated. When the reasonable estimate of the potential loss is within a range of amounts, the minimum of the range of potential loss is accrued, unless a higher amount within the range is a better estimate than any other amount within the range. Moreover, if an accrual is not required, we provide additional disclosure related to litigation and other claims when it is reasonably possible (i.e., more than remote) that the outcomes of such litigation and other claims include potential material adverse impacts on us. Legal costs to be incurred in connection with a loss contingency are expensed as such costs are incurred.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div>The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Items subject to significant estimates and assumptions include loss contingencies, share-based compensations, useful lives and realizability of long-lived assets, deferred revenue and revenue recognition related to breakage, deferred franchise costs, calculation of ROU assets and liabilities related to leases, realizability of deferred tax assets, impairment of goodwill, intangible assets, other long-lived assets, and purchase price allocations and related valuations. Deferred revenue related to breakage, goodwill and intangible assets are related to discontinued operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Guidance and Accounting Pronouncements Not Yet Adopted</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Guidance and Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (&#8220;ASU 2023-09&#8221;), which requires public entities to provide greater disaggregation within their annual rate reconciliation, including new requirements to present reconciling items on a gross basis in specified categories, disclose both percentages and dollar amounts, and disaggregate individual reconciling items by jurisdiction and nature when the effect of the items meet a quantitative threshold. ASU 2023-09 also requires disaggregating the annual disclosure of income taxes paid, net of refunds received, by federal (national), state, and foreign taxes, with separate presentation of individual jurisdictions that meet a quantitative threshold. ASU 2023-09 is effective for annual periods beginning after December 15, 2024 on a prospective basis, with a retrospective option, and early adoption is permitted. We have adopted ASU 2023-09 for the 2025 annual period on a retrospective basis. Refer to Note 9, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for the revised disclosures. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (&#8220;ASU 2023-07&#8221;), which requires public entities with a single reportable segment to provide all the disclosures required by this standard and all existing segment disclosures in Topic 280 on an interim and annual basis, including new requirements to disclose significant segment expenses that are regularly provided to the Chief Operating Decision Maker (&#8220;CODM&#8221;) and included within the reported measure(s) of a segment&#8217;s profit or loss, the amount and composition of any other segment items, the title and position of the CODM, and how the CODM uses the reported measure(s) of a segment&#8217;s profit or loss to assess performance and decide how to allocate resources. ASU 2023-07 is effective for annual periods beginning after December 15, 2023 and interim periods beginning after December 15, 2024, applied retrospectively with early adoption permitted. We have adopted ASU 2023-07 for the 2024 annual period and have identified no material effect on our consolidated financial statements or disclosures.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (&#8220;ASU 2024-03&#8221;), and in January 2025, the FASB issued ASU No. 2025-01, Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date, which clarified the effective date of ASU 2024-03. ASU 2024-03 will require us to disclose the amounts of purchases of inventory, employee compensation, depreciation and intangible asset amortization, as applicable, included in certain expense captions in the consolidated statements of operations, as well as qualitatively describe remaining amounts included in those captions. ASU 2024-03 will also require us to disclose both the amount and our definition of selling expenses. The transition method is prospective with the retrospective method permitted and will be effective for our annual period ending December 31, 2027 and interim periods for the interim period beginning January 1, 2028. We are currently evaluating the impact of adoption of ASU 2024-03 on our consolidated financial statements and disclosures.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurement</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Authoritative guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The guidance establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability, developed based on market data obtained from sources independent of our company. Unobservable inputs are inputs that reflect our assumptions of what market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on reliability of the inputs as follows:</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level 1:&#160;&#160;&#160;&#160;Observable inputs such as quoted prices in active markets;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level 2:&#160;&#160;&#160;&#160;Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly;&#160;and</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level 3:&#160;&#160;&#160;&#160;Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its   own assumptions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_AdvertisingFundPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the advertising fund.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_AdvertisingFundPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_CoOpMarketingFundsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for co-op marketing funds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_CoOpMarketingFundsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NatureofOperationsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for nature of operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NatureofOperationsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 35<br> -Topic 720<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 450<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477850/954-450-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Paragraph 2AA<br> -Subparagraph (a)<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-2AA<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-5A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security. Includes, but is not limited to, methodology used to estimate allowance for credit loss, how writeoff of uncollectible amount is recognized, and determination of past due status and nonaccrual status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.M.2.Q4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483530/326-20-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479391/326-20-30-5A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-3C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479366/326-20-35-8A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-3D<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479175/326-30-30-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-3C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-3A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-3D<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 13A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479148/326-30-35-13A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 4A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479391/326-20-30-4A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 7A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479148/326-30-35-7A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-21<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditLossFinancialInstrumentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for discontinued operations. Includes, but is not limited to, method of interest allocation to a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section S99<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480781/205-20-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478609/920-350-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478609/920-350-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478609/920-350-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalUseSoftwarePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-40/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalUseSoftwarePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for postemployment benefits. Postemployment benefits are benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement, except for: a) benefits provided through a pension or postretirement benefit plan, b) individual deferred compensation arrangements, c) special or contractual termination benefits, and d) stock compensation plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 712<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/712/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-4<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock', window );">Schedule of Franchisor Disclosure</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the number of clinics in operation under franchise agreements and as company-owned or managed for the years ended December&#160;31, 2025 and 2024. All company-owned or managed clinics operations are recorded as discontinued operations:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Franchised clinics:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinics open at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Opened during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Acquired during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Sold during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Closed during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinics in operation at the end of the year</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">885&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Company-owned or managed clinics:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinics open at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Opened during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Acquired during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Sold during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Closed during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinics in operation at the end of the year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total clinics in operation at the end of the year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">960&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">967&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinic licenses sold but not yet developed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Executed letters of intent for future clinic licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock', window );">Schedule of Variable Interest Entities</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">VIE net income (including the management fee) for the years ended December&#160;31, 2025 and 2024 is included in Income (loss) from discontinued operations before income tax expense and income tax expense from discontinued operations in the consolidated income statements as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.984%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations before income tax expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,011,689&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,641,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">210,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">986,482&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,431,062&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of the VIEs&#8217; assets and liabilities is included in discontinued operations as of December&#160;31, 2025 and 2024 in the consolidated balance sheets as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.276%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">994,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,087,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,079,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,125,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Schedule of Reconciliation of Accounts Receivable Allowance for Credit Losses</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a rollforward of the activity related to our allowance for credit losses:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.351%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Allowance for credit losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt expense recognized during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">220,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Write-off of uncollectible amounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2024</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">220,893&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt expense recognized during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">286,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Write-off of uncollectible amounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(77,638)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2025</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">429,487&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock', window );">Schedule of Net Loss (Gain) on Disposition or Impairment Related to Continuing Operations</a></td>
<td class="text">During the year ended December&#160;31, 2024, certain long-lived asset groups were determined to not be recoverable and were written down from their carrying values to their respective fair values resulting in the following non-cash impairment losses which are included in <span style="-sec-ix-hidden:f-447">Net loss on disposition or impairment</span> related to continuing operations. Net impairment losses on long-lived assets were not material for the year ended December&#160;31, 2025.<div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.271%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net loss on disposition or impairment related to continuing operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">57,959&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">40,872&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">17,087&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">703,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">667,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">36,368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">12,564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Total Net loss on disposition or impairment related to continuing operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">66,019&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Schedule of Impairment Losses and Disposal Gains and Losses Recorded in (Loss) Income from Discontinued Operations</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2024, certain long-lived asset groups classified as held and used were determined to not be recoverable were written down from their carrying values to their respective fair values resulting in the following non-cash impairment losses which are included in Income (loss) from discontinued operations before income tax expense in the consolidated income statements. </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.149%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net loss on disposition or impairment related to discontinued operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,929,036&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,755,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1,173,718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">5,779,712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">4,347,457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1,432,255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">298,510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">252,746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">45,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Total Net loss on disposition or impairment related to discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">2,651,737&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div>As a result of its evaluation of the recoverability of the carrying value of the assets and liabilities held for sale relative to the clinics estimated fair values, we recorded an estimated net loss on disposal, which is included in Income (loss) from discontinued operations before income tax expense in the consolidated income statements:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Net loss on disposition or impairment related to discontinued operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">2,734,726&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">4,540,530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the composition of our impairment losses and disposal gains and losses recorded in Income (loss) from discontinued operations before income tax expense for the years ended December&#160;31, 2025 and 2024:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Impairment on long-lived assets held for use</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1,173,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1,432,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">45,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Impairment on assets held for sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">2,734,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">4,540,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Loss on disposal of assets other than by sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">383,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">161,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1,396,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">406,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Loss (gain) on the sale of assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">926,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(44,807)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Total net loss on disposition or impairment related to discontinued operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">5,441,010&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">7,714,555&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The key components of Net income (loss) from discontinued operations that were included in our consolidated income statements are as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from company-owned or managed clinics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">54,038,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">69,982,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">54,038,508&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">69,982,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">IT cost of revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47,817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,971&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47,817&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,755,830&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,850,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">69,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,350,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">39,450,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">54,988,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">45,276,306&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">66,190,144&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss on disposition or impairment from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,441,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,714,555&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,300,221&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,970,172)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income tax expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,200,629&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,972,286)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">210,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from discontinued operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,175,422&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,182,549)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the major classes of assets and liabilities of discontinued operations that were included in our consolidated balance sheets:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">315,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,484,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">581,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">549,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,051,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">38,395,986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">67,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">208,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets (attributable to VIEs)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">994,138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,087,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deposits and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">235,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">425,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets, discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">22,246,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">43,151,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">83,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">67,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,519,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,066,941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Payroll liabilities ($0.6 million and $0.9 million attributable to VIEs, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">988,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,333,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">651,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">153,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">38,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities (attributable to VIEs)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">756,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,079,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities to be disposed of ($4.7 million and $5.2 million attributable to VIEs, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,368,318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">28,629,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, discontinued operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21,368,446&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">37,367,459&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The key components of cash flows from discontinued operations are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Significant operating and investing non-cash items</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">69,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,350,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss on disposition or impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,441,010&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,714,555&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Capital expenditures</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">84,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">664,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The principal components of the held for sale assets and liabilities to be disposed of as of December&#160;31, 2025 and 2024 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,497,545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,457,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,111,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,643,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,288,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,906,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,482,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,459,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(6,327,644)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5,071,603)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,051,965&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">38,395,986&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,065,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,526,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue from company-owned or managed clinics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,302,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,102,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities to be disposed of</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,368,318&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">28,629,103&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings (Loss) per Common Share</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(268,157)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,614,344)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,175,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,182,549)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,907,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5,796,893)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8212; basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,134,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,919,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock and stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">52,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">228,156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8212; diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,186,868&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,147,247&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings (loss) per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive securities excluded from the calculation of diluted net income (loss) per common share as the effect would be anti-dilutive were as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">71,030&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">87,651&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for impairment of long-lived assets held and used by an entity which includes a description of the impaired long-lived asset and facts and circumstances leading to the impairment, aggregate amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired long-lived asset is reported.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-3A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-4A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-4B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5D<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of franchisors that are included in the discussion of the nature of an entity's operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-5A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-9<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfVariableInterestEntitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Disclosures (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows our revenues disaggregated according to the timing of transfer of services:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized at a point in time</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">45,486,703&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">43,478,254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized over time</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,408,889&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,685,176&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">54,895,592&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">52,163,430&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Rollforward of Accounts Receivable</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Changes in our accounts receivable, net during the years ended December&#160;31, 2025 and 2024 were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.351%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Accounts Receivable, Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,580,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash received against accounts receivable included at the beginning of the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,387,577)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net increase during the year ended December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,614,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(220,893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,586,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash received against accounts receivable included at the beginning of the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,067,962)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net increase during the year ended December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,760,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(429,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2025</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,849,864&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of Rollforward in Contract Liabilities and Contract Assets</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Changes in our contract liability for deferred franchise fees during the years ended December&#160;31, 2025 and 2024 were as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.684%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Revenue<br/>Short and Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,113,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized that was included in the contract liability at the beginning of the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,841,085)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net increase during the year ended December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,724,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2024</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,997,105&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized that was included in the contract liability at the beginning of the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,006,059)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net increase during the year ended December 31, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,427,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2025</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,418,289&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our deferred franchise and development costs represent capitalized sales commissions. Changes during the years ended December&#160;31, 2025 and 2024 were as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Franchise and Development Costs<br/>Short and Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,251,366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Recognized as cost of revenue during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,221,140)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net increase during the year ended December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">539,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2024</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,569,473&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Recognized as cost of revenue during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,190,555)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Net increase during the year ended December 31, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">394,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2025</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,773,062&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock', window );">Schedule of Estimated Revenue Related to Performance Obligations</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates revenues expected to be recognized in the future related to performance obligations that were unsatisfied (or partially unsatisfied) as of December&#160;31, 2025. We have elected to exclude short term contracts, sales and usage-based royalties and any other variable consideration recognized on an &#8220;as invoiced&#8221; basis.</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Contract liabilities expected to be recognized in:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,519,018&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,413,277&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,254,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,899,640&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,630,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,701,180&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,418,289&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of expected timing for satisfying remaining performance obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Divestitures (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Schedule of Discontinued Operations</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2024, certain long-lived asset groups classified as held and used were determined to not be recoverable were written down from their carrying values to their respective fair values resulting in the following non-cash impairment losses which are included in Income (loss) from discontinued operations before income tax expense in the consolidated income statements. </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.149%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net loss on disposition or impairment related to discontinued operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,929,036&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,755,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1,173,718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">5,779,712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">4,347,457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1,432,255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">298,510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">252,746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">45,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Total Net loss on disposition or impairment related to discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">2,651,737&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div>As a result of its evaluation of the recoverability of the carrying value of the assets and liabilities held for sale relative to the clinics estimated fair values, we recorded an estimated net loss on disposal, which is included in Income (loss) from discontinued operations before income tax expense in the consolidated income statements:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Net loss on disposition or impairment related to discontinued operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">2,734,726&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">4,540,530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the composition of our impairment losses and disposal gains and losses recorded in Income (loss) from discontinued operations before income tax expense for the years ended December&#160;31, 2025 and 2024:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Impairment on long-lived assets held for use</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1,173,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1,432,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">45,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Impairment on assets held for sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">2,734,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">4,540,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Loss on disposal of assets other than by sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">383,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">161,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1,396,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">406,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Loss (gain) on the sale of assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">926,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(44,807)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Total net loss on disposition or impairment related to discontinued operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">5,441,010&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">7,714,555&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The key components of Net income (loss) from discontinued operations that were included in our consolidated income statements are as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from company-owned or managed clinics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">54,038,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">69,982,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">54,038,508&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">69,982,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">IT cost of revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47,817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,971&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47,817&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,755,830&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,850,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">69,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,350,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">39,450,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">54,988,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">45,276,306&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">66,190,144&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss on disposition or impairment from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,441,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,714,555&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,300,221&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,970,172)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income tax expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,200,629&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,972,286)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">210,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from discontinued operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,175,422&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,182,549)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the major classes of assets and liabilities of discontinued operations that were included in our consolidated balance sheets:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">315,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,484,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">581,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">549,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,051,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">38,395,986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">67,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">208,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets (attributable to VIEs)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">994,138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,087,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deposits and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">235,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">425,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets, discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">22,246,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">43,151,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">83,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">67,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,519,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,066,941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Payroll liabilities ($0.6 million and $0.9 million attributable to VIEs, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">988,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,333,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">651,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">153,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">38,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities (attributable to VIEs)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">756,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,079,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities to be disposed of ($4.7 million and $5.2 million attributable to VIEs, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,368,318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">28,629,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, discontinued operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21,368,446&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">37,367,459&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The key components of cash flows from discontinued operations are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Significant operating and investing non-cash items</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">69,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,350,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss on disposition or impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,441,010&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,714,555&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Capital expenditures</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">84,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">664,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The principal components of the held for sale assets and liabilities to be disposed of as of December&#160;31, 2025 and 2024 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,497,545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,457,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,111,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,643,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,288,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,906,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,482,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,459,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(6,327,644)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5,071,603)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,051,965&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">38,395,986&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,065,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,526,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue from company-owned or managed clinics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,302,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,102,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities to be disposed of</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,368,318&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">28,629,103&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-3A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-4A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-4B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5D<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consist of the following:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Office and computer equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">982,766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">937,551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,594,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,585,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Internally developed software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,103,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,914,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,680,909&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,437,414&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(7,511,832)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5,982,533)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,169,077&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,454,881&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">990,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">751,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property and Equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,159,226&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,206,754&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Valuation Assumptions used for Stock Options</a></td>
<td class="text">We have computed the fair value of all options granted using the Black-Scholes-Merton model during the year ended December&#160;31, 2024, using the following assumptions:<div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">64%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.25</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.86%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Options Activity</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The information below summarizes the stock options activity:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual Life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">486,334&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8.88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,903,699&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted at market price</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">38,059&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.51&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(227,952)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,435,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(9,201)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">26.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5,263)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">41.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December&#160;31, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">281,977&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11.80&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">777,566&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(123,460)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.04&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">656,751&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(89,604)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(432)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">45.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December&#160;31, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">68,481&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14.33&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">59,412&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December&#160;31, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">39,936&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17.06&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">59,412&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at December&#160;31, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">66,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14.47&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">59,412&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Activity</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The information below summarizes the restricted stock activity:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.445%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant-Date Fair Value per Award</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at December&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">231,901&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17.32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">285,656&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(107,103)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(104,472)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at December&#160;31, 2024</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">305,982&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11.97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">301,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(107,854)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(146,534)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at December&#160;31, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">353,490&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.86&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Loss From Continuing Operations Before the Provision for Income Taxes</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The components of loss from continuing operations before the provision for income taxes, by taxing jurisdiction are as follows: </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Domestic </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(229,504)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,608,738)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(229,504)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,608,738)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense reported in the consolidated income statements is comprised of the following:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Current expense:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">State, net of state tax credits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">38,653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">62,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total current expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">38,653&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">62,759&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Deferred expense (benefit):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(57,153)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(57,153)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">38,653&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,606&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The tax effects of temporary differences that give rise to significant components of the deferred tax assets and liabilities are provided below:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">757,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,607,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,535,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,909,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,795,895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,710,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill - component 1</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">383,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill - component 2</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">49,829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">55,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">471,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nonqualified stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">117,962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">322,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,261,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,029,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">35,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">35,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,416,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,921,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">141,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">139,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,968,588&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18,730,802&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(11,327,659)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(12,307,555)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,640,929&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,423,247&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Lease ROU asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,320,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5,392,996)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred franchise costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(320,837)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(75,284)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill - component 1</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(807,824)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(147,143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,640,929)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(6,423,247)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income taxes</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Reconciliation</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes differs from the amount calculated using the statutory federal corporate income tax rate of 21% due to the following items:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.162%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Percent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss from continuing operations before provision for income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(229,504)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,608,738)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected federal tax expense at U.S. federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(48,388)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(337,835)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes (net of federal income tax effect) (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(128,782)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">56.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">79,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Changes in valuation allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(507,419)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">221.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">66,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nontaxable or nondeductible items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Section 162(m) officer compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">85,992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Share based compensation (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(28,302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(119,263)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Payroll tax penalty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(45,749)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Meals and entertainment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">23,549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(10.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">30,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">26,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Changes in unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">300,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(130.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">212,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(13.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Other adjustments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Deferred true-up to deferred franchise costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">285,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(124.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Current year expirations of non-qualified stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">217,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(94.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(47,819)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(39,286)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax expense and effective rate</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">38,653&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(16.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,606&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">___________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(1) State taxes in Arizona, California and Texas made up the majority (greater than 50%) of the tax effect in this category.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(2) Share based compensation includes incentive stock options, non-qualified stock options and restricted stock awards.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Uncertain Tax Position Rollforward</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">948,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,175,766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for expiration of the statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(314,468)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(227,584)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">633,714&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">948,182&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Schedule of Cash Paid For Income Taxes (Net of Refunds Received)</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The amount of cash paid for income taxes (net of refunds received) was as follows: </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">321,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">285,510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">State:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Arizona</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">62,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;California</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">168,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">182,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Texas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">62,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">51,026&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other state jurisdictions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">91,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid (net of refunds received)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">626,752&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">610,492&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Expense</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the components of lease expense and income statement location for the years ended December&#160;31, 2025 and 2024:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.423%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Line Item in our Consolidated Income Statements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Operating lease costs:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">355,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">325,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">355,912&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">325,396&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Schedule of Supplemental Lease Information</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information and balance sheet location related to leases for the years ended December&#160;31, 2025 and 2024 was as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of -use asset</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,572,173&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">555,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability, current portion</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">194,179&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">483,337&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,815,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">311,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liability</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,009,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">795,026&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining lease term (in years):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.6</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases for the years ended December&#160;31, 2025 and 2024 were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in measurement of liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">460,056&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">505,577&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash transactions: ROU assets obtained in exchange for lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,554,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturities of Operating Lease Liabilities</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of December&#160;31, 2025 were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.789%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">268,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">467,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">479,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">491,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">503,374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">211,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,421,699&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(411,993)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total lease obligations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,009,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(194,179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Long-term lease obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,815,527&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Total Revenue and Significant Expense Categories</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes total revenue and significant expense categories and amounts for our reportable segment that aligns with the segment level information that is regularly provided to the CODM:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">54,895,592</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">52,163,430</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Franchise and regional developer cost of revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,500,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,063,644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">IT cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,724,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,453,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,299,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,973,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">27,256,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">27,359,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,297,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,679,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items, net</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">401,706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">871,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,644,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,371,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">38,653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Segment loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(268,157)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,614,344)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(268,157)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,614,344)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,175,422&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,182,549)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,907,265&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5,796,893)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">(a) </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other segment items, net includes interest income, acquisition related expenses, net loss on disposition or impairment, costs related to restatement filings, and restructuring costs.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Financial Data (Unaudited) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Schedule of Quarterly Financial Data</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Selected quarterly financial data for the years ended December&#160;31, 2025 and 2024 is summarized below:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.068%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.407%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Q1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Q2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Q3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Q4</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Q1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Q2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Q3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Q4</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">13,077,590&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">13,270,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">13,380,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">15,167,047&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">54,895,592&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">12,184,716&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">12,610,036&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">12,654,396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">14,714,282&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">52,163,430&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Total costs of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">2,972,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">2,772,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">2,661,234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">2,819,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">11,225,474&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">2,704,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">2,812,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">2,814,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">3,184,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">11,516,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Selling and marketing expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">3,505,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">3,483,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">2,816,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">3,494,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">13,299,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">2,237,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">3,440,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">2,504,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">2,791,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">10,973,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">361,930&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">402,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">446,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">433,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">1,644,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">329,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">342,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">345,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">353,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">1,371,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">6,914,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">7,745,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">7,295,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">7,676,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">29,632,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">7,339,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">7,793,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">7,478,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">7,513,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">30,124,589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Total selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">10,782,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">11,631,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">10,558,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">11,603,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">44,575,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">9,906,525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">11,576,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">10,328,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">10,658,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">42,469,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Net loss on disposition or impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">1,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">4,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">1,485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">7,898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">3,581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">61,501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">66,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(Loss) income from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(678,534)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(1,138,167)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">160,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">742,410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(913,376)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(426,596)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(1,779,325)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(492,820)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">809,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(1,889,025)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">185,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">159,922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">139,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">198,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">683,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">36,259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">80,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">83,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">79,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">280,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(Loss) income from continuing operations before income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(492,617)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(978,245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">300,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">940,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(229,504)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(390,337)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(1,698,854)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(408,992)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">889,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(1,608,738)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">13,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">11,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">10,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">3,513&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">38,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">8,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">11,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">5,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(19,536)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">5,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Net (loss) income from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(506,021)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(989,635)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">290,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">937,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(268,157)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(398,919)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(1,710,023)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(414,383)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">908,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(1,614,344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations before income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">1,577,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">1,183,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">664,269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(224,068)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">3,200,629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">1,516,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(1,719,222)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(2,693,562)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(1,075,745)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(3,972,286)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Income tax expense(benefit) from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">103,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">100,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">99,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(278,036)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">25,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">170,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">167,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">57,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(184,429)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">210,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">1,473,817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">1,082,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">564,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">53,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">3,175,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">1,345,898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(1,886,375)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(2,750,756)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(891,316)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(4,182,549)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">967,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">93,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">855,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">991,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">2,907,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">946,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(3,596,398)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(3,165,139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">17,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(5,796,893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Net (loss) income from continuing operations per common share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.06)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.06)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss) from discontinued operations per common share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.06)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.06)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss) per common share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">(0.38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations and Summary of Significant Accounting Policies - Clinics in Operation Under Franchise Agreements or Company-Owned or Managed (Details) - clinic<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward', window );"><strong>Product Information, Franchised Clinics, Company-Owned Or Managed Clinics, Activity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Clinics open at beginning of year</a></td>
<td class="nump">967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Clinics in operation at the end of the year</a></td>
<td class="nump">960<span></span>
</td>
<td class="nump">967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ClinicLicensesSoldButNotYetDeveloped', window );">Clinic licenses sold but not yet developed</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ExecutedLettersOfIntentForFutureClinicLicenses', window );">Executed letters of intent for future clinic licenses</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FranchisorDisclosureAxis=us-gaap_FranchisedUnitsMember', window );">Franchised Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward', window );"><strong>Product Information, Franchised Clinics, Company-Owned Or Managed Clinics, Activity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Clinics open at beginning of year</a></td>
<td class="nump">842<span></span>
</td>
<td class="nump">800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ClinicsOpenedDuringThePeriod', window );">Opened during the year</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ClinicsAcquiredDuringPeriod', window );">Acquired during the year</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ClinicsSoldDuringPeriod', window );">Sold during the year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ClinicsClosedDuringThePeriod', window );">Closed during the year</a></td>
<td class="num">(27)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Clinics in operation at the end of the year</a></td>
<td class="nump">885<span></span>
</td>
<td class="nump">842<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FranchisorDisclosureAxis=us-gaap_EntityOperatedUnitsMember', window );">Company-Owned or Managed Clinics | Discontinued Operations, Held-for-Sale or Disposed of by Sale | Corporate Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward', window );"><strong>Product Information, Franchised Clinics, Company-Owned Or Managed Clinics, Activity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Clinics open at beginning of year</a></td>
<td class="nump">125<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ClinicsOpenedDuringThePeriod', window );">Opened during the year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ClinicsAcquiredDuringPeriod', window );">Acquired during the year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ClinicsSoldDuringPeriod', window );">Sold during the year</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ClinicsClosedDuringThePeriod', window );">Closed during the year</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Clinics in operation at the end of the year</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ClinicLicensesSoldButNotYetDeveloped">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of clinics that have been sold as franchises, but are not yet operational.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ClinicLicensesSoldButNotYetDeveloped</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ClinicsAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of clinics acquired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ClinicsAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ClinicsClosedDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of clinics closed during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ClinicsClosedDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ClinicsOpenedDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of number of clinics opened during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ClinicsOpenedDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ClinicsSoldDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Clinics Sold During Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ClinicsSoldDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ExecutedLettersOfIntentForFutureClinicLicenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of future clinic's licenses that have an executed letter of intent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ExecutedLettersOfIntentForFutureClinicLicenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Product Information, Franchised Clinics, Company-Owned Or Managed Clinics, Activity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStores">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of stores.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStores</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FranchisorDisclosureAxis=us-gaap_FranchisedUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FranchisorDisclosureAxis=us-gaap_FranchisedUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FranchisorDisclosureAxis=us-gaap_EntityOperatedUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FranchisorDisclosureAxis=us-gaap_EntityOperatedUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations and Summary of Significant Accounting Policies - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>option </div>
<div>corporation</div>
</th>
<th class="th">
<div>Sep. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>clinic </div>
<div>corporation</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>clinic </div>
<div>corporation </div>
<div>option</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>clinic</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ManagementAgreementNumberOfProfessionalCorporations', window );">Number of agreements with PCs | corporation</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ManagementAgreementTerminationNumberOfProfessionalCorporations', window );">Number of professional corporations with management agreements terminated | corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">$ 19,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,200,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit losses on accounts receivable</a></td>
<td class="nump">429,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">220,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">429,487<span></span>
</td>
<td class="nump">220,893<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Net loss on disposition or impairment</a></td>
<td class="nump">$ 1,485<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 4,440<span></span>
</td>
<td class="nump">$ 1,973<span></span>
</td>
<td class="nump">61,501<span></span>
</td>
<td class="nump">$ 3,581<span></span>
</td>
<td class="nump">$ 662<span></span>
</td>
<td class="nump">$ 275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,898<span></span>
</td>
<td class="nump">66,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_LesseeOperatingLeaseNumberOfRenewalOptions', window );">Number of lease renewal options | option</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage', window );">Monthly marketing fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_FranchiseRoyaltyGrossSalesPercentage', window );">Royalties percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_RevenueRecognitionFranchiseAgreementTerm', window );">Franchise agreement term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage', window );">Royalty sales generated by franchises percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage', window );">Forecasted turnover percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Company matching contribution (maximum)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Employer contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Net loss on disposition or impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember', window );">Discontinued Operations, Held-for-Sale or Disposed of by Sale | Corporate Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax', window );">Net loss on disposition or impairment from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,441,010<span></span>
</td>
<td class="nump">7,714,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Uncertain tax positions</a></td>
<td class="nump">$ 633,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">948,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 633,714<span></span>
</td>
<td class="nump">$ 948,182<span></span>
</td>
<td class="nump">$ 1,175,766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember', window );">Discontinued Operations, Held-for-Sale or Disposed of by Sale | Corporate Clinics | Company-Owned or Managed Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ClinicsSoldDuringPeriod', window );">Number of clinics sold | clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember', window );">Discontinued Operations, Held-for-Sale or Disposed of by Sale | Corporate Clinics | Kansas and Missouri | Company-Owned or Managed Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ClinicsSoldDuringPeriod', window );">Number of clinics sold | clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember', window );">Discontinued Operations, Disposal Other than Sale By Sale | Operating lease right-of-use asset | Corporate Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax', window );">Net loss on disposition or impairment from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,396,870<span></span>
</td>
<td class="nump">$ 406,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember', window );">Discontinued Operations, Assets Held For Sale | Corporate Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent', window );">Valuation allowance in discontinued operations current assets</a></td>
<td class="nump">$ 6,327,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,071,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,327,644<span></span>
</td>
<td class="nump">$ 5,071,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life, property and equipment</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Computer Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Reacquired franchise rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful life</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful life</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life, property and equipment</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Computer Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Reacquired franchise rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful life</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful life</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ClinicsSoldDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Clinics Sold During Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ClinicsSoldDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Valuation Allowance, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of gross sales a franchise pays for monthly marketing fees as stipulated in the typical franchise agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_FranchiseRoyaltyGrossSalesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of gross sales collected as royalties from franchises typically collected bi-monthly two working days after each sales period has ended as stipulated in the franchise agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_FranchiseRoyaltyGrossSalesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_LesseeOperatingLeaseNumberOfRenewalOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Number Of Renewal Options</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_LesseeOperatingLeaseNumberOfRenewalOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ManagementAgreementNumberOfProfessionalCorporations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Management Agreement, Number Of Professional Corporations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ManagementAgreementNumberOfProfessionalCorporations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ManagementAgreementTerminationNumberOfProfessionalCorporations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Management Agreement, Termination, Number Of Professional Corporations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ManagementAgreementTerminationNumberOfProfessionalCorporations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of sales generated by franchised clinics in their region regional developers receive as royalties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RevenueRecognitionFranchiseAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue Recognition, Franchise Agreement, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RevenueRecognitionFranchiseAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Forfeitures, Historical And Forecasted Turnover, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483385/720-35-55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FranchisorDisclosureAxis=us-gaap_EntityOperatedUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FranchisorDisclosureAxis=us-gaap_EntityOperatedUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=jynt_KansasAndMissouriMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=jynt_KansasAndMissouriMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=jynt_OperatingLeaseRightOfUseAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=jynt_OperatingLeaseRightOfUseAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_FranchiseRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_FranchiseRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations and Summary of Significant Accounting Policies - VIE Income Statement (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Income from discontinued operations before income tax expense</a></td>
<td class="num">$ (224,068)<span></span>
</td>
<td class="nump">$ 664,269<span></span>
</td>
<td class="nump">$ 1,183,199<span></span>
</td>
<td class="nump">$ 1,577,229<span></span>
</td>
<td class="num">$ (1,075,745)<span></span>
</td>
<td class="num">$ (2,693,562)<span></span>
</td>
<td class="num">$ (1,719,222)<span></span>
</td>
<td class="nump">$ 1,516,243<span></span>
</td>
<td class="nump">$ 3,200,629<span></span>
</td>
<td class="num">$ (3,972,286)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation', window );">Income tax expense from discontinued operations</a></td>
<td class="num">(278,036)<span></span>
</td>
<td class="nump">99,630<span></span>
</td>
<td class="nump">100,201<span></span>
</td>
<td class="nump">103,412<span></span>
</td>
<td class="num">(184,429)<span></span>
</td>
<td class="nump">57,194<span></span>
</td>
<td class="nump">167,153<span></span>
</td>
<td class="nump">170,345<span></span>
</td>
<td class="nump">25,207<span></span>
</td>
<td class="nump">210,263<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Net income (loss) from discontinued operations</a></td>
<td class="nump">$ 53,968<span></span>
</td>
<td class="nump">$ 564,639<span></span>
</td>
<td class="nump">$ 1,082,998<span></span>
</td>
<td class="nump">$ 1,473,817<span></span>
</td>
<td class="num">$ (891,316)<span></span>
</td>
<td class="num">$ (2,750,756)<span></span>
</td>
<td class="num">$ (1,886,375)<span></span>
</td>
<td class="nump">$ 1,345,898<span></span>
</td>
<td class="nump">3,175,422<span></span>
</td>
<td class="num">(4,182,549)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember', window );">Corporate Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation', window );">Income tax expense from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,207<span></span>
</td>
<td class="nump">210,263<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Net income (loss) from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,175,422<span></span>
</td>
<td class="num">(4,182,549)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity | Corporate Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Income from discontinued operations before income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,011,689<span></span>
</td>
<td class="nump">1,641,325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation', window );">Income tax expense from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,207<span></span>
</td>
<td class="nump">210,263<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Net income (loss) from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 986,482<span></span>
</td>
<td class="nump">$ 1,431,062<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477349/740-270-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Nature of Operations and Summary of Significant Accounting Policies - VIE Assets and Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Discontinued operations current assets</a></td>
<td class="nump">$ 22,246,318<span></span>
</td>
<td class="nump">$ 43,151,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Discontinued operations current liabilities</a></td>
<td class="nump">21,368,446<span></span>
</td>
<td class="nump">37,367,459<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Discontinued operations current assets</a></td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Discontinued operations current liabilities</a></td>
<td class="nump">6,100,000<span></span>
</td>
<td class="nump">7,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity | Corporate Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Discontinued operations current assets</a></td>
<td class="nump">994,138<span></span>
</td>
<td class="nump">1,087,203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Discontinued operations current liabilities</a></td>
<td class="nump">$ 6,079,903<span></span>
</td>
<td class="nump">$ 7,125,071<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations and Summary of Significant Accounting Policies - Reconciliation of of Accounts Receivable Allowance for Credit Losses (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Allowance for credit losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning balance</a></td>
<td class="nump">$ 220,893<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt expense recognized during the year</a></td>
<td class="nump">286,232<span></span>
</td>
<td class="nump">220,893<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Write-off of uncollectible amounts</a></td>
<td class="num">(77,638)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending balance</a></td>
<td class="nump">$ 429,487<span></span>
</td>
<td class="nump">$ 220,893<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations and Summary of Significant Accounting Policies - Net Loss (Gain) on Disposition or Impairment Related to Continuing Operations (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Gain (Loss) on Sale of Assets and Asset Impairment Charges<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Net loss on disposition or impairment related to continuing operations</a></td>
<td class="nump">$ 66,019<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment', window );">Carrying Value</a></td>
<td class="nump">57,959<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment', window );">Fair Value</a></td>
<td class="nump">40,872<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Net loss on disposition or impairment related to continuing operations</a></td>
<td class="nump">17,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=jynt_OperatingLeaseRightOfUseAssetMember', window );">Operating lease right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment', window );">Carrying Value</a></td>
<td class="nump">703,682<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment', window );">Fair Value</a></td>
<td class="nump">667,314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Net loss on disposition or impairment related to continuing operations</a></td>
<td class="nump">36,368<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=us-gaap_FiniteLivedIntangibleAssetsMember', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment', window );">Carrying Value</a></td>
<td class="nump">12,564<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Net loss on disposition or impairment related to continuing operations</a></td>
<td class="nump">$ 12,564<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impaired Long-Lived Assets Held And Used, Carrying Value After Impairment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impaired Long-Lived Assets Held And Used, Carrying Value Before Impairment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes impairment of long-lived asset held for use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=jynt_OperatingLeaseRightOfUseAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=jynt_OperatingLeaseRightOfUseAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=us-gaap_FiniteLivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=us-gaap_FiniteLivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations and Summary of Significant Accounting Policies - Impairment Losses and Disposal Gains and Losses Recorded in (Loss) Income from Discontinued Operations (Details) - Corporate Clinics - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember', window );">Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax', window );">Net loss on disposition or impairment related to discontinued operations</a></td>
<td class="nump">$ 5,441,010<span></span>
</td>
<td class="nump">$ 7,714,555<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=jynt_DiscontinuedOperationsHeldForUseMember', window );">Discontinued Operations, Held For Use</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax', window );">Net loss on disposition or impairment related to discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,651,737<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=jynt_DiscontinuedOperationsHeldForUseMember', window );">Discontinued Operations, Held For Use | Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,929,036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,755,318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax', window );">Net loss on disposition or impairment related to discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,173,718<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=jynt_DiscontinuedOperationsHeldForUseMember', window );">Discontinued Operations, Held For Use | Operating lease right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,779,712<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,347,457<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax', window );">Net loss on disposition or impairment related to discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,432,255<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=jynt_DiscontinuedOperationsHeldForUseMember', window );">Discontinued Operations, Held For Use | Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298,510<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">252,746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax', window );">Net loss on disposition or impairment related to discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">45,764<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember', window );">Discontinued Operations, Assets Held For Sale | Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax', window );">Net loss on disposition or impairment related to discontinued operations</a></td>
<td class="nump">2,734,726<span></span>
</td>
<td class="nump">4,540,530<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember', window );">Discontinued Operations, Disposal Other than Sale By Sale | Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax', window );">Net loss on disposition or impairment related to discontinued operations</a></td>
<td class="nump">383,311<span></span>
</td>
<td class="nump">161,057<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember', window );">Discontinued Operations, Disposal Other than Sale By Sale | Operating lease right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax', window );">Net loss on disposition or impairment related to discontinued operations</a></td>
<td class="nump">1,396,870<span></span>
</td>
<td class="nump">406,038<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Sale of Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax', window );">Net loss on disposition or impairment related to discontinued operations</a></td>
<td class="nump">$ 926,103<span></span>
</td>
<td class="num">$ (44,807)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impaired Long-Lived Assets Held And Used, Carrying Value After Impairment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impaired Long-Lived Assets Held And Used, Carrying Value Before Impairment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=jynt_DiscontinuedOperationsHeldForUseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=jynt_DiscontinuedOperationsHeldForUseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=jynt_OperatingLeaseRightOfUseAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=jynt_OperatingLeaseRightOfUseAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_FiniteLivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_FiniteLivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=jynt_AssetsHeldForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=jynt_AssetsHeldForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations and Summary of Significant Accounting Policies - Earnings (Loss) Per Common Share (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net loss from continuing operations</a></td>
<td class="nump">$ 937,129<span></span>
</td>
<td class="nump">$ 290,370<span></span>
</td>
<td class="num">$ (989,635)<span></span>
</td>
<td class="num">$ (506,021)<span></span>
</td>
<td class="nump">$ 908,981<span></span>
</td>
<td class="num">$ (414,383)<span></span>
</td>
<td class="num">$ (1,710,023)<span></span>
</td>
<td class="num">$ (398,919)<span></span>
</td>
<td class="num">$ (268,157)<span></span>
</td>
<td class="num">$ (1,614,344)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Net income (loss) from discontinued operations</a></td>
<td class="nump">53,968<span></span>
</td>
<td class="nump">564,639<span></span>
</td>
<td class="nump">1,082,998<span></span>
</td>
<td class="nump">1,473,817<span></span>
</td>
<td class="num">(891,316)<span></span>
</td>
<td class="num">(2,750,756)<span></span>
</td>
<td class="num">(1,886,375)<span></span>
</td>
<td class="nump">1,345,898<span></span>
</td>
<td class="nump">3,175,422<span></span>
</td>
<td class="num">(4,182,549)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 991,097<span></span>
</td>
<td class="nump">$ 855,009<span></span>
</td>
<td class="nump">$ 93,363<span></span>
</td>
<td class="nump">$ 967,796<span></span>
</td>
<td class="nump">$ 17,665<span></span>
</td>
<td class="num">$ (3,165,139)<span></span>
</td>
<td class="num">$ (3,596,398)<span></span>
</td>
<td class="nump">$ 946,979<span></span>
</td>
<td class="nump">$ 2,907,265<span></span>
</td>
<td class="num">$ (5,796,893)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,134,215<span></span>
</td>
<td class="nump">14,919,091<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Unvested restricted stock and stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,653<span></span>
</td>
<td class="nump">228,156<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,186,868<span></span>
</td>
<td class="nump">15,147,247<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic earnings (loss) per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="num">$ (0.06)<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (0.11)<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="num">$ (0.11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0.01<span></span>
</td>
<td class="nump">0.04<span></span>
</td>
<td class="nump">0.07<span></span>
</td>
<td class="nump">0.09<span></span>
</td>
<td class="num">(0.06)<span></span>
</td>
<td class="num">(0.18)<span></span>
</td>
<td class="num">(0.13)<span></span>
</td>
<td class="nump">0.09<span></span>
</td>
<td class="nump">0.21<span></span>
</td>
<td class="num">(0.28)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss) per common share, basic (in dollars per share)</a></td>
<td class="nump">0.07<span></span>
</td>
<td class="nump">0.06<span></span>
</td>
<td class="nump">0.01<span></span>
</td>
<td class="nump">0.06<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.21)<span></span>
</td>
<td class="num">(0.24)<span></span>
</td>
<td class="nump">0.06<span></span>
</td>
<td class="nump">0.19<span></span>
</td>
<td class="num">(0.39)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted earnings (loss) per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">0.06<span></span>
</td>
<td class="nump">0.02<span></span>
</td>
<td class="num">(0.06)<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="nump">0.06<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="num">(0.11)<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
<td class="num">(0.11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare', window );">Discontinued operation (in dollars per share)</a></td>
<td class="nump">0.01<span></span>
</td>
<td class="nump">0.04<span></span>
</td>
<td class="nump">0.07<span></span>
</td>
<td class="nump">0.09<span></span>
</td>
<td class="num">(0.06)<span></span>
</td>
<td class="num">(0.18)<span></span>
</td>
<td class="num">(0.12)<span></span>
</td>
<td class="nump">0.09<span></span>
</td>
<td class="nump">0.21<span></span>
</td>
<td class="num">(0.28)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss) per common share, diluted (in dollars per share)</a></td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (0.21)<span></span>
</td>
<td class="num">$ (0.24)<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="num">$ (0.38)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Weighted average dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted average dilutive securities (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,030<span></span>
</td>
<td class="nump">87,651<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477349/740-270-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 37: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 38: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue Disclosures - Narrative (Details) - clinic<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of clinics</a></td>
<td class="nump">960<span></span>
</td>
<td class="nump">967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ClinicLicensesSoldButNotYetDeveloped', window );">Clinic licenses sold but not yet developed</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ExecutedLettersOfIntentForFutureClinicLicenses', window );">Executed letters of intent for future clinic licenses</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FranchisorDisclosureAxis=us-gaap_FranchisedUnitsMember', window );">Franchised Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of clinics</a></td>
<td class="nump">885<span></span>
</td>
<td class="nump">842<span></span>
</td>
<td class="nump">800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ClinicLicensesSoldButNotYetDeveloped">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of clinics that have been sold as franchises, but are not yet operational.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ClinicLicensesSoldButNotYetDeveloped</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ExecutedLettersOfIntentForFutureClinicLicenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of future clinic's licenses that have an executed letter of intent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ExecutedLettersOfIntentForFutureClinicLicenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStores">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of stores.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStores</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FranchisorDisclosureAxis=us-gaap_FranchisedUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FranchisorDisclosureAxis=us-gaap_FranchisedUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Disclosures - Disaggregation of Revenue (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 15,167,047<span></span>
</td>
<td class="nump">$ 13,380,685<span></span>
</td>
<td class="nump">$ 13,270,270<span></span>
</td>
<td class="nump">$ 13,077,590<span></span>
</td>
<td class="nump">$ 14,714,282<span></span>
</td>
<td class="nump">$ 12,654,396<span></span>
</td>
<td class="nump">$ 12,610,036<span></span>
</td>
<td class="nump">$ 12,184,716<span></span>
</td>
<td class="nump">$ 54,895,592<span></span>
</td>
<td class="nump">$ 52,163,430<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember', window );">Revenue recognized at a point in time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,486,703<span></span>
</td>
<td class="nump">43,478,254<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember', window );">Revenue recognized over time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,408,889<span></span>
</td>
<td class="nump">$ 8,685,176<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Disclosures - Rollforward of Accounts Receivable (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward', window );"><strong>Accounts Receivable, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Beginning balance</a></td>
<td class="nump">$ 2,586,381<span></span>
</td>
<td class="nump">$ 2,580,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance', window );">Cash received against accounts receivable included at the beginning of the year</a></td>
<td class="num">(2,067,962)<span></span>
</td>
<td class="num">(2,387,577)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance', window );">Net increase during the year</a></td>
<td class="nump">2,760,932<span></span>
</td>
<td class="nump">2,614,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit losses</a></td>
<td class="num">(429,487)<span></span>
</td>
<td class="num">(220,893)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Ending balance</a></td>
<td class="nump">$ 2,849,864<span></span>
</td>
<td class="nump">$ 2,586,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, after Allowance for Credit Loss, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Decrease From Cash Received Included In Opening Balance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Increase (Decrease) From Other Than Cash Received Included In Opening Balance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Disclosures - Rollforward of Contract Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ContractWithCustomerLiabilityRollForward', window );"><strong>Deferred Revenue Short and Long-Term</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Beginning balance</a></td>
<td class="nump">$ 14,997,105<span></span>
</td>
<td class="nump">$ 16,113,879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized that was included in the contract liability at the beginning of the year</a></td>
<td class="num">(3,006,059)<span></span>
</td>
<td class="num">(2,841,085)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination', window );">Net increase during the year ended</a></td>
<td class="nump">1,427,243<span></span>
</td>
<td class="nump">1,724,311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Ending balance</a></td>
<td class="nump">$ 13,418,289<span></span>
</td>
<td class="nump">$ 14,997,105<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ContractWithCustomerLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract with Customer, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ContractWithCustomerLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Disclosures - Rollforward of Deferred Franchise and Development Costs (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ContractWithCustomerAssetRollForward', window );"><strong>Deferred Franchise and Development Costs Short and Long-Term</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Beginning balance</a></td>
<td class="nump">$ 5,569,473<span></span>
</td>
<td class="nump">$ 6,251,366<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ContractWithCustomerAssetRecognizedAsCostsOfRevenue', window );">Recognized as cost of revenue during the year</a></td>
<td class="num">(1,190,555)<span></span>
</td>
<td class="num">(1,221,140)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_CostsIncurredAndDeferredDuringTheYear', window );">Net increase during the year</a></td>
<td class="nump">394,144<span></span>
</td>
<td class="nump">539,247<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Ending balance</a></td>
<td class="nump">$ 4,773,062<span></span>
</td>
<td class="nump">$ 5,569,473<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ContractWithCustomerAssetRecognizedAsCostsOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount recognized as costs of revenue during the period related to contracts with customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ContractWithCustomerAssetRecognizedAsCostsOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ContractWithCustomerAssetRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract with Customer, Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ContractWithCustomerAssetRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_CostsIncurredAndDeferredDuringTheYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of costs incurred and deferred during the period related to contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_CostsIncurredAndDeferredDuringTheYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue Disclosures - Estimated Revenue Related to Performance Obligations (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue expected to be recognized, amount</a></td>
<td class="nump">$ 13,418,289<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue expected to be recognized, amount</a></td>
<td class="nump">$ 2,519,018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue expected to be recognized, period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2027-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue expected to be recognized, amount</a></td>
<td class="nump">$ 2,413,277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue expected to be recognized, period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2028-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue expected to be recognized, amount</a></td>
<td class="nump">$ 2,254,336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue expected to be recognized, period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2029-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2029-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue expected to be recognized, amount</a></td>
<td class="nump">$ 1,899,640<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue expected to be recognized, period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2030-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2030-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue expected to be recognized, amount</a></td>
<td class="nump">$ 1,630,838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue expected to be recognized, period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2031-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2031-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue expected to be recognized, amount</a></td>
<td class="nump">$ 2,701,180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue expected to be recognized, period</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2027-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2027-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2028-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2028-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2029-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2029-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2030-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2030-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2031-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2031-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Divestitures - Key Components of Net (Loss) Income from Discontinued Operations (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Income (loss) before income tax expense</a></td>
<td class="num">$ (224,068)<span></span>
</td>
<td class="nump">$ 664,269<span></span>
</td>
<td class="nump">$ 1,183,199<span></span>
</td>
<td class="nump">$ 1,577,229<span></span>
</td>
<td class="num">$ (1,075,745)<span></span>
</td>
<td class="num">$ (2,693,562)<span></span>
</td>
<td class="num">$ (1,719,222)<span></span>
</td>
<td class="nump">$ 1,516,243<span></span>
</td>
<td class="nump">$ 3,200,629<span></span>
</td>
<td class="num">$ (3,972,286)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation', window );">Income tax expense from discontinued operations</a></td>
<td class="num">(278,036)<span></span>
</td>
<td class="nump">99,630<span></span>
</td>
<td class="nump">100,201<span></span>
</td>
<td class="nump">103,412<span></span>
</td>
<td class="num">(184,429)<span></span>
</td>
<td class="nump">57,194<span></span>
</td>
<td class="nump">167,153<span></span>
</td>
<td class="nump">170,345<span></span>
</td>
<td class="nump">25,207<span></span>
</td>
<td class="nump">210,263<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Net income (loss) from discontinued operations</a></td>
<td class="nump">$ 53,968<span></span>
</td>
<td class="nump">$ 564,639<span></span>
</td>
<td class="nump">$ 1,082,998<span></span>
</td>
<td class="nump">$ 1,473,817<span></span>
</td>
<td class="num">$ (891,316)<span></span>
</td>
<td class="num">$ (2,750,756)<span></span>
</td>
<td class="num">$ (1,886,375)<span></span>
</td>
<td class="nump">$ 1,345,898<span></span>
</td>
<td class="nump">3,175,422<span></span>
</td>
<td class="num">(4,182,549)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember', window );">Corporate Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation', window );">Income tax expense from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,207<span></span>
</td>
<td class="nump">210,263<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Net income (loss) from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,175,422<span></span>
</td>
<td class="num">(4,182,549)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember', window );">Discontinued Operations, Held-for-Sale or Disposed of by Sale | Corporate Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,038,508<span></span>
</td>
<td class="nump">69,982,344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold', window );">Total cost of revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,971<span></span>
</td>
<td class="nump">47,817<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses', window );">Selling and marketing expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,755,830<span></span>
</td>
<td class="nump">7,850,616<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,558<span></span>
</td>
<td class="nump">3,350,748<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,450,918<span></span>
</td>
<td class="nump">54,988,780<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses', window );">Total selling, general and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,276,306<span></span>
</td>
<td class="nump">66,190,144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax', window );">Net loss on disposition or impairment from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,441,010<span></span>
</td>
<td class="nump">7,714,555<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss', window );">Income (loss) from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300,221<span></span>
</td>
<td class="num">(3,970,172)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense', window );">Other expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,592<span></span>
</td>
<td class="nump">2,114<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Income (loss) before income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,200,629<span></span>
</td>
<td class="num">$ (3,972,286)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Income (Expense)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Selling And Marketing Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Selling, General And Administrative Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of depreciation and amortization expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477349/740-270-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Divestitures - Assets and Liabilities of Discontinued Operations (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">$ 22,246,318<span></span>
</td>
<td class="nump">$ 43,151,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities to be disposed of</a></td>
<td class="nump">21,368,446<span></span>
</td>
<td class="nump">37,367,459<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities to be disposed of</a></td>
<td class="nump">6,100,000<span></span>
</td>
<td class="nump">7,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember', window );">Corporate Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Total assets, discontinued operations</a></td>
<td class="nump">22,246,318<span></span>
</td>
<td class="nump">43,151,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Total liabilities, discontinued operations</a></td>
<td class="nump">21,368,446<span></span>
</td>
<td class="nump">37,367,459<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember', window );">Corporate Clinics | Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">994,138<span></span>
</td>
<td class="nump">1,087,203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities to be disposed of</a></td>
<td class="nump">6,079,903<span></span>
</td>
<td class="nump">7,125,071<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember', window );">Discontinued Operations, Held-for-Sale or Disposed of by Sale | Corporate Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Accounts receivable</a></td>
<td class="nump">315,201<span></span>
</td>
<td class="nump">2,484,248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent', window );">Prepaid expenses and other assets</a></td>
<td class="nump">581,504<span></span>
</td>
<td class="nump">549,605<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent', window );">Property and equipment, net</a></td>
<td class="nump">67,779<span></span>
</td>
<td class="nump">208,074<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent', window );">Deferred tax assets (attributable to VIEs)</a></td>
<td class="nump">994,138<span></span>
</td>
<td class="nump">1,087,204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets', window );">Deposits and other assets</a></td>
<td class="nump">235,731<span></span>
</td>
<td class="nump">425,938<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">83,503<span></span>
</td>
<td class="nump">67,107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">2,519,433<span></span>
</td>
<td class="nump">5,066,941<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent', window );">Payroll liabilities ($0.6 million and $0.9 million attributable to VIEs, respectively)</a></td>
<td class="nump">988,865<span></span>
</td>
<td class="nump">2,333,335<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent', window );">Operating lease liability</a></td>
<td class="nump">651,844<span></span>
</td>
<td class="nump">153,517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent', window );">Finance lease liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">38,015<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember', window );">Discontinued Operations, Held-for-Sale or Disposed of by Sale | Corporate Clinics | Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent', window );">Payroll liabilities ($0.6 million and $0.9 million attributable to VIEs, respectively)</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities', window );">Other current liabilities (attributable to VIEs)</a></td>
<td class="nump">756,483<span></span>
</td>
<td class="nump">1,079,441<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember', window );">Discontinued Operations, Assets Held For Sale | Corporate Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">20,051,965<span></span>
</td>
<td class="nump">38,395,986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent', window );">Property and equipment, net</a></td>
<td class="nump">4,497,545<span></span>
</td>
<td class="nump">8,457,627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent', window );">Operating lease liability</a></td>
<td class="nump">11,065,542<span></span>
</td>
<td class="nump">20,526,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities to be disposed of</a></td>
<td class="nump">16,368,318<span></span>
</td>
<td class="nump">28,629,103<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember', window );">Discontinued Operations, Assets Held For Sale | Corporate Clinics | Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities to be disposed of</a></td>
<td class="nump">$ 4,700,000<span></span>
</td>
<td class="nump">$ 5,200,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Deferred Tax Assets, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Finance Lease Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Payroll Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Divestitures - Key Components of Cash Flows from Discontinued Operations (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationAlternativeCashFlowInformationAbstract', window );"><strong>Significant operating and investing non-cash items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationDiscontinuedOperations', window );">Depreciation and amortization</a></td>
<td class="nump">$ 69,558<span></span>
</td>
<td class="nump">$ 3,350,748<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember', window );">Discontinued Operations, Held-for-Sale or Disposed of by Sale | Corporate Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationAlternativeCashFlowInformationAbstract', window );"><strong>Significant operating and investing non-cash items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax', window );">Net loss on disposition or impairment</a></td>
<td class="nump">5,441,010<span></span>
</td>
<td class="nump">7,714,555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_CapitalExpendituresDiscontinuedOperationsAbstract', window );"><strong>Capital expenditures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpenditureDiscontinuedOperations', window );">Purchase of property and equipment</a></td>
<td class="nump">$ 84,256<span></span>
</td>
<td class="nump">$ 664,423<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_CapitalExpendituresDiscontinuedOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital Expenditures, Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_CapitalExpendituresDiscontinuedOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpenditureDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of capital expenditure attributable to discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpenditureDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortizationDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deprecation and amortization expense attributable to property, plant and equipment and intangible assets of discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortizationDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationAlternativeCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationAlternativeCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Divestitures - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Income (loss) from discontinued operations before income tax expense</a></td>
<td class="num">$ (224,068)<span></span>
</td>
<td class="nump">$ 664,269<span></span>
</td>
<td class="nump">$ 1,183,199<span></span>
</td>
<td class="nump">$ 1,577,229<span></span>
</td>
<td class="num">$ (1,075,745)<span></span>
</td>
<td class="num">$ (2,693,562)<span></span>
</td>
<td class="num">$ (1,719,222)<span></span>
</td>
<td class="nump">$ 1,516,243<span></span>
</td>
<td class="nump">$ 3,200,629<span></span>
</td>
<td class="num">$ (3,972,286)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember', window );">Discontinued Operations, Assets Held For Sale | Corporate Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DisposalGroupHeldForSaleClinicsExpectedToSellPeriod', window );">Clinics expected to sell, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue', window );">Estimated fair value</a></td>
<td class="nump">2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent', window );">Valuation allowance</a></td>
<td class="nump">6,327,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,071,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,327,644<span></span>
</td>
<td class="nump">5,071,603<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss', window );">Income (loss) from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
<td class="nump">4,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember', window );">Discontinued Operations, Assets Held For Sale | Corporate Clinics | Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax', window );">Net loss on disposition or impairment from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,734,726<span></span>
</td>
<td class="nump">4,540,530<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Sale of Assets | Corporate Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax', window );">Net loss on disposition or impairment from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">926,103<span></span>
</td>
<td class="num">(44,807)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Total consideration</a></td>
<td class="nump">7,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,800,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold', window );">Assets sold that were previously classified as held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,400,000<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent', window );">Valuation allowance</a></td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold', window );">Liabilities sold that were previously classified as held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,400,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Income (loss) from discontinued operations before income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (600,000)<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DisposalGroupHeldForSaleClinicsExpectedToSellPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Held-for-Sale, Clinics Expected To Sell, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DisposalGroupHeldForSaleClinicsExpectedToSellPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Assets Held For Sale, Sold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Estimated Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Liabilities Held For Sale, Sold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Valuation Allowance, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=jynt_AssetsHeldForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=jynt_AssetsHeldForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Divestitures - Held For Sale Assets and Liabilities To Be Disposed Of (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total assets held for sale</a></td>
<td class="nump">$ 22,246,318<span></span>
</td>
<td class="nump">$ 43,151,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total liabilities to be disposed of</a></td>
<td class="nump">21,368,446<span></span>
</td>
<td class="nump">37,367,459<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember', window );">Discontinued Operations, Assets Held For Sale | Corporate Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent', window );">Property and equipment, net</a></td>
<td class="nump">4,497,545<span></span>
</td>
<td class="nump">8,457,627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent', window );">Operating lease right-of-use asset</a></td>
<td class="nump">14,111,081<span></span>
</td>
<td class="nump">19,643,917<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent', window );">Intangible assets, net</a></td>
<td class="nump">4,288,265<span></span>
</td>
<td class="nump">6,906,807<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent', window );">Goodwill</a></td>
<td class="nump">3,482,718<span></span>
</td>
<td class="nump">8,459,238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent', window );">Valuation allowance</a></td>
<td class="num">(6,327,644)<span></span>
</td>
<td class="num">(5,071,603)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total assets held for sale</a></td>
<td class="nump">20,051,965<span></span>
</td>
<td class="nump">38,395,986<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent', window );">Operating lease liability</a></td>
<td class="nump">11,065,542<span></span>
</td>
<td class="nump">20,526,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent', window );">Deferred revenue from company-owned or managed clinics</a></td>
<td class="nump">5,302,776<span></span>
</td>
<td class="nump">8,102,389<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total liabilities to be disposed of</a></td>
<td class="nump">$ 16,368,318<span></span>
</td>
<td class="nump">$ 28,629,103<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Lease, Right-of-Use Asset, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Valuation Allowance, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as deferred revenue attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment - Summary of Property and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 3,159,226<span></span>
</td>
<td class="nump">$ 3,206,754<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress</a></td>
<td class="nump">990,149<span></span>
</td>
<td class="nump">751,873<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office and computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">982,766<span></span>
</td>
<td class="nump">937,551<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">1,594,291<span></span>
</td>
<td class="nump">1,585,609<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Internally developed software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">7,103,852<span></span>
</td>
<td class="nump">5,914,254<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember', window );">Property and equipment, excluding Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">9,680,909<span></span>
</td>
<td class="nump">8,437,414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation and amortization</a></td>
<td class="num">(7,511,832)<span></span>
</td>
<td class="num">(5,982,533)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 2,169,077<span></span>
</td>
<td class="nump">$ 2,454,881<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="nump">$ 1.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Consideration (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Discontinued operations current assets</a></td>
<td class="nump">$ 22,246,318<span></span>
</td>
<td class="nump">$ 43,151,055<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember', window );">Discontinued Operations, Assets Held For Sale | Corporate Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Discontinued operations current assets</a></td>
<td class="nump">20,051,965<span></span>
</td>
<td class="nump">38,395,986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent', window );">Valuation allowance</a></td>
<td class="nump">6,327,644<span></span>
</td>
<td class="nump">5,071,603<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=jynt_DiscontinuedOperationsHeldForUseMember', window );">Discontinued Operations, Held For Use | Corporate Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax', window );">Net loss on disposition or impairment from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,651,737<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=jynt_DiscontinuedOperationsHeldForUseMember', window );">Discontinued Operations, Held For Use | Corporate Clinics | Operating lease right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax', window );">Net loss on disposition or impairment from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,432,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment', window );">Carrying value of impaired asset before impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,779,712<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment', window );">Fair value of impaired asset after impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,347,457<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=jynt_DiscontinuedOperationsHeldForUseMember', window );">Discontinued Operations, Held For Use | Corporate Clinics | Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax', window );">Net loss on disposition or impairment from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,173,718<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment', window );">Carrying value of impaired asset before impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,929,036<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment', window );">Fair value of impaired asset after impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,755,318<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=jynt_DiscontinuedOperationsHeldForUseMember', window );">Discontinued Operations, Held For Use | Corporate Clinics | Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax', window );">Net loss on disposition or impairment from discontinued operations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">45,764<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment', window );">Carrying value of impaired asset before impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298,510<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment', window );">Fair value of impaired asset after impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">252,746<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember', window );">Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_AssetsHeldForSaleCashFlowForecastPeriod', window );">Assets held for sale cash flow forecast period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember', window );">Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_AssetsHeldForSaleMeasurementInputPositiveCashFlow', window );">Assets, held-for-sale, measurement input, positive cash flow</a></td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_AssetsHeldForSaleMeasurementInputNegativeCashFlow', window );">Assets, held-for-sale, measurement input, negative cash flow</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 | Discontinued Operations, Assets Held For Sale | Corporate Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Discontinued operations current assets</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 | Discontinued Operations, Assets Held For Sale | Corporate Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Discontinued operations current assets</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="nump">$ 26,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds | Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents fair value</a></td>
<td class="nump">$ 19,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_AssetsHeldForSaleCashFlowForecastPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets, Held-For-Sale, Cash Flow Forecast Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_AssetsHeldForSaleCashFlowForecastPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_AssetsHeldForSaleMeasurementInputNegativeCashFlow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets, Held-For-Sale, Measurement Input, Negative Cash Flow</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_AssetsHeldForSaleMeasurementInputNegativeCashFlow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_AssetsHeldForSaleMeasurementInputPositiveCashFlow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets, Held-For-Sale, Measurement Input, Positive Cash Flow</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_AssetsHeldForSaleMeasurementInputPositiveCashFlow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Valuation Allowance, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impaired Long-Lived Assets Held And Used, Carrying Value After Impairment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impaired Long-Lived Assets Held And Used, Carrying Value Before Impairment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482881/825-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482881/825-10-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=jynt_DiscontinuedOperationsHeldForUseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=jynt_DiscontinuedOperationsHeldForUseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=jynt_OperatingLeaseRightOfUseAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=jynt_OperatingLeaseRightOfUseAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_FiniteLivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_FiniteLivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Details) - Line of Credit - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2022</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jan. 17, 2024</div></th>
<th class="th"><div>Feb. 28, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jynt_SeniorSecuredCreditFacilitiesMember', window );">Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jynt_A2022CreditFacilityMember', window );">2022 Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs incurred</a></td>
<td class="nump">$ 76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount', window );">Maximum borrowing capacity, additional amount</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | 2022 Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount', window );">Maximum borrowing capacity, additional amount</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Debt under credit agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | 2022 Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | 2022 Credit Facility | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | 2022 Credit Facility | Federal Reserve Bank Of New York Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | 2022 Credit Facility | Minimum | SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | 2022 Credit Facility | Maximum | SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=jynt_DevelopmentLineOfCreditMember', window );">Development Line of Credit | Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet', window );">Termination of line of credit</a></td>
<td class="nump">$ 5,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | 2022 Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Maximum Borrowing Capacity, Additional Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jynt_SeniorSecuredCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jynt_SeniorSecuredCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jynt_A2022CreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jynt_A2022CreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=jynt_FederalReserveBankOfNewYorkRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=jynt_FederalReserveBankOfNewYorkRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=jynt_DevelopmentLineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=jynt_DevelopmentLineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 04, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jun. 03, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase amount authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ShareRepurchaseProgramAdditionalAuthorizedAmount', window );">Share repurchase additional authorized amount</a></td>
<td class="nump">$ 12,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Common stock repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,313,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average cost of stock repurchased (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Authorized amount remaining for repurchasing shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Common stock surrendered and netted as payment for minimum statutory withholding requirements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,440<span></span>
</td>
<td class="nump">$ 9,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ShareRepurchaseProgramAdditionalAuthorizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Repurchase Program, Additional Authorized, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ShareRepurchaseProgramAdditionalAuthorizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>installment </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Common stock available for issuance (in shares) | shares</a></td>
<td class="nump">1,725,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage', window );">Forecasted turnover percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Fair value of stock options vested</a></td>
<td class="nump">$ 157,000<span></span>
</td>
<td class="nump">$ 319,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">1,297,433<span></span>
</td>
<td class="nump">1,679,005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Income tax benefit from exercise of stock options and restricted stock awards</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Contractual term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage', window );">Forecasted turnover percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">38,059<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant-date fair value for options granted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 73,000<span></span>
</td>
<td class="nump">$ 141,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock-based compensation expense</a></td>
<td class="nump">$ 166,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized stock-based compensation, period of recognition</a></td>
<td class="text">2 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Unvested restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock-based compensation expense</a></td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized stock-based compensation, period of recognition</a></td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments', window );">Number of equal annual installments | installment</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Unvested restricted stock | Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Forfeitures, Historical And Forecasted Turnover, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Payment Arrangement, Equity Instruments Other than Options, Vesting, Number of Annual Installments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479983/718-10-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Valuation Assumptions used for Stock Options (Details) - Stock options<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">64.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">6 years 3 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">3.86%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock Options Activity (Details) - Stock options - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning (in shares)</a></td>
<td class="nump">281,977<span></span>
</td>
<td class="nump">486,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted at market price (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">38,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(123,460)<span></span>
</td>
<td class="num">(227,952)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired (in shares)</a></td>
<td class="num">(89,604)<span></span>
</td>
<td class="num">(9,201)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled (in shares)</a></td>
<td class="num">(432)<span></span>
</td>
<td class="num">(5,263)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, ending (in shares)</a></td>
<td class="nump">68,481<span></span>
</td>
<td class="nump">281,977<span></span>
</td>
<td class="nump">486,334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable, number of shares (in shares)</a></td>
<td class="nump">39,936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Vested and expected to vest (in shares)</a></td>
<td class="nump">66,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, weighted average exercise price, beginning (in dollars per share)</a></td>
<td class="nump">$ 11.80<span></span>
</td>
<td class="nump">$ 8.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted at market price, weighted average exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">5.04<span></span>
</td>
<td class="nump">4.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">19.01<span></span>
</td>
<td class="nump">26.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Cancelled, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">45.39<span></span>
</td>
<td class="nump">41.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, weighted average exercise price, ending (in dollars per share)</a></td>
<td class="nump">14.33<span></span>
</td>
<td class="nump">$ 11.80<span></span>
</td>
<td class="nump">$ 8.88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">17.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest , weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 14.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted Average Remaining Contractual Life</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding, weighted average remaining contractual life (in year)</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">3 years 3 months 18 days<span></span>
</td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable, weighted average remaining contractual life (in year)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vest , weighted average remaining contractual life (in year)</a></td>
<td class="text">5 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Outstanding, aggregate intrinsic value</a></td>
<td class="nump">$ 59,412<span></span>
</td>
<td class="nump">$ 777,566<span></span>
</td>
<td class="nump">$ 1,903,699<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Exercised, aggregate intrinsic value</a></td>
<td class="nump">656,751<span></span>
</td>
<td class="nump">$ 1,435,074<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Exercisable, aggregate intrinsic value</a></td>
<td class="nump">59,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest, aggregate intrinsic value</a></td>
<td class="nump">$ 59,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Restricted Stock Activity (Details) - Unvested restricted stock - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-vested (in shares)</a></td>
<td class="nump">305,982<span></span>
</td>
<td class="nump">231,901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">301,896<span></span>
</td>
<td class="nump">285,656<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(107,854)<span></span>
</td>
<td class="num">(107,103)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Cancelled (in shares)</a></td>
<td class="num">(146,534)<span></span>
</td>
<td class="num">(104,472)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-vested (in shares)</a></td>
<td class="nump">353,490<span></span>
</td>
<td class="nump">305,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant-Date Fair Value per Award</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Non-vested (in dollar per share)</a></td>
<td class="nump">$ 11.97<span></span>
</td>
<td class="nump">$ 17.32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">10.54<span></span>
</td>
<td class="nump">9.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="nump">12.61<span></span>
</td>
<td class="nump">16.17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Cancelled (in dollars per share)</a></td>
<td class="nump">11.24<span></span>
</td>
<td class="nump">14.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Non-vested (in dollar per share)</a></td>
<td class="nump">$ 10.86<span></span>
</td>
<td class="nump">$ 11.97<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Loss From Continuing Operations Before the Provision for Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (229,504)<span></span>
</td>
<td class="num">$ (1,608,738)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss from continuing operations before income tax expense</a></td>
<td class="nump">$ 940,642<span></span>
</td>
<td class="nump">$ 300,716<span></span>
</td>
<td class="num">$ (978,245)<span></span>
</td>
<td class="num">$ (492,617)<span></span>
</td>
<td class="nump">$ 889,445<span></span>
</td>
<td class="num">$ (408,992)<span></span>
</td>
<td class="num">$ (1,698,854)<span></span>
</td>
<td class="num">$ (390,337)<span></span>
</td>
<td class="num">$ (229,504)<span></span>
</td>
<td class="num">$ (1,608,738)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income Tax Expense (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Current expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State, net of state tax credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,653<span></span>
</td>
<td class="nump">$ 62,759<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,653<span></span>
</td>
<td class="nump">62,759<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Deferred expense (benefit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(57,153)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(57,153)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax expense</a></td>
<td class="nump">$ 3,513<span></span>
</td>
<td class="nump">$ 10,346<span></span>
</td>
<td class="nump">$ 11,390<span></span>
</td>
<td class="nump">$ 13,404<span></span>
</td>
<td class="num">$ (19,536)<span></span>
</td>
<td class="nump">$ 5,391<span></span>
</td>
<td class="nump">$ 11,169<span></span>
</td>
<td class="nump">$ 8,582<span></span>
</td>
<td class="nump">$ 38,653<span></span>
</td>
<td class="nump">$ 5,606<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Deferred income tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">$ 757,576<span></span>
</td>
<td class="nump">$ 1,607,324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred revenue</a></td>
<td class="nump">3,535,528<span></span>
</td>
<td class="nump">3,909,555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DeferredTaxAssetsOperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="nump">3,795,895<span></span>
</td>
<td class="nump">5,710,136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DeferredTaxAssetsGoodwillComponent1', window );">Goodwill - component 1</a></td>
<td class="nump">383,987<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DeferredTaxAssetsGoodwillComponent2', window );">Goodwill - component 2</a></td>
<td class="nump">49,829<span></span>
</td>
<td class="nump">55,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Fixed assets</a></td>
<td class="nump">471,855<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DeferredTaxAssetsNonqualifiedStockOptions', window );">Nonqualified stock options</a></td>
<td class="nump">117,962<span></span>
</td>
<td class="nump">322,376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">3,261,907<span></span>
</td>
<td class="nump">3,029,413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">35,850<span></span>
</td>
<td class="nump">35,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DeferredTaxAssetsIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">3,416,636<span></span>
</td>
<td class="nump">3,921,742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation expense</a></td>
<td class="nump">141,563<span></span>
</td>
<td class="nump">139,038<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total</a></td>
<td class="nump">15,968,588<span></span>
</td>
<td class="nump">18,730,802<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(11,327,659)<span></span>
</td>
<td class="num">(12,307,555)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred Tax Assets, Net</a></td>
<td class="nump">4,640,929<span></span>
</td>
<td class="nump">6,423,247<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred income tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset', window );">Lease ROU asset</a></td>
<td class="num">(4,320,092)<span></span>
</td>
<td class="num">(5,392,996)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DeferredTaxLiabilitiesDeferredFranchiseCosts', window );">Deferred franchise costs</a></td>
<td class="num">(320,837)<span></span>
</td>
<td class="num">(75,284)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill', window );">Goodwill - component 1</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(807,824)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Fixed assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(147,143)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred income tax liabilities</a></td>
<td class="num">(4,640,929)<span></span>
</td>
<td class="num">(6,423,247)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred income taxes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetsGoodwillComponent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Goodwill - Component 1</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetsGoodwillComponent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetsGoodwillComponent2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to the difference between the book value and the taxable value of goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetsGoodwillComponent2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetsNonqualifiedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Nonqualified Stock Options</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetsNonqualifiedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetsOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Operating Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetsOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxLiabilitiesDeferredFranchiseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Deferred Franchise Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxLiabilitiesDeferredFranchiseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Operating Lease, Right-of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred tax assets, valuation allowance</a></td>
<td class="nump">$ 11,327,659<span></span>
</td>
<td class="nump">$ 12,307,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Deferred tax assets, valuation allowance decrease</a></td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 10,200,000<span></span>
</td>
<td class="nump">$ 12,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="num">(16.80%)<span></span>
</td>
<td class="num">(0.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Accrued interest and penalties</a></td>
<td class="nump">$ 178,000<span></span>
</td>
<td class="nump">$ 202,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember', window );">Research Tax Credit Carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credits</a></td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=jynt_CaliforniaAlternativeMinimumTaxCreditMember', window );">California Alternative Minimum Tax Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credits</a></td>
<td class="nump">22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=country_US', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">2,100,000<span></span>
</td>
<td class="nump">2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Net operating losses</a></td>
<td class="nump">7,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Net operating losses with an indefinite carryforward</a></td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">10,200,000<span></span>
</td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember', window );">Discontinued Operations, Held-for-Sale or Disposed of by Sale | Corporate Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent', window );">Deferred tax assets (attributable to VIEs)</a></td>
<td class="nump">994,138<span></span>
</td>
<td class="nump">1,087,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Uncertain tax positions</a></td>
<td class="nump">633,714<span></span>
</td>
<td class="nump">948,182<span></span>
</td>
<td class="nump">$ 1,175,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that if recognized would affect the annual effective tax rate</a></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="nump">$ 22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Deferred Tax Assets, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=jynt_CaliforniaAlternativeMinimumTaxCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=jynt_CaliforniaAlternativeMinimumTaxCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Effective Income Tax Reconciliation (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss from continuing operations before provision for income taxes</a></td>
<td class="nump">$ 940,642<span></span>
</td>
<td class="nump">$ 300,716<span></span>
</td>
<td class="num">$ (978,245)<span></span>
</td>
<td class="num">$ (492,617)<span></span>
</td>
<td class="nump">$ 889,445<span></span>
</td>
<td class="num">$ (408,992)<span></span>
</td>
<td class="num">$ (1,698,854)<span></span>
</td>
<td class="num">$ (390,337)<span></span>
</td>
<td class="num">$ (229,504)<span></span>
</td>
<td class="num">$ (1,608,738)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Amount</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Expected federal tax expense at U.S. federal statutory rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(48,388)<span></span>
</td>
<td class="num">(337,835)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State and local income taxes (net of federal income tax effect)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(128,782)<span></span>
</td>
<td class="nump">79,774<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Changes in valuation allowances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(507,419)<span></span>
</td>
<td class="nump">66,503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount', window );">Section 162(m) officer compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">85,992<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28,302)<span></span>
</td>
<td class="num">(119,263)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount', window );">Payroll tax penalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45,749)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment', window );">Meals and entertainment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,549<span></span>
</td>
<td class="nump">30,462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther', window );">Other nontaxable or nondeductible items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,710<span></span>
</td>
<td class="nump">26,572<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxContingencies', window );">Changes in unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,582<span></span>
</td>
<td class="nump">212,687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItemsAbstract', window );"><strong>Other adjustments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount', window );">Deferred true-up to deferred franchise costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">285,915<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Current year expirations of non-qualified stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">217,356<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47,819)<span></span>
</td>
<td class="num">(39,286)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax expense</a></td>
<td class="nump">$ 3,513<span></span>
</td>
<td class="nump">$ 10,346<span></span>
</td>
<td class="nump">$ 11,390<span></span>
</td>
<td class="nump">$ 13,404<span></span>
</td>
<td class="num">$ (19,536)<span></span>
</td>
<td class="nump">$ 5,391<span></span>
</td>
<td class="nump">$ 11,169<span></span>
</td>
<td class="nump">$ 8,582<span></span>
</td>
<td class="nump">$ 38,653<span></span>
</td>
<td class="nump">$ 5,606<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Percent</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Expected federal tax expense at U.S. federal statutory rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and local income taxes (net of federal income tax effect)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.10%<span></span>
</td>
<td class="num">(5.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Changes in valuation allowances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">221.10%<span></span>
</td>
<td class="num">(4.10%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent', window );">Section 162(m) officer compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(5.30%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.30%<span></span>
</td>
<td class="nump">7.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent', window );">Payroll tax penalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.90%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment', window );">Meals and entertainment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.20%)<span></span>
</td>
<td class="num">(1.90%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther', window );">Other nontaxable or nondeductible items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.70%)<span></span>
</td>
<td class="num">(1.60%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies', window );">Changes in unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(130.90%)<span></span>
</td>
<td class="num">(13.20%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercentAbstract', window );"><strong>Other adjustments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent', window );">Deferred true-up to deferred franchise costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(124.50%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent', window );">Current year expirations of non-qualified stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(94.70%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.80%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16.80%)<span></span>
</td>
<td class="num">(0.30%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Deferred Franchise Costs, Deferred True Up, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Deferred Franchise Costs, Deferred True Up, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Officer Compensation, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Officer Compensation, Percent"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Payroll Tax Penalty, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Payroll Tax Penalty, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479176/718-740-35-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479176/718-740-35-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(8)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible meals and entertainment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(8)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Uncertain Tax Position Rollforward (Details) - Discontinued Operations, Held-for-Sale or Disposed of by Sale - Corporate Clinics - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Unrecognized Tax Benefits [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning balance</a></td>
<td class="nump">$ 948,182<span></span>
</td>
<td class="nump">$ 1,175,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Reductions for expiration of the statute of limitations</a></td>
<td class="num">(314,468)<span></span>
</td>
<td class="num">(227,584)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Ending balance</a></td>
<td class="nump">$ 633,714<span></span>
</td>
<td class="nump">$ 948,182<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CorporateClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Cash Paid For Income Taxes (Net of Refunds Received) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems', window );"><strong>Income Tax Paid, by Individual Jurisdiction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPaidFederalAfterRefundReceived', window );">Federal</a></td>
<td class="nump">$ 321,000<span></span>
</td>
<td class="nump">$ 285,510<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid (net of refunds received)</a></td>
<td class="nump">626,752<span></span>
</td>
<td class="nump">610,492<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=stpr_AZ', window );">Arizona</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems', window );"><strong>Income Tax Paid, by Individual Jurisdiction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPaidStateAndLocalAfterRefundReceived', window );">State:</a></td>
<td class="nump">62,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=stpr_CA', window );">California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems', window );"><strong>Income Tax Paid, by Individual Jurisdiction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPaidStateAndLocalAfterRefundReceived', window );">State:</a></td>
<td class="nump">168,000<span></span>
</td>
<td class="nump">182,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=stpr_TX', window );">Texas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems', window );"><strong>Income Tax Paid, by Individual Jurisdiction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPaidStateAndLocalAfterRefundReceived', window );">State:</a></td>
<td class="nump">62,000<span></span>
</td>
<td class="nump">51,026<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalTaxJurisdictionOtherMember', window );">Other state jurisdictions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems', window );"><strong>Income Tax Paid, by Individual Jurisdiction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPaidStateAndLocalAfterRefundReceived', window );">State:</a></td>
<td class="nump">$ 13,752<span></span>
</td>
<td class="nump">$ 91,956<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPaidFederalAfterRefundReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after income tax refund received, of cash paid to federal (national) tax jurisdiction for tax on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPaidFederalAfterRefundReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPaidStateAndLocalAfterRefundReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after income tax refund received, of cash paid to state and local tax jurisdictions for tax on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPaidStateAndLocalAfterRefundReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=stpr_AZ">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=stpr_AZ</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=stpr_TX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=stpr_TX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalTaxJurisdictionOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalTaxJurisdictionOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Lease Expense and Supplemental Lease Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeAndExpensesLesseeAbstract', window );"><strong>Operating lease costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">$ 355,912<span></span>
</td>
<td class="nump">$ 325,396<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease costs</a></td>
<td class="nump">355,912<span></span>
</td>
<td class="nump">325,396<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Operating Leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="nump">1,572,173<span></span>
</td>
<td class="nump">555,536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current portion</a></td>
<td class="nump">194,179<span></span>
</td>
<td class="nump">483,337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, net of current portion</a></td>
<td class="nump">1,815,527<span></span>
</td>
<td class="nump">311,689<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liability</a></td>
<td class="nump">$ 2,009,706<span></span>
</td>
<td class="nump">$ 795,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_WeightedAverageRemainingLeaseTermAbstract', window );"><strong>Weighted average remaining lease term (in years):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases</a></td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
<td class="text">3 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_LeasesWeightedAverageDiscountRateAbstract', window );"><strong>Weighted average discount rate:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases</a></td>
<td class="nump">6.50%<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_CashFlowLesseeAbstract', window );"><strong>Cash paid for amounts included in measurement of liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 460,056<span></span>
</td>
<td class="nump">$ 505,577<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract', window );"><strong>Non-cash transactions: ROU assets obtained in exchange for lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating lease</a></td>
<td class="nump">$ 1,554,504<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_CashFlowLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Flow, Lessee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_CashFlowLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_LeasesWeightedAverageDiscountRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Leases, Weighted Average Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_LeasesWeightedAverageDiscountRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Assets and Liabilities, Lessee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-of-Use Asset Obtained in Exchange for Lease Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_WeightedAverageRemainingLeaseTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Lease Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_WeightedAverageRemainingLeaseTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeAndExpensesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeAndExpensesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Maturities of Lease Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2026</a></td>
<td class="nump">$ 268,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2027</a></td>
<td class="nump">467,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2028</a></td>
<td class="nump">479,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2029</a></td>
<td class="nump">491,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2030</a></td>
<td class="nump">503,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">211,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">2,421,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="num">(411,993)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liability</a></td>
<td class="nump">2,009,706<span></span>
</td>
<td class="nump">$ 795,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: Current obligations</a></td>
<td class="num">(194,179)<span></span>
</td>
<td class="num">(483,337)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term lease obligations</a></td>
<td class="nump">$ 1,815,527<span></span>
</td>
<td class="nump">$ 311,689<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Feb. 25, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>lease</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_NumberOfFutureOperatingLeasesCommitted', window );">Number of future operating leases committed | lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_GuarantorObligationsRemainingExposureUndiscounted', window );">Guarantor obligations, remaining exposure, undiscounted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Discontinued operations current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,368,446<span></span>
</td>
<td class="nump">$ 37,367,459<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Discontinued operations current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,246,318<span></span>
</td>
<td class="nump">43,151,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">3,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=jynt_EmploymentMattersMember', window );">Employment Matters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Settlement agreement amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=jynt_MedicalInjuryClaimMember', window );">Medical Injury Claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Settlement agreement amount</a></td>
<td class="nump">$ 3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Discontinued operations current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Discontinued operations current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_GuarantorObligationsRemainingExposureUndiscounted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Guarantor Obligations, Remaining Exposure, Undiscounted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_GuarantorObligationsRemainingExposureUndiscounted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfFutureOperatingLeasesCommitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Future Operating Leases Committed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfFutureOperatingLeasesCommitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=jynt_EmploymentMattersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=jynt_EmploymentMattersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=jynt_MedicalInjuryClaimMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=jynt_MedicalInjuryClaimMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>clinic </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>clinic</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>clinic</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of clinics | clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">960<span></span>
</td>
<td class="nump">967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FranchisorDisclosureAxis=us-gaap_FranchisedUnitsMember', window );">Franchised Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of clinics | clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">885<span></span>
</td>
<td class="nump">842<span></span>
</td>
<td class="nump">800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStores">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of stores.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStores</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FranchisorDisclosureAxis=us-gaap_FranchisedUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FranchisorDisclosureAxis=us-gaap_FranchisedUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Total Revenue and Significant Expense Categories (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 15,167,047<span></span>
</td>
<td class="nump">$ 13,380,685<span></span>
</td>
<td class="nump">$ 13,270,270<span></span>
</td>
<td class="nump">$ 13,077,590<span></span>
</td>
<td class="nump">$ 14,714,282<span></span>
</td>
<td class="nump">$ 12,654,396<span></span>
</td>
<td class="nump">$ 12,610,036<span></span>
</td>
<td class="nump">$ 12,184,716<span></span>
</td>
<td class="nump">$ 54,895,592<span></span>
</td>
<td class="nump">$ 52,163,430<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing expenses</a></td>
<td class="nump">3,494,324<span></span>
</td>
<td class="nump">2,816,081<span></span>
</td>
<td class="nump">3,483,844<span></span>
</td>
<td class="nump">3,505,150<span></span>
</td>
<td class="nump">2,791,468<span></span>
</td>
<td class="nump">2,504,168<span></span>
</td>
<td class="nump">3,440,391<span></span>
</td>
<td class="nump">2,237,583<span></span>
</td>
<td class="nump">13,299,399<span></span>
</td>
<td class="nump">10,973,610<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">433,200<span></span>
</td>
<td class="nump">446,736<span></span>
</td>
<td class="nump">402,295<span></span>
</td>
<td class="nump">361,930<span></span>
</td>
<td class="nump">353,466<span></span>
</td>
<td class="nump">345,835<span></span>
</td>
<td class="nump">342,454<span></span>
</td>
<td class="nump">329,634<span></span>
</td>
<td class="nump">1,644,161<span></span>
</td>
<td class="nump">1,371,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">3,513<span></span>
</td>
<td class="nump">10,346<span></span>
</td>
<td class="nump">11,390<span></span>
</td>
<td class="nump">13,404<span></span>
</td>
<td class="num">(19,536)<span></span>
</td>
<td class="nump">5,391<span></span>
</td>
<td class="nump">11,169<span></span>
</td>
<td class="nump">8,582<span></span>
</td>
<td class="nump">38,653<span></span>
</td>
<td class="nump">5,606<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net loss from continuing operations</a></td>
<td class="nump">937,129<span></span>
</td>
<td class="nump">290,370<span></span>
</td>
<td class="num">(989,635)<span></span>
</td>
<td class="num">(506,021)<span></span>
</td>
<td class="nump">908,981<span></span>
</td>
<td class="num">(414,383)<span></span>
</td>
<td class="num">(1,710,023)<span></span>
</td>
<td class="num">(398,919)<span></span>
</td>
<td class="num">(268,157)<span></span>
</td>
<td class="num">(1,614,344)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Reconciliation of loss</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net loss from continuing operations</a></td>
<td class="nump">937,129<span></span>
</td>
<td class="nump">290,370<span></span>
</td>
<td class="num">(989,635)<span></span>
</td>
<td class="num">(506,021)<span></span>
</td>
<td class="nump">908,981<span></span>
</td>
<td class="num">(414,383)<span></span>
</td>
<td class="num">(1,710,023)<span></span>
</td>
<td class="num">(398,919)<span></span>
</td>
<td class="num">(268,157)<span></span>
</td>
<td class="num">(1,614,344)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Net income (loss) from discontinued operations</a></td>
<td class="nump">53,968<span></span>
</td>
<td class="nump">564,639<span></span>
</td>
<td class="nump">1,082,998<span></span>
</td>
<td class="nump">1,473,817<span></span>
</td>
<td class="num">(891,316)<span></span>
</td>
<td class="num">(2,750,756)<span></span>
</td>
<td class="num">(1,886,375)<span></span>
</td>
<td class="nump">1,345,898<span></span>
</td>
<td class="nump">3,175,422<span></span>
</td>
<td class="num">(4,182,549)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 991,097<span></span>
</td>
<td class="nump">$ 855,009<span></span>
</td>
<td class="nump">$ 93,363<span></span>
</td>
<td class="nump">$ 967,796<span></span>
</td>
<td class="nump">$ 17,665<span></span>
</td>
<td class="num">$ (3,165,139)<span></span>
</td>
<td class="num">$ (3,596,398)<span></span>
</td>
<td class="nump">$ 946,979<span></span>
</td>
<td class="nump">2,907,265<span></span>
</td>
<td class="num">(5,796,893)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_FranchiseMember', window );">Franchise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,371,504<span></span>
</td>
<td class="nump">2,997,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,500,559<span></span>
</td>
<td class="nump">10,063,644<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_TechnologyServiceMember', window );">Software fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,037,385<span></span>
</td>
<td class="nump">5,687,326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,724,915<span></span>
</td>
<td class="nump">1,453,204<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jynt_FranchiseOperationsMember', window );">Franchise Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,895,592<span></span>
</td>
<td class="nump">52,163,430<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,299,399<span></span>
</td>
<td class="nump">10,973,610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_GeneralAndAdministrativeExpenseAdjusted', window );">Adjusted General and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,256,923<span></span>
</td>
<td class="nump">27,359,643<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,297,433<span></span>
</td>
<td class="nump">1,679,005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other segment items, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">401,706<span></span>
</td>
<td class="nump">871,673<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,644,161<span></span>
</td>
<td class="nump">1,371,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,653<span></span>
</td>
<td class="nump">5,606<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net loss from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(268,157)<span></span>
</td>
<td class="num">(1,614,344)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Reconciliation of loss</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net loss from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(268,157)<span></span>
</td>
<td class="num">(1,614,344)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Net income (loss) from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,175,422<span></span>
</td>
<td class="num">(4,182,549)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,907,265<span></span>
</td>
<td class="num">(5,796,893)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jynt_FranchiseOperationsMember', window );">Franchise Operations | Franchise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,500,559<span></span>
</td>
<td class="nump">10,063,644<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jynt_FranchiseOperationsMember', window );">Franchise Operations | Software fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,724,915<span></span>
</td>
<td class="nump">$ 1,453,204<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_GeneralAndAdministrativeExpenseAdjusted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>General And Administrative Expense, Adjusted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_GeneralAndAdministrativeExpenseAdjusted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479983/718-10-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477349/740-270-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 37: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 38: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherItemAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherItemAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_FranchiseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_FranchiseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_TechnologyServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_TechnologyServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jynt_FranchiseOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jynt_FranchiseOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">13 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>franchise</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>USD ($) </div>
<div>clinic</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($) </div>
<div>franchise</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=jynt_UnaffiliatedFranchiseeMember', window );">Unaffiliated Franchisee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_NumberOfClinics', window );">Number of clinics | clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=jynt_UnaffiliatedFranchiseeMember', window );">Unaffiliated Franchisee | Mr Jefferson Gramm</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Unsecured loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 196<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=jynt_FranchiseLicensesMember', window );">Franchise Licenses | Mr Jefferson Gramm</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_RelatedPartyTransactionCoPartnerPercentageDivested', window );">Co-partner percentage divested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_DirectorMember', window );">Directors | Franchise Licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangesFranchisesSold', window );">Number of franchises | franchise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_RelatedPartyTransactionAmountsOfTransactionDiscount', window );">Discount per the franchise disclosure document</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_RelatedPartyTransactionCoPartnerPercentage', window );">Co-partner percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_DirectorMember', window );">Directors | Franchise Licenses One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Amount of related party transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jynt_RelatedPartyTransactionAmountsOfTransactionDiscount', window );">Discount per the franchise disclosure document</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_DirectorMember', window );">Directors | Franchise Licenses Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Amount of related party transaction</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jynt_BanderaPartnersLLCMember', window );">Bandera Partners LLC | Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfClinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Clinics</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfClinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RelatedPartyTransactionAmountsOfTransactionDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Amounts Of Transaction, Discount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RelatedPartyTransactionAmountsOfTransactionDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RelatedPartyTransactionCoPartnerPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Co-Partner Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RelatedPartyTransactionCoPartnerPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RelatedPartyTransactionCoPartnerPercentageDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Co-Partner Percentage, Divested</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RelatedPartyTransactionCoPartnerPercentageDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-5<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantChangesFranchisesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of franchises sold during the period when there are significant changes in franchisor-owned outlets or franchised outlets during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 952<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482948/952-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantChangesFranchisesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=jynt_UnaffiliatedFranchiseeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=jynt_UnaffiliatedFranchiseeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=jynt_UnaffiliatedFranchiseeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=jynt_UnaffiliatedFranchiseeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=jynt_MrJeffersonGrammMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=jynt_MrJeffersonGrammMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=jynt_FranchiseLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=jynt_FranchiseLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=jynt_FranchiseLicensesOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=jynt_FranchiseLicensesOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=jynt_FranchiseLicensesTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=jynt_FranchiseLicensesTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jynt_BanderaPartnersLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jynt_BanderaPartnersLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Financial Data (Unaudited) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 15,167,047<span></span>
</td>
<td class="nump">$ 13,380,685<span></span>
</td>
<td class="nump">$ 13,270,270<span></span>
</td>
<td class="nump">$ 13,077,590<span></span>
</td>
<td class="nump">$ 14,714,282<span></span>
</td>
<td class="nump">$ 12,654,396<span></span>
</td>
<td class="nump">$ 12,610,036<span></span>
</td>
<td class="nump">$ 12,184,716<span></span>
</td>
<td class="nump">$ 54,895,592<span></span>
</td>
<td class="nump">$ 52,163,430<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Total costs of revenues</a></td>
<td class="nump">2,819,507<span></span>
</td>
<td class="nump">2,661,234<span></span>
</td>
<td class="nump">2,772,607<span></span>
</td>
<td class="nump">2,972,126<span></span>
</td>
<td class="nump">3,184,984<span></span>
</td>
<td class="nump">2,814,963<span></span>
</td>
<td class="nump">2,812,389<span></span>
</td>
<td class="nump">2,704,512<span></span>
</td>
<td class="nump">11,225,474<span></span>
</td>
<td class="nump">11,516,848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing expenses</a></td>
<td class="nump">3,494,324<span></span>
</td>
<td class="nump">2,816,081<span></span>
</td>
<td class="nump">3,483,844<span></span>
</td>
<td class="nump">3,505,150<span></span>
</td>
<td class="nump">2,791,468<span></span>
</td>
<td class="nump">2,504,168<span></span>
</td>
<td class="nump">3,440,391<span></span>
</td>
<td class="nump">2,237,583<span></span>
</td>
<td class="nump">13,299,399<span></span>
</td>
<td class="nump">10,973,610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">433,200<span></span>
</td>
<td class="nump">446,736<span></span>
</td>
<td class="nump">402,295<span></span>
</td>
<td class="nump">361,930<span></span>
</td>
<td class="nump">353,466<span></span>
</td>
<td class="nump">345,835<span></span>
</td>
<td class="nump">342,454<span></span>
</td>
<td class="nump">329,634<span></span>
</td>
<td class="nump">1,644,161<span></span>
</td>
<td class="nump">1,371,389<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">7,676,121<span></span>
</td>
<td class="nump">7,295,719<span></span>
</td>
<td class="nump">7,745,251<span></span>
</td>
<td class="nump">6,914,945<span></span>
</td>
<td class="nump">7,513,147<span></span>
</td>
<td class="nump">7,478,669<span></span>
</td>
<td class="nump">7,793,465<span></span>
</td>
<td class="nump">7,339,308<span></span>
</td>
<td class="nump">29,632,036<span></span>
</td>
<td class="nump">30,124,589<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Total selling, general and administrative expenses</a></td>
<td class="nump">11,603,645<span></span>
</td>
<td class="nump">10,558,536<span></span>
</td>
<td class="nump">11,631,390<span></span>
</td>
<td class="nump">10,782,025<span></span>
</td>
<td class="nump">10,658,081<span></span>
</td>
<td class="nump">10,328,672<span></span>
</td>
<td class="nump">11,576,310<span></span>
</td>
<td class="nump">9,906,525<span></span>
</td>
<td class="nump">44,575,596<span></span>
</td>
<td class="nump">42,469,588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Net loss on disposition or impairment</a></td>
<td class="nump">1,485<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,440<span></span>
</td>
<td class="nump">1,973<span></span>
</td>
<td class="nump">61,501<span></span>
</td>
<td class="nump">3,581<span></span>
</td>
<td class="nump">662<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="nump">7,898<span></span>
</td>
<td class="nump">66,019<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from continuing operations</a></td>
<td class="nump">742,410<span></span>
</td>
<td class="nump">160,915<span></span>
</td>
<td class="num">(1,138,167)<span></span>
</td>
<td class="num">(678,534)<span></span>
</td>
<td class="nump">809,716<span></span>
</td>
<td class="num">(492,820)<span></span>
</td>
<td class="num">(1,779,325)<span></span>
</td>
<td class="num">(426,596)<span></span>
</td>
<td class="num">(913,376)<span></span>
</td>
<td class="num">(1,889,025)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">198,232<span></span>
</td>
<td class="nump">139,801<span></span>
</td>
<td class="nump">159,922<span></span>
</td>
<td class="nump">185,917<span></span>
</td>
<td class="nump">79,729<span></span>
</td>
<td class="nump">83,828<span></span>
</td>
<td class="nump">80,471<span></span>
</td>
<td class="nump">36,259<span></span>
</td>
<td class="nump">683,872<span></span>
</td>
<td class="nump">280,287<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss from continuing operations before income tax expense</a></td>
<td class="nump">940,642<span></span>
</td>
<td class="nump">300,716<span></span>
</td>
<td class="num">(978,245)<span></span>
</td>
<td class="num">(492,617)<span></span>
</td>
<td class="nump">889,445<span></span>
</td>
<td class="num">(408,992)<span></span>
</td>
<td class="num">(1,698,854)<span></span>
</td>
<td class="num">(390,337)<span></span>
</td>
<td class="num">(229,504)<span></span>
</td>
<td class="num">(1,608,738)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">3,513<span></span>
</td>
<td class="nump">10,346<span></span>
</td>
<td class="nump">11,390<span></span>
</td>
<td class="nump">13,404<span></span>
</td>
<td class="num">(19,536)<span></span>
</td>
<td class="nump">5,391<span></span>
</td>
<td class="nump">11,169<span></span>
</td>
<td class="nump">8,582<span></span>
</td>
<td class="nump">38,653<span></span>
</td>
<td class="nump">5,606<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net loss from continuing operations</a></td>
<td class="nump">937,129<span></span>
</td>
<td class="nump">290,370<span></span>
</td>
<td class="num">(989,635)<span></span>
</td>
<td class="num">(506,021)<span></span>
</td>
<td class="nump">908,981<span></span>
</td>
<td class="num">(414,383)<span></span>
</td>
<td class="num">(1,710,023)<span></span>
</td>
<td class="num">(398,919)<span></span>
</td>
<td class="num">(268,157)<span></span>
</td>
<td class="num">(1,614,344)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Income (loss) from discontinued operations before income tax expense</a></td>
<td class="num">(224,068)<span></span>
</td>
<td class="nump">664,269<span></span>
</td>
<td class="nump">1,183,199<span></span>
</td>
<td class="nump">1,577,229<span></span>
</td>
<td class="num">(1,075,745)<span></span>
</td>
<td class="num">(2,693,562)<span></span>
</td>
<td class="num">(1,719,222)<span></span>
</td>
<td class="nump">1,516,243<span></span>
</td>
<td class="nump">3,200,629<span></span>
</td>
<td class="num">(3,972,286)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation', window );">Income tax expense(benefit) from discontinued operations</a></td>
<td class="num">(278,036)<span></span>
</td>
<td class="nump">99,630<span></span>
</td>
<td class="nump">100,201<span></span>
</td>
<td class="nump">103,412<span></span>
</td>
<td class="num">(184,429)<span></span>
</td>
<td class="nump">57,194<span></span>
</td>
<td class="nump">167,153<span></span>
</td>
<td class="nump">170,345<span></span>
</td>
<td class="nump">25,207<span></span>
</td>
<td class="nump">210,263<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Net income (loss) from discontinued operations</a></td>
<td class="nump">53,968<span></span>
</td>
<td class="nump">564,639<span></span>
</td>
<td class="nump">1,082,998<span></span>
</td>
<td class="nump">1,473,817<span></span>
</td>
<td class="num">(891,316)<span></span>
</td>
<td class="num">(2,750,756)<span></span>
</td>
<td class="num">(1,886,375)<span></span>
</td>
<td class="nump">1,345,898<span></span>
</td>
<td class="nump">3,175,422<span></span>
</td>
<td class="num">(4,182,549)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 991,097<span></span>
</td>
<td class="nump">$ 855,009<span></span>
</td>
<td class="nump">$ 93,363<span></span>
</td>
<td class="nump">$ 967,796<span></span>
</td>
<td class="nump">$ 17,665<span></span>
</td>
<td class="num">$ (3,165,139)<span></span>
</td>
<td class="num">$ (3,596,398)<span></span>
</td>
<td class="nump">$ 946,979<span></span>
</td>
<td class="nump">$ 2,907,265<span></span>
</td>
<td class="num">$ (5,796,893)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract', window );"><strong>Net (loss) income from continuing operations per common share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="num">$ (0.06)<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (0.11)<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="num">$ (0.11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Diluted (in dollars per share)</a></td>
<td class="nump">0.06<span></span>
</td>
<td class="nump">0.02<span></span>
</td>
<td class="num">(0.06)<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="nump">0.06<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="num">(0.11)<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
<td class="num">(0.11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract', window );"><strong>Net income (loss) from discontinued operations per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Basic (in dollars per share)</a></td>
<td class="nump">0.01<span></span>
</td>
<td class="nump">0.04<span></span>
</td>
<td class="nump">0.07<span></span>
</td>
<td class="nump">0.09<span></span>
</td>
<td class="num">(0.06)<span></span>
</td>
<td class="num">(0.18)<span></span>
</td>
<td class="num">(0.13)<span></span>
</td>
<td class="nump">0.09<span></span>
</td>
<td class="nump">0.21<span></span>
</td>
<td class="num">(0.28)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare', window );">Diluted (in dollars per share)</a></td>
<td class="nump">0.01<span></span>
</td>
<td class="nump">0.04<span></span>
</td>
<td class="nump">0.07<span></span>
</td>
<td class="nump">0.09<span></span>
</td>
<td class="num">(0.06)<span></span>
</td>
<td class="num">(0.18)<span></span>
</td>
<td class="num">(0.12)<span></span>
</td>
<td class="nump">0.09<span></span>
</td>
<td class="nump">0.21<span></span>
</td>
<td class="num">(0.28)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income (loss) per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss) per common share, basic (in dollars per share)</a></td>
<td class="nump">0.07<span></span>
</td>
<td class="nump">0.06<span></span>
</td>
<td class="nump">0.01<span></span>
</td>
<td class="nump">0.06<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.21)<span></span>
</td>
<td class="num">(0.24)<span></span>
</td>
<td class="nump">0.06<span></span>
</td>
<td class="nump">0.19<span></span>
</td>
<td class="num">(0.39)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss) per common share, diluted (in dollars per share)</a></td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (0.21)<span></span>
</td>
<td class="num">$ (0.24)<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="num">$ (0.38)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477349/740-270-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 37: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 38: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>215</ContextCount>
  <ElementCount>467</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>79</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952151 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952152 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952153 - Statement - Consolidated Income Statements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/ConsolidatedIncomeStatements</Role>
      <ShortName>Consolidated Income Statements</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952154 - Statement - Consolidated Statements of Changes in Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Changes in Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952155 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952156 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Nature of Operations and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - Revenue Disclosures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/RevenueDisclosures</Role>
      <ShortName>Revenue Disclosures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Divestitures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/Divestitures</Role>
      <ShortName>Divestitures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/PropertyandEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Fair Value Consideration</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/FairValueConsideration</Role>
      <ShortName>Fair Value Consideration</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - Quarterly Financial Data (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/QuarterlyFinancialDataUnaudited</Role>
      <ShortName>Quarterly Financial Data (Unaudited)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Nature of Operations and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Nature of Operations and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Revenue Disclosures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/RevenueDisclosuresTables</Role>
      <ShortName>Revenue Disclosures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/role/RevenueDisclosures</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Divestitures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/DivestituresTables</Role>
      <ShortName>Divestitures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/role/Divestitures</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/PropertyandEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/role/PropertyandEquipment</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/role/StockBasedCompensation</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/role/IncomeTaxes</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/CommitmentsandContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/role/CommitmentsandContingencies</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/role/SegmentReporting</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Quarterly Financial Data (Unaudited) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedTables</Role>
      <ShortName>Quarterly Financial Data (Unaudited) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/role/QuarterlyFinancialDataUnaudited</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - Clinics in Operation Under Franchise Agreements or Company-Owned or Managed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails</Role>
      <ShortName>Nature of Operations and Summary of Significant Accounting Policies - Clinics in Operation Under Franchise Agreements or Company-Owned or Managed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Nature of Operations and Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - VIE Income Statement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEIncomeStatementDetails</Role>
      <ShortName>Nature of Operations and Summary of Significant Accounting Policies - VIE Income Statement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - VIE Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEAssetsandLiabilitiesDetails</Role>
      <ShortName>Nature of Operations and Summary of Significant Accounting Policies - VIE Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - Reconciliation of of Accounts Receivable Allowance for Credit Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesReconciliationofofAccountsReceivableAllowanceforCreditLossesDetails</Role>
      <ShortName>Nature of Operations and Summary of Significant Accounting Policies - Reconciliation of of Accounts Receivable Allowance for Credit Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - Net Loss (Gain) on Disposition or Impairment Related to Continuing Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNetLossGainonDispositionorImpairmentRelatedtoContinuingOperationsDetails</Role>
      <ShortName>Nature of Operations and Summary of Significant Accounting Policies - Net Loss (Gain) on Disposition or Impairment Related to Continuing Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - Impairment Losses and Disposal Gains and Losses Recorded in (Loss) Income from Discontinued Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails</Role>
      <ShortName>Nature of Operations and Summary of Significant Accounting Policies - Impairment Losses and Disposal Gains and Losses Recorded in (Loss) Income from Discontinued Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - Earnings (Loss) Per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails</Role>
      <ShortName>Nature of Operations and Summary of Significant Accounting Policies - Earnings (Loss) Per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Revenue Disclosures - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/RevenueDisclosuresNarrativeDetails</Role>
      <ShortName>Revenue Disclosures - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - Revenue Disclosures - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/RevenueDisclosuresDisaggregationofRevenueDetails</Role>
      <ShortName>Revenue Disclosures - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - Revenue Disclosures - Rollforward of Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/RevenueDisclosuresRollforwardofAccountsReceivableDetails</Role>
      <ShortName>Revenue Disclosures - Rollforward of Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - Revenue Disclosures - Rollforward of Contract Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/RevenueDisclosuresRollforwardofContractLiabilitiesDetails</Role>
      <ShortName>Revenue Disclosures - Rollforward of Contract Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - Revenue Disclosures - Rollforward of Deferred Franchise and Development Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/RevenueDisclosuresRollforwardofDeferredFranchiseandDevelopmentCostsDetails</Role>
      <ShortName>Revenue Disclosures - Rollforward of Deferred Franchise and Development Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - Revenue Disclosures - Estimated Revenue Related to Performance Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/RevenueDisclosuresEstimatedRevenueRelatedtoPerformanceObligationsDetails</Role>
      <ShortName>Revenue Disclosures - Estimated Revenue Related to Performance Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - Divestitures - Key Components of Net (Loss) Income from Discontinued Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails</Role>
      <ShortName>Divestitures - Key Components of Net (Loss) Income from Discontinued Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - Divestitures - Assets and Liabilities of Discontinued Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails</Role>
      <ShortName>Divestitures - Assets and Liabilities of Discontinued Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - Divestitures - Key Components of Cash Flows from Discontinued Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/DivestituresKeyComponentsofCashFlowsfromDiscontinuedOperationsDetails</Role>
      <ShortName>Divestitures - Key Components of Cash Flows from Discontinued Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - Divestitures - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/DivestituresNarrativeDetails</Role>
      <ShortName>Divestitures - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - Divestitures - Held For Sale Assets and Liabilities To Be Disposed Of (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails</Role>
      <ShortName>Divestitures - Held For Sale Assets and Liabilities To Be Disposed Of (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - Property and Equipment - Summary of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails</Role>
      <ShortName>Property and Equipment - Summary of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - Property and Equipment - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/PropertyandEquipmentNarrativeDetails</Role>
      <ShortName>Property and Equipment - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - Fair Value Consideration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/FairValueConsiderationDetails</Role>
      <ShortName>Fair Value Consideration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/role/FairValueConsideration</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/DebtDetails</Role>
      <ShortName>Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/role/Debt</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/StockholdersEquityDetails</Role>
      <ShortName>Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/role/StockholdersEquity</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - Stock-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9955546 - Disclosure - Stock-Based Compensation - Valuation Assumptions used for Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/StockBasedCompensationValuationAssumptionsusedforStockOptionsDetails</Role>
      <ShortName>Stock-Based Compensation - Valuation Assumptions used for Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9955547 - Disclosure - Stock-Based Compensation - Stock Options Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Stock Options Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9955548 - Disclosure - Stock-Based Compensation - Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/StockBasedCompensationRestrictedStockActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9955549 - Disclosure - Income Taxes - Loss From Continuing Operations Before the Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/IncomeTaxesLossFromContinuingOperationsBeforetheProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Loss From Continuing Operations Before the Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9955550 - Disclosure - Income Taxes - Income Tax Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/IncomeTaxesIncomeTaxExpenseDetails</Role>
      <ShortName>Income Taxes - Income Tax Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9955551 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9955552 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9955553 - Disclosure - Income Taxes - Effective Income Tax Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails</Role>
      <ShortName>Income Taxes - Effective Income Tax Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9955554 - Disclosure - Income Taxes - Uncertain Tax Position Rollforward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/IncomeTaxesUncertainTaxPositionRollforwardDetails</Role>
      <ShortName>Income Taxes - Uncertain Tax Position Rollforward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9955555 - Disclosure - Income Taxes - Cash Paid For Income Taxes (Net of Refunds Received) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails</Role>
      <ShortName>Income Taxes - Cash Paid For Income Taxes (Net of Refunds Received) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9955556 - Disclosure - Commitments and Contingencies - Lease Expense and Supplemental Lease Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Lease Expense and Supplemental Lease Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9955557 - Disclosure - Commitments and Contingencies - Maturities of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails</Role>
      <ShortName>Commitments and Contingencies - Maturities of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9955558 - Disclosure - Commitments and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/CommitmentsandContingenciesNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9955559 - Disclosure - Segment Reporting - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/SegmentReportingNarrativeDetails</Role>
      <ShortName>Segment Reporting - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9955560 - Disclosure - Segment Reporting - Total Revenue and Significant Expense Categories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails</Role>
      <ShortName>Segment Reporting - Total Revenue and Significant Expense Categories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9955561 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/role/RelatedPartyTransactions</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="jynt-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9955562 - Disclosure - Quarterly Financial Data (Unaudited) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails</Role>
      <ShortName>Quarterly Financial Data (Unaudited) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="jynt-20251231.htm">jynt-20251231.htm</File>
    <File>jynt-20251231.xsd</File>
    <File>jynt-20251231_cal.xml</File>
    <File>jynt-20251231_def.xml</File>
    <File>jynt-20251231_lab.xml</File>
    <File>jynt-20251231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>jynt-20251231_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2025</BaseTaxonomy>
    <BaseTaxonomy items="1105">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="15">http://xbrl.sec.gov/cyd/2025</BaseTaxonomy>
    <BaseTaxonomy items="39">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="5">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>96
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "jynt-20251231.htm": {
   "nsprefix": "jynt",
   "nsuri": "http://www.thejoint.com/20251231",
   "dts": {
    "inline": {
     "local": [
      "jynt-20251231.htm"
     ]
    },
    "schema": {
     "local": [
      "jynt-20251231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-af-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-af-sub-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "jynt-20251231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "jynt-20251231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "jynt-20251231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "jynt-20251231_pre.xml"
     ]
    }
   },
   "keyStandard": 397,
   "keyCustom": 70,
   "axisStandard": 33,
   "axisCustom": 0,
   "memberStandard": 54,
   "memberCustom": 20,
   "hidden": {
    "total": 15,
    "http://fasb.org/us-gaap/2025": 11,
    "http://xbrl.sec.gov/dei/2025": 4
   },
   "contextCount": 215,
   "entityCount": 1,
   "segmentCount": 79,
   "elementCount": 816,
   "unitCount": 11,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2025": 1105,
    "http://xbrl.sec.gov/dei/2025": 39,
    "http://xbrl.sec.gov/cyd/2025": 15,
    "http://xbrl.sec.gov/ecd/2025": 5,
    "http://fasb.org/srt/2025": 1
   },
   "report": {
    "R1": {
     "role": "http://www.thejoint.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.thejoint.com/role/AuditInformation",
     "longName": "0000002 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.thejoint.com/role/ConsolidatedBalanceSheets",
     "longName": "9952151 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.thejoint.com/role/ConsolidatedBalanceSheetsParenthetical",
     "longName": "9952152 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
     "longName": "9952153 - Statement - Consolidated Income Statements",
     "shortName": "Consolidated Income Statements",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
     "longName": "9952154 - Statement - Consolidated Statements of Changes in Stockholders' Equity",
     "shortName": "Consolidated Statements of Changes in Stockholders' Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-19",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-19",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows",
     "longName": "9952155 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPolicies",
     "longName": "9952156 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies",
     "shortName": "Nature of Operations and Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.thejoint.com/role/RevenueDisclosures",
     "longName": "9952157 - Disclosure - Revenue Disclosures",
     "shortName": "Revenue Disclosures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.thejoint.com/role/Divestitures",
     "longName": "9952158 - Disclosure - Divestitures",
     "shortName": "Divestitures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.thejoint.com/role/PropertyandEquipment",
     "longName": "9952159 - Disclosure - Property and Equipment",
     "shortName": "Property and Equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.thejoint.com/role/FairValueConsideration",
     "longName": "9952160 - Disclosure - Fair Value Consideration",
     "shortName": "Fair Value Consideration",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.thejoint.com/role/Debt",
     "longName": "9952161 - Disclosure - Debt",
     "shortName": "Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.thejoint.com/role/StockholdersEquity",
     "longName": "9952162 - Disclosure - Stockholders' Equity",
     "shortName": "Stockholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.thejoint.com/role/StockBasedCompensation",
     "longName": "9952163 - Disclosure - Stock-Based Compensation",
     "shortName": "Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.thejoint.com/role/IncomeTaxes",
     "longName": "9952164 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.thejoint.com/role/CommitmentsandContingencies",
     "longName": "9952165 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.thejoint.com/role/SegmentReporting",
     "longName": "9952166 - Disclosure - Segment Reporting",
     "shortName": "Segment Reporting",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.thejoint.com/role/RelatedPartyTransactions",
     "longName": "9952167 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.thejoint.com/role/QuarterlyFinancialDataUnaudited",
     "longName": "9952168 - Disclosure - Quarterly Financial Data (Unaudited)",
     "shortName": "Quarterly Financial Data (Unaudited)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-211",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-211",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "a",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "a",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9955511 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies (Policies)",
     "shortName": "Nature of Operations and Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables",
     "longName": "9955512 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies (Tables)",
     "shortName": "Nature of Operations and Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFranchisorDisclosureTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFranchisorDisclosureTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.thejoint.com/role/RevenueDisclosuresTables",
     "longName": "9955513 - Disclosure - Revenue Disclosures (Tables)",
     "shortName": "Revenue Disclosures (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.thejoint.com/role/DivestituresTables",
     "longName": "9955514 - Disclosure - Divestitures (Tables)",
     "shortName": "Divestitures (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R28": {
     "role": "http://www.thejoint.com/role/PropertyandEquipmentTables",
     "longName": "9955515 - Disclosure - Property and Equipment (Tables)",
     "shortName": "Property and Equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.thejoint.com/role/StockBasedCompensationTables",
     "longName": "9955516 - Disclosure - Stock-Based Compensation (Tables)",
     "shortName": "Stock-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.thejoint.com/role/IncomeTaxesTables",
     "longName": "9955517 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.thejoint.com/role/CommitmentsandContingenciesTables",
     "longName": "9955518 - Disclosure - Commitments and Contingencies (Tables)",
     "shortName": "Commitments and Contingencies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.thejoint.com/role/SegmentReportingTables",
     "longName": "9955519 - Disclosure - Segment Reporting (Tables)",
     "shortName": "Segment Reporting (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedTables",
     "longName": "9955520 - Disclosure - Quarterly Financial Data (Unaudited) (Tables)",
     "shortName": "Quarterly Financial Data (Unaudited) (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails",
     "longName": "9955521 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - Clinics in Operation Under Franchise Agreements or Company-Owned or Managed (Details)",
     "shortName": "Nature of Operations and Summary of Significant Accounting Policies - Clinics in Operation Under Franchise Agreements or Company-Owned or Managed (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:NumberOfStores",
      "unitRef": "clinic",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-50",
      "name": "jynt:ClinicsOpenedDuringThePeriod",
      "unitRef": "clinic",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails",
     "longName": "9955522 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - Narrative (Details)",
     "shortName": "Nature of Operations and Summary of Significant Accounting Policies - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "jynt:ManagementAgreementNumberOfProfessionalCorporations",
      "unitRef": "corporation",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ConsolidationVariableInterestEntityPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-59",
      "name": "jynt:ManagementAgreementTerminationNumberOfProfessionalCorporations",
      "unitRef": "corporation",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ConsolidationVariableInterestEntityPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEIncomeStatementDetails",
     "longName": "9955523 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - VIE Income Statement (Details)",
     "shortName": "Nature of Operations and Summary of Significant Accounting Policies - VIE Income Statement (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-211",
      "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-60",
      "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEAssetsandLiabilitiesDetails",
     "longName": "9955524 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - VIE Assets and Liabilities (Details)",
     "shortName": "Nature of Operations and Summary of Significant Accounting Policies - VIE Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R38": {
     "role": "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesReconciliationofofAccountsReceivableAllowanceforCreditLossesDetails",
     "longName": "9955525 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - Reconciliation of of Accounts Receivable Allowance for Credit Losses (Details)",
     "shortName": "Nature of Operations and Summary of Significant Accounting Policies - Reconciliation of of Accounts Receivable Allowance for Credit Losses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNetLossGainonDispositionorImpairmentRelatedtoContinuingOperationsDetails",
     "longName": "9955526 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - Net Loss (Gain) on Disposition or Impairment Related to Continuing Operations (Details)",
     "shortName": "Nature of Operations and Summary of Significant Accounting Policies - Net Loss (Gain) on Disposition or Impairment Related to Continuing Operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-18",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-18",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails",
     "longName": "9955527 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - Impairment Losses and Disposal Gains and Losses Recorded in (Loss) Income from Discontinued Operations (Details)",
     "shortName": "Nature of Operations and Summary of Significant Accounting Policies - Impairment Losses and Disposal Gains and Losses Recorded in (Loss) Income from Discontinued Operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-93",
      "name": "us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-93",
      "name": "us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails",
     "longName": "9955528 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies - Earnings (Loss) Per Common Share (Details)",
     "shortName": "Nature of Operations and Summary of Significant Accounting Policies - Earnings (Loss) Per Common Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-211",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.thejoint.com/role/RevenueDisclosuresNarrativeDetails",
     "longName": "9955529 - Disclosure - Revenue Disclosures - Narrative (Details)",
     "shortName": "Revenue Disclosures - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:NumberOfStores",
      "unitRef": "clinic",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R43": {
     "role": "http://www.thejoint.com/role/RevenueDisclosuresDisaggregationofRevenueDetails",
     "longName": "9955530 - Disclosure - Revenue Disclosures - Disaggregation of Revenue (Details)",
     "shortName": "Revenue Disclosures - Disaggregation of Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-211",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-97",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.thejoint.com/role/RevenueDisclosuresRollforwardofAccountsReceivableDetails",
     "longName": "9955531 - Disclosure - Revenue Disclosures - Rollforward of Accounts Receivable (Details)",
     "shortName": "Revenue Disclosures - Rollforward of Accounts Receivable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-25",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.thejoint.com/role/RevenueDisclosuresRollforwardofContractLiabilitiesDetails",
     "longName": "9955532 - Disclosure - Revenue Disclosures - Rollforward of Contract Liabilities (Details)",
     "shortName": "Revenue Disclosures - Rollforward of Contract Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ContractWithCustomerLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-25",
      "name": "us-gaap:ContractWithCustomerLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.thejoint.com/role/RevenueDisclosuresRollforwardofDeferredFranchiseandDevelopmentCostsDetails",
     "longName": "9955533 - Disclosure - Revenue Disclosures - Rollforward of Deferred Franchise and Development Costs (Details)",
     "shortName": "Revenue Disclosures - Rollforward of Deferred Franchise and Development Costs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-25",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.thejoint.com/role/RevenueDisclosuresEstimatedRevenueRelatedtoPerformanceObligationsDetails",
     "longName": "9955534 - Disclosure - Revenue Disclosures - Estimated Revenue Related to Performance Obligations (Details)",
     "shortName": "Revenue Disclosures - Estimated Revenue Related to Performance Obligations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails",
     "longName": "9955535 - Disclosure - Divestitures - Key Components of Net (Loss) Income from Discontinued Operations (Details)",
     "shortName": "Divestitures - Key Components of Net (Loss) Income from Discontinued Operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-211",
      "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-107",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails",
     "longName": "9955536 - Disclosure - Divestitures - Assets and Liabilities of Discontinued Operations (Details)",
     "shortName": "Divestitures - Assets and Liabilities of Discontinued Operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-111",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.thejoint.com/role/DivestituresKeyComponentsofCashFlowsfromDiscontinuedOperationsDetails",
     "longName": "9955537 - Disclosure - Divestitures - Key Components of Cash Flows from Discontinued Operations (Details)",
     "shortName": "Divestitures - Key Components of Cash Flows from Discontinued Operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationAndAmortizationDiscontinuedOperations",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationAndAmortizationDiscontinuedOperations",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.thejoint.com/role/DivestituresNarrativeDetails",
     "longName": "9955538 - Disclosure - Divestitures - Narrative (Details)",
     "shortName": "Divestitures - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-211",
      "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-117",
      "name": "jynt:DisposalGroupHeldForSaleClinicsExpectedToSellPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails",
     "longName": "9955539 - Disclosure - Divestitures - Held For Sale Assets and Liabilities To Be Disposed Of (Details)",
     "shortName": "Divestitures - Held For Sale Assets and Liabilities To Be Disposed Of (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-84",
      "name": "jynt:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.thejoint.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails",
     "longName": "9955540 - Disclosure - Property and Equipment - Summary of Property and Equipment (Details)",
     "shortName": "Property and Equipment - Summary of Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ConstructionInProgressGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.thejoint.com/role/PropertyandEquipmentNarrativeDetails",
     "longName": "9955541 - Disclosure - Property and Equipment - Narrative (Details)",
     "shortName": "Property and Equipment - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.thejoint.com/role/FairValueConsiderationDetails",
     "longName": "9955542 - Disclosure - Fair Value Consideration (Details)",
     "shortName": "Fair Value Consideration (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-130",
      "name": "jynt:AssetsHeldForSaleCashFlowForecastPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.thejoint.com/role/DebtDetails",
     "longName": "9955543 - Disclosure - Debt (Details)",
     "shortName": "Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-154",
      "name": "us-gaap:DeferredFinanceCostsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-154",
      "name": "us-gaap:DeferredFinanceCostsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.thejoint.com/role/StockholdersEquityDetails",
     "longName": "9955544 - Disclosure - Stockholders' Equity (Details)",
     "shortName": "Stockholders' Equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-158",
      "name": "srt:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-158",
      "name": "srt:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails",
     "longName": "9955545 - Disclosure - Stock-Based Compensation - Narrative (Details)",
     "shortName": "Stock-Based Compensation - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.thejoint.com/role/StockBasedCompensationValuationAssumptionsusedforStockOptionsDetails",
     "longName": "9955546 - Disclosure - Stock-Based Compensation - Valuation Assumptions used for Stock Options (Details)",
     "shortName": "Stock-Based Compensation - Valuation Assumptions used for Stock Options (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-162",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-162",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails",
     "longName": "9955547 - Disclosure - Stock-Based Compensation - Stock Options Activity (Details)",
     "shortName": "Stock-Based Compensation - Stock Options Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-165",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-160",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.thejoint.com/role/StockBasedCompensationRestrictedStockActivityDetails",
     "longName": "9955548 - Disclosure - Stock-Based Compensation - Restricted Stock Activity (Details)",
     "shortName": "Stock-Based Compensation - Restricted Stock Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-170",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-168",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.thejoint.com/role/IncomeTaxesLossFromContinuingOperationsBeforetheProvisionforIncomeTaxesDetails",
     "longName": "9955549 - Disclosure - Income Taxes - Loss From Continuing Operations Before the Provision for Income Taxes (Details)",
     "shortName": "Income Taxes - Loss From Continuing Operations Before the Provision for Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.thejoint.com/role/IncomeTaxesIncomeTaxExpenseDetails",
     "longName": "9955550 - Disclosure - Income Taxes - Income Tax Expense (Details)",
     "shortName": "Income Taxes - Income Tax Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
     "longName": "9955551 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "shortName": "Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails",
     "longName": "9955552 - Disclosure - Income Taxes - Narrative (Details)",
     "shortName": "Income Taxes - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails",
     "longName": "9955553 - Disclosure - Income Taxes - Effective Income Tax Reconciliation (Details)",
     "shortName": "Income Taxes - Effective Income Tax Reconciliation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-211",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.thejoint.com/role/IncomeTaxesUncertainTaxPositionRollforwardDetails",
     "longName": "9955554 - Disclosure - Income Taxes - Uncertain Tax Position Rollforward (Details)",
     "shortName": "Income Taxes - Uncertain Tax Position Rollforward (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-96",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-107",
      "name": "us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.thejoint.com/role/IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails",
     "longName": "9955555 - Disclosure - Income Taxes - Cash Paid For Income Taxes (Net of Refunds Received) (Details)",
     "shortName": "Income Taxes - Cash Paid For Income Taxes (Net of Refunds Received) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxPaidFederalAfterRefundReceived",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxPaidFederalAfterRefundReceived",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails",
     "longName": "9955556 - Disclosure - Commitments and Contingencies - Lease Expense and Supplemental Lease Information (Details)",
     "shortName": "Commitments and Contingencies - Lease Expense and Supplemental Lease Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails",
     "longName": "9955557 - Disclosure - Commitments and Contingencies - Maturities of Lease Liabilities (Details)",
     "shortName": "Commitments and Contingencies - Maturities of Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.thejoint.com/role/CommitmentsandContingenciesNarrativeDetails",
     "longName": "9955558 - Disclosure - Commitments and Contingencies - Narrative (Details)",
     "shortName": "Commitments and Contingencies - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "jynt:NumberOfFutureOperatingLeasesCommitted",
      "unitRef": "lease",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "jynt:NumberOfFutureOperatingLeasesCommitted",
      "unitRef": "lease",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.thejoint.com/role/SegmentReportingNarrativeDetails",
     "longName": "9955559 - Disclosure - Segment Reporting - Narrative (Details)",
     "shortName": "Segment Reporting - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-190",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-190",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails",
     "longName": "9955560 - Disclosure - Segment Reporting - Total Revenue and Significant Expense Categories (Details)",
     "shortName": "Segment Reporting - Total Revenue and Significant Expense Categories (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-211",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-191",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.thejoint.com/role/RelatedPartyTransactionsDetails",
     "longName": "9955561 - Disclosure - Related Party Transactions (Details)",
     "shortName": "Related Party Transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-206",
      "name": "jynt:NumberOfClinics",
      "unitRef": "clinic",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-206",
      "name": "jynt:NumberOfClinics",
      "unitRef": "clinic",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails",
     "longName": "9955562 - Disclosure - Quarterly Financial Data (Unaudited) (Details)",
     "shortName": "Quarterly Financial Data (Unaudited) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-211",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-211",
      "name": "us-gaap:CostOfRevenue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jynt-20251231.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "jynt_A2022CreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "A2022CreditFacilityMember",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2022 Credit Facility",
        "label": "2022 Credit Facility [Member]",
        "documentation": "2022 Credit Facility"
       }
      }
     },
     "auth_ref": []
    },
    "stpr_AZ": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2025",
     "localname": "AZ",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arizona",
        "label": "ARIZONA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r1004"
     ]
    },
    "jynt_AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "AccountsReceivableAfterAllowanceForCreditLossCurrentRollForward",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosuresRollforwardofAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable, Net",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current [Roll Forward]",
        "documentation": "Accounts Receivable, after Allowance for Credit Loss, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation of Accounts Receivable Allowance for Credit Losses",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r1247"
     ]
    },
    "jynt_AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosuresRollforwardofAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cash received against accounts receivable included at the beginning of the year",
        "label": "Accounts Receivable, Decrease From Cash Received Included In Opening Balance",
        "documentation": "Accounts Receivable, Decrease From Cash Received Included In Opening Balance"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosuresRollforwardofAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net increase during the year",
        "label": "Accounts Receivable, Increase (Decrease) From Other Than Cash Received Included In Opening Balance",
        "documentation": "Accounts Receivable, Increase (Decrease) From Other Than Cash Received Included In Opening Balance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets",
      "http://www.thejoint.com/role/RevenueDisclosuresRollforwardofAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, net",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1242"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accumulated depreciation and amortization",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r210",
      "r751"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1082"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r1004",
      "r1400"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid In Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r796",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1336",
      "r1402"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1095"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1095"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1095"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1095"
     ]
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.thejoint.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedNetLabel": "Purchases of treasury stock under employee stock plans",
        "terseLabel": "Common stock surrendered and netted as payment for minimum statutory withholding requirements",
        "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1314"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r494"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by operating activities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdvertisingCostsPolicyTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advertising Costs",
        "label": "Advertising Cost [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for advertising cost."
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "us-gaap_AdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdvertisingExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advertising expense",
        "label": "Advertising Expense",
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line."
       }
      }
     },
     "auth_ref": [
      "r543",
      "r957"
     ]
    },
    "jynt_AdvertisingFundPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "AdvertisingFundPolicyTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advertising Fund",
        "label": "Advertising Fund, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the advertising fund."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdvertisingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdvertisingMember",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advertising fund revenue",
        "label": "Advertising [Member]",
        "documentation": "Announcement promoting product, service, or event."
       }
      }
     },
     "auth_ref": [
      "r1281",
      "r1282"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1140"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1053",
      "r1064",
      "r1074",
      "r1107"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1056",
      "r1067",
      "r1077",
      "r1110"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1141"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r1095"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r1102"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r1057",
      "r1068",
      "r1078",
      "r1102",
      "r1111",
      "r1115",
      "r1123"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r1121"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails",
      "http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation expense",
        "verboseLabel": "Stock compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r526",
      "r532",
      "r541"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesReconciliationofofAccountsReceivableAllowanceforCreditLossesDetails",
      "http://www.thejoint.com/role/RevenueDisclosuresRollforwardofAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for credit losses on accounts receivable",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "negatedTerseLabel": "Allowance for credit losses",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r316",
      "r326",
      "r329",
      "r332",
      "r1366"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesReconciliationofofAccountsReceivableAllowanceforCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for credit losses",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesReconciliationofofAccountsReceivableAllowanceforCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Write-off of uncollectible amounts",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance."
       }
      }
     },
     "auth_ref": [
      "r331"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of debt issuance costs",
        "label": "Amortization of Debt Issuance Costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r423",
      "r1216",
      "r1346"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average dilutive securities (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r270"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r148",
      "r212",
      "r235",
      "r238",
      "r239",
      "r273",
      "r285",
      "r303",
      "r307",
      "r320",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r598",
      "r603",
      "r644",
      "r733",
      "r734",
      "r741",
      "r825",
      "r921",
      "r922",
      "r935",
      "r1004",
      "r1019",
      "r1020",
      "r1031",
      "r1274",
      "r1275",
      "r1352"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASSETS",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Supplemental Lease Information",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "documentation": "Assets And Liabilities, Lessee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r214",
      "r235",
      "r238",
      "r239",
      "r320",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r598",
      "r603",
      "r644",
      "r1004",
      "r1274",
      "r1275",
      "r1352"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_AssetsHeldForSaleCashFlowForecastPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "AssetsHeldForSaleCashFlowForecastPeriod",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets held for sale cash flow forecast period",
        "label": "Assets, Held-For-Sale, Cash Flow Forecast Period",
        "documentation": "Assets, Held-For-Sale, Cash Flow Forecast Period"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_AssetsHeldForSaleMeasurementInputNegativeCashFlow": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "AssetsHeldForSaleMeasurementInputNegativeCashFlow",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets, held-for-sale, measurement input, negative cash flow",
        "label": "Assets, Held-For-Sale, Measurement Input, Negative Cash Flow",
        "documentation": "Assets, Held-For-Sale, Measurement Input, Negative Cash Flow"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_AssetsHeldForSaleMeasurementInputPositiveCashFlow": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "AssetsHeldForSaleMeasurementInputPositiveCashFlow",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets, held-for-sale, measurement input, positive cash flow",
        "label": "Assets, Held-For-Sale, Measurement Input, Positive Cash Flow",
        "documentation": "Assets, Held-For-Sale, Measurement Input, Positive Cash Flow"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_AssetsHeldForSaleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "AssetsHeldForSaleMember",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresNarrativeDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets held for sale",
        "label": "Assets Held For Sale [Member]",
        "documentation": "Assets Held For Sale"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets, discontinued operations",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r56",
      "r74",
      "r121",
      "r204",
      "r205"
     ]
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "ASSETS",
        "terseLabel": "ASSETS",
        "label": "Disposal Group, Including Discontinued Operation, Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      },
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets",
      "http://www.thejoint.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails",
      "http://www.thejoint.com/role/FairValueConsiderationDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discontinued operations current assets ($1.0 million and $1.1 million attributable to VIEs, respectively)",
        "verboseLabel": "Discontinued operations current assets",
        "netLabel": "Assets held for sale",
        "totalLabel": "Total assets held for sale",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r56",
      "r74",
      "r118",
      "r121",
      "r204",
      "r205"
     ]
    },
    "jynt_AuditInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "AuditInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Audit Information [Abstract]",
        "documentation": "Audit Information"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.thejoint.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r1036",
      "r1037",
      "r1060"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.thejoint.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r1036",
      "r1037",
      "r1060"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorName",
     "presentation": [
      "http://www.thejoint.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r1036",
      "r1037",
      "r1060"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r1118"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r1119"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1114"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1114"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1114"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1114"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1114"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1114"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.thejoint.com/role/StockBasedCompensationRestrictedStockActivityDetails",
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails",
      "http://www.thejoint.com/role/StockBasedCompensationValuationAssumptionsusedforStockOptionsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r498",
      "r499",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r1117"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1116"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r1115"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1115"
     ]
    },
    "jynt_BanderaPartnersLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "BanderaPartnersLLCMember",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bandera Partners LLC",
        "label": "Bandera Partners LLC [Member]",
        "documentation": "Bandera Partners LLC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BaseRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BaseRateMember",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Base Rate",
        "label": "Base Rate [Member]",
        "documentation": "Minimum rate investor will accept."
       }
      }
     },
     "auth_ref": [
      "r1162",
      "r1272"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r1220"
     ]
    },
    "stpr_CA": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2025",
     "localname": "CA",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "California",
        "label": "CALIFORNIA"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_CaliforniaAlternativeMinimumTaxCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "CaliforniaAlternativeMinimumTaxCreditMember",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "California Alternative Minimum Tax Credit",
        "label": "California Alternative Minimum Tax Credit [Member]",
        "documentation": "California Alternative Minimum Tax Credit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalExpenditureDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CapitalExpenditureDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresKeyComponentsofCashFlowsfromDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase of property and equipment",
        "label": "Capital Expenditure, Discontinued Operations",
        "documentation": "Amount of capital expenditure attributable to discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "jynt_CapitalExpendituresDiscontinuedOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "CapitalExpendituresDiscontinuedOperationsAbstract",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresKeyComponentsofCashFlowsfromDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Capital expenditures",
        "label": "Capital Expenditures, Discontinued Operations [Abstract]",
        "documentation": "Capital Expenditures, Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unpaid purchases of property and equipment",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r25"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets",
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalent",
        "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r208",
      "r899"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAxis",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Axis]",
        "label": "Cash and Cash Equivalents [Axis]",
        "documentation": "Information by type of cash and cash equivalent balance."
       }
      }
     },
     "auth_ref": [
      "r208"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents fair value",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r641",
      "r642",
      "r643",
      "r1337",
      "r1338"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Cash",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r135"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of period",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of period",
        "totalLabel": "Total cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r112",
      "r234"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of cash, cash equivalents and restricted cash:",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "(Decrease) increase in cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation",
        "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r112"
     ]
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents",
        "label": "Cash Equivalents, at Carrying Value",
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r1159",
      "r1364"
     ]
    },
    "jynt_CashFlowLesseeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "CashFlowLesseeAbstract",
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for amounts included in measurement of liabilities:",
        "label": "Cash Flow, Lessee [Abstract]",
        "documentation": "Cash Flow, Lessee"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1093"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1090"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r1088"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_ClinicLicensesSoldButNotYetDeveloped": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "ClinicLicensesSoldButNotYetDeveloped",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails",
      "http://www.thejoint.com/role/RevenueDisclosuresNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Clinic licenses sold but not yet developed",
        "label": "Clinic Licenses Sold But Not Yet Developed",
        "documentation": "The number of clinics that have been sold as franchises, but are not yet operational."
       }
      }
     },
     "auth_ref": []
    },
    "jynt_ClinicsAcquiredDuringPeriod": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "ClinicsAcquiredDuringPeriod",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquired during the year",
        "label": "Clinics Acquired During Period",
        "documentation": "Represents the number of clinics acquired during the period."
       }
      }
     },
     "auth_ref": []
    },
    "jynt_ClinicsClosedDuringThePeriod": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "ClinicsClosedDuringThePeriod",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Closed during the year",
        "label": "Clinics Closed During The Period",
        "documentation": "Represents the number of clinics closed during the period."
       }
      }
     },
     "auth_ref": []
    },
    "jynt_ClinicsOpenedDuringThePeriod": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "ClinicsOpenedDuringThePeriod",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Opened during the year",
        "label": "Clinics Opened during the period",
        "documentation": "Represents the number of number of clinics opened during the period."
       }
      }
     },
     "auth_ref": []
    },
    "jynt_ClinicsSoldDuringPeriod": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "ClinicsSoldDuringPeriod",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Sold during the year",
        "terseLabel": "Number of clinics sold",
        "label": "Clinics Sold During Period",
        "documentation": "Clinics Sold During Period"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_CoOpFundsLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "CoOpFundsLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Co-op funds liability",
        "label": "CoOp Funds Liability, Current",
        "documentation": "Aggregate carrying amount of Co-op funds liability (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": []
    },
    "jynt_CoOpMarketingFundsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "CoOpMarketingFundsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Co-Op Marketing Funds",
        "label": "Co-Op Marketing Funds, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for co-op marketing funds."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r1094"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1094"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies (Note 10)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r140",
      "r743",
      "r811"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r382",
      "r383",
      "r879",
      "r1261",
      "r1266"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r880"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r1022",
      "r1023",
      "r1024",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1229",
      "r1230",
      "r1232",
      "r1336",
      "r1398",
      "r1402"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.thejoint.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r812"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "periodStartLabel": "Balance, beginning common stock (in shares)",
        "periodEndLabel": "Balance, ending common stock (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r92",
      "r812",
      "r831",
      "r1402",
      "r1403"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, $0.001 par value; 20,000,000 shares authorized, 15,471,715 shares issued and 14,142,626 shares outstanding and 15,192,893 shares issued and 15,159,878 shares outstanding, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r432",
      "r436",
      "r745",
      "r1004"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1099"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1098"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1100"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1097"
     ]
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Comprehensive Income (Loss)",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer Software",
        "label": "Computer Software, Intangible Asset [Member]",
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks."
       }
      }
     },
     "auth_ref": [
      "r893",
      "r986",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1254",
      "r1255",
      "r1257",
      "r1258"
     ]
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEAssetsandLiabilitiesDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Axis]",
        "label": "Consolidated Entities [Axis]",
        "documentation": "Information by consolidated entity or group of entities."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r183",
      "r236",
      "r246",
      "r598",
      "r599",
      "r602",
      "r603",
      "r604",
      "r679",
      "r737",
      "r885",
      "r1153",
      "r1154",
      "r1155",
      "r1273",
      "r1276",
      "r1277"
     ]
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEAssetsandLiabilitiesDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Domain]",
        "label": "Consolidated Entities [Domain]",
        "documentation": "Entity or group of entities consolidated into reporting entity."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r183",
      "r236",
      "r246",
      "r598",
      "r599",
      "r602",
      "r603",
      "r604",
      "r679",
      "r737",
      "r885",
      "r1153",
      "r1154",
      "r1155",
      "r1273",
      "r1276",
      "r1277"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principles of Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r910"
     ]
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entities",
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined)."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r48",
      "r50"
     ]
    },
    "us-gaap_ConstructionInProgressGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConstructionInProgressGross",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction in progress",
        "label": "Construction in Progress, Gross",
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosuresTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Rollforward in Contract Liabilities and Contract Assets",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability."
       }
      }
     },
     "auth_ref": [
      "r1280"
     ]
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerAssetNet",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosuresRollforwardofDeferredFranchiseandDevelopmentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r454",
      "r456",
      "r475"
     ]
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerAssetNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred franchise and regional development costs, current portion",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r454",
      "r456",
      "r475"
     ]
    },
    "us-gaap_ContractWithCustomerAssetNetNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerAssetNetNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred franchise and regional development costs, net of current portion",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent",
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r454",
      "r456",
      "r475"
     ]
    },
    "jynt_ContractWithCustomerAssetRecognizedAsCostsOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "ContractWithCustomerAssetRecognizedAsCostsOfRevenue",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosuresRollforwardofDeferredFranchiseandDevelopmentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Recognized as cost of revenue during the year",
        "label": "Contract With Customer, Asset Recognized As Costs Of Revenue",
        "documentation": "Represents the amount recognized as costs of revenue during the period related to contracts with customers."
       }
      }
     },
     "auth_ref": []
    },
    "jynt_ContractWithCustomerAssetRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "ContractWithCustomerAssetRollForward",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosuresRollforwardofDeferredFranchiseandDevelopmentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Franchise and Development Costs Short and Long-Term",
        "label": "Contract with Customer, Asset [Roll Forward]",
        "documentation": "Contract with Customer, Asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosuresRollforwardofContractLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Contract with Customer, Liability",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r453",
      "r456",
      "r475"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred franchise fee revenue, current portion",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r453",
      "r456",
      "r475"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosuresRollforwardofContractLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net increase during the year ended",
        "label": "Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from business combination."
       }
      }
     },
     "auth_ref": [
      "r937"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred franchise fee revenue, net of current portion",
        "label": "Contract with Customer, Liability, Noncurrent",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r453",
      "r456",
      "r475"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosuresRollforwardofContractLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Revenue recognized that was included in the contract liability at the beginning of the year",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due."
       }
      }
     },
     "auth_ref": [
      "r476"
     ]
    },
    "jynt_ContractWithCustomerLiabilityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "ContractWithCustomerLiabilityRollForward",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosuresRollforwardofContractLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Revenue Short and Long-Term",
        "label": "Contract with Customer, Liability [Roll Forward]",
        "documentation": "Contract with Customer, Liability"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_CorporateClinicsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "CorporateClinicsMember",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails",
      "http://www.thejoint.com/role/DivestituresKeyComponentsofCashFlowsfromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresNarrativeDetails",
      "http://www.thejoint.com/role/FairValueConsiderationDetails",
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails",
      "http://www.thejoint.com/role/IncomeTaxesUncertainTaxPositionRollforwardDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEAssetsandLiabilitiesDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate Clinics",
        "label": "Corporate Clinics [Member]",
        "documentation": "Represents the corporate clinics segment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "us-gaap_CostOfRevenue",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cost of revenues",
        "label": "Cost of Product and Service Sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r104",
      "r694",
      "r904",
      "r909",
      "r992",
      "r1210"
     ]
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total cost of revenues",
        "verboseLabel": "Total costs of revenues",
        "label": "Cost of Revenue",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r235",
      "r238",
      "r239",
      "r320",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r644",
      "r921",
      "r1274"
     ]
    },
    "us-gaap_CostOfRevenueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostOfRevenueAbstract",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenues:",
        "verboseLabel": "Cost of revenues:",
        "label": "Cost of Revenue [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_CostsIncurredAndDeferredDuringTheYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "CostsIncurredAndDeferredDuringTheYear",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosuresRollforwardofDeferredFranchiseandDevelopmentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net increase during the year",
        "label": "Costs Incurred And Deferred During The Year",
        "documentation": "Represents the amount of costs incurred and deferred during the period related to contract with customer."
       }
      }
     },
     "auth_ref": []
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]",
        "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r194",
      "r235",
      "r244",
      "r245",
      "r405",
      "r440",
      "r677",
      "r688",
      "r740",
      "r900",
      "r901",
      "r902",
      "r1163",
      "r1164",
      "r1165",
      "r1166",
      "r1167",
      "r1168",
      "r1169",
      "r1170",
      "r1171",
      "r1331",
      "r1332",
      "r1333",
      "r1334"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Axis]",
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r1271"
     ]
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Domain]",
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r1271"
     ]
    },
    "us-gaap_CreditLossFinancialInstrumentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CreditLossFinancialInstrumentPolicyTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for Credit Losses",
        "label": "Credit Loss, Financial Instrument [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security. Includes, but is not limited to, methodology used to estimate allowance for credit loss, how writeoff of uncollectible amount is recognized, and determination of past due status and nonaccrual status."
       }
      }
     },
     "auth_ref": [
      "r323",
      "r324",
      "r325",
      "r327",
      "r328",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346"
     ]
    },
    "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current expense:",
        "label": "Current Federal, State and Local, Tax Expense (Benefit) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesIncomeTaxExpenseDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current expense",
        "label": "Current Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r575",
      "r1221",
      "r1226"
     ]
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesIncomeTaxExpenseDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State, net of state tax credits",
        "label": "Current State and Local Tax Expense (Benefit)",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1151",
      "r1221",
      "r1226",
      "r1326"
     ]
    },
    "us-gaap_CustomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CustomerRelationshipsMember",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer relationships",
        "label": "Customer Relationships [Member]",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": [
      "r971",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1254",
      "r1255",
      "r1257",
      "r1258"
     ]
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1045",
      "r1134"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1045",
      "r1134"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1047",
      "r1136"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1047",
      "r1136"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1049",
      "r1138"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1047",
      "r1136"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1040",
      "r1129"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1041",
      "r1130"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1041",
      "r1130"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r1039",
      "r1128"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1039",
      "r1128"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r1039",
      "r1128"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1042",
      "r1131"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1044",
      "r1133"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1044",
      "r1133"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1045",
      "r1134"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1048",
      "r1137"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1046",
      "r1135"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1043",
      "r1132"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/Debt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r235",
      "r237",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r390",
      "r391",
      "r401",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r417",
      "r424",
      "r425",
      "r427",
      "r605",
      "r651"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r81",
      "r82",
      "r137",
      "r139",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r408",
      "r413",
      "r414",
      "r415",
      "r416",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r1002",
      "r1221",
      "r1222",
      "r1223",
      "r1228",
      "r1262",
      "r1263",
      "r1264",
      "r1345",
      "r1347",
      "r1362"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis spread on variable rate",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, face amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r402",
      "r651",
      "r652",
      "r931",
      "r932",
      "r1002"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r408",
      "r413",
      "r414",
      "r415",
      "r416",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r426",
      "r605",
      "r737",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r1002",
      "r1221",
      "r1222",
      "r1223",
      "r1228",
      "r1345",
      "r1347"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r408",
      "r413",
      "r414",
      "r415",
      "r416",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r1002",
      "r1221",
      "r1222",
      "r1223",
      "r1228",
      "r1262",
      "r1263",
      "r1264",
      "r1345",
      "r1347",
      "r1362"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r37",
      "r38",
      "r54",
      "r127",
      "r128",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r408",
      "r413",
      "r414",
      "r415",
      "r416",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r426",
      "r605",
      "r737",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r1002",
      "r1221",
      "r1222",
      "r1223",
      "r1228",
      "r1345",
      "r1347"
     ]
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredChargesPolicyTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Franchise Costs and Regional Development Costs",
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges."
       }
      }
     },
     "auth_ref": [
      "r211"
     ]
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesIncomeTaxExpenseDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1221",
      "r1226",
      "r1325",
      "r1326"
     ]
    },
    "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred expense (benefit):",
        "label": "Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredFinanceCostsGross",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt issuance costs incurred",
        "label": "Debt Issuance Costs, Gross",
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs."
       }
      }
     },
     "auth_ref": [
      "r1345",
      "r1347"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesIncomeTaxExpenseDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred expense (benefit)",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r160",
      "r1221",
      "r1226"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total deferred income tax liabilities",
        "label": "Deferred Tax Liabilities, Gross",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r89",
      "r138",
      "r566"
     ]
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income taxes",
        "label": "Deferred Income Taxes and Tax Credits",
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsDeferredIncome",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Deferred Tax Assets, Deferred Income",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income."
       }
      }
     },
     "auth_ref": [
      "r1323"
     ]
    },
    "jynt_DeferredTaxAssetsGoodwillComponent1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "DeferredTaxAssetsGoodwillComponent1",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill - component 1",
        "label": "Deferred Tax Assets, Goodwill - Component 1",
        "documentation": "Deferred Tax Assets, Goodwill - Component 1"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_DeferredTaxAssetsGoodwillComponent2": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "DeferredTaxAssetsGoodwillComponent2",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill - component 2",
        "label": "Deferred Tax Assets, Goodwill - Component 2",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to the difference between the book value and the taxable value of goodwill."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r567"
     ]
    },
    "us-gaap_DeferredTaxAssetsGrossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsGrossAbstract",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income tax assets:",
        "label": "Deferred Tax Assets, Gross [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_DeferredTaxAssetsIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "DeferredTaxAssetsIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets",
        "label": "Deferred Tax Assets, Intangible Assets",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets excluding goodwill."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred Tax Assets, Net",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1320"
     ]
    },
    "jynt_DeferredTaxAssetsNonqualifiedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "DeferredTaxAssetsNonqualifiedStockOptions",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nonqualified stock options",
        "label": "Deferred Tax Assets, Nonqualified Stock Options",
        "documentation": "Deferred Tax Assets, Nonqualified Stock Options"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_DeferredTaxAssetsOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "DeferredTaxAssetsOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities",
        "label": "Deferred Tax Assets, Operating Lease, Liability",
        "documentation": "Deferred Tax Assets, Operating Lease, Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss carryforwards",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1323"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating losses with an indefinite carryforward",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates."
       }
      }
     },
     "auth_ref": [
      "r1323"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating losses",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates."
       }
      }
     },
     "auth_ref": [
      "r1323"
     ]
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed assets",
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r1323"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credits",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1323"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r1323"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities."
       }
      }
     },
     "auth_ref": [
      "r1323"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: valuation allowance",
        "terseLabel": "Deferred tax assets, valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r568"
     ]
    },
    "us-gaap_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Net deferred income taxes",
        "label": "Deferred Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1320"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxLiabilitiesAbstract",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income tax liabilities:",
        "label": "Deferred Tax Liabilities, Gross [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_DeferredTaxLiabilitiesDeferredFranchiseCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "DeferredTaxLiabilitiesDeferredFranchiseCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Deferred franchise costs",
        "label": "Deferred Tax Liabilities, Deferred Franchise Costs",
        "documentation": "Deferred Tax Liabilities, Deferred Franchise Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Goodwill - component 1",
        "label": "Deferred Tax Liabilities, Goodwill",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from goodwill."
       }
      }
     },
     "auth_ref": [
      "r1323"
     ]
    },
    "jynt_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Lease ROU asset",
        "label": "Deferred Tax Liabilities, Operating Lease, Right-of-Use Asset",
        "documentation": "Deferred Tax Liabilities, Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Fixed assets",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r1323"
     ]
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employer contributions",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company matching contribution (maximum)",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DepositsAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DepositsAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deposits and other assets",
        "label": "Deposits Assets, Noncurrent",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1160"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/PropertyandEquipmentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation expense",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r32",
      "r225",
      "r903",
      "r904",
      "r906",
      "r908"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "us-gaap_SellingGeneralAndAdministrativeExpense",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails",
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "netLabel": "Depreciation and amortization expense",
        "verboseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r32"
     ]
    },
    "us-gaap_DepreciationAndAmortizationDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DepreciationAndAmortizationDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresKeyComponentsofCashFlowsfromDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation and Amortization, Discontinued Operations",
        "documentation": "Amount of deprecation and amortization expense attributable to property, plant and equipment and intangible assets of discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r1216"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r226",
      "r273",
      "r290",
      "r307",
      "r903",
      "r921",
      "r922"
     ]
    },
    "us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Net Loss (Gain) on Disposition or Impairment Related to Continuing Operations",
        "label": "Details of Impairment of Long-Lived Assets Held and Used by Asset [Table Text Block]",
        "documentation": "Tabular disclosure for impairment of long-lived assets held and used by an entity which includes a description of the impaired long-lived asset and facts and circumstances leading to the impairment, aggregate amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired long-lived asset is reported."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r123"
     ]
    },
    "jynt_DevelopmentLineOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "DevelopmentLineOfCreditMember",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Development Line of Credit",
        "label": "Development Line of Credit [Member]",
        "documentation": "Development Line of Credit"
       }
      }
     },
     "auth_ref": []
    },
    "srt_DirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "DirectorMember",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails",
      "http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Directors",
        "label": "Director [Member]",
        "documentation": "Person serving on board of directors."
       }
      }
     },
     "auth_ref": [
      "r1156",
      "r1241",
      "r1399"
     ]
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosuresDisaggregationofRevenueDetails",
      "http://www.thejoint.com/role/RevenueDisclosuresEstimatedRevenueRelatedtoPerformanceObligationsDetails",
      "http://www.thejoint.com/role/RevenueDisclosuresNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Line Items]",
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r473",
      "r474",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosuresDisaggregationofRevenueDetails",
      "http://www.thejoint.com/role/RevenueDisclosuresEstimatedRevenueRelatedtoPerformanceObligationsDetails",
      "http://www.thejoint.com/role/RevenueDisclosuresNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Table]",
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r473",
      "r474",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosuresTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Disaggregation of Revenue",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r1281"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r492",
      "r496",
      "r527",
      "r528",
      "r530",
      "r955"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DiscontinuedOperationAlternativeCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DiscontinuedOperationAlternativeCashFlowInformationAbstract",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresKeyComponentsofCashFlowsfromDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Significant operating and investing non-cash items",
        "label": "Discontinued Operation, Alternative Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresNarrativeDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEIncomeStatementDetails",
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income (loss) from discontinued operations before income tax expense",
        "netLabel": "Income from discontinued operations before income tax expense",
        "totalLabel": "Income (loss) before income tax expense",
        "verboseLabel": "Income (loss) from discontinued operations before income tax expense",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax",
        "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r62",
      "r63",
      "r64",
      "r65",
      "r71",
      "r102",
      "r1367"
     ]
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails",
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Discontinued operation (in dollars per share)",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share",
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresKeyComponentsofCashFlowsfromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresNarrativeDetails",
      "http://www.thejoint.com/role/FairValueConsiderationDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss on disposition or impairment from discontinued operations",
        "verboseLabel": "Net loss on disposition or impairment related to discontinued operations",
        "netLabel": "Net loss on disposition or impairment",
        "label": "Discontinued Operation, Provision for Loss (Gain) on Disposal, before Income Tax",
        "documentation": "Amount before tax of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r63",
      "r65"
     ]
    },
    "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEIncomeStatementDetails",
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax expense from discontinued operations",
        "netLabel": "Income tax expense from discontinued operations",
        "verboseLabel": "Income tax expense(benefit) from discontinued operations",
        "label": "Discontinued Operation, Tax Effect of Discontinued Operation",
        "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r63",
      "r64",
      "r65",
      "r71",
      "r76",
      "r548",
      "r580",
      "r582"
     ]
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discontinued Operations, Disposal Other than Sale By Sale",
        "label": "Discontinued Operations, Disposed of by Means Other than Sale [Member]",
        "documentation": "Component or group of components representing strategic shift that has or will have major effect on operation and financial result, disposed of by means other than sale."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "us-gaap_DiscontinuedOperationsDisposedOfBySaleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DiscontinuedOperationsDisposedOfBySaleMember",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresNarrativeDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discontinued Operations, Sale of Assets",
        "label": "Discontinued Operations, Disposed of by Sale [Member]",
        "documentation": "Component or group of components representing strategic shift that has or will have major effect on operation and financial result, disposed of by sale."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresKeyComponentsofCashFlowsfromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails",
      "http://www.thejoint.com/role/IncomeTaxesUncertainTaxPositionRollforwardDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discontinued Operations, Held-for-Sale or Disposed of by Sale",
        "label": "Discontinued Operations, Held-for-Sale or Disposed of by Sale [Member]",
        "documentation": "Component or group of components representing strategic shift that has or will have major effect on operation and financial result, classified as held-for-sale or disposed of by sale, and business and nonprofit activity on acquisition and upon joint venture formation, classified as held-for-sale."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r6"
     ]
    },
    "jynt_DiscontinuedOperationsHeldForUseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "DiscontinuedOperationsHeldForUseMember",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discontinued Operations, Held For Use",
        "label": "Discontinued Operations, Held For Use [Member]",
        "documentation": "Discontinued Operations, Held For Use"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DiscontinuedOperationsHeldforsaleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DiscontinuedOperationsHeldforsaleMember",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails",
      "http://www.thejoint.com/role/DivestituresNarrativeDetails",
      "http://www.thejoint.com/role/FairValueConsiderationDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discontinued Operations, Assets Held For Sale",
        "label": "Discontinued Operations, Held-for-Sale [Member]",
        "documentation": "Component or group of components representing strategic shift that has or will have major effect on operation and financial result and business and nonprofit activity on acquisition and upon joint venture formation, classified as held-for-sale."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r6",
      "r204"
     ]
    },
    "us-gaap_DiscontinuedOperationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DiscontinuedOperationsPolicyTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discontinued Operations",
        "label": "Discontinued Operations, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for discontinued operations. Includes, but is not limited to, method of interest allocation to a discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r18"
     ]
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupClassificationAxis",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails",
      "http://www.thejoint.com/role/DivestituresKeyComponentsofCashFlowsfromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresNarrativeDetails",
      "http://www.thejoint.com/role/FairValueConsiderationDetails",
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails",
      "http://www.thejoint.com/role/IncomeTaxesUncertainTaxPositionRollforwardDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Classification [Axis]",
        "label": "Disposal Group Classification [Axis]",
        "documentation": "Information by disposal group classification."
       }
      }
     },
     "auth_ref": [
      "r204"
     ]
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupClassificationDomain",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails",
      "http://www.thejoint.com/role/DivestituresKeyComponentsofCashFlowsfromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresNarrativeDetails",
      "http://www.thejoint.com/role/FairValueConsiderationDetails",
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails",
      "http://www.thejoint.com/role/IncomeTaxesUncertainTaxPositionRollforwardDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Classification [Domain]",
        "label": "Disposal Group Classification [Domain]",
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations."
       }
      }
     },
     "auth_ref": []
    },
    "jynt_DisposalGroupHeldForSaleClinicsExpectedToSellPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "DisposalGroupHeldForSaleClinicsExpectedToSellPeriod",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Clinics expected to sell, period",
        "label": "Disposal Group, Held-for-Sale, Clinics Expected To Sell, Period",
        "documentation": "Disposal Group, Held-for-Sale, Clinics Expected To Sell, Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts receivable",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r56",
      "r74",
      "r121"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable, Current",
        "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r56",
      "r74",
      "r118",
      "r121"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued expenses",
        "label": "Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current",
        "documentation": "Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r56",
      "r74",
      "r118",
      "r121"
     ]
    },
    "jynt_DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets sold that were previously classified as held for sale",
        "label": "Disposal Group, Including Discontinued Operation, Assets Held For Sale, Sold",
        "documentation": "Disposal Group, Including Discontinued Operation, Assets Held For Sale, Sold"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total consideration",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total cost of revenues",
        "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold",
        "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r205"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue from company-owned or managed clinics",
        "label": "Disposal Group, Including Discontinued Operation, Deferred Revenue, Current",
        "documentation": "Amount classified as deferred revenue attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r56",
      "r74",
      "r118",
      "r121"
     ]
    },
    "jynt_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets (attributable to VIEs)",
        "label": "Disposal Group, Including Discontinued Operation, Deferred Tax Assets, Current",
        "documentation": "Disposal Group, Including Discontinued Operation, Deferred Tax Assets, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails": {
       "parentTag": "jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Depreciation and amortization",
        "label": "Disposal Group, Including Discontinued Operation, Depreciation and Amortization",
        "documentation": "Amount of depreciation and amortization expense attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "jynt_DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated fair value",
        "label": "Disposal Group, Including Discontinued Operation, Estimated Fair Value",
        "documentation": "Disposal Group, Including Discontinued Operation, Estimated Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease liability",
        "label": "Disposal Group, Including Discontinued Operation, Finance Lease Liability, Current",
        "documentation": "Disposal Group, Including Discontinued Operation, Finance Lease Liability, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails": {
       "parentTag": "jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "General and administrative expenses",
        "label": "Disposal Group, Including Discontinued Operation, General and Administrative Expense",
        "documentation": "Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Disposal Group, Including Discontinued Operation, Goodwill, Current",
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r56",
      "r74",
      "r118",
      "r121"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, net",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets, Current",
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r56",
      "r74",
      "r118",
      "r121"
     ]
    },
    "jynt_DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities sold that were previously classified as held for sale",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities Held For Sale, Sold",
        "documentation": "Disposal Group, Including Discontinued Operation, Liabilities Held For Sale, Sold"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income (loss) from discontinued operations",
        "terseLabel": "Income (loss) from discontinued operations",
        "label": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)",
        "documentation": "Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating lease liability",
        "terseLabel": "Operating lease liability",
        "label": "Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current",
        "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use asset",
        "label": "Disposal Group, Including Discontinued Operation, Operating Lease, Right-of-Use Asset, Current",
        "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease, Right-of-Use Asset, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deposits and other assets",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets, Current",
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r56",
      "r74",
      "r118",
      "r121"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current liabilities (attributable to VIEs)",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities, Current",
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r56",
      "r74",
      "r118",
      "r121"
     ]
    },
    "jynt_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other expense, net",
        "label": "Disposal Group, Including Discontinued Operation, Other Income (Expense)",
        "documentation": "Disposal Group, Including Discontinued Operation, Other Income (Expense)"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payroll liabilities ($0.6 million and $0.9 million attributable to VIEs, respectively)",
        "label": "Disposal Group, Including Discontinued Operation, Payroll Liabilities, Current",
        "documentation": "Disposal Group, Including Discontinued Operation, Payroll Liabilities, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Prepaid expenses and other assets",
        "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current",
        "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r56",
      "r74",
      "r118",
      "r121"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current",
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r56",
      "r74",
      "r118",
      "r121"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total revenues",
        "label": "Disposal Group, Including Discontinued Operation, Revenue",
        "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r205"
     ]
    },
    "jynt_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails": {
       "parentTag": "jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling and marketing expenses",
        "label": "Disposal Group, Including Discontinued Operation, Selling And Marketing Expenses",
        "documentation": "Disposal Group, Including Discontinued Operation, Selling And Marketing Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total selling, general and administrative expenses",
        "label": "Disposal Group, Including Discontinued Operation, Selling, General And Administrative Expenses",
        "documentation": "Disposal Group, Including Discontinued Operation, Selling, General And Administrative Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails",
      "http://www.thejoint.com/role/DivestituresNarrativeDetails",
      "http://www.thejoint.com/role/FairValueConsiderationDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation allowance in discontinued operations current assets",
        "verboseLabel": "Valuation allowance",
        "negatedTerseLabel": "Valuation allowance",
        "label": "Disposal Group, Including Discontinued Operation, Valuation Allowance, Current",
        "documentation": "Disposal Group, Including Discontinued Operation, Valuation Allowance, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/Divestitures"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Divestitures",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r117"
     ]
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails",
      "http://www.thejoint.com/role/DivestituresKeyComponentsofCashFlowsfromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresNarrativeDetails",
      "http://www.thejoint.com/role/FairValueConsiderationDetails",
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails",
      "http://www.thejoint.com/role/IncomeTaxesUncertainTaxPositionRollforwardDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEAssetsandLiabilitiesDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Name [Domain]",
        "label": "Disposal Group Name [Domain]",
        "documentation": "Name of disposal group."
       }
      }
     },
     "auth_ref": [
      "r373",
      "r374",
      "r952",
      "r953"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r1036",
      "r1037",
      "r1060"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r1036",
      "r1037",
      "r1060",
      "r1103"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r1081"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Documents Incorporated by Reference",
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r1034"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails",
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Domestic Tax Jurisdiction",
        "label": "Domestic Tax Jurisdiction [Member]",
        "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r550"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1092"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails",
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income (loss) per common share:",
        "verboseLabel": "Earnings (loss) per share:",
        "netLabel": "Net income (loss) per common share:",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasic",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails",
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income (loss) per common share, basic (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r221",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r263",
      "r265",
      "r267",
      "r268",
      "r269",
      "r272",
      "r430",
      "r531",
      "r590",
      "r596",
      "r618",
      "r619",
      "r732",
      "r757",
      "r912"
     ]
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasicAbstract",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic earnings (loss) per share:",
        "label": "Earnings Per Share, Basic [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareDiluted",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails",
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income (loss) per common share, diluted (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r221",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r265",
      "r267",
      "r268",
      "r269",
      "r272",
      "r430",
      "r531",
      "r590",
      "r596",
      "r618",
      "r619",
      "r732",
      "r757",
      "r912"
     ]
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareDilutedAbstract",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted earnings (loss) per share",
        "label": "Earnings Per Share, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareDilutedOtherDisclosuresAbstract",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average dilutive securities:",
        "label": "Earnings Per Share, Diluted, Other Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings (Loss) per Common Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r27",
      "r271"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails",
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective tax rate",
        "totalLabel": "Effective rate",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r550",
      "r959"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percent",
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected federal tax expense at U.S. federal statutory rate",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r241",
      "r550",
      "r578",
      "r959"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in valuation allowances",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r554",
      "r959",
      "r1221",
      "r1227",
      "r1316"
     ]
    },
    "jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred true-up to deferred franchise costs",
        "label": "Effective Income Tax Rate Reconciliation, Deferred Franchise Costs, Deferred True Up, Amount",
        "documentation": "Effective Income Tax Rate Reconciliation, Deferred Franchise Costs, Deferred True Up, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred true-up to deferred franchise costs",
        "label": "Effective Income Tax Rate Reconciliation, Deferred Franchise Costs, Deferred True Up, Percent",
        "documentation": "Effective Income Tax Rate Reconciliation, Deferred Franchise Costs, Deferred True Up, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Meals and entertainment",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment expense."
       }
      }
     },
     "auth_ref": [
      "r1221",
      "r1227",
      "r1316",
      "r1318"
     ]
    },
    "jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Section 162(m) officer compensation",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Officer Compensation, Amount",
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Officer Compensation, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Section 162(m) officer compensation",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Officer Compensation, Percent\"",
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Officer Compensation, Percent\""
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other nontaxable or nondeductible items",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r959",
      "r1221",
      "r1227",
      "r1316",
      "r1318"
     ]
    },
    "jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payroll tax penalty",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Payroll Tax Penalty, Amount",
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Payroll Tax Penalty, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payroll tax penalty",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Payroll Tax Penalty, Percent",
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Payroll Tax Penalty, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share based compensation",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent",
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r959",
      "r1221",
      "r1227",
      "r1316",
      "r1318"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other items",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r959",
      "r1221",
      "r1227",
      "r1316",
      "r1317"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercentAbstract",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other adjustments:",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current year expirations of non-qualified stock options",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount",
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1315",
      "r1316",
      "r1317"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current year expirations of non-qualified stock options",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent",
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1315",
      "r1316",
      "r1317"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and local income taxes (net of federal income tax effect)",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r553",
      "r959",
      "r1221",
      "r1227",
      "r1316"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxContingencies",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in unrecognized tax benefits",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies."
       }
      }
     },
     "auth_ref": [
      "r555",
      "r959",
      "r1221",
      "r1227",
      "r1316"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payroll liabilities",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized stock-based compensation, period of recognition",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r529"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1312"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax benefit from exercise of stock options and restricted stock awards",
        "label": "Share-Based Payment Arrangement, Exercise of Option, Tax Benefit",
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails",
      "http://www.thejoint.com/role/StockBasedCompensationValuationAssumptionsusedforStockOptionsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": [
      "r1285",
      "r1286",
      "r1287",
      "r1288",
      "r1289",
      "r1290",
      "r1291",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1297",
      "r1298",
      "r1299",
      "r1300",
      "r1301",
      "r1302",
      "r1303",
      "r1304",
      "r1305",
      "r1306",
      "r1307",
      "r1308",
      "r1309",
      "r1310",
      "r1311"
     ]
    },
    "jynt_EmploymentMattersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "EmploymentMattersMember",
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employment Matters",
        "label": "Employment Matters [Member]",
        "documentation": "Employment Matters"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1033"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity [Domain]",
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1033"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r1033"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r1143"
     ]
    },
    "us-gaap_EntityOperatedUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EntityOperatedUnitsMember",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company-Owned or Managed Clinics",
        "label": "Entity Operated Units [Member]",
        "documentation": "Units that are owned and operated by the entity (franchisor)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Public Float",
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1033"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r1033"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r1033"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1033"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r1144"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1086"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1139"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r1139"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1139"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r198",
      "r200",
      "r201",
      "r218",
      "r219",
      "r220",
      "r247",
      "r248",
      "r249",
      "r251",
      "r258",
      "r260",
      "r262",
      "r275",
      "r321",
      "r322",
      "r370",
      "r429",
      "r451",
      "r531",
      "r576",
      "r577",
      "r587",
      "r588",
      "r589",
      "r591",
      "r595",
      "r596",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r617",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r653",
      "r655",
      "r671",
      "r756",
      "r779",
      "r780",
      "r781",
      "r796",
      "r854"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Domain]",
        "label": "Investment, Name [Domain]",
        "documentation": "Name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r317",
      "r318",
      "r319",
      "r586",
      "r644",
      "r1145",
      "r1146",
      "r1147",
      "r1327",
      "r1328",
      "r1329",
      "r1330"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, ownership percentage",
        "label": "Equity Method Investment, Ownership Percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r317",
      "r644"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1096"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1053",
      "r1064",
      "r1074",
      "r1107"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r1050",
      "r1061",
      "r1071",
      "r1104"
     ]
    },
    "jynt_ExecutedLettersOfIntentForFutureClinicLicenses": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "ExecutedLettersOfIntentForFutureClinicLicenses",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails",
      "http://www.thejoint.com/role/RevenueDisclosuresNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executed letters of intent for future clinic licenses",
        "label": "Executed Letters Of Intent For Future Clinic Licenses",
        "documentation": "The number of future clinic's licenses that have an executed letter of intent."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1102"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresNarrativeDetails",
      "http://www.thejoint.com/role/FairValueConsiderationDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Class [Domain]",
        "label": "Asset Class [Domain]",
        "documentation": "Class of asset."
       }
      }
     },
     "auth_ref": [
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r635",
      "r895",
      "r996",
      "r1001"
     ]
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r641",
      "r642",
      "r643",
      "r895",
      "r1001",
      "r1343"
     ]
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByAssetClassAxis",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresNarrativeDetails",
      "http://www.thejoint.com/role/FairValueConsiderationDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Class [Axis]",
        "label": "Asset Class [Axis]",
        "documentation": "Information by class of asset."
       }
      }
     },
     "auth_ref": [
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r635",
      "r895",
      "r996",
      "r1001"
     ]
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByBalanceSheetGroupingTable",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r641",
      "r643",
      "r895",
      "r1001",
      "r1342",
      "r1343"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r415",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r487",
      "r488",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r633",
      "r634",
      "r636",
      "r641",
      "r680",
      "r681",
      "r682",
      "r895",
      "r931",
      "r932",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r993",
      "r997",
      "r1001"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsideration"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Consideration",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r622",
      "r629",
      "r631",
      "r632",
      "r633",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r731",
      "r993",
      "r998"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Inputs, Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r415",
      "r480",
      "r485",
      "r487",
      "r621",
      "r634",
      "r641",
      "r680",
      "r895",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r993",
      "r1001"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Inputs, Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r415",
      "r480",
      "r485",
      "r487",
      "r489",
      "r621",
      "r622",
      "r634",
      "r641",
      "r681",
      "r895",
      "r931",
      "r932",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r993",
      "r1001"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Inputs, Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r415",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r487",
      "r488",
      "r621",
      "r622",
      "r623",
      "r624",
      "r634",
      "r641",
      "r682",
      "r895",
      "r931",
      "r932",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r993",
      "r997",
      "r1001"
     ]
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r415",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r487",
      "r488",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r633",
      "r634",
      "r636",
      "r641",
      "r680",
      "r681",
      "r682",
      "r895",
      "r931",
      "r932",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r993",
      "r997",
      "r1001"
     ]
    },
    "jynt_FederalReserveBankOfNewYorkRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "FederalReserveBankOfNewYorkRateMember",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal Reserve Bank Of New York Rate",
        "label": "Federal Reserve Bank Of New York Rate [Member]",
        "documentation": "Federal Reserve Bank Of New York Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeasePrincipalPayments",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of finance lease obligations",
        "label": "Finance Lease, Principal Payments",
        "documentation": "Amount of cash outflow for principal payment on finance lease."
       }
      }
     },
     "auth_ref": [
      "r658",
      "r664"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, useful life",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r695",
      "r696",
      "r786",
      "r893",
      "r898",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r786",
      "r893",
      "r898",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsMember",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNetLossGainonDispositionorImpairmentRelatedtoContinuingOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, net",
        "label": "Finite-Lived Intangible Assets [Member]",
        "documentation": "Assets, excluding financial assets, that lack physical substance, having a limited useful life."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r1057",
      "r1068",
      "r1078",
      "r1111"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r1057",
      "r1068",
      "r1078",
      "r1111"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r1057",
      "r1068",
      "r1078",
      "r1111"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1057",
      "r1068",
      "r1078",
      "r1111"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1057",
      "r1068",
      "r1078",
      "r1111"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1091"
     ]
    },
    "jynt_FranchiseLicensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "FranchiseLicensesMember",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Franchise Licenses",
        "label": "Franchise Licenses [Member]",
        "documentation": "Franchise Licenses"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_FranchiseLicensesOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "FranchiseLicensesOneMember",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Franchise Licenses One",
        "label": "Franchise Licenses One [Member]",
        "documentation": "Franchise Licenses One"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_FranchiseLicensesTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "FranchiseLicensesTwoMember",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Franchise Licenses Two",
        "label": "Franchise Licenses Two [Member]",
        "documentation": "Franchise Licenses Two"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FranchiseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FranchiseMember",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Franchise fees",
        "terseLabel": "Franchise",
        "label": "Franchise [Member]",
        "documentation": "Right granted by another party to operate business using grantor's name, merchandise, service, methodology, promotional support, marketing and supplies."
       }
      }
     },
     "auth_ref": [
      "r1281",
      "r1282"
     ]
    },
    "jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "FranchiseMonthlyMarketingFeeGrossSalesPercentage",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Monthly marketing fee",
        "label": "Franchise Monthly Marketing Fee, Gross Sales Percentage",
        "documentation": "Represents the percentage of gross sales a franchise pays for monthly marketing fees as stipulated in the typical franchise agreement."
       }
      }
     },
     "auth_ref": []
    },
    "jynt_FranchiseOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "FranchiseOperationsMember",
     "presentation": [
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Franchise Operations",
        "label": "Franchise Operations [Member]",
        "documentation": "Franchise Operations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FranchiseRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FranchiseRightsMember",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reacquired franchise rights",
        "label": "Franchise Rights [Member]",
        "documentation": "Rights, generally of limited duration, that the entity has obtained through a franchise arrangement to operate a business using another company's name, merchandise, services, methodologies, promotional support, marketing and supplies."
       }
      }
     },
     "auth_ref": [
      "r979",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1253",
      "r1254",
      "r1255",
      "r1256",
      "r1257",
      "r1258"
     ]
    },
    "jynt_FranchiseRoyaltyGrossSalesPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "FranchiseRoyaltyGrossSalesPercentage",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalties percentage",
        "label": "Franchise Royalty Gross Sales Percentage",
        "documentation": "Represents the percentage of gross sales collected as royalties from franchises typically collected bi-monthly two working days after each sales period has ended as stipulated in the franchise agreement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FranchisedUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FranchisedUnitsMember",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails",
      "http://www.thejoint.com/role/RevenueDisclosuresNarrativeDetails",
      "http://www.thejoint.com/role/SegmentReportingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Franchised Clinics",
        "label": "Franchised Units [Member]",
        "documentation": "Units that have been franchised by the franchisor."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FranchisorDisclosureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FranchisorDisclosureAxis",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.thejoint.com/role/RevenueDisclosuresNarrativeDetails",
      "http://www.thejoint.com/role/SegmentReportingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Franchisor Disclosure [Axis]",
        "label": "Franchisor Disclosure [Axis]",
        "documentation": "Information by whether or not the unit is franchised."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FranchisorDisclosureDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FranchisorDisclosureDomain",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.thejoint.com/role/RevenueDisclosuresNarrativeDetails",
      "http://www.thejoint.com/role/SegmentReportingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Franchisor Disclosure [Domain]",
        "label": "Franchisor Disclosure [Domain]",
        "documentation": "Represents franchised stores, restaurants, or other units and company owned stores, restaurants, or other units."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GainLossOnSalesOfAssetsAndAssetImpairmentCharges",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net loss on disposition or impairment",
        "negatedTerseLabel": "Net loss on disposition or impairment",
        "label": "Gain (Loss) on Sale of Assets and Asset Impairment Charges",
        "documentation": "Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value."
       }
      }
     },
     "auth_ref": [
      "r1216"
     ]
    },
    "jynt_GainLossOnTerminationOfFranchisingAgreements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "GainLossOnTerminationOfFranchisingAgreements",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net franchise fees recognized upon termination of franchise agreements",
        "label": "Gain (Loss) On Termination Of Franchising Agreements",
        "documentation": "Gain (loss) related to the termination of franchising agreements with third parties."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "us-gaap_SellingGeneralAndAdministrativeExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative expenses",
        "verboseLabel": "General and administrative expenses",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r834"
     ]
    },
    "jynt_GeneralAndAdministrativeExpenseAdjusted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "GeneralAndAdministrativeExpenseAdjusted",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjusted General and administrative expenses",
        "label": "General And Administrative Expense, Adjusted",
        "documentation": "General And Administrative Expense, Adjusted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined."
       }
      }
     },
     "auth_ref": [
      "r347",
      "r358",
      "r928"
     ]
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of goodwill",
        "label": "Goodwill, Impairment Loss",
        "documentation": "Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r348",
      "r354",
      "r358",
      "r359",
      "r594",
      "r928",
      "r995"
     ]
    },
    "jynt_GuarantorObligationsRemainingExposureUndiscounted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "GuarantorObligationsRemainingExposureUndiscounted",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Guarantor obligations, remaining exposure, undiscounted",
        "label": "Guarantor Obligations, Remaining Exposure, Undiscounted",
        "documentation": "Guarantor Obligations, Remaining Exposure, Undiscounted"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r1036",
      "r1037",
      "r1060"
     ]
    },
    "us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNetLossGainonDispositionorImpairmentRelatedtoContinuingOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impaired Long-Lived Assets Held and Used, Asset Name [Domain]",
        "label": "Impaired Long-Lived Assets Held and Used, Asset Name [Domain]",
        "documentation": "The name of the impaired assets to be held and used by the entity."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ImpairedLongLivedAssetsHeldAndUsedByTypeAxis",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNetLossGainonDispositionorImpairmentRelatedtoContinuingOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impaired Long-Lived Assets Held and Used by Type [Axis]",
        "label": "Impaired Long-Lived Assets Held and Used by Type [Axis]",
        "documentation": "Information by type of impaired long-lived asset held and used."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNetLossGainonDispositionorImpairmentRelatedtoContinuingOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value",
        "verboseLabel": "Fair value of impaired asset after impairment",
        "label": "Impaired Long-Lived Assets Held And Used, Carrying Value After Impairment",
        "documentation": "Impaired Long-Lived Assets Held And Used, Carrying Value After Impairment"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNetLossGainonDispositionorImpairmentRelatedtoContinuingOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying Value",
        "verboseLabel": "Carrying value of impaired asset before impairment",
        "label": "Impaired Long-Lived Assets Held And Used, Carrying Value Before Impairment",
        "documentation": "Impaired Long-Lived Assets Held And Used, Carrying Value Before Impairment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ImpairedLongLivedAssetsHeldAndUsedLineItems",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNetLossGainonDispositionorImpairmentRelatedtoContinuingOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impaired Long-Lived Assets Held and Used [Line Items]",
        "label": "Impaired Long-Lived Assets Held and Used [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNetLossGainonDispositionorImpairmentRelatedtoContinuingOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "label": "Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of income or comprehensive income that includes impairment of long-lived asset held for use."
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNetLossGainonDispositionorImpairmentRelatedtoContinuingOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss on disposition or impairment related to continuing operations",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r31",
      "r120",
      "r223",
      "r904",
      "r994"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Assets - Continuing Operations",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r123"
     ]
    },
    "us-gaap_IncomeAndExpensesLesseeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeAndExpensesLesseeAbstract",
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease costs:",
        "label": "Income and Expenses, Lessee [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsAttributableToParentAbstract",
     "presentation": [
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net (loss) income from continuing operations per common share",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesLossFromContinuingOperationsBeforetheProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesLossFromContinuingOperationsBeforetheProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Domestic",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r240",
      "r549"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.thejoint.com/role/IncomeTaxesLossFromContinuingOperationsBeforetheProvisionforIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails",
      "http://www.thejoint.com/role/IncomeTaxesLossFromContinuingOperationsBeforetheProvisionforIncomeTaxesDetails",
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from continuing operations before income tax expense",
        "terseLabel": "Loss from continuing operations before provision for income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r143",
      "r147",
      "r733",
      "r735",
      "r753",
      "r905",
      "r907",
      "r909",
      "r916",
      "r921",
      "r1235",
      "r1237",
      "r1238",
      "r1239",
      "r1240"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails",
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails",
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss from continuing operations",
        "terseLabel": "Net loss from continuing operations",
        "netLabel": "Net loss from continuing operations",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r147",
      "r201",
      "r235",
      "r238",
      "r239",
      "r250",
      "r258",
      "r320",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r430",
      "r531",
      "r590",
      "r596",
      "r619",
      "r644",
      "r753",
      "r916",
      "r1235",
      "r1237",
      "r1238",
      "r1239",
      "r1240",
      "r1274"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails",
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "Continuing operations (in dollars per share)",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r144",
      "r201",
      "r221",
      "r250",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r265",
      "r267",
      "r268",
      "r430",
      "r590",
      "r596",
      "r619",
      "r732",
      "r1368"
     ]
    },
    "jynt_IncomeLossFromContinuingOperationsPerBasicShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "IncomeLossFromContinuingOperationsPerBasicShareAbstract",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net (loss) income from continuing operations per common share:",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share [Abstract]",
        "documentation": "Income (Loss) from Continuing Operations, Per Basic Share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails",
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Continuing operations (in dollars per share)",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r201",
      "r221",
      "r250",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r265",
      "r267",
      "r268",
      "r269",
      "r596",
      "r619",
      "r732",
      "r1368"
     ]
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerDilutedShareAbstract",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income (loss) from discontinued operations per common share:",
        "verboseLabel": "Net income (loss) from discontinued operations per common share:",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEIncomeStatementDetails",
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails",
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income (loss) from discontinued operations",
        "terseLabel": "Net income (loss) from discontinued operations",
        "netLabel": "Net income (loss) from discontinued operations",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r62",
      "r63",
      "r64",
      "r65",
      "r76",
      "r205",
      "r583",
      "r754"
     ]
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discontinued operations:",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails",
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "Discontinued operations (in dollars per share)",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r221",
      "r266",
      "r267",
      "r268",
      "r1361",
      "r1368"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails",
      "http://www.thejoint.com/role/DivestituresKeyComponentsofCashFlowsfromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresNarrativeDetails",
      "http://www.thejoint.com/role/FairValueConsiderationDetails",
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails",
      "http://www.thejoint.com/role/IncomeTaxesUncertainTaxPositionRollforwardDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEAssetsandLiabilitiesDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Name [Axis]",
        "label": "Disposal Group Name [Axis]",
        "documentation": "Information by name of disposal group."
       }
      }
     },
     "auth_ref": [
      "r373",
      "r374",
      "r952",
      "r953"
     ]
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails",
      "http://www.thejoint.com/role/DivestituresKeyComponentsofCashFlowsfromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r373",
      "r374"
     ]
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails",
      "http://www.thejoint.com/role/DivestituresKeyComponentsofCashFlowsfromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r15",
      "r17",
      "r56",
      "r66",
      "r67",
      "r68",
      "r69",
      "r70",
      "r75",
      "r77",
      "r78",
      "r122",
      "r373",
      "r374"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails",
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Jurisdiction [Axis]",
        "label": "Income Tax Jurisdiction [Axis]",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r550",
      "r551",
      "r559",
      "r572",
      "r959",
      "r1322"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails",
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Jurisdiction [Domain]",
        "label": "Income Tax Jurisdiction [Domain]",
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r550",
      "r551",
      "r559",
      "r572",
      "r959",
      "r1322"
     ]
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxContingencyLineItems",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails",
      "http://www.thejoint.com/role/IncomeTaxesUncertainTaxPositionRollforwardDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Contingency [Line Items]",
        "label": "Income Tax Contingency [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxContingencyTable",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails",
      "http://www.thejoint.com/role/IncomeTaxesUncertainTaxPositionRollforwardDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Contingency [Table]",
        "label": "Income Tax Contingency [Table]",
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months."
       }
      }
     },
     "auth_ref": [
      "r1319"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r241",
      "r544",
      "r550",
      "r556",
      "r557",
      "r558",
      "r563",
      "r570",
      "r579",
      "r581",
      "r584",
      "r585",
      "r739",
      "r785",
      "r790",
      "r959"
     ]
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued interest and penalties",
        "label": "Income Tax Examination, Penalties and Interest Accrued",
        "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations."
       }
      }
     },
     "auth_ref": [
      "r1319"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0,
       "order": 8.0
      },
      "http://www.thejoint.com/role/IncomeTaxesIncomeTaxExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails",
      "http://www.thejoint.com/role/IncomeTaxesIncomeTaxExpenseDetails",
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails",
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax expense",
        "totalLabel": "Total income tax expense",
        "netLabel": "Income tax expense",
        "verboseLabel": "Income tax expense (benefit)",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r161",
      "r235",
      "r261",
      "r262",
      "r273",
      "r293",
      "r307",
      "r548",
      "r550",
      "r580",
      "r758",
      "r905",
      "r907",
      "r909",
      "r959"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount",
        "label": "Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxPaidByIndividualJurisdictionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxPaidByIndividualJurisdictionLineItems",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Paid, by Individual Jurisdiction [Line Items]",
        "label": "Income Tax Paid, by Individual Jurisdiction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r572"
     ]
    },
    "us-gaap_IncomeTaxPaidByIndividualJurisdictionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxPaidByIndividualJurisdictionTable",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Paid, by Individual Jurisdiction [Table]",
        "label": "Income Tax Paid, by Individual Jurisdiction [Table]",
        "documentation": "Disclosure of information about income tax paid by jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r572"
     ]
    },
    "us-gaap_IncomeTaxPaidFederalAfterRefundReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxPaidFederalAfterRefundReceived",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails": {
       "parentTag": "us-gaap_IncomeTaxesPaidNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Income Tax Paid, Federal, after Refund Received",
        "documentation": "Amount, after income tax refund received, of cash paid to federal (national) tax jurisdiction for tax on income."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r571"
     ]
    },
    "us-gaap_IncomeTaxPaidStateAndLocalAfterRefundReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxPaidStateAndLocalAfterRefundReceived",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails": {
       "parentTag": "us-gaap_IncomeTaxesPaidNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State:",
        "label": "Income Tax Paid, State and Local, after Refund Received",
        "documentation": "Amount, after income tax refund received, of cash paid to state and local tax jurisdictions for tax on income."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r571"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r217",
      "r546",
      "r547",
      "r563",
      "r564",
      "r569",
      "r574",
      "r788"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in valuation allowances",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r554",
      "r959",
      "r1316"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected federal tax expense at U.S. federal statutory rate",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r550",
      "r959"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Meals and entertainment",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible meals and entertainment expense."
       }
      }
     },
     "auth_ref": [
      "r1316",
      "r1318"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseOther",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other nontaxable or nondeductible items",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r959",
      "r1316",
      "r1318"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share based compensation",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r959",
      "r1316",
      "r1318"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other items",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r959",
      "r1316",
      "r1317"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherReconcilingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationOtherReconcilingItemsAbstract",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other adjustments:",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and local income taxes (net of federal income tax effect)",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r553",
      "r959",
      "r1316"
     ]
    },
    "us-gaap_IncomeTaxReconciliationTaxContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationTaxContingencies",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in unrecognized tax benefits",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies."
       }
      }
     },
     "auth_ref": [
      "r555",
      "r959",
      "r1316"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.thejoint.com/role/IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes",
        "totalLabel": "Income taxes paid (net of refunds received)",
        "label": "Income Taxes Paid, Net",
        "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r233",
      "r571",
      "r572"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInContractWithCustomerAsset",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Deferred franchise costs",
        "label": "Increase (Decrease) in Contract with Customer, Asset",
        "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r1215"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r690",
      "r1215"
     ]
    },
    "us-gaap_IncreaseDecreaseInDepositOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInDepositOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Deposits and other assets",
        "label": "Increase (Decrease) in Deposit Assets",
        "documentation": "The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payroll liabilities",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating leases",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r1150",
      "r1215"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "jynt_IncreaseDecreaseInRegionalDeveloperFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "IncreaseDecreaseInRegionalDeveloperFees",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Upfront regional developer fees",
        "label": "Increase (Decrease) In Regional Developer Fees",
        "documentation": "Increase (Decrease) In Regional Developer Fees"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1057",
      "r1068",
      "r1078",
      "r1102",
      "r1111",
      "r1115",
      "r1123"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1121"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1038",
      "r1127"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1038",
      "r1127"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1038",
      "r1127"
     ]
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Assets",
        "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets."
       }
      }
     },
     "auth_ref": [
      "r691",
      "r692",
      "r693",
      "r695",
      "r911",
      "r1248"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activity",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r228",
      "r231",
      "r232"
     ]
    },
    "us-gaap_InternalUseSoftwarePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InternalUseSoftwarePolicy",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized Software",
        "label": "Internal Use Software, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "jynt_KansasAndMissouriMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "KansasAndMissouriMember",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kansas and Missouri",
        "label": "Kansas and Missouri [Member]",
        "documentation": "Kansas and Missouri"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease costs",
        "label": "Lease, Cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r662",
      "r1003"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Lease Expense",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1348"
     ]
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.thejoint.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r669"
     ]
    },
    "jynt_LeasesWeightedAverageDiscountRateAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "LeasesWeightedAverageDiscountRateAbstract",
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average discount rate:",
        "label": "Leases, Weighted Average Discount Rate [Abstract]",
        "documentation": "Leases, Weighted Average Discount Rate"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Entity [Axis]",
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Line Items]",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r661",
      "r670"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r661",
      "r670"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r660"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maturities of Operating Lease Liabilities",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1349"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r668",
      "r1222",
      "r1228",
      "r1362"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r668",
      "r1222",
      "r1228",
      "r1362"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r668",
      "r1222",
      "r1228",
      "r1362"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2030",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r668",
      "r1222",
      "r1228",
      "r1362"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r668",
      "r1222",
      "r1228",
      "r1362"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r668",
      "r1222",
      "r1228",
      "r1362"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r668",
      "r1222",
      "r1228",
      "r1362"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: Imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r668"
     ]
    },
    "jynt_LesseeOperatingLeaseNumberOfRenewalOptions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "LesseeOperatingLeaseNumberOfRenewalOptions",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of lease renewal options",
        "label": "Lessee, Operating Lease, Number Of Renewal Options",
        "documentation": "Lessee, Operating Lease, Number Of Renewal Options"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LetterOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LetterOfCreditMember",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Letter of Credit",
        "label": "Letter of Credit [Member]",
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r81",
      "r82",
      "r83",
      "r85",
      "r86",
      "r87",
      "r90",
      "r235",
      "r238",
      "r239",
      "r320",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r599",
      "r603",
      "r604",
      "r644",
      "r810",
      "r915",
      "r935",
      "r1031",
      "r1274",
      "r1352",
      "r1353"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders\u2019 equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r142",
      "r748",
      "r1004",
      "r1019",
      "r1020",
      "r1221",
      "r1225",
      "r1246",
      "r1344"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r207",
      "r235",
      "r238",
      "r239",
      "r320",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r599",
      "r603",
      "r604",
      "r644",
      "r1004",
      "r1274",
      "r1352",
      "r1353"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities, discontinued operations",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r56",
      "r74",
      "r121",
      "r204",
      "r205"
     ]
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "LIABILITIES",
        "terseLabel": "LIABILITIES",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 7.0
      },
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 9.0
      },
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets",
      "http://www.thejoint.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/DivestituresHeldForSaleAssetsandLiabilitiesToBeDisposedOfDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discontinued operations current liabilities ($6.1 million and $7.1 million attributable to VIEs, respectively)",
        "netLabel": "Discontinued operations current liabilities",
        "verboseLabel": "Liabilities to be disposed of",
        "totalLabel": "Total liabilities to be disposed of",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r56",
      "r74",
      "r118",
      "r121",
      "r204",
      "r205"
     ]
    },
    "us-gaap_LineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt under credit agreement",
        "label": "Long-Term Line of Credit",
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r139",
      "r1363"
     ]
    },
    "us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LineOfCreditFacilityIncreaseDecreaseForPeriodNet",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Termination of line of credit",
        "label": "Line of Credit Facility, Increase (Decrease), Net",
        "documentation": "Amount of increase (decrease) of the credit facility."
       }
      }
     },
     "auth_ref": [
      "r1221",
      "r1223"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum borrowing capacity",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r84"
     ]
    },
    "jynt_LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum borrowing capacity, additional amount",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity, Additional Amount",
        "documentation": "Line of Credit Facility, Maximum Borrowing Capacity, Additional Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LineOfCreditMember",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit",
        "label": "Line of Credit [Member]",
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Settlement agreement amount",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "documentation": "Amount awarded to other party in judgment or settlement of litigation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LitigationSettlementExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LitigationSettlementExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation expenses",
        "label": "Litigation Settlement, Fee Expense",
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees."
       }
      }
     },
     "auth_ref": [
      "r1152"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r139",
      "r236",
      "r246",
      "r414",
      "r428",
      "r737",
      "r931",
      "r932",
      "r1002",
      "r1363"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r1262",
      "r1263",
      "r1264"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r36",
      "r1262",
      "r1263",
      "r1264"
     ]
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingency Nature [Axis]",
        "label": "Loss Contingency Nature [Axis]",
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r384",
      "r385",
      "r386",
      "r389",
      "r542",
      "r784",
      "r929",
      "r1267",
      "r1268"
     ]
    },
    "us-gaap_LossContingencyNatureDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LossContingencyNatureDomain",
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingency, Nature [Domain]",
        "label": "Loss Contingency, Nature [Domain]",
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r384",
      "r385",
      "r386",
      "r389",
      "r542",
      "r784",
      "r929",
      "r1267",
      "r1268"
     ]
    },
    "jynt_ManagementAgreementNumberOfProfessionalCorporations": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "ManagementAgreementNumberOfProfessionalCorporations",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of agreements with PCs",
        "label": "Management Agreement, Number Of Professional Corporations",
        "documentation": "Management Agreement, Number Of Professional Corporations"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_ManagementAgreementTerminationNumberOfProfessionalCorporations": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "ManagementAgreementTerminationNumberOfProfessionalCorporations",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of professional corporations with management agreements terminated",
        "label": "Management Agreement, Termination, Number Of Professional Corporations",
        "documentation": "Management Agreement, Termination, Number Of Professional Corporations"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r166",
      "r168",
      "r169",
      "r171",
      "r189",
      "r191",
      "r192",
      "r196",
      "r197",
      "r280",
      "r385",
      "r386",
      "r387",
      "r388",
      "r491",
      "r522",
      "r523",
      "r524",
      "r542",
      "r624",
      "r689",
      "r777",
      "r778",
      "r784",
      "r802",
      "r803",
      "r862",
      "r864",
      "r866",
      "r867",
      "r869",
      "r873",
      "r874",
      "r876",
      "r877",
      "r891",
      "r892",
      "r926",
      "r936",
      "r954",
      "r960",
      "r961",
      "r962",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1014",
      "r1278",
      "r1354",
      "r1355",
      "r1356",
      "r1357",
      "r1358",
      "r1359"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1094"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1094"
     ]
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputDiscountRateMember",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input, Discount Rate",
        "label": "Measurement Input, Discount Rate [Member]",
        "documentation": "Measurement input using interest rate to determine present value of future cash flows."
       }
      }
     },
     "auth_ref": [
      "r960",
      "r961",
      "r962",
      "r1339",
      "r1340",
      "r1341"
     ]
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Axis]",
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r622",
      "r623",
      "r624",
      "r960",
      "r961",
      "r962",
      "r997"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Domain]",
        "label": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r622",
      "r623",
      "r624",
      "r960",
      "r961",
      "r962",
      "r997"
     ]
    },
    "jynt_MedicalInjuryClaimMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "MedicalInjuryClaimMember",
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medical Injury Claim",
        "label": "Medical Injury Claim [Member]",
        "documentation": "Medical Injury Claim"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r166",
      "r168",
      "r169",
      "r171",
      "r189",
      "r191",
      "r192",
      "r196",
      "r197",
      "r280",
      "r385",
      "r386",
      "r387",
      "r388",
      "r491",
      "r522",
      "r523",
      "r524",
      "r542",
      "r624",
      "r689",
      "r777",
      "r778",
      "r784",
      "r802",
      "r803",
      "r862",
      "r864",
      "r866",
      "r867",
      "r869",
      "r873",
      "r874",
      "r876",
      "r877",
      "r891",
      "r892",
      "r926",
      "r936",
      "r954",
      "r960",
      "r961",
      "r962",
      "r997",
      "r998",
      "r999",
      "r1014",
      "r1278",
      "r1354",
      "r1355",
      "r1356",
      "r1357",
      "r1358",
      "r1359"
     ]
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling Interest",
        "label": "Equity, Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r141",
      "r235",
      "r238",
      "r239",
      "r320",
      "r392",
      "r394",
      "r395",
      "r396",
      "r399",
      "r400",
      "r747",
      "r814",
      "r1344"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1114"
     ]
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money Market Funds",
        "label": "Money Market Funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r1283",
      "r1284"
     ]
    },
    "jynt_MrJeffersonGrammMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "MrJeffersonGrammMember",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mr Jefferson Gramm",
        "label": "Mr Jefferson Gramm [Member]",
        "documentation": "Mr Jefferson Gramm"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1122"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1095"
     ]
    },
    "jynt_NatureofOperationsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "NatureofOperationsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nature of Operations",
        "label": "Nature of Operations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for nature of operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r230"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities:",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r230"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities:",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r113",
      "r114"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities:",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_NetGainLossOnDispositionOfAssetsOrAssetImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "NetGainLossOnDispositionOfAssetsOrAssetImpairment",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Net loss on disposition or impairment",
        "label": "Net Gain (Loss) On Disposition Of Assets Or Asset Impairment",
        "documentation": "Net Gain (Loss) On Disposition Of Assets Or Asset Impairment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Adopted Accounting Guidance and Accounting Pronouncements Not Yet Adopted",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1094"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r1057",
      "r1068",
      "r1078",
      "r1102",
      "r1111"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1085"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1084"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r1102"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1122"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1122"
     ]
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash investing and financing activity:",
        "label": "Noncash Investing and Financing Items [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling Interest",
        "label": "Noncontrolling Interest [Member]",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r451",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1402"
     ]
    },
    "us-gaap_NotesReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NotesReceivableNet",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unsecured loan",
        "label": "Financing Receivable, after Allowance for Credit Loss",
        "documentation": "Amortized cost, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r820",
      "r1242",
      "r1365"
     ]
    },
    "jynt_NumberOfClinics": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "NumberOfClinics",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of clinics",
        "label": "Number Of Clinics",
        "documentation": "Number Of Clinics"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_NumberOfFutureOperatingLeasesCommitted": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "NumberOfFutureOperatingLeasesCommitted",
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of future operating leases committed",
        "label": "Number Of Future Operating Leases Committed",
        "documentation": "Number Of Future Operating Leases Committed"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.thejoint.com/role/SegmentReportingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r922",
      "r1236"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.thejoint.com/role/SegmentReportingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r917",
      "r925",
      "r1236"
     ]
    },
    "us-gaap_NumberOfStores": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfStores",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails",
      "http://www.thejoint.com/role/RevenueDisclosuresNarrativeDetails",
      "http://www.thejoint.com/role/SegmentReportingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Clinics open at beginning of year",
        "periodEndLabel": "Clinics in operation at the end of the year",
        "terseLabel": "Number of clinics",
        "label": "Number of Stores",
        "documentation": "Represents the number of stores."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OfficeEquipmentMember",
     "presentation": [
      "http://www.thejoint.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Office and computer equipment",
        "label": "Office Equipment [Member]",
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from continuing operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r905",
      "r909",
      "r916",
      "r1235",
      "r1237",
      "r1238",
      "r1239",
      "r1240"
     ]
    },
    "jynt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "OperatingLeaseAssetsAndLiabilitiesLesseeAbstract",
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Leases:",
        "label": "Operating Lease, Assets and Liabilities, Lessee [Abstract]",
        "documentation": "Operating Lease, Assets and Liabilities, Lessee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease costs",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r663",
      "r1003"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails",
      "http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating lease liability",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r657"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails",
      "http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails",
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liability, current portion",
        "negatedLabel": "Less: Current obligations",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r657"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails",
      "http://www.thejoint.com/role/CommitmentsandContingenciesMaturitiesofLeaseLiabilitiesDetails",
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Operating lease liability, net of current portion",
        "terseLabel": "Operating lease liability, net of current portion",
        "verboseLabel": "Long-term lease obligations",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r657"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows from operating leases",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r659",
      "r664"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails",
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use asset",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r656"
     ]
    },
    "jynt_OperatingLeaseRightOfUseAssetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "OperatingLeaseRightOfUseAssetMember",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNetLossGainonDispositionorImpairmentRelatedtoContinuingOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use asset",
        "label": "Operating Lease, Right-Of-Use Asset [Member]",
        "documentation": "Operating Lease, Right-Of-Use Asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating leases",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r667",
      "r1003"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating leases",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r666",
      "r1003"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss carryforwards",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r573"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nature of Operations and Summary of Significant Accounting Policies",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r1158",
      "r1219"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current liabilities",
        "label": "Other Liabilities, Current",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r1004"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income, net",
        "verboseLabel": "Other income, net",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r992"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r1094"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1055",
      "r1066",
      "r1076",
      "r1109"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1058",
      "r1069",
      "r1079",
      "r1112"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1058",
      "r1069",
      "r1079",
      "r1112"
     ]
    },
    "us-gaap_ParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ParentMember",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total The Joint Corp. stockholder's equity",
        "label": "Parent [Member]",
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1083"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of common stock under stock repurchase programs",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of treasury stock under employee stock plans",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r227"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1093"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1093"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1085"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r1102"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r1095"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1084"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1086"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1142"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1085"
     ]
    },
    "us-gaap_PostemploymentBenefitPlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PostemploymentBenefitPlansPolicy",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Benefit Plan",
        "label": "Postemployment Benefit Plans, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for postemployment benefits. Postemployment benefits are benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement, except for: a) benefits provided through a pension or postretirement benefit plan, b) individual deferred compensation arrangements, c) special or contractual termination benefits, and d) stock compensation plans."
       }
      }
     },
     "auth_ref": [
      "r478"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A preferred stock, par value (in dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r438"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A preferred stock, shares authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r812"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A preferred stock, shares issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r438"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A preferred stock, shares outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r812",
      "r831",
      "r1402",
      "r1403"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A preferred stock, $0.001 par value; 50,000 shares authorized, zero issued and outstanding, respectively",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r432",
      "r435",
      "r744",
      "r1004"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1161"
     ]
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of clinics",
        "label": "Proceeds from Divestiture of Businesses",
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of stock options",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r14"
     ]
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProductAndServiceOtherMember",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other revenues",
        "label": "Product and Service, Other [Member]",
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1281",
      "r1282"
     ]
    },
    "jynt_ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "ProductInformationFranchisedClinicsCompanyOwnedOrManagedClinicsActivityRollForward",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product Information, Franchised Clinics, Company-Owned Or Managed Clinics, Activity [Roll Forward]",
        "label": "Product Information, Franchised Clinics, Company-Owned Or Managed Clinics, Activity [Roll Forward]",
        "documentation": "Product Information, Franchised Clinics, Company-Owned Or Managed Clinics, Activity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProductInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProductInformationLineItems",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product Information [Line Items]",
        "label": "Product Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r195",
      "r310",
      "r694",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r896",
      "r904",
      "r907",
      "r909",
      "r938",
      "r940",
      "r1013",
      "r1014",
      "r1015",
      "r1018",
      "r1021",
      "r1149",
      "r1157",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1186",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1269",
      "r1270",
      "r1369",
      "r1370",
      "r1371",
      "r1372",
      "r1373",
      "r1374",
      "r1375",
      "r1376",
      "r1377",
      "r1378",
      "r1379",
      "r1380",
      "r1381",
      "r1382",
      "r1383",
      "r1384",
      "r1385",
      "r1386",
      "r1387",
      "r1388",
      "r1389",
      "r1390",
      "r1391",
      "r1392",
      "r1393",
      "r1394",
      "r1395",
      "r1396",
      "r1397"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]",
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r195",
      "r310",
      "r694",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r896",
      "r904",
      "r907",
      "r909",
      "r938",
      "r940",
      "r1013",
      "r1014",
      "r1015",
      "r1018",
      "r1021",
      "r1149",
      "r1157",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1186",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1269",
      "r1270",
      "r1369",
      "r1370",
      "r1371",
      "r1372",
      "r1373",
      "r1374",
      "r1375",
      "r1376",
      "r1377",
      "r1378",
      "r1379",
      "r1380",
      "r1381",
      "r1382",
      "r1383",
      "r1384",
      "r1385",
      "r1386",
      "r1387",
      "r1388",
      "r1389",
      "r1390",
      "r1391",
      "r1392",
      "r1393",
      "r1394",
      "r1395",
      "r1396",
      "r1397"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails",
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails",
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net (loss) income",
        "terseLabel": "Net income (loss)",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r205",
      "r215",
      "r216",
      "r229",
      "r235",
      "r238",
      "r239",
      "r243",
      "r250",
      "r258",
      "r261",
      "r262",
      "r320",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r430",
      "r531",
      "r590",
      "r596",
      "r597",
      "r600",
      "r601",
      "r619",
      "r644",
      "r733",
      "r735",
      "r755",
      "r795",
      "r832",
      "r852",
      "r853",
      "r990",
      "r991",
      "r1030",
      "r1172",
      "r1274"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.thejoint.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r669"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/PropertyandEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r154",
      "r158",
      "r159"
     ]
    },
    "jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "PropertyPlantAndEquipmentExcludingConstructionInProgressMember",
     "presentation": [
      "http://www.thejoint.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, excluding Construction in progress",
        "label": "Property Plant and Equipment, Excluding Construction in Progress [Member]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale, not including construction in progress."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, gross",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r209",
      "r752"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.thejoint.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r669"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentMember",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNetLossGainonDispositionorImpairmentRelatedtoContinuingOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment [Member]",
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.thejoint.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets",
      "http://www.thejoint.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r669",
      "r738",
      "r752",
      "r1004"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r154",
      "r158",
      "r750"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/PropertyandEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property and Equipment",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.thejoint.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r669"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Useful life, property and equipment",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProvisionForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesReconciliationofofAccountsReceivableAllowanceforCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision for credit losses",
        "verboseLabel": "Bad debt expense recognized during the year",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r224",
      "r330"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r1083"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1083"
     ]
    },
    "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "QuarterlyFinancialInformationDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Quarterly Financial Information Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "QuarterlyFinancialInformationTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Quarterly Financial Data (Unaudited)",
        "label": "Quarterly Financial Information [Text Block]",
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r274"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r166",
      "r168",
      "r169",
      "r171",
      "r189",
      "r191",
      "r192",
      "r196",
      "r197",
      "r280",
      "r385",
      "r386",
      "r387",
      "r388",
      "r479",
      "r491",
      "r522",
      "r523",
      "r524",
      "r530",
      "r542",
      "r624",
      "r683",
      "r687",
      "r689",
      "r777",
      "r778",
      "r784",
      "r802",
      "r803",
      "r862",
      "r864",
      "r866",
      "r867",
      "r869",
      "r873",
      "r874",
      "r876",
      "r877",
      "r891",
      "r892",
      "r926",
      "r936",
      "r954",
      "r960",
      "r961",
      "r962",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1014",
      "r1024",
      "r1265",
      "r1278",
      "r1340",
      "r1355",
      "r1356",
      "r1357",
      "r1358",
      "r1359"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeMember",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r166",
      "r168",
      "r169",
      "r171",
      "r189",
      "r191",
      "r192",
      "r196",
      "r197",
      "r280",
      "r385",
      "r386",
      "r387",
      "r388",
      "r479",
      "r491",
      "r522",
      "r523",
      "r524",
      "r530",
      "r542",
      "r624",
      "r683",
      "r687",
      "r689",
      "r777",
      "r778",
      "r784",
      "r802",
      "r803",
      "r862",
      "r864",
      "r866",
      "r867",
      "r869",
      "r873",
      "r874",
      "r876",
      "r877",
      "r891",
      "r892",
      "r926",
      "r936",
      "r954",
      "r960",
      "r961",
      "r962",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1014",
      "r1024",
      "r1265",
      "r1278",
      "r1340",
      "r1355",
      "r1356",
      "r1357",
      "r1358",
      "r1359"
     ]
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesUncertainTaxPositionRollforwardDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized Tax Benefits [Roll Forward]",
        "label": "Unrecognized Tax Benefits [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1050",
      "r1061",
      "r1071",
      "r1104"
     ]
    },
    "jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty sales generated by franchises percentage",
        "label": "Regional Developers, Royalty Sales Generated By Franchises, Percentage",
        "documentation": "Represents the percentage of sales generated by franchised clinics in their region regional developers receive as royalties."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related and Nonrelated Parties [Domain]",
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r242",
      "r243",
      "r315",
      "r486",
      "r490",
      "r675",
      "r676",
      "r742",
      "r749",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r830",
      "r861",
      "r1401"
     ]
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of related party transaction",
        "label": "Related Party Transaction, Amounts of Transaction",
        "documentation": "Amount of transactions with related party during the financial reporting period."
       }
      }
     },
     "auth_ref": [
      "r675"
     ]
    },
    "jynt_RelatedPartyTransactionAmountsOfTransactionDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "RelatedPartyTransactionAmountsOfTransactionDiscount",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount per the franchise disclosure document",
        "label": "Related Party Transaction, Amounts Of Transaction, Discount",
        "documentation": "Related Party Transaction, Amounts Of Transaction, Discount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Axis]",
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r242",
      "r243",
      "r675",
      "r676",
      "r1351"
     ]
    },
    "jynt_RelatedPartyTransactionCoPartnerPercentage": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "RelatedPartyTransactionCoPartnerPercentage",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Co-partner percentage",
        "label": "Related Party Transaction, Co-Partner Percentage",
        "documentation": "Related Party Transaction, Co-Partner Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_RelatedPartyTransactionCoPartnerPercentageDivested": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "RelatedPartyTransactionCoPartnerPercentageDivested",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Co-partner percentage divested",
        "label": "Related Party Transaction, Co-Partner Percentage, Divested",
        "documentation": "Related Party Transaction, Co-Partner Percentage, Divested"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Domain]",
        "label": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r242",
      "r243",
      "r1351"
     ]
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Line Items]",
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r242",
      "r243",
      "r315",
      "r675",
      "r676",
      "r677",
      "r835",
      "r836",
      "r839"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related and Nonrelated Parties [Axis]",
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r242",
      "r243",
      "r315",
      "r486",
      "r490",
      "r675",
      "r676",
      "r742",
      "r749",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r830",
      "r861",
      "r1351",
      "r1401"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transactions",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r672",
      "r673",
      "r674",
      "r676",
      "r678",
      "r791",
      "r792",
      "r793",
      "r837",
      "r838",
      "r839",
      "r858",
      "r860"
     ]
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RepaymentsOfNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayment of Debt under the Credit Agreement",
        "label": "Repayments of Notes Payable",
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]",
        "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r194",
      "r235",
      "r244",
      "r245",
      "r405",
      "r440",
      "r677",
      "r688",
      "r740",
      "r900",
      "r901",
      "r902",
      "r1163",
      "r1164",
      "r1165",
      "r1166",
      "r1167",
      "r1168",
      "r1169",
      "r1170",
      "r1171",
      "r1331",
      "r1332",
      "r1333",
      "r1334"
     ]
    },
    "us-gaap_ResearchMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchMember",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research Tax Credit Carryforward",
        "label": "Research Tax Credit Carryforward [Member]",
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes."
       }
      }
     },
     "auth_ref": [
      "r1322"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1051",
      "r1062",
      "r1072",
      "r1105"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r1052",
      "r1063",
      "r1073",
      "r1106"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1059",
      "r1070",
      "r1080",
      "r1113"
     ]
    },
    "us-gaap_RestrictedCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCash",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r1159",
      "r1218",
      "r1360",
      "r1364"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash and Cash Equivalent, Current",
        "documentation": "Amount of cash and cash equivalent restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r208",
      "r234"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Domain]",
        "label": "Cash and Cash Equivalents [Domain]",
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r208"
     ]
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.thejoint.com/role/StockBasedCompensationRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unvested restricted stock",
        "label": "Restricted Stock [Member]",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r1234",
      "r1285",
      "r1286",
      "r1287",
      "r1288",
      "r1289",
      "r1290",
      "r1291",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1297",
      "r1298",
      "r1299",
      "r1300",
      "r1301",
      "r1302",
      "r1303",
      "r1304",
      "r1305",
      "r1306",
      "r1307",
      "r1308",
      "r1309",
      "r1310",
      "r1311"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r129",
      "r746",
      "r782",
      "r783",
      "r789",
      "r813",
      "r1004"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r200",
      "r201",
      "r247",
      "r248",
      "r249",
      "r251",
      "r258",
      "r260",
      "r262",
      "r321",
      "r322",
      "r370",
      "r429",
      "r531",
      "r576",
      "r577",
      "r587",
      "r588",
      "r589",
      "r591",
      "r595",
      "r596",
      "r606",
      "r608",
      "r609",
      "r611",
      "r617",
      "r653",
      "r655",
      "r779",
      "r781",
      "r796",
      "r1402"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails",
      "http://www.thejoint.com/role/RevenueDisclosuresDisaggregationofRevenueDetails",
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total revenues",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r146",
      "r273",
      "r286",
      "r287",
      "r301",
      "r307",
      "r310",
      "r312",
      "r314",
      "r472",
      "r473",
      "r474",
      "r694"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r894"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosures"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Disclosures",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r455",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r474",
      "r477"
     ]
    },
    "jynt_RevenueRecognitionFranchiseAgreementTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "RevenueRecognitionFranchiseAgreementTerm",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Franchise agreement term",
        "label": "Revenue Recognition, Franchise Agreement, Term",
        "documentation": "Revenue Recognition, Franchise Agreement, Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueRemainingPerformanceObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosuresEstimatedRevenueRelatedtoPerformanceObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue expected to be recognized, amount",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosuresEstimatedRevenueRelatedtoPerformanceObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue expected to be recognized, period",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosuresEstimatedRevenueRelatedtoPerformanceObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosuresTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Estimated Revenue Related to Performance Obligations",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]",
        "documentation": "Tabular disclosure of expected timing for satisfying remaining performance obligation."
       }
      }
     },
     "auth_ref": [
      "r1148"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/DivestituresKeyComponentsofNetLossIncomefromDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues:",
        "verboseLabel": "Revenues:",
        "label": "Revenues [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevolvingCreditFacilityMember",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving Credit Facility",
        "label": "Revolving Credit Facility [Member]",
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount."
       }
      }
     },
     "auth_ref": []
    },
    "jynt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract",
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash transactions: ROU assets obtained in exchange for lease liabilities",
        "label": "Right-of-Use Asset Obtained in Exchange for Lease Liability [Abstract]",
        "documentation": "Right-of-Use Asset Obtained in Exchange for Lease Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r665",
      "r1003"
     ]
    },
    "us-gaap_RoyaltyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RoyaltyMember",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty fees",
        "label": "Royalty [Member]",
        "documentation": "Money for usage-based right to asset."
       }
      }
     },
     "auth_ref": [
      "r1281",
      "r1282"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1122"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1122"
     ]
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosuresTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Rollforward of Accounts Receivable",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r99"
     ]
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash Paid For Income Taxes (Net of Refunds Received)",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Income Tax Expense",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r1324"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1320"
     ]
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/DivestituresTables",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Impairment Losses and Disposal Gains and Losses Recorded in (Loss) Income from Discontinued Operations",
        "terseLabel": "Schedule of Discontinued Operations",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r15",
      "r17",
      "r56",
      "r66",
      "r67",
      "r68",
      "r69",
      "r70",
      "r75",
      "r77",
      "r78",
      "r122",
      "r1259",
      "r1260"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Earnings (Loss) per Common Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1233"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Effective Income Tax Reconciliation",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r552",
      "r959",
      "r1316"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Axis]",
        "label": "Investment, Name [Axis]",
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r317",
      "r318",
      "r319",
      "r586",
      "r644",
      "r1145",
      "r1146",
      "r1147",
      "r1327",
      "r1328",
      "r1329",
      "r1330"
     ]
    },
    "us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfFranchisorDisclosureTableTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Franchisor Disclosure",
        "label": "Schedule of Franchisor Disclosure [Table Text Block]",
        "documentation": "Tabular disclosure of franchisors that are included in the discussion of the nature of an entity's operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNetLossGainonDispositionorImpairmentRelatedtoContinuingOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impaired Long-Lived Asset, Held and Used [Table]",
        "label": "Impaired Long-Lived Asset, Held and Used [Table]",
        "documentation": "Disclosure of information about impairment of long-lived asset held and used. Includes, but is not limited to, description of impaired long-lived asset, facts and circumstances leading to impairment, amount of impairment loss, income statement caption that includes impairment loss, method of fair value determination, and segment in which impaired long-lived asset is reported."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Loss From Continuing Operations Before the Provision for Income Taxes",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r1221",
      "r1226"
     ]
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfProductInformationTable",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesClinicsinOperationUnderFranchiseAgreementsorCompanyOwnedorManagedDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nature of Operation, Product Information, Concentration of Risk [Table]",
        "label": "Nature of Operation, Product Information, Concentration of Risk [Table]",
        "documentation": "Disclosure of information about concentration risk of product within nature of operation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.thejoint.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r669"
     ]
    },
    "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Quarterly Financial Data",
        "label": "Quarterly Financial Information [Table Text Block]",
        "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data."
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Table]",
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r242",
      "r243",
      "r675",
      "r676",
      "r677",
      "r835",
      "r836",
      "r839"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.thejoint.com/role/SegmentReportingNarrativeDetails",
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r30"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/SegmentReportingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Total Revenue and Significant Expense Categories",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r30"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.thejoint.com/role/StockBasedCompensationRestrictedStockActivityDetails",
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails",
      "http://www.thejoint.com/role/StockBasedCompensationValuationAssumptionsusedforStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r493",
      "r495",
      "r497",
      "r498",
      "r499",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r530"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Options Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r13",
      "r130"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Valuation Assumptions used for Stock Options",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restricted Stock Activity",
        "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": [
      "r1296"
     ]
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Uncertain Tax Position Rollforward",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r560",
      "r958"
     ]
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEAssetsandLiabilitiesDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Variable Interest Entities [Table]",
        "label": "Variable Interest Entity [Table]",
        "documentation": "Disclosure of information about variable interest held, whether or not such variable interest entity (VIE) is included in consolidated financial statements."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r47",
      "r49",
      "r51",
      "r52",
      "r598",
      "r599",
      "r603",
      "r604",
      "r684",
      "r685",
      "r686"
     ]
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfVariableInterestEntitiesTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Variable Interest Entities",
        "label": "Schedule of Variable Interest Entities [Table Text Block]",
        "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r47",
      "r49",
      "r51",
      "r52"
     ]
    },
    "us-gaap_SecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SecuredDebtMember",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Secured Debt",
        "label": "Secured Debt [Member]",
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SecuredOvernightFinancingRateSofrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SecuredOvernightFinancingRateSofrMember",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SOFR",
        "label": "Secured Overnight Financing Rate (SOFR) [Member]",
        "documentation": "Interest rate at which bank can borrow U.S. dollar overnight while posting U.S. Treasury bond as collateral."
       }
      }
     },
     "auth_ref": [
      "r1335"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1032"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r1035"
     ]
    },
    "us-gaap_SegmentDiscontinuedOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentDiscontinuedOperationsMember",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesImpairmentLossesandDisposalGainsandLossesRecordedinLossIncomefromDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discontinued Operations",
        "label": "Discontinued Operations [Member]",
        "documentation": "Component or group of components representing strategic shift that has or will have major effect on operation and financial result, classified as held-for-sale or disposed of by sale or by means other than sale, and business and nonprofit activity on acquisition and upon joint venture formation, classified as held-for-sale."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r57",
      "r58",
      "r60"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r146",
      "r147",
      "r148",
      "r273",
      "r282",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r307",
      "r308",
      "r309",
      "r314",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r368",
      "r380",
      "r381",
      "r592",
      "r593",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r918",
      "r921",
      "r922",
      "r928",
      "r1017",
      "r1369",
      "r1370",
      "r1371",
      "r1372",
      "r1373",
      "r1374",
      "r1375",
      "r1376",
      "r1377",
      "r1378",
      "r1379",
      "r1380",
      "r1381",
      "r1382",
      "r1383",
      "r1384",
      "r1385",
      "r1386",
      "r1387",
      "r1388",
      "r1389",
      "r1390",
      "r1391",
      "r1392",
      "r1393",
      "r1394",
      "r1395",
      "r1396",
      "r1397"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]",
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r167",
      "r170",
      "r172",
      "r179",
      "r180",
      "r181",
      "r182",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r191",
      "r192",
      "r277",
      "r312",
      "r313",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r733",
      "r734",
      "r735",
      "r736",
      "r799",
      "r800",
      "r801",
      "r863",
      "r865",
      "r868",
      "r870",
      "r873",
      "r875",
      "r876",
      "r877",
      "r881",
      "r882",
      "r883",
      "r884",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r897",
      "r913",
      "r938",
      "r941",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1016",
      "r1024",
      "r1369",
      "r1370",
      "r1371",
      "r1373",
      "r1374",
      "r1375",
      "r1376",
      "r1377",
      "r1378",
      "r1379",
      "r1380",
      "r1381",
      "r1382",
      "r1383",
      "r1384",
      "r1385",
      "r1386",
      "r1387",
      "r1388",
      "r1389",
      "r1390",
      "r1391",
      "r1392",
      "r1393",
      "r1394",
      "r1395",
      "r1396",
      "r1397"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/SegmentReporting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r273",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r297",
      "r299",
      "r300",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r314",
      "r917",
      "r919",
      "r920",
      "r921",
      "r923",
      "r924",
      "r925"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.thejoint.com/role/SegmentReportingNarrativeDetails",
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingInformationProfitLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingInformationProfitLossAbstract",
     "presentation": [
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of loss",
        "label": "Segment Reporting Information, Profit (Loss) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingOtherItemAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingOtherItemAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other segment items, net",
        "label": "Segment Reporting, Other Segment Item, Amount",
        "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)."
       }
      }
     },
     "auth_ref": [
      "r273",
      "r299",
      "r300",
      "r307",
      "r921"
     ]
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "us-gaap_SellingGeneralAndAdministrativeExpense",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails",
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling and marketing expenses",
        "netLabel": "Selling and marketing expenses",
        "verboseLabel": "Selling and marketing expenses",
        "label": "Selling and Marketing Expense",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/QuarterlyFinancialDataUnauditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total selling, general and administrative expenses",
        "label": "Selling, General and Administrative Expense",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r904",
      "r905",
      "r906",
      "r909",
      "r1210"
     ]
    },
    "jynt_SeniorSecuredCreditFacilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "SeniorSecuredCreditFacilitiesMember",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facilities",
        "label": "Senior Secured Credit Facilities [Member]",
        "documentation": "Senior Secured Credit Facilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cancelled (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cancelled (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r512"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r512"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Non-vested (in shares)",
        "periodEndLabel": "Non-vested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r509",
      "r510"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Non-vested (in dollar per share)",
        "periodEndLabel": "Non-vested (in dollar per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r509",
      "r510"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Grant-Date Fair Value per Award",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Vested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r513"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r513"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationValuationAssumptionsusedforStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationValuationAssumptionsusedforStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r524"
     ]
    },
    "jynt_ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forecasted turnover percentage",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Forfeitures, Historical And Forecasted Turnover, Percentage",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Forfeitures, Historical And Forecasted Turnover, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.thejoint.com/role/StockBasedCompensationRestrictedStockActivityDetails",
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails",
      "http://www.thejoint.com/role/StockBasedCompensationValuationAssumptionsusedforStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r493",
      "r495",
      "r497",
      "r498",
      "r499",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r530"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock available for issuance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Remaining Contractual Life",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable, number of shares (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r503"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable, weighted average exercise price (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r503"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised, aggregate intrinsic value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r516"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Expired (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements."
       }
      }
     },
     "auth_ref": [
      "r508"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cancelled (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r507"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Options granted (in shares)",
        "terseLabel": "Granted at market price (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r505"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average grant-date fair value for options granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r515"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding, beginning (in shares)",
        "periodEndLabel": "Outstanding, ending (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r501",
      "r502"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding, weighted average exercise price, beginning (in dollars per share)",
        "periodEndLabel": "Outstanding, weighted average exercise price, ending (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r501",
      "r502"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable, aggregate intrinsic value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest, aggregate intrinsic value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r517"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest , weighted average exercise price (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r517"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.thejoint.com/role/StockBasedCompensationRestrictedStockActivityDetails",
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails",
      "http://www.thejoint.com/role/StockBasedCompensationValuationAssumptionsusedforStockOptionsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Award [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r498",
      "r499",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised, weighted average exercise price (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r506"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expired, weighted average exercise price (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired."
       }
      }
     },
     "auth_ref": [
      "r508"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cancelled, weighted average exercise price (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r507"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted at market price, weighted average exercise price (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r505"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r492",
      "r500",
      "r519",
      "r520",
      "r521",
      "r522",
      "r525",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540"
     ]
    },
    "jynt_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of equal annual installments",
        "label": "Share-based Payment Arrangement, Equity Instruments Other than Options, Vesting, Number of Annual Installments",
        "documentation": "Share-based Payment Arrangement, Equity Instruments Other than Options, Vesting, Number of Annual Installments"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_ShareRepurchaseProgramAdditionalAuthorizedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "ShareRepurchaseProgramAdditionalAuthorizedAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share repurchase additional authorized amount",
        "label": "Share Repurchase Program, Additional Authorized, Amount",
        "documentation": "Share Repurchase Program, Additional Authorized, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Intrinsic Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding, aggregate intrinsic value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding",
        "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r1313"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contractual term",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r956"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationValuationAssumptionsusedforStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term (years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable, weighted average remaining contractual life (in year)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding, weighted average remaining contractual life (in year)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest , weighted average remaining contractual life (in year)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r517"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of stock options vested",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value",
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock."
       }
      }
     },
     "auth_ref": [
      "r516"
     ]
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchases of treasury stock under employee stock plans (in shares)",
        "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1314"
     ]
    },
    "us-gaap_SignificantChangesFranchisesSold": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SignificantChangesFranchisesSold",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of franchises",
        "label": "Significant Changes, Franchises Sold",
        "documentation": "The number of franchises sold during the period when there are significant changes in franchisor-owned outlets or franchised outlets during the period."
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SoftwareDevelopmentMember",
     "presentation": [
      "http://www.thejoint.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Internally developed software",
        "label": "Software Development [Member]",
        "documentation": "Internally developed software for sale, licensing or long-term internal use."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and Local Jurisdiction",
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r550"
     ]
    },
    "us-gaap_StateAndLocalTaxJurisdictionOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StateAndLocalTaxJurisdictionOtherMember",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other state jurisdictions",
        "label": "State and Local Tax Jurisdiction, Other [Member]",
        "documentation": "Designated state and local jurisdiction entitled to levy and collect income tax in country of domicile, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1217",
      "r1321"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r146",
      "r147",
      "r148",
      "r202",
      "r273",
      "r282",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r307",
      "r308",
      "r309",
      "r314",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r368",
      "r372",
      "r380",
      "r381",
      "r592",
      "r593",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r918",
      "r921",
      "r922",
      "r928",
      "r1017",
      "r1369",
      "r1370",
      "r1371",
      "r1372",
      "r1373",
      "r1374",
      "r1375",
      "r1376",
      "r1377",
      "r1378",
      "r1379",
      "r1380",
      "r1381",
      "r1382",
      "r1383",
      "r1384",
      "r1385",
      "r1386",
      "r1387",
      "r1388",
      "r1389",
      "r1390",
      "r1391",
      "r1392",
      "r1393",
      "r1394",
      "r1395",
      "r1396",
      "r1397"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r92",
      "r96",
      "r97",
      "r198",
      "r200",
      "r201",
      "r218",
      "r219",
      "r220",
      "r247",
      "r248",
      "r249",
      "r251",
      "r258",
      "r260",
      "r262",
      "r275",
      "r321",
      "r322",
      "r370",
      "r429",
      "r451",
      "r531",
      "r576",
      "r577",
      "r587",
      "r588",
      "r589",
      "r591",
      "r595",
      "r596",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r617",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r653",
      "r655",
      "r671",
      "r756",
      "r779",
      "r780",
      "r781",
      "r796",
      "r854"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r167",
      "r170",
      "r172",
      "r179",
      "r180",
      "r181",
      "r182",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r191",
      "r192",
      "r277",
      "r312",
      "r313",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r733",
      "r734",
      "r735",
      "r736",
      "r799",
      "r800",
      "r801",
      "r863",
      "r865",
      "r868",
      "r870",
      "r873",
      "r875",
      "r876",
      "r877",
      "r881",
      "r882",
      "r883",
      "r884",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r897",
      "r913",
      "r938",
      "r941",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1016",
      "r1024",
      "r1369",
      "r1370",
      "r1371",
      "r1373",
      "r1374",
      "r1375",
      "r1376",
      "r1377",
      "r1378",
      "r1379",
      "r1380",
      "r1381",
      "r1382",
      "r1383",
      "r1384",
      "r1385",
      "r1386",
      "r1387",
      "r1388",
      "r1389",
      "r1390",
      "r1391",
      "r1392",
      "r1393",
      "r1394",
      "r1395",
      "r1396",
      "r1397"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r275",
      "r431",
      "r432",
      "r433",
      "r434",
      "r655",
      "r694",
      "r787",
      "r797",
      "r798",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r812",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r821",
      "r822",
      "r823",
      "r824",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r833",
      "r834",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r854",
      "r907",
      "r909",
      "r1025",
      "r1401"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r275",
      "r315",
      "r431",
      "r432",
      "r433",
      "r434",
      "r655",
      "r694",
      "r787",
      "r797",
      "r798",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r812",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r821",
      "r822",
      "r823",
      "r824",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r833",
      "r834",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r854",
      "r907",
      "r909",
      "r1025",
      "r1401"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1054",
      "r1065",
      "r1075",
      "r1108"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": [
      "r1285",
      "r1286",
      "r1287",
      "r1288",
      "r1289",
      "r1290",
      "r1291",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1297",
      "r1298",
      "r1299",
      "r1300",
      "r1301",
      "r1302",
      "r1303",
      "r1304",
      "r1305",
      "r1306",
      "r1307",
      "r1308",
      "r1309",
      "r1310",
      "r1311"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of restricted stock (in shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r91",
      "r92",
      "r129"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.thejoint.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of stock options (in shares)",
        "negatedTerseLabel": "Exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r91",
      "r92",
      "r129",
      "r506"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of restricted stock",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r129"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of stock options",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r92",
      "r96",
      "r97",
      "r129"
     ]
    },
    "jynt_StockOptionExerciseReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "StockOptionExerciseReceivable",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock option exercise receivable",
        "label": "Stock Option Exercise Receivable",
        "documentation": "Stock Option Exercise Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase amount authorized",
        "label": "Share Repurchase Program, Authorized, Amount",
        "documentation": "Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": [
      "r1279"
     ]
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Authorized amount remaining for repurchasing shares",
        "label": "Share Repurchase Program, Remaining Authorized, Amount",
        "documentation": "Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total The Joint Corp. stockholders\u2019 equity",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r96",
      "r97",
      "r116",
      "r814",
      "r831",
      "r855",
      "r856",
      "r1004",
      "r1031",
      "r1221",
      "r1224",
      "r1225",
      "r1246",
      "r1344",
      "r1402"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders\u2019 equity:",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets",
      "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total equity",
        "periodStartLabel": "Balance, beginning",
        "periodEndLabel": "Balance, ending",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r44",
      "r53",
      "r198",
      "r199",
      "r200",
      "r201",
      "r219",
      "r247",
      "r248",
      "r249",
      "r251",
      "r258",
      "r260",
      "r321",
      "r322",
      "r370",
      "r429",
      "r451",
      "r531",
      "r576",
      "r577",
      "r587",
      "r588",
      "r589",
      "r591",
      "r595",
      "r596",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r617",
      "r645",
      "r646",
      "r650",
      "r654",
      "r671",
      "r780",
      "r781",
      "r794",
      "r814",
      "r831",
      "r855",
      "r856",
      "r871",
      "r1019",
      "r1020",
      "r1030",
      "r1221",
      "r1224",
      "r1225",
      "r1246",
      "r1344",
      "r1402"
     ]
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.thejoint.com/role/StockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders' Equity",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r437",
      "r439",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r605",
      "r616",
      "r857",
      "r859",
      "r872"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental cash flow disclosures:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_SupplementalCashFlowNetCashPaidAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "SupplementalCashFlowNetCashPaidAbstract",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net cash paid for:",
        "label": "Supplemental Cash Flow, Net Cash Paid [Abstract]",
        "documentation": "Supplement Of Net Cash Paid"
       }
      }
     },
     "auth_ref": []
    },
    "stpr_TX": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2025",
     "localname": "TX",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesCashPaidForIncomeTaxesNetofRefundsReceivedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Texas",
        "label": "TEXAS"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1101"
     ]
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TaxCreditCarryforwardAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credits",
        "label": "Tax Credit Carryforward, Amount",
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r573"
     ]
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TaxCreditCarryforwardAxis",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Credit Carryforward [Axis]",
        "label": "Tax Credit Carryforward [Axis]",
        "documentation": "Information by specific tax credit related to an unused tax credit."
       }
      }
     },
     "auth_ref": [
      "r573"
     ]
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TaxCreditCarryforwardNameDomain",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Credit Carryforward, Name [Domain]",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "documentation": "The name of the tax credit carryforward."
       }
      }
     },
     "auth_ref": [
      "r573"
     ]
    },
    "us-gaap_TechnologyServiceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TechnologyServiceMember",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/SegmentReportingTotalRevenueandSignificantExpenseCategoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Software fees",
        "label": "Technology Service [Member]",
        "documentation": "Technology assistance, including but not limited to, training, installation, engineering, and software design."
       }
      }
     },
     "auth_ref": [
      "r1281",
      "r1282"
     ]
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosuresDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Timing of Transfer of Good or Service [Axis]",
        "label": "Timing of Transfer of Good or Service [Axis]",
        "documentation": "Information by timing of transfer of good or service to customer."
       }
      }
     },
     "auth_ref": [
      "r474",
      "r938",
      "r945"
     ]
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosuresDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Timing of Transfer of Good or Service [Domain]",
        "label": "Timing of Transfer of Good or Service [Domain]",
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time."
       }
      }
     },
     "auth_ref": [
      "r474",
      "r938",
      "r945"
     ]
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title and Position [Axis]",
        "label": "Title and Position [Axis]",
        "documentation": "Information by title and position of individual or group within organization."
       }
      }
     },
     "auth_ref": [
      "r1241",
      "r1350"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.thejoint.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title and Position [Domain]",
        "label": "Title and Position [Domain]",
        "documentation": "Title and position of individual or group within organization."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1093"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1100"
     ]
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable",
        "label": "Accounts Receivable [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r1243",
      "r1244",
      "r1245"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1121"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r1123"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.thejoint.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransferredAtPointInTimeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TransferredAtPointInTimeMember",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosuresDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognized at a point in time",
        "label": "Transferred at Point in Time [Member]",
        "documentation": "Contract with customer in which good or service is transferred at point in time."
       }
      }
     },
     "auth_ref": [
      "r938",
      "r939",
      "r945"
     ]
    },
    "us-gaap_TransferredOverTimeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TransferredOverTimeMember",
     "presentation": [
      "http://www.thejoint.com/role/RevenueDisclosuresDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognized over time",
        "label": "Transferred over Time [Member]",
        "documentation": "Contract with customer in which good or service is transferred over time."
       }
      }
     },
     "auth_ref": [
      "r938",
      "r939",
      "r945"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r1125"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r1125"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1123"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r1123"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r1126"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "presentation": [
      "http://www.thejoint.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Average cost of stock repurchased (in dollars per share)",
        "label": "Shares Acquired, Average Cost Per Share",
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury Stock",
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock, shares (in shares)",
        "periodStartLabel": "Balance, beginning treasury stock (in shares)",
        "periodEndLabel": "Balance, ending treasury stock (in shares)",
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_TreasuryStockCommonValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TreasuryStockCommonValue",
     "crdr": "debit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury stock 1,329,089 shares and 33,015 shares, at cost, respectively",
        "label": "Treasury Stock, Common, Value",
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r40",
      "r96"
     ]
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TreasuryStockSharesAcquired",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock repurchased under authorized stock repurchase programs (in shares)",
        "label": "Treasury Stock, Shares, Acquired",
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r92",
      "r129"
     ]
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.thejoint.com/role/StockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Common stock repurchased under authorized stock repurchase programs",
        "terseLabel": "Common stock repurchased",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r39",
      "r129"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "US",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_UnaffiliatedFranchiseeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "UnaffiliatedFranchiseeMember",
     "presentation": [
      "http://www.thejoint.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unaffiliated Franchisee",
        "label": "Unaffiliated Franchisee [Member]",
        "documentation": "Unaffiliated Franchisee"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r1120"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails",
      "http://www.thejoint.com/role/IncomeTaxesUncertainTaxPositionRollforwardDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Uncertain tax positions",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Unrecognized Tax Benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r545",
      "r560",
      "r958"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "crdr": "debit",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesUncertainTaxPositionRollforwardDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Reductions for expiration of the statute of limitations",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations."
       }
      }
     },
     "auth_ref": [
      "r561"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax benefits that if recognized would affect the annual effective tax rate",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate."
       }
      }
     },
     "auth_ref": [
      "r562",
      "r958"
     ]
    },
    "jynt_UpfrontRegionalDeveloperFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "UpfrontRegionalDeveloperFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Upfront regional developer fees, current portion",
        "label": "Upfront Regional Developer Fees, Current",
        "documentation": "Upfront Regional Developer Fees, Current"
       }
      }
     },
     "auth_ref": []
    },
    "jynt_UpfrontRegionalDeveloperFeesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "UpfrontRegionalDeveloperFeesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Upfront regional developer fees, net of current portion",
        "label": "Upfront Regional Developer Fees, Noncurrent",
        "documentation": "Upfront Regional Developer Fees, Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r153",
      "r276",
      "r278",
      "r279",
      "r280",
      "r733",
      "r735",
      "r914"
     ]
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.thejoint.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Deferred tax assets, valuation allowance decrease",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r565"
     ]
    },
    "us-gaap_ValuationTechniqueAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationTechniqueAxis",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation Approach and Technique [Axis]",
        "label": "Valuation Approach and Technique [Axis]",
        "documentation": "Information by valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r622",
      "r623",
      "r960",
      "r962",
      "r997",
      "r1341"
     ]
    },
    "us-gaap_ValuationTechniqueDiscountedCashFlowMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationTechniqueDiscountedCashFlowMember",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation Technique, Discounted Cash Flow",
        "label": "Valuation Technique, Discounted Cash Flow [Member]",
        "documentation": "Valuation technique calculating present value of future cash flows."
       }
      }
     },
     "auth_ref": [
      "r927",
      "r928",
      "r997",
      "r1339",
      "r1340",
      "r1341"
     ]
    },
    "us-gaap_ValuationTechniqueDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationTechniqueDomain",
     "presentation": [
      "http://www.thejoint.com/role/FairValueConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation Approach and Technique [Domain]",
        "label": "Valuation Approach and Technique [Domain]",
        "documentation": "Valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r622",
      "r623",
      "r960",
      "r962",
      "r997",
      "r1341"
     ]
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VariableInterestEntityLineItems",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEAssetsandLiabilitiesDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity [Line Items]",
        "label": "Variable Interest Entity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r598",
      "r599",
      "r603",
      "r604",
      "r684",
      "r685",
      "r686"
     ]
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.thejoint.com/role/DivestituresAssetsandLiabilitiesofDiscontinuedOperationsDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEAssetsandLiabilitiesDetails",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesVIEIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity, Primary Beneficiary",
        "verboseLabel": "Variable Interest Entity",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r598",
      "r599",
      "r603",
      "r604"
     ]
    },
    "us-gaap_VariableRateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VariableRateAxis",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Axis]",
        "label": "Variable Rate [Axis]",
        "documentation": "Information by type of variable rate."
       }
      }
     },
     "auth_ref": [
      "r1162",
      "r1272",
      "r1335"
     ]
    },
    "us-gaap_VariableRateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VariableRateDomain",
     "presentation": [
      "http://www.thejoint.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Domain]",
        "label": "Variable Rate [Domain]",
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "auth_ref": [
      "r1162",
      "r1272",
      "r1335"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1089"
     ]
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "calculation": {
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unvested restricted stock and stock options (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation."
       }
      }
     },
     "auth_ref": [
      "r1233"
     ]
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "presentation": [
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of dilutive securities:",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted weighted average shares outstanding (in shares)",
        "totalLabel": "Weighted average common shares outstanding - diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r264",
      "r269"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.thejoint.com/role/ConsolidatedIncomeStatements",
      "http://www.thejoint.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic weighted average shares outstanding (in shares)",
        "verboseLabel": "Weighted average common shares outstanding - basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r263",
      "r269"
     ]
    },
    "jynt_WeightedAverageRemainingLeaseTermAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.thejoint.com/20251231",
     "localname": "WeightedAverageRemainingLeaseTermAbstract",
     "presentation": [
      "http://www.thejoint.com/role/CommitmentsandContingenciesLeaseExpenseandSupplementalLeaseInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining lease term (in years):",
        "label": "Weighted Average Remaining Lease Term [Abstract]",
        "documentation": "Weighted Average Remaining Lease Term"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r1087"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-10"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1B"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1B"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1D",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1D"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-3"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "S99",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480781/205-20-S99-3"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "460",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Paragraph": "2AA",
   "Subparagraph": "(a)",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-2AA"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-4"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-4"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-5A"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-5A"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-6"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-9"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205-20/tableOfContent"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-11"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1A"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1B"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1B"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1C"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3A"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3B"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-4"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-3A"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4A"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4B"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5A"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5D"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "270",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/270/tableOfContent"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-9"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3A"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "35",
   "Topic": "720",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(1)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column C",
   "Footnote": "5",
   "Publisher": "SEC"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column C",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(a)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column C",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column F",
   "Footnote": "7",
   "Publisher": "SEC"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column A",
   "Publisher": "SEC"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "3",
   "Publisher": "SEC"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "4",
   "Subsection": "08",
   "Paragraph": "m",
   "Subparagraph": "(1)(iii)",
   "Publisher": "SEC"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "4",
   "Subsection": "08",
   "Paragraph": "m",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "L",
   "Publisher": "SEC"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 4",
   "Publisher": "SEC"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1B"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-6"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479391/326-20-30-4A"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479391/326-20-30-5A"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479366/326-20-35-8A"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-5"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-17"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-21"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-3C"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-3D"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.M.2.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483530/326-20-S99-1"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479175/326-30-30-1B"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "13A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479148/326-30-35-13A"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479148/326-30-35-7A"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-3A"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-3C"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-3D"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-2"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-6"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-40/tableOfContent"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3A"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3A"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-3"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-11"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-7"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "712",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/712/tableOfContent"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479983/718-10-S45-1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-2"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-3"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-4"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-5"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10A"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.1.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477349/740-270-45-3"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2AG",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-2AG"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481435/852-10-45-14"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-4"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-1"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "952",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482948/952-10-50-1"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "450",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477850/954-450-50-1"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-12"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-24"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-18"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-6"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "64",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-7"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483385/720-35-55-1"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "43",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-29"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-29"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(1)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "6",
   "Subsection": "04",
   "Paragraph": "12",
   "Subparagraph": "(b)(1)",
   "Publisher": "SEC"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-12"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(r)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1203": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(s)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1204": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(t)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1205": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(u)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1206": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-30"
  },
  "r1207": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-31"
  },
  "r1208": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-32"
  },
  "r1209": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-33"
  },
  "r1210": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1211": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1212": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1213": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1214": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1215": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1216": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1217": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r1218": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r1219": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r1220": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r1221": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r1222": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r1223": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1224": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1225": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1226": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1227": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1228": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r1229": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1230": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1231": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1232": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1233": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1234": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1235": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1236": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r1237": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1238": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1239": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1240": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1241": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r1242": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r1243": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r1244": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r1245": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r1246": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1247": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r1248": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r1249": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r1250": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1251": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1252": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1253": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1254": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1255": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1256": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1257": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1258": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1259": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3A"
  },
  "r1260": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3A"
  },
  "r1261": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1262": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1263": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1264": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1265": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1266": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1267": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r1268": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1269": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1270": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r1271": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1272": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480190/470-10-S50-1"
  },
  "r1273": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1274": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1275": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1276": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1277": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r1278": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1279": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r1280": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r1281": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1282": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1283": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1284": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r1285": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1286": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1287": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1288": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1289": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1290": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1291": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1292": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1293": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1294": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1295": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1296": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1297": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1298": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1299": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1300": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1301": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1302": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1303": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1304": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1305": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1306": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1307": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1308": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1309": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1310": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1311": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1312": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1313": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1314": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-4"
  },
  "r1315": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479176/718-740-35-2"
  },
  "r1316": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1317": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1318": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r1319": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r1320": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1321": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r1322": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r1323": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1324": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1325": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1326": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r1327": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1328": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1329": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1330": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1331": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A"
  },
  "r1332": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1333": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1334": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1335": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480682/815-20-25-6A"
  },
  "r1336": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1337": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1338": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1339": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1340": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1341": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1342": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r1343": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-13"
  },
  "r1344": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1345": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1346": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r1347": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1348": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1349": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1350": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r1351": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1352": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1353": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1354": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1355": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1356": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1357": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1358": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1359": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1360": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r1361": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r1362": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r1363": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1364": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1365": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1366": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1367": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r1368": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r1369": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1370": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1371": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1372": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1373": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1374": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1375": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1376": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1377": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1378": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1379": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1380": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1381": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1382": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1383": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1384": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1385": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1386": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1387": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1388": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1389": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1390": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1391": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1392": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1393": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1394": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1395": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1396": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1397": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1398": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1399": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1400": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1401": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1402": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1403": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>97
<FILENAME>0001612630-26-000022-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001612630-26-000022-xbrl.zip
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M(AEFUR*5'^25C)*:W065-0M6>@M6>@HJ:[FZUQ:0W'KKD\<W6O1%DV26YA2
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M;(''E_E=<SQV4)_NMOL[N[VMQ\CG^T^]0'OW6" >02#]A,/8#W(,B\:GX'@
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MEQ=*TW<3) H91'L)R"A,/@55F3/@T"FQ9VOLQ?O)3\B2#==0-%,AWRXQ1ES
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MYN5044:F88T^ZKW8="KL-$N+)@*D4^L;1T<#*\O:1XGW0JI-YZR8PVV.+8;
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M-Z19'=)$&"#F8!CN(./",6D=>"!B :G$(^!O.O(9$_Q_1:*@ZN^;)DL7;41
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M')H3'!A,,2# "LD,&&+Q3PH;UN\@P@T0H!K.2O!=K!P(3#\<(!R 0[(ZB;$
MJ4;"5CH& ).^YW,U">M$2I/%P92M51%;@@JT%HPV;B*)7Q"!NX(K$@K)K257
M1\YV'V";DD"-V?BBQ@Y1ST$PV2@W5)@U$1&^]0V9O$&D0/Y<\O/'; 4WZG++
M^&&=(/IR_ED@E9^& Z!UC!,)XY;6J2U $X'W<.$3^!A(_).Q6XP+E^KP@0X6
MC^1;?+ZAXQK3\;QT4=C["AY<\$0,=0]A6[&2WK"LMS,O9#98X/TPP#]Z6)2A
M-! >X$1(VF'C^'-J8&C.[OIWF <[[J% #C)C&= XKAJ<<_/>Q+A(>FN&+^AN
M SU]-#&L#$V*ZU44EM'I,0I5"BRDBN$9REC#="4R4#+0QQJ%DY"S2ELZ>]!9
MXB+GG6Y"+KLL8UI>)XJQ%%1;;"YG[L>2K($J$\-2Y9"6%^2X[53PQN3S<(5&
MS#K4^#T$A&K*/&*<F@FM1&.<%1LMUE/ 5H )/$)0/-=H YC1;4M=8, SDDX0
MI$@[A,MBNGB+" .1QAE"?.&0"Z&;+@VD$"-3L:2JE2ND8%3N='D_+/)#7(_#
M1BG="/J&G1_"4S@@;)Y-_R K0,NH^:62R!C!8)#HN2P!8U:SA9-G,J)#4A2H
M+$D*;&L'WH\Z) =\#<.,I!=>+?EM[.OY-ESW!*+R10+V-'C+Z]9&;P4C(S'N
MMI; S#@]++!%AWZ*.32!J<Y.2Q=C63R>&U,P>Q("&)I;&@_K TO'_5%X_IDL
M51Z1<=:/L+J18/03!$O),7AM<3I4," S00+V$H.]$U]Q%0N$:!ZEB"P^&:5+
M:OF1.!YN+>V4.XWEFU1F73DN%Z%A%,"*3KLX)V*B5)44=?0\:/%N85V5,-9J
M$M%C/,2#ZO,EJP^?CIIRKG$]IR$)!JI(N+PX/FIIWH ;:1"(-8H,,H L@M<U
MU,1YJ+YZFOEH] 1^Q976M1 ^4,!S:?A+^JPS ^X! SZT]PZ6HJ$D0SJA<&OQ
M#G!B/V<@I-*1B(HM(17;P-O1?_7J,U44X"-#M&:65L\[C.EFO19IT(Z2Y*N&
M)\NT3K*X)W!>]:UJ O*8*"*<%!XO@TA0Y$<.3;9'01XTNEL@"Z*0CCAPR2M9
MXH8T]QI=N;M+1;A+$'9"QI^LVDSN%#T/L6JZR2UT2>*@CC!/ZP5U>K#HK-GF
MM6QI;OD??^GN=-[JKW-EOC;\%5BT^08/6/&MN;C-KW MHT,OF2^.A%G.BLXR
MV>>LC$*,'$_I*]WFWT^.#0=_S>(,51E,4)MCX0 Y> AW90H,KMP+R^R_8]+_
MEV33Z[:\3Y^.6IPMX^NKS_1CWS2=U1/ML&9T)PSIL%A7HAK%Y766E+]Q9.K"
ML*L;<O>0O><M1S"%:^55^%H3SF#FQHK 7? J+/^&<JFDG&A1@+Z23S>U&DD4
M&HE)4[XV.;"T.M?%6^S"]L$8*4"#A+G_%EM]%5ZM?@1Y/<$8:T;*UYBK5T)@
MBRU?U-6<#%EBO*<FY19N,JB6,UV;597?@5XLG[7$G]IW8'.!%4Z*W^;?EX'E
MW# T%/#H:*5:::2DKJ)W_8XBA4XHM A:@[?I(+;A#G_F(&$%H:\-=CIK:ZY)
M)L.[6F0QE(".&1J2$ST6*E\Y/?,KI?[78+FKFH%NO:+#+X>'9TO8MT]E-QDX
M'<3S<$I(QHR'C>99'Q,*+:($W=7PZ2(C,@02.,14'U]LWGX95R<4&ML.@Y\W
MOATNV]W9:.*GF_CI[XZ?=KB6+U&$?LJ+>+FZ>79X?LG*PLFM1_2V8=X6B'3/
M0[2_X;ST[!,_N3S^['4WC:(T_^_[WR].OAQ?7-POS&K7:N'FPL%O'A&O=6M#
M&9&797TIT"CZ<:@B[8'YXVT0*JQD>1#&-&%ZZ:V^/36_1(Y#A;I]$>E-I?[X
MYX(9;7:8(64I_']@>M8_;\)/;Q:_W]_;W.\L_ZFSV:7OWU![W"8,&]?DYXW^
MQNU>JDYG;R!ZYNXZZ$UOO&[YPL>%FY_2) R"2&X\YK1IMUB)Z [1= ND)F+5
M7J"WK6]Q&5K(C3N8[(.[[-VKR],\?<I.%\Y5YUN7R7<O[?(N-?#5D_:\?(6Q
M]E[R_!,V0 H/YMC/,SQRVC&N=A0.Y1KV17MGU[ ST&^&(6K//^>[%*CUTH/
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MJL$4'M3)5$"VZL,T_!<([4QYW H5YU!<@0 ]:$X;: G P)=D:M.TY!4Z\^>
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MK0!E;"UGR(E 39HM;;-8VE*;1^+//';\==:,AR(A'0:26B/:67L&/N4W(,W
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M-=Q4G^C1X\ =1\_EZ#EK\@NRFK<=.8:(%)4E:?GIU,9HIA>AX5#$11)SU\)
MWB1Z&*.I6]&!H;EO:F9<%6*+D?CX.,SA7"O'&J"*40O.#(=XTYOCVJ)- MNB
MO5,L*^/V]80L-S,)L%DR51O4#\6BY](CDBOD:")=F2'$G0JX0H)@C3_+#5)J
M++]TR6'HX>0<%F!X^HK@3AS0\$PC\QI8<ENP'I3J*X*D9I!%&LOX623=;=::
M]&3!Y]:@':"EM^N1!Q!3F%PT9$FJX*ERR[Q/^ &#XAVBL569M>\%4R.."IFT
M4.-T_:(A_3)T<\&ZJL9K;+1";ZDE#$.5-&8ID[N*N=\:8'C+Z&QD#]<P09DV
M30N[]B[[Q@EWLV3B**>4+$@%9_$*R?@GCQ*.,[._?.Z.^?X1PY(IR4M,'*?#
M;[YEMMT#J:O:V]G;RX,B;8*0(@OCE']0 3<<'8W-1L [= EYTL@J">"K])O(
M.P4UIN?.RV*[ >]1V+T_R4- $U&NM>JV@P ML=5<',=!C2YU#\4_-C8T:2X'
M?!)9,.4SZR8FP!8A%:+BI26D5HN'8?U+) 'R.?(T+IF@P#U^\);CW\*.\%:^
MKNZ\6K-5S?;%.193AHK#AQ_H1:5:929:B+"(CQEZ"T7VJM[XA[R9%ZWUZH(T
M!B0QP5$,Q="HCR[GE18Z88G4V\$P>R4S1@=Q>2,'+<M%TP=*0,&E*>&H/O1@
M+CG/\,]^<9%C(F*$U5WZ>7;G'Y.N9!6FN469:U/W,FF66+7G=$E3'$J)J0M<
M6&94>@&OBC1140H2Z,W)"/+]/FW";/*WGLPR;T%7F67VL*+5OH<LL7U\UY]8
M/=[0808.F]+OF2OK!9^IY>3[L!JG5I!<J.9;4)?5TE.HGBIXB/T763@2S"_D
MB@%+-94ROT2L"(-L2NT,0Q<X+?IR(S,;;FF+#5R7VJ(3%K?6\L@LE(;Z-Y9S
M6AI)[57&8_A@OI=BH8M[\ U@J!(<BQ\U ZQT:.5GR+$P'M(D5[D>O0H:=<T<
MC(4H6L:VN79M0"0$)I84 '??]2 0#BD$1':RP%[8W/(>#=Y-6! VM8?,>)OT
M'+<A1!VLC7560#Z8; 2SC8+OD.9'8L$PM7H.>PH P4@W2H[O%H1C:DD#@^M\
MUC)\/V7BBBH68%H /HT!)>]Y)3$G<!@N//>!#8Q.9S(^8RLV$AM#KL-J6N:=
M+3B%(HIJ H?<;;-NW'+1A$6?/28Z8]%()# % M2C34AS<C21;23X2^T:4G!V
MYXS5*;G)(4AE3)/ZO$4QO1PB$8**E<P##^#2]DUTX;9QY4Z1EM),R4I[KM@1
M R$A>Y,JV1()8_PRW$(8L)X0^ICV#OAW*]W#WR5V9+X@4!XWG6;%I]J3%=/N
M$]\6$A R"A4>3[ISZQM_Q;QNW;6IR^ICHF=AOF$!74'6:=/>5#SX>RP=I$V:
M?961"U4WP-GM\H 4*Z(<<M*%=)T'#(5[;O1^:(3)AJNOBKF'3G0WC>U6)$IO
M0BO 'M5Y60%LAAD0I"J,3@QY4KXC?BZ*N2S4^/A'DQR<& 9[?\'?<2HU!%+;
M<9VSBO"QPI/' $X;$_SS&T"E;_? J_I#AD$Q=6J@[&5:! ,TH%@JPB )-R7F
MU9F-6*+H%+<ICFTZR%Q.76PR34R]K4#M)0LMDF%S)TQ%TJ9@/<W!8Y#>4_Z/
M><.9;\:,,.BR;',(*R4X=C7D'$PYIV"KA8Y9I =M='*62:1WMTCJCXG*?".M
M*VS^D!#AUMYE$+ ^92CQT;&D,1V#"SGY?>NC+W4/W]+/V\G;F#$?HL[M^[<#
MSUVW#)*,DH;?D>)[ *#(;'[U $!Y *#\@@"4?3)C']GOXFS.6V?K#=%,__R=
MR+KN5T>-*G+3\?I/A]/5O/F PL*(!=^=")%?UC!LT+>^V+<-<\I]UH'H.97G
MB!2$.Z\EY!,6T2E:G/.ZKUZ\,#"\!Y4,.!7(XPF-C$E\HWPS 1"N/HK=D"GF
M),_HR!3ICD&@DQS>'FD@U^FH@8H0")X:U$*=7/]@,0\$(D7MD)3O I)/=RK:
M]!",(I[3V'W'K #6^@<L!Q=-%KWVXTFQ)'UM]\^0=.; 3;3U3&(B,GP,J$+J
M:F)L'X*U$/9I@2-HJ@YMPZ@/TK>3NP_YSV.M:T -F/S*HLGK$,ES2HB^H-L]
M^3)H$$R1%(]EO/[N#I%0&# %8P47WZ?=BH=C3!34Z^.3BT>;?\A7:_DU!CU9
M/Q"AD9!3E]G,-S&+]DB(]9:UNQR[1JP8M81[/O"HC594"81N4W9 2DH>S* I
M TTAOD&.EG59T)^)S*E_&7'C;0%_KGWG>.@?-_4*O2<22X#)FLL?DQ?9^[K+
M=)111MZ^[=,OK?4YD"#=KZ3,N04GH65ZS!I&]9L#EY3P2;>)D@!SAIG15Q.H
MSE:;T I^'B]>DVM7";U 6@-B?>P+Q; O^B:VQ[=S6KD\TH K4 R5=U)L"FU!
MCMM>.::!H'1Z87P^H'D>75T-X$N2:F*UI&MO8Y@T;$T1Y7P3"[>R.HY7.<O
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M)]_D]&Z5XY1?T@\H,- 0C$>0^8-T[TLP)YH+MTHK7+,@\IA-F6VPU<+4LR'
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MF)"+]4@8)#.JH3(L[O? L==1A0EI-VV7<]II4-\CEW:Y]*M0"B/A=^HF&WS
M 6?E@I:JHM\O\G_U2);7.&7JI@N.MN0C:6-D58LRY3N4/\0 PG/G;P[LL>X"
M^H2-(C+:G,0=KORM5&-<2L- YU!J'U94&UEIB&45RZ)0%I\7,%B+1(MA3,ER
MS/,%,"H:.<8Q0XV6<Y TXH5M;1P*\J *SNGR;#59(9-)C_EC# >EQKB8T"/-
MW],3YA52HEHYQU&$9*0.94CLA,&6=RI6:QYQ'>DXP=,02] #M%J>T%$;S(<_
M0[;VXD<:,KQBD].2YSP3 JSUA;:DT%5/W_%NZ&"Z::08+C&E6W4N(T)C?L6
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M]$>G'R-H]T9W*JIY$L*S [SC:JA5[/B,5ZENN^GP=IKKL\:*I,_070&YD$1
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MDWVRT_3>L1:B7'UTOD=5H3+O4*0'\+4S(WSTY*LX&@:$LKY4:0C5$ TCOWO
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M*("IC\23'TD"DR+ILF>.L,CS)4>T,5Z[VP5\[SQ;HY&881[MUP]H#45K?/F
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M^-V[E_>'3!]>_@\)-A ;<9DO '5LW*J.[.^L4D5[L!42-5BRB(84D:FL"LT
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MW&RI;<8LM-@Q9@C.2=&8?Z2UJ%!A_?->4@MBHUN(OZ/@RJWHB2HO)_S3+T)
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MCRG_5P>ODNBWY#B^D=L_,VB-EO5J,9AH\^]%D&HL?!2SG"[%%3A80<-(V>3
ME8 #*3F4NS=!3C8$PA?^X_RLJG*^9..>0L1;;+JSB%\]I8\E6U>)L@\BQN$
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M@W]LTN GOC^S6Y^ &4[T4*[W__-?K7[SG4H1D,;@$Z?5=5O=MMMO]U$AHJH
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M+]OJRT>70YS%>1W39NPDE+J;]EHG\*7YYEABUJPD AMZ*ZNGS!1;X2#R)S)
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MW!C/UZ2 NQ7.Y])0%?_!G6-1PJ*PE0(RRUF$A0NT-4AW]CS9^G_/-<EF1><
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MZP_I"TM>Z#3KY(4Z>>$1DA<.6=J3LSN845P.C-3%#"0N.4/%\^IC5K?V$9L
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M515'OY)[&IN3^%%*9[UJR]KJP6>?-!T"RLN3\NRYMV0Q.EIJI[+"B%9KU?@
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MZ ]IGY:_LST=<K#0JUXC/L;J,O0#;^P>MIE*1@LF['%AL+30$Z0B#96F4 [
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M..EMO B1^AD?*R!D<6; RS"W=#$"NF6+S*<7R)&$%\""IC -?"C"P4%>9O@
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M0%L $C_(='PD74RG,#Q=IS%,&T8IOM3:)')F8YR)-#?R;I%(AR6%(//X2HZ
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MV..6VQP\L&URS;$_?@-?',?VFAVW,^C6'%MS[(%P;+O5<H^;E>/8-;TT=LV
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M;<T$6+((2>=^@QYI,:Y#3JF(O8U02Y +0@X%:0$:I([@/DN<.%IUL),'EI\
MZ5IPIZ8R,'L4\_1^*]=LD[6]O7?&C=$"D:5'UE0Y.0"2W)5,^P:9EWB%  3T
MP^2B.KXD*KX9OH2W2WQY$'_[Y^1G9:Y)TV8IQ8UH\YXEV,+7>=BL%,AE>A=.
M&X ;(!SMN'99N1/6YXA?V^6]L,Q6=[[5UGQCK*.BR&]^#+!5TPEBVS(V*&*#
M>CW56FX=U5JZWI8!11E0/)! E!>A//S]6OG'W<WM@W)U]_7+1@;\K98ZTV[[
ME\O/E[=7U\K]WZ^OIXVVCZ'5KZ.W;:_&5K].I4<M_[EEU+@H[P#]A\7YBA.;
MG4V&3'@D_8E;W6) C. P==?:HF_O&=+)G*'3]BTEFK73R_O[@E9;P0)+A_,5
M#[9J4^8Z7K7F)-:.I6SX",DKD4/)LQ#>;W)2509QONGW*Q_=@/ZO=!RDIK=U
MJ\''N&S@TL9#,DOV?D+S3\MVU]@IIR(&\"GV>V)P4, C ).DWYH+"9@M!2!_
M\.R/DO]N=;+XP"2Y>/+]\7MDB\NPC_^YGO+$97HEDO7^B;'YEL+'*H+#^"-]
M'TZ>+_H1.1+X5) 6( BC9XL @]7JZH9J=S35U3I9:"%;;+?B;-85(K>/F<%S
MK]MH9K"4C,9LJXID6(>7#!LDPU([EJ8:EM40R:@)OQR#$?S*DC0.>ED>[E(L
MHU?;?:FP'ZU8K#884Q+N14"<5A?\!) 0=U?I6,&E!YXU+]EJO;;=,UNYK:YG
M@N)UM8:PU1EY'I=9F13.X8;S?,02KI"E6VG?3:'6T8K):NV;T?)K3LI;E@H/
MO:I,>(!%5-?T5-<V&P)%:@#IDHO6*]L:N<CN(!=9KJT:N^M6"6BK\L3'K#76
M #N+#(.$9:UA*!4&F. [&T5CRB_#FKI$G=9$\Q'6$@-O$32!S^)3_@C2X=4D
M@=VPF$I?MQ<CC0,4SS : E D[CU,E*%^5M);70T<* NTLMX09CHCM/LE9F,_
MZ&<#U'GA=D1-:'HS-RD2_E97O(*XUYRVX"7>(6%YUX$MI<5 :7%,4[4LNR'X
M1:+@@ZC>/3"32<SD.JKG-<6E.O3M]+*<=DTCM?T&$+FT("B9T\;*N[]6X2R[
MR%G(9W,.%CWS;O!1]/'X%2@\OLD*5XHKNLL6E'.<8"H[9RH+F*J]>(TV+34#
M U-I\<X!%V_CXA<=P^GBTS0.'B<\FRV-E'_>7(./(EIH4OO?=3-ZSQI<KHD6
M[7"2U12?T^KJNJJ;MFIH,G)_8DRV)IAT,":C*:RJ9I%WTQ FJ].ST=WFNC4/
M48KM3FOS8#9*L3L]4=I$7V\I'5ZK:^EJQW55R_!J I\;G](1N#EGRG&;*._M
M.,[IM+H.^,V.HYKFSD;_$!QWXIFZ7V)T;])77C?^YR08\WZ]V]ZUGCRP61=L
MXN3\,O+#]#+L7V<4O665145K=1&Y>*JN[QQEDO"X65RT+LI4'Q?IR$5ZQU8=
M:^?P4K/P;U-5JG!9PB=EQ'QJ  ^_NX@&%Y.$<10LP_C5-6M.U<](U*_XCKO!
M[PDC-%)5*"B ;SFZJCD[WYW* 'ZSV&BU:JV5C4QPG_#.U&C*+=")@]4M,E>P
M0W8TD DL^TU@N8W"WG;^H(7PQ-4=5=-W#D!(D-LL?MH^BV5[?K);75.U-. I
M[TC2MK-V"[!0MIS]]ODIN<!S7^"QNUP?&;59*B9.R82I;0U]1DP>Y]U>%3M@
MVC5/->T3*N>5_+/>L-?%/R[P3Z>C.DY=-U,-\:Z.Y-ZV7(&NV^MN-V9-HL+F
MQ>Z5MWX22F"3:^FJ(N^UNG9']6Q;M72G)OC>B/OH%;ZBE"@I49M?NU>4*+?3
MZKIXBVBJ9J>N)+M#W+=GB\B(R=. ZT1P&WR_L%$#MM*/)IAQ6K%_6%-6MX?8
M<+.ZPGV^N?SEYO/-P\WUO7)Y^U&Y?[B[^I^_WWW^>/WU_O\JU__O]YN'?\E.
M9,?CU&=-Y H3++?K)%>3O-7^_3.J.<[[.8S]5TS;WR4&>WHXY_2@S&8=*;YP
M9M@NE=#5Z!+?=57;;DIF]P'< 2D);[^M^KMJ["8)5+WM6. Y&TTII#FCZFTX
MPQCK!+/J;7GGL)5%0!I^GD*]+46!9W9A%]'=14%>.S2+A=:JTGI8R.0L9&%:
M2D-8Z(P\A:OH(AHK ]A+DGM^KS)?:W.5^N_7,'U_%=V-/R$-,W%XW5(8+-E;
M\T2YIUR;ULL]=M9"4S85.GQEE_\:1Z-1,7PFD6EU9'K]/!Y%KXQ]Q8EO=< +
M!S,4L=668^TL%1*A-HN55B/4VED),V14R](:5,9R1DAUOLXK1ZNR7V;M]5Z[
M A$/?#K/!#F1108GQD55RKUVY"*O Z;;-53#J"LWZ=Q+"VJ_HFY>)[G%DK4!
MPVGAWUDX8<LM1?6^92</KJJ7I^TJ[QKU*=<\M;-[@S()U9O%3=6+TW;E)IVX
MR;15;_=^'H=!ZT=H/TZM$^GOXT$,'UJH<68QVI$5K?EEX\LJ\7)!YJ^"RA\S
M(G]BVSKGG@'B[CBJL7M77^ER-(N/5D3.]\!')O"1ZZH=KRE)3F<40[^;Z<$O
M(^F[1720F#L'/3VKU;4U3=6-IHP.DI#\,*&<>MC'QA(S0]6MIE0EGSW$7==L
MOZ!VZ^VX7V"F>CK7>PXPU\K.]36WW:]_!VZKZ\C>^V]D(7<^SFJJ$(<Y:JIA
MNZIIR@ZC)\9IJXWI83D-5M_J&N +VXYJ6DVY@CO/-OPU.3%GVAE]8_V]K:!@
MTV===35;M6J;C=J(#@@U>3]GRG<;:_-M^4YO=4U/[9@X#:*NK'?9EW\OR46R
MI>F><XRV;EFE=:C\R-6L&OO72$3=$%[:*M-H!UXRL7^>IMKND0#FQM\6-WZ!
M^TB':ES&TQKS)1.?ZDQ\VD']X C1CNIZGJH[\JKEQ%AJA^RG'5@*![OJJFEU
MZDC$/M[KE^8E$=6NDT\>#&Z92[2#\& [91PVLOO(>>E8-(N7MLPGVH&7W%;7
M=G35,)J2FW;LR+WQ"SRQVXQ]WV*<L+;9^ JCLE;Q6EW34EW75CUCYV3%2B=T
M!+[$.;+:QK<655E-ZX ! T_"L55]]_#8WEGMQ.\JKJ+GYR#%J6M\  M/&WAB
M88]2MFZCE"E:YZ>EBKHR>*RJ[WXDP?LP&/UW*XTG;-'9S5=_&?:OBFN?\IL&
M[YSGL@8T$:XJC;L30E]*B!/O1GR?1KUOPV@$*B+YK[^XNN9\H'G9Z:ML2GQL
M\9![^!H\Z%(9QUFP.L'C55<G9WYA\?W0C]E*,W=S^VEQG+-X"_'0%S^^B^]3
M[ #R3W\T8=.G+IHY8[6$+UN0N;<%F:UNI]WI+,:#%S-&QWZL?,?G?5"6[B'!
M]R2[T9/6FEQ.TF$4 P_T*V,):P61RQ=8C;X[+]!N=:V."M*P =7Y@A4_?YMZ
M".K?),ED?F.#X ?K7_R'Q5'9GIS*1-]F77>3-$D!DH!BJK(X]R <L>7BO(,L
MKO*)Z@#)\5?K>70#+@[H[7R:WY1*LWGF,CJ]K8\_>]ZD\ZL<-&!A D#ZAX8$
M#V4@^B#^^HYLHS>-;<XA&0-]NBC<"=VNLQ[\%561I+XEM%V' K9<S4%P;05*
M[HH9]>J@M@)E=UX=(%J=$.W!4&UEVI<!H UV!KA6LU33T51'6XR!9QLIX)M]
M[V,IRMQ@,X"#-5/53%VU2UK69)LI(+1M=E29[[8\&8].1O-TU?46NV7N?C*5
M]['#R1@=OAG+4UUGL355R<G4AIU//C5J7;9=?HHE"&B#D],R!=&0_">94G>@
ME+H=^4;/U%=#^.;$[[0N894I3Y8;^T'_(@B5GC\.4G\D"VVV&.^34_,+$/,F
MO.*DK"P$X#18NMK1;=7LR/J:$V.A->-]:F(ADPH==:VCFM:)==1J="3B(69^
M,HE?>2RB;K<G>SH96&%KQ8,J\@>6/:B&[JF=DL22W!&MWSVH;P?@7!N&VEGN
M?JJ*G\+JDO2\G8)W]=FWDL/;#N4Y5"&!3FJGI/Q_(85&.@?'PC^KC5MM_..V
MNJY3/J[KX,QSZAY"KS=YGM D%SC:0= +TO-Q#7;2G0FL_+];%_-"\)6E/KRH
M?^W'(5 B*1#X(Z=O97' #E>FZGB6JG<6S>'F$B%=A8:QU+PZ/1A+F1ULZZPZ
M'<P^7KRZ.#A+G5?9Q\.0*?^(@C!5KJ)XW.:^1&E2IJP*J3-^4TQ^O2;Z5I8;
M'O?N6*9JU1;#E,4A1\QQJQ%Q#1RGTR6S;1FJILD:D3?FC-LHO,#SQY&D>%%\
M ZP0L^2,('-]VOBW((QBD(B,AI4E T=36*6I%S*$?M1\LUJG[LPW9L/XYKS
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MV7C#]C$835+6E]$5Z1H>Q!P*?ENJ )R=#:*,O#2&VZ1X'=R\KI,O=V<#>ZB
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M'$CTS 0="W?[XI4Q%6=$<<JG;FUVUK1ZT!Y$.E1LA>H-HF RLU=XQR..>%>
MG%.J4(C!^9 HC\@%W\+H9<3Z3Z18*>0(V\==XO:&09)&,;IUM-,X8&$/M]0K
M$.^%P;-?^23&%(DM=C.8D+K&)</KD?VB22+(M'@"N%0V"N#%?3RU1Z2.GT0A
ML>QTRF,OB'N39Z (K -V? F;Q++[R2BE54U@H?R?"2T*'M,/X'!I4S2I-YVE
M49O42E%.N\JG"!9(E)TDB>#$I&!79IGIWY/^$S^<9[]/FX\!1<*G_X/GD_.+
M/S5&P+K*"(<Z)&I^H(5?%7E%51)P\<C.Z^HZ@'X8OU.GEC&T*V5J]9/]K6WE
M2E1.'*]!Q!%Y/ _%/)Z#4P7YBL/#3H-(@W/.@W2JRJY([IY J01O1JOE49$F
MH@HTDIF" [4438$P_(O;D,P4]^#; $D31NIIP> (-GT'\@O&BG0CJKP,;A8?
M_<A +[&"8LK,'CX'(<*,X1(?*U@MU&K^:"2ZXB>*P#?P662"E+8THN]RFTL_
M+IA=_'$$IA _0?9^V4)QC[T1?!I4-3UMR2>7O:?,#C_Z(S0V2C)D])4TK]GB
M3E;6@)8>AN4R',G,/".G1=9UE$HODRE *_PL(P4805S+TJT*PQ$CND=H-:WH
MY!"&DWT5I01VX.Q RL)HD*[X&%#.3/J&Q@7PQ6B*)SB.X]%XPO,;@[:8%5D^
MR7PZFO$S>Z+L!S'$:DF>A".6""3U@E=W& (&)ANS'D$41.M+61] $^$;\ KQ
MG[#2PIX0WPX0:47-YH?V&S&$LA OV-SWGPFI+/7XW1*/WZWF\1_(3%5T\+_$
MH.R"\8CG(LT0XUC=?+VSRLUWA9L_ZZ^MUQ;")G!GE'L&<SY^'8YY%B)X046!
MXH_^T3(SW5;^F-%S"@8*4/^)9S!2<2GY[P%%XAY9R$ 5X7+P<]Q0D1DE^UV(
MS-V#*]?W8WC=5=0G]454=!&WSG#)-$QQ>7^%OY]&#BC/$LX@!GK@,[,(QVPL
M)8C[%V,?$^ P4)!RPL7),!@7O@"+Q<UQS5]T^N@C%_Y@0 W$"T=#$";VPR1S
MBA]9^L)86')@1+:A_QU=7?@ N+O/P $"C_6*FRUS2W?2/<] AR% -E"B'/BM
MB3QZ%31.$]3+S YS;/L9L>VQX'L]J_,-9I Y-26?V=W<[X7H)7#B),+XCU?F
MQPD.HRJT&%@&5U>KWXWXC-(8>'@^&DR#\ZMYS.X<OU4KNY(X*GY;B!S[P"\C
M_X4\*6$\"!BBH4"<R(.)O_DQ*'[4T7I'Z^1L-^9&'@S:> +?38@R U".O6&0
M@&96E3[[SD;1F/Z>,*ZN8_;$D:CX)0!02BG!Z-=DC!XK];.!Y\^ZN]F#L=TF
M:/=H3'DN/0&7R54#AO.S*&,<39Z&T82'>=$<PO?H HL>=DD,[G/GK;!D\MC*
MGAZ@=7F:<&?M\96>^HGU88$CY2'&4"!%.W@$$84MBX"2K5?\23J,8G([ZY#
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MFL5&,,6ZF&IM8/QD>!GV\3_7?TZ"[W!&89KPSB\+*>)FQUG(_X>?G4(+&"0
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M@2P);)<+:J$0-U,ODV2V.5 F+X+Q\U9 TW7E[4P(-0DQHB9#T;3YV-R+<2=
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M.)%CDZ763)=3LDNL;LIR1]=D/E<29_!8X-GIZQ<P[>EEV,="B?&J+$Y],9D
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MNE'$H&*N[CN\COIIRZGLF]V7E%C[I=:]B3KDXVQN_<87.KU9=[(09%U&Z!>
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MDT>RIJV<_2R3>/[EV1U>-FIA@-+\'/792"@*O K$S%E,WO(I@:%P#\2WSN-
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M#]B_!QN.^@%\@+>! MX=!F.%VNF(GNW(TZ6$+\IY7- *7.PG">OG3:[&DQA
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M8&YJ90)"[J3(T;"L74U&&SZC) '\##N*R9AR4><6<I9X=*O'"8@H/2<?+(B
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M(M-0A%:X3O@[[1K-5+E)%6[V4A618"BJ_(USJ,)/9EB3,]4(&&24L58/!+/
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MP[6+[<V@7C^M;^3,'YF>JOR@#!FN^KY'.7*NH-D0%D <=1X)V_!/-9T#1*Z
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M%[">!E6-SG@X4/M676&'PY>T9MT@>PZ5DPE7;(K 95[(H4L,^=J;WG@HP.%
MOKFV%_*)<PGLS/,?-$<"Z(H H*0A<%8#YE8FRQ+U7?$1IW-[R<>@KHR4G:3V
M&@^3Y8_0%%/R)XFIV%-E9CL!39QF<MB9_6P'TU!.4,7QJWCE/K!Q!#:L9\I
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M!MP:K(60<4:BKF8)?O_ZN_@D?<!U^*I0"J?9,O!;W&1NX?%W(OMGO'3DBTY
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M;@OE?\;>NF+^ '?"AF Q'% A-VA>V:\5,A@P[S5^;D9ZP*N[U^FD^^QEY55
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MUEK=>LM^YMC_JG5('UNS)J^@H!-.-)6IQ0"]QK#4@5%71Y)6F6X*FM6F3->
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M(YO5H]+8P4@UVSC'$;$F=63(H.\8UA_ V6/MP:QRQ,,J#A5(M$I];+=>1KE
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M@C?GA6L?MJ^YMT3G(0G\JM;->A_-CX Z*"R)Q?-J5%'QB^;-;PS8RK2(F>!
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M+@_\7_%Y8[^@0M-FP#MAKMHV^Y&'&!%V;N1!W?5!HH8[4<?*IBM3QV:@-8L
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M%0"NB\O:H77:Z%!KQ<!E-Y\0(]>ZVCFM>C.R?%\ WI^F[K9D_?40.FY;LA2
ML>2S6]"^4B+#^A9DZ_M7#'(=+)K6><P<9;9_69W'?M@_E7?,8S,G"INVE;5\
M^0O#[F% LDQYY?IA^)HH-=L0%ZZ["V38\P#[:?R,B9J:$O'&4J4, "A[CV:Z
M.>(M1N,":K,P>- M:%NY.^L=UK4T]!YW"[KTEG#:/S),8<:FV/I-GAJ>QYW
M/ 1VC;#>BH, Y@O$_Q3XCW*JQ]=9EAENT>HM!1^],_X/"_P\@&H_LQJWF-^&
MT1GWN@6]2"4&QLW)F'@E'>!*RT[8<9G<S%'JVO['A6W'UK?WQHUL[M"$ K>
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MG4AX=E^(@(G=M.P9#-P=P&YYT4+A&,SX3JU6?+I#%Y;6:AK-EI:6@*&58[#
M6I>,_->%]/"E6D!Y=9R2U8KGI2D=$[.[)WY(R_-=T$IM,/!94O<O\_L2@UF:
MW>)T ;K3:/4M2SFC^]\YPUI8J\S/83#+,'XFY]V .#_.G0&,\\(9O3IO(9)4
M%ID RX7E6YSYWN>7%GM8\=[!8!?O940)_-1GIW N@ 62 *^"97":, QA&"!/
M^]OFXF0FUF9$W@PDB0>,D#S_\<&YS,/-ZL):2FYA+?5LY3V4#;;W:(>F6G6=
MHC -O7E'.TS#Y$<[^-$.?K1CQPM6\6A'4R,9&Q(_,HXPIA3RQ(^6.T"O>CVP
MA-+H5?%3$T5C]4V:;&E_2/O\&EJA(%MJ;6-1U?BSV-/Q0&"4+P3M<(H=>%",
MH8Q97MH/HIQ=FKHIZF9=GI C<$%RTCG\M,J0CMY,TE%9>0A35*NW@^--/PL5
MO$S4I8"\$#"\3Z?WYPXES7QTO3058(,U45=U45>6BZ0<[>$\CJ0M&&]%).F(
M)%NR15U?;CG4R.-LQVZ#?"5.2+*A!YZ&7IRA_OGF1<LT$->I\I[IVB;JQ5MI
M8C"0&$Q;%RV[,C$T1S/G>%K-5G>+)Q/CW:8LB;+:%$NOY<KJK[[??W5'(^%\
M%@869*ZR5N6PR;JFU>?DTL1@8;H6Z!K6<L,MKK$>-9#*L-9-0%J;RV[:=>>R
M<UVU/#M5N,):.SM5RK)32SJ[U&S14NHZ1\X5U8;@J!(W+8\C&714752-RGXD
MKJ 6.GJ.\BT.-W.UM 9/ZO< NP!&;]]'CA==>;21_02+_Y:F! 4XJBF+5F,<
M85Q!/8Q+M2"DUJJJELI5U;WBX<[W_C.%(0S<M#UOW+N7JZM5U=7LVJ[L)UV$
MQ6IGE[)LBK:A-$3;X%KK ;36VN"$P2M%$=7&Y-'P(A4'%@)8'3EQWK.>T3TG
M"-X 5[15.]>X:]"X9]$16-_K[/*6)F :<%,,6;0E[A5N&:I**MTUHLI$5$F*
M+6IR4TI7MT\P')=U\+2Z4C[7W[;+E+ZFRUF-4C$FJ(N6+C5$?^/FP,&RA^N
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MN73I#&"TZ0*FL'*\M]F=<R_/>/8ZY675,<@XT ]P&6"-WL3\A8^BP.U.J0Z
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MCS<.&55[M,"GD8L6./#"&1NDYCGEA8M\4#%.A+S_($"^+VC]A+ 'Z%;QT$D
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M:TCTJ=OC*DH^U=+X[=UT##/L+8=%YEG%8V](^M,1N1_<4!,4"#)-VWH D?H
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MT#[HP8;=\5#C[%*51,VHG&C">6@#>6B-QQJJ,5&,'^9X,DZ*AYZHJ_L^&I*
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M^E.2P"H?KP+2G L !+Z-3PTS(B*''H'N4'4OANX#3#*'6+.T//?L%0M2='I
MAN79\A&P\S]@=2836%9'B%[]\S B$_P@\)W>$)<Y*:F#3 Z7<4R<D+&\%1R1
MP6#@!B&HI?@T4 W@.83M%4FUA[D=B-]"_^["%A-0.L:NAZ]QF<+!)H'X=%X<
M=X0J(CS3[5.D 9=W>Y3#N1&^;^P#GQNY/P@*'U1=/#_"7R+ZJ/3-KRY(ABZ
M$Q8?Y@%;CTB:]MU(C%4!'  0LC^:TAO@[4RX]7&-:&%[&/P(GO;,8 CKAKE:
M*)A@W(X74WZ(H:M^=CG8,LY6(RY5A(_SNZ/D<8![O&#D!"#X@&)IPB&;2#++
M1#-+I@M#[!(V;$ 65D*:3I!=CB*@GPB'$D4C@B&SCO ''J7U0EC$ '0^#V@3
M^((/(N9U"&0;[UBR\3  ? +^B60Z+P7Q@FS%)1$>X0* QLX;#.0_4Q=&"IS4
M]6&?LJ?65^N*0.S/KL<,'&7>$#T8K6PEAU^),'3Z IAY8;A2BW BT!J[4VKY
M),SM7[<WH4@I(\ 7 1;Z;MACD@FAFDHF$3?][V7<.+:>E8[G^J)4_#U326N6
M=S@3@<9, FHH 5<Y:F#Y1Q3'L!KE!FC4-D =![BJ@4$\P$5I/8_*.65]63F:
M']EC;TCZTQ&Y'ZP8XX,_&@&0T"QXPNT&\ROZ- +5=#9D&#V!B4Q01 13<E:>
M,!B0$B\#\Q4 @8R<24@NDE\^ IXF(^?MPO4HUNE-'^/GQZX'?;+D*J O9%]_
M?'7[T1!-^8[$?(EQC#E^<_QU![[ZL/RYJ70TU<K]2NK(N9^O>I0L=TQ#+_6H
MU9_K:OY+MAJ4N?91&^+R:]V!]M)E.4Z['FVZTI2J)0FS%(!/ELE/*%I?HZA3
MK+DKA,*C2.AGXTQ/8JFT4TIR^42 +U.5N.N,T-39TJE\JA&\DPC0S2M.2P&Z
ME7I3R0"=B2?V+%&N7L6SU!X=* +'"8L3EFRN#WW715G8+$*435TTC9K#WSN@
MK0T2-[$O8 ID-2GN\BH^0#[ A@_PV$\;/K!R_.C%0D_NK"I($BIFKG^"?X[<
ML1LYV]<$.<JS$>4.W$CF-F)FM@D/)$1?K_?\)?#'7]'-<S^XFDQ&L!#=$7ED
M>W$_^#K;B=(BRCZ[5&5-U(PJ"9W\5$[CD+>5@K-/Y-E8DT8Q1=U:/M.S=^2U
MW-MPX_6KNQKR\]=.W5ZJMBJ-Y3;;!Z!V94S9\MFEH:JB*5<^ UCC#C;;B<%)
MEI/L 3V+MK(CS^+>238GEWDQ[1/_C@/Z5"&:B_/&&Z4I'1.#L$FNP 5-0'%?
MR"SV^LM\@#B>J32[Q>G2#);5MRS%>/:?6V%*"RFRF9_#8!8(?";GW8 X/\Z=
M 8SSPAF].F\AKG<V1.YZYPO+MSCSO<\OS2E8\=[!8!?O97CM8PX)1=@%T <)
M\"I8!J<)PQ"& ?*7O[G.P%)5BRBJU.]K!E&MWD W)"(;MM7OF63P;_/LDB9,
MH",!$S0Q?^@?'YS+/-PL$%;,72Q=.]>VR*;8,U2N:#W5-8E%^0F*(GI; L*2
M?*ND RW58UC!VY^&3O2'/QWU;VE":9I*&R?1IMQ=G7%W%<.V2XP=!NY/0YQ9
MU42A'0X=FS0MRZ1TZ/,I1#0E:V4_PCB#;R!DOG_%T0@..U*!;C/' _".<M)A
MCRMG[A;%"4U>I*G]GC.*7'BP$X9^SZ69E*]N-%Q,APO(+/'-91G$+'T0;\0$
M2YH/]PSKB:G$%#E]S!<-HX *QR2S/^P(5[U>,*6/R1U(>6K1UB,N<P82EM*C
M_.=[\KHKKY\L2#RN/*AA R=SV;E6@4PV$'@-8S9H0L::,0^V29Z<IREVP&:6
M#^G3@G8CU^FZF(-+%M-)MTS<NW;"X9>1__HXG4Q8JJPS^NR&O9&/*;OABJP]
MVZR<M;=GTL3,Y#BE&+A5#V8M3!R7[53N21V0U""X0]P# EO2?T\S\QUT_&/Z
M?7BQ.D6>9RWRK$6>M=CB5#R>M<BS%O/F^X4=]^*YBCRE:LNB6=]!)XE1=(4^
MGP>JA3S$.DAI!R,6T5)D$5:@\>E5/'61T]D>B_;43&@V:_BHR\TGM-:D:.7K
M'+00R'8-@HODS1SB_I9K3:M*^,<U7'A#K?P4;;LXHZ,T<>7UO_J].M@=C%8Z
MNS24&O6*!F@/'%=,?DJ[PM6Z=D$P4+E175O:)"A+]CU,*V:=3MIR.0HI8<O5
MSWEI[2"K#M;+LY*;!BSED,!2 5A6+3*=)QU7X;^T1"%7>O,I1#TDA6A<Z6TK
MKK1#XDH_N]1E45*:TGSX1!5?UC*050G\<QJX8=_MG=CQO7)$L_Y<PXZ)Q@!U
M115-O7+J-%>#FX:K]<GW.\855ON01;MZ)_C]:,&-/_+-!UC_H?GC,G1NL^EU
M-.EN98X=/WK)SW$=(.N"A"A+[DC9YBTP( MM0J,./82?NN34>N+46C!WHP*Y
MVD"NLB1J]K&3:X$3E\L9Z?$H:5)Z$Y/T_\#3,>1GCTR2?A-I@6AV_"5*"BQ/
M(W?D_I66WJ'Z!*L1[3T+(Q_/S6!Y\5Y ^K1"M[/FF!DM6XVG<#P?;O6>T0DP
M[?Y)SR;Y:0G_60<!,CLW$F(!=U!L:-WP:33$3C)XT(:>_W!^QN<_NF2 U<OA
M74IRW$->J,*\W#)E^:PL@GCSR4'X[2SG3$*,MW-DE1>JD6RXZ_6)%UV<XR=[
MS=6A^WWGPW+*TL4JCXP@E#O6<NV/QRXKM@XV(6ML <#IP9;,SK0LG6:1)5EB
MK(@6&[^*D@_Q!?.G7#(OH#LY]PIA^<SSP@&=G&.:R7OR7J^L/5:SD^VB#[MP
M(V $O0(;^)4X0&D5#B+1!US[891_T B686D/CN&D$3O<TR4C_Q5XR1B;>?Q%
M6'\#;(GC>Q1!6"0,YS_7P3D^C$19#0(-6%+/6>K>4?!0V<4)G%%2C(ZBVK4<
M!U+-CJJ7.UFT^G/5TNHYHZ1W-*61@U)W=G"JWLN.\!C6_U(:OYFC\1T=R3J:
M-?D*GPBWP!63=FP@?:E&34]6QUZFQX1OKH[:\$-K_-#:21Y:RY_O_<QNHLI(
M#[2Q<+L$^L)G%TJGQA=)83B5D;4\/)^+QSK.<S1\WK]N+O!1]ZF6RD'F)JU?
M<<=KWNS:X4!=ZS]-"2LUNDO[3V7E[%+5==&66Y1VP:F@952P/HQ0!QFH>*Y:
M%U7[2+)$CD='S=_^)S\"R5A5'ZA)5=MCZ)-'/XLN3#LXUUK&58%?:;6)[7JW
MK5V)"IQ:3XM:U^L9%<A5KTV].#RY%DM46-U"OE X\<\W+[JX"D-" []?9T42
MOV+]3+(RN&CD!5Z-Y;AOTV..V>J-@NLQO"6Y$G%;"R$<$I())R;-W2.?*5;A
M-@'&Q:*(RWD,O ;XBAK@,J\!7O][>0WPI>02)3^Y1#U;<Q>RP):F"YA (/55
M#S7D<ID'>REI:BCK7WYB)4WW&$MO1_B31XIYI'A]9([E_?$@\8F%8JFI=P[J
MR/D4LQ71WEIAB;;"#=(^E\7Z,@?SD9$'?,?]X/>04,.ZO!?#Q.[>NJF(LJF6
M\V/PH" /"M:,_/6U"FI&OG5VJ>NZJ*L\/'@0.95T27D3A=XT"#"+?N('N/X5
MRO N>DU;R@%*3KP5S*&,6$R<RV_7#%GEN8,-<M'60"K:]=>*7K=7S0ZV<1)K
M-8F5D;^524R1SBXU2Q55U6P^B9V8#9F1S7$5D TB.EV3DZZ*M)6(NO.]WK8D
M)*/U9LF@Q2J5B:@YN9X<3%LSXRI@PK1A618-J[+*PPVBXOF2_BK66ULSDI-2
MTDXAIVDK,5.>'V!K9%&2;-&4:DYQ.O:<0TYCK:>QK:1O>1K3SBY-6Z^QK/#N
MTP2C-.\I65R-UCFI4_$K<'\!8^]0O:'*#*TU.DY^-/H/^@<VQX8!.<_81'WL
MN-Y,W8E(,!;>N1[+9WQ?*5I]Z)CTB4>>=W7^MXDR)#_565LO)Q)BN&*T\)"0
M OWR"0A!GA,@YR'I7?2G 5)&1F1@(?J.MK*,U0%[Z1WUWNG[V#L#3.R.L7;O
M:I&Q366(G*&6DY9]-^S!="(AX/TRFZKX5)2-I]/3!>RA+@G6.C/44DSX<TP=
M#T <WTG0HU[/V,C"C/J4[9IGET9';T+CEKWOQB\[4ZA/';CZ'H!K<>!FM*+Y
M XK'=-JOYX1#88"%1K/G_FHZW$<"LOITW]K2M,=R%L@RC>:=!:JM2B<_"\3/
M O&S0/PL4/TR]!K%#FWF@X+%&:/.$6+QZM$4:<OUA#'(G6G :EACI>O9H7Q^
M;J@@AVDX!F:&:*J$@*X0^./%S(,E$Y6?$FJ,!5*QC.!WYXU66RX?G[3/+C5#
M$J6RG?9V$\M?$[+G*&TF2LN4^=L:IJIT=JE+NJB;);,@=YRAUOBNA8T9X&*X
M0^?ACM9H('>^=TYUCRAPO)"197@A/-S_SDXGAX+?C1RXC6JDY&=OZ'C/A*JL
M\RF1;J$0\XY[5K3<9%B(6_"P17G=:^%DZGT,[EOO)H;V%S^H*X%,I2< =%T3
M=4EK@I^X9JYYVC!;KSS5AK.!^Y/TS_\B@9\+,>4,@&0ILO*Q(0!;4:UPOFA=
MR0YG6(%PQ6)]<Z)I /]?5:!054M4(MQ_("(>/O:^2WN9923JVJZ+K0\N6'I'
MDLMY_E?Z\96.::T/+IQ8+ZC%4D2GY'I5:$IW3;G;IWJTH(7G"M:?W5DKAQ+W
MR.<IN8,'/KV2T0OY!D\?;N$QT0"BAB6:1LW%QG?51;D-27\K.87)CU/OCE8P
MFOSTZI<G$1U]WZ:HZ24+8_'SL%L3@L7]#3LFA&% 2'E2,( 43%N4E;JJX7"9
ML(D4;"X3=DL*7_QI4)X23* $6Q:ELI$F+A2VI015XD)AQY3@OFPA$[!^HJ2*
MJMD4OW/+9<+3D 2$]I?@DF%W]'"%"[P]4=C L619M*L'8[AX*-MS<!+O8A5Q
M4:W QXG33FERT20L,:,ILFC8.ZBSN;,"&&T5,;C1%\+M>#*-:#(&L$(2+E6/
M;Z^X>;<GFOG=2P[VDO[-SQY<>D5SL\L3D SF",H;>]E']9Z+FIV)&K\+0Z&!
M9BYMFEJ_3%..K'[920B7N%IP90HZ=?E2<S%F35U=[YP+DIH)P?>>SVG=JXW"
MI" _XCV0>0_D!I6EUK0:RU(?2W/D%8EP^ZI%0!]VX8**ZO;6IV;1I,!?IT[@
M>#3_S_6P<:E'&(Y>W6A(2Q \.JRI*?[^V7T!.Q!,PD_3$!X5AD73 !M1B>'6
M0WI8FF 83[#GCV$\;^?^*YY \ ,!WN4\PZ\]>)3;"T7AE0C/;+T(?+R2\B@W
M7TM[MW=?YIIAW]'"(O>#+]-H&BP8B^&U/QZ[$:QZ+HEA]_%E42T,Z).6BDKW
MZ+.HGP;/7 !L^T+WC2Y#=_I&@K C_$$$)TB%$:M* 4]!TA=H8UQZ]7,&-X/,
M_<+ <4?YM[ 1.,\!(?$ (@'66XA@>X7^-,!1XG6L,B3>%:..BLCX]\6'B.Q3
M&&A(#RZ_#MW>4" _)VZ >:Y>;CZKJG:$JS79KNRATXQQ#ECXZ8ZGXZ6RE8FO
M$:8,) <7_KTZ0Z:0B G3#^YG6D%:;.[FY\3'X]I9_T&*#B.##@-K!$K+\ #"
M&L$O=+>'S@L1/#^"N?60??8%9U9\G)$)K.4$R ;WU9\&644E'Q+K4HE%_/85
MH9@</X^&@(1X(?.?AWW+<823P.\B^^V42#\^.(O]ZD;Q:BWW6^?]U>/^Z@KO
MKU[_>WE_]:7^ZNH6G=+WKZ8@^_-0UQX!FYP&(9UU-]:YJ!Z"(GKB!,"@L6A4
MRF%H-:C>R'''<6T'*ESA$OP_Y?8H0?!\$*A[($$<KT>_[OF@]0H]T'SQJ]SG
MB4(X[?X92X$)*-:]-[@0M G0&8Y*#?P\4S5"P"1,\#\@:2*F;V!E&+K E!&R
MX(</UT41J^&5U5_H F?6*E/&BXPG(Y\)-#"8(E2,X.&E= /9,K/:P7)=VIE<
M>4R'Q\('5Z\.RO$G_QXF&7Q'F.1J!]CS=655N5A%8-(9!; _C4*W3]:#,U;
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M$DQ0K:"NG:Q0=\+,+'_W9DLP&^?L,[P+IOF6S#%O#,E$CTL->-HPFUQQ-V-
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M,Q#<,6H>)*O4T*<&0!@=X1/I.=.0I+(QLX@BX@UD*%V@P U_L-5)I>78#3.
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M$<$\@2).H#!7)U#P5 B>"K%U*D036&I&SYYY/6<\8"[8E3 T:D5F8X3H<0I
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MC0M3806>@K$7%1Z6NOT"E'N1=G:)U@O-9MF\!$YB?K"L!WCCN8QA%:K0.4&
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MJ8K\_G0EZ0D:L"<M2$]NSBSVJNQ@XNT3I+S04W,$::T&[((@C6U8-%HE5?F
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MI!6D%4DKES2*AE#WJ4:NXQYSE5M4%XQN4O4J^.B+P28O-_I-"_]F$0D!=_<
M]YI[U+7)=XV<T._,=:ERF(-@JR38;D'P$6T1;>=.3>)?U/,8N=1$7OA;!<\+
M$&V51-LM"#ZB+:+M+-HN9$I7#'(0:XN!M5OV4)%3L$KV=R,(,X)N,5;9;X#N
M\3!P0E@_0Q8(T?-L?Z_-TA!YBXR\6[\4WH;L(^8BYLYB;J?'R"?N#92#&\19
M)7%V<_*.V(K8NF!(;3OD,PT"J%L](Q]$6"41=M-2OTD@6A%*Z+UTT5SP#WST
MRSG 5B;H2VWNO&CZ9X_;8_AO&(W<]_\'4$L#!!0    ( #:<;%Q87=&:IQ4
M #S^   1    :GEN="TR,#(U,3(S,2YX<V3M75MSV[B2?I]?P=7+9JI6L:W$
M3NP:YY0LVUGOL2T?7V;./$U!)"@AH0 -2-K6_OJ#!B^BQ M BK*84%-3,Q:)
M[D;WUP0:C=MO_WB=.L8SYBYA]+1S\'Z_8V!J,HO0\6GGZ?&R^[GSCR^__/+;
M?W6[_SZ[OS;.F>E/,?6, <?(PY;Q0KR)X4VP\0?CW\DS,NX<Y-F,3[O=+Y)L
MP&9S3L83S^CM]XZB8M%;?K)_<#S:/SY"W:/]#U;WTV?[J(L^?_C8-7N]8_&O
M^>G3OO4_XQ/4,X]Z'_&H^WGTT>Y^[.W;7?3ID]6UC@]0[W ?'XG_2J:O[HEK
M3O 4&4(UZIZ\NJ>=B>?-3O;V7EY>WK]\>,_X>*^WOW^P]^^;ZP=9M!.6=0C]
MOE3Z=<2=J/R'/7@]0BZ.BG^;4V^IN+##-T:H]]YD4T'2.SSH?3B(2@,O4L"=
M4-=#U(RY6Q[O>O,9=K-IQ.L]> UR/G;W#[H@"7D>)R/?PY<"@7-L(]\1-?3I
MWSYRB$VP)>!U, "X5"#QVD-\C+U;-,7N#)E80[TOOQ@&6)U,9XQ[!DV1VL@=
MR2J[W)-D'2- Z)J9R)..!R5=451JERJ_AQW/A5]=^/7^U;4Z>_I2?;<[1FA6
M2G*2)I >/BE3@R*(LZJ120*_NA%=%QYU#WH"Z\IU6#AQN3I$=&O6(=-M\T!1
M4<K?KF8U)",7F^_'['G/9#[U^%S'*;)(HA]EW&&9V=SJ(KOK^J-259A;H?B8
MO'(-+$S*B(Z*PQ^596+3*B,S*@Y_5);I>C->1FA<7OZ5(191RCS) 9Z$SV8S
M0FT6/!"/X&,YB;Z8>VQ'74"J@PF[HX/CX^,]^5:T_I(8<9,S!Q<7WIMQ-L/<
M(]A-=DZ2P81C^[0#750W:JK_FG'\7M0D*I(2L/S9PVLA ;NBNY#Z7B\4BEC
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M&?WOV1PYWKR:SH7$C= S/M'49.-@0C-]_2JT<;FZZC/84.L7$6DINY(B=D.
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MV--O^**?QM5T/1V_E)^W'UF#P8$*7Y<P2["9DNN'3N?QSINFM4#FU?6_G/H
MT_6KOZ\6Y*/WE[__,O%A,ITL)[!XOJJJL@Q^_\9>EB(Q@F42?%9$&)4LS=Z
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MX;(0,3EF+;;\[P 84\0/0=ZG3RZ:?'^"L@-/EHL-E,/:Q\M4YUL-$3I$:A0
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M[: !NLH?YU#S,8#KMD<;L >TE%26N.@ET4*4[Y4-+C)L)Z()8PRFUAA(.+!
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M+1 A$TV#-*!2 O18W@DP![1EK]O6K[M#E'WCE[F?W;I:Y77SGJ@D@'A%#<E
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M-#/F#6 T$Z\+.IJ9,S+'Z%5?>]<]L$:5J!F4+AU%U!]W=E.7ZRU4)R!6!$M
M*VDX2T:CYY/;Z!.$\95OKE_;F@WO8 '5YW4+YW4[&#]=--O"-&;$!N)X?1Q2
M\$!C,2\\?NM.).RCULG'\^W!M36$B/M;@'<-Z%U0ADIB%;6$428% ^-"Z'TE
MWH4T)J=\"#IU$ A2^>,NH@-G"'>A"5.W48R,Z&2$"YJ%LL&T*W%L^<0QU7HC
M4J&_6>^)$#<ENO.+R_D,9DO60*4R<5#G]S3URKE$Z>Z5?VVYT'S8F.JI>Z=!
MQ[D>B@%\%Y6K,\O% 2$V&08I&VI80&( 'U,;H^$9<-Q<]V<ZM"GQVC T,!(<
M,T1Z0V,$+ZWKW8KH5*XW5$.A(0P*'#'UI$A>SV?_7>SC29Y >K^<QS_>7*XK
M2=;NJ:,^$1UC725(39F"&$FR"9R6R6??LG-:VT>.J7M/[TH%9=[[4RW?C)\R
M[.>^JJ[RO/KBJ]28 Y4C"3(XPB5W$8K;Q'GOL<?#\-J0R#X^$O4MJ/Z85+YY
M7GZ>+!O@ZN@7$"F9)R8Q2BP7@D#RAF6KP 7LG@PMH;5AD/N.&(0@H)[VIMW#
MLKN8#'?$2^](3-E"5 ;2J2;N[J-:Q=#HXV-!#Q/=J^K8">S5)GCYVV_/.VPS
MP(OWGWP%/Q8O/=U^0WTI=:-<0R;B&+?E2RHCXM))B7ZFOH=QM.+C]QW4[5?V
M_973W!-RMIH39^H*HNRX$MDPSK'K\N[#@Z6N;[>SNJ]!1\-OKG-J227B!<LL
M4\N5;=FN_OB'CS$MTIDDA_1Z+Q)!W^;OE(UL:WTJ/XN?)O5R7RP;<R$#E-4;
M8OF1\K(W&>:/#VL^^-0Q9CR&8 J"#/HP!FXAO [%%?V_:[-<_ZI9:VN+X6K6
M<+.5,BB&?H7UR6#'F%!!8]JPHNR9>:V#>#1%XGSYPEAT%*PR6O=5']L2XACS
M-0.Q#$=L/7.K@4477]L:(#&:&+B$*(0;A$+H+ERSINK.0&,@5G))0"CCP 7K
MC#IG@>:#5N%@)6FGTN-!QZJ#1,[B([$H2)!ULUDADA0I.>'[XLC#/M(XC,$>
M^-%9%$-5UK_(&>)R\OG;*>=W$.>S6#!O^V%@E-:W?0IR;?U)@T/MZO#P\0I6
M2!!=<1.=""XFYT%C7UK3T[F? Y-ZX&G/EMMS)_4)UU7YY*MO_]XO&X5ARECB
M*=1]\107"DRVT-MA4HP!C"D>@L&]_=T2SB%M_'/,=X=PY\CU+>W1\-1%)BZ!
M(Y)&;Y/+2NQ&2_JBY"&(8]I-!R0=BL3ZIM7S3\4++SM/R\,+=TP.YTFP(1'I
MK'; ,[,,N\"H.^HQ15L&)%]?<L4)!^\Q><I:N3N"U_/:OEF5MX4I;"?L3<Z3
M"-6=K-!%?2%U0U7+2$(HJCJ*3+5E*246'S(%^X$VID ,)@%'(,B^E>,^Y.U3
MCZ:^UR>$2(06V@IPBJ=^FF]U!#ZFPMX!562/TCVOEMS>-%W>_Q9F?KJ\VK^T
MA(_$TJ3*=Q*$4W4SY7YUY %@8ZH-'HV&Q!#B.?3CKU ?O)NE%W7SNZ6?S/8&
MWNL>J#RYPBUOG8E<:X,=[.Z*>4R5R6?6BMUE>@XFKN_E;80S=2+.AD!HTBQG
M9J2V SDM!S&.J7SYS$P[7F9],ZNNE%TWW?P(Y<4]\?' ZWO(%?'6LQRLE%EB
MIRI:0AM3$?. /.HDH>$LM?V%-C?^>;6"WRZ_[?&QS(8CSE!13$WOB T^$ 6!
MQTQY-@;/4&N/:U3UT6<QU'J2(9H.:S.&_2[.BZ\1%G4![G5H?&<4D2M>;$PM
M25#,$,^#TU;+1!UV<R7L,8RJBKH/M7A6H?>]_:X-@F?I7ZO%LC8Z&\K= ".!
M&DVX*"L*A+')#;3][D)K1;3O,,_1240]J[Y]_=(;<T!-L0]LW0 YI!@YTR9@
M.Z/MT0VQ!1R9]_09B(48")?>"O @06(WB46 /:;<=D]L/$7U8PI[6$.E9?XT
MB4RL<IHHI3DHE5P$["V@"]XQI;]'Q$L4\0Y*R XYU:R .)Y9&80U2ML<06 7
M4"$/84R)\Q'1MB\2C"ZQ_A:JN"?,ZZTAP5I%=-:!.R@SNJMM^\^L;[&-*;7>
M,T7'(-U!E6VW[&SVF?@$D3C*<G1*N+*#G$'?/MY$_(A4;H]4&%FB_L"J=(81
M;R,E+GN?6=+4>-JKSCV$;$RI^C%K7!3)GEW?MLK[VOIN>.8X<4YFGD!J)K!K
MX%$',*;$_LBU;'<"G)W#>S/*.DGB50"20+#(@Q8RGR./\2A* D;.T>,%/"@G
M'\I.!Q>)]5R0)*ED#*3C%KL)VBDXQU1,,"(&=A+GN(H-;IDDFW1?9FS=,M 6
M%]!Y MG8%+SU5.,Y^$< &U6YP5B,S;X$.\(2A)UA>,*\U\28I,M4EF%(JX1F
MW')@YU"81PUB5$4((U*G_3%A4$(_E (/@1(?R]:@(W#%I<T"L ]EGH)S5"4+
M(Z)E)WD.U13AN5]\>NLGZ>6\NO7J:UC.<_F\U2PMRJ"@##3AM$<X_GG(C1(Z
M#AB[90(L:C#?;@US@3 C'#$I9A*DU20[FE-660'T=O#K!@5: =9ZBC<E \]R
M\?LW<WL]M;N#Y9*28$ 2IVGD2N60(W;KJY;0QE0 TI$E!TNO$(6#7[I7@[N3
MUF\!$8(A=4$8$=;)9$*D(??60J,-P#&5:_3)(E1!];KG%=/P8K+9B/TLW7&_
MU^U-MX&@\KOWJ\NRI]7O]-/UKU[-\KRZV'I.)V^"N  P=L4>IP1IFUP_:U\^
M+A8R!1"BZ*1 32&3 X-] NOFX5U5V]T^NON&X\ 33U5]?XLTB0&E#+ SS4T4
M8]KJ3I/TKF[J.--HFUG+&^"D#"2(X@$HI96028!)V#6QK2[D0QOA\U55[<M0
M4EU\*S D!)=R-@4D>E_*^Q&-B>L8[+B?^9WDT?<J>%U\Y/VP N7$Y1!(I(E2
M)VS(Z%&Y!T&-R70;D"DG2N5<-MNO?KFJUKTFY_G.0-;=R/LPTMH\L6>K[.A!
MHYEABP7  >*\]5=KL#^M&K6JS%-BI15$QF2C]]Q9].8U;;$-M*7[3(F'2 G+
M6H;@LTX9^V*.#G?L#F?.]<"8EIKL*)&@;7;WCOBW69HL8GTNLKZ4ILY+'&A4
M52<C#*,DE6V9<JI$,G;(!7,(Z)@VQ4&XU;\X1[QS_LZ&WSM_9R/8/7<'?N;]
MDZI$ DV&<&&I]0)RL>X>Z?[9]CG_#WSU<O*Y,1<F21)XY,5Q+[.A8G(L8/O*
MQV+\'G;<>SEVE%;L*L1AMN)=E/-5H^Z/4T%LCI(88:CEX)2.^,'%XS!^#QMP
M?U0[5HAGH=J'+_-&A:FNHY%>D @L*.]"\NQ<#M(6XIA.;(Z.:,>*<'">K5-P
MA[2O!$]<3HEP!47W0HR@L,^XGP1T3$<P1\6YT\4Y./->%UOYPQ>8?H9?B]']
MJ7FI:U#$Y\"(XI):)[CC?%#7]AZL8SHR.2K^=1+J>3;90J6FYY_JBR<S$ $<
M$K.:68M=.7DTR#&=@AP5Z4X38Z_AE/?PL4;W#B[G58W]PWSII^_@,\Q6Z_*(
MR<?9)$^BGRVOKYSV2_@XK[HE(Q">BA%2P1X\:@GE+_/%XF7A\[X*W_*.Z2J5
ME][6P.LF1LMJ$E9+'Z;P85XGO,H_JD_8EK>\J@\G0K->0&=+?+",B.RSR5'H
MS+'##OV,I*O6W4KX&E+EX_*?D^6GYZO%LJ"M;B#5C4O*G[J'26/!UFEFF1-)
MY56KLW9E.I$G[P288PK;C(#%NWJZ;\&CV05U?<^;7-_Y6Q\O?@_5YTF$Q?OY
M-#5,Y2B(\W7[)\>2X%%)4-A$/(SFR-A-OS>%CI!P2')$X]5[6(^M8/G55W]
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M#A2.LY1(S@25,H1N-14R'0X/M),/F3Y[G"UW5WU?-V<=1M,@S+5E@C.@(71
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MV+1C/QPG0I >E9$AR>>-GEY5F]IW/8[ IZ]F;W19WD6:S\-HGZ3"G<- 4&R
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ME$6GHU'W9QX_$7(*.8,#J38(.\KD^Z@ZGD4KJUH"JZ7P8O(0QOW:1U'Y14[
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MU_Y$D6YKWY<X@*T=[Y'&I1&"! B:SB,F&3 ..<"1"Y0+;W#(T]7\')?6[#1
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M.@BBW8J->\*1BIUUTS%2L:M@,QQTWNM1^3<]OO6O[^:%M^?6>AWQO1) ^F"
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MJQG.F:O[<C61JC.T.ZF%NQ!_96:_;ZI4O\'B9H@!&:P'6GGII#?6VPS->5)
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MVHDI!58+29$-WNA.7JI-REM^Z!$J;V>993!6_Z;+4;6)5RUCZE83:PQ0!@5
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MJ%:.YBI9^V]%E9!554^NBMZN#M%+ J05&&!/E/+":\=2UYGM85@#9'7F(\_
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MKPTJ]K;^C.+G8,AA0F\T/;.ZQ*ZKAX?1/+THS_3$O82BC/SLHYY.E_59C_"
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M(H<[\+>Z@328@L7,$]P#PF+%6J-ZX!["C%CD\RUFJ/O;K,H"QL10O-0/6D?
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MGGLGKP'X)#H$0U)9YI^AX?":]IFR\_: =8^INW[Z.S<\EV'T5'>J6T=[=]F
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MKA+P;%Z8F4;:/N7^&"9I^75BG'5XALKB74T=$MR_I53<%&7MP P-C$L*=1S
ML^\[W!O;4TOA/RD);7A0+Y@O,/4PJ_GBK.U\[C0K]8JZ7!3X:\_*8ST?U3Z-
M*35DY0R7GAI3W9)6H=IV0=SQR[L//VG\_G^KEOWDOT/-/S0Q/';WX(QAL$/D
M9,#[5I/&O3.&M-+&,P:>T\*ZXS64WQG#" Y[QK PM8=CP/U"E.?_=]=K.[.:
MV"",\J7(8(4E;HU2W[*]=@V $:^:Y0SX$BR)2AMN:+0)6+'[:T.7D8L/%]W
M9>0QP ='WRD*RK],G10\(DKC Y9#2\N\L#:&+>/9MBU/"_8" ,871D"P;TEY
M]/WS2QS8L,:-SC=[[A\L+X[5OV8E@QV5P$?UR?.FI13@HFE>(<)RX#'YBO^W
M]"EW]0=6],BE!Q?+<CX&!#6K(ZB55!:O]]Z^/)DGL:Z0#(L=A;)Z3\J,I:E5
MXI6\VXC* @]FE)M6=;.V#0&4@CA$-91E\GOOV#%%N\4P00]%;&QM784&CS#P
MTI#D(*-7JTI4.07:8F+:<\,]!'U,:$W9SF76?]$$'4PT=X387*M8+BULGQF\
M*U)P9/I:S6/3!!.\VCM[MZD@JWS/OJ[+Y[&G4SW_E43_O8944)J)]W*>DQK)
M#%YO*<I7!&PLA'2+6',).D0CNH+T?NN=I5IPS\?YR1"N$Z<%X'#@K:XG[N,U
M#G>[03K;:\;0LJ4YG.5^>+_-3<Q![,GG6H-KNYX"*\I6=WINBM:3,0B*V.P#
MM79;$H)E6"W(BLNEN'*TGVG7QSTQ,_!XEZ+*?&XS  H8P%DU3-HD4AV<#GZM
MT_W,470)^ZEXAD+4JOM<XQS/[72M27CBQ,36BA4I6%JR@5BM0=A*7HVI^6@5
M8P CU(A#KK$TD] HRT8!,;[U@U30M_ZDELHZ2[F9S+"I/6X;NZVVB;UK/A\J
M(0YPRYF>FF$[$^L.SQOUEE%.E&:569$.C3EDWHO/\K;_+#1_0?UQG+<I9M62
MO-[<G6F.O[9LH&R)EG2/<*GTUC]2>+1G'5O+H@W3Z!3[VE#_]96IWU?:H\#8
MM#<342+0?+]GQ5E[P4="!QJ(K%_HTV<,QIE^7_U%-F)-FTQ-@HM*F^>-RQIJ
M]T/+PV(<UK-J2UI4DD/LCS\&Z43R\AL0))@K[LN2UW+'AC7UXPWHCDDHCZ+<
M1'TN&-RP.*_Q4.QM)R/:1G3/;UV/J<<G<P)A(1 W*"(F9F=S/%:VMY2\V1(!
M*QYNQOU8MAK3U\@/ZYQ_:B.Q%\.ENI)H^KD[,R$Z'-N9VA%;)N%IH+@%HN?>
M=N2*&0IM@0'?/V5NM+2;J_O<]/TZ3(9_5F9Y\]W3K9MS5J@';HK7?'0@V:T:
MW/+<'LX(MK2$E51Y?&[N4%'.P)7O%&HR5YH0#V^3;;)AE4F>A;R=K,\+DA=)
MHONA=1]4=!Z'"18GM9_\/BE']=K5#UH8;H 'A?1_J3KRGC=$!@XF6?BKP5J
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M<9(^%'VTIOGEI1_)N(SKTO$D3@9:7,6YB2\"6L^-B5'\L^YV>$?:A3C?X7)
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M1(V2C(W]F 6VVC:;LZN<'M;APYO[*J'8R:%?#*IL]P]O3+"\MAQ3'UQ4*[&
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MY^[4G"*MW823J]8/#Q-[%NOM5QF[3JW*)QT]XD[,_9TDXAZ2]U8M8G5UKZU
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M<#<6L!;DF<34-%994XJ/T)?4T!PIIATW$^&)./_:X/U_+KGB%M$?R$.GJ'I
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M&[ZW(7Z=14;M7195:'0V3SYT76@:R"EL$0;M+6HC4$^A_>>\8#E5CWB/0BW
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M?C8%J.2-J?O7RX@UHB]1.W,;<G]_$UP)%5N3"?L<-[&+H7+%57D+6&NE.]P
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M5\_Z6+"*?PYF:B,4^F'VCM^$G#N0ANF4&^E5T]=DR9@)IR;Z?ZHO5=0E5X#
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M:_R\H+$</BV0K*Q)1L*)/&=Z[DYZKE#$C@'\3OK9?[&2<8;"3W*FR_.Y%DM
M0>^K1,C[/A\]/=-CN*&HCLOQ.>#X(ME*.G:;[PLN_\>_?#2"DH4W-=7F-6O4
MX0SRAFV [<+(C_4^);+'FK390;E6&+J$02TA."([6+$TKWYVJZ_+0?Q2>T'A
MTF?_-R.L5HOB1P%L\NRUIO5;@[\8U#DA_BA,W4KN383P[0*5\I&?W)#;TQL7
MX9NL0!AA_7I)KWFR?:2#TE.-^,41H/O">FXIR%M3<\8TJW<P7+TCPE!M7B']
M39]17YQ$87,W+ C73*[:DY$X6Y>KUZ>4B%CR9,%#7<0^>Y"Z"+>%_QU6-EV'
M#!;[38.Y#YF*V5\S*4J/XK['*V!O'X2.D:H!'?,5KW77-FFY0/'W,II?=VQS
M!G2->09K8\9B \63 )6,G*;90</=&VA<9;9W:ER1BU?]1$.6/["]>5%P=LQ;
M]<29;*S6H,H7V:L2E>O,ZD]&W])UC&"2<+41,1<? T_/U)W>._!)0&R&1NNL
M[Y)T/1JMC40(V?DM">ERHQ-9KOLX<;9,J\YT!Q\+E@=UE$\X4&&N[=&/76(4
M 0'*!)F>+-:N5J[]8ECS[3W=XE--6%\X-1]H[&L:[A4E[RZ*'(TE?U@I7>EI
M$/?&?7HUI (O(?E1!#R%-<?4-2TCGOQBT+6[-A]\(9\:L+.Y?=_F[?MJ<SN=
MU=1KW:1P"Y_N%EX30J;9:E?./!)\00N8)W$.Q))LDPYN>R\,8&/LS]T+7RR,
M'5XU5.AH5E6^HFA/WO,0U/_GW'GW'_BRJL@:44.E^3N'_4*P+]6 D4_DRD_-
M\6JKR!K[I4Z^5,]Z/XD>[VU<$'>2VF<[0W\(Z^;I<;W2D8Y)(KZ5#F]7ZDC(
M&(DZ1>."6 ZCX KV7I.98;@ZRX??NH,X.5^.6=9O6IG@*/JP#E336&)Z;&JR
MDI[9I+.&;LVLJ./LU%A&Z0^5YX>PR90/TY(0^^]C*@$6!P)PR=YD\U?48//V
M-.#K#G,O><=(+ V&\O%WY0>IJT[0*^AH.]8=@-T?\X^3]XO"$^6@;^J?]&!E
MBE.WA7KP6<Y5;O'(Y$'3IA'SQ-:!EHS!/,T"=MIMFF)@?'WDXEG?O$Q7][3+
MLRJ=M2][KQ.J1%OT%FWZF_68<E>V7@YU$0O*L(N3S=\H7,D=1#J/_UKP8Q9U
MC"HX<395ON=C'\>*2 \^(]:TU!Y3Q/-:,I G&,1GQ9DB\1$OC+G#?*X>_(MA
M73&0&ARM,&^DM2N4GU*W=6)UHY[JF!W/AC;GM*C7D4UMIH@EWOM6L&B#*S8^
MT%SF*TW&_&*8/*GZ/[A[SZ"VMFU=D!T<<0)LD\$F)X')&;9-LB0$1N1L<I1
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M-W$BY7Q?>>YW85[-/#-UGS//E?[LX6]AIS)=:A9\IO0^!)7OA#OOOH!50N1
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M@U]PD^.RQ^0><LO> GF:OW>A^I?=H.>3UXM;-&Q3DZA')FII=$#UU!U6Q#L
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MCV#A #"F_J!,9! 7]]8[KQ>UN(?)\J2\TCG"I4U7E/MT3>C6U=:#]*.@<15
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M!W 4T6:93(KMOS@QM#50+[<F.IN"1<?!<@RP8[!\K'QI[KN5H_^;C(<;@B3
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M2:?B:-:Y^4TU@.IZOV9WL%UR>M\=ZZJ<>IT3/=GQGN3F+3?XT)ZP.R_!R&Y
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M;>*O&.NT?A%8=A96YYJH&]<T4\G59P)IOQ_]K6T6%+B>#Z]K_/H6'GZ@08=
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M?ALUPH2?!N,]UV ^7Q>5NE;8XK(D*WQ+1N>SY;@_I<E;[E?\6- C1OK4Q5A
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MNOM["/9.#J@Z:CY=I)_^5&&I)RFM>YV<:ES;I_=N Y+FJ97E+,R=.T-)LSF
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MGJO;C A*I9_H%::+@Z ]F92^>N86%!AKHN1A(1AL;K\O=L[50:=4O8 9@@[
MJ >UDT7L[8I9:_2IHP1 V2#5-E=&P=3TY'K2L(020:0_U4DW+2V7X-=B,GY>
M%:H4]H1*M"U8RG./V[:A&?]& P =@'';O=+*UR.,<F%$A4UI,D70<8@7C#ZD
M\WJ!^<QY&2%'V?+X$]!^:YR9TG9;HJY=:YHTF=-@O642WYCN4>K'AP48RY2U
M?45DVJ2GD(_6D2MSED3?&VG0OIX$';&/:B*(J#"K:RJMN39&&7U/4YZ>04T9
M'N!5 1L(X#AR,5;*?-='::EB9MOE0C--SS)OE+\M!1+$.K[^[,2A?#8G;N7L
MFBHJL"KD&8CSR-JETLMH8]2@[_DEBR36 -\@<V!L7ZJFH:7D=(IG:A.HXT;G
MF!EHG%G^9 ^U--!5#4UX%GW('4J'T9G?YD=SGO:"8'G\&J-JH^B^O7ISK):]
MS%=#XP)C(,0L4)ZO?JUUM2Q2NY0\*]=X-I^Y:@V<;26[5#1EPCW']5,T\B,@
MC71RDHG&(F,$YQJ126SD3WUFRS>ZZINGM<*@\G=H%_]PK;W*UL'<L7P15')*
M1*WB=ME LE[M4KEV:&6NU6NJ2I1LTISKOB*-TTS?MI:?=@2-A=_QQH?+XQ%O
M*7"242B(-0;U?&<,=O#$%?9Z,WF\11 )XNI?$T&GQ;-]BS_,/$@K#?!LEW%B
MKU_P3R26>]]ET06OZ%!, W<BH9>-W&6IM!T!X]UR'-V$$_X7BN?+TT2NRV3C
MLO!70QCO\W:P=ANO1][TJGN*9]TT_-@@T=BW6A[W41S"#.]$?JOF:WD2_QW4
M7U,!;H>[L_WM?_LC2U\>S[#%34I4*F=AGD.&7*94@E(.Y VZ$)V])E6JBB0O
M1&'GHARC,!2?\:%^I9ZNWJM]S85MIORI:MQI.HXCRA'AL5/;8\B"D-Q.!8V7
MQW;&+O@RY-E6U^E^J5C+#7O0FGQ ^V"<@5M BKV@WE5K-_N\?F$8*?K'Z>K4
MEQW]UBG+N;G,VT"+D0B'D]LK,I_J1?18XITH;A%^ 2=XDU/EP4H=N.<1"*Q?
MADFW;D.=:W_.) _^"I9F @7K ]S^2.=V7>OM!H76< V3 ?0Z+H%AZ\,3&7*M
M%@4V4L6&%]Q3EQM:RH*R#:W@O:M;WFU-;_MK["\;_.=;-C'DJ^5B2H1*?<#7
MGDH2**>=T9\YV_?NVW[ZUQ%+D/NG+M/K4$)4&(T%<* I.-X-\%V(P?,VBT^^
M$>.:I*PQY,]M8HCTX9Q$TCK;AVVU'X9>G*76J_L[/PC>JX UF:N.GF2V4W2T
MNJOQN7.U[XZ #;GCHKZKN2\VPQ_64W;JZS(1RQA\AN\XXXPGGL[>)$:VA@'S
M]Z?WP@^MGJF]NL/'G0W*!OAQM=YA7(77SCN6MT+2#U#H/)Z9/)XC-Q3BS[?W
MBA'&===4]Q?5K0 3(+O6Q%73N2+(.1K1I5&!"(T-84#Z03E$[KT_7(W1'%AW
MLI(#?3)C4(I[ ]KW4KNF<IMJF:/.+FJ&_V[M ""\" <5;W#'.4IMK.]_%53+
M7B\OAD\O/A/^C8I*%KGYR]^XF-<KV%&AV8[+O39RLG8+8Z]E$MX;YZ)-]T[=
MJ$A9[UQON];D=<_\Y[& 0<B?Q;#(@+C$K$\__<\DP'_2?0WI+H8!/KPYQ+2T
M)H0]-<!I6XYW]AOI#<WBA(GZQJO1LM$T76=IV+M B3+)2DG9;&7^M8?2](F(
MJS*(B YC,1_6&I$JA@%.$*3JA-EK:/<>ZJ#*(&8:K@WQPWS#+=3'9XM?H1 '
M< _U2>5PA4 94&M,K202Z230,E(\PH,0A*&'N>+=R=FK'SA(_;^-1.NP3N_<
M]9)3TW),+KI0J-1+ZN'DIG\AC729>?4Q%E]23XK]<,2^6I.A$,=HXG2_MC/A
MX["8P2ANU"YX'A2RIC86-N'P:3H6OVM\GEFPH$*H86T9B,F?GC*6K2L8BA?&
M/HK'K"94&>_;]GT<_B AQ5:^]")#RI91&=! \$C5\WY#A!!\*WW#LDIO0E(0
M(=QVB$0&$OK#=Q;66(\:,%T3TQ52.6#UC!;)H%OEG:<P]7#BU/W";J,A&EV(
MV8BKW0F_6GZ*@]Y$K#Y.W0'9[I*6*=<W81YM2NH5_)U5)?@PE)U_N4A0M%%5
M=6/PN1T0;=&MPQ =DF?"^)9I.KY/L"$OVPU7#%I(/=0P-L9U5DEO2)]J-]\Q
MD3&%4?(89S)AUJ)1: ^M"^C88FQ6EY!A+/YF\A2=_&)!G?@]&1V_!E*>@;P.
M27(J[IQI=S5EO)>-F[GM$>['51]['_2JQD%QZH<+)#3_FHHS)O.D&XN0WW'+
M\1TD'DMMP=Z4A;9AB\Q*1<E95LX%>0Y%IU.N1DQ.?S$4YNFI^YV9-)H?U] =
MHEE8JX;>K#'J\SQ5=75K;'E6W#659-OC%]ESK8TS'>:3'.'OK<.?FP+9-1SR
MX(!H MH50M!BJ">&!A_N(B&]UJ<,YP&7##ODB.-TPV2!'VV?VG\<R^'\F+.6
M@(YSGW#D"Y_7/23&()0_Q" H<1O3O10CCN']JGAZ%VLUK_MA2UZDVEJ]^IW/
MZ9)N-D IZL8<G<2;9FKG"/"H>4'E(=GR"?0K0AI"7G[UNWLLT*3%J34?2;PC
M#IF"&D-ZQ^H3GVZ, B]D5S^064W&$8O"=Q;S4]Y6BW? *_L!7-*XUR!X;7#B
MG5>/WW-E\8O^\;&>G>RK]-O_R,>F' %Y$R]L_QW5IJ#S&/Y$M?'\0*4_46T^
MU6@0RKC=5L'YET\=Q6Z-<=8J5&A[H,]O>3R0P0] "*Z+'V@7%%Y<K6X3F&9F
MJO+3KHD0+W=>G;+KE<992^#06.9LL:3&8$"(<S/Y7 #EDT1M-$(^W/[@A"]H
M+[;FD\'KWS["J1;OHN*?_;M,WV ]T'UGU-.[9'?7X8[.'MQG0,VZ9K/T=KAO
M%2EKW3N!9K VR<]V.:G*N.#M(\^L,/;6VA8V"!YVBH?EO06A85]%%<3:;, 3
MSXK5;I>:@&9=O0&ES.B%O#.,L,)YX[XT8B:B_.&6S)0%TV36K50]Z)N>V96\
M%Y&VV5$%IZ^-[S,2;3T<TNFURQ*!NCD_CDC^=2=.M."#$0+%P#VWX/Z+7PY3
M!PF_9)!$T8N:H>NV$O[=E0-/^XD4"9VP%S0I+P3%:JVA-PUGHXB:LI7G]N5\
M3D^FP@R9HP4&9C[VK4VN+)YZZWW.L0?2N*/0AU%2[]%Z8_F)91L()E>SK^G7
M5!)]54,9HFS3)<5W-ZUCF:ZIH!K2Q<M>3]+*BB3UBK*  S&$ BT4-MUC"+3<
M^+Y1FD2EH#;!+@XOIG6-:8DC'GUS<KNO+G5I&M48D=%U;*5>68=-1C8]H^X]
M<QW=-WVIR#2+U>UY9?$.CS66[VYJ:4I@P:$%&_#<6J@(>#>=%($W&Z6ER#TE
M13<#2P#Z>UC%Q=<)E=S9F90]FD=]8$ZQ3HU6JXQBAY]6I-;6GVCG2?%AQG?>
M; 5S>CJ9&9&>_=?MRW^3A&-C]WJ;#7D2M!CU!:Y:!3+7Q7E'[K:J7"*-+P6.
M^U* XJ)Z)Z#,SA"K84>\*&LI0A"%VYR .E!:VKY)$]:Q#!K6,_L41O>^,I;I
M[XLP271JC:V;&2_7GZLY4EWXA0?[V[_!C,<4JR(XT:KA)O>G+Z04YGPDGJ7Q
M;:*":(.AYXWS]=:I[:>3":%<C,DND0FS0#WS7)74.EO2EDD(4P:33A^V5OIE
M:W$C#>0[BAGWM'A:])RY.!IN.ARUS:R!^%!E,[-;UM4JAJCTM# MSG2L1E3I
MH%Q2H-T @.?K?5S5;D%-*W9H]Q;)OVNQ 7XEG=S"K]%JDS&DR8=KLH.$E_NS
MH)N^!19NK(MS<K)/\F ;L'Y3%=X^&C4P(M[6><]T*9=X<EP[T<8BI2S:JKY$
M=WI-E>ELRKJA.+6ED*_-VS#B'Y>]CF>2U%K?5A= M%9LCZSAU.^*Y_ZCFIG_
M3?<R%Z^I0IJ8^F8:.5W8![,GXO=GA(KE79&J7B./" T\*>'@++AFRZ<9-#5#
MGF,7D!)#$T^P)A]DG#UR6#2"A%8T!:0%J:FW.6&T!^6[JW$4;NDFJP)C#;O
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M /BHHFL:.2Z*TP,DVIAJ8@S<ROK,,6"-R<0[T!NOBK,\YMPFQ$Q9V+D^=N_
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MOH8<*0R*REPU@*!G%>!Z52&==22 $7?GE@ABON8UK !SFP]92@56:+E*+ Z
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M65@EHH[$QL=JFAJCH=PH-[7YKHQ_;O2PRR/\$:JBKZ=Q2 CC0\KYTPFI/C:
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M7Y(T55!?1$=L?N0 5#Q2X\Y_L)#Z,I.QFN-M [:P14K=+3V\T,[XSP;K[QG
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MJB9[JC^1VEV+G;JDRU)JF9^8FX<FO2/,/R)XVMT=RH#:A9<114#=$SB6V#,
MQ_:CI^>P)!,XB+IGG218FFG58NK=H%MO6OJ.J-E;N"EVY<O3$.M(0^@Y+)*2
MQG\W5EWNX:% %.'KIV[J@LA1H0(QQ!3*,-]]](!7;J]4)S [I+.AVFB\D*,8
M)$49P^2)AQF"[UOQG=R7OB6K*.G9E^,[#TM=MCA KP@ @-1B2V7K$=[4"91N
MGE!J+O(>5$Q)"=EW( ,U->22M,^;]?TX@7HET13BGBLJJ4^T^O99SY*9GI+B
M>X]'/.!&DL$T%%5THM[[:AE!'B(D-+_2?336,L/EV"J>^G5]/1_B)Q9-VW<U
M^'J20FGWFZK7DP<MR'?:&86*U$+W-"N,MH'U-KG+!I4FB[FYH3,YLY8@9J?%
M[?#&H&I6&J^6'[-B L@D?EG2)\'V"XG-2)SOZ5QX;HC$'*<.V:0(5&\O I(Z
M\EEA#?=0:N*&:Y'@+2R!=@X&=:'3W92?^R'>+2IY,F[0*IDMZ^BD;>2WQ9H3
MBF 3!(G9-ZROA!*!KN-1<@DK9>>'E7=44:J<;621!FVVM-!V/;N=O]E"K[-3
M,,\EG32Y_E18^!SX;./,BC\O1R,T\&J2GE8JY?=]LYV>V3\G+WRCW _WGV85
M$8R_PBLWC7 );B.MI=$;&-)4D4WG1S2E[D:T_@//)M-ZU7 A_SUP6US(%'5M
MG@!"+E[2R=I1:XZIM5SZ+/#=^"6-ENXJ;3*"9-L9M+7U@E3L%1X_-/>VHA_D
M4%FX33_1Q^,?ME#N-F,@+)5 0<8[B)E$,3CUF+T8K^HDMQGO_L#O \0X2L%K
MB.2*PK(DM3A^+8$@JRI8P]K<4D@TK4W,GG3*W[0[Z:";#/?L(/Q,\.CQ&)%J
M4J8>KN::[E)'#FBZ?\A_"_Z/B+^2;6TG.M7.9',U[J3N?EH$$_I"5)7[6\U4
MP(4W'FV3^T-SS6$IA$@A*,7D)*N)@LY[78><Y]XEXUV,Z^8UAR5H#C8\AWTP
M3;&Y$+NO/D(IO7L/N-KA6XA!\VBB4XH4=J#<P7$Q1=6WV]E*"M;EN<+\C5LK
M[B;81@"U^U'YE2C4.-28NV=5V\1)7\:=TQF>1EQVKY],T,0 *>:<_8Q<IK?@
ML%X=70.$^76YX.^QY%&HE=)?!^95/\\I8J]VL.0XO,M\7Y\#?HF\O3#I[?VN
MI^,K]A[6F\3GT%7-?Q;IB(RFB<_?V0B EJZMS?'6X]K:<)D(/X2,9EQ%16P$
MW]#G;)%.97X3C!A OWEOJ&101Y+EJHR,"K.2N#CWHYVRZ%@'1K0#8PV0;X0W
M[O;,40@A=$9"MF7[\4;+G"C5VF>\=ZC?+=,S:^4?O5V&#,NVH*7]^(^'?&MG
M7M25'#TLS3YYAZ]_M6+C-E#T20L>_CFZS ^7<3A:D(Y;ZF+?PZ7@)+9$DU.&
M=T2%<ODVL6(//IBEPHS.E-O<G?;>EMJ%.O4^$WN+UYO)+;@#!B<$[?@Z+I8/
M5L#]@6W)=O6$X&HAW6/1,U9]*A#I_1GP[L *_,M_ODGK_]_8V*/;'YN-?H7E
M.Y5(F7R8>GTZ")+IM#'Y5)L9;1Q>P%(\%GP:>!H7,E1%SO3!!?:9#=8?KO,?
MK/J"NZOFHSZ_7#!GN;G6D7=3#&P4AP J!^X3]%N0A#6Y(IO_DAOCEW0]U^+N
M53>K=?O;(X(LN^B-(JJO5_B96.H_L'C/3>:<&^OW;7"[+XMN(QY!V3S0A8#P
M>WYMX8U+F<[!<CD4$=^!=*IN(#*>&JB]N5E[AO$9[>:X;Y2D,'5Z<NKV;9G=
MA6>PV0@["ZYQ ,#OQ;>1_)EXLZ=\HINNMKBA6VW/+"8* 3H9+_?=9)JI?_Z+
M2TH__-TO:.%G%R^4/EZT;&F5_30XV9AN&U&,.'D2O]R:?TEW;L=N0&/H"ATS
MR?EK;Q#ZE]LQ8VW0-<;B?NC.=%Z25$&4U\.":FNT0Z7<@>8W[P.!*(:F(9F"
M7)'FCB&)-3-"/+>U>,.F(GP;[+WE30HQ!=]Z65!KB+MKT1NR;M;:E1FC+U(\
MYLZXW%SY;FEQ!<%^EMTF)GEU0[%8KPF<-GE#&)-T\:0F-LE*AUF-^5E7CYJ.
M[&[WF9E2RB6=P\7BQ8KEPTXO@V..IE 'B;8>?KVS*Y=T*F<"%^9NEW3;X?+E
M=]]S;5@VJZ)O^YU.>YBH&K1MJ,Q?1$4<O0M0A1R=*2U<TDW$)ARH"5_2I7-M
M-[Q67;K2>4FW/INFU3AW=@AK6\UN.TOAJ]^?OZ1;.U[*G8@'7>0U[/ONB3R'
MC'-!ZB=":G%[8MRB4GOZO-\I^G6X?^B)"_8")20D5&[#E/(*LAR38JRD+@1
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M)E]-*L.-;^-33NHGNCR%-@*M%$4P>>;@*5IX,H*\)II69! OVQ?XPYDRV\J
MQYA<<-:1A%EL6]$BTK9XGV;?T+($3I=:.P%*4Q%9!4]^EVKFJ- ((4<EFSTA
MN7J0FCQ2@XP(U8V^_35-A#\7'?N@AS560 .>"J;)6?%$"BKR'*-CK&]AJMXG
M[LSI4@BK;')\#QA#65FW0)95D[H"G#FQFZUF7U6'\J8V;/%0LH!IA4H<Q#K0
M=3$_7T0D?Z#UWMR8P[O>LH[>#*)IPX*3_?">XC2XAI0>P:H-5 .?(&(R=!HM
M9^Z_*BM(_H B1O7G#[&IL7O/?,$IW%[B2,G5<P&K]J68K:L]"OC&%Z*1Y#:>
MDV=@%) PEVXF /IJ'4TFZ*[CXBM<4ZD.=TVQ&8&K^R0MJTSX<%+KNJ@XG'/O
MMZQ:LF=5/1.955 ^U-(Z" CLU#7)"LJ?3O4D89.8361!Z8C<Z!T&P2E4?ZP"
MT'S'!(9'5X8AWU'&/+F=?+7QC0#M30/3\RM_)<8EQOPO3MXSJJVDW1*FN]VV
ML8UIL,G)! $" R9G>&T3+$#(9(O8)($ D446ZK;)P1A)Y&23D\ DD<& $1F,
M1# Y9X3).4SW?>]WOSMSWYDU<_=:Y\<Y]>-YGCI5N_:N4^LX5"68;]6" QV8
MF'(.UTD.[(%<5/\2\4>ZS9\GZFM41*@?/I*P$BA= 0A)O2QWV$)U,6(D768E
M^#%EM'G.O!+S,3:RS20VC3FE@IQ:TGT*]O"J\VQH1R=U]R$O6GIYQ&5WYSUG
M\\F 6'^QLOWX_.IA&1>Y1W98TN]T# B*(AN1#+]$<XKH&&<3998^"?' E95!
M>D=UF9!=T9P-,5T_;K499 IC[U9:0A6"<&467&"=[.?7& SPDWL=^\:[[<5O
M<>K,G8Z8RX@UZ&N2N<1VH%;JV7;S%0-]]K,3JR*N$:?GA6<;HBB4]K>K.Z4.
M@B MFB*QJ #)+821E5G^*1$)<ESB2W7>AA_:T6%/2_(]79>R$O6TN2V+ F+7
MA$D)62!@9V4O)CS13@-M!1C)D5S[YB#N+W,626J*[%6U.\PZP9M>$2-N_UC,
M_*G9^6DL(;4,W9YCRHIV39!K:]W,$4%9&5B:]74]P!J;U@NE*H<]CU!Y%Z",
MU1L[C.#+6H_Y#@@[?X5M*TQ4;S=8;U%)J+?99B]A\\(;)"\8!P3 R^*SYCBL
MRJ<X@H_*L\?$^/S0WHLIM*HVH1/I/MH6^C\J8Y6-BH'.M#$N>MI@PT.XEM?:
M6[E4W(Y5*GXY]='WC]8A(LJ(.AR_;1]*J037$OGK-W-Z#&(_.$K4]O)"LF'S
M&3WZJ47L5?-0#>!,T;(U 14:?[A4&1@8O-!=P#=#Z.(4AQ0?+Y:F)1U9+C\V
MT6@T.\2(53?)LF?$J_4"1CN#%Q]3&_6_\E%"QFLF+^FJCFC#M?7'7')CSNLD
M0)Z:;1Y4)F:L&?? !OQIIH<(YQPRQ;1U3D;EC1^V+RQHZ]U &7T(C+03 UM<
M81 SS%UB'.]2"X:V[9YNZT2-R;_6>:-P<?"Z#J&XPX$Q?V46Y9W88@G)KI/@
M%8-\X2#4LLAK-P#YCE#TA^1M\D+!IU6YY(K0!(WB49]Z^;+1W.D&4 \\-ST)
M)%O6^@CS)O.9T9JQ(8.JF\R%P&_S73*Q9:$RX%U'R75^G"//VO =DF7FNZYZ
ME1LJK_J+U*VR9N31N)4%\C3SNI.S:Z&1^]1U<': R<TUU>?XW&>##)8B%WPZ
MSB<6BJ\RL6*R?[4598W]JA8SA4(%L48Z\4@#^>U/6789H?:5/PBZ^A=F?ZTC
M:D==1.+7\HG.,@:CLN;/45&CYX<@7LJQD.Z:[_:HQ6S+FB]E3S%CL*RLI67(
MQ,JD7.F@^W#D(BL%]SB15I8' 0Y*H5&93ER69\!^2)I8J]Y0 0D$I*V1Q[_Y
M_^6WV4SQJNZ'&>Z9&7L0S>)1YQS+6%0LJL!5B7/^_TTW_A,OS4K<]3>?0K=
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M0^A.TTO,=L\4ZU@P_5$"G=-Z.>$-I58T%<TKW].,UHC_W"0PU,*W-O94N%*
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M)&4=S8V=%>G=V U3&(:1B^EM/ FY*T]69U0&9;8?KJ11JL-ZS+$N,N\37T\
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M*23MW648FG?8NR[MGE>R(?[-=P0]-C<*FUA^"&HCI,=81-M_KW6)89FH71
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M378\#A-9'LISBB]PDU:!"$>8OJ][%29>%E="0%::H^BG\G$GC0+U/]6C8#/
M2>[;%@;+!5,3P6SZA'H9=Z6:?2D1QQK#.7R8C< #$?&'_R:QFG#M,6'=2T]
M(,$4>_?V>D[&U?;.JMA8,SNXT)+_Z%A &;HVC%<JLWB/<<B6J]F![,Z7%:&)
MJBA3=6:/D1&_EON2">7Z^]PNNPOU5$T\8FP26?\IUBZ?#.&^CT<9VBWFK;Q.
M,Q*<XJOO?1S =E2I/R'ON/N&2_Y;=E!AWSG3WU*K"P9WPR,O= =N9<DE<\#%
MR^.0&436D?0X1;'.Y"%#H93<)ZZ*:46_#O*PI"=GPG.-%.2^_.=P\ZOG3/"
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MH_&4S/<?MF9LY]+9!5,=%"OPSG,>*JFC?8ZBI>8/8E@V^$W3.;N%&G?K"45
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MOG *SEU9VA\TX6UL?<J6B]T:'VD^IC?;G.]96% ^OVG2L9CN;747HZ[!G4'
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M9A:11;W6"M'L'=UW6Z^]%:-POS63#C3!39T2MK2A2[J":V/O+.5_850Y'17
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M;Y#HX9,LFV\F0AOOC:63QK$Q>GR\K1:57&.O2,?=Z_JB<WQ=R'94>-*"8)I
MI7XB4X9VE;? M_8J2<YU(\_1RVNJFVFSLU&A6X5^U$F*B;N,%%XB^U9?C*+=
M"4^^5])5ZN_@+%QAC-)>B%H@],#Y@&7I86 UEG?[(G_1N+%KBV_&QG2@BB#.
M:6$OZV6%[:AN481/N;KJ+&]Y?<@^$AP(VAI_&WVD]:*(MB0J^:,)\W3M]J9,
M( .1B&VULOWR$'7\"M31J]YLW3SE/&Y2$AIH$!.P^?>6(;2.,6R7OPO%/ZE8
MR1)KV_@F44YS8GQ.0 RNG#/G[[VU_3[F^ '?2NU_Y#5'0<E+L'$$LW$2#P]
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MWTZNJ4B=^9^',CU^'3,EV:<SSCS0M()#>=*VRNT+5LPMM)UO0VL5IEK5*B%
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M_3&GA54E=_@])'=,%HS#>&Z_NY)2U>;X@,LXO+IT14)J]>['OE[5!L7XM+6
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MWZ[^B*#;VUD^(6MRGS!G6LW&]^;V3^4V(X-JQB:NO-C#\G>10>VU\WB%_\F
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M[BE'_CR]D:$S*]H]8%ZL1.)G\(,;FG9F?9R?#0L^<:R?4+5#.4@[HO+^5;"
M\%S070..5Z\!HYPZQ+.]:T!_[E46_AIPV1YU^B,A]^RS,)C\FSZ4/T>.32CP
M9[RDAV[EAC9YUJ-O>LD7M2$96K>Y6QHC,.D!*9,6C^0GA'\?L!,R-$UEV-_
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MS]VR"7IZE7QA,-W:=52^T\TZT%TXIA"5L>T^$58KD_=$5D5%D/>0'?[<(QP
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MN7D/Y\!-*3N9D9IQF;DL1P$UUX /59*O:1*SC?1&5]4V<J=K''PN4=FL(9/
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MDYVQ%N_9?+OX/D@C'P?,#F=8>P^/VG4@3,WVJHIDXXRWDC*L5,T<MU^5??R
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M[S1^>@L5$I??'Z/6U <ADGPZTA7>J%N@4/:R'.5:UGY;M@'-G]RLYT"ACI+
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M!KT_$'M7TJT NH#[WO9O5;;ZVXA>_8V_B 8N#GF4H2X$;REU1RX87!GN71W
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M+M4[^70F8'EO_%AJN9.1N(^;<QC,W[@;.)EV#2!!Q> TJ?K58?E08#7X[P!
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M7#L[ND<+F20./Z5=>@U><37!:$R9-$VIBUA8REE W:97B?AB_T<E,G;C19>
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MUW\<3'<V=^,SM%C%UML)"-:>_;9P<%) DLM?*8O3087J[*;;L^Y^EFR60@
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MVA0QY*LY)Y'?W69NR7]4H2?.[I7H Z(E3(?-Z8QZDJYI.EINB0/?;&N@->U
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M8\J2J 4<9=H(P_H5KUQ?^2E.^S7=E>;38(R8)-S9Z/9UT=>9XK+"';I_>:Z
M&QJ=+1[?"L! _XOZ_K\0V=8]?T?N6.X($I")JTRUPMJA91C-Y:N=WR:U4OUI
MK;_%,]NK+S+1+>H6N/#VPK =RF1]1BRP-W')7JBQ[J6".L&<9F01(C-,P,(_
M'JX76UXQU))\\K!,;I;_'VOO'=7DNOV)YS2[("@B13@" 0("A]X$KE03FO0.
M2C6$ *%*S3D*TD$2BG2ID1:D)1 $#B"]EQ @%"%T#+V79+@S\_VN>V?.]]Z9
MW_SVN];SU[/>=^^]]F>W]3SOEDJB U@2NU_Z6&K7:G'?E+AK&+@Q/:NC:!BC
M"UH?!6MKOG730_WY?\7L)?''S.V\)L[U*I_2*L\]F<KLCE]F7<2UT $"T]H>
M 73 AWA9.D"X7N!LKOV9-1CR_M^][_J6E\B&M;[Z4NJMH. 2.L"\X0IQB9 *
MM!N93_/3"I^O5_^Z,^MT)+XNL\ZLQU8\7OS\J%A!$Z$LDZ\Y3_CFH.0)&C!\
M,UKH34C?)!1NPZ8S\)C\^LYCX.12%+E^)YZU&V_NYV6]J;!!T,4\R0R^];WL
MUJWNBH'8;-$GGH:I%FT_L@9:9OSQ\^>"O]3$3Q,>G:;O7-2.B=%_(O82_;/R
ME)&)=<DR13=&=@G<:DS]MS^.3;,?6L1") WJ=% G/ 9 !=Y%+%A9M]=+8G^4
M_=UJ<7"0<!*AN<G0*R5+:G-TOO2"YP)XG)=PYUC-=5+QHI^$>#-=M5A#/=>T
M,9&]MII26?+!2*_"3, JI1BL83O\H\SS_\[(ND=QKJ/QH92?"/ISV4(]L[8K
M&"0$;Z4%7%VM C*Q)9YR?U.:ER=*.\&+VXMR)DCYRF;#>B9W.[JBLY7>(Y+L
M3 2[H7RD=JDIYU@_&B&YU+LW5O< -/&]6%(HQVYGKB0)S\ S%LQ4_(Q:7&UV
M?4/*UP=36E !C_"UZB#?PJ%JE2<+5PMJ2/KU106I+4K2@:Z^*XMZCT3O]HA.
M4@2>@(!PYE!L&GZJ\+"'00*KKS'];1&E"WP0VW+E?^B1<8]][^EY:^FB9/\M
M_%7=#=8)UE2:JO-W6X>=I0;)>S97CKNYWJ+KA7CU'EI)^S-H2O5X#I$]RJO6
M@2 ^'_Y5:OQ!LI/"41M_MVL3N_GIQ9220E8LXMJ"U9^'L=:SG1IGIB+N$C#P
MD8.:^2LZ0)&@L&]C.784LP-;@8MESXHX*#+ DU7]N1Y.MAYE2]J&M7CE2[]K
M*9%1XRK4U$Z(=_%]I1'+:@G\JEV"OLT 6I5@GFGN/'KMP1'L 0\54A&)"@8>
MKAV"?>T83=;3"KD@\V:>\=K./_.J$&5#T>P>%;X>XZ)V;.,TL, >E"R#RK3:
M\]@;79EI1BOZ#M[T>=Q9]="I@*NK*J[P96P/&EA&>O'M^*)]T^(^Q%Q*,S5F
MK2RTR#NA=,/MNU7*>KU@XOBOTVT!*:'ZZV6R,PFF6#CRAH%N\_0;?;MFNTJ.
M7^9%&<T>3C5GG4V9;,I'WRG4!5*)COD/I"M,%)<$"W>H"+M6E!CK9B,=\,)#
ML#EY6N6TW\>I[NI) N^YJ<KL,X^QB#-9'!V0ZT8'\ G);JDB71)855!/.D]W
M'1TNT7M2S7VN9S<;I3^*/+M>C\PKI0-XE7)BU,>>_R<D?FP[;LS A\%[9 OE
MH'\$I@H"O>8+:[!>&8?8?8Y(N =ZE7]X3!-9+B%ZZX3)_>6;/1GHP,W]I&Z+
MLRAIL>GA(Y5ULPDKVIU%IHD3HOF1MH[;Z:PB<=\('5L2Z(I&9YK ;.S6V+5-
MW3_%QD9V75)L; )*0L500N(R';E7W^CR7\RHT,A($&@7__(3T/MQJ.SG9",A
M^9: @53^C&Z9#.AU,"BX?)1'_V?-0L^D"V=U^08_95-3N,G+HEW.T4OG&7@4
MJK%^L):W_N)$=*F&:L5@ZGXB*(*5ZC<OV-\RU%.>&BU-.O@>;6,%%2V*O-+Z
M\-7O_]Y/LF4W4NL_C+3X=*77>]G*K1B:%J1+F#/O'* :7-6B(&BGEF)^B/Z3
MU.);SGME?F1XPHIQ<LREPP:Z=)[FS.P#O[!6#9A%1#A OM3KLZQG6#H1G[BL
MCMJ('.A*KS?>D@<;WBL0X4\NZ!>"1(X4% NTH@IRKFAJVA9(0(MJ;</T_NEX
MQ'^ZMI_7/E*5<$9.>H4AK#XCBH(K1"-7TQC^,8UN9L(+:;ZZ\U L4NOJ[>7C
MID,B9U*3JYL^[=!.F YH18AY8*ASV]8]_5B/_8"Z:G (SJ2P$EEOB3_JM10R
M\NXCVYCSX,4P(:3[H]KO=>0*F-*V3SB"V5B+/YXV895TGZ1>';RZ8!M1$Z*-
MW1-YYC2Q]3'3Z7#::9EX;L;NRQ]QIV(9=$-"?$^I1QC[Q?=C!;G!MHD6=[=R
MC24QNZ/@V<M4WAKBZ(A>^SNRH36<0;)'P=#16L81M<0?W'O$I85&U\R3=*OB
M3=QME^.*IA5#ZF5WB#)T0(G^=Y"[Y,)%*6Q9<=G4_:$?E>VW8DI08NS'?"1A
M%Q9K2_#K$8]>3<>"15&!DXTFQ>)P[6>$LD#YHR5A;$<[$>3E4I=<48-/RI=<
MNIW&^LM^(AUP#V7-]$)69%32M^M<T[$V)9V/(%A1*19Q)+8P:;\3*E"Y?=%P
MX-QIAM<.&46'C%N(Z:WU+M"^UL2&\* D=4I.1<7B;1:-3'7;,>7)\BOWH)#G
M*1S2S"F%:4!!(*([YYM:A*Y1T\2PX7AWMX98+3Z/%I71WYOOT897$8+(U9@(
M"PBLYE^K!],6=-/]\B<X&@0G4-5?E-B 22MEUKZ?XHH<]N/:#3.U65"HU <5
M$$4E=>S]J;$5JS#':L/P1G3MSI?;6$7W>:&/8TC%O,I>BO1PKTWH<LV( C1/
MJL)UJ<EHT;IIUJ #UM<D.L-BJ6=>66J:JS->60Q\Z!LRA,[QC8; N\B'=QT2
M+2DLDE6$-_G-@1+*2Y9ZA0O.JJ'):2#04\]")MJ;E1T>'HE'!HNJ'^SD'+H'
MP@7((E+$8*X<QB[W=S/N\.-[,W4CGP:3$7ZF!46Y2LJOBK$H\*GTNE^J7_\P
MZ5E5X..U.$UP>0<L7]0Z^PWXT[B.[&D[D,^VD<^5]J/D/K=@>P]$6-?JN)%U
MJRGF2,\$;=)JJFWVH&@VJGM_8T1<%W_(EQ$:)0.C _SA.JEN3Q]K_]PJ^0DG
MC3/Q&R[CQ*"-%^41-@)F#T\D'"70W@49(?FJSPC*%8:\!GHR2@V,;HTN[FD/
M$MB?9P89CTVC+5U1^I@29./&T,>3(_[9$],Y496O?OWK'+5FHQZ-0D[JL"2!
MZ;P5>2UPJ-O":5$-:C7#3-) *5/E]^<5]AWJUL7B9]Y6JF0$3"T8&.'(H:Y;
MI!TI:LVW^\9LQ[A@.S]J4_B&/$ZDOL?<9HX7BL%L'@PKQ]B6OYI-,+8.=@[Z
M?LAIX?7*[/;9E.WN6SVE7A-LY4E0^G"_FCFH7E#V7@8JXMK OW='_X*N;O=%
MQO9U14;V]0V^X1$SDI3<Y^$!P%QZYG@&[(M@3T0A(<5,M2AK+?]DD(TVO*?H
MWN0V1"IU(T"2#VC-O7&K.^-NY$ZS;Z??@'ZE$BS&MMEQ;KKY[6%M15'6U.!R
MA2"-069[0$5JUX5ANC2/#D#KFPCQD+:GUF"TG^U<5NJ# O?O0XL__DM?&GK]
M(6:W!+.(GPDWK&>[M<]MIOJ-DLC])84<K>9>+!B0OJ?%E\PM]"VRK^N=HE]F
M+G[RFI)(I1#EPB3.-*=MN-?.[@_0O(^)/["C@4=IX@/6PE24H+#S\G$4)@\.
MTL1P1341^&8CVPN>^1E'+#VS0YR(*3Y:VB]4<O]2*[=P^ARL&IB2KWPM,F:?
M(?@1^[?2B&<:?,T\JY$S1V1T\*Y'",E"%J3$/&X8B,\;%K':!XM]/DYP6/Q?
MA/#>H#Y>MSV2-I7<X&/E?%:1RL,Q!]ZU*X^EP/8E]P^XA2M7NQ*<U1\Y*G<#
M@6?]DAEOZ]T5G>8BR5ZBG5TT::-D+QKU2LZ^SH=J<N>Q\+L2"571G(I'F#]>
M2HUE#_L*S541IP@HT@U>%-3@TYBCJW)NRX5!%..>9%7"CGR/^#$=\),98\).
MH(]MUO4;RPW]4R+C<@UOUDA"T=1JC$?Y1657X*=54D,^$9>9C9F,.3<Z=1KI
M6!DR;S!#7!&)EP]ZA"@MG#2"E,<YS]ALF'HM-MH =]]/*7\;T6T]/1UNO5KX
M(2@^6OE<M%"/&5%56Y;D7$"9LXJ&@/WP5#RF**'X,#^(HE)0"3_ZMM++?CKO
M+JJ3*915H_?)NKC+3,^KQ,NT527ZS::=K$^HFIT9C4'3N_"UZ&)>BKLP*OPS
M C:MK!:BUPO64I^&!MVH7P$+.D386&L:ZY6-P_V.32IC%C<<1GW(\/B<UDX<
MJY@&"3?7UBTVL)HTIX'Q:Y2"!9W*=5:#/0<LPF%HFKYW6W<+BMCO5RK.M6*<
M'=TH(&]T=4Y P,X9%5[Q16WW2N+-4*XKATYW&JV0ME:&*U5<6L;&1PQHUL]5
M70N!O>#][K#>L*1RS>R4<2C*_N1FE&,MAU>*=(ZSNH"J;7,;3KS\5+DR,S6/
M9%I;+%M16"%'O>-O[U8]4]G$/+75.5T(W!5!,D; ZY^?'XQ,":=$>R&H8=.P
M@W;@@)+\5,-IC(*BC-P6R?IOJ1;RV3I=#97\-5_?G4BE!18T_R#2V=/15VP7
MY2B2>PIA-HPYCQ?)BYOQ"R';]Z>0&Q<6YS=_.U^OP/I:<*_G.CH 5R\,B GU
M?S4IZW\C1D,%#DY;8('T%85=+G<3/UQ;? MF-N&1F^6$H5H-/E9?G2>>(NZV
M\H3L_-;";RBGW*4GX6_R15[3 >Y+:5>RO/MK-0K&*V.G7^R'^"+ C3X;%1JK
MS7K-^M.!P68MT_KV]7KRQM\?Z$WT&*#CQH=O8B-\E,T>6#E2KF2<W N%-J?U
M_OB;U;=_XNAANP9?!CHXKY&E5HN_'_H>_[P0.) '_#7#:3:/5^OJ,:(;>4WV
MH\*:068$\+@",1V_/FF!*2W4#&</3!Q+^C34) ].8^4+_EW>Q-<+OIAIW@,5
MUH8$0 *TM:&JMT'*NM<0UNDIZK8Y!1Q#W#'L1^M+6,ZW<+U'@F96FH4R-75O
M+-AOOX)K:@Q>[68M?B#P2?EYGJ*"$=.#M<VF*M7;SHYO]B6E!4>2!5%)B6G;
MFL$ Q8B=>@.,)C;0*=!16S6%M.'(KL0R$E9V40$R*M(:76M)UZE?>:/"GJTG
M4LO7XR21IMDS<FK\"A$N\FKIBGH!6QT9 DP43-BFO+W,S /TC5K& !*RE5$[
M'T,ZM(<H5;K 47@G]U:JW<]DYS MRZ!2:28$<=5EW6G]"6S[R8=ONW_U$UFB
M0$](4@J"^O#YVZ=JG^LG#@V?#?=&\*<SW+[/E!M\<4W;K$HA)N%3O\IV@8SL
MVF[T4B)AL3%D0HU+>%=W>F[_)??J!<8XI_8NHKO4;3Y(Q_+\X=%F*AA*:HI\
MH=K(W>*W:%%RC&MJT^-UULO]_?_$ROZ1_G]O)%R6/,G.-I^D]9#77X7[QN0Y
MI_6Z!GDK\,L_G>M&<&)_VFS@E\\;?-A@?-V-.5VF@'B$>JN3DP>L"3I#\@Q>
MND-S4FV:\:F/*=2&".;+Z754ZM+6*H-3/<Q]&TYZR/5:,7*#LE]=L^;<3=WD
M:Z!*_#L-5=O>L*1,2N%$/2/[Z>C;\+K0];?Q6KV Z]"_O&#)C4M'K' XI8QO
M#)3?EAI]9A2O0(GFR\4-H:1%8 :)3$QL:1]V0((8D%1>2GGS'ULV?E:.KB6B
MIMT%*%T<>9@OU92\BEJ?W+IJ!<%E57RN3QT:MO,5?E"8"/L%E]*&$&CX(;SG
M)2X3L7+GW:PDS[IE7^_86,77T]F^<)8ELJU49F6^8Q+PL!W\J5ECO28T9I>[
M3"2!U[-WTG,7'TA4+*^KU5L?@:I.FK$Z,KOK"O;W@.3!!03\NG-;K-/_$. G
MVR8$#%.HEC]!_,X<_:5IV*]HR+FI;4._ZOUZ_;>1WO A%,]*^*>^8S!"^5L#
M"B/4C^O<G6K(OS V,Z$#0KBW5 *P.<\S+0/.-%4$V^-Q\[(V4X&$,EB5':I!
MP<?N6WE3XEHY IK^/VV)B__)O5:$$GJO>WFV>6!5N"I33'+P_+3#*]-KYDVB
ME:^&=Z7$!QF34?8E(1G']@"PY-_/BZ^#49&Q)>5Y)5O+;#XS+$*8)V&C^]#N
M];BVY;0T*V388?!W4$]9SRNRP/7._-A\8W;8K@3>8QTI&'KM2SLY*9"7%Q]3
MAG]'Z!.N==<-86D0*HOYI<L\O4/6 <1=7IB(EV(P U:K1[#!E^1&;+UX??U=
M8WC_2'O8%NGNI\:@ZT"^+BA+E&O6.O0?IZDT8-SVO6['S\HN8P5B_(ZLN2@1
MB58$ID#(?0V,5'/8I^XW@053PZL%5 Q!]NQ/E?C)0#,*ZX"8I*STDZ^;-O/S
MR,N !/-Z$%?O\FZ]0>EIZH0 GZSCD8MX(O47'XA5M!0A.NQS]K,E\-_ZOI-Y
MVR<DCG0*+BM(/Y'&XM,.!N9 FL4I35=Y_&E]IU+\SB(\(Y)ZUZ[$\RA8W[=]
MOVHI!%:-T;J!E-77HVTMM*,Q_]PS\);[CYZ!CNS_>\_@IT-RO,3"0R@,.IZ2
MRNY;"V*06;@'41VJ20/=5(W\>X4OOF!@J"<!;B]G1]Z=;1 P)M;*<O",ZBJQ
MPTJ@V&(,47K5'=;1.,KH:A]G!C9,3';PM)?T&X0[CD8J.U1*8Q2NYZD72C@G
M,:5];$(OCCC[^#^:%)FLM@Y!/(:/TY:**I$/'4ITST-"%43_#(8.(@+&VSDR
M1@,[PGC1MZ4@<+ P[[!H;Q!0L+ TPKQ9?2;YP8\=?X5@\6D\3TR4@VS:8R*S
M_<AX=_9N4G+Q=>UKDNN6!@?IUZV].Z]VKHE]#7E5U!>3JZ%MY0*\US0^&W,J
MP*HHRPUO:4#TIKH#6?2ZFZONQ"3E;/)-YEU$57F%I(7P;#S*/(LTP@K=ABHO
MS)M)5--X;^= [NV.:$S[%PI9)#(Q/T]Z)-LT6KW@=MP3ZY@5%SP*6T:?T;:J
ME&.VX'A2A-3R&4EV!IA3W]]Y7^3,&*3B_N$BT38>#IUSL!E%.AH[/#AW>N;Y
M[[WR#]T1H"Y)GOY7[S$ON^V-P)Y)\.*NS<(QYFXAU;@K!:Q/V+BY"R(*:TMA
MR88DG %T[:B<09-?9WNWM+=8P,E4$ZJB:S^60I#:)_H.5_0XLGTQS5UF$Q8?
M+ '-F#\+PQH[UTDL8JU92LL%+40,N)]^BHWLZNOJ36R;*DO.@#/G[&:/&3>7
M:(.1&I+R?>(E[4M6X>9;UG8=5D)SMK4#[K[X$GVSZQHU(]#]$!US[ZZ)_V#[
MBMWOYEEZ\.C!=2D9(A7F=9O/U: -#:RK-D2!"_JU(W>[&I'/.K:D'F>5\F1)
MNZ=!3PS=58:?)6_#.ZSTQ<F2HXA82:@AK/1[TMACRY#MI$0_:KF1-K^\GF-&
M64!;]$&Q@LT'R?OK[-%1Y<779>PAE@1F.L"@4)3=L HLF"3H8529+]VQ+F U
M;=8>UEMJA)KD1=PN?J8*_KI;^*D.\MRNX+*^JI?<Y^7B5NNQT5Y6UAH" *ZA
M76&LA]:6JU=1$V.FDJ(*U'7S^>>BWV0HT>@K+_F&=J3%,;=K]T$W)/C2! FO
ME4/G,@_/;+;#@/XP X]QYF,]%8;5IE+C8>[%H)_EN3AESK8(96*!$K@[4.%U
MNQR-!+TM]Z]3J8YY-(7]H430*^C.ZF,S(S-U;!1;@039P*&FV^?7R)C2FC!?
M;LP)=TN+IYQ1YO>,JHXEF0-XH]5Y>1I!,/_^!PI%E872 GW0+M@!"@2RY(%#
MHA[6'2A__&%/[7$-YCY95P9O,K;^?NHYAJ4[QR@:S%1N_>E"/^?K#_^OHV2O
MMAJ%K%99KD,4*V<]RNW:M:Q<]0V;=XI7T(" HSZ>,\X&T-OIS;,G\9MB_IC\
M>NKW)<GIU74[+3NM)U[!WL<?)G1Q@T'NG7A=Q4]O1[^/@[)<O;YXM'C%]3(V
M-$P.=KTC0"O@H_$$U_V_W[)9._SP;?DOYO/] ]V:"D/;12_+"D&BUG2)"[4;
MR@K@#:AP=27BNA7#HU%W;)Q;63=4YF)$?\=0IS(@<*;.P4&L/R:KZOR]3:5M
MHW16M'8^J?(B]H-;M-P3F.],04Z#([2M^/Q>109A'!VC#T$L63<YSF]IG-;5
MAL7F,OXU%S\U(?D;LFQ+8J#-'T#)T^OYW92O/8+),^YJ8KZ&BX\MB*5?^O#/
MFRQ.AQ90P:C8A"C.6Y#-<XT[AU[(!"-?BU'-IL!IE^$"DFV<P+:DF==#BN0O
M5*NLN?@I+@)EJ8/MPU8]1(+$+21K>)8OWV$G8#X 7B\XB-D\4'[?HZO=/%H7
M8Y@ZW)_">3#PBWC3_=;I[Z844W'/??^H9*"-B?::@,GP\/[^<B5^0/?M**-7
MEZ==2[WJP<Y!<J*_#VG>E:2!;?3%^B>PO0Y"R2KM1<,1W2DYA2W)9VXD<SS9
M%/BYQ6:F7,FS,"^S03'4=L+KK"U$R2V*P7X2APS7MDQ:?!5P&\X59*Q%3@DE
M;@AU_@83K)P.JAS944^A/-O@A1,]<Q^U[PKP=4)='%XNF>WX]OCH$WT-4IOO
M[V^NS?T\FV5/8-$[VL]=*!^X6QVWQ;$\G#3[^9V)^5FR,OH$"-=WQS%Y'>ZG
M%YVH*JVUD@HB7?=:;Z>TE+\.-<%6OR,.4_.J4:'Z>,NDNE49[K@<S8Z2*=24
MG72:M/QA4I+@^P52*X-&W.),NHTL9_"TV8Y[<R W5_'0]PP;J8UKM27C(%\A
M.&5UKTL*+RI<[Z;8[Z'7I26\+8N;-G/+K5=C3I8JK.A.=&2/37J<M/_VC5<Y
M4_UV)*RZQS<48?1\ZM["EG6G6P%E#<*6^&CDR9N[S%#"I#UO*4*)5C0R%:>N
MCEXP^J.G;G;%/O^JXOV^%#H ?<13=@ .C=?5+X4*D$DFF&(=+[N;)["(!:5.
M%**?PNH:#5_\8N44C8J]S!FPL-C5<?&P)> FC.6Z/'!J/ZHCN.SW?XD'AJ/[
M^=X"W973T%33WOK;5 T.?=F'AM/07MBU[3L;"$,*!(4C_AJ; 2P8=^H$#O+&
M9"5]]G3O1^E)$>5KL>F'&KVZ@6MK&_FC8_V(QO0!C2Y/N0M#3[RB3*POD%66
MU;>R7/KGA>71E!(01F#4!(LI.V)/>.B:P/0N[VM\Z"R?.56FC2FO\O33\(>7
M>=HZ56V"$.:P1""(AV?_H=> =Y5[+T<R"HZ;+<<3<7.FY .7]?'80''!=Z*/
M'YF*/'\>]FN2PS4-Z(,.$/!!.U_^/128+R7B6V#.\W^2\58"2\;W38?$G-N]
MO)'-?Y[(ZL3E=.X?C:!6=K[UO0Z-0&>EMWZWP(/XU*/*$DMW#@+B4Z;WSZ\U
M.">T[:?1 2WJ#XO86WF>5N*"Z\#,[R&T@,>:3[^<HH^94&..=HL?7Z=., X@
M[F2ZW\Y &NK$2T:+_3E4)4M)8Z5T[EP@TY_>\=R.M)FL$@"IZ&@VP-,P=(#D
ML\78D?P+02<A7LK^X^9O)^\5=-YY%5GWAMPT *:"W]U*> MQX'X*NI)CN.X3
MYXA,^"3V-Q>#AR[">=8N<: /W8\80-:"9%18CK/ALZ8\M46MP=Q087 H9P)7
M[(,F:=7%4@$6\7QM%NSV&8Q'PLOP7LCCT"OAA?S9A31@YR_'@@%NW'VX;RM]
MASJE']ZG./68]-BB.R'3RLIH_GHI@1W:ZY-O%]=_8N;2_PM[8;<] 5>_[*,#
MC$;N)6.-.>^/STPXZQ].Q"%0O6_9#8T+[CE8XS]QJ4;=D$[\+;N*1\J[5AF0
MAYC8V\TTPS^I:U?.LA;6K<#GI8<$!L\H"^APUVQXY\WQ(LJS9631FMWPD8KE
M$?%F(<^P45BUQ1=H^R%>;!B[B'Y'P+.NC3__"X;^)?T\'$038V\X<9FS&U>)
M_U$ZA@ZX)=E<6:>R>!8%WU+98^J@ Y;\^>B H./BFU$@P[]^RP_D,8>CR9\2
M)-7 'G[[/D#2U*?R-$?*[6(;$&)1S6E)*EQXZ!*\SG(G;*\_)!KVX@AYLU$#
M$%!S@VFM1(9M9Z-'BEYY*J.PQ(2(XZ>27FNC0 &@M>.(1U%%$2;H3'8B9_VF
M%*VP0J6/-^ITPX4.4*(@X]O.=M)H+[P'#]'^= !X$9F<,-GTE0YX;H$Y$ F@
MO60D6:F<;'&<^W'/1>S]E(VLR6@^U><]+^M7:6GK0E)OUM,!XPUR=,"S#MF3
ME38Z@ S'7TAK'>W:7'P,WJ(#F /\SQ+JD.6#9%N9DUN4.%R@F(>6P/TPCKW:
M 1N[ZV\,H_CWZ_=*'%K?LC0%9@:L<$ +F(I=(<_ZOFBG>QX7T0&6U$&--<[H
M0H$CP0YW0X]O*'A3E$P0:?]B!?8XSN.=UP>05$/9U)XK5J%Y("O%@'WCS4'2
M]Z27US9 8 V94)66%4]D,>.%R@(=L#:Q=[Y-R5E)N!B8VXK '$;O8LXNJ\QV
M.>3&V\-F;C\='_P1+\F'\<E;WT\6>NNC#PK3)P0X'0N*2H&#ZV7Q0C-0J%HC
M=JK_!E_:=O!KZP:G[*9.BFATH+Q)>)J;[\$HX4N E@T[$59"="5D[VY[O!>,
M19HK15R9Q"[9.M,!G^<M*:4)7A@Q[Z+9#@H?9I(L<!\=^%N@PJPDU*2C=21I
MJPY__5,X_G-L<GO-E)6*9_$#D2(S&[:;5N^2<E?(K_NOA#Q4$C(Z&4Z0+9+A
M6G$T7*<#KON&!.Z/'!,%#M?S*$1?DG%"6T:1$G2S8>M..T%WC9&4$6J%  </
M6/E.UCZ5F3+(2JRLPT^2R0(\O#?>FN3*$'ED9&ZFF8_.P. 9AYP*))[/J?$:
M6#QA_/#^7:"E/7&BILYTP"UZOVG&*2RJ8 -Q>Q%X^S$Z(BBKGK/:H^=U@/G8
MI*F>;+T/++JRYTYWK&%<52V$^UUE.]GZ97YU+1Y8MLNIQ@C?3A6<I#1_;\"%
M\ML2&V@<5[Z7NL3<J.B:*L=UST28<FXT;M;U="TX62&#$39#L<+I<<_O4BS^
M]A?XN!T6_-*U)PNSU,39/WUO@O2":-K A.#TQ4W))S&2U(J3:LKY\<E6" \N
M;:CJ^[R )#$TQ#C<Q-9I5FQ*3FFH$QV>YM?&;;)!E@;IALP,A>4=D);@@37C
MJR$_>]HT9URHOY@C&&._3FQCI\>L(,K4NT69 ;7Y7CZ+CB8^]ZPMJ^K ^ <]
M$@<+ZO]!&BU,K+E,3(%,3+=!*D\%_B.'=9BTE;9*I> F9JIO-U^9XACF4@O+
MU]^XXYC,K?I^GHF;,E)0BD'QB@9P6XKBN5;GM!$X9EV52NRGA947"YOFIM23
M(=.7<]:Y<HT^28XUJ+5\2\QZ.HPHU7_G.Z=,Z \?9A?\KGMF%6=NZ"C,,W%^
M@"@ORC\IB+IAE#B6W91MF'H=O++&NDRL,R/ #Y;;U%>X2K^CUH!G":-V)OG'
M6=[>7-*)7P/X3=L22^-D0N/UCWVUE[$A"J[?2%XVO,JKI^T?7G0Q_?YW.7[J
MN-JQ11L37LK9K5]1.7K>_8M-);)-)V=')V'+C5SQ*QW0ITFBA9.;NUX$?MC-
M;^/F.A_(^U.<2@>$5:?\.=[P8^I+"H/,[HL!5U^'KK,B>1E7-L3):UL7VS=1
MON;..OU.(F*K:';A[^:*\:1P@NJ=O@@OK*OVD9+9@80-7Y-*,G]M1>PN]2AR
M)N3LX4#QHH$09L=2I3_=-KIGKM_ZPO[ Q@&D::.5PT3YNLW1+U=I[BQE/OMK
M  >7U"OJHP\[E.HBR?N3+]]90:R@*1E@( C,;(CBX?D6N'5=) <DIM]F=;&@
M10J#&*YPJ!>0T3,(*P]B\U?35W-'MI=PE4VRZ]GDOG F\%C_=-Z92!/FW@+V
M'SRB]5.;5ZU4NF_$G0WE3%+:!Q<3Q&E?TA[,(FENG73 W=2C/*/].5JKN]UJ
M"1W0->BR,"S]CS>799#?L,+L_"+HI0OG8OQ]$:(/BCCTP;=]&B[DUEN0"6*H
MP^:I% OS2(CF6.9D+0W,]'S1WU8H)89:-#77%SB<#5)EA=<H+IB[T8M;('QR
M6O+4Z?[S7.@O&/*,4UQS-,+NQY-(\<]_@1WN-@D>24D>'MZ__W@TLE&G;W H
M,O('W6 <^0-1^2=H6&NUN[-&(N]DYC,)A61VMO0;1JB95_V"3KIR4 EE[$(D
MF4*$J%='P2WD,[("0IK'DWKKN['I%?W:U,!5.J#PX&!8P;]ON@TV<9RMUR_L
M.^M=XJM:I[W\' WI'M3OCW" 5>S&'0(QP?G%?WBEB_Y5] LEPSLSU70?N1/6
M1R[KQ&213D[+*$'5.__1[?1R?@*!@'IT!0M+/;X%D:RIZ24%2X[I8& I?!\,
M).).^1KU3J8M3Q_[+4_^>7:/M?[[A&/52PK+(/-SO+61#-NMZ"Z]W!2RM C8
ML[OJP" 5.'C;7<X[ YMVAJLP'\NJLF.H+(=HFY[Z;&Q+FB+*M]@CES:E0F_>
M0&:X6V^TE5CRD^/J#4MP>6@O5UT-WY3T/$G"9#KL@0#RMTV=7_ 66F;5'<X6
M+KL%=0@]0P=U]%O3N6&.'EZ(0G;F5Q]"4[A",M Q<UQFL&O/YYR+G+(P5YX8
MKV#C0RQ=LDD/;.2]KJU1$J,+LW6GJ>U<)L870;TRS\B_5."CG!J2EL\4QQXI
M$<HRW5=&%"83;5R]J,E1':[B#;/FKZGWW5ZK;X[CG;S>]Y$_?,B6MK!C4,C0
M-^X2YW>6*!<9(J\?J)63RH8T':VWU<2YKO>Y84W7_K!.\HU]B(/H;JP)L!N_
M'%W(BK%K* ;@UUW^/)[T70!YN95D1<O8W7H,*0FSW%"8=_;9; 0AKWAVH*/A
M(C[JNQH_&M_8("@&3J/9&Z KJU40LU2>DLG(K1*I^)YI>!I38=O[M^[J+F17
M'7_EU#MHB671K$K<ZTGI@<RI=%,SZ8)O4T1847$1H</ 7<+&?M)W+1P=KKE3
MO>2PR1DD(9$B8_LDL[A)'!UV9F60)'!=E RM^@U7'(Q3%2D/Y9T^_OT_388M
MV]6%1U/%S1EF,@!4>]2I.]8P&UJBL).FST8'J MP)JM6^]?W]&_6>CDZBF?8
M==^LI+$X3M2,ZMZ;(Z1.YIF*2*T5Q9 ,K7HSFLX?]J_/VI+B^ \,-Y/%7Z-3
MR:794IEGM>XA@Z;IO[6@>?XS(-U7,WJ]]=F[[C=)R'%91V$,PKHH'A);.!#?
MM]J3RL,7:C!.?NP+^MF5UW/$KET5-?\5/V" _Z;7WPRV",*"#]<*K&*&90\W
MB@@">4C7(<(7Y(*H5A>T8[&1Z #OY:]_:C$SY\CK&+3RH!#C&HV.\$%GQ,<\
MJY4X'(66QH;KI3QEJV.1T(4FL\-"/)Z]'%6F7&6"+IY &@.C0!(J&E[6-Y#U
M8FK^#8$'?#K>4^L<"L'L780=V(D=O&4WPEP:'*<$XXT)6Y(<&999Q"MF23.G
MY,GK_DHI:^@'=G-5+&_L/#GU$6!:#_A'9/ZH>%'V@OL2YK1T;//(_$IMMK36
M&H?9#Y8C87,%<9?I&LG*?>K:F*.Z*Z)G'Q>V&UJ4S\-S(,DP+JT)_['U=H%I
M$4G;WDTKLK^>*4N[O/3M/'@=G ,9RIL'*]]#B]Z*['K]) M^J*L56_WPK+NI
MNU@/5,1"+>S>0%S?, RTUWI?L)UCJQ,9D92Q_T0F<:HME2OX676>_$R,C"0S
M17$(=U:Y6).:YIT[EOO5%U>E?$\];V4LLO-M=_=?9]G_AJ[P9K?65[5)O)+;
M;W[ISY_GX%LM9]C '%<M]7CH+;#.FBFQH#E6JW.-VPUJ<BM2[[C^>5%F*OG>
M:<6,#</])5.G,S\-CI#HLI-1.:),[?/*]D^Z%=&Q-?!@'RD6*%>'2-+QX2HJ
M1M/YF4:T,T@[R0A,#$*_KTU/H?0$H0UC!S\-9NMG:[8Y#&0(ANTTV"I&4T='
M\7KI(5/!#-5'0I([^)NK,RPQ7N%5IL6XE4U_9=KR@;O-%(X<V$2H_ET9<^U?
M2?:3-$$,OR 79_>0T4*4(I2DF<TIL]2C\=#^H22TEIG#/HJ4KB\LFJ99I7Q?
MW;S/;M3=0O:TXP:+6'7>$1!C%U,IL#:N$'S=;[/YIW9<8X.N2)?_LC[&1D Z
M 8(4"A2DZ'E:]A8.@->D4NY).*K_"SX86INFQG/; DL&6BLI4H(S%1G\=]\5
MG3:XRO+*3<4.CV,9<_3T$[X&NW=V=B>X:WA6J3CF%33GI0VTS,B*8 >#W+J:
MN6:,-DNZQP\LU\9O*Z<W*O?;32&P/1F/I86EO_X6.T-24$1[?5%^,TX-N?ER
M4"?WN66/Y::0Q&7B^FDSL;2BM-CZS$'SG"'#6=/TL5F!*Z%+C4+[97H]M%'Z
M[6A1^JMXY6U<MLYT?2BQ>NN^MJY;?TM'PZ/5RQJB/[XV[:$UJ[^[>A#-G1I4
M6":+I" 3 D!/\EH]M@,\?.NBS+GLY)]_>/\*]<RPN-I/DF&?%[$HTL&>RJ()
M9Y+9$)1\EFB_QV 7GG=N8F%2$;[?68_-:<L=+2!(%<R+V:5+A$!R@K89WYS\
MF)DRF%&]I&^*P:U84#LL]357IWFS9FRK8@NM10N;OI96?<(S<S1M1[]3O;]Y
MM\XB?K>IP,SMB?) D>(O1-8#C9!WD/[LK'T09?.AM:UQF,#'*%<C+TX[X/+3
M3YM!WDG(N 0?Y[D*._<EU80V3(.8Z<$JND2V(G\&=:PH%R$<[M=44CYZ9<J!
MNV_M.//Z)G-U?N71$X7 CINUH'I5[L9M4A"1VT3C%U%?CK)T@<_61=&[AMF&
MBX6W[RLO=ED8'!D]2 H_8QB)&Q^"R)J000QBB<>U%Q)P_/U0@IWQMYHUTO2(
MB0^IY$C:4A;C.E9R5%&P)05/:("UMLTB#D8;W/LZNS+0WL.A;).V+B:W'<3:
M_&3EGH(G1=OM=F,%)%N6>9JEOGH%JP9EV=SQBKYI>3UFS55Q?34.SLS;L^9L
MI:U\=S7U.?)-3)HSPPIN,_F,[*S!QB(V;^+XV+8\L*5V/?V\^"(V_X3[SM(7
M19$77M0*Q%1U3F' !Y*#^;X!>H15E3E0TS,54[!PP5?;<54N_O?_PHXMD R(
MD9XG6:/2RRB+O_5.]M3)ZJ+$NK:=E[.<\WBE[R)?K*^*K6;Z()\\X@(/7-BU
M^"M>*%9FV:;3 8^)*A=HTOS&M@SOFE@"4IZ6?_R.7-0TOG6K>> R?7:8=PXE
M7,R](^&/+?W.]2%JZHPC+_[YXS]<0)+"@5!)R/L\0V.[*)! -QM2*O9W9E\Z
MX&0O3K,2"MJ4<>LQ9.JIDUQ^DO(^] O:7>RR;.;>OEJR.BC0<Z"A&_NU%)RH
M].B:DU,WVP6_(;_($^X2W24?6HX&'=#R"W&=<28@>9G_NYY"@3I4!\AG75I_
M#_5=#[4XIDYQ3/(^#:W8_6GX[9EE1>6"NXX$7_,CX?=OE)_U=_.GV.<4[^;Q
M=PM_J]M?.2EB+/W97BGA*DSWU9+.\A)OL@RR%#7I&3)^SVE<HSO1%_/&,$1[
MG6=E%'6E]N?D)/.2DD;;R9\C5NJ*&HHA1B/.DW>QGWK?&A5-@4$JPW0 (")O
M?9#O;TJ#?^FZ(T.UJ:'SBP^EF!,FSYM+*Z.Q6_[UFQ?$<:/WF?'QHZ%S'[>"
ME#@KLDEF9L21K)9M6Y7J5HPSX6QR?%!722K<9&V#M"=-PF#3?8C[VF=:>/UQ
M[N?&]D$A.7]0ZGQ@,Q5(WY, I:E7#3[G6B[N5><#U%#WB8TAZZ(W_Y6)_!?T
M@]+QD86&+WI)VJA$7+BOROVF\SBV;,")7T92]D7>!E>@4G"!BK_:CTY9':+$
M,B&<(X$BC$-S'+A:/ )'[9[M5GY^U50J(42F)+,F"]W'=7)7?5VL"5O,OVEC
MA#, E^0K%[MF37YK;'">.;F_A'.VIP9D9E-3EJI'Z_K5F/O['>U[I'6U>=GK
M9T+9^SK;L),]]<[DA%-9("OW%^I68+]/,*33S%7SU^<VMN:26F(_&''#&O'V
MZ5472YU^[8SB,D9R??RVD OMJ8(Z7MZ5$:QPC'#VO%[H-RKNDT:_787/KRM"
MXR4*<AC':1^:I/)DTZM9US\C6 <IF;8/Y"P"[G=R!<$2JA.#7Y7RZXD2!2?E
M%AQ:VT5+)Z.'I092#_OI &R^-AWPO/DTB;-BF40'!,NJ[%SF'C5?D? <.N#*
MZX2S+#J '$'-H -L-%-IN<@#0>[^"MJQ.Y)"!UR\HI%5:+=VN(\4Z0 \(UF6
M1H@3NU"E ]:?JV3876Q/TP&7==KI\ 4.><ZVH++I3P>X<^,\+GS9[4[#Z8"Q
MCTB9YK/Y>CH@@0XXR#]SHP..);\BI[=HTRIN<Z?K4LT'-^F XK_1X,BC-F\Z
M@)L.V- ZG*0#METBZ8#ZN8NZ[X_/W_6N],@S>?8S/NO.O28HG:WPBF1?".8%
M*FC7_PE?/J@_/Q)C1_X>&?QJ_LS7Y- "32"+(!6LXKV0Z,4FIK43!C_*BKM)
M!FJK8^JUZ4-+('6TO6[_8_KQ1B@Y)+TY'@<]Y+M$.;Z,<O'C*/=1W>N=BXT(
M\DEQ+1WP;M-N,WZ>1I!3(5=\H ,RZRZ%4/UB1P>H)9#'$;0_H EGTT]>TPY:
MSL>FZ( V?[$C+<]+)3)227W( 6LM.B#75NQRZ:1NR-$!?ZOIO-CD>H(,_$9S
MA2/G&U+/\NN0V(C#C665%5%>.F"H@O5RH1P>9"(_6CK0CABY5!H]D=(RS=LS
MO1?#TRHDM3/?/>Z]5"8Z8-4LYG)!G 4.J R)B-,!01$)W+-U*ND9=L?N2[35
M3>Z-W O"2<))[Z4.]X7;+Q>YBT87[M7[ET(TMG4F;%ES]^M6G,MZT0$^_HP'
M0[29X,[SI:_(4Y;+H'S*N:2[J^4UF'3>N=OUR4^UOY/I)G/K1EZAIKJU^)7F
MAS$W))14HLFO]/>N#C2Q=JR7FW$&R!7NX-949I+*O)#)N $]NYSSZ@STDP:\
M L5MMMPL_ _CN[040N5+:]:9:^TAG:SGC_!73ROH@-$K8C04(V9/)1YY:8)'
MVLCF3 _JQI+^X:651GVF \8I_[3SZC]L3/C_M&_E^WG"W#7X+1(U=HX+*HQH
MKXV<Z6FS0E&BX/R+B_;11;IOR-KJNAF+\S6:V/CL0N]YSP'!.5]RJ,C(Z/B$
M<,W!^9Q_,YY4X9Z^3[)AVCP_6_Y@6O+GXEG'+V#<^'WU[7MD,,R^U4?8T@ B
M.K#R2X5[U@AIA\9$4Z,#/,H':03YSM/73^@ 23GDF1'NLLQ_13L.1'IL74*K
MT]V&]MV=>^./_V4W=]\ -VV,VKQFJ=+$2+U801Y3>YMGXMHN/'T/@U8";#3D
M9!5S8&15PZ'UW,GOUDW!1HAJ27A;@M#\>-PKR7UE>;$AY3&$GDB<2T,<CGI
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MY[,3T;EI]VW2$EWY57[OFN'/D4D7U F!D(]6_'5OVC7- )5S+NJ!?6#&H<+
M3CE_ QT\W\3=W4]0HS_M2?>9$N,Y6M;<5-=8-;WTY8";%'F)VRJ7%5#Q-TM%
M3*HH[6(9&-BG$%U<+B^BD:2I=5WA8Q=V;%,XR-NGO\PX?CZ'3Z:\;DET)\4E
M#3NJ#]1;S*QO+T>D+-6OR?@I$_E?HDEC#7%.]FXPM>319AZG=\-JED]/QY[
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M3R+$YK,58D5'_<NR;/."TOYRVWG[HG=UQ-7T!1IS>8-TGU Q=YQ1T&I'U:<
M^"&DF;;,J,?-9+#K-)F=*BJ5]&E^.SVYY2!"I+8:\J)^,=G^K @PN]GPJ$.^
M^6O <)9%XM8F]XB(:K67DID%=L&2-==3D'(X>:C(Y2HNMRR8D757(/)7F15@
M:-[C'&I.]VXP6*\9/OGT>P:L&O>Q;,^O#UK/!8^'T$2!WKL5([3<^I&N^9JR
MKG#CP?1[FULO756;+0?UO"%I)'V$AKO3.- & PT>UML>DAQ2S][9^#'&VN/"
M\7F_VH%16>=4NFJPF:"U%5GK0:&Z2-Z^)_II/+_.[O9$HT*Z0J;(Z-QZ[T-+
MU8DO]X^RW+<SC\Y"H*61Z.0,[V3O),\(C[^RZ#O(8/77IWZ?:<=S[Z9]XUTC
M;TOS_-36;80F5K@9$5UM1(P]546-3\#%FT8$6$^QH9,@]*]_)^U<&\EB= :3
M(7-N"D]PHI#%WF#B0WT4Y]FHX)/P<4"YM6.&*!B2C,Y(SR[\:>I./L9B(J\&
M Q0DP-L2!2G$N>)'5HNFB;J[^(KK#5XO\E:42CBUQ6U $+A(EZBRT!10B/YQ
M5U[(,!OO8IC]X"1@J6TS&U)*8>RZ]"([U<X3;U/*U/:^J)5 )DH41?7=W'LV
MD^[$^5E,9'@G 06;@%+?;0AF%6L)37)Q+,UIU%0-3>/<5E0'R:  # *2D8N
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M2W$/Z-#1:,9Z,$)(':#NXK*M@45/-B\,_S21[?WTE?X:*[+OM5G\\&,1=(G
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MBY@V3];2%IPI5JQ-X2Z](NE4U=(R+X (5N^C>UR_SZ@20L7T92LTS"SY&Y-
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M([X[-=S2<@KZ$;T:8S>#>,/P;:C>+_'%-U'Z4[V;S7)U:BNQ4]-QSE*N44T
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M][GV8'NDW;"D\HT>_GNAL%<\5J;6BQR?FC1(Y[^]A;YKH7WJW])O>7%X/[W
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MR21K*3F&Y=*0?ISR4#6X#U&C6Y7\0///E82Y3U_\- !)<W;CSWNA+J74J)[
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MQ.7+;<S4;A?IZ_K&31VOCT%,,01C94&0DN^8B7? 8K_7MTQ2O'J[GR6O",+
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MPI@0##&\.U=&P<:8/^'T910.7-]-OJ,8]'N=W<\^EQ(UQG?WN%\.3EW0<EV
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M1/DL?PBV0I"6K'M!.C"_8CB*D^^ZUARF] WA[;[QGAM,.!0,B$0Z'*7T]\I
MR[T#S3>7=.V8Q6#K3LSS@U&GUFG7H9+=X7>;1KYD#\GWXJ2@';W=\#39++>+
M08TOT&&"Z8%1R?5O@I2<RMT!NOM468"KXRB;H=17<G)I1)+$:[I *=(*:0V4
M_9+7?<5P'/,&>-GAQ=E:/\,FF*5P=C_V\GW968<^7_850SN,?B:&OC2R7QA:
MQ-WL55=2MY2KR[ BH3<G\(,]JW5D1Y_\)T1KF\&"L!"C7Y]B)*C\^PT9H;*W
M1\@=)='\E5<,8_63'Y#3?CUK58X+ 5OIZ_H;\$_A20:8U"N&EH-(\K[\NTYJ
M^OD50Q?[8P.?O$!#.=^ND-9,N5XE1\O582W#'LG6G@ C^FKH@OG "[ON[638
MNP5L"\GR8Z0#]-2JXD8J"&^<MJ55+YIE>!<Q H#UW*L>@#R*S_C1QB2AN/!O
MYK^)C&H9Y&R'5KRQ%M\K0>&]]6M;)*&+T%VAZ1,FPN,;'YRVF[:2U/),$GRV
MD97V$NH6PU(CF@:$98!H]? !VC:SIN2*83IOQV@W*7_RTLYI/SQ^H,ZSPJY<
M'*NS L^!10V^R!X?R73@!MD6]P5R O]*B?X3%?LFE=T;L6@\<Z,N],VX9Z!4
M;C?UQH5XI!*!"%JY/&:)'-,3/#=;C^_TP54H?CS" _://*S,V:7HFA5.K9BF
M@SM"2W7_&HI8D YS%6,I?Z8Y)Z>8$@0 ,FTP/_3;F/2.A8)BJW"^[$+#/^'O
M:NOJ"XBQUUW"S\L3 T"M-1'Z=+;6Z6V3LXBA]W'6O<R=M-K$3X(XV]FM(=-1
MOUXBK>"T=O^0ZY9_7(@2_UAC+HN,T_/_"93N^1NP"L\[9?#I(Z/GT]4CT4]Z
M]$U\:7XL;00"U=1\I':0'Z-ABZS>$4[$F::QEC#=3QPKSS")EAROE"G& 4(B
M4&OK(82X$6#-CE5A1GR>RU!BO=>!"I]:E<M4%:*BYMFWP_/L]$. '%5!%!YU
M8/C ![X&?P:2_WWU_Y%RO59=TDC,AS<@ P^1E5/VQMEI)NH0?S2?1->T34#K
MW7&(R>T I/ 7UQ'WWW@>I]Y_KRLI;_,H&$R!N:T7S1?5K-4,8VN&6UI#951<
M=AH]ZIHJLL2$'HB^]/;#]I*%6$9]?*,*IJP3K(&KI49 D #)2%#U?7>2$GAK
M(/<]K\X+X8\N+G6'-3[SM9,<;N_=8:[ <M@=^;<&87*GE;RK7_4JZ_7N]X/.
M=2EO%T7<%TKP,EX0:]\$1TD"A6 7Z[8Q^_(R:$+ ;FW0OI</#"Z=LSFZDU4:
MQ6QLG*A@Z0S0X2\L4C>M3HK"&2P3D/N8NX54"1OM#YB,SI;V;V4Z?5I)BFN9
M&>Y;JEE'+PW\3U]@,,\!S" G.*_PH?F'\\BT::$_-JD"ZXR>23G/R#J6$\T:
ML87A=N8EKANM-G8FC:*EQ;MZ:?$F7E5"]W]<?D9#F-GLH%Z@"+A51)R^M+N(
M@-AH6-:VA0![69B)V<)=7GUS4:W]# %GQ ZPHV2BO]D$I5V>L Q%UJ[E$]UD
M^4 VO*N*6^9O%<.G1[H;E3,45^"5#3H:[]S!2NHM9<W0E<P#"4C>(2*8]J,<
MN>&K3]-I6NR@25=O*54+7,XGZO?$E#NS>&!8C7/<.#=329>PJ.D'(YIG*O^T
M#'3RD,RRU\? [NY? ,)+CM]KXU#N!P("L%36_-1+7HW4_9-XP59&HN7-54I+
MM%HDGQD%MRTS-'G%X,Z]!_:UIMSM[*EI31MNL$R"CY;"JQ@%>M=7Q@K@JX4'
M B&MB$V9L^1'XS]4E4[J@SR4S&;$0NCQ:S(@;G?(I2(*!/C^(D_V/!P@@E<I
M]2NW'ANA;6G.T.H[Z7T%/\N,SKS</<>4U5R.>CV<=D(==)_<4P-(4O2^[G)&
M/A*FIB845.^[@[Q&==8,'O'\JBXQJ30L)M?2C=B,W0TYNMG+,NM74J"H+^[)
MK;NJS^L]! =4M;M?N K"38.$VLX/HRLL]J?.JD=8S8@!)ZW/UZTBMH/ HQ0#
M\]<7?_( .=-R,K*P<W7=M*VMGK](< KX5&/=PJFOM2SD\"Q2O"4\U!3#82<:
MYMGSB$F.1OC18UF^CDVE3.&3$T:BFEXJXDXJ &%KV@U<M#,$24@\,UQ.A-_G
MG/#8+UM].9"*/..Q[2F+V,H=S0LBE >,DO=?5!W:E5XQX"1.R(^Y[:L^3V4E
MSWN@N&,%9^MWYS1+5G+C9KIF4@$D8T,09NCCG91"L<=#'VUB9?FQC^5>NBA.
MCSB_L(YU_H4N6CL(LD/A4 #!4=* KDZWH*9&VL?M=$D#!49)--N1^JG'^]0#
M\I'.Z^KULA7+,P5XDU]/H4W]%<.O5%DZ+*Y>-6S#^FP#IJ/)/5VYE84 Z$ %
M)ZW<^P>,!?B2ZD>8AE0#9.:#Z3MT)%K55YJ?IAMVIWY?0TM*B^^"X1]$;=6'
M05 $E\!QR2'<;B$K]OMDKOVI*L&DMP7F>&]6MJ^B+/?HT6&&VD4".U>=U79[
M%E3RA6NC43YN<NOC&GBD&@-8?L>K\=M$%Q68?N:IKM9G4%90W^L?HOA9L,8*
M5VAW(__DQ>+)<19.8EI!]=99NI)*$K"F3X][;8/H%U4-!UEUXHK@T.&B4[:_
MEIF^_'\E@?]H_(G!-3*;7I%)4Z86&O+$MVL"C>DY11DRGPRPU)08%S/:B,BL
MJ^"C0A$3(W;^;%YST$,T<QH+ZYN)P,UUY@V/#\+3,,/;$T45[\MTA(V I@6G
M>*+_,#;+,/*S*H*D>/WD#^)FT.#&'?%ZVV]XY')T2J& F&@K5Q\M)TA'T:@
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M!6@05)?$11P(T-*L+%2RW;J\ %-A\5R/MVM&),8&?"00AI37D?1[.1$NR)"
M]=&2A7$Z9\^G;:^C4\92C:"9P[PW93F66\VMT-;-B_4[06=<^P'[>Z/CN6\6
M8AS23^J#,R^9)RLV1VU[=:V@^,S#.BQ13>Y[5DL+IR1OTUCK3K<9I>Y/;VT<
MK5;B+Z=5&L-[NAOKB&J34)POA<PEO)#^^W_+2Y>.#^9M-BO,QIW3+?N[/_;J
MAQ.Q96H-L[9G06E<J](4D5AC,2@M9?(+^K$;A<OJ_OM>+DD>FTAS'CMKU[<*
M?:H!]"GQ\-F>?5UF$LJHX?BQE._M'G.'T@#KU+!\84,PQ?DE7C8Y8+!3M)"F
M\*5[HV-&'5._:&N^FSN7]NE-%J^9WCVV7,HZ5_=D5FD?-(T\;2CYS"-A/;&6
M'( V; @TYLB6RFFH_N9E,!"U]VC+&;GW$*&X-T'TM*Q<%8"T++A]RW,^5.Y/
M=).,+HZ/JA ,2V3X^YFCY;'WTPWF:8U:]E.!Q[VA2*-[8)%N\#3-F573.S>S
M&'#4)K$NNH2&;MY(O>SF*:J@O6YD=*I"P*S+"RZ:,O?F0J/VPYL/G(R= \VG
M"[-9ZY1T%-LF:5M6_5,AV&7@\@/O]6 )B]KTX8W5+78H3<X'*&VDP.VCK;"@
M=&NL-V'O7C6F+'_)? 13F-]Y9+R_N1RA<O"(+N[%ZW/J&@,E]GLT ?JF4((0
M?>;*&/=H'Z)DHRBQS/'FT6B IW?IK&]Q1$A$641FL-U(<KKON0E)1FP(XTA&
MO\NQ42MV?36SS%'YZ%Z?LS:YQBXY0#;[3*J #$&;;$X[64C)6O]W'2T>^+7T
MK+9RF/U2?=;P/B.C;8GPMM[A88#2N)2SAN1 1BYVP-A5L[5YL,C2_#E,N_##
M%8/]@L#*NDG*C$KDW%$SQ:TO\@1DJ1%'5G-4EDAPPW3366V$$P-UKACNJ>UX
MR@+L6DQID9;'>]%[X7'*WFN!,56!)+4ZX_HYFDO@'*?5.(LY(K6>AH[WX&X9
MR!WXF%BM;V;.)"/\ZS_X6#M9U0]!X\M>.1ZFKN^%!3:(Z\5P3WMI$Z-MNT?B
MCA4^-;[W>-(">H?F=L@$" C+P/C_^#/"]R)GAG7W<@?=)V_@>SSTM!^Y4=NO
MP^B]U1(..;*WI.TUA(U:U,WK4I4&.\5<Q0R'(K*N&-R[QWC^.+PC>;^G^//2
MX_L_RI%U+$<JL\_#W$_%/<*[\-O#Q>L<,R[R'B5Q>&+V:_PS>,T50P^+CNB/
MU*Z 3AV)N.8'\LN_HE-U88)N"Z/7!<P4"_T10X 2.D"X9T!0VTU9*"ZB%\_S
MCJC'E[G'U>X[R6IN*/BS=3@\/$1EDS3%"@T)$AXIHI>:Q+L;4VUA9]XG2XM5
M!JS=V3>@DPI4?TMV6@X-8PRLL/%9;9^<#8%,X\U)HH:2+Y$.<Z)\B(4C:LX!
MR@A!U? )]3YY_O%C"O!)]Y06\.,(:/1N%;<*$[WR_:1;]1-LIN;+*(P(K^3(
M&Z-;\RV*\_4V0E%SX+H=6 O.5EW-T_!I/!(GN*ADV"?DC,A!_5TUI]8PT%+)
M$(18C>G)U5YJL5QJ_)Z<8NLA1#^UD45/,W I4QH\@<^&.=HG&DR!O(PV'35]
M I;3? 2^:7ZSTY\7I/G7/P^[6]L]':6>04"TK-B,R3*1;N-T?'I1-JR6XQ2F
M7_<@)":_R]I^EH16["#BZ==K63<:^  '\A_R[KI7E ZT&&_V= STE Z6K MY
M5)B%U#9/6#/ZH^"0BX"5:>IR?9]LQKQO7,518,7VJ\G*G3RG?.J+IZ5M*/DD
M4:EOYO-VT=/6:;[GZB6XZ9M_>VL!>O6? P,8^AGPG6)7("<YTJ 8.1F7![K+
M;N[=TFR*IJR_Q-CXTZR1QQV.0>]63:;= ?Q(@/ 0J^'?2^8]B4>JS7('%P(C
M1 -L7GNM5:1!0<AJB5=PG''O5"#7H+%Q;^\\IVCN=[".?V<[:PVH*_2W'ULN
M'*;.\A<4%>3_)BCZR[_ZDK4G(.J9."([S-?(W?HK[1B>;I6[U95G*7N;5"10
M7<$%C]H07Y-)>6V<T>0)A^?>I+#10&7(K32YHF5# >+^<)?^&GIV"J.-((<$
MKLRVS2W"47;OCR/\/;8*$C;W&&N.H(PB55[]< !^%D:I'YF?/Z5NX1X5^/Z[
M#,P_6],$'3^3FYMO&MTJJ_YMR(M^&[F?#I9QM:1;>J4P?R35%?7Z& OPS7X-
MD&/J/4C%\W+H VL$*G6LL]CF*[HE^,LZ%M)1*TAL(:?H7^8 _AH[B<-I2?*(
M)_!(\&"JXCTM"-TI;VFQC&X^1H=U^"'7L8'6L5F]N#]>X.3GY+9@]19R9?S9
M)8D^\7CCM]'L+*G8/_]?G/V[Y%3B'#7"6>2ESQUS?M(2QJ.Z^,TT5\Y"40-_
MCN)FJ9J-I2%\5GC+G_5Q6;Z-W^<D%L_%.EC-66/B/IU<&$)5_/RZFE*>^7?U
MI,Q"C>YCG,ABAM3]N,W&]\OIV2:$!]P;L3C)+3+MA9"$,TV2C"746H7(F$IQ
M!C8I@&;,(8GK_O[:/HNP.^NW*96%!1Y\'^U%,22OLDH1YC@A1AN7)\T"^&IF
M&J!"]6MD;M;/J90?@UR:K>S>%VQ$G=E!3];P8 Q!1P2HL[*/&$:!3B-W721*
M'V?Q>$WP%3UNM=Y2B: JEHD=.>2JNP M07DN\#3PL(K]]"/E463 9&($NT'I
M)V*X01+:]_K#C:6M"C#G)(#DYZ;;KF0&E-?0-Z/4(WYFLJ^>JU]P7TF=!(V_
MEN/B4NL6"N^O2EGR;Q31:5->*\UW7RN5HA<@LB>']7L' ?PC*D)M\]9&B?)W
M[%@W-.3O#8FQZ QR(?JGA&B/^QOYL&7$@*[,)T(BX'C@(WU?'U\_K%A\72)4
M/-F%UK3 CDILCI^[^5NF0+-H")B#U"8:VW'8D\^Y>< .'QFQ 3T_37&0JG?I
M4PDM=.K6!YN1ZRXR]<H=KAB":BXRZPGO)"7E/IIWUU^/5)]:%*WRM1>W^8D(
M)$W;PSZ%5,C%-/Z\,O;$ Q[2;B&L'^?]7[W?(VUYD);!]>PL$]Y<FJB4-EBL
M81?^>"@?]D30"?U8$E_TQ$Y_#*[??*?[@7K9=EME.52M;)&5IO'IBF'2[CK%
ME(C'>B4NP<XBSN(SB'3Q 6)CP0:.TB)5" @!5 0DV/4)(IV'JT(X9IG:?>+X
M>]I?6W;/.5V?[O^0^+%^36CQV;MG)3&<SB\.1[3A@/SK  #K3]K:IMRV9K:0
M9BI*O\^A,<"KL8"";0ZP)4!LB>ME8QNN+I/RX7E,HY6.YO&Q'M/X7V)J&[&H
MBG;M^7UC2(7D&-(?P%_TY!]_'_Y_W'XX!\&C2J @4%31&$:X5T0?9%.B;_Q-
M&\Y[\/1Z3E-7>;PUT?7QZW(=</0C< +"WL"<F+*'L#R28DY)BDE2#?SB)@D"
M_.;M,/MUW' @K0M8P[B GJI.J+8+K/3:K773&^.64#S?:G2/<E0Y/,7)-[L*
MJ)2!T#/Y-D]&[5!B]!)P1T_A?_+K3AU+[8<VS)=IB;9N0BS6)?/^>&VH+J'6
MMAK!MTCJSE:?-R!/]/GP#+&R;;9S]Q8OSF..)P-\+C.E]LHB_>&KAP"=\UMZ
MG%,[;FF-DMLB$?D#^O)NES\[!1SZ.K1,.LWZ0EQ-RV.^H7($FDU)!B)I)B-1
M?5$[U=MN'<2^Z,\2.'I37O[*" ?(!N:\4BV<T'S'=Z=2C%2@]'!]<\"]9N5R
MG_(9-TQX9\46/@HC48\8 _O'4$#9S1 YX=8XI!-1GSD>%(4&Z&")LA4\CMS_
M\G'N)K\<IU'>Q/24MZ8^IWD]R\@T(,DFY%LMGNK+[_@_'Y3K^@TOH ,L@YZ5
M5%UG^5N#1%D21GD2% E(3P+_7YR]=U23:;<^S#OSCHX%'5%$^M ["$AOKP68
M) (2" @A,$A-0D!*0$I@1A&DMP"24!0(H08)/8&@(+U)"1%"$4*'@/02RC=G
MG?.=WZGK_7[?_OM>Z]GWOJ]][6L_ZRX=RV6AH1-D;X:<X=3MO'L.&$RX;D:B
M$]9_^_#R-[5VPC/YLF@*0?E4H4Z3R#QJ=@B(\-<<DW1S0%3.6\U!'YZ\&?\]
MRQN:[+C*3HI4UWP?/,UKD=1+[JG2B;1035A0&F^7*<_*)]]O>;K2I>(*=GN7
M3$[I]65O)CIO^KW. ##"=(.,E>PY(C2*D7FS1@3<_;FH[*;#9>J6+S+*?,8?
MO+^.38UDE,\6# 4II]F'3=Q?I8:LWS1=718P JYR*T'@:MN53Q#LB+(R[W5^
M=WW.FSL79*QBVFIR1%2S Z6?FI: 2.];WBO8I6)^CO*X*:+]MO99>[U 6?S-
M\ ICJ<J-Y?M!.3VA UN95";O%;5M5&,[VC)PP,K7; ^NXUDK";U\>/N+#,3^
M4[2'K<<U,TPZ*M+=_>.'/S72.[(N!.C(^NDW^+$:BJ;@GTNNB9FDWTC)NMZ4
M7YCMFA9G?^],Y@>JC#4+!?8E*]T;&2JB%.%6<1@KQZA4?="AY%;EYQ999%-&
MIW_YFH:CE+KBA['C<RZ%:"!;1-!(S!N&>K2T_H69MJWS-N<G;)2XGIBL4Y-F
MT7;F^#]B44T/?T1-W@Z3T=FO8_$5I3#RUU9W+8I:1&C%#8VFN,;KLBP_%F/(
M3)[^$^J#WT:5J:ED9N&M^;14^Q-*VU#UBP=/K?[QG_%SP>G/>R-9:(EAP8=5
M99)4C!*1NZ9F73]0X6"8&3 %'!IW0"SPG*6+ O(N67XW39Q:D*ICWM$DND+@
M%6AP5>F(?1@Z=62DLITGEQ?BOZ =Y,2K'X84>3RW"V#$77+M!U$A$[/66(I6
M$45ZUX(W>,E5?STZPUN?$Q?,X#WQ$$:;U-^N7"Q!J*LFQ[O\7&P,OU7CE'*C
M#$7FN&'Z>\:[>\R.ZZ8KSM8,'W;O_#/^^>'*=E%?Z4D8.=%QI@7KE:V<5:./
ML.JI*"/VJ50XQ3*]"]Y_';M1]@NA 6CA_2 U54,4+-DDDA>1R5!NQCK#M(C$
M *+9<PMB05SM,F7MUHQY(NX8.WF;^:TOUK9^<T/_U0^1A$K_4IPZV1O+@S2]
MXAS#)R=-1:6"&@],(<_V=.G_S,$?ZXN[5*H.1$*B-J935GX&65 MW=1J.YE
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M%,VP)!66HQKE=#2W[[V8:;!,1V1KCMS(2G+:L+UCSGN!@SLRO[M'Q:YE^3C
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MPZDCI0^7PW)^'WYD)O7W)//ZJV]ZF"RJ:^":2JXPG5EK/_J^8,P2$Z))T2B
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M=.U2=)7824 AGP;6EB#*0,%2+*1V5FE8[Z+L $LP(]UU?N6GJ2'.U^VJ4$S
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M,>5GY)6CZG *T.C"V=<5^NJ>\J9H<&8$J_$IQ_W I9=%Z6B6(38^-KA55EV
MD*MP=DEE)WD)&9BE+X2 [-8C#8+A26V0A'X%U:PJV?Z# I/@0LI(O,S[>GZ,
M) G@"18"X!+D 24FZ'"1S<;?I:Z"B)='.52K(RB'46 QEV>Z!;M11YVY.G>2
MZ$\-_M39(AU :>XV#HV]7MEK-!"?O^>+M<>B,172>^\8(OSNOCO+;_LA:7ZJ
MW4-.N.R<PP[XRXP$I^%4"4+'Y4<%$H"45-P#6N7';DGJY=R@V._"C+%S+E%^
M*39QV/Z<ZQ* .-&,ACE2_D+M6/D,,8?NI^V,.D(>4747M%*TB;H3(?)3",L#
MZ;TXL/D-9".-P<OO5W'RZ]>[$._U*ZLZ']Y]('[37@K4&Q-6[5^H*XHQSW9!
M#2^O&H;$K4IF;IE6.'"N648W&Z?@(S03[E&.*TV.T2/&^XA3"Z]!HO#J;8?O
M6D)(N=@QVO_#VGOX-8%]^Z+,.*.CB XH*'V4WJ5W&)5B@( $0@L!A0!""!"$
M('U&*=(E"2T$&.D0"-(2"&T$(72DA "A"*%7Z1W>_.X]Y[U[[COGW7L_G_?]
M"_9>:^WO:GNO?63*@1EV&"^8N1\R(^>+K754B=LU>BU0:A^'DM %?5E:QY7.
M/=T@\V=X 4S,Z%VK%C)5C.Z3M*Y\M$'(=S'%3N+] 2E"R>.!7$1-:M,](B5(
MSL*QF.'K/?6@^NQ#;_:3HD6T>?SDJ8[[VD1NP9J,GS&1PLL8.7*^?ZNY QD%
MK"6RO;Z!W=5S-\E(>B#[[ ,L3W'-W["[Q5 W^N?/G#_4N9KI:DQVG8RK[)W>
M^QPV-Q@V.WZ-=]R=F7E+E)J4%Z7,_@Y^!#)>RG$T/:X'5+P+U> 0G\WX]&^\
M)='1-S3FC0Z\$N@J445XJ)G4[B#ABYM(W?F)" R-6,)9K.I/ 3[EX].NLZX@
M.7B$2VIQUT656'L=S>ROK&YA#?$^B8[1^J?0VXANFZ/!?M-N.0KR-5R1^W.1
M2^R=#;Q<^1-_4W QN=)>JHLOKDW3>$QU(_54JJ?2Q6+3;GE(Q?JGO=',X!85
M6?-1V?H  W,0[6X0;'*8RE8 -WZ*.<U0VQN[CB]F#:3$C:%SK2?PZOM;O DY
MOIK+[O,YH Q_L:_-H)3$ND,V:J<C0.=5'W/2+?#PM4I9++@_37QN$>QB"3NU
M'M19/ON*AY/D*&!;[F 4_)?>\<80+]5%'3:#!<JW XLT^].[0ZA!M?[NAK7*
M5R=&LL_A^FJU4_R\,?64\=X)Z]^K$]-^;8\7KTY_^@7;F.KR*8:M8.2CUP-9
MD5OLXC%&#W7_'M@6_"NKR#<O<**2' )68[HXT_WNHD'FI!M($*!+0D2D% 1W
M-*!;$+5Z(8]\-UIKBQ J1AQP*&\$W@&7OT?SHXD5?>8;_*#V?[N3_[_PPW<,
MCU8'?X)$ZDSB3A"_^PCZ0\V)8(G@BI#LLTL6#H7YIM]Y!G8".NK2+UFJ>_RG
M+%/([A[O44J?AKQ4VG9-T&V5-D;7I4G>)]QB$>B;([FRD3)6NEP+BKYO(.5Q
M$_&\\0MK._M(S-'>'KT"J+&:X+BS]7[[O-C[3),K/+[ZH3PE-K4RC+F1D/(Y
MS!4S"#1\YBZ[\3!/].)8\!TF7 X\T*8 [JWWO1NP_MN,2/KV5."BG1V&'7E_
M[3W#2)D;G; O*(Q>>@=J='J]IGT<IO/^@K\Y>[JI*_1\ !"BK:DS4Q^\Y6BJ
MUO)']&Z SL HTE%W#G10N =U6HT.-88Z)$ '"RH,Q9ZL$Q8LQP9*\6^]$+!Q
M\"ZOT=<Y2,KU0Z%G3^P?E]SB@'IV8@U@X3&L/'&$SD)N3FV/*DG B1^:YG<6
M3]MHNR8&'VCQ[#523S\T+<D?-O+O:C4&EP8!E$N7+Z[]%&IZ__\M]:MN[QF?
M72R0C"6V^]-Z)I7*<X!R,)<)S\7P!P7 N9MR!24W5&)U\PMR9*\$RN>L*@V'
M?<Q\7]N?9\UY]J9EH/R2Q3*M^^*.>5!!B<P<HY ?U/!R.I\N.&">@!ZVUJ^D
MCW4E9H7K2R@[V1T.:PHQ)%#N29,CIA]KLLQ@$W:9#B?IH>+F:A/Q=2!^E]83
MZ,L#; JI:@]TU\#Q_:(SC):6=!,G4 OT:)[I_.^CDI9?'"(J%&&3Q GR+\6+
MYJK<POMF<P7WMN,QH/@T0R[<OL;G0_G_:)K\^]J]1U??(^V-$<]2A_"*3ZR(
MEH69UF:.H#LC$=_=J+I]>[+*#?W3/VX7H=<ZE[2H')-92_!Q7ZD"@Y5A-JG(
M0^M-C6"9')?JU_'0IIAR3:6LV&#.;Y<LFL>"'0?FK6^BP#8,G:5&YOCKE.>4
MH'X_L!N)N%7*O__X"0A\6'LF\Q(2D91RR=)]_9+EM.<"&J_QUXG4)4O9 ,\E
M2[_NEA5R(F#4^AQ2+WCA?<D2^BBI0XQ3OL2Y."Y:1*)+-D=KQ\/V8[/N'PTR
M1<-'@7R7+.5$EXSNB[\"3*3$IDCK-/-W20+3TV.MQ5-A36'N6H2*H5#><JNF
MAXG7!J-__3(W_3-#42K:B]D("4-L-310+*HLAXO,4J6X<,K1EF4H75O%]Q3(
MX91]K:,FYX):$>_[08VZ<N$!K%(X\:F',/OW$!+QS9D)\/L_*>]>7\<!/NQV
M#--3>\FYB$=IJGZ^,8A\,Z;X@)',M>W9?&M<#L7C^GQVFGD?E)O[5%&+;5^H
M\] ^$9XR;]^4%]P@:FU!8A+6_Z:^2_.WV3$6I;B6QATL$4560V-!6413@RO!
M/-W:[TJK%2!;&75IS_,L9(6R6:M<]6",$!^ @A" /2CL2K5@D8#MG)<94UHK
M_';[8,?!7G&V\H>$0$M(+K:%\WZ]!!35O+X9OQXYC,TOPV*Q05,GT7/-8*:#
M44]+#]IZ1_I@*TK_=4HZ'4R(#V>5$*\;MLJ>E,!*9<G'6Q EVGL*[W7I__$?
MSP<WT9S&D?E+B6X[/O0TNB7WDH6J.KH[3QZ>7#$SG+")&3 R7EL]P=K?[WCA
M[FIE9<CP?;NW1V1WO+TR>:&#\X," H0V.R90H94G;5>M>W9;=$5/76OH^D65
M/-KWE@+\T8/IS[N2_ZN)!/\/V-P"_X01;C^H'C7!/WG%\Z7RKM+ZNU"@U.W6
MREY70Q'&JSRUO6XR/_(M  5%OE($O1\)D$N2 "-OVOIY+?E/%!0V[Q_8-4^!
M0 #C(X#8H/:M)IU2U>MNQ_3@DA(#-?/6S^:^F\@WFF&RPA>LE=W=;NKTHN4E
MB<>D84SYCQ[PL?\S)@>&:16(U'JXJ<UQ)^@G>H84^HZ:BG=7<XS6HX"O4I\/
M>\ET&5>4^$OGO16AN N!GO7I<R^R-;WMSLW,(CO3!%?+NPJ+URK:*'#K[W8U
M.1^]WTC*.QBW]U89J1U!PM8RG(,N640B:Y9<)G/1B#Z:WL@]?8FZPKE,=.1/
MZ?_YFY;_##]^?M7975XR>3Q_R!V7R)S 2+?#G@4Y?W7(PGB>=*6C1!Y;[>FI
MRS/4S0 I+TB_ZDW&=M>_#P4D>NVR+RA:SR,:P( >A8U6 @@ ,"ASERJO JQP
MWL7"0:'.+K5U8CI#.]]'M4CGU:F[)N-/FJ*OQ"W.=H/PA)2,X";%OUL["I^;
M=D'53=<SK.]^]!(5L)?%OD*M.>K5Y?TOUO^C_[2\R'#1<V=%J9F28-ZAHP96
M0OJ7].%9[>3I!=O)X>POPX<(70VJ3!"(HPIPYS;I&4#UZ\-&N^X=!V:6/2VY
MX77MH2@>1HBT-*REYIDG&,D!PUXU.:(*^A:U[,M+M:P3%P:U(*@+H>A[)DPU
MB'U5E:(JKW;G^&Z)K1<B31\@3*BZ<=UZ[/$32XO?_GU-]R<G>WXEDI.2QEQL
M)EE7O/1=9809W9VD'2B^IO9Z\7Y%MQX5GSX7(R,BKH@TT,LV04H/?"[=3T#0
M#$6!(M?42K1#E>*"FL+X-<YNCJKRSJMGAAR&:-UDH$I'\,1(KN[B8AG7!9C3
M-RS'*+!+G%CQM.Y3945)Y,..43^-[B-$YM#2&,"53[R</9FW2@0 \7PTSIWL
M+Z'GD+>%J+6 D%8,./4])G$ N:;F]QUS+Q<VN1^U_5W:LRL=](3"E.@W6X]W
MPN=?S&>J^66P737F[!I;6- ^X\J7%:J6D)ZU:_>P0-3L,-4?LFY5Q?SBLB?]
MU=5(N%R,>O7IL* 4K^RM7H@4J69OE -DMQ?DD6FW3#=KXLL:<)LB049E=^,P
M,2GB$L50^U5,'$)"O%_>2Z8#H%1#4R:69/U]FO[MWR5XO8+[B<LR6Q-[T:^@
MO];+'Z U6KM:0:LO!C?+4) -Z4P5H.>$RR>+KQY&(VE @)"PW/M^^,&QUQ0,
MLY[*A7"_9#&3F+7!'.TG6 2M% $%2V4VM>_/'^EBY^@B1[C VP+=R*#5E0K!
M\'8\9IAL,Y69V  !>7B9 Y_8/7EK8OG?%'GUO8YG52_AWB7+U? >=97'B:=;
M#-6F4\Z^!,/&@YFJ',1F\XRH;MW!Q6Q_8G.0!HW*;]A??WS)HJIX>]]L5N8?
ME]<.'Y<PA.K>+FPJAQ=6 $.5W3QFJL62UC6W=AG[TURB;K4G.=4SA0W!FBUV
MAZC3Y#3O ,_@FF$'6D6NJB%! &5029=K7DMJOKCV7FMW0,948Y?HO-^#I-O;
MEGBIS8VX%G!G9.2(RI5G@U('XR14YK=+$2U6IP_]2_K7B$1D(\W2TB-Q+14-
M$$9W5@JCE]%0#BB'UONCO,7FK]L#WA9N7/6BMIFS50P-Z34.4G..5Z:)*RQ]
MLSOY>5\C[4L,VK*!G^.!CA&L[Y4%*U):9UL*H.:F.W5$.G:8]2?#7OS#J_:%
M"U,0=S*G6&Z5AL3CO3TDP@!$WY-;&BAT8%LT$X!MA]R4:8'/I[2$7Y,M?6!!
M$&5'QR/\/IN^&2W1V(S" )0]7VR4%C:%OZCOD*GZ=!:@U4I\,.,T#K8/#H+;
MR"F=*CSL!.RK5+O#15V?ADHY/954\-6*&AWJDGKRGOS.:_+1H2</6::Y<SS:
M[VZ>\#Y0=Y,GJ$0.+#R\FG$\N6#O&#IK'Z<8Z^L)EU==9UT TTQE%>+SMNT*
MRL2XBNSI/2Z^\7.3L,ROT5T'+FF#@73F/E  C+8 ]_Z];SRTYE$AO498T!3R
M6=K.09FHH3,23Y.H+FSE1@#<!S1@1T]/N:&G_GAL6I\A0:5,K*2J:"+C%^Z3
M=KS,+'%FENAP)./VUR5>)J-BB"H[,/7H4=7KM:D ?5:97()T;.+@G^+%_4C?
MV/A,-" _GP&%:+,E9&N$_\OL,AO#-P']&R7LXZ]W=0A3Z;O/YT]]G5J'PC[V
MI<6W@0JV^8N2I)-^\%0K^ WW@0%?-3,3N;\P\=2C0F*U*?Y,BM=N[3Y5-L=_
M;Y5>LPXRACI-#*Y]]#G2;+YP3ZDQK'(L>T/_K?UYCC>";%NY>9N#;6 !=.:)
M++#/3'*IC#C-8Y3^C_>BAXMRPGD4 [*!4@'+[BE^FL"#;P2Q=M%.2;OX;JBO
M"(^"$2/BP:OB/OXGSH^J JIO@&R->_S3NNC"YMF ;6U\G,S.+75Q<*-24S=C
M(X&H<;:=]AUQ-K(_Q#$(J.NQENUHQNB0Y!LA54\[!*R(9\W7KRDGI/QR.CK;
M2N5'KA?4;+293>(VMBA%JO8O$::_EGYLGVEY-)$<]3TSU*5*T7I-XT-?;[E*
M4^HE"^FEQQ_I_:YOE$-.&,UI'V5:0X\5"K32 &W^"!G,K^]]'=4]*R&A1QFV
M'-'YV7+->U"E0_>X^)/"?5]L-N50:<Y3^4+T/$OG<>T.HB%D'-5=,4AQ;I0A
M:0\Y+/FV]54U2!R[W:^SAH(?4RNM>86<U.\[_G'A'AA3N;([H%@5\H[SRP/_
M2@D&7!K9V#51.!7<8O'NI9^YBW-Z0!/N<X! &H<0+ 6+I:;M%82-":@L-2[Y
M1RT,R)+P]_="AZ(I3+K-L.6=2+M:6K>\8YMYCMZ%5MHJ=:5H92 *AC0K[.4S
MN7CJA8XM;8R.*G=',;(R0O*2,\:OAWPJ9< F_+K7PZJ2/C;J_MKA<]/NW8TV
M]X_,,9*<-0<N%O>C57KM_E><:+K+#7\OG=TH_1$FL=Q;:PY+OEM08J2=]?GS
M%X;/&N.[5(*-WV<#=H?DV#U'^"D#028@2./#ERP/YR$S,C.^QZK"7=6*8?W-
M 8[^"0&VL.DJ;[T\SN_Q3GF_Z(NWRL<"W)]J;U/?C)]5/9[ZH%P(D+(DX^#!
M/R_)R/.MW+E1!'(:02FP#7\P0\U!GOI'G@LD_G;)8EC\5X"L5"=B5R_PYS>I
M31DP<[E@_?%\)"$BA]@DC O5-A_/N;,K%_>I^0_$=JK#8>2M4)EJ9/E+=>.9
MUV14=W/="J.PNA2).VY1>3:=/H8A")D(RO%<\]V2^QY\CH9/OM,ZJSBU.?M\
M(&H3L.$8?(X+)4P%Y,L/;S4/BN4E!JX3LG]F6]Q4;MX1I.64R".Z#L+OS(QA
M-K8.-/UI%0[C[L?<XX;KNSOTA#/(V=;%F&:'*.UHB^88?3B9UK!^4748'.PL
MUWL(WZ2;#1A,[#>%3&0%_ FVH?J*1+K>B[,>>+_-KLGEJ:$F7V#H][XWID,0
M ;"^&I8O6_Z?O/'T/^[=V2;?>MG@-MMG&QVVE.+RV@$=L87/$SDTDE$^5%3B
MVU'ZM_-X%?*'TR5+UFZC%.MAV>B%=P^RT7%3P9J1=&7K\-%JTWJT!M^RJUS#
MFNT>(2)_X-W955U4_[EU+6P32@R/IE9-T];DO&Z%$K:"7L48_L+,&;CE7H,4
M#+K_3PX58&*OB_)^1C_*7"N:Q RNW \X5,T;%!L\X6]F]$CMEF?@7?RVTV[%
M,H6K@OFCMAS#!%3:EF[SQ3PPK5LC&L49"FAZE1N!4N> !JZNSDG4@U-2.>:>
M=Q<Z%>S7;D//JRSWA .Y$KV PC7&>O%%6'6=VPH[ KM=)-R4IHK#K&<E/+6)
M-F< 3?^$\0+VW]\F*F(0W8 NTGC*S![DS7EYF<68Q)M"ZK@-?B1O\L% [93%
MMWH#M=V8@%+-@28G0HT,4$(T:AR6^E;1B/[W%[I@FNO0_L'.H\KRI**E)P$T
MIQ6:B*!+_CDD-8DF(7L\7G^DF;1$K=Z&N%ZR-+RT2?,-Z]M#C*=7!:UQ&UDU
MM2KXP$F/2HRNUTJT_O<N@:L:J7%@-U)"S8HM??&&T90[H+TRL^Q/ #)J(O!@
M!/RH($,FU?')J&,LJ";CA/LF"K5=@X!#!Z1XN5_EK" B0WG=PT+2"$"Y)@7K
MCB,QM440<HY798W2I8)K^]+9Y=XN =!UK=^/=^'ZUV6#O5<?K)FC?Q.-^UU>
M/^)C2^5:,Y8><'E1RV7LGW;?Y55<@FJHG#3^;=!CX2FG*V5_#377%I&:\1H+
MI_H3TK\L+'3E7[(\30AAYM'VJQE@PUPZP";_Y%4VP;:W\5[_(R%-=>4&T1Y+
M/LQ9V ;9'(ZU=QJ1YS+9]80. ?H;W>E<13-J!V9DB>B\VNHWV>;I8UNXWK<-
M-S,-687B",H'MEB;+UIH:#Q/3/+$F/$(N^MH<"GMH66^]MA+;^ICB?;F"?#G
M:JRWF4^>5Y%[EBJLP[=\ 0:V="3E211N7[)P,65$RISH?EC7/2,.#T#<[(!@
M6[R75H4NCNGV J'J3$]AR_'LZR4)QF75#JJ5#Z[[5&6?X+THB@=K*=C'1ETS
M]@[2"S.)^U=GP=]X#>7#/^KU3E:\^.K,"2LPTKF^[L;=6N:)M_OM+XI5YN+P
MM,\Q N"]CU^(ZU50.MSYCLRK %MII_8,S[J0#:06CS0$]8< S<D-JDD_(;R,
M$6/'HANH)%+OU  O1Y;])4MD3,R?B/)2.D"F6ZK9S&[A?LA2 -Q'\WV;_RUL
M6P:(:TBS3@%E\A;AFVB4RCS-I;J(@/!&S\?K(E2>/5%SE_&OIR]JO63D39+Y
M!T3MUH8N6=KD@-J/F G#M&4&K26C1S]WX)%UQ(* 6'M=%,W"5 I:[U4U.-!$
MEKF8&@^H9=P3[[@AGYC2T7RJ26DH/Z5X,_$2#%5YIT_TJ5,1F2]X;X&MPZGD
M36,!*AC\#-10(;@6VO(Z'YT=!$++-:MR,-4PAQZ?.P)6BD*^E54#.88GJRE!
M?GN;PU '',DY(%PU," X[WL@/LX_:JHB8'9[*UM4+L"O8.;(WMI4-ZPJ7+=V
MJLC3?R,>=.IT8J'65\GKN:,5FSZ(CD>#^5@;N&_.-[!-/OFTP[?\";<X9XS:
M>)/PL&DAKI^H*6%$^969=%$<Y.:+J/"<E)HH+,/NEYL^C_5G$@HV!K>,+3]N
MF<V7BXC.6.7=3C]%#ORZ*^#87E5??J>]@E^ZGDE+]LQ+HQA?S6GWTB6L/L_L
M?*.V-=.-7P"[ZW2:]ERRZ#UU>F8YSRQGSNW9[3JM,QJ=6N0IU"I@<(133?V/
MA17W8G0UR\?2%*LT@T[&:>B-!<O?Z=T>? &"!ZYGS>3Q4''A7YKWM=;+F;=A
M[<UOQN@6R?[5%>0I9*[-]P0?;)[(S^HPN+KXX4';,R.95?N0'Q/5J[X#3SLS
M.Z8,-AJ^;?*ZSD0GH=??^%0C"7[-O835TFZWD.4*3Y_<$MOUX+3#&?#@VS\3
M74X=?^O9GCC[?4T^WHV32$E#"PE^$1_/(Z9],'G'4]F3^:-Q4F>F<NERS$LB
MF>WF7_2OV,Q$GOI,U.<8LJN9SU;SV?$(X5 V$Y_B80I-WC./P_@&R4"&K4ZM
MTF]9S/?M8M>5D&Y)9,0D7% VT)CWFH#:OIEH]ZQQ\Q1?@4MLL>3LE!C/W-+X
M_0;1!3X#C.C=]-T'G6'"=4FUHM+%_75?TH=LD+*5#S4W)&2K3F7SL9'Y70!S
M]N0=18L(Z7?$+P7V&*!RJ?N>>]%@89/Y#]3.%HXC%Z=^?Q>PLIHI6\=SK!T2
M"\,AL79 I6&@:'9^)J%Z==U0,2<T]7-URY]HY^-$L0^]D?)ONYRL/7DT^9Q%
MFHLPKWH[?7VOKA!=#KK-_;3()EA2'_3+M\.IPHTV1)3HC+@%0M4"X5ZT4>_<
MKT*_7EQ#"_T>U=0$,M;;VT"))1PW7^-:(&_99^/QZ_QMUS19)?W'!=M;RP<$
M)DT:<6)^GA$[X'M3$T0HR0AAY.,]F<1T73MI5%[5#+&6C,-]RXB'J!]E__[^
MC@2"#4=P!W-QVO+?W+NSKUJ[137"&QMCV$<=W3V;FPL^MFB*;H4M\")WMQ?B
M*$PC>5+S@MJ:FD0'>%P $X%Q]\A38HJ(E]\)R];[Q@BX0[[MQX1D!5-9I^"D
M2>D4^^4&4F:1?LV"LTU#<5>IN:D1!RFCM7L)/#R*),IR#]7]FQ>_PLB)5<?8
MSB3A*/N-J*V[MDZTE*I7"C?&:2K/1:ST/816U%  D_8GH8C#A\W$W!1N1&.*
MQ"T10WJ.1.LYM+,:J3U18=Z9:64MWJ\ "NU:$\ M[^&M%_N,Y QPNN87?/.L
MV*.*%S-<7 Z3FQ/+9KRB!'%*"?AGR]PU\EXV \M74KE*+*#[01)B*/J[K)]\
M)P4[NF^L6ZWJ:W)O!HW>2Q&5>^)0V>'F="P2,3'L-^3UJ?=0BF.XXQV@@=^T
MAOA\;@AU.P)5QC:04;]D5?:FKJJY*53($U$HGYV=T ZL6UN1$:;D]SF>?\0/
MH)&W?S!(5,=HV6SQTC11D*BLT9=3,5F(D1+W,F=X[J_5M44:^%6,3Y7[\;NL
MQ"FKX<&9@8H@&1WC0\5<W KI6350*_])%4KANNMV-9?3J4$UX(&IB#L@XR,L
MJY6@R+.>B93$I>KS-VT[?MZ"#IK-$J!^=*B2-PT^J./:UK!Q:B5PF*FW-D&^
M'?Q]5%NIWEP92F1UV!RS.>7#F?N"XB$^:,=&QX?5;3N> 3(%=CQU[5L>"I)I
M4)$2TOJ*M-#XWY 81 <>Q"ZI<+-+$I 1=M5P5<OMY6#=MRGR?.%V1:E_G]Q<
MOZS"/OW;S.?L,^^P2;6*!W\O\.IA Z!DE?A2"*W 2[N21!IRKRGZA9QG9F;0
M!&3.FUIUUT!K'U!*;Z)E4+:)Y?-*$Y/4'<I1/:<D-M7APX"YU;@*9L4VS5SP
M6T@R7/0&Y?YJ?+GN/9,", Y^5@#R'Z")'0^&7ZG;. D.,UV0&7;;#!:=A=K6
M$0&BVZ\]HJPT_S75Z*#\;1!@WVQP-<U W?7^C$IFL[/PJ!JT)B [)-_\B3'A
M0YYEXBE0Y%;!/BYM9,?2T1R-M=^QS[GB<"@=Z+1YC]DE/.N9&C<,=,"%3@2%
M4EWP$&1% /,-;Q8(RT2)@$;-;#V^-31D5RR":,:$8\SJ.>"13_SV*+3;BTV[
MC&H%)/,T.W?;I:9V-B GS4,]%(2+1_3TSX8%0/^ZCCT'BG=:$,6":.3EY"(@
M)W%L2M-AL$=5FJ?(P^0L%E:C-#1:@A935[@)F"8\T9X569!ZIZ#H.3Q0\7!V
M7A-[P(\K"PD;^&(D64/9BW^97R!H9I8B$QZ?D>^@-'=TH;=DVU"XL*5=11##
MB#98I)"@4V"4;H;L_J8I %Y!%L;1+7RW\\@<2F_*DC'RZ1Z:>B&^P*H)R&/!
MG_2[1$1.?M;PVC[\]S)>]NLX 7C,M%/[:[??K9\+1! T4C[6>]XI45C1R5U%
M297.RM6DJ'@K>'B7"^?)7]LQ9 U[^NTTC142Y3I&OND^LB./2_BTZ9 $+B-@
MAE2MN:TV2OHK?.4S7</CMN(2O(\:F!UY<M]'2TY1A;,RNG7H_0@<.F(O!XXT
MJ")J&4^K965V?^$4.([<?T3+NO7XCF#JO#Z/_4J:P$2HW?@JQ'T5<:LY.U=(
M2$>=7\O[GZ O',0G^*8JA(U6SS2V,11BU2B3<K'PL(/<S*S$^R.3_!ZX#&X"
M2@#"?31&XRF3[?2&U(>2N8D:#/%$).3N204:_&3D1#4?_V+/.Y?^5&[4@7\1
ME3;H=9"7O.J!P[WVE!AT$9@^6!AI9,:ZFM29FE0D"3B7B&@MA=*Q$_'OT=6K
M>EMM+;]//YX.5.:+ZWM-N :+,FP*D^R,LG*UQQ:(L<J46@W>V$"#2 -!/2[7
MC20?54&_)^UZ%R>JOZNU)?D\&Q#2 1]8OR:"S8T&99RO%]M*//;X*-#Y&2 Z
MF=O@4OU@\D'!B__=4O;_ =AEU\<^U"9><4=WOZSWSF?$0#G=7?K7C\4F$O-K
MCM%\HGASGB;.H6Q+=W/ASAU-JRFOM1P'3BA?CO6!O@SD?,NL=KE9&)ZVXVGZ
M@%JENEZSP..$?5$SB@(4MTI9-<&&4W&U/TN\VOL:O7]U=.#0-*_;A4XV9U4B
M)(MFU)LJK,(+&L]$GKD\2TQ+& 6EYJM@K'WH7>(]]'=:V<<U3NN9C?*%2ZXW
M\[A/B!>C$W H!WTAR,_X:ZS/+;>&W6GNL!4]^>W#DW522BDF;RI>2,V87-_W
MU/BW_ 9\+0@.SE763Z9#+!TGK68XNA?YXTF>?>V'7/7Y.WV'P/Y?Z-.V.$J3
MNM"\?;JU\[R3-4KN&/<<VL+&E<65PZ:MI.0=VCI)VEB3NO:&MIDRHPSW;K ]
M5)4(" G.W#2;RRYZ]C__R?MO2,Z\9,DS@:5?Z%A$_Z[KB=X/VF5/ZL8[KYYD
MY<0E[__V_B2%I3=&RU!12^J2I2MPZB(SS.3D/&7R0M</<72>&M2"SWEZR8+;
MU"K9GV\ ZHIM5SW*HU$KEFRCU^YF5W#7Y!7PU,V[OO^/HT^NB0J>!=R[9$'9
M7++TE[![^5^R_!B0M&[E>)+=:MZJ.YL]>(YMOV01*TM3:#E^K'O)$AC>4QEM
M**@?OI_!=#RFGJ_V:WXZZ;YD(00(7;+T7;)L%;(?MXN( J5AR6GVSKZ:$0YX
M'BX/[V&,;DE!?N^Y=B!?1;D#?T:[SE^JG@1G7=IIHT1_+FAMBE<R(4 FV%D0
M(TK(NT]<)!R<YL^/MY\H+XSAB_YNL)+Q36(>9$ C0YR':^FPLH*5*;%=YKA)
M@=A$5M9YI?FS%?%O\R93$N,]P8Q+%I/@E/(YB((&.M>[*@ET$>MN[H/=RX]O
MTKTR%E[<(A0J_<^I-ZM9S]8H\K;/NKB]'ZK$U-CYU" &:=FV>E4PS T%-AW,
M;#FJV31UI'RG7[(4M0B$FJT[A#0$[7".;R7(=83IK/ERIM=G?:\T/[+;AY]]
M7:$T=Q<?%$=\.Z\YC[E0)'.O$-VV0["GD4>^49; _.-_-!('0*ZL#3EGG*H<
ME&^JVQ<%VU$331LU!"@KKB;\![+3.%6@15IX+SZ<W2'6"$B-/M4G W$VC<XN
M0<8?.GI[1G%P!ZT4Y>9-2H'_)VB.%.A C& J8:3!7Y+E\,=_4&D8 T'%/P4^
M\**L#C& *BDR5#Z[&/$GOZ*59>#FR>SLOJY:1D82W4#Q H+WMV"Z_0:N-'\!
MA@.(_&L*@PB-="+<9$+6@3AF$IT^P3PMU>_QOP1</,SH^*N=.F'AH<H/8ECX
M1[B#L!X@D_ASDTYG4J0<C68KUU^I*;A ,J5^A_JG@9>;V,47=RJ.A],23!/Q
MMD^Y9(+4YJQOVM2. @M+@"H,N,$)*5X+]OZO_Q7+\->R!3(<AF@<;&W5)&*%
MZ% -J>B69X>SGT@[#C1.J/\LWON^A9W:T_#]*'4>7D2V+ZBH6"P\U_7I6D^7
M\YM&JGS!9QN P:]PP%-,O!)M.96R0EA.D-NPCU&/^CK.[<$7N^H;?_JH$[W^
M$/D(#YQ^ZNQJJF?<XS_2;@M8J )A<Q^GB;JMJBB^; M&M4>2:X67OQ0VB102
MJNJH1)Q,D/^@>\E(#OIP>:=":.>6.;>U^"9D&@7R7R7 A209_F\QOL]#3ZA6
M,UXXTDGZ+SV_?O@_XUC<GKE*Q]/,29U:S%V*10!O@M*$O?^A M 1\^W3AT0R
MSY-?^Z)L>OJ+>WLSW$.%"_SRF5HE];-S3$/3M0 MV8K!X$"PH]R[_02@W J.
M5D"0V;HIN3P3D#"Z>(XW?="I#!"3T&K*4?0JE[$'F9-5[F32P?9B$P4R#V?_
MLT\!_TM@_4G!MG&%A]P]*P6PB1EE?;AZ*&?('ABJ*)K59?I\P:8IKW*AX\\4
M9UFS#\C$IQP/=;ZD,74F,D.-3%F#)KS[_=T0HP8):[SUP^J&%#8S,U^"$\ZW
MM'_L$-6M&)]WO0/0+N9\=,F2B3CS56\,2'&RK?O.-@7F6P\JLYPW\%-O].S5
MQ+O=J);G)YV:3JP7=F^T"*Q.!:@*=GS]^\4LU]T[\@QJ58B0"G4P95;];NE0
M499.WB:I[NPH=?]9!JP/09-]JJ_ %V7^8#['1;8 >NNOZ*PD%-FO<'57TM(K
MG1QL;54P<W^@BDN_-4B_^P[1!P^)#;6W&Y7>VU']I77V>$P]^!;L4("_\479
M5(ND?S"7K6$32OE#<XI+)4%(4(KG1"8"4:G3.<Z-LN60YVYM^(^RZ]-U/;US
M_M@U9Z1VZ3C"61?J><FRU.B]/18>)M+2>ROP8LCKDF5%*VFG6C*2N7E2%?ME
M=4.(7-2*?NNKU&E'5TSA>NKJJL?DN%^ +'KN:KB*4>#C#0RX4T@%,PJG6)U.
M2F!#N+.2 4L 4HMWL:^-ASN=3Q,[$^TTRF5=L]3/X>CIPA? +=>DDNA^Q&R<
M0,C:K-TD"*IRS7$[2T?@=>#S0Q#0=,(5"52N9WK!E/!A)@+(TSEDM&KTOMEQ
M0$=&K$!]!)J[NIK6Q$ELXBNUB W5YJ4#!7!*KP7_..L!>_2U)7K9R *+J2JU
M[V UQK9/&JGZF.C>M!"GV:DRRX8\X4CFZ#"B5O<E)):YC29-2 2Z]M..0L0<
M_65EZ@8+%]13M&Q!6(:4M7M!>7\$3]VW^+;CF4]=!\.:F]FX%2L5X!# G=91
MZCJTFEHN0C"&/OGNB'X):= 41'RF @U;5 ,F'L&Q.(0!EZO;X/6^XJZ#)Z T
M#]]AO3'OIPLQYJ5MTD,I/E^C^<)>9YX:0T2PI(E1M.2ZFT9S4RHY%?W$0D"H
M>]6<._DW;'Z.%&-B"!_:W\-K9_B=^Q/]XF1"ZNTP[1 8Y$=;Q@EPS@^FH5!+
M7^0K.;RL=(P_.>2B$6%Q=Y!=G9F8(0DP,,DJTT@2Y#BZUV:$K&DA[^4;L+G_
M(SL<$#WIFJ!G^LQ7V__FVK6OW>KF'Z,$ O7L'[":HTV.I=&AF:@E"??!8'F[
MEFI;V_OEH<I8K'5[P8CUG%T!##Q9]!YL#*=XZW05&SI4(0D\/;!<2AW=?MW=
M_1<CH/[9)8O+F.[YX(GSQ<O V^>ST3GTAJ)3X_KP@']<))U:=$">G=F^9/G7
MNYECPTN6-K?!WCO/%9@) D=QPA-VF>J_UA)A=6:XN^ZJN;)(:Z"E]9M5S^G$
MML)WLJ2O1) #UUIG/K8%;*11 8 -3S8O,:;XK:D  'QY8C5XO/7,&HPNV35:
M1R("K&O=* MYPY1; Q[4:VOW7, #M<3561FGEK@.OY_T2"--355%1DH\,P&\
M0W=?ES[/0[8^-3'N)%N)O-KI0@,J2ED!1B/N@+*XLA[5U/$R N-3'EN0E*(;
M]X45H94D1:2XJPX3AK\:)[W1Y9&OD,+N\%;YC9K=2W(>-PIJNNN6TC(+%6/D
MI=9]-P)VR+H'Z%AJ#/! @I0",XB;G[PLUO0R+>&>O +ZFJ*I0ST+S[/R4AM"
M3V@2IL(%ORM]_ FP!JHWZ^\Y+LN3H"?4?F[W2YKSKFXZLPZ?]0#O+><@LARA
M'&N=[8SF[#421>$P[&4H"E@R22IOX#3GYXAOBFQT;<PNKQ=!*9K'FF_YCJJA
M6D<#;S6D_/"Z7Z99\<-#O49-U7P(>MN^@Z1N ,%(>%HR7$&YU>KO,G[>JWYI
MS^STLKA9!TM&3Z@V:L_5ES80^@L*_.^L(!2"]O!A'4S9KG;*.J"['N#_L'&-
MFKEUI2LW<'K:FK\?E'UU-G'R^VYIDO-K:FW!;JN*]19S[",F3DK( :AL,V*Z
M9O'"9MKY>&)-II[\9^+:I/4NHM9*[D>91&CHW4W)E3M<*1D[0K]'<\:@^B0]
ME[2IGQ)#F?&[[CX,IO<IR6OJR![13%G*R BOO0X1XR&$HK.KD:; VJL??V;,
MR*4URU#MR?%O3#__$Q;:>YWER4DF1#LQPGG]U?Q;)]?3@_>8Q<X=XT\HL]Q3
MUY*3Y0*^TW0#OA^TJJC!MHY9X8"7 @:%G_VG"Q+LFDLS_(ZR9,&X+Z!?H\;3
MR^/PO[=T,R$/),Q+]5_32FSK*FC)?@5:][=OAI3:JU^U<IU5K\@R':<9GUK/
M+J?XJP6%D*24!OWI5O,!@73?\=V/X?$H:'0<D]GT*NN^S7%F! _ @$KQXIQ?
M;-VK'9V$R%OB%TZ4&BQ?$.!PR)HZW3H5=<^:"YV=Z89 J  3LN+'654%TS1"
MJ (ILA:;W"5>:K4R!B$9Z5@FDSEG?M/3YDF9QUS>_2>2\O'6N?$@@,AWP*M8
MY]=3JMI;/@T!T[YR/5.^GBFI4_X8$L,3,VI1U55O^AJS)F%D"MSW7*..??OC
MW]U"X-^[0N>';-?._GK3<AX\S&:]%+X[3KIDR45=LNS89/6%JH6?-*N['0AA
MPHN)JC\L+1WACEG/<GHO6>1^OQ>-;ODFNG01%3Z91]S*;SGI1-Y>;]1MM+&X
M9(G4W;89:!G_(27\=;GE;Q<_7K+\.:X[KJG;*=_W_KQ0=W>KYI_4@L_QL,U/
MY4+N"O';OZ_G>H4]K^]^TH?:N"=#Q6\,.-,4'\B*Y4^6,-)%)7WL80Q%D+!R
M5LGFK(QHI('P7G&J:WK_3E;PXD#0,, %:N%(FW/T1E'.^*^[%SEL^-OYD^M8
M*Z2H(6O>. _+]2/N2C0<Z#Y]L*Z+H)J6FD_:GV(Q<26&  GR_>> V/\^W/?K
MM?[PB]:E\X;P$_8$]Y/H2Q;F/\D(ZR7+IC-I8!Q^R3) OW"Y9%FH;#@'GL<I
M%^V$1UVR0%+R7APX'@C>.6>S/GR?]>+U)<M18-,_M+BK2^,2L O3TG)N"R&X
M=2(",*):K(7^YVR%;&E\UL*];3M16P(>RAB@XD,AC-0\*<\5!E8#=KZT/]&(
MPGN;-;[\\DD=&P"LD'LV7?E1TG/8&IRU!9#A&94;,J<#Y)KTB0=AGT)FNK18
MW6XO\@IE-7B2@U?[OVR:1SDHYLJ"24QEUH=#62K%A];*VQ%E$4LM5\YR^L^D
MIZS#1 /Y8K!J]I/)E'=>JY A'EJ]WV*:PL_E%LF9Z6U'#B@4.SX44?PQ^9EK
M%_G7B0))/0Q5JP'Y3?,<+X4]M/Y3*CC,=8):NP]*Q!6!IP:]S=+*$$ QG=6<
MU8K/D]:KD(XW+<\%>/P7=NP^95&&?[Y'<7I<; LN->5(=+U-AKW(;UI<J[[A
M@Z7=R-Y=,#L+:T1=F.T+'KX:<TY>U#WNFKAD^3HVLTKH=?SJ?6ZAGG3@^(\U
M!I)V!X\FWA4^_V]6TK&??[B9'<%\A5)>_-)>Z=YI6X?1Z"5-J,B_*K0:3BBO
M?T8D^9M48(0U (I&[Q/$N!?_45V&=L?(1)8-BB&X6OJ.I+'V??,M+<2J1.DD
M]? /D7N+FQ+1,,O*W8!U+<T[]&-IQL>8UW% 967PKD^HI6ON!-I4]IY_$3>R
MPP&!T!H:'2[7B%1AFJKD&3&0-QZ"N"+9DY.3N;FO2\/RL;G#<7:%S2* _^*O
MDR,!L]__JQCWQR]O!@$* ZJ=,A*$[$X%O(6CB^H;KP=L'9B7:2Y6UR.C:5:M
MB?7L^3;G?^VD3';%\3LLZO&0O\Z,A&!U,V%T SJ06]'R&\R%QDIT/Z!9!A/Q
M^7L>VA=#A0II/=P,KI-[+<.C VEUNWP;5/?<P$F,Y]BNPJ-'</A47V^M]3L@
MN+V;@SQV!JO>*"S:9"1%^SV@K1+JTN\^UEWS[AF7)8Z=G#[L1S9RMR_87 U^
M#$\#M( !NDE6;GZJM=MKE8T!8I0P<(UTJ<((\F%Y.Y'UNAWPY]$1XZ S5Z[3
MR(;9N2ELJHX^ET&!8UBJ49P4)B45_--?JVCH#D"BJS ' +W0.=?OU/)N^8XX
M#60<N/>\9JA*PZM=T"N;[47(CJY292>G19A1 #W#,J?:I$#">:CHWL]3CM??
MC/Z99SSC/Z'>[";/ZD]R^A:TJ@T5COC8P6N2 JOO-S9#\M]BIS 1YW]ZV'&,
MRYB4>!B'ZV?V^-8</$(B">X>6YV^N/V@8#]K-=VWWMNLAL18@)BL<-UAA,J;
M@?TTX6G5D)KY/#8R/$%M!] NT=A$E8V;RQD0I^[#\+E_%4D6J!NTS.T"'YBD
M95*5LJ*>S5FM*&IZ>!)Z5+(!=:V_[I3L8]ELYH7Y7%/S*[?F2XJR=8IFGG!@
M=DC]9NB1:E6UYS5VU'L\['!Z49A)50.E!M]45\0YQ(ZHE(7.;A0J5KR8N[=Y
MQQ1*\M8DZ0^B1R4 @S76U10Z#$8+CZEM[6I>(T;<==P//I6,2,-]D0^%5HP%
M>A'P$+NY"H82(_%134=2ZH*/0LB$EE5F?-3)'9C>JD9#4[O:7-HL4IK5+Y49
MAK)'.W;/3_RU1R>4EH"-O:WV_?>"4,M8D''?9!J'8D7L1J.W<Z&7V<F >UO*
M(+"]V%!5I;&O]9$1>Y)'CQ%R\S"TR[3+^%:/2O]0/P.)ISLOV7H&A'+>>]@C
MY_4 '=HM4E X.X _LTK7*QR:@QA=_P7T;$C_,Q+]-_.4:V2$U"MM'UB1X/_D
M]C#0/]["VS2!3'#(M\ $:G;Q#7$0TK9.1U?TFEZF9&)"@P(DEC^ZH".<"K%8
M2TNG(7<9=L&;]5?%9/@?@+(GWL1.V3FYG%C ,GLE4F?>[YZ<)$-0-PHX1M/N
M0SAJ5WAOU1C,P7@XPDLAN7+=#S:H5WP P>FGV2I)4![;.V?"-:?^MH(*H9K^
MX?A<^VR^9EM57P<Y=>4$RC8;@Z)=^AQ+Z@UH&ETBF,HJ3@P3?4:-^L=:!OM;
MV3C>9K+<.KS7L?E:&AUWA_J1V'HH3*[(+XZ8V<ZWL>WV$+;JL^=^<'6M8"3O
MY'FV95B$<UQ69@)I%E+G"GC*A5M0[UF/MT!<["PWZT3!$Y'GC%3O(WMGIY*9
MQDUNL/.@W7X*&?B$U?'M)IK6G&Q''E1P8=3G+BN>@3 .\[<KK^D-C;R\GPW4
M%UF.E+R(:O6?MDVWT)E!'-AVHMAJL<L$$':IUA^+HX"PA:I4$BVM9M[%^VZ1
MUYKG%JD^?X_8V<%IH;P\]>8[D<,AJ]L,"/$:VTF33>WJ.^C+>;MD>M]>CB.A
MA56.QS<ZS%29!'-=,A?)S^,K[U]OC(4QTJHU<J>3XYUIG3MWG/H"?<L^KC8$
M#OCA"9KEUSYNEB]I8 NNB79/TR$FU=6X%;$TP0]K21I$RUH) U>=[W.\RN;@
M8>F358?DJ#"_!YP'!NQ=YO'6K?( D4'A>/\+OZ7ZU,:L5J)R2J:,YF8G,^3U
MPU,!7  CE&&Y2:$65E6-]W<UN4BHJ_0Z2TT<9[N8]&MZ+,H[/NG+## J:OMT
M\XH#'4AV$DZ7ERYW>F'3H=37._;K8O.(FPBF.SY&[H[!V\!I(NKJ9])&O9PB
MOZ,6^5;_:95<)_;%!":>_V!LEENMO>MI+:!#UNZ ^FQ+=,=;9B'31(6_'^+/
M*ZU@]33OFB<#U5W6_"C+A[2,J$M/;NXF5'6"I6B)Z0R/DL\0-[_VE*,%Z$.$
M=EAN_T?7>N$SN1^Z%^'P@_1VU!UX_R?<S5$^>R>M$JG<@4N6_M/% 0:M&YKG
MQ<%0@S]U_[#W^DH&]$99PX>Y'MX;W*HC57"OR8!UJ(O,Q- 6]9@0KEP)5LX[
MO./%7ANH^L=WN9[VS]NH7=.MEID:1#T)82N?*+"8S20SO3C;.!0S.R8O6?0Q
M@H-.4.G.+M/;',\CO$F58Z-CP_TIUMX_(J#X:VD\_O[QUM_ZHQ]4SW;NY (0
M)>S3GN=W(_.QCOD1TYDEG:6JS'X5<^4R%ZX"KIQVY5+XED&#V\;QJ16BP6M%
M?XR1H.A317@IN4XT'E6,&,+"FB4!R@=\#_;5(M'#NJ']GQ):2DRGFY9OM'+W
M?:>$$#<+,WD+^HH5)]E0XS^'+@(E.;D>O!1S4/?GT4OICNKMP*8ZV(V:=SUJ
M!AQ!"7Z,^FMD9>^YK'NFQ:8HTTSQEJKZ)[424YS)Z]WRYIGO3,T! 6N?!$3.
M_7N/PB6WWW7GOC%S2YS]T\!+_ZX3<_,^(W5BLXL@).O/_,;0+E^B(:HHL5OO
M$JRZ?2U%:'D=Y1G:YH/QNL3= %?9#JU?;!PF1JT/54AW^PZ)DB7RQ<=VOL&G
M-Q;99$M^?=EE7"9S6^&?$."6U.8QL0ODK>[JU"$I:[IN@IN]W[=RW91J76L/
M.Q%3IP+$N,6[E"J_GH3L"/A]%-#4CGY31?>$5UP)FE#PE25%3H6J'27WV0:J
MT/A%F4GZI?[=7"/KI3[XOV+D\ULQ#_DZM[ZDL1\Z&\6)%-W'\!C?DBAB=KX<
M*1AU=!G!646R2T@*"<GJ$>]$?K"R&B&@@4K[0)V20HH2/4_",SYX6RY;UE+,
M"FSA@Q?%NUS7KQ7OEA'CUB_$N2L- SU"KE5N_RO0J+FXOPZT((1$ME;+#%A-
M9;-"#T47*1N0-.!P?_+U+]90?F?YA2ZL#RR,/S5UU[69Z3+Z5O[:CNAPTU:(
MA9 W<P<Y"?LV9+'^.A:]&1WL+KMP4'NO"!ZDZ!26<DQ-T@I<+*_&!NJDV[:7
M1 ZBC*(Q?,%%$,MY#>?K_6&3Y_P^61]\#Q_<$Q>B.R3,\%1T:NFO4\VAQ-W[
MD;!]R7G9W(YDD[[8")FQ):@[U]T.P"\^\10<0#P^02N_<P 0,*W;L%VV16N8
MDHV?;M>97C9;2*4HBQN9!RV?"Y8.YGPTXSM6?7?LEGC)HJD5BB>SO9O)TEDM
M/;$C-=/5-'8D"\=J"NZ-7E<6'G9?-<]1#7'L/,O<$:1*6ZUV;&NXE)Z-4A_I
MF[CR %T2(."XBL?C&>I"D_,2'TB4H&?I2?S#3[XRF]RS?62=$]J.+C;2$GA:
M\"B-!T\SO6VZ!EKFEVL(^G*..%"L>X>&MM<)YKO*VI*WZ/?RM "RW"G8^2FR
MP2>!/4*[@9"H.SO<5 (PEFL:2?->7BM<@EC9X$:O]7BQZ9<="&#^1MY0NVOC
M(%=ZP4ALCWZP0 %6>]0 ]-(W*_?V<,]S0^:UUJ/Y?":-@,)DK]M77>>]@L-6
MZI8@F@&LU99E6/3JI+*9Y84<>"(7"XI-+%GAYSC/LP_WG+//C$:&:<88"-[_
MFSE,X*$LR*$?=2)]D,B]>$N1S0;/?UB5Z@1*"L6A[U72?R"?7T<3%+=/H>.4
MVJ:749W-HUQ;:FNNM2DW4ZMNNO>W"LF/ORR#B"7\7."O/GD:%-^+-5IR5#>X
MMSH-R=0#6<Z7[KRH"?\60W>B6Q,./; S^D5US3S\14<6'WI2CS1?3DI[!3),
M=E!Q\Q.T"QYDUY?04O:-V+9>@L!MV\,P+F#S@@PL^;WTCV%#F0U2]'%35?ZS
M6.3+97ROL637K3M?[?Y\$%HK%QU&$FJWZVKGN&LO(O;Y]=]Q.[>TH^N<H*&<
M^E[0ID'T\CP=*I#%B[;S/ZH=(8? Y_NV$K;4(&&S&<YSTW/$[J7\C_9BI19Q
M:7V_T$4+1^R@)>4"%-[22 69^&>['[4FWU?AGO9J#:%K9&K3A&'Y&6DB1]QA
M[V1_EATV,QS,"Q82[Y8T=V\OMW!(X#<%/RO#\-5_-,&\1WT5?+<)$&X><C1[
MDC*4:RZ>( H++WJWIZ!KO@5,S'3VL*OKTIT.PH=,OEJ<942+,GD]L+P.)4:R
M&A5=)7^NLJDGN*]R@D$!(GVIS?L%C6@S"FZKZ+KU8Y%?7'(?&H'0 !_[[:[T
MI<T&DL,VY@A?2)$1XCRN='2Z6"#3+H <B=\O^*M]LDH0$"W8<)I_JIFA"V9O
M$P.0C<MW0L=;MUF++GR.%WGQ_U5M%UQ8RM<-=#R,T<+5-N9N-]C0CZ\%Q%M3
M25WN-=%1JJ<.=('2#.'9+]6-%7_/SO245*1()Q1.?XAB0'( W(2O/S@)7WS?
MVI(XJII D5-TKMD;#E<*ZY5U"F^970U8Q'ZQ-1[*J,8<3$6RO='R,/EXXI&1
MH.?KG/HK#D%U\+WYSEV;)2CJ"'[^;>!^,R3TX!.<_]-7'2OFF]-C_M$/7;*\
MG1Y5DV'D<<776 _\;.GJ^V/]4%A,'YZR8OYB4@]AY)>>S%GDDL^ZM4.>]^K=
MOL<D]'B+^,V7OH'HFJ[&W6QA30L'T384[\EO2.8J-=R(GG3/V.[*@"_4BK\?
M>'?.<OMG.XO#2-W I"X3JS:-[6$J_EWX2V7UG\I,A^6'LJ^Z:5IPEG?_10?;
MFW:4*?!QX0YR!1[?RCVX6?12;0=&YG&^5?)3=";HCW3=J0_GF[=/WX;\<<ER
M_L)KYO0F2S#GD?5,\^M B6\;7 /'OX[:&N3O&%AUCEF.OD$Y%N[(W/'M%S)_
MR5X&^OSFJKFC+5Q :YFH5KC JQ<C;)\_\,?5\;__M_LE_S-^J##3J%9KMXU_
M428SWV?/;,0!EJKJ$-3 *)Q/'Y\_9O.C^ZQ!6'37O2+%S9\CU1<AV4,''QV=
M3H/SAU>.'V:W8.ERQ>4[L2K2IMK7C;?3YJ7RT2L;UMQ4@W.-<;4:#'T^:&48
MHL[LD #'K,:;:KOK(]=N=(ZJ* KY24WU8C&A[>5?1$1SC;)TT#I X1#?\)CV
MP]Z&UP'P33(TM$M?['N\0TS8SMKA*J3QFNN7L3K4S)\Q$\PCNR4)&9U@Z5C\
M4JDQU$5L8KJB5M]C3UP09Z.G!7?^O?-E6<\NGON.<%4(=R'8(\\ ,J7_F<,>
ML?=1XAL%-!BFM8.Z_5-_U1FK3]%Q#4"MA1(Z8#;IWC*E7+$J](+Z][Q:YKZ<
ML>J-(MY[>T>K=247&Z\C_"XPCC&F/RW3_[,NVI5/I359QLZW1FMWDU2N+"?S
M#ST$!7T(M_ B$9_OWOZM[Y9*KI+:1(*D$"#C=J*!MJVEL<#^E.5H0OCD*<\^
MT-_,@(+?J/;M'3^\$:#=[-78+5IP;XT6PA,JPBWC+-[D+$[F%LTT *:!/RNU
M=K^R$94_BY@&O22YUGRU__0,7*BSEEWPQ5\CS9F'8CEO"+$&")K?NX;H)-MN
M''O;=_L=M[3]=LFBT'[L-^0(&[8[X9"U(,W6#7>A;,0] S>!5I0+GJ.5+6?
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MBZB[/UA/1ZYRB^<2D'()H/_@UK8THH;K#X+1 )[]<#6G?^]8@2HQ6S3(X+B
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M*W^G-Y#\J3.BL]5!5-L :,U]PKQYT"]Z;-1%ECV59E[B?/ >^'G+8MDW62,
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MY+,]><< >]?;N'4XM6,XV7,M)]XVJ+RZA=T???\=V5L/]JY9)&'@GZ;ORBQ
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M4%?5XTN HGQ,L2=C"3YZ?_*]ZA_1VXO4T(/T,_[>[GKA-PX?-48_\"S[,X[
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M2;1PJ7/XH$  _5VYNV(#E$)"F@]J+<4,DSX/U>57^SFDJ^58!B2L9+Q_)CD
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MCMKTU)LY?Z!^]T]O5T*?D*BW1FZ@K8FIH#_P-47>.[")^KPGN[ M;/G,@TL
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M4<%7+1C4UUFB:!Y@ESWMPK]UCA8K?I+E!ZL5]PX0;RF[:WCS^3]A21#Q!1H
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M+A8M_O-7LK##F]?0#*Y#L<2WR9M!ZNR+E \Y,)!=,;Z#C5".V9C*,CU-Q51
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M'60E!B1/U#]Y^]SBMQ]KW^M"SF5<BS\?)]R,I03Z?B15 =C[@_([4\R/!3\
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MFT]R4IZPYA3^JKWEYG[ZA'DOV5;LXZN V2FO.##J4$\"B3KGR[)8_+)[%TA
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M,T7S0"P<E"QV4 , F[(AYYY(@_8[A.O2!O7B &!HFV^R!(5A50?F"B'JN(K
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MSB_]=4.*T_04,G<16Q7,0'$NV&/#9$(GKGQ0_?G@S].9K[-+VO "[=1P5"5
MI$(R9_->)P#H&Q?OHY,^G5@#+S^$'GYON'H!(8[J/NN =B^K6,@96SB.(I -
MTF=H.X;=OOX:<[RA)6"C5P2:D;W;HF,#()[.9WG/ORN1FPYL%H&>/SR0[B.M
M3)L%C;B6:KL:/"AM47__]*^YA14+@QF!CQM#Z5DN=./<7L]1A)(?IO:B^5A*
M6"@S=)';/#3C2)3_/DFH5R3\=6/Z.K]$'R?9%9%9I5T6W1Y<F/PVB7?E:CWN
M=)=74C(.W.+;6W,)%T$1O4M%=@O#99VGMT](3I6=;?PV">EK)27K_^ 6^=^/
M=,&>/^6<_T'4X<JPFINIJDMDG7 R^'0WO$G?2:57QZ#]T-?D5?$A("$AK,9B
M,*<WNC@TG@SV3&_<F#TMN3(>(JY_M ]G@KS*A_M#/J!^#Z_/\-0;E<K:<Q7:
M2CN5SU'>;8T1+5O,"<L.W,5K?'39%Y6;V[%>_:'5NS<;G(1])Q==9RG70X*E
M5("2#MUR@Q8]@)4^XB8,6SBFY: @5E4C3B:S<O9<AGI>SQ..+$/^T):!B%1@
MC]! T^P$0/BYMFCA"'Q78#:,B%EQ6@?&H\)[S<@!C@,D+?I?8M&HOE]D9Q;X
MG_7"K,VXW5ON*(BZBZYZK]*O6;=;?O7A&) 1K;3$ WMB[IFZE$8G2KW6??&F
M6HY35&KY:]07#L"&9FA2):2VL@<)&"-CW6Z/QWU%S19;2*=E>>*.TG H(OAZ
M>R,U;IPOPW5(*89_W7:XY8[84(-"8 9L>B<W[DPD+HJ7I5,JRD3?DL@XKR J
M..^R+NQ47*#S'P9+X1;)?9WATCK8[?@1C[_^IPMMR;$TNU(>_:!B14I[H+0>
M\JYM;,+:L[D2C&O?HYQ"85)%Q>/7J).UME25W(2Z G8ZD\,3CAQ X?P)5O;B
M<./J\6C8$PE#6L+NBHIB8I8YMBNL/[W4 N'%I$@4:S@OF8W_;BWB4_;9-Z3O
M(,-@;[$K;'MPIR^NY/N'VCK].#GW$QGO40P X6+H.G0?<0O"&)<5= 7@L/6"
M-?:ZOY>KK31$K1ST<_Z3> JD=<&6M[J8:SC=5QLWT:L8'7'E$#4=EX7GM?%@
MY)MJ-V,VD]/"G^]K=)MM]OVT=;/7V&8K]ZH9P"E56B=_*@;56,N4 E^EDYYZ
M;>SD0G[/?W=0^RV7+-QTU!21#W^X=S7@YA]T!3[69JV86=/T98&HRLW/&YP\
M-K-^=I8'4]XI'YBA_#%GD^_8$'>Z.'#B Y?P/J/S'24B3OB5M\%$BV3K@.=O
MRID:LSP3;%(]^%F;_*ZLKKA^!FWWL_W&*?:V*FD_#QT+5+<P<'ZHVKU$=%B6
M%B@7"_TBNWW"#T; "'>4!@<=1?@;91>6J$31*N2,%6[ZP>>4!EB2=8-XJ8PH
MH76(2H9>OB\PI7)$T",\1JV#2G1L/GOI>\I^;I ':O>U1/Q*F874"M(?B,7'
M&P8*Y'G7>,B6-(&<B?PUB4A#[7WF>-7BGZ/ZR1]&OOJB$LER$>(_ZB5D8 #I
MQ&:"U4$&!*9?;T1LF"\#<E"C<G5P,,&!B/Q1&$Z]Z4#+G*D[_P[1C,ES6D4W
MU$&BZ3:(V1(W,>_IKR*DAL)ULTS$^O#-@\6?E):8V.[&H*\: AH"J-<V?:7E
M_)985POM&QHZ^CAH'F>MD:_QN#I!"9:V(]/'!;J66;V49(L*!^[X^(]]2#09
MM@HB9*.?A[BLD A"!&WJA(0/4Q5VK6V69$JN4<":!WE/M^W;/EA84' W9[F.
M&A#Y4BLW_5D\O ><ZT)J2*IWY2E6D7C0'V+BM?*WL2BJ+=(<YS;0,^5IG&]9
M.2G@#V1?M9K$IHX';OBZI-:WB<7GB1GI>193NHR 7X'W7U'DB5%7\L;?6@D?
M5AT>4AK!U_QS\E<RQ[FEPB27$R<B>UB"GFY[^3WK4_U)L)'5HI"#R*X_7 &>
MX#PMGT(I-_V6Y<7$CC@65.VTN'A;!K^?Q9(>$3W\4?O-E([N8.[S:V$CQO?U
MGH^;!,DHN,TAV#/-:](,/GXI%^DE?VUUNM^N9!+%:<8MI .6V.B%/(::3)JS
M8GZNI$T ?P<K,)85^R8G"7L<%-,M,O@W+^Z +^N93$.3S6=4;'T,T[]79\F+
M7\A55BOZ?E%*[X[GWM<BJ_IR*!CD2?QL@;:6X!-WEW/HVG;M)Q%,LJ7W3(5[
M &@)RL: N7"O>$_-5#$BY"DC]HJ]T\'\P@<NCT%M[#%FL0\G -9%(%5ORSD'
M<!E/,R2J1 M@_K;>SMYB@4 +Q4&UM>% ]:KJV:>3'HX]/'*/DKKQ)\TOAK-)
M_"=?_ME0F\%(J_Q1M9,+0MMB&@O(3%T_3/$501;Z%8QCEB'0Y)93NUS**Q]M
M03N2FMQV>:"GX<8-3:"67_ B73%\KVT[AN"^U&%'9K6B:W]FF@$=*)I5N;!-
MCFS:!4 _I!IN-8%&"IZA:THC=7<NX38O!^N&!W9\ <XMP0D&$#-!)H\K%[T$
MU,$6$OU^4[C2V**I,LO$=:HDURR4VG-RNA^>FK_& $IDRVS+%.<Z,@[A5]2#
M14U,Z)T+(C1D"YRI^>U_['-&TF!]O\][?\\UXF7R? 5&@@*TK)5]14(ZM_CF
MJG*]K,7YEI_\\;>8'4;NY2<M_'-:Q9T';BDASG\,LNL13X@>*1-G-K<QF)%@
MMDY=T4WD'AW'I,HGKB@2A*8G8X'E9Q>23Q>>Q\2;D<3BH YAEI:<9]N,DG6-
M39-X';@-0/P$="%]#"(^Z&4[/LA)=K6U#Z#^ENR2F8*=^:))L*RUUJ3/<LX%
M)?6/-@DJ[R0$!@AIU?_[A.&&1J:C4,THRJ=VX3TU4,=[D,#\E.2WSL6E7/C:
M[$5=OI$(_NX,]ND'VL%M9UL+#:;!FA=;;+&/>%X$LH5_%,J<36U,^<RB^\E6
M(^QZVVA8W904DR*?<_OY4N;>UYK*CH$BZ8J@A>^3%B>9O\MQI?D?^3!\VFMX
MY,B]^= %5JV\G?*I1C0WP)A!6/_6U\;DIHZ0L;754QQ*Y9<TTG8?9=*CWD"Z
MW-TV:"1Y3H$R'\L)2#,W;54M&20U&^>%TY.7GYVSPV)QV9CLU_<<3H!"PG5&
M^49J==Z^[6HZ:HE!8ZO\OS$:O*B4\A*N;.VD#F)JVJ7-2BNEEIXG1/_0<7-)
MSZJXY71#TWYP+:I.&REY07^1KTL3$G&:?T,3,D0RNOJ3D^V&I@EO]Z<@K42K
MU52$5Q )U>JTP$*.T*X-6. ")XR=9/SP=G/.K'=J.0M5Z+VZ,))SR'9D=NDI
M->A.46(*L\C32_E\JS.+XDD>2:X,^W$P1CK@05_42-URF"<///%R51%EJIHY
MU_!R4C851O^E-/Z7%>]!8D1/= :F8@?QPC-H?H7;D)OOSCGG?[:T0I)IZFJ+
MKM8"IHU58!'N\:F?H[:S=5(#\0T9CHEX*\4=*ZF<N.;N(=P/%AZHCT)7O$;)
MJ0R'8[CCE>@^Q&L(72L+9FUFN?2YDS@D*L TB$]Q/65P$+8TA"+Q!!'ATL#1
M&0\E_954PS;D7FV6/#+>[?M/0KJ+=<LB1@21SL (K>49G$A?62E%U/N%UT4U
MQ3E(XS7O[JU?R#V_H4%NW]#L8[5LU/^\H=E^E'@5-W)-I9L\C[VA@7M%CJ='
MAKC-Z8;$./S\']UI_#\#)I\NB_9N[FDS>\"4KPOVR&(M-WLCHY>KYVD$Y7-[
MO_Y!(HCS1]X2OZ)\2;MHL7H SOP(XY/@;I:9)*U7UMY;J..U/DC+!LT+90Q4
MP#>ZVZ_Z9PQTQ#"N,LB:PST5[)/OCM5W.E5C8XA\=*\ O%NKO_X=/^,*(6TT
MZ?:J5[Z\Q(P2S#,$29]513G<K@6I*6_7<#I0+08LN="?J6&*SNLD0X*_%^19
MQE,%9_-M K/M1"3/^U>F./V7Q]LE-K=+_N,[@NSQS7S)<)]L0[C&ZQ4+&=G;
MK:&\+9ZR;(R5]ZF[EJ[C4@E<MWMW$#NNFN6A3C8KXL"\G7MN>KX3$]ZZ#$O\
M[B;&^JMAN7W^\*[H6OSE8]J7/;+G@0I5XY<NXQC6L[J]W3CHEP]V%F<A43"O
M&YIPT!T5L=Q4H/V4$XE1Z%RS68__QW%/=1.P:>(TW+YC:D9"LF8/XV;MUL'>
M7?G%9!KE_2+QUU+U*7FXV39S49>')"!L+O7LKW12O&5%$Y2ZT5-IFGBWLW2C
MJ-'ARJ%C:G*^SV\N,*S%'9)EFY*C,.V7EK9%'/?::/)YB:0[Y3,FOZ.J_%S[
MOL]E?28IJ>^<KC2-18M6-C8WZKQYQO%!_8%$6Z*5NZ*A$\^X-7'YI&QJS55^
M4K^0N&/-,+/IB))2@(Z4[<P>S!LG_@C9P.@8_5QE'&\\WZ8>9E89"@2I&ZT%
ML3TVXHQV3>OLC_%,7X0U"9YM83GKC?-@\?$^:/NM"_ZJS/[;;VN3!35:DU<2
MVTU]_@J[-QU]M&:8;C])9E^(B]V4),[8$@;J.IN8&';>Y$NMJ$$=U7M#_E(M
MQ4"*4+K@7[T5,=MYZX !TX;QZ0$Y)?XMXO2S9$J;?>%4QU?"#4WY@H:%G/7<
M(G2"Y:C3#"_\IJ@HM?Y"+MS2TSC9=[.\A</!K*E\E3GQ+*;3)^>:E9*GKIWT
MW/Q,\I<1=Y6%K$?PX47FHJK.R\Q.;FON=3;M )/YH?W?)US4L]_ZZA37(AOY
MYKY16.2IAI/,(DA7SOZA_0%^-N?:F2,\Q>3'U]/%/[H/:)_,'R<T/26?()$A
MZK/K@F[\B>%?R?H@9G^$KXW"Y$(T5Y9S\#5_O'NV:[=J#.U(W: !EJ&CU@3_
MRP';@"C/W+C=<]M/8*\8=TNY\EP9@,&/^I5/=HS6(%SO5FZ&:9Q'K4XN3F->
M)W5U>>7UJNW'K#OV('D ??Q1PL\Y5^:3LERW%VJC_R[4$^ _?5 !_F/.HCFS
M#-^>-6,R 90OEC!!%7A?9UF%EPH__N.*X2,KU[(ZJR+.E33V] AI:J.!WB_?
M\S@R^GF>PU'N/TQ0$ D$M0.4T@T!XDC34\6!,&>^O^<9[VF\,O@@4?%^\(N+
MF7BN5.NG@@AZ@6(;A%BV;#B1*PAW/NKE !/HS,#-?R(!MDPPITOD%OD!HP?B
MV_DZ<4:GU,@<I^M*R9PP@9)&?2VEP8!6Y5+@57U/C49!J0BIIB;>N;PC43SD
M.LX$B#K:+8,-84QV)Q^R2O/]-QO2;?=/3W3=Q9I-&#RJNI$LX' 18X:\V/X9
MA"WO-K@!"H4L6-Z7D08W50K+_='<"W%0K:-F(7.D?/8M\C%7&*^[M8,3/CKZ
M0?5FYAA(O9$!N&:CO#A2WC3ZJ7VEYU**2V/(95UZ*D34X#_U Z7AL@!!8VS#
M,^"0QL;FV:$DDT968<'O*2E[KN?A#YU.1M(\5[#REIR+0M' $7BR*S-./-0;
M,=,,%.^I%'>:I<2;Q&\SY1H,>L.G-_L4$D W-"X8JXM>QCT,W+G<7[P&\#;5
M4+&-+TM/D%4BU5 ^H0SHX"6B^F8'RK&_)-D^J ?4<["\*_#CC3K>\DN.X!3N
M]*U]3)F=[H9[EZI&&J6U.-6KA3J@H*IJ4 F0?3U)F/?"]+C8ZW^@))I@7^(
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MV#8CL\.S_R@]HZ!*LO#=MS!D7V !Z"OX&-KNT>BHKZ&<FR=8MZH9;&9R0_.
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MA$H7KJM_+0UY^H'W](;F[/YT$-!1O/\HV)63-79ELJ N_FE[> 2NMY( YR9
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M7]_#;\7:IYC4R%M%]G;H=&H<Z(>5MD>YYL6<<[\8S/CUW^^LL[?2+GE<\K
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MW(+@^XIV?>9I<<#ZZTC*.YC&*_,XY<2RYAXZS:0*5-577MBG4N+<EF8@9F/
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MB%_GL4[Z"U6]:V"#.PU8A;72W>[O =O50R+< %^L1*H)H&*#NDD\/NDV.J^
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M85(^T8)<UE-JS"_&#[)2T_I"UNT,B__3Q'?Y2'9PUY^I+"B;O^@E3W9$S%E
MO4R9(PA>$[TC>W:ZD1EP>ZA=X(/W-&\\KHLGN%XZ4IN?#%P[;2H)#&] O+8.
MFBXBO.:7MD\K+;EO[S8QM)H=.&2T4AP+5C?\#RO6_PUNUX2R"6D-OZ]LY'DD
M)<:=PC="W 6+C4AYC0ZGDFOROKN[NVM[7K6[=X,-RS-03#+;*8Y\UG3F4)B2
MJ$Y/N5(.XV2*DY:'TQ*5#XKA\.Z*\'2W\'BM;I\'AZ4/>BB*=>%W.OXX;_+0
M3/FZP,95$P\S&8&,)*Z+W7$],^"!&3FF H;W<1ZRM_DW3Z-\[W]EK'9 -I\?
M?8/099?''?90J+P>IB.)H+C&+5YRK]#(^2>+5?8]+.HGBY1O1*&F=YH VY2J
MSUL7=_J&77PJ*SKQ&T7 WKI.N7;![I'W*BZPT"><*6KMHJ5<_E_[+\+G5878
MS[6\_4<E+,M^(4BO$^4 H):_4&@'Y*,VJLKCV$S'<^Q@MQ8^=#YS]O)(?Z)?
M(])]IW']Z'3Z4I4,LKY9H]ZMI X47RY=<4(S]]))]";%+X^K;V]I36F%=DK.
M/'"YF7VE(O1Y,'F[>MLC&_FUJR*";(GPQ]JCT]TSB1+@._!#<I7WI!S,X_V(
M$$[R)?7 ?GLF:E6@"JRJ-01+5O9>0RAT;4S@WK? #KI)F\#(RT5^A=OMNUN3
M!XX^DX29MC[<9G"%\*;10E6;RHQ;)N9U8W@@W:A,^^R?W0GA>;Z9Y/7-=J)Y
MEFK\IK(41";3(8[@92A[Q.PCA7BO'UJ=WB\LR@Y6O'3S/\;F'T:CX;?L#_JV
M_9_-NA\M.B>8M2K>1\*W'DHE^+<@$ 69L7 .J0R0Y^7%M/L=Q$Q \$P"&L5:
M4\+CQ!L^/KIM8,S9E= 3S@Q2^3LCVW%U:=3J8!+RU5O,P^#<VO?=L=B?+.W9
MFX[W4+VYAGR:25^H&Z-//5W')6RVYA@P&[6693$-6<)9F%SQLA@#9FX9DVK<
M53*VZ2@L\(5X-/#C5.J&HZ)H&TIZB0WCOP&G]%C ]AX0[IB_D\PQL@^I/5N:
MJ4SS0?].*2AU9T1":\Z>3Z^D4S<&<YE7;>K,4Q"<'R7$U8?<\V><7_2.NUOY
MO*;6%*41AVSZ=OI9QXY\)0A)4BE19FR3P3TR[==#J#C,_8AU[RTK=ZJNP5$V
M'."AW$?BZNIR');:7$\ *RZX_Y^QXR[^15>CI+, NE:\F8H9KE)XQ&H.J4-(
MO+=@JENZ9SRQY(0KP$5;JQSM9)H&F0U#BT-O+2!>6AY;D)&45]*(A9$C7AX0
MV/A:I\[1BHSK<,$<[AXG[A[__) ]>OIV5L\!P0"R];DP[9A36DR\(2QG*#'@
M5<&(QK!TP@JQ'@;Z1&0KZ[!=JS)61/D?8J2-")U^<;[=-=;D;R2"#"P<;>ZR
M%W:A W=+5166 KV=?=X@&<;#[C8@ZU D$LYUP$H@(4%"H9%IPI.BEO4WI,2F
MR<]W>LD/""%F@D,\F7C*--F2V(_Z,E49@3=NXVFRGI(R6^7)?*!^N;_FXM<;
M @$ER2X,3'KBJV2RD1]%WD39X>BFQC*-9ONI23,L>7:U,[M*S,,>TCU13'Z;
M7_G]EP=KZ\V78F,7N2ZW5';;@##S1_P./&NWTDTA06EJ^C=7WQ?H6H?P3MCI
M$0EC;(ZKIA_[%/8@W6LF<4I&JI'U0=6H]BGR6V9YIGA3R0WL*8P7I[]O\6I4
M(:%JKED%2+/8\X)[_T!:MFRK$=9:U$=X"R="^-H1O:\-+RT?EE)\*U&%1*OY
M1\2)#7P V1Y?BI4N)NW2_-<[H"U*O_DO3376^^Q(7JH>,7MK#C][6>EADK;;
M!:L]C&MTX5E-8A?]R>*X_IX"Z:.B10>X)>VQ_6R:)3)UCS@UW26ZZ4OD4(YN
M;A'2*%_R]EW_%Y()I:6R%;U%V&KRCY\L5[X;;\Q-NV#RB.)P0TZ=<0QX0[T+
M+*E^6T@*WDX@G0 9X"B?172T/%.BSKKSX_![R+>8P%%,4^^F8I=]#+00LJ"6
MXX\DABW[@SA7OU1N=Z^)$J6\RX8D"'1=J#. QC9KH Y_6'2NH'YYJ8IA5:=M
M2]J C(\?E56DPRS@\X=KQ%KJK'I$7,??WW]FP,'0\#S"26Y.QZBU&_^5NYYF
MH_RU+?2&9T]+J;N'M>->\WXP6!:$ESSQ'A)Z3G9E.DB.Q'//]['*7B*7DO*K
M<TQ"[5Q,4#82RY @E6]%=#LZ**D:<83Y8(K(, <\F.6!,-X8#\*^I%QSTC'4
M@?[>V98M0R-*FF>+X+@-3M0Z5?[64KD)18?:E0'CJC?(B4O\9R Z3Z<-0M5&
MHZ*LHQ%P0RHS85:M"9U04)1G^!9Y)9DWN.62PR4WZQ_7(\,A(R.4\:3;B>Z0
MH&3]M]JE([;D1VCK>7**S>7PVVS,KW[U9N3FN0I1U&EH+'_QN,56]JGHK(0-
MZ,"&6W2.J0DG6+<=&IH/6D)=Z66P_)COR>)++C8Y?$UQ',-297@Q7=^O7=12
M/4Z\1&M7=XGLLL8ZH6^U-'.=R'8VWM;4-*2/H,;A-4N?&V21L)]RB!2,[7X0
M?6*-2TG4 /=*:<BS(]:.?=(LV.2-B4S0/7M,Y^V*^_AD=^>;WCL?*LG&#RPL
M8@/SBER7N$K$?L1%]G_/^#(9(;=PJQ+1,;43')&!&,/6^^8HX(7'BS4DIGR>
M$3OUWGO7;V"M_49"@-YO:&1J4%O"];C:2K/JFBQ.*O6F.R]:%)Q]BBHP2!H/
MJ]U[RXJ["HR25!#,IJY6K>0:[#PIJ*TS-BLPCQNA'(J08$&4[QZ;=7N(<(1E
M/:J3RF'MR$DD=HOD7S6(@$DHLS?)% PXNW^+>%Z8\A)^<X*#,.YDYM='&SOJ
MO:/GI,A61FTBRMZIK-94^]C!V:7PV[BVSF!#OK(,*E]6(VU",_Z5JXM#CT+:
M6I-K5Y/.QU?M[<3(:68V3BS*0#YJFM",L+'.V;P.*2V:CG<[)#R*^9Z8&R'7
MKMFFK@,.3]R>4G4T?8&8T\LL*^:-&L_SX32)ZPP-=E]TB^*_9UP.-)=HX9\_
ML<'!ZLW:3S.J/: >-F%X3\V4"6">PO3J3N7=<;6>9RH4,[5=8N)DE/)T_>NW
MOG4M+H^Q_9>=5CS4Y5_/5/FOKI4IN[DN?2^;*\B_:CP)=\S_K<#>=C9%]6IE
M?P+L@C/!H.Y^7J?.[>[N;HI<\-0172C4!MPMU]%1<B/X:TR(.[#+DL[#S0N]
M0^U<_DA>#:O\VE.AYPW_SN(YT7\S/G>AQ^W@GDF[]T1!#S$\/LV[;]64Q_3>
MK>8^V?3KA3,CQ5U?NLJ#YHU@%F[Y[<,O+3\",^/O-FY"$)KA/<6XH,T)[^C[
M]>PED2,#K"L'W61)B)AHH6A!;HIOOLKV$AMM<;* ES_8X3.C,"8O/7*[9/MN
MI0#R<^>D E]@.!:/")SK4X9LE"E4M1EW&-1)KRGU!66L'MGW_U+:NW"7ERW8
M/Y3?5Z>TY ]Y8?[$Y$9+\T>&9GJPD*9!Q=TBM1UZS]7>0BP:^[R" I_^R>+4
M'3Y5WI94BRID%"AZ@VS7+;.7BO(\B E":.>BK,A _?ZT73G^YON6S+Z[\0VV
M^<UVM1=2?D3L6D*56Z+D,UK[)D%.F(A7D$Y%I]6.[;?:E@(_ST$L/O_OM/G;
MF^8,C6J:#,+A3F75YVYR<=>GICA4HD*UI]^J(Z>L(H;OU;LAP0E[X2Z?-:Z$
MV#XA467!KSBSTHMA739JY1(WQ?:<@?HA7^A QTFN3*_C2=KL2QO6[D7,Z>^S
MG,/LFI61NW*JR)- YFF4](LK,51_Z,3D^V O[2_?F1O?OG8?0KTMVMO//#P
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ME8R"JOA>=Y>V0U&.@%OY@,Z,DSNWY1-P *[B^>FW<I!^$VE"Y@*":%XF068
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MYT?%5@Q'=VPV0!RL^#*[T"''_]6*&)^;^HK(WJCBO,X-RK%9>]U] 2F%G/K
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M=J+X?6+TB4HER^%NQ 9M$]F_\(SZ)!Q$@B_&9X86^44B$A^?9KTQ>0^VF['
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M0$$"** XQ+K0AU&DMZ:Y+E=U >O]Q)2BYQ0:K$^+KS.S^.(C<M"I'#E(*D)
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MM(2+<SX?CXBQF'D^*+4OXOD'%DQ^,&H+X.4$R3M)/V5+?8?#*78T]D4KX!=
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M\1Y7T<7T3G;GJMAS25D14M6'@G?9S?"5,@3,W-1$:&6AP(^Z"7'?=?_/6\C
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M)NY?3<NIW_$_&&A=C8%$ZLD)T!'ON(VVEY O&XQ_[0#+\ R:PGH$C)E4BHK
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MZ9$M?C!T9L1<;3B04=%5.!^CB(HFE851[+?)[3?Z3CAMQQVKYT#G+O^^A"S
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M&!7:"Z+-\]B@ 'I5DZ6*9$Q05E AY,R;G?V;U>5$4J#&/?C:_L,_'C^'?.I
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MM!VX?\$4=QDC4K\TDA?QFSU4K4AE$V+H.2DNH^!G$:54",$*<C<F;5\20%?
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MY@-]2'-ZL0F%7,:WM]5YKGK^%:'TU[8A0_^D8\<!T4G=S>F-F7]Z!0KI0T_
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M&0TWZ-NO)VH+Z.6B[ISS.>8DOIC4-.-XZX#VG@[#3 OP;ZC2O_Z?M;Y27]2
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MD]BW;$M "B<, YV+_,KB[CY.$G=WL;T#W:YWV R%4.P<QA+^I%5U26+3$HX
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M,.3GHB_CZYA4B6V[BQVD>X 7QYIU TJ8_)<B?MR":5@T%7;(;KDYX86VJ],
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MW6LJU%>OS&L^H*Y-Q:-GH/.OLFELHFM*K1O\%AU4QU(.;KSHIEMN&E)@V2(
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MZ:YAI1!LP$PLUECC\7GR+=\RD?C4')]T<.G<@%)_36.+JU,#QH-"]]T0<O^
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M]8E,#GOH9^8.QC""=+]K'(5G!Z:G\["Y6=,C_"BYAH&#4F8H6T\@W@(2Z$'
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MHE^NY(YLB=ND3-+8V,X#O[E0E.L2UQ'VT6M'$8^/8><?_)**4=E^0\2&^L;
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M$!O),D;(><N2H'&^AY+ZF8%8('#SIGR:NC_A[J/CT:L?1:NZJ7A1)$C* J>
M"%PMG2FPQJH&/6^)D#_>A:GYP+3<=2,-&CD""E572&Z# 7FH:62UD&J?"T_=
M;/A&C(6G/!!HT'5H^U.H2T7$:8M&[4:Q49J?_8?T-XN=EO64L4F=%IPTIYUL
M.2I#-=^#1EY_97ZW-)>[?\%_1C9GS"]$AF=BO 5WTE1W.C<]A3XJRW!(%ON'
M6M25XSRGF.T9]2*1[D["8+<W>;/-K<\Z&]%;;CF&/@:P]2K!GRVB76&JUR<9
MIA]KXJ5^GNA3+>WX>Q@EEC3H&R+:!/95]\#"BOMFMY.VK&E!GI-N/#0 SL^C
MK'69HDCNZ^AC[CZ/*[)"N5OO%P0;/LUW9$A0)0W.!\3\C#XO_/[_5"TNS^X;
M!PL?L3"C L6^VW<;,?VT($W2DP]A'BN6N%>GB;9VPO@_$QCW?T9%5M&ZS5'/
MJ_/1_K79/CZ^#GT>;_;7.!/U]R^V7 NKH713_931,P4#[IEK\PK%4KH7@A$'
M.G;^9+O!A90E6EV;0;)QF#,J$BJKA1%;3'\G\_]$\W]A<[VMQ/C[I6%!X+FO
M[4U=Z*[?]TN<_[1VXS'BPGIV7]#Q)&M!/_I%RK_8^7+CV ,2%._5?"U!4-9R
M## Y9@FSM]'H& ^Y,_L[LR_#Y<%(9LOG1O8MLGX6#,"C&I.>>ZLW:JPZ^_C[
MI>QF+,6'?T'SM<H7'YY7$R@C&Q=G,_:E7QQT)$DWE^QU^H2"ZM6[K!FJ&8YD
MTU*]GXXZ/@K>902W\2-(\_#&K5>PUPS%D=>O&:HNCZAVF6$@BZW,K# K *]$
MTA*O%$'1@V4GU'TFXC51XY)GTKN9P&N9<+),O/)^S!H3'F+"Z1ILQED^\R6^
M.PEU6HI"CA<_>E);*'!"W'W^QT&8:A3O_*:ZKS!P-EWFZG1V&GVYDNB=1WSZ
M%D\'^9752_92%J3%EOCV5CY_OQ1W@3D\"?DJM[R+^.C<V<UWCP^U^K'3_.PP
M-=[*#W</5FP]*]$G/-'5P/1>@'NJB'/NK-@\WD6/_NQ?#,F23O4J"[A*4LV
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MRW4.X?7&^4WM6&092&(-HMY8GO3JT>0'XZSV9'5$J>5< YU]Q3. I@$HV7T
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M\8@'Y"DG]BJB?86TQ+9BK%K?\\^EZ>71POP&I*WAVAE"POM@_.$C*0[:1O6
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M^%[RR^YU$WK)F=S:HZ2,T:J2;/(2E1HT2NXQP-])J6S\LM<L2QLQ'V(&IT2
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MMF 'X@Y>8*W8+^&:]-IF9((OA6<'!X0;"2!_3*DN2O&7?P"D_D<@Z2*56</
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MJUN-LZZV:6\& 2+$1"^OIG<M!![_'4,XA>+?#2IT.NQ-X%@<A7J4QQS$]:K
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M_H48V&]C$&R#RXY\49@EX.B^.<4%3;6YJSR2ITM9!#Z:B[?@ORGG)^X('Q5
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M53P!::T^,I,*QP/+7]OD]<U#<E?K.A1;: \FTB-O5CV$3L-<K<F\6UJ=Y\M
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M8Y'[EP\00[T=W6CTR^ZT^3\61\&0F/M,#_'">\PQ0BP@P'A5#)RE;NQ(QY8
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M!%[38?FV&1;V"_.DG>%2\F1/44P_GKT\U7B[94!AOIC#]GFV0Z(6*635A.^
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M_!8F]+^5:^]S?Y\?D3]O3L2U++@-2P2G.!O_/#P5UW:C-]M!@E3:T3AJ)*^
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MTWUH5R&VYQ#\5T*@";Y1* P41*UQFBTDQMF2J/JEJTVGRZ$$Y.99.O)C?&;
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MM&;&VQ,J/>*^ 'HIW:>%FIHLH!- D')MH$1&1%^36Y_K1QV47U,VE1QO*#M
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M1\Z<?]B&OPW9JVJ!27X-2S59D%X%A<E/$$M\[A_/=B;T6@7M<7_5>]I:YH&
M41;4MJWPTN?G.")Q)]QLIVGZ^.C2@$LV:??:\TBUJPX8%ZF]U8+J:LY<O="L
M)M>:HRO'K9:,TGY)Q\F\NE8%853^9=7AZZ&5*=+-?*/]4SJ+;VH?4W&&6;@,
M:\>7*N#+RWJ9ELH)&YF"4^IYQ^T\T6JG0CY?_3=(D77'H#/O2$O?;^*-AWXS
MK3&ZGND'TUT8UZ][+J.'66(]A\#,*LMO>ZWR?'6*?X3<& N4*GC=AJ0DS/$Y
M@5U7HTQ/O3/*OP2@U,45K-)MF]'3JV('/@]-/QC6 ;V? P*<"PWDVUP"0/B/
M_4E_,'OR5ZLM*ZA7ED\@^Z!MQ5^HBB'7L[U,> &JC6%.U:UZW,&-=XYS0LL1
MU2XY7!4"XM7@'DFUS#:(X3J;J%J(E?,#7W -S2F"3%4M!5]:"Q$!KNKF(A'H
M0RO))NW[-J_$@]-5[IM%3XNT@:>:"N+Q*.IK*8,F$UULV0GT8TJJ+9E4P<!?
M]L<-*D![&,EBN0Z:T0DUZ:/ALL*IC5YCN9E589Z.^:&959@[\ I9NEF@74"!
M-)AUGC<O,S]5HM0>Z!Q4P1?<I-#5,# Y<)]JL-SP"[R,\%#M5X*Q,VP9PW<P
M--QV:^]@K6AFS(;N*;1IOK*\YW=/\?;3J3M43/"F,#Q>K3JW?Z WLGR.6*%S
MF5M$7NU,^UE9<P9_"=%K.:GX,WK?VQTA7_SIM5/P*#YTGQ<+8R1K$N$Y,:#D
MZ5Y'KJD+%J/W;Y 2IO>J)$R5%U[*/IE);24_BRGZ?;!HIAJN.G7Y-#TR4H_W
MBUDG+:6OA]X&F>-YDNY850=H\,!9!X&(!46):5RY3 $EH*/I32M0XZ<(2GDF
M[;5UBFM/Q*5FBVZT/FK [\88(UD>[NBA!4%%BJNC1Y!P;8L_DB5 (L!' ]G^
M5UNH7B1S@R&,D$05%'M ?21>,;DWN@_8>^9Z;<<IR;^KF[H;-(^R<]]LLP"[
M(C7;&E3JJ\S5)F[Z!IEKW$9\CP$!+\GM;7* N(J#G]<! F.^ ;+)3Q:^1.98
M"4_D%R0V!;+'?2G=!_N9'NTS?I\-<16GS7HSXFT3S3W :>4N4-[D.M9ZG#Q;
MQ+G^<3OEG;$DYXQ*D#_9[.ZV_'#]$QQOF'O/D3'@@N42$'BT4ISB!$KN^HTA
M-[T*_:M/4GJ"%]VA_*\^R17KI!(OZ[_Z)(MS'_8EA2@=*_(/)&8JS+[UMQYM
M<;.!Q<; (MG/B9\+[:;DDIW(/'_U2?IQQM#_ZI,TGJLMER\[\<7ZNI/O3!NE
M1L6V?W&Q.L4?-I]V.Z^.0#9._[4__<2C?7*KM+ZBL+!YMU=,^<EQ2T0NDX."
MW""Z$HP=_>IR#S#E6#VU_=$T%W+J%I4;<[)U79&-OKE^N-)8QZ3KM$'[>MLP
M6#V*7T4PF20@-9_]S[\?0UBNEO:R;<=]:1_0KV/BI3[[Y5RP_'E./>6#,^\I
M4[^QG9U^*SIV:;I@P=^95Q!#//QO(I(:G L3G,"JYO7V$TDXH%S 4UIE01K=
ME]Q[3=>._O++E-!X] NWLNC OM[N>CHA7[;&12TCP]X-UYP21D=M1N%-NRA!
M6_V#()2+VC!A&>?F?QM1<H13-5&?X2)4\GFMK8<=I.5<MWZD$VCE[DC=%-<S
M!<,'4_[?&[N$Y*+/^-&,>(@=0=[Q#4/>0"%Y.43#0J,O3'LV8/_WO#@;JE7X
MZ'_<UJ7TO]EXB_F;KK'P'" QGRO5)00@!>,BA[_4XMXJG%1-FGA_KC17+/2T
MY7QKY=3MOIGE\JY*3L3IN;I-,\+;XQ:>L<D3I6^A3O*H"2H VA+T)\J8A+"1
M!E2U]4;Z:U^ >CPF^=!"L3%DJ"9\,;M&(]%CD:R;Z^6&XR%SG\E *= C8T>+
M4!V_Y.W$:NLD[REH&%?IU.GE.Z-AQR[),4&O^H9V:W=B^MY]IED_<:>8",L;
M6%FZ*3QZ?]OVA"GW,^-@1[^+5>S,(\+7'>,:Y TQ'NT+TRO5@?129W5=2,]&
M#8/R[.;I>6YS2UIB""U/K2BXR4S>1F:\>8^2\7I(/7<$=_[V- \VV#]!HY#'
M>[METR[@8W)VE/%EH?YS$R-.B^ :7F0CIZX_U<#N"SSC<-BF<Z V#[)YZ@W*
M4B^T1JUZ![8<J_4XP1?2%I^UJLO6^Y3WBA;YR)-EE1^.'W.^T^\D/ZN+=.][
M,:FFZNEB7)(UMYX/T^'DNV08EO7:5<]6#6PW;X)NZ1:7H:TEIRZX=25LCKFQ
M"G#C(M@^3T1(!N]X3P6JQPD/T%5"/+P%706G?#$R ^5TK<>E,K3G&#^RJ5PZ
M$DMQ&3;[.3U[N4IET=F4=.I[,.VW*T&(DIU1#6OPE_/AJS/0_KK:'*,3H;=/
M>#D-3'O:3PLG^5KQPFK+U*=MKY4FW]C U[XL@]5<"@I*"AV[NS74R.XHKTT6
MRRJQ-"Z.X&_JXN%!;[;JAF1X;V(L!B3EI@&IH?+HX259Q8.7!PI&L)#T!E2Z
M,T*_*2,]PZL[T&"\(2/0Y O\EMM]?@F/Z?5')RZF-"<_\/4\WI0!7E3$C2H7
MD)E*:0Y2?+S4$FB[%V7Y:]& 'J6OR[;FG=ZUV)8E/A'4WMK5T#W'9;(@_TS/
MG9W#REE-C'/ZQCN+E5:+3 I(1S@U0'S,*K!5RM.&!B.UK'$%^C]C'P]\L$TU
M-<[(T+2:;]6(<)10J0&#2^[9NP;4.$;X/25-9 "23B5*%,JD<#^L\R61P7D]
M2S+[CG6T.ZOXX65W8S\W8X;4P/KS!X1/=O%1+9_8WMO#TC?RFC[0BB5R@0>-
M&J>5>2G82JHM')T5*H:]=.B9O:KAOGHNS0M\/&L"6T17-S_RL:-0#5_5?PJ;
M*'2<!&+'XI6*/,>-)MYR%Q?=><-T4L%HV5>38B2L2-""+U:YY-&6?N53WE]V
MF$8<AT$OEWZI%Y>D:J"L@]_D@LPH?>%6&@(0*W2-+%AA&1#*&GAV'L<7H^9:
M'"<.+Y[<^7JT^X>P><*IKSA*0FPREY!C)7YWEB,/@BCNF3 LR^%A?].2251E
MZ&CPW$/R9LX62:&V+13%RXM*S57)QLV<QUUY1,^ WIXYDN>]*F/(=HJ:RP=8
M9,_C1CY#GZO=RPQ-@*FRJ16H;*3WZ$$ V[[;!4OY#;=S,<'8G+.0LZT+%JS3
M^=D><QIO<\$"CCW*8SL/$#L6FI<;>0'4J)L-XF@K.S5HKB6P9V:=M"&C/)W+
MM9]820V@ 6(<T"LM>U=># N[%N39T?)#1YF\!=\C<90:>8MLE;:TI;T07G-<
M))LA1\8:()O&'3.Q==V1"8EDB_&,T.7,@BN1CW)4//MRE!_L+ Q IY01 $CO
M/ %VF@ YYA""F$*6IB'&"*2Q+S!I<"1-](VP,R<$P3L' \ASF/VU[2B^G% C
M*G+6M@2':U'A_K0E+8RT!1#<#TS__OF+$PY-C2SZ83WZM[\\.:M41-!.0='1
M[+Q"!_%V;CT;0?;N3'\A975L<57LN#W[19*?;%2[H,A-G9AIHSF*I>7<N[Z1
M\<''NM1!IRS.^6.=F_H"7$033-F"=/GI:EUOM8NV%NJ8?:J(N/0EE6-7X[UZ
MJMAFU 'C;4%KC"PVMZH<TO7MN%6S!FT-'<&J2N.@_+DN'+*QIQBJY:G)V@7+
M:J+H!4O\^_KS7S&I!^U\IY\&BBY8[-A^O&!)YFL_<1-BKL#<VU6=="0'MIW!
MY_*_=WL($Z26IV%#S-\P'BBP#]>/J<UO2XLME.,OE:6=\&15+CR-6 L?&*[@
M>'*G7YUZ1;U"#Y@!(Q^JW?V4?N#[#9J:ZK-E&PR>")N==8M,+!60UJZ&)\A7
M5)OWFE2XL'Z(.%P4-)O=%/ZG9_:T@$EV>_9\9FBPAZMET0^5X-]J'^WI=WX5
M_^N ;5VZ>"3[=6N"[I+BZZ<,KSDKEQW\U+TJ-,Q4>[59=6!%987H=9(PKX,?
MP 4X.$&<PCC#>VSNM[:V4C=:" ZC8MB]M2J)EY %;^D%='EB/A$EF"=;\2'!
M_'6<! #/U/B @$7<[-V$B3WLW60P\3^E Q @21XUONT94^4S[ASW$!=X@*JX
MJ[^0%\FOIB[2CS@WJS;!<;2?@AN%/2ZJ'/E'X 6+)?ZWIL0 Y4*+CO3+,3,Y
M5"I_?LP&;V9NC]9MLWD\#F+92.*T)6D]^=2_3?/XI;_1^$Z ]=&!1L3+09^,
M,C5A2B[!FNI.*ETS"U30$C=V+3-9%N<Y9KMU:;VE;,'6.M>20>7:.Z=?"TG>
M@&SEQ_WHA0[@]/8>?0 #M-2 DP, ^LD(>2!434JREYQW;)_CAFH?G-0W>!<S
M;" <I=CP9'+D-&OQ@F6X<(D.[9#>B#+HW]@+C>7#UL7^@Q.3=/8Z9_B"A>_H
M4V3EF6)3A6?9*6XFW"4*IWHPD0NMI1K4U)>SQJVT'^-.TD,':.W.3(/VF3KL
M>7MG#!L&0]W?.K-I0^UM.$8V><R-J_[[4SX*ARF":I;-'_V>@M>U'_#NUWK6
M;T?F304099\Z4+0_1T/8UTK-Z_L6&48\^U-ZPF_O#C3D^L79Q,LC* /9NZ95
M51O\4>)Z])D-JO98T2SC-CV7T&/;0P<BC5V&  ,+%AQ!-,4?H/K>FUJC2X+6
ME-JXGU/H1_G:RCXR@DO@8:5NJVHN6[BWI"<B2\</T@FYCY1_T8=T^,@M#Y<_
MCO/BDJ-0M<WX77O@K"*L'MDHI%Q2L+?!33FQYFXO7ZD%&=VPR?M.2:],P.)?
M#&7@R;QK2<\S2D/EDQL*<6-VG;[='L&D?I<54POS5CT(U.&3"ET<#JU_4=?V
M4?GN1A?Z#3STDT[#0J*WG+!CDF^5QQ#)1M94M=ND418E*OA'>?>W0<@GDY]Z
MOLYE'[88KJP;13ZBFJV)W2HCI9A U'HEG=K9E?D-[<:?I[(CJN30KYT2W!0E
MSNB]2IM\2&+?(!$MC[A#%LSM:3%YV*%W*WU-NCF_;"_AB7PZB)%OYI[*/1L%
MU?'NGJYMO)NQWB9!JLM<\'Q"S^J_!DQ6@J*LK@)LG9W7,XX?C,__S7PW'/)D
M@[2FSD8DXY[EEEN)A%C9$!MSDO!;>_WNMPJWCX8.DO*#T!/ODL;,5'-'2=U]
M0]V?,X33U2Y[C,FOID.UPV-\ UWCFV=<U$97LJCJ C,1Y:?H:LDT_N?23XI+
M\Y_N'Y_CH(1[8?@58X6[ 3(!"D'D,O[27[PT[1=@_2!X-G+>PYS@-(%[-PWI
MY?6**_#6$M'B6XQ7_O".1.R V?@0@OJ^!L2FG/V<" 8LHLH@(% - (]3,[-#
M'968?&[/6TN;&X!KR;]2"6Y#F9I7]E@HC0FII^<F>5%)1ICJ?74CQF)$EK]N
M6?;GU5_G<M-_44X9-W;'"1IUY-L_:\XJ*ZT6?=?O"/9]VFIMZAAI UJ=JYY!
M?P)7OZ]M$P\[#!^2K-YX1=*H/EM<($F<Z/&-AFJP]49C0A=.WS9.-8 ZOFI>
MM06^\!TH\L^P<3SG]W"TRICEI-]<EM0J'W@_X7#_P%+Q9D PF_!;%T&*440:
MXO.?&:CBN#&?WJ#KUKX*U@3VLKXC_9]<B+X(3\UV=T*WV2P-!HYQX?5J;OJX
M4""/<F#K[:RDK)$7;8>!23X5V\[%4JLXWK7R&M?SF\US=/!-==3'LN)Y81!P
MRO%#%C .:.Q-R1@;*Q'].B1A<G3GF+]T^;^'P/^T_*,]0NM:U;E&CNG'&M_N
M993EZ<_(J\#9_B")1X,FTO;BG&.2L2: /S)<JX1S&&,-@2^G:?E\:&U<*,EO
MPN!PP/:TC(_PHJ?H'_183E/L]6L]Z8"#$=3!$]0>9 "PMMH&4<U7?%WW];_3
M0B?W>NO+C6:SYY[4Q!2_!Z-%ELZ@+V7J+;LU"Z5?R%RA)G;$-\:F8C49.5+O
M!Y)S$ET#=!LV2)++Y%K/P@;8Z=R8WY8+Q-C)8UH9+3",'&$WMG[M^Q@VP64O
MQO"R=KOC<%G*S%PP]0E*+#<SF*]2,T7)L(?/G6J[CWAG:R]?N8$"6]_?X:T+
M*.\'YHBF>]S<Q-_G.&$U#:0&Q['*BCP*O\Y%[]6?VGQ!LG;VS0U\8M%=FS^'
M6N&Y;Q6@2&ZK)D&:,'3J]<0@FLQ+^'G3$ &CGE-9.6.LFN%KXZ0A5$C9D4'+
M]*$9ZVM76X;$+\4[F/_S;TX.#USQ4;2)>C;TJDW]P,L3.VBWO.O)$)7H?M52
MRM+A&=T;Q5VL,6:R_^TE#>G3,D<B+QSZ,]<X7=M/ZW(5,6Z_RU%42Q.W> (-
MU\\DU'&0F(4QP@8@U)')UDHX"3NHV'W^?[E>"\G11?NA#J8:/EA499_$/3=<
M]KKBE!@EW%D7]-RGDP:2!E5AD"TK.][FPL8P8 O@/$@63JW[^2X1ZY0BN[:"
M".\D?X,Z/QT[I9 0X[W!<M4O-#4D1]I;26Y<]-DR('A -K#]9KL]9TF3"$<>
MV?8* 2$-XBXK;JQX_.O_5PU/-:T ^P<\+Y9W_-]EBJ96FZ7Y!M36E&J)@]%_
M$7(&.X LJ\H?ISMD62%^<OYFJ!G!%W/)F91C8PV.!]7.\NAIX]1 .+7 BNG!
MQ:E^+86!!]U3&/[U1P[F0YUY&]4*YF+SC*O_(N.D_(N,TYM3IPOR6'U7U2GV
M^1A*&!1T4!UVR>%?Q;MTT/P#M)>"O/2>J!5/VHTP$VZ&%MA,-J ##0@-Z:UV
MC#%_NB<>Y99]UM9 UD:[VA+NKN99F":/J",D,N,)]M'6H%#S_2^;J7T;JVL@
MWP'0(@^'HU.*B2YV=)#0EQ ACYA[=6"3%_='\8Z7P.?&,O&_CAP,O@]JS\FW
M4\3FW_!U<H%6GFJOU!7TUW7+JT5JU.7B;K3M;N5L(.U;@EW(^DK@WFV,[N%E
ML0Q<JW?4#M(,K==_4\9"FJ#^05%8_75R51Y/2\S]_DQJI9\"R;%".4 E&?$Y
M_8,5?-9>NMXI/I30]31/XTHZF316*#3$FJ"(S9XGRJM.U-960_;.MGR7PR-#
M-\D66%#-]>%"XX* VE-T[4F>N1P]SWOD,4@-Z:<1B+.AI ,A!ZU('=1&RJOI
MK#$^)WM-A8PV2Z< $Y4QR@QOL PLBV-6>)U-\'-!1AS!:SQ'!BJMRO['!^^Z
MTKG)#]#)*:<"2XMV<@Z7W\HW_ "0>.(Z8U^'4U54";2?6*.C785S!*Q3F;]1
M&OAYS?7$T7.SIKZ.2-NZS_G6KQ(W-[EF*S]0LEM&3X +KYT"FJ>(WD?4)&V*
MLXFC]]?6 ^EG.UQQCS*((]J$' ZL-@Q^Z[@U[3(]&1L &3 7&C'/K2OJP"<^
MP^D!@?N.RY3K_6TN^]AP5X'/RBLD55QR%WL/0*VZ*8#V$0GSM7QB$8+$B4_1
M[Z *UISH+@W*_6?JC'M/;>);#'>30^*]\F ";[C75OW]80%-Z>N#>+R_/9E=
MRO%JIK-83JZSZ!WD%C=TZN!X\PD5[5*'$7 '/PE0!N9[C)*2'Y5,8"MJW/P!
M1:F8(OZ087.36_27QH0X?E2@UY%#V[I\G:TUN :KE8>&V-VWN*:<\$:\'(>6
ML$W346OY6R_VWU]#8QQ<SX\MQ7HPCRY8! WP[V.U#]J_(0?.AVD&$Z6GIB%"
MNUOL%RS+-8D7+"N_G_X\;#!*5[I@B8Y-%9HQ-"B(<CNR6V N!0BM69TCM%*/
M#]]?L.S9=G__^O,\WK'W1/[@9E8%+!8H&C/Q<3"]I>-$_((%^MK!"R(/T81+
M-L^_>6AI"<P3DT;)GRV50(.^'>H('S Y5D_."S ]5>UQMMR"6&G?7,L-@U:K
MG8"V)?;/?5 ; Y>G7FM";W!#6%J_1PTIS'22TKP)]^5X4W:>=,&R1AZ[8"&1
MF25=QP,7+-/G(V<>%RQU0I2\"Y;. %'F\@7+0=HISP4+N1YQP5)3?VX4MYMU
MP8([+3KJO6!Q-D!I7+"\H9F<CUZP;$BN-^\;AHV?]WP;RQCDH((J;BYI$/BA
M9(ZYDUO7?_XSN(WK\1M5[PI7K_*'@^GD\;*RLUC-'8G3(#1NF "J.9:N-R(>
MV<_8N-67!+C6F]_RP6[;D8T"-LC9VS=,(0"#V!<#P>GFRS54-(WZ#)8X$?)&
MUO+AX:&I--/ :]+@?/3$@^D>P78^&U=$;JLX-6N-#:=^5[NWX@ S.[-]P?+=
MTHACDPN6+H\#E]<7+'2A<H-%[@_?AWS'P'6S:$-AX7SF>RWEQK81V-7.N&#Y
M/HEF.ZD7+.]&IOR@('94F]>\_L]WD\'HP6A+5II=4P30&3@-2RIU??HE)V'F
MGF3FO.X*TJL+JF=J&8<+#-.GJ$>W[*UNM-U4.@IUG3#:"=SIEN>NPTIN?HIE
MT'SI;7$Z4_*.B#NS3P,Q#B3U!;4<U :IY[HA*KDI+R,3?G (B#$0 WTWZG=5
MAD>D+EC44@V06D*G]A<LW6JQ-#V#'*;L!4N*P5G\()/Y?SP9MV9APB1=L&R;
MNQU>WC7HCMW^/E5I6D4S(U-SN8)\SW58"7DC$%++0V/1\F<4]2XP L^I1:L'
M/4T !TIW28QUBF5=L:H=W8-]DF/:>YS?I"9>03"O9S/JZQ>K&P+)EJDAJ=5$
M5VP47F76WY0XLI#7?4# <7%U7<\ FB%3-5Y2<X/!!]4,WS%Y0M<"\ R:V)NZ
M4=IZP3+!??F"9355,)9ST&!8)_#D+TI*_LB8\F\F9YX+,^>L&Q<L%RR<; TO
MM\^;PPU..K]^_]]J]JC.G1E$C262O[]5LR=Y'4+;Z5FQ>QJ8"Y8S&RB_(C^A
M]RH\ -5L9J6*X>MP# +#4HLM5+,$S?R +U4 \IXF*P2F:"<SXGE;NYTTB'P<
M?BY81!.=[OYJY FWS.I'NB8CL?+(2/5TF'F]#4*LR-RM:O>"Y3C\.W2^8[I:
M\_N/H>\PB#(X#"%>L*R;_$4->Y9J$.#\<KD_OAPUO=9@]AQ\66]HZ-58M5,\
M^*>]5U46[_ R\YI;5HBB**DOA5=H#B>IU_ER .%F*OZOP6?MK_&1T,3V;=+A
M<YR;)X0IH[>$/>*HBK)=UVT740)$I<90*T,B%5:B9)/G3P$#=L5'B?EV\5.2
MXVJQC*8 =91O0=_.XV;Y1VWXCXW@<82A-_'=2 I8]^&+Q-?+CK8=)SQ"E6:W
MLIO'1JC6?J2G+L2MM1;4Z4K"8?N/]_N&G7TR+:3+YXXE+L$ )_K3\CS/SP63
M]?1XH9:]2U"#\]+VXT4OH<5[2_MNHA<L8(.CW/K3BHK=KN\0TKE@@4T5S;!-
M^;NXL:(XPU.SHY<*G+Q1"U,]$\W@=U2S_)+K3\I]7DFC/E5<H5FOP9R%Q=Z4
MKJJ]/#?'3UZPF+?-=TK'_FZ5*  UT**:GZQ\V[#:C\00+2$CT2'Q3D_X^7RQ
M4VHU0S2-O R@)<+OND$ B("BK<-K'B(XV7+Z)DB=CD$8:T9,AIIJLR8LC-&G
MD:<F;%@BR1,5U3)0J:)H@Y0Q3?S2UR?^<3/80C&2MN<WRXJ+-7JZVB[#>:P8
M1_+T3TT]>IWAZ.=TK)I9M3:A/!^@[.8+*L>JCAZ=-\6N57YW@^.*3,3EHL7O
M2(O6,/CN,IC->TRJ ?/&MM#A]^%CA%!;T<7-Z"%O(82,>^/K!T'LQ<W[<]@,
M1DK+6F9$##?,M<]Q8O:"Q2BSN5@,<$]<#*!X/>$ISBO&>,DK^82IHRP4EJ!*
M=^;>O.>WNA]H/>T*FH?TJ(&I]K]T?WXU>B\(ERB\2DT/6%^_41NO/O-M$Y8P
M=M<J 7"]3R]_P,^WT9@]!4%"S[_^#!$L[7+.+ ?..4B//&O1TVGZT*&+I[@"
MQUX[)HL9>[.]]P^&DGME%K,LPQ45-M2(KB3PKA79J"[7KX3\15'KF*.:'@7-
MT__)DYCU%6V>_A]D?%$0C@83K$MU@*F">;?$U)X?06"!LU6J=DKKY^NPJ4<^
MBPR9N$2*C+:G26;0:&"J86VS5Y90PA3R2H3TB_3.]T0"F\,+O+Q'8ONU/ _N
MZF3<1*\++[FQ5PI3&JF.C:RKP,7$[DJHRJ70^U0^UJ*O<32QD^-"4D-]*/7=
M;S6,%1XGPI+&,G._IQ/:;:SG..0LSLT/BZ;G7Q5H#[K4Y;&HXMY.@;"AII,E
M%B9<-G3'[ K+BDQAQJYE#](L.>9:#F0;#H;P7/4 $\%L5/7H\O@MQW+RO-(4
M,W#7>"5>EW4D:R<IGT]ULXY.UNY?H(QGA4I&)8X! +Y8U=S5M"(_N<UVU5("
MY.9P?PA#/C'MJU!FXSM75P\^?DQ%VH=[X!K^X,T3),I^BD"X8[W[#+<UU\ )
M;J96?9ACNX7;L-O(L0F63TFR7-,./)3QFPJ[[]NJP2?LC']>/5]Z58%@"B!T
M=RB#&<,^KP?"P%W=A88T#$YCHPM\)N'IN5N<".4@(&6#@I5!%C4564Y-(CE,
MB=R5?)FZOAE/@<BVJO0'D$ 3)7\MA<PQZ*,*4>GNGF#S4(P[OF4-@G:QO@9)
M5^7]\);WY?S[\Y_:N45X7I(6['+K* RU^CH8 !D*]BM=(S&!"=/J P<N5%GO
M_A>9=A+F&4,=&&Z9"BE -XIKCN9DWJVG2I+\LMI+Z^6Y*9_@&8';N^%QJR(/
M&NNSF<+J$N6YGD6\Q)_(4Y?&@[CR3"#:Q W2S?N8:E[EJVSZJ)?-P(#-_W-A
MV*RG[^=W!6-9AFVY2?8+P;[2"LCF+#L?S1F>F>-W^Y;\C#M9WEL1 DRZFKR/
MN$LPNO>;J1KIZI26>NF5^\!T*_/TU ^JO;R7JM&8YEX#7=$K\?_T?HGB B5Y
M!XSA:I[9/6LAU2+FLK(^!NVYS$F]%8!L(7/ 4W9#D!Z8Q1_#BI^#HS9&>GOK
MMDB!TC/F3>44FPEK./I>U,<WM>L8O&E?Q647N!'@H'%^-W-L^UO+\!+6\WO$
M&>%LZ@*/=/6,?!YYN3,U:R$H3GSIP,/)D$L23W5NJ,U03'&5\$JODYG$.!E^
M(?]GSBW=KQ%IS--WKYF/==V8N)5W-;OMQ^O4V%&=V&,YBT5\OL&Y&W_3*3NA
M?=Q>,+5G7$ Y][=C/+,[U^#XM[YV9$\/'GHO]N-I[(E$[/3-D0L6;[8SW06A
MR:38_0=J5?4+ 8$I+FFE&NFL6FEK&Z/5WP:[YQ]X37+RA(GG6 /G'03;\[0]
MM49K&@?MHFI;J+55W3!KKGLPQP_SP=7JA*UI>7K8YH/;&U25;ZNHY=QD./6.
M12B::-6(*37WO6!1=H4%:=AG63%B:PMY^J-=_#.Y%1E.!]Z\(;""EIR7X2ZI
MJ457[K^ 9[?:5O58Y2: 9TP#0CL91.O3!]=H>(WY4TE7N@FN6SG9+7.D/K.?
MNG6WJ5<N7:&Q7YL_Z+&"#$(\:*''X? .%"7L6J8^X82?:0]RPK@T=GL+3(9I
MHE;Q #\>Q3<E^\#$U5Q0@:AM1ZM&\MG(Z\[C&-7M\'6!78ZV7XEC9MN<+4[.
MN:X+ZKUF,@W13756L.6AWZ+OQ*Y;7;!0S"Y82KZ6X@L-CKY[ZPZ#T[)UDP-$
M[.[WW+NP_1@8>.;?,)[];[+]']+=6Y(WHS*^S+8,2OHK!LM*[<.W*:##A_E0
MMUKXKZ4JPHM_=+C+QICAKIDI49T23H#>FDZ9LXFHITZMWH0'7-E: '1618GC
M7ZN=278XSS$7!^&Y:+?(Q4_IU^.W*5XQNT5IO+ZO@%D.^DU9GEY29.>H6C04
M:>_LHQ7=X#^M[JZMEFD=JW!5-6&!,NA;5<Z7,OARG[W0QO%] R7^7([V$E7;
M3/6<D1(3:U%1M*IM ZN4!I;70 [A05M@-(TR <:0[26HY+K:31VX-V.3/UU'
MEM7HJ6X>IXR,4M+S-_E2;SS8THPYC7])2.TOR4RN*U?7*HO^3U:XV8EO]"JE
MOP=#<MCY$JWVFL<L"V_/7;#\M-M;')FSO6PL:REU'/+J9?A3YHO=_.Y40VJR
MVKWP>4]S4*T40G6141LU3_-#FBH0.E3IJ0S%6[NI"ELSE9H6HO@C<5ED^GIO
M[VLR8,;/_)Z>D"<0GJF)<I8@FDGK<H6;B*L+MXZYW4/,F=BO*"S=JRE+W=O[
M7G#Q^K%1=!AQ11M3'P/]_ YY#V\WN.!R\5-1"J2;!\T!@LQX-!Q&M&^Y=5XH
M^.")_D+40?^A =@ W"MN.U,RH;]3-8+2 Q8UU  TKJR5?%[Z#>[T*\/,KWE%
M+-.UK R)XH$YWX=YF]Y/EF3>2TO[YNFIX=>K;SJ+MV?<7?C$)^^UOM-H2SCH
MY[(-O>VE'5 ',N6Z9R%?WN;%<[]_07OIZL"CZ#A&BOO<,$!?>JA!4&*#E^%I
M'^IS'90'>TMRN,307IP5RXWLL8*'),F]F17<;+O55#@F)D5Y/_#&]![>=Q-Y
MR1CDR'O?QC/=X,@#D",D3F -VZF86'H?#?HTTQ-D%W#8IU0^Z_^"X=A;/DF0
M)GF;-[T*20@F?_O6E^3#;0NK\S75^9G!5K(E'R'D4PKSTM7+<B<D%  'X$7O
MT55&+4ZN>H_S'J>;6<:$FCZ&H5NF+G,KEJWKCXGZ1I1Z>SP'5 $\)RS9V8-+
M)3)A:R+,GRK'8_]4PFN=;'S;TJ1736+>^_@[I1@E<([(V\O92P.,V2,X+2S0
MU#79ZNKLV&M$T7G%XAF%;\CJC=WGA3>/,:-.^;,)ZRG I&<+6G)1[IS/ *')
MZ@[^[:^MXI,G5 =91%T4 [T^@.B6T!"E-;Y$'.B5$V7RH;)-_(3=$Y0-@2BD
M"@,& C)V)DI%1%:M4M_)(71]ER1K"X+ YQNBHFTD%SZT[6T$;W&:Y[.L$M-@
M0,R<F,^,MXHB +9KQ>@%]<X_A'Y6';C1_#J(7 CI,N4%E8F-(Z3Z8$:$U.:R
MDORRL01'-//R)>R2/\E64E9L#"#O%%@"4$!B1L57;3YAAH:N)F+]C;"M@V*B
M&%H@1X5-9AK-U,[9HC7-Q/&"Q93+N(XX'%HD;5";+,Y#6#A5T!E3*6ADPK0O
M6(PM9 _SSG>H%%VAD<.'IYFC%@*!+H)&N1H5ED-()S4R$2OKYF:<HP#:&$W8
M_&0W<+='F$XBV=('BS/R,_7\>8QD6,%>I3L<N:=.3[JOE#JB#5':<(BX<]G[
M]R/2J(!)*EZUL6&<X>P]=SIF:9-.+H41 8JI%$.MU&OT%HL-UQ&L16+P1HEZ
M[U1(1I275H=B(2=^PP]ZVW&T#KL*CQG1W1YO*>@:'_]%405A9"5BCI+N2+R/
M""VR?N$SF+8IQS4V\%;^QJU+)OW\#C<$ U6H2DB(%0^-7%M:DKJIOA^+JYB<
M<O<7_'F!BN8=I,F5_F >C9JBR\;*%7.6J1U)*BRL2'T>A%S..FD#TQ[T\!KA
MI>&6UL@_J_%>;XV:(,V?ME6<P%>7&/*[263[@/L>\G[Z[PA=7TD#E&,+>BNE
M@0QQ4-Y+P@G-PU;JBBY7N"9:LP[JZO6_3.$_!&"##ZK'0AK+3_\H3'0@B^4Z
MXM1>YYHMIB>0S9Z(O;7XWVZ+QX(GT\%=2R# Q*[.]=5V^%QE7_;'-TTB\'^8
MVL4Y.2GS*>B7*19[PM,@8G$_AE"7Z7<KXF(7":&Q=PB1 .C*^9IM-91/+-HZ
M/8#?!%H*I>8=RF0-L8;:39Q8M(9"Q7""J6A3%3.L=$UK^G-P;&M0XW H*>.A
M@UBGK^$Z&/CXO66_-;A5JS[ >/>+5Z.%N'$&-Y%P"/2SM[)OX4\-G0R.M=L*
MRMB>)=KA0W&W$B/#>RO,8P13C8J;=!.[:69]>=8+NC<IE;2Z,0L91RLMU?Q9
M?Y&RY58)E!4@W&_FTM)TL3-WSR,FT7UB;@I\N]IQ+SWS%D*[68OWT954L8Q.
ML>YH,H]U^IEK75Q\G4U&[OOW\WQ9=ZG%Z/YS;+<N9J='7G6.0FZM4J@V"*O"
M<>%,J8DOS=+=^GW_7+@S5NK]*LS!TXNGL^\^("JH(.38*P"GD^]S)]P28UL<
MTS"45ZTV;3B1_ME4%:#TZU D7YSP3?OSR;YYD=MDJHA(I*5#"X(#B^5 5"96
M9F+71'\,'_I<> Y#:"/$\HMJCL+%SVQ+4O#QRUFE1)^PZ0==ZGJ+10(;UG7Y
M_2L9Q8\,E 6BZ &.[41S4[L#G"<YM&P_(ZKF_J>XTMZFP29/U[S@W0G1]K==
MGZ687Q>4[E45J:&]!S#0]]O>M_I?T$0!"#!FK'#F1>8S@!OOR$!7Z8^<( R@
MIJ!I [B9+Y)O<SL_,QY42M*HV23>KR7L%/%-A>.Z/FR.A2QP&C]A[^H]%'?#
M&!T '.3BR;R+2UI:X6+YLK[ZQ**(9]%>DQI\YDX_JA6Q8RO3%;X:)3^FQ7DA
MXNX@W2VUQ[,<GL(% J1=I,6X39.=<RH'1W[N0V/#HE8ZW^ &;%W&,@NP:UH@
MHCU)?)5* GV34^0)/IL.PBQND4E'T0!OF=4:W"1CRMQEP[SG:@\PLTJJ#$%?
MI0:0WJ]X_?-O+4W^3\H+>5EWFOU@S4<O#F$+][X='L?'S4C,]=2Y%O@?X^E?
M!V#*\XE?(I(05Z6-4&+[YH*9]M?=99 )\&!SU8FJBM'R(N/<9>*^FG6;+H!P
MM_0CX6Z7Z[WD7Z<S]G[Z=7@,5:K?], <G9+S2&/_19$10N^**,3[V?AD:X&6
M7G9>.7P^U#3VSZQ]M^[ "M>&0/N=NG?%QY<[(JANN$_;7#OJ"W0MC_:%&E>D
M;<G8I +69*%!_ ["'Y5F?ALN;'I_#.3X:*RL,EG&%!8M+0/X'KV]5N^_S/6S
M7?:K+94B] "J)$LM22H[_W\:ZG\C@XV;4+P <72C78)\ZDH.1/72-O6V+ .)
M]9O3C-81TO3:$CDMF=J\12"[7K!\'G"!QJH+X-O'PE8.0<5R"P+3/<3RHKAS
M:S?O7% %+K:UO$@HBKY%KH\-PSU2]7S_[]+-?R<_Y,CUZ^.38/J<@=G#:AQ.
M]R!<6@#7AQKT^<RZU_VV%,M+1N.S)R%KR6[ZVY),[F2A\['@/;>CNO;#LD:P
M54>-&5DVK,F%8^W(.;)Y,Z;>LD>_FR3O#U5;>Y>4=NOO ^+'*]1TY]K1*'Q'
M)B7HX(7II'GZ_"PZ<T<@\?>Y7><5<$]& ,8E;"=W_@2X(C9N*J)::/*LRJU?
M'>M)>3V045C87MJ+GSQ9&^V_[M9FT[POS+0:*)R9+?0H>.0A6]Q(<MPD&S9B
MS#$W>TO\JFM$>F]BI0_09>F)Q!>3Z=7_3I]_^&TO2,LW )3(OPPZ^LK_#GN"
MG]4L:[!.\OM4+X*)SO/"N$+\;2=TRXJO FE6'$!C[_LJ@WSG]\!!YE->+?O=
MT":,2/57[')F(\P14[+OA?N:W7OJ/;O@('[#_Y'\B,R4GF.R9I1K@.W.F PP
M/5EUJ+);"X"XG??\[4_9E;_]+9-M!?GU*B7E"1 <0($ZJ:[CKJH#P9SLO<Y5
M'U/U6#6DY;&5 T%6??&=]Y,O17^+?J'9.EFC<VE=6K448OTZTJ\BVAE"+,?C
M<Y'0&V2^:7_&I[@?/]ARZ[P(>=YG!7P1'$KEX[ VM6!M62Y+#X*&1C[W/AV&
M:VXN49J']#9+'DQJ@>R&Q1OG_'V%/N7)%(Y6B")[^)^-(1<]U<NDQLHTC5U?
M<W<WNOKP_DF ;30^@82;U ^H7:GJ7B,_(6CB(E?CXW+"WJ_K.\ZWF5L?!OG.
MJ$!KU!+M1N42)8T(W2TM]$?%_LY.%BKFH2(-A;*/_TL[_./>A*9:2FRF<66<
M^X&FVI?:8/]TJ:"LZ?CW<Y,T$_E 90#T;7/]RI6TP5(,[?F">5#VLH/VSB71
M*+HT)>S8TX$M;*I?C6Q7I0-NJ+R/JFO/GQG<@WX$YKDT>"[U1FL8Y =''M1^
M+_ NQQFI+RPL:O8_[NSJ?MTFJ@"M4]Q[G (WP=]<6S#_!=8X*81KS;;S%RC]
MV%0=>6P+:8UQ_^"9)CP<='/$5$%NWM+ZX-(8+2GQ:IU^1=&#RQO4B&YAF 3L
ME2)_5$#[\\F/![4Y/>$>#'NG($>3^824-'*]/W C,6MPS,*1@(XZ-H&#SY8(
M?%LJE,HFOD!ZN'-^Y?V>@GBWT-I@#*I%UC\XS(%W!G6UWZI*9AR8TO/T]TSR
M#Q/9&X+LR0']K ,?I0+6"C/H0RGMY _@])I&A1JN7SO[P:(;OG(4?".EE;5R
MG?&EW;'93',E: G&$&FG8VH'D<-,E2STG%.B:IMH6II4C$P[G$#B3M3VDC*S
MW3 ]FLS7H20Y>_I?L%S=WNQJ^K;1/L@G*3]S%Y,4,>06,(4B!T_MH-!JY)S0
M\'QH9W5@E1%3 8D==#!>,O0!-S262$U'J'-G^_L]2KSD#91=EUV.V55:-5WW
MEE]TY\J]K=LF4=GC)P07$JPD;#':GPZJ0,Q\:+*PYTDY@0;='S%Z;=[O!)<9
M6_?#PL2U'&?-\@O4+ ABZP6V+1-+)98H2-:2:>.NHO"<;DV1YQ9-G4ON^G+/
MX9)<9(-P6L$UV7=A+G<R^H.Z2U4DU#T[X]1G-_'P\NHZ80X.Y'_V3<.7<X2V
M6IX;+/S8?<&R-IWMVZ[SO; ?PIS?PERPP#YO^JUT7;"0M@<,&OCSSHV"EL_
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MUII5->>L[UMCU:S$W,L,,>7"EU<K750'0'IWW_IB,P!*W9QL\YE+BK-B].:
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M=D7 Q_$[SD4/K@)$.,GTO;!<R:P"YC#0<!T-0AJ0FI^[8&G=\&)C3OT8>"Q
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M_8+EZ(<2Z4JZ8 GFY#ROF;U@^3G\6.J"9?-S85,W.WS*.5\\KTJ^8\?."(.
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MZHORWO?<//%'>WM[O#>,^/P_D35=N IG:?DCYI4WU^92,@- INM5O6Y" C5
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M;"44*__H28S8^,R'#2M?BUAC82A"\)%<[V!ONHOB7OF,]>(DFJ3]"AP5I=V
MLA*MWP[SIV"TUJW=/3XT&7\&YZN>F[#061=G')TMHVKY4W=NR_JJ<5"">9^T
MZ,_(VY,&V[3POYKE#7,YY_QSG/ ,;&(F,@W<$#J*2I?=F *>Q13D8C=(<<6+
M%K67VP2&$K$DUZF2P'$)G#XNB)2.HBOT;4SFK><'6+NDC"E-%P^5S4[P_SET
M?\)"IJA*4,=Q\:4B+TS,AX]7<?Q%*?F^U >*H"7S9^O2Y;[1"6VK+>R9278A
M[$(PNS".O*WF>WE"BGK(.*5:D'=;$-TDX0L(]UXH )@M]<*&PI_47'L_UB&P
M*AW8V- 8TNKMKM4][HBYCZ#VY:P&'[$4@9T2>6T=!XRY,XJL/3?4&I?&TEM?
MO'[(QS(N+@L$ZK5K_?RC"G0F7)S>FJX_Q>X[AS.WBAJL*:J'T$2: I?V5'_<
M"/I7CE5WB$9+<%45VXH'%PN)(ZT^R6@T8[BC=U$&]N))'SW@1H6>$U7X^VNE
M<KO]W64R6.]'$L_(-L>5[<(<-"[9USEI,5SP:7SL%X]!^U9(>FMC,/PH]?OA
M-J9/T]TSA&A,5EP0'JOTW$"CAEF@<CW?*OM3TZ!U-JI&OP>L\IEWIFAM("A9
M]$$AO'6IY>GER\4+'BFW3E&_V-Q:RN^[>&#>[>^U )(P+5"?X=&I-D#%0YP(
M,A<O'W<M._AI2(=B3FCBKOU-Y531\J"B>N(9UVB%'U,DLJQM,_*.ZI=-51S8
M=5D<E1M9P<WK,SEI[!B@W)@K+J+GX?DI=<B3J]O\CJI2M5^US[GBI?@[/U]<
MBJ?^7I;LZP)/+I$*+M&R5,1&7BQWK-7:Z+O]_]6=7IT[N>HDYYWXQE*U34(!
M[J&NJP9S,R/Q9B-+5CP 4CZ:+79JPF+@Y:'GI:7&Q>8VII$_#WF<@HB'7E(O
M4D@=;U<A^0%>>\U635N[85[+CMP+ CC+*&G'-?A15E&RN/*T<4/$M*,=V7>(
MO_Z-I/[.+$1!1E@LHUTD>EV8$,"5R1WUR^DZ@[G7F"N3.9DG; 8S&X+*#>]>
M9V/88?6OF,*WHCJ3OF'O+9YJ:#\O<_^T@788B>>1SBD\B,\^!)S*663\F=.C
MB/@[=/5_F*ZS^ZOBY(2>Y@U"'PWX^'<,5IE\Q4TZ<7%;&S@A%PW/?VGAM_+9
M("A&9+F+-?>+LC?^I28?A3Z(.UWV&TXITW&]HFG;T2I4:=KS_4Y;1[/98:;2
MA917-HO%(2Z1I;@KU;G ,2R'AA/U(TN@IF0(>&)Y\1& # ;EEKBX+#3M7MJ*
M+>@;^@RE$,IS,M_4^\)D$]>H).$QG2"7<E:A!-#_ANL?\IJ2#)+N_L1 /OS]
MG[-9'L DN_<Y[+D_):]:S^,+9FZ,4;"NN9 /D_TFN5SF)9K&,@G"AJDY2^I2
MA:J*(ZLWPUK\.$'E[6[+%(3/(=)#"+%V7IE%P,AFI*48!#X<0?W,Q89^:)*
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M0387[-+E[<J4+=(YRVR)0;IDFY<*FR2_B 2YU7:;(I4#!TM<,<GY4J6YMRS
M!4.//?K^OF?(W]//S6VC[VGTN8%;23<SS%[YO@^"O]0J]8UK[(:J&6Q,5(AW
MM_A$/HPY9[$L-69F,7*<4\'(+8[AL;&YD>;@'#7ER4;&N]>VA['V?\R#6D".
M*ZFI(O"R^UY3)0XN!,?&!2H01"&UUDLC9_*2C85LGFHHE?\=%WE[>#:.WJV6
MAR]U!/(;0R&L2#/<Y.*&IWOKR+&I8FV7N&D)S<GW]H#E$Y W+V+4N$HB=:5"
MRQG_V:&Y]_J3KJ9+[H:?;UZ<Z_1CVK4@H62#VFUM-?=3E2RP>3*M192_IZ#1
MC."=TE<OZ@#Y2W9U<BLSH0B8,-8/'O0'@NV_5!+\4 T4[! Z]%KK*'[O1V_)
M4Q=I"D;YNRTU7\!&K@LOTT,UY6JD6?:6:G*%WV23-U<-TE'(62L)^YJ9RA;;
MA(CM*R:$U%9]/^0LQ*]%ASE;^I!$=_C2U$@X'I$CG:CB,:U["]CIFU19[BVE
MX#GG%+#8E)B9K51JBOA(*CCD660Z%_^FH$CCR8?Z[FM;/=UL;+?"4QG\5'.'
MAK/>N*7==9ZMYBLF:H%,S\"DK>G[BV^F%^,;E<+Q<0];B4(7HSZ?#:54$5H/
MFHN!D>G4TZV!#TM8<$"5";!ZK17%Q@?J5!DN(U*]NG?BFZZ[OOFI,[\ (#,\
MO%%V6C! JW[2XV!&MZ:HJWM3:OTHVRG(]>?CY"!^^8BD2H9%#]7*SR&)):"6
M[MNOD)I@(4HEKTQS"^EGNG49I7U!N?80IE]QX<H>>ODI5I&DNUUX :_]G138
MQAH_M:Z>'8\:^E\\41-J3";:W*A@/5^C0(YF5ZZ8/H %SPXBL="5EE_?4#*P
M"Q_KZ M)!K4T,;+X\,BZ:/E.O66]A8GX![%/WG2Z==Q,X^3GB>(X!O;L0" J
MY>#Z].7),8:V-W<"]J6G&7:L;P:/;=NO%D6U_PR$;\Z/\*5(>IQH%G=-+,Q3
MYBEHH,O<&FU]?:93G'E/5NN2U&$TQ7AU"NR-JQZTO128/8Z=%10[IG?,MA<7
M8L/QVD"=![NH;H%=31+R?/1@9^O^3OX_R$_H\]3  1?R=L2*Y-/C3MRE>S_]
M(F-0<_M?O8=MXU$X9S[ I]V[7(R>J:WI^/NGV! 1VW!ZW%SA5PQ?>_NQ'PJ/
M(6"=%=?1=7&5,6=73$:8R*3A3NM+%$-F#'2OX13;?1(=R65+[UA=V&N-[KP_
M-;75KJ[>.A^6673<4_-%!=0^ ,N)!\UB9'-L^FH+IO!<EM\)B[\LS$QH2FC@
M_IBS @@9)PKB&MQTC<#7>Z\+S87%W+EB\F]],?,'*C&4%UR)WLQR!!IWKXL-
MFL.-LU5^6(U!]A1T7L_?DYS3.L//\SPX0GJ,QVLJ?QBX&^I\QX_0L8QRJN #
M$;(4OLQGM)&_,([G'_2TI3'(KY;W+BIML5)'[ME#E$?B'00 )][4ORIM<IEU
M6Z.\TK8N$F\'6YGHAY68V?+R]$0G7I]!(9((= IL$""6H^V;DW=L;.9"]^:+
M5Z^K+$ &6D^28_5CG?:*/Q2)9S0&.JGL\I;]''O:FA!=6C=!G<9@K <AKQKX
MEQ&PZ-TL_[004$Q]ZG& =(/1/__->X7,=./FQ'&P.,O]TI("/S=7VVU,R'K:
M36FB1U..I'6+A*45OX05YW!W;N9#WF*M5_?ZZOCC!4;^S C)/@T'M8+JSVA9
M4;(IM+$8>XT]KS,PUWXX[W(.@>08=X%?QGMD29JD$FH#0J+$OAC%C$/$>FUW
MGQ1<,7&YL!6N-/M]B,7+2>&%>ISTD&5]\(2O,\/5#D)&;_293\8_%$A#F)4K
MH#[GIHF"+T8<BT@I+88&]7(T?*E/'/R6\_T-I$O2$9B_4C9_;VKOKD_KGCKK
MDA>9X.FFI&9@">2FB_M:)O:+B]ZM3QR8PV@JRC&_>_3]OXWLUPJ(G,HV@*S%
M9P=2LHI571J_5>#)JMMZ)+9D&V$NRX>Z29EC\M5GDAT)%L\9QI9<KDTM(C>Q
M'V-](9XWEELK?S;_63\_P%PI/WW,7UX*VZ&I6>N("6R)AA98+W&(9'FCPO7&
MZOB%%]J0+Y;S742EIE5B7*1'Y&2GZZ Y2E7#7A*T-R -9ZM(I3'_*D*?+9?)
MS%]0Q_/$A.59@",LQVXT "75#]E7J5/43@,59B]3OC4%25+[@)1U?N0CW>#J
M^T*3.(I[!8*FQ!RK8X%?@AQ.[#\6Q[Q?5O)H=>54,S&.(1J+K%8FM?B>^^R*
MCP!;]V,8W[8*\H,&1O'^EEWHV;Z&1ZQDZ^7VFDASRV<E0,*SM"C=%2B@*CD]
MDOOOQ*6,*E/Q3IMT6&QUF -9N;[U?).'+QOB=(/P;:4,^"2I^/8)?0SRU!;^
MHC/94D2:U$Z>COX%/EB*K;IBJL36%.8/119Y+YZU(@5Q@YX:IK.5(2B5V_RW
MK+ WG]LJP8(P$D&OY;3OVUPQ%?MWWD=(4,^!YRKG[>?_F&=<__V0/H3;0B59
MV3Q^$S#?8>M,CUO*=D\(#[@'Q>$S(#G#9$_$"$/XV^!RI<#KKK0ZY /O2RF?
M/ I  _R G%VA)DWO>3QXP_Y.-[P,QFHW-Y>GGT4T5CV#/QG^Y<%DA;BQ3 7;
M#X0(%*UL0R7B\U1D!W&P@5^J8G,TO'3S%U.85]%6T8ISQ.'&TK7Y;ZC0"?<;
M!M"@5]-W\H<[&P+759[/1-Y+#Q^Y_5N#H$!<>Z*H0,C(8"AMD[3UG9(=EPQ2
MNA=,SKAI'F8>E%S?K0OL\]<5WN>JK2U:O%];%W%'SC'-1@(@3W4/1O?[U>!M
M0BK?*BMDJO4*%83 I!]O)M3^O)2&*]O2C'UT=CWAXM'H)WZ)9=5FWGF)D+X9
M:#:TNOWS(!UD_J@O.=Q]?#TM8N"*R1<T#]*$37'[$+X95J".2(OS#RY@MD>2
M*QW2N2VGM%N$/>4:%7^95E\4#\$N%\L>H'IFS]R7W0+M"=<I\*NO)>2"8UGM
M)8FNB-,,G%EJQD,\:?)^_YOI$WN- 0;TH+%<M%2QD:)NY2DLE\0G;D)_ZX=8
M6_IPMG'BLZ -GOLQK4T["<)8NN\;-N R23&CIW-  PD#15+R=;0PE9H"S1;*
M?BMK 4<@M'4^4]OS9&*Y:K5@-71O).RP*E5S:XX!00=M!F= ;&NF%CP=JBVV
M7ON?N *@-LUHX5GNG2LF\28J_[W@WV@\G.%($ RX9&;2&V^1L:0$-("VG'S_
MU@UIAH/='H8ME+)D46(J1AKA+-DS\\973+HNSLN7YI0V]$J;1EI#VH*W;G!V
M=.)H<3-5IV]9AV-I2MS1231P%*G1AQ8MKSXNWRR@D:^8:G>F=;]C^!9FR9_C
M@5RGK;TR,\H4Y??.39<9_M-!J]9[_@T"$A]Z4OPQ&6,+NO^PK.Y8 ^_H*.FT
MP@S4%[05_\U[((Y?HFC1M?=D.@@YB^XD>HC0^\^EMB8YLZ\BV1^^UEM/]E=N
MJ@WB[\HQ#S(15!EWRBSO6RM^!$Y+&2"1*4[NFH1R>CDR$ _;P73VV$IK5]%'
M!BZS'JLXSW_&?7_N2J5 >%$R?<TV:F@0Z.[\G8?3^0$MKL8 />()"TFU<4N<
M-M-=[[]BV6)IKHQ_NU-!7NIZ\PSU+*#SI!]V.=4DGLUBO6HL-;B^"E]A/E^%
MY'20JH?YB\LL&[#F*11+TA&MDA!CEAG#D4V>WM\33J[@D*7EDE+*K?P(X+>%
MSE7-C06-EG%Y&TV7[+R5A+B%+->F>9V<'97AF3!+YU@A[*"4R\GDCG%03G2U
M3.F&T/G>ZE$><E_18Q0+'#OVNWQ"(P*;UM>)+HD9*V5H8&^ NAD?3SQ9XG+>
M67LHLW\[T#R9;\NW%4XKVVQ.#3U04#XQ,5%S"&8$C(1;3JR://LTUYK"<O[,
MHR*/[N%27M1I#DZ>\;IBTD^AD!DLWWI/+IH"EQW\3M:TK8.CV%NB>YO'::?^
M@!H2K=2"8?KQ: R&0 846D<3?!7(8^?-YIZ!XZ_AD<XBZO-!YT\FL"0J/^G.
M/N;^^1+XVD81,/'2KOALNJ.3.(4Z]/W+2*X#ZQ@.N[Y*8P%3#L(HIQB75:+M
M>NXWI#/'NGJCLSOVZ>RB*2Q:XR&+JHXE>1ZJ[C.#7MM6$]U,ZFE%:[$1*9L5
M&D@AS#WD0CC77_:=M43&XIT$SUAV3D+I1^03K7MD7K?"^-L-:$5CV2ZJL_<4
MNGCABNGFS$7HUB; ICHGPV+%O(FT*=>FW+D&>+'$FQ1(\=$4,(F7YYL/]EV3
M<0JI73HZOP B-_H&S_SVO<E@*J]2_"DV\"0G95M@9%"2O.L81S340Q[5R(Y)
M/XEWOA0$'=+4PH'DE8VCX8WZH8[J-ROG(X-;S-)5GN/NP:4@\D2KCXC)DD'D
MQONCW5(1)6<]O5J3=U/"Y5I9RO,T8)9;O?(%7E"FYLG#;7OGZC"\N-E3:0<K
M*&(R)$J8 QT\":0>O8<4Y&=MY8NXG#5[Q''P2+)$G+Y+L+&2K%"Y86)M4/V]
MQ.Q72RA.7$=9S/;>N*;K[9MJ%K_];[/X]74)2];L$H/L\GYC2]/Q\BK1 >ML
MCI\-#%S>W!%IC$M\/V !SW*T!%J3J[UB9B] 0+YF-3B9>SC'<CC,G2]!4UC<
MYZ>9B$@A@]LM/M=$O"H .KP?#7\"8X WI#0^[C\6V:*P9-^A23B.P3:H5O&Y
MLO5WJN</L56JV!B*&M_M>SDJ+DLWQ$C%G"U O<:TR* ,1[0+YK0GTF),EFAH
M)!5PPM_06ZXX_,JL*M>,GDR[D?'(V;-&5XM9'A<BXM_O"D:]$L9A*WQT^L:=
M-DVG%9Y3 ;%C42;2/F+:BP.RU?%?XZJ:R@3ID]W-FRH]!6O=)(_H:AR+5>5:
MC%1U'Z,AY?3<1)9:X*ZX2) ;>/SG_WT]R[%:0"*;CP%PLGRB7YWUT["AU.*=
MJBJ,ZG1ALI&KO^I;H9>.%^8/*#KC'H9]O<O;$<VY6<]GIEL%6_%$?0IJ%48*
M]RN/TG3P*Q&>;B[::=N,3GSP*=7E[C0Z##4[0TIW(!RFI+8W\=-@64YNQ#':
M^,:I3?7#Z<'"!LA78&RU">T%IX5BN8K0NU?9JD/T%)HEJ!(.1EM:9A],( %O
M59[,UEBFC]F:'%KETZ,8=8P4\U4:>NLP6/G^^L&;)0)DI24)(&P>NE2)V#21
MG,6[8 G.(Q\N_5)M\DXDV?/EV%H:'_RWL.[_%/VZLD"TZYFI.,8SI];^4?>@
M:M,AV$R;F6SII9?-?,C%?6&48V)HNP<O/>32Q(8-3<N>[ F71H7K'UD"OE\Q
M;==RG\J+#T8$] XK[_P9:-.B6A4=IM_TI$(8%2J ^N3')<KUHA6A6(M<M+73
MTO5, W=!A1-"MA5C(;5W!EQEI'\92O4S,0LN9U$SWC5 4"4>65K#VW ,1NP@
M"U?$J,-RNY9</&=G'39CI];*E$:'[PV/)N^H^+?6\$)]$6-K=/\W6%R?"NUF
M174<NL8CJTRH+G/H\8._.^</N186)#ZGU'PAA'#>"^*8\ZV.'Y3#[._ '7U-
M/\B!@R9(_B_D^"']+$XZ_4(;+*^E?<^#6R(C!=ZF__R+VW[%W743AV,RGX.E
M#PR!,#,0KPV%-"+MO08;(%A(0R;TMM0;HO- ]08:&"XQD;7J)'24]@S#DEJ+
ML\@IW$U]J :@KNU(S[4U(KP.I/1W6,/LDM@D3%\\*]'W^N6&'+Q)^K,;*^=P
M8WH%-^&94^Y[JIN[(<O;,79J92W^/WZD G>R\@/WWT-60_&1,_XSD->2.Q:I
MKC]-2&*:#0CH-[4=T[37KGR.4?J^E">9?7*__>>#QY0;9;"H[U=H#;VHRPW3
MRY7GTY5;ZO6\%;PZ']DMC,OU:<S+JN 2%A=4T/JA,0?[]8!SP-(B.<!L#7[D
M?\6D?F=U^>[%0?[R*X7]SMYAML)(P>L@?R?'1Y-19VFN19OGJD\&[<&]!LU^
MZEV/[<9JT<%#U<[>,U+/I8]_;<EAL;,:X<ZI&+>/;,GO.)/NO94[A\X+SO"H
M;'UPZ;+66PTT<Z [.N3OU&\Z"ORR=Z'A'CN,"BPRUUB 83:J$(2USG!*?<_B
MZD]T5VG^S%27E%)'S6]73,)@9;H[TS#L3?A>P/ *Q\?@Z"%U\:KX+P+R-^^O
MU4NLLX59C'=.JU4AL]E-TO#WCQH7A'WD+8VZ7EZ<9"\3-:)Q%[X%3@['LAMY
M8U=,-S#*5TS\I^%^(RCHYV4,5Y8CST/9WN^A6=SP^/Y8=/4I)B'P5&3N;/5-
M491C1%W;7AO-OF>?I;3A5M.GD+:X569"=UA7A!254+3XU_VP3[)TCGSI6=J0
M;<NE-5OV+GRW7-IEMMX^2/6-)\5E]YC1/-($M0B&!_O&?80H59.4D929XI('
M!Z#^A,$(O4B904\UEC_SZY5MQ4842CH&E[BZFSOZA55(ZUOFDBM1_&O_<UU>
M:YX&V*[YQ+B+&QN(MZB4 D@-79U]*MF.(2O 08;D9X%[(YZ8A&[Y'9)+$[L[
MJQI?1>C+RH&3'IBR4%*5MZWK8R_U8ROE_'<'\JSEC9OK>VXJUCN.Z4"QF87&
MK;PVU4'R]^FU3>1AYN6]7FP9U&A&ZW9/&)9E#]"2(3FN/ML4%U U<!.SY@[*
M<YAU!\QLC/NAG[VNO'"/\%Y4QNXB_KG(S0/2\2BQDI^M=$44Z.LU?LO_&0(+
MU2C3;O?IS[FKXAY#]3,.T&Z.;/[5+N-.=IA@H[X[)#I BYC(JP'["^J<#CA(
M>UQ$M6O-I>@1!.TB \5G6M+/ DY:^D^&C\EW8#;6^4'5FAQ&&T=1HN)J9HQQ
M3Q37/^3_:U#@RI^U:#J*A"ZP];CZKAH:EU2("E160?#LL6"L@HO>HL7Z>4?V
M;KQ]IKM@^4GN>5P*MP#R$%&$WKXT\SL^I-^$M']CL"?4- [.!D1%2<M]*!$Y
M9\Q"R\N(U/'8.*\<3GF/_^&XP/^@'VWC0 /B+GI;Q>L9T&6IBFF?6]LGK?)K
MKKH5^;=;)LJ+*15DC/9-!>.P4V#)KZVJK.JJ<?-$_2?J9#,ED/&(_!53AZ4E
M/>IH ]9[)(LX+=: PN:WS0O[QT2QX?Y[:"S_P!&-D;61'<L#:# Z-,*Z.?TM
M(/F)S)2?L%0$*G.8"1>:C6*\>PD1#Q",,+_=<(=4-;=01?TF^?P!'*YC7)_L
MY86I%^J!!,QYIA/$B#B/N)WV..5"Q77*:?@>;7:MD1;H*K&G<;,%-U,[HQ8W
M53HF? V_1<'5ML,03=O!8V$5; #(8+O8YY>FUG\;M/^.N]GER' 5EW"_KP-
M\7S[@JIOF)-%\Q#MDNIA)]R;=<V'MQ*"6@]R^A]Z32GN&_]D))1IH.H]V!,L
M1KI\*5]FT!A\+%4H<>=%QXOHV P;3!6-;+EPL'&BT=X>X/P1""44=C<#".R:
M@]R%GV8=M^''.Y$R&W3/Z1(/:Y9D8YU'YE9__K?<7>N?B8Y^;H@T;'K,6Z9(
M/KI\NJC_SF/"NL6B\IK9"EN.9QZ5\X)U(()5WF_==Z\M3* AO3SZ;1..?SBP
M[\4$2C)=K1>71 [XTFJ1A@P;R]PBJ9$.S#EL0(8M2FIV%6KV'G0JUK\&.V/Q
MNA'@KX&E:@4;@ 3@S0;4ULT(#9H?P]Q%6<LKFYB)7UG9\N/@#K5->U*WWM5=
M]JVJ=Q9U7W2WGG!>4.&IS*Y6]?V_%_,/\]9N4TKT0$W=]+G9!CX?GQ-?"2FI
M?-=NT2KIMN;@.8"?9:Q1EH>7;E)F\:NW$]#MZBJE:JL"=^PRJ=9TDMQS=O?,
M:6LJ2"%$XI6)>;)TDWY3M26LQUB94'Z^!G@6 ]Y_!'4!;[J[3E8@?$1J4K@_
M=L,W"D7-Q-]&"MKH*XZ;"=@KS&SM%W44E1_\AB_8/<\#UWQ<F>OLG^())0+!
MD%$\N9+@1S8+]2Q./*2NQO0- ),"O^V] CC5 ((F"IK&=/>"43/$II/HV-EV
M]<;M]!;&O5LJ?@-K>%![#W+[YDNSHOXN"-NX 1QVE"/@B<B_(^_[O7\DT>;3
MX4,GSB[*<H<2&^;)4+L/=C M5/O1A:(OJ;/5YKC1;+?C':/3OS7<L ZRO[,U
M/DN^M;J[C6#<:2FL?G)DN94_=MSCH*"*V87ZA%[00YZGPC2RD-1JJ>V34K70
M<+[HG??;/%_F+0Z5TQ=MB$?2_*]XPA%_7#$-M098K5_>]OR5=BPS*+-^C$?-
MY,I].E<==(@C4%NEE/+ D^\IZ0:9ZVCDHER05@ 6)[<-!.8%K7G#BC@W['PA
MMNH";LLO3FXXUH+<5"?9L2]>/6WAPE,]IM:CDZY-&,=0UKV_#J-BC=QV]E4>
MUBFE)28 B&79N%GRUIB-H3Z12K9EO$!HMJ[+]G#"4V;Q%W0M_D6H]8+;<ZWN
MRH^612[4 T U2'4=;+AE3^(B>:=>JMN$M7Q1D$K$BY5C#UR^.,X>BC9T1Q=G
MR;5)5K;'EFVLK<-CNT/;BLO*.,+E5SAH%[ T\SKBH=VY#^T@+F^P(Z!=Z2Q*
MVNV<IDBY+&+<P1U?,2VG4=1Q(R>GLV.#+3+S8]I_+D+.K0^CCM<#AZ5E,@8I
M1=:T6)5_5I+,*I30/Q-I<'#8[[&Y%<#:1J7!I%&H5(7,Q]<X@QQ60][L@=98
M$XLB6<&P9?NHFL+1)PZU6L:V0*!+43?LQ153)6/G#4'(+&SDQ\4TN$4.L4OU
MD-=K]=RW/H2(,(8YYH#<@HVE)>-+R?9AX<IS,$>/T-CBP295G/166K<!H^+-
M8D1Q$VRN8_E])U+<3[.Q&U9,HZQ'[YZWWTYU_C8V0-Y#=%SN@*-H$)+LJQ-1
M:?<+R?63^]*=0=$JWAN\$#SD^"B(P7Z7G<.CB# BD-"+JN]%7PB%%J.&QWR&
M"K,\)F/!T#ZL_Y,I5=K)Y#'+>1D:6Y40OJPV,=":3!4]++8XC\HP^?CXQ:5.
MGFL9F?K:%HPO/:*/@+R%EM73.VL4#@(G^; S'5,T#DQ=['B\K"V1B*:;OX8.
M_<=XF1\0;C9RD&U'_>1S"<DR0 O!XDE.@8T-X':NC"*,&XX-U\@7VSS<]Z!5
M::D*\O+U/AKR!ZTY+(^8_+I>O9._978Q1B: H1Z)*5OO*95;G-OW\+ZE+?/O
MCBP"\MPV"QX<@37S)-!$VWG5=D73A?EY.X\P\RD[M8&T.[U)? *FON>GU+&[
MA/MZ>F\>Z7J_+A'2'ZW.R!8WB#?5, GZ8&U)\$/'<QE?AI9?2G?47BZNP55;
M5TX*.[=99A0J:AHM7G,8V5A'V=H$'Z8^Y,\$[" FS?#CZ19O_]M(-K!6CZQ>
M:K'R9&[=#  43BF&\%F]\#F007Q$Y1@'3SNZ&1+G7Z3F%%=,J&;\X;Y_?#JO
MA- K5!MSD'S4;KOG11#_<FZ[3N/@F(!OSL!G"4F0Z 2+X:5C "'B6!F.1+7J
M'4)[6\V+ECF&.AS=/;2L,@-3Y)\Y=7936R(S'A"WS_, X:K[A5H\&>\^^9B'
M.2I=W!D*? ]G=7F34.RC]9[RNIV46,P&\CND[=NCT!B@&;C[$V./SGU6+!BZ
M!(N[Z[C*B[//O^77:9U]BG')',!(']?&V8'Y?)HPZ??CIK_\;)KT'\?D$.U*
M3<]>SRVJ:Q=1YZ+:^G82,"_C0NXTFQL$.T_PO(8<UL#3LUDL%U-/98WNJ7:U
M&Z21!9Q]<M*NF#A !9X7E#+RXF+:N_.XN; S2O/N5K>NZ0;]>S$P!,>21CH_
M"L"59X7&UM71QGRB8OS^7*4-!Q_SV"6G>*0F/G"D64YBP_G8997^82%L.#ZF
MQGR3*I3%)2!4NK'\%'_1PU.Y*C5PQ83(>@ GFBF^CD9N UJQX);UDH]::DLJ
MP?R2H'XX<A%-.!$IAN:%3VV-;F]7@ ['?/9,''*87(W[_H?(X/]G^L&4\6FB
MAOH^I*7;7;KT@-436O'A'1P*LV2!OQO(T0,H-8Y'98[:5QGIL.A/E+',/6P=
M#)P!2:==LA^77JYK92)W&%AB&>F<E9S7[*0FRU%$2V,[GP]X79M"K-D ./H%
MDLMM6ZZ15S)\ >T-5H^6%5_\+1L*_A5&&6:O0=W^F=<W[SGGER_RJ>%PQY9+
M#@#+?!-CD7YKA7ME$U^?]:6>MW"V_;2:G1V;X1A+O:.I[GH#=8W>OE_4R7_%
M]/$]U%@GK<R;LE=:EG@J[N%7'4<E4U2=E<<=PNAL8Q12MP6)5O4ZM>3>O^]>
M-B^H*IKI".[BJ_O <$IPVB9--XT%"4U3/+[6V:EN\T2*WQSU=RJ40X'HDQ'Y
M+-7VD'0D):K_7GF_U >W\(&0^K!!.=QA)[/;%JE=,86Q2D?;T F,F\5,P]^4
M1VQ2"%![8\C[\;#CGKL!8?IQ22_:%?.M((>^=[59:F+D8\*6BYC6- :TB %E
MQZOX_64G[PK=%RG)U36!]]1-"F/3]>L\[_06;RU-?;.OG2A/DW&LR@Z9$N2\
ME*VW;W#M]_ Y;?6L:8PJ+ZM.)I\X_H66B=^-8UI&@\]&SDQQ(U=,$\W98:29
M5D_Q*8JD%[F:].&3;#TWPZSKIIQ548#6\PZ1\"NF+'Z#C4 )C7\B4DB;4=42
MTZE'RE.\_C*A&HE@2A.D]IA-NN3S.[3D>(ITD%!5+X\UR(=&-[87)P;<Z6]>
M\5HH=%G"J:+'31PZYNJB>HP9X$\7A75?O\FRGNFZ+47_;,M%]>V'[.=G.W\,
M$^5QIT LT]%&&ZTY22?J4F3SO/D=K<.=]T7 F CU#TKE45+J?<Z9^EA?9>JM
M_>H7S>??:]^/0)P".J5,1>WBDD<^)302:U38UM^Q48+O")/?<Q6N<H3,* ._
M6)2'^%M8.=1JHXPO,DZ4P(2WVM=GFXMY5]&P&:?M;\&K_A^0'@5-)+I"$-E&
MB- XD^5)4BG-7)74C=%DC)Y^"HR/_P,*B4=CZZ/6)D[P$9-?NRGX8@L6X^&
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MC];9=A1F5>YTBKQU=7RR)$'QB7&I'#R5?+N',6Q<G>]P)2(@D;^F.A$#Q+^
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MJ8Y-X*&+>C:;NEW[T&"!,\K+99'+7/)6QYU0];>PKUY]HKE>S(K/<@93>=X
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MF>-=O]).9?>+RAQZ^_NQ?-A)M*EB!;I"=#PKM[B$\\P9IGK46B_*O>Y2C[
MV):2VEE(C9WB@W]2#DY,FY]#LIP1A5[M3:2;]AZM5HBMU_<1X^+]:P0AREIN
ML?5ZVI>XI:$QW]CLT,-08?)TU2?Y%%%.B,DZ(.,1G]4 Y)9M"??;MT-N4#59
MWJ[D'-!"@K7CF-J\M55\6+T# H+M*@+-;68[RG(MJ^5\\A,VF,WU2P[46T97
MFHF<^Y[[>EQ?2C_R:6SU1"O\ I.I[5G*<0:M<"\WR>=,['WREK!1)[[[I)&^
MF&LR_LK!V,# 0[5X5$M2E&(>IS0LTS'1OJ5$-E^UC4HG:-XG.O._@9W>'CH"
MU<RH3M)^YU(N.YUV^3$_V=QE)D0SR:YLEG_UFC"'4#GQQ04R(_\F*B_#7=MF
MS C\?"XI,S#VH;[G-1:61$?HYSRBJT%+PN!=X9&$7E'6*3@<L=RRQ]B9HG(\
M<2WV?[)&^S1<+T]$#:HN-0.JB3;22FM3VVU<(VB<HO=\ST=L;/O7@>68:.[I
M";@/19]2((NE^CK75QEW5Y8>.5S>1_EQ 3(< V;%@6R-S%G98,^I6X4P<^5I
M0;QSPO,S_4^U>@U@^QX1RRP!RW$ON"VR;P=AT4M149<*)%(JVSFFJ; CW6UB
M:PMM3(L09=BM#K/(;BU^O,CY?@Q<M!]2GX_P$:O&773*7[C4GCS)]M$_,5-A
M^[^(>\^H)K>M;9BSM]L.*DIO6R%4 >D=MM(,$) NA(#TFM!!^MDJ("4@(8!T
MZ3V1ED" L*5WA! ")( 0>NB]\WG>[WW'\YSRC?&.[\^S?M]CK#77FO.:\YKW
M6.L2+UD 2?TM3)9,W7SIF-"H^TTFW-1_D]LD?/YUL3Y4RI(3GWY;5]=D&)OD
M52]0&:,2KF:YJVO6<&9N[UG2FF(B;;E:>9&27*)?IDXY%BB!J/S,O#G\;;FP
MU<&(!S?5+5J:7 9Z-M-@Y=*B;2$&X0@WQL!+-E& X!& ^^>7;3M##UV?]&*M
M7^[%>8W7?OMJ!6CXF28//Z6VNH3\S>Q.D%:M$=P;6 -\  C3<MW;W!.QV>5P
ME- ]5SVK/R"AYW;._%:W4UN"JQ1/E=5^L3-#4(+"YSPRB9<H,N;@&F($<$KP
M#6A4W;#Q%Q;B0YYE)FYMS2A]\_V,ZX?.B$8%6X;3O.WJ4PB+R/!<;\787)!8
MUU->9)@S6V9RX)<8U>7<RK?G A+UX<E*GF5R1'6&21T1FY=#0=DH2[]-OU6T
M]?"?6Z>TOXY]+S'4Y@))KZBDE+--+E,+U6FERJX"VX V_!5=YA1:K16[>*[5
M*G$L&EWQ&%. WCECR@9T8K2"G +KGLY)MQDM>Q5H==94<ALYRL\5T +4JQ",
MCN1%C<*3"X/6UU=TH*995L#E;UK2#K,&YE#S*I5@P1)4KFR<]DKC++S:W?/&
M>RC6 8C>@U&;IJWLDDDUK$&9?F/DC9,2C_G\C,,#-T,1;S/)U,FR44NC'!$7
M2?G>O/X:)L6U+._.'I]NF2')N/>6,0X)[Q!Z18)B2+Y!K7QJ6F^C RPD.U6.
MMFEL';=N6!R;=T0C4P[69D&,NYAI$WNSR?;C*'YI\Z6G'NO%"V28_G2[UT"K
M>3FDG&AI"/D*ZNT_#/]C.;Z91DQA3XW1GM73%O)31;Q7K"I!8$9CR6U_<?;8
MMW"E*8(1/L2G#8#,XF41-9Y!KG)#0_Q@&Y%@?;X^J07R/\D[3H067]A/Y&UO
M$/(VSZF#;ABSC8EFF]LVDN^[J5GA34)&(("9]EIW"IN6^$OR5M-XK#Y)[?.Y
M0,_T?)O5&:RO9X4KZ!JAUMNY8#[ _4T6E)I08>4F8YK4":YZK.O>1+;(X\]7
MO9,H'K43)+-E:^QA3-0:VTC 9QQ.+'/Y>6H75Y@7J/ N#TN,L(6C%Y2BZ&LA
MJ $%[=LD+I,FR$12\4P7E7ENEBSP:"KXB?=.6MCZ6?;&.Z/E$+4WCC+I=JAG
M-ZL<)L,-/V&ODQ6J M*X4^C+#HU:"N"+L57@. ,@!S1=5"/!Q# <VBFK;"V:
MDE+_9MXP0,U)_7"U'+]B"%!ZN!%+VK>>!]*(:ZDM=Q)7J8,Y6M/G(S4;G(2D
MK<S4V<:FPYZGS>L#11 RW("'V<L,K-I5:_VT!)#O]=[83;$^A+(9R#)-VSRH
M:**L;08J)J+1%6NTM>6<L" FI-](P"JY!$0_4MO:<H8[RVCQ/R!142W^)-*_
M*P.PA4NX6S#RJQL[/X'X*MQE]6*8NLMZ**ZAX?XR]8[M"JKWP^X772L3CF)"
MQUP 85_>JM"^=F>KIL]'T#"K+*MH4DB^I)+3'R0DMEA!,"TQ'U<M+$F @0/$
M9 ,F&X:FA(:+<1=K-'C-N\CO]5VOD+1D%.Q.2YN;+D8-$/<ZZ\Z 6U^,B_="
M2'DC1*2R^6.T56F];9M11C!GO>R'C$%!2;#.:E!*T4OO6Y8FB--Y9\/4++LS
M']X38HO2CTMAW;.H^OAD?='B]+:9MY=S-7VR$!Y?:&V5PGTC/PA+A1$*"D#%
M'#U?=?0QBDR*I_)5[PP\^Y><>OW]I27>1G*6?B\>W'6/_=G-D#N]5DOY^8.3
M1_YF0?1BCSG$LOG3'I;D=906:6(&#D7/,2;K+\LM[;0 FC+UR@O"2EZ7P%[H
MU&;"[)^_*9\4GA:/^0?S(6A":N_V(8HJ?F)7="QO*UA2Y\ ])TR;"2IZ"W7Q
M2$>Y:T4*.C[Z,D2F4:/SY3V7N9_Q1T3"MF9@XREQ%#:S6Y[0][F-#=8/#*I"
M;0>MWD-<(8JA+HCM08_.5-I[AG<2B-9BLW3#:5M,<4-]&;3Q?:UXS@A/Q^3U
MM8,-PW((^^53_]J266(H\%!V<'^U8?*T@OU86ZHPK!>2;HT2Y2>FUB=0<B='
MBBF,EC+8V8]HA$KC[L/(]56PO48[B<4R?Z;X7;]2!V# V=KAY+<X7X>AKCRJ
MA4K\.9:S9^<8I!V@SKTVF3#VH8Q$%=6KV\^$>S8J$<V4,TP 8&"?6@;YV&6F
M#)5Q$-YBN9)MNJC& [5Z*,ZN9.W>4R+,B$!UM$QHNB I/Y "MU2,PKX&HV*!
MLNBTU$MSMX@[=3!3?"#3AY[C<94)=$5)V9NB!;8H<X?HR_:/]DG,F,F F<45
MVIRG:.G(9VCOO08RO?R\+T<J%5X_KRLEU I38;2N\1P5V8IH;K'1>/$6RSJM
M$+YGUEO7J1RGV A<9?]1MUGC>5Q-^I$)+>U4D$X4'K>1B!!3]5H\<3#XI<ZO
M6>I&=[$&G\+?:3<YW'__\O'L3C!?V)]?,?0JF&:[F9U7A8ULJ>5K8\6,4.FT
MU+X%L>8T@87,^AJPBAB3YA7=]=O0"%,A 2X;B*)X$T1&UJ[UX3$V:IXHYIF!
M&JA66X3Y:8%44>7E2.A&0IGLLFJ+=4PI*N8G-_5,G[V)=LW=4WK5DF:7AA%Q
MC-R8EOL5K-WP(OU/,4U5IJ\'IJI"'R\.K[V$/46LNP?R%H/+D[C:^&_E:O<&
MZ1.DCW2:*CR/O39(A$+':P7H35U0,!JDVM\9SKLDK:^L+62:<O/@4#Q0_K1(
M1!AGG.L.#987F&IRP$/#G-["%[H$ENXE*E)[L@1X^B0\(FQ)!HC!Z[;6KV B
M L96K^T/=V+&D0LB;@M31)4- 2W+]#2>O"$.BZKB=2A6M67X-EN]EN$'PBJ
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MIZ&?RPB  H/+H<1U]_(#;1XHY8@^5[:EVQWGYT0$" Z):V703M@C6.NH@)]
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M%!@6MUU&WP.SY<XD#ECY?<4#)(L9Z"O&RLH;,478M"#QHQ1HGU?>!L(&PF)
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MP:AV%,T)[!CGSL_NGH2@WBF=,+;"F^:7*ZE7Z8%/EF$B\X<U$@\_U^\>%G%
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MK#!%PVRDC^N_6#<I, ^88<YS/M0\_61JX>8[A8;#VH'!J3KFYD%>6MO18[M
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M.1?OB(B^Z>*+)XI8G>VR/K5PP?KG0&62TWYSRCCA[W85?+?4P)$E8G</,-S
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MTQ,3;+TC@T&XMGEN+=.C"ESMV_*_O\W1;>PC-SNR/7N2KS[6F]9JF1X(,HQ
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M;[XBS:BF?9/["5.T4MD3"BO?7:/7PP\JF.^RM>^HX(;V;78>&-[Y>?FF=]A
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MR1-0/$%.'XN+4]@V>(I5',P%&Z7?3:X3H76*Z2VI!4=J;J[+=U05P>KZ.!Q
M,)Y4HM@V;6?AC.U>ULQ1-K^\**,AJTC=:<;5U'>8TQM9/FH,E&PL$<L?- ;
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M:WE7E0W>NL?LQXF2QK].]+K&.%!_;.W(SHU#NDS3UZ' ^R<_,S?J7R=POQM
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MC;][)4(WO#\F2K.,O,2_0+KL:KJNKR;!5&VA#%QAW?:8C("3UTY/P]YXK;^
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MJ_I.84=,H.^(GO_G*0WIM#,C1>RBQRSE]2A= ,%^^@\TP:J\Q:,<:=RX63)
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MBH$<F]K;B6T'EK.M:[IM:IOT!]GE8K%% 2OJG0J;/%QGK94IJ.UR)5((I<F
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M<=^U0VYH..;/72B6/;W/4%BZU=.R ,<)U;J,LXV[(@;:FW.YVH%0R3*U&YH
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M33]D>-%13@H8=W(IT[Y%!P"5Q<%_5PQ#?CY1@N)]<J%;W9=-YRY]QU6>JMU
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M^0/8W?%?MZJQ@H-)8U'^J*0:QG76O-NCNHZ.KEJW$'('%>27M59/BF^].(0
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ME&KOM#BE[<&L\IPJO"E>U'<&,W/LE;<4C:-M]\M+=7;5++U1=88&.07?2X?
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M=E%!0:J;$JJ ] Y;>L 0";T$E&J T(OTO94B'1**A+8E0*A! DGH*-*K$"!
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M^Z&6'_VU=/"O4?#SFZ!660EW=T;\8]2->,AS#?DTZN/E,K+P@%1'\U>0_(2
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MD$YC*K=L5%!2FU%)S4Y.R,AI#ER7(!N,<G:M4XFVKOU%R?S%/WO,WC\BQ5*
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M_GBT!,M$&M)DE!FZ EM;H^NH#;%]3X3IZ(2!U!*MV=9:ADCF]A$9P-:D!AI
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M:<5D(%"_(T>3B6RH37O]?I -@5M4O9WMR=E5,PUR5W*3+9SZKJ %!##'C,+
MC(._]/&(B63,.,K0 F:LP54@%M6&*L/FOH5::OF0_;G1,9@W[VPJR%!  PG]
MV/ZI+SXI'AB"F/Z88]O<\X6"&!:<I7DG.7!T@[E6U C,M85FK/IIHXW]=YXX
M7S\H5>%9_%#5O5J[\4Y:YJ#+6U7[<TG\^L.37<.7-B9Y/^=/?0@3MZO?TJ_#
MGSCF3^1_>-RUCWDCM>77A0!SO9K*TYG)9:>K \/9*\J9W4CZA?BUI4QC_IC:
MVDKD5=Y&_XW)6T5C'UM?5Q"YPQAY;M>%:O9ZZPL/UA8VV"A1W%[U)_)C"TOB
MHYS[>H0SG2C.CD[%S:KE++GALM:.QM2UJ?!D$+OT<8ON+DN8VL55B8F*4F#'
MT84\"[ P?R_HO<6XS&@&,@%PA0:=&498IED^/(_?B#?.6^^KU]//,!(B=!+J
M<S;T(!!,5A6VUW'(NY!VKZ2GZH-:V;=WG6H1L<4B00_K:9J;>0+/>/,GED72
MC,]G6W^V3 [HRO7MHLBWR&>E(,/>GXZ3PA(%T6FNY5(!,O@Q_)UT_XQ8:?[8
MZ&6Y9SDHE"A'=^'ZA$U%V-O6N.GHKY3XI .40\X7*29*MQ$!ST0WT>VZHJ,0
MX)$=)O6]NZ$!4]Q@<4X@VY:"\?CA2G.047['0BC2"[/+8<NBXRR%C,^3B6#^
MC1_IG;9VQ,<&$&H9'ZV%4=&ZE@(9*\P>RE+%@WS/L@"K_)_2OL"%QD$(&^M*
M'B%I;ZV\.\G&B[N/@O>J*UUE+6T*SYD0P6?!K_K#=88;7[:9.2TLF=IP(WRQ
MWD;!5+1/G$&582MWC(7:BL)_E$)D5A238WW+YC>U4&EPY/KKY^\WY88[G6VQ
M[9Z 6K3^W<5XG]D%@S+YVP9\OAB$/@1!;/*\)BX*K3[;D,(M"V(;\.E^S.?=
M&J(80Q2=,/LVS-K1$3R096'NAV%UF73#JI8&Z(2H,6J1A@4H+:?.T_B,FDTR
M7END1#"Z]L__#2,&,J_G+Y[064]<QN;('0\3?=6/'S5&./BT=@M8A_]TR9 ?
MSGS)($J(./K"&=6>5OHOG_'+-ONS]Q"'_AB>8\2"VNA['%IID<D!^+*]H?W=
M]H^@[?O>@("P( $ +1W=;EH.CR-7 $!D"06K-/ZA3WY4R^O)!#7MX\POHBR^
MY2*EI6U>'E*1/U0*FO^'4AF!%:-@,C3QMOVX+*OB2X:7F_T<SQN1[@F> EU/
MCLH^8NS=$PXG#6W&!5\-A:O&6^APV+U;AKH%#Q)PLO@S.DTK=1KNPU^,L[;5
MDJ<3PE73ZRH>BY;AED61705*&G91<=Z!,Z)EPR(5!%.CFP]2ADN>;AZ<9$PB
M%U6V I>YLN,-4O9NMTJP7C'9W(O>J+>9.:A<Z-$9(WXSC<J:$97:E109F,9Y
M%\5'A/FT\D!^<D$%_-,E'(R[-[OL0@]46_/:C!\\?[#M-17_\/O]$-FB(G:I
MH!+D>*'Y9R-:V_(U>2Y]1Z;&5[J!)553MVFAATVAR9BA!XZ=,T?B:H/;F<F.
MY_V.2T@*S'\M]T@"*0T$F9L4Q0N%$"R_'U6>BH6_'=]'QM) *TU X\Z=HNWO
M%I:FXV5]B+?>,WM\'I4.#JTC+P(U&"GH6Q,3)6685 ]9PE'5E+6!?(=DLHLH
MTQ?JAS+9#1'OCCEK==G' ^E<KOQRJ))BI-/;IT+Y4L;M>!XXPN^7_GR#$.+;
M4([.H#FY,VW.2X:4+;/R)\7H!V_C;]A0L>TYA7N58]8^R/@BA<6&1:> WK"_
MCZ]NJ#O0D^DI*]PRNW/S/J$O.P)07-:)'L89B]G.&MC3,J11W!<,T#CI6R&.
MTR6M,E>.]-#(4_62H>:*_!F*=,D 97NW>?/0Y))A;"/HDB$C*&+;XZO?V*G;
M)<.&T<<(NOKG2X:PHY%4QOZD_']*DY]?S=D=[&J?)?R(9W*B#9^-\7D\\110
M=\G0PJ9-7&D]=HBZ9.!_777)@#A5O!DK#/EWB/ (M/J63J\QGS\VT4D_BOWZ
MPD6QOXM1&JO7YX.RZM$UZ]L=I8HTLI0(_$Y 6&4K M/V5+F7:%V!,^)S@?VY
M(UWGGFR]<:RF1;*&!O48S(#[:?$LZC#$.R+[ \4\N<[V3F*3+][[ED7K.-'8
M=K%NXI0CP\-95?K008A8:>$7\GI7WU!\&>D>;%W>VW4+\9\@_"<E:A@2]4VX
MU^)+]:K$H];8*[5%/%DB(M;7?5@9&R"S+XL^U/8%Z[Y"X'%NYK]F,M.8T)S)
M, J1S<C9?SW=SI=D6O$-D38RME%F (4$B_F#BS/FXD\R!18?K"YZ;[98[O6:
M=,@4C\DKZC<XR3^L750$$W$^,7YI(2Y<_$4$J&"\X^OHQN+2OL>SA%;?YI<O
MA8_,3DN#O8L6XSP5BH1'M58)48^ *":;(L%>_<(9*4E<S?=61KR9:&;?_=IA
M_HP&"9V#+;=OE/5ST,!"2,!&[>ZTS>UM@:"06E$/BN-T=D[ARN(TO5?V*,0;
M.5S7H<K2(/SB_W?K\!^N6&88O30QQCV.\Y6EI7\O)4/]M71J>.EL3H\Z_5=-
MVR!IJ5E9.YJ;R<D!IL-=7?&YI&#^%O7#4+L"J)UF5-V6@K+.[<:,97?AS\6,
MQCEY<<(1VH0#(/]TME$<O!#FXN_! :_*:GQM"(P"VZQG=W[+CLY\^20=T0L9
MG<QDYO;FQQIWP?E_M)%::F[W:*)L<B>L_+Y3NOTY'PU,-ZW:@5"/FNVZM#^T
M /=8[.3FQFVE<;GH!]3$VWYI81P$*[4,4"%='2$B":JKUV=A^KE6'5ZW*,XS
MGD'(A<&\,=:0E$4/'JU"L9M 1$JMT+ON[A,^;L #_D7^'*MAS*[J!LX?9&WL
MC1.3(0T7-Q2CUE%AQK8QXR:ES(4]V9*K_'T9IR-%>D'.Q$*]E(7<L%4SK F1
MR]^YB(V>]7X7ZE56-V9EA!7FSRPP*##8TJ,[+LUEI3K;FBP[F]:DK0JK.@D#
MZ_4AGF,$BN?"9-?_:VG=K<%\^]6TJZR;;.&:U^M 2$F^@G'KE$5<V@&@^*7:
M1O7=*:,U(+^7-O7XEH?. -Y)47F7FK9$\\0+RQ_6\Q=5;2&:B3G[8@6R7SRG
M]\L+2DK:N ^6;>R;><NRTV$2;S:'^=X=>F;IY97+^S2]^\Y25+$BL/*9..+!
MU .#P[N?XB:+G+72_ H1H??N!=]YO1GBZ'K(HJHV-#G)TAIH.G:^C6TV5&UJ
M39]Y?W1]ZP>!)8Z=K9^:9#2L%XQFN@[7HKF8P%JU:\^4AGHJD=CK[V$Y00_X
M=+0/&P--%B.3:O,UY6YHCG#PH],$2W+X^;L16D @"[/?@K+MP@Q>P@%P9M]B
M=G'L9Q="TKF0*!><UARPJ4G0>!B$L(XF_U80-1*^9%9*Y:A-&X\W?2"KT*%Z
MWP\H?NH0!,?5E!39V1)VCF]XCZG,**_[&'^OB"]06JGK,P1<.Q?1!SIK:>EH
MD\E=E-=FE!CU0.&F6.HP$';_8G9TMC65T++I1P+TJNSW!O:JWZQI4W82!_6:
M#K6,M]P[XG2@D,N]$ASI8I M2/D(OU[&/LY)[2#KSN/I8*T8L_W!NBI3,;(-
M)&-A-"(V*^O]>XV[6)$'10\!!<!7F4MZA9XM9^5%J4C%R53YBB*!96'Y]>F\
M2N(AP06U[[+"WC;#<ER9[*155$H_@9++5L2>5:9A371F7XP3>D)3BX#25/[R
MTBN%>=+^DQ\#XYJ;ZEIH5(4U#'?#6C88?0 K;@W4,5"(4%I2X9-<=A\7?(;?
M+AZD&CMLPA0UI.*WDAHZC=*<RH!$+OOM:.P^-+OO]?V0G_-^XY"0@E?QV?MP
MO/-)H20)]R3J"_4_=6I["N#7MQ.1$H^(;IFI,]3A8NKYE%,%O'#Q'$('^PVW
MK+2H\I%*<4W20R$>)_FVY.[J#<JJ@E_KK&U7,*CE@G;'50+$._W]!!7O!C5
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ML.T?XB?BXK9S$,2]D=]>K]\*YDZ/2!$GBW(GFO?9%&&Z5F 1ND3Z%<JY_'P
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M<W$R85*]A=5!X9)A*]-<+&+;[Y2#7^$"MF,&%5G;Z[<)H!FR/>1H<@>IVVW
M6\4Q++6PT^;9THY7^ &>97IO#WD".ZV4?O3^U2S_LT%J]6$^7$*FYU!@F7&8
M7#E'9NI!^^5"KNL U9"+',Z,M&<F6 KQ-Y8#JM9WV-J<*22GEEK< ,/F!B.F
M#8T7!]IZ2'_U'C=M18;4UGBC'P"%==3%LI*YBR^<Q =I\@\$"DYML^Y;[+I\
MC#4-8GG@>V^P0&OJ\=&-IC=N&HDWW69'[0;BP'*%YWJR- Q"FI=/_#628&J
MH^-<JR.N](IC[3()_AW4(^J'O"XTAUQZ*M%ED^TUCFP@211KY6TV'J[R2<CF
MF<ZO"&G,!)F;N&)Z8<^ >WR>15%'-QIE:PO"PD3T#0.4X%\G#ND](L8 -?R(
M1D)\*>>CWX9^WO_V,4TA?'J9U,HN)['N?L[O?WKJB#]]I%FI7LH9YZ.RW8LV
MV#J4#ZDN/("%O&]PL"YND'\44'K8S%(]O(;_^F?DQ\(_&?[7+4-&-L<*NEPL
M[L).NH%QVRA7C(-=68QBN6('%GE*F&1C'P?)A++^J#G^7/:S1'80'[O6'KE3
M]GCQ!^,F Q)KN(&=XL7$VB!DK,=D8H6*+0@_XV!@/FGKSYP1OW!J_Z/\T WT
MEWKE4;FV(A8#&)D"EZ8M.2G4#0*Q&=_ER5P>A+ZREX8XY[>0NV@P9^JCO_OM
MES0EV)O*2*84&V<\;00HBTVL] L+;NW]XR@1=YX9T#N)RP&DQR*=I+W@';VE
MO4S><.TZ(@O)&PR2!1XH51])?OH77_G;6:!^#\9$Q?/GW<%,9Q/)Y'DBX33$
M:YE-CB-Y*: >^B L1V8^\R $;/%M9S?V*HSRU]T5BXD^2_9I?QT])U2&"HI-
MQ+*1L._!J-FPILG,5(;%U8TI:I^.#;$*'+ENCO<<FMNP:C\8A\QLJ&BFXO6Q
MZFVO&05YICZ\_0L9?M3B[/3-P0F:G6R*K[B5$[;XBE+>GMD\F6C0*BIRXJ8L
MAGQ>AHK%^9Q.XTZ*L:6EWM&["H;V)A/1RK9E4\\,<;?QE0EQ%K?4!<+>SJUN
MUDY*M(J;U'OVI"Q,!SECM6-PFQ.-X7P9LAESCV-#:AIZ @TG]>_%Y:",XDYX
MKG4^2>!YV"DB"63'+S$:-^V%;<EZ'+_/]@]QDKB1P&F5:W%L0@X;[^.NZPV@
M2&QDX\1P?5L-&V*$GDEWRFARM,W;?_KORO#.D()LF YK_-<Y!\5&@O_K,575
M:C/C14.35I';[J^EQJY+2;UV.Y2H1,OP@/B*KHXXK2DI[<E_[]F/^'U/YZ2W
M#DOK=)OT)>8T-=FU+V])]D:9+UGZZZ_:4MS#UG2 AMZ$X %%87]UW7#!\X^7
M#(:A=NTYOE&^MJK]8DO*GH\^?QZP>*]LLE/1^(BI*21/B1A88!>#>XZ,%'RF
M_!)PE3O7!?ZH$1\PCF^J^B2I;!/@! J%9=RQ>+Z(OX9D.Q'X I);%L/'5PDS
M9@JD%PGSTOB67+='5TGJ.2K,U? 08OK1&=>BYU ?#L6C$S"?L8%[<-0+27(6
M5WF1$RS\M!=T !,O7@GC.G\1IG"NOP====A)?CA-X"*[?RX[RY8*V*RZ(3?F
MA*W3D/XTT)LS[;*O,/FP0[R4^#5&97S2 N2L"*_ /!],S5FRN%#T!87/0 T^
M_CY>_?X(&D<K)U'J$M8I!1E:T>C*&GED;YT5/4#PT.W8I2=D[LFG?5MRP\+8
MXFUTP+2D]!,G9#K'5G?>\"3'R_@;@%A'DQIOZUQBF]L4TLBC890&/FP,^^/U
MVV0OU2'J:M"DK\0^]WGUIN4$1YK7#B8Y.=;V=$[)O3]/R[<L!TUT!D 5QLUF
M=@QAUF[1I;HA72O_33<+M/+<)AQ&3JU :FN27]++[\$\ZC(Y$;,<95X51LPY
M,H01:^@;6.R^^[N>&E]T*515EVV!O<\^<834\#VGW#;_3HC(1DB8W<K1X<8N
M"<K2P'*4R^6U)SOQ0*#LTQ3!G9\"&GCA3@EGJEXK0.*-MA2*"CD;_3-R!^\S
MV7_X=R0U4RR6BI8A-W3):SKV9>G\9KBT@G"32>^4Y W_+93.1*!LRJKMWT,"
M"'VE8H0]B+X4+_M85O3A#$79S=,T.5.6]1Q0)C_><O00^I"X/FW]:O,T<?OK
M\C1KTOZU#HV0C!Y-G*C=\B[ @X+D1UF)^CRI)$A:E71V=\BE3MU)3?WWY'FG
M-B"L/9KOR-*A9?_94:$$GBMO?21I8\L+2Q&C^11YA?(G=%4L3UY5Y1B6+UB?
MS?^U9>XC?=B\-51H*U)Y!3TC6.A03K)4CS0OC_AM=.)J<G"!LW!J5W-\KMM9
M-C?.7L:-WCTN5H=MFX&\#XO)]2[8[@IB! C8T#X8R!0.%?:6+YW.*&=(=35R
M\.:\!ULH5JI1!?)MRW5)PT5DD/_T(R8OS@O1!K#OYQG"]\TRNHE'U.VA3?]!
MZ7B2*8 _FRJD>+ U7)EQC>?CG__3Z>._QMAW]LN%4]I#K>\GVD^QY<2L3(PS
M"WF3GW_95/BR$01U38J>A;=<B[WA2WXKI=^-.;O)*.=$R5*0VX@SRJCD7RYS
M \>[[5%/K&3[U@6#&UF=ODP*-4@FF2+2\8<880ULU_5 F6FF_&*48C,$KJ,W
M_JTV4>/?O\SM\F/YE-/SP, _%F/(FJ'4CSUU1;OL(;#W1$12Y(>T,LU>,&=6
MR8C+$'?4<]\<3Y?7YA(&KO'G$QN/MIC.#SRZ2!?4X]D[C]G4\^](=0.PK?RC
M<#"()7;0U\J57DS;*&BT9[?]X[_++5Z.IN,&2\OF3Q'.V)JC>WS-O<=2&VJ+
MKLLV;)GJ[W[YC4"BM^SJ--JP<J!JO,D-<Q5)^,!\->CK$[!^CA%]SS'BV%DQ
M;4LY6FDD?NL-"9SA V4M6#N_)>#)MAB2T$B\W7KE1%'1S>D!Z$C=,G0XS*Z#
MCGM,V&4%6@&@#P_*R,"H6E+ZH2_?!WQY><QH+Y>!I]);=<,6XS7;'!_=#$SZ
M]D%+%J,!U"_-02Q\JWI,HGN8<6#G*,G7H?!PPEQM'(GM<W.S2TJMUL:O-Z(!
MA\4-]Z*ZWKQ6R=M(FS1[:C./U.J3*.8LJ3Q A91[C??T>!N(O^:UTDOH.U90
M*5+9#HB.6Z?FA*ORYV^7PBX9WFA)M^0I>&CXM'4/=547%6QCO:#!1#;S69K5
MCXO\><GSZ 2Q,\:>+$BF0;;I,XU\*7A6^@A?W73X@[:9E-@;FDFH=RUI!.WU
M\):\>JO0O^X\2W!N".X,IITEB6J?5KQ;#9.;RLZ@-&ICQ%,)T;5)^5V)N*U@
M*@DGJKM!THT9?9U%W%5!9%#IO=FO:,9QDT(5...MH_+[D&^ %9-^#W2X]:OE
M:Y99J6P^MM&A"2U.M:LO*''I8X/= 6?#M@BJ&+O/@16]J@8MV2CQMC[ST9)"
M2&W16Z2A[/I2.0YV9'*Z#C'3:!U$)95)A3$;&J"]$K'O* >Q5A5>'..Q!!-Z
M3S1Z$&+]E"T+]7LWHJ5FD0KFTC__U5X3+#CA&:PI<'T#TU_T:!OH=WK.VEXI
M'0I:>G;MR YO!YB:6UN&#FD?F2HVAW=?^!X+Z!(>;CV%&"A;B:+:7J5@&-MP
M[KQP<:&4J0P?"\^_<R#O$"['6?1;18IU0>SAW.L59!+!*!-3A7;457XY)U<[
MNQJ5F52 #-^4,R_PU)H+-4.UQ-N9^7U!V/\(:<J=M_CP/G/*A%^+W>L>?KUS
MU]<PV^&T/]83L)$TXKE$6[-I6X]MZ]^E6]Z>]<V'?N=<DLG@5DO_TPO/V:\S
MVPSS%ZQ_EA^@SG3@X_X'P4*F%<%B#G0Q-74I!/D;]EU,YHO_.SBX(>'FM5+^
MNJF&SJ,[]YA9*%Z9X<.Z28N2$SU_<QCAKA@<?\]OT*Q>0M$11#O_11E6L-41
M<YM*ZM;9RTTV)D]ISWS[L>(9Z3'RT5FE_B/[! <R-KY ?8ICX=U.\A/SP8"I
M-#DUD&8#M-I5<A!-:"H\=ZBL]EN2+_/!4?SC-K?RL!V#K_YK9^BNP"HO&7 "
MOUTRV+XGGIV]D<PFG][)O(@FGK;'>C)<,L1D"Q[:W3DWLIA\-,FL>LE0]0QS
M$6YX._,\IOV20=/T?($O_Y+AR\#VJ4361<G'MLYGL?^J%=;RGWMYT=H35FZA
MXAL<0S2S)UNF@B^7$J>7[WNJ;$$Z9?VV6C[BN]^WRUZ V=7LN-OX4JF#GYE>
M-CSK511-<C'SF)!3,[XA7X'"3DEOFSX./A5!Z6,<U>\]'-_J+FUPLAG%'DZ[
M<*^?WA\8F%=)9E=C:_79O1C.).XG21-5>K:R],_Z@X KNLP\FQDSZ9Q<->+W
M!LM%LDS?[#G 6<IPMEHE'@E*&\D*BT,*1%M_-W\RU"K'F\QI5.JA@&<K=;-*
MZ/^'=10]+"EZ6%B0$2OQ5S'!THF@3W%<=L^&$RCP9FLX#=Y2V5*9_Q][4G^1
M_')XQ:5JJ3\KVE'NX4'V%8Y$V74:(:K[)4:YLG;5FWAM).8.XN)5E4K,0@3G
MB<.=1YY[<L.QC?/VUJ+"4>L@<T5= B39'3W6A3Z--^X(]]P;BI2_U4QN/]T*
MZ*A;-6:OJF$W2JC$,FTG &;8_" G&2A_-;8 SPP7PC,;9_D:W$V%KU:5]HXT
M'D_9G[*8G&0?"$QQB(_P/_-WH@Z)2O;N7C(D*CR*.W1[?90LUP3%.#6*6#(7
M1XX"0N>AD.I21;55J&P'[>"-0KC1WB4#4F6LE=0;6MZTXID3\XCQ8?H<4JBW
MVZ&MSR-*N%,2FDHX+<Y ;3@VO"_)2:_[IP- E(/9U/?VAWV!TS6^Q3*<[TFW
M#UKJ72M&CN7D78DF!M8EP:KGG)TLADQF;HYCGXN $#2G 8'#_Y@*$SEZ?#".
M@LUDA:62YM%8+P2I.!EL,E(7.KW9F@YOS%G>,LYL?SW]06U94-[P"]'>9LX<
M(+2T.&>3=H!,XVSHZ#2\Q^23]^]B?B(Y)AM&6=/]L"=;MY_RTM%\JL#ME;>A
M5L87R%XHAC'S2_3(A@=O1Z82ZVUD2<VZ>UH!0@^DN:0:]7+F;/T+4,<7VU1R
M7HHW-9=(]N.(%"3KFB5K3Y;/7C(4@04GFU]>,L"@Y[T!QH9FAGWV8 M#D:"@
M]](;Z+)CC;.$,+XYSI;UT4+<?0=X^ZVI_P28VZ*2C7WOAD#8RG2!6Y;//_3E
M1&=X\ZJKCCB+.*IHP=PS%MXE7#+\NF>SV^/;T:K,S.Y:CGE($>K55Z*YBIH7
M'!]<,M1\>$^IN]AM6!R2_H6;\J0<U[!J'_\]LC+3_7[1&A[N>L%>Z3?FIK9Q
MR<!= PL)8.%PGOQ#20/;[2Y6(#S6+G2E"/CGDB)C%TRK/KG#BGD\LB06 Q(V
M^AM1TKG:ZP6H;FKR1 4&FC\TT"*15K: +:GQ8'3PD;8K?LPZU+A=):[J]R_.
M,U;ECWXS13K1Y!:% N4A99"$<+?'D7\WHED?>4P"Q < ]3KL @^=WD@;29'@
M3,E?1T%_I^@XVN9DW<4,D-7^_I\DM?\".ZM\!1>QCM>_BU@VL(H5!D;<2$/S
M\C)$0 HKA:WNI_,  0"@U#_.6Q"&F-C\X[R%6S^=,VB=NGC:T]'<F2[>LGA+
MX?1B;%$1H*?&J52]3(-M'2P,$$HXD<D$EZ(@^A ?96=R9J-CA;O%^H74Q2US
MBN#.Q3)=S))].;3&>9YB<@1=Z'C(/_I[[9%8?MN#+MO*@[$+=_,!@8)LF>$:
M.3/-VCV7/9LH$,^8G-'\ER0=HWDMC31X;5Y$09.CT[1O)&U'2RL-< U$KME\
M2)$3G*^F(3TM@?1>*]AI_'>[.W@"Y6N+YT"@K7]3.'XZ33229]+T.9G00(.+
MV5F"B!4K!S[A<9)&"0Z?TWD^_5LG_11TQM+-*."+7(SS&I"_#Q]P2N?HU3<U
MVVO^4EF8_'%J'&(-$+HHNG?OWB/.])"AW=/JZKV1L\G>VP<73&-AY\JV^8Q5
MFW)VU%;?[]-'JBC014;<5MQ&P6'QO$#F2F78FN#:;"H-2*VMMN!P_A_K/D[A
M!_@1>I+--4BB#M*\+N[+C Z"%UA>-U4OD^IE]XFA#4X3KVV!I'N_70RX0AS4
M;^YPN+$>V@/<RF+22]1*SV+=N;=C^S;3<#X_^<*E8<*/M)R3":Y!'SR9G Y,
MWH(W]UV]PU,?J!Z ^CYN!:L:8"7KC+<T2(D1=D7UIC+5,VS_7(#LRI51V+Q2
M#%6[-EA& SDT"Z<04&'U'_%PCU5 JG8OEYX_T(V$JBOJV.:/"5PRB.=:WAW8
M94VJ:: 03*_[#Y.574F-6UAO,/@-K&C'2K["SOL;]C?^C(;0?-X*+Y0^N].0
MBXB\5X8S)L^X0EPCX2M6"5*8.6(74YIGEA?8^'\P]QYN36[;^BAK+<NR+U%
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MB![GH]65ND<6D .3HY%$UW\\FO32%#9^'5G^6P#))Z]QF"Y]P:"WUW7PH'"
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MI[-L<PGII9&VJD=\LL=8J$><<<6!.7*)PV>)F390[MQ *S6(5:)& L3QS'D
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M7=80B1X4=;D- V,+M:DBQZ @F<1O9,<D_7=)O(ZG8Q!237I]CA#7;:,9VG'
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M36L0 WG3*9&E8NAROVJK@E^OO0'^G4<^7P]_TH.[DB<H\:S^;!+P8RSH=M"
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MQYR[]GG[ [/2KB_;V83@F5Y/Y5(3N3%.IVR2ZC)IO;B"QAOCCFZ0#ICNE!1
MB% 6N '6SK?C_O9?6?[O01[+$,B\MJAEJ/,3@YTP*>,/&CVOQP,.^/$G+-]+
MRQVL!@YP=9W\P<WHDWK(?LIJFK%7\7<'T"T%E0N&F+6FO-O*@2<ZK1$WH)$J
M^\^!Q3W"-+//DOV9*3$K1', &'RO*_#5TCGG3,7\M.+@F7GS3(28"6G-VL9+
M3UD$H[O64[@ZCC$P;$RZ3W2.!$DG^(3]\I>5;^,M?-W^#8/])\^9*C7,+VNU
M5-?L_\&.Q.OB6W%I;^Q%0QOR5GV66&B'L9YDS*S3(1,BPUVEB<V:_#M-^&U+
MO\V"X$EYM7*OC_W#);-$F51465PGBN,D"TLFF5LLQ/ MT$>NK\:I-SR[:XD<
MHC>K57H5,LF8T]G@:<RLUM(M'LD<3HE"72;5OFB0'3&W2UO00TO)7:$FP_F9
M=<,J-3,,YO[=678R\6?45:F)?PUVG!9-QMU+,OM49.N@+?GJ0&GIRK"OZCC%
M+\'7(=%$A]OG7NIA30*QSUL"XNV?D+X6ZM7+SB( [9K O:+%0N7;[B5QE'H^
M$QET=GN7$+)8,+)BR5U[$'NX%R9:N/G1VUR\+K<"P>K0M;Z*"(W,JV.2?(DC
MB*U+\,FUWTR P?5OI?@8(X0!E:6S7Y!9<5%SO7>L\+&J3Y:F^ H4Z\'J=:C,
M L%<<^:&GUJP5%KUY?92O'][DT&K#[=;#8JRM6PX.N4^<IVVCAJ^3QV#2*&2
M,I*2'=R&588=I(9?^Z3DR]+NU)+75"=)/JD?4ME\BAC?(HM,381OR\W=M\E/
M8V7EOB*3$)F 3- 6?SMRF#SE:0*-QY0HD)G3X;4C.H8CY@8Z:$>TK>[X^<U#
M;+',(5D-YLCR>&V</04<9V^0Y132!O;L;^H[!.-S^KB[IDM]L'V1/',BH@%"
MLG*)B"L?+<:H ]Q5ZV"O220G>XA9;9)SJTZ&(=&Z[ELG[:A"I;0PXFUMJT_1
MF&"6?T1'T;=ZS"&62\:J'%3JZKDDMPHG N(Y7LR+&D2.CSE@8 000AM&E@(
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MHAX$BFIB*?!H?U<@%>F<>3( !IBY*$?[3.G2]K@_5_@1ZH'-!DYEGFJ&!E5
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M%00*&8K"HPH:4>NR9A] ,8+U%+M1I5-%RZ@!!%7/>VS!U/WN3K:ALF"-I<B
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MK][J_8W*Y7U76E/:K4*A\F(HSC&1JNHEFFWW(9]Y!!2^;CBX6QNHKP<"Q2_
M[?YAUY#[YZ7U#[5<86\>J^:W\$^JO><AYTXW)9\23*NS#&*W+T*U=ZJ?UK=%
ML3PD[D/&B#84YU^E/:X96#%&31,SMF\3^CK$9[6I&U%\(0,K<@6Y*)#9 '@W
M)M+*.BM.?O0+$EW:WQ^7>+,C1"3$ZW1A*/<5^6%20 +9<M_!*S4(BWM*- 4F
MM,J*8>YRK<D5P.7/6A29)SPLA@O/YBXSKQD,-?YV9KG<8?9=SL-N5#)?U3Y_
M*.L4<G//W^V>>)$CL%G+R&P97!S[+'X6;=_X<D=N(6;V@P+QQ,(RZ,[I8-"
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M_58SR_141C=/:;N*NOPK8T/0QC&?=,MI[I J\2Y;P$I6FC2KK.FK5N]AK!A
MKK! =1F-1",#804P".?3S. 2H4YXJD>].!GK4&542VQOCT"Y*14>E/69R+P@
MP%V-\S)>QO=#=W\\17"F"LJ;"S6Z_Q[O>X$3+'LXIRS\9$$\ CP5ZN[X"MYK
M%X(MQ3:ZBQ$ 0B1=$N1!N->0R/^+I#>GWIQ:YKO5G:G"R%E]&;MM[AGRVXJ0
M:,4 T=9R7/,ABM%8GCY@G?Y*B! UG^A!>/ON;9?PPV848(S5T]9<U[QY&N,
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M,UA<H_=X'4G,MKX:X_UUE^,]:%^1NZN$+<429WZ_:V RO[ZL_T.Y@M5C^L/
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M/.O W_5-&[R4$%ZPOLH[.^L<EQY71+KNA?T3R[WDUS5,_8T=/N,"F^.*%^1
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MH)E=*]OC +92>ZH09_"*<XMF\Q33]?F%[[G=)=-OETS1";5Y]2>*ZU [_#C
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M[ V!CI=,6CC5>MZ,VU(8ZJ$*P^,7W\2OHCO]A)Z*E]O^+YLT[06WW="4D;U
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MN3=Y<O_&YWEH^WXM\F[_0^BVXW*?#VQ1R9VPN(G9) 28EAJ/XF"3SN4/QS3
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M\=@T22CU49]Z^M.BK6&Q$=G^QTXV![#'^?[\3&9 0WK/[T__*!E5VU!4Z>!
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M5/.P+[TXI0*19,[<1S=0@,W-MGD:U<-2Q=N3PLE7,#^6D^)(=E J[W@]&3'
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MJI/D.?<7+)#N.#X"]@:,P  7G/T7*1=52]^T%C\IOS%56JV6*"^8^Q95AT+
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MS/BV;C;?)'H>[<:2R#?_?D!V3(<6W.BEK]NT8IZ>FHK&Y$_:L@%8-PP,DA^
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M K.Z_JWVP:R$(./NK9K\&:J3XS1#<7-K<[.,'%VL@$OZ_/GY!^&J?3%/K_R
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MSC4FC\9<(XIE]W5WC&U38N&7!2E[9$FJQ8J0F+:L1D3Q*H:U'S<BF?1Q@+?
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MIL/><V@ZQ2:R_F9%>5&X+6&_D"J_4;+-IC?'J5[<'4OJ>Z>[>NV>+KFB+9;
M.-\ZHVAN8G5WHY$PBJC\YI*'>O71.LL>3U79,.A/J\AAE6./XKY5*=A>'F^X
MX6WXZMA]BP<NGR=^N.RV?7.XH(?LZZ@TD8O.HE9*"WL3+;T2YBI.%Q!($%_8
M7<;_H^M5_D]QI'YB]"%4;TUP,FD,UC*7DL%;DNRE6">04HH7!N7EL_\E=[*@
MO5/_UBXDJ>LT'CEO<2.@D6&2Z-GH?TT5'M'(D690J.0W_AH293DEA'%RJO_I
M5)BYU1K''MRQTB^878ZBG&:MA\I.I/XH.">(!QYJO-(,,>R57V^..%3<HV6<
MF#FKS^J7BN;/LC^*&!=<= I%<8JZ/1[U&#6T?$V6_:</5ZM7O[]P!80#%F2]
M \]^R3, L[= FXY)^B43+SR/&;HS$Y9UD3_@1N>IW^?OS?+,3-F4!99/]MOF
MPIY%[OC9YCF<7&_^;)7W'3O? =UW<;"RM GP>X<4*E@I3_0']8\H">R%JO7&
M!5 ^_\OT_EX#/;4HC[W:%BO_,&+">#52A&P$YX$,+IOABV(%1LKFO\/>2"[M
MX,.ZUK[M(:<?]@42D-=]N]A^ MV-HKZS9]QR'#_][?N=K57;=[9%SL=TK![Z
M"PJ8Q %T=C&^"IWP&@9P<K>2Y"#I^2+FMB-$/$I'M<-]4K_'OUD>!7%O05.;
M_I/]4C<9TCROOY?V\)R74?X;!C'PH?:VGMO2A#501+)G'+8E<2/F0]]3.,(*
M8FA"+'<M_@='/##W1TJ?*O3S!YF6\SUM,Y1X!*":-<KJZ9)]K_F*N*/#M6V<
MOJ7J6D'"H'"L[I/>ID\^+67#/LX4ANY^UDPW)WN'"[K.^-"SE9)S\<RN]C/V
M"-EMD=:67/%8F/H!0,S*3\HI*[3A^'H^&\_KZ (J\[DI6Z%YU+V><BEECG"7
MUTQR]0BY$??RCSH@W@_)]M+I_)^F&341^9AOFK]@]S'ZV@D-CPMAPP^=""P"
MU:OZ#,UF9TB$+-'&[_;09\S0,.A3E%=W"8NI-6L*&C>??U4KG/]N,7,;/3^.
MAS_]/S)V!TT8MSP)F#?^69680%@8]X?HT"H+F<ZG']TJR_"U!BCPB:6;61=W
MIY-*3Y_65[QEU7&G-(JGRJN\(P3\&(@I*M@-U3 Y9]!(L'0[->8[[7GK:WA_
MG<TWTNU5(M938646/+*15+'CREJ?%J0SP6HN/'2KTBEC?KEWT& CB7(B9*HX
MG^MZIW<FT7J;#%VV*?H$XUAZU4-V\WA4) 'O5L(>LHL-),##BQI)[[TKX%N5
M:IN:J @[:1O&6H:.KPV'P=V6$=.AQWF9WLHOYVT%MF=.J%U"JM!F!5UGP>SB
MQ #>E+B%^>G-EP<FRUL0@FQNV:.")R;?__E8]XZY?&A1?SH;-]2_3Q:E!)PY
MLAY4C3U5>QS&YQ$]5OFM1XF-M=2A=2G=97U\^V!L^K&PW,F[ACR-U<MFM(E.
M+Q)%I3 ]&;%N9GYWY8@F_!!;K75K<(V\M+N.]&KQV+<?B>G[M+EHG>/J\\-\
M-L7T+KP+CQF?^/ 34=UVNT#/7#4Q@L+6>.W^\J;Y#[[:<BZPB<C+!,S[!PYR
M]"4@S+>I6I+35$I]='$! "GHI G:.U7D( %U_?Q2O<"KI#U/VCO<6DD3P<3$
M/0XD  <!"D 2L8 1P A_YACXP32[/6;*N0C.Z58$P) >Z47G7WW(^!2!_*YI
M??MG6-Z?_RDM]RP^V4]IIOS>(<IDK^?LJ1L/*%+M7&^R$85.I&N_S=<Z_J?R
M3)L!OAKAC_P^&HC6>@^Q^+Y=,6*VI,3'I%>MSPJ^9O_.2C:CAI8^;3*:[%2"
MB"Z[K V77G+PLCA4&B%O2=2V=C!MF '5SY=7]_9"5T\:B%CYW+*Z*ZV^MG*]
M332R3OB7+CR5[5M9KMA:?#&!2^5YQ1A&A*LF<+]H#>$HK-@GY='RU6? ZE)^
M>;?4->75:R)/Q,PFS(E:[C)W[O<\XG11 4&!*V[U\G"!\[^!^/Z.PT5GIZ4%
M0TD)OSH1O)(N!-H'\38C15;5Y=1#.6V_-%#7LP35%+.T 5+EF>YQ;P/-_U9X
M]=$=D/;?M[9*^_Z4OO];1ZJ5C13(NNEVL?AE[31\7.<J"/G=S;C4* 6Y0W>O
M@^_?(7'U?>O5]_'?WK__[>P7W5>X]9^DWDY?TH*)URLBG\:*88YOKX) >K%Z
M91#(/*203WJ/3X;.D;GI\ITDEE=/'1"R75#R21Y)E*]#:6E3C="G2,-X*RZK
MEYN+:,SQA&W7UH9%,3FG!U6Q!637VSD06MG("4&S=3050^QQ!1LGYTQ>1"[!
MI[K-KCO/R3R@[<C]?*=JXKCNM_$ ":KE#@>Z&YA7D^.^J[QTNX\[SQ&X B]2
M=N,SCK?:K$@*63&DEWS$QQ/1XT]6\,SKVC W.,V=[,%YFY.8$>8+H*A?<=GC
M&\G?_=* < R+?4Z%GABV.K<1'CR-KUUI_M6H3T!2H8WH^"=5OVK6_21ZOG\^
M5_\=ZHQ%? (6TI3S&):8(J6UGF_][KZ1[84K3RYU;&SVSKEPYD&=36O9)*KY
MIRRZ""8QW&Y[2J;.J1;]E=)!*MN.5?1_K3GEDN(]X9I/C%!ON&)\PU6"-N0:
MO]LBO%'7WH->3*0F&D%^C$9EY^**]O8L\])GI;P/LROZPPOAM'V5H/7SQTT+
MQD+">!RT'Q=P.H*8'ZWJDL#K<@!(0ESL;#=6K/\?*UED!@WY-EHL1\;VNRXK
MF:<]>XR76I4=)^LB;S).XY)W)-I0<W?:#!Z M^&GM_*,KBV34?PQ6RO>SPB/
MUAP]>4F"HT<DRU7<KOREE;S.+-><\$)S.DJ=]^?.NNM\!U"IZ*4<*; .)DH"
M3JS8DUT^I^V/G8\<7] =%_1>T,T[)%S0%;%NG1.I4<$9D\3S2NXK%W0<"E&[
M;1IG(__A6_L+NB?BU+/J[O--J0NZBBNO+NBZ$V?/)&$7= %D%]$%FXG'<]'5
MPK8](M19G=&0]'$QBS((X6G%#8?7VW-QA1]J#][>-$X#/B+V6 !<G%<U)575
MC5/2/N=)ICVU$/5NY"<1]@_,Z?$Z=C8\7HG'>\J+LRU*&"@/).U0NH6TW&"8
M:D^+BO-]W4C"M\4Y>SL<J<Q7024'H>)/9C\;/MBV>U!SXX). /]@557I5$6@
MLC"1(RG\B*;O'N& JCH@J@&MO.3K=U.$OO4ZM$"'_(Z&;AK8VK",B(@G,+Z!
MRE+1U1#7/=?=E=HSY6VN0N>I8+&J[JJ>:_V+HG/6]^Z)[X\[5/P8LPG=&V]W
MZ)-[0"<_N&6TZ(A[XQ'94]LOHWVI?EDK_BG$.@1L[&I0=4<T]?;[<9+XPM=Y
M_B;MMQR+,NQ 64:*G%&;QUS\RVDV@<_OFM.9[; EF<,\$^!3J^(U +&(*W-M
M>V6R??UX9[U)01$9&R*HG6V<;,,2.[- X,P:9>GF"DCP3S49-MEKNTM!TT\N
MKH)%=$?3\D$09CC$)!4  !GYI0&T\!SZL&_=A5QS//_%\S;^KR!\QKGL1C/7
M+E-"&RFA9;H]CFI0]&V>Y;2+5UN;;EPR?9SYP[GSM4;VSY9=(A73(;?(GZ,]
MS6?U<L&JTS<?/7OLCKQ=@'-)4RS>K<Z]VFHP-:?$9I?HN>UG,X&I1T/\$,R!
MX!^D4#W3'_4K^YG0Y=:ZZ]X4*9'I_0_V#H\8_7O+/_QJUAH;NCDZ[L3G1)))
MD-0L8V]-'"Y=Z'+[/^L!.Z8)Z\\S_.DD:"!^:D'.92[3I(V_%=BTG9#\]N-X
MM>?VH<1+F=,G_7!5EYVD6DQVG+I$AML1A!"EQ6?Q14'H[]<B^.Q&R[A#]D[Q
M^$>A+\:(M9"QN>IR#Y.#C<[>Y$YISF7,";@EZ>5R_CCCV#"H3'6W8I<]^:-!
M#ZST?V_=?\"-Q_+=_(NR<-[F"0A__M3M]"039U[QBN++KP&!3"UW_#3=^;_W
MYYGD(7;M]X"7JLJ0UFZV<5#WA\>^JZG2OR3J]XA;*8>_?)ZYGHGO7*YZX8R:
MUY<GI<<H8W7I0>KS#(+:NCH\"U'T//FW&-S#A/(=2F5FVQ?]1?@D:J:#\@OT
M+=Y;T?I#O)@BQ';;B@!> H,V(-WK8^,)O5@-[7K+W.D]@2_?M_\UE[B5VK0_
M>>@S#7!AN<-#H%_Q8A7;JTI^F8\!;N;^%BR2 W$(\?"O#ML"O64R>S()X1=T
M])MLL0H<P=Q_1%?X!GU#Z8^>W\A7*(@*J^J(.N@]73_S\;7>$-\#]G*;B"5Q
M+_P8ZLD>U9VN+FA0>JPS<1M?S1<]DXBSK9@WFG/*_/!/F\G)<X@=E=J_H$L=
MGV@,&/&24G.UX1?'N(0^"_J=EJ[W)K$G5&9 ';7 YY@$=D0UD(+HE<@ @#C6
MZ"@O>=AY7OIK=ZWITO*S<IA7N>WT455H2;T!\)$MKD)V3)L<'//C>M?NS@6=
MDGG;1A-A8>M<)5ZUGR5.NFIAV-)G?DZX'^=;:XROWF$62D#-5CI>5_/,OPJ]
M"JW_)>-TGT;S"B!XZ?E^/13% G4AUG?8\F^/76I_\P_GXO\OXO?2HR\UM\Q?
M5F&W,2Y*=L^?A1];6@QRT/<BC^ZPB#._PT_D.GMX37A8 YQ'JSMW?_H-76^H
M6OX )044H$RV\X$]-'3CQC/<B^,.QM/<8O$]]H'BS^%L?2%@,YR_\-0F.IXU
MLU,(&,G&ZH&5)?M)E!6-@:O4A>*EVI>75/_- KE7VWOG@HUV?9?ISVT1(I(*
M49_U-$9D+^C\!A?.<NWVDKO/O[I&O8R=#'?Q%/L=UB$N9!Z<;;^[[QOEQKV$
M&Q,LKL[C:6^4F;IQ,->?.? N;&3F<>PJ*)!7LV!76FIW2V(90ST\\4;Q\\5M
MV)[7I"7'6RZ0)\KJ)\I01S=Y)F9O+S:CQ@\$ATGRK3U"EX<)%(QI8F!:?Z/;
MYWA:]OWY7;AOJ'JB['&)G7Q0;DWRFKY4S2>%V8BOTOUBBX<G22UK<0+R8^""
M+CW?'M8"@:+W P.'O(X]+Z<!@+N+CDH*!;J3[K,'CB:5W[/GRQ>AS?)K' 59
MT'DG ;@EAE3];RM5N8X<ST6Y]:)J?KD<Y5^9X*B$.KU)::_)L%M@$N3^[8(N
M+Y+I@DX4$W70>6_B2L>M?;$9GK[+*F=>BB(\J-E]'I\+.LW.DR\M>?4GY]R^
M4>O:.L?YG.V<EP/_HN/!Y/@B.4.0K&.#XC?KU_2,O62I[@#>[HE4 .\+HSLI
MOY"\)5PFQ"XP/Y&H$;MIDV[J!"TWD.\JR83*CA%DB29CJYFK&6O7J=X#I>?:
M'F:?6OHZ1,,\?HOA8&CV4F/)8 ?K";N]QYH\<YJWAA0+XV7H2_ ESGL!Q1BR
M_2502^$70.=!3,I;=K48$0-3-4Y3_"I%PF[TN-.\,G]U@2H8&1V9%%D$W*F^
M9.5Z'].P4)7;9)[!Y<CN; 9/D)FS=%MQ'%522WE:S6_#;Q,T=LFE *W _-^0
M%/\P6:Z1.:K.D-ZO)"#SH.ZMM5CCC5440*(GV>#/5%;90N>>IV,]#,OX+OD"
MB,TC!A%^_N_;64&+:K@6F"-.27X\GQU5"!MFD]S NY6OYB9&C*B#NVJ.U TH
MQYVD1O?.OK0)(\6#1\OK4]?VU@K7L\>SG;)=N7_@Y496XSU7CS*W)RP79HVF
MI)2G'3RHVA]&T=;17GCC(.GG74GOA=_-U;H)W;7 N$OSZ8;(EI F%:8/0M-\
MRGL-FB16W([5-_+$G$C0/:(.T3!^+]1Q <:]Z-."=UIP<: 8:&M23,L J;1&
M^<K:XJL=#XZLPSZ>A-7K2A$Q#PY36%[^_Y/!#N4&\.UP]V].(4AN7PL((#\V
M3W**8N7RB2FGZT1T[5=AFN):O'KA(A DM"HGQ(5LZF12X+QI!%WH<].;XYY<
M(]+\H *X<-M66;_$K 2[EG4K]!$X)2$(MY)5#79V;?5V'"LW2O0USEXD[":8
M1+H*GSWP9+V@L[>3@5$'=90,9-=CB@VBIHD/$_I"K#-&C^\)KP?ZY*)O$;2.
ME:1WL!L?F@U$^_J]ZTS@EDJ@]M?@ZOY5''\/T[Q5CPPE?;A.F_O $8&2)P1V
M15WS2W :]7Y2Q4=*U3,T:YMJ8]Q@4"K'6EQ6"73031],<*<?&A8I,^+6<_F*
M0K*_&Z \ZAUU4P^%U\JF $3LACTHK"M6.&:*J9J*3:S$+K$RP'OLH-ZM9,\M
MXBB8,>]V7_4E?I4KDDH'%?8P)?"8HFRSYT:T+%2NX'01H-@GVJ!D?TE8\\__
MF=O9=Z7M8H76]LBB6@CJF[GR7&29"#220D]K>F=2+SO/J-47(B,YI_'58RA2
M8T[&J^N"[CK&Z&QI9"J/AYR^4V/OU7]!%SY/\/X2F,TOF DN&H/*9HWLCB?'
MW.[_ZU^.>I8Z7_MO'WFSX["YPUBXYQ"4Y]O)T)VFF-MYRV'9P@/Q(VKJ;[^<
MJ6]%79K0F__S!=1+M+A>O(OG.T)@O/IK_$\0^[F@&LQXO=3O6U&^41Z@$JL;
MIK=JGL\S:J.:D<)3_3,R^<J77]+XA:7)6X%#B(EVFD#_UJ_4Z>V]=<4-I$+#
M?!,$>CSVU+,GAKE+RSRZIPO+O;7K.[RC<3LR)FW55EGO.#M.J*4L/19\IUBB
M"*N7H%BT%T1Y>)R"+/.S+AJ O5&_$3[][9BK]^>_Y#6#97CQ2ZPQ5K:J9*3"
M3<I_4,?8-;D'06(HZT_P8G;NQQ7"BPK)S608#_;N^W%G0#U 0)/Z+JCG/?;M
MJ3_<'#--QK1V])K*53^Q$"+9Q'^O]\;8C<K/+A7J1C:UL#4>F7>Q6]<QBK0Y
M=OMZ#Y2X _O6W;^O]W6EZF'+S*] @>Z$;T8@4=?JM-]PKLO_M.59N^9))W:]
M S65>N;4)$OU5*@9TIAY0=7OM2A,NJ^8;,DD&<"H\K76_MWLAU7&0K>TW8KW
M1*'%9IX[7TZ]=KR]VC.L(SW$0A6*^,M/9#=2$YC&<'HF5I'W?\:DA,_UFO-\
M?V:[Z9)TFF55S<1ZTP@6<1#4#U9I,#7GE,PVR3$9QEB&UOU,[0SW_ZI_+4+/
M#-B[DU#^V-__7O:<U)69>PZRYJ::SHT"+0138W>+>A*LM7-8=8X]& PHL=[)
M=ME)G%!"/I[Z4B(A2R O%.19@-IBAZ 22_"5NSK57M7M=B6SJ$BU75JG^&30
MV@4=3Z\_VMS5!4<UQCTUD#.]*@1\S/V^SW9<R&D6ZSSAP1/8H?#\86+LOQSM
M_P4(F^-M:\.<#V/K[W 03+WMY5P_G8%MI\/#%<\/Y#'&+QZEK^C'W'GA]'[T
M"1S:5"C[<33H5GRP<]U.]G7G/Q1GW0LW;2_H?E %SKEJX=[$9P< 0DE#_!IG
MM,70>8Z2!(O2+6Y:._T&:&^]!CJ].&4R"L9;F/HG*!=SMI;A][M0U!_>1D>=
M_V8*P_/PUJC8*N+VJ]=1R.)K\8.S/QF'=\$:Y+H0#5?DF9-4>PW[[ R?^P5=
M5WN<X4_$B*+$VEEKI-[IRE'6^;LHY_8/YZ0C?ZE>7XTC_Q.M_(/<G75UZKFL
M1R/EQS$NE/#TYP7=K]9=^7!)_8+NN/_7V_L##9W#R/.9?E>[Y;"?1-NAS4%+
M#Y2-7!A^V:X:1A-=!!.[HP8-)Z(J-!C._(^'?YXOSS_8VKZ@2SFSBW)U;:?]
M4C82&S.;R.8&RQN&<PK;;:8)"[-S4IOM$@O,Q+;^?1E:Z_*TF..S,#O_$[,4
MVEE/XX\U6G5A;JAISQ7)CI]7ON^(])]!*30K]I5#&SD:/#WSG'<%G>E1.+8N
M///P!-QNNZ[4++0C-'WJ A@//F_:6#_P2(N@M)<74DB4:N^ P#&P>5G#!9U8
M5)<CWGM?8\-P(S E/B\SZC.-=,*>=OY0YJ'JI0LZ]5.A<W//"[K-=TJ5MZ)Y
MUBU:-! W@H_)/B8:ANWKZG/GL3$';T(TW Y.5><OZ"838'N/%"+E;ZS]&A-Z
M5YT-ZYZ'ZP,>KG.,XUVM?T,[=1A7>+$L/EY"6!A-\0H486_Z__'#)0T8,TJB
M_5P#ERERZ_7X*!D,!O4W57^;;K.0'$)[5'K"IH3;-T:\))_A4<XO87WA69W6
M!U?R?"U6<F+E*\O!Y;6^RZ/K'G"B)0U6.();-Z78IA/I=::&8:1FYFTV4X?F
MQ[?#";^?7_) TL\@],L:7-/%19:ETX2S4NV>CU56%TV,ID\G-C3-ZL5]:WM8
MX^K;.G^&]+5T&E&3LX7'K['W'%MTE8D'N*EQ@&7;=2.EMR6YMGO^(&$OZ%BS
MTD>:OI442J0;.WBQ&;G;L-1;L1/4)[XO<J\N*B^R][VXZ_ /1,1_!ZYTZ%(;
MN1;[?4L*F=R%R!%N4 2F8,7<MRL3@LC@N9>1?,G\Q%%FZ[SS0?M700?PQ&-T
MO-*[.@Y-YN597(,O8U[FE.PVQ3+#)&D[L4,N#(&+N5TH(_<L3)V"7^NH\.G$
M-@ EOPTV5/*."%%&!--CQ=7-6?.FJJQG4P^SA"+[J2H;-QQ%UI![M-MOW$]V
ML\D15=;%5]2/#")F2\RTGT98+XK[HWS*;[ RLVF(N&AD-[/5N*I/U3AZV[%/
M21(_+9H6#FNGZ^->" #2\AOIBP,P7MB)EVK4"/+VP970(.I0COUT\1%LQ[4P
M+BG)T":0<"HW(E#)?8NZ(52[54JC.7C)+BM2-H:*SWP93.L/'OG7R%E;CNA@
M&,*'KD%2TWC(TT?*%W3B*8S*5 4;EX4,0AK>,D4=)^0+7->/WMD&/!CEAF2Y
M=57$-.M1W^B^K\R5:^X/(HU70DZU0K7]/(J*]TO@X)5"N%U6^8EQ:,VB%Y/=
M]05X!6O >56?'R:3*IF+V[,3^[X(+"U3N+8TDQZD![[GA- 4 #S_7P?JM\EQ
M4\.6^E>&YER02K'%FFN<]-\3>Q84P1\1A<=64,'P,IV.IW 9&3Y^J:W>W@K6
MV(69$[=HZZP3Y('DNFW5KHZ*)\E?(;$CI]K[39T"WR3QZEEMZHC[K":RLFC7
M"(09!6<I=X9K(VW0$KX>^F4^E;4Q:T6DWJKG[TDPEFYN&P>S.CLQ>"8D%%;1
MI"<#@6A#XV J:<-"P15^Z \G 4!A;4,[$Z+_F$$;3&L%51$!'J.><_=,-YG9
ML>('Z[94HM?2]@DL7,SWG&F/F\WF1HTVTI-TP4U%Y*MU[JOX<U7[J1N>OX4$
M5H2$/;V+Q5MK,KF7X&K\!%JFF']WT#0.E"AM;FU(=>Y#8!!@CNTPEV5NO6;(
M00SLKA%YCD&@%:^GA1I8R$T4(I5[E\3I-3^I%IU/W3*_,6S-K9)&]+K9-)N\
M:'U!=\O4AM8^THWM;)/)CNBRIOY!_I6"-.Q37]?,9*>[;3)0)$4SO]CYYA"2
M @$3]@L_C3$ E_/@![JQ)5:/-+AOC!<*%"7J\JES1T:JD^+%!DH(1F-C%=!6
M1KWYV0LZ\*[^D.^0"LZO:J8J]<7K="ANA;R;X,B\"#2P"8C36X>V\J6F@B8G
M JM8Q<W-J_U,M5(_+&,%?@_MKI%\HEP96F*55&5J[*SMI>*EIR?R*&%DW/5^
MXA-+2SY%DX.!EM-XA00685I3@-Z3?JU9IXD\50>2FWL>.D]2.SLCTIA*0R;2
MFEHXDY77%\.6(FPFQHLE75DSL K@](?:TIGQ\1/*C>[^T00C3173,O^*?:)T
M4I+)=$&],J:2:_TA9'BF@5[:N@I^9-' +AHA.!];#"A87=7(MP95+U@9"*19
MF'4K<<_ZQTW8,01LZ#6T90+*B26YI67[FW=WQ)<:,^KMI[RF#I&Z&)N&M9W2
M8!P*X/>:H-36_1&1G8<7ESY+TZD.7!7XK@6;LEANJ/G8&)B"]1<44V0=ZGH\
M.@FS3">RF@1P)!>QW=M5^=(\GLH+FZH-SIGV"$C[5.V!6"29.UDA3#(M^PD:
M)C-M-<1&;9#2!/&+(I1Q7G:.DM9?48+RLFMWXK6IJS+0E7.;4GQ!%493 NIT
M7 ,X[AN) O]]C8("P]S@D;5;[VU$@?%ND$P%9<\3=]N[JK=4\%LQ$"A,$1I'
M,^C)A?IHNNKZG48Y1OZJWY>[V*LI<887=/0:9 5B!PE.#@]^RW:*5JG-"(WZ
M':^X4ACUW>\=[@>)L%*2./V%7=QXCD__16+6:)$4.UR=8>HFIM\IG/VGAR\(
MQ/.WJ*+?MM_87QN$^=L!,WQ/DNIF[)VH$1-F4-QKHU!V3*VTQE+R]I@-3]F\
M=$)ZC5N5Y<H^JO!L>>1L^<$_VN__#PL[A[5PZJ2U6TU&&E=4M]O^Z/R-0VG
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M4:UO+H?DQD$VW<1@4/H1#$"P\.=L_I]_;3E!.KIX)2^3F'_5$PM"8N:G9BL
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M!F?0;?L'!G<VC5V;3"<W*"@?_MV$9'#QI2/]^@QG9SXLF;*!&\?Q*=E*X4?
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M0!8,.ZXN-WXOD!FM\E<[PR3W2V8<,=8GT^IUU^D$NG07EUV64'F0K\3NGCB
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M*]".F[<W-P(F(/K51R,%W$OGK?"\(_O/M2X;?).R;E9V!V.2MH5YCG5'A<\
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ML;'*T_16*_2\7%/KJS*L<!_S,^5(<O&5T^<>E,:KO!E9&BF79,11)D5V8P.
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MKI$9<<*[4NLC+L>$O-UU3DU%95([U^M,F>YPSLC2]K/,Q,X K=]49@IA0OM
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M]Z:T J/(7SV-XF5[5S=7@P;7<QA:6[S2*RH0>^?["[@ZZ4_</!17(25!G9*
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MK[YV'*P,(PA=53=6[VQSTTGY9Q;Z8VR?QTK-%Z][SV&7@K>RSU$4PI;LH/%
MNF>:N\.JY+[L&WU%R3/]?-?4<H21BK>?M\BHAJFG1G7S;NL5M_/A0Q=68LJ"
M]#-GF.>RQ)"8;HEC.88BV;GDB(O("S!YK?4!X0%NB?B)K2SCWZ"WJ82*ET+_
M*G60"EWVB6\$9R/='Q'L^])<6G/@ZRIL*2HLBVQ6PPRSSOWY VJ8>6?>^*:&
M+<"$H@:^8F0+7V%TK6'.<9#%FPGKGC^U[Z%_N!>/ L8:P:K!"@0=(]65D"P3
M/UY6$897$-'SF":+W[Y_5,K>'-FFLB?B\OJ,VWCDT;\SV,35.1,5@&SPMTDE
M89X<8<"NXT6)ZGY;4\W9@Q3,! ,[?'-Q,^.VI+K#'5^<;1?T:,VG1=0T2\,S
M(YS/M-Q#74.Y9T?*U,4L9@XDDU RS#A?#077,=O#'L/013VS(+VP//E"WJ<L
M6GIA;(/_:Q5!4FI>8GG<=[F__^_H_?T^;+^B"SC=U]^%/%L>_?%<42#<&/@4
M4%^AQS9GK4ZO#GCBU)7%DQ1?G6P("%01V@( I))_[[1?\[W<FZV/US/%=%[F
M3.G>T.JRMTG:W]"YY)G/</=AYM^>D%YVN*1Z$F2Q46'^Y_Y# UES%&-*!#V;
M?WIX(2)_!H[0JWO09?_I/\1BOI<P!RD3R_'\)NPUIL7<-V7P+O6S"7F^D(5N
M"O'H*=1E!.<SP2RZ\SUQJV>4'M9@(<"6 Q &.7F:([T#K^)VS@.2K5WJ7G&K
M%DSTZ$XSCE>JEEC!-?$Z1(FWV-61JE^7_(N,PH<=' O7&LOB14$'=6<[IR6/
MY_3T>'.(.3S+5REJ0&3**2>.VFHBB3ZYIEFP^E;!YR+K? RU(]+N.N;<BI.Y
MH9K5 ?[I)OG*6K9+RGZ0%^K%&F/BF;>^2UN6^L$:!*MSP@-:E9 [K5B[^)T&
M*&,;1N^.1+*%'/RC0[$>TJ-:F#\V(F-91B;NHX\\9\HV_=FD85/K>E;K!MW0
M,Q,NXORY7DRH-OKY 5,FQK4="W>/L$E.$ZF)>R.8^T*L(S$5ZHSI?('[=ME*
M%Q@:A1PQ=V:#0WD^+?"_IG_7^S(1:\G/ ^R:PA<5SZF(7\I[^Z[J_[X@@RZE
ME0W%;* 7:(K8LY(]Y=37KX+&B^0R-9RQ'*\(U$8FC[ZW>#-?&JW*0N;I"MP)
MWL\E3[=XLC9#XH1"A2JN]YQ7D.<XAZ+FV10]88>P6CU3"C>F9U/D0 ]%]QQE
MB_JA0?>FE_DJ2OK&"(/KQXFT-O/+7@,I$SC;=*])HBTRE5T5 !"VR_'F0/8#
M"4L+#3%1#/K34@"@2G7-).-"N8;.+9U0;?!T71>Q[EQ;#F'\!^HL;A=/R^OI
M<X[6!T.VJ";%6DL.FY14^,I-1XP1E)^G?/[WV>S NGIT+5]S1X)H\[PCD;8E
M\[LC$3])S2-2!B;\37*RL/_REL.?XP8^G7#&-V:U8K<6M+C']-[G_:H_(TV'
MKYF9RN*K_K6NAG[2'"F+)$@EQ:%7[M33A"?:!7IUE5[%T&]N3Z?"Z'1>I0\(
M9D,;G><+.;)$7R.5B^B=1?L'*\D@S<8>F[DL)^I/6H6#O!.V!S7J!,[39<FR
MK,B'3!5VY.N, ^UWF=-=>?Y2M9FJLP!!HM!'!GX\Q8:)_55_/0ZY?U32>9.W
M7-RS?V9Z05%QI $XX9.=5ZT5H99*$K*#6XETNTLQH>* ZWVFTI4AKQH_3[>6
MQ0&WC.XGO]337"IV%)%]E,0T>U'?L^B<@*S4]N@PYQX6$[WA+<;78R  I"G1
M4\+L1]6P>9GLK'W2UN*N,9#/M)C2(+1)J"+P!T\2Z?-[;$&7_C-#G3URCP3*
M&Y.VK^N35Z0;ZEN- %+<UNC*->C6.KT@.[^A,=ON;$(PBH#?6(D<XIW>+V!&
M%_UD:WQ@?[/;^HAG*B7WC^86I]G3H\K-3K_?4F+,9;;H0%I;#=:?:OY"394)
M3X7I/#UFU>%7G#8I5DQYS(^5GOPE,P.5@7Z&M/F&;@8:1X_]GB&:6!ZGF9%%
M_%+D1$S-\\=_MZS.R&F++RH36'P;&TJ>4M18QZHU7I1>^GV_X2I1-$/_L"&[
M/O26,8%E^*\)T>@X0.F.W:%'.;0FG_G2KD@T7?O;N>$H(E/XAQ$A1E3^?I:R
M!-7J;]K@/20K5?OP+=_^#IBNO7/H&3@WL\"@-AY<#96SHL(TXW5] J"B63D_
M6?7G=T8CLSRW%-MJ!\,<-!E<BKM2'ED<FD/BK9C:A@^2/5?J3@Z/7VUW&G&K
M((G*UPWOLU3-;DO'W5][L;H:6OU5>KBAZV6VJETC0],6DU SC>E4OC_AC6.(
M1Y:?KQP%>2<!L;-C<><=348#!=9PUNXH&<%O_I$($4\7&;[[*VE&RWL_X_Y.
M2T!;MV MV9]&6WS[2$8GQX D&)'M>@5\4IER^":M2&0^),?*4TXM=UEOIE2*
MR"C\=##EA+6M!._\K!$4$8<F=17XMB]Z>&7<_Z<XFL'$W<8)\Q>7F2Y+QYX'
M1WN<H@]7AD_#5;<SN%L@DF?.:QD:9 5)CF@ID>M@1JS(DGD86=E+RX&ZK",G
MP(:;J0^IO0]TN6& :8_,V9S#RSO^CN0O]!T)O1FM?=MG>E)\6GO].%**0K9)
MM^45!2Q=+-Y ]<=A;/A/6_ZGTIEE0BAEW4IP8BA^_*^HW2G*3B?[#BYI[YOU
MA!@9V,IP.M6MFR.G3WAR:JRS!V267\5Z1&2&SSM;@>]5[E*C3HM7U='3F.9,
M8'03J@[=4%?]+7(YBET^W/!?9]?_U/Z.\1T)F7GO0\3MSKS5)P#9@GGUE&"[
MS+5E]H?J553%X6WM[*80;*GUR->Z2J8^']JO;W;J;*!0$V.V^I:VF_FT 'A1
M"1AO7,0*W\O<DF&^ZL],[LEB+]"[T-Q/SCIOJ#UN8Y<)F?Q@V9)CUMHG'*X0
M7JL*5C)_=DV;.%/KVVB"D.?L!U%&KCKQ C7IE)\E76',Z>??!]B?(S&>U4MS
M9F*[ Z]@SH_]QSXLRPJNIEZ1/?)BN+T7LW@!P*&N8XRV+JB#@Q+"=/W=HEL>
M_S%@AD',S'HW/ER[QHY17,<?4.!R&1V*KI[)'!&##L:HQIJGH=/#,Y)8SA^+
M_;O*K/$+#4D^R!-QQ2]$I)\;R:'5U5<SIZUM=Y#37@RX0[;#R%>WV#M\I+^6
M%Y:$YDKX:U! XN5FQI1P[4L+YO7)S/L&MN.B6*C9CUH Y:[@%2S+F2$4<6_+
MOZ_F'W;V\9H+>RZ<HJM,Q2)Z$OW:;EGM[E7^5ZPADCVB$C$C^%HIUD&A9^*Z
M\%=/4W)>;T%NPA ^NV7L?Y-),K59?7,-K-EWN!V8]'66RX'.'KGZ;"$7TW.
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M:BWGPKO6RMHP"\_^HQ=V39Z1H]"E[#6>-BXN,!L2KZW;CVYKAN%"$OM@?^%
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MJVIDGGF,0/(:YZ5F+E+&ZH/(TJQUG="<^FK0B_KJ-S&[V7% =;\&8S!;6P,
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M?/'_\/:>06UMW98H/CXV3I@#&&RR;7(V.<.Q,6"1<P:9; $"!(@HP(D<9)!
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M=WG=6!QBIV=,UQ02<"R?<X?LZ^@2X^LHB^3<LUGT09MP"B?GTZN?BG^V_:)
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M?]OE)]#\.,J@).13&=> "C\XK. @,*_.3?=ST[&--0&QD64[2+'>42XF4$#
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M1QEHH^7D2+MAU^#>]_D5S\=_3Y'?I2OO%-CT:YR-0)>\X$Y/GJ9;/MM/<5"
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M2(9FC%0(92_]$-[^9VC4RE)N]IH,+>_F3:;R!'G$S()[DKWH'"68A%.$=4Y
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MB4/V0L[NMI:3BLS,R29^5,VTX*T,Z7_17&!:J8=E>JW)LH!?':*TL6N_$$:
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M1TE5*MH#L4BI8Z! (1*LN2SRVE85!DI4@EG?*7S&2@H()69(69;#W(,@[-7
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MG1!KVJ&2GH.BXD6]=.L'7O$6!GKD=ACI/JIN 6[TE(W*QH$#A(M&7C%6L>B
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ME9HBKN,\D(QW4:N3;1Z/XZVC,7"7;>M.MQXZLQG#QT"SGJ^D@01FDM;0HH@
M-(A_J"*P&3DZ+J??XPZ_I+9W3UU=>.@F=_=08O\I^(&Z4%AC9*)>112&QM[
MR%Z\EU<<KP//< .W!9<B/XC')_S;/&TRTUQ\Z@1L<.-$%(-24 >J%I*-5BK:
M6!E\R(L3DT0[>L7WYJB;13_6=K _.=^R[YI3H4@7O26J@J:G06KLYKZMA=O
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M M]B!\+6M<8K6S?(Y]>?[PQB0YS9U7W[!\F3UB!\^<%#5FF4^WLU$\</\[>
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M 1%=7C=96.?#FFU)K>S,[(*QN<G#EQ+L/%))WT?L##=F+H^[/502W9#/. ]
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ML*H,G=$L*;H%R+?OSE+8/!)829W4<^<3.2_>7'WJH_#81P9C(UJ,0M9ME^V
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MF[:PUP#QF\TL3'6@  %Q@[P9;Q1\D"VP5'$+"$*&0?^MZRZW@):Y@;=$B%M
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M,[@.<\,H#\2=&+KVZJH;8S+J&V0S;JR2ZPD]B-.\<NZOK=3F>?IQ2H.A<_D
M&^AR^,^NAE\K(8$W-0<AW.<V_;!__,,$@KM%M[@V9LL7))FXZIJT7)WM+R3'
M[YA LO[,T&XF><E8N[EXY0=UOP_T,S(M)L[L[WF'3'XU@_AA,]"=BF7$LF&?
M#\L65=3/6\L%C+4>"*O_U3J3&7FN:WMD>0T^HI6N/99.5/(P$_]7=/QL&-7E
M,;=-*6T7=H9/1QO=]WDQ<>^&68SHRVP0L=E:AX^.7?-?G*GKGM^.8!=_>*M9
M&<(EQW=[L:[.Y;HP\.FO\WV]9YG%FZI[@---W.'<PAOHHQ#YP9<R+^H[H5R'
M'G7SVB'^+]O3'7*S!.OZ&8-F]$RXGT>!O?-ZP=) 2#N71;SY<W$&@U?!;'-M
M<(8(6UIYJEK;N9G])07R02^W9XUE!FG@JOJEL$PJ'0&B1M=&MD[^;C96%0;0
MC/1>/H2UV#P!*Z@P08X,^;= ?W?%+8;9@X#TBZHFV <;./,^4Z7*.9F@17@6
M:5K4Z$D5@A)T-3'>@EI4?.G&_;6TI3ZM&Z*A#XNRQC\DZQD'IGD4%')>%PB<
M-&QE",0 :;$F6527DK7*V4K1^08.V,RV!<%:.R.'9^*'9 MGW@5AP)9:SHUU
M=M,U9HI:8%#JI*,IPC'SU:5<HRS%K V#3>?JEG^,=.5D'WO);"$3DZ?Z]W'W
M??#>&6E$/BA7TW53*M/!A[JBT0769H62' MQ9LJ^])4-\-31^C2@67FWCK#C
M@1MKL\&]D&C%XZL CL#O58TMF30G ^WU^*6JY=%6HE^_,-:Y]F_,VWWFQSG]
M:D6:! YYDEP/QVNN_K;>'V*1XW_V/"!%L+@Z-H>?\\."0B^A>TP,.O  ,4M3
M'Z<DY0BD%I,K_?2HU&TYDE6KZGEBIKZ#7X/[FLF"\9(#I817U9:2Q9ML_6+)
M/B<X2G'Z03Z0=!\U!^UV.*-)W'M,>V@7Z ^CIF:0W"U"=D::;X$JNG06%\8N
M<'?][-\Y6GILUNM_]GKGTOEH^Q&7VS*DZ![JVSW\#L&V*VJUFSOL8J5IM4
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MY1; 37CU_GA$8@S>.W.TV:TP-V>&.5\GJ_:[/RA0<_ZX/Q1%U=B3H7)9!C3
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M-8C#9^Q_$5<DQQPB(4H]K['Q#H?FX#W-JM%'R(#SY5I\A+J2MI62N*&BQ2W
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M+3LU#3SV!O8Y<+4$\PCI_L.3SKWG60PU<._,$-.</OB _J9%VN:<$05G9JP
MFXXP^I4Y><PH>LM"HM_/GF#=O!(]=2TJ^C<W0DND@D\H7K93/,]R,!CHMH4S
M/;&J:*Z7S*(9%TOJH:H$39M\===@KT*_2%U\M23XW[:*_O^(NSD0,XC6V&'F
M[S,M7$#\)<O:?/5_V=)V[LL??DW\!3W&X0WX&(?3&_<H_6?0")Q;XJSQPDYF
MVL?).<J3GG2O='-9*EG'^F-FG4P_[Y)JE9L9!7>K@[L/Y^\[DOEMU<OHSS(9
M<[SSQ-D\N_R63U%E_Z'?%/F?P6 O]\6]_BE;5!0??**AWT233_MS[/'_O#G.
M>+7-]HL5=A\./?28:S9++E0L)WM.TJ%3S%N+UQ;<V=>6:Y?<&N/9\'+;RJG&
M#ST?3$IY*"60R>PK<?_=PAK-QS=/W^SIE_O&YAM1)KQ&,?O,Y-K<G1*FZ3NF
M%2TXE&JZTS8L/CG>*\;D<)G8Y^HWRSO35<YZ!4A_NV)5'YXAF]GV<J]V8]*O
MPV'9K\I6%)P1YUW9Z]UW(<SL]:68+!F)%5ZA2CDO]4Y.53P<TSGI7IGSZ\+G
M,84.GG@\Q1PK%_PGZL?\9^:3Y^G^+-Z59=QYN__PG<6BI[\<N5-N,M/1D>LY
MWPV3WV93*WF%!><F_;(RFF7QNG"[2%/AI.#T%S4-9O"3USGVGE5='G=[PO;7
ML[;'KZX(?_BMZI?<W3]+W:)EY\@]*O6=VJ?Z\Z1!U\\S=2ZO+-;]#K5;%K!L
MWY3E*VL=O* &[$]YJ6N]4^7!I&_7UE[_;>2VX8SD#:NW9SX++3X%K 32!5>M
M>:GT=,<E?45?5S]'H4W/O'V]4B9]CCVW1&/:E)4*7C2,^^$"N*[N+%1.BK:4
M81-;]DSC]KQI%[+4GBS9J>XS:9['?,_B7W5+UISY8:3TO?N'W*9X(68C(]!U
M',I&1D8/3IS^J*Q_(04T=?$LW+6HY,=$J<Q\W9\\VWP7[ SJ]%.9XA)_^&#C
MTZKI]S;MTO7AV/KAMG?@HRUM$SR] J]D*JE:+/(4E.[3?A7X;[+A)[MVBX$.
MB%% *F!_FN'<&23C%-8JSN5TR<NK^X?(5,&)$YA93WW]JN;+<<-9\-73R4L^
MJ;MTG K+,C8NU%O(<M/"[_.KQ;\Z3G^9KE(7G/'AVM*8TQNZ<YR"?7U4[.4\
M5]\ZE3PY]['G1"D+(U7ASB<[]3C^>E_8J5=[^<K7;*?D*Q(A'2IK)IV==^E^
M]K*MTP-BS[7^9Y *G+0W6ME_4;W7KIZ_'-VKK_D_J.RZO-*./YC>!V6- FH
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MMQ#,JT?P:4I*1DTGHVE:BYYRI,0^/+'(W03WU]Z1>+,FU8>\;MA?UY1'"$6
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MR2R+.@'DTPF@;=SH%YP@P0H:\@+[J$+0E/NP&L((MG-/PX-V?+#SOPE;70$
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M8^'0\F(<.M2WLCAV;%^J\3N4L'F?E"!^(8;2-:) 9\M U\Y0TD\!AE3RRVT
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MB,,^ E(8RFEPW<C U&]+'7_HYM3M9[M<H)8%]&$*(+#"A$BL2=M)D5Q454%
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MY"]0TC* GLJ*PPU393 , S?#H6V[. X\/KXS)>Q[\'M![WDI[V(H1BV*0[(
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MCC%QZ I[-$Q<WN:.1%*9:X;X,^XZ$J1$C55:KM>DJOE V;;>"EAN9?C)$"?
MD><2;/D.L0FA"4UL6"''*SX;I=J/O:SALN?FNWQ8<A^35WP 4*_=>+YVE[OV
M ^?VCVT6_:E+>5\)=JIE7(LT-=1O-<&YUBP0$Y#JRQ?1RMW2F24FH!W)03%"
M9N$Y%*T3>S>+K][6[W=QGX]E\2QZ&']BNNNZK/A-1\ER<8*C511A+[&(ZY X
M(PDH66Y9]DUGW8E"TX5&'J@]/TF'Y'?[5(#A[/.')72QGH%(W8FFX7U2MJ,4
MMG+U@Q3XMZ1]'] 7+BOJA-7I*GV5I_3:XQ?4F/_'F,UPUH/1-KCA/"Y4AS9V
M8^1OR[HAZ_\W?[HJ4WK8T5RXD^,TQ+8565ZZRE:N*W7:FR9C.OVHG5O84>9>
M4TX;,>*(4X?.;!P%:EJOZQ,?IG]5)5<8V3@EV!D3&T>777A@XY1HQ_,:)Z^&
M9^Y\8AN=-$)?O*7LY7_,B[:*@_U0-B5G:@W#>V] &NW1%@,\Y#-C)F&8WGPZ
M$8!M/T7A00DG,I(I99),+KQ8BHB,>,/<#ZGKSQR:VGEKW]""9GESF,J1AA:.
MXIAB[@D-["R*5R'H2':"CO%HJ_#4\*J"+K:B./IT&AW?<G%DA2Y.B)OXP2J-
M1'47S]-:#ITM-6ETVD2R?!F, NHSC!P'.XYMK8B5!7::_5Y0R39OYR"T+4\!
M=G9;Z.U9K7P<^[Z/G3B,4YJ0@"$$\VEK>'^4?-/'"*$?XI8VT!5]"BLYUX(&
M^6$?P4'Y\K;1T)LYP=5'_HZ+I7NJ[P&5UQG<.R[JR=F\)RY7#"O2N-F=4-D1
M-J\_/U64I#?%;Z3*><(3KSRV#UL'Q;:#XYA]!$+'R[+4B7S+AL4+)0D;_EP*
MPJ@6E'E*\G-'&U729BT82LF8D0& @,$@WGYMQ\(%:L'ZO 6KYT/T,] 8V@%*
MKBMF(TMVV6 ,$(RC* OT_G.,ZLFX33T(W' ^DL-PMTAW].P01R0+L)6X*W^U
MHD[B.W"S6X&3!31-HB6&K0UK9K7CT ]LG*99&(1DE6;^2L4,,XRVQB2"^I6?
M ,2X,XRJDODWGP'0IO)M6\*UC3/&KCM.%6BWB.9$@;.QU&ISJO#Q"E;I&7"-
MVZWG+*B<5]L6AP]Z%[=5FH?!]R@),2%N@$4@Q";)RJ52DU_F29D.E-,JIS6Z
M1$\]!P<M[O.V EFYE?@$B'*:3 \T,%6UI;G?2;PKQ]::,CLCF[Y,V5.$EDZ0
MG1%X)"]V[@YX*.6VJ(O+]*_UY^?DJFY@5<UC]QK>I+?LM"YR)=*_;NJF37U@
M&_<Y3]H&;_+!DU'!YX,FY\H,W'TSXFHNU)T23BE>,KK@8G&2*7&&\9')Z]0^
MF-<DKT33@C<OV[_^>\X^T57R\/*!/C.9O^7UX<<S#1U,$L?%ML5D=6@2$ _T
M\90C:WB/<LIM8PZTI2WLV(^7OZ$OG %@2:LDF'(?4?T0P;;T.>B OZHP835]
M826)+OJUA0%Q^.4%WJWJ/6Y(OJYOLO>/3XP(5_8WV8>RN!?E<6WYR[_3=7I9
MI+_6-'WS(GXTWC*2!\SL (<VM; 3DCBR5W;L9RG,J7P6/Z:M]4$S27[T%4,;
M?OB9Y,4?N3>U/3+G;5EXA78BH$]TS;O,\0[+5^WAB?<3VAV?H'[J\QZ:K/MZ
ML4<!]6H+QOA#&$#,_L69:PMRNRH[Q/D3>HYSR/-;Q<_--K?4 YLVE_AYW"SL
M*=<"W;$#7<^RYXT;;^E\+(N_;\@ZS_+N1-4EDHK6F9%%$AS93HR#%:$XHDRO
M6G;@A-1)$R>VI?O02Y,UK"^'9%7ZS0$QG-9KYI"!JJ_#%I=MUOP.J;W&<D:0
M4ALHK@\Q#=/$ST!.>92X' "R<\1G5GN5(>)R$IZ:("YYM_*P.68O-2^W[)UH
MF*[FR?E/_"7ZN6)FV*$E:GDQ)C2P<!"N+-OSW"@)(^"XN0ERICU.'7%AN]">
M\@6ZY[3!T]*F8)-U NL" ^H(;NE>($%9P/%N!\?/DW"HC$B3D%+?D+0I8DN/
M29,0?&10FLQ=FG=[YS0]R&:BD<\L)Y[-&J2)99.$;7U0TL$,O5?:[P65="[+
MPG;F=C?N>I[:[QK]SD!!36_Y)7W40-&E-_U9'NQVN#H#S&G'85X3/B2E>3G:
M[*+XC<8A)EGB8BOS4R^)B&4%4@W5ILD8WN.<;#_MLR<,,.Y/HR-Q[-$B,VPK
MCXD[OX,A<@,.,5KD5SNT@!X[[&0R*]7D2>3TW<N=/&8EV#MIS%^ML3.3< EE
M)9_"2X_5D&@5FSF8V$F '>K%64;MS(Y!TP$DZ1K62R>3NX8^U.NR0I\91QIZ
M]8P *^F0U@\7T'-S"BG. V9,8 Z1 3,%*+G)%C@C5%^_M<UI**1:UDS<KE.A
M,&MI;W1J?1G73442P/Q@R*J+[X/]M-&6&?2E9\?X=I@%PNBV.$W].]@>L]#(
M;9/Y952#T%E>\.8<15/E\8;3XL>+=X]/Z_*%]XBJDXKRGY+J97C1;NK8\'1@
M!Q2'-@EP%KB>%21NYJ8Q+ 9]#CN&O]8]%R@94 ;'C\_"6U);+88B./S"^4)#
MFL+;<(&VV.XQMW^E[KEC>F#2%BT^BYF%@\4Z@#N.%6M9%9X2RSL372;-AJS7
M+WRZRF_U5?F9M@-4?J&DWE2#V:*2J;*0-0VKK?V>8QU/[1B9Y_I'T9*,%"^H
MYPYU[,EGUH+PF]9@)J&#Z2I%U- 7K9DMJG@H)>^"""V6U*LB_C#95^E^Y<!)
M0FDJ:G6DAARN A>';ICAS(^<*(U"-TFAH9-IBN:#)X)^6]-&]8PXG(=1.I2B
M#QQP,&6 B_%IA=*2ZHNFS-!;.IXB)_Y(1$7RQC.[)7'%<TW9C61]F;%]]HEF
MFR+]1!/*\^!$!IKO1SXF<1CAP(H(CFP_QN'*L3T_6D4)L92Z)TW3-:P<.L**
MC5UF()-3 0: @"F"0>,7SL(%ZIBX0(2S@5H^4,^(@5XP<I+K[@TS0_5U>L7(
M07&R=XSD[? #R.5Z?5>1-"_N!XU1:UAMWM0:AO<Y(XTZVL.>QI)?_5D YD\,
MNF2';>U38FNNT9,13LG<GUQX,?->1KRA.2]U/7P+;D=C7J9_O2[ Q_T3MYMV
M2.Z-@!W4C++/3%DV10EI+GH*@?GMIT%XV,Z3D-O .7Q&3*4]>&K-Q;;?C%##
MG3=W*7S3B8:2HJ[]H5RS6SXUQ6_U+:65"'& -Z'D<H8W9=LE<\ &,^Z:356@
MWVK$F6FC<_+[4A:D^7UJ !_8OI6#QL#6!4JNM)5E:2RVM8%"#[<Z]-8SIL;$
M\[,!XL/9 -TI_3?1_I\G0GY[$NZ\NY+_Z&;3U TIN(GP9YK?/_!KGIG1?D\_
MT4>2\RGJ(GQ A%/PCE:/]J%?+B0.)ID?XGCE4#OUB>_9H /X]R.:86W7,MKF
M3G>L\DI;/ID!7:"O'9.(M%RBJF>SC:&V?*)UGE'19N>%D@K89.?[01HRUN:[
M8-B<HM<P\F8[U&;PAKT;O&'\Q^RJG=07J)<;=8*CK>1H(#KBLFN>?_-=/4Z=
MLW&^#\&6GYOS?<A]PB'U'7*H9@!<)DFUH>F'G,0\HSBGHS.;V?<X\CP<D9!B
M)_%H$#A9;(>@.-E)2J9=8RW=[:1FV+?M-#YRGQHM4@.=8IW  YH&YBW/"J9)
M!YZFLZA*FA7W4$/,WZ"V89F^><Q;5PM3'VT[E7M:)(Q .\Y]M#N-R RD*QP[
M=HA7*S=P?-?U22K55 %.VO"6%HUG]NC#-C4 0[E=;@89V+8?\" LM3TN^,@M
MS@?ZTOUII/D+' 9-2@) >%&M 0?D4(THK'!FG/P3Y<(QG25,FG8._,Z]>UAY
M;)$81U;*#^SVRH[\P'-<4*,!2;J&-4H[RC-OZ"-0E<C"!HR5ZP,#Z-;/,F:.
MYL\4#:+FO+\^VN?HHAM^NN?XUYT<#$1#=_Q\ANKKQ,_EH#@9/Y>\7:%\^8K]
M(D_JS^4Z?;NIF)*ZI55>'J7;>7Z$XX0Z>&79 3-$XLB.P]\+>L\;Q$UKC"DR
M4CMB.U1J1TS>G<((HE101 PUX28#E/%*HI-$&8X"IE?#(+$)(5[B4RFGY]G8
MG-'E:COF.&GIHYHQH &;:96I2V*@D=6)*%Z'EB1J:6H0&%#1K4%PM7IN!0!@
M5=TSDDW6=)^Z=[F*[AGN]^JYYZY5KB;K^U$-SI[;6LN#"2I^1#%)78)3)W56
M5F9[(6QTP#0YPZIGVQ%M,!!QO>/B3^"ZL"GDY"PX?7C %--><[@]SX]H1V2F
M$%5*5GW%65/$EBZ^DA!\I+A*YJXS KEFA[RW'_JC^HDHP"19V=B/5XEO!0YU
M4^_W)Z'*/C>DDAP6NAC_D"UX*(6\3506N"6J/KKDU9XH25<X<H,(I[$51H'K
M1H&5=$_T73%CI/\#/,]>AO^A3Q,0 O_>GL_B$>XNBW$@3>?7:)@\N_CW5B3V
M5R&4YMCUDL]!9VAZ$;Z7CSPO^3A& \N+,J ]#,6KQ-<E+^H$VLZ@-5\ID()V
MG!BQJ94P,!]%&:']O0123L,"B*5,+*(XC(AMV.0AK\MJL/3^^"$1/XG<#$=^
M0+#C.S8A:9AF<IWNYP@9/GKOR.[O"(5)0Z>0DE,:.N2'Z0<ET>%CA&;DTC4X
MZ!2994<%S0A[-!QH[GJU3=OU.:'=N+?Q;_'V.]K6OH@\[>'O^8RXCV7S%]KP
M8,M]D?_W\:R+X0 RFYVYPA4-,25!8!$_6&4^J(_B(EP;5B>_%M66;-NW (O4
M.90,#?LNA0NF7Y9YJ'+*ZKM[5.HGKNU):F>:#@Y*^RG$%^W@1,8T>J$-VK&M
M/V:\*,*:=/ R/"^JT!=]#(=?AV6)JWUJ/M+FBM0/MU7YG*=\ZA*?O?2^Z+H-
M%O>7/ M#.(B/':XI#FW;QPFUX]"FU(["^/>&\R_WO9 G#5+Z6P;D_6I,%R2,
M$_34L<*]-67/!B);/F *'P"MG-8V QCP4,IQNAW@](.8Z<9'[VWY0!TC+Q<\
M>V>]$67QX]U*]2E<.#B:M": \**J#P[(H?Y26.&\0RK]Q&L-ZO%Q UX8XSA.
M/.R0T+$C/W9#"LKP&Z5BV)[\1$GR]TW. Z)93QY5@K[:Z70?(MC15%EPM7,I
M12T] YVX)R72?"+=I_$JQ]%1,4^=1<<OUCS^AVF";+/^D&?T<)O&H<_, B_"
M-/0=.W!)X,&R^R5HFCX$"D*B%/6"VP0C,X$TC0,:P"BWE36# ]O8,V/ .M@X
M#PN,!CH6V/1XH '%[V-$T#$$TF."1FY5U1!=-HDXD]R2ZJ;ZW/"T5C$H^Y96
MXM1S>'9(DQ!'P2K!L1>D81*%44@)3$G(D#6L)]BYCD=B+IF.Z+.>A,N(*0U2
MH6<QYYT'ZM-RO295C=BC:(/VP)B]),:R&D0W<E ETF/UN<6*L<#'=+=,(,$%
MS^1LP^4Z%0E$;FVZ1(KHPNH$ L2Q1@'=K9A$U@UXO\G&8\Q#_P>GV\:FZWKS
MV/Y,S!4?K3_DRL>F"0X#0G"2^4&09BLGBT"3"?2R9UI)=<SRQ/@M,VC #=KP
M WPFMB!XX+&A)R:GRE[O.0#=U8-',)$$M ?_Q8F']44P;:9LT@R>NA)]]#*W
M;#:/$6"/4G;,4%%IH,A3@$9(O,TS]O&@##.EOHJ050UKU2YA;VR/HAT_:KT7
M0>!-:TJSN,&T(!0R(VT;5:!0[.8((K5@DT<5"/9[/RJM %<CM[3<1L,N'QM9
M/7%PFV%%</ON!K6]#/=3?Z?#R;.RSF_K,\0$'MB4) 3MRQ.R*&V\P[46VUDG
MA!ANG5.7J)V2/I3%/7MC']_2N+EC2QRD]0EO[(I8F*2^BYTTC@*76B1PI68T
M3Q$QO*4X2<QI(D[T G&R2AE]HP#)'2W.%1NVQ83$=S")P=;]E$B:;/11$HM:
MVE-"'MK+D]>J%KT^531IFQH<NAT<]I_8R7P<6DF6A79* \N'E;CN%C>\!8>D
MU++=]I"0VW.J\L'VVI"*SA+48]ZU%9P.EEZXO/18J.-BTI%K%BX=5>UEV(_V
MN:WRA!ZFP\:^S7:JDV#;MEW/67FI[8#BF*\KCF$% >SUNYT&]L1YTQ(4>>6W
M1=)#^0_S#@ ]FM]'4]]>6B3$_0Z*(;4^MM>ND-0CS#]&V:36!Z>MEE(O5VI?
MY5_*@K[\0JJ_T>9Z4Z3#Y#S799_'.,HR=LY<A3BDA!>/N![Q$L=.XP#RM1PG
M8_@K)HBBEBH29&'?H!/8R'T;SI<8IK./A360F#<ME":-=H+(HIIF6M!##3!S
MM:*]S./N7%>T'EFN6Q@97E0Z4M]IQS:.,X^W1XG\T"<.#6-8T'N*VC+1EAU-
M)7?0-%Z2!ITN%)1B)_( P$T>&<%T6223M)8U&&3$/OJ>2]VD.>/V0U[0][PO
M[)%?*8MQ[(4$.W$66WZ<!E:::$FXW9(T'4.9RBM%7S@;2/ !W/ 26,KM>KT(
M <,OYX.C+^GV2%[3.;<[@M]'RNT1 -(9M\=W*C>W_<"L>CY!@G=L?+/IJ@/?
MTF>Z9K2/>KD&"6%??M_%?NBLK'3E><25^O)+4S2L'EH6T+KC0;1U1?&F0457
MQYOVC(![G\X@.:T=C. #4PX=-#WYMALJ8T"4.#,6T%M3T(![Q.J#2*UA[-T#
M1<51B^#F@33H@3Q3%%-:M*\6J7>U6O6%>-/8X7S[MI5][2)9_ZBUUZP<0A*-
M9V<66KH+K9Q<(RUI)6]4,[3N:/)0E.OR_J4KSSZJ.A2-:4/7Q81'T;W(=>,H
MB2QJIQ#KZ@0=PSKS<YDU7_E;FU%HV?(I8.1,)0WBPE3@CB#J*!IP:\Q(I<D*
M.D5E4=-G1M1#>V?N<@4CYVU>/Y4U68L!H]L"\F']^+9\_#HOF**F'RAA&Z3K
M9?LR-CC,Q4%DL9W,STEN2NR$$G982J0&A^EDRO"V[TBC-:>];4'] OCXZP)?
MPG1Z!4AAJJ5GL)U%/-_,X +U^ M&M^VO7^;'GIE[$ !#[14>B)HMM^"#@1ER
MFA&<M/5TT5K.'-2,SI[%J'MM>+KRQ[+XM%E3VXI7]F557:;E4T/3ZS6YE\U<
M/KV"X<\&;RS-*2-.&MM[4?R."_E4Y@D<IC\*^B" J7D)Z=$7SH*F*H1Y&942
MGR>672P'>EZT83JTQ-6*,^0>GPCON<(S/#_DSS2]K&O:U/].USR*SKO8G/2F
M1T&"H]1.<.9ZD1_X5N*GH/&R -J&=W7/"1+IQ8(7U#*#.#?"DRR:-ZE[V"%
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M9$!:,1OM+/SE%-CBJ (]V5G6UB*A0<;;)U[+N\_O!=KC&'4L7XPW1=IUL+E
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M!AC<[EDS4#)_/D#ZCD"JC"Q]0#H3L)'CT[DK*F1.[8PIWGBJ-;"8]AST#?A
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MH;,3OH"")388>G.]*=*9!/_$(IADJPP3*^!1&2<+K4C: )NF95AI#*<O<>H
M:V(&(PE32Y_D, 5Q*+22(@ # K"J] %CSICB)U@R #)CC.HRIN3DG[2A9I98
MSG22DV7/8I*\146O;<>U7Y?59[*F5Z1^N%Z77]D_:4+JYFC$LCAANDZ*0YN$
M.+56CN^2S$XBJ9H!"%'3FJ[UD3\P-L3[6S-&$*/^@#+&"O^1X 4]38_B5<=4
M1B'J1PJH&3L3B;. &5',F;A G W$^4 ](W,3B]5A@JA)_7"IZ4MML '5)$S^
M:7TIN=:"BA,FW;X&!=ZKVKSKBO(:L/7[(J7?_I.^'$95:.#C>)7X. GBD-(H
M("25Z@=RDH)A)=DUK.J((D$5,;+0/EV'N$SK/BW2PA0=6%"%EEPGA#FC%]?A
MB@LWX3HAT''WK5,7PIMTWM+R(WFDLFTWN\L-[Y+;=S>(DY'OC]F+,;T/%"6
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MAQF1?%J7:!(:IDO:CC$[(0?E"1H;QYR62+V#S,B:R[:2.2W444^9B4L5/M^
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M5SP.%<]'I64FFD:Q'W6#E489CF,WQA&-K,2-K<R-I?+3EP.EPC FA(E]U ;
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M@J)2(2-EJ;XRF&EQ:]>Z2!D_4M B]YS&(KZZS2-@O\G?B0Y)(SM:YA1HZK&
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MZ"CJ3P.GF%HX<2R"DSSQ<H?0U+-!]7EP%0R[H98&N.KZN0&C)#B>DN&1493
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MQT%$<>;8KA?X09S%H,9DP\$-N^(/-&FZ]+14R$.D;W@//0P< ")[_*=F)O#
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MTJ#AL>7T!\WV(14E?FU0WX7^IU>"61YADN86MA,[RDD0Q+X;R'527JZ,0OX
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M5++7X@IQ/13SDV3PE O6-*,$<\>?M^5#QS=X?\0V:" ?"6"HI@A.1N*JX1P
M@M/8#O*H:E?W;?K?-W6]H]F'7<7<4)O8W1:YTKJI"LZ=*C[55CY1WC%Z6^6T
M:)BSJKLR4^8Z/">A.*0Y"_W<(,"$^+[CI780NR&LX_LRA0P[EYN^9G2;LPBP
M5Z<M+X7V?U^(O)RG61-/F!L2,E&K&FIUVQ?.=#<U!P51^^F^!K3MY#504V=K
M>3V :6L[OU"=E5O2ZP'OO%V]IG$7>,EO])E]DQ])39E;?JC(TSYTN]XUC]N*
M)PP=/M/>:+<,_Z[K1C@)*"^N=#-,LBC";I[D<6!1+TU "9WJJACVC ?)B B!
M@QTR+XZL>GWX+]I<'06'J?82 *[2.+1 )REZSAX$HDZKX5[OH)C^W)OEF.CT
M@VJ*K.\!%P$VZON6C:CF]7CCTC;WG=.A==GO==^;Z^@BW IQ1&,+D]#+7&([
M0>+Z,.KAR\(@DTN)4IB+;N.Y'[3<0=W2!$IR;D>/Y3"WTIO,ODR\AZW8(_=%
M*7HZ)LE;I\E!3 A:U0',&WPZP26>4.:!/S1/>M_UC4O%N=/9Z8\@I8XM@HG%
M2:E#ZH>6Y\9^ KJ+FY5H. @Y;AV&CC50//691U%NGFO%!C;=%\*B0@8M9ZH^
MKN<9>6M3.<N9/\+4+/F@QL80=2N5_29_]_*%DO+ B\8;J'75WR?GQ'$08I([
M,4[2.'-"*_$BUUG<$$)*%?,N9"13J[[:TZ@/R1FY5NC=B_BW!CI[N5<A[6Y6
M !CLAZ:PI8+L.GE!0K,SG/45X>O#R"19O9PBKT]2#P),BIP>-J*&X&BZL^1=
M19])D;'@3*C1]NWI&B>?UF3QW(<DLVV<N^R?.2%L+V2#N[#HT,SXOJD3SO,?
M:%G3EDM]*R8M$8HLB+,6O!"%:&P=D)?$;#)=</OWP5]#ZSO['F*=LH8"O.7H
MF0@#%VCU>L'B<B@G0TH-P\-3G.]^/-\?=Y203'0^>]!TX@!Y03]$)6.^K9[$
M+1_':=,ET@ 9EL[-GG9,BRV&N9<18TUTO)BT2BEG^GRTU3*G+QHRS)^^_"'X
MU/G$M-R6]!M-MVR%?OFPH_?;?Q3;35=%^5_;)_J>G_16+Y_)7]=/C>S,@HYK
M>.)UZJ!>'Y3M*&_=ME>);PNX4JC3"C&U9N\ZEJ,Y/V%- @F;SV8P!,US53"4
MW !8V&I>0A6&H1-1'F-EQN&QALO?BOJ_/U64WI3,%="Z^48:>I8A[N4X=E,/
MQQ[-B)-&<>IEJW ,RVILV.5QD3AG,A&+O:#-O(R_+<G[\K?T#A2NU<VTO>>&
M(&X)ZDU!WZ9>\7HDOU#87YO65UK?OP>1+Q1^;=2]8,&*%$=/VZHI_J=;HO9E
MLOQV\ZQR/H\ICJPLPB0-0YJX3IQY$8BY:$*8Z42G@6@>5&4T:0Z]1%*N 9"#
M: HX.5>L"PZ8%SU%X@-'8I\A^WX2"3@+D(2)NLA]ID2MR]DC8?09%8_,,[ I
MGM'BSX]E4S0O]^3G3<8<R_Y>LFV%<78]&#J8L F.D]RVXM3W72+7;6A6DN')
MW<H6I'O'TKN^,W(S>QZOZ6FM%078G%8&0'I"2QLWL2]D8[03F?UPF+_S(Z\R
M>:4-[&>N_ .Z"O$_[$O,.,7%I\WVK_-K?KY.A[Z+(\_B=_U9DH74\CQW87'^
M)=&&)_:A7'VOR14ZZ(($LPO79FG)_D5HY59R,X#!?( T5@:NY.'V&ZO\ORCX
ME=D Y@"99PB8'6%IG_=_D*K@A^#]]D)XMX+6HWW=N:,)<A_'$?&P$X41Y]&B
MM@4[$)*7;=C3#)N.][H<S@)Z;53[M\\C*WEX8P8OX#&,%%0KM6*7QD%[Z_5Y
MR:_4:ET:DLNMU>6'>)UF>;>[IFZ(X!8_Z6;T\2>MTH(77!3IV0%VFA,<I23'
M"<GLV(Z)0PB!L\ZOI#UD!BNSV ]TN4)_G;(VTTX?],P5ND+)GO/^+73)4_P6
M!"$+C]/,QD&>YY:5^V%FQ5!*_3?['0!3],.^ ;0E]/\[O7[#]R+F7NCJMR/[
MIHA'WXFS?HB]04A8] ;N2-1>P6O?E "U_GO<EZB]"MT-#Z'B%?C6OM+F-U*4
MG[=U?5NV^7I%>WC;IN#=MJEX-T_/I*B>3G..V>;)33+>UCW"?N+'3AS&U'7L
M/TOZ0)BV]Y*T:V MI/Q/W/J?,UVD?1&G>M@PG1!S/]E!*]Y%J]BK F *@X,]
M[?0-8J?DNSE>7!?T"]?F5W1;HH%"Z#;ODH+1;9<>C&[6@1% N&843C7"-2.P
MPEC7E%&99%V#C[H>ZYJRQ4>L:^JCJ);-/SUM2U&UW_:';WE+SDZ\:(H3FD38
M"5T_B;PL\0FH@NZ"',.G6ZW4EO#HJN/Q$+??7;]SI2X\ER"3B[<U  'SL1T&
MWUL,6IE7'9.1SLKY2;.TE<V/2UFY9G[2U/."^>F/J\W;K@ZB?/A,62QX$NSM
MZ3;$'UD<\V2?%L^'OH6CP/:P%>5.D :.G\.(K*$*&)[I>W70AHL$GEB#T92;
MZR8Q@CF! SQ"VLCF]L#0(SZ!N$+ZW(,J$IK\!EC\J@Y%%9Q33Z,\CF+HT!9;
M?:+L$;+YSF)4>EUFG]EW87-/?GYLZRR[CH372=U4)#W;#.8!Q7'DA]C.0L*[
MHV9V$H#B"@4E3 <=K4I]I:ED0XI%J$J&'H:Q L8E'4R=.BPTX0J)>E"ATI5(
MZ^FT0K]T>OV*_NA5TWBOM@097:&-B@KKQCT+0#H+BI:,M?2^_U-%RO2QJ+?5
MH6+RI/KQQ$UY28PC*T]P%KIQ$'M!DL,R@"'"5[SQ/R@S*!Y5O>R7@!5ZVZ\7
M+/7K_E&<5KKIE\= ^U6_A.A7NNN7!^7R93]@#-4$Y+M=LBG23YLM.6^''!$<
M>9F/G31.:&B%89I)Y1"-CKY.HG$K$ F)T-SB(133;F"Q@;!Y#K%-(6UXQ(8%
MJ<+#T59.#QXQY#PE>.Q#\$KR^XKP*ZSKJH*TFCM^RO",Z(0-+YD!G>=.#)R>
M#\ML@TV&$;.T]J(;MT.IIOIDJ-4JIL=-&-9#7_B$PCS@O5'%H>'C=L,>^=:4
M -Z$\:=-SPLN% VDHF^TV54EF/_@@NT24V6QV< IHV@Q;-Y,&J4V?\:'7&\>
M39IT-)^F/ZF0Q/"%E*3U;M</%14_\!.QHAR4L=SF=]4VIW7-?D,V[[?5\[;C
M>Q-M1 (_)3@G#L6AF^68Q'F$P\A+T]ARHCASI3O(+=/%\'1NQ?,MT/-  90.
M-$!_%<TC>MI;@4AO1HV:SA!0>[2%+V?:0ZP,.<R5'/1">\6NT$"UJZZNC5_A
M#]5#0_W6@QJ0);$>Y&HI$X:AAR5/Z %K,I-BH8CUTBKT8'&48Z%I2/BAP'>:
M[BJV2_KX,WWDX?57\D3/NA.$*4X\)\1!',0D<JGOR[4CO23 ]'%B)Q+U,A$7
M*G\Z,(K)_ '!4DN!9X$P(T''!%.6*)T4C ZXVF'!E#G#\X+)SZGDI7;3]CW[
M0)'69TRW68KCT'+8M+*]B$TR/[%3Z1CM9/#5@JZTE0=)=3R!02(:6F <;!8=
M%M#WB^V")&BJVZ>8?BEM)S"G<MR0Z8S)DV=6S(<<U_8XV_'"9Q03$LASP7:*
MXO8P:UNIW90IOVG,WNV:K]OF?]/FCA39:2Z4'W@X"GP'YY'K!-3QT\23\@U0
MP8;]QN^E8%3N^RK5W;9--.44]^JT[\@)3$F0Q77:V9A$"^:(.@W04 74ZX"2
M78.8%NB%-HCKH3'- &BYKM0"6;'KIA, P3A+(8 ^K^94/A<E90Z*C5HTGTA:
M;%C,\H7\+)YV3^^V5;7]B[,5D6?VE^;E-.C(2(B)%>68AF%&4\N* AO$$P 1
M;MBY=&)1TLM%:2<8YDQ >,HY%%,HP9P*UX)[W%8/U"MRA7KD]KJ@]W/(@3V+
M"@2:O M(]*H>1@644R^C-(9B2C?GL?]<D(0+*>A8SPY1QLT"E=CR$VQ901CY
MA"8TM4&9V^-R#/N/ML=#VB7];0[B@9G:%T"2\Q0:3(<YA=;J@40#[2UFC-*5
M0GU!RKJ9TM.FGB5$SWQ<;9X.&4II4W^AA&<.9;?E-WZDP?L]OR-U4?]>;I.:
M5C]:/I'G7</YL4ON0<1N\MV+>%ST33OK;RA. @G-<9*G*;;3,/>S)+(\/X9,
M=%.*&O84;46BD*?8!-'8&Y+S,F\!=YB; D$.=E"F\=#DX8RIN:J+- WVJ8\U
M+D\QVYNGE/.C#A[ W; ?STZ$DS3#D1MG.$]HX$<)"Z=\8'/[4Q&FKUIZ@>@/
ML=D0,H&N<007.:>VS%K@=0O,4(4^\9=LT=;__4S RGW=+QEXWJ_]XB?A^6K?
M=AMJ6XEO\]2W;/O<T.S3ACS()JQ=>-SPK.)2$1>+[:.TQTX#^8RU2]9/SR]-
MAL,FV(S-Z \N7E/*YXQQ2KEKE\9<+7EMQJAA]MK<1U7O.NK'ZU(PHG[\]Z[X
M038\X>JZ>4^JZH4MNF))/EWR4C_',24>MK,HR^PTH*YOP2XZ)*0:GJ^"SY??
M9J3\!WI0 WJI(0.@[(V&9EB@UQD=(N*'@P8Z+RX !FJ[M9"1N?*5!0"&\_L*
MR,-J7N$;K2E[Z'&<']WGJ45IZN(L8O^SK#A-<U"Q]?'PIM?E3I@H ^X.U056
M^;;BE&>PZ7Z"C-R\5K<7N!S/F&J N7S<-$U3]V3P5>?HN&&GD_'"IQ9S*)U/
M/'YD'V4.CGV>*FX'29#:EA-$JNQ)J\R](6>0,CD2:*HMLA"X7 Z,,S"S+EJB
MGP/I->;71?,F>(_T\/6K<F/RU;9YN2GKIA+)7+6X%KA_)&7'FOD/6K.@_*:\
M$T3"9ZMF3#&Q@QC[E"V:N1U3VPE[ODK)DZ*55)>:,\<DES"_T(I3ITY;[1U*
MGFF]I??R6N3'K2UH8 QJ;RT;9LZ!&KE[]>S-MS:] ?ICQ;?PVOS'4+7_'@3(
MBB]#&P.RJGSUXY>3G1P+*9NJ2+LV-6RG=_R+P2=;#6[*M.)47!]H^V_VWYL=
MKQON,^)YE\N/>4[/6;-<G@+B!"&V8]L/HS@/B6/_V? R2?ESG/74!P6K>R.D
M?> OO0J_,N_4_L3=%#\>NCH[)!+G)-7>-/%W^,'1BJ]>_@3J;;Y0^%'6U>DY
MUA4ZJ([:3_"W>/++HP=:DU!O$SI\1Z[0WK!#-0\W#;6VB:%%RZFR*4I.%-O1
MZFU+O>=IZ[\NC0=S*RJ_^@G?^B]F[*CP%;106PI/>";;DHX/Q6;'?M<2W@ZZ
M$EQG_]K5S5A; ))2G-AI@NW42=FK"[V(2#5A7:B'X9.4W\L?;> \6',$';7P
M,^U/VS9 4=]6J;X"N;5E!6!AB\09=^VA8*[5Y[B/2Z?J%3KHIL^3+P1'DTM6
MU6)5W[H0JE,GN70XF+>KJ^;/;]QOCI_PAA[A76<M[*>Q2_W,H5XD=;-Z,NX*
M&41%W10IV: N4ZM-LP&E69YB,>U&%E@(/ M1-4YZTE\P96H2LT<&$YC]UV'R
MGHZVRF2\8$(_N2[]6;%VBM8UI<>TU'TZ]DNW>:\_[.AUSK[+_YN2ZE/QXRQI
M(8E=G 0QQ788)DE"K,!-8454*EH8GHCWCY2%95P@L'I*"5&Y==XX3K#IW*IS
MA<ZHZ_<Z7:%FBQ(JBC39EI"KA;A>B"NFL;9J"2ZZBJR4=%BWVFH)3&=E5XL&
M4_-6'TG%^?'Y!DK$#UTL(<X1#PRQ]2B5/2_V=%(<$3O$L>M%06:3("2@<@V@
M?,,>ZI^G'3$SK@Y#&=4M<T=!:R"U/11@.;=E$#:8P^H5X8=/[49DL/=HKU2&
MY-$&:.P5H=#DHZ#25_5.BM"<^B758533N3;\CO:.5,W+?47*F@W);T,X9^S)
M\0F-<QSE5H[]S NR.,^C%-:@:T*6\40O(1D)T6@@>XYY%HR9G$/1A 3,>2B#
MH)#Y-6N>MC2PRY)6S@F;-?D\06S^$=5)_8.6NT,_'N9*\FWU1)@EM\FF>!!7
M#9S5@I\5WA=/[".W^7>^M<U;'42W\P^\8\:('R 9Q4GB)MB.J6]9H1\&<K3R
M9M0S[CJ$LE>#[E4#?=%!X2O4JXQ:G<5AX4!KT7ZF:A!77-'O:'VMLJ[JM5X6
MU+N]QGM2<(TFX-3F3;4JM[(#-@'LN<\V(F4A2\"PM/7$8POVL90&.$XM!^<Q
MB7V/)IF7@SSV14F&G>]1T;B"Q[R,D)SSTV(WS(\!3%:ODK]DCNXR]S,YKU.G
M?LG<BX7F%Q]0FZA\3.$9[FGZ6!;_WM%S.@Z1Q)^F.$JHC1/+2FF2VUZ4Y9!Y
M>DF0X6FZ%XNNGY^K+4G;6K&]$HH<&Q=ADYN\.L" S=WE.("G])R1FF;T13&K
M3N@Y8T_G\^SGU:;SH3/Z;=7V3R>;V_SSMGSX7/R@6<M2<;?=%.G+6+L_-\QP
MZ%D>COP\P0'U M_)<C],0(<I*DH8=@-<.!;242L>8?2^S7'C8?8^R0U81JL$
MMYR+, TBS'T<M$%M%T"A#]^>G"%[A5JMT!_=OXUT"%P"CR;'HZ3"JDYI"4BG
M#FO16'JNI#B53GJIEW*<4TQHE.'48N%)Y!'+MZ3:T$A),^R>A"Q$^RN47S;;
MNOX5,:?49L0MO&DZQDWM7DD9C>6W2"TX:]P8C1IIZ'[H6-:KW@:-FCUW]S/^
MD&+4<I:N>YVFO'U8?4=>.&?6Z6XD=2(<D]#&:4P\/XV"S(+=]\Q*-'UZT$E#
MSZTX8-@QBY=DC*$3!6! <5Z;P,M6]KC<S> "#QAD;=45'<S*6S<4D#7_;-V7
M?G!I8_(^JOBMVNZ>ZWW*_K :Y1"GLS]OG^B>O^L=V?"#SN^/E#;797:=944C
M>A<-KJ4O]C=/XP@G*0\=:.+E41J$$<G__$&K9 OO<+Z:%9"Y.;1%/J-TT )\
M$/]_9K$)K?M"H78?\!O;N;:_ZO[*^0W9ET!4S/[R640SK:V(?S4O5!@!-U]O
MX)L3! F.XCC$)$[S/ X2+PA!0><;_]ZH)%D/OC5_V]<LMWR^\9<'6Y /<UG8
M,"P4O/ :T1^B7[R9_?TK8JNK0OX5+%BW6/[U7M%9W?PKJJ+*FE2*G=,_B^;Q
M_:YNF!Z5.$/Y2IN1U@=\L;$3%J98B84]RW5<*Z=>;H%J!"5D&EX</M"<BBY#
M><60?BQ8_-]6I#^TW40S^H-NMJ))$TJW-3],['LF/&^KR2ID993E?+UF[&"^
MN1?>-AONQ5^U!ZY][O_U9K/]2R24Y-NJYU'CH9>!I@L -+3Q/LU+7)D)2AJ"
M<VXH^4?5O,NAX*_N4OGNM_?D)Q?(FX@SA_AI6XV3C0BOXSJ)C1.:N#RU-FYK
M^\(T<B,G)U:66CT!%%-8SO4L4$AJ6AW3.O5J24^PNV'3N*82Y7,O77WRKN1=
M[>G3\V;[0FGWRV?V.#".7?Q.7)?Y_X"RE<!R(K;M2'ULY22C:6!;) ,=?YE^
M'8NY]UJ4:S$9&/R\$(.M$R5M1$V&.#83BP1W=4]%*3I,U6P=WS&_]2+<9&<'
M6UO^O2O:6L@57YC<HK+2:X M-J-D60<&HBO4GP0)\#EGYT#?03*COM5& TR:
M5J$EFJRZ.FF ['35TC$DG%3_OB*B@KVJWKW<E)G8<<HRZH\]:]A]=2*'$X;%
M7PDGF,N*'T6V(QMY2OU1VZ<]BPZS8>Y"PN+NH$ 3H_Z4>4IT^J,#KL:E/V7.
MD$A_\G,:[]=/"SL=]H^8.@3;H>NG2>0EEN-!V-9&I8"F(9P4C06 G V-GS</
M[M+3+K9HKY43<:W,66>R[69#JOIPWPXDH!G'<<$]^RO<KQN^5%_C,OT-7**#
M+L^7SEY!7U7\H.TI%EN*.:G5<6,I]LLVR^V!LE_2LWJI- YQ9"<9]@++#^,P
MMJ/(!R7-*"AA>@<A"+YJ?O.T*RNFR4-9_ ^+91L6J2:TI'D!W0@H(2TY_0WC
M!_0.O3;]91V/[@4[X+%&5RU5_UZI%T$YF&H]8EJ"C"XOHZ+"NDYH 4AG/FK)
M6&HNK#\.9L.V^8._56RQ/DWV29P<$S_S<$R2T+=2+_'B&!*!C(LQ'(+<\T=@
M?N8"''*>9+F1P/O"_BB?NX(^\U?(U.<#IFW2-,LO"%EU'D\;>CI39SZM&$YT
M!YS?:?6CX)=@8QMY)O%=NX1^8C9\_,F<?E'3VUST.>B8ID]CC"R@.(Y2#UNA
ME7O$<JS4 G7LUJ:9X<"C6S,'<4:;[$([9?C9\C'EY0D;<\>,R?F\H1&*MI<G
M&;:\QBO1?(SY<?!:6FW:L*;366,DHQLL7>&--KW6C7ETPWD6"&D7H.:1!RR.
MHF>PR&'8E0T/RT9:G'&R0"_#46*EF-BQZV192/(05*0Y+]*P#QTR5PH-KE"O
M@]B(P-RB!()R_DXO+C!'-@>)@29.\N9J<D42 E?U,?( G#H/P)-+\Z6_TP<N
MYAL5J3'EPTTI^![:AN+='R]FKGIQ@(GKQ3BS4IOZCN_1.%'+7 7IL6+VJ=B!
MH8X60\1:WXN'LLB+E+"IPYDP2K;ZOV<OYF%;L<VL:EHJ[#W(.9P5T 6&4P-@
M.ZEHKQ,:*"7N?OI/K),AJ@21]BQ/F!:OE*FI!-7E;$NUX98=%GVB[!FR$5F;
MUV7VF7U1-BP:Z^9S%Y1=HBG-<P<GE";8B5W/LNTLB2B!N#TE+=;*JJ2=3_NE
MVW_^"BP<58,8=CYE##C%XZM.'\&LU="NAB7EO^";P7Z5^*53[%<C=:B+L-%\
M# ;3X55.R91@NG2(IC88S(7]ZZ5LI,[7OV[+C+E6]C&V;'8JW.8L8J'544.X
M)QY2<M^6!D$08R\)64@7!2&./<?".0WLQ/.<+':D0CHSZIF.]&A+$&H'SB]/
MO[*P1*C![_CW>L@Y/T,O9]HKOC[DIFX&CQ3N_><5ZG0^:M-YA5JU7_4]9=M4
M=$QL\S;?[OLZTO.-OS?I!= LK.W*R&6(Y<YV7%LL>8:DKK(6FD6L7R0-2S%(
M'7QZ>>RZ*8Y<-^ 5NID7^KYO4:G61""IAM>Z_@R#]NRP;>>/0W++%2( 3PH#
M5"Z\UPX3;'T"4.SJ\EU*EJ_)AOL&26XO!>.PA_5<I]RS8<ZY+D567)[A),A]
M3*T@I8%KA3:)EERC'$2M?7V"N&A%CLL)P-1N3=1@6'A;(HG XCN2<^,,W8T,
M!+WJG<BYP7-W(2-/++T#:7E):';"0_=?=).QS?SO->VJ)DY8I]W Q\3V(NR&
M$4G", \2/U6[_9#4P'3N2:?%&1WC%>*:B&,MKLML*88FO*&W' 90A/D-;0 N
MN,< @J#]!D-6_BO=70#AN7QK 1T(7K5VS7.X[I\>OI3/!;\!/ES_29:N71S
ML!\1<OOF$U^^WMT,FG;)%ZY=-G_:+VBS'#;WIXQF\UWGY:64A4I5;)='7:V4
M;=:P83W;_(=5">VK@L_>FY)]_6G=?"P;WC2Q*IY(]=(>YZ<%^W$D@XHGJ_HI
M)J&7XCA,4M?V@Y D 8SF'B+>\&SNE4&]-JA5YPIU"J&!1E "_"4P^W&&8Y>F
M.(A#2L/<C@('R+AG#F@ELKQ+4!M%52[*,H<4S,V"OHT&LMK4<-#6I0 D?.7>
M!2K G'<T4!I%D>!F(]YWU^O^+#NW.XD^JV4F.8YSRK9]KI,X463;G@?*_I 3
M:_KF4V2V)R*S?7C=V:=_ %E.E)!TG0@GL>W@*(E<WPFCP,U]F /7CZ4:RZDH
MNE@-1SF7K1\;F*N6*)Z8A@C.\0*R6!>=BYS0=9E;0$"<D;3 GE9TOF*[W#&5
M7>S'P&L1K"1B(5[J)6%@V]0"':*/2C'L6CMIB C9P.RY<5@D)_Q28X$[WJY>
ML[?71%+;I$FZ)O"HC'7GZY299]-S\L.*A^&C,WW@K=^]'#[2.7.Q^>ZJE#YM
MJYP6#2<WO2GO:%5LL[/VVAG;$ =>C%-"\R0,G<C._)X#\!YP:JY?5:DY<LP.
M>*_@%_A-Y&;#5D/.%R,X8FH@28R)UR1YROY*J"^./(;J#L,/46$P%J%PI:^Z
M8D[FW0:*<S:05G6-!_?F<-5UM&] PW4/_\U!?'8]8%"4FF/_S+;3Q:9H"EI?
MEYG8IW"B/>:]/OY[Q[;6IZE./N$4&19ENUN7>K:7QFY((#P9<P)!P9<B8P;:
M')00EV[U0(W_Z_^('#O\?Q 5ZL#\[RR:<LY4)T8PS_CY!)B/TR" W9FL99I\
MTZRX51V-K/&G7D/ZN14+!IAS8J;S(H8[6I)-\])Q,_7U A1;$4EQZ*4)COS8
MQHD7YHX;IJD;2NW0C&AG>&?7B17L',^MX!72SB^^BFEG\^H PSS3XB3S_N7P
MYSJEYQG%5GA+*]0&Z'A;KU0:H/36UBD-F$/52&7 1:%OOS!@#B\M=0&S0E[G
M_.-VU]0-"ZB*\N$;4X_%\?R/9XD!3HX3V_%Q1E,[8<MHZ- 8E#%H1$W#J^;7
M';^K$S7_XLQCW2./"V]FG5./Y7B_WL''0'?T!]<>=>KK3%LTBN\;.0"YH.3?
MZ@QD&FC=QR STA2V05]H5J1D<U/^:U>]O-^0XFD\I\BV'1SG+MO3.%9BT]!S
MK%1^.W-)BF$'VXE%K5PD! ,BWHO82.PO=%@,<W%CQL[G^0"L!L3K.JQ7B[M!
MKQP6+L\9-1GV7GQXO?!U3O^C,'3VPPJ^9L"L.CC9Z1H&E@^?>=N;;\7#8W.;
M_UY3<9MW6EH2NS%.LLAA;NC_(^]=FR.WE;3!OX+8W=BQ(PHG>+_,^TE6=WLT
MT6[I[99]XKS^X !)4.*<4E%#LN26?_T"(%G%JF*QD"! Z<S.Q=TMD<C,!T0"
MR*MG^UD4YR&Q>U^9A")28$'!!P;34H(H^GK[:^L8!RQ5%4 E=)<ID.970AZP
MLT([AI#@:(4$3[C,,>.J32\QC"5 (QK&5$U9FL$6IE5G #.I<%7&74X7SY#Z
M0$W/&4<Q/*GM3\_3B,MUP<O4C\0H"5T=6#$F;D1QY'HT\X(L33,/%*-TEI3A
M<^.>,.HIRP3Q0/&2NVKK00&F=!4!@$<Q791-5RC3>4++QC-=%/@DJ.GR&XH.
M<,JT 3U4%;T.>?V%--N*_2E2]4;+G'*?N.U03*(DQ!;3O:YK98GM@J(0%7@P
MO/2'E3@[!HJV<>G1ECC<+X&^<@7@)=WG9N$$>M0%,R-'B1U'JZ[2RATILE6/
M]JO1LJ8S$-+EF5?@8%EGO3I$)_[[&4.I*;7[KKNPB!5HN]V>*>9.?1RE;BY\
M#U$0A2G37Q#5=9:28075TT6",$SSG$='3K]HD1FF10[%7:&N@['^_+6+LFE:
M_^?I++K*+XI[O)8OOZ"V8ELWY^>RKGFKA[;_U98IBTYKE)N:/;'>9N( 5 ES
M>=-41;)MA-XHOS!Y><?W<KT6)9+;]+AC\W5""8X=+\-99(>9Y=MAQ(L.R4?O
MF6'3<,P?;]3)&W2VG7+2'=.HW'$-4R#+3%8>ISB.@P0'5AJZ=N@Z;NQ"=/,[
MF"P%;_"_YF0%CHNC*$FQ'021X]*0>G[TQX8V[WZJ=C;;YG_F1,GMZ6^_5F '
M@BZ<ZH?/HO&PF((]TVC/]0KQ>>*-*LCW%=K)@#HAT% *?@\YE&.71:_O@&$6
M:$VG$T-,+GJT,0OT\;G(,+4YARH>.W8Q;NP72M8\NOHCI]R08O/4!3,?5!1)
M+$QB-\1Q[GBI'T?4)Q2^(ZLS9#Q0@-$4<?]T2%5%C<\ ':*PEX$2IIIGQ[SN
MI^& 8_U5975AJ%7KSF#G#?3K?/#&-:F&<>$5Y>[(ZV_UH"SNOD+9YV)#;QKZ
M=*EWI^0HYA8?(XY>ZH.ZS,,Z:YP#)%C05&<-(*Q2Q369\1>KO080=EB%#?*:
MVD9_QK9ZO']'48Z3V'&PS39OXN<>\7P;8OXX0\>P_:+-62QW#H2U<+ST.8S
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M9EJ6G >Y\\-BZ,*.#^V7+H*I]_16:,\):I_@&!_]\."%ZWUG[UWE-(T]9G6
MIZOO["Q>ENU%JP.VD_ZT6@:=X\+9=?P92QWAJC#+,QPE),-^[E#/BDC@$Q?N
MPSFALXP39]_02.+L#H()XL*9);R2#P<DMZ(#YZQ46CTXIU3>P(5S5M1Q'\[Y
MQQ6<.)]I75-ZV.'QRY;[<&_SKW1#_R3KVS8&X]B7$SDV3CR/_2=+@BBV<B^)
MI&H; >D:7LHM47XN%)UDV?%$$$?E,Z!$+A1*"1>/&8!@R[WE877<#7:%.M!N
M<]2Q@FY-P@7P^YB!3<W]HQ$^F$<&#L*D8P8PW'+^&;B,!VX:A==AVK6N&EY1
M*MNF3<W.6=]H]5*DM/Y0/I%B<U(9)\YP'(0$VTF<!"0+@LB6:OPR2<6PYNSH
MB@M'1QC]WE*6/ 5-8S2M)+5)#E.)2D)+KUXIH:8.0&R P>&'_6M_\)D>>Y&%
M*R5>OTSE'IYS._E<UO4GQMS^1CPH)4ZK#\5ZR^Y%PAY[O& ]DF"2$8HMCWBN
M%3HYC17N+0 .#"_FCA3Z@;=C*M=K4M7<4(9J3ENI!^4,=)/ Q9$=6]BV"'$M
MQ_8<*Y=KM;0(ODJME09VET&+J[?!&W*]-(2ATL7S!\[,CXAKE%$[%L\S8R#V
M'[-@2O?%5 $/K5=6"/TWN,PJP#-^S5492+&Z+^'-9<;#_YTD9Q=<)\4>=6D0
M4#].(E )@.'@AG5X:WJ_?Z3H/\MBT_#^VL]_0W53IO]\+-<,CW^KA34>FLQU
M@(^<ZE"5&G@8$U0,!/N/L:^K=NYPZ&7KXXX(=5(#=^P9Y9K9>='P57R\IJ(T
MQE'J4.Q2XE"2Q*F?!Q#_UWYHP\XL7LBFZ\C]PYIO/>"2UV<@X$T^"<W8A8_8
MB9>Z@9.$/NR$HP:"TM&%P]#*WZ&A"X8\)CB)7!];/@GS*(^M%%P?7>5+4# 3
M:OL2)!6HDF P]3DHT]0>K(:]^>[*JLTT/0H^YF5 V8[,R*U%_=8- Y/6&C/X
M3R775[6\'WCINN1' HU4'C]^ EY;G'OR.L? AY+67\KF*]_L*\H+B+!E/ZBP
M+UE\7'Y$PXMOP B[+-$:;<H&52TOJ&=&OGXY *GIQ6H.)-A"'N+#F1!=R;\>
MX6.@/3E<=J5"Z@ RBU5:AXL^+,6N\+;!8LHBQ'=?2-DE-K=P>0F.0W;[B?,H
M\'PK=JQ8RB0-)[V,LUZN K!@R$3]Y!9DB.%%-W1*%A<MJ)DIF7P P)+EDEO"
M[Z]4\@$@2F62#T=0""?X5)%-^EBP)5JDO!M=?;NAXX:5.*<XSIBFH=0+@]BU
M+=_RI<,'SM,QK$QVA%%/&3'2 +?W!$+3RD&CW#!-,"[R9:L+2': BU\/!FHN
M?>#TP]SVEP6;=--/O+Z<6_ZR# =N>(G'85HHH\4?USRYO:+DNLSHB>TI\3 [
MSR38]ZGGI8F3$]^143O' QO6,YP4XK00)R:WQDYDGU8H<R2":1!)8:17RSG.
M)VX7[)5V_V=_V6_[)P,MLE#.L=^OC+._AQL%1$6E^Z>'_RC__&7S7%QOZHS]
M&VH(F![%\$H0Q-%]\51L'E:(L8!^^7)WP]U_=<% H)*9'!)H7+[LZP,"MH N
M8F#@<B\GJ]*%_L+0BUWBY40<7MPEWU"IIE+4SV5-UC]7Y?9Y9X8=[7-_&+76
M%^%\O=Y6U6$AWM;&[A,<>[Z/'3>,HRBW?3^(Y5P->ADS[J;8QUFVH;Q]MP9)
MTZ#9::"NBV-"/#87B1=X$4D=1ZJ.W-M-@H*R?E]3('&A>A-@8<J_9Q$)'H<^
MFB&;^R"8DX#C72'FUQ7JN'V3Z8"4[WF+:5'L_KWD]  K\^A&<;I^CS9J"U;Y
MT8W082T@[:,K9OYSARU)F[\7S>/UMF[*)UJ)XD17FVQ'ZGR]()ZH%Z4)CM(\
MQ3GU[)0DEFN%H-ZM"CP8WJN&U8*^ENMU7E;BF%UL4,_LL(2]"/G>_>)*H?:_
MRC3(.0P,@PN\[?<8_<FX03T[JR/L5J<@O_;)RRDM7D2\@<F:0S,PTY6?K,#!
MLEG)ZA"=Y"+/&$IG_Y+C+$8[L3#Q+:;<PMP+TB!*V55IUZ9$/B1MG)K4(COJ
M1J(6I;8K&]@%*37D.[1]TQG Y#30#/DU-QIA:)AN)Z)9#YPA\@Z:@YQ;S1>>
M5C!_G':)^TH?V+F(K#_0%[KF&1.?*#TII6(E*8YM$F KI%84N'Z8A%+MGB%$
M#9]#?GUFT['A 4TM;;:6.^(HI[*+& 2BQ+W8 #2P!3[6!O)F@WHNT(X-],D,
M2(#;J@&PU.ZBFD"#W3*!TD_>(67'6NZ&")3NX/X'?5?MH,,V/%Z[I>^P^M,K
M;Z]ZL[G9O-":WRB[UJI,09^KPN+;%,>QE6&'QEF0VFX:)BGD<@=GP;3[E%<]
MRM?EGW6;+%;TG""R8P78P5<!9KFCDUGP@'>W\[UZ=_P<]NJ=M'49J0^CCI>F
M\YH" XN>Y=0!.C[GS1A)39?]3#>\5SV[%%YE3\6FX(/R9JJ\ ="F/DD4SET'
MD]1E][@\S7UVA2.194$4UP5ZAK541UU8/<@!?41;!H!7."!\A%!V^67_B6D6
MIXZ3$!*%L"PDC0 J^?P6AU!.IVN$!:; AW@<DD8=;7V*6%)(35KW$K5%5:RD
MZ,?Z5/8U>*#/W<MS&V$N&=+3/V]8P]V15_12\Z1\45"<MZO8UT"6#]S923>]
M^E0%@RVQ29GTQ<*/":,4;;,;9+&XFF.VAQ$T)[]3;=XG*F;?D:IYO:_(IB8B
M@!UZ]KXTC+FOJ*.,!&DTI&WDT"PKJ+9&=A?(+=S23D[XT^9VDN^I?</"U<MK
MOA\[)=R$X#B(71QGJ>LD-+&I!2H0O1L9I-Y5BSVWH3XI+UX/.VOM 9!;K4IB
MP99E5Z&/$]&W^$[XUK3*]N,NNIQ.Q#E>-Z</S%P@$[V,7!QF<8R3F+K8]6B<
M9G[B9+943/\%.@O&'[2!0)=.Z""0@$MJJ>B P0(SZMZ_()CN%?B6;OH+HIY=
MG4;<[9]HQJ\XNW3#[IO^B=U\\N(D*C9P4QS1(,26G21IX)(@<4!9QG)D#:_D
MCKB:N_T"8'++6#\,L%6]<\=W#/1U1;AWON,!_=!Q<;YTBK)[7DYLS>[Z"T3?
MQ'TO!\0Y=[[DVZHW-BY+L2[:>,?\UTW%?O*P*?X2<00=D?KC]\ZET#;/Y*7>
M>(=I]H/[\N-W\L2;3;/'O])F6VUJ'K?WJ8W;.W%J618F619C/XK2C&16DMN@
MVD*F&38=5C!@5ZS#GF'T.V<"=5P :QT8GT79>_O[F1N8IIP]+0I7_V6PTF8Z
M,,SNPJ:'9< _-5TL1%<AUJN-G?X/NL[88-_(>J1"A @YST(<QWF(0S=,";4=
M*PCE*T2<(6)8Z;94T2,CB_*R0C4C#(A-.H?,M%+4)2],D76B<HI<:2%.4Z4H
MQ#F9 ?%7&F17;/ ]@H&FJ*H+,DU&49U[=[FHJ0O<'T1)77H67@#BBJDT!NT7
M\G12_X&DW*I*+!P''K'LU,IL5ZIP^]&XIO5(2PEQ4O+%'X9R3ZN,&=( M82,
M(*#"#R-L*]5]&(ZS6-F'$>:'51_&?JUVV_J8YY0'Y]#=9>XK:>CAJ4#4SA;]
MB(>]:-F1@-;U_HS0G@R.UU'BL<W9\B+L1.RG7IC9@1=!;E>Z&32\(+M$//1*
M2<4C2XJ^@'^9HTVYP?^])>LB+]B97M3;AK6/,C9I<I>IMYP*F#;9<3JT+W%F
MT2&WJW'#TPI=Z,&]0JT$^BY?IK#5=-G2SMZBERM3X!Y?IHS14=/MW[;/SVOQ
MO9(U#\_\M"[_O-F(8!1.<RS*6[0RB"P<Y;&'@S2W;(O8?AJ W&22=$V[S09<
MM!V&>9PWRG8A.-# ;EDXY92I 9!@.O( 'Q'/S5E  QZ,!)@ Y=:DOV2I+JJ6
M@% <:QOHZ_!@P=OFD58\?NT72OB*N7IJ9.,&1UXUO-X%Q8-HNX[TQ<U:2N[I
M5:U!9-CJ59<6%%@X(9-2C.'8>(N%&TX(,XP\G'I,<2,>W?,'Y\F?7O>/=,=-
M44&L:RUYNVWJAFRX_?7OM'AX;&AV]4(K\D _?J=56M3TKBI2.BA.<5+.,H]Q
MXELA)GD>YTE,@SR3RG]].Q$,JXN>"]2Q@7H^D& $>#18?H(E3QGO>MJ !Y;!
MG6PHS?!BQE/11N]NG+55WSZ7_64OUPI=^!3,'(/>;&)TG:B6%V#9P]F;3=#)
M.>_M.%';[CZ1HOJ-K+>TVT Y0W?ENDA?V_^>#= ,B(^3P&5G!B=)_2#P/$)!
MQD)IRJ8#O1@?2#""!IS ]A1Y%.6V B/8P#3X."PKU#* ?N_^-!+G"19?DYZ4
MI[NH>@/#<:R5X /,3^ Y:8HNSK8AM7$4)!1[L9,3VTE):@>P *YC$H;50Y_3
MPY,OOY2;:I#BPPO(P9JC3P EIQCFB0_3 ',EGY7/)-\>73&#:<D>Z9<%G,I2
MTM@=_23^<ZP1[]X@?F ,'S%!B\0F/^7=%]( >[87^0%;U2%1:RHUFS73#GR
M:<H [G(:XFW0A&F6J4#R%9)W"+838N3.IQ]&W=VLYC/V-MVNM %ZMAN6/@JJ
MQR V3)$R_<U-_<<AD-1F^C)*71PED4OBP [\.(<=@8;#&S_^],2$7PYZS#D
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MYNF9%!6_MEZS)?= 3]H=N7Z 8^+Y/!D\]P-VP_1]IR^M([<+0EF06C2'U7.
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M<%2H9,\E2E[1\+F.4R18Y6ZNGEG4<JLQPELW@+H"OK7QM6S\MVXX3\+!M1.
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MA^[KWU,%G(MEX)*X%V@& >A@%,111QV=P*%2@U0&%\#503,^:K>(2SAINE0
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M&H4X\=T,!VZ6I$GDDC &16B6R5DW$HUH'GN#'@8NNDLMF_[VROBVB_:=E@N
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MTN,KMO7WOEY.,7"B[Y-KP*QF=.V"![.I"Y[RGI^]IWPY*\F*+ZV/ER%SJ<'
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M0)CC#'L5X(E5>\^6&Z<9V:#J/T*.90#@PWTSRPW2B00&1@ +SRD)UC%/3TO
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M=D#CH %AA+,@ M'9YY)N):20$RV/R3I=U,7@Y=>Z=JL.XI=ZLIFCP64$O2.
M(!>\-U11GON(ZZ9F7"N40=5;P7.RW(N(\SR3SL:M@H?4B"D R[D@BA.B8.Z+
MUS,"QK4Q0R'E&.D6T&CJBV_[9$6(_Z:;O_O4Y/_MCUL_G6UP8I4%6B$!D/<Z
M2L2X>,SFOF)U4E-ZM=1!!U,FH1=P.KWQ<65;+14Q=1<WJ27;?[=_W2BQL#+N
MJ6@FL;'&IE%;*GO.U YR2J^-.@A N<1> ()^]5/?Z$GBPMU4TRH9Y'GUW7=L
M"(<"D% %@+F-KCZC'LK<5F@/2:672!V$I)SB+P!-]Y;U0*XD<BG^:0'W2(A@
MF&$Z>V..7I257C5US#&74QD%>$R_ZFKZH9[-+J=?]"05VB\;1"3VTA?O;VYU
MU20AOK[6S=5F'JL0'FC)XKF.(*'(>45A[H?W0VDLO:SJ,),VI(**Z,__..1T
MF4N9F-VXP7 $E% .6,HQX@)2D7V2U18R2J^J.@A(IXJY &/5/OI]K*?U<U:Z
M;AM4 97&DG()/4/4"9;]#78W1:775AV&GWS"+\"U>MH$#^'Y:KJ(3#UVD9F]
M\J%N_/+WONH??O;V1SSJH]*JJ6[N6GGVZ\ZM;?0R9;RS4,P\=\@@*'(;KP'9
M*;[ ZR 4EZ+W JSI(XOW6WC9LW#+DQ>.;*1!=((%K)2U&.4VHQVD%%\;=@3T
M3I/WB["<.48:8"J DC(E\1A/F$2,T=P=&H;AI!]H7\JK8P':+L94/DAA:]>Y
MV4<_OPQQ=W>]P@0<@*+: AE\@"$XB;,/M3B&SGYX?2F/$8-KJ@ +O)6K'HRO
M>38;>9,RLNV( - ZYX5&R-K<XPPRD5Y"S>>0&%M_(!E!X:7B//E/(7@[;WN"
M;OY\H^VG3F.^- 30<\YP/&2HR_Y0=PRAXR8.E('AK,HL +&'2'4C8F)H:F7D
M --,2\6D\7[8,,%N^L;-43@[/@=370'NZZ>FCA?-;1%?J!4P5A(@H>/806D5
MS>V4/JW>[]A^*6D+1TIU1#RD#BP];G2??/-*SRK;=J[IVEQ,"&""H !YZ77Z
M_YJOA84V&[Z<0D _\)2>J7 V%11W&NYE<[- 3 &I@HP\.B&#]=:$W'D,!Y(X
MSKWC?)@Y./ASO )?"C[?5)/%W+NM#"(H4G5&VO8J7IX8CW_F[KUW,)'CW"O*
MQNC12BP.I=L=TXNI>QB0T7&3>O1=UZ31I0,N&5#(6D 8QE)KS9 9UO@.Q5D_
MF_U2LM *1,,+V2,K+'<?6=1RH'"T"$1R)JB4(?1K0370);P [Z-DY)UPAS\>
M!@7@_=B <(?P-RP29T!#Z(# )'"KL=$H=R@J,POE1U-'WAMC0J: '?-6-]/H
M%<X>1A%TR=2IU'0O7EP8]H18'XPRN1NS=M'2S[Z_E,3E+!(O$#GMJ;$1\6.1
M"6L(,)0ZYI7S,.2^"6XE9%R?((^.]P#G<($7$')?9^+>=FXDO@@&)-0>. X-
M]X$(AG.?M!VDC'MBG@4YQPB] .S\U5=7UY'NB^_Q#+[R'Q>IR]5EV!A(L'5C
M4!> UL$ *"RDUC+C9>YTS8,([&>A7DH5Q7"Z*>"HZV!NU>_;-1 #"PD,5@$X
MJ+S4$@5M<A^"!Y+8#WPOI01C2/V\A)D33[,;ZO#Z6D^O_*Q:#FNYKB=1E;.W
M_[6HYG?/63I\%$7?9;)/J#B*OTR#*Q[7CL9L8\4MIS/6!@CM!5"$"A H1HA*
MS;#+7?W9B[#!AEJT;$I&@<9> 4LDYMYH&[(/,2UIJ$5^+/0><;%?W@6<DX_4
M+R7RNKZYK:=IVZZU\5_*15B@K9> L/A-RJT-+O>IN).@0K!TA*:[0'.RV O
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MY80:2;EE++<].I#$DR>'/OO4Q]3L[50\'1//=P(AD "GL <B7MF #!H"Y'&
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M9QOO9^_THX2)M\SHF!D9C'1,(HY>3J>?+_;:N\4D.A3O&CV->WU6-RN- I.
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M0<S^<U22Z'Q)(R-VHD-OM;60Y)X/=2")^0S@SH5WG_<BWG&TM@9 HZG5CO/
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MGCXQ-9V<1^'&_?1ND0I%GC.\SIKE DCF#,"<(>\U14[37O@Y;-UQGSD'0=*
M@O\#EGY]U$WZ)]_]."5<&\N/78JU6QYG+ZFR' *CL 0P(!*4<ZFQ9V:WI:"2
M*J$1D) A$/]/*.5HL!!E9O</4U*U$QLGEU3M5,6(A^NLF?_MLYY>/55T>*H9
M\-0(( BQ0-I  7&*,D^XX ;WP4_\U!7LQ+\]X>;9@B^L2&JW$NM3)5H"#%:>
MUE?)IAYH;S%@QC 5''8].Q3T <*8*0TG*&M=W4=(;F2%_Q8]MYO%S7;">0B)
M< 4XQ4Q[KK3M5RNP1^7/%AU9Z<>HK,XAO[$5KW]T$XXP TI8$=D/V$B#*<:]
M&CWN4_SJHN-<N;,I_FCY%?#J_BZB=NX_1)_<Q:M<E$853[IEW\!7=[_I_ZR;
M-DU\U2#&.YP+%@BH%- &::!P4-18"3'*_21_ 'DOK):HE_<PM);*!N 38VMI
M@ROL!6B 5EX ZHUG-.ZQ8'-G!!](XLA%MD-!I3\D3]9; ;!,(?Q%_+@O=9C_
MKM,0IF<\/C?V#TQ1PH'T2 !L!*16*\:LRPS&7H05"\'3H5$/K:<"P/?XH/2Y
MNKI^5HT<F9  Z=2ORZ0^6DA!P$7<K19RQWQVR[>-D)&+P,\(KM/U4 "87B]F
M\_K&-^U0SA2NO:YN.UCARD:7USL %>52<@:)R&Z_NLD9][WDK%8KDTX*@%>?
M&N=63 $2"H25 4CB @C$!P/37(WL Q-R-!THI_KPH(M"3FV4#:[U7;AD2,6;
MMF(H=9@T%D8_5@H^0.WW2V\ZT!L"1S4=Z*N/,@!V?,FZY<QJ$#3VD5$?74K$
M)<"!(J&IP(KE[E?XAVXZT!LT.9L.]-9@L5!=Y>TWKZ>SR_FU;[Y>Z^E:>X45
M^>K@@>)QR\>][@)Q$DJ7>UCN\=2.>[T8 ZS9=5@L6M.VC-[.;(,M"2Q%)'J[
MQ@-C" /4A7B-\H$R?AYH;I VKILXEM$\7CL%@.Z=KIJ_Z,G"O[IK+VY;(IU+
M81F+@)'" :><9=(S:7CNT[J3F!=63WW80T46#90$I?L(@->I:8:[G'[V=M&D
ME/Y7>E;-ODUK,_/-]R2X]]/;Q?SYG-Y5*6S?ME13(*W!@&OBN2>:A.Q#78;B
M9>0H<QZH=0%X3+V/G5[]?"Y7&_R\#-]FVT/J]T).*<3"0*"M= P9RXGOUQZ@
MQV*% &U42-0#ZJ< >WO&!D8K4H&$ ZU8=*6Q\E(C$FS([6X6U%)ML%GCPSH5
M!6*C@!US2M^EU?B?BIH(V@&EN72.6P[M #>N_VFIE@-U&5NJ]87 V+[(CFY?
M*RQP;D D'0+$N&*62Z@\[^5^_-%:JO76:\^6:GV%/'(2Z^,^_=775XV^O:ZL
MGCQLL-4P+]<**(@)H(PC&'TL"/L5_>Q):.TD8)Q2Y>&K&O)(?&S8+,=WKK+P
MM)=6F4#, 2GC5TSI:$$B&4'U2HW8!YLN L9+AL^DV#JWE,<^B?Y=3V<Z#<;^
MK9K-ZD53K;PC*:@H0 (J(*2&P BD@&'!!:FLD][V.HHZ%A@1"7GT5F<68@'.
M]ZXI2*N"L21>NZ'&0*4+-U6689$['^&DF6/B91T\6>5?*(ZV;S%'/3#6&<"]
M0IX@IZ159T!2"5>Q/-H^:.98;]$7 **= XQ6&2%!1M$("$@PC#BEI92Y4X9/
MFQTUTNRQ_MH^9'94;]$7@*'W-[<ZM=#[4$^OVAS89; [/0G'P_K;S+M7=U_C
M9SUN.P4E 9A8F^Z%%FCA/7 *"1,"P2'[P)5#Z.N%-/DR#[[!]/0B,-A^XWG
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MWR.WQ;VLB:Y(" 98QK5V5B'M>R6K_R.]9.]6]!$OV3NE7B!RML>Y$%; "!U
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MW:WQ!$GC0K9*&.T&?\5T6C=$]X^.\Y&!1I*#$L%);"4C:(#U(\>)&MVREH-
M>WAUT$<= -MS#O\C3/W;9O[%3,/'^9KG]-?QY4W^D_W3!5W$H'&*:WGD5OM
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MJEF:Z7 %4Y_FS<_)(OWB;3//I?*_F<GLX^Q.6"]#;.9AK=\]2PH1RWUM-*E
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M]DGM2^+IKH0W_38XLUA^"O-)XW>2;9:!,D&"$R$B3HFG%+4*?UI^L!)O\YQ
M&TP?U6%LNY;N4[.8Y'%_=[SN/!-0!.D/&%#+-3.*"8EL-[0]]>E*O,GQ<5=4
M1]4C\$,>*GR$.Z<$&,$Y^"1%C@P*@N(R"-S^="T5_M4AL)>.*O  UPQVW1Z[
MR:F*#C12#ACA"A%JD"_N$G:GMI8JW1%\Q#.I>-158*>NM;_O%WLQ38<VJ^0
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M"F ]./;%S-^783?YCYZ4B_*YVE4S8%Z1Y*%:A]IMOCSC46G+VX7&^76<H$$
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M\WMH/T4T!F$PS'!06'@70J!8U-9"TI*U"[T8ZWCE& (^S^!^._#2VM$.621
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M5@=6W_R5))Q4.YF9^<WJS2S=0BX/A$W79?I/W\T2>4D8#Z((CB05:"S <**
M,H8,PYAQ5#J).B [XZ9%*X+Z(/KO?A3RO+:S>!OWO\R3:V:+4,:#./132WL%
MK:@_STU_ZX92Z4$R)T%9DS%"D?18\6!+IU(&O.E?7<_SZ7T;TNDWTR])1[ES
M]WWZ[Z8/HGX99B%.EH=$$*Q,YS7%X!HI@YE"GK#23=)=Z*SZ;F^-H6V#-[C&
M*KC4;WD\SMPV4]0)L,YY<%I9;3%RGI4N=&A%V+BX&QX?^P%94%GU('#[TCG
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M F2/&ZR- K<.'FQ)W5\(W)^J%[SCE0@$EE$#3A,B7?3!N])#Y_K0.VX\=BD
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M7_2ZKQ 3%9R4DQC\8*["?C/D(@:%:03*+"?8(!%]Z=*"CJ36X+K6A;ICCLI
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M!>2Y<SI9+Q%\*\.V_^>/NX3[3%:L@&BK,UF?S,W]?I)'L0M+]SEW H3BW-K
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M+GF]B_F428\IRB,, D?(J=]WI9\6H6M&E/%X&2.$[@EN6943V3 J_1H48^F
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MH*4X6Q6B3DMWV*7F.=CG!J$&<XD36RSPA>,:SJ#3EQZ#&JP0WF'R?,[SI0G
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MJT_95O]#30_[(Q<;?Q00\_GT5O5P&I.M93;<R.;R579P=5$UVKOLA_QZ9_8
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MQXALY595/O*%4_T;OK?:\]]Y_0]02P,$%     @ -IQL7')U&/JZ!    14
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M:-$@,5?6%6)2:EZ^.#@\VG@\)64,M-#,>&+Z!_O3$8J"(83]9KM;_JW+:/T
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MD@,P78V=PL&+S_;(]XO*\*P_+2*_]Q)LLD$02-YG, I'C+H?1+'7&UH8H+H
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M^8EUJ&67NXWV'"&E1]Q>X(T*<HS)7E^JE$(7 H[$O)0K##I@].$!5+3GQ@-
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MV/:R2F.PC$ 0H@J)5T:DX3F*798+2Y.,=EPF@B'EA!@$!="-NZGT*LXS;4F
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M;7Q!43 N^'P5/^4%0:A:R$OWD6:7[I)BO4![X6Y&6_%CT5K]^&#(C7,#QR/
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M?<)H)E'M]'(Q*!V!U'?5<MP PQND)-LU=R7K#3+569.?$JHO]V"-9KDT)]P
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M9W_G00"DAM#F!P]&FY\@H&II!/-K=PJ&T^JO;A.#5JVT)9LO.V(,;@?604M
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M$HYT1![-<STO*!41:ET/RX19%D>@ZDBW^5Y^2%JJN.E)V'7+-1M1)BG.=[[
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MP:LO-&1>!N.$W78J3!(A<7N(WYXF327MG:G>R)]K+C^7*GZN>)27),*P%"3
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MXY>=X_!X3V;.EZ]UWG /6$)%K-V1&B=6M=6PRP2.O?!OJIZWYJ2Q>W,9,,)
M^ >MP*^W!;E&@BYW8::'+_C'4^R+Z[6<KRIB@NW:)HX'P"5_72F:W]P&,^V?
M_;6ZX>,"&#RYV'EU$4>__W)V?@9_"6K0P E_?W7Y2W3R^G7T\N2WUY?FVZ$
ML*ZBPA!K;JC$NIDG=55@5]W=D4O<P=0:*7YDEW#9&Y*52ZT8P(NN^]*8]A+#
M-T8($U<P]XZ0W.4B=$3(>I@=(3NX9I8^YOI#D464/='E30%"L&@J^%4<O41'
MZ!>)HN-U>WM_^\O1\Q_V]_:B%P4Z%F +_?4@/M[;VXXC#UTS:6K*'QM< -I>
MQ/5G^8[1'9ICQ<P=#>&>&K%'X:'TLHV]M!5,%Q:?S\5UK]!FU0N,T*"F>W)B
M1NS$= G]#EUFB+E?#B6"UG,H(D:J[AZMTV*IE35_9B /BAO"[!0(^]$I=V&P
M6]@K,7%Q0\Y<2!6P9QP:T\_Z4 CTHR=4C@35DK2881$%1O@<2<X2@JJHJ@WM
M$D:GF;I._T![PY' TR(E C5(K94[TQ6:8"N%*@&YH=+H!6@N3*Y'A_MQ=+!W
M /_;_NA@_:-#-OO;'Q\%;/6_%F"VGRM*ZK[D)_\/^H)G>6I&ZK'>?M0V&?/&
M"%]_=)ND8WNXAC8+N,T<+1;DP>&-<M)<@3XP*WU\VTK_2G=86VK'%-R]WG69
M,$:MOE$9F#4\D,V[P Z_\UI^"=KN^-T_FQR,R#W>KG'T%FP<?P/'T9OB6O:T
M_1$^J?7Z/8#%D4>$G@\9$<(EZCH'&]J+"W.I'PO NZR1N[6=^RV7-T#3NBGS
MS@=LQQZ2&?PB; Z0=D%M?SXY>>>-A"'/0@0#]S-\T%A;3F4IW=V71 2;&7@"
M#Q!X8'^,X($[&<9?W@RV_KQ)28=T"Q@Y\\VF-0FO2[]F*:7F$[X",+(2_LY%
M8(;D.J,1:B9B-)@T&]V,S(L;C-T,*-ZE2/TVNT<"P[;=1HXU*1GN:"2V1QV-
M]NF.PD1 BD?-475FR?0]1BR4U]]@LF+QO)5CZACV.\M^ TBT4MCA$)AVSX Y
MKJZ0" B4@:M76B2:*G 1$D%PU:0$2W0%LG]!!PJT0Y.S/T2,IE74Y)H*@2BO
MW49!8W4OUQ!5R+N23#(F$*)41XK\2E6M-FB>1^"_CR<6?:%Q;M?W:>">M!G=
M/#/!(]K-!;4%3\#<_6G1E)6P7K=R([#A#3$6W023_K^:C7DBG5Q.&:@MO2Z(
M%)NNHN)SW!Z\B0P&VS;6G"@BY)D*>9L/;^IY!NSTW_U&2Z8N2XIW!$C!X0(X
M' 4%"WL@9X%U.0&+JKK+! >54 $'DH^,ESFC4,(=S\#1T6C/0#**,[#[C%X>
M+$-;7QO;%BPEYP.3JH*Y(PFULNFSTL6M76*=6PS9O#IC&[M:T_QU/][#L#08
M$P]_)2>C6$E\<Y5?@6&<6NAA62P*AH_&U"F(UHVZ5#9^3@)S#-?:[RY$N*?-
M@H5D( &\N642:T)!0F+M##VON\LD/N:&[N]J0UJW)S%'=2U(V9O7K7O8!EX/
M?_M,1[%]1!!PQ0CN#(%AX+2;>L'$L TXQ</,)V:+(&,)%=-X6Z1#[9S1CKG/
MZ=_L<CWL1%)OAY'?<M,H%M$PMLG6@/ 2/H*V#8B/K\R]DH\VSZ&AN6G18U2Q
M937T32.J8HTF";8AF/$M8@^PN74S5_0DY&"FK=KD]"?"0_D;U%%ES<JKR<V_
MO.]-FRL&XDLC,^_[Z;1L[.7\#_=MIL'5X#P)_<#]6YC Y7=8ULZRS[5UVP[
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MK"N",Z+&R'5?K(M4=]D\*L+FX@=;CRU!R+K.N"$>^9*5^)4.3+5V)GM$@$B
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MJ<' LWH+5A29:/2N6I@2R(#I"K2(TJQ>M1!.R).KNLT$85]-LD;>,BW*O:W
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MJ:]%><5?M 7_,\;C,2R?/],_0*XE#K0 6S$.8HZ=2%)6I2+B9^KN0-9FVC(
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M#_Y'P5OP_Z%IFM+VOWU&"[7'-5,Z"5>D9ZJU:U*'#8+A7/2+G2"C/S5MO4X
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MQ/"#/.+;"EB'2W;YDC0K$]%4" ZACVE6S).:U0]3R\F"G@YT.D[(()>U5?Q
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M5.O@^I%;O#^]BC?-%RQA&I@"SR:%5%SG>HYD([HPTT4A'BO0L^_)PRF78-2
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MT+1[4_,()^C>3;5PQ>R/#A]S_%AEP.A(0S:@57O"Q<<]^A$FK*W,$TN[0"=
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MPJ1P>D0+,5KHY8@6&O;_MFRYP>H-0I? 'ABQ!U_4R'JV?MZ7<FYZ2#QU_U%
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M6[-FA67I] C62>8>10X0-%'G%I(B6W+6$-B<C%:ZX 4MV_G1HG=\0+T!R$%
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MN8C63=,6Y[[7AL7B O'9U ;-"]-Q@Q9_1</@-S>T-IRO5G/J#JQ)#<F_"=H
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MY3KX</@.L+:/%  )Z/?,T-@R@I\*A%+ISWR%/ N&(6/L(5Q:LLV636 3H-)
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M2?_ -BO_BU6-X7_WXT'_7_\/4$L! A0#%     @ -IQL7$XRR'W< @   PH
M !\              ( !     &-O;G-E;G1O9F)D;W5S87!C,C R-7AE>#(S
M,2YH=&U02P$"% ,4    "  VG&Q<*1<Z/KBW @!T*AX $0
M@ $9 P  :GEN="TR,#(U,3(S,2YH=&U02P$"% ,4    "  VG&Q<6%W1FJ<5
M   \_@  $0              @ $ NP( :GEN="TR,#(U,3(S,2YX<V102P$"
M% ,4    "  VG&Q<RKS'29XH  #A P( %0              @ '6T ( :GEN
M="TR,#(U,3(S,5]C86PN>&UL4$L! A0#%     @ -IQL7-0_5FBN<0  ^UL&
M !4              ( !I_D" &IY;G0M,C R-3$R,S%?9&5F+GAM;%!+ 0(4
M Q0    ( #:<;%QH4]2[+28- *Q<#@ 4              "  8AK P!J>6YT
M+3(P,C4Q,C,Q7V<Q+FIP9U!+ 0(4 Q0    ( #:<;%S6>TX3+58! $9C#@ 5
M              "  >>1$ !J>6YT+3(P,C4Q,C,Q7VQA8BYX;6Q02P$"% ,4
M    "  VG&Q<5V$K^_[$  " ( L %0              @ %'Z!$ :GEN="TR
M,#(U,3(S,5]P<F4N>&UL4$L! A0#%     @ -IQL7!B^:#_F!P  [B4  !L
M             ( !>*T2 &IY;G0M,C R-3$R,S%X,3!K>&5X,S$R+FAT;5!+
M 0(4 Q0    ( #:<;%QR=1CZN@0   $5   ;              "  9>U$@!J
M>6YT+3(P,C4Q,C,Q>#$P:WAE>#,R,2YH=&U02P$"% ,4    "  VG&Q<,VCZ
MW?('  #,)0  '               @ &*NA( :GEN="TR,#(U,3(S,7@Q,'AK
M>&5X,S$Q+FAT;5!+ 0(4 Q0    ( #:<;%R[_/?9#&\  ,-5 P ,
M      "  ;;"$@!S;V-A;&%P82YH=&U02P$"% ,4    "  VG&Q<UOV4DKH&
M 0 ;]0< $               @ 'L,1, <V]U=&AE87-T87!A+FAT;5!+!08
1    #0 - &T#  #4.!0    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>jynt-20251231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2025"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:jynt="http://www.thejoint.com/20251231"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="jynt-20251231.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
        </entity>
        <period>
            <instant>2026-03-09</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FranchiseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FranchiseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:AdvertisingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:AdvertisingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:TechnologyServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:TechnologyServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:FranchisedUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:FranchisedUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:FranchisedUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:FranchisedUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:FranchisedUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:EntityOperatedUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:EntityOperatedUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:EntityOperatedUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:EntityOperatedUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:EntityOperatedUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jynt:KansasAndMissouriMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:EntityOperatedUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">jynt:OperatingLeaseRightOfUseAssetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">jynt:OperatingLeaseRightOfUseAssetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:FranchiseRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:FranchiseRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">jynt:OperatingLeaseRightOfUseAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">us-gaap:FiniteLivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">jynt:DiscontinuedOperationsHeldForUseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">jynt:DiscontinuedOperationsHeldForUseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">jynt:OperatingLeaseRightOfUseAssetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">jynt:DiscontinuedOperationsHeldForUseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:FiniteLivedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">jynt:DiscontinuedOperationsHeldForUseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">jynt:AssetsHeldForSaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">jynt:AssetsHeldForSaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">jynt:DiscontinuedOperationsHeldForUseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">jynt:DiscontinuedOperationsHeldForUseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">jynt:OperatingLeaseRightOfUseAssetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">jynt:DiscontinuedOperationsHeldForUseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:FiniteLivedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2027-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2028-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2029-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2030-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2031-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">jynt:PropertyPlantAndEquipmentExcludingConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">jynt:PropertyPlantAndEquipmentExcludingConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">jynt:DiscontinuedOperationsHeldForUseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-28</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-28</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">jynt:DevelopmentLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-28</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-28</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:A2022CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:A2022CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:A2022CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">jynt:DevelopmentLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-28</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:A2022CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-28</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:A2022CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-28</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:A2022CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-28</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:A2022CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">jynt:FederalReserveBankOfNewYorkRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-28</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-17</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-28</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:A2022CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
        </entity>
        <period>
            <instant>2025-06-03</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
        </entity>
        <period>
            <startDate>2025-11-04</startDate>
            <endDate>2025-11-04</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">jynt:CaliforniaAlternativeMinimumTaxCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">stpr:AZ</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">stpr:AZ</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">stpr:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">stpr:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">stpr:TX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">stpr:TX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalTaxJurisdictionOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalTaxJurisdictionOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">jynt:EmploymentMattersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">jynt:MedicalInjuryClaimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-25</startDate>
            <endDate>2025-02-25</endDate>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">jynt:MedicalInjuryClaimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:FranchiseOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:FranchiseOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FranchiseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:FranchiseOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FranchiseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:FranchiseOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:TechnologyServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:FranchiseOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:TechnologyServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:FranchiseOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jynt:BanderaPartnersLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">jynt:FranchiseLicensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">jynt:FranchiseLicensesOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">jynt:FranchiseLicensesTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">jynt:FranchiseLicensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">jynt:FranchiseLicensesOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">jynt:FranchiseLicensesTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">jynt:FranchiseLicensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">jynt:MrJeffersonGrammMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">jynt:UnaffiliatedFranchiseeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">jynt:MrJeffersonGrammMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">jynt:UnaffiliatedFranchiseeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">jynt:UnaffiliatedFranchiseeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">jynt:MrJeffersonGrammMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
        </entity>
        <period>
            <startDate>2025-10-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001612630</identifier>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="clinic">
        <measure>jynt:clinic</measure>
    </unit>
    <unit id="corporation">
        <measure>jynt:corporation</measure>
    </unit>
    <unit id="option">
        <measure>jynt:option</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="installment">
        <measure>jynt:installment</measure>
    </unit>
    <unit id="lease">
        <measure>jynt:lease</measure>
    </unit>
    <unit id="segment">
        <measure>jynt:segment</measure>
    </unit>
    <unit id="franchise">
        <measure>jynt:franchise</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-33">0001612630</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-34">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-35">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag contextRef="c-1" id="f-36">false</dei:AmendmentFlag>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-64" id="f-425">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-68" id="f-430">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-72" id="f-437">P1Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-74" id="f-439">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration contextRef="c-18" id="f-447">http://fasb.org/us-gaap/2025#GainLossOnSalesOfAssetsAndAssetImpairmentCharges</us-gaap:ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-101" id="f-588">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-102" id="f-589">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-103" id="f-590">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-104" id="f-591">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-105" id="f-592">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-106" id="f-593" xsi:nil="true"/>
    <dei:DocumentType contextRef="c-1" id="f-1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2025-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-4">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">001-36724</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-7">Joint Corp</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-9">90-0544160</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-10">16767 North Perimeter Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-11">Suite 110</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-12">Scottsdale</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-13">AZ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-14">85260</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-15">480</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-16">245-5960</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, $0.001 Par Value Per Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">JYNT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-20">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-21">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-22">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-23">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-24">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-25">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-26">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-27">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-28">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c-1" id="f-29">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c-2" decimals="-5" id="f-30" unitRef="usd">172500000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-31" unitRef="shares">14114334</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="c-1" id="f-32">&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Portions of the registrant&#x2019;s Proxy Statement relating to its 2026 Annual Meeting of Stockholders, filed with the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) pursuant to Regulation&#160;14A within 120 days after the registrant&#x2019;s fiscal year ended December&#160;31, 2025, are incorporated by reference in Part&#160;III of this Form&#160;10-K.&lt;/span&gt;&lt;/div&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="c-1" id="f-38">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Chief Technology Officer (&#x201c;CTO&#x201d;) is responsible for cybersecurity within our company, including information technology risks, controls, strategies and procedures. The Cybersecurity Subcommittee of the Board of Directors oversees cybersecurity for our company and meets with the CTO at least quarterly to discuss the status of cybersecurity efforts as well as any security incidents. Cybersecurity Subcommittee materials are provided to the Audit Committee as well as the full Board of Directors. The members of the Cybersecurity Subcommittee collectively bring at least 40 years of expertise and executive-level experience in information technology and cybersecurity to successfully support the CTO to maintain a strong cybersecurity strategy within our company. The Board of Directors believes that a strong cyber strategy based on industry accepted best practices is vital to protect our business, customers and assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our CTO leverages more than 20 years of technology experience in the healthcare and financial services industries involving managing information security, developing cybersecurity strategy, implementing effective information and cybersecurity programs and managing within highly regulated global environments. He has managed technology compliance under the regulatory governance of frameworks such as HIPAA, GDPR, FDA, CCPA and TJC Hospital Accreditation. Management has the responsibility to manage risk and bring to the Board of Directors attention the most material near-term and long-term risks to our Company. The CTO leads management&#x2019;s assessment and management of cybersecurity risk and regularly reviews cybersecurity matters with management. The CTO reports to our Chief Executive Officer.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A dedicated team of technology professionals works throughout the year to monitor all matters of risk relating to cybersecurity. We completed our ISO 27001 Information Security Management certification project culminating in a primary and secondary audit against the standard. We received our ISO 27001 certification after the successful completion of an external audit and remediation steps and will complete a regular external audit in March 2026. Additionally, we operate and are compliant under the following provisions: HIPAA attestation for the HIPAA Security Rule and the Health Information Technology for Economic and Clinical Health Act (HITECH) Breach Notification requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vendors that have access to our information are required to manage such information in accordance with laws and appropriate privacy and security standards. Standards are applied on a per-contract basis and include requirements to have an information security program and report to us any incidents in which its confidential information or systems are compromised. Depending &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;on the nature of the vendors&#x2019; access to our information, we monitor and evaluate the controls and governance established with the vendors ranging from a continuous cadence to at least quarterly.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have not directly encountered any incidents from cybersecurity threats to date, but in November 2022, a breach was suffered by one of our vendors, which resulted in the release of certain information with respect to our patients and employees. This breach is discussed in more detail in Item 1. Business, under Regulatory Environment entitled "HIPAA and State Privacy and Breach Notification Rules". Based upon our investigation and the cooperation with our vendor, we believe the data breach did not have a material adverse effect on our business or result in any material damage to us and do not believe are reasonably likely to materially affect our business strategy, results of operations, or financial condition. Although we have not yet been materially impacted by any cybersecurity incident, we are subject to cybersecurity threats, as discussed in Item 1A. Risk Factors, including in the risk factor entitled &#x201c;If we fail to properly maintain the integrity of our data or to strategically implement, upgrade or consolidate existing information systems, our reputation and business could be materially adversely affected&#x201d; and &#x201c;If our security systems are breached, we may face civil liability and public perception of our security measures could be diminished, either of which would negatively affect our ability to attract and retain patients&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We annually assess our cybersecurity programs against third-party requirements, including HIPAA and the Sarbanes-Oxley Act of 2002. We test multiple aspects of cybersecurity regularly, including annual pen testing over our proprietary information systems and our technical recovery and incident response procedures annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We maintain a robust privacy compliance program. Employees receive periodic email communications, which train them to detect and report malware, ransomware and other malicious software and social engineering attempts that may compromise our information technology systems. In the second quarter of 2024, we implemented the KnowBe4 security training system and completed our first annual training in August 2024. In 2025, we completed a semi-annual security and privacy training cycle utilizing the SIMBUS360 platform. In 2026, we will re-engage the KnowBe4 system with a heightened focus on phishing awareness.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Currently, we rely on an established major incident management and communication process to address any potential cybersecurity incidents. This established process includes the use of third party partnerships to make available the distinct skill sets needed to assist in properly responding to any cybersecurity threat. We have established defined response procedures to effectively address any cyber threat that may occur regardless of the safeguards in place that minimize the chance of a successful cyberattack. The response procedures are designed to identify, analyze, contain and remediate such cyber incidents expeditiously. These procedures and approach to safeguard our information and assets will be continuously monitored by management and updated to evolve with the current cyber landscape in alignment with the ISO 27001 standard mentioned above.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock contextRef="c-1" id="f-37">Our Chief Technology Officer (&#x201c;CTO&#x201d;) is responsible for cybersecurity within our company, including information technology risks, controls, strategies and procedures. The Cybersecurity Subcommittee of the Board of Directors oversees cybersecurity for our company and meets with the CTO at least quarterly to discuss the status of cybersecurity efforts as well as any security incidents. Management has the responsibility to manage risk and bring to the Board of Directors attention the most material near-term and long-term risks to our Company. The CTO leads management&#x2019;s assessment and management of cybersecurity risk and regularly reviews cybersecurity matters with management. The CTO reports to our Chief Executive Officer.</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-39">Our Chief Technology Officer (&#x201c;CTO&#x201d;) is responsible for cybersecurity within our company, including information technology risks, controls, strategies and procedures.</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag contextRef="c-1" id="f-40">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-42">The Cybersecurity Subcommittee of the Board of Directors oversees cybersecurity for our company and meets with the CTO at least quarterly to discuss the status of cybersecurity efforts as well as any security incidents. Cybersecurity Subcommittee materials are provided to the Audit Committee as well as the full Board of Directors. The members of the Cybersecurity Subcommittee collectively bring at least 40 years of expertise and executive-level experience in information technology and cybersecurity to successfully support the CTO to maintain a strong cybersecurity strategy within our company.</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="c-1" id="f-41">The Cybersecurity Subcommittee of the Board of Directors oversees cybersecurity for our company and meets with the CTO at least quarterly to discuss the status of cybersecurity efforts as well as any security incidents. Cybersecurity Subcommittee materials are provided to the Audit Committee as well as the full Board of Directors. The members of the Cybersecurity Subcommittee collectively bring at least 40 years of expertise and executive-level experience in information technology and cybersecurity to successfully support the CTO to maintain a strong cybersecurity strategy within our company. The Board of Directors believes that a strong cyber strategy based on industry accepted best practices is vital to protect our business, customers and assets.</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-43">Cybersecurity Subcommittee</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag contextRef="c-1" id="f-44">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock contextRef="c-1" id="f-45">Our CTO leverages more than 20 years of technology experience in the healthcare and financial services industries involving managing information security, developing cybersecurity strategy, implementing effective information and cybersecurity programs and managing within highly regulated global environments. He has managed technology compliance under the regulatory governance of frameworks such as HIPAA, GDPR, FDA, CCPA and TJC Hospital Accreditation.</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-46">Management has the responsibility to manage risk and bring to the Board of Directors attention the most material near-term and long-term risks to our Company. The CTO leads management&#x2019;s assessment and management of cybersecurity risk and regularly reviews cybersecurity matters with management. The CTO reports to our Chief Executive Officer.</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="c-1" id="f-47">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="c-1" id="f-48">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock contextRef="c-1" id="f-49">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Currently, we rely on an established major incident management and communication process to address any potential cybersecurity incidents. This established process includes the use of third party partnerships to make available the distinct skill sets needed to assist in properly responding to any cybersecurity threat. We have established defined response procedures to effectively address any cyber threat that may occur regardless of the safeguards in place that minimize the chance of a successful cyberattack. The response procedures are designed to identify, analyze, contain and remediate such cyber incidents expeditiously. These procedures and approach to safeguard our information and assets will be continuously monitored by management and updated to evolve with the current cyber landscape in alignment with the ISO 27001 standard mentioned above.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="c-1" id="f-50">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="c-1" id="f-51">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <dei:AuditorName contextRef="c-1" id="f-52">BDO USA, P.C.</dei:AuditorName>
    <dei:AuditorFirmId contextRef="c-1" id="f-53">243</dei:AuditorFirmId>
    <dei:AuditorLocation contextRef="c-1" id="f-54">Phoenix, Arizona</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="0" id="f-55" unitRef="usd">23601810</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="0" id="f-56" unitRef="usd">25051355</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="0" id="f-57" unitRef="usd">700058</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="0" id="f-58" unitRef="usd">945081</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-4" decimals="0" id="f-59" unitRef="usd">2849864</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-5" decimals="0" id="f-60" unitRef="usd">2586381</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent contextRef="c-4" decimals="0" id="f-61" unitRef="usd">945933</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent contextRef="c-5" decimals="0" id="f-62" unitRef="usd">1055582</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="0" id="f-63" unitRef="usd">1744556</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-5" decimals="0" id="f-64" unitRef="usd">1787994</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-6" decimals="-5" id="f-65" unitRef="usd">1000000.0</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-7" decimals="-5" id="f-66" unitRef="usd">1100000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-4" decimals="0" id="f-67" unitRef="usd">22246318</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-5" decimals="0" id="f-68" unitRef="usd">43151055</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="0" id="f-69" unitRef="usd">52088539</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-5" decimals="0" id="f-70" unitRef="usd">74577448</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="0" id="f-71" unitRef="usd">3159226</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-5" decimals="0" id="f-72" unitRef="usd">3206754</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="0" id="f-73" unitRef="usd">1572173</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-5" decimals="0" id="f-74" unitRef="usd">555536</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:ContractWithCustomerAssetNetNoncurrent contextRef="c-4" decimals="0" id="f-75" unitRef="usd">3827129</us-gaap:ContractWithCustomerAssetNetNoncurrent>
    <us-gaap:ContractWithCustomerAssetNetNoncurrent contextRef="c-5" decimals="0" id="f-76" unitRef="usd">4513891</us-gaap:ContractWithCustomerAssetNetNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="c-4" decimals="0" id="f-77" unitRef="usd">319460</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="c-5" decimals="0" id="f-78" unitRef="usd">300779</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-4" decimals="0" id="f-79" unitRef="usd">60966527</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-5" decimals="0" id="f-80" unitRef="usd">83154408</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="0" id="f-81" unitRef="usd">1588665</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-5" decimals="0" id="f-82" unitRef="usd">1750938</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="0" id="f-83" unitRef="usd">1501838</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-5" decimals="0" id="f-84" unitRef="usd">1505827</us-gaap:AccruedLiabilitiesCurrent>
    <jynt:CoOpFundsLiabilityCurrent contextRef="c-4" decimals="0" id="f-85" unitRef="usd">700058</jynt:CoOpFundsLiabilityCurrent>
    <jynt:CoOpFundsLiabilityCurrent contextRef="c-5" decimals="0" id="f-86" unitRef="usd">945082</jynt:CoOpFundsLiabilityCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="0" id="f-87" unitRef="usd">4055752</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-5" decimals="0" id="f-88" unitRef="usd">3551173</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="0" id="f-89" unitRef="usd">194179</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-5" decimals="0" id="f-90" unitRef="usd">483337</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="0" id="f-91" unitRef="usd">2519018</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-5" decimals="0" id="f-92" unitRef="usd">2546926</us-gaap:ContractWithCustomerLiabilityCurrent>
    <jynt:UpfrontRegionalDeveloperFeesCurrent contextRef="c-4" decimals="0" id="f-93" unitRef="usd">277394</jynt:UpfrontRegionalDeveloperFeesCurrent>
    <jynt:UpfrontRegionalDeveloperFeesCurrent contextRef="c-5" decimals="0" id="f-94" unitRef="usd">288095</jynt:UpfrontRegionalDeveloperFeesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-4" decimals="0" id="f-95" unitRef="usd">611231</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-5" decimals="0" id="f-96" unitRef="usd">603250</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-6" decimals="-5" id="f-97" unitRef="usd">6100000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-7" decimals="-5" id="f-98" unitRef="usd">7100000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-4" decimals="0" id="f-99" unitRef="usd">21368446</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-5" decimals="0" id="f-100" unitRef="usd">37367459</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="0" id="f-101" unitRef="usd">32816581</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-5" decimals="0" id="f-102" unitRef="usd">49042087</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="0" id="f-103" unitRef="usd">1815527</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-5" decimals="0" id="f-104" unitRef="usd">311689</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-4" decimals="0" id="f-105" unitRef="usd">10899271</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-5" decimals="0" id="f-106" unitRef="usd">12450179</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <jynt:UpfrontRegionalDeveloperFeesNoncurrent contextRef="c-4" decimals="0" id="f-107" unitRef="usd">355556</jynt:UpfrontRegionalDeveloperFeesNoncurrent>
    <jynt:UpfrontRegionalDeveloperFeesNoncurrent contextRef="c-5" decimals="0" id="f-108" unitRef="usd">672334</jynt:UpfrontRegionalDeveloperFeesNoncurrent>
    <us-gaap:Liabilities contextRef="c-4" decimals="0" id="f-109" unitRef="usd">45886935</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-5" decimals="0" id="f-110" unitRef="usd">62476289</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-111" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-5" id="f-112" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-113"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-114"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-5" decimals="INF" id="f-115" unitRef="shares">50000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-116" unitRef="shares">50000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c-5" decimals="INF" id="f-117" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-5" decimals="INF" id="f-118" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-119" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-4" decimals="INF" id="f-120" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue contextRef="c-4" decimals="0" id="f-121" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-5" decimals="0" id="f-122" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-123"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-124"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-125" unitRef="shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-5" decimals="INF" id="f-126" unitRef="shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="INF" id="f-127" unitRef="shares">15471715</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-128" unitRef="shares">14142626</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-5" decimals="INF" id="f-129" unitRef="shares">15192893</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-5" decimals="INF" id="f-130" unitRef="shares">15159878</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="0" id="f-131" unitRef="usd">15471</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-5" decimals="0" id="f-132" unitRef="usd">15192</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-4" decimals="0" id="f-133" unitRef="usd">52026407</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-5" decimals="0" id="f-134" unitRef="usd">49210455</us-gaap:AdditionalPaidInCapital>
    <us-gaap:TreasuryStockCommonShares contextRef="c-4" decimals="INF" id="f-135" unitRef="shares">1329089</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-5" decimals="INF" id="f-136" unitRef="shares">33015</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue contextRef="c-4" decimals="0" id="f-137" unitRef="usd">12192081</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue contextRef="c-5" decimals="0" id="f-138" unitRef="usd">870058</us-gaap:TreasuryStockCommonValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="0" id="f-139" unitRef="usd">-24795205</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-5" decimals="0" id="f-140" unitRef="usd">-27702470</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="0" id="f-141" unitRef="usd">15054592</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="0" id="f-142" unitRef="usd">20653119</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="c-4" decimals="0" id="f-143" unitRef="usd">25000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="c-5" decimals="0" id="f-144" unitRef="usd">25000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="0" id="f-145" unitRef="usd">15079592</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-5" decimals="0" id="f-146" unitRef="usd">20678119</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="0" id="f-147" unitRef="usd">60966527</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-5" decimals="0" id="f-148" unitRef="usd">83154408</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-8" decimals="0" id="f-149" unitRef="usd">33203885</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-9" decimals="0" id="f-150" unitRef="usd">32144796</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-10" decimals="0" id="f-151" unitRef="usd">3371504</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-11" decimals="0" id="f-152" unitRef="usd">2997850</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-12" decimals="0" id="f-153" unitRef="usd">10451281</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-13" decimals="0" id="f-154" unitRef="usd">9180281</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-14" decimals="0" id="f-155" unitRef="usd">6037385</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-15" decimals="0" id="f-156" unitRef="usd">5687326</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-16" decimals="0" id="f-157" unitRef="usd">1831537</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-17" decimals="0" id="f-158" unitRef="usd">2153177</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-1" decimals="0" id="f-159" unitRef="usd">54895592</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-18" decimals="0" id="f-160" unitRef="usd">52163430</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-10" decimals="0" id="f-161" unitRef="usd">9500559</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-11" decimals="0" id="f-162" unitRef="usd">10063644</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-14" decimals="0" id="f-163" unitRef="usd">1724915</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-15" decimals="0" id="f-164" unitRef="usd">1453204</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfRevenue contextRef="c-1" decimals="0" id="f-165" unitRef="usd">11225474</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-18" decimals="0" id="f-166" unitRef="usd">11516848</us-gaap:CostOfRevenue>
    <us-gaap:SellingAndMarketingExpense contextRef="c-1" decimals="0" id="f-167" unitRef="usd">13299399</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-18" decimals="0" id="f-168" unitRef="usd">10973610</us-gaap:SellingAndMarketingExpense>
    <us-gaap:DepreciationAndAmortization contextRef="c-1" decimals="0" id="f-169" unitRef="usd">1644161</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-18" decimals="0" id="f-170" unitRef="usd">1371389</us-gaap:DepreciationAndAmortization>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="0" id="f-171" unitRef="usd">29632036</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-18" decimals="0" id="f-172" unitRef="usd">30124589</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="0" id="f-173" unitRef="usd">44575596</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-18" decimals="0" id="f-174" unitRef="usd">42469588</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="c-1" decimals="0" id="f-175" unitRef="usd">-7898</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="c-18" decimals="0" id="f-176" unitRef="usd">-66019</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="0" id="f-177" unitRef="usd">-913376</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-18" decimals="0" id="f-178" unitRef="usd">-1889025</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="0" id="f-179" unitRef="usd">683872</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-18" decimals="0" id="f-180" unitRef="usd">280287</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="0" id="f-181" unitRef="usd">-229504</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-18" decimals="0" id="f-182" unitRef="usd">-1608738</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="0" id="f-183" unitRef="usd">38653</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-18" decimals="0" id="f-184" unitRef="usd">5606</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c-1" decimals="0" id="f-185" unitRef="usd">-268157</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c-18" decimals="0" id="f-186" unitRef="usd">-1614344</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="c-1" decimals="0" id="f-187" unitRef="usd">3200629</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="c-18" decimals="0" id="f-188" unitRef="usd">-3972286</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation contextRef="c-1" decimals="0" id="f-189" unitRef="usd">25207</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation contextRef="c-18" decimals="0" id="f-190" unitRef="usd">210263</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="c-1" decimals="0" id="f-191" unitRef="usd">3175422</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="c-18" decimals="0" id="f-192" unitRef="usd">-4182549</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="0" id="f-193" unitRef="usd">2907265</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-18" decimals="0" id="f-194" unitRef="usd">-5796893</us-gaap:ProfitLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="c-1"
      decimals="2"
      id="f-195"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="c-18"
      decimals="2"
      id="f-196"
      unitRef="usdPerShare">-0.11</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="c-1"
      decimals="2"
      id="f-197"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="c-18"
      decimals="2"
      id="f-198"
      unitRef="usdPerShare">-0.11</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="c-1"
      decimals="2"
      id="f-199"
      unitRef="usdPerShare">0.21</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="c-18"
      decimals="2"
      id="f-200"
      unitRef="usdPerShare">-0.28</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="c-1"
      decimals="2"
      id="f-201"
      unitRef="usdPerShare">0.21</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="c-18"
      decimals="2"
      id="f-202"
      unitRef="usdPerShare">-0.28</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-203"
      unitRef="usdPerShare">0.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-18"
      decimals="2"
      id="f-204"
      unitRef="usdPerShare">-0.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-205"
      unitRef="usdPerShare">0.19</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-18"
      decimals="2"
      id="f-206"
      unitRef="usdPerShare">-0.38</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-207" unitRef="shares">15134215</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-18" decimals="0" id="f-208" unitRef="shares">14919091</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-209" unitRef="shares">15134215</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-18" decimals="0" id="f-210" unitRef="shares">15147247</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-19"
      decimals="INF"
      id="f-211"
      unitRef="shares">14783757</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-19" decimals="0" id="f-212" unitRef="usd">14783</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-20" decimals="0" id="f-213" unitRef="usd">47498151</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-21"
      decimals="INF"
      id="f-214"
      unitRef="shares">32124</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-21" decimals="0" id="f-215" unitRef="usd">-860475</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-22" decimals="0" id="f-216" unitRef="usd">-21905577</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-23" decimals="0" id="f-217" unitRef="usd">24746882</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-24" decimals="0" id="f-218" unitRef="usd">25000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-25" decimals="0" id="f-219" unitRef="usd">24771882</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-26" decimals="0" id="f-220" unitRef="usd">1679005</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-27" decimals="0" id="f-221" unitRef="usd">1679005</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-18" decimals="0" id="f-222" unitRef="usd">1679005</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-28"
      decimals="INF"
      id="f-223"
      unitRef="shares">181184</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-28" decimals="0" id="f-224" unitRef="usd">181</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-26" decimals="0" id="f-225" unitRef="usd">-181</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-18" decimals="0" id="f-226" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-28"
      decimals="INF"
      id="f-227"
      unitRef="shares">227952</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-28" decimals="0" id="f-228" unitRef="usd">228</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-26" decimals="0" id="f-229" unitRef="usd">33480</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-27" decimals="0" id="f-230" unitRef="usd">33708</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-18" decimals="0" id="f-231" unitRef="usd">33708</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="c-29"
      decimals="INF"
      id="f-232"
      unitRef="shares">891</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-29" decimals="0" id="f-233" unitRef="usd">9583</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-27" decimals="0" id="f-234" unitRef="usd">9583</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-18" decimals="0" id="f-235" unitRef="usd">9583</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProfitLoss contextRef="c-30" decimals="0" id="f-236" unitRef="usd">-5796893</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-27" decimals="0" id="f-237" unitRef="usd">-5796893</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-18" decimals="0" id="f-238" unitRef="usd">-5796893</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-31"
      decimals="INF"
      id="f-239"
      unitRef="shares">15192893</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-31" decimals="0" id="f-240" unitRef="usd">15192</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-32" decimals="0" id="f-241" unitRef="usd">49210455</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-33"
      decimals="INF"
      id="f-242"
      unitRef="shares">33015</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-33" decimals="0" id="f-243" unitRef="usd">-870058</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-34" decimals="0" id="f-244" unitRef="usd">-27702470</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-35" decimals="0" id="f-245" unitRef="usd">20653119</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-36" decimals="0" id="f-246" unitRef="usd">25000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-5" decimals="0" id="f-247" unitRef="usd">20678119</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-37" decimals="0" id="f-248" unitRef="usd">1297433</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-38" decimals="0" id="f-249" unitRef="usd">1297433</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="0" id="f-250" unitRef="usd">1297433</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-39"
      decimals="INF"
      id="f-251"
      unitRef="shares">155362</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-39" decimals="0" id="f-252" unitRef="usd">155</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-37" decimals="0" id="f-253" unitRef="usd">-155</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-1" decimals="0" id="f-254" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-39"
      decimals="INF"
      id="f-255"
      unitRef="shares">123460</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-39" decimals="0" id="f-256" unitRef="usd">124</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-37" decimals="0" id="f-257" unitRef="usd">1518674</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-38" decimals="0" id="f-258" unitRef="usd">1518798</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-1" decimals="0" id="f-259" unitRef="usd">1518798</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="c-40"
      decimals="INF"
      id="f-260"
      unitRef="shares">779</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-40" decimals="0" id="f-261" unitRef="usd">8440</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-38" decimals="0" id="f-262" unitRef="usd">8440</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="0" id="f-263" unitRef="usd">8440</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-40"
      decimals="INF"
      id="f-264"
      unitRef="shares">1295295</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-40" decimals="0" id="f-265" unitRef="usd">11313583</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-38" decimals="0" id="f-266" unitRef="usd">11313583</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-1" decimals="0" id="f-267" unitRef="usd">11313583</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:ProfitLoss contextRef="c-41" decimals="0" id="f-268" unitRef="usd">2907265</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-38" decimals="0" id="f-269" unitRef="usd">2907265</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="0" id="f-270" unitRef="usd">2907265</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-42"
      decimals="INF"
      id="f-271"
      unitRef="shares">15471715</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-42" decimals="0" id="f-272" unitRef="usd">15471</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-43" decimals="0" id="f-273" unitRef="usd">52026407</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-44"
      decimals="INF"
      id="f-274"
      unitRef="shares">1329089</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-44" decimals="0" id="f-275" unitRef="usd">-12192081</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-45" decimals="0" id="f-276" unitRef="usd">-24795205</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-46" decimals="0" id="f-277" unitRef="usd">15054592</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-47" decimals="0" id="f-278" unitRef="usd">25000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="0" id="f-279" unitRef="usd">15079592</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="0" id="f-280" unitRef="usd">2907265</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-18" decimals="0" id="f-281" unitRef="usd">-5796893</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="0" id="f-282" unitRef="usd">1713719</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-18" decimals="0" id="f-283" unitRef="usd">4722137</us-gaap:DepreciationDepletionAndAmortization>
    <jynt:NetGainLossOnDispositionOfAssetsOrAssetImpairment contextRef="c-1" decimals="0" id="f-284" unitRef="usd">-5448908</jynt:NetGainLossOnDispositionOfAssetsOrAssetImpairment>
    <jynt:NetGainLossOnDispositionOfAssetsOrAssetImpairment contextRef="c-18" decimals="0" id="f-285" unitRef="usd">-7780574</jynt:NetGainLossOnDispositionOfAssetsOrAssetImpairment>
    <jynt:GainLossOnTerminationOfFranchisingAgreements contextRef="c-1" decimals="0" id="f-286" unitRef="usd">347097</jynt:GainLossOnTerminationOfFranchisingAgreements>
    <jynt:GainLossOnTerminationOfFranchisingAgreements contextRef="c-18" decimals="0" id="f-287" unitRef="usd">239335</jynt:GainLossOnTerminationOfFranchisingAgreements>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="c-1" decimals="0" id="f-288" unitRef="usd">93066</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="c-18" decimals="0" id="f-289" unitRef="usd">-55556</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-1" decimals="0" id="f-290" unitRef="usd">286232</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-18" decimals="0" id="f-291" unitRef="usd">220893</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="0" id="f-292" unitRef="usd">1297433</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-18" decimals="0" id="f-293" unitRef="usd">1679005</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="0" id="f-294" unitRef="usd">-1534554</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-18" decimals="0" id="f-295" unitRef="usd">1645078</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="0" id="f-296" unitRef="usd">35389</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-18" decimals="0" id="f-297" unitRef="usd">-101167</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset contextRef="c-1" decimals="0" id="f-298" unitRef="usd">-547192</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset contextRef="c-18" decimals="0" id="f-299" unitRef="usd">-499285</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInDepositOtherAssets contextRef="c-1" decimals="0" id="f-300" unitRef="usd">5276</us-gaap:IncreaseDecreaseInDepositOtherAssets>
    <us-gaap:IncreaseDecreaseInDepositOtherAssets contextRef="c-18" decimals="0" id="f-301" unitRef="usd">-8827</us-gaap:IncreaseDecreaseInDepositOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="0" id="f-302" unitRef="usd">-391127</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-18" decimals="0" id="f-303" unitRef="usd">68258</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-1" decimals="0" id="f-304" unitRef="usd">-2994297</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-18" decimals="0" id="f-305" unitRef="usd">4609759</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-1" decimals="0" id="f-306" unitRef="usd">-839892</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-18" decimals="0" id="f-307" unitRef="usd">2398765</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-1" decimals="0" id="f-308" unitRef="usd">-5103266</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-18" decimals="0" id="f-309" unitRef="usd">-3796648</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-1" decimals="0" id="f-310" unitRef="usd">-1444410</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-18" decimals="0" id="f-311" unitRef="usd">-597489</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <jynt:IncreaseDecreaseInRegionalDeveloperFees contextRef="c-1" decimals="0" id="f-312" unitRef="usd">-285443</jynt:IncreaseDecreaseInRegionalDeveloperFees>
    <jynt:IncreaseDecreaseInRegionalDeveloperFees contextRef="c-18" decimals="0" id="f-313" unitRef="usd">-421213</jynt:IncreaseDecreaseInRegionalDeveloperFees>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="c-1" decimals="0" id="f-314" unitRef="usd">-543663</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="c-18" decimals="0" id="f-315" unitRef="usd">-121408</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="0" id="f-316" unitRef="usd">1838509</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-18" decimals="0" id="f-317" unitRef="usd">9415050</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromDivestitureOfBusinesses contextRef="c-1" decimals="0" id="f-318" unitRef="usd">7778287</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses contextRef="c-18" decimals="0" id="f-319" unitRef="usd">554100</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="0" id="f-320" unitRef="usd">1503785</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-18" decimals="0" id="f-321" unitRef="usd">1185647</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="0" id="f-322" unitRef="usd">6274502</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-18" decimals="0" id="f-323" unitRef="usd">-631547</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-1" decimals="0" id="f-324" unitRef="usd">4354</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-18" decimals="0" id="f-325" unitRef="usd">25484</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="0" id="f-326" unitRef="usd">8440</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-18" decimals="0" id="f-327" unitRef="usd">9583</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="0" id="f-328" unitRef="usd">11313583</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-18" decimals="0" id="f-329" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-1" decimals="0" id="f-330" unitRef="usd">1518798</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-18" decimals="0" id="f-331" unitRef="usd">33708</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:RepaymentsOfNotesPayable contextRef="c-1" decimals="0" id="f-332" unitRef="usd">0</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="c-18" decimals="0" id="f-333" unitRef="usd">2000000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="0" id="f-334" unitRef="usd">-9807579</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-18" decimals="0" id="f-335" unitRef="usd">-2001359</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="0" id="f-336" unitRef="usd">-1694568</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-18" decimals="0" id="f-337" unitRef="usd">6782144</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="0" id="f-338" unitRef="usd">25996436</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-25" decimals="0" id="f-339" unitRef="usd">19214292</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="0" id="f-340" unitRef="usd">24301868</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="0" id="f-341" unitRef="usd">25996436</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="0" id="f-342" unitRef="usd">23601810</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="0" id="f-343" unitRef="usd">25051355</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash contextRef="c-4" decimals="0" id="f-344" unitRef="usd">700058</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash contextRef="c-5" decimals="0" id="f-345" unitRef="usd">945081</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="0" id="f-346" unitRef="usd">24301868</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="0" id="f-347" unitRef="usd">25996436</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="0" id="f-348" unitRef="usd">50694</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-18" decimals="0" id="f-349" unitRef="usd">69445</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-1" decimals="0" id="f-350" unitRef="usd">626752</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-18" decimals="0" id="f-351" unitRef="usd">610492</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-1" decimals="0" id="f-352" unitRef="usd">245250</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-18" decimals="0" id="f-353" unitRef="usd">124699</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <jynt:StockOptionExerciseReceivable contextRef="c-1" decimals="0" id="f-354" unitRef="usd">0</jynt:StockOptionExerciseReceivable>
    <jynt:StockOptionExerciseReceivable contextRef="c-18" decimals="0" id="f-355" unitRef="usd">896766</jynt:StockOptionExerciseReceivable>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-356">Nature of Operations and Summary of Significant Accounting Policies&lt;div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;These financial statements represent the consolidated financial statements of The Joint Corp., which includes its variable interest entities (&#x201c;VIEs&#x201d;), and its wholly owned subsidiary, The Joint Corporate Unit No. 1, LLC (collectively, the &#x201c;Company&#x201d;). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amount of assets, liabilities, revenue, costs, expenses, other (expenses) income, and income taxes that are reported in the consolidated financial statements and accompanying disclosures. These estimates are based on management&#x2019;s best knowledge of current events, historical experience, actions that we may undertake in the future and on various other assumptions that are believed to be reasonable under the circumstances. As a result, actual results may be different from these estimates. For a discussion of significant estimates and judgments made in recognizing revenue, accounting for leases, and accounting for income taxes, see Note 2, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Revenue Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, Note 9, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, and Note 10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The results of operations of the corporate clinic segment are reported in Income (loss) from discontinued operations before income tax expense in its consolidated income statements for all periods presented and the related assets and liabilities associated with discontinued operations are classified as discontinued operation assets and liabilities in the consolidated balance sheets at December&#160;31, 2025 and 2024. The consolidated statement of cash flows includes cash flows related to the discontinued operations and accordingly, cash flow amounts for discontinued operations are disclosed in Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Divestitures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;. All results and information in the consolidated financial statements are presented as continuing operations and exclude the corporate clinic segment unless otherwise noted specifically as discontinued operations. For additional information, refer to Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Divestitures.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements include the accounts of The Joint and its wholly owned subsidiary, The Joint Corporate Unit No. 1, LLC, which was dormant for all periods presented. We consolidate VIEs in which we are the primary beneficiary in accordance with Accounting Standards Codification 810, Consolidations (&#x201c;ASC 810&#x201d;). Non-controlling interests represent third-party equity ownership interests in VIEs. All significant inter-affiliate accounts and transactions between The Joint and its VIEs have been eliminated in consolidation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income (loss) and comprehensive income (loss) are the same for the years ended December&#160;31, 2025 and 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nature of Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Joint Corp., a Delaware corporation, was formed on March 10, 2010 for the principal purpose of franchising, developing, selling regional developer rights, supporting the operations of franchised chiropractic clinics at locations throughout the United States of America. The franchising of chiropractic clinics is regulated by the Federal Trade Commission and various state authorities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the number of clinics in operation under franchise agreements and as company-owned or managed for the years ended December&#160;31, 2025 and 2024. All company-owned or managed clinics operations are recorded as discontinued operations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.777%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Franchised clinics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinics open at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Opened during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sold during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Closed during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinics in operation at the end of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.777%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Company-owned or managed clinics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinics open at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Opened during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sold during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Closed during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinics in operation at the end of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total clinics in operation at the end of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinic licenses sold but not yet developed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Executed letters of intent for future clinic licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain states prohibit the &#x201c;corporate practice of chiropractic,&#x201d; which restricts business corporations from practicing chiropractic care by exercising control over clinical decisions by chiropractic doctors. In states that prohibit the corporate practice of chiropractic, we typically enter into long-term management agreements with professional corporations (&#x201c;PCs&#x201d;) that are owned by licensed chiropractic doctors, which, in turn, employ or contract with doctors who provide professional chiropractic care in our clinics. Under these management agreements with PCs, we provide, on an exclusive basis, all non-clinical services of the chiropractic practice. We have entered into such management agreements with four PCs. In connection with the sale of five company-owned or managed clinics located in Kansas and Missouri, we terminated our management agreement with one PC as of June 30, 2025. For additional information on clinic sales, refer to Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Divestitures.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; If an entity is deemed to be the primary beneficiary of a VIE, the entity is required to consolidate the VIE in its financial statements. An entity is deemed to be the primary beneficiary of a VIE if it has both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE&#x2019;s economic performance, and (b) the obligation to absorb the majority of losses of the VIE or the right to receive the majority of benefits from the VIE. In accordance with relevant accounting guidance, these PCs were determined to be VIEs, as fees paid by the PCs to us as our management service provider are considered variable interests because the fees do not meet all the following criteria: (1) the fees are compensation for services provided and are commensurate with the level of effort required to provide those services; (2) the decision maker or service provider does not hold other interests in the VIE that individually, or in the aggregate, would absorb more than an insignificant amount of the VIE&#x2019;s expected losses or receive more than an insignificant amount of the VIE&#x2019;s expected residual returns; and (3) the service arrangement includes only terms, conditions, or amounts that are customarily present in arrangements for similar services negotiated at arm&#x2019;s length. Additionally, we have determined that we have the ability to direct the activities that most significantly impact the performance of these PCs and has an obligation to absorb losses or receive benefits which could potentially be significant to the PCs. Accordingly, the PCs are VIEs for which we are the primary beneficiary and are consolidated by us. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The revenues of VIEs represent the revenues of company-managed clinics in states that prohibit the corporate practice of chiropractic. Our involvement with VIEs affects our financial performance and cash flows primarily through amounts recorded as revenues from company-owned or managed clinics and general and administrative expenses, which are principally comprised of payroll and related expenses, merchant card fees and insurance expense, all of which are reported in Income (loss) from discontinued operations before income tax expense in our consolidated income statements. The management fees/income &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;provided by the management agreements are considered intercompany transactions and therefore eliminated upon consolidation of VIEs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;VIE net income (including the management fee) for the years ended December&#160;31, 2025 and 2024 is included in Income (loss) from discontinued operations before income tax expense and income tax expense from discontinued operations in the consolidated income statements as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.689%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.443%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.984%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations before income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,641,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;986,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,431,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amount of the VIEs&#x2019; assets and liabilities is included in discontinued operations as of December&#160;31, 2025 and 2024 in the consolidated balance sheets as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.981%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.859%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.276%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discontinued operations current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,079,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,125,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. We continually monitor our positions with, and the credit quality of, the financial institutions with which we invest. As of the balance sheet date and periodically throughout the period, we have maintained balances in various operating accounts in excess of federally insured limits. We invest our cash primarily in short-term bank deposits and money market funds. We had $19.2&#160;million and zero cash equivalents invested in money market funds as of December&#160;31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash relates to cash that franchisees and company-owned or managed clinics contribute to our National Marketing Fund and cash that franchisees provide to various voluntary regional Co-Op Marketing Funds. Cash contributed by franchisees to the National Marketing Fund is to be used in accordance with our Franchise Disclosure Document with a focus on regional and national marketing and advertising. While such cash balance is not legally segregated and restricted as to withdrawal or usage, our accounting policy is to classify these funds as restricted cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable and Allowance for Credit Losses &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable primarily represent amounts due from franchisees for royalty and software fees. Receivables are unsecured; however, the franchise agreements provide us the right to withdraw funds from the franchisee&#x2019;s bank account or to terminate the franchise for nonpayment. We record an allowance for credit losses as a reduction to our accounts receivables for amounts that we do not expect to recover. An allowance for credit losses is determined through assessments of collectability based on historical trends, the financial condition of our franchisees, including any known or anticipated bankruptcies, and an evaluation of current economic conditions, as well as our expectations of conditions in the future. Actual losses ultimately could differ materially in the near term from the amounts estimated in determining the allowance. As of December&#160;31, 2025, we had a $0.4 million allowance for credit losses. As of December&#160;31, 2024, we had a $0.2 million allowance for credit losses on accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a rollforward of the activity related to our allowance for credit losses:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.351%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad debt expense recognized during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-off of uncollectible amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad debt expense recognized during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-off of uncollectible amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77,638)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Franchise Costs and Regional Development Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred franchise and regional development costs represent commissions that are direct and incremental to us and are paid in conjunction with the sale of a franchise license or regional development rights. These costs are recognized as an expense, in franchise and regional development cost of revenues when the respective revenue is recognized, which is generally over the term of the related franchise or regional developer agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost and relate mostly to the corporate headquarters leasehold improvements, its furniture and fixtures and other office and computer equipment. Depreciation is computed using the straight-line method over estimated useful lives, which is generally &lt;span style="-sec-ix-hidden:f-425"&gt;three&lt;/span&gt; to ten years. Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the assets. Maintenance and repairs are charged to expense as incurred; major renewals and improvements are capitalized. When items of property or equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is included in income. We recorded Net loss on disposition or impairment of $8 thousand and $17 thousand in our consolidated income statements related to continuing operations for the years ended December&#160;31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Capitalized Software&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We capitalize certain software development costs, including costs to implement cloud computing arrangements that is a service contract. These capitalized costs are primarily related to software used by clinics for operations and by us for the management of operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct, are capitalized as assets in progress until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. We also capitalize costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Internally developed software is recorded as part of property and equipment. Maintenance and training costs are expensed as incurred. Internally developed software is amortized on a straight-line basis over its estimated useful life, which is generally &lt;span style="-sec-ix-hidden:f-430"&gt;three&lt;/span&gt; to five years. Implementation costs incurred in&#160;connection with a cloud computing arrangement that is a service contract are included in prepaid expenses in our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;We lease property and equipment under operating and finance leases. We lease our corporate office space and the space for each of the company-owned or managed clinics in the portfolio. We recognize a right-of-use (&#x201c;ROU&#x201d;) asset and lease liability for all leases. The lease for our corporate office space is recognized as a ROU and lease liability in our consolidated balance sheets as continuing operations while all other leases for each of the company-owned or managed clinics are reported in discontinued operations. Certain leases include one or more renewal options, generally for the same period as the initial term of the lease. The exercise of lease renewal options is generally at our sole discretion and, as such, we typically determine that exercise of these renewal options is not reasonably certain. As a result, we do not include the renewal option period in the expected lease term and the associated lease payments are not included in the measurement of the ROU asset and lease liability. When available, we use the rate implicit in the lease to discount lease payments; however, the rate implicit in the lease is not readily determinable for substantially all of our leases. In such cases, we estimate our incremental borrowing rate as the interest rate we would pay to borrow an amount equal to the lease payments over a similar term, with similar collateral as in the lease, and in a similar economic environment. We estimate these rates using available evidence such as rates imposed by third-party lenders to us in recent financings or observable risk-free interest rate and credit spreads for commercial debt of a similar duration, with credit spreads correlating to our estimated creditworthiness.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For operating leases that include rent holidays and rent escalation clauses, we recognize lease expense on a straight-line basis over the lease term from the date we take possession of the leased property. Pre-opening costs are recorded as incurred in general and administrative expenses. Variable lease payments, such as percentage rentals based on location sales, periodic adjustments for inflation, reimbursement of real estate taxes, any variable common area maintenance and any other variable costs associated with the leased corporate office space are expensed as incurred in general and administrative expenses on the consolidated income statements. Any variable costs associated with the leased property for company-owned or managed clinics are expensed as incurred and are included in Income (loss) from discontinued operations before income tax expense in our consolidated income statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2025 and 2024, certain leases related to discontinued operations were terminated early with the landlord as a result of corporate clinic closures. The net losses to terminate the leases were recorded in Income (loss) from discontinued operations before income tax expense in our consolidated income statements of $1.4 million for the year ended December&#160;31, 2025 and $0.4 million for the year ended December&#160;31, 2024.&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consist primarily of reacquired franchise rights and customer relationships. All of our intangible assets are reported in discontinued operations. We amortize the fair value of reacquired franchise rights over the remaining contractual terms of the reacquired franchise rights at the time of the acquisition, which generally range from &lt;span style="-sec-ix-hidden:f-437"&gt;one&lt;/span&gt; to nine years. The fair value of customer relationships is amortized over their estimated useful life of &lt;span style="-sec-ix-hidden:f-439"&gt;two&lt;/span&gt; to four years. Intangible assets are attributable entirely to discontinued operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill consists of the excess of the purchase price over the fair value of tangible and identifiable intangible assets acquired in the acquisitions of franchises. Goodwill and intangible assets deemed to have indefinite lives are not amortized but are tested for impairment annually and more frequently if a triggering event occurs that makes it more likely than not that the fair value of a reporting unit is below carrying value. As required, we perform an annual impairment test of goodwill as of the first day of the fourth quarter or more frequently if a triggering event occurs. Goodwill is attributable entirely to discontinued operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2025, we performed a quantitative assessment of the fair value of the reporting unit and concluded that the fair value of the corporate clinic reporting unit exceeded its carrying value. The fair value of the reporting unit was determined using Level 2 inputs, which includes a potential buyer agreed-upon selling price, or Level 3 inputs, which includes consideration of a market approach using a multiple of earnings assumption based on clinic-level historical financial performance as well as an income approach using discounted cash flow models that use significant unobservable inputs and assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No impairment of goodwill was recorded for the years ended December&#160;31, 2025 and 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Discontinued Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining whether a group of assets which has been disposed of (or is to be disposed of) should be presented as discontinued operations, we first analyze whether the group of assets being disposed of represents a component of the entity or group of components of the entity. A component typically has historic operations and cash flows that are clearly distinguishable for both operations and financial reporting purposes. In addition, we consider whether the disposal represents a strategic shift that has or will have a major effect on our operations and financial results. This strategic shift could include a disposal of a major geographical area, a major line of business, a major equity method investment or other major parts of an entity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We report financial results for discontinued operations separately from continuing operations to distinguish the financial impact of disposal transactions from ongoing operations. The assets and liabilities of a discontinued operation held for sale, other than goodwill, are measured at the lower of its carrying amount or fair value less cost to sell. When a portion of a reporting unit that constitutes a business is to be disposed of, the goodwill associated with that business is included in the carrying amount of the business based on the relative fair values of the business to be disposed of and the portion of the reporting unit that will be retained. See Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Divestitures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Lived Assets - Continuing Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recovered. We look primarily to estimated undiscounted future cash flows in our assessment of whether &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;or not long-lived assets are recoverable. We record an impairment loss when the carrying amount of the asset is not recoverable and exceeds its fair value. During the year ended December&#160;31, 2024, certain long-lived asset groups were determined to not be recoverable and were written down from their carrying values to their respective fair values resulting in the following non-cash impairment losses which are included in &lt;span style="-sec-ix-hidden:f-447"&gt;Net loss on disposition or impairment&lt;/span&gt; related to continuing operations. Net impairment losses on long-lived assets were not material for the year ended December&#160;31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.271%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net loss on disposition or impairment related to continuing operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;17,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;36,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;12,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Total Net loss on disposition or impairment related to continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;66,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Lived Assets - Discontinued Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2024, certain long-lived asset groups classified as held and used were determined to not be recoverable were written down from their carrying values to their respective fair values resulting in the following non-cash impairment losses which are included in Income (loss) from discontinued operations before income tax expense in the consolidated income statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.338%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.149%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net loss on disposition or impairment related to discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,929,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,755,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;1,173,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;5,779,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;4,347,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;1,432,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;298,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;252,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;45,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Total Net loss on disposition or impairment related to discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;2,651,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets that meet the criteria for the held for sale designation are reported at the lower of their carrying value or fair value less estimated cost to sell. As a result of its evaluation of the recoverability of the carrying value of the assets and liabilities held for sale relative to the clinics estimated fair values, we recorded an estimated net loss on disposal, which is included in Income (loss) from discontinued operations before income tax expense in the consolidated income statements:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.291%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Net loss on disposition or impairment related to discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;2,734,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;4,540,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A valuation allowance of $6.3 million and $5.1 million as of December&#160;31, 2025 and 2024, respectively, are included in Discontinued operations current assets on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the composition of our impairment losses and disposal gains and losses recorded in Income (loss) from discontinued operations before income tax expense for the years ended December&#160;31, 2025 and 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.291%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Impairment on long-lived assets held for use&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;1,173,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;1,432,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;45,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Impairment on assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;2,734,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;4,540,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Loss on disposal of assets other than by sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;383,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;161,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;1,396,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;406,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Loss (gain) on the sale of assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;926,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(44,807)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Total net loss on disposition or impairment related to discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;5,441,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;7,714,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advertising Fund&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have established an advertising fund for national or regional marketing and advertising of services offered by our clinics. The monthly marketing fee is 2% of clinic sales. We segregate the advertising funds collected and any unspent amounts, if applicable, are included in restricted cash on our consolidated balance sheets. As amounts are expended from the fund, we recognize a related expense. Such costs are included in selling and marketing expenses on the consolidated income statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Co-Op Marketing Funds&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some franchises have established regional Co-Ops for advertising within their local and regional markets. We maintain a custodial relationship under which the Co-Op Marketing Funds collected are segregated and used for the purposes specified by the Co-Ops&#x2019; officers. The Co-Op Marketing Funds are included in restricted cash on our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generate revenue primarily through company-owned or managed clinics and through royalties, franchise fees, advertising fund contributions, IT related income and computer software fees from our franchisees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenues from Company-Owned or Managed Clinics.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We earn revenues from clinics that we own and operate or manage throughout the United States. Revenues from clinics that we own and operate are recognized when services are performed and are related to discontinued operations. We offer a variety of membership and wellness packages which feature discounted pricing as compared with our single-visit pricing. Amounts collected in advance for membership and wellness packages are recorded as deferred revenue and recognized when the service is performed. Any unused visits associated with monthly memberships are recognized on a month-to-month basis. We recognize a contract liability (or a deferred revenue liability) related to the prepaid treatment plans for which we have an ongoing performance obligation. We derecognize this contract liability, and recognize revenue, as the patient consumes his or her visits related to the package and we transfer our services. If we determine that it is not subject to unclaimed property laws for the portion of the package that we do not expect to be redeemed (referred to as &#x201c;breakage&#x201d;), then we recognize breakage revenue in proportion to the pattern of exercised rights by the patient.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Royalties and Advertising Fund Revenue.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We collect royalties, as stipulated in the franchise agreement, equal to 7% of gross sales, and a marketing and advertising fee currently equal to 2% of gross sales. Royalties, including franchisee contributions to advertising funds, are calculated as a percentage of clinic sales over the term of the franchise agreement. The revenue accounting standard provides an exception for the recognition of sales-based royalties promised in exchange for a license (which generally requires a reporting entity to estimate the amount of variable consideration to which it will be entitled in the transaction price). As the franchise agreement royalties, inclusive of advertising fund contributions, represent sales-based royalties that are related entirely to our performance obligation under the franchise agreement, such sales-based royalties are recognized as franchisee clinic level sales occur. Royalties are collected semi-monthly, two working days after each sales period has ended.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Franchise Fees.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We require the entire non-refundable initial franchise fee to be paid upon execution of a franchise agreement, which typically has an initial term of 10 years. Initial franchise fees are recognized ratably on a straight-line basis over the term of the franchise agreement. Our services under the franchise agreement include the training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. We provide no financing to franchisees and offer no guarantees on their behalf. The services provided by us are highly interrelated with the franchise license and as such are considered to represent a single performance obligation. Renewal franchise fees, as well as transfer fees, are also recognized as revenue on a straight-line basis over the term of the respective franchise agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Software Fees.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;We collect a monthly fee from our franchisees for the use of our proprietary chiropractic software, computer support and internet services support. These fees are recognized ratably on a straight-line basis over the term of the respective franchise agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Capitalized Sales Commissions. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Sales commissions earned by the regional developers and our sales force are considered incremental and recoverable costs of obtaining a franchise agreement with a franchisee. These costs are deferred and then amortized as the respective franchise fees are recognized ratably on a straight-line basis over the term of the franchise agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Upfront Regional Developer Rights Fees &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have a regional developer program where regional developers are granted an exclusive geographical territory and commit to a minimum development obligation within that defined territory. Upon granting of the exclusive rights to develop a territory, a regional developer will pay an upfront fee to us. Upfront regional developer fees represent consideration received from a vendor to act as our agent within an exclusive territory. The upfront regional developer rights fee is accounted for as a reduction of cost of revenues, in franchise and regional development cost of revenues, to offset the respective future commissions paid to the regional developer. The fees are ratably recognized over the term of the related regional developer agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Regional developers receive fees which are funded by the initial franchise fees collected from franchisees upon the sale of franchises within their exclusive geographical territory and a royalty of 3% of sales generated by franchised clinics in their exclusive geographical territory. Initial fees related to the sale of franchises within their exclusive geographical territory are initially deferred as deferred franchise costs and are recognized as an expense in franchise cost of revenues when the respective revenue is recognized, which is generally over the term of the related franchise agreement. Royalties of 3% of sales generated by franchised clinics in their regions are also recognized as franchise cost of revenues as franchisee clinic level sales occur. This 3% fee is funded by the 7% royalties we collect from the franchisees in their regions. Certain regional developer agreements result in the regional developer acquiring the rights to existing royalty streams from clinics already open in the respective territory. In those instances, fees collected from the sale of the royalty stream is recognized as a decrease to franchise and regional developer cost of revenues over the remaining life of the respective franchise agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:106%"&gt;Regional Developer Rights Contract Termination Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, subject to our strategy, regional developer rights are reacquired by us, resulting in a termination of the contract. The termination costs to reacquire the regional developer rights are recognized at fair value, less any unrecognized upfront regional developer fee liability balance, as a general and administrative expense in the period in which the contract is terminated in accordance with the contract terms and are recorded within general and administrative expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Advertising Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising costs are advertising and marketing expenses incurred by us, primarily through advertising funds. We expense production costs of commercial advertising upon first airing and expenses the costs of communicating the advertising in the period in which the advertising occurs. Advertising expenses, excluding National Marketing Fund costs, were $0.6 million and $0.8 million for the years ended December&#160;31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes are accounted for using a balance sheet approach known as the asset and liability method. The asset and liability method accounts for deferred income taxes by applying the statutory tax rates in effect at the date of the consolidated balance sheets to differences between the book basis and the tax basis of assets and liabilities. Deferred tax assets and liabilities represent the future tax consequence for those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. The differences relate principally to depreciation of property and equipment and treatment of revenue for franchise fees and regional developer fees collected. Tax positions are reviewed at least quarterly and adjusted as &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;new information becomes available. The recoverability of deferred tax assets is evaluated by assessing the adequacy of future expected taxable income from all sources, including reversal of taxable temporary differences, forecasted operating earnings and available tax planning strategies. These estimates of future taxable income inherently require significant judgment. To the extent it is considered more likely than not that a deferred tax asset will be not recovered, a valuation allowance is established. We applied the intra-period allocation rules under ASC 740-20-45-1 to allocate the tax provision between continuing operations and discontinued operations. The tax provision amount reported as Income tax expense and disclosed at Note 9, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; is all related to continuing operations and the remaining provision amount is allocated as discontinued operations and reported as Income tax expense from discontinued operations for the years ended December&#160;31, 2025 and 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for uncertainty in income taxes by recognizing the tax benefit or expense from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the position. We measure the tax benefits and expenses recognized in the consolidated financial statements from such a position based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution. We have identified $0.6&#160;million and $0.9&#160;million in uncertain tax positions related to our VIEs in discontinued operations as of December&#160;31, 2025 and 2024, respectively. Interest and penalties associated with tax positions are recorded in the period assessed as general and administrative expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With exceptions due to the generation and utilization of net operating losses or credits, as of December&#160;31, 2025, we are no longer subject to federal and state examinations by taxing authorities for tax years before 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings (Loss) per Common Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per common share is computed by giving effect to all potentially dilutive common shares including restricted stock and stock options. Diluted earnings (loss) per common share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268,157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,614,344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,175,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,182,549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,907,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,796,893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2014; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,134,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,919,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested restricted stock and stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2014; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,186,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,147,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings (loss) per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potentially dilutive securities excluded from the calculation of diluted net income (loss) per common share as the effect would be anti-dilutive were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for share-based payments by recognizing compensation expense based upon the estimated fair value of the awards on the date of grant. We determine the estimated grant-date fair value of restricted shares using the closing price on the date of the grant and the grant-date fair value of stock options using the Black-Scholes-Merton model. In order to calculate the fair value of the options, certain assumptions are made regarding the components of the model, including risk-free interest rate, volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. We recognize compensation costs ratably over the period of service using the straight-line method. Forfeitures are estimated based on historical and forecasted turnover, which is approximately 5%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Retirement Benefit Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our employees are eligible to participate in a defined contribution retirement plan, the Joint Corp. 401(k) Retirement Plan (the &#x201c;401(k) Plan&#x201d;), under Section 401(k) of the Internal Revenue Code. Under the 401(k) Plan, employees may contribute their eligible compensation, not to exceed the annual limits set by the IRS. The 401(k) Plan allows us to match participants&#x2019; contributions in an amount determined in our sole discretion. We matched participants&#x2019; contributions for the years ended December&#160;31, 2025 and 2024, up to a maximum of 4% of the employee&#x2019;s eligible compensation. Employer contributions for both continuing and discontinued operations totaled $0.6 million for each of the years ended December&#160;31, 2025 and 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%"&gt;Loss Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC Topic 450 governs the disclosure of loss contingencies and accrual of loss contingencies in respect of litigation and other claims. We record an accrual for a potential loss when it is probable that a loss will occur and the amount of the loss can be reasonably estimated. When the reasonable estimate of the potential loss is within a range of amounts, the minimum of the range of potential loss is accrued, unless a higher amount within the range is a better estimate than any other amount within the range. Moreover, if an accrual is not required, we provide additional disclosure related to litigation and other claims when it is reasonably possible (i.e., more than remote) that the outcomes of such litigation and other claims include potential material adverse impacts on us. Legal costs to be incurred in connection with a loss contingency are expensed as such costs are incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Items subject to significant estimates and assumptions include loss contingencies, share-based compensations, useful lives and realizability of long-lived assets, deferred revenue and revenue recognition related to breakage, deferred franchise costs, calculation of ROU assets and liabilities related to leases, realizability of deferred tax assets, impairment of goodwill, intangible assets, other long-lived assets, and purchase price allocations and related valuations. Deferred revenue related to breakage, goodwill and intangible assets are related to discontinued operations. Refer to Note 3,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Divestitures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information on discontinued operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Guidance and Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (&#x201c;ASU 2023-09&#x201d;), which requires public entities to provide greater disaggregation within their annual rate reconciliation, including new requirements to present reconciling items on a gross basis in specified categories, disclose both percentages and dollar amounts, and disaggregate individual reconciling items by jurisdiction and nature when the effect of the items meet a quantitative threshold. ASU 2023-09 also requires disaggregating the annual disclosure of income taxes paid, net of refunds received, by federal (national), state, and foreign taxes, with separate presentation of individual jurisdictions that meet a quantitative threshold. ASU 2023-09 is effective for annual periods beginning after December 15, 2024 on a prospective basis, with a retrospective option, and early adoption is permitted. We have adopted ASU 2023-09 for the 2025 annual period on a retrospective basis. Refer to Note 9, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for the revised disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (&#x201c;ASU 2023-07&#x201d;), which requires public entities with a single reportable segment to provide all the disclosures required by this standard and all existing segment disclosures in Topic 280 on an interim and annual basis, including new requirements to disclose significant segment expenses that are regularly provided to the Chief Operating Decision Maker (&#x201c;CODM&#x201d;) and included within the reported measure(s) of a segment&#x2019;s profit or loss, the amount and composition of any other segment items, the title and position of the CODM, and how the CODM uses the reported measure(s) of a segment&#x2019;s profit or loss to assess performance and decide how to allocate resources. ASU 2023-07 is effective for annual periods beginning after December 15, 2023 and interim periods beginning after December 15, 2024, applied retrospectively with early adoption permitted. We have adopted ASU 2023-07 for the 2024 annual period and have identified no material effect on our consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the FASB issued ASU 2024-03, Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (&#x201c;ASU 2024-03&#x201d;), and in January 2025, the FASB issued ASU No. 2025-01, Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date, which clarified the effective date of ASU 2024-03. ASU 2024-03 will require us to disclose the amounts of purchases of inventory, employee compensation, depreciation and intangible asset amortization, as applicable, included in certain expense captions in the consolidated statements of operations, as well as qualitatively describe remaining amounts included in those captions. ASU 2024-03 will also require us to disclose both the amount and our definition of selling expenses. The transition method is prospective with the retrospective method permitted and will be effective for our annual period ending December 31, 2027 and interim periods for the interim period beginning January 1, 2028. We are currently evaluating the impact of adoption of ASU 2024-03 on our consolidated financial statements and disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-357">&lt;div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;These financial statements represent the consolidated financial statements of The Joint Corp., which includes its variable interest entities (&#x201c;VIEs&#x201d;), and its wholly owned subsidiary, The Joint Corporate Unit No. 1, LLC (collectively, the &#x201c;Company&#x201d;). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amount of assets, liabilities, revenue, costs, expenses, other (expenses) income, and income taxes that are reported in the consolidated financial statements and accompanying disclosures. These estimates are based on management&#x2019;s best knowledge of current events, historical experience, actions that we may undertake in the future and on various other assumptions that are believed to be reasonable under the circumstances. As a result, actual results may be different from these estimates.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-358">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;The accompanying consolidated financial statements include the accounts of The Joint and its wholly owned subsidiary, The Joint Corporate Unit No. 1, LLC, which was dormant for all periods presented. We consolidate VIEs in which we are the primary beneficiary in accordance with Accounting Standards Codification 810, Consolidations (&#x201c;ASC 810&#x201d;). Non-controlling interests represent third-party equity ownership interests in VIEs. All significant inter-affiliate accounts and transactions between The Joint and its VIEs have been eliminated in consolidation.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="c-1" id="f-359">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income (loss) and comprehensive income (loss) are the same for the years ended December&#160;31, 2025 and 2024.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <jynt:NatureofOperationsPolicyPolicyTextBlock contextRef="c-1" id="f-360">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nature of Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Joint Corp., a Delaware corporation, was formed on March 10, 2010 for the principal purpose of franchising, developing, selling regional developer rights, supporting the operations of franchised chiropractic clinics at locations throughout the United States of America. The franchising of chiropractic clinics is regulated by the Federal Trade Commission and various state authorities.&lt;/span&gt;&lt;/div&gt;</jynt:NatureofOperationsPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfFranchisorDisclosureTableTextBlock contextRef="c-1" id="f-361">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the number of clinics in operation under franchise agreements and as company-owned or managed for the years ended December&#160;31, 2025 and 2024. All company-owned or managed clinics operations are recorded as discontinued operations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.777%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Franchised clinics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinics open at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Opened during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sold during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Closed during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinics in operation at the end of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.777%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Company-owned or managed clinics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinics open at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Opened during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sold during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Closed during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinics in operation at the end of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total clinics in operation at the end of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinic licenses sold but not yet developed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Executed letters of intent for future clinic licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFranchisorDisclosureTableTextBlock>
    <us-gaap:NumberOfStores
      contextRef="c-48"
      decimals="INF"
      id="f-362"
      unitRef="clinic">842</us-gaap:NumberOfStores>
    <us-gaap:NumberOfStores
      contextRef="c-49"
      decimals="INF"
      id="f-363"
      unitRef="clinic">800</us-gaap:NumberOfStores>
    <jynt:ClinicsOpenedDuringThePeriod
      contextRef="c-50"
      decimals="INF"
      id="f-364"
      unitRef="clinic">29</jynt:ClinicsOpenedDuringThePeriod>
    <jynt:ClinicsOpenedDuringThePeriod
      contextRef="c-51"
      decimals="INF"
      id="f-365"
      unitRef="clinic">57</jynt:ClinicsOpenedDuringThePeriod>
    <jynt:ClinicsAcquiredDuringPeriod
      contextRef="c-50"
      decimals="INF"
      id="f-366"
      unitRef="clinic">41</jynt:ClinicsAcquiredDuringPeriod>
    <jynt:ClinicsAcquiredDuringPeriod
      contextRef="c-51"
      decimals="INF"
      id="f-367"
      unitRef="clinic">3</jynt:ClinicsAcquiredDuringPeriod>
    <jynt:ClinicsSoldDuringPeriod
      contextRef="c-50"
      decimals="INF"
      id="f-368"
      unitRef="clinic">0</jynt:ClinicsSoldDuringPeriod>
    <jynt:ClinicsSoldDuringPeriod
      contextRef="c-51"
      decimals="INF"
      id="f-369"
      unitRef="clinic">0</jynt:ClinicsSoldDuringPeriod>
    <jynt:ClinicsClosedDuringThePeriod
      contextRef="c-50"
      decimals="INF"
      id="f-370"
      unitRef="clinic">27</jynt:ClinicsClosedDuringThePeriod>
    <jynt:ClinicsClosedDuringThePeriod
      contextRef="c-51"
      decimals="INF"
      id="f-371"
      unitRef="clinic">18</jynt:ClinicsClosedDuringThePeriod>
    <us-gaap:NumberOfStores
      contextRef="c-52"
      decimals="INF"
      id="f-372"
      unitRef="clinic">885</us-gaap:NumberOfStores>
    <us-gaap:NumberOfStores
      contextRef="c-48"
      decimals="INF"
      id="f-373"
      unitRef="clinic">842</us-gaap:NumberOfStores>
    <us-gaap:NumberOfStores
      contextRef="c-53"
      decimals="INF"
      id="f-374"
      unitRef="clinic">125</us-gaap:NumberOfStores>
    <us-gaap:NumberOfStores
      contextRef="c-54"
      decimals="INF"
      id="f-375"
      unitRef="clinic">135</us-gaap:NumberOfStores>
    <jynt:ClinicsOpenedDuringThePeriod
      contextRef="c-55"
      decimals="INF"
      id="f-376"
      unitRef="clinic">0</jynt:ClinicsOpenedDuringThePeriod>
    <jynt:ClinicsOpenedDuringThePeriod
      contextRef="c-56"
      decimals="INF"
      id="f-377"
      unitRef="clinic">0</jynt:ClinicsOpenedDuringThePeriod>
    <jynt:ClinicsAcquiredDuringPeriod
      contextRef="c-55"
      decimals="INF"
      id="f-378"
      unitRef="clinic">0</jynt:ClinicsAcquiredDuringPeriod>
    <jynt:ClinicsAcquiredDuringPeriod
      contextRef="c-56"
      decimals="INF"
      id="f-379"
      unitRef="clinic">0</jynt:ClinicsAcquiredDuringPeriod>
    <jynt:ClinicsSoldDuringPeriod
      contextRef="c-55"
      decimals="INF"
      id="f-380"
      unitRef="clinic">41</jynt:ClinicsSoldDuringPeriod>
    <jynt:ClinicsSoldDuringPeriod
      contextRef="c-56"
      decimals="INF"
      id="f-381"
      unitRef="clinic">3</jynt:ClinicsSoldDuringPeriod>
    <jynt:ClinicsClosedDuringThePeriod
      contextRef="c-55"
      decimals="INF"
      id="f-382"
      unitRef="clinic">9</jynt:ClinicsClosedDuringThePeriod>
    <jynt:ClinicsClosedDuringThePeriod
      contextRef="c-56"
      decimals="INF"
      id="f-383"
      unitRef="clinic">7</jynt:ClinicsClosedDuringThePeriod>
    <us-gaap:NumberOfStores
      contextRef="c-57"
      decimals="INF"
      id="f-384"
      unitRef="clinic">75</us-gaap:NumberOfStores>
    <us-gaap:NumberOfStores
      contextRef="c-53"
      decimals="INF"
      id="f-385"
      unitRef="clinic">125</us-gaap:NumberOfStores>
    <us-gaap:NumberOfStores contextRef="c-4" decimals="INF" id="f-386" unitRef="clinic">960</us-gaap:NumberOfStores>
    <us-gaap:NumberOfStores contextRef="c-5" decimals="INF" id="f-387" unitRef="clinic">967</us-gaap:NumberOfStores>
    <jynt:ClinicLicensesSoldButNotYetDeveloped contextRef="c-4" decimals="INF" id="f-388" unitRef="clinic">82</jynt:ClinicLicensesSoldButNotYetDeveloped>
    <jynt:ClinicLicensesSoldButNotYetDeveloped contextRef="c-5" decimals="INF" id="f-389" unitRef="clinic">92</jynt:ClinicLicensesSoldButNotYetDeveloped>
    <jynt:ExecutedLettersOfIntentForFutureClinicLicenses contextRef="c-4" decimals="INF" id="f-390" unitRef="clinic">57</jynt:ExecutedLettersOfIntentForFutureClinicLicenses>
    <jynt:ExecutedLettersOfIntentForFutureClinicLicenses contextRef="c-5" decimals="INF" id="f-391" unitRef="clinic">53</jynt:ExecutedLettersOfIntentForFutureClinicLicenses>
    <us-gaap:ConsolidationVariableInterestEntityPolicy contextRef="c-1" id="f-392">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain states prohibit the &#x201c;corporate practice of chiropractic,&#x201d; which restricts business corporations from practicing chiropractic care by exercising control over clinical decisions by chiropractic doctors. In states that prohibit the corporate practice of chiropractic, we typically enter into long-term management agreements with professional corporations (&#x201c;PCs&#x201d;) that are owned by licensed chiropractic doctors, which, in turn, employ or contract with doctors who provide professional chiropractic care in our clinics. Under these management agreements with PCs, we provide, on an exclusive basis, all non-clinical services of the chiropractic practice. We have entered into such management agreements with four PCs. In connection with the sale of five company-owned or managed clinics located in Kansas and Missouri, we terminated our management agreement with one PC as of June 30, 2025. For additional information on clinic sales, refer to Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Divestitures.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; If an entity is deemed to be the primary beneficiary of a VIE, the entity is required to consolidate the VIE in its financial statements. An entity is deemed to be the primary beneficiary of a VIE if it has both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE&#x2019;s economic performance, and (b) the obligation to absorb the majority of losses of the VIE or the right to receive the majority of benefits from the VIE. In accordance with relevant accounting guidance, these PCs were determined to be VIEs, as fees paid by the PCs to us as our management service provider are considered variable interests because the fees do not meet all the following criteria: (1) the fees are compensation for services provided and are commensurate with the level of effort required to provide those services; (2) the decision maker or service provider does not hold other interests in the VIE that individually, or in the aggregate, would absorb more than an insignificant amount of the VIE&#x2019;s expected losses or receive more than an insignificant amount of the VIE&#x2019;s expected residual returns; and (3) the service arrangement includes only terms, conditions, or amounts that are customarily present in arrangements for similar services negotiated at arm&#x2019;s length. Additionally, we have determined that we have the ability to direct the activities that most significantly impact the performance of these PCs and has an obligation to absorb losses or receive benefits which could potentially be significant to the PCs. Accordingly, the PCs are VIEs for which we are the primary beneficiary and are consolidated by us. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The revenues of VIEs represent the revenues of company-managed clinics in states that prohibit the corporate practice of chiropractic. Our involvement with VIEs affects our financial performance and cash flows primarily through amounts recorded as revenues from company-owned or managed clinics and general and administrative expenses, which are principally comprised of payroll and related expenses, merchant card fees and insurance expense, all of which are reported in Income (loss) from discontinued operations before income tax expense in our consolidated income statements. The management fees/income &lt;/span&gt;&lt;/div&gt;provided by the management agreements are considered intercompany transactions and therefore eliminated upon consolidation of VIEs.</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <jynt:ManagementAgreementNumberOfProfessionalCorporations
      contextRef="c-4"
      decimals="INF"
      id="f-393"
      unitRef="corporation">4</jynt:ManagementAgreementNumberOfProfessionalCorporations>
    <jynt:ClinicsSoldDuringPeriod
      contextRef="c-58"
      decimals="INF"
      id="f-394"
      unitRef="clinic">5</jynt:ClinicsSoldDuringPeriod>
    <jynt:ManagementAgreementTerminationNumberOfProfessionalCorporations
      contextRef="c-59"
      decimals="INF"
      id="f-395"
      unitRef="corporation">1</jynt:ManagementAgreementTerminationNumberOfProfessionalCorporations>
    <us-gaap:ScheduleOfVariableInterestEntitiesTextBlock contextRef="c-1" id="f-396">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;VIE net income (including the management fee) for the years ended December&#160;31, 2025 and 2024 is included in Income (loss) from discontinued operations before income tax expense and income tax expense from discontinued operations in the consolidated income statements as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.689%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.443%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.984%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations before income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,641,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;986,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,431,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amount of the VIEs&#x2019; assets and liabilities is included in discontinued operations as of December&#160;31, 2025 and 2024 in the consolidated balance sheets as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.981%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.859%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.276%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discontinued operations current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,079,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,125,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfVariableInterestEntitiesTextBlock>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="c-60" decimals="0" id="f-397" unitRef="usd">1011689</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="c-61" decimals="0" id="f-398" unitRef="usd">1641325</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation contextRef="c-60" decimals="0" id="f-399" unitRef="usd">25207</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation contextRef="c-61" decimals="0" id="f-400" unitRef="usd">210263</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="c-60" decimals="0" id="f-401" unitRef="usd">986482</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="c-61" decimals="0" id="f-402" unitRef="usd">1431062</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-62" decimals="0" id="f-403" unitRef="usd">994138</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-63" decimals="0" id="f-404" unitRef="usd">1087203</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-62" decimals="0" id="f-405" unitRef="usd">6079903</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-63" decimals="0" id="f-406" unitRef="usd">7125071</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-407">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;We consider all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. We continually monitor our positions with, and the credit quality of, the financial institutions with which we invest. As of the balance sheet date and periodically throughout the period, we have maintained balances in various operating accounts in excess of federally insured limits. We invest our cash primarily in short-term bank deposits and money market funds. We</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-4" decimals="-5" id="f-408" unitRef="usd">19200000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-5" decimals="INF" id="f-409" unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="c-1" id="f-410">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash relates to cash that franchisees and company-owned or managed clinics contribute to our National Marketing Fund and cash that franchisees provide to various voluntary regional Co-Op Marketing Funds. Cash contributed by franchisees to the National Marketing Fund is to be used in accordance with our Franchise Disclosure Document with a focus on regional and national marketing and advertising. While such cash balance is not legally segregated and restricted as to withdrawal or usage, our accounting policy is to classify these funds as restricted cash.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="c-1" id="f-411">Accounts receivable primarily represent amounts due from franchisees for royalty and software fees. Receivables are unsecured; however, the franchise agreements provide us the right to withdraw funds from the franchisee&#x2019;s bank account or to terminate the franchise for nonpayment.</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:CreditLossFinancialInstrumentPolicyTextBlock contextRef="c-1" id="f-412">We record an allowance for credit losses as a reduction to our accounts receivables for amounts that we do not expect to recover. An allowance for credit losses is determined through assessments of collectability based on historical trends, the financial condition of our franchisees, including any known or anticipated bankruptcies, and an evaluation of current economic conditions, as well as our expectations of conditions in the future. Actual losses ultimately could differ materially in the near term from the amounts estimated in determining the allowance.</us-gaap:CreditLossFinancialInstrumentPolicyTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-4" decimals="-5" id="f-413" unitRef="usd">400000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-5" decimals="-5" id="f-414" unitRef="usd">200000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock contextRef="c-1" id="f-415">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a rollforward of the activity related to our allowance for credit losses:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.351%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad debt expense recognized during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-off of uncollectible amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad debt expense recognized during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-off of uncollectible amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77,638)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-25" decimals="0" id="f-416" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-18" decimals="0" id="f-417" unitRef="usd">220893</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs contextRef="c-18" decimals="0" id="f-418" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-5" decimals="0" id="f-419" unitRef="usd">220893</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-1" decimals="0" id="f-420" unitRef="usd">286232</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs contextRef="c-1" decimals="0" id="f-421" unitRef="usd">77638</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-4" decimals="0" id="f-422" unitRef="usd">429487</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:DeferredChargesPolicyTextBlock contextRef="c-1" id="f-423">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Franchise Costs and Regional Development Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred franchise and regional development costs represent commissions that are direct and incremental to us and are paid in conjunction with the sale of a franchise license or regional development rights. These costs are recognized as an expense, in franchise and regional development cost of revenues when the respective revenue is recognized, which is generally over the term of the related franchise or regional developer agreement.&lt;/span&gt;&lt;/div&gt;</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c-1" id="f-424">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;Property and equipment are stated at cost and relate mostly to the corporate headquarters leasehold improvements, its furniture and fixtures and other office and computer equipment. Depreciation is computed using the straight-line method over estimated useful lives, which is generally &lt;span style="-sec-ix-hidden:f-425"&gt;three&lt;/span&gt; to ten years. Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the assets. Maintenance and repairs are charged to expense as incurred; major renewals and improvements are capitalized. When items of property or equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is included in income.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-65" id="f-426">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="c-66" decimals="-3" id="f-427" unitRef="usd">-8000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="c-67" decimals="-3" id="f-428" unitRef="usd">-17000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:InternalUseSoftwarePolicy contextRef="c-1" id="f-429">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Capitalized Software&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We capitalize certain software development costs, including costs to implement cloud computing arrangements that is a service contract. These capitalized costs are primarily related to software used by clinics for operations and by us for the management of operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct, are capitalized as assets in progress until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. We also capitalize costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Internally developed software is recorded as part of property and equipment. Maintenance and training costs are expensed as incurred. Internally developed software is amortized on a straight-line basis over its estimated useful life, which is generally &lt;span style="-sec-ix-hidden:f-430"&gt;three&lt;/span&gt; to five years. Implementation costs incurred in&#160;connection with a cloud computing arrangement that is a service contract are included in prepaid expenses in our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:InternalUseSoftwarePolicy>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-69" id="f-431">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c-1" id="f-432">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;We lease property and equipment under operating and finance leases. We lease our corporate office space and the space for each of the company-owned or managed clinics in the portfolio. We recognize a right-of-use (&#x201c;ROU&#x201d;) asset and lease liability for all leases. The lease for our corporate office space is recognized as a ROU and lease liability in our consolidated balance sheets as continuing operations while all other leases for each of the company-owned or managed clinics are reported in discontinued operations. Certain leases include one or more renewal options, generally for the same period as the initial term of the lease. The exercise of lease renewal options is generally at our sole discretion and, as such, we typically determine that exercise of these renewal options is not reasonably certain. As a result, we do not include the renewal option period in the expected lease term and the associated lease payments are not included in the measurement of the ROU asset and lease liability. When available, we use the rate implicit in the lease to discount lease payments; however, the rate implicit in the lease is not readily determinable for substantially all of our leases. In such cases, we estimate our incremental borrowing rate as the interest rate we would pay to borrow an amount equal to the lease payments over a similar term, with similar collateral as in the lease, and in a similar economic environment. We estimate these rates using available evidence such as rates imposed by third-party lenders to us in recent financings or observable risk-free interest rate and credit spreads for commercial debt of a similar duration, with credit spreads correlating to our estimated creditworthiness.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For operating leases that include rent holidays and rent escalation clauses, we recognize lease expense on a straight-line basis over the lease term from the date we take possession of the leased property. Pre-opening costs are recorded as incurred in general and administrative expenses. Variable lease payments, such as percentage rentals based on location sales, periodic adjustments for inflation, reimbursement of real estate taxes, any variable common area maintenance and any other variable costs associated with the leased corporate office space are expensed as incurred in general and administrative expenses on the consolidated income statements. Any variable costs associated with the leased property for company-owned or managed clinics are expensed as incurred and are included in Income (loss) from discontinued operations before income tax expense in our consolidated income statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <jynt:LesseeOperatingLeaseNumberOfRenewalOptions contextRef="c-4" decimals="INF" id="f-433" unitRef="option">1</jynt:LesseeOperatingLeaseNumberOfRenewalOptions>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-70" decimals="-5" id="f-434" unitRef="usd">1400000</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-71" decimals="-5" id="f-435" unitRef="usd">400000</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="c-1" id="f-436">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consist primarily of reacquired franchise rights and customer relationships. All of our intangible assets are reported in discontinued operations. We amortize the fair value of reacquired franchise rights over the remaining contractual terms of the reacquired franchise rights at the time of the acquisition, which generally range from &lt;span style="-sec-ix-hidden:f-437"&gt;one&lt;/span&gt; to nine years. The fair value of customer relationships is amortized over their estimated useful life of &lt;span style="-sec-ix-hidden:f-439"&gt;two&lt;/span&gt; to four years. Intangible assets are attributable entirely to discontinued operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-73" id="f-438">P9Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-75" id="f-440">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="c-1" id="f-441">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill consists of the excess of the purchase price over the fair value of tangible and identifiable intangible assets acquired in the acquisitions of franchises. Goodwill and intangible assets deemed to have indefinite lives are not amortized but are tested for impairment annually and more frequently if a triggering event occurs that makes it more likely than not that the fair value of a reporting unit is below carrying value. As required, we perform an annual impairment test of goodwill as of the first day of the fourth quarter or more frequently if a triggering event occurs. Goodwill is attributable entirely to discontinued operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2025, we performed a quantitative assessment of the fair value of the reporting unit and concluded that the fair value of the corporate clinic reporting unit exceeded its carrying value. The fair value of the reporting unit was determined using Level 2 inputs, which includes a potential buyer agreed-upon selling price, or Level 3 inputs, which includes consideration of a market approach using a multiple of earnings assumption based on clinic-level historical financial performance as well as an income approach using discounted cash flow models that use significant unobservable inputs and assumptions.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-18" decimals="INF" id="f-442" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-1" decimals="INF" id="f-443" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:DiscontinuedOperationsPolicyTextBlock contextRef="c-1" id="f-444">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Discontinued Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining whether a group of assets which has been disposed of (or is to be disposed of) should be presented as discontinued operations, we first analyze whether the group of assets being disposed of represents a component of the entity or group of components of the entity. A component typically has historic operations and cash flows that are clearly distinguishable for both operations and financial reporting purposes. In addition, we consider whether the disposal represents a strategic shift that has or will have a major effect on our operations and financial results. This strategic shift could include a disposal of a major geographical area, a major line of business, a major equity method investment or other major parts of an entity.&lt;/span&gt;&lt;/div&gt;We report financial results for discontinued operations separately from continuing operations to distinguish the financial impact of disposal transactions from ongoing operations. The assets and liabilities of a discontinued operation held for sale, other than goodwill, are measured at the lower of its carrying amount or fair value less cost to sell. When a portion of a reporting unit that constitutes a business is to be disposed of, the goodwill associated with that business is included in the carrying amount of the business based on the relative fair values of the business to be disposed of and the portion of the reporting unit that will be retained.</us-gaap:DiscontinuedOperationsPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c-1" id="f-445">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Lived Assets - Continuing Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recovered. We look primarily to estimated undiscounted future cash flows in our assessment of whether &lt;/span&gt;&lt;/div&gt;or not long-lived assets are recoverable. We record an impairment loss when the carrying amount of the asset is not recoverable and exceeds its fair value.Long-lived assets that meet the criteria for the held for sale designation are reported at the lower of their carrying value or fair value less estimated cost to sell.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock contextRef="c-1" id="f-446">During the year ended December&#160;31, 2024, certain long-lived asset groups were determined to not be recoverable and were written down from their carrying values to their respective fair values resulting in the following non-cash impairment losses which are included in &lt;span style="-sec-ix-hidden:f-447"&gt;Net loss on disposition or impairment&lt;/span&gt; related to continuing operations. Net impairment losses on long-lived assets were not material for the year ended December&#160;31, 2025.&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.271%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net loss on disposition or impairment related to continuing operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;17,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;36,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;12,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Total Net loss on disposition or impairment related to continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;66,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock>
    <jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment contextRef="c-67" decimals="0" id="f-448" unitRef="usd">57959</jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment>
    <jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment contextRef="c-67" decimals="0" id="f-449" unitRef="usd">40872</jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-67" decimals="0" id="f-450" unitRef="usd">17087</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment contextRef="c-76" decimals="0" id="f-451" unitRef="usd">703682</jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment>
    <jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment contextRef="c-76" decimals="0" id="f-452" unitRef="usd">667314</jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-76" decimals="0" id="f-453" unitRef="usd">36368</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment contextRef="c-77" decimals="0" id="f-454" unitRef="usd">12564</jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment>
    <jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment contextRef="c-77" decimals="0" id="f-455" unitRef="usd">0</jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-77" decimals="0" id="f-456" unitRef="usd">12564</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-18" decimals="0" id="f-457" unitRef="usd">66019</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock contextRef="c-1" id="f-458">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2024, certain long-lived asset groups classified as held and used were determined to not be recoverable were written down from their carrying values to their respective fair values resulting in the following non-cash impairment losses which are included in Income (loss) from discontinued operations before income tax expense in the consolidated income statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.338%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.149%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net loss on disposition or impairment related to discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,929,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,755,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;1,173,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;5,779,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;4,347,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;1,432,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;298,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;252,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;45,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Total Net loss on disposition or impairment related to discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;2,651,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;As a result of its evaluation of the recoverability of the carrying value of the assets and liabilities held for sale relative to the clinics estimated fair values, we recorded an estimated net loss on disposal, which is included in Income (loss) from discontinued operations before income tax expense in the consolidated income statements:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.291%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Net loss on disposition or impairment related to discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;2,734,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;4,540,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the composition of our impairment losses and disposal gains and losses recorded in Income (loss) from discontinued operations before income tax expense for the years ended December&#160;31, 2025 and 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.291%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Impairment on long-lived assets held for use&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;1,173,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;1,432,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;45,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Impairment on assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;2,734,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;4,540,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Loss on disposal of assets other than by sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;383,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;161,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;1,396,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;406,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Loss (gain) on the sale of assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;926,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(44,807)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Total net loss on disposition or impairment related to discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;5,441,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;7,714,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The key components of Net income (loss) from discontinued operations that were included in our consolidated income statements are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from company-owned or managed clinics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,038,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,982,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,038,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,982,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IT cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and marketing expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,755,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,850,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,350,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,450,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,988,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,276,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,190,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss on disposition or impairment from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,441,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,714,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,300,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,970,172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,200,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,972,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,175,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,182,549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the major classes of assets and liabilities of discontinued operations that were included in our consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,484,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,051,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,395,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets (attributable to VIEs)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deposits and other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets, discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,246,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,151,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,519,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,066,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll liabilities ($0.6 million and $0.9 million attributable to VIEs, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;988,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,333,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities (attributable to VIEs)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;756,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,079,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities to be disposed of ($4.7 million and $5.2 million attributable to VIEs, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,368,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,629,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities, discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,368,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,367,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The key components of cash flows from discontinued operations are as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Significant operating and investing non-cash items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,350,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss on disposition or impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,441,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,714,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Capital expenditures&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The principal components of the held for sale assets and liabilities to be disposed of as of December&#160;31, 2025 and 2024 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.221%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.224%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,497,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,457,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,111,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,643,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,288,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,906,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,482,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,459,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,327,644)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,071,603)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,051,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,395,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,065,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,526,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue from company-owned or managed clinics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,302,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,102,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities to be disposed of&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,368,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,629,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment contextRef="c-78" decimals="0" id="f-459" unitRef="usd">3929036</jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment>
    <jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment contextRef="c-78" decimals="0" id="f-460" unitRef="usd">2755318</jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-78" decimals="0" id="f-461" unitRef="usd">1173718</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment contextRef="c-79" decimals="0" id="f-462" unitRef="usd">5779712</jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment>
    <jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment contextRef="c-79" decimals="0" id="f-463" unitRef="usd">4347457</jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-79" decimals="0" id="f-464" unitRef="usd">1432255</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment contextRef="c-80" decimals="0" id="f-465" unitRef="usd">298510</jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment>
    <jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment contextRef="c-80" decimals="0" id="f-466" unitRef="usd">252746</jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-80" decimals="0" id="f-467" unitRef="usd">45764</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-81" decimals="0" id="f-468" unitRef="usd">2651737</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-82" decimals="0" id="f-469" unitRef="usd">2734726</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-83" decimals="0" id="f-470" unitRef="usd">4540530</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <jynt:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent contextRef="c-84" decimals="-5" id="f-471" unitRef="usd">6300000</jynt:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent>
    <jynt:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent contextRef="c-85" decimals="-5" id="f-472" unitRef="usd">5100000</jynt:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-86" decimals="0" id="f-473" unitRef="usd">0</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-78" decimals="0" id="f-474" unitRef="usd">1173718</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-87" decimals="0" id="f-475" unitRef="usd">0</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-79" decimals="0" id="f-476" unitRef="usd">1432255</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-88" decimals="0" id="f-477" unitRef="usd">0</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-80" decimals="0" id="f-478" unitRef="usd">45764</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-82" decimals="0" id="f-479" unitRef="usd">2734726</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-83" decimals="0" id="f-480" unitRef="usd">4540530</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-89" decimals="0" id="f-481" unitRef="usd">383311</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-90" decimals="0" id="f-482" unitRef="usd">161057</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-70" decimals="0" id="f-483" unitRef="usd">1396870</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-71" decimals="0" id="f-484" unitRef="usd">406038</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-91" decimals="0" id="f-485" unitRef="usd">926103</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-92" decimals="0" id="f-486" unitRef="usd">-44807</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-93" decimals="0" id="f-487" unitRef="usd">5441010</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-94" decimals="0" id="f-488" unitRef="usd">7714555</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <jynt:AdvertisingFundPolicyTextBlock contextRef="c-1" id="f-489">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advertising Fund&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have established an advertising fund for national or regional marketing and advertising of services offered by our clinics. The monthly marketing fee is 2% of clinic sales. We segregate the advertising funds collected and any unspent amounts, if applicable, are included in restricted cash on our consolidated balance sheets. As amounts are expended from the fund, we recognize a related expense. Such costs are included in selling and marketing expenses on the consolidated income statements.&lt;/span&gt;&lt;/div&gt;</jynt:AdvertisingFundPolicyTextBlock>
    <jynt:FranchiseMonthlyMarketingFeeGrossSalesPercentage contextRef="c-1" decimals="2" id="f-490" unitRef="number">0.02</jynt:FranchiseMonthlyMarketingFeeGrossSalesPercentage>
    <jynt:CoOpMarketingFundsPolicyPolicyTextBlock contextRef="c-1" id="f-491">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Co-Op Marketing Funds&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some franchises have established regional Co-Ops for advertising within their local and regional markets. We maintain a custodial relationship under which the Co-Op Marketing Funds collected are segregated and used for the purposes specified by the Co-Ops&#x2019; officers. The Co-Op Marketing Funds are included in restricted cash on our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</jynt:CoOpMarketingFundsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-492">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generate revenue primarily through company-owned or managed clinics and through royalties, franchise fees, advertising fund contributions, IT related income and computer software fees from our franchisees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenues from Company-Owned or Managed Clinics.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We earn revenues from clinics that we own and operate or manage throughout the United States. Revenues from clinics that we own and operate are recognized when services are performed and are related to discontinued operations. We offer a variety of membership and wellness packages which feature discounted pricing as compared with our single-visit pricing. Amounts collected in advance for membership and wellness packages are recorded as deferred revenue and recognized when the service is performed. Any unused visits associated with monthly memberships are recognized on a month-to-month basis. We recognize a contract liability (or a deferred revenue liability) related to the prepaid treatment plans for which we have an ongoing performance obligation. We derecognize this contract liability, and recognize revenue, as the patient consumes his or her visits related to the package and we transfer our services. If we determine that it is not subject to unclaimed property laws for the portion of the package that we do not expect to be redeemed (referred to as &#x201c;breakage&#x201d;), then we recognize breakage revenue in proportion to the pattern of exercised rights by the patient.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Royalties and Advertising Fund Revenue.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We collect royalties, as stipulated in the franchise agreement, equal to 7% of gross sales, and a marketing and advertising fee currently equal to 2% of gross sales. Royalties, including franchisee contributions to advertising funds, are calculated as a percentage of clinic sales over the term of the franchise agreement. The revenue accounting standard provides an exception for the recognition of sales-based royalties promised in exchange for a license (which generally requires a reporting entity to estimate the amount of variable consideration to which it will be entitled in the transaction price). As the franchise agreement royalties, inclusive of advertising fund contributions, represent sales-based royalties that are related entirely to our performance obligation under the franchise agreement, such sales-based royalties are recognized as franchisee clinic level sales occur. Royalties are collected semi-monthly, two working days after each sales period has ended.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Franchise Fees.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We require the entire non-refundable initial franchise fee to be paid upon execution of a franchise agreement, which typically has an initial term of 10 years. Initial franchise fees are recognized ratably on a straight-line basis over the term of the franchise agreement. Our services under the franchise agreement include the training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. We provide no financing to franchisees and offer no guarantees on their behalf. The services provided by us are highly interrelated with the franchise license and as such are considered to represent a single performance obligation. Renewal franchise fees, as well as transfer fees, are also recognized as revenue on a straight-line basis over the term of the respective franchise agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Software Fees.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;We collect a monthly fee from our franchisees for the use of our proprietary chiropractic software, computer support and internet services support. These fees are recognized ratably on a straight-line basis over the term of the respective franchise agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Capitalized Sales Commissions. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Sales commissions earned by the regional developers and our sales force are considered incremental and recoverable costs of obtaining a franchise agreement with a franchisee. These costs are deferred and then amortized as the respective franchise fees are recognized ratably on a straight-line basis over the term of the franchise agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Upfront Regional Developer Rights Fees &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have a regional developer program where regional developers are granted an exclusive geographical territory and commit to a minimum development obligation within that defined territory. Upon granting of the exclusive rights to develop a territory, a regional developer will pay an upfront fee to us. Upfront regional developer fees represent consideration received from a vendor to act as our agent within an exclusive territory. The upfront regional developer rights fee is accounted for as a reduction of cost of revenues, in franchise and regional development cost of revenues, to offset the respective future commissions paid to the regional developer. The fees are ratably recognized over the term of the related regional developer agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Regional developers receive fees which are funded by the initial franchise fees collected from franchisees upon the sale of franchises within their exclusive geographical territory and a royalty of 3% of sales generated by franchised clinics in their exclusive geographical territory. Initial fees related to the sale of franchises within their exclusive geographical territory are initially deferred as deferred franchise costs and are recognized as an expense in franchise cost of revenues when the respective revenue is recognized, which is generally over the term of the related franchise agreement. Royalties of 3% of sales generated by franchised clinics in their regions are also recognized as franchise cost of revenues as franchisee clinic level sales occur. This 3% fee is funded by the 7% royalties we collect from the franchisees in their regions. Certain regional developer agreements result in the regional developer acquiring the rights to existing royalty streams from clinics already open in the respective territory. In those instances, fees collected from the sale of the royalty stream is recognized as a decrease to franchise and regional developer cost of revenues over the remaining life of the respective franchise agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:106%"&gt;Regional Developer Rights Contract Termination Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, subject to our strategy, regional developer rights are reacquired by us, resulting in a termination of the contract. The termination costs to reacquire the regional developer rights are recognized at fair value, less any unrecognized upfront regional developer fee liability balance, as a general and administrative expense in the period in which the contract is terminated in accordance with the contract terms and are recorded within general and administrative expenses.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <jynt:FranchiseRoyaltyGrossSalesPercentage contextRef="c-1" decimals="2" id="f-493" unitRef="number">0.07</jynt:FranchiseRoyaltyGrossSalesPercentage>
    <jynt:FranchiseMonthlyMarketingFeeGrossSalesPercentage contextRef="c-1" decimals="2" id="f-494" unitRef="number">0.02</jynt:FranchiseMonthlyMarketingFeeGrossSalesPercentage>
    <jynt:RevenueRecognitionFranchiseAgreementTerm contextRef="c-1" id="f-495">P10Y</jynt:RevenueRecognitionFranchiseAgreementTerm>
    <jynt:RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage contextRef="c-1" decimals="2" id="f-496" unitRef="number">0.03</jynt:RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage>
    <jynt:RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage contextRef="c-1" decimals="2" id="f-497" unitRef="number">0.03</jynt:RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage>
    <jynt:RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage contextRef="c-1" decimals="2" id="f-498" unitRef="number">0.03</jynt:RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage>
    <jynt:FranchiseRoyaltyGrossSalesPercentage contextRef="c-1" decimals="2" id="f-499" unitRef="number">0.07</jynt:FranchiseRoyaltyGrossSalesPercentage>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="c-1" id="f-500">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Advertising Costs&lt;/span&gt;&lt;/div&gt;Advertising costs are advertising and marketing expenses incurred by us, primarily through advertising funds. We expense production costs of commercial advertising upon first airing and expenses the costs of communicating the advertising in the period in which the advertising occurs.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense contextRef="c-1" decimals="-5" id="f-501" unitRef="usd">600000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense contextRef="c-18" decimals="-5" id="f-502" unitRef="usd">800000</us-gaap:AdvertisingExpense>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-503">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes are accounted for using a balance sheet approach known as the asset and liability method. The asset and liability method accounts for deferred income taxes by applying the statutory tax rates in effect at the date of the consolidated balance sheets to differences between the book basis and the tax basis of assets and liabilities. Deferred tax assets and liabilities represent the future tax consequence for those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. The differences relate principally to depreciation of property and equipment and treatment of revenue for franchise fees and regional developer fees collected. Tax positions are reviewed at least quarterly and adjusted as &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;new information becomes available. The recoverability of deferred tax assets is evaluated by assessing the adequacy of future expected taxable income from all sources, including reversal of taxable temporary differences, forecasted operating earnings and available tax planning strategies. These estimates of future taxable income inherently require significant judgment. To the extent it is considered more likely than not that a deferred tax asset will be not recovered, a valuation allowance is established. We applied the intra-period allocation rules under ASC 740-20-45-1 to allocate the tax provision between continuing operations and discontinued operations. The tax provision amount reported as Income tax expense and disclosed at Note 9, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; is all related to continuing operations and the remaining provision amount is allocated as discontinued operations and reported as Income tax expense from discontinued operations for the years ended December&#160;31, 2025 and 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for uncertainty in income taxes by recognizing the tax benefit or expense from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the position. We measure the tax benefits and expenses recognized in the consolidated financial statements from such a position based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution. We have identified $0.6&#160;million and $0.9&#160;million in uncertain tax positions related to our VIEs in discontinued operations as of December&#160;31, 2025 and 2024, respectively. Interest and penalties associated with tax positions are recorded in the period assessed as general and administrative expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With exceptions due to the generation and utilization of net operating losses or credits, as of December&#160;31, 2025, we are no longer subject to federal and state examinations by taxing authorities for tax years before 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-95" decimals="-5" id="f-504" unitRef="usd">600000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-96" decimals="-5" id="f-505" unitRef="usd">900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c-1" id="f-506">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings (Loss) per Common Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per common share is computed by giving effect to all potentially dilutive common shares including restricted stock and stock options. Diluted earnings (loss) per common share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-507">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268,157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,614,344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,175,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,182,549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,907,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,796,893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2014; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,134,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,919,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested restricted stock and stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2014; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,186,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,147,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings (loss) per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potentially dilutive securities excluded from the calculation of diluted net income (loss) per common share as the effect would be anti-dilutive were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c-1" decimals="0" id="f-508" unitRef="usd">-268157</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c-18" decimals="0" id="f-509" unitRef="usd">-1614344</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="c-1" decimals="0" id="f-510" unitRef="usd">3175422</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="c-18" decimals="0" id="f-511" unitRef="usd">-4182549</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="0" id="f-512" unitRef="usd">2907265</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-18" decimals="0" id="f-513" unitRef="usd">-5796893</us-gaap:ProfitLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-514" unitRef="shares">15134215</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-18" decimals="0" id="f-515" unitRef="shares">14919091</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="c-1" decimals="0" id="f-516" unitRef="shares">52653</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="c-18" decimals="0" id="f-517" unitRef="shares">228156</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-518" unitRef="shares">15186868</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-18" decimals="0" id="f-519" unitRef="shares">15147247</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="c-1"
      decimals="2"
      id="f-520"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="c-18"
      decimals="2"
      id="f-521"
      unitRef="usdPerShare">-0.11</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="c-1"
      decimals="2"
      id="f-522"
      unitRef="usdPerShare">0.21</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="c-18"
      decimals="2"
      id="f-523"
      unitRef="usdPerShare">-0.28</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-524"
      unitRef="usdPerShare">0.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-18"
      decimals="2"
      id="f-525"
      unitRef="usdPerShare">-0.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="c-1"
      decimals="2"
      id="f-526"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="c-18"
      decimals="2"
      id="f-527"
      unitRef="usdPerShare">-0.11</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="c-1"
      decimals="2"
      id="f-528"
      unitRef="usdPerShare">0.21</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="c-18"
      decimals="2"
      id="f-529"
      unitRef="usdPerShare">-0.28</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-530"
      unitRef="usdPerShare">0.19</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-18"
      decimals="2"
      id="f-531"
      unitRef="usdPerShare">-0.38</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="0" id="f-532" unitRef="shares">71030</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-18" decimals="0" id="f-533" unitRef="shares">87651</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c-1" id="f-534">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for share-based payments by recognizing compensation expense based upon the estimated fair value of the awards on the date of grant. We determine the estimated grant-date fair value of restricted shares using the closing price on the date of the grant and the grant-date fair value of stock options using the Black-Scholes-Merton model. In order to calculate the fair value of the options, certain assumptions are made regarding the components of the model, including risk-free interest rate, volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. We recognize compensation costs ratably over the period of service using the straight-line method. Forfeitures are estimated based on historical and forecasted turnover, which is approximately 5%.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <jynt:ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage contextRef="c-4" decimals="2" id="f-535" unitRef="number">0.05</jynt:ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage>
    <us-gaap:PostemploymentBenefitPlansPolicy contextRef="c-1" id="f-536">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Retirement Benefit Plan&lt;/span&gt;&lt;/div&gt;Our employees are eligible to participate in a defined contribution retirement plan, the Joint Corp. 401(k) Retirement Plan (the &#x201c;401(k) Plan&#x201d;), under Section 401(k) of the Internal Revenue Code. Under the 401(k) Plan, employees may contribute their eligible compensation, not to exceed the annual limits set by the IRS. The 401(k) Plan allows us to match participants&#x2019; contributions in an amount determined in our sole discretion. We matched participants&#x2019; contributions for the years ended December&#160;31, 2025 and 2024, up to a maximum of 4% of the employee&#x2019;s eligible compensation.</us-gaap:PostemploymentBenefitPlansPolicy>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent contextRef="c-18" decimals="2" id="f-537" unitRef="number">0.04</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent contextRef="c-1" decimals="2" id="f-538" unitRef="number">0.04</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="c-1" decimals="-5" id="f-539" unitRef="usd">600000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="c-18" decimals="-5" id="f-540" unitRef="usd">600000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="c-1" id="f-541">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%"&gt;Loss Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC Topic 450 governs the disclosure of loss contingencies and accrual of loss contingencies in respect of litigation and other claims. We record an accrual for a potential loss when it is probable that a loss will occur and the amount of the loss can be reasonably estimated. When the reasonable estimate of the potential loss is within a range of amounts, the minimum of the range of potential loss is accrued, unless a higher amount within the range is a better estimate than any other amount within the range. Moreover, if an accrual is not required, we provide additional disclosure related to litigation and other claims when it is reasonably possible (i.e., more than remote) that the outcomes of such litigation and other claims include potential material adverse impacts on us. Legal costs to be incurred in connection with a loss contingency are expensed as such costs are incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-542">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Items subject to significant estimates and assumptions include loss contingencies, share-based compensations, useful lives and realizability of long-lived assets, deferred revenue and revenue recognition related to breakage, deferred franchise costs, calculation of ROU assets and liabilities related to leases, realizability of deferred tax assets, impairment of goodwill, intangible assets, other long-lived assets, and purchase price allocations and related valuations. Deferred revenue related to breakage, goodwill and intangible assets are related to discontinued operations.</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-543">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Guidance and Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (&#x201c;ASU 2023-09&#x201d;), which requires public entities to provide greater disaggregation within their annual rate reconciliation, including new requirements to present reconciling items on a gross basis in specified categories, disclose both percentages and dollar amounts, and disaggregate individual reconciling items by jurisdiction and nature when the effect of the items meet a quantitative threshold. ASU 2023-09 also requires disaggregating the annual disclosure of income taxes paid, net of refunds received, by federal (national), state, and foreign taxes, with separate presentation of individual jurisdictions that meet a quantitative threshold. ASU 2023-09 is effective for annual periods beginning after December 15, 2024 on a prospective basis, with a retrospective option, and early adoption is permitted. We have adopted ASU 2023-09 for the 2025 annual period on a retrospective basis. Refer to Note 9, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for the revised disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (&#x201c;ASU 2023-07&#x201d;), which requires public entities with a single reportable segment to provide all the disclosures required by this standard and all existing segment disclosures in Topic 280 on an interim and annual basis, including new requirements to disclose significant segment expenses that are regularly provided to the Chief Operating Decision Maker (&#x201c;CODM&#x201d;) and included within the reported measure(s) of a segment&#x2019;s profit or loss, the amount and composition of any other segment items, the title and position of the CODM, and how the CODM uses the reported measure(s) of a segment&#x2019;s profit or loss to assess performance and decide how to allocate resources. ASU 2023-07 is effective for annual periods beginning after December 15, 2023 and interim periods beginning after December 15, 2024, applied retrospectively with early adoption permitted. We have adopted ASU 2023-07 for the 2024 annual period and have identified no material effect on our consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the FASB issued ASU 2024-03, Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (&#x201c;ASU 2024-03&#x201d;), and in January 2025, the FASB issued ASU No. 2025-01, Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date, which clarified the effective date of ASU 2024-03. ASU 2024-03 will require us to disclose the amounts of purchases of inventory, employee compensation, depreciation and intangible asset amortization, as applicable, included in certain expense captions in the consolidated statements of operations, as well as qualitatively describe remaining amounts included in those captions. ASU 2024-03 will also require us to disclose both the amount and our definition of selling expenses. The transition method is prospective with the retrospective method permitted and will be effective for our annual period ending December 31, 2027 and interim periods for the interim period beginning January 1, 2028. We are currently evaluating the impact of adoption of ASU 2024-03 on our consolidated financial statements and disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c-1" id="f-544">Revenue Disclosures&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Franchising Fees, Royalty Fees, Advertising Fund Revenue, and Software Fees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2025, we had 885 franchised clinics in operation, 82 clinic licenses sold but not yet developed and 57 executed letters of intent for future clinic licenses. The franchise arrangement is documented in the form of a franchise agreement. The franchise arrangement requires us to perform various activities to support the brand that do not directly transfer goods and services to the franchisee, but instead represent a single performance obligation, which is the transfer of the franchise license. The intellectual property subject to the franchise license is symbolic intellectual property as it does not have significant standalone functionality, and substantially all of the utility is derived from its association with our past or ongoing activities. The nature of our promise in granting the franchise license is to provide the franchisee with access to the brand&#x2019;s symbolic intellectual property over the term of the license. The services provided by us are highly interrelated with the franchise license and as such are considered to represent a single performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction price in a standard franchise arrangement primarily consists of (a) initial franchise fees, (b) continuing franchise fees (royalties), (c) advertising fees, and (d) software fees. The revenue accounting standard provides an exception for the recognition of sales-based royalties promised in exchange for a license (which otherwise requires a reporting entity to estimate the amount of variable consideration to which it will be entitled in the transaction price). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize the primary components of the transaction price as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Initial and renewal franchise fees, as well as transfer fees, are recognized as revenue ratably on a straight-line basis over the term of the respective franchise agreement commencing with the execution of the franchise, renewal, or transfer agreement. As these fees are typically received in cash at or near the beginning of the contract term, the cash received is initially recorded as a contract liability until recognized as revenue over time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;We are entitled to royalties and advertising fees based on a percentage of the franchisee&#x2019;s gross sales as defined in the franchise agreement. Royalty and advertising revenue are recognized when the franchisee&#x2019;s sales occur. Depending on timing within a fiscal period, the recognition of revenue results in either what is considered a contract asset (unbilled receivable) or, once billed, accounts receivable, on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;We are entitled to a software fee, which is charged monthly. We recognize revenue related to software fees ratably on a straight-line basis over the term of the franchise agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining the amount and timing of revenue from contracts with customers, we exercise significant judgment with respect to collectability of the amount; however, the timing of recognition does not require significant judgment as it is based on either the franchise term or the reported sales of the franchisee, neither of which requires estimation. We believe that our franchising arrangements do not contain a significant financing component.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize advertising fees received under franchise agreements as advertising fund revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Capitalized Sales Commissions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales commissions earned by the regional developers and our sales force are considered incremental and recoverable costs of obtaining a franchise agreement with a franchisee. These costs are deferred and then amortized as the respective franchise fees are recognized ratably on a straight-line basis over the term of the franchise agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We believe that the captions contained on the consolidated income statements appropriately reflect the disaggregation of our revenue by major type for the years ended December&#160;31, 2025 and 2024. Other revenues primarily consist of merchant income associated with preferred vendor royalties associated with franchisees&#x2019; credit card transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows our revenues disaggregated according to the timing of transfer of services:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.660%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognized at a point in time&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,486,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,478,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognized over time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,408,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,685,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,895,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,163,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Rollforward of Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in our accounts receivable, net during the years ended December&#160;31, 2025 and 2024 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.351%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accounts Receivable, Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,580,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received against accounts receivable included at the beginning of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,387,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net increase during the year ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,614,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(220,893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,586,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received against accounts receivable included at the beginning of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,067,962)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net increase during the year ended December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,760,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(429,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,849,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in our contract liability for deferred franchise fees during the years ended December&#160;31, 2025 and 2024 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:77.116%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.684%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred Revenue&lt;br/&gt;Short and Long-Term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,113,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognized that was included in the contract liability at the beginning of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,841,085)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net increase during the year ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,724,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,997,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognized that was included in the contract liability at the beginning of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,006,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net increase during the year ended December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,427,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,418,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our deferred franchise and development costs represent capitalized sales commissions. Changes during the years ended December&#160;31, 2025 and 2024 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:77.993%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.807%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred Franchise and Development Costs&lt;br/&gt;Short and Long-Term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,251,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized as cost of revenue during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,221,140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net increase during the year ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,569,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized as cost of revenue during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,190,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Net increase during the year ended December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,773,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table illustrates revenues expected to be recognized in the future related to performance obligations that were unsatisfied (or partially unsatisfied) as of December&#160;31, 2025. We have elected to exclude short term contracts, sales and usage-based royalties and any other variable consideration recognized on an &#x201c;as invoiced&#x201d; basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contract liabilities expected to be recognized in:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,519,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,413,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,254,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,899,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,630,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,701,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,418,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:NumberOfStores
      contextRef="c-52"
      decimals="INF"
      id="f-545"
      unitRef="clinic">885</us-gaap:NumberOfStores>
    <jynt:ClinicLicensesSoldButNotYetDeveloped contextRef="c-4" decimals="INF" id="f-546" unitRef="clinic">82</jynt:ClinicLicensesSoldButNotYetDeveloped>
    <jynt:ExecutedLettersOfIntentForFutureClinicLicenses contextRef="c-4" decimals="INF" id="f-547" unitRef="clinic">57</jynt:ExecutedLettersOfIntentForFutureClinicLicenses>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-548">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows our revenues disaggregated according to the timing of transfer of services:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.660%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognized at a point in time&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,486,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,478,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognized over time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,408,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,685,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,895,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,163,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-97" decimals="0" id="f-549" unitRef="usd">45486703</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-98" decimals="0" id="f-550" unitRef="usd">43478254</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-99" decimals="0" id="f-551" unitRef="usd">9408889</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-100" decimals="0" id="f-552" unitRef="usd">8685176</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-1" decimals="0" id="f-553" unitRef="usd">54895592</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-18" decimals="0" id="f-554" unitRef="usd">52163430</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="c-1" id="f-555">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in our accounts receivable, net during the years ended December&#160;31, 2025 and 2024 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.351%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accounts Receivable, Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,580,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received against accounts receivable included at the beginning of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,387,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net increase during the year ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,614,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(220,893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,586,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received against accounts receivable included at the beginning of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,067,962)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net increase during the year ended December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,760,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(429,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,849,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-25" decimals="0" id="f-556" unitRef="usd">2580589</us-gaap:AccountsReceivableNetCurrent>
    <jynt:AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance contextRef="c-18" decimals="0" id="f-557" unitRef="usd">2387577</jynt:AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance>
    <jynt:AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance contextRef="c-18" decimals="0" id="f-558" unitRef="usd">2614262</jynt:AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-5" decimals="0" id="f-559" unitRef="usd">220893</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-5" decimals="0" id="f-560" unitRef="usd">2586381</us-gaap:AccountsReceivableNetCurrent>
    <jynt:AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance contextRef="c-1" decimals="0" id="f-561" unitRef="usd">2067962</jynt:AccountsReceivableDecreaseFromCashReceivedIncludedInOpeningBalance>
    <jynt:AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance contextRef="c-1" decimals="0" id="f-562" unitRef="usd">2760932</jynt:AccountsReceivableIncreaseDecreaseFromOtherThanCashReceivedIncludedInOpeningBalance>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-4" decimals="0" id="f-563" unitRef="usd">429487</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-4" decimals="0" id="f-564" unitRef="usd">2849864</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock contextRef="c-1" id="f-565">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in our contract liability for deferred franchise fees during the years ended December&#160;31, 2025 and 2024 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:77.116%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.684%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred Revenue&lt;br/&gt;Short and Long-Term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,113,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognized that was included in the contract liability at the beginning of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,841,085)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net increase during the year ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,724,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,997,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognized that was included in the contract liability at the beginning of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,006,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net increase during the year ended December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,427,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,418,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our deferred franchise and development costs represent capitalized sales commissions. Changes during the years ended December&#160;31, 2025 and 2024 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:77.993%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.807%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred Franchise and Development Costs&lt;br/&gt;Short and Long-Term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,251,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized as cost of revenue during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,221,140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net increase during the year ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,569,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized as cost of revenue during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,190,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Net increase during the year ended December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,773,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability contextRef="c-25" decimals="0" id="f-566" unitRef="usd">16113879</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-18" decimals="0" id="f-567" unitRef="usd">2841085</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination contextRef="c-18" decimals="0" id="f-568" unitRef="usd">1724311</us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination>
    <us-gaap:ContractWithCustomerLiability contextRef="c-5" decimals="0" id="f-569" unitRef="usd">14997105</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-1" decimals="0" id="f-570" unitRef="usd">3006059</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination contextRef="c-1" decimals="0" id="f-571" unitRef="usd">1427243</us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination>
    <us-gaap:ContractWithCustomerLiability contextRef="c-4" decimals="0" id="f-572" unitRef="usd">13418289</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-25" decimals="0" id="f-573" unitRef="usd">6251366</us-gaap:ContractWithCustomerAssetNet>
    <jynt:ContractWithCustomerAssetRecognizedAsCostsOfRevenue contextRef="c-18" decimals="0" id="f-574" unitRef="usd">1221140</jynt:ContractWithCustomerAssetRecognizedAsCostsOfRevenue>
    <jynt:CostsIncurredAndDeferredDuringTheYear contextRef="c-18" decimals="0" id="f-575" unitRef="usd">539247</jynt:CostsIncurredAndDeferredDuringTheYear>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-5" decimals="0" id="f-576" unitRef="usd">5569473</us-gaap:ContractWithCustomerAssetNet>
    <jynt:ContractWithCustomerAssetRecognizedAsCostsOfRevenue contextRef="c-1" decimals="0" id="f-577" unitRef="usd">1190555</jynt:ContractWithCustomerAssetRecognizedAsCostsOfRevenue>
    <jynt:CostsIncurredAndDeferredDuringTheYear contextRef="c-1" decimals="0" id="f-578" unitRef="usd">394144</jynt:CostsIncurredAndDeferredDuringTheYear>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-4" decimals="0" id="f-579" unitRef="usd">4773062</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock contextRef="c-1" id="f-580">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table illustrates revenues expected to be recognized in the future related to performance obligations that were unsatisfied (or partially unsatisfied) as of December&#160;31, 2025. We have elected to exclude short term contracts, sales and usage-based royalties and any other variable consideration recognized on an &#x201c;as invoiced&#x201d; basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contract liabilities expected to be recognized in:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,519,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,413,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,254,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,899,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,630,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,701,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,418,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-101" decimals="0" id="f-581" unitRef="usd">2519018</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-102" decimals="0" id="f-582" unitRef="usd">2413277</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-103" decimals="0" id="f-583" unitRef="usd">2254336</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-104" decimals="0" id="f-584" unitRef="usd">1899640</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-105" decimals="0" id="f-585" unitRef="usd">1630838</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-106" decimals="0" id="f-586" unitRef="usd">2701180</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-4" decimals="0" id="f-587" unitRef="usd">13418289</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock contextRef="c-1" id="f-594">Divestitures&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Corporate Clinic Segment Divestiture&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2023, we initiated plans to refranchise the majority of our company-owned or managed clinics with plans to retain a small portion of high-performing clinics. During the third quarter of 2024, we expanded the refranchising plan to include additional clinic markets of company-owned or managed clinics, marketing the clinics in clusters grouped by proximity to larger private equity firms. Because we have formalized a plan to sell our entire corporate clinic reportable segment, we have concluded that the overall refranchising plan represents a strategic shift that will have a major effect on our operations and financial results. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since December&#160;31, 2024, the corporate clinics classified as held for sale are reported separately as discontinued operations in the consolidated income statements and consolidated balance sheets. As permitted, we elected not to adjust the consolidated statements of cash flows for the years ended December&#160;31, 2025 and 2024 to exclude cash flows attributable to discontinued operations. Accordingly, we disclosed the depreciation and amortization, capital expenditures and significant operating and investing non-cash items related to the corporate clinic segment below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The key components of Net income (loss) from discontinued operations that were included in our consolidated income statements are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from company-owned or managed clinics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,038,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,982,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,038,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,982,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IT cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and marketing expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,755,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,850,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,350,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,450,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,988,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,276,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,190,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss on disposition or impairment from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,441,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,714,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,300,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,970,172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,200,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,972,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,175,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,182,549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the major classes of assets and liabilities of discontinued operations that were included in our consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,484,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,051,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,395,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets (attributable to VIEs)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deposits and other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets, discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,246,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,151,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,519,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,066,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll liabilities ($0.6 million and $0.9 million attributable to VIEs, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;988,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,333,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities (attributable to VIEs)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;756,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,079,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities to be disposed of ($4.7 million and $5.2 million attributable to VIEs, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,368,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,629,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities, discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,368,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,367,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The key components of cash flows from discontinued operations are as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Significant operating and investing non-cash items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,350,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss on disposition or impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,441,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,714,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Capital expenditures&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The clustered clinics are in varying stages of sales negotiations with approximately all of the company-owned or managed clinics expected to be recognized as a completed sale within one year with an estimated fair value of $2.6 million at December&#160;31, 2025. Effective with the designation as held for sale, we discontinued recording depreciation on property and equipment, net, amortization of intangible assets, net and amortization of ROU assets for the clinics as required by GAAP. We reported the related assets and liabilities of the clinics as held for sale as discontinued operations in our December&#160;31, 2025 and 2024 consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets that meet the criteria for the held for sale designation are reported at the lower of their carrying value or fair value less estimated cost to sell. As a result of our evaluation of the recoverability of the carrying value of the assets and liabilities held for sale relative to the clinics estimated fair values, we recorded an estimated loss on disposal of $2.7 million and $4.5 million for the years ended December&#160;31, 2025 and 2024, respectively, in Income (loss) from discontinued operations before income tax expense in our consolidated income statements and a valuation allowance included in discontinued operations current assets in our consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2025, in connection with the sale of company-owned or managed clinics classified as held for sale as of December&#160;31, 2024 for a combined sales price of $7.8 million, we sold $16.4 million assets held for sale, net of a $1.0 million valuation allowance and $7.4 million of liabilities to be disposed of in the consolidated balance sheets as of December&#160;31, 2024. As a result of the sales, we recorded a loss of $0.6 million included in Income (loss) from discontinued operations before income tax expense on the consolidated income statements for the year ended December&#160;31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2024, in connection with the sale of company-owned or managed clinics classified as held for sale as of December 31, 2023 for a combined sales price of $0.6 million, we sold $1.3 million assets held for sale, net of a $0.1 million valuation allowance and $0.8 million of liabilities to be disposed of in the consolidated balance sheets as of December 31, 2023. As a result of the sales, we recorded a gain of $0.1 million included in Income (loss) from discontinued operations before income tax expense on the consolidated income statements for the year ended December&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The principal components of the held for sale assets and liabilities to be disposed of as of December&#160;31, 2025 and 2024 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.221%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.224%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,497,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,457,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,111,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,643,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,288,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,906,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,482,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,459,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,327,644)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,071,603)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,051,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,395,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,065,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,526,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue from company-owned or managed clinics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,302,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,102,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities to be disposed of&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,368,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,629,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The pre-tax income of the clinics designated as held for sale as of December&#160;31, 2025 was $4.6 million and $4.7 million for the years ended December&#160;31, 2025 and 2024, respectively, the results of which exclude the allocation of corporate overhead.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue contextRef="c-107" decimals="0" id="f-595" unitRef="usd">54038508</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue contextRef="c-108" decimals="0" id="f-596" unitRef="usd">69982344</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue contextRef="c-107" decimals="0" id="f-597" unitRef="usd">54038508</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue contextRef="c-108" decimals="0" id="f-598" unitRef="usd">69982344</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold contextRef="c-107" decimals="0" id="f-599" unitRef="usd">20971</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold contextRef="c-108" decimals="0" id="f-600" unitRef="usd">47817</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold contextRef="c-107" decimals="0" id="f-601" unitRef="usd">20971</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold contextRef="c-108" decimals="0" id="f-602" unitRef="usd">47817</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <jynt:DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses contextRef="c-107" decimals="0" id="f-603" unitRef="usd">5755830</jynt:DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses>
    <jynt:DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses contextRef="c-108" decimals="0" id="f-604" unitRef="usd">7850616</jynt:DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpenses>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization contextRef="c-107" decimals="0" id="f-605" unitRef="usd">69558</us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization contextRef="c-108" decimals="0" id="f-606" unitRef="usd">3350748</us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense contextRef="c-107" decimals="0" id="f-607" unitRef="usd">39450918</us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense contextRef="c-108" decimals="0" id="f-608" unitRef="usd">54988780</us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense>
    <jynt:DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses contextRef="c-107" decimals="0" id="f-609" unitRef="usd">45276306</jynt:DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses>
    <jynt:DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses contextRef="c-108" decimals="0" id="f-610" unitRef="usd">66190144</jynt:DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpenses>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-107" decimals="0" id="f-611" unitRef="usd">5441010</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-108" decimals="0" id="f-612" unitRef="usd">7714555</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss contextRef="c-107" decimals="0" id="f-613" unitRef="usd">3300221</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss contextRef="c-108" decimals="0" id="f-614" unitRef="usd">-3970172</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <jynt:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense contextRef="c-107" decimals="0" id="f-615" unitRef="usd">-99592</jynt:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense>
    <jynt:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense contextRef="c-108" decimals="0" id="f-616" unitRef="usd">-2114</jynt:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="c-107" decimals="0" id="f-617" unitRef="usd">3200629</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="c-108" decimals="0" id="f-618" unitRef="usd">-3972286</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation contextRef="c-109" decimals="0" id="f-619" unitRef="usd">25207</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation contextRef="c-110" decimals="0" id="f-620" unitRef="usd">210263</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="c-109" decimals="0" id="f-621" unitRef="usd">3175422</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="c-110" decimals="0" id="f-622" unitRef="usd">-4182549</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet contextRef="c-95" decimals="0" id="f-623" unitRef="usd">315201</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet contextRef="c-96" decimals="0" id="f-624" unitRef="usd">2484248</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent contextRef="c-95" decimals="0" id="f-625" unitRef="usd">581504</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent contextRef="c-96" decimals="0" id="f-626" unitRef="usd">549605</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-84" decimals="0" id="f-627" unitRef="usd">20051965</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-85" decimals="0" id="f-628" unitRef="usd">38395986</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent contextRef="c-95" decimals="0" id="f-629" unitRef="usd">67779</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent contextRef="c-96" decimals="0" id="f-630" unitRef="usd">208074</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent>
    <jynt:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent contextRef="c-95" decimals="0" id="f-631" unitRef="usd">994138</jynt:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent>
    <jynt:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent contextRef="c-96" decimals="0" id="f-632" unitRef="usd">1087204</jynt:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets contextRef="c-95" decimals="0" id="f-633" unitRef="usd">235731</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets contextRef="c-96" decimals="0" id="f-634" unitRef="usd">425938</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation contextRef="c-111" decimals="0" id="f-635" unitRef="usd">22246318</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation contextRef="c-112" decimals="0" id="f-636" unitRef="usd">43151055</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent contextRef="c-95" decimals="0" id="f-637" unitRef="usd">83503</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent contextRef="c-96" decimals="0" id="f-638" unitRef="usd">67107</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent contextRef="c-95" decimals="0" id="f-639" unitRef="usd">2519433</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent contextRef="c-96" decimals="0" id="f-640" unitRef="usd">5066941</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent>
    <jynt:DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent contextRef="c-113" decimals="-5" id="f-641" unitRef="usd">600000</jynt:DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent>
    <jynt:DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent contextRef="c-114" decimals="-5" id="f-642" unitRef="usd">900000</jynt:DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent>
    <jynt:DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent contextRef="c-95" decimals="0" id="f-643" unitRef="usd">988865</jynt:DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent>
    <jynt:DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent contextRef="c-96" decimals="0" id="f-644" unitRef="usd">2333335</jynt:DisposalGroupIncludingDiscontinuedOperationPayrollLiabilitiesCurrent>
    <jynt:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent contextRef="c-95" decimals="0" id="f-645" unitRef="usd">651844</jynt:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent>
    <jynt:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent contextRef="c-96" decimals="0" id="f-646" unitRef="usd">153517</jynt:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent>
    <jynt:DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent contextRef="c-95" decimals="0" id="f-647" unitRef="usd">0</jynt:DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent>
    <jynt:DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent contextRef="c-96" decimals="0" id="f-648" unitRef="usd">38015</jynt:DisposalGroupIncludingDiscontinuedOperationFinanceLeaseLiabilityCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities contextRef="c-113" decimals="0" id="f-649" unitRef="usd">756483</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities contextRef="c-114" decimals="0" id="f-650" unitRef="usd">1079441</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-115" decimals="-5" id="f-651" unitRef="usd">4700000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-116" decimals="-5" id="f-652" unitRef="usd">5200000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-84" decimals="0" id="f-653" unitRef="usd">16368318</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-85" decimals="0" id="f-654" unitRef="usd">28629103</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation contextRef="c-111" decimals="0" id="f-655" unitRef="usd">21368446</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation contextRef="c-112" decimals="0" id="f-656" unitRef="usd">37367459</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DepreciationAndAmortizationDiscontinuedOperations contextRef="c-1" decimals="0" id="f-657" unitRef="usd">69558</us-gaap:DepreciationAndAmortizationDiscontinuedOperations>
    <us-gaap:DepreciationAndAmortizationDiscontinuedOperations contextRef="c-18" decimals="0" id="f-658" unitRef="usd">3350748</us-gaap:DepreciationAndAmortizationDiscontinuedOperations>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-107" decimals="0" id="f-659" unitRef="usd">5441010</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-108" decimals="0" id="f-660" unitRef="usd">7714555</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:CapitalExpenditureDiscontinuedOperations contextRef="c-107" decimals="0" id="f-661" unitRef="usd">84256</us-gaap:CapitalExpenditureDiscontinuedOperations>
    <us-gaap:CapitalExpenditureDiscontinuedOperations contextRef="c-108" decimals="0" id="f-662" unitRef="usd">664423</us-gaap:CapitalExpenditureDiscontinuedOperations>
    <jynt:DisposalGroupHeldForSaleClinicsExpectedToSellPeriod contextRef="c-117" id="f-663">P1Y</jynt:DisposalGroupHeldForSaleClinicsExpectedToSellPeriod>
    <jynt:DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue contextRef="c-84" decimals="-5" id="f-664" unitRef="usd">2600000</jynt:DisposalGroupIncludingDiscontinuedOperationEstimatedFairValue>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-82" decimals="-5" id="f-665" unitRef="usd">2700000</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-83" decimals="-5" id="f-666" unitRef="usd">4500000</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration contextRef="c-118" decimals="-5" id="f-667" unitRef="usd">7800000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <jynt:DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold contextRef="c-91" decimals="-5" id="f-668" unitRef="usd">16400000</jynt:DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold>
    <jynt:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent contextRef="c-118" decimals="-5" id="f-669" unitRef="usd">1000000.0</jynt:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent>
    <jynt:DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold contextRef="c-91" decimals="-5" id="f-670" unitRef="usd">7400000</jynt:DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="c-91" decimals="-5" id="f-671" unitRef="usd">-600000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration contextRef="c-119" decimals="-5" id="f-672" unitRef="usd">600000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <jynt:DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold contextRef="c-92" decimals="-5" id="f-673" unitRef="usd">1300000</jynt:DisposalGroupIncludingDiscontinuedOperationAssetsHeldForSaleSold>
    <jynt:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent contextRef="c-119" decimals="-5" id="f-674" unitRef="usd">100000</jynt:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent>
    <jynt:DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold contextRef="c-92" decimals="-5" id="f-675" unitRef="usd">800000</jynt:DisposalGroupIncludingDiscontinuedOperationLiabilitiesHeldForSaleSold>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="c-92" decimals="-5" id="f-676" unitRef="usd">100000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent contextRef="c-84" decimals="0" id="f-677" unitRef="usd">4497545</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent contextRef="c-85" decimals="0" id="f-678" unitRef="usd">8457627</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent>
    <jynt:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent contextRef="c-84" decimals="0" id="f-679" unitRef="usd">14111081</jynt:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent>
    <jynt:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent contextRef="c-85" decimals="0" id="f-680" unitRef="usd">19643917</jynt:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent contextRef="c-84" decimals="0" id="f-681" unitRef="usd">4288265</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent contextRef="c-85" decimals="0" id="f-682" unitRef="usd">6906807</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent contextRef="c-84" decimals="0" id="f-683" unitRef="usd">3482718</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent contextRef="c-85" decimals="0" id="f-684" unitRef="usd">8459238</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent>
    <jynt:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent contextRef="c-84" decimals="0" id="f-685" unitRef="usd">6327644</jynt:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent>
    <jynt:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent contextRef="c-85" decimals="0" id="f-686" unitRef="usd">5071603</jynt:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-84" decimals="0" id="f-687" unitRef="usd">20051965</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-85" decimals="0" id="f-688" unitRef="usd">38395986</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <jynt:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent contextRef="c-84" decimals="0" id="f-689" unitRef="usd">11065542</jynt:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent>
    <jynt:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent contextRef="c-85" decimals="0" id="f-690" unitRef="usd">20526714</jynt:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent contextRef="c-84" decimals="0" id="f-691" unitRef="usd">5302776</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent contextRef="c-85" decimals="0" id="f-692" unitRef="usd">8102389</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-84" decimals="0" id="f-693" unitRef="usd">16368318</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-85" decimals="0" id="f-694" unitRef="usd">28629103</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss contextRef="c-117" decimals="-5" id="f-695" unitRef="usd">4600000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss contextRef="c-120" decimals="-5" id="f-696" unitRef="usd">4700000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c-1" id="f-697">Property and Equipment&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office and computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;982,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;937,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,594,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,585,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internally developed software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,103,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,914,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,680,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,437,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,511,832)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,982,533)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,169,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,454,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;990,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;751,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and Equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,159,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,206,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense was $1.6 million and $1.4 million for the years ended December&#160;31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Construction in progress at December&#160;31, 2025 and 2024 related primarily to internal use software in development.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-698">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office and computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;982,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;937,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,594,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,585,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internally developed software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,103,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,914,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,680,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,437,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,511,832)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,982,533)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,169,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,454,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;990,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;751,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and Equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,159,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,206,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-121" decimals="0" id="f-699" unitRef="usd">982766</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-122" decimals="0" id="f-700" unitRef="usd">937551</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-123" decimals="0" id="f-701" unitRef="usd">1594291</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-124" decimals="0" id="f-702" unitRef="usd">1585609</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-125" decimals="0" id="f-703" unitRef="usd">7103852</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-126" decimals="0" id="f-704" unitRef="usd">5914254</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-127" decimals="0" id="f-705" unitRef="usd">9680909</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-128" decimals="0" id="f-706" unitRef="usd">8437414</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-127" decimals="0" id="f-707" unitRef="usd">7511832</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-128" decimals="0" id="f-708" unitRef="usd">5982533</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-127" decimals="0" id="f-709" unitRef="usd">2169077</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-128" decimals="0" id="f-710" unitRef="usd">2454881</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:ConstructionInProgressGross contextRef="c-4" decimals="0" id="f-711" unitRef="usd">990149</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross contextRef="c-5" decimals="0" id="f-712" unitRef="usd">751873</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="0" id="f-713" unitRef="usd">3159226</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-5" decimals="0" id="f-714" unitRef="usd">3206754</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation contextRef="c-1" decimals="-5" id="f-715" unitRef="usd">1600000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-18" decimals="-5" id="f-716" unitRef="usd">1400000</us-gaap:Depreciation>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-717">Fair Value Consideration&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our financial instruments include cash and cash equivalents, restricted cash, accounts receivable, accounts payable and accrued expenses. The carrying amounts of our financial instruments, excluding cash equivalents, approximate their fair value due to their short maturities. Cash equivalents consist of money market funds for which cost approximates fair values. Cash equivalents have an approximate fair value of $19.2&#160;million as of December&#160;31, 2025, which was determined using Level 1 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Authoritative guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The guidance establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability, developed based on market data obtained from sources independent of our company. Unobservable inputs are inputs that reflect our assumptions of what market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on reliability of the inputs as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:63pt;text-indent:-45pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1:&#160;&#160;&#160;&#160;Observable inputs such as quoted prices in active markets;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:63pt;text-indent:-45pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2:&#160;&#160;&#160;&#160;Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly;&#160;and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:63pt;text-indent:-45pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3:&#160;&#160;&#160;&#160;Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its   own assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2025 and 2024, we did not have any financial instruments that were measured on a recurring basis as Level 1, 2 or 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our non-financial assets, included in both continuing and discontinued operations, which primarily consist of goodwill, intangible assets, property, plant and equipment, and operating lease ROU assets, are not required to be measured at fair value on a recurring basis, and instead are reported at their carrying amount. However, on a periodic basis whenever events or changes in circumstances indicate that their carrying amount may not be fully recoverable (and at least annually for goodwill), non-financial assets are assessed for impairment. If the fair value is determined to be lower than the carrying amount, an impairment charge is recorded to write down the asset to its fair value, which is considered Level 3 within the fair value hierarchy. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assets and liabilities resulting from acquisitions, included in discontinued operations, were recorded at fair values on a nonrecurring basis at the date of acquisition and are considered Level 3 within the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets that meet the held for sale criteria are reported at the lower of their carrying value or fair value, less estimated costs to sell. The estimated fair values of the company-owned or managed clinics classified as Held for Sale (see Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Divestitures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) were recorded in discontinued operations current assets at fair values on a nonrecurring basis and are based upon Level 2 inputs, which includes a potential buyer agreed-upon selling price or Level 3 inputs, which includes consideration of a market approach using a multiple of earnings assumption based on clinic-level historical financial performance as well as an income approach using discounted cash flow ("DCF") models that use significant unobservable inputs and assumptions. Key inputs in the DCF models included projected cash flows over a 10-year forecast period, based on clinic-level historical financial performance and management's expectations of future operating results. A terminal value was estimated using the Gordon Growth Model for locations with positive cash flows. For locations with projected negative cash flows, no terminal value was assigned, as these clinics were assumed to cease operations upon lease termination. The future cash flows and terminal value were discounted to present value using a discount rate of 13.5% for clinics with positive cash flows and 4.2% for clinics with negative cash flows, which reflect the risk profile of the underlying operations and market conditions as of the measurement date. The fair value measurement of the assets held for sale as of December&#160;31, 2025, which included all company-owned or managed clinics, was recorded as $0.1 million based upon Level 2 inputs and $2.5 million based upon Level 3 inputs. As a result, we maintain a valuation allowance of $6.3 million to adjust the carrying value of the disposal group to fair value less cost to sell as of December&#160;31, 2025. The fair value measurement of the assets held for sale as of December&#160;31, 2024, which included all company-owned or managed clinics, was recorded as $0.4&#160;million based upon Level 2 inputs and $26.9&#160;million based upon Level 3 inputs as of December&#160;31, 2024. As a result, we recorded a valuation allowance of $5.1&#160;million to adjust the carrying value of the disposal group to fair value less cost to sell during the year ended December&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets classified as held and used where the asset group was not determined to be recoverable are tested for impairment. During the years ended December&#160;31, 2025 and 2024, in connection with the planned sale or determined closure of certain company-owned or managed clinics, we recorded an impairment loss of zero and $2.7&#160;million, respectively, included in Income (loss) from discontinued operations before income tax expense in our consolidated income statements for impairment of long-lived assets classified as held and used where the asset group was not determined recoverable. The asset group was determined to be the clinic level, as this is the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. The long-lived assets fair values were determined by the following: Level 1 inputs, which included observable inputs from executed lease termination agreements; Level 2 inputs where available, which included using a valuation multiple (e.g., price per square foot) based on observable prices for comparable long-lived assets; and Level 3 inputs, which included a multiple of earnings assumption using our historical earnings trend data, comparable historical asset sales by us and franchisees that were not exact matc&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;hes, and (for calculating the fair value of intangible assets specifically) our historical experience, future projections and comparable market data include future cash flows, long-term growth rates, attrition rates and discount rates. Generally, a change in the assumption used for the multiple inputs would have resulted in a directionally similar change of the fair value measurement where a multiple of earnings assumption was used.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying values of these asset groups impaired to their fair value during the year ended December&#160;31, 2024 included ROU assets of $5.8&#160;million that were written down to $4.3&#160;million determined by Level 1 and Level 2 inputs. The carrying values of these asset groups impaired to their fair value also included property and equipment of $3.9&#160;million that were written down to $2.8&#160;million and reacquired rights of $299 thousand that were written down to $253 thousand both determined by Level 3 inputs discussed above. The carrying value for nearly all company-owned or managed asset groups were reclassified to assets held for sale as of December&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-129" decimals="-5" id="f-718" unitRef="usd">19200000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c-1" id="f-719">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Authoritative guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The guidance establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability, developed based on market data obtained from sources independent of our company. Unobservable inputs are inputs that reflect our assumptions of what market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on reliability of the inputs as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:63pt;text-indent:-45pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1:&#160;&#160;&#160;&#160;Observable inputs such as quoted prices in active markets;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:63pt;text-indent:-45pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2:&#160;&#160;&#160;&#160;Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly;&#160;and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:63pt;text-indent:-45pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3:&#160;&#160;&#160;&#160;Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its   own assumptions.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <jynt:AssetsHeldForSaleCashFlowForecastPeriod contextRef="c-130" id="f-720">P10Y</jynt:AssetsHeldForSaleCashFlowForecastPeriod>
    <jynt:AssetsHeldForSaleMeasurementInputPositiveCashFlow contextRef="c-131" decimals="3" id="f-721" unitRef="number">0.135</jynt:AssetsHeldForSaleMeasurementInputPositiveCashFlow>
    <jynt:AssetsHeldForSaleMeasurementInputNegativeCashFlow contextRef="c-131" decimals="3" id="f-722" unitRef="number">0.042</jynt:AssetsHeldForSaleMeasurementInputNegativeCashFlow>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-132" decimals="-5" id="f-723" unitRef="usd">100000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-133" decimals="-5" id="f-724" unitRef="usd">2500000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <jynt:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent contextRef="c-84" decimals="-5" id="f-725" unitRef="usd">6300000</jynt:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-134" decimals="-5" id="f-726" unitRef="usd">400000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-135" decimals="-5" id="f-727" unitRef="usd">26900000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <jynt:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent contextRef="c-85" decimals="-5" id="f-728" unitRef="usd">5100000</jynt:DisposalGroupIncludingDiscontinuedOperationValuationAllowanceCurrent>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-136" decimals="-5" id="f-729" unitRef="usd">0</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax contextRef="c-81" decimals="-5" id="f-730" unitRef="usd">2700000</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment contextRef="c-79" decimals="-5" id="f-731" unitRef="usd">5800000</jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment>
    <jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment contextRef="c-79" decimals="-5" id="f-732" unitRef="usd">4300000</jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment>
    <jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment contextRef="c-78" decimals="-5" id="f-733" unitRef="usd">3900000</jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment>
    <jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment contextRef="c-78" decimals="-5" id="f-734" unitRef="usd">2800000</jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment>
    <jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment contextRef="c-80" decimals="-3" id="f-735" unitRef="usd">299000</jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueBeforeImpairment>
    <jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment contextRef="c-80" decimals="-3" id="f-736" unitRef="usd">253000</jynt:ImpairedLongLivedAssetsHeldAndUsedCarryingValueAfterImpairment>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-737">Debt&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 28, 2020, we entered into a Credit Agreement (the &#x201c;Credit Agreement&#x201d;), with JPMorgan Chase Bank, N.A., individually, and as Administrative Agent and Issuing Bank (&#x201c;JPMorgan Chase&#x201d; or the &#x201c;Lender&#x201d;). The Credit Agreement provided for senior secured credit facilities (the &#x201c;Credit Facilities&#x201d;) in the amount of $7.5 million, including a $2.0 million revolver (the &#x201c;Revolver&#x201d;) and a $5.5 million development line of credit (the &#x201c;Line of Credit&#x201d;). The Revolver included amounts available for letters of credit of up to $1.0 million and an uncommitted additional amount of $2.5 million. All outstanding principal and interest on the Revolver were due on February 28, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 28, 2022, we entered into an amendment to the Credit Facilities (as amended, the &#x201c;2022 Credit Facility&#x201d;) with the Lender. Under the 2022 Credit Facility, the Revolver increased to $20.0 million (from $2.0 million), the portion of the Revolver available for letters of credit increased to $5.0 million (from $1.0 million), the uncommitted additional amount increased to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$30.0 million (from $2.5 million) and the developmental line of credit of $5.5 million was terminated. The Revolver will be used for working capital needs, general corporate purposes and for acquisitions, development and capital improvement uses. At our option, borrowings under the 2022 Credit Facility bear interest at: (i) the adjusted Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;), which is the daily simple SOFR, plus 0.10%, plus 1.75%, payable on the last day of the selected interest period of one, three or six months, and on the three-month anniversary of the beginning of any six-month interest period, if applicable; or (ii) an Alternative Base Rate (ABR), plus 1.00%, payable monthly. The ABR is the greatest of: (A) the prime rate (as published by the Wall Street Journal), (B) the Federal Reserve Bank of New York rate, plus 0.5%, and (C) the adjusted one-month term SOFR rate. Amounts outstanding under the Revolver on February 28, 2022 continued to bear interest at the rate selected under the Credit Facilities prior to the amendment until the last day of the interest period in effect, at which time, if not repaid, the amounts outstanding under the Revolver will bear interest at the 2022 Credit Facility rate. The 2022 Credit Facility will terminate and all principal and interest will become due and payable on the fifth anniversary of the amendment (February 28, 2027). On January 17, 2024, we paid down the outstanding balance on our Debt under the Credit Agreement of $2.0 million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Facilities contain customary events of default, including but not limited to nonpayment; material inaccuracy of representations and warranties; violations of covenants; certain bankruptcies and liquidations; cross-default to material indebtedness; certain material judgments; and certain fundamental changes such as a merger or sale of substantially all assets (as further defined in the Credit Facilities). The Credit Facilities require us to comply with customary affirmative, negative and financial covenants, including minimum interest coverage and maximum net leverage. A breach of any of these operating or financial covenants would result in a default under the Credit Facilities. If an event of default occurs and is continuing, the lenders could elect to declare all amounts then outstanding, together with accrued interest, to be immediately due and payable. The Credit Facilities are collateralized by substantially all of our assets, including the assets in our company-owned or managed clinics. We intend to use the Revolver for general working capital needs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 30, 2025, we entered into a consent and third amendment to the Credit Agreement (as amended, the &#x201c;2025 Credit Facility&#x201d;) with the Lender. Among other things, the 2025 Credit Facility contains the consent of the Lender to our refranchising of all company-owned or managed clinics which would have triggered certain default events included in the Credit Agreement. The 2025 Credit Facility also extended the maturity date of the Credit Facilities to August 31, 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2025, there are no outstanding balances under our Credit Facilities or the 2025 Credit Facility. As of December&#160;31, 2025, we were in default of our Credit Facilities due to a violation of our fixed charge coverage ratio covenant primarily due to stock repurchases under the 2025 SRP, which constitute restricted payments. This prohibits our ability to draw upon our $20.0&#160;million Revolver under the 2022 Credit Facility until the covenant violation is resolved.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the issuance of the Credit Facilities and the 2022 Credit Facility, we incurred debt issuance costs of $53 thousand and $76 thousand, respectively. Interest expense and amortization expense related to debt issuance costs are being amortized to &#x201c;Other expense, net&#x201d; and was $22 thousand and $79 thousand for the years ended December&#160;31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-137" decimals="-5" id="f-738" unitRef="usd">7500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-138" decimals="-5" id="f-739" unitRef="usd">2000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-139" decimals="-5" id="f-740" unitRef="usd">5500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-140" decimals="-5" id="f-741" unitRef="usd">1000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <jynt:LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount contextRef="c-137" decimals="-5" id="f-742" unitRef="usd">2500000</jynt:LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-141" decimals="-5" id="f-743" unitRef="usd">20000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-142" decimals="-5" id="f-744" unitRef="usd">2000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-143" decimals="-5" id="f-745" unitRef="usd">5000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-144" decimals="-5" id="f-746" unitRef="usd">1000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <jynt:LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount contextRef="c-145" decimals="-5" id="f-747" unitRef="usd">30000000.0</jynt:LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount>
    <jynt:LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount contextRef="c-146" decimals="-5" id="f-748" unitRef="usd">2500000</jynt:LineOfCreditFacilityMaximumBorrowingCapacityAdditionalAmount>
    <us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet contextRef="c-147" decimals="-5" id="f-749" unitRef="usd">-5500000</us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-148"
      decimals="INF"
      id="f-750"
      unitRef="number">0.0010</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-149"
      decimals="INF"
      id="f-751"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-150"
      decimals="INF"
      id="f-752"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-151"
      decimals="INF"
      id="f-753"
      unitRef="number">0.005</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LongTermDebt contextRef="c-152" decimals="-5" id="f-754" unitRef="usd">2000000.0</us-gaap:LongTermDebt>
    <us-gaap:LineOfCredit contextRef="c-153" decimals="-5" id="f-755" unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-141" decimals="-5" id="f-756" unitRef="usd">20000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DeferredFinanceCostsGross contextRef="c-154" decimals="-3" id="f-757" unitRef="usd">53000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DeferredFinanceCostsGross contextRef="c-155" decimals="-3" id="f-758" unitRef="usd">76000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-156" decimals="-3" id="f-759" unitRef="usd">22000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-157" decimals="-3" id="f-760" unitRef="usd">79000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-761">Stockholders&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt; Equity&lt;/span&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On June 3, 2025, our Board of Directors approved the 2025 SRP to repurchase up to $5.0&#160;million of our common stock, par value $0.001 per share, from time to time until June 3, 2027 or such other date as we have exhausted, or the Board of Directors otherwise terminates, the repurchase authorization. On November 4, 2025, the Board of Directors authorized an additional $12.0&#160;million under the 2025 SRP and extended the repurchase date through November 4, 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The timing, volume, price, and terms of the repurchases will depend on market and business conditions, applicable legal requirements, and other factors. The repurchases may be made on the open market, in privately negotiated transactions, or in such other manner (e.g., accelerated share repurchase transactions, block trades, derivatives, or otherwise) that complies with the terms of applicable federal and state securities laws and regulations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;During the year ended December&#160;31, 2025, we repurchased $11.3 million of common stock at an average price of $8.73 per share, excluding related costs and fees. As of December&#160;31, 2025, we had a remaining $5.7 million authorized for repurchasing shares of our common stock. All shares of common stock that we repurchased are held as treasury stock.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Treasury Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2025 and 2024, shares of common stock at a total cost of $8 thousand and $10 thousand, respectively, were netted and surrendered as payment for minimum statutory withholding obligations in connection with the vesting of outstanding stock awards. hares surrendered by the participants in accordance with the applicable award agreements and plan are deemed repurchased by us but are not part of publicly announced stock repurchase programs.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <srt:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-158" decimals="-5" id="f-762" unitRef="usd">5000000.0</srt:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-158"
      decimals="3"
      id="f-763"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <jynt:ShareRepurchaseProgramAdditionalAuthorizedAmount contextRef="c-159" decimals="-5" id="f-764" unitRef="usd">12000000.0</jynt:ShareRepurchaseProgramAdditionalAuthorizedAmount>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-1" decimals="-5" id="f-765" unitRef="usd">11300000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="c-1"
      decimals="2"
      id="f-766"
      unitRef="usdPerShare">8.73</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="c-4" decimals="-5" id="f-767" unitRef="usd">5700000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-3" id="f-768" unitRef="usd">8000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-18" decimals="-3" id="f-769" unitRef="usd">10000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-770">Stock-Based Compensation&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We grant stock-based awards under our 2024 Incentive Stock Plan (the &#x201c;2024 Plan&#x201d;). The shares issued as a result of stock-based compensation transactions generally have been funded with the issuance of new shares of our common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may grant the following types of incentive awards under the 2024 Plan: (i) non-qualified stock options; (ii) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; and (v) restricted stock units. Each award granted under the 2024 Plan is subject to an award agreement that incorporates, as applicable, the exercise price, the term of the award, the periods of restriction, the number of shares to which the award pertains, and such other terms and conditions as the plan committee determines. Awards granted under the 2024 Plan are classified as equity awards, which are recorded in stockholders&#x2019; equity in our consolidated balance sheets. Through December&#160;31, 2025, we have granted under the 2024 Plan (i) non-qualified stock options; (ii) incentive stock options; and (iii) restricted stock. There were no stock appreciation rights or restricted stock units granted under the 2024 Plan as of December&#160;31, 2025. As of December&#160;31, 2025, 1,725,057 shares of common stock remained available for issuance under the 2024 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our closing price on the date of grant is the basis of fair value of its common stock used in determining the value of share-based awards. To the extent that the value of our share-based awards involves a measure of volatility, we use available historical volatility of our common stock over a period of time corresponding to the expected stock option term. We use the simplified method to calculate the expected term of stock option grants to employees. Accordingly, the expected life of the options granted is based on the average of the vesting term, which is generally four years and the contractual term, which is generally ten years. The risk-free interest rate is based on United States Treasury yields in effect at the date of grant for periods corresponding to the expected stock option term. Forfeitures are estimated based on historical and forecasted turnover, which is approximately 5%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We did not grant any options during the year ended December&#160;31, 2025. We have computed the fair value of all options granted using the Black-Scholes-Merton model during the year ended December&#160;31, 2024, using the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.638%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.25&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.86%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The information below summarizes the stock options activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,903,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted at market price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(227,952)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,201)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December&#160;31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;777,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123,460)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89,604)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(432)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest at December&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average grant-date fair value of our stock options granted during the year ended December&#160;31, 2024 was $6.21.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate fair value of our stock options vested during 2025 and 2024 was $157 thousand and $319 thousand, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize compensation costs ratably over the period of service using the straight-line method. Forfeitures are estimated based on historical and forecasted turnover, which is approximately 5%. For the years ended December&#160;31, 2025 and 2024, stock-based compensation expense for stock options was $73 thousand and $141 thousand, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrecognized stock-based compensation expense for stock options as of December&#160;31, 2025 was $166 thousand, which is expected to be recognized ratably over the next 2.8 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock awards granted to employees generally vest in four equal annual installments.&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock awards granted to non-employee directors vest on the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting of the shareholders of our company occurring after the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The information below summarizes the restricted stock activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant-Date Fair Value per Award&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested at December&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107,103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested at December&#160;31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107,854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested at December&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2025 and 2024, stock-based compensation expense for restricted stock was $1.2 million and $1.5 million, respectively. Unrecognized stock-based compensation expense for restricted stock awards as of December&#160;31, 2025 was $2.9 million to be recognized ratably over 2.9 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Tax Benefits&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income (loss) for 2025 and 2024 included pre-tax expense related to stock-based compensation of $1.3 million and $1.7 million, respectively. We recognized federal income tax benefits of zero and $0.1 million from the exercises of stock options and restricted stock awards for 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="c-4" decimals="INF" id="f-771" unitRef="shares">1725057</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-160" id="f-772">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-160" id="f-773">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <jynt:ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage contextRef="c-161" decimals="2" id="f-774" unitRef="number">0.05</jynt:ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-160"
      decimals="INF"
      id="f-775"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-776">We have computed the fair value of all options granted using the Black-Scholes-Merton model during the year ended December&#160;31, 2024, using the following assumptions:&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.638%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.25&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.86%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-162" decimals="2" id="f-777" unitRef="number">0.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-162" id="f-778">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-162" decimals="4" id="f-779" unitRef="number">0.0386</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-780">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The information below summarizes the stock options activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,903,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted at market price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(227,952)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,201)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December&#160;31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;777,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123,460)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89,604)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(432)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest at December&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-163"
      decimals="INF"
      id="f-781"
      unitRef="shares">486334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-163"
      decimals="2"
      id="f-782"
      unitRef="usdPerShare">8.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-164" id="f-783">P3Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding contextRef="c-163" decimals="0" id="f-784" unitRef="usd">1903699</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-162"
      decimals="INF"
      id="f-785"
      unitRef="shares">38059</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-162"
      decimals="2"
      id="f-786"
      unitRef="usdPerShare">10.51</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-162"
      decimals="INF"
      id="f-787"
      unitRef="shares">227952</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-162"
      decimals="2"
      id="f-788"
      unitRef="usdPerShare">4.08</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-162" decimals="0" id="f-789" unitRef="usd">1435074</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="c-162"
      decimals="INF"
      id="f-790"
      unitRef="shares">9201</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-162"
      decimals="2"
      id="f-791"
      unitRef="usdPerShare">26.52</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c-162"
      decimals="INF"
      id="f-792"
      unitRef="shares">5263</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-162"
      decimals="2"
      id="f-793"
      unitRef="usdPerShare">41.18</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-165"
      decimals="INF"
      id="f-794"
      unitRef="shares">281977</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-165"
      decimals="2"
      id="f-795"
      unitRef="usdPerShare">11.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-162" id="f-796">P3Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding contextRef="c-165" decimals="0" id="f-797" unitRef="usd">777566</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-160"
      decimals="INF"
      id="f-798"
      unitRef="shares">123460</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-160"
      decimals="2"
      id="f-799"
      unitRef="usdPerShare">5.04</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-160" decimals="0" id="f-800" unitRef="usd">656751</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="c-160"
      decimals="INF"
      id="f-801"
      unitRef="shares">89604</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-160"
      decimals="2"
      id="f-802"
      unitRef="usdPerShare">19.01</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c-160"
      decimals="INF"
      id="f-803"
      unitRef="shares">432</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-160"
      decimals="2"
      id="f-804"
      unitRef="usdPerShare">45.39</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-161"
      decimals="INF"
      id="f-805"
      unitRef="shares">68481</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-161"
      decimals="2"
      id="f-806"
      unitRef="usdPerShare">14.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-160" id="f-807">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding contextRef="c-161" decimals="0" id="f-808" unitRef="usd">59412</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c-161"
      decimals="INF"
      id="f-809"
      unitRef="shares">39936</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-161"
      decimals="2"
      id="f-810"
      unitRef="usdPerShare">17.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-160" id="f-811">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue contextRef="c-161" decimals="0" id="f-812" unitRef="usd">59412</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="c-161"
      decimals="INF"
      id="f-813"
      unitRef="shares">66000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="c-161"
      decimals="2"
      id="f-814"
      unitRef="usdPerShare">14.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="c-160" id="f-815">P5Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue contextRef="c-161" decimals="0" id="f-816" unitRef="usd">59412</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-162"
      decimals="2"
      id="f-817"
      unitRef="usdPerShare">6.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="c-1" decimals="-3" id="f-818" unitRef="usd">157000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="c-18" decimals="-3" id="f-819" unitRef="usd">319000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <jynt:ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage contextRef="c-161" decimals="2" id="f-820" unitRef="number">0.05</jynt:ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresHistoricalAndForecastedTurnoverPercentage>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-160" decimals="-3" id="f-821" unitRef="usd">73000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-162" decimals="-3" id="f-822" unitRef="usd">141000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="c-161" decimals="-3" id="f-823" unitRef="usd">166000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-160" id="f-824">P2Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <jynt:ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments
      contextRef="c-166"
      decimals="INF"
      id="f-825"
      unitRef="installment">4</jynt:ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsVestingNumberOfAnnualInstallments>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-167" id="f-826">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock contextRef="c-1" id="f-827">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The information below summarizes the restricted stock activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant-Date Fair Value per Award&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested at December&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107,103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested at December&#160;31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107,854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested at December&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-168"
      decimals="INF"
      id="f-828"
      unitRef="shares">231901</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-168"
      decimals="2"
      id="f-829"
      unitRef="usdPerShare">17.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-169"
      decimals="INF"
      id="f-830"
      unitRef="shares">285656</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-169"
      decimals="2"
      id="f-831"
      unitRef="usdPerShare">9.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-169"
      decimals="INF"
      id="f-832"
      unitRef="shares">107103</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-169"
      decimals="2"
      id="f-833"
      unitRef="usdPerShare">16.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-169"
      decimals="INF"
      id="f-834"
      unitRef="shares">104472</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-169"
      decimals="2"
      id="f-835"
      unitRef="usdPerShare">14.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-170"
      decimals="INF"
      id="f-836"
      unitRef="shares">305982</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-170"
      decimals="2"
      id="f-837"
      unitRef="usdPerShare">11.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-171"
      decimals="INF"
      id="f-838"
      unitRef="shares">301896</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-171"
      decimals="2"
      id="f-839"
      unitRef="usdPerShare">10.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-171"
      decimals="INF"
      id="f-840"
      unitRef="shares">107854</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-171"
      decimals="2"
      id="f-841"
      unitRef="usdPerShare">12.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-171"
      decimals="INF"
      id="f-842"
      unitRef="shares">146534</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-171"
      decimals="2"
      id="f-843"
      unitRef="usdPerShare">11.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-166"
      decimals="INF"
      id="f-844"
      unitRef="shares">353490</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-166"
      decimals="2"
      id="f-845"
      unitRef="usdPerShare">10.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-171" decimals="-5" id="f-846" unitRef="usd">1200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-169" decimals="-5" id="f-847" unitRef="usd">1500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="c-166" decimals="-5" id="f-848" unitRef="usd">2900000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-171" id="f-849">P2Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-5" id="f-850" unitRef="usd">1300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-18" decimals="-5" id="f-851" unitRef="usd">1700000</us-gaap:ShareBasedCompensation>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions contextRef="c-1" decimals="-5" id="f-852" unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions contextRef="c-18" decimals="-5" id="f-853" unitRef="usd">100000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-854">Income Taxes&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of loss from continuing operations before the provision for income taxes, by taxing jurisdiction are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,608,738)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,608,738)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense reported in the consolidated income statements is comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State, net of state tax credits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred expense (benefit):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax effects of temporary differences that give rise to significant components of the deferred tax assets and liabilities are provided below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.438%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,607,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,535,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,909,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,795,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,710,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill - component 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill - component 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonqualified stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,261,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,029,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,416,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,921,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,968,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,730,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,327,659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,307,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,640,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,423,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease ROU asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,320,092)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,392,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred franchise costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(320,837)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill - component 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(807,824)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147,143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,640,929)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,423,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A valuation allowance of $11.3 million and $12.3 million was recorded against the deferred tax asset balance of The Joint Corp., without its VIEs, as of December&#160;31, 2025 and 2024, respectively. During the year ended December&#160;31, 2025, the valuation allowance decreased by $1.0 million. As of each reporting date, we consider new evidence, both positive and negative, that could impact our view with regard to future realization of deferred tax assets in each reporting jurisdiction. A significant piece of objective evidence evaluated was the cumulative loss incurred in each jurisdiction over the three-year period ended December&#160;31, 2025. Such objective evidence limits the ability to consider other subjective evidence, such as projections for future growth, in evaluating the need for a valuation allowance. As a result, we determined that it is more likely than not that The Joint Corp. will not realize its deferred tax assets as of December&#160;31, 2025, and has recorded a valuation allowance after consideration of any recorded deferred tax liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, deferred tax assets attributable to its VIEs of $1.0 million and $1.1 million were classified as discontinued operations as of December&#160;31, 2025 and 2024, respectively, and are related to deferred revenue. See Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Divestitures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information on discontinued operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Joint Corp., without the VIEs, has federal gross net operating loss carryforwards of $10.2 million and $12.3 million as of December&#160;31, 2025 and 2024, respectively. The federal tax effected impacts of these net operating losses were $2.1 million and $2.6 million as of December&#160;31, 2025 and 2024, respectively. $7.8 million of the federal net operating loss as of December&#160;31, 2025 is subject to a 20-year carryforward, with a portion beginning to expire in 2036. $2.3 million of the federal net operating loss as of December&#160;31, 2025 has an indefinite carryforward period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Joint Corp., without the VIEs, has state net operating loss carryforwards of $10.2&#160;million and $3.6&#160;million as of December&#160;31, 2025 and 2024, respectively. The determination of the state net operating loss carryforwards is dependent upon apportionment percentages and state laws that can change from year to year and impact the amount of such carryforwards. If such net operating loss carryforwards are not utilized, a portion will begin to expire in 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have research and development credits of $14 thousand that will begin to expire in 2031 and California Alternative Minimum Tax credits of $22 thousand that do not expire.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes differs from the amount calculated using the statutory federal corporate income tax rate of 21% due to the following items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.677%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.162%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Percent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Percent&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from continuing operations before provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,608,738)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected federal tax expense at U.S. federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48,388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337,835)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local income taxes (net of federal income tax effect) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128,782)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in valuation allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(507,419)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nontaxable or nondeductible items:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Section 162(m) officer compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Share based compensation (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Payroll tax penalty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,749)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Meals and entertainment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Other items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Deferred true-up to deferred franchise costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(124.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Current year expirations of non-qualified stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Other items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,819)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income tax expense and effective rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;___________&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) State taxes in Arizona, California and Texas made up the majority (greater than 50%) of the tax effect in this category.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) Share based compensation includes incentive stock options, non-qualified stock options and restricted stock awards.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in our income tax expense relate primarily to state income taxes (net of federal tax and permanent differences), changes in tax rates, stock compensation, shortfall/windfall on stock compensation expense, change in valuation allowance and uncertain tax positions during the year ended December&#160;31, 2025, as compared to the year ended December&#160;31, 2024. For the years ended December&#160;31, 2025 and 2024, effective tax rates were (16.8)% and (0.3)%, respectively. The difference between the statutory federal income tax rate and our effective tax rate was primarily due to the uncertain tax position net impact and state taxes (net of federal taxes) for the year ended December&#160;31, 2025. The difference between the statutory federal income tax rate and our effective tax rate was primarily due to the valuation allowance, change in tax rate and uncertain tax position for the year ended December&#160;31, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit or obligation as the largest amount that is more than 50% likely of being realized upon ultimate settlement. We consider many factors when evaluating and estimating our tax positions and tax benefits, which may require periodic adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2025 and 2024, we had gross uncertain tax positions attributable to the VIEs, recorded as discontinued operations, of $0.6&#160;million and $0.9&#160;million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.438%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;948,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,175,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for expiration of the statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(314,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(227,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;948,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2025 and December&#160;31, 2024, there were $20 thousand and $22 thousand, respectively, of unrecognized tax benefits that if recognized would affect the annual effective tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest and penalties associated with tax positions are recorded in the period assessed as general and administrative expenses. Accrued interest and penalties were $178 thousand and $202 thousand for the years ended December&#160;31, 2025 and 2024, respectively, and recorded as other liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of cash paid for income taxes (net of refunds received) was as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.438%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;State:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Arizona&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;California&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Texas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Other state jurisdictions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid (net of refunds received)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With exceptions due to the generation and utilization of net operating losses or credits, as of December&#160;31, 2025, we are no longer subject to federal and state examinations by taxing authorities for tax years before 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="c-1" id="f-855">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of loss from continuing operations before the provision for income taxes, by taxing jurisdiction are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,608,738)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,608,738)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-1" decimals="0" id="f-856" unitRef="usd">-229504</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-18" decimals="0" id="f-857" unitRef="usd">-1608738</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="0" id="f-858" unitRef="usd">-229504</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-18" decimals="0" id="f-859" unitRef="usd">-1608738</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c-1" id="f-860">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense reported in the consolidated income statements is comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State, net of state tax credits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred expense (benefit):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-1" decimals="0" id="f-861" unitRef="usd">38653</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-18" decimals="0" id="f-862" unitRef="usd">62759</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-1" decimals="0" id="f-863" unitRef="usd">38653</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-18" decimals="0" id="f-864" unitRef="usd">62759</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-1" decimals="0" id="f-865" unitRef="usd">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-18" decimals="0" id="f-866" unitRef="usd">-57153</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="0" id="f-867" unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-18" decimals="0" id="f-868" unitRef="usd">-57153</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="0" id="f-869" unitRef="usd">38653</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-18" decimals="0" id="f-870" unitRef="usd">5606</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c-1" id="f-871">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax effects of temporary differences that give rise to significant components of the deferred tax assets and liabilities are provided below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.438%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,607,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,535,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,909,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,795,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,710,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill - component 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill - component 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonqualified stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,261,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,029,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,416,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,921,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,968,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,730,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,327,659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,307,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,640,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,423,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease ROU asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,320,092)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,392,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred franchise costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(320,837)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill - component 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(807,824)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147,143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,640,929)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,423,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities contextRef="c-4" decimals="0" id="f-872" unitRef="usd">757576</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities contextRef="c-5" decimals="0" id="f-873" unitRef="usd">1607324</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="c-4" decimals="0" id="f-874" unitRef="usd">3535528</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="c-5" decimals="0" id="f-875" unitRef="usd">3909555</us-gaap:DeferredTaxAssetsDeferredIncome>
    <jynt:DeferredTaxAssetsOperatingLeaseLiability contextRef="c-4" decimals="0" id="f-876" unitRef="usd">3795895</jynt:DeferredTaxAssetsOperatingLeaseLiability>
    <jynt:DeferredTaxAssetsOperatingLeaseLiability contextRef="c-5" decimals="0" id="f-877" unitRef="usd">5710136</jynt:DeferredTaxAssetsOperatingLeaseLiability>
    <jynt:DeferredTaxAssetsGoodwillComponent1 contextRef="c-4" decimals="0" id="f-878" unitRef="usd">383987</jynt:DeferredTaxAssetsGoodwillComponent1>
    <jynt:DeferredTaxAssetsGoodwillComponent1 contextRef="c-5" decimals="0" id="f-879" unitRef="usd">0</jynt:DeferredTaxAssetsGoodwillComponent1>
    <jynt:DeferredTaxAssetsGoodwillComponent2 contextRef="c-4" decimals="0" id="f-880" unitRef="usd">49829</jynt:DeferredTaxAssetsGoodwillComponent2>
    <jynt:DeferredTaxAssetsGoodwillComponent2 contextRef="c-5" decimals="0" id="f-881" unitRef="usd">55368</jynt:DeferredTaxAssetsGoodwillComponent2>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="c-4" decimals="0" id="f-882" unitRef="usd">471855</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="c-5" decimals="0" id="f-883" unitRef="usd">0</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <jynt:DeferredTaxAssetsNonqualifiedStockOptions contextRef="c-4" decimals="0" id="f-884" unitRef="usd">117962</jynt:DeferredTaxAssetsNonqualifiedStockOptions>
    <jynt:DeferredTaxAssetsNonqualifiedStockOptions contextRef="c-5" decimals="0" id="f-885" unitRef="usd">322376</jynt:DeferredTaxAssetsNonqualifiedStockOptions>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-4" decimals="0" id="f-886" unitRef="usd">3261907</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-5" decimals="0" id="f-887" unitRef="usd">3029413</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="c-4" decimals="0" id="f-888" unitRef="usd">35850</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="c-5" decimals="0" id="f-889" unitRef="usd">35850</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <jynt:DeferredTaxAssetsIntangibleAssets contextRef="c-4" decimals="0" id="f-890" unitRef="usd">3416636</jynt:DeferredTaxAssetsIntangibleAssets>
    <jynt:DeferredTaxAssetsIntangibleAssets contextRef="c-5" decimals="0" id="f-891" unitRef="usd">3921742</jynt:DeferredTaxAssetsIntangibleAssets>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c-4" decimals="0" id="f-892" unitRef="usd">141563</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c-5" decimals="0" id="f-893" unitRef="usd">139038</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-4" decimals="0" id="f-894" unitRef="usd">15968588</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-5" decimals="0" id="f-895" unitRef="usd">18730802</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-4" decimals="0" id="f-896" unitRef="usd">11327659</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-5" decimals="0" id="f-897" unitRef="usd">12307555</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-4" decimals="0" id="f-898" unitRef="usd">4640929</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-5" decimals="0" id="f-899" unitRef="usd">6423247</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <jynt:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset contextRef="c-4" decimals="0" id="f-900" unitRef="usd">4320092</jynt:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset>
    <jynt:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset contextRef="c-5" decimals="0" id="f-901" unitRef="usd">5392996</jynt:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset>
    <jynt:DeferredTaxLiabilitiesDeferredFranchiseCosts contextRef="c-4" decimals="0" id="f-902" unitRef="usd">320837</jynt:DeferredTaxLiabilitiesDeferredFranchiseCosts>
    <jynt:DeferredTaxLiabilitiesDeferredFranchiseCosts contextRef="c-5" decimals="0" id="f-903" unitRef="usd">75284</jynt:DeferredTaxLiabilitiesDeferredFranchiseCosts>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill contextRef="c-4" decimals="0" id="f-904" unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill contextRef="c-5" decimals="0" id="f-905" unitRef="usd">807824</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-4" decimals="0" id="f-906" unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-5" decimals="0" id="f-907" unitRef="usd">147143</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-4" decimals="0" id="f-908" unitRef="usd">4640929</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-5" decimals="0" id="f-909" unitRef="usd">6423247</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities contextRef="c-4" decimals="0" id="f-910" unitRef="usd">0</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities contextRef="c-5" decimals="0" id="f-911" unitRef="usd">0</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-4" decimals="-5" id="f-912" unitRef="usd">11300000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-5" decimals="-5" id="f-913" unitRef="usd">12300000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-1" decimals="-5" id="f-914" unitRef="usd">-1000000.0</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <jynt:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent contextRef="c-95" decimals="-5" id="f-915" unitRef="usd">1000000.0</jynt:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent>
    <jynt:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent contextRef="c-96" decimals="-5" id="f-916" unitRef="usd">1100000</jynt:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsCurrent>
    <us-gaap:OperatingLossCarryforwards contextRef="c-4" decimals="-5" id="f-917" unitRef="usd">10200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-5" decimals="-5" id="f-918" unitRef="usd">12300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-172" decimals="-5" id="f-919" unitRef="usd">2100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-173" decimals="-5" id="f-920" unitRef="usd">2600000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c-172" decimals="-5" id="f-921" unitRef="usd">7800000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration contextRef="c-172" decimals="-5" id="f-922" unitRef="usd">2300000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:OperatingLossCarryforwards contextRef="c-174" decimals="-5" id="f-923" unitRef="usd">10200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-175" decimals="-5" id="f-924" unitRef="usd">3600000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-176" decimals="-3" id="f-925" unitRef="usd">14000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-177" decimals="-3" id="f-926" unitRef="usd">22000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c-1" id="f-927">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes differs from the amount calculated using the statutory federal corporate income tax rate of 21% due to the following items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.677%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.162%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Percent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Percent&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from continuing operations before provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,608,738)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected federal tax expense at U.S. federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48,388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337,835)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local income taxes (net of federal income tax effect) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128,782)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in valuation allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(507,419)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nontaxable or nondeductible items:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Section 162(m) officer compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Share based compensation (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Payroll tax penalty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,749)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Meals and entertainment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Other items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Deferred true-up to deferred franchise costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(124.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Current year expirations of non-qualified stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Other items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,819)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income tax expense and effective rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;___________&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) State taxes in Arizona, California and Texas made up the majority (greater than 50%) of the tax effect in this category.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) Share based compensation includes incentive stock options, non-qualified stock options and restricted stock awards.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="0" id="f-928" unitRef="usd">-229504</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-18" decimals="0" id="f-929" unitRef="usd">-1608738</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-1" decimals="0" id="f-930" unitRef="usd">-48388</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-1" decimals="INF" id="f-931" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-18" decimals="0" id="f-932" unitRef="usd">-337835</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c-18"
      decimals="INF"
      id="f-933"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c-1" decimals="0" id="f-934" unitRef="usd">-128782</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-1" decimals="3" id="f-935" unitRef="number">0.561</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c-18" decimals="0" id="f-936" unitRef="usd">79774</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-18" decimals="3" id="f-937" unitRef="number">-0.050</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-1" decimals="0" id="f-938" unitRef="usd">-507419</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-1" decimals="3" id="f-939" unitRef="number">2.211</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-18" decimals="0" id="f-940" unitRef="usd">66503</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-18" decimals="3" id="f-941" unitRef="number">-0.041</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <jynt:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount contextRef="c-1" decimals="0" id="f-942" unitRef="usd">0</jynt:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount>
    <jynt:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent contextRef="c-1" decimals="3" id="f-943" unitRef="number">0</jynt:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent>
    <jynt:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount contextRef="c-18" decimals="0" id="f-944" unitRef="usd">85992</jynt:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount>
    <jynt:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent contextRef="c-18" decimals="3" id="f-945" unitRef="number">-0.053</jynt:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationPercent>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-1" decimals="0" id="f-946" unitRef="usd">-28302</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-1" decimals="3" id="f-947" unitRef="number">0.123</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-18" decimals="0" id="f-948" unitRef="usd">-119263</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-18" decimals="3" id="f-949" unitRef="number">0.074</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <jynt:EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount contextRef="c-1" decimals="0" id="f-950" unitRef="usd">-45749</jynt:EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount>
    <jynt:EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent contextRef="c-1" decimals="3" id="f-951" unitRef="number">0.199</jynt:EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent>
    <jynt:EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount contextRef="c-18" decimals="0" id="f-952" unitRef="usd">0</jynt:EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyAmount>
    <jynt:EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent contextRef="c-18" decimals="3" id="f-953" unitRef="number">0</jynt:EffectiveIncomeTaxRateReconciliationNondeductibleExpensePayrollTaxPenaltyPercent>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment contextRef="c-1" decimals="0" id="f-954" unitRef="usd">23549</us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment contextRef="c-1" decimals="3" id="f-955" unitRef="number">-0.102</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment contextRef="c-18" decimals="0" id="f-956" unitRef="usd">30462</us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment contextRef="c-18" decimals="3" id="f-957" unitRef="number">-0.019</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther contextRef="c-1" decimals="0" id="f-958" unitRef="usd">17710</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther contextRef="c-1" decimals="3" id="f-959" unitRef="number">-0.077</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther contextRef="c-18" decimals="0" id="f-960" unitRef="usd">26572</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther contextRef="c-18" decimals="3" id="f-961" unitRef="number">-0.016</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationTaxContingencies contextRef="c-1" decimals="0" id="f-962" unitRef="usd">300582</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies contextRef="c-1" decimals="3" id="f-963" unitRef="number">-1.309</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies contextRef="c-18" decimals="0" id="f-964" unitRef="usd">212687</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies contextRef="c-18" decimals="3" id="f-965" unitRef="number">-0.132</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <jynt:EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount contextRef="c-1" decimals="0" id="f-966" unitRef="usd">285915</jynt:EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount>
    <jynt:EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent contextRef="c-1" decimals="3" id="f-967" unitRef="number">-1.245</jynt:EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent>
    <jynt:EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount contextRef="c-18" decimals="0" id="f-968" unitRef="usd">0</jynt:EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpAmount>
    <jynt:EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent contextRef="c-18" decimals="3" id="f-969" unitRef="number">0</jynt:EffectiveIncomeTaxRateReconciliationDeferredFranchiseCostsDeferredTrueUpPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount contextRef="c-1" decimals="0" id="f-970" unitRef="usd">217356</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent contextRef="c-1" decimals="3" id="f-971" unitRef="number">-0.947</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount contextRef="c-18" decimals="0" id="f-972" unitRef="usd">0</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent contextRef="c-18" decimals="3" id="f-973" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c-1" decimals="0" id="f-974" unitRef="usd">-47819</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-1" decimals="3" id="f-975" unitRef="number">0.208</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c-18" decimals="0" id="f-976" unitRef="usd">-39286</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-18" decimals="3" id="f-977" unitRef="number">0.024</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="0" id="f-978" unitRef="usd">38653</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-979" unitRef="number">-0.168</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-18" decimals="0" id="f-980" unitRef="usd">5606</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-18" decimals="3" id="f-981" unitRef="number">-0.003</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-982" unitRef="number">-0.168</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-18" decimals="3" id="f-983" unitRef="number">-0.003</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-95" decimals="-5" id="f-984" unitRef="usd">600000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-96" decimals="-5" id="f-985" unitRef="usd">900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock contextRef="c-1" id="f-986">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.438%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;948,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,175,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for expiration of the statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(314,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(227,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;948,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-96" decimals="0" id="f-987" unitRef="usd">948182</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-178" decimals="0" id="f-988" unitRef="usd">1175766</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c-107" decimals="0" id="f-989" unitRef="usd">314468</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c-108" decimals="0" id="f-990" unitRef="usd">227584</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-95" decimals="0" id="f-991" unitRef="usd">633714</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-96" decimals="0" id="f-992" unitRef="usd">948182</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-95" decimals="-3" id="f-993" unitRef="usd">20000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-96" decimals="-3" id="f-994" unitRef="usd">22000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued contextRef="c-4" decimals="-3" id="f-995" unitRef="usd">178000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued contextRef="c-5" decimals="-3" id="f-996" unitRef="usd">202000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock contextRef="c-1" id="f-997">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of cash paid for income taxes (net of refunds received) was as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.438%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;State:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Arizona&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;California&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Texas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Other state jurisdictions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid (net of refunds received)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:IncomeTaxPaidFederalAfterRefundReceived contextRef="c-1" decimals="0" id="f-998" unitRef="usd">321000</us-gaap:IncomeTaxPaidFederalAfterRefundReceived>
    <us-gaap:IncomeTaxPaidFederalAfterRefundReceived contextRef="c-18" decimals="0" id="f-999" unitRef="usd">285510</us-gaap:IncomeTaxPaidFederalAfterRefundReceived>
    <us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived contextRef="c-179" decimals="0" id="f-1000" unitRef="usd">62000</us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived>
    <us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived contextRef="c-180" decimals="0" id="f-1001" unitRef="usd">0</us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived>
    <us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived contextRef="c-181" decimals="0" id="f-1002" unitRef="usd">168000</us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived>
    <us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived contextRef="c-182" decimals="0" id="f-1003" unitRef="usd">182000</us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived>
    <us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived contextRef="c-183" decimals="0" id="f-1004" unitRef="usd">62000</us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived>
    <us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived contextRef="c-184" decimals="0" id="f-1005" unitRef="usd">51026</us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived>
    <us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived contextRef="c-185" decimals="0" id="f-1006" unitRef="usd">13752</us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived>
    <us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived contextRef="c-186" decimals="0" id="f-1007" unitRef="usd">91956</us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-1" decimals="0" id="f-1008" unitRef="usd">626752</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-18" decimals="0" id="f-1009" unitRef="usd">610492</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-1010">Commitments and Contingencies &lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the components of lease expense and income statement location for the years ended December&#160;31, 2025 and 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.420%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.423%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Line Item in our Consolidated Income Statements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating lease costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental information and balance sheet location related to leases for the years ended December&#160;31, 2025 and 2024 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of -use asset&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,572,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;555,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability, current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,815,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,009,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;795,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining lease term (in years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases for the years ended December&#160;31, 2025 and 2024 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in measurement of liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash transactions: ROU assets obtained in exchange for lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,554,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of December&#160;31, 2025 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.789%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;479,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,421,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(411,993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,009,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(194,179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,815,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Guaranties in Connection with the Sale of the Divested Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the sale of company-owned or managed clinics, we guaranteed 39 future operating lease commitments assumed by the buyers. We are obligated to perform under the guaranties if the buyers fail to perform under the lease agreements at any time during the remainder of the term of the lease agreements, the latest of which expires on December&#160;31, 2033. As of December&#160;31, 2025, the undiscounted maximum remaining lease payments totaled $5.0 million. We have not recorded a liability with respect to our obligations under the guaranties as of December&#160;31, 2025, as we concluded that payment under the guaranties was not probable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, we are party to litigation and claims from time to time. We maintain insurance to cover certain litigation and claims, subject to policy limits. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2024, we entered into settlement agreements from litigation related to employment matters of $1.5&#160;million that was outside the normal course of business which we have accrued for in discontinued operations current liabilities as of December&#160;31, 2025. The settlement is expected to be paid out during the first quarter of 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, ongoing litigation related to a medical injury claim between a patient (&#x201c;the Claimant&#x201d;) and us filed on September 5, 2023 reached a settlement agreement on February 25, 2025. Per the terms of the settlement agreement, we and our insurance will pay the claimant $3.4 million. We accrued the settlement recorded in discontinued operations current liabilities for $3.4 million as of December&#160;31, 2024. The expense from the accrual was offset by a receivable recorded as discontinued operations current assets from our insurance providers for $1.9 million as of December&#160;31, 2024. The settlement was paid in full during the first quarter of 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2025, we determined that the likelihood of a loss related to multiple lawsuits, including three cases consolidated into one class action lawsuit (but not yet certified), six individual cases related to each other by the court and two unrelated individual cases, all filed against us and a chiropractor employed by the professional corporation providing clinical services in 2024, 2025 and 2026 in the State of California became probable. The initial lawsuit was filed against us on June 6, 2024 with the Superior Court of California in Los Angeles County. The lawsuits allege, among other claims, an invasion of privacy, negligence, emotional distress, sexual harassment, unlawful recording, failure to provide a safe environment and trespass on person at one of our company-owned or managed clinics. The lawsuits are currently in discovery and trial is scheduled to begin in early 2027. We intend to continue to defend these cases vigorously, but it is not possible at this time to reasonably estimate the outcome of or any potential liability from these cases and therefore, no accrual exists as of December&#160;31, 2025. We also note that our exposure to these cases may be limited by our insurance coverage, but the potential exposure is undetermined as of December&#160;31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2025, we incurred litigation expenses, including settlement costs related to employment matters that were outside the normal course of business, of $0.4&#160;million, included as Income (loss) from discontinued operations before income tax expense in our consolidated income statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2024, we incurred litigation expenses, including settlement costs related to employment matters that were outside the normal course of business and a medical injury claim, of $3.0&#160;million, included as Income (loss) from discontinued operations before income tax expense in our consolidated income statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-1011">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the components of lease expense and income statement location for the years ended December&#160;31, 2025 and 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.420%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.423%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Line Item in our Consolidated Income Statements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating lease costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="0" id="f-1012" unitRef="usd">355912</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-18" decimals="0" id="f-1013" unitRef="usd">325396</us-gaap:OperatingLeaseCost>
    <us-gaap:LeaseCost contextRef="c-1" decimals="0" id="f-1014" unitRef="usd">355912</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-18" decimals="0" id="f-1015" unitRef="usd">325396</us-gaap:LeaseCost>
    <jynt:AssetsAndLiabilitiesLesseeTableTextBlock contextRef="c-1" id="f-1016">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental information and balance sheet location related to leases for the years ended December&#160;31, 2025 and 2024 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of -use asset&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,572,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;555,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability, current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,815,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,009,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;795,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining lease term (in years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases for the years ended December&#160;31, 2025 and 2024 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in measurement of liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash transactions: ROU assets obtained in exchange for lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,554,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</jynt:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="0" id="f-1017" unitRef="usd">1572173</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-5" decimals="0" id="f-1018" unitRef="usd">555536</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="0" id="f-1019" unitRef="usd">194179</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-5" decimals="0" id="f-1020" unitRef="usd">483337</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="0" id="f-1021" unitRef="usd">1815527</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-5" decimals="0" id="f-1022" unitRef="usd">311689</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability contextRef="c-4" decimals="0" id="f-1023" unitRef="usd">2009706</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability contextRef="c-5" decimals="0" id="f-1024" unitRef="usd">795026</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-4" id="f-1025">P5Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-5" id="f-1026">P3Y7M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-4" decimals="3" id="f-1027" unitRef="number">0.065</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-5" decimals="3" id="f-1028" unitRef="number">0.065</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="0" id="f-1029" unitRef="usd">460056</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-18" decimals="0" id="f-1030" unitRef="usd">505577</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="0" id="f-1031" unitRef="usd">1554504</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-18" decimals="0" id="f-1032" unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-1033">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of December&#160;31, 2025 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.789%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;479,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,421,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(411,993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,009,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(194,179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,815,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-4" decimals="0" id="f-1034" unitRef="usd">268762</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-4" decimals="0" id="f-1035" unitRef="usd">467453</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-4" decimals="0" id="f-1036" unitRef="usd">479129</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-4" decimals="0" id="f-1037" unitRef="usd">491077</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="c-4" decimals="0" id="f-1038" unitRef="usd">503374</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-4" decimals="0" id="f-1039" unitRef="usd">211904</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-4" decimals="0" id="f-1040" unitRef="usd">2421699</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-4" decimals="0" id="f-1041" unitRef="usd">411993</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-4" decimals="0" id="f-1042" unitRef="usd">2009706</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="0" id="f-1043" unitRef="usd">194179</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="0" id="f-1044" unitRef="usd">1815527</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <jynt:NumberOfFutureOperatingLeasesCommitted contextRef="c-4" decimals="INF" id="f-1045" unitRef="lease">39</jynt:NumberOfFutureOperatingLeasesCommitted>
    <jynt:GuarantorObligationsRemainingExposureUndiscounted contextRef="c-4" decimals="0" id="f-1046" unitRef="usd">5000000.0</jynt:GuarantorObligationsRemainingExposureUndiscounted>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty contextRef="c-187" decimals="-5" id="f-1047" unitRef="usd">1500000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty contextRef="c-188" decimals="-5" id="f-1048" unitRef="usd">3400000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-189" decimals="-5" id="f-1049" unitRef="usd">3400000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="c-189" decimals="-5" id="f-1050" unitRef="usd">1900000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LitigationSettlementExpense contextRef="c-1" decimals="-5" id="f-1051" unitRef="usd">400000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense contextRef="c-18" decimals="-5" id="f-1052" unitRef="usd">3000000.0</us-gaap:LitigationSettlementExpense>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-1053">Segment Reporting&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An operating segment is defined as a component of an enterprise for which discrete financial information is available and is reviewed regularly by the Chief Operating Decision Maker (&#x201c;CODM&#x201d;) to evaluate performance and make operating decisions. We have identified the Chief Executive Officer as our CODM.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Historically, we had two operating business segments: (1) Corporate Clinics, and (2) Franchise Operations. The Corporate Clinics segment is comprised of the activities of the company-owned or managed clinics. In the fourth quarter of 2024, as part of our refranchising strategy, all but one of the company-owned or managed clinics in the Corporate Clinic segment met the criteria to be reported as discontinued operations as of December 31, 2024 (Refer to Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Divestitures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for financial information on the discontinued operating Corporate Clinics segment). Therefore, since December 31, 2024, we have had one reportable segment: Franchise Operations. As of December 31, 2025, all company-owned or managed clinics in the Corporate Clinic segment met the criteria to be reported as discontinued operations. In accordance with Accounting Standards Codification 205-20, Discontinued Operations, expenses that in prior periods were partially allocated to the Corporate Clinic segment that are not wholly related to the activity of the segment have been recast to be presented in continuing operations, which is now Franchise Operations. Additionally, any expenses previously identified as Corporate Unallocated have been allocated entirely to the Franchise Operations segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue primarily from customers by providing access to our franchise license, which represents symbolic intellectual property (See Note 2, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional details). The Franchise Operations segment is managed on a consolidated basis because all operations are located within a similar economic and regulatory environment, provide the same services and share the same business model and pricing strategies. As of December&#160;31, 2025, the franchise system consisted of 885 clinics in operation. The accounting policies for the franchise segment are the same as those described in Note 1, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nature of Operations and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The CODM uses the following metrics to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;assess performance and determine how to allocated resources; Net Income, Gross Profit, Operating Income, and Adjusted EBITDA. Net Income, Gross Profit, and Operating Income are reported on the consolidated income statements. Adjusted EBITDA is presented in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations, Non-GAAP Financial Measures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and is reconciled back to consolidated Net loss from continuing operations on the consolidated income statements. The measure of segment assets is reported on the balance sheet as total consolidated assets. The CODM uses these financial measures to evaluate income generated from segment assets (return on assets) in deciding whether to reinvest profits in the Franchise Segment or into other parts of the entity, such as new products or services, expanding into new geographic territories, acquisitions or reacquisitions, or stock buybacks. Net Income and Adjusted EBITDA are used to monitor budget verses actual results. The CODM also uses Net Income and Adjusted EBITDA in conjunction with certain non-financial metrics in competitive analysis by benchmarking to our competitors. The competitive analysis along with the monitoring of budgeted verses actual results are used in assessing performance of the segment and in establishing management&#x2019;s compensation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes total revenue and significant expense categories and amounts for our reportable segment that aligns with the segment level information that is regularly provided to the CODM:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,895,592&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,163,430&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Franchise and regional developer cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,500,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,063,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IT cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,724,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,453,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and marketing expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,299,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,973,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,256,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,359,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,297,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,679,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other segment items, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;871,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,644,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268,157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,614,344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reconciliation of loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268,157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,614,344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,175,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,182,549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,907,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,796,893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline"&gt;(a) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other segment items, net includes interest income, acquisition related expenses, net loss on disposition or impairment, costs related to restatement filings, and restructuring costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-190"
      decimals="INF"
      id="f-1054"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-1055"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfStores
      contextRef="c-52"
      decimals="INF"
      id="f-1056"
      unitRef="clinic">885</us-gaap:NumberOfStores>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-1057">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes total revenue and significant expense categories and amounts for our reportable segment that aligns with the segment level information that is regularly provided to the CODM:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,895,592&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,163,430&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Franchise and regional developer cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,500,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,063,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IT cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,724,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,453,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and marketing expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,299,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,973,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,256,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,359,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,297,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,679,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other segment items, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;871,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,644,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268,157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,614,344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reconciliation of loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268,157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,614,344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,175,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,182,549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,907,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,796,893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline"&gt;(a) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other segment items, net includes interest income, acquisition related expenses, net loss on disposition or impairment, costs related to restatement filings, and restructuring costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-191" decimals="0" id="f-1058" unitRef="usd">54895592</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-192" decimals="0" id="f-1059" unitRef="usd">52163430</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-193" decimals="0" id="f-1060" unitRef="usd">9500559</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-194" decimals="0" id="f-1061" unitRef="usd">10063644</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-195" decimals="0" id="f-1062" unitRef="usd">1724915</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-196" decimals="0" id="f-1063" unitRef="usd">1453204</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:SellingAndMarketingExpense contextRef="c-191" decimals="0" id="f-1064" unitRef="usd">13299399</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-192" decimals="0" id="f-1065" unitRef="usd">10973610</us-gaap:SellingAndMarketingExpense>
    <jynt:GeneralAndAdministrativeExpenseAdjusted contextRef="c-191" decimals="0" id="f-1066" unitRef="usd">27256923</jynt:GeneralAndAdministrativeExpenseAdjusted>
    <jynt:GeneralAndAdministrativeExpenseAdjusted contextRef="c-192" decimals="0" id="f-1067" unitRef="usd">27359643</jynt:GeneralAndAdministrativeExpenseAdjusted>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-191" decimals="0" id="f-1068" unitRef="usd">1297433</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-192" decimals="0" id="f-1069" unitRef="usd">1679005</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-191" decimals="0" id="f-1070" unitRef="usd">401706</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-192" decimals="0" id="f-1071" unitRef="usd">871673</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:DepreciationAndAmortization contextRef="c-191" decimals="0" id="f-1072" unitRef="usd">1644161</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-192" decimals="0" id="f-1073" unitRef="usd">1371389</us-gaap:DepreciationAndAmortization>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-191" decimals="0" id="f-1074" unitRef="usd">38653</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-192" decimals="0" id="f-1075" unitRef="usd">5606</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c-191" decimals="0" id="f-1076" unitRef="usd">-268157</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c-192" decimals="0" id="f-1077" unitRef="usd">-1614344</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c-191" decimals="0" id="f-1078" unitRef="usd">-268157</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c-192" decimals="0" id="f-1079" unitRef="usd">-1614344</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="c-191" decimals="0" id="f-1080" unitRef="usd">3175422</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="c-192" decimals="0" id="f-1081" unitRef="usd">-4182549</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss contextRef="c-191" decimals="0" id="f-1082" unitRef="usd">2907265</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-192" decimals="0" id="f-1083" unitRef="usd">-5796893</us-gaap:ProfitLoss>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c-1" id="f-1084">Related Party Transactions&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mr. Jefferson Gramm, Managing Partner of Bandera Partners LLC, who is a beneficial holder of more than 5% of our outstanding common stock (approximately 28% as of December&#160;31, 2025), was appointed to the Board of Directors effective as of January 2, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2020, we sold two franchise licenses at $40 thousand and $30 thousand each (which reflects the $10 thousand multi-unit discount for the second license per the Franchise Disclosure Document) to Marshall Gramm, who is a family member of Mr. Jefferson Gramm. In April 2020 and 2021, we sold two franchise licenses at $40 thousand and $30 thousand, respectively (which reflects the $10 thousand multi-unit discount for the second license per the Franchise Disclosure Document), to a franchisee of which Mr. Jefferson Gramm is a 50% co-partner in the business. In the fourth quarter of 2024, Mr. Jefferson Gramm divested his interest in the clinics to which he is a 50% co-partner in the business.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These transactions involved terms no less favorable to us than those that would have been obtained in the absence of such affiliation. Although we have no way of estimating the aggregate amount of franchise fees, royalties, advertising fund fees, IT &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;related income and computer software fees that these franchisees will pay over the life of the franchise licenses, the franchisees affiliated with Mr. Gramm are subject to such fees under the same terms and conditions as all other franchisees.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, Mr. Gramm loaned approximately $370 thousand to an unaffiliated franchisee that owns and operates one franchise clinic. The loan is not secured by the assets of the business and there are no foreclosure rights. As of December&#160;31, 2025, the remaining balance on the unsecured loan was approximately $196 thousand.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c-197"
      decimals="2"
      id="f-1085"
      unitRef="number">0.28</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:SignificantChangesFranchisesSold
      contextRef="c-198"
      decimals="INF"
      id="f-1086"
      unitRef="franchise">2</us-gaap:SignificantChangesFranchisesSold>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-199" decimals="-3" id="f-1087" unitRef="usd">40000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-200" decimals="-3" id="f-1088" unitRef="usd">30000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <jynt:RelatedPartyTransactionAmountsOfTransactionDiscount contextRef="c-199" decimals="-3" id="f-1089" unitRef="usd">10000</jynt:RelatedPartyTransactionAmountsOfTransactionDiscount>
    <us-gaap:SignificantChangesFranchisesSold
      contextRef="c-201"
      decimals="INF"
      id="f-1090"
      unitRef="franchise">2</us-gaap:SignificantChangesFranchisesSold>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-202" decimals="-3" id="f-1091" unitRef="usd">40000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-203" decimals="-3" id="f-1092" unitRef="usd">30000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <jynt:RelatedPartyTransactionAmountsOfTransactionDiscount contextRef="c-201" decimals="-3" id="f-1093" unitRef="usd">10000</jynt:RelatedPartyTransactionAmountsOfTransactionDiscount>
    <jynt:RelatedPartyTransactionCoPartnerPercentage
      contextRef="c-201"
      decimals="2"
      id="f-1094"
      unitRef="number">0.50</jynt:RelatedPartyTransactionCoPartnerPercentage>
    <jynt:RelatedPartyTransactionCoPartnerPercentageDivested
      contextRef="c-204"
      decimals="2"
      id="f-1095"
      unitRef="number">0.50</jynt:RelatedPartyTransactionCoPartnerPercentageDivested>
    <us-gaap:NotesReceivableNet contextRef="c-205" decimals="-3" id="f-1096" unitRef="usd">370000</us-gaap:NotesReceivableNet>
    <jynt:NumberOfClinics
      contextRef="c-206"
      decimals="INF"
      id="f-1097"
      unitRef="clinic">1</jynt:NumberOfClinics>
    <us-gaap:NotesReceivableNet contextRef="c-207" decimals="-3" id="f-1098" unitRef="usd">196000</us-gaap:NotesReceivableNet>
    <us-gaap:QuarterlyFinancialInformationTextBlock contextRef="c-1" id="f-1099">Quarterly Financial Data (Unaudited)&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selected quarterly financial data for the years ended December&#160;31, 2025 and 2024 is summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.068%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.393%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.232%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.393%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.232%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.393%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.232%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.393%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.232%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.393%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.232%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.393%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.232%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.393%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.232%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.393%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.232%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.393%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.232%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.407%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Q1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Q2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Q3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Q4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Q1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Q2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Q3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Q4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,077,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,270,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,380,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15,167,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;54,895,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,184,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,610,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,654,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14,714,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;52,163,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total costs of revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,972,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,772,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,661,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,819,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11,225,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,704,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,812,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,814,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,184,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11,516,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Selling and marketing expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,505,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,483,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,816,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,494,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,299,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,237,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,440,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,504,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,791,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,973,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;361,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;402,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;446,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;433,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,644,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;329,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;342,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;345,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;353,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,371,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,914,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,745,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,295,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,676,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;29,632,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,339,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,793,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,478,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,513,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;30,124,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,782,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11,631,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,558,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11,603,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;44,575,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,906,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11,576,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,328,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,658,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;42,469,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net loss on disposition or impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;61,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;66,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(Loss) income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(678,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,138,167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;160,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;742,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(913,376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(426,596)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,779,325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(492,820)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;809,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,889,025)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;185,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;159,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;139,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;198,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;683,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;80,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;83,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;79,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;280,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(Loss) income from continuing operations before income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(492,617)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(978,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;300,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;940,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(229,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(390,337)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,698,854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(408,992)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;889,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,608,738)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;38,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(19,536)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net (loss) income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(506,021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(989,635)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;290,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;937,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(268,157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(398,919)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,710,023)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(414,383)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;908,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,614,344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations before income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,577,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,183,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;664,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(224,068)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,200,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,516,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,719,222)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,693,562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,075,745)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,972,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income tax expense(benefit) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;103,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(278,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;25,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;170,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;167,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;57,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(184,429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;210,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,473,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,082,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;564,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,175,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,345,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,886,375)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,750,756)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(891,316)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4,182,549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;967,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;93,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;855,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;991,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,907,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;946,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,596,398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,165,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,796,893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net (loss) income from continuing operations per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.06)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.06)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net income (loss) from discontinued operations per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.06)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.06)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net income (loss) per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock contextRef="c-1" id="f-1100">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selected quarterly financial data for the years ended December&#160;31, 2025 and 2024 is summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.068%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.393%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.232%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.393%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.232%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.393%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.232%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.393%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.232%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.393%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.232%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.393%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.232%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.393%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.232%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.393%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.232%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.393%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.232%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.407%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Q1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Q2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Q3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Q4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Q1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Q2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Q3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Q4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,077,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,270,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,380,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15,167,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;54,895,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,184,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,610,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,654,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14,714,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;52,163,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total costs of revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,972,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,772,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,661,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,819,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11,225,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,704,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,812,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,814,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,184,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11,516,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Selling and marketing expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,505,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,483,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,816,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,494,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,299,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,237,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,440,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,504,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,791,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,973,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;361,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;402,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;446,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;433,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,644,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;329,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;342,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;345,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;353,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,371,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,914,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,745,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,295,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,676,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;29,632,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,339,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,793,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,478,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,513,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;30,124,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,782,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11,631,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,558,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11,603,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;44,575,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,906,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11,576,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,328,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,658,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;42,469,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net loss on disposition or impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;61,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;66,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(Loss) income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(678,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,138,167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;160,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;742,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(913,376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(426,596)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,779,325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(492,820)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;809,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,889,025)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;185,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;159,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;139,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;198,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;683,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;80,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;83,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;79,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;280,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(Loss) income from continuing operations before income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(492,617)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(978,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;300,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;940,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(229,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(390,337)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,698,854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(408,992)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;889,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,608,738)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;38,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(19,536)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net (loss) income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(506,021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(989,635)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;290,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;937,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(268,157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(398,919)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,710,023)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(414,383)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;908,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,614,344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations before income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,577,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,183,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;664,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(224,068)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,200,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,516,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,719,222)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,693,562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,075,745)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,972,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income tax expense(benefit) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;103,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;100,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(278,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;25,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;170,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;167,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;57,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(184,429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;210,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,473,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,082,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;564,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,175,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,345,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,886,375)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2,750,756)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(891,316)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4,182,549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;967,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;93,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;855,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;991,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,907,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;946,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,596,398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3,165,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5,796,893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net (loss) income from continuing operations per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.06)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.06)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net income (loss) from discontinued operations per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.06)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.06)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net income (loss) per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-208" decimals="0" id="f-1101" unitRef="usd">13077590</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-209" decimals="0" id="f-1102" unitRef="usd">13270270</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-210" decimals="0" id="f-1103" unitRef="usd">13380685</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-211" decimals="0" id="f-1104" unitRef="usd">15167047</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-1" decimals="0" id="f-1105" unitRef="usd">54895592</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-212" decimals="0" id="f-1106" unitRef="usd">12184716</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-213" decimals="0" id="f-1107" unitRef="usd">12610036</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-214" decimals="0" id="f-1108" unitRef="usd">12654396</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-215" decimals="0" id="f-1109" unitRef="usd">14714282</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c-18" decimals="0" id="f-1110" unitRef="usd">52163430</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:CostOfRevenue contextRef="c-208" decimals="0" id="f-1111" unitRef="usd">2972126</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-209" decimals="0" id="f-1112" unitRef="usd">2772607</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-210" decimals="0" id="f-1113" unitRef="usd">2661234</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-211" decimals="0" id="f-1114" unitRef="usd">2819507</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-1" decimals="0" id="f-1115" unitRef="usd">11225474</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-212" decimals="0" id="f-1116" unitRef="usd">2704512</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-213" decimals="0" id="f-1117" unitRef="usd">2812389</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-214" decimals="0" id="f-1118" unitRef="usd">2814963</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-215" decimals="0" id="f-1119" unitRef="usd">3184984</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-18" decimals="0" id="f-1120" unitRef="usd">11516848</us-gaap:CostOfRevenue>
    <us-gaap:SellingAndMarketingExpense contextRef="c-208" decimals="0" id="f-1121" unitRef="usd">3505150</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-209" decimals="0" id="f-1122" unitRef="usd">3483844</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-210" decimals="0" id="f-1123" unitRef="usd">2816081</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-211" decimals="0" id="f-1124" unitRef="usd">3494324</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-1" decimals="0" id="f-1125" unitRef="usd">13299399</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-212" decimals="0" id="f-1126" unitRef="usd">2237583</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-213" decimals="0" id="f-1127" unitRef="usd">3440391</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-214" decimals="0" id="f-1128" unitRef="usd">2504168</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-215" decimals="0" id="f-1129" unitRef="usd">2791468</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-18" decimals="0" id="f-1130" unitRef="usd">10973610</us-gaap:SellingAndMarketingExpense>
    <us-gaap:DepreciationAndAmortization contextRef="c-208" decimals="0" id="f-1131" unitRef="usd">361930</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-209" decimals="0" id="f-1132" unitRef="usd">402295</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-210" decimals="0" id="f-1133" unitRef="usd">446736</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-211" decimals="0" id="f-1134" unitRef="usd">433200</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-1" decimals="0" id="f-1135" unitRef="usd">1644161</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-212" decimals="0" id="f-1136" unitRef="usd">329634</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-213" decimals="0" id="f-1137" unitRef="usd">342454</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-214" decimals="0" id="f-1138" unitRef="usd">345835</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-215" decimals="0" id="f-1139" unitRef="usd">353466</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-18" decimals="0" id="f-1140" unitRef="usd">1371389</us-gaap:DepreciationAndAmortization>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-208" decimals="0" id="f-1141" unitRef="usd">6914945</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-209" decimals="0" id="f-1142" unitRef="usd">7745251</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-210" decimals="0" id="f-1143" unitRef="usd">7295719</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-211" decimals="0" id="f-1144" unitRef="usd">7676121</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="0" id="f-1145" unitRef="usd">29632036</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-212" decimals="0" id="f-1146" unitRef="usd">7339308</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-213" decimals="0" id="f-1147" unitRef="usd">7793465</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-214" decimals="0" id="f-1148" unitRef="usd">7478669</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-215" decimals="0" id="f-1149" unitRef="usd">7513147</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-18" decimals="0" id="f-1150" unitRef="usd">30124589</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-208" decimals="0" id="f-1151" unitRef="usd">10782025</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-209" decimals="0" id="f-1152" unitRef="usd">11631390</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-210" decimals="0" id="f-1153" unitRef="usd">10558536</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-211" decimals="0" id="f-1154" unitRef="usd">11603645</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="0" id="f-1155" unitRef="usd">44575596</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-212" decimals="0" id="f-1156" unitRef="usd">9906525</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-213" decimals="0" id="f-1157" unitRef="usd">11576310</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-214" decimals="0" id="f-1158" unitRef="usd">10328672</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-215" decimals="0" id="f-1159" unitRef="usd">10658081</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-18" decimals="0" id="f-1160" unitRef="usd">42469588</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="c-208" decimals="0" id="f-1161" unitRef="usd">-1973</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="c-209" decimals="0" id="f-1162" unitRef="usd">-4440</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="c-210" decimals="0" id="f-1163" unitRef="usd">0</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="c-211" decimals="0" id="f-1164" unitRef="usd">-1485</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="c-1" decimals="0" id="f-1165" unitRef="usd">-7898</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="c-212" decimals="0" id="f-1166" unitRef="usd">-275</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="c-213" decimals="0" id="f-1167" unitRef="usd">-662</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="c-214" decimals="0" id="f-1168" unitRef="usd">-3581</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="c-215" decimals="0" id="f-1169" unitRef="usd">-61501</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="c-18" decimals="0" id="f-1170" unitRef="usd">-66019</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:OperatingIncomeLoss contextRef="c-208" decimals="0" id="f-1171" unitRef="usd">-678534</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-209" decimals="0" id="f-1172" unitRef="usd">-1138167</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-210" decimals="0" id="f-1173" unitRef="usd">160915</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-211" decimals="0" id="f-1174" unitRef="usd">742410</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="0" id="f-1175" unitRef="usd">-913376</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-212" decimals="0" id="f-1176" unitRef="usd">-426596</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-213" decimals="0" id="f-1177" unitRef="usd">-1779325</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-214" decimals="0" id="f-1178" unitRef="usd">-492820</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-215" decimals="0" id="f-1179" unitRef="usd">809716</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-18" decimals="0" id="f-1180" unitRef="usd">-1889025</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-208" decimals="0" id="f-1181" unitRef="usd">185917</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-209" decimals="0" id="f-1182" unitRef="usd">159922</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-210" decimals="0" id="f-1183" unitRef="usd">139801</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-211" decimals="0" id="f-1184" unitRef="usd">198232</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="0" id="f-1185" unitRef="usd">683872</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-212" decimals="0" id="f-1186" unitRef="usd">36259</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-213" decimals="0" id="f-1187" unitRef="usd">80471</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-214" decimals="0" id="f-1188" unitRef="usd">83828</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-215" decimals="0" id="f-1189" unitRef="usd">79729</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-18" decimals="0" id="f-1190" unitRef="usd">280287</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-208" decimals="0" id="f-1191" unitRef="usd">-492617</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-209" decimals="0" id="f-1192" unitRef="usd">-978245</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-210" decimals="0" id="f-1193" unitRef="usd">300716</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-211" decimals="0" id="f-1194" unitRef="usd">940642</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="0" id="f-1195" unitRef="usd">-229504</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-212" decimals="0" id="f-1196" unitRef="usd">-390337</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-213" decimals="0" id="f-1197" unitRef="usd">-1698854</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-214" decimals="0" id="f-1198" unitRef="usd">-408992</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-215" decimals="0" id="f-1199" unitRef="usd">889445</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-18" decimals="0" id="f-1200" unitRef="usd">-1608738</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-208" decimals="0" id="f-1201" unitRef="usd">13404</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-209" decimals="0" id="f-1202" unitRef="usd">11390</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-210" decimals="0" id="f-1203" unitRef="usd">10346</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-211" decimals="0" id="f-1204" unitRef="usd">3513</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="0" id="f-1205" unitRef="usd">38653</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-212" decimals="0" id="f-1206" unitRef="usd">8582</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-213" decimals="0" id="f-1207" unitRef="usd">11169</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-214" decimals="0" id="f-1208" unitRef="usd">5391</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-215" decimals="0" id="f-1209" unitRef="usd">-19536</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-18" decimals="0" id="f-1210" unitRef="usd">5606</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c-208" decimals="0" id="f-1211" unitRef="usd">-506021</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c-209" decimals="0" id="f-1212" unitRef="usd">-989635</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c-210" decimals="0" id="f-1213" unitRef="usd">290370</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c-211" decimals="0" id="f-1214" unitRef="usd">937129</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c-1" decimals="0" id="f-1215" unitRef="usd">-268157</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c-212" decimals="0" id="f-1216" unitRef="usd">-398919</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c-213" decimals="0" id="f-1217" unitRef="usd">-1710023</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c-214" decimals="0" id="f-1218" unitRef="usd">-414383</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c-215" decimals="0" id="f-1219" unitRef="usd">908981</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c-18" decimals="0" id="f-1220" unitRef="usd">-1614344</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="c-208" decimals="0" id="f-1221" unitRef="usd">1577229</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="c-209" decimals="0" id="f-1222" unitRef="usd">1183199</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="c-210" decimals="0" id="f-1223" unitRef="usd">664269</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="c-211" decimals="0" id="f-1224" unitRef="usd">-224068</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="c-1" decimals="0" id="f-1225" unitRef="usd">3200629</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="c-212" decimals="0" id="f-1226" unitRef="usd">1516243</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="c-213" decimals="0" id="f-1227" unitRef="usd">-1719222</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="c-214" decimals="0" id="f-1228" unitRef="usd">-2693562</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="c-215" decimals="0" id="f-1229" unitRef="usd">-1075745</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="c-18" decimals="0" id="f-1230" unitRef="usd">-3972286</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation contextRef="c-208" decimals="0" id="f-1231" unitRef="usd">103412</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation contextRef="c-209" decimals="0" id="f-1232" unitRef="usd">100201</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation contextRef="c-210" decimals="0" id="f-1233" unitRef="usd">99630</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation contextRef="c-211" decimals="0" id="f-1234" unitRef="usd">-278036</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation contextRef="c-1" decimals="0" id="f-1235" unitRef="usd">25207</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation contextRef="c-212" decimals="0" id="f-1236" unitRef="usd">170345</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation contextRef="c-213" decimals="0" id="f-1237" unitRef="usd">167153</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation contextRef="c-214" decimals="0" id="f-1238" unitRef="usd">57194</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation contextRef="c-215" decimals="0" id="f-1239" unitRef="usd">-184429</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation contextRef="c-18" decimals="0" id="f-1240" unitRef="usd">210263</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="c-208" decimals="0" id="f-1241" unitRef="usd">1473817</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="c-209" decimals="0" id="f-1242" unitRef="usd">1082998</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="c-210" decimals="0" id="f-1243" unitRef="usd">564639</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="c-211" decimals="0" id="f-1244" unitRef="usd">53968</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="c-1" decimals="0" id="f-1245" unitRef="usd">3175422</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="c-212" decimals="0" id="f-1246" unitRef="usd">1345898</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="c-213" decimals="0" id="f-1247" unitRef="usd">-1886375</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="c-214" decimals="0" id="f-1248" unitRef="usd">-2750756</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="c-215" decimals="0" id="f-1249" unitRef="usd">-891316</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="c-18" decimals="0" id="f-1250" unitRef="usd">-4182549</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss contextRef="c-208" decimals="0" id="f-1251" unitRef="usd">967796</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-209" decimals="0" id="f-1252" unitRef="usd">93363</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-210" decimals="0" id="f-1253" unitRef="usd">855009</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-211" decimals="0" id="f-1254" unitRef="usd">991097</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="0" id="f-1255" unitRef="usd">2907265</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-212" decimals="0" id="f-1256" unitRef="usd">946979</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-213" decimals="0" id="f-1257" unitRef="usd">-3596398</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-214" decimals="0" id="f-1258" unitRef="usd">-3165139</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-215" decimals="0" id="f-1259" unitRef="usd">17665</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-18" decimals="0" id="f-1260" unitRef="usd">-5796893</us-gaap:ProfitLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="c-208"
      decimals="2"
      id="f-1261"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="c-209"
      decimals="2"
      id="f-1262"
      unitRef="usdPerShare">-0.06</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="c-210"
      decimals="2"
      id="f-1263"
      unitRef="usdPerShare">0.02</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="c-211"
      decimals="2"
      id="f-1264"
      unitRef="usdPerShare">0.06</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="c-1"
      decimals="2"
      id="f-1265"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="c-212"
      decimals="2"
      id="f-1266"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="c-213"
      decimals="2"
      id="f-1267"
      unitRef="usdPerShare">-0.11</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="c-214"
      decimals="2"
      id="f-1268"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="c-215"
      decimals="2"
      id="f-1269"
      unitRef="usdPerShare">0.06</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="c-18"
      decimals="2"
      id="f-1270"
      unitRef="usdPerShare">-0.11</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="c-208"
      decimals="2"
      id="f-1271"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="c-209"
      decimals="2"
      id="f-1272"
      unitRef="usdPerShare">-0.06</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="c-210"
      decimals="2"
      id="f-1273"
      unitRef="usdPerShare">0.02</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="c-211"
      decimals="2"
      id="f-1274"
      unitRef="usdPerShare">0.06</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="c-1"
      decimals="2"
      id="f-1275"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="c-212"
      decimals="2"
      id="f-1276"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="c-213"
      decimals="2"
      id="f-1277"
      unitRef="usdPerShare">-0.11</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="c-214"
      decimals="2"
      id="f-1278"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="c-215"
      decimals="2"
      id="f-1279"
      unitRef="usdPerShare">0.06</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="c-18"
      decimals="2"
      id="f-1280"
      unitRef="usdPerShare">-0.11</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="c-208"
      decimals="2"
      id="f-1281"
      unitRef="usdPerShare">0.09</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="c-209"
      decimals="2"
      id="f-1282"
      unitRef="usdPerShare">0.07</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="c-210"
      decimals="2"
      id="f-1283"
      unitRef="usdPerShare">0.04</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="c-211"
      decimals="2"
      id="f-1284"
      unitRef="usdPerShare">0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="c-1"
      decimals="2"
      id="f-1285"
      unitRef="usdPerShare">0.21</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="c-212"
      decimals="2"
      id="f-1286"
      unitRef="usdPerShare">0.09</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="c-213"
      decimals="2"
      id="f-1287"
      unitRef="usdPerShare">-0.13</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="c-214"
      decimals="2"
      id="f-1288"
      unitRef="usdPerShare">-0.18</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="c-215"
      decimals="2"
      id="f-1289"
      unitRef="usdPerShare">-0.06</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="c-18"
      decimals="2"
      id="f-1290"
      unitRef="usdPerShare">-0.28</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="c-208"
      decimals="2"
      id="f-1291"
      unitRef="usdPerShare">0.09</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="c-209"
      decimals="2"
      id="f-1292"
      unitRef="usdPerShare">0.07</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="c-210"
      decimals="2"
      id="f-1293"
      unitRef="usdPerShare">0.04</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="c-211"
      decimals="2"
      id="f-1294"
      unitRef="usdPerShare">0.01</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="c-1"
      decimals="2"
      id="f-1295"
      unitRef="usdPerShare">0.21</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="c-212"
      decimals="2"
      id="f-1296"
      unitRef="usdPerShare">0.09</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="c-213"
      decimals="2"
      id="f-1297"
      unitRef="usdPerShare">-0.12</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="c-214"
      decimals="2"
      id="f-1298"
      unitRef="usdPerShare">-0.18</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="c-215"
      decimals="2"
      id="f-1299"
      unitRef="usdPerShare">-0.06</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="c-18"
      decimals="2"
      id="f-1300"
      unitRef="usdPerShare">-0.28</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-208"
      decimals="2"
      id="f-1301"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-209"
      decimals="2"
      id="f-1302"
      unitRef="usdPerShare">0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-210"
      decimals="2"
      id="f-1303"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-211"
      decimals="2"
      id="f-1304"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-1305"
      unitRef="usdPerShare">0.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-212"
      decimals="2"
      id="f-1306"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-213"
      decimals="2"
      id="f-1307"
      unitRef="usdPerShare">-0.24</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-214"
      decimals="2"
      id="f-1308"
      unitRef="usdPerShare">-0.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-215"
      decimals="2"
      id="f-1309"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-18"
      decimals="2"
      id="f-1310"
      unitRef="usdPerShare">-0.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-208"
      decimals="2"
      id="f-1311"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-209"
      decimals="2"
      id="f-1312"
      unitRef="usdPerShare">0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-210"
      decimals="2"
      id="f-1313"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-211"
      decimals="2"
      id="f-1314"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-1315"
      unitRef="usdPerShare">0.19</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-212"
      decimals="2"
      id="f-1316"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-213"
      decimals="2"
      id="f-1317"
      unitRef="usdPerShare">-0.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-214"
      decimals="2"
      id="f-1318"
      unitRef="usdPerShare">-0.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-215"
      decimals="2"
      id="f-1319"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-18"
      decimals="2"
      id="f-1320"
      unitRef="usdPerShare">-0.38</us-gaap:EarningsPerShareDiluted>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-211" id="f-1321">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-211" id="f-1322">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-211" id="f-1323">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-211" id="f-1324">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c-1" id="f-1325">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
